Citrus Sinensis ID: 039107
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 817 | 2.2.26 [Sep-21-2011] | |||||||
| Q3E8W4 | 858 | Receptor-like protein kin | yes | no | 0.992 | 0.945 | 0.642 | 0.0 | |
| Q9SR05 | 850 | Receptor-like protein kin | no | no | 0.990 | 0.951 | 0.642 | 0.0 | |
| Q9SCZ4 | 895 | Receptor-like protein kin | no | no | 0.986 | 0.900 | 0.544 | 0.0 | |
| Q9LK35 | 855 | Receptor-like protein kin | no | no | 0.914 | 0.873 | 0.459 | 0.0 | |
| Q9FID8 | 873 | Putative receptor-like pr | no | no | 0.966 | 0.904 | 0.434 | 1e-180 | |
| Q9SA72 | 849 | Probable receptor-like pr | no | no | 0.902 | 0.868 | 0.453 | 1e-174 | |
| Q9FLJ8 | 842 | Probable receptor-like pr | no | no | 0.921 | 0.894 | 0.442 | 1e-173 | |
| Q9FID9 | 880 | Probable receptor-like pr | no | no | 0.971 | 0.902 | 0.422 | 1e-170 | |
| Q9LX66 | 830 | Receptor-like protein kin | no | no | 0.880 | 0.866 | 0.418 | 1e-167 | |
| Q9SJT0 | 871 | Probable receptor-like pr | no | no | 0.892 | 0.836 | 0.433 | 1e-162 |
| >sp|Q3E8W4|ANX2_ARATH Receptor-like protein kinase ANXUR2 OS=Arabidopsis thaliana GN=ANX2 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 1098 bits (2839), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 534/831 (64%), Positives = 648/831 (77%), Gaps = 20/831 (2%)
Query: 1 CGSKDGGIDADGRSWEPDDKYLSKGESKPTRATYQDSSLVSKVPYMDARVFKQEMSYELP 60
CG+ + +D D + WEPD K+L + ATYQD SL+S VPYM +R+F +YE+P
Sbjct: 34 CGASEPAVDQDKKKWEPDTKFLKTPNTVHAPATYQDPSLLSTVPYMTSRIFTAPATYEIP 93
Query: 61 IRSQSRYWVRFHFYPSTYPELNVANSYFSVVANDVTLLSNFSASITAQAVAQAYLIKEFS 120
++ R+ +R HFYPSTY LN+ +SYFSV AND+TLLSNFSA+IT QA+ QAYL++E+S
Sbjct: 94 VKGDKRHMLRLHFYPSTYTGLNILDSYFSVAANDLTLLSNFSAAITCQALTQAYLVREYS 153
Query: 121 LAPMDSDILKIIFRPSDKHSGTFAFINGIELVPSPDLFEQAIIVGLG-ETIDGMTANMQT 179
LAP + D+L IIF PSDKH FAFINGIE++P P+LF+ A +VG +T D TAN+QT
Sbjct: 154 LAPSEKDVLSIIFTPSDKHPKAFAFINGIEVIPMPELFDTASLVGFSDQTSDTKTANLQT 213
Query: 180 MFRLNVAGQYISPKNDSGGLMRSWQNDEPYLFGAGYGIPMKA-DEVQIDYKSLPDYSAPP 238
MFRLNV GQ I DSGGL R+W ND PY+F AG G+ ++A + +IDY+ +P +AP
Sbjct: 214 MFRLNVGGQDIPGSQDSGGLTRTWYNDAPYIFSAGLGVTLQASNNFRIDYQKMPVSTAPA 273
Query: 239 DVYMTARYMGVDAHTNMEFNLTWIFRVDANFTYYVRLHFCEFKPDINKINQRVFNIYINN 298
DVY TAR G + NM+ NLTW+F+VD NFTY +RLHFCEF+ + KINQ+VFNI+INN
Sbjct: 274 DVYKTARSQGPNGDINMKSNLTWMFQVDTNFTYIMRLHFCEFQ--LAKINQKVFNIFINN 331
Query: 299 QTAQAD---ADVIAWTHGQGVPIYKDYAVYVEDLPGD--DQIFVAMSPSLKYQPEYLDAL 353
+TAQ D AD++ WT G+G+P YKDYA+YV+ G ++I + M+PS QPEY D+
Sbjct: 332 RTAQGDTNPADILGWTGGKGIPTYKDYAIYVDANTGGGGEEISLQMTPSTFGQPEYYDSQ 391
Query: 354 LNGLEIFKIETAKNLAGPNPEPSALPAKSEGNSTKGFTNKSKSNIHVIGGAAGGAAAFGL 413
LNGLEIFKI+T KNLAGPNP+PS P ++ + K F + VIG A G AA L
Sbjct: 392 LNGLEIFKIDTMKNLAGPNPKPS--PMQANEDVKKDFQGDKRITAFVIGSAGGVAAV--L 447
Query: 414 VAALCFVVYQRKQRIPGTESHTSSWLPIYGHSQTTQSKSTISGKSNASSHLSAIAQGLCR 473
ALCF +YQRK++ G++SHTSSWLPIYG+S T+ +KSTISGKSN SHLS +A GLCR
Sbjct: 448 FCALCFTMYQRKRKFSGSDSHTSSWLPIYGNSHTSATKSTISGKSNNGSHLSNLAAGLCR 507
Query: 474 RFSLAEIKHATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIE 533
RFSL+EIKH T +FDES VIGVGGFGKVYKGVI+ KVAIK+SNP+SEQG+NEF TEIE
Sbjct: 508 RFSLSEIKHGTHNFDESNVIGVGGFGKVYKGVIDGGTKVAIKKSNPNSEQGLNEFETEIE 567
Query: 534 MLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKK-ALSWKQRLEICIGAA 592
+LS+LRHKHLVSLIG+C+EG EMCL+YDYM+LGTLREH+YNTK+ L+WK+RLEI IGAA
Sbjct: 568 LLSRLRHKHLVSLIGYCDEGGEMCLIYDYMSLGTLREHLYNTKRPQLTWKRRLEIAIGAA 627
Query: 593 RGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFG 652
RGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNM GHV+TVVKGSFG
Sbjct: 628 RGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMNGGHVTTVVKGSFG 687
Query: 653 YLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILD 712
YLDPEYF+RQQLTEKSD+YSFGVVLFEVLCARPALNPSL KEQVSL DWA++CKRKG L+
Sbjct: 688 YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNPSLSKEQVSLGDWAMNCKRKGTLE 747
Query: 713 DIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVESTEASSNR 772
DIIDP LK KI+PECLKKFADTAEKCLSDSG+DRP+MGDVLWNLEF LQL E+ + S +R
Sbjct: 748 DIIDPNLKGKINPECLKKFADTAEKCLSDSGLDRPTMGDVLWNLEFALQLQETADGSRHR 807
Query: 773 SRGSSIDGAEDDNAR-----NCSIG-SDHGSNESSDQDSAIFSQMVNPTGR 817
+ + + N S G SD G + SS+++S IFSQ+VNP GR
Sbjct: 808 TPSNGGGSVDLGGGGGGVTVNISAGESDLGDDLSSEENSGIFSQIVNPKGR 858
|
Receptor-like protein kinase that controls pollen tube behavior by directing rupture at proper timing to release the sperm cell. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SR05|ANX1_ARATH Receptor-like protein kinase ANXUR1 OS=Arabidopsis thaliana GN=ANX1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 1092 bits (2825), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 531/826 (64%), Positives = 650/826 (78%), Gaps = 17/826 (2%)
Query: 1 CGSKDGGIDADGRSWEPDDKYLSKGESKPTRATYQDSSLVSKVPYMDARVFKQEMSYELP 60
CG+ + D D + WEPD K+L G S ATYQD SL+S VPYM AR+F +YE+P
Sbjct: 33 CGTSEASADQDKKKWEPDTKFLKTGNSIHATATYQDPSLLSTVPYMTARIFTAPATYEIP 92
Query: 61 IRSQSRYWVRFHFYPSTYPELNVANSYFSVVANDVTLLSNFSASITAQAVAQAYLIKEFS 120
I+ R+ +R +FYPSTY LN++NSYF+V ANDVTLLSNFSA+IT QA+ QAYL+KE+S
Sbjct: 93 IKGDKRHLLRLYFYPSTYTGLNISNSYFTVEANDVTLLSNFSAAITCQALTQAYLVKEYS 152
Query: 121 LAPMDSDILKIIFRPSDKHSGTFAFINGIELVPSPDLFEQAIIVGL-GETIDGMTANMQT 179
LAP D D+L I F PSDK+ FAFINGIE++ P+LF+ A +VG +T+D TAN+Q+
Sbjct: 153 LAPTDKDVLSIKFTPSDKYRDAFAFINGIEVIQMPELFDTAALVGFTDQTMDAKTANLQS 212
Query: 180 MFRLNVAGQYISPKNDSGGLMRSWQNDEPYLFGAGYGIPMKA-DEVQIDYKSLPDYSAPP 238
MFRLNV GQ I DSGGL R+W ND PY+F AG G+ ++A + +I+Y+++P AP
Sbjct: 213 MFRLNVGGQDIPGSQDSGGLTRTWYNDAPYIFSAGLGVTLQASNNFRINYQNMPVSIAPA 272
Query: 239 DVYMTARYMGVDAHTNMEFNLTWIFRVDANFTYYVRLHFCEFKPDINKINQRVFNIYINN 298
D+Y TAR G + N++ NLTW+F++D NFTY +RLHFCEF+ ++KINQ+VFNIYINN
Sbjct: 273 DIYKTARSQGPNGDINLKSNLTWMFQIDKNFTYILRLHFCEFQ--LSKINQKVFNIYINN 330
Query: 299 QTAQAD---ADVIAWTHGQGVPIYKDYAVYVEDLPGDDQIFVAMSPSLKYQPEYLDALLN 355
+TAQAD AD+I WT +G+P+YKDYA+YV+ G ++I + M+PS QPEY D+ LN
Sbjct: 331 RTAQADTTPADIIGWTGEKGIPMYKDYAIYVDANNGGEEITLQMTPSTFGQPEYYDSSLN 390
Query: 356 GLEIFKIETAKNLAGPNPEPSALPAKSEGNSTKGFTNKSKSNIHVIGGAAGGAAAFGLVA 415
GLEIFK++T KNLAGPNPEPS P ++E K F N+ K + +IG A G A L+
Sbjct: 391 GLEIFKMDTMKNLAGPNPEPS--PMQAEEEVKKEFKNE-KRHAFIIGSAGGVLAV--LIG 445
Query: 416 ALCFVVYQRKQRIPGTESHTSSWLPIYGHSQTTQSKSTISGKSNASSHLSAIAQGLCRRF 475
ALCF Y++KQ G +SHTSSWLPIYG+S T+ +KSTISGKSN SHLS +A GLCRRF
Sbjct: 446 ALCFTAYKKKQGYQGGDSHTSSWLPIYGNSTTSGTKSTISGKSNNGSHLSNLAAGLCRRF 505
Query: 476 SLAEIKHATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEML 535
SL EIKH T++FD+S VIGVGGFGKVYKGVI+ KVA+K+SNP+SEQG+NEF TEIE+L
Sbjct: 506 SLPEIKHGTQNFDDSNVIGVGGFGKVYKGVIDGTTKVAVKKSNPNSEQGLNEFETEIELL 565
Query: 536 SKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKK-ALSWKQRLEICIGAARG 594
S+LRHKHLVSLIG+C+EG EMCLVYDYMA GTLREH+YNTKK L+WK+RLEI IGAARG
Sbjct: 566 SRLRHKHLVSLIGYCDEGGEMCLVYDYMAFGTLREHLYNTKKPQLTWKRRLEIAIGAARG 625
Query: 595 LHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYL 654
LHYLHTGAKYTIIHRDVKTTNIL+DENWVAKVSDFGLSKTGPNM GHV+TVVKGSFGYL
Sbjct: 626 LHYLHTGAKYTIIHRDVKTTNILVDENWVAKVSDFGLSKTGPNMNGGHVTTVVKGSFGYL 685
Query: 655 DPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDI 714
DPEYF+RQQLTEKSD+YSFGVVLFE+LCARPALNPSLPKEQVSL DWA++CKRKG L+DI
Sbjct: 686 DPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPSLPKEQVSLGDWAMNCKRKGNLEDI 745
Query: 715 IDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVESTEASSNRS- 773
IDP LK KI+ ECLKKFADTAEKCL+DSG++RP+MGDVLWNLEF LQL E+ + + +R+
Sbjct: 746 IDPNLKGKINAECLKKFADTAEKCLNDSGLERPTMGDVLWNLEFALQLQETADGTRHRTP 805
Query: 774 --RGSSIDGAEDDNARNCSIGSDHGSNESSDQDSAIFSQMVNPTGR 817
GSS D A N + G D S+ SS+ ++ IFSQ+VNP GR
Sbjct: 806 NNGGSSEDLGRGGMAVNVA-GRDDVSDLSSEDNTEIFSQIVNPKGR 850
|
Receptor-like protein kinase that controls pollen tube behavior by directing rupture at proper timing to release the sperm cell. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SCZ4|FERON_ARATH Receptor-like protein kinase FERONIA OS=Arabidopsis thaliana GN=FER PE=1 SV=1 | Back alignment and function description |
|---|
Score = 844 bits (2181), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 472/867 (54%), Positives = 578/867 (66%), Gaps = 61/867 (7%)
Query: 1 CGSKDGGI-DADGRSWEPD--DKYLSKGESKPTR--ATYQDSSLVSKVPYMDARVFKQEM 55
CG + D D R W D K+LS A QD S V +VPYM ARVF+
Sbjct: 40 CGGGASNLTDTDNRIWISDVKSKFLSSSSEDSKTSPALTQDPS-VPEVPYMTARVFRSPF 98
Query: 56 SYELPIRSQSRYWVRFHFYPSTYPELNVANSYFSVVANDVTLLSNFSASITAQAVAQAYL 115
+Y P+ S R +VR +FYP++Y LN NS FSV TLL NFSAS TA+A+ A++
Sbjct: 99 TYTFPVAS-GRKFVRLYFYPNSYDGLNATNSLFSVSFGPYTLLKNFSASQTAEALTYAFI 157
Query: 116 IKEFSLAPMDSDILKIIFRPSDKHSGTFAFINGIELVPSPDLFEQA----IIVGLGE--T 169
IKEF + ++ L + F P S +AF+NGIE+ PD++ +VG T
Sbjct: 158 IKEF-VVNVEGGTLNMTFTPESAPSNAYAFVNGIEVTSMPDMYSSTDGTLTMVGSSGSVT 216
Query: 170 IDGMTANMQTMFRLNVAGQYISPKNDSGGLMRSWQNDEPYLFGAGYGIPMKAD-EVQIDY 228
ID TA ++ ++RLNV G ISP D+G L RSW +D+PY+FGAG GIP AD + I Y
Sbjct: 217 IDNSTA-LENVYRLNVGGNDISPSADTG-LYRSWYDDQPYIFGAGLGIPETADPNMTIKY 274
Query: 229 KS-LPDYSAPPDVYMTARYMGVDAHTNMEFNLTWIFRVDANFTYYVRLHFCEFKPDINKI 287
+ P Y AP DVY TAR MG A N+ +NLTWIF +D+ FTY VRLHFCE +I KI
Sbjct: 275 PTGTPTYVAPVDVYSTARSMGPTAQINLNYNLTWIFSIDSGFTYLVRLHFCEVSSNITKI 334
Query: 288 NQRVFNIYINNQTAQADADVIAWTHGQGVPIYKDYAVYVEDLPGDDQIFVAMSPSLKYQP 347
NQRVF IY+NNQTA+ +ADVIAWT GVP +KDY V + G +++A+ P+ +P
Sbjct: 335 NQRVFTIYLNNQTAEPEADVIAWTSSNGVPFHKDYVVNPPEGNGQQDLWLALHPNPVNKP 394
Query: 348 EYLDALLNGLEIFKIETAK-NLAGPNPEPSALPAKSEGNSTKGFTNKSKSNIHVIGGAAG 406
EY D+LLNG+EIFK+ T+ NLAG NP P + T KSKSN +I GAA
Sbjct: 395 EYYDSLLNGVEIFKMNTSDGNLAGTNPIPGPQVTADPSKVLRPTTRKSKSNTAIIAGAAS 454
Query: 407 GAAAFGLVAALC-FVVYQRKQR---IPGTESHTSSWLPI--YGHSQTTQSKSTISGKSNA 460
GA L+ C F Y+R++R P +++ TS WLP+ YG+S + S T +
Sbjct: 455 GAVVLALIIGFCVFGAYRRRKRGDYQPASDA-TSGWLPLSLYGNSHSAGSAKT----NTT 509
Query: 461 SSHLSAIAQGLCRRFSLAEIKHATKSFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNP 519
S+ S++ LCR FS AEIK ATK+FDES V+GVGGFGKVY+G I+ KVAIKR NP
Sbjct: 510 GSYASSLPSNLCRHFSFAEIKAATKNFDESRVLGVGGFGKVYRGEIDGGTTKVAIKRGNP 569
Query: 520 SSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKK-A 578
SEQGV+EF TEIEMLSKLRH+HLVSLIG+CEE EM LVYDYMA GT+REH+Y T+ +
Sbjct: 570 MSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAHGTMREHLYKTQNPS 629
Query: 579 LSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNM 638
L WKQRLEICIGAARGLHYLHTGAK+TIIHRDVKTTNILLDE WVAKVSDFGLSKTGP +
Sbjct: 630 LPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTL 689
Query: 639 ENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSL 698
++ HVSTVVKGSFGYLDPEYF+RQQLTEKSD+YSFGVVLFE LCARPALNP+L KEQVSL
Sbjct: 690 DHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEALCARPALNPTLAKEQVSL 749
Query: 699 ADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758
A+WA +C +KG+LD I+DP LK KI+PEC KKFA+TA KC+ D GI+RPSMGDVLWNLEF
Sbjct: 750 AEWAPYCYKKGMLDQIVDPYLKGKITPECFKKFAETAMKCVLDQGIERPSMGDVLWNLEF 809
Query: 759 VLQLVESTEASSNRSRGS-SIDGAEDDNARNC-------------------------SIG 792
LQL ES E + G +D + D+ NC SIG
Sbjct: 810 ALQLQESAEENGKGVCGDMDMDEIKYDDG-NCKGKNDKSSDVYEGNVTDSRSSGIDMSIG 868
Query: 793 SDHGSNESSD--QDSAIFSQMVNPTGR 817
++E SD SA+FSQ++NP GR
Sbjct: 869 GRSLASEDSDGLTPSAVFSQIMNPKGR 895
|
Receptor-like protein kinase that mediates the female control of male gamete delivery during fertilization, including growth cessation of compatible pollen tubes ensuring a reproductive isolation barriers. Required for cell elongation during vegetative growth, mostly in a brassinosteroids- (BR-) independent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK35|THE1_ARATH Receptor-like protein kinase THESEUS 1 OS=Arabidopsis thaliana GN=THE1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 640 bits (1651), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 368/801 (45%), Positives = 490/801 (61%), Gaps = 54/801 (6%)
Query: 45 YMDARVFKQEMSYELPIRSQSRYWVRFHFYPSTYPELNVANSYFSVVANDVTLLSNFSAS 104
Y ARVF SY I S R+W+R HF P N+ ++ +VV D LL +
Sbjct: 81 YQTARVFSSLASYRFKITSLGRHWIRLHFSPINNSTWNLTSASITVVTEDFVLL----NN 136
Query: 105 ITAQAVAQAYLIKEFSLAPMDSDILKIIFRPSDKHSGTFAFINGIELVPSPD--LFEQAI 162
+ +Y+ KE+++ + S+ L + F PS+ + F+N IE+V PD + +QA+
Sbjct: 137 FSFNNFNGSYIFKEYTVN-VTSEFLTLSFIPSNN---SVVFVNAIEVVSVPDNLIPDQAL 192
Query: 163 IVGLGETIDGMTA-NMQTMFRLNVAGQYISPKNDSGGLMRSWQNDEPYLFGAGYGIPMKA 221
+ G++ +T++RLN+ G ++ +ND+ G R W ND YL + + A
Sbjct: 193 ALNPSTPFSGLSLLAFETVYRLNMGGPLLTSQNDTLG--RQWDNDAEYLHVNSSVLVVTA 250
Query: 222 DEVQIDYK-SLPDYSAPPDVYMTARYMGVDAHTNMEFNLTWIFRVDANFTYYVRLHFCEF 280
+ I Y S+ +AP VY TA MG + FN+TW+ VD +F Y+VR+HFC+
Sbjct: 251 NPSSIKYSPSVTQETAPNMVYATADTMGDANVASPSFNVTWVLPVDPDFRYFVRVHFCDI 310
Query: 281 KPDINKINQRVFNIYINNQTAQADADVIAWTHGQGVPIYKDYAVYVEDLPGDDQIFVAMS 340
+N VFN+Y+N+ A D+ T+G VP +KD+ + + + V++
Sbjct: 311 VSQ--ALNTLVFNLYVNDDLALGSLDLSTLTNGLKVPYFKDF-ISNGSVESSGVLTVSVG 367
Query: 341 PSLKYQPEYLDALLNGLEIFKIET-AKNLAGPNPEPSALPAKSEGNSTKGFTNKSKSNIH 399
P Q + +A +NGLE+ KI AK+L+G + S LP S S K
Sbjct: 368 P--DSQADITNATMNGLEVLKISNEAKSLSGVSSVKSLLPGGSGSKSKKKAV-------- 417
Query: 400 VIGGAAGGAAAFGLVAALCF--VVYQRKQRIP----GTESHTSSWLPIYGHSQTTQSKST 453
+IG G L+A C+ +V RKQR G H LP+YG SQT +KST
Sbjct: 418 IIGSLVGAVTLILLIAVCCYCCLVASRKQRSTSPQEGGNGHPWLPLPLYGLSQTL-TKST 476
Query: 454 ISGKSNASSHLSAIAQGLCRRFSLAEIKHATKSFDESYVIGVGGFGKVYKGVIEDKLKVA 513
S KS +S +S + L R F EI AT FDES ++GVGGFG+VYKG +ED KVA
Sbjct: 477 ASHKSATASCISLASTHLGRCFMFQEIMDATNKFDESSLLGVGGFGRVYKGTLEDGTKVA 536
Query: 514 IKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIY 573
+KR NP SEQG+ EF TEIEMLSKLRH+HLVSLIG+C+E +EM LVY+YMA G LR H+Y
Sbjct: 537 VKRGNPRSEQGMAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLY 596
Query: 574 NTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLS 632
LSWKQRLEICIGAARGLHYLHTGA +IIHRDVKTTNILLDEN VAKV+DFGLS
Sbjct: 597 GADLPPLSWKQRLEICIGAARGLHYLHTGASQSIIHRDVKTTNILLDENLVAKVADFGLS 656
Query: 633 KTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLP 692
KTGP+++ HVST VKGSFGYLDPEYF+RQQLTEKSD+YSFGVVL EVLC RPALNP LP
Sbjct: 657 KTGPSLDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCCRPALNPVLP 716
Query: 693 KEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDV 752
+EQV++A+WA+ ++KG+LD I+D L K++P LKKF +TAEKCL++ G+DRPSMGDV
Sbjct: 717 REQVNIAEWAMAWQKKGLLDQIMDSNLTGKVNPASLKKFGETAEKCLAEYGVDRPSMGDV 776
Query: 753 LWNLEFVLQLVESTEA-------SSNRSRGSSIDGAE---------DDNARNCSIGSDHG 796
LWNLE+ LQL E++ A S+N G + E D N G+D
Sbjct: 777 LWNLEYALQLEETSSALMEPDDNSTNHIPGIPMAPMEPFDNSMSIIDRGGVNSGTGTDDD 836
Query: 797 SNESSDQDSAIFSQMVNPTGR 817
+ +++ SA+FSQ+V+P GR
Sbjct: 837 AEDAT--TSAVFSQLVHPRGR 855
|
Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner. Mediates the response of growing plant cells to the perturbation of cellulose synthesis and may act as a cell-wall-integrity sensor. Controls ectopic-lignin accumulation in cellulose-deficient mutant backgrounds. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FID8|Y5900_ARATH Putative receptor-like protein kinase At5g39000 OS=Arabidopsis thaliana GN=At5g39000 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 631 bits (1628), Expect = e-180, Method: Compositional matrix adjust.
Identities = 376/865 (43%), Positives = 508/865 (58%), Gaps = 75/865 (8%)
Query: 1 CGSKDGGIDADGRSWEPDD-KYLSKG---ESKPTRATYQDSSLVSKVPYMDARVFKQEMS 56
CG +D GR+W ++ K LS S +A+YQ+S VS++PYM AR+F+ E +
Sbjct: 36 CGDTSNNVDVSGRNWTAENQKILSSNLVNASFTAQASYQESG-VSQIPYMTARIFRSEFT 94
Query: 57 YELPIRSQSRYWVRFHFYPSTY-PELNVANSYFSVVANDVTLLSNFSASITAQAVA--QA 113
Y P+ S + +R +FYP+ Y + N S+FSV N TLL+NFSA +T +A
Sbjct: 95 YSFPVTPGSNF-LRLYFYPTRYGSQFNAVKSFFSVKVNGFTLLNNFSADLTVKASKPQTE 153
Query: 114 YLIKEFSLAPMDSDILKIIFRPSDKHSGTFAFINGIELVPSPDLFEQA-----IIVGLGE 168
++IKEF + + L + F PS + AF+NGIE+V P+ F +I +G
Sbjct: 154 FIIKEFIIPVYQT--LNLTFTPS---LDSLAFVNGIEIVSIPNRFYSKGGFDDVITNVGS 208
Query: 169 TIDGMTAN---MQTMFRLNVAGQYISPKNDSGGLMRSWQNDEPYLFGAGYGIPMKADEVQ 225
++D N +T++RLNV G+ + G+ R W +D+ + GI +++
Sbjct: 209 SVDFHIENSTAFETVYRLNVGGKTVG----DSGMFRRWVSDDEIILSESSGISPIVPDIK 264
Query: 226 IDY-KSLPDYSAPPDVYMTARYMGVDAH--TNMEFNLTWIFRVDANFTYYVRLHFCEFKP 282
I+Y + P Y AP DVY T+R MG H N+ FNLTW+F VDA F+Y VRLHFCE
Sbjct: 265 INYTEKTPSYVAPDDVYATSRSMGNADHPEQNLNFNLTWLFTVDAGFSYLVRLHFCETLS 324
Query: 283 DINKINQRVFNIYINNQTAQADADVIAWTHGQGVPIYKDYAVYVEDLPGDDQ-IFVAMSP 341
++NK QRVF+I+I NQTA + DV + G +P+Y DY V G + + + P
Sbjct: 325 EVNKEGQRVFSIFIENQTATLEMDVFRMSGGSWIPMYLDYTVIAGSGSGRRHDLRLDLHP 384
Query: 342 SLKYQPEYLDALLNGLEIFKI-ETAKNLAGPNPEPSALPAKSEGNSTKGFTNKSKSNIHV 400
+ P+Y DA+LNG+EI K+ + NLAGPNP+P P +T K+KS+I
Sbjct: 385 LVSINPKYYDAILNGVEILKMNDPDGNLAGPNPDPLVSPDLIPNRATPRI-RKNKSHILP 443
Query: 401 IGGAAGGAAAFGLVAALCFVV---YQRKQRIPGTESHTSSWLPIYGHSQTTQSKSTISGK 457
I A G+ LV FVV K++ S SSW P+ + +T +K
Sbjct: 444 ITLAVVGS----LVVLAMFVVGVLVIMKKKKKSKPSTNSSWCPLPHGTDSTNTKPA---- 495
Query: 458 SNASSHLSAIAQGLCRRFSLAEIKHATKSFDESYVIGVGGFGKVYKGVIEDKLK-VAIKR 516
++ LCRRFS+ EIK AT F++ +IGVGGFG VYKG I+ VA+KR
Sbjct: 496 -------KSLPADLCRRFSIFEIKSATNDFEDKLIIGVGGFGSVYKGQIDGGATLVAVKR 548
Query: 517 SNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTK 576
+S QG EF TE+EMLSKLRH HLVSLIG+C+E NEM LVY+YM GTL++H++
Sbjct: 549 LEITSNQGAKEFETELEMLSKLRHVHLVSLIGYCDEDNEMVLVYEYMPHGTLKDHLFRRD 608
Query: 577 KA----LSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLS 632
K LSWK+RLEICIGAARGL YLHTGAKYTIIHRD+KTTNILLDEN+V KVSDFGLS
Sbjct: 609 KTSDPPLSWKRRLEICIGAARGLQYLHTGAKYTIIHRDIKTTNILLDENFVTKVSDFGLS 668
Query: 633 KTGP-NMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSL 691
+ GP + HVSTVVKG+FGYLDPEY++RQ LTEKSD+YSFGVVL EVLC RP S+
Sbjct: 669 RVGPTSASQTHVSTVVKGTFGYLDPEYYRRQVLTEKSDVYSFGVVLLEVLCCRPIRMQSV 728
Query: 692 PKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGD 751
P EQ L W R+G +D IID L I+ L+KF + A +C+ D G++RP M D
Sbjct: 729 PPEQADLIRWVKSNYRRGTVDQIIDSDLSADITSTSLEKFCEIAVRCVQDRGMERPPMND 788
Query: 752 VLWNLEFVLQL----------VESTEASSNRSRGSSIDGAEDDNARNCS-IGSDHGSNES 800
V+W LEF LQL VES + + G++ DG +D +R +G +++S
Sbjct: 789 VVWALEFALQLHETAKKKNDNVESLDLMPSGEVGTTTDGEDDLFSRTTGHVGKSTTTDDS 848
Query: 801 ----SDQDS----AIFSQMVNPTGR 817
D+ S +FS++ P R
Sbjct: 849 VLVVGDERSGSSWGVFSEINEPKAR 873
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SA72|Y1357_ARATH Probable receptor-like protein kinase At1g30570 OS=Arabidopsis thaliana GN=At1g30570 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 612 bits (1577), Expect = e-174, Method: Compositional matrix adjust.
Identities = 359/791 (45%), Positives = 481/791 (60%), Gaps = 54/791 (6%)
Query: 1 CGSKDGGIDADGRSW----EPDDKYLSKGESKPTRATYQDSSLVSKVPYMDARVFKQEMS 56
CGS + + DGR+W P+ +G T +T + SS+ +++ Y ARVF ++
Sbjct: 37 CGS-NATTEVDGRTWVGDLSPNKSVTLQGFDAITASTSKGSSVYAEI-YKTARVFDAVLN 94
Query: 57 YELPIRSQSRYWVRFHFYPSTYPELNVANSYFSVVANDVTLL-----------SNFSASI 105
Y +Q Y+VR HF P NV S FSV A+ + L+ N
Sbjct: 95 YTFEGITQGNYFVRLHFSPFAIENHNVNESSFSVFADGLRLMLDINIAGEIAHKNLILES 154
Query: 106 TAQAVAQAYLIKEFSLAPMDSDILKIIFRPSDKHSGTFAFINGIELVPSPD-LFEQAII- 163
T + L+KEF L P L + F P G+F F+N IE+V D LF++++
Sbjct: 155 TGHNATASSLVKEF-LLPTGPGKLVLSFIP---EKGSFGFVNAIEIVSVDDKLFKESVTK 210
Query: 164 VGLGETIDGMTAN-MQTMFRLNVAGQYISPKNDSGGLMRSWQNDEPYLFGAGYGIPMKAD 222
VG E G+ ++TM+RLNV G + P D L R+W+ D Y+ G+ +K +
Sbjct: 211 VGGSEVELGLGGRGIETMYRLNVGGPKLGPSKDLK-LYRTWETDLSYMVIENAGVEVK-N 268
Query: 223 EVQIDYKSLPDYS--APPDVYMTARYMGVDAHTNMEFNLTWIFRVDANFTYYVRLHFCEF 280
I Y +L D S AP VY TAR M FN++W F VD NF Y VRLHFCE
Sbjct: 269 SSNITY-ALADDSPVAPLLVYETARMMSNTEVLEKRFNISWKFEVDPNFDYLVRLHFCEL 327
Query: 281 KPDINKINQRVFNIYINNQTAQADADVIAWTHGQGVPIYKDYAVYVEDLPGDDQIFVAMS 340
D K NQR+F IYINNQTA + D+ A G+ IY+DY V +D +++ +
Sbjct: 328 LVD--KQNQRIFRIYINNQTAAGNFDIFAHAGGKNKGIYQDYLDPVSS--KNDVLWIQLG 383
Query: 341 PSLKYQPEYLDALLNGLEIFKIETAKNLAGPNPEPSALPAKSEGNSTKGFTNKSKSNIHV 400
P DALL+GLEIFK+ NLA + S G+S S S + +
Sbjct: 384 PDSSVGASG-DALLSGLEIFKLSKNGNLA------HLIRFDSTGHSV------SDSKMRI 430
Query: 401 IGGAAGGAAA---FGLVAALCFVVYQRKQRIPGTESHTS--SWLPIYGHSQTTQSKSTIS 455
I + G A F + + V +K+R ES + W P++ H + + + +
Sbjct: 431 IWISVGAGIAIIIFFVFLGILVVCLCKKRRSKSDESKNNPPGWRPLFLHVNNSTANAKAT 490
Query: 456 GKSNASSHLSAIAQGLCRRFSLAEIKHATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIK 515
G S + L+A G R+F+LAEI+ ATK+FD+ IGVGGFGKVY+G +ED +AIK
Sbjct: 491 GGSLRLNTLAASTMG--RKFTLAEIRAATKNFDDGLAIGVGGFGKVYRGELEDGTLIAIK 548
Query: 516 RSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNT 575
R+ P S+QG+ EF TEI MLS+LRH+HLVSLIGFC+E NEM LVY+YMA GTLR H++ +
Sbjct: 549 RATPHSQQGLAEFETEIVMLSRLRHRHLVSLIGFCDEHNEMILVYEYMANGTLRSHLFGS 608
Query: 576 K-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634
LSWKQRLE CIG+ARGLHYLHTG++ IIHRDVKTTNILLDEN+VAK+SDFGLSK
Sbjct: 609 NLPPLSWKQRLEACIGSARGLHYLHTGSERGIIHRDVKTTNILLDENFVAKMSDFGLSKA 668
Query: 635 GPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKE 694
GP+M++ HVST VKGSFGYLDPEYF+RQQLTEKSD+YSFGVVLFE +CAR +NP+LPK+
Sbjct: 669 GPSMDHTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEAVCARAVINPTLPKD 728
Query: 695 QVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLW 754
Q++LA+WAL +++ L+ IID L+ SPE L+K+ + AEKCL+D G +RP MG+VLW
Sbjct: 729 QINLAEWALSWQKQRNLESIIDSNLRGNYSPESLEKYGEIAEKCLADEGKNRPMMGEVLW 788
Query: 755 NLEFVLQLVES 765
+LE+VLQ+ E+
Sbjct: 789 SLEYVLQIHEA 799
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FLJ8|Y5613_ARATH Probable receptor-like protein kinase At5g61350 OS=Arabidopsis thaliana GN=At5g61350 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 608 bits (1567), Expect = e-173, Method: Compositional matrix adjust.
Identities = 366/827 (44%), Positives = 494/827 (59%), Gaps = 74/827 (8%)
Query: 1 CGSKDGGIDADGRSWEPDDKYLSKGESKPTRATYQDS-----SLVSKVP-YMDARVFKQE 54
CGS D +DGR+++ D + ++ ++ T DS S S +P Y+ AR+F +
Sbjct: 38 CGSSDETKLSDGRNFKSDQQSVAFLQTDEDIKTSVDSIPITDSNASTLPLYLTARIFAGK 97
Query: 55 MSYELPIRSQSRYWVRFHFYPSTYPELNVANSYFSVVANDVTLLSNFSASITAQAVAQAY 114
+Y I R+W+R HFYP +P N+ NS FSV + LL +FSA T+ V + Y
Sbjct: 98 STYSFYISRPGRHWIRLHFYPLNHPLYNLTNSVFSVTTDTTVLLHDFSAGDTSSIVFKEY 157
Query: 115 LIKEFSLAPMDSDILKIIFRPSDKHSGTFAFINGIELVPSPDLF--EQAIIVGLGETIDG 172
LI ++ L + F+P H G+ AFIN +E+V PD + A V G
Sbjct: 158 LIYA-------AEKLSLYFKP---HKGSTAFINAVEIVSVPDELVPDSASSVPQAPDFKG 207
Query: 173 MTA-NMQTMFRLNVAGQYISPKNDSGGLMRSWQNDEPYLFGAGYGIPMKADEVQIDYKSL 231
+++ +++ + R+N+ G ISPK D L R+W +D+PY P + V +D ++
Sbjct: 208 LSSFSLEILHRINIGGDLISPKIDP--LSRTWLSDKPY-----NTFPEGSRNVTVDPSTI 260
Query: 232 --PD-----YSAPPDVYMTARYMGVDAHTNM-EFNLTWIFRVDANFTYYVRLHFCEFKPD 283
PD AP VY TA M DA T+ FNL+W VD Y++RLHFC+
Sbjct: 261 TYPDGGATALIAPNPVYATAEEMA-DAQTSQPNFNLSWRMSVDFGHDYFIRLHFCDIVS- 318
Query: 284 INKINQRVFNIYINNQTAQADADVIAWTHGQGVPIYKDYAVYVEDLPGDDQIFVAMSPSL 343
+N +FN++IN +A + D+ + T G Y D+ + + + I V + P+
Sbjct: 319 -KSLNDLIFNVFINKLSAISALDLSSLTSALGTAYYADFVLNASTIT-NGSILVQVGPTP 376
Query: 344 KYQPEYLDALLNGLEIFKIETAKNLAGPNPEPSALPAKSEGNSTKGFTNKSKSNIHVIGG 403
Q +A+LNGLEI K+ N AG + K +G G ++K K I IG
Sbjct: 377 NLQSGKPNAILNGLEIMKL---NNAAGSLDGLFGVDGKYKG-PIGGMSSK-KLAIAGIGF 431
Query: 404 AAGGAAAFGLVAALCFVVYQRKQRIPGTESHTSSWL-PIYG-HSQTTQSK--------ST 453
A G+V L V +QR+ + ++ SSWL P++ HS SK S
Sbjct: 432 VMALTAFLGVVVLL--VRWQRRPKDWQKQNSFSSWLLPLHASHSSYISSKGGSTSRRMSI 489
Query: 454 ISGKSNASSHLSAI--AQGLCRRFSLAEIKHATKSFDESYVIGVGGFGKVYKGVIEDKLK 511
K + S+ S+ QGL R F E++ AT++FDE+ V GVGGFGKVY G I+ +
Sbjct: 490 FGSKKSKSNGFSSFFSNQGLGRYFPFTELQTATQNFDENAVCGVGGFGKVYIGEIDGGTQ 549
Query: 512 VAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREH 571
VAIKR + SSEQG+NEF TEI+MLSKLRH+HLVSLIGFC+E EM LVY+YM+ G LR+H
Sbjct: 550 VAIKRGSQSSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDENKEMILVYEYMSNGPLRDH 609
Query: 572 IYNTKK-------ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVA 624
+Y +K+ LSWKQRLEICIG+ARGLHYLHTGA IIHRDVKTTNILLDEN VA
Sbjct: 610 LYGSKENDPNPIPTLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVA 669
Query: 625 KVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCAR 684
KVSDFGLSK P M+ GHVST VKGSFGYLDPEYF+RQQLT+KSD+YSFGVVLFEVLCAR
Sbjct: 670 KVSDFGLSKDAP-MDEGHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 728
Query: 685 PALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGI 744
P +NP LP+EQV+LA++A++ RKG+L+ IIDP + IS L+KF + AEKCL++ G+
Sbjct: 729 PVINPQLPREQVNLAEYAMNLHRKGMLEKIIDPKIVGTISKGSLRKFVEAAEKCLAEYGV 788
Query: 745 DRPSMGDVLWNLEFVLQLVESTEASSNRSRGSSIDGAEDDNARNCSI 791
DRP MGDVLWNLE+ LQL E++ + +D +ED N +
Sbjct: 789 DRPGMGDVLWNLEYALQLQEAS---------AQVDLSEDKTTMNIEM 826
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FID9|Y5389_ARATH Probable receptor-like protein kinase At5g38990 OS=Arabidopsis thaliana GN=At5g38990 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 598 bits (1542), Expect = e-170, Method: Compositional matrix adjust.
Identities = 368/871 (42%), Positives = 501/871 (57%), Gaps = 77/871 (8%)
Query: 1 CGSKDGGIDADGRSWEPDD-KYLSKGE----SKPTRATYQDSSLVSKVPYMDARVFKQEM 55
CG +D GR+W ++ K++S S + A+YQ+S + +VPY+ AR+F+ +
Sbjct: 33 CGDTSNNMDYSGRNWTTENPKFMSSNAVDDASFTSSASYQESG-IPQVPYLKARIFRYDF 91
Query: 56 SYELPIRSQSRYWVRFHFYPSTY-PELNVANSYFSVVANDVTLLSNFSASITAQAVAQAY 114
+Y P+ S ++R +FYP+ Y + + S+FSV N TLL NFS + A +
Sbjct: 92 TYSFPV-SPGWKFLRLYFYPTRYGSDFDAVKSFFSVNVNRFTLLHNFS--VKASIPESSS 148
Query: 115 LIKEFSLAPMDSDILKIIFRPSDKHSGTFAFINGIELVPSPDLFEQA-----IIVGLGET 169
LIKEF + P++ L + F PS + AF+NGIE++ PD F ++ +G
Sbjct: 149 LIKEF-IVPVNQ-TLDLTFTPS---PNSLAFVNGIEIISMPDRFYSKGGFDDVVRNVGRD 203
Query: 170 IDGMTAN---MQTMFRLNVAGQYISPKNDSGGLMRSWQNDEPYLFGAGYGIPMKADEVQI 226
+D N +T++R+NV G+ + DSG + R W +DE +L G G V+I
Sbjct: 204 VDFEIDNSTAFETVYRVNVGGKVVGDVGDSG-MFRRWLSDEGFLLGINSGAIPNITGVKI 262
Query: 227 DYK-SLPDYSAPPDVYMTARYMGV--DAHTNMEFNLTWIFRVDANFTYYVRLHFCEFKPD 283
+Y P Y AP DVY T R MG N+ FNLTW+F VDA F Y VRLHFCE +P+
Sbjct: 263 NYTDKTPAYVAPEDVYTTCRLMGNKDSPELNLNFNLTWLFEVDAGFAYIVRLHFCETQPE 322
Query: 284 INKINQRVFNIYINNQTAQADADVIAWTHGQGVPIYKDYAVYVEDLPGDDQ---IFVAMS 340
+NK RVF+I+ Q A + DV + G +P+Y D+ V V D G Q + V ++
Sbjct: 323 VNKTGDRVFSIFFGYQLAMREMDVFRLSGGFRLPMYLDFKVLV-DADGTSQRPSLRVDLT 381
Query: 341 PSLKYQPEYLDALLNGLEIFKIETAK-NLAGPNPEPSALPAKSEGNSTKGFTNKSKSNIH 399
P + P Y DA+L+G+EI K+ + NLAG NP P P KG KS +
Sbjct: 382 PYKEDYPTYYDAILSGVEILKLSNSDGNLAGLNPIPQLSPPPQSITPLKG-KGKSSHVLP 440
Query: 400 VIGGAAGGAAAFGLVAALCFVVYQRKQR--------IPGTESHTSSWLPIYGHSQTTQSK 451
+I G A A + +V ++++ S SSW P+ + +T +K
Sbjct: 441 IIIAVVGSAVALAFFVLVVVLVVMKRKKKSNESSVDTTNKPSTNSSWGPLLHGTGSTNTK 500
Query: 452 STISGKSNASSHLSAIAQGLCRRFSLAEIKHATKSFDESYVIGVGGFGKVYKGVIEDKLK 511
S S++ LCRRFS+ EIK AT F+E +IGVGGFG VYKG I+
Sbjct: 501 SA-----------SSLPSDLCRRFSIYEIKSATNDFEEKLIIGVGGFGSVYKGRIDGGAT 549
Query: 512 -VAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLRE 570
VA+KR +S QG EF TE+EMLSKLRH HLVSLIG+C++ NEM LVY+YM GTL++
Sbjct: 550 LVAVKRLEITSNQGAKEFDTELEMLSKLRHVHLVSLIGYCDDDNEMVLVYEYMPHGTLKD 609
Query: 571 HIYNTKKA----LSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKV 626
H++ KA LSWK+RLEICIGAARGL YLHTGAKYTIIHRD+KTTNILLDEN+VAKV
Sbjct: 610 HLFRRDKASDPPLSWKRRLEICIGAARGLQYLHTGAKYTIIHRDIKTTNILLDENFVAKV 669
Query: 627 SDFGLSKTGP-NMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
SDFGLS+ GP + HVSTVVKG+FGYLDPEY++RQ LTEKSD+YSFGVVL EVLC RP
Sbjct: 670 SDFGLSRVGPTSASQTHVSTVVKGTFGYLDPEYYRRQILTEKSDVYSFGVVLLEVLCCRP 729
Query: 686 ALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGID 745
S+P EQ L W K +D IID L I+ ++KF + A +C+ D G++
Sbjct: 730 IRMQSVPPEQADLIRWVKSNFNKRTVDQIIDSDLTADITSTSMEKFCEIAIRCVQDRGME 789
Query: 746 RPSMGDVLWNLEFVLQL----------VESTEASSNRSRGSSIDGAEDDNARNCS-IGSD 794
RP M DV+W LEF LQL VES + + G++ DG +D +R +G
Sbjct: 790 RPPMNDVVWALEFALQLHETAKKKNDNVESLDLMPSGEVGTTTDGEDDLFSRTTGHVGKS 849
Query: 795 HGSNES----SDQDS----AIFSQMVNPTGR 817
+++S D+ S +FS++ P R
Sbjct: 850 TTTDDSVLVVGDERSGSSWGVFSEINEPKAR 880
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LX66|HERK_ARATH Receptor-like protein kinase HERK 1 OS=Arabidopsis thaliana GN=HERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 589 bits (1518), Expect = e-167, Method: Compositional matrix adjust.
Identities = 338/808 (41%), Positives = 476/808 (58%), Gaps = 89/808 (11%)
Query: 45 YMDARVFKQEMSYELPIRSQSRYWVRFHFYPSTYPELNVANSYFSVVANDVTLLSNFSAS 104
Y ARVF + SY+ + ++ R+WVR +F P Y + ++ F+V + LLS+F+
Sbjct: 77 YHTARVFTEVSSYKFSV-TRGRHWVRLYFNPFDYQNFKMGSAKFAVSSQSHVLLSDFT-- 133
Query: 105 ITAQAVAQAYLIKEFSLAPMDSDILKIIFRPSDKHSGTFAFINGIELVPSPDLFEQAIIV 164
V + ++KE+SL +D++ + F PS SG+FAF+N IE++ PD +I
Sbjct: 134 -----VTSSKVVKEYSLNVTTNDLV-LTFTPS---SGSFAFVNAIEVISIPD----TLIT 180
Query: 165 GLGETI-------DGMTANMQTMFRLNVAGQYISPKNDSGGLMRSWQNDEPYLFGAGYGI 217
G + D ++T+ R+N+ G ++ ND+ L R+W D +L
Sbjct: 181 GSPRFVGNPAQFPDMSMQGLETIHRVNMGGPLVASNNDT--LTRTWVPDSEFLLEKNLAK 238
Query: 218 PM-KADEVQIDYKSLPDYSAPPDVYMTARYMGVDAHTNMEFNLTWIFRVDANFTYYVRLH 276
M K V + SAP VY + M + N FN+TW F VD F YY R H
Sbjct: 239 SMSKFSTVNFVPGYATEDSAPRTVYGSCTEMNSADNPNSIFNVTWEFDVDPGFQYYFRFH 298
Query: 277 FCEFKPDINKINQRVFNIYINNQTAQADADVIAWTHGQGVPIYKDYAVYVEDLP-GDDQI 335
FC+ +NQ FN+Y+++ A D D+ Y +V P G +++
Sbjct: 299 FCDIVSL--SLNQLYFNLYVDSMVAATDIDLSTLVDNTLAGAYS--MDFVTQTPKGSNKV 354
Query: 336 FVAMSPSLKYQPEYLDALLNGLEIFKIETAKNLAGPNPEPSALPAKSEGNSTKGFTNKSK 395
V++ PS + +Y +A++NGLEI K+ +K S G G ++ SK
Sbjct: 355 RVSIGPSTVHT-DYPNAIVNGLEIMKMNNSKG------------QLSTGTFVPGSSSSSK 401
Query: 396 SNIHVIGGAAGGAAAFGLVAALCFVVYQRKQRIPGTESHTSSWLPIYGHSQTTQSKSTIS 455
SN+ +I G+A G+ + CFV+Y++++R G + H+ +W+P + + +++
Sbjct: 402 SNLGLIVGSAIGSLLAVVFLGSCFVLYKKRKR--GQDGHSKTWMPF------SINGTSMG 453
Query: 456 GKSNASSHLSAIAQGLCRRFSLAEIKHATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIK 515
K + + L++I R A +K AT +FDES IGVGGFGKVYKG + D KVA+K
Sbjct: 454 SKYSNGTTLTSITTNANYRIPFAAVKDATNNFDESRNIGVGGFGKVYKGELNDGTKVAVK 513
Query: 516 RSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNT 575
R NP S+QG+ EF TEIEMLS+ RH+HLVSLIG+C+E NEM L+Y+YM GT++ H+Y +
Sbjct: 514 RGNPKSQQGLAEFRTEIEMLSQFRHRHLVSLIGYCDENNEMILIYEYMENGTVKSHLYGS 573
Query: 576 K-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634
+L+WKQRLEICIGAARGLHYLHTG +IHRDVK+ NILLDEN++AKV+DFGLSKT
Sbjct: 574 GLPSLTWKQRLEICIGAARGLHYLHTGDSKPVIHRDVKSANILLDENFMAKVADFGLSKT 633
Query: 635 GPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKE 694
GP ++ HVST VKGSFGYLDPEYF+RQQLT+KSD+YSFGVVLFEVLCARP ++P+LP+E
Sbjct: 634 GPELDQTHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARPVIDPTLPRE 693
Query: 695 QVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLW 754
V+LA+WA+ ++KG LD IID L+ I P+ L+KFA+T EKCL+D G+DRPSMGDVLW
Sbjct: 694 MVNLAEWAMKWQKKGQLDQIIDQSLRGNIRPDSLRKFAETGEKCLADYGVDRPSMGDVLW 753
Query: 755 NLEFVLQLVESTEASSNRSRGSSIDGAEDDNARN------------------CSIGSDHG 796
NLE+ LQL E+ IDG +DN+ N ++ G
Sbjct: 754 NLEYALQLQEAV-----------IDGEPEDNSTNMIGELPPQINNFSQGDTSVNVPGTAG 802
Query: 797 SNESSDQD-------SAIFSQMVNPTGR 817
E S D S +FSQ+V GR
Sbjct: 803 RFEESSIDDLSGVSMSKVFSQLVKSEGR 830
|
Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SJT0|Y2214_ARATH Probable receptor-like protein kinase At2g21480 OS=Arabidopsis thaliana GN=At2g21480 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 572 bits (1474), Expect = e-162, Method: Compositional matrix adjust.
Identities = 338/779 (43%), Positives = 461/779 (59%), Gaps = 50/779 (6%)
Query: 1 CGSKDGGIDADGRSWEPDDKYLSKGESKP-TRATYQDSSLVSKVPYMDARVFKQEMSYEL 59
CGSK +GR ++ D + + E+K + + S + Y+ A++F++E Y+
Sbjct: 61 CGSKSSTKTPEGRVFKSDSETVQYIEAKDDIQVSAPPSDKLPSPIYLTAKIFREEAIYKF 120
Query: 60 PIRSQSRYWVRFHFYPSTYPELNVANSYFSVVANDVTLLSNFSASITAQAVAQAYLIKEF 119
+ +WVR HF+ + ++ + FSV+ LL NF S +QA + KE+
Sbjct: 121 HLTRPGWHWVRLHFFAFPNDKFDLQQATFSVLTEKYVLLHNFKLS-NDNNDSQATVQKEY 179
Query: 120 SLAPMDSDILKIIFRPSDKHSGTFAFINGIELVPSPDLFEQAIIVGLGET---IDGMTA- 175
L D+ + F+P G+ AFINGIELV +PD +I G + ++G +
Sbjct: 180 LLNMTDAQ-FALRFKP---MKGSAAFINGIELVSAPD----ELISDAGTSLFPVNGFSGL 231
Query: 176 ---NMQTMFRLNVAGQYISPKNDSGGLMRSWQNDEPYLFGAGYGIPMKADEVQIDYK-SL 231
Q+++R+NV G I+P+ND+ G R+W D+ YL +K + I Y +
Sbjct: 232 SDYAYQSVYRVNVGGPLITPQNDTLG--RTWTPDKEYLKDENLAKDVKTNPTAIIYPPGV 289
Query: 232 PDYSAPPDVYMTARYMGVDAHTNMEFNLTWIFRVDANFTYYVRLHFCEFKPDINK-INQR 290
AP VY T M + FN+TW F + +F Y++RLHFC+ I+K +N
Sbjct: 290 TPLIAPQTVYATGAEMADSQTIDPNFNVTWNFPSNPSFHYFIRLHFCDI---ISKSLNDL 346
Query: 291 VFNIYINNQTAQADADVIAWTHGQGVPIYKDYAVYVEDLPGDDQIFVAMSPSLKYQPEYL 350
FN+YIN +TA + D+ P YKD V + + Q+ + +
Sbjct: 347 YFNVYINGKTAISGLDLSTVAGDLSAPYYKDIVVNSTLMTSELQVQIG---PMGEDTGKK 403
Query: 351 DALLNGLEIFKIETAKNLAGPNPEPSALPAKSEGNSTKGFTNKSKSNIHVIGGAAGGAAA 410
+A+LNG+E+ K+ + N +L + + + K + AG
Sbjct: 404 NAILNGVEVLKMSNSVN---------SLDGEFGVDGQRASMGKQG-----MVATAGFVMM 449
Query: 411 FGLVAALCFVVYQRKQRIPGTESHTS--SWL-PIYGHSQTTQSKSTISGKSNASSHLSAI 467
FG L +VY+ K+R + S SWL PI+ T + T S KSN L
Sbjct: 450 FGAFVGLGAMVYKWKKRPQDWQKRNSFSSWLLPIHAGDSTFMTSKTGSHKSN----LYNS 505
Query: 468 AQGLCRRFSLAEIKHATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNE 527
A GL R FSL+E++ TK+FD S +IGVGGFG VY G I+D +VAIKR NP SEQG+ E
Sbjct: 506 ALGLGRYFSLSELQEVTKNFDASEIIGVGGFGNVYIGTIDDGTQVAIKRGNPQSEQGITE 565
Query: 528 FVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTK-KALSWKQRLE 586
F TEI+MLSKLRH+HLVSLIG+C+E EM LVY+YM+ G R+H+Y L+WKQRLE
Sbjct: 566 FHTEIQMLSKLRHRHLVSLIGYCDENAEMILVYEYMSNGPFRDHLYGKNLSPLTWKQRLE 625
Query: 587 ICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTV 646
ICIGAARGLHYLHTG IIHRDVK+TNILLDE VAKV+DFGLSK +N HVST
Sbjct: 626 ICIGAARGLHYLHTGTAQGIIHRDVKSTNILLDEALVAKVADFGLSKDVAFGQN-HVSTA 684
Query: 647 VKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCK 706
VKGSFGYLDPEYF+RQQLT+KSD+YSFGVVL E LCARPA+NP LP+EQV+LA+WA+ K
Sbjct: 685 VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLLEALCARPAINPQLPREQVNLAEWAMLWK 744
Query: 707 RKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVES 765
+KG+L+ IIDP L ++PE +KKFA+ AEKCL+D G+DRP+MGDVLWNLE+ LQL E+
Sbjct: 745 QKGLLEKIIDPHLVGAVNPESMKKFAEAAEKCLADYGVDRPTMGDVLWNLEYALQLQEA 803
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 817 | ||||||
| 225437596 | 857 | PREDICTED: receptor-like protein kinase | 0.993 | 0.947 | 0.661 | 0.0 | |
| 15241880 | 858 | receptor-like protein kinase ANXUR2 [Ara | 0.992 | 0.945 | 0.642 | 0.0 | |
| 297813101 | 857 | kinase family protein [Arabidopsis lyrat | 0.992 | 0.946 | 0.639 | 0.0 | |
| 15229329 | 850 | receptor-like protein kinase ANXUR1 [Ara | 0.990 | 0.951 | 0.642 | 0.0 | |
| 297833154 | 850 | kinase family protein [Arabidopsis lyrat | 0.990 | 0.951 | 0.642 | 0.0 | |
| 224123448 | 861 | predicted protein [Populus trichocarpa] | 0.990 | 0.939 | 0.643 | 0.0 | |
| 224131230 | 870 | predicted protein [Populus trichocarpa] | 0.987 | 0.927 | 0.641 | 0.0 | |
| 255580913 | 842 | ATP binding protein, putative [Ricinus c | 0.965 | 0.937 | 0.674 | 0.0 | |
| 359477216 | 857 | PREDICTED: receptor-like protein kinase | 0.979 | 0.933 | 0.626 | 0.0 | |
| 255556384 | 854 | ATP binding protein, putative [Ricinus c | 0.992 | 0.949 | 0.629 | 0.0 |
| >gi|225437596|ref|XP_002271113.1| PREDICTED: receptor-like protein kinase ANXUR1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1098 bits (2840), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 548/829 (66%), Positives = 653/829 (78%), Gaps = 17/829 (2%)
Query: 1 CGSKDGGIDADGRSWEPDDKYLSKGESKPTRATYQDSSLVSKVPYMDARVFKQEMSYELP 60
CGS GG DADGR W D YL ES A QD SL S VPYM AR+F E SY+
Sbjct: 34 CGSASGGTDADGRKWVSDSAYLVSDESISATAQSQDPSLPSPVPYMSARIFSAESSYKFS 93
Query: 61 IRSQSRYWVRFHFYPSTYPELNVANSYFSVVANDVTLLSNFSASITAQAVAQAYLIKEFS 120
+++ RYW+R HFYPSTY L+ A++YFS VA VTL++NFSASITAQA+ QAY+++E+S
Sbjct: 94 VKTNQRYWLRLHFYPSTYSSLDPADAYFSAVAGGVTLMTNFSASITAQALTQAYIVREYS 153
Query: 121 LAPMDSDILKIIFRPSDKHSGTFAFINGIELVPSPDLFEQAIIVGLG-ETIDGMTANMQT 179
LAPMD +IL + F+PSD+H G++AF+NGIELVP PDLF++A +VG +++D TAN+QT
Sbjct: 154 LAPMDFEILNVTFKPSDQHKGSYAFVNGIELVPIPDLFDKASMVGFSDQSLDVGTANVQT 213
Query: 180 MFRLNVAGQYISPKNDSGGLMRSWQNDEPYLFGAGYGIPMKA-DEVQIDYKSLPDYSAPP 238
MFRLNV GQYI NDSG L R+W +D PYL+GA +G+ +A D+++I Y+ + DY AP
Sbjct: 214 MFRLNVGGQYIPASNDSG-LTRTWYDDSPYLYGAAFGVTSEASDKLKIQYQGMEDYVAPV 272
Query: 239 DVYMTARYMGVDAHTNMEFNLTWIFRVDANFTYYVRLHFCEFKPDINKINQRVFNIYINN 298
DVY T+R MG D N FNLTW+F+VD NFTY VRLHFCEF +NKINQRVF+IY+NN
Sbjct: 273 DVYRTSRSMGPDPKLNQNFNLTWVFQVDGNFTYLVRLHFCEFI--LNKINQRVFDIYVNN 330
Query: 299 QTAQADADVIAWTHGQGVPIYKDYAVYVEDLPGDDQIFVAMSPSLKYQPEYLDALLNGLE 358
QTA A ADVIAWT + VP YKDY+VYV D GD++++VA+ PS+ +PEY D+LLNGLE
Sbjct: 331 QTAMASADVIAWTGSKAVPTYKDYSVYVTDGTGDEELWVALHPSIAVKPEYYDSLLNGLE 390
Query: 359 IFKIETA-KNLAGPNPEPSALPAKSEGNSTKGFTNKSKSNIHVIGGAAGGAAAFGLVAAL 417
+FKI A K+LAGPNP PS + K+E + + F + +KS+ VIG +AGG AA GL AA+
Sbjct: 391 VFKISNANKSLAGPNPTPSDMLVKAE--AARSFASNTKSSNSVIGVSAGGIAAAGLAAAV 448
Query: 418 CFVVYQRKQRIPGTESHTSSWLPIYGHSQTTQSKSTISGKSNASSHLSAIAQGLCRRFSL 477
C V+YQRK R PGT+S T+SWLP+YG+S +T SKSTISG+S ASSH+S +A LCR FSL
Sbjct: 449 CIVLYQRKNRQPGTDSRTTSWLPLYGNSHSTASKSTISGRSTASSHVSTMAASLCRHFSL 508
Query: 478 AEIKHATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSK 537
EIKHATK+FDE+ VIGVGGFGKVYKG+I+ KVAIKRSNPSSEQGVNEF TEIEMLSK
Sbjct: 509 PEIKHATKNFDENLVIGVGGFGKVYKGIIDGGTKVAIKRSNPSSEQGVNEFQTEIEMLSK 568
Query: 538 LRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKA-LSWKQRLEICIGAARGLH 596
LRH+HLVSLIG+CEE EM LVYDYMA GTLREH+Y + K LSWKQRLEICIGAARGLH
Sbjct: 569 LRHRHLVSLIGYCEEDGEMALVYDYMAHGTLREHLYKSNKPHLSWKQRLEICIGAARGLH 628
Query: 597 YLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDP 656
YLHTGAKYTIIHRDVKTTNIL+DE WVAKVSDFGLSKTGP++ HVSTVVKGSFGYLDP
Sbjct: 629 YLHTGAKYTIIHRDVKTTNILVDEKWVAKVSDFGLSKTGPDINQNHVSTVVKGSFGYLDP 688
Query: 657 EYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIID 716
EYF+RQQLTEKSD+YSFGVVLFEVLCARPALNPSLPKEQVSLADWALHC++KGIL+DIID
Sbjct: 689 EYFRRQQLTEKSDVYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCQKKGILEDIID 748
Query: 717 PLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVESTEASSNRSRGS 776
P LK I+PECLKKFADTAEKCLSD G+DRPSMGD+LWNLEF LQL E+ + + S
Sbjct: 749 PHLKGTINPECLKKFADTAEKCLSDHGLDRPSMGDILWNLEFALQLQENPDGAKAVSERE 808
Query: 777 SIDGAEDDNA----RN-CSIGSDHGS-NESSD--QDSAIFSQMVNPTGR 817
+ + +N RN S+GSD NE SD S +FSQ+V P GR
Sbjct: 809 NPEEFNHNNIMGMHRNMLSLGSDDSDMNEVSDDLNGSEVFSQIVKPKGR 857
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15241880|ref|NP_198220.1| receptor-like protein kinase ANXUR2 [Arabidopsis thaliana] gi|122233185|sp|Q3E8W4.1|ANX2_ARATH RecName: Full=Receptor-like protein kinase ANXUR2; Flags: Precursor gi|332006443|gb|AED93826.1| receptor-like protein kinase ANXUR2 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1098 bits (2839), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 534/831 (64%), Positives = 648/831 (77%), Gaps = 20/831 (2%)
Query: 1 CGSKDGGIDADGRSWEPDDKYLSKGESKPTRATYQDSSLVSKVPYMDARVFKQEMSYELP 60
CG+ + +D D + WEPD K+L + ATYQD SL+S VPYM +R+F +YE+P
Sbjct: 34 CGASEPAVDQDKKKWEPDTKFLKTPNTVHAPATYQDPSLLSTVPYMTSRIFTAPATYEIP 93
Query: 61 IRSQSRYWVRFHFYPSTYPELNVANSYFSVVANDVTLLSNFSASITAQAVAQAYLIKEFS 120
++ R+ +R HFYPSTY LN+ +SYFSV AND+TLLSNFSA+IT QA+ QAYL++E+S
Sbjct: 94 VKGDKRHMLRLHFYPSTYTGLNILDSYFSVAANDLTLLSNFSAAITCQALTQAYLVREYS 153
Query: 121 LAPMDSDILKIIFRPSDKHSGTFAFINGIELVPSPDLFEQAIIVGLG-ETIDGMTANMQT 179
LAP + D+L IIF PSDKH FAFINGIE++P P+LF+ A +VG +T D TAN+QT
Sbjct: 154 LAPSEKDVLSIIFTPSDKHPKAFAFINGIEVIPMPELFDTASLVGFSDQTSDTKTANLQT 213
Query: 180 MFRLNVAGQYISPKNDSGGLMRSWQNDEPYLFGAGYGIPMKA-DEVQIDYKSLPDYSAPP 238
MFRLNV GQ I DSGGL R+W ND PY+F AG G+ ++A + +IDY+ +P +AP
Sbjct: 214 MFRLNVGGQDIPGSQDSGGLTRTWYNDAPYIFSAGLGVTLQASNNFRIDYQKMPVSTAPA 273
Query: 239 DVYMTARYMGVDAHTNMEFNLTWIFRVDANFTYYVRLHFCEFKPDINKINQRVFNIYINN 298
DVY TAR G + NM+ NLTW+F+VD NFTY +RLHFCEF+ + KINQ+VFNI+INN
Sbjct: 274 DVYKTARSQGPNGDINMKSNLTWMFQVDTNFTYIMRLHFCEFQ--LAKINQKVFNIFINN 331
Query: 299 QTAQAD---ADVIAWTHGQGVPIYKDYAVYVEDLPGD--DQIFVAMSPSLKYQPEYLDAL 353
+TAQ D AD++ WT G+G+P YKDYA+YV+ G ++I + M+PS QPEY D+
Sbjct: 332 RTAQGDTNPADILGWTGGKGIPTYKDYAIYVDANTGGGGEEISLQMTPSTFGQPEYYDSQ 391
Query: 354 LNGLEIFKIETAKNLAGPNPEPSALPAKSEGNSTKGFTNKSKSNIHVIGGAAGGAAAFGL 413
LNGLEIFKI+T KNLAGPNP+PS P ++ + K F + VIG A G AA L
Sbjct: 392 LNGLEIFKIDTMKNLAGPNPKPS--PMQANEDVKKDFQGDKRITAFVIGSAGGVAAV--L 447
Query: 414 VAALCFVVYQRKQRIPGTESHTSSWLPIYGHSQTTQSKSTISGKSNASSHLSAIAQGLCR 473
ALCF +YQRK++ G++SHTSSWLPIYG+S T+ +KSTISGKSN SHLS +A GLCR
Sbjct: 448 FCALCFTMYQRKRKFSGSDSHTSSWLPIYGNSHTSATKSTISGKSNNGSHLSNLAAGLCR 507
Query: 474 RFSLAEIKHATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIE 533
RFSL+EIKH T +FDES VIGVGGFGKVYKGVI+ KVAIK+SNP+SEQG+NEF TEIE
Sbjct: 508 RFSLSEIKHGTHNFDESNVIGVGGFGKVYKGVIDGGTKVAIKKSNPNSEQGLNEFETEIE 567
Query: 534 MLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKK-ALSWKQRLEICIGAA 592
+LS+LRHKHLVSLIG+C+EG EMCL+YDYM+LGTLREH+YNTK+ L+WK+RLEI IGAA
Sbjct: 568 LLSRLRHKHLVSLIGYCDEGGEMCLIYDYMSLGTLREHLYNTKRPQLTWKRRLEIAIGAA 627
Query: 593 RGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFG 652
RGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNM GHV+TVVKGSFG
Sbjct: 628 RGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMNGGHVTTVVKGSFG 687
Query: 653 YLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILD 712
YLDPEYF+RQQLTEKSD+YSFGVVLFEVLCARPALNPSL KEQVSL DWA++CKRKG L+
Sbjct: 688 YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNPSLSKEQVSLGDWAMNCKRKGTLE 747
Query: 713 DIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVESTEASSNR 772
DIIDP LK KI+PECLKKFADTAEKCLSDSG+DRP+MGDVLWNLEF LQL E+ + S +R
Sbjct: 748 DIIDPNLKGKINPECLKKFADTAEKCLSDSGLDRPTMGDVLWNLEFALQLQETADGSRHR 807
Query: 773 SRGSSIDGAEDDNAR-----NCSIG-SDHGSNESSDQDSAIFSQMVNPTGR 817
+ + + N S G SD G + SS+++S IFSQ+VNP GR
Sbjct: 808 TPSNGGGSVDLGGGGGGVTVNISAGESDLGDDLSSEENSGIFSQIVNPKGR 858
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297813101|ref|XP_002874434.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297320271|gb|EFH50693.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1095 bits (2831), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 531/830 (63%), Positives = 647/830 (77%), Gaps = 19/830 (2%)
Query: 1 CGSKDGGIDADGRSWEPDDKYLSKGESKPTRATYQDSSLVSKVPYMDARVFKQEMSYELP 60
CG+ + +D D + WEPD K+L + ATYQD SL+S VPYM +R+F +YE+P
Sbjct: 34 CGASEPAVDQDKKKWEPDTKFLKTPNTVHAPATYQDPSLLSTVPYMTSRIFTAPATYEIP 93
Query: 61 IRSQSRYWVRFHFYPSTYPELNVANSYFSVVANDVTLLSNFSASITAQAVAQAYLIKEFS 120
++ R+ +R HFYPSTY LN+++SYFSV ANDVTLLSNFSA+IT QA+ QAYL++E+S
Sbjct: 94 VKGDKRHLLRLHFYPSTYTGLNISDSYFSVAANDVTLLSNFSAAITCQALTQAYLVREYS 153
Query: 121 LAPMDSDILKIIFRPSDKHSGTFAFINGIELVPSPDLFEQAIIVGLG-ETIDGMTANMQT 179
LAP + D+L I F PSDKH FAFINGIE++ P+LF+ A +VG +T D TAN+QT
Sbjct: 154 LAPSEKDVLSITFTPSDKHPKAFAFINGIEVIQMPELFDTASLVGFSDQTSDTKTANLQT 213
Query: 180 MFRLNVAGQYISPKNDSGGLMRSWQNDEPYLFGAGYGIPMKA-DEVQIDYKSLPDYSAPP 238
MFRLNV GQ I DSGGL R+W ND PY+F AG G+ ++A + +IDY+ +P +AP
Sbjct: 214 MFRLNVGGQDIPGSQDSGGLTRTWYNDAPYIFSAGLGVTLQASNNFRIDYQKMPVSTAPA 273
Query: 239 DVYMTARYMGVDAHTNMEFNLTWIFRVDANFTYYVRLHFCEFKPDINKINQRVFNIYINN 298
DVY TAR G + NM+ NLTW+F+VD NFTY +RLHFCEF+ ++KINQ+VFNI+INN
Sbjct: 274 DVYKTARSQGPNGDINMKSNLTWMFQVDTNFTYIMRLHFCEFQ--LSKINQKVFNIFINN 331
Query: 299 QTAQAD---ADVIAWTHGQGVPIYKDYAVYVEDLPGD--DQIFVAMSPSLKYQPEYLDAL 353
+TAQ D AD++AW+ G+GVP YKDYA+YV+ G ++I + M+PS +PEY DA
Sbjct: 332 RTAQGDTNPADILAWSGGKGVPTYKDYAIYVDANTGGGGEEISLQMTPSTFGKPEYYDAQ 391
Query: 354 LNGLEIFKIETAKNLAGPNPEPSALPAKSEGNSTKGFTNKSKSNIHVIGGAAGGAAAFGL 413
LNGLEIFK++T KNLAGPNP+PS P ++ + K F + VIG A G A L
Sbjct: 392 LNGLEIFKMDTMKNLAGPNPKPS--PMQANEDVKKEFQGNKRITAFVIGSAGGVATV--L 447
Query: 414 VAALCFVVYQRKQRIPGTESHTSSWLPIYGHSQTTQSKSTISGKSNASSHLSAIAQGLCR 473
+ ALCF +YQRKQ+ G+ESHTSSWLPIYG+S T+ +KSTISGKSN SHLS +A GLCR
Sbjct: 448 LCALCFTMYQRKQKFSGSESHTSSWLPIYGNSHTSATKSTISGKSNNGSHLSNLAAGLCR 507
Query: 474 RFSLAEIKHATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIE 533
RFSL+EIKH T +FDES VIGVGGFGKVYKGVI+ KVAIK+SNP+SEQG+NEF TEIE
Sbjct: 508 RFSLSEIKHGTHNFDESNVIGVGGFGKVYKGVIDGGTKVAIKKSNPNSEQGLNEFETEIE 567
Query: 534 MLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKK-ALSWKQRLEICIGAA 592
+LS+LRHKHLVSLIG+C+EG EMCL+YDYM+LGTLREH+YNTK+ L+WK+RLEI IGAA
Sbjct: 568 LLSRLRHKHLVSLIGYCDEGGEMCLIYDYMSLGTLREHLYNTKRPQLTWKRRLEIAIGAA 627
Query: 593 RGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFG 652
RGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNM GHV+TVVKGSFG
Sbjct: 628 RGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMNGGHVTTVVKGSFG 687
Query: 653 YLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILD 712
YLDPEYF+RQQLTEKSD+YSFGVVLFEVLCARPALNPSL KEQVSL DWA++CKRKG L+
Sbjct: 688 YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNPSLSKEQVSLGDWAMNCKRKGTLE 747
Query: 713 DIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVESTEASSNR 772
DIIDP LK KI+PECLKKFADTAEKCLSDSG+DRP+MGDVLWNLEF LQL E+ + S +R
Sbjct: 748 DIIDPNLKGKINPECLKKFADTAEKCLSDSGLDRPTMGDVLWNLEFALQLQETADGSRHR 807
Query: 773 SRGSSIDGAEDDNARNCSIG-----SDHGSNESSDQDSAIFSQMVNPTGR 817
+ + ++ SD G + SS+++S IFSQ+VNP GR
Sbjct: 808 TPSHGGGSVDLGGGGGVAVNIGAGESDLGDDLSSEENSGIFSQIVNPKGR 857
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15229329|ref|NP_187120.1| receptor-like protein kinase ANXUR1 [Arabidopsis thaliana] gi|75337541|sp|Q9SR05.1|ANX1_ARATH RecName: Full=Receptor-like protein kinase ANXUR1; Flags: Precursor gi|6175184|gb|AAF04910.1|AC011437_25 putative protein kinase [Arabidopsis thaliana] gi|332640599|gb|AEE74120.1| receptor-like protein kinase ANXUR1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1092 bits (2825), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 531/826 (64%), Positives = 650/826 (78%), Gaps = 17/826 (2%)
Query: 1 CGSKDGGIDADGRSWEPDDKYLSKGESKPTRATYQDSSLVSKVPYMDARVFKQEMSYELP 60
CG+ + D D + WEPD K+L G S ATYQD SL+S VPYM AR+F +YE+P
Sbjct: 33 CGTSEASADQDKKKWEPDTKFLKTGNSIHATATYQDPSLLSTVPYMTARIFTAPATYEIP 92
Query: 61 IRSQSRYWVRFHFYPSTYPELNVANSYFSVVANDVTLLSNFSASITAQAVAQAYLIKEFS 120
I+ R+ +R +FYPSTY LN++NSYF+V ANDVTLLSNFSA+IT QA+ QAYL+KE+S
Sbjct: 93 IKGDKRHLLRLYFYPSTYTGLNISNSYFTVEANDVTLLSNFSAAITCQALTQAYLVKEYS 152
Query: 121 LAPMDSDILKIIFRPSDKHSGTFAFINGIELVPSPDLFEQAIIVGL-GETIDGMTANMQT 179
LAP D D+L I F PSDK+ FAFINGIE++ P+LF+ A +VG +T+D TAN+Q+
Sbjct: 153 LAPTDKDVLSIKFTPSDKYRDAFAFINGIEVIQMPELFDTAALVGFTDQTMDAKTANLQS 212
Query: 180 MFRLNVAGQYISPKNDSGGLMRSWQNDEPYLFGAGYGIPMKA-DEVQIDYKSLPDYSAPP 238
MFRLNV GQ I DSGGL R+W ND PY+F AG G+ ++A + +I+Y+++P AP
Sbjct: 213 MFRLNVGGQDIPGSQDSGGLTRTWYNDAPYIFSAGLGVTLQASNNFRINYQNMPVSIAPA 272
Query: 239 DVYMTARYMGVDAHTNMEFNLTWIFRVDANFTYYVRLHFCEFKPDINKINQRVFNIYINN 298
D+Y TAR G + N++ NLTW+F++D NFTY +RLHFCEF+ ++KINQ+VFNIYINN
Sbjct: 273 DIYKTARSQGPNGDINLKSNLTWMFQIDKNFTYILRLHFCEFQ--LSKINQKVFNIYINN 330
Query: 299 QTAQAD---ADVIAWTHGQGVPIYKDYAVYVEDLPGDDQIFVAMSPSLKYQPEYLDALLN 355
+TAQAD AD+I WT +G+P+YKDYA+YV+ G ++I + M+PS QPEY D+ LN
Sbjct: 331 RTAQADTTPADIIGWTGEKGIPMYKDYAIYVDANNGGEEITLQMTPSTFGQPEYYDSSLN 390
Query: 356 GLEIFKIETAKNLAGPNPEPSALPAKSEGNSTKGFTNKSKSNIHVIGGAAGGAAAFGLVA 415
GLEIFK++T KNLAGPNPEPS P ++E K F N+ K + +IG A G A L+
Sbjct: 391 GLEIFKMDTMKNLAGPNPEPS--PMQAEEEVKKEFKNE-KRHAFIIGSAGGVLAV--LIG 445
Query: 416 ALCFVVYQRKQRIPGTESHTSSWLPIYGHSQTTQSKSTISGKSNASSHLSAIAQGLCRRF 475
ALCF Y++KQ G +SHTSSWLPIYG+S T+ +KSTISGKSN SHLS +A GLCRRF
Sbjct: 446 ALCFTAYKKKQGYQGGDSHTSSWLPIYGNSTTSGTKSTISGKSNNGSHLSNLAAGLCRRF 505
Query: 476 SLAEIKHATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEML 535
SL EIKH T++FD+S VIGVGGFGKVYKGVI+ KVA+K+SNP+SEQG+NEF TEIE+L
Sbjct: 506 SLPEIKHGTQNFDDSNVIGVGGFGKVYKGVIDGTTKVAVKKSNPNSEQGLNEFETEIELL 565
Query: 536 SKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKK-ALSWKQRLEICIGAARG 594
S+LRHKHLVSLIG+C+EG EMCLVYDYMA GTLREH+YNTKK L+WK+RLEI IGAARG
Sbjct: 566 SRLRHKHLVSLIGYCDEGGEMCLVYDYMAFGTLREHLYNTKKPQLTWKRRLEIAIGAARG 625
Query: 595 LHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYL 654
LHYLHTGAKYTIIHRDVKTTNIL+DENWVAKVSDFGLSKTGPNM GHV+TVVKGSFGYL
Sbjct: 626 LHYLHTGAKYTIIHRDVKTTNILVDENWVAKVSDFGLSKTGPNMNGGHVTTVVKGSFGYL 685
Query: 655 DPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDI 714
DPEYF+RQQLTEKSD+YSFGVVLFE+LCARPALNPSLPKEQVSL DWA++CKRKG L+DI
Sbjct: 686 DPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPSLPKEQVSLGDWAMNCKRKGNLEDI 745
Query: 715 IDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVESTEASSNRS- 773
IDP LK KI+ ECLKKFADTAEKCL+DSG++RP+MGDVLWNLEF LQL E+ + + +R+
Sbjct: 746 IDPNLKGKINAECLKKFADTAEKCLNDSGLERPTMGDVLWNLEFALQLQETADGTRHRTP 805
Query: 774 --RGSSIDGAEDDNARNCSIGSDHGSNESSDQDSAIFSQMVNPTGR 817
GSS D A N + G D S+ SS+ ++ IFSQ+VNP GR
Sbjct: 806 NNGGSSEDLGRGGMAVNVA-GRDDVSDLSSEDNTEIFSQIVNPKGR 850
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297833154|ref|XP_002884459.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297330299|gb|EFH60718.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1092 bits (2824), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 531/826 (64%), Positives = 650/826 (78%), Gaps = 17/826 (2%)
Query: 1 CGSKDGGIDADGRSWEPDDKYLSKGESKPTRATYQDSSLVSKVPYMDARVFKQEMSYELP 60
CG+ + D D + WEPD K+L G S ATYQD SL+S +PYM AR+F +YE+P
Sbjct: 33 CGASEASADQDKKKWEPDTKFLKTGNSIHATATYQDPSLLSTIPYMTARIFTAPATYEIP 92
Query: 61 IRSQSRYWVRFHFYPSTYPELNVANSYFSVVANDVTLLSNFSASITAQAVAQAYLIKEFS 120
I+ R+ +R +FYPSTY LN++NSYF+V ANDVTLLSNFSA+IT QA+ QAYL+KE+S
Sbjct: 93 IKGDKRHLLRLYFYPSTYTGLNISNSYFNVQANDVTLLSNFSAAITCQALTQAYLVKEYS 152
Query: 121 LAPMDSDILKIIFRPSDKHSGTFAFINGIELVPSPDLFEQAIIVGL-GETIDGMTANMQT 179
LAP++ D+L I F PSDK+ TFAFINGIE++ P+LF+ A +VG +T+D TAN Q+
Sbjct: 153 LAPIEKDVLSITFTPSDKYRDTFAFINGIEVIQMPELFDTAALVGFTDQTVDAKTANFQS 212
Query: 180 MFRLNVAGQYISPKNDSGGLMRSWQNDEPYLFGAGYGIPMKA-DEVQIDYKSLPDYSAPP 238
MFRLNV GQ I DSGGL R+W ND PY+F AG G+ ++A + +I+Y+ +P AP
Sbjct: 213 MFRLNVGGQDIPGSQDSGGLTRTWYNDAPYIFSAGLGVTLQASNNFRINYQKMPVSIAPA 272
Query: 239 DVYMTARYMGVDAHTNMEFNLTWIFRVDANFTYYVRLHFCEFKPDINKINQRVFNIYINN 298
DVY TAR G + N++ NLTW+F++D NFTY +RLHFCEF+ ++KINQ+VFNIYINN
Sbjct: 273 DVYKTARSQGPNGDINLKSNLTWMFQIDKNFTYILRLHFCEFQ--LSKINQKVFNIYINN 330
Query: 299 QTAQAD---ADVIAWTHGQGVPIYKDYAVYVEDLPGDDQIFVAMSPSLKYQPEYLDALLN 355
+TAQAD AD++ WT +G+P YKDYA+YV+ G ++I + M+PS+ +PEY D+ LN
Sbjct: 331 RTAQADTNPADILGWTGEKGIPTYKDYAIYVDANNGGEEITLQMTPSVFGEPEYYDSSLN 390
Query: 356 GLEIFKIETAKNLAGPNPEPSALPAKSEGNSTKGFTNKSKSNIHVIGGAAGGAAAFGLVA 415
GLEIFK++T KNLAGPNPEPS P ++EG K F N+ K N +IG A G A LV
Sbjct: 391 GLEIFKMDTLKNLAGPNPEPS--PMQAEGEVKKEFKNE-KRNAFIIGSAGGVLAV--LVC 445
Query: 416 ALCFVVYQRKQRIPGTESHTSSWLPIYGHSQTTQSKSTISGKSNASSHLSAIAQGLCRRF 475
ALCF Y++K G +SHTSSWLPIYG+S T+ +KSTISGKSN SHLS +A GLCRRF
Sbjct: 446 ALCFTAYKKKHGYQGGDSHTSSWLPIYGNSTTSGTKSTISGKSNNGSHLSNLAAGLCRRF 505
Query: 476 SLAEIKHATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEML 535
SL EIKH T++FD+S VIGVGGFGKVYKGVI+ KVA+KRSNP+SEQG+NEF TEIE+L
Sbjct: 506 SLPEIKHGTQNFDDSNVIGVGGFGKVYKGVIDGTTKVAVKRSNPNSEQGLNEFETEIELL 565
Query: 536 SKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKK-ALSWKQRLEICIGAARG 594
S+LRHKHLVSLIG+C++G EMCL+YDYMA GTLREH+YNTKK L+WK+RLEI IGAARG
Sbjct: 566 SRLRHKHLVSLIGYCDDGGEMCLIYDYMAFGTLREHLYNTKKPQLTWKRRLEIAIGAARG 625
Query: 595 LHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYL 654
LHYLHTGAKYTIIHRDVKTTNIL+DENWVAKVSDFGLSKTGPNM GHV+TVVKGSFGYL
Sbjct: 626 LHYLHTGAKYTIIHRDVKTTNILVDENWVAKVSDFGLSKTGPNMNGGHVTTVVKGSFGYL 685
Query: 655 DPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDI 714
DPEYF+RQQLTEKSD+YSFGVVLFE+LCARPALNPSLPKEQVSL DWA++CKRKG L+DI
Sbjct: 686 DPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPSLPKEQVSLGDWAMNCKRKGNLEDI 745
Query: 715 IDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVESTEASSNR-- 772
IDP LK KI+ ECLKKFADTAEKCL+DSG++RP+MGDVLWNLEF LQL E+ + + +R
Sbjct: 746 IDPNLKGKINSECLKKFADTAEKCLNDSGLERPTMGDVLWNLEFALQLQETADGTRHRTP 805
Query: 773 -SRGSSIDGAEDDNARNCSIGSDHGSNESSDQDSAIFSQMVNPTGR 817
S GSS D A N + G D S+ SS+ ++ IFSQ+VNP GR
Sbjct: 806 NSGGSSEDLGGGGMAVNVA-GRDDVSDLSSEDNTEIFSQIVNPKGR 850
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224123448|ref|XP_002319081.1| predicted protein [Populus trichocarpa] gi|222857457|gb|EEE95004.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1086 bits (2808), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 536/833 (64%), Positives = 641/833 (76%), Gaps = 24/833 (2%)
Query: 1 CGSKDGGIDADGRSWEPDDKYLSKGESKPTRATYQDSSLVSKVPYMDARVFKQEMSYELP 60
CGS++GG D DGR WE D KY++ G RA YQDSS+VS+VPYMDAR+F E++Y LP
Sbjct: 37 CGSENGGTDGDGRKWESDVKYIA-GNYPHARAQYQDSSIVSEVPYMDARIFTSEVTYNLP 95
Query: 61 IRSQSRYWVRFHFYPSTYPELNVANSYFSVVANDVTLLSNFSASITAQAVAQAYLIKEFS 120
I ++RYW+R +FYPS Y LN+ANSYFSVVA VTLL+NFSASITAQA+ QAYLIKE+S
Sbjct: 96 IMLKTRYWLRLYFYPSEYSGLNIANSYFSVVAGGVTLLNNFSASITAQALTQAYLIKEYS 155
Query: 121 LAPMDSDILKIIFRPSDKHSGTFAFINGIELVPSPDLFEQAIIVGLG-ETIDGMTANMQT 179
LAPM+ IL + F+P+D+ FAFIN IELVP DLF +VG + D +AN++T
Sbjct: 156 LAPMNHQILNVTFKPADR-PDAFAFINAIELVPMTDLFGSGTMVGFADQNFDAESANLET 214
Query: 180 MFRLNVAGQYISPKNDSGGLMRSWQNDEPYLFGAGYGIPMKADE-VQIDYKSLPDYSAPP 238
M+RLNVAGQYISP DSG L R+W ND PYLFGA G+ ++ +E ++ Y L + APP
Sbjct: 215 MYRLNVAGQYISPTKDSGNLTRTWYNDAPYLFGAATGVNLQTNESYKVQYGELTESVAPP 274
Query: 239 DVYMTARYMGVDAHTNMEFNLTWIFRVDANFTYYVRLHFCEFKPDINKINQRVFNIYINN 298
DVY TAR MG N+ FNLTW+F+ DANFTY VRLHFCEF+ + K+NQ+VFNIYINN
Sbjct: 275 DVYRTARGMGYHKDLNLAFNLTWLFQADANFTYVVRLHFCEFQ--LTKVNQKVFNIYINN 332
Query: 299 QTAQAD---ADVIAWTHGQGVPIYKDYAVYVEDLPGDDQIFVAMSPSLKYQPEYLDALLN 355
QTAQ + AD+I WT GVP YKDYAV+V+D PGD++I V + P+ +PE+ DA LN
Sbjct: 333 QTAQVEPNAADIIGWTGEIGVPTYKDYAVFVKDRPGDEEIRVDLHPATYSKPEFYDATLN 392
Query: 356 GLEIFKI-ETAKNLAGPNPEPSALPAKSEGNST-KGFTNKSKSNIHVIGGAAGGAAAFGL 413
G+E+FK+ + NLAGPNP S + A+ ++ K F K+ I G AGG F
Sbjct: 393 GIEVFKMSDRNNNLAGPNPVLSEMQAQHIAKASHKKFQTDHKT--LTIVGTAGGVGFF-F 449
Query: 414 VAALCFVVYQRKQRIPGTESHTSSWLPIYGHSQTTQSKSTISGKSNASSHLSAIAQGLCR 473
VAA C Y+RK+ IPG +SHTSSWLP+YG+S T +KSTISGKS S HLS++AQGL R
Sbjct: 450 VAAACIAAYRRKKIIPGFDSHTSSWLPVYGNSHTG-TKSTISGKSTQSGHLSSLAQGLSR 508
Query: 474 RFSLAEIKHATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIE 533
F+L EI ATK+FD+S VIGVGGFGKVYKGVI+ KVAIKRSNP SEQGVNEF+TEIE
Sbjct: 509 HFTLPEILRATKNFDDSNVIGVGGFGKVYKGVIDQTTKVAIKRSNPQSEQGVNEFMTEIE 568
Query: 534 MLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKA-LSWKQRLEICIGAA 592
MLSKLRHKHLVSLIGFC+E EMCLVYDYMALGT+REH+YNTKK LSWKQRLE+C+GAA
Sbjct: 569 MLSKLRHKHLVSLIGFCDEDGEMCLVYDYMALGTMREHLYNTKKPRLSWKQRLEVCVGAA 628
Query: 593 RGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFG 652
RGLHYLHTGAKYTIIHRDVK+TNILLDENWVAKVSDFGLSKTGP+M+ GHVSTVVKGSFG
Sbjct: 629 RGLHYLHTGAKYTIIHRDVKSTNILLDENWVAKVSDFGLSKTGPDMDKGHVSTVVKGSFG 688
Query: 653 YLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILD 712
YLDPEYF+RQQLTEKSD+YSFGVVLFE LC RPALNP+LPKEQVSLADWALHC+RKGI++
Sbjct: 689 YLDPEYFRRQQLTEKSDVYSFGVVLFEALCGRPALNPNLPKEQVSLADWALHCQRKGIIE 748
Query: 713 DIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVESTEASSNR 772
DIIDP +K KI+ ECLKKFADTAEKCL++SG +RP+MGDVLWNLE LQL ++ E S
Sbjct: 749 DIIDPHVKGKITTECLKKFADTAEKCLAESGPERPNMGDVLWNLELALQLQDNPEGSKRS 808
Query: 773 SRGSSIDGAEDD--------NARNCSIGSDHGSNESSDQDSAIFSQMVNPTGR 817
S+G + +E+ + N S+GS+ SD IFSQ+VNP GR
Sbjct: 809 SKGEGSETSEESIRNRKLEMHYSNLSLGSNSEKTAESDDSGDIFSQIVNPKGR 861
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224131230|ref|XP_002328487.1| predicted protein [Populus trichocarpa] gi|222838202|gb|EEE76567.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1073 bits (2775), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 534/833 (64%), Positives = 641/833 (76%), Gaps = 26/833 (3%)
Query: 1 CGSKDGGIDADGRSWEPDDKYLSKGESKPTRATYQDSSLVSKVPYMDARVFKQEMSYELP 60
CGS++GG D DGR WE D KY++ G RA YQDSS+VS+VPYMDAR+F E +Y LP
Sbjct: 48 CGSENGGTDGDGRKWESDVKYIT-GNHPHARAQYQDSSIVSEVPYMDARIFTSEATYNLP 106
Query: 61 IRSQSRYWVRFHFYPSTYPELNVANSYFSVVANDVTLLSNFSASITAQAVAQAYLIKEFS 120
I ++RYW+R FYPS Y LN+++SYFSVV +TLL+NFSASITAQA+ QAYLIKE+S
Sbjct: 107 ITEKTRYWLRLSFYPSEYSGLNISDSYFSVVTGGITLLNNFSASITAQALTQAYLIKEYS 166
Query: 121 LAPMDSDILKIIFRPSDKHSGTFAFINGIELVPSPDLFEQAIIVGLG-ETIDGMTANMQT 179
LAPM+S IL + F+P+DK FAFIN IELVP PDLF +VG +T D N+QT
Sbjct: 167 LAPMNSHILNVTFKPADKPEA-FAFINAIELVPIPDLFGSGTMVGFSDQTFDATDGNLQT 225
Query: 180 MFRLNVAGQYISPKNDSGGLMRSWQNDEPYLFGAGYGIPMKADE-VQIDYKSLPDYSAPP 238
M+RLNVAGQYISP DSG L R+W ND PYLF A G+ ++++E ++ Y L + APP
Sbjct: 226 MYRLNVAGQYISPTKDSGNLTRTWYNDAPYLFSAATGVNLQSNESFEVRYGELAESVAPP 285
Query: 239 DVYMTARYMGVDAHTNMEFNLTWIFRVDANFTYYVRLHFCEFKPDINKINQRVFNIYINN 298
DVY TAR MG NM+FNLTW+F+ DANFTY VRLHFCEF+ ++K+NQ+VFNIYINN
Sbjct: 286 DVYRTARSMGYYKDLNMKFNLTWLFQADANFTYVVRLHFCEFQ--LSKVNQKVFNIYINN 343
Query: 299 QTAQAD---ADVIAWTHGQGVPIYKDYAVYVEDLPGDDQIFVAMSPSLKYQPEYLDALLN 355
QTAQ D AD+I WT +G+P YKDYAV+V+D GD++I V + PS +PE+ DA LN
Sbjct: 344 QTAQVDPNAADIIGWTGEKGLPTYKDYAVFVKDREGDEEIRVDLHPSTSSKPEFYDASLN 403
Query: 356 GLEIFKI-ETAKNLAGPNPEPSALPAKSEGN-STKGFTNKSKSNIHVIGGAAGGAAAFGL 413
G+EIFK+ + NLAG NP S + A S K F SK+ + G GG A L
Sbjct: 404 GIEIFKMSDRNNNLAGHNPVLSEMLANHMAKASQKAFKTDSKA----VMGTVGGVGAL-L 458
Query: 414 VAALCFVVYQRKQRIPGTESHTSSWLPIYGHSQTTQSKSTISGKSNASSHLSAIAQGLCR 473
A +C VYQR +RIPG +SHTS+WLP+YG+S T S KS+ SSHLS +AQGLCR
Sbjct: 459 FAVVCVAVYQRTKRIPGFDSHTSTWLPVYGNSHTVSKSSISG-KSSQSSHLSTLAQGLCR 517
Query: 474 RFSLAEIKHATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIE 533
F+L E++ ATK+FDES VIGVGGFGKVYKGVI+ KVAIKRSNP SEQGVNEF+TEIE
Sbjct: 518 HFTLPEMQRATKNFDESNVIGVGGFGKVYKGVIDQATKVAIKRSNPQSEQGVNEFMTEIE 577
Query: 534 MLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKA-LSWKQRLEICIGAA 592
MLSKLRHKHLVSLIGFC+E EMCLVYDYMALGT+REH+YNTKK LSWKQRLE+CIGAA
Sbjct: 578 MLSKLRHKHLVSLIGFCDEDGEMCLVYDYMALGTMREHLYNTKKPRLSWKQRLEVCIGAA 637
Query: 593 RGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFG 652
RGLHYLHTGAKYTIIHRDVK+TNILLDENWVAKVSDFGLSKTGP+M+ GHVSTVVKGSFG
Sbjct: 638 RGLHYLHTGAKYTIIHRDVKSTNILLDENWVAKVSDFGLSKTGPDMDKGHVSTVVKGSFG 697
Query: 653 YLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILD 712
YLDPEYF+RQQLTEKSD+YSFGVVLFE LC RPALNPSLPKEQVSLADWALHC++KGI++
Sbjct: 698 YLDPEYFRRQQLTEKSDVYSFGVVLFEALCGRPALNPSLPKEQVSLADWALHCQKKGIIE 757
Query: 713 DIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVESTEASSNR 772
DIIDP +K KI+PECLKKFA+TA+KCL++SG +RP+MGDVLWNLEF LQL ++ E S++R
Sbjct: 758 DIIDPHIKGKITPECLKKFAETADKCLAESGPERPNMGDVLWNLEFALQLQDNPEGSNDR 817
Query: 773 SRGSSIDGAEDD--------NARNCSIGSDHGSNESSDQDSAIFSQMVNPTGR 817
S+G + +E+ + N S+GS + S+ IFSQ+VNP GR
Sbjct: 818 SQGEGSETSEESIRNRNLEMHYNNLSLGSISEVSGGSEDSGDIFSQIVNPKGR 870
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255580913|ref|XP_002531275.1| ATP binding protein, putative [Ricinus communis] gi|223529108|gb|EEF31088.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1065 bits (2753), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 543/805 (67%), Positives = 629/805 (78%), Gaps = 16/805 (1%)
Query: 1 CGSKDGGIDADGRSWEPDDKYLSKGESKPTRATYQDSSLVSKVPYMDARVFKQEMSYELP 60
CGS +GG DADGR WE D KYL G RA +QDSS+VS +P+M+AR+F E +Y+LP
Sbjct: 36 CGSDNGGNDADGRKWESDVKYLI-GNHPQARAQHQDSSIVSDIPFMNARIFTSEATYKLP 94
Query: 61 IRSQSRYWVRFHFYPSTYPELNVANSYFSVVANDVTLLSNFSASITAQAVAQAYLIKEFS 120
I+ ++RY++R FYPS Y LN++ SYFSVVA VTLL+NFSASITAQA+ QAYLIKE+S
Sbjct: 95 IKPKTRYFLRLFFYPSEYASLNISRSYFSVVAAGVTLLNNFSASITAQALTQAYLIKEYS 154
Query: 121 LAPMDSDILKIIFRPSDKHSGTFAFINGIELVP-SPDLFEQAIIVGLGETI-DGMTANMQ 178
LA +DS+ L + F+PSDK FAF+NGIE++P DLF + IVG + I D AN++
Sbjct: 155 LAGIDSNTLNVTFKPSDKSEDAFAFVNGIEVIPIHGDLFGTSPIVGFSDQIADSKHANLE 214
Query: 179 TMFRLNVAGQYISPKNDSGGLMRSWQNDEPYLFGAGYGIPMKAD-EVQIDYKSLPDYSAP 237
TM+RLNVAGQYI P DSGGL R+W ND PYLF A G+ MKA+ V I Y P+Y AP
Sbjct: 215 TMYRLNVAGQYIPPNQDSGGLARTWYNDAPYLFSAAMGVDMKANGRVPIKYGDFPEYVAP 274
Query: 238 PDVYMTARYMGVDAHTNMEFNLTWIFRVDANFTYYVRLHFCEFKPDINKINQRVFNIYIN 297
+VY TAR MG D+ N++FNLTW+ +VD NF+Y VR HFCEF + ++NQ FNIYIN
Sbjct: 275 LNVYETARNMGPDSLINLKFNLTWLLQVDPNFSYIVRFHFCEFV--LIRVNQMAFNIYIN 332
Query: 298 NQTAQAD---ADVIAWTHGQGVPIYKDYAVYVEDLPGDDQIFVAMSPSLKYQPEYLDALL 354
NQ+AQAD AD++ WT G P YKDY + V D GDD I V + PS +PE DA L
Sbjct: 333 NQSAQADPSPADILGWTEQPGQPTYKDYMIIVNDKQGDDYIQVDLHPSTLTKPEIYDAAL 392
Query: 355 NGLEIFKI-ETAKNLAGPNPEPSALPAKSEGNST-KGFTNKSKSNIHVIGGAAGGAAAFG 412
NGLE+FKI + NLAGPNPE SA+ AK T K F KS + VIGGAAGGAA F
Sbjct: 393 NGLEVFKISDKDNNLAGPNPELSAMLAKDVAEGTQKDF--KSTDDKAVIGGAAGGAAGFC 450
Query: 413 LVAALCFVVYQRKQRIPGTESHTSSWLPIYGHSQTTQSKSTISGKSNASSHLSAIAQGLC 472
LVAA+C Q+K+R+ TE H+ SWLPIYG+S TT SKSTISGKSN ++HLS +AQGLC
Sbjct: 451 LVAAICIAYNQKKRRVASTEPHSYSWLPIYGNSHTTTSKSTISGKSNNNTHLSTLAQGLC 510
Query: 473 RRFSLAEIKHATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEI 532
R FSL E+K AT +F ES VIGVGGFGKVYKGVI+ K KVAIKRSNP SEQGVNEF TEI
Sbjct: 511 RHFSLNEMKQATNNFTESNVIGVGGFGKVYKGVIDQKTKVAIKRSNPQSEQGVNEFQTEI 570
Query: 533 EMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKK-ALSWKQRLEICIGA 591
EMLSKLRHKHLVSLIGFCEE EMCLVYDYMALGTLREH+Y T + LSWKQRLEICIG+
Sbjct: 571 EMLSKLRHKHLVSLIGFCEEDEEMCLVYDYMALGTLREHLYRTTRPKLSWKQRLEICIGS 630
Query: 592 ARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSF 651
ARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG V TVVKGSF
Sbjct: 631 ARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGQVITVVKGSF 690
Query: 652 GYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGIL 711
GYLDPEYFKRQQLTEKSD+YSFGVVLFEVLC RPALNPSLPKEQVSLADWALHC++KGIL
Sbjct: 691 GYLDPEYFKRQQLTEKSDVYSFGVVLFEVLCGRPALNPSLPKEQVSLADWALHCQKKGIL 750
Query: 712 DDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVESTEAS-- 769
+DIIDPL+K KI PECLKKFADTAEKCLS++GI+RPSMGDVLWNLEF LQL +S+++S
Sbjct: 751 EDIIDPLIKGKIKPECLKKFADTAEKCLSEAGIERPSMGDVLWNLEFALQLQQSSDSSGY 810
Query: 770 SNRSRGSSIDGAEDDNARNCSIGSD 794
S + GSSI +N N S+ +D
Sbjct: 811 SIQIDGSSISEESLENQGNSSLHND 835
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359477216|ref|XP_002272797.2| PREDICTED: receptor-like protein kinase ANXUR1-like [Vitis vinifera] gi|296083244|emb|CBI22880.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1021 bits (2641), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 524/836 (62%), Positives = 634/836 (75%), Gaps = 36/836 (4%)
Query: 1 CGSKDGGIDADGRSWEPDDKYL-SKGESKPTRATYQDSSLVSKVPYMDARVFKQEMSYEL 59
CG GG DADGR W PD K+L S G+S A QD SL S VPYM AR+F E +Y+
Sbjct: 39 CGDSSGGADADGRKWVPDTKFLASPGKSISATAQLQDPSLPSPVPYMSARIFTSESTYQF 98
Query: 60 PIRSQSRYWVRFHFYPSTYPELNVANSYFSVVANDVTLLSNFSASITAQAVAQAYLIKEF 119
+ ++R WVR HFYPS Y LN ++S+FSV A TLL+NFSAS TAQA+ QAY+IK+F
Sbjct: 99 SVSPKNRLWVRLHFYPSFYSALNASDSFFSVTAGGFTLLNNFSASTTAQALTQAYIIKDF 158
Query: 120 SLAPMDSDILKIIFRPSDKHSGTFAFINGIELVPSPDLFEQAIIVGLGETIDGMTANMQT 179
SL P +S L I F+PS H+G++AFINGIE++ PD+F A +VG + +D +++QT
Sbjct: 159 SLMPPESGHLNITFKPSPNHNGSYAFINGIEVISMPDIFGSATMVGYSD-LDAAGSSLQT 217
Query: 180 MFRLNVAGQYISPKNDSGGLMRSWQNDEPYLFGAGYGIPMKAD-EVQIDYKS-LPDYSAP 237
M+RLNV GQYI+ NDSG L R+W +D PYL+GA +G+ +AD V I Y S +P+Y AP
Sbjct: 218 MYRLNVGGQYIAANNDSG-LSRTWYDDSPYLYGAAFGVTSEADSNVTIQYPSHVPEYIAP 276
Query: 238 PDVYMTARYMGVDAHTNMEFNLTWIFRVDANFTYYVRLHFCEFKPDINKINQRVFNIYIN 297
DVY TAR MG D N +NLTW+F+VDANFTY VR HFCEF ++KINQRVF+IY+N
Sbjct: 277 VDVYRTARTMGPDPKINQNYNLTWVFQVDANFTYIVRFHFCEFL--LSKINQRVFDIYVN 334
Query: 298 NQTAQADADVIAWTHGQGVPIYKDYAVYVEDLPGDDQIFVAMSPSLKYQPEYLDALLNGL 357
NQTAQ AD+IAW +GVP+YKD+AV+V+D PGD+Q++VA+ PS+ +PE+ DA+LNGL
Sbjct: 335 NQTAQPAADLIAWAESEGVPVYKDFAVFVKDEPGDEQLWVALHPSVSMKPEFYDAILNGL 394
Query: 358 EIFKI-ETAKNLAGPNPEPSALPAKSEGNSTKGFTN-KSKSNIHVIGGAAGGAAAFGLVA 415
EIFK+ ++ NLAGPNP PS + K+E T+ F + +S N VIGG AGGAA +V
Sbjct: 395 EIFKLNDSNGNLAGPNPVPSPMLVKAE--ETRNFASPESSDNAQVIGGIAGGAAGLVVVV 452
Query: 416 ALCF-VVYQRKQRIPGTESHTSSWLPIYGHSQTTQSKSTISGKSNASSHLSAIAQGLCRR 474
A+ + ++RK+ + + S TS WLP++G S TT SKSTISGKS ASSHLS++A LCR
Sbjct: 453 AVVAVIAFRRKKMLDRSGSRTSGWLPVHGSSGTTASKSTISGKSTASSHLSSMAAALCRH 512
Query: 475 FSLAEIKHATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEM 534
F+LAE++H TK+FDES VIGVGGFGKVYKGV++ KVAIKRSNPSSEQGV+EF TEIEM
Sbjct: 513 FTLAEMRHGTKNFDESQVIGVGGFGKVYKGVVDGSTKVAIKRSNPSSEQGVHEFQTEIEM 572
Query: 535 LSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKA-LSWKQRLEICIGAAR 593
LSKLRH+HLVSLIG+CEE NEM LVYDYMA GTLREH+Y + K LSWKQRLEICIGAAR
Sbjct: 573 LSKLRHRHLVSLIGYCEEDNEMILVYDYMANGTLREHLYKSDKPQLSWKQRLEICIGAAR 632
Query: 594 GLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGY 653
GLHYLHTGAKYTIIHRDVKTTNILLDE WVAKVSDFGLSKTGP + HVSTVVKGSFGY
Sbjct: 633 GLHYLHTGAKYTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPELNQTHVSTVVKGSFGY 692
Query: 654 LDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDD 713
LDPEYF+RQQLTEKSD+YSFGVVLFE LCARPALNPSLPKEQVSLADWAL C++KGIL++
Sbjct: 693 LDPEYFRRQQLTEKSDVYSFGVVLFEALCARPALNPSLPKEQVSLADWALQCQKKGILEE 752
Query: 714 IIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVESTEASSNRS 773
IIDP LK I+PECL KFA+TAEKCLSD G++RPSMGDVLWNLEF LQL E +
Sbjct: 753 IIDPHLKGNITPECLMKFAETAEKCLSDHGLERPSMGDVLWNLEFALQLQE-------KP 805
Query: 774 RGSSIDGAEDDNARNCSIGSDHGSNESSDQDSA------------IFSQMVNPTGR 817
+G+ ID + N I + H S S D++SA +FS MVNP GR
Sbjct: 806 QGAKIDVEK----VNADINAMHRSMLSIDEESAVSEDTEDLSTSEVFSHMVNPKGR 857
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255556384|ref|XP_002519226.1| ATP binding protein, putative [Ricinus communis] gi|223541541|gb|EEF43090.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1019 bits (2635), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 520/826 (62%), Positives = 623/826 (75%), Gaps = 15/826 (1%)
Query: 1 CGSKDGGIDADGRSWEPDDKYL-SKGESKPTRATYQDSSLVSKVPYMDARVFKQEMSYEL 59
CG+ + G D DGR WEPD KY+ S G S A QD SL S VPYM R+F +Y
Sbjct: 35 CGASNAGTDGDGRKWEPDTKYVKSSGNSIMATADNQDPSLPSTVPYMTGRLFTSAFTYTF 94
Query: 60 PIRSQSRYWVRFHFYPSTYPELNVANSYFSVVANDVTLLSNFSASITAQAVAQAYLIKEF 119
P+ ++ R WVR HFYPSTY L+ N+YFSV AN + LL NFSASITA+A+ AY+I+E+
Sbjct: 95 PVPAKGRLWVRLHFYPSTYSSLDPNNAYFSVTANKLQLLKNFSASITAKALTMAYIIREY 154
Query: 120 SLAPMDSDILKIIFRPSDKHSGTFAFINGIELVPSPDLFEQAIIVGLG-ETIDGMTANMQ 178
SL+P++S L + F PS H +AF+NGIE++P P++++ A +VG + ID T++MQ
Sbjct: 155 SLSPIESGTLNLTFTPSQDHDDAYAFVNGIEVIPMPEIYQSAGMVGFSDQMIDVTTSSMQ 214
Query: 179 TMFRLNVAGQYISPKNDSGGLMRSWQNDEPYLFGAGYGIPMKAD-EVQIDYKSLPDYSAP 237
TMFRLNV GQ+I NDSG L R W +D PYLFGAG GI +A+ ++Q + LP AP
Sbjct: 215 TMFRLNVGGQFIPSTNDSG-LTRIWYDDTPYLFGAGAGITNQANIKIQYPTQELPKAIAP 273
Query: 238 PDVYMTARYMGVDAHTNMEFNLTWIFRVDANFTYYVRLHFCEFKPDINKINQRVFNIYIN 297
DVY +AR MG D+ NM FNLTW+F VDANFTY VR HFCE+ ++ + NQR FNIYIN
Sbjct: 274 YDVYSSARSMGPDSKVNMNFNLTWLFDVDANFTYLVRFHFCEY--EMTRSNQRAFNIYIN 331
Query: 298 NQTAQADADVIAWTHGQGVPIYKDYAVYVEDLPGDDQIFVAMSPSLKYQPEYLDALLNGL 357
NQTAQ ADVI W +GVPIYKDYA++V D GDD+++VA+ PS++ +PEY DA+LNGL
Sbjct: 332 NQTAQEGADVIGWAGSKGVPIYKDYAIHVGDQSGDDELWVALHPSVELKPEYYDAILNGL 391
Query: 358 EIFKI-ETAKNLAGPNPEPSALPAKSEGNSTKGFTNKSKSNIHVIGGAAGGAAAFGLVAA 416
EIFK+ E N+AGPNP PSA+ K+E K F + S SN VIGG AGGAA + A
Sbjct: 392 EIFKLNEPDGNMAGPNPVPSAMMQKAE--EKKSFKS-SGSNGPVIGGIAGGAAGLAIAAI 448
Query: 417 LCFVVYQRKQRIPGTESHTSSWLPIYGHSQTTQSKSTISGKSNASSHLSAIAQGLCRRFS 476
+ V ++K+ + G++S + +WLP+YGHS T+ SKSTISGKS ASSHLS +AQGLCR FS
Sbjct: 449 ISIFVLRKKRGLTGSQSGSHNWLPLYGHSHTSGSKSTISGKSTASSHLSTLAQGLCRHFS 508
Query: 477 LAEIKHATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLS 536
L EIK ATK+FDES VIGVGGFGKVYKG+I+ KVA+KRSNPSSEQGVNEF TEIEMLS
Sbjct: 509 LPEIKQATKNFDESNVIGVGGFGKVYKGIIDQGTKVAVKRSNPSSEQGVNEFQTEIEMLS 568
Query: 537 KLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKK---ALSWKQRLEICIGAAR 593
KLRHKHLVSLIGFCEE EM LVYDYMA GTLREHIY K +LSWKQRLEICIGAAR
Sbjct: 569 KLRHKHLVSLIGFCEEDGEMALVYDYMANGTLREHIYKGNKPTSSLSWKQRLEICIGAAR 628
Query: 594 GLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN-GHVSTVVKGSFG 652
GLHYLHTGA+YTIIHRDVKTTNILLDE WVAKVSDFGLSKTGPN+ N HVSTVVKGSFG
Sbjct: 629 GLHYLHTGARYTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPNLNNQSHVSTVVKGSFG 688
Query: 653 YLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILD 712
YLDPEYFKRQQLTEKSD+YSFGVVLFEVLCARPALNP+L KEQVSLADWALHC++KGI++
Sbjct: 689 YLDPEYFKRQQLTEKSDVYSFGVVLFEVLCARPALNPNLAKEQVSLADWALHCQKKGIIE 748
Query: 713 DIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVESTEASSNR 772
D+IDP +K I PECL+KFA+TAEKCLSD GI RPSMGDVLWNLEF LQL ++ +
Sbjct: 749 DLIDPHIKADIQPECLRKFAETAEKCLSDHGIHRPSMGDVLWNLEFALQLQDNPAGAKLV 808
Query: 773 SRGSSIDGAEDDNARNCSIGSDHGSNESSD-QDSAIFSQMVNPTGR 817
S +D + + S ++ D ++ IFSQ+VNP GR
Sbjct: 809 SENKGLDTYGMNRQMHSIEEESSISEDTDDLNNTEIFSQIVNPRGR 854
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 817 | ||||||
| TAIR|locus:2148830 | 858 | ANX2 "ANXUR2" [Arabidopsis tha | 0.992 | 0.945 | 0.606 | 7.6e-270 | |
| TAIR|locus:2084953 | 850 | ANX1 "ANXUR1" [Arabidopsis tha | 0.990 | 0.951 | 0.601 | 2.7e-267 | |
| TAIR|locus:2081895 | 895 | FER "FERONIA" [Arabidopsis tha | 0.971 | 0.887 | 0.525 | 8.1e-214 | |
| TAIR|locus:2151349 | 855 | THE1 "THESEUS1" [Arabidopsis t | 0.965 | 0.922 | 0.430 | 7e-157 | |
| TAIR|locus:2177202 | 873 | AT5G39000 [Arabidopsis thalian | 0.949 | 0.888 | 0.420 | 8e-156 | |
| TAIR|locus:2152312 | 880 | AT5G38990 [Arabidopsis thalian | 0.960 | 0.892 | 0.408 | 1.3e-148 | |
| TAIR|locus:2204564 | 849 | HERK2 "hercules receptor kinas | 0.955 | 0.919 | 0.419 | 1.9e-147 | |
| TAIR|locus:2075346 | 830 | HERK1 "hercules receptor kinas | 0.523 | 0.515 | 0.476 | 8.8e-145 | |
| TAIR|locus:2163158 | 842 | AT5G61350 [Arabidopsis thalian | 0.906 | 0.880 | 0.424 | 7e-141 | |
| TAIR|locus:2050080 | 871 | AT2G21480 [Arabidopsis thalian | 0.417 | 0.391 | 0.574 | 2.2e-137 |
| TAIR|locus:2148830 ANX2 "ANXUR2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2595 (918.5 bits), Expect = 7.6e-270, P = 7.6e-270
Identities = 504/831 (60%), Positives = 616/831 (74%)
Query: 1 CGSKDGGIDADGRSWEPDDKYLSKGESKPTRATYQDSSLVSKVPYMDARVFKQEMSYELP 60
CG+ + +D D + WEPD K+L + ATYQD SL+S VPYM +R+F +YE+P
Sbjct: 34 CGASEPAVDQDKKKWEPDTKFLKTPNTVHAPATYQDPSLLSTVPYMTSRIFTAPATYEIP 93
Query: 61 IRSQSRYWVRFHFYPSTYPELNVANSYFSVVANDVTLLSNFSASITAQAVAQAYLIKEFS 120
++ R+ +R HFYPSTY LN+ +SYFSV AND+TLLSNFSA+IT QA+ QAYL++E+S
Sbjct: 94 VKGDKRHMLRLHFYPSTYTGLNILDSYFSVAANDLTLLSNFSAAITCQALTQAYLVREYS 153
Query: 121 LAPMDSDILKIIFRPSDKHSGTFAFINGIELVPSPDLFEQAIIVGLGE-TIDGMTANMQT 179
LAP + D+L IIF PSDKH FAFINGIE++P P+LF+ A +VG + T D TAN+QT
Sbjct: 154 LAPSEKDVLSIIFTPSDKHPKAFAFINGIEVIPMPELFDTASLVGFSDQTSDTKTANLQT 213
Query: 180 MFRLNVAGQYISPKNDSGGLMRSWQNDEPYLFGAGYGIPMKA-DEVQIDYKSLPDYSAPP 238
MFRLNV GQ I DSGGL R+W ND PY+F AG G+ ++A + +IDY+ +P +AP
Sbjct: 214 MFRLNVGGQDIPGSQDSGGLTRTWYNDAPYIFSAGLGVTLQASNNFRIDYQKMPVSTAPA 273
Query: 239 DVYMTARYMGVDAHTNMEFNLTWIFRVDANFTYYVRLHFCEFKPDINKINQRVFNIYINN 298
DVY TAR G + NM+ NLTW+F+VD NFTY +RLHFCEF+ + KINQ+VFNI+INN
Sbjct: 274 DVYKTARSQGPNGDINMKSNLTWMFQVDTNFTYIMRLHFCEFQ--LAKINQKVFNIFINN 331
Query: 299 QTAQAD---ADVIAWTHGQGVPIYKDYAVYVEDLPGD--DQIFVAMSPSLKYQPEYLDAL 353
+TAQ D AD++ WT G+G+P YKDYA+YV+ G ++I + M+PS QPEY D+
Sbjct: 332 RTAQGDTNPADILGWTGGKGIPTYKDYAIYVDANTGGGGEEISLQMTPSTFGQPEYYDSQ 391
Query: 354 LNGLEIFKIETAKNLAGPNPEPSALPAKSEGNSTKGFTNKSKSNIHVIXXXXXXXXXXXX 413
LNGLEIFKI+T KNLAGPNP+PS P ++ + K F + VI
Sbjct: 392 LNGLEIFKIDTMKNLAGPNPKPS--PMQANEDVKKDFQGDKRITAFVIGSAGGVAAVLFC 449
Query: 414 XXXLCFVVYQRKQRIPGTESHTSSWLPIYGHSQTTQSKSTISGKSNASSHLSAIAQGLCR 473
LCF +YQRK++ G++SHTSSWLPIYG+S T+ +KSTISGKSN SHLS +A GLCR
Sbjct: 450 A--LCFTMYQRKRKFSGSDSHTSSWLPIYGNSHTSATKSTISGKSNNGSHLSNLAAGLCR 507
Query: 474 RFSLAEIKHATKSFDESXXXXXXXXXXXXXXXXEDKLKVAIKRSNPSSEQGVNEFVTEIE 533
RFSL+EIKH T +FDES + KVAIK+SNP+SEQG+NEF TEIE
Sbjct: 508 RFSLSEIKHGTHNFDESNVIGVGGFGKVYKGVIDGGTKVAIKKSNPNSEQGLNEFETEIE 567
Query: 534 MLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKA-LSWKQRLEICIGAA 592
+LS+LRHKHLVSLIG+C+EG EMCL+YDYM+LGTLREH+YNTK+ L+WK+RLEI IGAA
Sbjct: 568 LLSRLRHKHLVSLIGYCDEGGEMCLIYDYMSLGTLREHLYNTKRPQLTWKRRLEIAIGAA 627
Query: 593 RGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFG 652
RGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNM GHV+TVVKGSFG
Sbjct: 628 RGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMNGGHVTTVVKGSFG 687
Query: 653 YLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRXXXXX 712
YLDPEYF+RQQLTEKSD+YSFGVVLFEVLCARPALNPSL KEQVSL DWA++CKR
Sbjct: 688 YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNPSLSKEQVSLGDWAMNCKRKGTLE 747
Query: 713 XXXXXXXXXXXSPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVESTEASSNR 772
+PECLKKFADTAEKCLSDSG+DRP+MGDVLWNLEF LQL E+ + S +R
Sbjct: 748 DIIDPNLKGKINPECLKKFADTAEKCLSDSGLDRPTMGDVLWNLEFALQLQETADGSRHR 807
Query: 773 SR---GSSID--GAEDDNARNCSIG-SDHGSNESSDQDSAIFSQMVNPTGR 817
+ G S+D G N S G SD G + SS+++S IFSQ+VNP GR
Sbjct: 808 TPSNGGGSVDLGGGGGGVTVNISAGESDLGDDLSSEENSGIFSQIVNPKGR 858
|
|
| TAIR|locus:2084953 ANX1 "ANXUR1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2571 (910.1 bits), Expect = 2.7e-267, P = 2.7e-267
Identities = 497/826 (60%), Positives = 613/826 (74%)
Query: 1 CGSKDGGIDADGRSWEPDDKYLSKGESKPTRATYQDSSLVSKVPYMDARVFKQEMSYELP 60
CG+ + D D + WEPD K+L G S ATYQD SL+S VPYM AR+F +YE+P
Sbjct: 33 CGTSEASADQDKKKWEPDTKFLKTGNSIHATATYQDPSLLSTVPYMTARIFTAPATYEIP 92
Query: 61 IRSQSRYWVRFHFYPSTYPELNVANSYFSVVANDVTLLSNFSASITAQAVAQAYLIKEFS 120
I+ R+ +R +FYPSTY LN++NSYF+V ANDVTLLSNFSA+IT QA+ QAYL+KE+S
Sbjct: 93 IKGDKRHLLRLYFYPSTYTGLNISNSYFTVEANDVTLLSNFSAAITCQALTQAYLVKEYS 152
Query: 121 LAPMDSDILKIIFRPSDKHSGTFAFINGIELVPSPDLFEQAIIVGL-GETIDGMTANMQT 179
LAP D D+L I F PSDK+ FAFINGIE++ P+LF+ A +VG +T+D TAN+Q+
Sbjct: 153 LAPTDKDVLSIKFTPSDKYRDAFAFINGIEVIQMPELFDTAALVGFTDQTMDAKTANLQS 212
Query: 180 MFRLNVAGQYISPKNDSGGLMRSWQNDEPYLFGAGYGIPMKA-DEVQIDYKSLPDYSAPP 238
MFRLNV GQ I DSGGL R+W ND PY+F AG G+ ++A + +I+Y+++P AP
Sbjct: 213 MFRLNVGGQDIPGSQDSGGLTRTWYNDAPYIFSAGLGVTLQASNNFRINYQNMPVSIAPA 272
Query: 239 DVYMTARYMGVDAHTNMEFNLTWIFRVDANFTYYVRLHFCEFKPDINKINQRVFNIYINN 298
D+Y TAR G + N++ NLTW+F++D NFTY +RLHFCEF+ ++KINQ+VFNIYINN
Sbjct: 273 DIYKTARSQGPNGDINLKSNLTWMFQIDKNFTYILRLHFCEFQ--LSKINQKVFNIYINN 330
Query: 299 QTAQAD---ADVIAWTHGQGVPIYKDYAVYVEDLPGDDQIFVAMSPSLKYQPEYLDALLN 355
+TAQAD AD+I WT +G+P+YKDYA+YV+ G ++I + M+PS QPEY D+ LN
Sbjct: 331 RTAQADTTPADIIGWTGEKGIPMYKDYAIYVDANNGGEEITLQMTPSTFGQPEYYDSSLN 390
Query: 356 GLEIFKIETAKNLAGPNPEPSALPAKSEGNSTKGFTNKSKSNIHVIXXXXXXXXXXXXXX 415
GLEIFK++T KNLAGPNPEPS P ++E K F N+ + H
Sbjct: 391 GLEIFKMDTMKNLAGPNPEPS--PMQAEEEVKKEFKNEKR---HAFIIGSAGGVLAVLIG 445
Query: 416 XLCFVVYQRKQRIPGTESHTSSWLPIYGHSQTTQSKSTISGKSNASSHLSAIAQGLCRRF 475
LCF Y++KQ G +SHTSSWLPIYG+S T+ +KSTISGKSN SHLS +A GLCRRF
Sbjct: 446 ALCFTAYKKKQGYQGGDSHTSSWLPIYGNSTTSGTKSTISGKSNNGSHLSNLAAGLCRRF 505
Query: 476 SLAEIKHATKSFDESXXXXXXXXXXXXXXXXEDKLKVAIKRSNPSSEQGVNEFVTEIEML 535
SL EIKH T++FD+S + KVA+K+SNP+SEQG+NEF TEIE+L
Sbjct: 506 SLPEIKHGTQNFDDSNVIGVGGFGKVYKGVIDGTTKVAVKKSNPNSEQGLNEFETEIELL 565
Query: 536 SKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKA-LSWKQRLEICIGAARG 594
S+LRHKHLVSLIG+C+EG EMCLVYDYMA GTLREH+YNTKK L+WK+RLEI IGAARG
Sbjct: 566 SRLRHKHLVSLIGYCDEGGEMCLVYDYMAFGTLREHLYNTKKPQLTWKRRLEIAIGAARG 625
Query: 595 LHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYL 654
LHYLHTGAKYTIIHRDVKTTNIL+DENWVAKVSDFGLSKTGPNM GHV+TVVKGSFGYL
Sbjct: 626 LHYLHTGAKYTIIHRDVKTTNILVDENWVAKVSDFGLSKTGPNMNGGHVTTVVKGSFGYL 685
Query: 655 DPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRXXXXXXX 714
DPEYF+RQQLTEKSD+YSFGVVLFE+LCARPALNPSLPKEQVSL DWA++CKR
Sbjct: 686 DPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPSLPKEQVSLGDWAMNCKRKGNLEDI 745
Query: 715 XXXXXXXXXSPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVESTEASSNRSR 774
+ ECLKKFADTAEKCL+DSG++RP+MGDVLWNLEF LQL E+ + + +R+
Sbjct: 746 IDPNLKGKINAECLKKFADTAEKCLNDSGLERPTMGDVLWNLEFALQLQETADGTRHRTP 805
Query: 775 ---GSSIDGAEDDNARNCSIGSDHGSNESSDQDSAIFSQMVNPTGR 817
GSS D A N + G D S+ SS+ ++ IFSQ+VNP GR
Sbjct: 806 NNGGSSEDLGRGGMAVNVA-GRDDVSDLSSEDNTEIFSQIVNPKGR 850
|
|
| TAIR|locus:2081895 FER "FERONIA" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2026 (718.2 bits), Expect = 8.1e-214, Sum P(2) = 8.1e-214
Identities = 436/830 (52%), Positives = 537/830 (64%)
Query: 1 CGSKDGGI-DADGRSWEPD--DKYLSKG--ESKPTRATYQDSSLVSKVPYMDARVFKQEM 55
CG + D D R W D K+LS +SK + A QD S V +VPYM ARVF+
Sbjct: 40 CGGGASNLTDTDNRIWISDVKSKFLSSSSEDSKTSPALTQDPS-VPEVPYMTARVFRSPF 98
Query: 56 SYELPIRSQSRYWVRFHFYPSTYPELNVANSYFSVVANDVTLLSNFSASITAQAVAQAYL 115
+Y P+ S R +VR +FYP++Y LN NS FSV TLL NFSAS TA+A+ A++
Sbjct: 99 TYTFPVAS-GRKFVRLYFYPNSYDGLNATNSLFSVSFGPYTLLKNFSASQTAEALTYAFI 157
Query: 116 IKEFSLAPMDSDILKIIFRPSDKHSGTFAFINGIELVPSPDLFEQA----IIVGL-GE-T 169
IKEF + ++ L + F P S +AF+NGIE+ PD++ +VG G T
Sbjct: 158 IKEF-VVNVEGGTLNMTFTPESAPSNAYAFVNGIEVTSMPDMYSSTDGTLTMVGSSGSVT 216
Query: 170 IDGMTANMQTMFRLNVAGQYISPKNDSGGLMRSWQNDEPYLFGAGYGIPMKAD-EVQIDY 228
ID TA ++ ++RLNV G ISP D+G L RSW +D+PY+FGAG GIP AD + I Y
Sbjct: 217 IDNSTA-LENVYRLNVGGNDISPSADTG-LYRSWYDDQPYIFGAGLGIPETADPNMTIKY 274
Query: 229 KS-LPDYSAPPDVYMTARYMGVDAHTNMEFNLTWIFRVDANFTYYVRLHFCEFKPDINKI 287
+ P Y AP DVY TAR MG A N+ +NLTWIF +D+ FTY VRLHFCE +I KI
Sbjct: 275 PTGTPTYVAPVDVYSTARSMGPTAQINLNYNLTWIFSIDSGFTYLVRLHFCEVSSNITKI 334
Query: 288 NQRVFNIYINNQTAQADADVIAWTHGQGVPIYKDYAVYVEDLPGDDQIFVAMSPSLKYQP 347
NQRVF IY+NNQTA+ +ADVIAWT GVP +KDY V + G +++A+ P+ +P
Sbjct: 335 NQRVFTIYLNNQTAEPEADVIAWTSSNGVPFHKDYVVNPPEGNGQQDLWLALHPNPVNKP 394
Query: 348 EYLDALLNGLEIFKIETAK-NLAGPNPEPSALPAKSEGNSTKGFTNKSKSNIHVIXXXXX 406
EY D+LLNG+EIFK+ T+ NLAG NP P + T KSKSN +I
Sbjct: 395 EYYDSLLNGVEIFKMNTSDGNLAGTNPIPGPQVTADPSKVLRPTTRKSKSNTAIIAGAAS 454
Query: 407 XXXXXXXXXXLC-FVVYQRKQR---IPGTESHTSSWLPI--YGHSQTTQSKSTISGKSNA 460
C F Y+R++R P +++ TS WLP+ YG+S + S T +
Sbjct: 455 GAVVLALIIGFCVFGAYRRRKRGDYQPASDA-TSGWLPLSLYGNSHSAGSAKT----NTT 509
Query: 461 SSHLSAIAQGLCRRFSLAEIKHATKSFDESXXXXXXXXXXXXXXXXED-KLKVAIKRSNP 519
S+ S++ LCR FS AEIK ATK+FDES + KVAIKR NP
Sbjct: 510 GSYASSLPSNLCRHFSFAEIKAATKNFDESRVLGVGGFGKVYRGEIDGGTTKVAIKRGNP 569
Query: 520 SSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKK-A 578
SEQGV+EF TEIEMLSKLRH+HLVSLIG+CEE EM LVYDYMA GT+REH+Y T+ +
Sbjct: 570 MSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAHGTMREHLYKTQNPS 629
Query: 579 LSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNM 638
L WKQRLEICIGAARGLHYLHTGAK+TIIHRDVKTTNILLDE WVAKVSDFGLSKTGP +
Sbjct: 630 LPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTL 689
Query: 639 ENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSL 698
++ HVSTVVKGSFGYLDPEYF+RQQLTEKSD+YSFGVVLFE LCARPALNP+L KEQVSL
Sbjct: 690 DHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEALCARPALNPTLAKEQVSL 749
Query: 699 ADWALHCKRXXXXXXXXXXXXXXXXSPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758
A+WA +C + +PEC KKFA+TA KC+ D GI+RPSMGDVLWNLEF
Sbjct: 750 AEWAPYCYKKGMLDQIVDPYLKGKITPECFKKFAETAMKCVLDQGIERPSMGDVLWNLEF 809
Query: 759 VLQLVESTEASSNRSRGS-SIDGAEDDNARNCSIGSDHGSN--ESSDQDS 805
LQL ES E + G +D + D+ NC +D S+ E + DS
Sbjct: 810 ALQLQESAEENGKGVCGDMDMDEIKYDDG-NCKGKNDKSSDVYEGNVTDS 858
|
|
| TAIR|locus:2151349 THE1 "THESEUS1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1529 (543.3 bits), Expect = 7.0e-157, P = 7.0e-157
Identities = 365/848 (43%), Positives = 490/848 (57%)
Query: 1 CGSKDGGIDADGRSWEPDDKY----LSKGESKPTRATYQDSSLVSKVPYMDARVFKQEMS 56
CGS I R + PD + L G S +T ++S S Y ARVF S
Sbjct: 36 CGSSQN-ITFQNRIFVPDSLHSSLVLKIGNSSVATSTTSNNSTNSI--YQTARVFSSLAS 92
Query: 57 YELPIRSQSRYWVRFHFYPSTYPELNVANSYFSVVANDVTLLSNFSASITAQAVAQAYLI 116
Y I S R+W+R HF P N+ ++ +VV D LL+NFS + +Y+
Sbjct: 93 YRFKITSLGRHWIRLHFSPINNSTWNLTSASITVVTEDFVLLNNFSFN----NFNGSYIF 148
Query: 117 KEFSLAPMDSDILKIIFRPSDKHSGTFAFINGIELVPSPD--LFEQAIIVGLGETIDGMT 174
KE+++ + S+ L + F PS+ + F+N IE+V PD + +QA+ + G++
Sbjct: 149 KEYTVN-VTSEFLTLSFIPSNN---SVVFVNAIEVVSVPDNLIPDQALALNPSTPFSGLS 204
Query: 175 A-NMQTMFRLNVAGQYISPKNDSGGLMRSWQNDEPYLFGAGYGIPMKADEVQIDYK-SLP 232
+T++RLN+ G ++ +ND+ G R W ND YL + + A+ I Y S+
Sbjct: 205 LLAFETVYRLNMGGPLLTSQNDTLG--RQWDNDAEYLHVNSSVLVVTANPSSIKYSPSVT 262
Query: 233 DYSAPPDVYMTARYMGVDAHT-NMEFNLTWIFRVDANFTYYVRLHFCEFKPDINKINQRV 291
+AP VY TA MG DA+ + FN+TW+ VD +F Y+VR+HFC+ +N V
Sbjct: 263 QETAPNMVYATADTMG-DANVASPSFNVTWVLPVDPDFRYFVRVHFCDIVSQA--LNTLV 319
Query: 292 FNIYINNQTAQADADVIAWTHGQGVPIYKDYAVYVEDLPGDDQIFVAMSPSLKYQPEYLD 351
FN+Y+N+ A D+ T+G VP +KD+ + + + V++ P Q + +
Sbjct: 320 FNLYVNDDLALGSLDLSTLTNGLKVPYFKDF-ISNGSVESSGVLTVSVGPDS--QADITN 376
Query: 352 ALLNGLEIFKIET-AKNLAGPNPEPSALPAKSEGNSTKGFTNKSKSNIHVIXXXXXXXXX 410
A +NGLE+ KI AK+L+G + S LP G +KSK +I
Sbjct: 377 ATMNGLEVLKISNEAKSLSGVSSVKSLLPG--------GSGSKSKKKAVIIGSLVGAVTL 428
Query: 411 XXXXXXLCF--VVYQRKQRI--PGTESHTSSWLPI--YGHSQTTQSKSTISGKSNASSHL 464
C+ +V RKQR P + WLP+ YG SQT +KST S KS +S +
Sbjct: 429 ILLIAVCCYCCLVASRKQRSTSPQEGGNGHPWLPLPLYGLSQTL-TKSTASHKSATASCI 487
Query: 465 SAIAQGLCRRFSLAEIKHATKSFDESXXXXXXXXXXXXXXXXEDKLKVAIKRSNPSSEQG 524
S + L R F EI AT FDES ED KVA+KR NP SEQG
Sbjct: 488 SLASTHLGRCFMFQEIMDATNKFDESSLLGVGGFGRVYKGTLEDGTKVAVKRGNPRSEQG 547
Query: 525 VNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTK-KALSWKQ 583
+ EF TEIEMLSKLRH+HLVSLIG+C+E +EM LVY+YMA G LR H+Y LSWKQ
Sbjct: 548 MAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGADLPPLSWKQ 607
Query: 584 RLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643
RLEICIGAARGLHYLHTGA +IIHRDVKTTNILLDEN VAKV+DFGLSKTGP+++ HV
Sbjct: 608 RLEICIGAARGLHYLHTGASQSIIHRDVKTTNILLDENLVAKVADFGLSKTGPSLDQTHV 667
Query: 644 STVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWAL 703
ST VKGSFGYLDPEYF+RQQLTEKSD+YSFGVVL EVLC RPALNP LP+EQV++A+WA+
Sbjct: 668 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCCRPALNPVLPREQVNIAEWAM 727
Query: 704 HCKRXXXXXXXXXXXXXXXXSPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLV 763
++ +P LKKF +TAEKCL++ G+DRPSMGDVLWNLE+ LQL
Sbjct: 728 AWQKKGLLDQIMDSNLTGKVNPASLKKFGETAEKCLAEYGVDRPSMGDVLWNLEYALQLE 787
Query: 764 ESTEA-------SSNRSRGSSIDGAED-DNARNC----SIGSDHGSNESSDQ--DSAIFS 809
E++ A S+N G + E DN+ + + S G+++ ++ SA+FS
Sbjct: 788 ETSSALMEPDDNSTNHIPGIPMAPMEPFDNSMSIIDRGGVNSGTGTDDDAEDATTSAVFS 847
Query: 810 QMVNPTGR 817
Q+V+P GR
Sbjct: 848 QLVHPRGR 855
|
|
| TAIR|locus:2177202 AT5G39000 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1519 (539.8 bits), Expect = 8.0e-156, P = 8.0e-156
Identities = 352/837 (42%), Positives = 475/837 (56%)
Query: 1 CGSKDGGIDADGRSWEPDD-KYLSKG---ESKPTRATYQDSSLVSKVPYMDARVFKQEMS 56
CG +D GR+W ++ K LS S +A+YQ+S VS++PYM AR+F+ E +
Sbjct: 36 CGDTSNNVDVSGRNWTAENQKILSSNLVNASFTAQASYQESG-VSQIPYMTARIFRSEFT 94
Query: 57 YELPIRSQSRYWVRFHFYPSTY-PELNVANSYFSVVANDVTLLSNFSASITAQAVAQA-- 113
Y P+ S + +R +FYP+ Y + N S+FSV N TLL+NFSA +T +A
Sbjct: 95 YSFPVTPGSNF-LRLYFYPTRYGSQFNAVKSFFSVKVNGFTLLNNFSADLTVKASKPQTE 153
Query: 114 YLIKEFSLAPMDSDILKIIFRPSDKHSGTFAFINGIELVPSPDLFEQA-----IIVGLGE 168
++IKEF + P+ L + F PS + AF+NGIE+V P+ F +I +G
Sbjct: 154 FIIKEF-IIPV-YQTLNLTFTPS---LDSLAFVNGIEIVSIPNRFYSKGGFDDVITNVGS 208
Query: 169 TIDGMTAN---MQTMFRLNVAGQYISPKNDSGGLMRSWQNDEPYLFGAGYGIPMKADEVQ 225
++D N +T++RLNV G+ + DSG + R W +D+ + GI +++
Sbjct: 209 SVDFHIENSTAFETVYRLNVGGKTVG---DSG-MFRRWVSDDEIILSESSGISPIVPDIK 264
Query: 226 IDY-KSLPDYSAPPDVYMTARYMGVDAHT--NMEFNLTWIFRVDANFTYYVRLHFCEFKP 282
I+Y + P Y AP DVY T+R MG H N+ FNLTW+F VDA F+Y VRLHFCE
Sbjct: 265 INYTEKTPSYVAPDDVYATSRSMGNADHPEQNLNFNLTWLFTVDAGFSYLVRLHFCETLS 324
Query: 283 DINKINQRVFNIYINNQTAQADADVIAWTHGQGVPIYKDYAVYVEDLPGD-DQIFVAMSP 341
++NK QRVF+I+I NQTA + DV + G +P+Y DY V G + + + P
Sbjct: 325 EVNKEGQRVFSIFIENQTATLEMDVFRMSGGSWIPMYLDYTVIAGSGSGRRHDLRLDLHP 384
Query: 342 SLKYQPEYLDALLNGLEIFKIETAK-NLAGPNPEPSALPAKSEGNSTKGFTNKSKSNIHV 400
+ P+Y DA+LNG+EI K+ NLAGPNP+P P +T K+KS+I
Sbjct: 385 LVSINPKYYDAILNGVEILKMNDPDGNLAGPNPDPLVSPDLIPNRATPRI-RKNKSHILP 443
Query: 401 IXXXXXXXXXXXXXXXLCFVVYQRKQRIPGTESHTSSWLPIYGHSQTTQSKSTISGKSNA 460
I + +V +K++ S SSW P+ H T S +T KS
Sbjct: 444 ITLAVVGSLVVLAMFVVGVLVIMKKKK-KSKPSTNSSWCPL-PHG--TDSTNTKPAKS-- 497
Query: 461 SSHLSAIAQGLCRRFSLAEIKHATKSFDESXXXXXXXXXXXXXXXXEDKLK-VAIKRSNP 519
+ LCRRFS+ EIK AT F++ + VA+KR
Sbjct: 498 ------LPADLCRRFSIFEIKSATNDFEDKLIIGVGGFGSVYKGQIDGGATLVAVKRLEI 551
Query: 520 SSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKA- 578
+S QG EF TE+EMLSKLRH HLVSLIG+C+E NEM LVY+YM GTL++H++ K
Sbjct: 552 TSNQGAKEFETELEMLSKLRHVHLVSLIGYCDEDNEMVLVYEYMPHGTLKDHLFRRDKTS 611
Query: 579 ---LSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTG 635
LSWK+RLEICIGAARGL YLHTGAKYTIIHRD+KTTNILLDEN+V KVSDFGLS+ G
Sbjct: 612 DPPLSWKRRLEICIGAARGLQYLHTGAKYTIIHRDIKTTNILLDENFVTKVSDFGLSRVG 671
Query: 636 P-NMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKE 694
P + HVSTVVKG+FGYLDPEY++RQ LTEKSD+YSFGVVL EVLC RP S+P E
Sbjct: 672 PTSASQTHVSTVVKGTFGYLDPEYYRRQVLTEKSDVYSFGVVLLEVLCCRPIRMQSVPPE 731
Query: 695 QVSLADWALHCKRXXXXXXXXXXXXXXXXSPECLKKFADTAEKCLSDSGIDRPSMGDVLW 754
Q L W R + L+KF + A +C+ D G++RP M DV+W
Sbjct: 732 QADLIRWVKSNYRRGTVDQIIDSDLSADITSTSLEKFCEIAVRCVQDRGMERPPMNDVVW 791
Query: 755 NLEFVLQL----------VESTEASSNRSRGSSIDGAEDDNARNCS-IGSDHGSNES 800
LEF LQL VES + + G++ DG +D +R +G +++S
Sbjct: 792 ALEFALQLHETAKKKNDNVESLDLMPSGEVGTTTDGEDDLFSRTTGHVGKSTTTDDS 848
|
|
| TAIR|locus:2152312 AT5G38990 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1451 (515.8 bits), Expect = 1.3e-148, P = 1.3e-148
Identities = 342/838 (40%), Positives = 467/838 (55%)
Query: 1 CGSKDGGIDADGRSWEPDD-KYLSKGE----SKPTRATYQDSSLVSKVPYMDARVFKQEM 55
CG +D GR+W ++ K++S S + A+YQ+S + +VPY+ AR+F+ +
Sbjct: 33 CGDTSNNMDYSGRNWTTENPKFMSSNAVDDASFTSSASYQESG-IPQVPYLKARIFRYDF 91
Query: 56 SYELPIRSQSRYWVRFHFYPSTY-PELNVANSYFSVVANDVTLLSNFSASITAQAVAQAY 114
+Y P+ S ++R +FYP+ Y + + S+FSV N TLL NFS + A +
Sbjct: 92 TYSFPV-SPGWKFLRLYFYPTRYGSDFDAVKSFFSVNVNRFTLLHNFS--VKASIPESSS 148
Query: 115 LIKEFSLAPMDSDILKIIFRPSDKHSGTFAFINGIELVPSPDLFEQA-----IIVGLGET 169
LIKEF + P++ L + F PS + AF+NGIE++ PD F ++ +G
Sbjct: 149 LIKEF-IVPVNQT-LDLTFTPSPN---SLAFVNGIEIISMPDRFYSKGGFDDVVRNVGRD 203
Query: 170 IDGMTAN---MQTMFRLNVAGQYISPKNDSGGLMRSWQNDEPYLFGAGYGIPMKADEVQI 226
+D N +T++R+NV G+ + DSG + R W +DE +L G G V+I
Sbjct: 204 VDFEIDNSTAFETVYRVNVGGKVVGDVGDSG-MFRRWLSDEGFLLGINSGAIPNITGVKI 262
Query: 227 DYKS-LPDYSAPPDVYMTARYMG-VDA-HTNMEFNLTWIFRVDANFTYYVRLHFCEFKPD 283
+Y P Y AP DVY T R MG D+ N+ FNLTW+F VDA F Y VRLHFCE +P+
Sbjct: 263 NYTDKTPAYVAPEDVYTTCRLMGNKDSPELNLNFNLTWLFEVDAGFAYIVRLHFCETQPE 322
Query: 284 INKINQRVFNIYINNQTAQADADVIAWTHGQGVPIYKDYAVYVEDLPGDDQ---IFVAMS 340
+NK RVF+I+ Q A + DV + G +P+Y D+ V V D G Q + V ++
Sbjct: 323 VNKTGDRVFSIFFGYQLAMREMDVFRLSGGFRLPMYLDFKVLV-DADGTSQRPSLRVDLT 381
Query: 341 PSLKYQPEYLDALLNGLEIFKIETAK-NLAGPNPEPSALPAKSEGNSTKGFTNKSKSNIH 399
P + P Y DA+L+G+EI K+ + NLAG NP P P KG S
Sbjct: 382 PYKEDYPTYYDAILSGVEILKLSNSDGNLAGLNPIPQLSPPPQSITPLKGKGKSSHVLPI 441
Query: 400 VIXXXXXXXXXXXXXXXLCFVVYQRKQRIPGTESHTSSWLPIYGHSQTTQSKSTISGKSN 459
+I + VV +RK++ + T++ P S T G +N
Sbjct: 442 IIAVVGSAVALAFFVLVVVLVVMKRKKKSNESSVDTTN-KPSTNSSWGPLLHGT--GSTN 498
Query: 460 ASSHLSAIAQGLCRRFSLAEIKHATKSFDESXXXXXXXXXXXXXXXXEDKLK-VAIKRSN 518
S S++ LCRRFS+ EIK AT F+E + VA+KR
Sbjct: 499 TKS-ASSLPSDLCRRFSIYEIKSATNDFEEKLIIGVGGFGSVYKGRIDGGATLVAVKRLE 557
Query: 519 PSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKA 578
+S QG EF TE+EMLSKLRH HLVSLIG+C++ NEM LVY+YM GTL++H++ KA
Sbjct: 558 ITSNQGAKEFDTELEMLSKLRHVHLVSLIGYCDDDNEMVLVYEYMPHGTLKDHLFRRDKA 617
Query: 579 ----LSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634
LSWK+RLEICIGAARGL YLHTGAKYTIIHRD+KTTNILLDEN+VAKVSDFGLS+
Sbjct: 618 SDPPLSWKRRLEICIGAARGLQYLHTGAKYTIIHRDIKTTNILLDENFVAKVSDFGLSRV 677
Query: 635 GP-NMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPK 693
GP + HVSTVVKG+FGYLDPEY++RQ LTEKSD+YSFGVVL EVLC RP S+P
Sbjct: 678 GPTSASQTHVSTVVKGTFGYLDPEYYRRQILTEKSDVYSFGVVLLEVLCCRPIRMQSVPP 737
Query: 694 EQVSLADWALHCKRXXXXXXXXXXXXXXXXSPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
EQ L W + ++KF + A +C+ D G++RP M DV+
Sbjct: 738 EQADLIRWVKSNFNKRTVDQIIDSDLTADITSTSMEKFCEIAIRCVQDRGMERPPMNDVV 797
Query: 754 WNLEFVLQL----------VESTEASSNRSRGSSIDGAEDDNARNCS-IGSDHGSNES 800
W LEF LQL VES + + G++ DG +D +R +G +++S
Sbjct: 798 WALEFALQLHETAKKKNDNVESLDLMPSGEVGTTTDGEDDLFSRTTGHVGKSTTTDDS 855
|
|
| TAIR|locus:2204564 HERK2 "hercules receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1440 (512.0 bits), Expect = 1.9e-147, P = 1.9e-147
Identities = 350/835 (41%), Positives = 471/835 (56%)
Query: 1 CGSKDGGIDADGRSW----EPDDKYLSKGESKPTRATYQDSSLVSKVPYMDARVFKQEMS 56
CGS + + DGR+W P+ +G T +T + SS+ +++ Y ARVF ++
Sbjct: 37 CGS-NATTEVDGRTWVGDLSPNKSVTLQGFDAITASTSKGSSVYAEI-YKTARVFDAVLN 94
Query: 57 YELPIRSQSRYWVRFHFYPSTYPELNVANSYFSVVANDVTLLS--NFSASI--------- 105
Y +Q Y+VR HF P NV S FSV A+ + L+ N + I
Sbjct: 95 YTFEGITQGNYFVRLHFSPFAIENHNVNESSFSVFADGLRLMLDINIAGEIAHKNLILES 154
Query: 106 TAQAVAQAYLIKEFSLAPMDSDILKIIFRPSDKHSGTFAFINGIELVPSPD-LFEQAII- 163
T + L+KEF L P L + F P G+F F+N IE+V D LF++++
Sbjct: 155 TGHNATASSLVKEF-LLPTGPGKLVLSFIPE---KGSFGFVNAIEIVSVDDKLFKESVTK 210
Query: 164 VGLGETIDGMTAN-MQTMFRLNVAGQYISPKNDSGGLMRSWQNDEPYLFGAGYGIPMKAD 222
VG E G+ ++TM+RLNV G + P D L R+W+ D Y+ G+ +K +
Sbjct: 211 VGGSEVELGLGGRGIETMYRLNVGGPKLGPSKDLK-LYRTWETDLSYMVIENAGVEVK-N 268
Query: 223 EVQIDYKSLPDYS--APPDVYMTARYMGVDAHTNMEFNLTWIFRVDANFTYYVRLHFCEF 280
I Y +L D S AP VY TAR M FN++W F VD NF Y VRLHFCE
Sbjct: 269 SSNITY-ALADDSPVAPLLVYETARMMSNTEVLEKRFNISWKFEVDPNFDYLVRLHFCEL 327
Query: 281 KPDINKINQRVFNIYINNQTAQADADVIAWTHGQGVPIYKDYAVYVEDLPGDDQIFVAMS 340
D K NQR+F IYINNQTA + D+ A G+ IY+DY V +D +++ +
Sbjct: 328 LVD--KQNQRIFRIYINNQTAAGNFDIFAHAGGKNKGIYQDYLDPVSSK--NDVLWIQLG 383
Query: 341 PSLKYQPEYLDALLNGLEIFKIETAKNLAGPNPEPSALPAKSEGNSTKGFTNKSKSNIHV 400
P DALL+GLEIFK+ NLA + S G+S +K + I +
Sbjct: 384 PDSSVGASG-DALLSGLEIFKLSKNGNLA------HLIRFDSTGHSVSD--SKMRI-IWI 433
Query: 401 IXXXXXXXXXXXXXXXLCFVVYQRKQRIPGTESHTS--SWLPIYGHSQTTQSKSTISGKS 458
+ V +K+R ES + W P++ H + + + +G S
Sbjct: 434 SVGAGIAIIIFFVFLGILVVCLCKKRRSKSDESKNNPPGWRPLFLHVNNSTANAKATGGS 493
Query: 459 NASSHLSAIAQGLCRRFSLAEIKHATKSFDESXXXXXXXXXXXXXXXXEDKLKVAIKRSN 518
+ L+A G R+F+LAEI+ ATK+FD+ ED +AIKR+
Sbjct: 494 LRLNTLAASTMG--RKFTLAEIRAATKNFDDGLAIGVGGFGKVYRGELEDGTLIAIKRAT 551
Query: 519 PSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTK-K 577
P S+QG+ EF TEI MLS+LRH+HLVSLIGFC+E NEM LVY+YMA GTLR H++ +
Sbjct: 552 PHSQQGLAEFETEIVMLSRLRHRHLVSLIGFCDEHNEMILVYEYMANGTLRSHLFGSNLP 611
Query: 578 ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPN 637
LSWKQRLE CIG+ARGLHYLHTG++ IIHRDVKTTNILLDEN+VAK+SDFGLSK GP+
Sbjct: 612 PLSWKQRLEACIGSARGLHYLHTGSERGIIHRDVKTTNILLDENFVAKMSDFGLSKAGPS 671
Query: 638 MENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVS 697
M++ HVST VKGSFGYLDPEYF+RQQLTEKSD+YSFGVVLFE +CAR +NP+LPK+Q++
Sbjct: 672 MDHTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEAVCARAVINPTLPKDQIN 731
Query: 698 LADWALHCKRXXXXXXXXXXXXXXXXSPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757
LA+WAL ++ SPE L+K+ + AEKCL+D G +RP MG+VLW+LE
Sbjct: 732 LAEWALSWQKQRNLESIIDSNLRGNYSPESLEKYGEIAEKCLADEGKNRPMMGEVLWSLE 791
Query: 758 FVLQLVESTEASSNRSRGSSIDGAEDDNARN-----CSIGSDHGSNESSDQDSAI 807
+VLQ+ E+ N S A ++ + CS D E S SA+
Sbjct: 792 YVLQIHEAWLRKQNGENSFSSSQAVEEAPESFTLPACS-NQDSSETEQSQTGSAL 845
|
|
| TAIR|locus:2075346 HERK1 "hercules receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1029 (367.3 bits), Expect = 8.8e-145, Sum P(2) = 8.8e-145
Identities = 215/451 (47%), Positives = 283/451 (62%)
Query: 382 SEGNSTKGFTNKSKSNIHVIXXXXXXXXXXXXXXXLCFVVYQRKQRIPGTESHTSSWLPI 441
S G G ++ SKSN+ +I CFV+Y++++R G + H+ +W+P
Sbjct: 388 STGTFVPGSSSSSKSNLGLIVGSAIGSLLAVVFLGSCFVLYKKRKR--GQDGHSKTWMPF 445
Query: 442 YGHSQTTQSKSTISGKSNASSHLSAIAQGLCRRFSLAEIKHATKSFDESXXXXXXXXXXX 501
+ + SK SN ++ L++I R A +K AT +FDES
Sbjct: 446 SINGTSMGSKY-----SNGTT-LTSITTNANYRIPFAAVKDATNNFDESRNIGVGGFGKV 499
Query: 502 XXXXXEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561
D KVA+KR NP S+QG+ EF TEIEMLS+ RH+HLVSLIG+C+E NEM L+Y+
Sbjct: 500 YKGELNDGTKVAVKRGNPKSQQGLAEFRTEIEMLSQFRHRHLVSLIGYCDENNEMILIYE 559
Query: 562 YMALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDE 620
YM GT++ H+Y + +L+WKQRLEICIGAARGLHYLHTG +IHRDVK+ NILLDE
Sbjct: 560 YMENGTVKSHLYGSGLPSLTWKQRLEICIGAARGLHYLHTGDSKPVIHRDVKSANILLDE 619
Query: 621 NWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEV 680
N++AKV+DFGLSKTGP ++ HVST VKGSFGYLDPEYF+RQQLT+KSD+YSFGVVLFEV
Sbjct: 620 NFMAKVADFGLSKTGPELDQTHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEV 679
Query: 681 LCARPALNPSLPKEQVSLADWALHCKRXXXXXXXXXXXXXXXXSPECLKKFADTAEKCLS 740
LCARP ++P+LP+E V+LA+WA+ ++ P+ L+KFA+T EKCL+
Sbjct: 680 LCARPVIDPTLPREMVNLAEWAMKWQKKGQLDQIIDQSLRGNIRPDSLRKFAETGEKCLA 739
Query: 741 DSGIDRPSMGDVLWNLEFVLQLVESTEASSNRSRGSSIDGAEDDNARNCSIGSDH----G 796
D G+DRPSMGDVLWNLE+ LQL E+ +++ G N S G G
Sbjct: 740 DYGVDRPSMGDVLWNLEYALQLQEAVIDGEPEDNSTNMIGELPPQINNFSQGDTSVNVPG 799
Query: 797 S----NESSDQD------SAIFSQMVNPTGR 817
+ ESS D S +FSQ+V GR
Sbjct: 800 TAGRFEESSIDDLSGVSMSKVFSQLVKSEGR 830
|
|
| TAIR|locus:2163158 AT5G61350 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1378 (490.1 bits), Expect = 7.0e-141, P = 7.0e-141
Identities = 339/798 (42%), Positives = 456/798 (57%)
Query: 1 CGSKDGGIDADGRSWEPDDKYLSKGESKPTRATYQDS-----SLVSKVP-YMDARVFKQE 54
CGS D +DGR+++ D + ++ ++ T DS S S +P Y+ AR+F +
Sbjct: 38 CGSSDETKLSDGRNFKSDQQSVAFLQTDEDIKTSVDSIPITDSNASTLPLYLTARIFAGK 97
Query: 55 MSYELPIRSQSRYWVRFHFYPSTYPELNVANSYFSVVANDVTLLSNFSASITAQAVAQAY 114
+Y I R+W+R HFYP +P N+ NS FSV + LL +FSA T+ V + Y
Sbjct: 98 STYSFYISRPGRHWIRLHFYPLNHPLYNLTNSVFSVTTDTTVLLHDFSAGDTSSIVFKEY 157
Query: 115 LIKEFSLAPMDSDILKIIFRPSDKHSGTFAFINGIELVPSPDLF--EQAIIVGLGETIDG 172
LI ++ L + F+P H G+ AFIN +E+V PD + A V G
Sbjct: 158 LIYA-------AEKLSLYFKP---HKGSTAFINAVEIVSVPDELVPDSASSVPQAPDFKG 207
Query: 173 MTA-NMQTMFRLNVAGQYISPKNDSGGLMRSWQNDEPY-LFGAGYGIPMKADEVQIDYKS 230
+++ +++ + R+N+ G ISPK D L R+W +D+PY F G + D I Y
Sbjct: 208 LSSFSLEILHRINIGGDLISPKIDP--LSRTWLSDKPYNTFPEG-SRNVTVDPSTITYPD 264
Query: 231 --LPDYSAPPDVYMTARYMGVDAHTNM-EFNLTWIFRVDANFTYYVRLHFCEFKPDINK- 286
AP VY TA M DA T+ FNL+W VD Y++RLHFC+ ++K
Sbjct: 265 GGATALIAPNPVYATAEEMA-DAQTSQPNFNLSWRMSVDFGHDYFIRLHFCDI---VSKS 320
Query: 287 INQRVFNIYINNQTAQADADVIAWTHGQGVPIYKDYAVYVEDLPGDDQIFVAMSPSLKYQ 346
+N +FN++IN +A + D+ + T G Y D+ + + + I V + P+ Q
Sbjct: 321 LNDLIFNVFINKLSAISALDLSSLTSALGTAYYADFVLNASTIT-NGSILVQVGPTPNLQ 379
Query: 347 PEYLDALLNGLEIFKIETAKNLAGPNPEPSALPAKSEGNSTKGFTNKSKSNIHVIXXXXX 406
+A+LNGLEI K+ N AG + K +G G ++K K I I
Sbjct: 380 SGKPNAILNGLEIMKLN---NAAGSLDGLFGVDGKYKG-PIGGMSSK-KLAIAGIGFVMA 434
Query: 407 XXXXXXXXXXLCFVVYQRKQRIPGTESHTSSWLPIYG-HSQTTQSK--ST-----ISG-- 456
L +R + S +S LP++ HS SK ST I G
Sbjct: 435 LTAFLGVVVLLVRW-QRRPKDWQKQNSFSSWLLPLHASHSSYISSKGGSTSRRMSIFGSK 493
Query: 457 KSNASSHLSAIA-QGLCRRFSLAEIKHATKSFDESXXXXXXXXXXXXXXXXEDKLKVAIK 515
KS ++ S + QGL R F E++ AT++FDE+ + +VAIK
Sbjct: 494 KSKSNGFSSFFSNQGLGRYFPFTELQTATQNFDENAVCGVGGFGKVYIGEIDGGTQVAIK 553
Query: 516 RSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNT 575
R + SSEQG+NEF TEI+MLSKLRH+HLVSLIGFC+E EM LVY+YM+ G LR+H+Y +
Sbjct: 554 RGSQSSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDENKEMILVYEYMSNGPLRDHLYGS 613
Query: 576 KK-------ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSD 628
K+ LSWKQRLEICIG+ARGLHYLHTGA IIHRDVKTTNILLDEN VAKVSD
Sbjct: 614 KENDPNPIPTLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVSD 673
Query: 629 FGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALN 688
FGLSK P M+ GHVST VKGSFGYLDPEYF+RQQLT+KSD+YSFGVVLFEVLCARP +N
Sbjct: 674 FGLSKDAP-MDEGHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARPVIN 732
Query: 689 PSLPKEQVSLADWALHCKRXXXXXXXXXXXXXXXXSPECLKKFADTAEKCLSDSGIDRPS 748
P LP+EQV+LA++A++ R S L+KF + AEKCL++ G+DRP
Sbjct: 733 PQLPREQVNLAEYAMNLHRKGMLEKIIDPKIVGTISKGSLRKFVEAAEKCLAEYGVDRPG 792
Query: 749 MGDVLWNLEFVLQLVEST 766
MGDVLWNLE+ LQL E++
Sbjct: 793 MGDVLWNLEYALQLQEAS 810
|
|
| TAIR|locus:2050080 AT2G21480 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 971 (346.9 bits), Expect = 2.2e-137, Sum P(2) = 2.2e-137
Identities = 201/350 (57%), Positives = 246/350 (70%)
Query: 420 VVYQRKQRIPGTESHTS--SWL-PIYGHSQTTQSKSTISGKSNASSHLSAIAQGLCRRFS 476
+VY+ K+R + S SWL PI+ T + T S KSN + SA+ GL R FS
Sbjct: 459 MVYKWKKRPQDWQKRNSFSSWLLPIHAGDSTFMTSKTGSHKSNLYN--SAL--GLGRYFS 514
Query: 477 LAEIKHATKSFDESXXXXXXXXXXXXXXXXEDKLKVAIKRSNPSSEQGVNEFVTEIEMLS 536
L+E++ TK+FD S +D +VAIKR NP SEQG+ EF TEI+MLS
Sbjct: 515 LSELQEVTKNFDASEIIGVGGFGNVYIGTIDDGTQVAIKRGNPQSEQGITEFHTEIQMLS 574
Query: 537 KLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKA-LSWKQRLEICIGAARGL 595
KLRH+HLVSLIG+C+E EM LVY+YM+ G R+H+Y + L+WKQRLEICIGAARGL
Sbjct: 575 KLRHRHLVSLIGYCDENAEMILVYEYMSNGPFRDHLYGKNLSPLTWKQRLEICIGAARGL 634
Query: 596 HYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLD 655
HYLHTG IIHRDVK+TNILLDE VAKV+DFGLSK +N HVST VKGSFGYLD
Sbjct: 635 HYLHTGTAQGIIHRDVKSTNILLDEALVAKVADFGLSKDVAFGQN-HVSTAVKGSFGYLD 693
Query: 656 PEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRXXXXXXXX 715
PEYF+RQQLT+KSD+YSFGVVL E LCARPA+NP LP+EQV+LA+WA+ K+
Sbjct: 694 PEYFRRQQLTDKSDVYSFGVVLLEALCARPAINPQLPREQVNLAEWAMLWKQKGLLEKII 753
Query: 716 XXXXXXXXSPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVES 765
+PE +KKFA+ AEKCL+D G+DRP+MGDVLWNLE+ LQL E+
Sbjct: 754 DPHLVGAVNPESMKKFAEAAEKCLADYGVDRPTMGDVLWNLEYALQLQEA 803
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q3E8W4 | ANX2_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6425 | 0.9926 | 0.9452 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | AT5G28680 | protein kinase family protein; protein kinase family protein; FUNCTIONS IN- protein serine/threonine kinase activity, protein kinase activity, kinase activity, ATP binding; INVOLVED IN- protein amino acid phosphorylation; LOCATED IN- endomembrane system; EXPRESSED IN- 10 plant structures; EXPRESSED DURING- L mature pollen stage, M germinated pollen stage, 4 anthesis, C globular stage, petal differentiation and expansion stage; CONTAINS InterPro DOMAIN/s- Protein kinase, ATP binding site (InterPro-IPR017441), Protein kinase, core (InterPro-IPR000719), Serine/threonine protein kinase-rel [...] (858 aa) | |||||||||
(Arabidopsis thaliana) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 817 | |||
| pfam12819 | 335 | pfam12819, Malectin_like, Carbohydrate-binding pro | 9e-63 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-53 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-53 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-52 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-51 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-51 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-47 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-47 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-37 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-36 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-35 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-32 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-31 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-30 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-28 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-28 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-28 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-27 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-27 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-26 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-26 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-26 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-26 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-25 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-25 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 9e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-24 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-24 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-24 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-24 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-24 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-23 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-23 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-23 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-23 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-22 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-22 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-22 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-22 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-22 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-22 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-22 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-21 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-21 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-21 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-21 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-21 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-21 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-21 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-20 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-20 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-20 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-19 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-19 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-19 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-19 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-19 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-18 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-18 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-17 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-17 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-17 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-17 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-17 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-17 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 9e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-16 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-16 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-16 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-15 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-15 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-15 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-15 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 8e-14 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-13 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-13 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-13 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 9e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-12 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-12 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-11 | |
| pfam11721 | 164 | pfam11721, Malectin, Di-glucose binding within end | 1e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-11 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-11 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 9e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-10 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-08 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-08 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 9e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-06 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 6e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 7e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 9e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.001 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.002 |
| >gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER | Back alignment and domain information |
|---|
Score = 214 bits (546), Expect = 9e-63
Identities = 95/372 (25%), Positives = 146/372 (39%), Gaps = 49/372 (13%)
Query: 1 CGSKDGGIDAD---GRSWEPDDKYLSKGESKPTRATYQDSSLVSKVPYMDARVF--KQEM 55
CG D G +W D ++ G+S + ++SS PY R F +
Sbjct: 3 CGLPSNESYTDPSTGITWVSDAGFIDTGKSG--NISKENSSSFLSKPYKTLRSFPDGKRN 60
Query: 56 SYELPIRSQ--SRYWVRFHFYPSTYPELNVANSYFSVVANDVTLLSNFSASITAQAVAQA 113
Y LP+ ++Y +R F Y LN +S S D+ L N ++ +
Sbjct: 61 CYTLPVTPGKGTKYLIRATFLYGNYDGLNSVSSPPSF---DLYLGVNLWTTVNLSNDSGD 117
Query: 114 YLIKEFSLAPMDSDILKIIFRPSDKHSGTFAFINGIELVP-SPDLFEQAIIVGLGETIDG 172
++KE+ + SD L + + + FI+ +EL P L+ + G
Sbjct: 118 SVVKEYIIHVTKSDTLSVCLVNTGTGT---PFISALELRPLPDSLYPSS----------G 164
Query: 173 MTANMQTMFRLNV--AGQYISPKNDSGGLMRSWQNDEPYLFGAGYGIPMKADEVQIDYKS 230
+ ++ + RLN + I +D R W EP+ G+ + V I +
Sbjct: 165 GSQALKLVARLNFGGSEGTIRYPDDVYD--RIW---EPFFSSPGWSQISTSLSVDISS-N 218
Query: 231 LPDYSAPPDVYMTARYMGVDAHTNMEFNLTWIFRVDANFTYYVRLHFCEFKPDINKINQR 290
Y P V TA + N TW VD NF YYV LHF E I + R
Sbjct: 219 NAPYIPPSAVLQTAVTPTN---ASAPLNFTWDL-VDPNFEYYVYLHFAE----IQSLETR 270
Query: 291 VFNIYINNQTAQADADVIAWTHGQGVPIYKDYAVYVEDLPGDDQIFVAMSPSLKYQPEYL 350
F+IYIN +T D + +Y D+ V V G + +++ P+ L
Sbjct: 271 EFDIYINGKTVYGDVS-PKYLGTDTGALYLDFPVNV---SGGGLLNISLVPTSGST---L 323
Query: 351 DALLNGLEIFKI 362
LLN LEIFK+
Sbjct: 324 PPLLNALEIFKV 335
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 186 bits (474), Expect = 1e-53
Identities = 84/270 (31%), Positives = 135/270 (50%), Gaps = 29/270 (10%)
Query: 492 VIGVGGFGKVYKGVIEDK-----LKVAIKRS-NPSSEQGVNEFVTEIEMLSKLRHKHLVS 545
+G G FG+VYKG ++ K ++VA+K +SEQ + EF+ E ++ KL H ++V
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 546 LIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYT 605
L+G C E + +V +YM G L ++ + LS L + ARG+ YL +
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK---N 122
Query: 606 IIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLT 665
IHRD+ N L+ EN V K+SDFGLS+ + + + K ++ PE K + T
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY-YRKRGGKLPIRWMAPESLKEGKFT 181
Query: 666 EKSDIYSFGVVLFEV--LCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKI 723
KSD++SFGV+L+E+ L +P P + E+V L + G L
Sbjct: 182 SKSDVWSFGVLLWEIFTLGEQP--YPGMSNEEV------LEYLKNGYR------L---PQ 224
Query: 724 SPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
P C + D +C ++ DRP+ +++
Sbjct: 225 PPNCPPELYDLMLQCWAEDPEDRPTFSELV 254
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 184 bits (470), Expect = 5e-53
Identities = 85/278 (30%), Positives = 131/278 (47%), Gaps = 37/278 (13%)
Query: 492 VIGVGGFGKVYKGVIEDK----LKVAIKR-SNPSSEQGVNEFVTEIEMLSKLRHKHLVSL 546
+G G FG+VYKG ++ K +VA+K +SE+ +F+ E ++ KL H ++V L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 547 IGFCEEGNEMCLVYDYMALGTLREHI--------YNTKKALSWKQRLEICIGAARGLHYL 598
+G C E + LV +YM G L +++ K LS K L I A+G+ YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 599 HTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEY 658
+HRD+ N L+ E+ V K+SDFGLS+ + + T K ++ PE
Sbjct: 122 A---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPES 178
Query: 659 FKRQQLTEKSDIYSFGVVLFEV--LCARPALNPSLPKEQVSLADWALHCKRKGILDDIID 716
K T KSD++SFGV+L+E+ L A P P L E+V L+ +
Sbjct: 179 LKDGIFTSKSDVWSFGVLLWEIFTLGATP--YPGLSNEEV--------------LEYLRK 222
Query: 717 PLLKDKISPE-CLKKFADTAEKCLSDSGIDRPSMGDVL 753
K PE C + + C DRP+ +++
Sbjct: 223 GYRLPK--PEYCPDELYELMLSCWQLDPEDRPTFSELV 258
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 3e-52
Identities = 84/274 (30%), Positives = 136/274 (49%), Gaps = 36/274 (13%)
Query: 492 VIGVGGFGKVYKGVIEDK-----LKVAIKRS-NPSSEQGVNEFVTEIEMLSKLRHKHLVS 545
+G G FG+VYKG ++ K ++VA+K +SEQ + EF+ E ++ KL H ++V
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 546 LIGFCEEGNEMCLVYDYMALGTLREHI-YNTKKALSWKQRLEICIGAARGLHYLHTGAKY 604
L+G C E + +V +YM G L +++ N K LS L + ARG+ YL +
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK--- 122
Query: 605 TIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTV---VKGSFGYLDPEYFKR 661
IHRD+ N L+ EN V K+SDFGLS+ + + V ++ ++ PE K
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR----WMAPESLKE 178
Query: 662 QQLTEKSDIYSFGVVLFEV--LCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719
+ T KSD++SFGV+L+E+ L P P + +V L +KG
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEP--YPGMSNAEV------LEYLKKG---------Y 221
Query: 720 KDKISPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
+ P C + +C ++ DRP+ +++
Sbjct: 222 RLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELV 255
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 1e-51
Identities = 73/191 (38%), Positives = 103/191 (53%), Gaps = 9/191 (4%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIKR-SNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFC 550
+G GGFG VY + KVAIK S + E + EIE+L KL H ++V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 551 EEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRD 610
E+ N + LV +Y G+L++ + + LS + L I + GL YLH IIHRD
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRD 117
Query: 611 VKTTNILLDE-NWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQ-LTEKS 668
+K NILLD N K++DFGLSK + + + G+ Y+ PE + +EKS
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLT--SDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 669 DIYSFGVVLFE 679
DI+S GV+L+E
Sbjct: 176 DIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 5e-51
Identities = 67/197 (34%), Positives = 108/197 (54%), Gaps = 9/197 (4%)
Query: 492 VIGVGGFGKVYKGVI-----EDKLKVAIKRSNP-SSEQGVNEFVTEIEMLSKLRHKHLVS 545
+G G FG+VYKG + + KVA+K +SE+ EF+ E ++ KL H ++V
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 546 LIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYT 605
L+G C +G + +V +YM G L + + + L+ K L++ + A+G+ YL +K
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE--SK-N 122
Query: 606 IIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLT 665
+HRD+ N L+ EN V K+SDFGLS+ + K ++ PE K + T
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFT 182
Query: 666 EKSDIYSFGVVLFEVLC 682
KSD++SFGV+L+E+
Sbjct: 183 SKSDVWSFGVLLWEIFT 199
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 4e-47
Identities = 82/266 (30%), Positives = 122/266 (45%), Gaps = 20/266 (7%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSE--QGVNEFVTEIEMLSKLRHKHLVSLIG 548
+G G FG VYK VA+K SE + EI +L +L H ++V LI
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 549 FCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIH 608
E+ + + LV +Y G L +++ + LS + +I + RGL YLH IIH
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL-SRGGPLSEDEAKKIALQILRGLEYLH---SNGIIH 121
Query: 609 RDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPE-YFKRQQLTEK 667
RD+K NILLDEN V K++DFGL+K +++ T G+ Y+ PE K
Sbjct: 122 RDLKPENILLDENGVVKIADFGLAKKL--LKSSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179
Query: 668 SDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPEC 727
D++S GV+L+E+L +P + L L + G D S E
Sbjct: 180 VDVWSLGVILYELLTGKP-----PFSGENILDQLQLIRRILGP-PLEFDEPKWSSGSEEA 233
Query: 728 LKKFADTAEKCLSDSGIDRPSMGDVL 753
D +KCL+ RP+ ++L
Sbjct: 234 K----DLIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 8e-47
Identities = 76/264 (28%), Positives = 118/264 (44%), Gaps = 22/264 (8%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNE-FVTEIEMLSKLRHKHLVSLIGF 549
+G G FGKVY + VAIK + E + EI++L KL+H ++V L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 550 CEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHR 609
E+ +++ LV +Y G L + + + LS + L YLH I+HR
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLLKK-RGRLSEDEARFYLRQILSALEYLH---SKGIVHR 121
Query: 610 DVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSD 669
D+K NILLDE+ K++DFGL++ ++ G T G+ Y+ PE + + D
Sbjct: 122 DLKPENILLDEDGHVKLADFGLARQ---LDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVD 178
Query: 670 IYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLK 729
I+S GV+L+E+L +P P +Q+ +K P + ISPE
Sbjct: 179 IWSLGVILYELLTGKP---PFPGDDQLLEL------FKKIGKPKPPFPPPEWDISPEAK- 228
Query: 730 KFADTAEKCLSDSGIDRPSMGDVL 753
D K L R + + L
Sbjct: 229 ---DLIRKLLVKDPEKRLTAEEAL 249
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 73/261 (27%), Positives = 122/261 (46%), Gaps = 39/261 (14%)
Query: 492 VIGVGGFGKVYKGVIED-KLKVAIKRSN--PSSEQGVNEFVTEIEMLSKLRHKHLVSLIG 548
++G G FG VY + +D +A+K SE+ + EI +LS L+H ++V G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 549 FC--EEGNEMCLVYDYMALGTLREHIYNTKKALS-------WKQRLEICIGAARGLHYLH 599
EE N + + +Y++ G+L + L +Q LE GL YLH
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLL-KKFGKLPEPVIRKYTRQILE-------GLAYLH 118
Query: 600 T-GAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEY 658
+ G I+HRD+K NIL+D + V K++DFG +K ++E G + V+G+ ++ PE
Sbjct: 119 SNG----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174
Query: 659 FKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPL 718
+ ++ +DI+S G + E+ +P P ++ AL+ I P
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKP------PWSELGNPMAALYK----IGSSGEPPE 224
Query: 719 LKDKISPECLKKFADTAEKCL 739
+ + +S E D KCL
Sbjct: 225 IPEHLSEEAK----DFLRKCL 241
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 7e-36
Identities = 65/203 (32%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKRSN--PSSEQGVNEFVTEIEMLSKLRHKHLVSLIG 548
IG G FGKVY D +K + SE+ + + E+++L KL H +++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 549 FCEEGNEMCLVYDYMALGTLREHIYNTKKA---LSWKQRLEICIGAARGLHYLHTGAKYT 605
EE ++C+V +Y G L + I KK +Q L+ + L YLH
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRK 123
Query: 606 IIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN--GHVSTVVKGSFGYLDPEYFKRQQ 663
I+HRD+K NI L N + K+ DFG+SK + + TVV G+ YL PE + +
Sbjct: 124 ILHRDIKPQNIFLTSNGLVKLGDFGISKV---LSSTVDLAKTVV-GTPYYLSPELCQNKP 179
Query: 664 LTEKSDIYSFGVVLFEVLCARPA 686
KSDI+S G VL+E+ +
Sbjct: 180 YNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 4e-35
Identities = 60/194 (30%), Positives = 101/194 (52%), Gaps = 7/194 (3%)
Query: 487 FDESYVIGVGGFGKVYKG-VIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVS 545
F+ IG GGFG+VYK +VAIK S++ + + EI++L K +H ++V
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 546 LIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYT 605
G + +E+ +V ++ + G+L++ + +T + L+ Q +C +GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNG 118
Query: 606 IIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLT 665
IIHRD+K NILL + K+ DFGLS + + + G+ ++ PE +
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQ---LSDTKARNTMVGTPYWMAPEVINGKPYD 175
Query: 666 EKSDIYSFGVVLFE 679
K+DI+S G+ E
Sbjct: 176 YKADIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 9e-32
Identities = 69/190 (36%), Positives = 107/190 (56%), Gaps = 9/190 (4%)
Query: 493 IGVGGFGKVYKGVIEDKLKVAIK--RSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFC 550
IG G FG V+ G +K KVAIK R SE+ +F+ E +++ KL H LV L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 551 EEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRD 610
E + +CLV+++M G L +++ + S + L +C+ G+ YL + +IHRD
Sbjct: 69 TERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRD 125
Query: 611 VKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDI 670
+ N L+ EN V KVSDFG+++ + + ST K + PE F + + KSD+
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLD-DQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDV 184
Query: 671 YSFGVVLFEV 680
+SFGV+++EV
Sbjct: 185 WSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 5e-31
Identities = 67/209 (32%), Positives = 112/209 (53%), Gaps = 15/209 (7%)
Query: 493 IGVGGFGKVYKGVIE---DK--LKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSL 546
+G G FGKV + D +VA+K N S EQ ++F EIE+L L H+++V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 547 IGFCEE--GNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKY 604
G CE+ G + L+ +Y+ G+LR+++ + ++ K+ L +G+ YL + +Y
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS-QRY 130
Query: 605 TIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGS--FGYLDPEYFKRQ 662
IHRD+ NIL++ + K+SDFGL+K P ++ + S F Y PE +
Sbjct: 131 --IHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECLRTS 187
Query: 663 QLTEKSDIYSFGVVLFEVLC-ARPALNPS 690
+ + SD++SFGV L+E+ P+ +P
Sbjct: 188 KFSSASDVWSFGVTLYELFTYGDPSQSPP 216
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 8e-31
Identities = 67/207 (32%), Positives = 112/207 (54%), Gaps = 13/207 (6%)
Query: 493 IGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE 552
IG G FG V G + KVA+K S F+ E +++ LRH +LV L+G +
Sbjct: 14 IGKGEFGDVMLGDYRGQ-KVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 553 GNEMCLVYDYMALGTLREHIYNTKKA-LSWKQRLEICIGAARGLHYLHTGAKYTIIHRDV 611
GN + +V +YMA G+L +++ + +A ++ Q+L + G+ YL +HRD+
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDL 128
Query: 612 KTTNILLDENWVAKVSDFGLSKTGP-NMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDI 670
N+L+ E+ VAKVSDFGL+K ++G + VK + PE + ++ + KSD+
Sbjct: 129 AARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLP--VK----WTAPEALREKKFSTKSDV 182
Query: 671 YSFGVVLFEVLCARPALNPSLPKEQVS 697
+SFG++L+E+ P +P + V
Sbjct: 183 WSFGILLWEIYSFGRVPYPRIPLKDVV 209
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 78/273 (28%), Positives = 124/273 (45%), Gaps = 26/273 (9%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKRSN-PSSEQGVNEFVTEIEMLSKLRHKHLVSLIG- 548
V+G G G VYK A+K+ + E+ + + E++ L ++V G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 549 FCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL--EICIGAARGLHYLHTGAKYTI 606
F +EG E+ +V +YM G+L + + K + + I +GL YLHT I
Sbjct: 68 FYKEG-EISIVLEYMDGGSLADLLKKVGK---IPEPVLAYIARQILKGLDYLHTKRH--I 121
Query: 607 IHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTE 666
IHRD+K +N+L++ K++DFG+SK N + + V G+ Y+ PE + + +
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV--GTVTYMSPERIQGESYSY 179
Query: 667 KSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPE 726
+DI+S G+ L E + P LP Q S + L I D L ++ SPE
Sbjct: 180 AADIWSLGLTLLECALGK---FPFLPPGQPSF--FELMQA---ICDGPPPSLPAEEFSPE 231
Query: 727 CLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759
F D CL RPS ++L F+
Sbjct: 232 ----FRDFISACLQKDPKKRPSAAELL-QHPFI 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 79/269 (29%), Positives = 124/269 (46%), Gaps = 43/269 (15%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIG 548
+IG G FG VYKG+ +E VAIK+ + E+ + + EI++L L+H ++V IG
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 549 FCEEGNEMCLVYDYMALGTLREHIYNTKK------ALSWKQRLEICIGAARGLHYLHTGA 602
E + + ++ +Y G+LR+ I A+ Q L+ GL YLH
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQ-------GLAYLH--- 116
Query: 603 KYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQ 662
+ +IHRD+K NIL ++ V K++DFG++ + V G+ ++ PE +
Sbjct: 117 EQGVIHRDIKAANILTTKDGVVKLADFGVATKLN--DVSKDDASVVGTPYWMAPEVIEMS 174
Query: 663 QLTEKSDIYSFGVVLFEVLCARPA---LNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719
+ SDI+S G + E+L P LNP + AL I+ D PL
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPYYDLNP-MA---------ALFR----IVQDDHPPLP 220
Query: 720 KDKISPECLKKFADTAEKCLSDSGIDRPS 748
+ ISPE D +C RP+
Sbjct: 221 EG-ISPEL----KDFLMQCFQKDPNLRPT 244
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 122 bits (305), Expect = 7e-30
Identities = 81/276 (29%), Positives = 123/276 (44%), Gaps = 23/276 (8%)
Query: 492 VIGVGGFGKVYKGVIEDKLKVAIKRSNP---SSEQGVNEFVTEIEMLSKLRH-KHLVSLI 547
+G G FG+VY D+ VA+K S + V F+ EI++L+ L H ++V L
Sbjct: 7 KLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 548 GFCEEGNEMCLVYDYMALGTLREHIYN--TKKALSWKQRLEICIGAARGLHYLHTGAKYT 605
F ++ + LV +Y+ G+L + + K LS + L I L YLH+
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--- 121
Query: 606 IIHRDVKTTNILLDEN-WVAKVSDFGLSK----TGPNMENGHVSTVVKGSFGYLDPEYFK 660
IIHRD+K NILLD + V K+ DFGL+K G + + G+ GY+ PE
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 661 RQQL---TEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717
L + SDI+S G+ L+E+L P P ++ S L + + P
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLP---PFEGEKNSSATSQTLKIILELPTPSLASP 238
Query: 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
L K +D +K L+ +R S L
Sbjct: 239 LSPS-NPELISKAASDLLKKLLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 68/214 (31%), Positives = 113/214 (52%), Gaps = 18/214 (8%)
Query: 493 IGVGGFGKVYKGVIEDKLKVAIK--RSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFC 550
IG G FG VYKGV++ +VA+K RS + +F+ E E+L + H ++V LIG C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKR-KFLQEAEILKQYDHPNIVKLIGVC 61
Query: 551 EEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRD 610
+ + +V + + G+L + K L+ K+ L++ + AA G+ YL + IHRD
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRD 118
Query: 611 VKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKG----SFGYLDPEYFKRQQLTE 666
+ N L+ EN V K+SDFG+S+ E G + TV G + PE + T
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRE----EEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 667 KSDIYSFGVVLFEVL----CARPALNPSLPKEQV 696
+SD++S+G++L+E P ++ +E++
Sbjct: 175 ESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI 208
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 59/189 (31%), Positives = 107/189 (56%), Gaps = 6/189 (3%)
Query: 493 IGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE 552
+G G FG+V++G+ +++++VAIK +F E++ L +LRHKHL+SL C
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 553 GNEMCLVYDYMALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDV 611
G + ++ + M G+L + + + + L +++ A G+ YL + IHRD+
Sbjct: 74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDL 130
Query: 612 KTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIY 671
NIL+ E+ V KV+DFGL++ E+ ++S+ K + + PE + KSD++
Sbjct: 131 AARNILVGEDLVCKVADFGLARL--IKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVW 188
Query: 672 SFGVVLFEV 680
SFG++L+E+
Sbjct: 189 SFGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 5e-28
Identities = 70/278 (25%), Positives = 122/278 (43%), Gaps = 35/278 (12%)
Query: 492 VIGVGGFGKVYKGVI------EDKLKVAIKRSNPSSEQGV-NEFVTEIEMLSKLRHKHLV 544
+G G FG+V+ + V +K + ++ + +EF E++M KL HK++V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 545 SLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKA--------LSWKQRLEICIGAARGLH 596
L+G C E ++ +Y LG L++ + TK LS KQ++ +C A G+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 597 YLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME-NGHVSTVVKGSFGYLD 655
+L +HRD+ N L+ KVS LSK N E + ++ +L
Sbjct: 132 HLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI--PLRWLA 186
Query: 656 PEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDII 715
PE + + KSD++SFGV+++EV L E+V L+ +
Sbjct: 187 PEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV--------------LNRLQ 232
Query: 716 DPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
L+ + C + +C + + DRPS +++
Sbjct: 233 AGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELV 270
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 65/191 (34%), Positives = 103/191 (53%), Gaps = 11/191 (5%)
Query: 493 IGVGGFGKVYKGVIEDKLKVAIK--RSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFC 550
+G G FG V+ G K+ VAIK R SE ++F+ E +++ KL H +LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE---DDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 551 EEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRD 610
+ + +V +YMA G L ++ K L + L++C + YL IHRD
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRD 125
Query: 611 VKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTV-VKGSFGYLDPEYFKRQQLTEKSD 669
+ N L+ E+ V KVSDFGL++ +++ + S+ K + PE F + + KSD
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARY--VLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSD 183
Query: 670 IYSFGVVLFEV 680
++SFGV+++EV
Sbjct: 184 VWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 62/202 (30%), Positives = 108/202 (53%), Gaps = 12/202 (5%)
Query: 492 VIGVGGFGKVYKGV-IED----KLKVAIKR-SNPSSEQGVNEFVTEIEMLSKLRHKHLVS 545
V+G G FG VYKGV I + K+ VAIK +S + E + E +++ + H H+V
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 546 LIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYT 605
L+G C +++ L+ M LG L +++ N K + + L C+ A+G+ YL +
Sbjct: 74 LLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKR 129
Query: 606 IIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLT 665
++HRD+ N+L+ K++DFGL+K E + + K ++ E + T
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYT 189
Query: 666 EKSDIYSFGVVLFEVLC--ARP 685
KSD++S+GV ++E++ A+P
Sbjct: 190 HKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 65/217 (29%), Positives = 103/217 (47%), Gaps = 39/217 (17%)
Query: 492 VIGVGGFGKVYKGVI------EDKLKVAIKR-SNPSSEQGVNEFVTEIEMLSKLRHKHLV 544
+G G FGKV+ G DK VA+K +S +F E E+L+ +H+++V
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71
Query: 545 SLIGFCEEGNEMCLVYDYMALGTLREHIY-------------NTKKALSWKQRLEICIGA 591
G C EG+ +V++YM G L + + + L+ Q L+I +
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 592 ARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTV----V 647
A G+ YL A +HRD+ T N L+ + V K+ DFG+S+ V T V
Sbjct: 132 ASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRD--------VYTTDYYRV 180
Query: 648 KGS----FGYLDPEYFKRQQLTEKSDIYSFGVVLFEV 680
G ++ PE ++ T +SD++SFGVVL+E+
Sbjct: 181 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 77/282 (27%), Positives = 123/282 (43%), Gaps = 46/282 (16%)
Query: 485 KSFDESYVIGVGGFGKVYKGV-IEDKLKVAIK--RSNPSSEQGVNEFVTEIEMLSKLRHK 541
+ FD +G G +G VYK + E VAIK + E + EI +L +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ----EIIKEISILKQCDSP 58
Query: 542 HLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTG 601
++V G + ++ +V +Y G++ + + T K L+ ++ I +GL YLH
Sbjct: 59 YIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH-- 116
Query: 602 AKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKR 661
IHRD+K NILL+E AK++DFG+S +TV+ G+ ++ PE +
Sbjct: 117 -SNKKIHRDIKAGNILLNEEGQAKLADFGVS-GQLTDTMAKRNTVI-GTPFWMAPEVIQE 173
Query: 662 QQLTEKSDIYSFGVVLFEVLCARPA---LNPS-----LPKEQVSLADWALHCKRKGILDD 713
K+DI+S G+ E+ +P ++P +P +
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKP------------------ 215
Query: 714 IIDPLLKD--KISPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
P L D K SPE F D +KCL +RPS +L
Sbjct: 216 --PPTLSDPEKWSPE----FNDFVKKCLVKDPEERPSAIQLL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 484 TKSFDESYVIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKH 542
+ + IG G G+VYK +VAIK+ Q + EI ++ +H +
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPN 76
Query: 543 LVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGA 602
+V G+E+ +V +YM G+L + I ++ Q +C +GL YLH
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH--- 133
Query: 603 KYTIIHRDVKTTNILLDENWVAKVSDFG----LSKTGPNMENGHVSTVVKGSFGYLDPEY 658
+IHRD+K+ NILL ++ K++DFG L+K E ++VV G+ ++ PE
Sbjct: 134 SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK-----EKSKRNSVV-GTPYWMAPEV 187
Query: 659 FKRQQLTEKSDIYSFGVVLFE 679
KR+ K DI+S G++ E
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 59/195 (30%), Positives = 106/195 (54%), Gaps = 8/195 (4%)
Query: 492 VIGVGGFGKVYKGVI----EDKLKVAIKRSNP-SSEQGVNEFVTEIEMLSKLRHKHLVSL 546
VIG G FG+V +G + + ++ VAIK SS++ +F+TE ++ + H +++ L
Sbjct: 11 VIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRL 70
Query: 547 IGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTI 606
G + + ++ +YM G+L + + + Q + + G A G+ YL ++
Sbjct: 71 EGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL---SEMNY 127
Query: 607 IHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTE 666
+HRD+ NIL++ N V KVSDFGLS+ + E + + K + PE ++ T
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTS 187
Query: 667 KSDIYSFGVVLFEVL 681
SD++SFG+V++EV+
Sbjct: 188 ASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 7e-26
Identities = 69/201 (34%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 491 YVIGVGGFGKVYKGVIEDKLK--VAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVS 545
VIG G FGKV V + K A+K N + V + E +L +L H LV+
Sbjct: 6 RVIGKGAFGKVCI-VQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVN 64
Query: 546 L-IGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEIC-IGAARGLHYLHTGAK 603
L F +E N M LV D + G LR H+ K + + IC I A L YLH+
Sbjct: 65 LWYSFQDEEN-MYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLA--LEYLHS--- 118
Query: 604 YTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQ 663
IIHRD+K NILLDE ++DF ++ + ++T G+ GY+ PE RQ
Sbjct: 119 KGIIHRDIKPDNILLDEQGHVHITDFNIAT---KVTPDTLTTSTSGTPGYMAPEVLCRQG 175
Query: 664 LTEKSDIYSFGVVLFEVLCAR 684
+ D +S GV +E L +
Sbjct: 176 YSVAVDWWSLGVTAYECLRGK 196
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 66/199 (33%), Positives = 109/199 (54%), Gaps = 13/199 (6%)
Query: 492 VIGVGGFGKVYKGVIED----KLKVAIKRSNPSSE-QGVNEFVTEIEMLSKLRHKHLVSL 546
VIG G FG VY G + D K+ A+K N ++ + V +F+ E ++ H +++SL
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 547 IGFC--EEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKY 604
+G C EG+ + +V YM G LR I + + K + + A+G+ YL A
Sbjct: 62 LGICLPSEGSPL-VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL---ASK 117
Query: 605 TIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME--NGHVSTVVKGSFGYLDPEYFKRQ 662
+HRD+ N +LDE++ KV+DFGL++ + E + H T K ++ E + Q
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177
Query: 663 QLTEKSDIYSFGVVLFEVL 681
+ T KSD++SFGV+L+E++
Sbjct: 178 KFTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 68/209 (32%), Positives = 104/209 (49%), Gaps = 23/209 (11%)
Query: 493 IGVGGFGKVYKGVI------EDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSL 546
+G G FGKV+ +DK+ VA+K +SE +F E E+L+ L+H+H+V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 547 IGFCEEGNEMCLVYDYMALGT----LREHIYNTK----------KALSWKQRLEICIGAA 592
G C EG + +V++YM G LR H + K L+ Q L I A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 593 RGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFG 652
G+ YL A +HRD+ T N L+ + V K+ DFG+S+ + + V
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 653 YLDPEYFKRQQLTEKSDIYSFGVVLFEVL 681
++ PE ++ T +SDI+SFGVVL+E+
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 68/210 (32%), Positives = 104/210 (49%), Gaps = 25/210 (11%)
Query: 493 IGVGGFGKVYKGVI------EDKLKVAIKRSNPSSEQGV-NEFVTEIEMLSKLRHKHLVS 545
+G G FGKVYKG + VAIK ++E V EF E E++S L+H ++V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 546 LIGFCEEGNEMCLVYDYMALGTLREHIY---------------NTKKALSWKQRLEICIG 590
L+G C + C++++Y+A G L E + K +L L I I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 591 AARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGS 650
A G+ YL + + +HRD+ N L+ E K+SDFGLS+ + + V +
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 651 FGYLDPEYFKRQQLTEKSDIYSFGVVLFEV 680
++ PE + T +SDI+SFGVVL+E+
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 64/207 (30%), Positives = 104/207 (50%), Gaps = 21/207 (10%)
Query: 493 IGVGGFGKVYKGVI------EDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSL 546
+G G FGKV+ +DK+ VA+K +S+ +F E E+L+ L+H+H+V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 547 IGFCEEGNEMCLVYDYMALGTLREHIY------------NTKKALSWKQRLEICIGAARG 594
G C EG+ + +V++YM G L + + N L+ Q L I A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 595 LHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYL 654
+ YL A +HRD+ T N L+ EN + K+ DFG+S+ + + V ++
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 655 DPEYFKRQQLTEKSDIYSFGVVLFEVL 681
PE ++ T +SD++S GVVL+E+
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIF 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 71/267 (26%), Positives = 123/267 (46%), Gaps = 23/267 (8%)
Query: 493 IGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE 552
+G G FG+V++G+ + VA+K P + +F+ E +++ KLRH L+ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 553 GNEMCLVYDYMALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDV 611
+ +V + M G+L E++ +AL Q +++ A G+ YL IHRD+
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDL 129
Query: 612 KTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTV-VKGSFGYLDPEYFKRQQLTEKSDI 670
N+L+ EN + KV+DFGL++ E+ + + K + PE + + KSD+
Sbjct: 130 AARNVLVGENNICKVADFGLARV--IKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDV 187
Query: 671 YSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKK 730
+SFG++L E++ P + +V +D + P C K+
Sbjct: 188 WSFGILLTEIVTYGRMPYPGMTNAEVL---------------QQVDQGYRMPCPPGCPKE 232
Query: 731 FADTAEKCLSDSGIDRPSMGDVLWNLE 757
D C + DRP+ + W LE
Sbjct: 233 LYDIMLDCWKEDPDDRPTFETLQWKLE 259
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 63/213 (29%), Positives = 111/213 (52%), Gaps = 15/213 (7%)
Query: 492 VIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVN-EFVTEIEMLSKLRHKHLVSLIGFC 550
++G G FG+V+KG ++DK VA+K Q + +F++E +L + H ++V LIG C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 551 EEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRD 610
+ + +V + + G + K L KQ ++ + AA G+ YL + IHRD
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRD 118
Query: 611 VKTTNILLDENWVAKVSDFGLSKTGPNMENGHV---STVVKGSFGYLDPEYFKRQQLTEK 667
+ N L+ EN V K+SDFG+S+ E+ + S + + + PE + + +
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR----QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174
Query: 668 SDIYSFGVVLFEV----LCARPALNPSLPKEQV 696
SD++S+G++L+E +C P + +EQV
Sbjct: 175 SDVWSYGILLWETFSLGVCPYPGMTNQQAREQV 207
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 64/191 (33%), Positives = 101/191 (52%), Gaps = 11/191 (5%)
Query: 493 IGVGGFGKVYKGVIEDKLKVAIK--RSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFC 550
+G G FG V G + VAIK + SE +EF+ E +++ KL H+ LV L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 551 EEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRD 610
+ + +V +YM+ G L ++ K Q LE+C G+ YL + IHRD
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRD 125
Query: 611 VKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTV-VKGSFGYLDPEYFKRQQLTEKSD 669
+ N L+D+ KVSDFGLS+ +++ + S+V K + PE + + KSD
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSD 183
Query: 670 IYSFGVVLFEV 680
+++FGV+++EV
Sbjct: 184 VWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 63/209 (30%), Positives = 105/209 (50%), Gaps = 27/209 (12%)
Query: 493 IGVGGFGKVYK-GVIEDKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGF 549
+G G +G VYK + D A+K + S++ + V EI +L+ + H ++ I +
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI---ISY 64
Query: 550 CE---EGNEMCLVYDYMALGTLREHIYNTKKA-------LSWKQRLEICIGAARGLHYLH 599
E +GN++C+V +Y G L + I KK W+ +++ RGL LH
Sbjct: 65 KEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL----RGLQALH 120
Query: 600 TGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYF 659
I+HRD+K+ NILL N + K+ D G+SK ++ T + G+ Y+ PE +
Sbjct: 121 E---QKILHRDLKSANILLVANDLVKIGDLGISKV---LKKNMAKTQI-GTPHYMAPEVW 173
Query: 660 KRQQLTEKSDIYSFGVVLFEVLCARPALN 688
K + + KSDI+S G +L+E+ P
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPPFE 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 25/213 (11%)
Query: 487 FDESYVIGVGGFGKVYKGVIE--DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKH 542
++ IG G FG V K V D + K + +E+ + V+E+ +L +L+H +
Sbjct: 2 YEVLETIGKGSFGTVRK-VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPN 60
Query: 543 LVSLIG--FCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLE------ICIGAARG 594
+V + +V +Y G L + I KK ++ +E I
Sbjct: 61 IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKE---RKYIEEEFIWRILTQLLLA 117
Query: 595 LHYLHTG--AKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV--STVVKGS 650
L+ H T++HRD+K NI LD N K+ DFGL+K + + T V G+
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK---ILGHDSSFAKTYV-GT 173
Query: 651 FGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCA 683
Y+ PE EKSDI+S G +++E LCA
Sbjct: 174 PYYMSPEQLNHMSYDEKSDIWSLGCLIYE-LCA 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 64/202 (31%), Positives = 97/202 (48%), Gaps = 20/202 (9%)
Query: 493 IGVGGFGKVYKGVIEDK-----LKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLI 547
+G G FGKV +D +KV +K+ + V +TE +LS++ H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKV-LKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 548 -GFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL---EICIGAARGLHYLHTGAK 603
F E + LV +Y G L H+ + + R EI + L YLH
Sbjct: 60 YAFQTEEK-LYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLA----LEYLH---S 111
Query: 604 YTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQ 663
II+RD+K NILLD + K++DFGL+K + E +T G+ YL PE +
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKELSS-EGSRTNTFC-GTPEYLAPEVLLGKG 169
Query: 664 LTEKSDIYSFGVVLFEVLCARP 685
+ D +S GV+L+E+L +P
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGKP 191
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 59/195 (30%), Positives = 97/195 (49%), Gaps = 11/195 (5%)
Query: 493 IGVGGFGKVYKGVIEDK----LKVAIKRSNPSSEQ-GVNEFVTEIEMLSKLRHKHLVSLI 547
+G G FG V KGV K ++VA+K G EF+ E ++++L H +V LI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 548 GFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTII 607
G C+ G + LV + LG L +++ ++ + E+ A G+ YL + +
Sbjct: 63 GVCK-GEPLMLVMELAPLGPLLKYLKK-RREIPVSDLKELAHQVAMGMAYLE-SKHF--V 117
Query: 608 HRDVKTTNILLDENWVAKVSDFGLSK-TGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTE 666
HRD+ N+LL AK+SDFG+S+ G + +T + + PE + +
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSS 177
Query: 667 KSDIYSFGVVLFEVL 681
KSD++S+GV L+E
Sbjct: 178 KSDVWSYGVTLWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 58/196 (29%), Positives = 107/196 (54%), Gaps = 9/196 (4%)
Query: 492 VIGVGGFGKVYKGVIE----DKLKVAIKRSNPS-SEQGVNEFVTEIEMLSKLRHKHLVSL 546
VIG G FG+V++G+++ ++ VAIK P +E+ +F++E ++ + H +++ L
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 547 IGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTI 606
G + ++ +YM G L +++ + S Q + + G A G+ YL +
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL---SDMNY 128
Query: 607 IHRDVKTTNILLDENWVAKVSDFGLSKTGPNM-ENGHVSTVVKGSFGYLDPEYFKRQQLT 665
+HRD+ NIL++ N KVSDFGLS+ + E + ++ K + PE ++ T
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFT 188
Query: 666 EKSDIYSFGVVLFEVL 681
SD++SFG+V++EV+
Sbjct: 189 SASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 4e-23
Identities = 69/207 (33%), Positives = 110/207 (53%), Gaps = 13/207 (6%)
Query: 492 VIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCE 551
+IG G FG V +G + KVA+K N + F+ E +++KL HK+LV L+G
Sbjct: 13 IIGEGEFGAVLQGEYTGQ-KVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 552 EGNEMCLVYDYMALGTLREHIYNTKKAL-SWKQRLEICIGAARGLHYLHTGAKYTIIHRD 610
N + +V + M+ G L + +AL S Q L+ + A G+ YL + ++HRD
Sbjct: 70 H-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRD 125
Query: 611 VKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDI 670
+ NIL+ E+ VAKVSDFGL++ G + V + PE K ++ + KSD+
Sbjct: 126 LAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV-----KWTAPEALKHKKFSSKSDV 180
Query: 671 YSFGVVLFEVLCARPALNPSLPKEQVS 697
+S+GV+L+EV A P + ++V
Sbjct: 181 WSYGVLLWEVFSYGRAPYPKMSLKEVK 207
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 4e-23
Identities = 62/191 (32%), Positives = 99/191 (51%), Gaps = 10/191 (5%)
Query: 493 IGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE 552
+G G FG+V+ G KVA+K P + F+ E +++ KLRH LV L C E
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 553 GNEMCLVYDYMALGTLREHIYN-TKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDV 611
+ +V +YM+ G+L + + + K L Q +++ A G+ YL IHRD+
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDL 129
Query: 612 KTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSF--GYLDPEYFKRQQLTEKSD 669
NIL+ EN V K++DFGL++ +E+ + F + PE + T KSD
Sbjct: 130 AARNILVGENLVCKIADFGLARL---IEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSD 186
Query: 670 IYSFGVVLFEV 680
++SFG++L E+
Sbjct: 187 VWSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 4e-23
Identities = 65/210 (30%), Positives = 104/210 (49%), Gaps = 11/210 (5%)
Query: 492 VIGVGGFGK--VYKGVIEDKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLI 547
V+G G FG+ +Y+ ED V K N + SE+ + + EI +LS L+H ++++
Sbjct: 7 VLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 548 GFCEEGNEMCLVYDYMALGTLREHIYNTKKAL-SWKQRLEICIGAARGLHYLHTGAKYTI 606
+ N + + +Y GTL + I K L + L + Y+H K I
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGI 122
Query: 607 IHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTE 666
+HRD+KT NI L + + K+ DFG+SK E TVV G+ Y+ PE + +
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKI-LGSEYSMAETVV-GTPYYMSPELCQGVKYNF 180
Query: 667 KSDIYSFGVVLFEVLCARPALNPSLPKEQV 696
KSDI++ G VL+E+L + + + P V
Sbjct: 181 KSDIWALGCVLYELLTLKRTFDATNPLNLV 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 6e-23
Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 487 FDESYVIGVGGFGKVYKGVIEDKLKV-AIKRSNPSSEQGV--NEFVTEIEMLSKLRHKHL 543
F+ IG G FG V+K V + +V A+K+ + S E + E +L+KL ++
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 544 VSLIGFCEEGNEMCLVYDYMALGTLREHIY-NTKKALSWKQRLEICIGAARGLHYLHTGA 602
+ + ++ +V +Y G L + + + L Q I GL +LH
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH--- 118
Query: 603 KYTIIHRDVKTTNILLDENWVAKVSDFGLSKT-GPNMENGHVSTVVKGSFGYLDPEYFKR 661
I+HRD+K+ N+ LD K+ D G++K N +T+V G+ YL PE +
Sbjct: 119 SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN--TNFANTIV-GTPYYLSPELCED 175
Query: 662 QQLTEKSDIYSFGVVLFEVLC 682
+ EKSD+++ GVVL+E C
Sbjct: 176 KPYNEKSDVWALGVVLYE-CC 195
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 7e-23
Identities = 68/240 (28%), Positives = 113/240 (47%), Gaps = 47/240 (19%)
Query: 493 IGVGGFGKVYK----GVI--EDKLKVAIKR-SNPSSEQGVNEFVTEIEMLSKLRHKHLVS 545
IG G FG+V++ G++ E VA+K +S +F E ++++ H ++V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 546 LIGFCEEGNEMCLVYDYMALGTLREHI-----YNT----------------KKALSWKQR 584
L+G C G MCL+++YMA G L E + LS ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 585 LEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVS 644
L I A G+ YL ++ +HRD+ T N L+ EN V K++DFGLS+ N + +
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR------NIYSA 183
Query: 645 TVVKGS------FGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNP--SLPKEQV 696
K S ++ PE + T +SD++++GVVL+E+ + P + E+V
Sbjct: 184 DYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY--GMQPYYGMAHEEV 241
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 1e-22
Identities = 64/229 (27%), Positives = 126/229 (55%), Gaps = 28/229 (12%)
Query: 493 IGVGGFGKVYK----GVIEDKLK----VAIKR-SNPSSEQGVNEFVTEIEMLSKL-RHKH 542
+G G FG+V G+ +DK K VA+K + ++E+ +++ V+E+EM+ + +HK+
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 543 LVSLIGFCEEGNEMCLVYDYMALGTLREHI-----------YNTKKA----LSWKQRLEI 587
+++L+G C + + ++ +Y + G LRE++ Y+ + +++K +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 588 CIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVV 647
ARG+ YL A IHRD+ N+L+ EN V K++DFGL++ N++ +T
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 648 KGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQV 696
+ ++ PE + T +SD++SFGV+++E+ + P +P E++
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 1e-22
Identities = 54/196 (27%), Positives = 105/196 (53%), Gaps = 10/196 (5%)
Query: 492 VIGVGGFGKVYKGV-IED----KLKVAIKR-SNPSSEQGVNEFVTEIEMLSKLRHKHLVS 545
++G G FG V+KG+ I + K+ VAIK + S Q E + + L H ++V
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 546 LIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYT 605
L+G C G + LV LG+L +H+ + +L ++ L C+ A+G++YL ++
Sbjct: 74 LLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHR 129
Query: 606 IIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLT 665
++HR++ NILL + + +++DFG++ + + + K ++ E + T
Sbjct: 130 MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYT 189
Query: 666 EKSDIYSFGVVLFEVL 681
+SD++S+GV ++E++
Sbjct: 190 HQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 2e-22
Identities = 67/217 (30%), Positives = 107/217 (49%), Gaps = 40/217 (18%)
Query: 492 VIGVGGFGKVYKGVIE---DKLKVAIKR-SNPSSEQGVNEFVTEIEMLSKL-RHKHLVSL 546
VIG G FG+V + +I+ K+ AIK +SE +F E+E+L KL H ++++L
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 547 IGFCEEGNEMCLVYDYMALGTL-----------------REHIYNTKKALSWKQRLEICI 589
+G CE + + +Y G L +EH T L+ +Q L+
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEH--GTASTLTSQQLLQFAS 126
Query: 590 GAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKG 649
A G+ YL ++ IHRD+ N+L+ EN +K++DFGLS+ VK
Sbjct: 127 DVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGE--------EVYVKK 175
Query: 650 SFGYLDPEYFKRQQL-----TEKSDIYSFGVVLFEVL 681
+ G L + + L T KSD++SFGV+L+E++
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 2e-22
Identities = 66/212 (31%), Positives = 108/212 (50%), Gaps = 23/212 (10%)
Query: 492 VIGVGGFGKV----YKGVIEDKLKVAIK-RSNPSSEQGVNEFVTEIEMLSKLRHKHLVSL 546
IG G FG V Y+G KVA+K N ++ Q F+ E ++++LRH +LV L
Sbjct: 13 TIGKGEFGDVMLGDYRGN-----KVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQL 64
Query: 547 IG-FCEEGNEMCLVYDYMALGTLREHIYNT-KKALSWKQRLEICIGAARGLHYLHTGAKY 604
+G EE + +V +YMA G+L +++ + + L L+ + + YL
Sbjct: 65 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN--- 121
Query: 605 TIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQL 664
+HRD+ N+L+ E+ VAKVSDFGL+K E K + PE + ++
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKF 176
Query: 665 TEKSDIYSFGVVLFEVLCARPALNPSLPKEQV 696
+ KSD++SFG++L+E+ P +P + V
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 208
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 3e-22
Identities = 58/197 (29%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 492 VIGVGGFGKVYKGV----IEDKLKVAIKRSNPSSEQGVNE-FVTEIEMLSKLRHKHLVSL 546
IG G FG VY+GV +K+ VA+K + V E F+ E ++ + H H+V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 547 IGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTI 606
IG E N + +V + LG LR ++ K +L + + L YL +
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES---KRF 128
Query: 607 IHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV--STVVKGSFGYLDPEYFKRQQL 664
+HRD+ N+L+ K+ DFGLS+ +E+ ++ K ++ PE ++
Sbjct: 129 VHRDIAARNVLVSSPDCVKLGDFGLSRY---LEDESYYKASKGKLPIKWMAPESINFRRF 185
Query: 665 TEKSDIYSFGVVLFEVL 681
T SD++ FGV ++E+L
Sbjct: 186 TSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 4e-22
Identities = 63/229 (27%), Positives = 128/229 (55%), Gaps = 28/229 (12%)
Query: 493 IGVGGFGKVYK----GVIEDK----LKVAIKR-SNPSSEQGVNEFVTEIEMLSKL-RHKH 542
+G G FG+V G+ +DK + VA+K + ++++ +++ V+E+EM+ + +HK+
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 543 LVSLIGFCEEGNEMCLVYDYMALGTLREHI-----------YNT----KKALSWKQRLEI 587
+++L+G C + + ++ +Y + G LRE++ ++T ++ L++K +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 588 CIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVV 647
ARG+ YL A IHRD+ N+L+ E+ V K++DFGL++ N++ +T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 648 KGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQV 696
+ ++ PE + T +SD++SFGV+L+E+ + P +P E++
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 5e-22
Identities = 71/258 (27%), Positives = 119/258 (46%), Gaps = 47/258 (18%)
Query: 493 IGVGGFGKVY---KGVIEDK--LKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLI 547
I G +G+V+ K D +KV IK+++ + V++ +TE ++LS+ + ++V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKV-IKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY 59
Query: 548 -GFCEEGNEMCLVYDYMA---LGTLREHI-----YNTKKALSWKQRLEICIGAARGLHYL 598
F + N + LV +Y+ L +L E++ + ++ EI + L YL
Sbjct: 60 YSFQGKKN-LYLVMEYLPGGDLASLLENVGSLDEDVARIYIA-----EIVLA----LEYL 109
Query: 599 HTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTG-------PNMENGHVSTVVKGSF 651
H IIHRD+K NIL+D N K++DFGLSK G N + +V G+
Sbjct: 110 H---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV-GTP 165
Query: 652 GYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGIL 711
Y+ PE Q ++ D +S G +L+E L P + P+E IL
Sbjct: 166 DYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQ-----------NIL 214
Query: 712 DDIIDPLLKDKISPECLK 729
+ I+ ++S E +
Sbjct: 215 NGKIEWPEDVEVSDEAID 232
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 8e-22
Identities = 62/214 (28%), Positives = 104/214 (48%), Gaps = 32/214 (14%)
Query: 493 IGVGGFGKVYKG------VIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSL 546
+G G FGKV+ +DK+ VA+K + +F E E+L+ L+H+H+V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 547 IGFCEEGNEMCLVYDYMALGTLREHI---------------YNTKKALSWKQRLEICIGA 591
G C +G+ + +V++YM G L + + K L Q L I
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 592 ARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME----NGHVSTVV 647
A G+ YL A +HRD+ T N L+ N + K+ DFG+S+ + + GH +
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 648 KGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVL 681
+ ++ PE ++ T +SD++SFGV+L+E+
Sbjct: 190 R----WMPPESIMYRKFTTESDVWSFGVILWEIF 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 1e-21
Identities = 61/191 (31%), Positives = 101/191 (52%), Gaps = 11/191 (5%)
Query: 493 IGVGGFGKVYKGVIEDKLKVAIK--RSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFC 550
+G G FG V+ G ++KVAIK SE+ +F+ E +++ KL H LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE---DFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 551 EEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRD 610
+ + +V ++M G L ++ + LS L +C G+ YL + + IHRD
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRD 125
Query: 611 VKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTV-VKGSFGYLDPEYFKRQQLTEKSD 669
+ N L+ V KVSDFG+++ +++ + S+ K + PE F + + KSD
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRY--VLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSD 183
Query: 670 IYSFGVVLFEV 680
++SFGV+++EV
Sbjct: 184 VWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 65/236 (27%), Positives = 118/236 (50%), Gaps = 46/236 (19%)
Query: 493 IGVGGFGKVYKGVI------EDKLKVAIKR-SNPSSEQGVNEFVTEIEMLSKL-RHKHLV 544
+G G FG+V K + VA+K + ++E+ +++ V+E+EM+ + +HK+++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 545 SLIGFCEEGNEMCLVYDYMALGTLREHI---------------YNTKKALSWKQRLEICI 589
+L+G C + + +V +Y A G LR+ + ++ L+ K +
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 590 GAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLS----------KTGPNME 639
ARG+ +L A IHRD+ N+L+ E+ V K++DFGL+ KT
Sbjct: 140 QVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTT---- 192
Query: 640 NGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQ 695
NG + VK ++ PE + T +SD++SFGV+L+E+ + P +P E+
Sbjct: 193 NGRLP--VK----WMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 64/265 (24%), Positives = 124/265 (46%), Gaps = 31/265 (11%)
Query: 501 VYKGVIEDKLKV--AIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGF----CEEGN 554
+YKG+ +K + K+ + + ++ EI+ L ++ +++ + GF ++
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 555 EMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTT 614
+ L+ +Y G LRE + +K LS+K +L++ I +GL+ L+ ++++ +
Sbjct: 96 RLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSV 152
Query: 615 NILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKR--QQLTEKSDIYS 672
+ L+ EN+ K+ GL K + +V+ +V Y + + T K DIYS
Sbjct: 153 SFLVTENYKLKIICHGLEKILSSPPFKNVNFMV-----YFSYKMLNDIFSEYTIKDDIYS 207
Query: 673 FGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFA 732
GVVL+E+ + +P E ++ K I D II+ K+ +C +
Sbjct: 208 LGVVLWEIFTGK------IPFENLTT---------KEIYDLIINKNNSLKLPLDCPLEIK 252
Query: 733 DTAEKCLSDSGIDRPSMGDVLWNLE 757
E C S I RP++ ++L+NL
Sbjct: 253 CIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 57/208 (27%), Positives = 100/208 (48%), Gaps = 27/208 (12%)
Query: 493 IGVGGFGKVYKGVIEDKLK-VAIKR-----SNPSSEQGVNEFVTEIEMLSKLRHKHLVSL 546
+G G FG+VY D + +A+K+ +P +++ VN EI++L L+H+ +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 547 IGFCEEGNEMCLVYDYMALGTLREHIYNTKKALS-------WKQRLEICIGAARGLHYLH 599
G + + + +YM G++++ + AL+ +Q LE G+ YLH
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQL-KAYGALTETVTRKYTRQILE-------GVEYLH 121
Query: 600 TGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSK--TGPNMENGHVSTVVKGSFGYLDPE 657
+ I+HRD+K NIL D K+ DFG SK + +V G+ ++ PE
Sbjct: 122 SN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT-GTPYWMSPE 177
Query: 658 YFKRQQLTEKSDIYSFGVVLFEVLCARP 685
+ K+D++S G + E+L +P
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLTEKP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 3e-21
Identities = 62/229 (27%), Positives = 125/229 (54%), Gaps = 28/229 (12%)
Query: 493 IGVGGFGKVYK----GVIEDK----LKVAIKR-SNPSSEQGVNEFVTEIEMLSKL-RHKH 542
+G G FG+V G+ ++K KVA+K + ++E+ +++ ++E+EM+ + +HK+
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 543 LVSLIGFCEEGNEMCLVYDYMALGTLREHI---------------YNTKKALSWKQRLEI 587
+++L+G C + + ++ +Y + G LRE++ ++ LS+K +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 588 CIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVV 647
ARG+ YL A IHRD+ N+L+ E+ V K++DFGL++ +++ +T
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 648 KGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQV 696
+ ++ PE + T +SD++SFGV+L+E+ + P +P E++
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 4e-21
Identities = 74/275 (26%), Positives = 120/275 (43%), Gaps = 43/275 (15%)
Query: 493 IGVGGFGKVYKGVIEDKLK------VAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSL 546
+G G FG VY+G+ D V++ + ++ V + EI +LSKL+H ++V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 547 IGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSW-------KQRLEICIGAARGLHYLH 599
+G E + + + + + G+L + + +Q L GL YLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSL-AKLLKKYGSFPEPVIRLYTRQILL-------GLEYLH 119
Query: 600 TGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYF 659
+HRD+K NIL+D N V K++DFG++K +E + KGS ++ PE
Sbjct: 120 DR---NTVHRDIKGANILVDTNGVVKLADFGMAKQ--VVEFSFAKS-FKGSPYWMAPEVI 173
Query: 660 KRQQL-TEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPL 718
+Q +DI+S G + E+ +P P E V+ R L P
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMATGKP---PWSQLEGVAA---VFKIGRSKEL-----PP 222
Query: 719 LKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
+ D +S E K F KCL RP+ ++L
Sbjct: 223 IPDHLSDE-AKDF---ILKCLQRDPSLRPTAAELL 253
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 4e-21
Identities = 69/215 (32%), Positives = 108/215 (50%), Gaps = 36/215 (16%)
Query: 492 VIGVGGFGKVYKGVIED---KLKVAIKR-SNPSSEQGVNEFVTEIEMLSKL-RHKHLVSL 546
VIG G FG+V K I+ ++ AIKR +S+ +F E+E+L KL H ++++L
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 547 IGFCEEGNEMCLVYDYMALGTLREHI---------------YNTKKALSWKQRLEICIGA 591
+G CE + L +Y G L + + +T LS +Q L
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 592 ARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSF 651
ARG+ YL ++ IHRD+ NIL+ EN+VAK++DFGLS+ VK +
Sbjct: 134 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ--------EVYVKKTM 182
Query: 652 GYLDPEYFKRQQL-----TEKSDIYSFGVVLFEVL 681
G L + + L T SD++S+GV+L+E++
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 5e-21
Identities = 69/209 (33%), Positives = 104/209 (49%), Gaps = 34/209 (16%)
Query: 492 VIGVGGFGKV----YKGVIEDKLKV----AIKRSNPSSEQGVNEFVTEIEMLSKLRHKHL 543
V+G G FGKV Y + ++ +KR +Q + + EI +L L H+++
Sbjct: 11 VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENI 68
Query: 544 VSLIGFCEEGNE--MCLVYDYMALGTLREHIYNTKKALSWKQRL----EICIGAARGLHY 597
V G C E + L+ +Y+ LG+LR+ Y K L+ Q L +IC G+ Y
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRD--YLPKHKLNLAQLLLFAQQIC----EGMAY 122
Query: 598 LHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGS-----FG 652
LH+ Y IHRD+ N+LLD + + K+ DFGL+K P GH V+ F
Sbjct: 123 LHS-QHY--IHRDLAARNVLLDNDRLVKIGDFGLAKAVP---EGHEYYRVREDGDSPVFW 176
Query: 653 YLDPEYFKRQQLTEKSDIYSFGVVLFEVL 681
Y E K + + SD++SFGV L+E+L
Sbjct: 177 YA-VECLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 6e-21
Identities = 64/225 (28%), Positives = 106/225 (47%), Gaps = 27/225 (12%)
Query: 492 VIGVGGFGKVYKGVI------EDKLKVAIK-RSNPSSEQGVNEFVTEIEMLSKLRHKHLV 544
+G G FG+VY+G+ +L+VA+K SEQ ++F+ E ++SK H+++V
Sbjct: 13 ALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIV 72
Query: 545 SLIGFCEEGNEMCLVYDYMALGTLREHIYNTK------KALSWKQRLEICIGAARGLHYL 598
LIG E ++ + MA G L+ + + +L+ K L A+G YL
Sbjct: 73 RLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL 132
Query: 599 HTGAKYTIIHRDVKTTNILLD---ENWVAKVSDFGLSK----TGPNMENGHVSTVVKGSF 651
IHRD+ N LL VAK++DFG+++ + G +K
Sbjct: 133 EE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK--- 186
Query: 652 GYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQV 696
++ PE F T K+D++SFGV+L+E+ P ++V
Sbjct: 187 -WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV 230
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 1e-20
Identities = 69/217 (31%), Positives = 107/217 (49%), Gaps = 40/217 (18%)
Query: 492 VIGVGGFGKVYKGVIED---KLKVAIKR-SNPSSEQGVNEFVTEIEMLSKL-RHKHLVSL 546
VIG G FG+V K I+ ++ AIKR +S+ +F E+E+L KL H ++++L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 547 IGFCEEGNEMCLVYDYMALGTL-----------------REHIYNTKKALSWKQRLEICI 589
+G CE + L +Y G L + +T LS +Q L
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN--STASTLSSQQLLHFAA 119
Query: 590 GAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKG 649
ARG+ YL ++ IHRD+ NIL+ EN+VAK++DFGLS+ VK
Sbjct: 120 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ--------EVYVKK 168
Query: 650 SFGYLDPEYFKRQQL-----TEKSDIYSFGVVLFEVL 681
+ G L + + L T SD++S+GV+L+E++
Sbjct: 169 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 78/297 (26%), Positives = 140/297 (47%), Gaps = 42/297 (14%)
Query: 487 FDESYVIGVGGFGKVYKGVIE----DKLK------VAIKRSNPSSEQGVNEFVTEIEMLS 536
F+E ++ + GK G +E D L+ VA+K+ S+ + + +F EIE+L
Sbjct: 1 FEERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILK 60
Query: 537 KLRHKHLVSLIGFCEEG--NEMCLVYDYMALGTLREHIYNTKKALSWKQRL----EICIG 590
L+H ++V G C + LV +Y+ G+LR+++ ++ L ++ L +IC
Sbjct: 61 SLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQIC-- 118
Query: 591 AARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGS 650
+G+ YL +Y +HRD+ T NIL++ K+ DFGL+K P + + S
Sbjct: 119 --KGMEYL-GSKRY--VHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGES 173
Query: 651 --FGYLDPEYFKRQQLTEKSDIYSFGVVLFEVL--CARPALNPSLPKEQVSLADWALHCK 706
F Y PE + + SD++SFGVVL+E+ + P+ +
Sbjct: 174 PIFWYA-PESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMG-------ND 225
Query: 707 RKG--ILDDIIDPLLKDK----ISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757
++G I+ +I+ LLK+ P C + ++C ++ RPS ++ +E
Sbjct: 226 KQGQMIVYHLIE-LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVE 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 4e-20
Identities = 82/285 (28%), Positives = 131/285 (45%), Gaps = 23/285 (8%)
Query: 486 SFDESYVIGVGGFGKVYKG-VIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLV 544
S E VI G G YKG I++ ++ +K N + +E I + KL+H ++V
Sbjct: 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSE----IADMGKLQHPNIV 746
Query: 545 SLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKY 604
LIG C L+++Y+ L E + N LSW++R +I IG A+ L +LH
Sbjct: 747 KLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSP 802
Query: 605 TIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQL 664
++ ++ I++D LS G T S Y+ PE + + +
Sbjct: 803 AVVVGNLSPEKIIID---GKDEPHLRLSLPGLLC----TDTKCFISSAYVAPETRETKDI 855
Query: 665 TEKSDIYSFGVVLFEVLCARPALNPSLPKEQV--SLADWALHCKRKGILDDIIDPLLKDK 722
TEKSDIY FG++L E+L + +P+ + V S+ +WA +C LD IDP ++
Sbjct: 856 TEKSDIYGFGLILIELLTGK---SPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD 912
Query: 723 IS--PECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVES 765
+S + + + A C + RP DVL LE + S
Sbjct: 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSS 957
|
Length = 968 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 4e-20
Identities = 70/237 (29%), Positives = 113/237 (47%), Gaps = 29/237 (12%)
Query: 493 IGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE 552
+G G FG+V+ G +VAIK P + F+ E +++ KLRH+ LV L E
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 553 GNEMCLVYDYMALGTLREHIY-NTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDV 611
+ +V +YM+ G+L + + K L Q +++ A G+ Y+ + +HRD+
Sbjct: 73 -EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 128
Query: 612 KTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSF--GYLDPEYFKRQQLTEKSD 669
+ NIL+ EN V KV+DFGL++ +E+ + F + PE + T KSD
Sbjct: 129 RAANILVGENLVCKVADFGLARL---IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 670 IYSFGVVLFEV----------LCARPALN--------PSLPKEQVSLADWALHCKRK 708
++SFG++L E+ + R L+ P P+ SL D C RK
Sbjct: 186 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRK 242
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 8e-20
Identities = 69/201 (34%), Positives = 99/201 (49%), Gaps = 19/201 (9%)
Query: 493 IGVGGFGKVY-----KGVIEDKLKVAIKRSNPSSEQGVNEFV---TEIEMLSKLRHKHLV 544
+G G FG VY K V E++LKV + P E NE V E ++LSKL H +V
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVL--KEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 545 SLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKA---LSWKQRLEICIGAARGLHYLHTG 601
E + C++ +Y L + K LS Q E I G+HY+H
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH-- 123
Query: 602 AKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKR 661
+ I+HRD+K NI L N + K+ DFG+S+ M + ++T G+ Y+ PE K
Sbjct: 124 -QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRL--LMGSCDLATTFTGTPYYMSPEALKH 179
Query: 662 QQLTEKSDIYSFGVVLFEVLC 682
Q KSDI+S G +L+E+ C
Sbjct: 180 QGYDSKSDIWSLGCILYEMCC 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 8e-20
Identities = 58/196 (29%), Positives = 103/196 (52%), Gaps = 10/196 (5%)
Query: 492 VIGVGGFGKVYKGVIED-----KLKVAIKRSNPSSEQGVN-EFVTEIEMLSKLRHKHLVS 545
V+G G FG VYKG+ K+ VAIK N ++ N EF+ E +++ + H HLV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 546 LIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYT 605
L+G C + LV M G L ++++ K + + L C+ A+G+ YL +
Sbjct: 74 LLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERR 129
Query: 606 IIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLT 665
++HRD+ N+L+ K++DFGL++ E + + K ++ E ++ T
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 189
Query: 666 EKSDIYSFGVVLFEVL 681
+SD++S+GV ++E++
Sbjct: 190 HQSDVWSYGVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 9e-20
Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 31/219 (14%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKL-RHKHLVSL 546
+IG G F V E + AIK + E+ V E E+L++L H ++ L
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 547 IG-FCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHT-GAKY 604
F +E N + V +Y G L ++I +L K L YLH+ G
Sbjct: 68 YYTFQDEEN-LYFVLEYAPNGELLQYI-RKYGSLDEKCTRFYAAEILLALEYLHSKG--- 122
Query: 605 TIIHRDVKTTNILLDENWVAKVSDFGLSK----TGPNMENGHVSTVV----------KGS 650
IIHRD+K NILLD++ K++DFG +K N +T + S
Sbjct: 123 -IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFAS 181
Query: 651 F-G---YLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
F G Y+ PE + + SD+++ G +++++L +P
Sbjct: 182 FVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP 220
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 9e-20
Identities = 62/221 (28%), Positives = 105/221 (47%), Gaps = 30/221 (13%)
Query: 493 IGVGGFGKVYKGVIEDKL-------KVAIK---RSNPSSEQGVNEFVTEIEMLSKLRHKH 542
+G G FG+VY+G D L +VA+K + E+ EF+ E ++S H +
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK--KEFLKEAHLMSNFNHPN 60
Query: 543 LVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKA------LSWKQRLEICIGAARGLH 596
+V L+G C ++ + M G L ++ + + L+ K+ L+IC+ A+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 597 YLHTGAKYTIIHRDVKTTNILLDE-----NWVAKVSDFGLSKTGPNMENGHVSTVVKGSF 651
YL + IHRD+ N L+ E + V K+ DFGL++ +
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 652 GYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC----ARPALN 688
++ PE + T +SD++SFGV+++E+L PALN
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN 218
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 1e-19
Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 14/206 (6%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCE 551
+G G FGKVYK E L A K SE+ + +F+ EI++LS+ +H ++V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 552 EGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDV 611
N++ ++ ++ G L + ++ L+ Q +C L++LH + +IHRD+
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDL 129
Query: 612 KTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEY-----FKRQQLTE 666
K NILL + K++DFG+S + + + G+ ++ PE FK
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI--GTPYWMAPEVVACETFKDNPYDY 187
Query: 667 KSDIYSFGVVLFEVLCARP---ALNP 689
K+DI+S G+ L E+ P LNP
Sbjct: 188 KADIWSLGITLIELAQMEPPHHELNP 213
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 1e-19
Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIK--RSNPSSEQ--GVNEFVT--EIEMLSKLRHKHLVS 545
+G G + VYK E VAIK + E G+N F EI++L +L+H +++
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGIN-FTALREIKLLQELKHPNIIG 66
Query: 546 LIG-FCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKY 604
L+ F + N + LV+++M L + I + L+ + RGL YLH
Sbjct: 67 LLDVFGHKSN-INLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SN 121
Query: 605 TIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPE-YFKRQQ 663
I+HRD+K N+L+ + V K++DFGL+++ + VV + Y PE F +
Sbjct: 122 WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV--TRWYRAPELLFGARH 179
Query: 664 LTEKSDIYSFGVVLFEVLCARPAL 687
D++S G + E+L P L
Sbjct: 180 YGVGVDMWSVGCIFAELLLRVPFL 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 64/238 (26%), Positives = 111/238 (46%), Gaps = 42/238 (17%)
Query: 493 IGVGGFGKVY------------KGVIEDKLK-----VAIKRSNPS-SEQGVNEFVTEIEM 534
+G G FG+V+ K E+ VA+K P S+ +F+ E+++
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 535 LSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGT----LREHIY------NTKKALSWKQR 584
LS+L ++ L+G C +C++ +YM G L++H+ K+LS+
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 585 LEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVS 644
L + A G+ YL +HRD+ T N L+ +N+ K++DFG+S+ N+ +
Sbjct: 133 LYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR---NLYSSDYY 186
Query: 645 TVVKGS----FGYLDPEYFKRQQLTEKSDIYSFGVVLFEV--LCARPALNPSLPKEQV 696
V+G ++ E + T KSD+++FGV L+E+ LC L +QV
Sbjct: 187 R-VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE-HLTDQQV 242
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 2e-19
Identities = 56/205 (27%), Positives = 101/205 (49%), Gaps = 25/205 (12%)
Query: 492 VIGVGGFGKVYKGVIEDKLKVAIKRSNPS---------SEQGVNEFVTEIEMLSKLRHKH 542
VIG G FG+V +G +LK+ KR +E+ +F++E ++ + H +
Sbjct: 11 VIGAGEFGEVCRG----RLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPN 66
Query: 543 LVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGA 602
++ L G + + ++ ++M G L + + Q + + G A G+ YL +
Sbjct: 67 IIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---S 123
Query: 603 KYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFG------YLDP 656
+ +HRD+ NIL++ N V KVSDFGLS+ +E+ S G + P
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRF---LEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 657 EYFKRQQLTEKSDIYSFGVVLFEVL 681
E ++ T SD++S+G+V++EV+
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (222), Expect = 2e-19
Identities = 64/236 (27%), Positives = 104/236 (44%), Gaps = 59/236 (25%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEF-VT---EIEMLSKLRHKHLVSLI 547
IG G +G+VYK + VA+K+ E F +T EI++L KLRH ++V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRM--ENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 548 GFC--EEGNEMCLVYDYMALGTLREH-----IYNTKKALS-------WKQRLEICIGAAR 593
+ + +V++YM +H + + + + KQ LE
Sbjct: 65 EIVTSKGKGSIYMVFEYM------DHDLTGLLDSPEVKFTESQIKCYMKQLLE------- 111
Query: 594 GLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG----HVSTVVKG 649
GL YLH+ I+HRD+K +NIL++ + V K++DFGL++ + V T+
Sbjct: 112 GLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITL--- 165
Query: 650 SFGYLDPE-------YFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSL 698
Y PE Y + D++S G +L E+ +P S EQ+
Sbjct: 166 --WYRPPELLLGATRY------GPEVDMWSVGCILAELFLGKPIFQGSTELEQLEK 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 81/275 (29%), Positives = 124/275 (45%), Gaps = 46/275 (16%)
Query: 492 VIGVGGFGKVYKGVIEDKLK-VAIKRSN-PSSEQGVNEFVTEIEMLSKLRHKHLVSLIGF 549
IG G FG+VYK + + + VAIK + +E + + EI+ LS+ R ++ G
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 550 CEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHR 609
+G+++ ++ +Y G+ + + K L I GL YLH K IHR
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLLKPGK--LDETYIAFILREVLLGLEYLHEEGK---IHR 122
Query: 610 DVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVS-------TVVKGSFGYLDPEYFKRQ 662
D+K NILL E K++DFG+S G ++ T V F ++ PE K+
Sbjct: 123 DIKAANILLSEEGDVKLADFGVS--------GQLTSTMSKRNTFVGTPF-WMAPEVIKQS 173
Query: 663 QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIID---PLL 719
EK+DI+S G+ E+ P P L+D LH R +L I P L
Sbjct: 174 GYDEKADIWSLGITAIELAKGEP---P--------LSD--LHPMR--VLFLIPKNNPPSL 218
Query: 720 K-DKISPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
+ +K S F D CL+ +RPS ++L
Sbjct: 219 EGNKFSKP----FKDFVSLCLNKDPKERPSAKELL 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 73/290 (25%), Positives = 124/290 (42%), Gaps = 43/290 (14%)
Query: 492 VIGVGGFGKVYKGVIEDK----LKVAIK--RSNPSSEQGVNEFVTEIEMLSKLRHKHLVS 545
++G G FG V +G + LKVA+K + + + + EF++E + H +++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 546 LIGFCEEGNEM------CLVYDYMALGTLREHIYNTK-----KALSWKQRLEICIGAARG 594
LIG C E + + ++ +M G L + ++ + L + L+ + A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 595 LHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT---GPNMENGHVSTV-VKGS 650
+ YL IHRD+ N +L E+ V+DFGLSK G G ++ + VK
Sbjct: 126 MEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK-- 180
Query: 651 FGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGI 710
++ E + T KSD+++FGV ++E+ A P E + D+ H R
Sbjct: 181 --WIAIESLADRVYTSKSDVWAFGVTMWEI--ATRGQTPYPGVENHEIYDYLRHGNRL-- 234
Query: 711 LDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVL 760
K +CL + D C DRP+ + LE +L
Sbjct: 235 -----------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-19
Identities = 67/237 (28%), Positives = 115/237 (48%), Gaps = 29/237 (12%)
Query: 493 IGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE 552
+G G FG+V+ G KVA+K P + F+ E +++ KLRH LV L E
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 553 GNEMCLVYDYMALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDV 611
+ +V +YM+ G+L + + + + +AL +++ A G+ Y+ + IHRD+
Sbjct: 73 -EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDL 128
Query: 612 KTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSF--GYLDPEYFKRQQLTEKSD 669
++ NIL+ + V K++DFGL++ +E+ + F + PE + T KSD
Sbjct: 129 RSANILVGDGLVCKIADFGLARL---IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 670 IYSFGVVLFEVLCA----RPALNPSLPKEQV--------------SLADWALHCKRK 708
++SFG++L E++ P +N EQV SL + L C +K
Sbjct: 186 VWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKK 242
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 63/199 (31%), Positives = 97/199 (48%), Gaps = 18/199 (9%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQ-GVNEFVTEIEMLSKLRHKHLVSLIGF 549
VIGVG VY + + + KVAIKR + Q V+E E++ +S+ H ++V
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67
Query: 550 CEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAA-----RGLHYLHTGAKY 604
G+E+ LV Y++ G+L + + K + E I +GL YLH
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIM---KSSYPRGGLDEAIIATVLKEVLKGLEYLH---SN 121
Query: 605 TIIHRDVKTTNILLDENWVAKVSDFGLSK---TGPNMENGHVSTVVKGSFGYLDPEYFKR 661
IHRD+K NILL E+ K++DFG+S G + T V G+ ++ PE ++
Sbjct: 122 GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV-GTPCWMAPEVMEQ 180
Query: 662 QQ-LTEKSDIYSFGVVLFE 679
K+DI+SFG+ E
Sbjct: 181 VHGYDFKADIWSFGITAIE 199
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 6e-19
Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 26/208 (12%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIK--RSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGF 549
IG G FGKVY V ++ +A+K R + + + E E+++L L+H +LV G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 550 CEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL-EICIGA-----ARGLHYLHTGAK 603
++ + +Y + GTL E L + L E I GL YLH+
Sbjct: 68 EVHREKVYIFMEYCSGGTLEE-------LLEHGRILDEHVIRVYTLQLLEGLAYLHSHG- 119
Query: 604 YTIIHRDVKTTNILLDENWVAKVSDFGLSK---TGPNMENGHVSTVVKGSFGYLDPEYFK 660
I+HRD+K NI LD N V K+ DFG + V ++ G+ Y+ PE
Sbjct: 120 --IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA-GTPAYMAPEVIT 176
Query: 661 RQQLTEK---SDIYSFGVVLFEVLCARP 685
+ +DI+S G V+ E+ +
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 6e-19
Identities = 75/289 (25%), Positives = 123/289 (42%), Gaps = 50/289 (17%)
Query: 493 IGVGGFGKVYKGVI------EDKLKVAIKRSNPSSEQG-VNEFVTEIEMLSKLRHKHLVS 545
+G G FG VY+G+ E + +VAIK N ++ EF+ E ++ + H+V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 546 LIGFCEEGNEMCLVYDYMALGTLR---------EHIYNTKKALSWKQRLEICIGAARGLH 596
L+G G +V + MA G L+ + ++ +++ A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 597 YLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYL-- 654
YL AK +HRD+ N ++ E+ K+ DFG+++ + KG G L
Sbjct: 134 YLA--AKK-FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYR-----KGGKGLLPV 185
Query: 655 ---DPEYFKRQQLTEKSDIYSFGVVLFEV--LCARPALNPSLPKEQVSLADWALHCKRKG 709
PE K T KSD++SFGVVL+E+ L +P L E+V
Sbjct: 186 RWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY--QGLSNEEV------------- 230
Query: 710 ILDDIIDPLLKDKISPECL-KKFADTAEKCLSDSGIDRPSMGDVLWNLE 757
L +ID D PE K + C + RP+ +++ +L+
Sbjct: 231 -LKFVIDGGHLDL--PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 7e-19
Identities = 53/200 (26%), Positives = 90/200 (45%), Gaps = 16/200 (8%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVT--EIEMLSKLRHKHLVSLIGF 549
IG G +G VYK VAIK+ E EI++L +L H +++ L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 550 CEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHR 609
++ LV+++M L + I + ++ L +GL + H + I+HR
Sbjct: 67 FRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHR 122
Query: 610 DVKTTNILLDENWVAKVSDFGLSK---TGPNMENGHVSTVVKGSFGYLDPE-YFKRQQLT 665
D+K N+L++ V K++DFGL++ + +V T Y PE + +
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPELLLGDKGYS 177
Query: 666 EKSDIYSFGVVLFEVLCARP 685
DI+S G + E+L RP
Sbjct: 178 TPVDIWSVGCIFAELLSRRP 197
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 7e-19
Identities = 67/270 (24%), Positives = 125/270 (46%), Gaps = 28/270 (10%)
Query: 493 IGVGGFGKVYKGVIED-KLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCE 551
+G G +G+VY+GV + L VA+K + + V EF+ E ++ +++H +LV L+G C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 552 EGNEMCLVYDYMALGTLREHIYNT-KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRD 610
++ ++M G L +++ ++ ++ L + + + YL K IHRD
Sbjct: 73 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 129
Query: 611 VKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGS---FGYLDPEYFKRQQLTEK 667
+ N L+ EN + KV+DFGLS+ + G T G+ + PE + + K
Sbjct: 130 LAARNCLVGENHLVKVADFGLSR----LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 185
Query: 668 SDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPEC 727
SD+++FGV+L+E+ + P + QV ++++ + + C
Sbjct: 186 SDVWAFGVLLWEIATYGMSPYPGIDLSQVY---------------ELLEKGYRMERPEGC 230
Query: 728 LKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757
K + C + DRPS ++ E
Sbjct: 231 PPKVYELMRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 1e-18
Identities = 45/147 (30%), Positives = 78/147 (53%), Gaps = 11/147 (7%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIKRS-NPSSEQGVNEFVT---EIEMLSKLRHKHLVSLI 547
+G G +G VYK + VA+K+ + E+G+ T EI +L +L+H ++V L+
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIP--STALREISLLKELKHPNIVKLL 64
Query: 548 GFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTII 607
++ LV++Y + L++++ LS I RGL Y H+ I+
Sbjct: 65 DVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RIL 120
Query: 608 HRDVKTTNILLDENWVAKVSDFGLSKT 634
HRD+K NIL++ + V K++DFGL++
Sbjct: 121 HRDLKPQNILINRDGVLKLADFGLARA 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 19/201 (9%)
Query: 493 IGVGGFGKVYKGVIEDKLKV-AIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIG 548
+G GGFG+V ++ K+ A K+ + +G + E ++L K+ + +VSL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 549 FCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL-----EICIGAARGLHYLHTGAK 603
E +++CLV M G L+ HIYN + + R +I GL +LH +
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIIC----GLEHLH---Q 113
Query: 604 YTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQ 663
I++RD+K N+LLD++ ++SD GL+ ++ G G+ GY+ PE + +
Sbjct: 114 RRIVYRDLKPENVLLDDHGNVRISDLGLAV---ELKGGKKIKGRAGTPGYMAPEVLQGEV 170
Query: 664 LTEKSDIYSFGVVLFEVLCAR 684
D ++ G L+E++ R
Sbjct: 171 YDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 52/195 (26%), Positives = 91/195 (46%), Gaps = 11/195 (5%)
Query: 493 IGVGGFGKVYKG----VIEDKLKVAIKRSNPSSEQG-VNEFVTEIEMLSKLRHKHLVSLI 547
+G G FG V +G + VA+K +++F+ E ++ L H++L+ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 548 GFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL-EICIGAARGLHYLHTGAKYTI 606
G + + +V + LG+L + + L + + A G+ YL +
Sbjct: 63 GVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RF 118
Query: 607 IHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTV-VKGSFGYLDPEYFKRQQLT 665
IHRD+ NILL + K+ DFGL + P E+ +V +K F + PE + + +
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFS 178
Query: 666 EKSDIYSFGVVLFEV 680
SD++ FGV L+E+
Sbjct: 179 HASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 2e-18
Identities = 60/199 (30%), Positives = 104/199 (52%), Gaps = 14/199 (7%)
Query: 493 IGVGGFGKVY------KGVIEDKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVS 545
+G G FGKV +G + VA+K P S + + EIE+L L H+++V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQ-VAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 546 LIGFCEE--GNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAK 603
G C E GN + L+ +++ G+L+E++ K ++ KQ+L+ + +G+ YL G++
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL--GSR 128
Query: 604 YTIIHRDVKTTNILLDENWVAKVSDFGLSKT-GPNMENGHVSTVVKGSFGYLDPEYFKRQ 662
+HRD+ N+L++ K+ DFGL+K + E V + + PE +
Sbjct: 129 -QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS 187
Query: 663 QLTEKSDIYSFGVVLFEVL 681
+ SD++SFGV L+E+L
Sbjct: 188 KFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 2e-18
Identities = 78/291 (26%), Positives = 125/291 (42%), Gaps = 58/291 (19%)
Query: 493 IGVGGFGKVY--KGVIEDKLKVAIKRSNPSSEQGV---NEFVTEIEMLSKLRHKHLVSLI 547
IG G FG VY + V +++ VAIK+ + S +Q + + E+ L +LRH + +
Sbjct: 23 IGHGSFGAVYFARDVRTNEV-VAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 548 GFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTII 607
G + LV +Y LG+ + + KK L + IC GA +GL YLH+ + I
Sbjct: 82 GCYLREHTAWLVMEY-CLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS---HERI 137
Query: 608 HRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEY---FKRQQL 664
HRD+K NILL E K++DFG S + + N V T ++ PE Q
Sbjct: 138 HRDIKAGNILLTEPGTVKLADFG-SASLVSPANSFVGTPY-----WMAPEVILAMDEGQY 191
Query: 665 TEKSDIYSFGVVLFEVLCARPAL----------------NPSLPKEQVSLADWALHCKRK 708
K D++S G+ E+ +P L +P+L DW+ +
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSN-----DWSDY---- 242
Query: 709 GILDDIIDPLLKDKISPECLKKFAD---TAEKCLSDSGIDRPSMGDVLWNL 756
+ +D CL+K ++E+ L + R V+ +L
Sbjct: 243 --FRNFVD---------SCLQKIPQDRPSSEELLKHRFVLRERPPTVIIDL 282
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 25/211 (11%)
Query: 493 IGVGGFGKVYKGVI-----EDKLKVAIKR-SNPSSEQGVNEFVTEIEMLSKLRHKHLVSL 546
+G FGK+YKG + + VAIK + ++ Q EF E ++++L H ++V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 547 IGFCEEGNEMCLVYDYMALGTLREHIY----------------NTKKALSWKQRLEICIG 590
+G + +C++++Y+ G L E + K +L L I I
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 591 AARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGS 650
A G+ YL + + +H+D+ NIL+ E K+SD GLS+ + + V
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 651 FGYLDPEYFKRQQLTEKSDIYSFGVVLFEVL 681
++ PE + + SDI+SFGVVL+E+
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 58/200 (29%), Positives = 101/200 (50%), Gaps = 17/200 (8%)
Query: 492 VIGVGGFGKVYKGVIEDKLKVAIKRSNP---------SSEQGVNEFVTEIEMLSKLRHKH 542
VIG G FG+V G +LK+ KR P +E+ +F++E ++ + H +
Sbjct: 11 VIGAGEFGEVCSG----RLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPN 66
Query: 543 LVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGA 602
++ L G + + +V +YM G+L + + Q + + G A G+ YL +
Sbjct: 67 IIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL---S 123
Query: 603 KYTIIHRDVKTTNILLDENWVAKVSDFGLSKT-GPNMENGHVSTVVKGSFGYLDPEYFKR 661
+HRD+ NIL++ N V KVSDFGLS+ + E + + K + PE
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 183
Query: 662 QQLTEKSDIYSFGVVLFEVL 681
++ T SD++S+G+V++EV+
Sbjct: 184 RKFTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 75/281 (26%), Positives = 133/281 (47%), Gaps = 40/281 (14%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKRSN-PSSEQG---------VNEFVTEIEMLSKLRH 540
+IG G +G+VY + + +A+K+ P++ G V +EIE L L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 541 KHLVSLIGFCEEGNEMCLVYDYMALGT----LREHIYNTKKALSW--KQRLEICIGAARG 594
++V +GF + + +Y+ G+ LR + ++ + + +Q LE G
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLE-------G 120
Query: 595 LHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYL 654
L YLH I+HRD+K N+L+D + + K+SDFG+SK ++ + + ++GS ++
Sbjct: 121 LAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177
Query: 655 DPE--YFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILD 712
PE + Q + K DI+S G V+ E+ R P +E ++ A + L KR
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR---RPWSDEEAIA-AMFKLGNKRSA--- 230
Query: 713 DIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
I P + +SP L F + + +RP+ ++L
Sbjct: 231 PPIPPDVSMNLSPVAL-DFLN--ACFTINP-DNRPTARELL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-18
Identities = 52/192 (27%), Positives = 100/192 (52%), Gaps = 10/192 (5%)
Query: 493 IGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE 552
+G G FG+V+ G + KVA+K P + V F+ E ++ L+H LV L +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 553 GNEMCLVYDYMALGTLREHIYNTKKA-LSWKQRLEICIGAARGLHYLHTGAKYTIIHRDV 611
+ ++ +YMA G+L + + + + + + ++ A G+ Y+ + IHRD+
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDL 129
Query: 612 KTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSF--GYLDPEYFKRQQLTEKSD 669
+ N+L+ E+ + K++DFGL++ +E+ + F + PE T KSD
Sbjct: 130 RAANVLVSESLMCKIADFGLARV---IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 186
Query: 670 IYSFGVVLFEVL 681
++SFG++L+E++
Sbjct: 187 VWSFGILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 70/280 (25%), Positives = 128/280 (45%), Gaps = 44/280 (15%)
Query: 493 IGVGGFGKVYKGVIEDKLK--VAIKR---SNP-------SSEQGVNEFVTEIEMLSK-LR 539
+G G FG VYK ++ + +A+K NP ++ + + V+E+ ++ + LR
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 540 HKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALS-------WKQRLEICIGAA 592
H ++V E + + +V D + L EH + K+ W +++ +
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA-- 125
Query: 593 RGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFG 652
L YLH + I+HRD+ NI+L E+ ++DFGL+K +++VV G+
Sbjct: 126 --LRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQ--KQPESKLTSVV-GTIL 178
Query: 653 YLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILD 712
Y PE K + EK+D+++FG +L+++ +P P +SLA I++
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQP---PFYSTNMLSLA--------TKIVE 227
Query: 713 DIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDV 752
+ +P L + + E D CL+ RP + V
Sbjct: 228 AVYEP-LPEGMYSE---DVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 3e-18
Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 17/198 (8%)
Query: 493 IGVGGFGKVYKGVIEDKLK---VAIKRSNPSSEQGV-NEFVTEIEMLSKLRHKHLVSLIG 548
+G G FG V KGV + + K VAIK +E+ V +E + E E++ +L + ++V +IG
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 549 FCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKY---- 604
CE M LV + + G L + + K ++ +E+ +H + G KY
Sbjct: 63 VCEAEALM-LVMEMASGGPLNKFLSGKKDEITVSNVVEL-------MHQVSMGMKYLEGK 114
Query: 605 TIIHRDVKTTNILLDENWVAKVSDFGLSKT-GPNMENGHVSTVVKGSFGYLDPEYFKRQQ 663
+HRD+ N+LL AK+SDFGLSK G + + K + PE ++
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174
Query: 664 LTEKSDIYSFGVVLFEVL 681
+ +SD++S+G+ ++E
Sbjct: 175 FSSRSDVWSYGITMWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 61/207 (29%), Positives = 103/207 (49%), Gaps = 11/207 (5%)
Query: 493 IGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE 552
+G G FG+V+ G KVAIK P + F+ E +++ KLRH LV L E
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 553 GNEMCLVYDYMALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDV 611
+ +V ++M G+L + + K L Q +++ A G+ Y+ + IHRD+
Sbjct: 73 -EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDL 128
Query: 612 KTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSF--GYLDPEYFKRQQLTEKSD 669
+ NIL+ +N V K++DFGL++ +E+ + F + PE + T KSD
Sbjct: 129 RAANILVGDNLVCKIADFGLARL---IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 670 IYSFGVVLFEVLCARPALNPSLPKEQV 696
++SFG++L E++ P + +V
Sbjct: 186 VWSFGILLTELVTKGRVPYPGMVNREV 212
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 6e-18
Identities = 61/196 (31%), Positives = 97/196 (49%), Gaps = 13/196 (6%)
Query: 492 VIGVGGFGKVY--KGVIEDKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLI 547
V+G G FG V+ + D+ V IK+ ++ E ++L L H +++
Sbjct: 7 VVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65
Query: 548 GFCEEGNEMCLVYDYMALGTLREHIYNTKKA-LSWKQRLEICIGAARGLHYLHTGAKYTI 606
E + +V +Y GTL E+I + L L + LH++HT I
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLI 122
Query: 607 IHRDVKTTNILLDEN-WVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLT 665
+HRD+KT NILLD++ V K+ DFG+SK + TVV G+ Y+ PE + +
Sbjct: 123 LHRDLKTQNILLDKHKMVVKIGDFGISKILSS--KSKAYTVV-GTPCYISPELCEGKPYN 179
Query: 666 EKSDIYSFGVVLFEVL 681
+KSDI++ G VL+E+
Sbjct: 180 QKSDIWALGCVLYELA 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 7e-18
Identities = 71/259 (27%), Positives = 113/259 (43%), Gaps = 40/259 (15%)
Query: 510 LKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFC--EEGNEMCLVYDYMALGT 567
LK NP ++ + + E+E+ + ++V G E + + + +Y G+
Sbjct: 31 LKTITTDPNPDLQK---QILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGS 87
Query: 568 LREHIYNTKKALSWKQR------LEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDEN 621
L + IY KK R +I +GL YLH+ IIHRD+K +NILL
Sbjct: 88 L-DSIY--KKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRK 141
Query: 622 WVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVL 681
K+ DFG+S + N T SF Y+ PE + + + SD++S G+ L EV
Sbjct: 142 GQVKLCDFGVSG---ELVNSLAGTFTGTSF-YMAPERIQGKPYSITSDVWSLGLTLLEVA 197
Query: 682 CAR----PALNPSL-PKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECL--KKFADT 734
R P P L P E +S + ++ +P LKD+ ++F D
Sbjct: 198 QNRFPFPPEGEPPLGPIELLS------------YIVNMPNPELKDEPGNGIKWSEEFKDF 245
Query: 735 AEKCLSDSGIDRPSMGDVL 753
++CL RP+ D+L
Sbjct: 246 IKQCLEKDPTRRPTPWDML 264
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 8e-18
Identities = 80/287 (27%), Positives = 120/287 (41%), Gaps = 53/287 (18%)
Query: 487 FDESYVIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVS 545
++ IG G +G VYK I VAIK EI ML + RH ++V+
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64
Query: 546 LIGFCEEGNEMCLVYDYMALGTLREHIYN-TKKALSWKQRLEICIGAARGLHYLHTGAKY 604
G +++ +V +Y G+L++ IY T+ LS Q +C +GL YLH K
Sbjct: 65 YFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAYLHETGK- 122
Query: 605 TIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFG----------YL 654
IHRD+K NILL E+ K++DFG VS + + ++
Sbjct: 123 --IHRDIKGANILLTEDGDVKLADFG------------VSAQLTATIAKRKSFIGTPYWM 168
Query: 655 DPEYF---KRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGIL 711
PE ++ K DI++ G+ E+ +P + + LH R L
Sbjct: 169 APEVAAVERKGGYDGKCDIWALGITAIELAELQPPM-------------FDLHPMRALFL 215
Query: 712 ---DDIIDPLLKDK--ISPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
+ P LKDK SP F D +KCL+ RP+ +L
Sbjct: 216 ISKSNFPPPKLKDKEKWSP----VFHDFIKKCLTKDPKKRPTATKLL 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 493 IGVGGFGKVYKGVIEDKLKV-AIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIG 548
+G GGFG+V + K+ A K+ N +G + E +L+K+ + +VSL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 549 FCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAAR---GLHYLHTGAKYT 605
+ ++CLV M G LR HIYN + C A+ GL +LH +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRR 117
Query: 606 IIHRDVKTTNILLDENWVAKVSDFGLS---KTGPNMENGHVSTVVKGSFGYLDPEYFKRQ 662
II+RD+K N+LLD + ++SD GL+ K G + G+ G+ G++ PE + +
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-----GTPGFMAPELLQGE 172
Query: 663 QLTEKSDIYSFGVVLFEVLCAR 684
+ D ++ GV L+E++ AR
Sbjct: 173 EYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 62/206 (30%), Positives = 106/206 (51%), Gaps = 19/206 (9%)
Query: 487 FDESYVIGVGGFGKVY--KGVIEDKLKVAIKRSN----PSSEQGVNEFVTEIEMLSKLRH 540
++ IG G FGK+Y K + + IK + P E+ ++ E+ +L+K++H
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSE-HCVIKEIDLTKMPVKEKEASK--KEVILLAKMKH 58
Query: 541 KHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKAL-SWKQRLEICIGAARGLHYLH 599
++V+ +E + +V +Y G L + I + L S Q L + + GL ++H
Sbjct: 59 PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH 118
Query: 600 TGAKYTIIHRDVKTTNILLDEN-WVAKVSDFGLSKTGPN-MENGHVSTVVKGSFGYLDPE 657
I+HRD+K+ NI L +N VAK+ DFG+++ + ME ++ G+ YL PE
Sbjct: 119 ---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME---LAYTCVGTPYYLSPE 172
Query: 658 YFKRQQLTEKSDIYSFGVVLFEVLCA 683
+ + K+DI+S G VL+E LC
Sbjct: 173 ICQNRPYNNKTDIWSLGCVLYE-LCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 55/197 (27%), Positives = 94/197 (47%), Gaps = 9/197 (4%)
Query: 493 IGVGGFGKVYK-GVIEDKLKVAIKR-SNPSSEQGV-NEFVTEIEMLSKLRHKHLVSLIGF 549
IG G G V+K E VA+K+ + E G+ N+ + EI+ L +H ++V L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 550 CEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHR 609
G+ LV +YM L E + + ++ L Q +G+ Y+H I+HR
Sbjct: 68 FPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHR 123
Query: 610 DVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPE-YFKRQQLTEKS 668
D+K N+L+ + V K++DFGL++ E S V + Y PE + ++
Sbjct: 124 DLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPELLYGARKYDPGV 182
Query: 669 DIYSFGVVLFEVLCARP 685
D+++ G + E+L P
Sbjct: 183 DLWAVGCIFAELLNGSP 199
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 61/225 (27%), Positives = 108/225 (48%), Gaps = 29/225 (12%)
Query: 493 IGVGGFGKVY----KGVIEDK--LKVAIKRSNPS-SEQGVNEFVTEIEMLSKLRHKHLVS 545
+G G FG VY KGV++D+ +VAIK N + S + EF+ E ++ + H+V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 546 LIGFCEEGNEMCLVYDYMALGTLREHIYNTKKAL---------SWKQRLEICIGAARGLH 596
L+G +G ++ + M G L+ ++ + + + S K+ +++ A G+
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 597 YLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFG---- 652
YL+ +HRD+ N ++ E++ K+ DFG+++ + KG G
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-----DIYETDYYRKGGKGLLPV 185
Query: 653 -YLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQV 696
++ PE K T SD++SFGVVL+E+ + EQV
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV 230
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 59/193 (30%), Positives = 99/193 (51%), Gaps = 11/193 (5%)
Query: 493 IGVGGFGKVYKGVIEDK-----LKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLI 547
+G G FG V KG+ + K + V I +++ + +E + E ++ +L + ++V +I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 548 GFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTII 607
G CE + M LV + LG L + + K ++ K E+ + G+ YL + +
Sbjct: 63 GICEAESWM-LVMELAELGPLNKFLQKNKH-VTEKNITELVHQVSMGMKYLE---ETNFV 117
Query: 608 HRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH-VSTVVKGSFGYLDPEYFKRQQLTE 666
HRD+ N+LL AK+SDFGLSK EN + T K + PE + +
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS 177
Query: 667 KSDIYSFGVVLFE 679
KSD++SFGV+++E
Sbjct: 178 KSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 4e-17
Identities = 55/229 (24%), Positives = 122/229 (53%), Gaps = 28/229 (12%)
Query: 493 IGVGGFGKVYK----GVIEDK----LKVAIKR-SNPSSEQGVNEFVTEIEMLSKL-RHKH 542
+G G FG+V + G+ + + + VA+K + ++++ + + ++E+E++ + +HK+
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 543 LVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTK---------------KALSWKQRLEI 587
+++L+G C + + ++ +Y A G LRE + + + LS+K +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 588 CIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVV 647
ARG+ YL IHRD+ N+L+ E+ V K++DFGL++ +++ ++
Sbjct: 140 AYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 648 KGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQV 696
+ ++ PE + T +SD++SFG++++E+ + P +P E++
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL 245
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 35/207 (16%)
Query: 496 GGFGKVYKGVIEDKL-----KVAIKR-SNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGF 549
G FG+++ G++ D+ +V +K + +SE V + E +L L H++++ ++
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76
Query: 550 CEEGNEMCLV-YDYMALGTLREHIYNTK-------KALSWKQRLEICIGAARGLHYLHTG 601
C E E V Y YM G L+ + + +ALS +Q + + I A G+ YLH
Sbjct: 77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH-- 134
Query: 602 AKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT---------GPNMENGHVSTVVKGSFG 652
K +IH+D+ N ++DE K++D LS+ G N EN V
Sbjct: 135 -KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDN-ENRPVK-------- 184
Query: 653 YLDPEYFKRQQLTEKSDIYSFGVVLFE 679
++ E ++ + SD++SFGV+L+E
Sbjct: 185 WMALESLVNKEYSSASDVWSFGVLLWE 211
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 5e-17
Identities = 58/202 (28%), Positives = 105/202 (51%), Gaps = 20/202 (9%)
Query: 492 VIGVGGFGKVYK----GVIEDK--LKVAIKRSNPSSEQGVNE-FVTEIEMLSKL-RHKHL 543
+G G FGKV + G+ + +KVA+K P++ E ++E++++S L H+++
Sbjct: 42 TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101
Query: 544 VSLIGFCEEGNEMCLVYDYMALGTLREHIY-NTKKALSWKQRLEICIGAARGLHYLHTGA 602
V+L+G C G + ++ +Y G L + + L+ + L A+G+ +L A
Sbjct: 102 VNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL---A 158
Query: 603 KYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGS----FGYLDPEY 658
IHRD+ N+LL + K+ DFGL++ N N VVKG+ ++ PE
Sbjct: 159 SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSN----YVVKGNARLPVKWMAPES 214
Query: 659 FKRQQLTEKSDIYSFGVVLFEV 680
T +SD++S+G++L+E+
Sbjct: 215 IFNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 7e-17
Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 23/207 (11%)
Query: 486 SFDESYVIGVGGFGKVYKGVIEDKLKV----AIKRSNPSSEQGVNEFVTEIEMLSKLRHK 541
+F + V+G GGFG+V + K+ +++ +G + + E ++L K+ +
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR 60
Query: 542 HLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL-----EICIGAARGLH 596
+VSL E + +CLV M G L+ HIY+ +A + R EIC G L
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG----LE 116
Query: 597 YLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN--GHVSTVVKGSFGYL 654
LH + I++RD+K NILLD++ ++SD GL+ P + G V TV GY+
Sbjct: 117 DLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTV-----GYM 168
Query: 655 DPEYFKRQQLTEKSDIYSFGVVLFEVL 681
PE K ++ T D ++ G +L+E++
Sbjct: 169 APEVVKNERYTFSPDWWALGCLLYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 7e-17
Identities = 55/201 (27%), Positives = 104/201 (51%), Gaps = 10/201 (4%)
Query: 487 FDESYVIGVGGFGKVYKGV-IED----KLKVAIKRSNPSSEQGVN-EFVTEIEMLSKLRH 540
F + V+G G FG VYKG+ I + K+ VAIK ++ N E + E +++ + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 541 KHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHT 600
H+ L+G C + + L+ M G L +++ K + + L C+ A+G++YL
Sbjct: 69 PHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 126
Query: 601 GAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFK 660
+ ++HRD+ N+L+ K++DFGL+K E + + K ++ E
Sbjct: 127 --ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL 184
Query: 661 RQQLTEKSDIYSFGVVLFEVL 681
+ T +SD++S+GV ++E++
Sbjct: 185 HRIYTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 9e-17
Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 23/207 (11%)
Query: 486 SFDESYVIGVGGFGKVYKGVIEDKLKV----AIKRSNPSSEQGVNEFVTEIEMLSKLRHK 541
+F + V+G GGFG+V + K+ +++ +G + + E ++L K+ +
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ 60
Query: 542 HLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL-----EICIGAARGLH 596
+V+L E + +CLV M G L+ HIYN ++R EI GL
Sbjct: 61 FVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILC----GLE 116
Query: 597 YLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME--NGHVSTVVKGSFGYL 654
LH + ++RD+K NILLD+ ++SD GL+ P E G V TV GY+
Sbjct: 117 DLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTV-----GYM 168
Query: 655 DPEYFKRQQLTEKSDIYSFGVVLFEVL 681
PE Q+ T D + G +++E++
Sbjct: 169 APEVLNNQRYTLSPDYWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 9e-17
Identities = 51/196 (26%), Positives = 97/196 (49%), Gaps = 23/196 (11%)
Query: 512 VAIKRSNPS-SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTL-- 568
VA+K ++ N+F+ EI+++S+L++ +++ L+G C + +C++ +YM G L
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 569 ----RE-----HIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLD 619
RE N ++S L + + A G+ YL A +HRD+ T N L+
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVG 163
Query: 620 ENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFE 679
++ K++DFG+S+ + + + ++ E + T SD+++FGV L+E
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 223
Query: 680 VLCARPALNPSLPKEQ 695
+ +L KEQ
Sbjct: 224 MF--------TLCKEQ 231
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 1e-16
Identities = 56/213 (26%), Positives = 104/213 (48%), Gaps = 28/213 (13%)
Query: 492 VIGVGGFGKVYKGVIEDKLKVAIKR-----SNP-SSEQGVNEFVTEIEMLSKLRHKHLVS 545
V+G G +G VY G+ +A+K+ SN ++E+ + E+++L L+H ++V
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 546 LIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALS-------WKQRLEICIGAARGLHYL 598
+G C + N + + +++ G++ I N L KQ L+ G+ YL
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISS-ILNRFGPLPEPVFCKYTKQILD-------GVAYL 118
Query: 599 HTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSK----TGPNMENGHVSTVVKGSFGYL 654
H ++HRD+K N++L N + K+ DFG ++ G + + ++ + G+ ++
Sbjct: 119 HNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175
Query: 655 DPEYFKRQQLTEKSDIYSFGVVLFEVLCARPAL 687
PE KSDI+S G +FE+ +P L
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 5/205 (2%)
Query: 493 IGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVN-EFVTEIEMLSKLRHKHLVSLIGFC 550
IG G FG+V+ G + D VA+K + + +F+ E +L + H ++V LIG C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 551 EEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRD 610
+ + +V + + G + L K+ +++ AA G+ YL + IHRD
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRD 119
Query: 611 VKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDI 670
+ N L+ E V K+SDFG+S+ + + + + PE + + +SD+
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDV 179
Query: 671 YSFGVVLFEVLCARPALNPSLPKEQ 695
+SFG++L+E +L +Q
Sbjct: 180 WSFGILLWEAFSLGAVPYANLSNQQ 204
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 57/214 (26%), Positives = 99/214 (46%), Gaps = 28/214 (13%)
Query: 492 VIGVGGFGKVYK------GVIEDKLKVAIKRSNPSSEQGVNE-FVTEIEMLSKLRHKHLV 544
+G G F Y+ G + +V R+ S ++ V E EI ++++L H H++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 545 SLIGFCEEGNEMCLVYDYMALGTLREHIYNT---KKALSWKQRLEICIGAARGLHYLHTG 601
++G E + L ++MA G++ + K+A+ ++ RGL YLH
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL----RGLSYLHEN 122
Query: 602 AKYTIIHRDVKTTNILLDEN-WVAKVSDFGLSK------TGPNMENGHVSTVVKGSFGYL 654
IIHRDVK N+L+D +++DFG + TG G + G+ ++
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLL----GTIAFM 175
Query: 655 DPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALN 688
PE + +Q D++S G V+ E+ A+P N
Sbjct: 176 APEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-16
Identities = 59/243 (24%), Positives = 108/243 (44%), Gaps = 49/243 (20%)
Query: 492 VIGVGGFGKVYK----------GVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHK 541
+G G FGKV K G +K+ + ++ S + + ++E +L ++ H
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSE---LRDLLSEFNLLKQVNHP 63
Query: 542 HLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKK-----------------------A 578
H++ L G C + + L+ +Y G+LR + ++K A
Sbjct: 64 HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA 123
Query: 579 LSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNM 638
L+ + +RG+ YL A+ ++HRD+ N+L+ E K+SDFGLS+
Sbjct: 124 LTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR----- 175
Query: 639 ENGHVSTVVKGSFG-----YLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPK 693
+ + VK S G ++ E T +SD++SFGV+L+E++ P +
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235
Query: 694 EQV 696
E++
Sbjct: 236 ERL 238
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 3e-16
Identities = 53/198 (26%), Positives = 97/198 (48%), Gaps = 15/198 (7%)
Query: 492 VIGVGGFGKVYKGVIE----DKLKVAIK--RSNPSSEQGVNEFVTEIEMLSKLRHKHLVS 545
++G G FG++ +G ++ +L VAI R+ S +Q F+ E L + H ++V
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRG-FLAEALTLGQFDHSNIVR 70
Query: 546 LIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYT 605
L G GN M +V +YM+ G L + + L Q + + G A G+ YL ++
Sbjct: 71 LEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL---SEMG 127
Query: 606 IIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYL--DPEYFKRQQ 663
+H+ + +L++ + V K+S F ++ + T + G L PE +
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHH 184
Query: 664 LTEKSDIYSFGVVLFEVL 681
+ SD++SFG+V++EV+
Sbjct: 185 FSSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 56/197 (28%), Positives = 103/197 (52%), Gaps = 12/197 (6%)
Query: 492 VIGVGGFGKVYKGV-IED----KLKVAIK--RSNPSSEQGVNEFVTEIEMLSKLRHKHLV 544
V+G G FG VYKG+ I D K+ VAIK R N +S + E + E +++ + ++
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN-TSPKANKEILDEAYVMAGVGSPYVC 72
Query: 545 SLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKY 604
L+G C + + LV M G L +++ K + + L C+ A+G+ YL +
Sbjct: 73 RLLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EV 128
Query: 605 TIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQL 664
++HRD+ N+L+ K++DFGL++ E + + K ++ E ++
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRF 188
Query: 665 TEKSDIYSFGVVLFEVL 681
T +SD++S+GV ++E++
Sbjct: 189 THQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-16
Identities = 58/201 (28%), Positives = 94/201 (46%), Gaps = 22/201 (10%)
Query: 556 MCLVYDYMALGTLREHIYNTKKALSWKQRLE---ICIGAARGLHYLHTGAKYTIIHRDVK 612
+ LV DY G LR+ I + K + E + I +H++H+ +IHRD+K
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIK 170
Query: 613 TTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYS 672
+ NILL N + K+ DFG SK + V G+ Y+ PE ++R+ ++K+D++S
Sbjct: 171 SANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFS 230
Query: 673 FGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFA 732
GV+L+E+L + P + ++ + +H G D L ISPE
Sbjct: 231 LGVLLYELLTLKR------PFDGENMEE-VMHKTLAGRYDP-----LPPSISPE----MQ 274
Query: 733 DTAEKCLSDSGIDRPSMGDVL 753
+ LS RPS +L
Sbjct: 275 EIVTALLSSDPKRRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 4e-16
Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 18/204 (8%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNE---------FVTEIEMLSKLRHK 541
+IG G FG VY G+ +A+K+ S ++ EI +L +L+H+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 542 HLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTG 601
++V +G + + + + +Y+ G++ + N A +GL+YLH
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSV-AALLNNYGAFEETLVRNFVRQILKGLNYLHNR 125
Query: 602 AKYTIIHRDVKTTNILLDENWVAKVSDFGLSK----TGPNMENGHVSTVVKGSFGYLDPE 657
IIHRD+K NIL+D K+SDFG+SK + + ++GS ++ PE
Sbjct: 126 G---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182
Query: 658 YFKRQQLTEKSDIYSFGVVLFEVL 681
K+ T K+DI+S G ++ E+L
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEML 206
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 57/209 (27%), Positives = 101/209 (48%), Gaps = 25/209 (11%)
Query: 492 VIGVGGFGKVYKGVIEDK-LKVAIKR-----SNPSSEQGVNEFVTEIEMLSKLRHKHLVS 545
++G G FG+VY D ++A+K+ +P + + VN EI++L L H+ +V
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 546 LIGFCEEGNE--MCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAK 603
G + E + + ++M G++++ + + AL+ + G+ YLH+
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTRKYTRQILEGVSYLHSN-- 125
Query: 604 YTIIHRDVKTTNILLDENWVAKVSDFGLSK-------TGPNMENGHVSTVVKGSFGYLDP 656
I+HRD+K NIL D K+ DFG SK +G M++ V G+ ++ P
Sbjct: 126 -MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS------VTGTPYWMSP 178
Query: 657 EYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
E + K+DI+S G + E+L +P
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 4e-16
Identities = 57/195 (29%), Positives = 103/195 (52%), Gaps = 10/195 (5%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCE 551
IG G G VY + + +VAIK+ N + + EI ++ + +H ++V+ +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 552 EGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDV 611
G+E+ +V +Y+A G+L + + T+ + Q +C + L +LH+ +IHRD+
Sbjct: 87 VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDI 141
Query: 612 KTTNILLDENWVAKVSDFGL-SKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDI 670
K+ NILL + K++DFG ++ P E ST+V G+ ++ PE R+ K DI
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 198
Query: 671 YSFGVVLFEVLCARP 685
+S G++ E++ P
Sbjct: 199 WSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 71/284 (25%), Positives = 119/284 (41%), Gaps = 34/284 (11%)
Query: 493 IGVGGFGKVYKGVI---EDKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLI 547
+G G FG V +G + + LKVA+K + + + +F++E + + H +++ LI
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 548 GFCEEGNEM------CLVYDYMALGTLREHIY-----NTKKALSWKQRLEICIGAARGLH 596
G C + E ++ +M G L + + + L + ++ A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 597 YLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDP 656
YL + + IHRD+ N +L+EN V+DFGLSK N + + K ++
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 657 EYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIID 716
E + T KSD++SFGV ++E+ A P E + D+ R
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEI--ATRGQTPYPGVENSEIYDYLRQGNRL-------- 233
Query: 717 PLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVL 760
K P+CL C + DRPS + LE L
Sbjct: 234 -----KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 6e-16
Identities = 53/194 (27%), Positives = 101/194 (52%), Gaps = 28/194 (14%)
Query: 510 LKVAIKRSNP-SSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTL 568
L VA+K P +++ N+F+ E+++LS+L+ +++ L+G C + + +C++ +YM G L
Sbjct: 47 LLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL 106
Query: 569 RE----HIYNTKK--------------ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRD 610
+ H + K+ A+S+ L + + A G+ YL + +HRD
Sbjct: 107 NQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRD 163
Query: 611 VKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGS---FGYLDPEYFKRQQLTEK 667
+ T N L+ EN K++DFG+S+ N+ G + + ++ E + T
Sbjct: 164 LATRNCLVGENLTIKIADFGMSR---NLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTA 220
Query: 668 SDIYSFGVVLFEVL 681
SD+++FGV L+E+L
Sbjct: 221 SDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 7e-16
Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCE 551
+G G FGKVYK E A K SE+ + +++ EIE+L+ H ++V L+G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 552 EGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDV 611
++ ++ ++ G + + + L+ Q IC L YLH+ IIHRD+
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDL 136
Query: 612 KTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTE----- 666
K N+LL + K++DFG+S N++ G+ ++ PE + + +
Sbjct: 137 KAGNVLLTLDGDIKLADFGVS--AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDY 194
Query: 667 KSDIYSFGVVLFEVLCARPA---LNP 689
K+DI+S G+ L E+ P LNP
Sbjct: 195 KADIWSLGITLIEMAQIEPPHHELNP 220
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 7e-16
Identities = 61/201 (30%), Positives = 96/201 (47%), Gaps = 22/201 (10%)
Query: 492 VIGVGGFGKV----YKGVIEDKLKVAIKRSNPSSEQGVNEFVTE---IEMLSKLRHKHLV 544
V+G G FGKV YK E A+K+ + + V + E E + RH LV
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65
Query: 545 SLIGFCEEGNEMCLVYDYMALGTLREHI----YNTKKALSWKQRLEICIGAARGLHYLHT 600
+L + + +C V +Y A G L HI ++ +A+ + + +G L YLH
Sbjct: 66 NLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAA--CVVLG----LQYLH- 118
Query: 601 GAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFK 660
+ I++RD+K N+LLD K++DFGL K G M G ++ G+ +L PE
Sbjct: 119 --ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEG--MGFGDRTSTFCGTPEFLAPEVLT 174
Query: 661 RQQLTEKSDIYSFGVVLFEVL 681
T D + GV+++E+L
Sbjct: 175 ETSYTRAVDWWGLGVLIYEML 195
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 492 VIGVGGFGKV----YKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKL-RHKHLVSL 546
V+G G FGKV KG E +K+ + V +TE +L+ +H L L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 547 IGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL---EICIGAARGLHYLHTGAK 603
+ + + V +Y+ G L HI + + + R EI +G L +LH +
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLG----LQFLH---E 114
Query: 604 YTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQ 663
II+RD+K N+LLD K++DFG+ K G + G ++ G+ Y+ PE Q
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEG--ILGGVTTSTFCGTPDYIAPEILSYQP 172
Query: 664 LTEKSDIYSFGVVLFEVLCARP 685
D ++ GV+L+E+L +
Sbjct: 173 YGPAVDWWALGVLLYEMLAGQS 194
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 59/212 (27%), Positives = 108/212 (50%), Gaps = 10/212 (4%)
Query: 476 SLAEIKHATKSFDESYVIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEM 534
S+ + K + IG G G VY + I +VAIK+ N + + EI +
Sbjct: 10 SIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILV 69
Query: 535 LSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARG 594
+ + ++ ++V+ + G+E+ +V +Y+A G+L + + T+ + Q +C +
Sbjct: 70 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQA 127
Query: 595 LHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGL-SKTGPNMENGHVSTVVKGSFGY 653
L +LH+ +IHRD+K+ NILL + K++DFG ++ P E ST+V G+ +
Sbjct: 128 LDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYW 181
Query: 654 LDPEYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
+ PE R+ K DI+S G++ E++ P
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 486 SFDESYVIGVGGFGKVYKGVIEDKLKV----AIKRSNPSSEQGVNEFVTEIEMLSKLRHK 541
+F V+G GGFG+V + K+ +++ +G + E +L K+ +
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR 60
Query: 542 HLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL-----EICIGAARGLH 596
+VSL E + +CLV M G L+ HIYN +QR E+C G L
Sbjct: 61 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCG----LE 116
Query: 597 YLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN--GHVSTVVKGSFGYL 654
L + I++RD+K NILLD+ ++SD GL+ P E G V TV GY+
Sbjct: 117 DLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTV-----GYM 168
Query: 655 DPEYFKRQQLTEKSDIYSFGVVLFEVL 681
PE ++ T D + G +++E++
Sbjct: 169 APEVINNEKYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCE 551
+G G FGKVYK E + A K + SE+ + +++ EI++L+ H ++V L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 552 EGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDV 611
N + ++ ++ A G + + ++ L+ Q +C L+YLH IIHRD+
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDL 129
Query: 612 KTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYF-----KRQQLTE 666
K NIL + K++DFG+S S + G+ ++ PE K +
Sbjct: 130 KAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI--GTPYWMAPEVVMCETSKDRPYDY 187
Query: 667 KSDIYSFGVVLFEVLCARPA---LNP 689
K+D++S G+ L E+ P LNP
Sbjct: 188 KADVWSLGITLIEMAQIEPPHHELNP 213
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 53/193 (27%), Positives = 96/193 (49%), Gaps = 13/193 (6%)
Query: 493 IGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE 552
+G G FG+V+ G KVAIK S F+ E ++ +L+H LV L +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72
Query: 553 GNEMCLVYDYMALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDV 611
+ ++ +YM G+L + + + L+ + +++ A G+ ++ + IHRD+
Sbjct: 73 -EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDL 128
Query: 612 KTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGS---FGYLDPEYFKRQQLTEKS 668
+ NIL+ E K++DFGL++ + E T +G+ + PE T KS
Sbjct: 129 RAANILVSETLCCKIADFGLARLIEDNE----YTAREGAKFPIKWTAPEAINYGTFTIKS 184
Query: 669 DIYSFGVVLFEVL 681
D++SFG++L E++
Sbjct: 185 DVWSFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-15
Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 23/207 (11%)
Query: 486 SFDESYVIGVGGFGKVYKGVIEDKLKV-AIKR---SNPSSEQGVNEFVTEIEMLSKLRHK 541
+F V+G GGFG+V + K+ A K+ +G + E ++L K+ +
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 60
Query: 542 HLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL-----EICIGAARGLH 596
+VSL E + +CLV M G L+ HIYN ++R EI G L
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCG----LE 116
Query: 597 YLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME--NGHVSTVVKGSFGYL 654
LH + I++RD+K NILLD+ ++SD GL+ P E G V TV GY+
Sbjct: 117 DLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTV-----GYM 168
Query: 655 DPEYFKRQQLTEKSDIYSFGVVLFEVL 681
PE K ++ T D + G +++E++
Sbjct: 169 APEVVKNERYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 3e-15
Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 29/225 (12%)
Query: 493 IGVGGFGKVYKGVIEDKLK------VAIKRSNPS-SEQGVNEFVTEIEMLSKLRHKHLVS 545
+G G FG VY+G D +K VA+K N S S + EF+ E ++ H+V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 546 LIGFCEEGNEMCLVYDYMALGTLREHIYNTKK---------ALSWKQRLEICIGAARGLH 596
L+G +G +V + MA G L+ ++ + + + ++ +++ A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 597 YLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFG---- 652
YL+ AK +HRD+ N ++ ++ K+ DFG+++ + KG G
Sbjct: 134 YLN--AK-KFVHRDLAARNCMVAHDFTVKIGDFGMTR-----DIYETDYYRKGGKGLLPV 185
Query: 653 -YLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQV 696
++ PE K T SD++SFGVVL+E+ L EQV
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV 230
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 3e-15
Identities = 57/212 (26%), Positives = 108/212 (50%), Gaps = 10/212 (4%)
Query: 476 SLAEIKHATKSFDESYVIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEM 534
++ I K + IG G G V+ + + +VAIK+ N + + EI +
Sbjct: 10 TIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILV 69
Query: 535 LSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARG 594
+ +L++ ++V+ + G+E+ +V +Y+A G+L + + T+ + Q +C +
Sbjct: 70 MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVCRECLQA 127
Query: 595 LHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGL-SKTGPNMENGHVSTVVKGSFGY 653
L +LH +IHRD+K+ N+LL + K++DFG ++ P E ST+V G+ +
Sbjct: 128 LEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYW 181
Query: 654 LDPEYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
+ PE R+ K DI+S G++ E++ P
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 81/290 (27%), Positives = 132/290 (45%), Gaps = 33/290 (11%)
Query: 477 LAEIKHATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLS 536
L+ ++ F+ V+G G +G+VYKG ++A + +E E EI ML
Sbjct: 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLK 67
Query: 537 KL-RHKHLVSLIG-FCEEG-----NEMCLVYDYMALGTLREHIYNTK-KALSWKQRLEIC 588
K H+++ + G F ++ +++ LV ++ G++ + + NTK AL IC
Sbjct: 68 KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYIC 127
Query: 589 IGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVK 648
RGL +LH + +IHRD+K N+LL EN K+ DFG+S + G +T +
Sbjct: 128 REILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ-LDRTVGRRNTFI- 182
Query: 649 GSFGYLDPEYFKRQQLTE-----KSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWAL 703
G+ ++ PE + + +SDI+S G+ E+ P L P + L
Sbjct: 183 GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL----- 237
Query: 704 HCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
+ P LK K + KKF D E CL + + RPS +L
Sbjct: 238 -------IPRNPPPKLKSK---KWSKKFIDFIEGCLVKNYLSRPSTEQLL 277
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 72/266 (27%), Positives = 117/266 (43%), Gaps = 32/266 (12%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIK--RSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIG 548
+G G G V K + +A+K R + + + E+++L K ++V G
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAI-QKQILRELDILHKCNSPYIVGFYG 66
Query: 549 FCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIH 608
++ + +YM G+L + + + + + +I + +GL YLH K+ IIH
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE--KHKIIH 124
Query: 609 RDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKS 668
RDVK +NIL++ K+ DFG+S + N T V G+ Y+ PE + + KS
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVSG---QLVNSLAKTFV-GTSSYMAPERIQGNDYSVKS 180
Query: 669 DIYSFGVVLFEVLCARPALN--PSLPKEQVSLADWALHCKRKGILDDIID---PLL-KDK 722
DI+S G+ L E+ A P P+ + L L I++ P L K
Sbjct: 181 DIWSLGLSLIEL-----ATGRFPYPPENDPPDGIFEL-------LQYIVNEPPPRLPSGK 228
Query: 723 ISPECLKKFADTAEKCLSDSGIDRPS 748
SP+ F D CL +RPS
Sbjct: 229 FSPD----FQDFVNLCLIKDPRERPS 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 5e-15
Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 43/226 (19%)
Query: 493 IGVGGFGKVYKGVIEDKL---KVAIKR--------SNPSSEQGVNE----FVT--EIEML 535
+G G +GKV K D L VAIK+ Q V F T E++++
Sbjct: 17 LGEGTYGKVEKA--YDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 536 SKLRHKHLVSLIG-FCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARG 594
++++H++++ L+ + E + LV D MA L++ + + K L+ Q I + G
Sbjct: 75 NEIKHENIMGLVDVYVEGDF-INLVMDIMA-SDLKK-VVDRKIRLTESQVKCILLQILNG 131
Query: 595 LHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLS-KTGPNMENGHV---------- 643
L+ LH K+ +HRD+ NI ++ + K++DFGL+ + G + +
Sbjct: 132 LNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188
Query: 644 ---STVVKGSFGYLDPE-YFKRQQLTEKSDIYSFGVVLFEVLCARP 685
S VV + Y PE ++ D++S G + E+L +P
Sbjct: 189 EMTSKVV--TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232
|
Length = 335 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 77/276 (27%), Positives = 127/276 (46%), Gaps = 44/276 (15%)
Query: 492 VIGVGGFGKVY---------KGVIED-KLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHK 541
V+G G +G+V + VI+ L+ A +R ++EQ E ++LS+L+H
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQ-------EAQLLSQLKHP 59
Query: 542 HLVSLIGFCEEGNEMCLVYDYMAL---GTLREHIYNTK-KALSWKQRLEICIGAARGLHY 597
++V+ E + L+Y M G L + K K L Q +E + A L Y
Sbjct: 60 NIVAYRESWEGED--GLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQY 117
Query: 598 LHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPE 657
LH + I+HRD+KT N+ L + KV D G+++ N + ST++ G+ Y+ PE
Sbjct: 118 LH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN-QCDMASTLI-GTPYYMSPE 172
Query: 658 YFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717
F + KSD+++ G ++E+ + A N K+ SL I++ + P
Sbjct: 173 LFSNKPYNYKSDVWALGCCVYEMATLKHAFN---AKDMNSLV--------YRIIEGKLPP 221
Query: 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
+ KD SPE + LS RPS+ +L
Sbjct: 222 MPKD-YSPE----LGELIATMLSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 8e-15
Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 23/206 (11%)
Query: 493 IGVGGFGK-VYKGVIEDKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGF 549
IG G FGK + ED + IK N S S + E E+ +LS ++H ++V
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 550 CEEGNEMCLVYDYMALGTLREHIYNTK-------KALSWKQRLEICIGAARGLHYLHTGA 602
EE + +V DY G L + I + + L W ++IC+ L ++H
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW--FVQICLA----LKHVH--- 118
Query: 603 KYTIIHRDVKTTNILLDENWVAKVSDFGLSKT-GPNMENGHVSTVVKGSFGYLDPEYFKR 661
I+HRD+K+ NI L ++ K+ DFG+++ +E ++ G+ YL PE +
Sbjct: 119 DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE---LARTCIGTPYYLSPEICEN 175
Query: 662 QQLTEKSDIYSFGVVLFEVLCARPAL 687
+ KSDI++ G VL+E+ + A
Sbjct: 176 RPYNNKSDIWALGCVLYEMCTLKHAF 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 2e-14
Identities = 57/212 (26%), Positives = 108/212 (50%), Gaps = 10/212 (4%)
Query: 476 SLAEIKHATKSFDESYVIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEM 534
S+ + K + IG G G VY + + +VAI++ N + + EI +
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 535 LSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARG 594
+ + ++ ++V+ + G+E+ +V +Y+A G+L + + T+ + Q +C +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQA 128
Query: 595 LHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGL-SKTGPNMENGHVSTVVKGSFGY 653
L +LH+ +IHRD+K+ NILL + K++DFG ++ P E ST+V G+ +
Sbjct: 129 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYW 182
Query: 654 LDPEYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
+ PE R+ K DI+S G++ E++ P
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 66/247 (26%), Positives = 112/247 (45%), Gaps = 27/247 (10%)
Query: 527 EFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLE 586
+ + E++++ + R ++VS G N +C+ ++M G+L + IY + + +
Sbjct: 49 QILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGK 107
Query: 587 ICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTV 646
I + GL YL+ + I+HRD+K +NIL++ K+ DFG+S + N T
Sbjct: 108 IAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSG---ELINSIADTF 162
Query: 647 VKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCAR-P-ALNPSLPKEQVSLADWALH 704
V G+ Y+ PE + + T KSD++S G+ + E+ + P A + Q
Sbjct: 163 V-GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPM----- 216
Query: 705 CKRKGILD---DIID---PLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758
GILD I+ P L PE L+ F D CL +RP+ + F
Sbjct: 217 ----GILDLLQQIVQEPPPRLPSSDFPEDLRDFVD---ACLLKDPTERPTPQQLCAMPPF 269
Query: 759 VLQLVES 765
+ L S
Sbjct: 270 IQALRAS 276
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 64/235 (27%), Positives = 102/235 (43%), Gaps = 41/235 (17%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEF-VT---EIEMLSKLRHKHLVSLI 547
+G G FG+VYK I+ VA+K+ +E+ + F +T EI++L KL+H ++V LI
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILKKLKHPNVVPLI 73
Query: 548 --------GFCEEGNEMCLVYDYMA------LGTLREHIYNTKKALSWKQRLEICIGAAR 593
+ + +V YM L + ++ Q LE
Sbjct: 74 DMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLE------- 126
Query: 594 GLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSK--TGPNMENGHVSTVVKGSF 651
G++YLH + I+HRD+K NIL+D + K++DFGL++ GP +
Sbjct: 127 GINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKY 183
Query: 652 G-------YLDPEY-FKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSL 698
Y PE ++ T DI+ G V E+ RP L +Q+ L
Sbjct: 184 TNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL 238
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 83/283 (29%), Positives = 122/283 (43%), Gaps = 35/283 (12%)
Query: 485 KSFDESYVIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNE----FVTEIEMLSKLR 539
K F + IG G FG VY + + VAIK+ + S +Q NE + E+ L KLR
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ-SNEKWQDIIKEVRFLQKLR 73
Query: 540 HKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLH 599
H + + G + LV +Y LG+ + + KK L + + GA +GL YLH
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEY-CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 600 TGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEY- 658
+ + +IHRDVK NILL E + K+ DFG S + N V T ++ PE
Sbjct: 133 S---HNMIHRDVKAGNILLSEPGLVKLGDFG-SASIMAPANXFVGTPY-----WMAPEVI 183
Query: 659 --FKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIID 716
Q K D++S G+ E+ +P P ++ H +
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKP------PLFNMNAMSALYHIAQNE------S 231
Query: 717 PLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759
P L+ E + F D+ CL DRP+ +VL FV
Sbjct: 232 PALQSGHWSEYFRNFVDS---CLQKIPQDRPT-SEVLLKHRFV 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 72/241 (29%), Positives = 112/241 (46%), Gaps = 33/241 (13%)
Query: 470 GLCRRFSLAEIKHATKSFDESYVIGVGGFGKVYKGVIEDKLK---VAIKRSNPSSEQ-GV 525
G CR S+ E F++ IG G +G VY+ D VA+K+ +E+ G+
Sbjct: 1 GRCR--SVTE-------FEKLNRIGEGTYGIVYRA--RDTTSGEIVALKKVRMDNERDGI 49
Query: 526 N-EFVTEIEMLSKLRHKHLVSL----IGFCEEGNEMCLVYDYMA--LGTLREHIYNTKKA 578
+ EI +L LRH ++V L +G + + + LV +Y L +L + N
Sbjct: 50 PISSLREITLLLNLRHPNIVELKEVVVG--KHLDSIFLVMEYCEQDLASL---LDNMPTP 104
Query: 579 LSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNM 638
S Q + + RGL YLH + IIHRD+K +N+LL + K++DFGL++T
Sbjct: 105 FSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161
Query: 639 ENGHVSTVVKGSFGYLDPE-YFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVS 697
VV + Y PE T D+++ G +L E+L +P L EQ+
Sbjct: 162 AKPMTPKVV--TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLD 219
Query: 698 L 698
L
Sbjct: 220 L 220
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 479 EIKHATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKL 538
EI + ++ +G G FG+V+ KVA+K P S V F+ E ++ L
Sbjct: 2 EIPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTL 58
Query: 539 RHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTK-KALSWKQRLEICIGAARGLHY 597
+H LV L + + ++ ++MA G+L + + + + + ++ A G+ +
Sbjct: 59 QHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 117
Query: 598 LHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSF--GYLD 655
+ + IHRD++ NIL+ + V K++DFGL++ +E+ + F +
Sbjct: 118 IE---QRNYIHRDLRAANILVSASLVCKIADFGLARV---IEDNEYTAREGAKFPIKWTA 171
Query: 656 PEYFKRQQLTEKSDIYSFGVVLFEVL 681
PE T KSD++SFG++L E++
Sbjct: 172 PEAINFGSFTIKSDVWSFGILLMEIV 197
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 26/206 (12%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIKR------SNPSSEQGVNEFVTEIEMLSKLRHKHLVS 545
IG G F VYK + + D VA+K+ + + Q + + EI++L +L H +++
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQ---DCLKEIDLLKQLDHPNVIK 66
Query: 546 LIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALS-------WKQRLEICIGAARGLHYL 598
+ E NE+ +V + G L I + KK WK +++C L ++
Sbjct: 67 YLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC----SALEHM 122
Query: 599 HTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEY 658
H+ I+HRD+K N+ + V K+ D GL + + S V G+ Y+ PE
Sbjct: 123 HS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV--GTPYYMSPER 177
Query: 659 FKRQQLTEKSDIYSFGVVLFEVLCAR 684
KSDI+S G +L+E+ +
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQ 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 3e-14
Identities = 59/227 (25%), Positives = 111/227 (48%), Gaps = 17/227 (7%)
Query: 493 IGVGGFGKVYKGVIEDKLKV----AIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIG 548
+G GGFG+V +++ K+ + + + G + E E+L K+ +V+L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 549 FCEEGNEMCLVYDYMALGTLREHIYNT-KKALSWKQRLEICIGAARGLHYLHTGAKYTII 607
E +CLV M G L+ HIYN ++ L ++ + G+ +LH+ I+
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIV 117
Query: 608 HRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEK 667
+RD+K N+LLD+ ++SD GL+ +++G T G+ GY+ PE K + +
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAV---ELKDGKTITQRAGTNGYMAPEILKEEPYSYP 174
Query: 668 SDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDI 714
D ++ G ++E++ R KE+V+ + KR+ + D++
Sbjct: 175 VDWFAMGCSIYEMVAGRTPFKDH--KEKVAKEE----LKRRTLEDEV 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 73/290 (25%), Positives = 121/290 (41%), Gaps = 43/290 (14%)
Query: 479 EIKHATKSFDESYVIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSK 537
E ++ E V+G G +G VY + ++++AIK + V EI + S
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 538 LRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSW---------KQRLEIC 588
L+H+++V +G E + + + G+L + + L KQ LE
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE-- 119
Query: 589 IGAARGLHYLHTGAKYTIIHRDVKTTNILLDE-NWVAKVSDFGLSK--TGPNMENGHVST 645
GL YLH I+HRD+K N+L++ + V K+SDFG SK G N +
Sbjct: 120 -----GLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN----PCTE 167
Query: 646 VVKGSFGYLDPEYFKRQQ--LTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWAL 703
G+ Y+ PE + +DI+S G + E+ +P P ++ A+
Sbjct: 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKP------PFIELGEPQAAM 221
Query: 704 HCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
+ G+ I P + + +S E K F +C R S D+L
Sbjct: 222 F--KVGMFK--IHPEIPESLSAEA-KNF---ILRCFEPDPDKRASAHDLL 263
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 54/190 (28%), Positives = 95/190 (50%), Gaps = 25/190 (13%)
Query: 586 EICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVST 645
+I + + L YLH+ K ++IHRDVK +N+L++ N K+ DFG+S + + T
Sbjct: 107 KIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISG---YLVDSVAKT 161
Query: 646 VVKGSFGYLDPEYF----KRQQLTEKSDIYSFGVVLFEVLCAR-PALNPSLPKEQVSLAD 700
+ G Y+ PE ++ KSD++S G+ + E+ R P + P +Q+
Sbjct: 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQL---- 217
Query: 701 WALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVL 760
K ++++ L +K SPE F D KCL + +RP+ ++L + F L
Sbjct: 218 -------KQVVEEPSPQLPAEKFSPE----FQDFVNKCLKKNYKERPNYPELLQHPFFEL 266
Query: 761 QLVESTEASS 770
L ++T+ +S
Sbjct: 267 HLSKNTDVAS 276
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 4e-14
Identities = 63/235 (26%), Positives = 99/235 (42%), Gaps = 58/235 (24%)
Query: 487 FDESYVIGVGGFGKVYKGVI---EDKLKVAIKRSNPSSEQGVN---EFVTEIEMLSKLRH 540
++ IG G +G+VYK +D + AIK+ EQ EI +L +L+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 541 KHLVSLIGFCEEGNEMC--LVYDYMA---LGTLREH-------IY-NTKKALSWKQRLEI 587
+++VSL+ E + L++DY ++ H I + K+L W Q L
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW-QILN- 119
Query: 588 CIGAARGLHYLHTGAKYTIIHRDVKTTNILL----DENWVAKVSDFGLSKTGPNM----- 638
G+HYLH+ ++HRD+K NIL+ E V K+ D GL++
Sbjct: 120 ------GVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA 170
Query: 639 -ENGHVSTVVKGSFGYLDPE-------YFKRQQLTEKSDIYSFGVVLFEVLCARP 685
+ V T Y PE Y T+ DI++ G + E+L P
Sbjct: 171 DLDPVVVT-----IWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTLEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 4e-14
Identities = 64/210 (30%), Positives = 94/210 (44%), Gaps = 33/210 (15%)
Query: 492 VIGVGGFGKVY--KGVIEDKL-------KVAIKRSNPS----SEQGVNEFVTEIEMLSKL 538
VIG G FGKV K + K K AI + +E+ V +L +
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNV--------LLKNV 53
Query: 539 RHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL---EICIGAARGL 595
+H LV L + +++ V DY+ G L H+ + + R EI A L
Sbjct: 54 KHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEI----ASAL 109
Query: 596 HYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLD 655
YLH+ II+RD+K NILLD ++DFGL K G +E+ ++ G+ YL
Sbjct: 110 GYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEG--IEHSKTTSTFCGTPEYLA 164
Query: 656 PEYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
PE ++Q D + G VL+E+L P
Sbjct: 165 PEVLRKQPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 46/159 (28%), Positives = 76/159 (47%), Gaps = 33/159 (20%)
Query: 492 VIGVGGFGKVYK------GVIEDKLKVAIK--RSNPSSEQGVNEFVTEIEMLSKLRHKHL 543
V+G G +G V K G I VAIK + + E + E+++L +LRH+++
Sbjct: 8 VVGEGAYGVVLKCRNKATGEI-----VAIKKFKESEDDEDVKKTALREVKVLRQLRHENI 62
Query: 544 VSLIGFCEEGNEMCLVYDYMALGTLREHI--------YNTKKALSWKQRLEICIGAARGL 595
V+L + LV++Y+ TL E + + ++ W Q L + +
Sbjct: 63 VNLKEAFRRKGRLYLVFEYVE-RTLLELLEASPGGLPPDAVRSYIW-QLL-------QAI 113
Query: 596 HYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634
Y H + IIHRD+K NIL+ E+ V K+ DFG ++
Sbjct: 114 AYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARA 149
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 46/162 (28%), Positives = 82/162 (50%), Gaps = 20/162 (12%)
Query: 487 FDESYVIGVGGFGKVYKG--VIEDKLKVAIKRSN-PSSEQGVNEF-VTEIEMLSKLR--- 539
++E IG G +G VYK + + VA+K+ P SE+G+ + EI +L +L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRF-VALKKVRVPLSEEGIPLSTLREIALLKQLESFE 59
Query: 540 HKHLVSLIGFC-----EEGNEMCLVYDYMA--LGTLREHIYNTKKALSWKQRLEICIGAA 592
H ++V L+ C + ++ LV++++ L T K L + ++
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKC--PKPGLPPETIKDLMRQLL 117
Query: 593 RGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634
RG+ +LH+ I+HRD+K NIL+ + K++DFGL++
Sbjct: 118 RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 5e-14
Identities = 56/205 (27%), Positives = 99/205 (48%), Gaps = 26/205 (12%)
Query: 492 VIGVGGFGKVYKGVIEDK-------LKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLV 544
++G G FGKV ++ +K +K+ +K+ ++ V +TE +L RH L
Sbjct: 2 LLGKGTFGKVI--LVREKASGKYYAMKI-LKKEVIIAKDEVAHTLTESRVLKNTRHPFLT 58
Query: 545 SLIGFCEEGNEMCLVYDYMALGTL-----REHIYNTKKALSWKQRLEICIGAARGLHYLH 599
SL + + +C V +Y+ G L RE +++ + + + L YLH
Sbjct: 59 SLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEI------VSALDYLH 112
Query: 600 TGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYF 659
+G I++RD+K N++LD++ K++DFGL K G + + G+ YL PE
Sbjct: 113 SG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEG--ITDAATMKTFCGTPEYLAPEVL 167
Query: 660 KRQQLTEKSDIYSFGVVLFEVLCAR 684
+ D + GVV++E++C R
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 53/176 (30%), Positives = 90/176 (51%), Gaps = 13/176 (7%)
Query: 526 NEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL 585
N+ + E+++L + ++V G E+ + ++M G+L + + KKA + +
Sbjct: 44 NQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPENI 100
Query: 586 --EICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLS-KTGPNMENGH 642
+I I RGL YL K+ I+HRDVK +NIL++ K+ DFG+S + +M N
Sbjct: 101 LGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 158
Query: 643 VSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSL 698
V G+ Y+ PE + T +SDI+S G+ L E+ R + P KE ++
Sbjct: 159 V-----GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAM 209
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 6e-14
Identities = 64/209 (30%), Positives = 97/209 (46%), Gaps = 19/209 (9%)
Query: 493 IGVGGFGKVYKGVIED-KLKVAIKRSNPSSEQGVNE---FVTEIEMLSKLRHKHLVSLIG 548
+G GG+G+V+ +D VA+KR S +NE +TE ++L+ + + LV L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 549 FCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQ-RLEIC--IGAARGLHYLHTGAKYT 605
++ + L +Y+ G R + N LS R + A LH L
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRT-LLNNLGVLSEDHARFYMAEMFEAVDALHEL------G 121
Query: 606 IIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLT 665
IHRD+K N L+D + K++DFGLSK N V GS Y+ PE + +
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV-----GSPDYMAPEVLRGKGYD 176
Query: 666 EKSDIYSFGVVLFEVLCARPALNPSLPKE 694
D +S G +L+E LC P + S P E
Sbjct: 177 FTVDYWSLGCMLYEFLCGFPPFSGSTPNE 205
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 6e-14
Identities = 53/190 (27%), Positives = 90/190 (47%), Gaps = 18/190 (9%)
Query: 511 KVAIK---RSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLI--GFCEEGNEMCLVYDYMAL 565
+VAIK P E F E + ++L H ++V+L+ G G + V++Y+
Sbjct: 5 EVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPG-LLFAVFEYVPG 63
Query: 566 GTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWV-- 623
TLRE + AL + + + L H I+HRD+K NI++ + V
Sbjct: 64 RTLRE-VLAADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRP 119
Query: 624 -AKVSDFGLSKTGPNMENGHVSTV-----VKGSFGYLDPEYFKRQQLTEKSDIYSFGVVL 677
AKV DFG+ P + + V+T+ V G+ Y PE + + +T SD+Y++G++
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIF 179
Query: 678 FEVLCARPAL 687
E L + +
Sbjct: 180 LECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 7e-14
Identities = 48/155 (30%), Positives = 74/155 (47%), Gaps = 21/155 (13%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKL-RHKHLVSLIG- 548
VIG G +GKVYK + VAIK + ++ E E +L K H ++ + G
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEE-EIKEEYNILRKYSNHPNIATFYGA 71
Query: 549 FCE-----EGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLE------ICIGAARGLHY 597
F + +++ LV + G++ + + K +RL+ I RGL Y
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLV---KGLRKKGKRLKEEWIAYILRETLRGLAY 128
Query: 598 LHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLS 632
LH + +IHRD+K NILL +N K+ DFG+S
Sbjct: 129 LH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 8e-14
Identities = 60/225 (26%), Positives = 100/225 (44%), Gaps = 27/225 (12%)
Query: 479 EIKHATKSFDESYVIGVGGFGKVYKGVI------EDKLKVAIKRSNPSSEQGV-NEFVTE 531
EI +T F E +G FGKVYKG + E VAIK +E + EF E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 532 IEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIY---------------NTK 576
M S+L+H ++V L+G + + +++ Y + L E + K
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 577 KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGP 636
L + I A G+ +L + + ++H+D+ T N+L+ + K+SD GL +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 637 NMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVL 681
+ + ++ PE + + SDI+S+GVVL+EV
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 8e-14
Identities = 55/205 (26%), Positives = 102/205 (49%), Gaps = 25/205 (12%)
Query: 492 VIGVGGFGKVYKGVIEDK-------LKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLV 544
++G G FGKV ++++K +K+ +K+ ++ V +TE +L RH L
Sbjct: 2 LLGKGTFGKVI--LVKEKATGRYYAMKI-LKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 58
Query: 545 SLIGFCEEGNEMCLVYDYMALGTL-----REHIYNTKKALSWKQRLEICIGAARGLHYLH 599
+L + + +C V +Y G L RE +++ +A + + L YLH
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI------VSALDYLH 112
Query: 600 TGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYF 659
++ +++RD+K N++LD++ K++DFGL K G +++G G+ YL PE
Sbjct: 113 --SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG--IKDGATMKTFCGTPEYLAPEVL 168
Query: 660 KRQQLTEKSDIYSFGVVLFEVLCAR 684
+ D + GVV++E++C R
Sbjct: 169 EDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 62/250 (24%), Positives = 109/250 (43%), Gaps = 29/250 (11%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKRSN-PSSEQGVNEFVTEIEMLSKLRH---KHLVSL 546
+IG G +G VY+G + VA+K N + + V++ E+ +LS+LR ++
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 547 IGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL-EICIGAA-----RGLHYLHT 600
G +G + ++ +Y G++R L + E I L Y+H
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVR--------TLMKAGPIAEKYISVIIREVLVALKYIH- 118
Query: 601 GAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFK 660
K +IHRD+K NIL+ K+ DFG++ N + ST V G+ ++ PE
Sbjct: 119 --KVGVIHRDIKAANILVTNTGNVKLCDFGVAAL-LNQNSSKRSTFV-GTPYWMAPEVIT 174
Query: 661 R-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719
+ K+DI+S G+ ++E+ P P + K + D+ LL
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNP---PYSDVDAFRAMMLIPKSKPPRLEDNGYSKLL 231
Query: 720 KDKISPECLK 729
++ ++ CL
Sbjct: 232 REFVA-ACLD 240
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 58/210 (27%), Positives = 83/210 (39%), Gaps = 21/210 (10%)
Query: 493 IGVGGFGKVY---KGVIED--KLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLI 547
I G FG VY K D +KV K + Q N M+ + ++ L
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 548 GFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAAR---GLHYLHTGAKY 604
+ + + LV +Y+ G I K L A G+ LH +
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLI----KTLGGLPEDWAKQYIAEVVLGVEDLH---QR 116
Query: 605 TIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQL 664
IIHRD+K N+L+D+ K++DFGLS NG + G+ YL PE
Sbjct: 117 GIIHRDIKPENLLIDQTGHLKLTDFGLS------RNGLENKKFVGTPDYLAPETILGVGD 170
Query: 665 TEKSDIYSFGVVLFEVLCARPALNPSLPKE 694
+ SD +S G V+FE L P + P
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYPPFHAETPDA 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 1e-13
Identities = 62/234 (26%), Positives = 96/234 (41%), Gaps = 75/234 (32%)
Query: 492 VIGVGGFGKVYKGVIEDKL---KVAIKRSNPSSEQGVNEFVT---------EIEMLSKLR 539
IG G +G V V DK KVAIK+ + N F EI++L LR
Sbjct: 7 PIGSGAYGVVCSAV--DKRTGRKVAIKKIS-------NVFDDLIDAKRILREIKLLRHLR 57
Query: 540 HKHLVSLIGF-----CEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLE-------- 586
H++++ L+ E+ N++ +V + M + K + Q L
Sbjct: 58 HENIIGLLDILRPPSPEDFNDVYIVTELMET--------DLHKVIKSPQPLTDDHIQYFL 109
Query: 587 --ICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT------GPNM 638
I RGL YLH+ +IHRD+K +NIL++ N K+ DFGL++
Sbjct: 110 YQIL----RGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF 162
Query: 639 ENGHVST-------VVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
+V T ++ S Y T+ DI+S G + E+L +P
Sbjct: 163 LTEYVVTRWYRAPELLLSSSRY-----------TKAIDIWSVGCIFAELLTRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 13/203 (6%)
Query: 492 VIGVGGFGKVY------KGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVS 545
++G G FG+VY G +V +P + + V+ EI++L L+H+ +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 546 LIGFCEEGNE--MCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAK 603
G + E + + +YM G++++ + AL+ + G+ YLH+
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRKYTRQILEGMSYLHSN-- 125
Query: 604 YTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNM-ENGHVSTVVKGSFGYLDPEYFKRQ 662
I+HRD+K NIL D K+ DFG SK + +G V G+ ++ PE +
Sbjct: 126 -MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE 184
Query: 663 QLTEKSDIYSFGVVLFEVLCARP 685
K+D++S G + E+L +P
Sbjct: 185 GYGRKADVWSLGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-13
Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 26/205 (12%)
Query: 492 VIGVGGFGKVYKGVIEDK-------LKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLV 544
++G G FGKV ++ +K +K+ K + ++ V VTE +L RH L
Sbjct: 2 LLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDE-VAHTVTESRVLQNTRHPFLT 58
Query: 545 SLIGFCEEGNEMCLVYDYMALGTL-----REHIYNTKKALSWKQRLEICIGAARGLHYLH 599
+L + + +C V +Y G L RE ++ ++A + + L YLH
Sbjct: 59 ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI------VSALEYLH 112
Query: 600 TGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYF 659
+ +++RD+K N++LD++ K++DFGL K G + +G G+ YL PE
Sbjct: 113 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKTFCGTPEYLAPEVL 167
Query: 660 KRQQLTEKSDIYSFGVVLFEVLCAR 684
+ D + GVV++E++C R
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 46/179 (25%), Positives = 93/179 (51%), Gaps = 15/179 (8%)
Query: 511 KVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLRE 570
+VA+K+ + +Q E+ ++ +H ++V + G+E+ +V +++ G L +
Sbjct: 46 QVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD 105
Query: 571 HIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFG 630
+ +T+ ++ +Q +C+ + L +LH +IHRD+K+ +ILL + K+SDFG
Sbjct: 106 IVTHTR--MNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFG 160
Query: 631 ----LSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
+SK P + S V G+ ++ PE R + DI+S G+++ E++ P
Sbjct: 161 FCAQVSKEVPRRK----SLV--GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 46/179 (25%), Positives = 93/179 (51%), Gaps = 15/179 (8%)
Query: 511 KVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLRE 570
+VA+K+ + +Q E+ ++ H+++V + G+E+ +V +++ G L +
Sbjct: 49 QVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTD 108
Query: 571 HIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFG 630
+ +T+ ++ +Q +C+ R L YLH +IHRD+K+ +ILL + K+SDFG
Sbjct: 109 IVTHTR--MNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFG 163
Query: 631 ----LSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
+SK P ++ + G+ ++ PE R + DI+S G+++ E++ P
Sbjct: 164 FCAQVSKEVPKRKS------LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 57/200 (28%), Positives = 99/200 (49%), Gaps = 14/200 (7%)
Query: 492 VIGVGGFGKVYKGVIEDKLK-VAIKRSNPSSEQG-VNEF-VTEIEMLSKLRHKHLVSLIG 548
++G G +G V K ++ + VAIK+ S + V + + EI ML +LRH++LV+LI
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 549 FCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIH 608
+ LV++++ T+ + + L + + RG+ + H+ + IIH
Sbjct: 68 VFRRKKRLYLVFEFVD-HTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS---HNIIH 123
Query: 609 RDVKTTNILLDENWVAKVSDFGLSKT--GPNMENGHVSTVVKGSFGYLDPEYF-KRQQLT 665
RD+K NIL+ ++ V K+ DFG ++T P G V T + Y PE +
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLAAP----GEVYTDYVATRWYRAPELLVGDTKYG 179
Query: 666 EKSDIYSFGVVLFEVLCARP 685
DI++ G ++ E+L P
Sbjct: 180 RAVDIWAVGCLVTEMLTGEP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 63/257 (24%), Positives = 125/257 (48%), Gaps = 32/257 (12%)
Query: 485 KSFDESYV-IGVGGFGKVYKGVIEDKLK-VAIKRSNPSSEQGVNEFVTEIEMLSKLRHKH 542
+++ ++++ IG G G V ++ K VA+K+ + +Q E+ ++ +H++
Sbjct: 19 RTYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 78
Query: 543 LVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGA 602
+V + G+E+ +V +++ G L + + +T+ ++ +Q +C+ + L LH
Sbjct: 79 VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLKALSVLHAQG 136
Query: 603 KYTIIHRDVKTTNILLDENWVAKVSDFG----LSKTGPNMENGHVSTVVKGSFGYLDPEY 658
+IHRD+K+ +ILL + K+SDFG +SK P ++ + G+ ++ PE
Sbjct: 137 ---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS------LVGTPYWMAPEL 187
Query: 659 FKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPL 718
R + DI+S G+++ E++ P P K ++ D + P
Sbjct: 188 ISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------------LKAMKMIRDNLPPK 235
Query: 719 LKD--KISPECLKKFAD 733
LK+ K+SP LK F D
Sbjct: 236 LKNLHKVSP-SLKGFLD 251
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-13
Identities = 77/276 (27%), Positives = 126/276 (45%), Gaps = 35/276 (12%)
Query: 487 FDESYVIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKL-RHKHLV 544
F+ ++G G +G+VYKG ++ AIK + + ++ E EI ML K H+++
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 66
Query: 545 SLIGFCEEGN------EMCLVYDYMALGTLREHIYNTK-KALSWKQRLEICIGAARGLHY 597
+ G + N ++ LV ++ G++ + I NTK L + IC RGL +
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 126
Query: 598 LHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPE 657
LH ++ +IHRD+K N+LL EN K+ DFG+S + G +T + G+ ++ PE
Sbjct: 127 LH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ-LDRTVGRRNTFI-GTPYWMAPE 181
Query: 658 YFKRQQLTE-----KSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILD 712
+ + KSD++S G+ E+ P L P + L +
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL------------IP 229
Query: 713 DIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPS 748
P LK K + KKF E CL + RP+
Sbjct: 230 RNPAPRLKSK---KWSKKFQSFIESCLVKNHSQRPT 262
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 4e-13
Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 30/209 (14%)
Query: 493 IGVGGFGKVYKGVIED--------KLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLV 544
+G G F K++KG+ + K +V +K + S F M+S+L HKHLV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 545 SLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKAL--SWKQRLEICIGAARGLHYLHTGA 602
G C G+E +V +Y+ G+L ++ K + SWK LE+ A LH+L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK--LEVAKQLAWALHFLE--- 117
Query: 603 KYTIIHRDVKTTNILLDENWVA--------KVSDFGLSKTGPNMENGHVSTVVKGSFGYL 654
+ H +V N+LL K+SD G+S T E ++ ++
Sbjct: 118 DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE------ILLERIPWV 171
Query: 655 DPEYFKR-QQLTEKSDIYSFGVVLFEVLC 682
PE + Q L+ +D +SFG L+E+
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFS 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 4e-13
Identities = 72/277 (25%), Positives = 128/277 (46%), Gaps = 28/277 (10%)
Query: 493 IGVGGFGKVYKGVIEDKLK--VAIKRSN-PSSEQGVNEFVTEIEMLSKLRHKHLVSLIGF 549
IG G FG+VYKG I+++ K VAIK + +E + + EI +LS+ ++ G
Sbjct: 12 IGKGSFGEVYKG-IDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70
Query: 550 CEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHR 609
+G ++ ++ +Y+ G+ + + L I +GL YLH+ K IHR
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLHSERK---IHR 125
Query: 610 DVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSD 669
D+K N+LL E K++DFG++ + + + V G+ ++ PE K+ K+D
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV--GTPFWMAPEVIKQSAYDFKAD 183
Query: 670 IYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLK 729
I+S G+ E+ P + P + L + P L+ + S K
Sbjct: 184 IWSLGITAIELAKGEPPNSDLHPMRVLFL------------IPKNSPPTLEGQYS----K 227
Query: 730 KFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVEST 766
F + E CL+ RP+ ++L + +F+ + + T
Sbjct: 228 PFKEFVEACLNKDPRFRPTAKELLKH-KFITRYTKKT 263
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 67/272 (24%), Positives = 118/272 (43%), Gaps = 33/272 (12%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIKRSN---PSSEQGVNEFVTEIEMLSKLRHKHLVSLIG 548
IG G F +VY+ + D+ VA+K+ + + V EI++L +L H +++ +
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 549 FCEEGNEMCLVYDYMALGTLREHIYNTKKA-------LSWKQRLEICIGAARGLHYLHTG 601
E NE+ +V + G L + I KK WK +++C + ++H+
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC----SAVEHMHS- 124
Query: 602 AKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKR 661
++HRD+K N+ + V K+ D GL + + S V G+ Y+ PE
Sbjct: 125 --RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV--GTPYYMSPERIHE 180
Query: 662 QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKD 721
KSDI+S G +L+E+ AL ++++L C++ D PL +
Sbjct: 181 NGYNFKSDIWSLGCLLYEM----AALQSPFYGDKMNLFSL---CQKIEQCD--YPPLPTE 231
Query: 722 KISPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
S +K + C+ RP +G V
Sbjct: 232 HYS----EKLRELVSMCIYPDPDQRPDIGYVH 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 69/298 (23%), Positives = 123/298 (41%), Gaps = 59/298 (19%)
Query: 492 VIGVGGFGKVYKGVIEDK----LKVAIK--RSNPSSEQGVNEFVTEIEMLSKLRHKHLVS 545
++G G FG V + ++ + KVA+K +++ S + EF+ E + + H +++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 546 LIG-------------------FCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLE 586
LIG F + G+ ++ ++ + + E + L + +
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGD----LHTFLLMSRIGEEPFT----LPLQTLVR 117
Query: 587 ICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSK---TGPNMENGHV 643
I A G+ YL + IHRD+ N +L+EN V+DFGLSK +G G
Sbjct: 118 FMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCA 174
Query: 644 STV-VKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWA 702
S + VK +L E T SD+++FGV ++E++ P E + ++
Sbjct: 175 SKLPVK----WLALESLADNVYTTHSDVWAFGVTMWEIMTR--GQTPYAGVENSEIYNYL 228
Query: 703 LHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVL 760
+ R K P+CL+ + +C S RPS + LE +
Sbjct: 229 IKGNRL-------------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 57/205 (27%), Positives = 100/205 (48%), Gaps = 26/205 (12%)
Query: 492 VIGVGGFGKVYKGVIEDK-------LKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLV 544
++G G FGKV ++ +K +K+ +K+ ++ V +TE +L RH L
Sbjct: 2 LLGKGTFGKVI--LVREKATGKYYAMKI-LKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58
Query: 545 SLIGFCEEGNEMCLVYDYMALGTL-----REHIYNTKKALSWKQRLEICIGAARGLHYLH 599
+L + + +C V +Y G L RE +++ +A + EI L YLH
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA--EI----VSALGYLH 112
Query: 600 TGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYF 659
+ +++RD+K N++LD++ K++DFGL K G + +G G+ YL PE
Sbjct: 113 SC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKTFCGTPEYLAPEVL 167
Query: 660 KRQQLTEKSDIYSFGVVLFEVLCAR 684
+ D + GVV++E++C R
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-13
Identities = 58/199 (29%), Positives = 90/199 (45%), Gaps = 11/199 (5%)
Query: 492 VIGVGGFGKVYKGVIEDK-----LKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSL 546
VIG G FGKV + +KV K++ ++ + +L L+H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 547 IGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTI 606
+ ++ V DY+ G L H+ + L + R A + YLH+ I
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLHS---LNI 117
Query: 607 IHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTE 666
I+RD+K NILLD ++DFGL K G +E ++ G+ YL PE +++
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCKEG--VEPEETTSTFCGTPEYLAPEVLRKEPYDR 175
Query: 667 KSDIYSFGVVLFEVLCARP 685
D + G VL+E+L P
Sbjct: 176 TVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 61/200 (30%), Positives = 97/200 (48%), Gaps = 21/200 (10%)
Query: 492 VIGVGGFGKVYKGVIEDKLKV----AIKRSNPSSEQGVNEFVTEIEMLS-KLRHKHLVSL 546
V+G G FGKV ++ + A+K+ + V + E +L+ H L L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 547 IGFC--EEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL---EICIGAARGLHYLHTG 601
FC + + V +Y+ G L HI ++ + + R EI G L +LH
Sbjct: 62 --FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICG----LQFLHKK 115
Query: 602 AKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKR 661
II+RD+K N+LLD++ K++DFG+ K N E ++ G+ Y+ PE K
Sbjct: 116 G---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--KASTFCGTPDYIAPEILKG 170
Query: 662 QQLTEKSDIYSFGVVLFEVL 681
Q+ E D +SFGV+L+E+L
Sbjct: 171 QKYNESVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 7e-13
Identities = 65/204 (31%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 493 IGVGGFGKVYKGVIEDKLK-VAIKRSNPSSEQGVNE----FVTEIEMLSKLRHKHLVSLI 547
IG G FG VY + VA+K+ + S +Q NE + E++ L +L+H + +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQ-TNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 548 GFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTII 607
G + + LV +Y LG+ + + KK L + I GA +GL YLH+ I
Sbjct: 88 GCYLKEHTAWLVMEY-CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM---I 143
Query: 608 HRDVKTTNILLDENWVAKVSDFG-LSKTGPNMENGHVSTVVKGSFGYLDPEY---FKRQQ 663
HRD+K NILL E K++DFG SK+ P N V T ++ PE Q
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSASKSSP--ANSFVGTPY-----WMAPEVILAMDEGQ 196
Query: 664 LTEKSDIYSFGVVLFEVLCARPAL 687
K D++S G+ E+ +P L
Sbjct: 197 YDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 7e-13
Identities = 55/200 (27%), Positives = 102/200 (51%), Gaps = 19/200 (9%)
Query: 493 IGVGGFGKVYKGVIEDKLK--VAIKRSN-PSSEQGVNEFVTEIEMLSKLRHKHLVSLIGF 549
IG G FG+V+KG I+++ + VAIK + +E + + EI +LS+ ++ G
Sbjct: 12 IGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 550 CEEGNEMCLVYDYM----ALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYT 605
+G ++ ++ +Y+ AL LR ++ + + + + +GL YLH+ K
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEI------LKGLDYLHSEKK-- 122
Query: 606 IIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLT 665
IHRD+K N+LL E K++DFG++ + + + V G+ ++ PE ++
Sbjct: 123 -IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV--GTPFWMAPEVIQQSAYD 179
Query: 666 EKSDIYSFGVVLFEVLCARP 685
K+DI+S G+ E+ P
Sbjct: 180 SKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 9e-13
Identities = 56/229 (24%), Positives = 110/229 (48%), Gaps = 43/229 (18%)
Query: 486 SFDESYVIGVGGFGKVYKGVIEDKLK-----------------VAIK--RSNPSSEQGVN 526
+F E +G G FG+V+ E K VA+K R + +++ N
Sbjct: 8 TFKEK--LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-ANKNARN 64
Query: 527 EFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYN----------TK 576
+F+ EI+++S+L+ +++ L+ C + +C++ +YM G L + +
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 577 KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGP 636
+S+ + + A G+ YL + +HRD+ T N L+ +N+ K++DFG+S+
Sbjct: 125 VTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSR--- 178
Query: 637 NMENGHVSTVVKGS----FGYLDPEYFKRQQLTEKSDIYSFGVVLFEVL 681
N+ +G ++G ++ E + T SD+++FGV L+E+L
Sbjct: 179 NLYSGDYYR-IQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 9e-13
Identities = 69/268 (25%), Positives = 122/268 (45%), Gaps = 33/268 (12%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIKRS---NPSSEQGVNEFVTEIEMLSKLRHKHLVSLIG 548
IG G F +VY+ + D + VA+K+ + + + + EI++L +L H +++
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 549 FCEEGNEMCLVYDYMALGTLREHIYNTKKA-------LSWKQRLEICIGAARGLHYLHTG 601
E NE+ +V + G L I + KK WK +++C L ++H+
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SALEHMHS- 124
Query: 602 AKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKR 661
++HRD+K N+ + V K+ D GL + + S V G+ Y+ PE
Sbjct: 125 --RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV--GTPYYMSPERIHE 180
Query: 662 QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKD 721
KSDI+S G +L+E+ AL ++++L ++L CK+ D PL D
Sbjct: 181 NGYNFKSDIWSLGCLLYEM----AALQSPFYGDKMNL--YSL-CKKIEQCD--YPPLPSD 231
Query: 722 KISPECLKKFADTAEKCLSDSGIDRPSM 749
S E L++ + C++ RP +
Sbjct: 232 HYSEE-LRQLVNM---CINPDPEKRPDI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 13/203 (6%)
Query: 492 VIGVGGFGKVYKGVIEDK-LKVAIKRS--NPSSEQG---VNEFVTEIEMLSKLRHKHLVS 545
++G G FG+VY D ++A+K+ +P S++ VN EI++L LRH +V
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 546 LIGFCEEGNE--MCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAK 603
G + E + + +YM G++++ + AL+ +G+ YLH+
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTRRYTRQILQGVSYLHSN-- 125
Query: 604 YTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNM-ENGHVSTVVKGSFGYLDPEYFKRQ 662
I+HRD+K NIL D K+ DFG SK + +G V G+ ++ PE +
Sbjct: 126 -MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGE 184
Query: 663 QLTEKSDIYSFGVVLFEVLCARP 685
K+D++S + E+L +P
Sbjct: 185 GYGRKADVWSVACTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 17/219 (7%)
Query: 489 ESYV----IGVGGFGKVYKGVIEDKLK---VAIKRSNPSSEQGVN-EFVTEIEMLSKLRH 540
E+YV +G G + V+KG KL VA+K E+G + E+ +L L+H
Sbjct: 5 ETYVKLDKLGEGTYATVFKG--RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKH 62
Query: 541 KHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHT 600
++V+L + LV++Y+ L++++ N +S RGL Y H
Sbjct: 63 ANIVTLHDIIHTERCLTLVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH- 120
Query: 601 GAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPE-YF 659
K I+HRD+K N+L++E K++DFGL++ + + VV + Y P+
Sbjct: 121 --KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLL 176
Query: 660 KRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSL 698
+ + D++ G +L+E+ RP S KE++ L
Sbjct: 177 GSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHL 215
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 1e-12
Identities = 55/195 (28%), Positives = 94/195 (48%), Gaps = 9/195 (4%)
Query: 493 IGVGGFGKVYKGVIEDKLKV-AIKRSN-PSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFC 550
IG G FG+V+KG+ KV AIK + +E + + EI +LS+ ++ G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 551 EEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRD 610
+ ++ ++ +Y+ G+ + + L Q I +GL YLH+ K IHRD
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSEKK---IHRD 126
Query: 611 VKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDI 670
+K N+LL E+ K++DFG++ G + G+ ++ PE K+ K+DI
Sbjct: 127 IKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADI 184
Query: 671 YSFGVVLFEVLCARP 685
+S G+ E+ P
Sbjct: 185 WSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 17/210 (8%)
Query: 485 KSFDESYVIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEF---VTEIEMLSKLRH 540
K F + IG G FG VY + VAIK+ + S +Q ++ + E++ L +++H
Sbjct: 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH 84
Query: 541 KHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHT 600
+ + G + LV +Y LG+ + + KK L + I GA +GL YLH+
Sbjct: 85 PNSIEYKGCYLREHTAWLVMEY-CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS 143
Query: 601 GAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEY-- 658
+ +IHRD+K NILL E K++DFG S + + N V T ++ PE
Sbjct: 144 ---HNMIHRDIKAGNILLTEPGQVKLADFG-SASIASPANSFVGTPY-----WMAPEVIL 194
Query: 659 -FKRQQLTEKSDIYSFGVVLFEVLCARPAL 687
Q K D++S G+ E+ +P L
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 67/248 (27%), Positives = 115/248 (46%), Gaps = 27/248 (10%)
Query: 492 VIGVGGFGKVY----KGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLS-KLRHKHLVSL 546
V+G G FGKV KG E +K+ + V+ +TE +L+ +H L +L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 547 IGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL---EICIGAARGLHYLHTGAK 603
+ + + V +Y+ G L I ++K + R E+ + L +LH
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLA----LMFLHR--- 114
Query: 604 YTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQ 663
+ +I+RD+K NILLD K++DFG+ K G + NG +T G+ Y+ PE + +
Sbjct: 115 HGVIYRDLKLDNILLDAEGHCKLADFGMCKEG--ILNGVTTTTFCGTPDYIAPEILQELE 172
Query: 664 LTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKI 723
D ++ GV+++E++ +P P + L + LH DD++ P+ K
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQP---PFEADNEDDLFESILH-------DDVLYPVWLSKE 222
Query: 724 SPECLKKF 731
+ LK F
Sbjct: 223 AVSILKAF 230
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 49/170 (28%), Positives = 86/170 (50%), Gaps = 9/170 (5%)
Query: 526 NEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL 585
N+ + E+++L + ++V G E+ + ++M G+L + + K + +
Sbjct: 48 NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKEAKRIPEEILG 106
Query: 586 EICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLS-KTGPNMENGHVS 644
++ I RGL YL K+ I+HRDVK +NIL++ K+ DFG+S + +M N V
Sbjct: 107 KVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV- 163
Query: 645 TVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKE 694
G+ Y+ PE + + +SDI+S G+ L E+ R + P KE
Sbjct: 164 ----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE 209
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 68/294 (23%), Positives = 127/294 (43%), Gaps = 50/294 (17%)
Query: 487 FDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLV- 544
+ + +G G G V+ V D +VA+K+ + Q V + EI+++ +L H ++V
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66
Query: 545 -------------SLIGFCEEGNEMCLVYDYMA--LGTLREH--IYNTKKALSWKQRLEI 587
+G E N + +V +YM L + E + L Q L
Sbjct: 67 VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLL-- 124
Query: 588 CIGAARGLHYLHTGAKYTIIHRDVKTTNILLD-ENWVAKVSDFGLSK-TGPNMEN-GHVS 644
RGL Y+H+ ++HRD+K N+ ++ E+ V K+ DFGL++ P+ + G++S
Sbjct: 125 -----RGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLS 176
Query: 645 TVVKGSFGYLDPE-YFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWAL 703
+ + Y P T+ D+++ G + E+L +P + EQ+ L
Sbjct: 177 EGLVTKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL----- 230
Query: 704 HCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757
IL+ + P+++++ E L +D G R + D+L +
Sbjct: 231 ------ILESV--PVVREEDRNELLNVI---PSFVRNDGGEPRRPLRDLLPGVN 273
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 54/200 (27%), Positives = 98/200 (49%), Gaps = 21/200 (10%)
Query: 492 VIGVGGFGK--VYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGF 549
V+G G FG+ + + V D+ + P S V + E +L+K++H ++V+
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 550 CEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL-----EICIGAARGLHYLHTGAKY 604
E + +V +Y G L + I + L + + ++C+G + ++H +
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLG----VQHIH---EK 119
Query: 605 TIIHRDVKTTNILLDENWVAKVSDFGLSK--TGPNMENGHVSTVVKGSFGYLDPEYFKRQ 662
++HRD+K+ NI L +N K+ DFG ++ T P G + G+ Y+ PE ++
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP----GAYACTYVGTPYYVPPEIWENM 175
Query: 663 QLTEKSDIYSFGVVLFEVLC 682
KSDI+S G +L+E LC
Sbjct: 176 PYNNKSDIWSLGCILYE-LC 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 63/198 (31%), Positives = 109/198 (55%), Gaps = 16/198 (8%)
Query: 492 VIGVGGFGKVY---KGVIEDKLKV-AIKRSNPSSEQGVNEFVTEIE--MLSKLRHKHLVS 545
V+G G FGKV+ K D ++ A+K ++ + + T++E +L+++ H +V
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 546 L-IGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGA-ARGLHYLHTGAK 603
L F EG ++ L+ D++ G L + +K+ + ++ ++ + A L +LH+
Sbjct: 63 LHYAFQTEG-KLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYLAELALALDHLHS--- 116
Query: 604 YTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQ 663
II+RD+K NILLDE K++DFGLSK + E S G+ Y+ PE R+
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC--GTVEYMAPEVVNRRG 174
Query: 664 LTEKSDIYSFGVVLFEVL 681
T+ +D +SFGV++FE+L
Sbjct: 175 HTQSADWWSFGVLMFEML 192
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 34/209 (16%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIKRSN---PSSEQGVNEFVTEIEMLSKL-RHKHLVSLI 547
+G G FG VY E VAIK+ S E+ +N + E++ L KL H ++V L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN--LREVKSLRKLNEHPNIVKLK 64
Query: 548 GFCEEGNEMCLVYDYMALGTLREHIYN-----TKKALSWKQRLEICIGAARGLHYLHTGA 602
E +E+ V++YM ++Y K S I +GL ++H
Sbjct: 65 EVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH--- 116
Query: 603 KYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN-----GHVSTVVKGSFGYLDPE 657
K+ HRD+K N+L+ V K++DFGL++ + + +VST Y PE
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLAR---EIRSRPPYTDYVSTR-----WYRAPE 168
Query: 658 YFKRQQL-TEKSDIYSFGVVLFEVLCARP 685
R + DI++ G ++ E+ RP
Sbjct: 169 ILLRSTSYSSPVDIWALGCIMAELYTLRP 197
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 63/240 (26%), Positives = 108/240 (45%), Gaps = 30/240 (12%)
Query: 455 SGKSNASSHLSAIAQGLCRRFSLAEIKHATKSFDESYVIGVGGFGKVYKGVIEDKLKV-A 513
S S++SS SA SL+E++ + IG G G VYK + ++ A
Sbjct: 51 SSSSSSSSSSSASGSAPSAAKSLSELERVNR-------IGSGAGGTVYKVIHRPTGRLYA 103
Query: 514 IKRSNPSSEQGV-NEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHI 572
+K + E V + EIE+L + H ++V + E+ ++ ++M G+L
Sbjct: 104 LKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH 163
Query: 573 YNTKKALS--WKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFG 630
++ L+ +Q L G+ YLH + I+HRD+K +N+L++ K++DFG
Sbjct: 164 IADEQFLADVARQILS-------GIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFG 213
Query: 631 LSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTE------KSDIYSFGVVLFEVLCAR 684
+S+ + S+V G+ Y+ PE L DI+S GV + E R
Sbjct: 214 VSRILAQTMDPCNSSV--GTIAYMSPERIN-TDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 4e-12
Identities = 55/198 (27%), Positives = 95/198 (47%), Gaps = 14/198 (7%)
Query: 493 IGVGGFGKVYKGVIEDKLKV----AIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIG 548
IG G FG+VY+ +D ++ + + +++ V + E +L + ++G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 549 F---CEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYT 605
+ +++ LV DYM+ G L H+ + + + I L +LH KY
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHLH---KYD 116
Query: 606 IIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQ-L 664
I++RD+K NILLD + DFGLSK N+ + + G+ YL PE ++
Sbjct: 117 IVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEKGY 174
Query: 665 TEKSDIYSFGVVLFEVLC 682
T+ D +S GV++FE+ C
Sbjct: 175 TKHVDFWSLGVLVFEMCC 192
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 61/201 (30%), Positives = 98/201 (48%), Gaps = 22/201 (10%)
Query: 493 IGVGGFGKVYKGVIEDKLK---VAIKR-SNP-SSEQGVNEFVTEIEMLSKLRHKHLVSLI 547
+G+G FG V D+L VAIK+ P S+ E+++L LRH++++SL
Sbjct: 18 VGMGAFGLVCSA--RDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLS 75
Query: 548 G-FCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLE-ICIGAARGLHYLHTGAKYT 605
F ++ V + + H T + L KQ ++ RGL Y+H+
Sbjct: 76 DIFISPLEDIYFVTELLGTDL---HRLLTSRPLE-KQFIQYFLYQILRGLKYVHSAG--- 128
Query: 606 IIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPE-YFKRQQL 664
++HRD+K +NIL++EN K+ DFGL++ G+VST Y PE Q+
Sbjct: 129 VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAPEIMLTWQKY 183
Query: 665 TEKSDIYSFGVVLFEVLCARP 685
+ DI+S G + E+L +P
Sbjct: 184 DVEVDIWSAGCIFAEMLEGKP 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 5e-12
Identities = 50/172 (29%), Positives = 89/172 (51%), Gaps = 13/172 (7%)
Query: 526 NEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL 585
N+ + E+++L + ++V G E+ + ++M G+L + + KKA +++
Sbjct: 48 NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQI 104
Query: 586 --EICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLS-KTGPNMENGH 642
++ I +GL YL K+ I+HRDVK +NIL++ K+ DFG+S + +M N
Sbjct: 105 LGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 162
Query: 643 VSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKE 694
V G+ Y+ PE + + +SDI+S G+ L E+ R + P KE
Sbjct: 163 V-----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE 209
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 5e-12
Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 26/205 (12%)
Query: 493 IGVGGFGKVYK------GVIEDKLKVAIKRSNPSSEQGVNEFVT--EIEMLSKLRHKHLV 544
IG G +G V+K G I VAIK+ S + V + + EI ML +L+H +LV
Sbjct: 9 IGEGSYGVVFKCRNRETGQI-----VAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLV 63
Query: 545 SLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKY 604
+LI ++ LV++Y L E N + + +I + +++ H K+
Sbjct: 64 NLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG-VPEHLIKKIIWQTLQAVNFCH---KH 119
Query: 605 TIIHRDVKTTNILLDENWVAKVSDFGLSK--TGPNME-NGHVSTVVKGSFGYLDPEYF-K 660
IHRDVK NIL+ + K+ DFG ++ TGP + +V+T Y PE
Sbjct: 120 NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAPELLVG 174
Query: 661 RQQLTEKSDIYSFGVVLFEVLCARP 685
Q D+++ G V E+L +P
Sbjct: 175 DTQYGPPVDVWAIGCVFAELLTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 5e-12
Identities = 62/202 (30%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 492 VIGVGGFGKVY--KGVIEDK---LKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSL 546
VIG G FGKV + E+K +KV K++ ++ + +L ++H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 547 IGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL---EICIGAARGLHYLHTGAK 603
+ +++ V DY+ G L H+ + L + R EI A L YLH+
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEI----ASALGYLHS--- 114
Query: 604 YTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQ 663
I++RD+K NILLD ++DFGL K N+E+ ++ G+ YL PE +Q
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 664 LTEKSDIYSFGVVLFEVLCARP 685
D + G VL+E+L P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 67/236 (28%), Positives = 110/236 (46%), Gaps = 39/236 (16%)
Query: 487 FDESYVIGVGGFGKVYKGVIEDKLK---VAIKRSNPSSEQGVNEF----VTEIEMLSKLR 539
FD IG G +G+VYK DK VA+K+ +E+ F + EI++L +L
Sbjct: 9 FDIIGQIGEGTYGQVYKAR--DKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLN 64
Query: 540 HKHLVSL----------IGFCEEGNEMCLVYDYM---ALGTLREHI--YNTKKALSW-KQ 583
H+++V+L + F ++ LV++YM +G L + ++ S+ KQ
Sbjct: 65 HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQ 124
Query: 584 RLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643
LE GL+Y H K +HRD+K +NILL+ K++DFGL++ N E
Sbjct: 125 LLE-------GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLY-NSEESRP 173
Query: 644 STVVKGSFGYLDPE-YFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSL 698
T + Y PE ++ D++S G +L E+ +P + Q+ L
Sbjct: 174 YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLEL 229
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 75/287 (26%), Positives = 138/287 (48%), Gaps = 40/287 (13%)
Query: 485 KSFDESYV-IGVGGFGKVYKGVIEDK---LKVAIKRSNPSSEQGVNEFVTEIEMLSKLRH 540
+S E+Y+ IG G G V + +K +VA+K + +Q E+ ++ +H
Sbjct: 20 RSLLENYIKIGEGSTGIVC--IAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 77
Query: 541 KHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHT 600
+++V + G E+ ++ +++ G L + + T+ L+ +Q +C + L YLH+
Sbjct: 78 QNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTR--LNEEQIATVCESVLQALCYLHS 135
Query: 601 GAKYTIIHRDVKTTNILLDENWVAKVSDFG----LSKTGPNMENGHVSTVVKGSFGYLDP 656
+IHRD+K+ +ILL + K+SDFG +SK P ++ + G+ ++ P
Sbjct: 136 QG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS------LVGTPYWMAP 186
Query: 657 EYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIID 716
E R + DI+S G+++ E++ P P + + KR L D
Sbjct: 187 EVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM---------KR---LRDSPP 234
Query: 717 PLLKD--KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQ 761
P LK+ KISP L+ F E+ L+ +R + ++L + F+LQ
Sbjct: 235 PKLKNAHKISP-VLRDF---LERMLTREPQERATAQELL-DHPFLLQ 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 1e-11
Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 35/213 (16%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGV-NEFVTEIEMLSKLRHKHLVSLI-- 547
IG G +G V +KVAIK+ +P Q + EI++L + +H++++ ++
Sbjct: 12 YIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDI 71
Query: 548 ---GFCEEGNEMCLVYDYM------ALGTLR---EHI-YNTKKALSWKQRLEICIGAARG 594
E N++ +V + M + T +HI Y + L RG
Sbjct: 72 IRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQIL-------------RG 118
Query: 595 LHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSK-TGPNMENGHVSTVVKGSFGY 653
L Y+H+ ++HRD+K +N+LL+ N K+ DFGL++ P ++ T + Y
Sbjct: 119 LKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWY 175
Query: 654 LDPEYFKRQQLTEKS-DIYSFGVVLFEVLCARP 685
PE + K+ DI+S G +L E+L RP
Sbjct: 176 RAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRP 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|221187 pfam11721, Malectin, Di-glucose binding within endoplasmic reticulum | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-11
Identities = 33/145 (22%), Positives = 58/145 (40%), Gaps = 20/145 (13%)
Query: 179 TMFRLNVAGQYISPKNDSGGLMRSWQNDEPYLFG-AGYGIPMKADEVQIDYKSLPDYSAP 237
+ +N G DS G +++ D + G A Y + I +
Sbjct: 1 VVLAINCGGPEH---TDSDG--ITYEADTYFTGGSADYYVSDTNGSSSIAG------TTD 49
Query: 238 PDVYMTARYMGVDAHTNMEFNLTWIFRVDANFTYYVRLHFCEFKPDINKINQRVFNIYIN 297
P++Y T RY + ++ N Y V LHF E + + +RVF++Y+
Sbjct: 50 PELYQTERY-SPS-------SFSYYIPCLENGNYTVILHFAEIYFGEDGLGRRVFDVYVQ 101
Query: 298 NQTAQADADVIAWTHGQGVPIYKDY 322
+ D D++A G+G +K+Y
Sbjct: 102 GKLVLKDFDIVAEAGGKGKTAHKEY 126
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan. Length = 164 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 493 IGVGGFGKVYKGVIEDKLKV----AIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIG 548
IG G FGKV + D ++ I++++ S V + E +L+++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 549 FCEEGNEMCLVYDYMALGTL-----REHIYNTKKALSWKQRLEICIGAARGLHYLHTGAK 603
+ ++ LV ++ G L RE ++ +A + L L LH K
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLC------ALENLH---K 111
Query: 604 YTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQ 663
+ +I+RD+K NILLD + DFGL K NM++ + G+ YL PE
Sbjct: 112 FNVIYRDLKPENILLDYQGHIALCDFGLCKL--NMKDDDKTNTFCGTPEYLAPELLLGHG 169
Query: 664 LTEKSDIYSFGVVLFEVLCARP 685
T+ D ++ GV+L+E+L P
Sbjct: 170 YTKAVDWWTLGVLLYEMLTGLP 191
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 53/218 (24%), Positives = 105/218 (48%), Gaps = 15/218 (6%)
Query: 489 ESYV----IGVGGFGKVYKG--VIEDKLKVAIKRSNPSSEQGVN-EFVTEIEMLSKLRHK 541
E+Y+ +G G + V+KG + + L VA+K E+G + E+ +L L+H
Sbjct: 6 ETYIKLEKLGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64
Query: 542 HLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTG 601
++V+L + LV++Y+ L++++ + +S RGL Y H
Sbjct: 65 NIVTLHDIVHTDKSLTLVFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH-- 121
Query: 602 AKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPE-YFK 660
+ ++HRD+K N+L++E K++DFGL++ + + VV + Y P+
Sbjct: 122 -RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLG 178
Query: 661 RQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSL 698
+ + + D++ G + FE+ RP S ++++ L
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHL 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 54/216 (25%), Positives = 105/216 (48%), Gaps = 15/216 (6%)
Query: 489 ESYV----IGVGGFGKVYKG--VIEDKLKVAIKRSNPSSEQGVN-EFVTEIEMLSKLRHK 541
E+Y+ +G G + VYKG + D L VA+K E+G + E+ +L L+H
Sbjct: 6 ETYIKLDKLGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64
Query: 542 HLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTG 601
++V+L + LV++Y+ L++++ + +++ RGL+Y H
Sbjct: 65 NIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH-- 121
Query: 602 AKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPE-YFK 660
+ ++HRD+K N+L++E K++DFGL++ + + VV + Y P+
Sbjct: 122 -RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLG 178
Query: 661 RQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQV 696
+ + D++ G + +E+ RP S +EQ+
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 13/198 (6%)
Query: 493 IGVGGFGKVYK-GVIEDKLKVAIKRSNPSS--EQGVNEFV-TEIEMLSKLRHKHLVSLIG 548
+GVGGFG+V V A+K E G E + +E E+L + H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 549 FCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEI-CIGAARGLHYLHTGAKYTII 607
++ + ++ +Y G L + + + R I C+ A YLH II
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLA--FEYLHN---RGII 115
Query: 608 HRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEK 667
+RD+K N+LLD N K+ DFG +K +++G + G+ Y+ PE +
Sbjct: 116 YRDLKPENLLLDSNGYVKLVDFGFAKK---LKSGQKTWTFCGTPEYVAPEIILNKGYDFS 172
Query: 668 SDIYSFGVVLFEVLCARP 685
D +S G++L+E+L RP
Sbjct: 173 VDYWSLGILLYELLTGRP 190
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 43/141 (30%), Positives = 71/141 (50%), Gaps = 5/141 (3%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCE 551
IG G +G VYK + AIK + EI M+ +H ++V+ G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 552 EGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDV 611
+++ + ++ G+L++ IY+ LS Q + +GL+YLH+ K +HRD+
Sbjct: 77 RRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLHSKGK---MHRDI 132
Query: 612 KTTNILLDENWVAKVSDFGLS 632
K NILL +N K++DFG+S
Sbjct: 133 KGANILLTDNGHVKLADFGVS 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 62/210 (29%), Positives = 101/210 (48%), Gaps = 30/210 (14%)
Query: 492 VIGVGGFGKVY---KGVIEDK-----LKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHL 543
V+G GG+GKV+ K D +KV K + +++ E +L ++H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 544 VSLIGFCEEGNEMCLVYDYMALGTL-----REHIYNTKKA---LSWKQRLEICIGAARGL 595
V LI + G ++ L+ +Y++ G L RE I+ A LS EI + L
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS-----EISLA----L 113
Query: 596 HYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLD 655
+LH + II+RD+K NILLD K++DFGL K ++ G V+ G+ Y+
Sbjct: 114 EHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKE--SIHEGTVTHTFCGTIEYMA 168
Query: 656 PEYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
PE R + D +S G +++++L P
Sbjct: 169 PEILMRSGHGKAVDWWSLGALMYDMLTGAP 198
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 14/218 (6%)
Query: 492 VIGVGGFGKVY--KGVIEDK---LKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSL 546
VIG G FGKV K ++ K +KV K+ + ++ + +L ++H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 547 IGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTI 606
+ ++ V D++ G L H+ + + R A L YLH+ I
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLHS---INI 117
Query: 607 IHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTE 666
++RD+K NILLD ++DFGL K G + +T G+ YL PE ++Q
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCKEG--IAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175
Query: 667 KSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALH 704
D + G VL+E+L P P ++ + D LH
Sbjct: 176 TVDWWCLGAVLYEMLYGLP---PFYCRDVAEMYDNILH 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 5e-11
Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 17/199 (8%)
Query: 492 VIGVGGFGKVYKGVIEDKLKV----AIKRSNPSSEQGVNEFVTEIEMLSKLR-HKHLVSL 546
V+G G FGKV +++ ++ +K+ + V +TE +LS R H L L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 547 IGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL---EICIGAARGLHYLHTGAK 603
+ + + V +++ G L HI +++ + R EI L +LH
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEI----TSALMFLHDKG- 116
Query: 604 YTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQ 663
II+RD+K N+LLD K++DFG+ K G + NG ++ G+ Y+ PE +
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCKEG--IFNGKTTSTFCGTPDYIAPEILQEML 172
Query: 664 LTEKSDIYSFGVVLFEVLC 682
D ++ GV+L+E+LC
Sbjct: 173 YGPSVDWWAMGVLLYEMLC 191
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 5e-11
Identities = 53/192 (27%), Positives = 80/192 (41%), Gaps = 32/192 (16%)
Query: 507 EDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALG 566
E + KV +K G EI++L + H+ +++LI + +C+V
Sbjct: 117 EQRKKVIVKAVTGGKTPG-----REIDILKTISHRAIINLIHAYRWKSTVCMV------- 164
Query: 567 TLREHIYN------TKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDE 620
+ ++ + L +Q + I L YLH IIHRDVKT NI LDE
Sbjct: 165 -MPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDE 220
Query: 621 NWVAKVSDFGLS-KTGPNMEN----GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGV 675
A + DFG + K + + G T+ S PE K+DI+S G+
Sbjct: 221 PENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNS-----PELLALDPYCAKTDIWSAGL 275
Query: 676 VLFEVLCARPAL 687
VLFE+ L
Sbjct: 276 VLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 8e-11
Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 34/227 (14%)
Query: 493 IGVGGFGKVYKGVIE---DKLKVAIKRSNPSS---EQGVNEFVTEIEMLSKLRHKHLVSL 546
IG G FGKV G K +V +K S+ EQ F+ E++ +L H +++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQ--LLFLQEVQPYRELNHPNVLQC 60
Query: 547 IGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSW------KQRLEICIGAARGLHYLHT 600
+G C E LV ++ LG L+ ++ + + ++ QR+ + A GL +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEV--ASGLLWLH- 117
Query: 601 GAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFG--YLDPEY 658
+ IH D+ N L + K+ D+GL+ + T + +L PE
Sbjct: 118 --QADFIHSDLALRNCQLTADLSVKIGDYGLALE--QYPEDYYITKDCHAVPLRWLAPEL 173
Query: 659 -------FKRQQLTEKSDIYSFGVVLFEV--LCARPALNPSLPKEQV 696
+ T+KS+I+S GV ++E+ +P P L EQV
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPY--PDLSDEQV 218
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 9e-11
Identities = 65/263 (24%), Positives = 112/263 (42%), Gaps = 43/263 (16%)
Query: 487 FDESYVIGVGGFGKVY----KGVIEDKLKVAIKRSNPSS---EQGVNEFVTEIEMLSKLR 539
F+ +I G +G VY K E + + A+K+ N + + + E ++L+
Sbjct: 3 FETIKLISNGAYGAVYLVRHK---ETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE 59
Query: 540 HKHLVSLIGFCEEGNEMCLVYDYMALG---TLREHIYNTKKALSWKQRLEICIGAARGLH 596
+ +VS+ E +C+V +Y+ G TL ++I ++ E + L
Sbjct: 60 NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLA----LE 115
Query: 597 YLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTG-----PNMENGHVSTVVK--- 648
YLH Y I+HRD+K N+L+ K++DFGLSK G N+ GH+ +
Sbjct: 116 YLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172
Query: 649 -----GSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWAL 703
G+ Y+ PE RQ + D ++ G++L+E L P+E
Sbjct: 173 DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG------ 226
Query: 704 HCKRKGILDDIIDPLLKDKISPE 726
+ I DDI P + + +
Sbjct: 227 ----QVISDDIEWPEGDEALPAD 245
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 24/202 (11%)
Query: 492 VIGVGGFGKVYKGVIEDKLKV----AIKRSNPSSEQGVNEFVTEIEMLSKLRH---KHLV 544
+IG GGFG+VY D K+ + + +QG + E MLS + +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 545 SLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKY 604
+ +++C + D M G L H+ + S K+ GL ++H
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHL-SQHGVFSEKEMRFYATEIILGLEHMHN---R 116
Query: 605 TIIHRDVKTTNILLDENWVAKVSDFGL----SKTGPNMENGHVSTVVKGSFGYLDPEYFK 660
+++RD+K NILLDE+ ++SD GL SK P H S G+ GY+ PE +
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HASV---GTHGYMAPEVLQ 168
Query: 661 RQQLTEKS-DIYSFGVVLFEVL 681
+ + S D +S G +LF++L
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 44/150 (29%), Positives = 78/150 (52%), Gaps = 18/150 (12%)
Query: 493 IGVGGFGKVYKGVIEDKLK---VAIKRSNPSSE-QGV-NEFVTEIEMLSKLRHKHLVSLI 547
IG G +G VYK DKL VA+K+ +E +GV + + EI +L +L H ++V L+
Sbjct: 7 IGEGTYGVVYKA--RDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLL 64
Query: 548 GFCEEGNEMCLVYDY--MALGTLREHIYNTKK--ALSWKQRLEICIGAARGLHYLHTGAK 603
N++ LV+++ + L + T L ++ +G+ Y H+
Sbjct: 65 DVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLL----QGIAYCHS--- 117
Query: 604 YTIIHRDVKTTNILLDENWVAKVSDFGLSK 633
+ ++HRD+K N+L+D K++DFGL++
Sbjct: 118 HRVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 55/217 (25%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 492 VIGVGGFGKVYKGVIEDKLKV----AIKRSNPSSEQGVNEFVTEIEMLSKLR-HKHLVSL 546
VIG G + KV ++ ++ +K+ ++ ++ TE + + + LV L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 547 IGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL---EICIGAARGLHYLHTGAK 603
+ + + LV +Y+ G L H+ +K R EICI L++LH +
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA----LNFLH---E 114
Query: 604 YTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQ 663
II+RD+K N+LLD + K++D+G+ K G + G ++ G+ Y+ PE + ++
Sbjct: 115 RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEG--LGPGDTTSTFCGTPNYIAPEILRGEE 172
Query: 664 LTEKSDIYSFGVVLFEVLCARPAL-----NPSLPKEQ 695
D ++ GV++FE++ R NP + E
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTED 209
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 56/197 (28%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 493 IGVGGFGKVYKGVIEDKLKV-AIKR-SNPSSEQGVNEFVTEIEMLSKLRH-KHLVSLIG- 548
IG G FG V K + + + A+KR + E+ + +++++ + ++V G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 549 -FCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL-EICIGAARGLHYLHTGAKYTI 606
F E +C+ ++L +++Y K++ ++ L +I + + L+YL K I
Sbjct: 72 LFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--I 129
Query: 607 IHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEY---FKRQQ 663
IHRDVK +NILLD N K+ DFG+S + + T G Y+ PE R
Sbjct: 130 IHRDVKPSNILLDRNGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPERIDPSARDG 186
Query: 664 LTEKSDIYSFGVVLFEV 680
+SD++S G+ L+EV
Sbjct: 187 YDVRSDVWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 26/206 (12%)
Query: 492 VIGVGGFGKVY-----KGVIEDKL---KVAIKRSNPSSEQGVNEFVTEIEMLSKLRHK-H 542
V+G G +GKV+ G KL KV K + + TE ++L +R
Sbjct: 7 VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPF 66
Query: 543 LVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL---EICIGAARGLHYLH 599
LV+L + ++ L+ DY+ G L H+Y + + R+ EI + L +LH
Sbjct: 67 LVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLA----LDHLH 122
Query: 600 TGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSK--TGPNMENGHVSTVVKGSFGYLDPE 657
+ II+RD+K NILLD ++DFGLSK E + G+ Y+ PE
Sbjct: 123 ---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC---GTIEYMAPE 176
Query: 658 YFKRQQLTEKS--DIYSFGVVLFEVL 681
+ D +S GV+ FE+L
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 71/256 (27%), Positives = 105/256 (41%), Gaps = 48/256 (18%)
Query: 492 VIGVGGFGKVYKGVIEDKLKV-AIK---RSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLI 547
+IG GGFG+VY D K+ A+K + +QG + E MLS LVS
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS------LVS-T 53
Query: 548 GFC----------EEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHY 597
G C +++ + D M G L H+ + S + GL +
Sbjct: 54 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEAEMRFYAAEIILGLEH 112
Query: 598 LHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGL----SKTGPNMENGHVSTVVKGSFGY 653
+H +++RD+K NILLDE+ ++SD GL SK P H S G+ GY
Sbjct: 113 MHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HASV---GTHGY 161
Query: 654 LDPEYFKRQQLTEKS-DIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILD 712
+ PE ++ + S D +S G +LF++L P Q D R +
Sbjct: 162 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS------PFRQHKTKD-KHEIDR---MT 211
Query: 713 DIIDPLLKDKISPECL 728
+ L D SPE
Sbjct: 212 LTMAVELPDSFSPELR 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 31/173 (17%)
Query: 481 KHATKSFDESYVIGVGGFGKVYKGV-IEDKLKVAIKR--SNPSSEQGVNEFVTEIEMLSK 537
+++ IG G FG+V+K + K VA+K+ E + EI++L
Sbjct: 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQL 67
Query: 538 LRHKHLVSLIGFCEE----GN----EMCLVYDYMA--LGTLREHIYNT------KKALSW 581
L+H+++V+LI C N LV+++ L L + KK +
Sbjct: 68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVM-- 125
Query: 582 KQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634
K L GL+Y+H I+HRD+K NIL+ ++ + K++DFGL++
Sbjct: 126 KMLLN-------GLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARA 168
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 60/224 (26%), Positives = 109/224 (48%), Gaps = 17/224 (7%)
Query: 512 VAIKRSNPSSEQGVNEFV------------TEIEMLSKLRHKHLVSLIGFCEEGNEMCLV 559
VA + S+P E+ V +FV +E+ L+ H +V + +++ L+
Sbjct: 85 VATRGSDPK-EKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143
Query: 560 YDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLD 619
+Y + G L + I K Q E+ + + + L ++HRD+K+ NI L
Sbjct: 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLM 203
Query: 620 ENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFE 679
+ K+ DFG SK + + V++ G+ YL PE ++R++ ++K+D++S GV+L+E
Sbjct: 204 PTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYE 263
Query: 680 VLCA-RPALNPSLPK--EQVSLADW-ALHCKRKGILDDIIDPLL 719
+L RP PS + +QV + C + ++DPLL
Sbjct: 264 LLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLL 307
|
Length = 478 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 493 IGVGGFGKVYKGVI-EDKLKVAIKR-SNP-SSEQGVNEFVTEIEMLSKLRHKHLVSLIG- 548
+G G +G+V + KVAIK+ S P S E+ +L + H++++ L+
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82
Query: 549 FC-----EEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAK 603
F E+ ++ LV M G +I +K LS + RGL Y+H+
Sbjct: 83 FTPASSLEDFQDVYLVTHLM--GADLNNIVKCQK-LSDDHIQFLVYQILRGLKYIHSAG- 138
Query: 604 YTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPE-YFKRQ 662
IIHRD+K +NI ++E+ K+ DFGL++ + G+V+T Y PE
Sbjct: 139 --IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWM 191
Query: 663 QLTEKSDIYSFGVVLFEVLCARP 685
+ DI+S G ++ E+L +
Sbjct: 192 HYNQTVDIWSVGCIMAELLTGKT 214
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 69/279 (24%), Positives = 112/279 (40%), Gaps = 38/279 (13%)
Query: 493 IGVGGFGKVYKGV--------IEDKLK-VAIKRSNPSSEQGVNE-FVTEIEMLSKLRHKH 542
+G G F +YKGV I + V++ S+ + F ++S+L HKH
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 543 LVSLIGFC-EEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTG 601
LV L G C + N M V +Y+ G L ++ K +S +L++ A LHYL
Sbjct: 63 LVKLYGVCVRDENIM--VEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK 120
Query: 602 AKYTIIHRDVKTTNILL--DENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYF 659
++H +V NIL+ V LS G + V+ ++ PE
Sbjct: 121 ---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI-PWIAPECI 176
Query: 660 KRQQ--LTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717
+ Q LT +D +SFG L E+ N P +S ++ + + L
Sbjct: 177 RNGQASLTIAADKWSFGTTLLEICS-----NGEEPLSTLSSSEKERFYQDQHRLP----- 226
Query: 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756
P+C + A+ +C + RPS +L +L
Sbjct: 227 ------MPDC-AELANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 46/145 (31%), Positives = 77/145 (53%), Gaps = 13/145 (8%)
Query: 493 IGVGGFGKVYKG--VIEDKLK-VAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIG- 548
+G G +G VYK + +L V I + P + + + EI M+ + +H ++V+ G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQ--QEIFMVKECKHCNIVAYFGS 74
Query: 549 -FCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTII 607
E +C+ +Y G+L++ IY+ LS Q +C +GL YLH+ K +
Sbjct: 75 YLSREKLWICM--EYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLHSKGK---M 128
Query: 608 HRDVKTTNILLDENWVAKVSDFGLS 632
HRD+K NILL +N K++DFG++
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVA 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 15/210 (7%)
Query: 486 SFDESYVIGVGGFGKVY----KGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHK 541
F+ V+G G FGKV KG E +K+ + V + E +L+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 542 HLVSLIGFC-EEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGA--ARGLHYL 598
++ + C + + + V +Y+ G L HI K +K+ + A + GL +L
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK---FKEPQAVFYAAEISVGLFFL 117
Query: 599 HTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEY 658
H + II+RD+K N++LD K++DFG+ K +M +G + G+ Y+ PE
Sbjct: 118 H---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKE--HMVDGVTTRTFCGTPDYIAPEI 172
Query: 659 FKRQQLTEKSDIYSFGVVLFEVLCARPALN 688
Q + D +++GV+L+E+L +P +
Sbjct: 173 IAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 21/200 (10%)
Query: 492 VIGVGGFGKVY----KGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLS-KLRHKHLVSL 546
++G G FGKV+ KG + A+K+ + V + E +LS H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 547 IGFCEEGNEMCLVYDYMALGTLREHI-----YNTKKALSWKQRLEICIGAARGLHYLHTG 601
+ + V +Y+ G L HI ++ +A + + IC GL +LH+
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEI-IC-----GLQFLHSK 115
Query: 602 AKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKR 661
I++RD+K NILLD + K++DFG+ K NM + G+ Y+ PE
Sbjct: 116 G---IVYRDLKLDNILLDTDGHIKIADFGMCKE--NMLGDAKTCTFCGTPDYIAPEILLG 170
Query: 662 QQLTEKSDIYSFGVVLFEVL 681
Q+ D +SFGV+L+E+L
Sbjct: 171 QKYNTSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 53/198 (26%), Positives = 81/198 (40%), Gaps = 19/198 (9%)
Query: 531 EIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIG 590
E +L + H ++ + G C+V + + L ++ + L Q L I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQ 165
Query: 591 AARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN--GHVSTVVK 648
GL YLH IIHRDVKT NI +++ + D G ++ G TV
Sbjct: 166 ILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVET 222
Query: 649 GSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRK 708
+ PE R + K+DI+S G+VLFE+L + P + ++ C
Sbjct: 223 NA-----PEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPS---TPEEYVKSCHSH 274
Query: 709 GILDDIIDPLLKDKISPE 726
L II L K+ PE
Sbjct: 275 --LLKIISTL---KVHPE 287
|
Length = 357 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 16/202 (7%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVT--EIEMLSKLRHKHLVSLIGF 549
IG G +G V E KVAIK+ + + ++ T EI++L L H++++++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 550 C-----EEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKY 604
E N++ +VY+ M T I + + LS RGL Y+H+
Sbjct: 73 MPPPHREAFNDVYIVYELM--DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA--- 127
Query: 605 TIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPE-YFKRQQ 663
++HRD+K +N+LL+ N K+ DFGL++T E G T + Y PE +
Sbjct: 128 NVLHRDLKPSNLLLNANCDLKICDFGLART--TSEKGDFMTEYVVTRWYRAPELLLNCSE 185
Query: 664 LTEKSDIYSFGVVLFEVLCARP 685
T D++S G + E+L +P
Sbjct: 186 YTTAIDVWSVGCIFAELLGRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-10
Identities = 58/201 (28%), Positives = 93/201 (46%), Gaps = 15/201 (7%)
Query: 492 VIGVGGFGKVY----KGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKH-LVSL 546
V+G G FGKV KG E +K+ + V + E +L+ L L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 547 IGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGA--ARGLHYLHTGAKY 604
+ + + V +Y+ G L HI K +K+ + A A GL +LH+
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK---FKEPHAVFYAAEIAIGLFFLHSKG-- 121
Query: 605 TIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQL 664
II+RD+K N++LD K++DFG+ K N+ G + G+ Y+ PE Q
Sbjct: 122 -IIYRDLKLDNVMLDAEGHIKIADFGMCKE--NIFGGKTTRTFCGTPDYIAPEIIAYQPY 178
Query: 665 TEKSDIYSFGVVLFEVLCARP 685
+ D ++FGV+L+E+L +P
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQP 199
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (149), Expect = 6e-10
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 33/208 (15%)
Query: 492 VIGVGGFGKV----YKGV-------IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRH 540
+G G FG+V +KG I K K+ + V + E +L +RH
Sbjct: 8 TLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-------VEHVLNEKRILQSIRH 60
Query: 541 KHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAAR---GLHY 597
LV+L G ++ + + LV +Y+ G L H+ + + AA+ L Y
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGR-FPEPV---ARFYAAQVVLALEY 116
Query: 598 LHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPE 657
LH+ I++RD+K N+LLD + K++DFG +K G T+ G+ YL PE
Sbjct: 117 LHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK----RVKGRTYTLC-GTPEYLAPE 168
Query: 658 YFKRQQLTEKSDIYSFGVVLFEVLCARP 685
+ + D ++ G++++E+L P
Sbjct: 169 IILSKGYGKAVDWWALGILIYEMLAGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 7e-10
Identities = 62/240 (25%), Positives = 92/240 (38%), Gaps = 65/240 (27%)
Query: 492 VIGVGGFGKVYKGVIEDKLK---VAIKRSNPS----SEQGVNEFVTEIEMLSKLRHKHLV 544
VIG G FG+V+ ++ DK A+K S Q + E ++L+ +V
Sbjct: 8 VIGRGAFGEVW--LVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADADSPWIV 64
Query: 545 SLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL----------EICIGAARG 594
L ++ + LV +YM G L L K E+ A
Sbjct: 65 KLYYSFQDEEHLYLVMEYMPGGDLMNL-------LIRKDVFPEETARFYIAELV--LA-- 113
Query: 595 LHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSK----------------TGPNM 638
L +H K IHRD+K NIL+D + K++DFGL K
Sbjct: 114 LDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 639 ENGHV-------------STVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
+N V STV G+ Y+ PE + + D +S GV+L+E+L P
Sbjct: 171 DNVLVRRRDHKQRRVRANSTV--GTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 7e-10
Identities = 62/220 (28%), Positives = 96/220 (43%), Gaps = 46/220 (20%)
Query: 493 IGVGGFGKVYKG-VIEDKLKVAIKRSNP---SSEQGVNEFVTEIEMLSKLR-HKHLVSLI 547
IG G F +V K + AIK S EQ VN EI+ L +L H +++ LI
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNL-REIQALRRLSPHPNILRLI 64
Query: 548 G--FCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYT 605
F + + LV++ M + L E I K+ L K+ + L ++H +
Sbjct: 65 EVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNG 120
Query: 606 IIHRDVKTTNILLDENWVAKVSDFGLSKT----GPNMENGHVST---------VVKGSFG 652
I HRD+K NIL+ ++ + K++DFG + P E ++ST + G +G
Sbjct: 121 IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTE--YISTRWYRAPECLLTDGYYG 177
Query: 653 YLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLP 692
K DI++ G V FE+L +L P P
Sbjct: 178 P-------------KMDIWAVGCVFFEIL----SLFPLFP 200
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 8e-10
Identities = 50/201 (24%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 492 VIGVGGFGKVYKGVIEDKLKV----AIKRSNPSSEQGVNEFVTEIEMLSKL-RHKHLVSL 546
VIG G + KV ++ ++ IK+ + ++ ++ TE + H LV L
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 547 IGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL---EICIGAARGLHYLHTGAK 603
+ + + V ++++ G L H+ +K R EI + L++LH
Sbjct: 62 HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNFLHERG- 116
Query: 604 YTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQ 663
II+RD+K N+LLD K++D+G+ K G + G ++ G+ Y+ PE + +
Sbjct: 117 --IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG--IRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 664 LTEKSDIYSFGVVLFEVLCAR 684
D ++ GV++FE++ R
Sbjct: 173 YGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 8e-10
Identities = 61/235 (25%), Positives = 101/235 (42%), Gaps = 37/235 (15%)
Query: 493 IGVGGFGKVYKGVIEDKLKVA------IKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSL 546
IG G FGKV I VA +K + S EQ NEF+ + + L+H +++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQ--NEFLQQGDPYRILQHPNILQC 60
Query: 547 IGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEI----CIGAARGLHYLHTGA 602
+G C E LV++Y LG L+ ++ + Q L + C AA G+ ++H
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAA-GVTHMH--- 116
Query: 603 KYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFG--YLDPEYFK 660
K+ +H D+ N L + KV D+G+ + + ++ T +L PE
Sbjct: 117 KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPS--RYKEDYIETEDDKCVPLRWLAPELVG 174
Query: 661 RQQ-------LTEKSDIYSFGVVLFEV----------LCARPALNPSLPKEQVSL 698
T+ S++++ GV L+E+ L R LN + +QV L
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKL 229
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 42/150 (28%), Positives = 83/150 (55%), Gaps = 17/150 (11%)
Query: 493 IGVGGFGKVYKGVIEDKLK-VAIKRSN-PSSEQGV-NEFVTEIEMLSKLRHKHLVSLIGF 549
IG G +G VYKG + + VA+K+ S E+GV + + EI +L +L+H ++V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 550 CEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL------EICIGAARGLHYLHTGAK 603
+ + + L+++++++ L++++ + K L +I +G+ + H
Sbjct: 68 LMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQI----LQGILFCH---S 119
Query: 604 YTIIHRDVKTTNILLDENWVAKVSDFGLSK 633
++HRD+K N+L+D V K++DFGL++
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 21/209 (10%)
Query: 486 SFDESYVIGVGGFGKVY---KGVIEDK-----LKVAIKRSNPSSEQGVNEFVTEIEMLSK 537
+F+ V+G G +GKV+ K D +KV K + + V TE +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 538 LRHK-HLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL---EICIGAAR 593
+R LV+L + ++ L+ DY++ G + H+Y + R EI +
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILA--- 117
Query: 594 GLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGY 653
L +LH K I++RD+K NILLD ++DFGLSK + E + G+ Y
Sbjct: 118 -LEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC-GTIEY 172
Query: 654 LDPEYFKRQQLTEKS-DIYSFGVVLFEVL 681
+ PE + + K+ D +S G+++FE+L
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELL 201
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 51/205 (24%), Positives = 96/205 (46%), Gaps = 17/205 (8%)
Query: 492 VIGVGGFGKVYKGVIEDKLKV----AIKRSNPSSEQGVNEFVTEIEMLSKL-RHKHLVSL 546
VIG G + KV ++ ++ +K+ + ++ ++ TE + + H LV L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 547 IGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL---EICIGAARGLHYLHTGAK 603
+ + + V +Y+ G L H+ +K R EI + L+YLH +
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNYLH---E 114
Query: 604 YTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQ 663
II+RD+K N+LLD K++D+G+ K G + G ++ G+ Y+ PE + +
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG--LRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 664 LTEKSDIYSFGVVLFEVLCARPALN 688
D ++ GV++FE++ R +
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 487 FDESYVIGVGGFGKVY----KGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKH 542
F+ V+G G FGKV KG E +K+ + V + E +L+
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 543 LVSLIGFC-EEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGA--ARGLHYLH 599
++ + C + + + V +Y+ G L I + +K+ + A A GL +LH
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR---FKEPHAVFYAAEIAIGLFFLH 118
Query: 600 TGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYF 659
+ II+RD+K N++LD K++DFG+ K NM +G + G+ Y+ PE
Sbjct: 119 SKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE--NMWDGVTTKTFCGTPDYIAPEII 173
Query: 660 KRQQLTEKSDIYSFGVVLFEVLCARP 685
Q + D ++FGV+L+E+L +
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQA 199
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 32/97 (32%), Positives = 48/97 (49%), Gaps = 9/97 (9%)
Query: 587 ICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTV 646
+ + + LHYL K+ +IHRDVK +NILLD + K+ DFG+S + + T
Sbjct: 119 MTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISG---RLVDSKAKTR 173
Query: 647 VKGSFGYLDPEYFKRQQLTEK----SDIYSFGVVLFE 679
G Y+ PE K +D++S G+ L E
Sbjct: 174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVE 210
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 55/200 (27%), Positives = 96/200 (48%), Gaps = 21/200 (10%)
Query: 492 VIGVGGFGKVY----KGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLS-KLRHKHLVSL 546
V+G G FGKV KG E A+K+ + V + E +L+ + L L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 547 IGFCEEGNEMCLVYDYMALGTLREHI-----YNTKKALSWKQRLEICIGAARGLHYLHTG 601
+ + V +++ G L HI ++ +A + + +C GL +LH+
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEI-VC-----GLQFLHSK 115
Query: 602 AKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKR 661
II+RD+K N++LD + K++DFG+ K N+ + ++ G+ Y+ PE +
Sbjct: 116 G---IIYRDLKLDNVMLDRDGHIKIADFGMCKE--NVFGDNRASTFCGTPDYIAPEILQG 170
Query: 662 QQLTEKSDIYSFGVVLFEVL 681
+ T D +SFGV+L+E+L
Sbjct: 171 LKYTFSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 68/269 (25%), Positives = 117/269 (43%), Gaps = 32/269 (11%)
Query: 492 VIGVGGFGKVYKGVIEDKLKVAIKRSNP--SSEQGVNEFVTEIEMLSKLRHKHLVSLIG- 548
++G G G VYK ++ + P + + + ++E+E+L K +++ G
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 549 -FCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTII 607
F E +C ++M G+L + + L I + +GL YL + I+
Sbjct: 68 FFVENRISICT--EFMDGGSLDVYRKIPEHVLG-----RIAVAVVKGLTYLWS---LKIL 117
Query: 608 HRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEK 667
HRDVK +N+L++ K+ DFG+S + N T V G+ Y+ PE +Q
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVST---QLVNSIAKTYV-GTNAYMAPERISGEQYGIH 173
Query: 668 SDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIID---PLLKDKIS 724
SD++S G+ E+ R P + K Q SL L L I+D P+L
Sbjct: 174 SDVWSLGISFMELALGRFPY-PQIQKNQGSLMPLQL-------LQCIVDEDPPVLPVGQF 225
Query: 725 PECLKKFADTAEKCLSDSGIDRPSMGDVL 753
E KF +C+ +RP+ +++
Sbjct: 226 SE---KFVHFITQCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 18/208 (8%)
Query: 486 SFDESYVIGVGGFGKVY-----KGVIEDKL---KVAIKRSNPSSEQGVNEFVTEIEMLSK 537
+F+ V+G G +GKV+ G KL KV K + + TE ++L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 538 LRHK-HLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGA-ARGL 595
+R LV+L + ++ L+ DY+ G L H+ +++ +Q ++I G L
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL--SQRERFKEQEVQIYSGEIVLAL 118
Query: 596 HYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLD 655
+LH K II+RD+K NILLD N ++DFGLSK E + G+ Y+
Sbjct: 119 EHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFC-GTIEYMA 174
Query: 656 PEYFKRQQLTEKS--DIYSFGVVLFEVL 681
P+ + D +S GV+++E+L
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-09
Identities = 63/232 (27%), Positives = 100/232 (43%), Gaps = 49/232 (21%)
Query: 493 IGVGGFGKVYKGVIE--DKLKVAIKR-----SNPSSEQGVNEFVTEIEMLSKLRHKHLVS 545
IG G FG V+ V + D +VA+K+ N S + V E++ML +H +++S
Sbjct: 8 IGYGAFGVVW-SVTDPRDGKRVALKKMPNVFQNLVSCKRV---FRELKMLCFFKHDNVLS 63
Query: 546 LIGFCEEGNEMCLVYDYMALGTLREHIY--------NTKKALSWKQRL----------EI 587
+ + + E IY + K + Q L +I
Sbjct: 64 ALDILQPPHIDPF-----------EEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQI 112
Query: 588 CIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVV 647
RGL YLH+ I+HRD+K N+L++ N V K+ DFGL++ E+ H++ V
Sbjct: 113 L----RGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEV 165
Query: 648 KGSFGYLDPEYFK-RQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSL 698
+ Y PE + T DI+S G + E+L R P +Q+ L
Sbjct: 166 VTQY-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDL 216
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 51/200 (25%), Positives = 101/200 (50%), Gaps = 15/200 (7%)
Query: 493 IGVGGFGKVYKGVIEDKLK---VAIKRSNPSSEQGV-NEFVTEIEMLSKLRHKHLVSLIG 548
+G G + VYKG ++ VA+K + +E+G + + EI ++ +L+H+++V L
Sbjct: 8 LGEGTYATVYKG--RNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHD 65
Query: 549 FCEEGNEMCLVYDYMALGTLREH--IYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTI 606
N++ LV++YM L+++ + + AL +G+ + H + +
Sbjct: 66 VIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRV 121
Query: 607 IHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTE 666
+HRD+K N+L+++ K++DFGL++ N + VV + Y P+ +
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVLLGSRTYS 179
Query: 667 KS-DIYSFGVVLFEVLCARP 685
S DI+S G ++ E++ RP
Sbjct: 180 TSIDIWSVGCIMAEMITGRP 199
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 42/154 (27%), Positives = 77/154 (50%), Gaps = 27/154 (17%)
Query: 493 IGVGGFGKVYKGVIEDKLK-VAIKR-SNPSSEQGVNEF-VTEIEMLSKLRHKHLVSLIGF 549
IG G +G V+K + + VA+KR ++GV + EI +L +L+HK++V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 550 CEEGNEMCLVYDYM----------ALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLH 599
++ LV++Y G + I S+ +L +GL + H
Sbjct: 68 LHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEI-----VKSFMFQL------LKGLAFCH 116
Query: 600 TGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSK 633
+ + ++HRD+K N+L+++N K++DFGL++
Sbjct: 117 S---HNVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 48/151 (31%), Positives = 73/151 (48%), Gaps = 17/151 (11%)
Query: 493 IGVGGFGKVYKGVIEDKL---KVAIK--RSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLI 547
IG G FGKV G + +V +K R + +S Q +F+ E + L+H +L+ +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVS-ASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 548 GFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWK------QRLEICIGAARGLHYLHTG 601
G C E LV ++ LG L+ ++ + +KA QR+ I A GL +LH
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEI--ALGLLHLH-- 117
Query: 602 AKYTIIHRDVKTTNILLDENWVAKVSDFGLS 632
K IH D+ N LL + K+ D+GLS
Sbjct: 118 -KNNFIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-09
Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 25/205 (12%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIKR-SNP-SSEQGVNEFVTEIEMLSKLRHKHLVSLIGF 549
+G G +G V + KVAIK+ P SE E+ +L ++H++++ L+
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 550 ------CEEGNEMCLVYDYMA--LGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTG 601
+ ++ LV +M LG L +H + LS + + +GL Y+H
Sbjct: 83 FTPDLSLDRFHDFYLVMPFMGTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA 137
Query: 602 AKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEY-FK 660
IIHRD+K N+ ++E+ K+ DFGL++ + G+V T Y PE
Sbjct: 138 G---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WYRAPEVILN 189
Query: 661 RQQLTEKSDIYSFGVVLFEVLCARP 685
T+ DI+S G ++ E+L +P
Sbjct: 190 WMHYTQTVDIWSVGCIMAEMLTGKP 214
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 4e-09
Identities = 43/150 (28%), Positives = 79/150 (52%), Gaps = 23/150 (15%)
Query: 496 GGFGKVYKGVIEDKLK---VAIKRSNPSSE-QGVNEF-VT---EIEMLSKLRHKHLVSL- 546
G +G VY+ DK VA+K+ E +G F +T EI +L KL+H ++V++
Sbjct: 16 GTYGVVYRAR--DKKTGEIVALKKLKMEKEKEG---FPITSLREINILLKLQHPNIVTVK 70
Query: 547 -IGFCEEGNEMCLVYDYMA--LGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAK 603
+ +++ +V +Y+ L +L E + K+ + + + G+ +LH
Sbjct: 71 EVVVGSNLDKIYMVMEYVEHDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLH---D 124
Query: 604 YTIIHRDVKTTNILLDENWVAKVSDFGLSK 633
I+HRD+KT+N+LL+ + K+ DFGL++
Sbjct: 125 NWILHRDLKTSNLLLNNRGILKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 52/205 (25%), Positives = 84/205 (40%), Gaps = 30/205 (14%)
Query: 491 YVIGV----GGFGKVYKGVIEDKLKVAIKRSN--PSSEQGVNEFVTEIEMLSKLRHKHLV 544
+IG + K + L VA+K+ N S++ + EI +L+H +++
Sbjct: 4 TLIGKCFEDLMIVHLAKHKPTNTL-VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNIL 62
Query: 545 SLIGFCEEGNEMCLVYDYMALGT----LREHIYNTKKALSWKQRLEICIGAARGLHYLHT 600
+ +E+ +V MA G+ L+ H L+ I L Y+H
Sbjct: 63 PYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF---ILKDVLNALDYIH- 118
Query: 601 GAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGS-------FGY 653
IHR VK ++ILL + +S GL + +++G VV +
Sbjct: 119 --SKGFIHRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPW 174
Query: 654 LDPEYFKRQQL---TEKSDIYSFGV 675
L PE +Q L EKSDIYS G+
Sbjct: 175 LSPEVL-QQNLQGYNEKSDIYSVGI 198
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 55/198 (27%), Positives = 88/198 (44%), Gaps = 18/198 (9%)
Query: 493 IGVGGFGKVYKGVIEDKLKV-AIKRSNPS-SEQGVNEFVTEIEMLSKLRHKHLVSLIG-- 548
+G G +G VYK + A+K E N+ + E+++L K ++V G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 549 FCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHT-GAKYTII 607
F E MC+ +YM G+L + +Y A + + L ++ II
Sbjct: 69 FIEGAVYMCM--EYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNII 125
Query: 608 HRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFK------R 661
HRDVK TN+L++ N K+ DFG+S N+ T + G Y+ PE K
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSG---NLVASLAKTNI-GCQSYMAPERIKSGGPNQN 181
Query: 662 QQLTEKSDIYSFGVVLFE 679
T +SD++S G+ + E
Sbjct: 182 PTYTVQSDVWSLGLSILE 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 40/103 (38%), Positives = 56/103 (54%), Gaps = 19/103 (18%)
Query: 592 ARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSK---TGPNMENGHVSTVVK 648
ARG+ +L A IHRD+ NILL EN V K+ DFGL++ P+ V K
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-------VRK 233
Query: 649 GS----FGYLDPEYFKRQQLTEKSDIYSFGVVLFEV--LCARP 685
GS ++ PE + T +SD++SFGV+L+E+ L A P
Sbjct: 234 GSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 67/229 (29%), Positives = 102/229 (44%), Gaps = 27/229 (11%)
Query: 477 LAEIKHATKSFDESYVIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEML 535
L + T +++ IG G +GKVYK +D A+K +P S+ E E +L
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNIL 72
Query: 536 SKL-RHKHLVSLIGFCEE-----GNEMCLVYDYMALGTLREHIYNTKKALSWKQRLE--- 586
L H ++V G + G ++ LV + G++ E + K L QRL+
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV---KGLLICGQRLDEAM 129
Query: 587 ---ICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643
I GA GL +LH IIHRDVK NILL K+ DFG+S +
Sbjct: 130 ISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 186
Query: 644 STVVKGSFGYLDPEYFKRQQLTEKS-----DIYSFGVVLFEVLCARPAL 687
++V G+ ++ PE +Q + S D++S G+ E+ P L
Sbjct: 187 TSV--GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 6e-09
Identities = 54/221 (24%), Positives = 98/221 (44%), Gaps = 35/221 (15%)
Query: 487 FDESY----VIGVGGFGKVYKGVIEDKL---KVAIKRSNPSSEQGVNEFVT--EIEMLSK 537
Y IG G +G V + D KVAIK+ + + T E+++L
Sbjct: 3 VGSRYKPIENIGSGAYGVVCSAI--DTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRH 60
Query: 538 LRHKHLVSLIG-FCEEGNEMCLVYDYMAL-GTLREHIYNTKKALSWK-------QRLEIC 588
+H +++++ G + VY M L + HI ++ + L+ + Q L
Sbjct: 61 FKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLL--- 117
Query: 589 IGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSK---TGPNMENGHVST 645
RGL Y+H+ +IHRD+K +N+L++E+ ++ DFG+++ + P ++
Sbjct: 118 ----RGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTE 170
Query: 646 VVKGSFGYLDPE-YFKRQQLTEKSDIYSFGVVLFEVLCARP 685
V + Y PE + T D++S G + E+L R
Sbjct: 171 YV-ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 9e-09
Identities = 38/100 (38%), Positives = 56/100 (56%), Gaps = 13/100 (13%)
Query: 592 ARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSK---TGPN-MENGHVSTVV 647
ARG+ +L A IHRD+ NILL EN V K+ DFGL++ P+ + G +
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239
Query: 648 KGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEV--LCARP 685
K ++ PE + T +SD++SFGV+L+E+ L A P
Sbjct: 240 K----WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 61/244 (25%), Positives = 95/244 (38%), Gaps = 59/244 (24%)
Query: 485 KSFDESYVIGVGGFGKVYKGVIEDK-------LKVAIKRSNPSSEQGVNEFVTEIEMLSK 537
K F + ++G G G+V+ ++ K LKV K+ V +TE E+L+
Sbjct: 1 KHFKKIKLLGKGDVGRVF--LVRLKGTGKLFALKVLDKKEM-IKRNKVKRVLTEQEILAT 57
Query: 538 LRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLE-ICIGAAR--- 593
L H L +L + +CLV DY G L L +Q + + AR
Sbjct: 58 LDHPFLPTLYASFQTETYLCLVMDYCPGGELF--------RLLQRQPGKCLSEEVARFYA 109
Query: 594 -----GLHYLHT-GAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT------------- 634
L YLH G I++RD+K NILL E+ +SDF LSK
Sbjct: 110 AEVLLALEYLHLLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALR 165
Query: 635 ----GPNMENGHVSTVVK----------GSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEV 680
++ + T + G+ Y+ PE D ++ G++L+E+
Sbjct: 166 KGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEM 225
Query: 681 LCAR 684
L
Sbjct: 226 LYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 65/229 (28%), Positives = 101/229 (44%), Gaps = 31/229 (13%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSE-QGVNEF-VTEIEMLSKLRHKHLVSLIG 548
V+G G +G V K E K VAIK+ S E + V E + E++ML L+ +++V L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 549 FCEEGNEMCLVYDYMA---LGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYT 605
++ LV++Y+ L L E K R I + +H+ H K
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLELLEEM---PNGVPPEKVRSYI-YQLIKAIHWCH---KND 120
Query: 606 IIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLT 665
I+HRD+K N+L+ N V K+ DFG ++ N + + V + Y PE
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRW-YRSPELLLGAPYG 179
Query: 666 EKSDIYSFGVVLFEVLCARP----------------ALNPSLPKEQVSL 698
+ D++S G +L E+ +P L P LP EQ+ L
Sbjct: 180 KAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGP-LPAEQMKL 227
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 30/218 (13%)
Query: 486 SFDESYVIGVGGFGKVYKGVIEDKLK---VAIKRSNPSSE-QGV-NEFVTEIEMLSKLRH 540
+F + IG G +G VYK +KL VA+K+ +E +GV + + EI +L +L H
Sbjct: 1 NFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 58
Query: 541 KHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAAR------- 593
++V L+ N++ LV++++ + KK + I + +
Sbjct: 59 PNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASPLSGIPLPLIKSYLFQLL 110
Query: 594 -GLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFG 652
GL + H+ + ++HRD+K N+L++ K++DFGL++ + VV +
Sbjct: 111 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLW 165
Query: 653 YLDPE-YFKRQQLTEKSDIYSFGVVLFEVLCARPALNP 689
Y PE + + DI+S G + E++ R AL P
Sbjct: 166 YRAPEILLGCKYYSTAVDIWSLGCIFAEMV-TRRALFP 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (135), Expect = 2e-08
Identities = 49/197 (24%), Positives = 78/197 (39%), Gaps = 32/197 (16%)
Query: 496 GGFGKVYKGVIEDK------LKVAIKRSNPSSEQGVNEFVTEIE-MLSKL--RHKHLVSL 546
G FGKV V++ K ++ IK N IE M+ +L + + + L
Sbjct: 27 GKFGKVS--VLKHKPTQKLFVQKIIKAKN----------FNAIEPMVHQLMKDNPNFIKL 74
Query: 547 IGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTI 606
L+ DY+ G L + + + LS + +I L+ LH K+ I
Sbjct: 75 YYSVTTLKGHVLIMDYIKDGDLFD-LLKKEGKLSEAEVKKIIRQLVEALNDLH---KHNI 130
Query: 607 IHRDVKTTNILLDEN-WVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLT 665
IH D+K N+L D + D+GL K + G+ Y PE K
Sbjct: 131 IHNDIKLENVLYDRAKDRIYLCDYGLCK------IIGTPSCYDGTLDYFSPEKIKGHNYD 184
Query: 666 EKSDIYSFGVVLFEVLC 682
D ++ GV+ +E+L
Sbjct: 185 VSFDWWAVGVLTYELLT 201
|
Length = 267 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIKR-SNP-SSEQGVNEFVTEIEMLSKLRHKHLVSLIGF 549
+G G +G V + L+VA+K+ S P S E+ +L ++H++++ L+
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 550 ------CEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAK 603
EE N++ LV M G +I +K L+ + RGL Y+H+
Sbjct: 85 FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSAD- 140
Query: 604 YTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPE-YFKRQ 662
IIHRD+K +N+ ++E+ K+ DFGL++ + G+V+T Y PE
Sbjct: 141 --IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWM 193
Query: 663 QLTEKSDIYSFGVVLFEVLCAR 684
+ DI+S G ++ E+L R
Sbjct: 194 HYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 53/199 (26%), Positives = 97/199 (48%), Gaps = 21/199 (10%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVT--EIEMLSKLRHKHLVSLIGF 549
+G G +G V + KVA+K+ + + ++ T E+ +L ++H++++ L+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 550 ------CEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAK 603
E NE+ LV + M G +I +K LS + + RGL Y+H+
Sbjct: 83 FTPATSIENFNEVYLVTNLM--GADLNNIVKCQK-LSDEHVQFLIYQLLRGLKYIHSAG- 138
Query: 604 YTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPE-YFKRQ 662
IIHRD+K +N+ ++E+ ++ DFGL++ + G+V+T Y PE
Sbjct: 139 --IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYRAPEIMLNWM 191
Query: 663 QLTEKSDIYSFGVVLFEVL 681
+ DI+S G ++ E+L
Sbjct: 192 HYNQTVDIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 45/169 (26%), Positives = 67/169 (39%), Gaps = 26/169 (15%)
Query: 529 VTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEIC 588
TE +L + H ++ L G CL+ L + +Y L+ K+ + IC
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLI-----LPRYKTDLYCY---LAAKRNIAIC 182
Query: 589 IGAA------RGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLS----KTGPNM 638
A R + YLH IIHRD+K NI ++ + DFG + N
Sbjct: 183 DILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239
Query: 639 ENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPAL 687
G T+ + PE R DI+S G+VLFE+ +L
Sbjct: 240 YYGWAGTIATNA-----PELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 54/222 (24%), Positives = 104/222 (46%), Gaps = 20/222 (9%)
Query: 479 EIKHATKSFDESYVIGVGGFGKV----YKGVIEDKLKVAIKRSNPSS---EQGVNEFVTE 531
+ K + F+ +G G FG+V YK ED VAIKR S ++ V+ +E
Sbjct: 24 KNKMKYEDFNFIRTLGTGSFGRVILATYKN--EDFPPVAIKRFEKSKIIKQKQVDHVFSE 81
Query: 532 IEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEI-CIG 590
++L+ + H V+L G ++ + + LV +++ G + K+ + ++ C
Sbjct: 82 RKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPN-----DVGCFY 136
Query: 591 AARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGS 650
AA+ + I++RD+K N+LLD++ K++DFG +K + + G+
Sbjct: 137 AAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-----TYTLCGT 191
Query: 651 FGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLP 692
Y+ PE + +D ++ G+ ++E+L P + P
Sbjct: 192 PEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 15/206 (7%)
Query: 490 SYV----IGVGGFGKVYKGV--IEDKLKVAIKRSNPSSEQGVN-EFVTEIEMLSKLRHKH 542
SY+ +G G + VYKG+ I +L VA+K + +E+GV + E +L L+H +
Sbjct: 6 SYLNLEKLGEGSYATVYKGISRINGQL-VALKVISMKTEEGVPFTAIREASLLKGLKHAN 64
Query: 543 LVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGA 602
+V L + V++YM + I + + RL RGL Y+H
Sbjct: 65 IVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIH--- 120
Query: 603 KYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPE-YFKR 661
I+HRD+K N+L+ K++DFGL++ + S VV + Y P+
Sbjct: 121 GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGA 178
Query: 662 QQLTEKSDIYSFGVVLFEVLCARPAL 687
+ DI+ G + E+L +PA
Sbjct: 179 TDYSSALDIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 55/202 (27%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 493 IGVGGFGKVYKGVIEDKLK---VAIKRSNPSSE-QGV-NEFVTEIEMLSKLRHKHLVSLI 547
IG G +G VYK D++ +A+K+ E +GV + + EI +L +++H ++V L
Sbjct: 10 IGEGTYGVVYKA--RDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67
Query: 548 GFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL--EICIGAARGLHYLHTGAKYT 605
+ LV++Y+ L L++H+ ++ + RL RG+ Y H+ +
Sbjct: 68 DVVHSEKRLYLVFEYLDL-DLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHS---HR 122
Query: 606 IIHRDVKTTNILLDENWVA-KVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPE-YFKRQQ 663
++HRD+K N+L+D A K++DFGL++ VV + Y PE +
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLWYRAPEILLGSRH 180
Query: 664 LTEKSDIYSFGVVLFEVLCARP 685
+ DI+S G + E++ +P
Sbjct: 181 YSTPVDIWSVGCIFAEMVNQKP 202
|
Length = 294 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 5e-08
Identities = 52/224 (23%), Positives = 96/224 (42%), Gaps = 43/224 (19%)
Query: 493 IGVGGFGKVYKGVIEDKL---KVAIKR------SNPSSEQGVNEFVTEIEMLSKLRHKHL 543
IG GG G+VY D + +VA+K+ NP + F+ E ++ + L H +
Sbjct: 10 IGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLK---KRFLREAKIAADLIHPGI 64
Query: 544 VSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEI--CIGA--------AR 593
V + C +G+ + Y+ TL+ + + + S + L +GA
Sbjct: 65 VPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124
Query: 594 GLHYLHTGAKYTIIHRDVKTTNILLDE-------NWVAKVS---------DFGLSKTGPN 637
+ Y+H+ ++HRD+K NILL +W A + D + +
Sbjct: 125 TIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 638 MENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVL 681
+ + + G+ Y+ PE +E +DIY+ GV+L+++L
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 50/212 (23%), Positives = 97/212 (45%), Gaps = 31/212 (14%)
Query: 487 FDESYVIGVGGFGKVYKGVIEDKLK---VAIKRSNPS------SEQGVNEFVTEIEMLSK 537
+ +G G FG+V+ + D++ A+K EQ V+ E +L +
Sbjct: 3 LERIKTVGTGTFGRVHL--VRDRISEHYYALKVMAIPEVIRLKQEQHVH---NEKRVLKE 57
Query: 538 LRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL---EI-CIGAAR 593
+ H ++ L + + ++ +Y+ G L ++ N+ + + EI C
Sbjct: 58 VSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVC----- 112
Query: 594 GLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGY 653
L YLH+ I++RD+K NILLD+ K++DFG +K + + + G+ Y
Sbjct: 113 ALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEY 164
Query: 654 LDPEYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
L PE + + + D ++ G++++E+L P
Sbjct: 165 LAPEVIQSKGHNKAVDWWALGILIYEMLVGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 7e-08
Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 38/226 (16%)
Query: 476 SLAEIKHATKSFDESYVIGVGGFG-----------KVYKGVIEDKLKVAIKRSNPSSEQG 524
+ +++ + FD VIG G FG +VY + K ++ IKRS+ +
Sbjct: 34 KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEM-IKRSDSAF--- 89
Query: 525 VNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQ- 583
F E ++++ + +V L ++ + +V +YM G L + N W +
Sbjct: 90 ---FWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARF 146
Query: 584 -RLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME-NG 641
E+ + A +H IHRDVK N+LLD++ K++DFG T M+ NG
Sbjct: 147 YTAEVVL-ALDAIH------SMGFIHRDVKPDNMLLDKSGHLKLADFG---TCMKMDANG 196
Query: 642 --HVSTVVKGSFGYLDPEYFKRQ----QLTEKSDIYSFGVVLFEVL 681
T V G+ Y+ PE K Q + D +S GV L+E+L
Sbjct: 197 MVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 9e-08
Identities = 30/108 (27%), Positives = 47/108 (43%), Gaps = 8/108 (7%)
Query: 201 RSWQNDEPYLFGAGYGIPMKADEVQIDYKSLPDYSAPPDVYMTARYMGVDAHTNMEFNLT 260
R W + FG+G + + + S P+ Y + Y T+ + +L+
Sbjct: 218 RFWNRMQT--FGSGSDQAISTEN------VIKKASNAPNFYPESLYQSALVSTDTQPDLS 269
Query: 261 WIFRVDANFTYYVRLHFCEFKPDINKINQRVFNIYINNQTAQADADVI 308
+ VD N Y V LHF E I +RVF++ IN TA D D++
Sbjct: 270 YTMDVDPNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAFKDVDIV 317
|
Length = 623 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-08
Identities = 40/116 (34%), Positives = 62/116 (53%), Gaps = 13/116 (11%)
Query: 576 KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSK-- 633
KK L+ + + A+G+ +L A IHRD+ NILL EN V K+ DFGL++
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDI 229
Query: 634 -TGPN-MENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEV--LCARP 685
P+ + G +K ++ PE + T +SD++SFGV+L+E+ L A P
Sbjct: 230 YKDPDYVRKGDARLPLK----WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 9e-08
Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 21/201 (10%)
Query: 493 IGVGGFGKV----YKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLI 547
+G G FG+V +KG E +K KR +Q V E +L +L H +V+++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQ-VQHVAQEKSILMELSHPFIVNMM 84
Query: 548 -GFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLE--ICIGAARGLHYLHTGAKY 604
F +E N + + +++ G L H+ +KA + + YLH+
Sbjct: 85 CSFQDE-NRVYFLLEFVVGGELFTHL---RKAGRFPNDVAKFYHAELVLAFEYLHS---K 137
Query: 605 TIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQL 664
II+RD+K N+LLD KV+DFG +K P+ + + G+ YL PE + +
Sbjct: 138 DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-----TFTLCGTPEYLAPEVIQSKGH 192
Query: 665 TEKSDIYSFGVVLFEVLCARP 685
+ D ++ GV+L+E + P
Sbjct: 193 GKAVDWWTMGVLLYEFIAGYP 213
|
Length = 329 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 9e-08
Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 493 IGVGGFGKVYKGVIEDKLK-VAIKRSN-PSSEQGVN-EFVTEIEMLSKLR---HKHLVSL 546
IGVG +G VYK VA+K ++E G+ V E+ +L +L H ++V L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 547 IGFC-----EEGNEMCLVYDYMALGTLREHIYNTKK-ALSWKQRLEICIGAARGLHYLHT 600
+ C + ++ LV++++ LR ++ L + ++ RGL +LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126
Query: 601 GAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVS-TVVKGSFGYLDPEYF 659
I+HRD+K NIL+ K++DFGL++ + + ++ T V + Y PE
Sbjct: 127 NC---IVHRDLKPENILVTSGGQVKLADFGLAR----IYSCQMALTPVVVTLWYRAPEVL 179
Query: 660 KRQQLTEKSDIYSFGVVLFEVLCARP 685
+ D++S G + E+ +P
Sbjct: 180 LQSTYATPVDMWSVGCIFAEMFRRKP 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 56/221 (25%), Positives = 97/221 (43%), Gaps = 36/221 (16%)
Query: 485 KSFDESYVIGVGGFGKVYKGVIEDK-------LKVAIKRSNPSSEQGVNEFVTEIEMLSK 537
K FD ++G G FG+V V+ +K +KV +K+S +++ V+ F E ++LS
Sbjct: 1 KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKV-MKKSVLLAQETVSFFEEERDILSI 57
Query: 538 LRHKHLVSLIGFCEEGNEMCLVYDYMALGTL------REHIYNTKKALSWKQRLEICIGA 591
+ L ++ + + LV +Y G L E ++ A + L + I
Sbjct: 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAI-- 115
Query: 592 ARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME-NGHV-STVVKG 649
H +H +HRD+K N+L+D K++DFG + + N V S + G
Sbjct: 116 ----HSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFG---SAARLTANKMVNSKLPVG 165
Query: 650 SFGYLDPEYFKRQQLTEKS------DIYSFGVVLFEVLCAR 684
+ Y+ PE K D +S GV+ +E++ R
Sbjct: 166 TPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 54.1 bits (131), Expect = 1e-07
Identities = 63/234 (26%), Positives = 107/234 (45%), Gaps = 54/234 (23%)
Query: 481 KHATKSFDESYVIGVGGFGKVYKGV-IEDKLKVAIKR-----SNPSSEQGVNEFVT--EI 532
KH + ++ +G G +G V+K + K VA+K+ N + Q T EI
Sbjct: 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQR-----TFREI 57
Query: 533 EMLSKLR-HKHLVSLIGF--CEEGNEMCLVYDYMAL--------GTLRE-HIYNTKKALS 580
L +L H ++V L+ E ++ LV++YM L + H K+ +
Sbjct: 58 MFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVH----KRYIM 113
Query: 581 WKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640
+ Q L + L Y+H+G +IHRD+K +NILL+ + K++DFGL+++ +E
Sbjct: 114 Y-QLL-------KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162
Query: 641 GH--------VSTVVKGSFGYLDPE-YFKRQQLTEKSDIYSFGVVLFEVLCARP 685
V+T Y PE + T+ D++S G +L E+L +P
Sbjct: 163 NPENPVLTDYVATR-----WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKP 211
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 53/210 (25%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 493 IGVGGFGKVYKGVIEDKLK-----VAIKRSN-PSSEQGVN-EFVTEIEMLSKLR---HKH 542
IG G +GKV+K LK VA+KR + E+G+ + E+ +L L H +
Sbjct: 9 IGEGAYGKVFKA---RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 65
Query: 543 LVSLIGFC-----EEGNEMCLVYDYMA--LGTLREHIYNTKKALSWKQRLEICIGAARGL 595
+V L C + ++ LV++++ L T + + + + + ++ RGL
Sbjct: 66 VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGL 123
Query: 596 HYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLD 655
+LH+ + ++HRD+K NIL+ + K++DFGL++ T V + Y
Sbjct: 124 DFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRA 177
Query: 656 PEYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
PE + D++S G + E+ +P
Sbjct: 178 PEVLLQSSYATPVDLWSVGCIFAEMFRRKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 48/186 (25%), Positives = 84/186 (45%), Gaps = 19/186 (10%)
Query: 512 VAIKRSN--PSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLR 569
V ++ ++ +E+ + E+ + RH ++++ G+ + ++ +MA G+
Sbjct: 28 VTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSAN 87
Query: 570 EHIYNT-KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSD 628
+ + +S I GA RGL+YLH IHR++K ++IL+ + + +S
Sbjct: 88 SLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLS- 143
Query: 629 FGLSKTGPNMENGHVSTVV-------KGSFGYLDPEYFKRQQL---TEKSDIYSFGVVLF 678
GLS + NG + VV +L PE RQ L KSDIYS G+
Sbjct: 144 -GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELL-RQDLYGYNVKSDIYSVGITAC 201
Query: 679 EVLCAR 684
E+ R
Sbjct: 202 ELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 28/217 (12%)
Query: 480 IKHATKSFDESYVIGVGGFG-----------KVYKGVIEDKLKVAIKRSNPSSEQGVNEF 528
++ + +D VIG G FG KVY + K ++ IKRS+ + F
Sbjct: 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEM-IKRSDSAF------F 90
Query: 529 VTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEIC 588
E ++++ +V L ++ + +V +YM G L + N W +
Sbjct: 91 WEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAE 150
Query: 589 IGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVK 648
+ A L +H+ +IHRDVK N+LLD++ K++DFG T V
Sbjct: 151 VVLA--LDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV- 204
Query: 649 GSFGYLDPEYFKRQ----QLTEKSDIYSFGVVLFEVL 681
G+ Y+ PE K Q + D +S GV LFE+L
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 34/105 (32%), Positives = 55/105 (52%), Gaps = 11/105 (10%)
Query: 592 ARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGS- 650
A+G+ +L A IHRD+ NILL + K+ DFGL++ N N VVKG+
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN----YVVKGNA 276
Query: 651 ---FGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLP 692
++ PE T +SD++S+G++L+E+ + P +P
Sbjct: 277 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP 321
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 47/154 (30%), Positives = 78/154 (50%), Gaps = 14/154 (9%)
Query: 493 IGVGGFGKVYKGVIEDKLKV----AIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIG 548
I G FGKVY G ++ K+ +K+++ ++ V++ E + L+ + +V L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 549 FCEEGNEMCLVYDYMALGTLRE--HIYNT-KKALSWKQRLEICIGAARGLHYLHTGAKYT 605
+ N + LV +Y+ G ++ HIY + ++ K E A L YLH ++
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISE----VALALDYLH---RHG 124
Query: 606 IIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639
IIHRD+K N+L+ K++DFGLSK N E
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE 158
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 11/93 (11%)
Query: 592 ARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGS- 650
A+G+ +L A IHRDV N+LL + VAK+ DFGL++ N N VVKG+
Sbjct: 222 AQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN----YVVKGNA 274
Query: 651 ---FGYLDPEYFKRQQLTEKSDIYSFGVVLFEV 680
++ PE T +SD++S+G++L+E+
Sbjct: 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 58/228 (25%), Positives = 96/228 (42%), Gaps = 59/228 (25%)
Query: 489 ESY----VIGVGGFGKVYKGV--IEDKLKVAIKRSNPSSEQGVN-EFVTEIEMLSKLRHK 541
E+Y +G G + VYKG + +L VA+K E+G + E +L L+H
Sbjct: 5 ETYKKLDKLGEGSYATVYKGRSKLTGQL-VALKEIRLEHEEGAPFTAIREASLLKDLKHA 63
Query: 542 HLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAA--------- 592
++V+L + LV++Y+ L KQ ++ C G
Sbjct: 64 NIVTLHDIIHTKKTLTLVFEYL------------DTDL--KQYMDDCGGGLSMHNVRLFL 109
Query: 593 ----RGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGL--SKTGPNMENGH-VST 645
RGL Y H + ++HRD+K N+L+ E K++DFGL +K+ P+ + V T
Sbjct: 110 FQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVT 166
Query: 646 -------VVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPA 686
V+ GS Y + D++ G + +E+ RP
Sbjct: 167 LWYRPPDVLLGSTEY-----------STSLDMWGVGCIFYEMATGRPL 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 485 KSFDESYVIGVGGFGKVYKGVIEDKLKV-AIKRSNPSSEQGVNE---FVTEIEMLSKLRH 540
+ F+ VIG G FG+V +++ KV A+K N E F E ++L +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 541 KHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALS------WKQRLEICIGAARG 594
+ + +L ++ N + LV DY G L + + L + + I I +
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 595 LHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV-STVVKGSFGY 653
LHY +HRD+K NIL+D N +++DFG ME+G V S+V G+ Y
Sbjct: 121 LHY---------VHRDIKPDNILMDMNGHIRLADFG--SCLKLMEDGTVQSSVAVGTPDY 169
Query: 654 LDPEYFK-----RQQLTEKSDIYSFGVVLFEVL 681
+ PE + + + + D +S GV ++E+L
Sbjct: 170 ISPEILQAMEDGKGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 38/131 (29%), Positives = 61/131 (46%), Gaps = 11/131 (8%)
Query: 566 GTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAK 625
T R+ + N ALS+ + A G+ +L A +HRD+ N+L+ E + K
Sbjct: 223 RTRRDTLINESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVK 279
Query: 626 VSDFGLSKTGPNMENGHVSTVVKGS----FGYLDPEYFKRQQLTEKSDIYSFGVVLFEVL 681
+ DFGL++ N + KGS ++ PE T SD++SFG++L+E+
Sbjct: 280 ICDFGLARDIMRDSN----YISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIF 335
Query: 682 CARPALNPSLP 692
P LP
Sbjct: 336 TLGGTPYPELP 346
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 57/209 (27%), Positives = 89/209 (42%), Gaps = 24/209 (11%)
Query: 492 VIGVGGFGKVYKGVIEDKL---KVAIKRSNPSSEQ--GVNEFVTEIEMLSKLRHKHLVSL 546
VIG G +G V + D KVAIK+ N E + EI++L LRH +V +
Sbjct: 7 VIGKGSYGVVCSAI--DTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEI 64
Query: 547 IGFC-----EEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTG 601
E ++ +V++ M + + L+ + R L Y+HT
Sbjct: 65 KHIMLPPSRREFKDIYVVFELM--ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA 122
Query: 602 AKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVS-TVVKGSFGYLDPE--- 657
+ HRD+K NIL + + K+ DFGL++ N + T + Y PE
Sbjct: 123 ---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 179
Query: 658 -YFKRQQLTEKSDIYSFGVVLFEVLCARP 685
+F + T DI+S G + EVL +P
Sbjct: 180 SFFSK--YTPAIDIWSIGCIFAEVLTGKP 206
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 61/223 (27%), Positives = 95/223 (42%), Gaps = 30/223 (13%)
Query: 475 FSLAEIKHATKSFDESYV----IGVGGFGKVYKGVIE-DKLKVAIKR-SNP-SSEQGVNE 527
F E+ E Y +G G +G V + + KVAIK+ S P SE
Sbjct: 1 FYREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKR 60
Query: 528 FVTEIEMLSKLRHKHLVSLIGF---CEEGNEM---CLVYDYMA--LGTLREHIYNTKKAL 579
E+ +L ++H++++ L+ G+E LV YM L + H + K
Sbjct: 61 AYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKV- 119
Query: 580 SWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639
Q L GL Y+H+ IIHRD+K N+ ++E+ K+ DFGL++
Sbjct: 120 ---QYL--VYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEM 171
Query: 640 NGHVSTVVKGSFGYLDPEY-FKRQQLTEKSDIYSFGVVLFEVL 681
G+V T Y PE + DI+S G ++ E+L
Sbjct: 172 TGYVVTR-----WYRAPEVILNWMHYNQTVDIWSVGCIMAEML 209
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 27/213 (12%)
Query: 493 IGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLR-HKHLVSLIGF- 549
IG G +GKV+K + + + K A+K +P + E E +L L H ++V G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 550 ----CEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLE------ICIGAARGLHYLH 599
+ G+++ LV + G++ + + K L +R+E I A GL +LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLV---KGFLKRGERMEEPIIAYILHEALMGLQHLH 141
Query: 600 TGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYF 659
IHRDVK NILL K+ DFG+S + ++V G+ ++ PE
Sbjct: 142 VN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV--GTPFWMAPEVI 196
Query: 660 K-RQQL----TEKSDIYSFGVVLFEVLCARPAL 687
QQL + D++S G+ E+ P L
Sbjct: 197 ACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 30/97 (30%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 593 RGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSK---TGPNMENGHVSTVVKG 649
GL Y+H+ ++HRD+K N+L++ + K+ DFGL++ P G ++ V
Sbjct: 116 CGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV-A 171
Query: 650 SFGYLDPE-YFKRQQLTEKSDIYSFGVVLFEVLCARP 685
+ Y PE Q T+ D++S G +L E+L +P
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKP 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 11/200 (5%)
Query: 486 SFDESYVIGVGGFGKVYKGV--IEDKLKVAIKRSNPSSEQGVN-EFVTEIEMLSKLRHKH 542
S+++ +G G + VYKG + KL VA+K E+G + E +L L+H +
Sbjct: 6 SYEKLEKLGEGSYATVYKGKSKVNGKL-VALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 543 LVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGA 602
+V L + LV++Y+ L +++ L + RGL Y+H
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH--- 120
Query: 603 KYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPE-YFKR 661
+ I+HRD+K N+L+ + K++DFGL++ + + + VV + Y P+
Sbjct: 121 QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPPDVLLGS 178
Query: 662 QQLTEKSDIYSFGVVLFEVL 681
+ + D++ G + E++
Sbjct: 179 TEYSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 5e-06
Identities = 58/253 (22%), Positives = 103/253 (40%), Gaps = 42/253 (16%)
Query: 507 EDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALG 566
E ++KV +K +PS F M+ ++ HKH+V L G C E +V +++ G
Sbjct: 30 EKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFG 89
Query: 567 TLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWV--- 623
L ++ L+ + ++ A L YL ++H +V T NILL +
Sbjct: 90 PLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGE 146
Query: 624 ----AKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFK-RQQLTEKSDIYSFGVVLF 678
K+SD G+ T + + ++ PE + + L+ +D +SFG L+
Sbjct: 147 CGPFIKLSDPGIPITVLSRQE------CVERIPWIAPECVEDSKNLSIAADKWSFGTTLW 200
Query: 679 EVLCARPALNPSLPKEQVSLAD----WALHCKRKGILDDIIDPLLKDKISPECLKKFADT 734
E+ N +P + +LA+ + C ++P C K+ AD
Sbjct: 201 EI-----CYNGEIPLKDKTLAEKERFYEGQCM---------------LVTPSC-KELADL 239
Query: 735 AEKCLSDSGIDRP 747
C++ RP
Sbjct: 240 MTHCMNYDPNQRP 252
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 5e-06
Identities = 49/183 (26%), Positives = 85/183 (46%), Gaps = 24/183 (13%)
Query: 510 LKVAIKR-SNPSSEQG-VNEFVTEIEMLSKLRHKHLVSLIGF------CEEGNEMCLVYD 561
+ VA+K+ S P Q E+ +L + HK+++SL+ EE ++ LV +
Sbjct: 47 INVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME 106
Query: 562 YMALGTLRE-HIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDE 620
M + H+ + +S+ +C G+ +LH+ IIHRD+K +NI++
Sbjct: 107 LMDANLCQVIHMELDHERMSYLLYQMLC-----GIKHLHSAG---IIHRDLKPSNIVVKS 158
Query: 621 NWVAKVSDFGLSKTGPN--MENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLF 678
+ K+ DFGL++T M +V T Y PE E DI+S G ++
Sbjct: 159 DCTLKILDFGLARTACTNFMMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMG 213
Query: 679 EVL 681
E++
Sbjct: 214 ELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 33/226 (14%)
Query: 475 FSLAEIKHAT----KSFDESYVIGVGGFGKV---YKGVIEDKLKVAIKR-SNPSSEQG-V 525
F EI +T K + IG G G V Y ++E VAIK+ S P Q
Sbjct: 10 FYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHA 67
Query: 526 NEFVTEIEMLSKLRHKHLVSLIGF------CEEGNEMCLVYDYMALGTLRE-HIYNTKKA 578
E+ ++ + HK+++ L+ EE ++ +V + M + + +
Sbjct: 68 KRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHER 127
Query: 579 LSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPN- 637
+S+ +C G+ +LH+ IIHRD+K +NI++ + K+ DFGL++T
Sbjct: 128 MSYLLYQMLC-----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179
Query: 638 -MENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC 682
M +V T Y PE E DI+S G ++ E++
Sbjct: 180 FMMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIK 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 6e-06
Identities = 38/145 (26%), Positives = 52/145 (35%), Gaps = 55/145 (37%)
Query: 588 CIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLS--------------- 632
C+ A +H K IHRD+K NIL+D K+SDFGLS
Sbjct: 110 CVLAIEAVH------KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKL 163
Query: 633 ------KTGPNMENGHV--------------------------STVVKGSFGYLDPEYFK 660
K + N STV G+ Y+ PE F
Sbjct: 164 LQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTV--GTPDYIAPEIFL 221
Query: 661 RQQLTEKSDIYSFGVVLFEVLCARP 685
+Q ++ D +S G ++FE L P
Sbjct: 222 QQGYGQECDWWSLGAIMFECLIGWP 246
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 8e-06
Identities = 44/157 (28%), Positives = 78/157 (49%), Gaps = 22/157 (14%)
Query: 493 IGVGGFGKVYKGVIEDKLK---VAIKRSNPSS-EQGV-NEFVTEIEMLSKLRHK-HLVSL 546
IG G +GKVYK DK VA+K++ E+G+ + EI +L L ++V L
Sbjct: 9 IGEGTYGKVYKA--RDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRL 66
Query: 547 IGF--CEEGN---EMCLVYDYMALGTLREHIYNTKKA----LSWKQRLEICIGAARGLHY 597
+ EE N + LV++Y+ L++ + + + L K +G+ +
Sbjct: 67 LDVEHVEEKNGKPSLYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH 125
Query: 598 LHTGAKYTIIHRDVKTTNILLD-ENWVAKVSDFGLSK 633
H K+ ++HRD+K N+L+D + + K++D GL +
Sbjct: 126 CH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-06
Identities = 33/122 (27%), Positives = 60/122 (49%), Gaps = 11/122 (9%)
Query: 574 NTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSK 633
+ + L+ L ARG+ +L A +HRD+ N+LL + + K+ DFGL++
Sbjct: 229 DGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLAR 285
Query: 634 TGPNMENGHVSTVVKGS----FGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNP 689
+ ++ +VS KGS ++ PE T SD++S+G++L+E+ P
Sbjct: 286 DIMH-DSNYVS---KGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYP 341
Query: 690 SL 691
+
Sbjct: 342 GM 343
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 57/222 (25%), Positives = 97/222 (43%), Gaps = 32/222 (14%)
Query: 477 LAEIKHATKSFDESYVIGVGGFG-----------KVYKGVIEDKLKVAIKRSNPSSEQGV 525
+ +++ + ++ VIG G FG KVY + K ++ IKRS+ +
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM-IKRSDSAF---- 89
Query: 526 NEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQ-- 583
F E ++++ +V L ++ + +V +YM G L + N W +
Sbjct: 90 --FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFY 147
Query: 584 RLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643
E+ + A +H + IHRDVK N+LLD++ K++DFG + N E
Sbjct: 148 TAEVVL-ALDAIHSM------GFIHRDVKPDNMLLDKSGHLKLADFG-TCMKMNKEGMVR 199
Query: 644 STVVKGSFGYLDPEYFKRQ----QLTEKSDIYSFGVVLFEVL 681
G+ Y+ PE K Q + D +S GV L+E+L
Sbjct: 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 55/214 (25%), Positives = 100/214 (46%), Gaps = 29/214 (13%)
Query: 493 IGVGGFGKVYKGVIED---KLKVAIKRSNPSSEQGVN-EFVTEIEMLSKLRHKHLVSL-- 546
+G G +G VYK +D A+K+ + G++ EI +L +L+H +++SL
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGT---GISMSACREIALLRELKHPNVISLQK 65
Query: 547 IGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAAR--------GLHYL 598
+ ++ L++DY A L I + + + K+ +++ G + G+HYL
Sbjct: 66 VFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 599 HTGAKYTIIHRDVKTTNILL----DENWVAKVSDFGLSK--TGPNMENGHVSTVVKGSFG 652
H ++HRD+K NIL+ E K++D G ++ P + VV +F
Sbjct: 125 HAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFW 180
Query: 653 YLDPE-YFKRQQLTEKSDIYSFGVVLFEVLCARP 685
Y PE + T+ DI++ G + E+L + P
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 58/224 (25%), Positives = 101/224 (45%), Gaps = 35/224 (15%)
Query: 481 KHATKSFDESYVIGVGGFGKVYKGV-IEDKLKVAIKR--SNPSSEQGVNEFVTEIEMLSK 537
+ KS+ +IG G FG VY+ + I+ KVAIK+ +P + E+ ++
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN------RELLIMKN 115
Query: 538 LRHKHLVSLIGF----CEEGNE----MCLVYDYMALGTLREHIYNTKKALSWKQRL---- 585
L H +++ L + C + NE + +V +++ + + + + L
Sbjct: 116 LNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLY 175
Query: 586 --EICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDEN-WVAKVSDFGLSKTGPNMENGH 642
++C R L Y+H+ K+ I HRD+K N+L+D N K+ DFG +K N+ G
Sbjct: 176 SYQLC----RALAYIHS--KF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAK---NLLAGQ 225
Query: 643 VSTVVKGSFGYLDPE-YFKRQQLTEKSDIYSFGVVLFEVLCARP 685
S S Y PE T D++S G ++ E++ P
Sbjct: 226 RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYP 269
|
Length = 440 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 29/203 (14%)
Query: 493 IGVGGFGKV---YKGVIEDKLKVAIKR-SNPSSEQG-VNEFVTEIEMLSKLRHKHLVSLI 547
IG G G V Y V++ VAIK+ S P Q E+ ++ + HK+++SL+
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 548 GF------CEEGNEMCLVYDYMALGTLRE-HIYNTKKALSWKQRLEICIGAARGLHYLHT 600
EE ++ LV + M + + + +S+ +C G+ +LH+
Sbjct: 83 NVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHS 137
Query: 601 GAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPN--MENGHVSTVVKGSFGYLDPEY 658
IIHRD+K +NI++ + K+ DFGL++T M +V T Y PE
Sbjct: 138 AG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPEV 189
Query: 659 FKRQQLTEKSDIYSFGVVLFEVL 681
E DI+S G ++ E++
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 60/256 (23%), Positives = 108/256 (42%), Gaps = 34/256 (13%)
Query: 509 KLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTL 568
+L+V +K +PS F ++S++ H HL + G C G+E +V +++ G L
Sbjct: 44 ELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL 103
Query: 569 REHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVA---- 624
+ K + ++ + A L YL ++H +V NILL +A
Sbjct: 104 DVCLRKEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTS 160
Query: 625 ---KVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEV 680
K+SD G+S T + E V + ++ PE L+ +D +SFG L E+
Sbjct: 161 PFIKLSDPGVSFTALSREE-RVERI-----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
Query: 681 LCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLS 740
+ +P ++ + ++ ++K L + P C K+ A +CL+
Sbjct: 215 -----CFDGEVPLKERTPSEKERFYEKKHRLPE-----------PSC-KELATLISQCLT 257
Query: 741 DSGIDRPSMGDVLWNL 756
RPS +L +L
Sbjct: 258 YEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 5e-05
Identities = 32/117 (27%), Positives = 46/117 (39%), Gaps = 40/117 (34%)
Query: 607 IHRDVKTTNILLDENWVAKVSDFGL----------------------------SKTGPNM 638
IHRD+K N+LLD K+SDFGL SK +
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 639 ENGHV----------STVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
STV G+ Y+ PE F + ++ D +S GV+++E+L P
Sbjct: 183 RKAETWKRNRRALAYSTV--GTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 5e-05
Identities = 29/93 (31%), Positives = 46/93 (49%), Gaps = 10/93 (10%)
Query: 594 GLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPN--MENGHVSTVVKGSF 651
G+ +LH+ IIHRD+K +NI++ + K+ DFGL++T M +V T
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 182
Query: 652 GYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCAR 684
Y PE E DI+S G ++ E++
Sbjct: 183 -YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 53/214 (24%), Positives = 101/214 (47%), Gaps = 29/214 (13%)
Query: 493 IGVGGFGKVYKGVIED---KLKVAIKRSNPSSEQGVN-EFVTEIEMLSKLRHKHLVSL-- 546
+G G +G VYK +D + + A+K+ + G++ EI +L +L+H ++++L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGT---GISMSACREIALLRELKHPNVIALQK 65
Query: 547 IGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAAR--------GLHYL 598
+ ++ L++DY A L I + + + K+ +++ + G+HYL
Sbjct: 66 VFLSHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124
Query: 599 HTGAKYTIIHRDVKTTNILL----DENWVAKVSDFGLSK--TGPNMENGHVSTVVKGSFG 652
H ++HRD+K NIL+ E K++D G ++ P + VV +F
Sbjct: 125 HAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFW 180
Query: 653 YLDPE-YFKRQQLTEKSDIYSFGVVLFEVLCARP 685
Y PE + T+ DI++ G + E+L + P
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 30/116 (25%), Positives = 47/116 (40%), Gaps = 18/116 (15%)
Query: 566 GTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAK 625
+L + + + L+ ++ +C+ L LH R K+ NILL + + K
Sbjct: 1 VSLADILEVRGRPLNEEEIWAVCLQCLGALRELH---------RQAKSGNILLTWDGLLK 51
Query: 626 VSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVL 681
+ KT F PE + Q TEK+DIYS G+ L+E L
Sbjct: 52 LDGSVAFKTPEQSR-------PDPYFM--APEVIQGQSYTEKADIYSLGITLYEAL 98
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 8e-05
Identities = 46/187 (24%), Positives = 70/187 (37%), Gaps = 61/187 (32%)
Query: 607 IHRDVKTTNILLDENWVAKVSDFGLSKTG----------------------PNMENGHVS 644
IHRD+K NIL+D + K++DFGL TG P+ E +
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLC-TGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEID 181
Query: 645 ----TVVK----------------GSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCAR 684
++ G+ Y+ PE R T+ D +S GV+L+E+L +
Sbjct: 182 RCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241
Query: 685 PALNPSLPKE-QVSLADW--ALHCKRKGILDDIIDPLLKDKISPECL---KKFADTAEKC 738
P P E Q+ + +W LH + K+S E + AE
Sbjct: 242 PPFLADTPAETQLKVINWETTLHIPSQA------------KLSREASDLILRLCCGAEDR 289
Query: 739 LSDSGID 745
L +G D
Sbjct: 290 LGKNGAD 296
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 33/121 (27%), Positives = 48/121 (39%), Gaps = 33/121 (27%)
Query: 607 IHRDVKTTNILLDENWVAKVSDFGLSK----------------------TGPNMENGHVS 644
IHRD+K N+LLD K+SDFGL T NM + +
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 645 TVVK-----------GSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPK 693
K G+ Y+ PE F + + D +S GV+++E+L P P+
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242
Query: 694 E 694
E
Sbjct: 243 E 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 54/222 (24%), Positives = 92/222 (41%), Gaps = 49/222 (22%)
Query: 487 FDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSK-----LRHK 541
F+ VIG G FG+V A+ + + + + + EML + R +
Sbjct: 3 FEIIKVIGRGAFGEV-----------AVVKMKHTERIYAMKILNKWEMLKRAETACFREE 51
Query: 542 HLVSLIGFCE----------EGNEMCLVYDYMALGTLREHIYNTKKALS------WKQRL 585
V + G C+ + N + LV DY G L + + L + +
Sbjct: 52 RNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEM 111
Query: 586 EICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV-S 644
+ I + LHY +HRD+K N+LLD N +++DFG ++G V S
Sbjct: 112 VLAIHSIHQLHY---------VHRDIKPDNVLLDMNGHIRLADFG--SCLKMNQDGTVQS 160
Query: 645 TVVKGSFGYLDPEYFKRQQ-----LTEKSDIYSFGVVLFEVL 681
+V G+ Y+ PE + + + D +S GV ++E+L
Sbjct: 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 61/275 (22%), Positives = 102/275 (37%), Gaps = 56/275 (20%)
Query: 443 GHSQTTQSK-STISGKSNASSHLSAIAQGLCRRFSLAEIKHATKSFDESYVIG---VGGF 498
G S S S + + + A++KH + VI G F
Sbjct: 108 GPSGAEDSDASHLDFDEAPPDAAGPVP------LAQAKLKHDDEFLAHFRVIDDLPAGAF 161
Query: 499 GKVY-----KGVIEDKLKVAIKRSN---PSSEQGVNEFV-----------TEIEMLSKLR 539
GK++ E + + + +N P E+ + + V EI L +L
Sbjct: 162 GKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLN 221
Query: 540 HKHLVSLIGFCE-EGNEMCLV--YDYMALGTLREHIYNTKKALSWK------QRLEICIG 590
H++++ + E N + YD+ L +Y+ +A WK Q I
Sbjct: 222 HENILKIEEILRSEANTYMITQKYDF----DLYSFMYD--EAFDWKDRPLLKQTRAIMKQ 275
Query: 591 AARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPN----MENGHVSTV 646
+ Y+H +IHRD+K NI L+ + + DFG + + G V TV
Sbjct: 276 LLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTV 332
Query: 647 VKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVL 681
S PE E +DI+S G++L ++L
Sbjct: 333 ATNS-----PEILAGDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 44/164 (26%), Positives = 61/164 (37%), Gaps = 49/164 (29%)
Query: 493 IGVGGFGKVYKGVIEDKL-----KVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLI 547
+G G FG VYK + +K K +K++ EI M ++R S
Sbjct: 140 LGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-------VEIWMNERVRRACPNSCA 192
Query: 548 GFC---------EEGNEMCLVYDYMALGTL------REHIYNTKKALSWK--------QR 584
F ++ +E LV+ Y TL +E YN + L K +R
Sbjct: 193 DFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLER 252
Query: 585 LEICIG--------AARGLHYLHTGAKYTIIHRDVKTTNILLDE 620
I A GLH TG I+HRDVK NI+ E
Sbjct: 253 ENKIIQTIMRQILFALDGLH--STG----IVHRDVKPQNIIFSE 290
|
Length = 566 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 34/122 (27%), Positives = 49/122 (40%), Gaps = 35/122 (28%)
Query: 607 IHRDVKTTNILLDENWVAKVSDFGLSKTG-----------------------PNMENGHV 643
IHRD+K N+LLD K+SDFGL TG NM +
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLC-TGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRK 181
Query: 644 STVVK-----------GSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLP 692
+ K G+ Y+ PE F + + D +S GV+++E+L P P
Sbjct: 182 AETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 693 KE 694
+E
Sbjct: 242 QE 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 9e-04
Identities = 56/226 (24%), Positives = 100/226 (44%), Gaps = 43/226 (19%)
Query: 493 IGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNE-----FVTEIEMLSKLRHKHLVSLI 547
IG G FG+V+ +++ K S +G+ E V E+ ++ +L+HK++V I
Sbjct: 21 IGNGRFGEVF--LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYI 78
Query: 548 G-FCEEGNE-MCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLH---YLHT-- 600
F + N+ + ++ ++ G L +I K + I + LH Y H
Sbjct: 79 DRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLK 138
Query: 601 ----GAKYTIIHRDVKTTNILLDENW-----------------VAKVSDFGLSKTGPNME 639
G + ++HRD+K NI L +AK+ DFGLSK N+
Sbjct: 139 DGPNGER--VLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK---NIG 193
Query: 640 NGHVSTVVKGSFGYLDPEYF--KRQQLTEKSDIYSFGVVLFEVLCA 683
++ G+ Y PE + + +KSD+++ G +++E LC+
Sbjct: 194 IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYE-LCS 238
|
Length = 1021 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 27/85 (31%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 492 VIGVGGFGKVYK------GVIEDKLKVAIKRSNPSSEQGVNE-FVTEIEMLSKL-RHKHL 543
+G G FGKV + G ++ L+VA+K S+ E ++E+++LS L +HK++
Sbjct: 45 TLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNI 104
Query: 544 VSLIGFCEEGNEMCLVYDYMALGTL 568
V+L+G C G + ++ +Y G L
Sbjct: 105 VNLLGACTHGGPVLVITEYCCYGDL 129
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.001
Identities = 29/97 (29%), Positives = 49/97 (50%), Gaps = 14/97 (14%)
Query: 591 AARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV-STVVKG 649
A +H L +HRD+K N+LLD+N +++DFG + +G V S V G
Sbjct: 114 AIDSVHQLG------YVHRDIKPDNVLLDKNGHIRLADFG--SCLRLLADGTVQSNVAVG 165
Query: 650 SFGYLDPEYFK-----RQQLTEKSDIYSFGVVLFEVL 681
+ Y+ PE + + + + D +S GV ++E+L
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 53/183 (28%), Positives = 82/183 (44%), Gaps = 21/183 (11%)
Query: 512 VAIKRSNPSSEQGVNEFVTEIE---MLSKL-RHKHLVSLIGFCEEGNEMCLVYDYMALGT 567
V ++R N E NE VT ++ +SKL H ++V NE+ +V +MA G+
Sbjct: 28 VTVRRIN--LEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGS 85
Query: 568 LREHI-YNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKV 626
++ I + +S I G + L Y+H +HR VK ++IL+ + KV
Sbjct: 86 AKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVD--GKV 140
Query: 627 SDFGLSKTGPNMENGHVSTVV----KGS---FGYLDPEYFKR--QQLTEKSDIYSFGVVL 677
GL + +G VV K S +L PE ++ Q KSDIYS G+
Sbjct: 141 YLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITA 200
Query: 678 FEV 680
E+
Sbjct: 201 CEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 817 | |||
| PF12819 | 347 | Malectin_like: Carbohydrate-binding protein of the | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.98 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.98 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.77 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.76 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.72 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.68 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.67 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.66 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.66 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.6 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.6 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 99.59 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.55 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.53 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.47 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.45 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.42 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.29 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.27 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 99.17 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.16 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.13 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.11 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.09 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.03 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.01 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.0 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.99 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.96 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.81 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.77 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.74 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.63 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.5 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.48 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.46 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.42 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.4 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.32 | |
| PF12819 | 347 | Malectin_like: Carbohydrate-binding protein of the | 98.18 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.17 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.15 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.12 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.09 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.05 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.03 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.91 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.9 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.9 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.77 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.73 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.55 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.51 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.47 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.41 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.37 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.32 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.26 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.22 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.14 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.06 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.98 | |
| PLN02236 | 344 | choline kinase | 96.9 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.78 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.62 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.61 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.28 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.11 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.05 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.93 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.57 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.39 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.22 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.12 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.98 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 94.36 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.2 | |
| KOG3593 | 355 | consensus Predicted receptor-like serine/threonine | 94.18 |
| >PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan [] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-58 Score=497.20 Aligned_cols=327 Identities=37% Similarity=0.595 Sum_probs=254.3
Q ss_pred CCCCCCC---cCC-CCCccccCCCcccCCCCCCceeeccCCCCCCCCccceeeeeecc--eeEEEecc--CCCeEEEEEE
Q 039107 1 CGSKDGG---IDA-DGRSWEPDDKYLSKGESKPTRATYQDSSLVSKVPYMDARVFKQE--MSYELPIR--SQSRYWVRFH 72 (817)
Q Consensus 1 CG~~~~~---~~~-~~~~w~~D~~~~~~g~~~~~~~~~~~~~~~~~~~~~t~R~f~~~--~~Y~~~~~--~~~~y~vR~~ 72 (817)
||++.+. +|. +||+|++|..|+++|.++.++...........++|+|||+||.| .||+||+. +|+|||||||
T Consensus 3 CG~~~~~s~y~D~~tg~~~~~D~~~~~~g~~~~i~~~~~~~~~~~~~~y~taR~F~~g~r~cY~l~~~~~~~~~yliRl~ 82 (347)
T PF12819_consen 3 CGSSSNSSSYVDDSTGRTWVSDDDFIDTGKSGNISSQPDSSSSDSSPPYQTARIFPEGSRNCYTLPVTPPGGGKYLIRLH 82 (347)
T ss_pred CCCCCCCcccccCCCCcEEeCCCCcccCCCccccccccCCcCCccccccceEEEcCCCCccEEEeeccCCCCceEEEEEE
Confidence 9998774 454 89999999999999998887322222234567889999999954 89999997 5679999999
Q ss_pred eccCCCCCCCcccceeEE----EeCCeEEEeccCcchhhhcccceeEEEE--EEecCCCCCcEEEEEeeCCCCCCcceeE
Q 039107 73 FYPSTYPELNVANSYFSV----VANDVTLLSNFSASITAQAVAQAYLIKE--FSLAPMDSDILKIIFRPSDKHSGTFAFI 146 (817)
Q Consensus 73 f~~~~~~~~~~~~~~f~v----~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~f~p~~~~~~~~~fi 146 (817)
|+|||||+.+ |+| +.||++++.|+|.+|+..+....++++| +++++.+...|||+ +++.|++|||
T Consensus 83 F~~gnyd~~~-----fs~~~~~~~FdL~~~~n~~~tV~~~~~~~~~~~~E~ii~v~~~~~l~vclv----~~~~g~~pFI 153 (347)
T PF12819_consen 83 FYYGNYDGLN-----FSVSSSPPTFDLLLGFNFWSTVNLSNSPSSPVVKEFIINVTWSDTLSVCLV----PTGSGTFPFI 153 (347)
T ss_pred eccccccccc-----cccccCCcceEEEECCceeEEEEecCCCcceEEEEEEEEEcCCCcEEEEEE----eCCCCCCCce
Confidence 9999999663 232 6799999999999998876222344444 33343456666666 5566889999
Q ss_pred eeeeeecCCccchhhhccccccccccccceeeeeeeeccCccc--cCCCCCcccccccccCCCCceeccCCCCccCCCce
Q 039107 147 NGIELVPSPDLFEQAIIVGLGETIDGMTANMQTMFRLNVAGQY--ISPKNDSGGLMRSWQNDEPYLFGAGYGIPMKADEV 224 (817)
Q Consensus 147 ~~iEl~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~R~n~Gg~~--i~~~~d~~~~~R~W~~d~~~~~~~~~~~~~~~~~~ 224 (817)
|||||||||+.+|+. .....+++|++++|+||||.. |||++|+ |||+|.+ | .....|.+.+++ .
T Consensus 154 saiEl~~lp~~ly~~-------~~~~~s~~L~~~~R~n~G~~~~~iryp~D~--~dR~W~~---~-~~~~~~~~ist~-~ 219 (347)
T PF12819_consen 154 SAIELRPLPDSLYPD-------TDANSSQALETVYRLNVGGSSSFIRYPDDT--YDRIWQP---Y-SSSPGWSNISTT-S 219 (347)
T ss_pred eEEEEEECCccceec-------cccCCCceeEEEEeecCCCcccccCCCCCc--ceeeccc---c-ccCccccccccc-e
Confidence 999999999995531 122456899999999999999 9999999 9999986 4 224445555543 2
Q ss_pred eee-eccCCCCCCChhhhhhhhhcCCCcccccccceeEEEEecCCCceEEEEEeeeccCCcccccceEEEEEEcCccccc
Q 039107 225 QID-YKSLPDYSAPPDVYMTARYMGVDAHTNMEFNLTWIFRVDANFTYYVRLHFCEFKPDINKINQRVFNIYINNQTAQA 303 (817)
Q Consensus 225 ~i~-~~~~~~~~~P~~v~~ta~~~~~~~~~~~~~~~~~~~p~~~~~~y~v~lhF~e~~~~~~~~~~R~F~i~i~~~~~~~ 303 (817)
.+. ...++.|.+|..||+||+++..+. .+++++|.+ ++++..|+|+||||||+....+.++|+|+|||||+.+.+
T Consensus 220 ~i~~~~~~~~~~~P~~V~~TA~~~~~~s---~~~nltw~~-~~~~~~y~v~lHFaEi~~~~~~~~~R~F~IyiN~~~~~~ 295 (347)
T PF12819_consen 220 NININSSNNPYDAPSAVYQTARTPSNSS---DPLNLTWSF-VDPGFSYYVRLHFAEIQSLSPNNNQREFDIYINGQTAYS 295 (347)
T ss_pred eeecccCCccCcChHHHHHhhhcccccc---cceEEEecc-CCCCccEEEEEEEeecccccCCCCeEEEEEEECCeEccC
Confidence 344 445678899999999999997653 348999999 999999999999999987444566899999999999997
Q ss_pred ccchhh-hccCCCccEEEEEEEEEecCCCCcceEEEeCCCCCCcchhhHhhccCceeeee
Q 039107 304 DADVIA-WTHGQGVPIYKDYAVYVEDLPGDDQIFVAMSPSLKYQPEYLDALLNGLEIFKI 362 (817)
Q Consensus 304 ~~~~~~-~~~~~~~p~~~~~~v~v~~~~~~~~l~v~l~p~~~~~~~~~~~~lnglei~~~ 362 (817)
|+.. +.+....|+|++|.+.+..++ .+.|.|++...+ .++++|||+|||++
T Consensus 296 --~~~~~~~~~~~~~~~~d~~~~~~~~~---~~~isL~~t~~S---~lppiLNalEIy~v 347 (347)
T PF12819_consen 296 --DVSPPYLGADTVPYYSDYVVNVPDSG---FLNISLGPTPDS---TLPPILNALEIYKV 347 (347)
T ss_pred --ccCcccccCcceEeecceEEEecCCC---EEEEEEEeCCCC---CcCceeEeeeeEeC
Confidence 5554 455677899999999887643 677888776532 44999999999985
|
This entry represents a malectin-like domain found in a number of plant receptor kinases. |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-56 Score=483.28 Aligned_cols=291 Identities=50% Similarity=0.844 Sum_probs=260.0
Q ss_pred cccccCHHHHHHhhcCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEE
Q 039107 471 LCRRFSLAEIKHATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFC 550 (817)
Q Consensus 471 ~~~~f~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 550 (817)
..+.|++.||+.||++|...++||+|+||.||+|.+.++..||||++.....+..++|.+|+++|.+++|||||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 35789999999999999999999999999999999999989999988876543246699999999999999999999999
Q ss_pred ecCC-eEEEEEEeccCCchhhhhhcccc-ccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEee
Q 039107 551 EEGN-EMCLVYDYMALGTLREHIYNTKK-ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSD 628 (817)
Q Consensus 551 ~~~~-~~~lV~Ey~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 628 (817)
.+.+ +.+||||||++|+|.++|+.... .|+|.+|++||.++|+||+|||+.+.++|||||||++|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9988 59999999999999999998776 899999999999999999999998888999999999999999999999999
Q ss_pred eccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhcc
Q 039107 629 FGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRK 708 (817)
Q Consensus 629 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 708 (817)
|||++..+.. ..+..+...||.+|+|||++..+..+.|+|||||||+|+||++|+.+.+...+.....+.+|++....+
T Consensus 221 FGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 221 FGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred ccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 9999775432 222222117999999999999999999999999999999999999998876656666799999999999
Q ss_pred CchhhccCcccc-CCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 039107 709 GILDDIIDPLLK-DKISP-ECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQL 762 (817)
Q Consensus 709 ~~~~~~~d~~l~-~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 762 (817)
+.+.+++|+.+. ..... ++..++..++.+|++.+|.+||+|.+|+++|+.+...
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 999999999987 55554 6788899999999999999999999999999665543
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-51 Score=481.08 Aligned_cols=323 Identities=22% Similarity=0.279 Sum_probs=250.2
Q ss_pred CCCCCCC-cCCCCCccccCCCcccCCCCCCceeeccCCCCCCCCccceeeeeec----ceeEEEeccCCCeEEEEEEecc
Q 039107 1 CGSKDGG-IDADGRSWEPDDKYLSKGESKPTRATYQDSSLVSKVPYMDARVFKQ----EMSYELPIRSQSRYWVRFHFYP 75 (817)
Q Consensus 1 CG~~~~~-~~~~~~~w~~D~~~~~~g~~~~~~~~~~~~~~~~~~~~~t~R~f~~----~~~Y~~~~~~~~~y~vR~~f~~ 75 (817)
||++.+. +|.+||+|++|..|.+ |.....+ .|. ...++|+|||+||. .+||+||++++|+|+||+||+|
T Consensus 30 CGs~~~~~~d~~~~~w~~D~~~~~-~~~~~~~----~~~-~~~~~~~t~R~F~~~~g~~~cY~~~~~~~g~ylVRl~F~~ 103 (623)
T PLN03150 30 CGARVNVRTAPTNTLWYKDFAYTG-GIPANAT----RPS-FIAPPLKTLRYFPLSDGPENCYNINRVPKGHYSVRVFFGL 103 (623)
T ss_pred CCCCCCcccCCCCCEEcCCccccc-Ccccccc----Ccc-cccchhhccccCCcccccccceEeeecCCCcEEEEEEeec
Confidence 9999887 6679999999988854 3322222 222 24566999999996 4799999999999999999999
Q ss_pred CCCCCCCcccceeEEEeCCeEEEeccCcchhhhc--ccceeEEEEEEecCCCCCcEEEEEeeCCCCCCcceeEeeeeeec
Q 039107 76 STYPELNVANSYFSVVANDVTLLSNFSASITAQA--VAQAYLIKEFSLAPMDSDILKIIFRPSDKHSGTFAFINGIELVP 153 (817)
Q Consensus 76 ~~~~~~~~~~~~f~v~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~f~p~~~~~~~~~fi~~iEl~~ 153 (817)
||||+.+.+ +.||+++++|+|.++.... .....+.|.++.+..+...|||+ +++.|. ||||+|||||
T Consensus 104 ~~y~~~~~~------~~Fdv~~~~~~~~tv~~~~~~~~~~v~~E~i~~~~~~~l~vcf~----~~~~~~-pFIs~iEv~~ 172 (623)
T PLN03150 104 VAEPNFDSE------PLFDVSVEGTQISSLKSGWSSHDEQVFAEALVFLTDGSASICFH----STGHGD-PAILSIEILQ 172 (623)
T ss_pred CCcCCCCCC------CceEEEECcEEEEEEecCcccCCCcEEEEEEEEecCCcEEEEEe----cCCCCC-CceeEEEEEE
Confidence 999999865 6788888888888876532 23345556666666666666665 455566 9999999999
Q ss_pred CCccchhhhccccccccccccceeeeeeeeccCccc----cCCCCCcccccccccCCCCceeccCCCCccCCCceeeeec
Q 039107 154 SPDLFEQAIIVGLGETIDGMTANMQTMFRLNVAGQY----ISPKNDSGGLMRSWQNDEPYLFGAGYGIPMKADEVQIDYK 229 (817)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~R~n~Gg~~----i~~~~d~~~~~R~W~~d~~~~~~~~~~~~~~~~~~~i~~~ 229 (817)
||+.+|.. ... .+.+.+|++++|+||||++ ++|++|..++||+|.+|.+|+ .+.+...+ +...|++.
T Consensus 173 l~~~~y~~-----~~~-~~~~~~L~~~~R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~~~--~~~~~~~s-t~~~I~~~ 243 (623)
T PLN03150 173 VDDKAYNF-----GPS-WGQGVILRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFG--SGSDQAIS-TENVIKKA 243 (623)
T ss_pred cCcccccc-----ccc-ccCceEEEEEEEEEecCcccccccCCCCCcccCccccCcCcccC--CCcccccc-cccccccc
Confidence 99997742 110 1235679999999999975 678888833499999998876 23344443 33456655
Q ss_pred cCCCCCCChhhhhhhhhcCCCcccccccceeEEEEecCCCceEEEEEeeeccCCcccccceEEEEEEcCcccccccchhh
Q 039107 230 SLPDYSAPPDVYMTARYMGVDAHTNMEFNLTWIFRVDANFTYYVRLHFCEFKPDINKINQRVFNIYINNQTAQADADVIA 309 (817)
Q Consensus 230 ~~~~~~~P~~v~~ta~~~~~~~~~~~~~~~~~~~p~~~~~~y~v~lhF~e~~~~~~~~~~R~F~i~i~~~~~~~~~~~~~ 309 (817)
.++.+.+|..||+||+++..+ ..+++|.|+++++..|+|+|||||++......++|+|||||||+.+.+++|+..
T Consensus 244 ~~~~~~~P~~VyqTA~~~~~~-----~~~lty~~~v~~~~~Y~VrLhFaEi~~~~~~~~~R~F~V~ing~~~~~~~di~~ 318 (623)
T PLN03150 244 SNAPNFYPESLYQSALVSTDT-----QPDLSYTMDVDPNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAFKDVDIVK 318 (623)
T ss_pred cCCCccChHHHhhhhccccCC-----CCceEEEeecCCCCCEEEEEEEEeccCccCCCceEEEEEEECCEEeecccChhh
Confidence 566778999999999987642 147899999999999999999999975455678999999999999999999999
Q ss_pred hccCCCccEEEEEEEEEecCCCCcceEEEeCCCCCCcchhhHhhccCceeeeec
Q 039107 310 WTHGQGVPIYKDYAVYVEDLPGDDQIFVAMSPSLKYQPEYLDALLNGLEIFKIE 363 (817)
Q Consensus 310 ~~~~~~~p~~~~~~v~v~~~~~~~~l~v~l~p~~~~~~~~~~~~lnglei~~~~ 363 (817)
++++...|++++|.+.+.. ..+.|.++|.. ...++|||+||+++.
T Consensus 319 ~~g~~~~~~~~~~~v~~~~----g~l~isl~p~~-----~s~pilNaiEI~~~~ 363 (623)
T PLN03150 319 MSGERYTALVLNKTVAVSG----RTLTIVLQPKK-----GTHAIINAIEVFEII 363 (623)
T ss_pred hcCCcccceEEEeEEeecC----CeEEEEEeeCC-----CCcceeeeeeeeecc
Confidence 9988889999999998753 46888888854 224899999999995
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-46 Score=401.85 Aligned_cols=256 Identities=34% Similarity=0.574 Sum_probs=214.7
Q ss_pred ceeEeeeCceEEEEEEEecccEEEEEecCCCCccc--HHHHHHHHHHHhccCccceeeEEEEEecCC-eEEEEEEeccCC
Q 039107 490 SYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQG--VNEFVTEIEMLSKLRHKHLVSLIGFCEEGN-EMCLVYDYMALG 566 (817)
Q Consensus 490 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~Ey~~~g 566 (817)
.+.||+|+||+||+|.+++...||||++....... .++|.+|+.+|.+++|||||+++|+|.+.. .+++|||||++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 33599999999999999887669999988653222 568999999999999999999999999887 799999999999
Q ss_pred chhhhhhcc-ccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCc-eeEEeeeccCccCCCCCCCcee
Q 039107 567 TLREHIYNT-KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENW-VAKVSDFGLSKTGPNMENGHVS 644 (817)
Q Consensus 567 sL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DFGla~~~~~~~~~~~~ 644 (817)
+|.++++.. +..+++..+++|+.|||+||.|||+++. ||||||||+||||+.++ ++||+|||+++...... ...
T Consensus 126 sL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~ 201 (362)
T KOG0192|consen 126 SLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TSM 201 (362)
T ss_pred cHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--ccc
Confidence 999999884 6689999999999999999999997642 99999999999999997 99999999998643211 233
Q ss_pred eeeecCcCCCChhhhc--cCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCC
Q 039107 645 TVVKGSFGYLDPEYFK--RQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDK 722 (817)
Q Consensus 645 ~~~~gt~~y~aPE~~~--~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (817)
+...||+.|||||++. ...|+.|+||||||++||||+||+.||..... .+ ....+ +....+..
T Consensus 202 ~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~--~~~~v------------~~~~~Rp~ 266 (362)
T KOG0192|consen 202 TSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQ--VASAV------------VVGGLRPP 266 (362)
T ss_pred cCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HH--HHHHH------------HhcCCCCC
Confidence 3468999999999999 66999999999999999999999999986644 21 11111 11222333
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhc
Q 039107 723 ISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVE 764 (817)
Q Consensus 723 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 764 (817)
++..+...+..++.+||+.||.+||++.+++..|+.+.....
T Consensus 267 ~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 267 IPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 444577889999999999999999999999999999886544
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=371.45 Aligned_cols=257 Identities=26% Similarity=0.383 Sum_probs=211.3
Q ss_pred ccCHHHHHHhhcCCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCC-CcccHHHHHHHHHHHhccCccceeeEEEEEe
Q 039107 474 RFSLAEIKHATKSFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPS-SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCE 551 (817)
Q Consensus 474 ~f~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 551 (817)
..++.||... +.||+|..|+|||+.++. ++.+|+|.+... .....+++.+|++++++.+||+||+++|.|.
T Consensus 75 ~i~~~dle~~-------~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~ 147 (364)
T KOG0581|consen 75 GISLSDLERL-------GVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFY 147 (364)
T ss_pred ccCHHHhhhh-------hhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE
Confidence 4566666553 489999999999999874 577999998544 3444678999999999999999999999998
Q ss_pred cCC-eEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeec
Q 039107 552 EGN-EMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFG 630 (817)
Q Consensus 552 ~~~-~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFG 630 (817)
... +..++||||++|+|++++... +.+++...-+|+.+|++||.|||+. ++||||||||+||||+..|++||||||
T Consensus 148 ~~~~~isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFG 224 (364)
T KOG0581|consen 148 SNGEEISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFG 224 (364)
T ss_pred eCCceEEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEecccc
Confidence 888 599999999999999988654 5699999999999999999999962 469999999999999999999999999
Q ss_pred cCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCcc--ccchHHHHHHHhhcc
Q 039107 631 LSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPK--EQVSLADWALHCKRK 708 (817)
Q Consensus 631 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~--~~~~l~~~~~~~~~~ 708 (817)
.++...+. ......||..|||||.+++..|+.++||||||+.++|+.+|+.|+....+. ....+..+
T Consensus 225 VS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~------- 293 (364)
T KOG0581|consen 225 VSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCA------- 293 (364)
T ss_pred ccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHH-------
Confidence 99875432 445678999999999999999999999999999999999999998765221 11222211
Q ss_pred CchhhccCccccCCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 709 GILDDIIDPLLKDKISP-ECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 709 ~~~~~~~d~~l~~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
+++.. ....+. .++.+++.++..||++||.+||+++|+++|--
T Consensus 294 -----Iv~~p-pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpf 337 (364)
T KOG0581|consen 294 -----IVDEP-PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPF 337 (364)
T ss_pred -----HhcCC-CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHH
Confidence 22211 112233 47788999999999999999999999998754
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=389.78 Aligned_cols=252 Identities=28% Similarity=0.446 Sum_probs=212.6
Q ss_pred ceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccCCchh
Q 039107 490 SYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLR 569 (817)
Q Consensus 490 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 569 (817)
.+.||+|.||.||.|.+++..+||+|.++.. ....+.|.+|+++|++|+|+|||+++|+|..++.++||||||+.|+|.
T Consensus 211 ~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl 289 (468)
T KOG0197|consen 211 IRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLL 289 (468)
T ss_pred HHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHH
Confidence 3479999999999999999889999999865 344578999999999999999999999999988999999999999999
Q ss_pred hhhhc-cccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceeeeee
Q 039107 570 EHIYN-TKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVK 648 (817)
Q Consensus 570 ~~l~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 648 (817)
++|.. .+..+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+||||++...+ +.........
T Consensus 290 ~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d-~~Y~~~~~~k 365 (468)
T KOG0197|consen 290 DYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGD-DEYTASEGGK 365 (468)
T ss_pred HHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCC-CceeecCCCC
Confidence 99986 4457999999999999999999999776 99999999999999999999999999995333 2222333344
Q ss_pred cCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCHHH
Q 039107 649 GSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPEC 727 (817)
Q Consensus 649 gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 727 (817)
-+..|.|||.+..+.++.|||||||||+||||+| |+.|+.+....+ .+.. ++.-.+-..+..|
T Consensus 366 fPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e------v~~~----------le~GyRlp~P~~C 429 (468)
T KOG0197|consen 366 FPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE------VLEL----------LERGYRLPRPEGC 429 (468)
T ss_pred CCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH------HHHH----------HhccCcCCCCCCC
Confidence 5779999999999999999999999999999998 777765543322 2222 2222233346678
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 039107 728 LKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQL 762 (817)
Q Consensus 728 ~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 762 (817)
+..+.+++..||+.+|++|||.+.+...|+.+...
T Consensus 430 P~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 430 PDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 89999999999999999999999999888877643
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=364.29 Aligned_cols=202 Identities=32% Similarity=0.517 Sum_probs=180.9
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
.+|...+.||+|+||+||+|+++ ++..||||.+... ..+..+.+..|+.+|+.++|||||+|+++++..+.++||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 45777778999999999999976 4688999998766 55666778899999999999999999999999999999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCC------ceeEEeeeccCccC
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDEN------WVAKVSDFGLSKTG 635 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~------~~~kl~DFGla~~~ 635 (817)
||.+|+|.++|+..+ .+++.+...++.|+|.||++||+++ ||||||||.||||+.. -.+||+|||+|+.+
T Consensus 90 yC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred eCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 999999999997654 6999999999999999999999776 9999999999999764 56899999999986
Q ss_pred CCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCcc
Q 039107 636 PNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPK 693 (817)
Q Consensus 636 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~ 693 (817)
. ........+|++.|||||+++.++|+.|+|+||+|++|||+++|++||......
T Consensus 166 ~---~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~ 220 (429)
T KOG0595|consen 166 Q---PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK 220 (429)
T ss_pred C---chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence 4 344556789999999999999999999999999999999999999999865443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=402.16 Aligned_cols=258 Identities=31% Similarity=0.500 Sum_probs=216.9
Q ss_pred CcceeEeeeCceEEEEEEEe------cccEEEEEecCCCCcc-cHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 488 DESYVIGVGGFGKVYKGVIE------DKLKVAIKRSNPSSEQ-GVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 488 ~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
...+.||+|.||+||+|... +.+.||||.++..... ..++|.+|+++|..|+|||||+|+|+|.+++.++||+
T Consensus 489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvF 568 (774)
T KOG1026|consen 489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVF 568 (774)
T ss_pred eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEE
Confidence 33557999999999999853 3467999999977555 7789999999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccc-------------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEe
Q 039107 561 DYMALGTLREHIYNTK-------------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVS 627 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~-------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 627 (817)
|||..|||.+||.... .+|+..+.+.||.|||.||.||-++. +|||||..+|+||.++..+||+
T Consensus 569 EYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VKIs 645 (774)
T KOG1026|consen 569 EYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVKIS 645 (774)
T ss_pred EecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEEec
Confidence 9999999999996321 13889999999999999999999776 9999999999999999999999
Q ss_pred eeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhh
Q 039107 628 DFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCK 706 (817)
Q Consensus 628 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 706 (817)
||||+|.....++......-.-+.+||+||.+..+++|.+||||||||||||+++ |+.|+.+-...+- ..+.
T Consensus 646 DfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV-------Ie~i 718 (774)
T KOG1026|consen 646 DFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV-------IECI 718 (774)
T ss_pred ccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH-------HHHH
Confidence 9999997655555443333345789999999999999999999999999999998 8888876544332 2223
Q ss_pred ccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhc
Q 039107 707 RKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVE 764 (817)
Q Consensus 707 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 764 (817)
+.+.+ -..++.|+.++..|+..||+.+|.+||+++||-..|+...+..+
T Consensus 719 ~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 719 RAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred HcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 33322 22466889999999999999999999999999999998775543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=382.12 Aligned_cols=251 Identities=27% Similarity=0.437 Sum_probs=213.8
Q ss_pred cCCCcceeEeeeCceEEEEEEE-ecccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVI-EDKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
..|...++||+|||+.||+++. ..|..||+|++.+. .....+...+||+|.+.|+|||||+++++|++.+..|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688889999999999999997 78899999998763 3445677889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
|+|++++|.+++. .++.+++.+++.+++||+.||.|||+.+ |||||||..|+||+++.++||+|||||......
T Consensus 98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~-- 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD-- 171 (592)
T ss_pred EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc--
Confidence 9999999999886 5678999999999999999999999765 999999999999999999999999999875432
Q ss_pred CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
.......+||+.|+|||++.....+..+||||+|||||-||.|+|||+...-.+....+ +.. +
T Consensus 172 ~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~I------k~~-------~---- 234 (592)
T KOG0575|consen 172 GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKI------KLN-------E---- 234 (592)
T ss_pred ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHH------Hhc-------C----
Confidence 34556789999999999999999999999999999999999999999865322211100 000 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
-.++...+.+..+||.++|+++|.+|||+++|+.+=.+
T Consensus 235 Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 235 YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 01223455667899999999999999999999988666
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=362.61 Aligned_cols=256 Identities=29% Similarity=0.393 Sum_probs=204.3
Q ss_pred cCCCcceeEeeeCceEEEEEEE-ecccEEEEEecCCCCcc-------cHHHHHHHHHHHhccCccceeeEEEEEecCCeE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVI-EDKLKVAIKRSNPSSEQ-------GVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEM 556 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 556 (817)
..|...+.||+|+||.|-+|.. ++++.||||+++...-. ......+|+++|++|+|||||+++++++..+..
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 3466788999999999999985 46789999998764211 122346999999999999999999999999999
Q ss_pred EEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCC---ceeEEeeeccCc
Q 039107 557 CLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDEN---WVAKVSDFGLSK 633 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~---~~~kl~DFGla~ 633 (817)
|||||||+||+|.+.+-.+ +.+.+..-..+++|++.||.|||++| |+||||||+|||+..+ ..+||+|||+|+
T Consensus 252 YmVlE~v~GGeLfd~vv~n-k~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVAN-KYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred EEEEEEecCccHHHHHHhc-cccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchhh
Confidence 9999999999999998654 35778888999999999999999876 9999999999999765 889999999999
Q ss_pred cCCCCCCCceeeeeecCcCCCChhhhccCCC---CchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCc
Q 039107 634 TGPNMENGHVSTVVKGSFGYLDPEYFKRQQL---TEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGI 710 (817)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 710 (817)
... ........+||+.|.|||++.+... ..+.|+||+|||||-+|+|.+||....... .+.+-+ .++.
T Consensus 328 ~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~eQI----~~G~ 398 (475)
T KOG0615|consen 328 VSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKEQI----LKGR 398 (475)
T ss_pred ccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHHHH----hcCc
Confidence 743 3445667899999999999976543 348899999999999999999997654322 111111 1111
Q ss_pred hhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 711 LDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 711 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
..+.| ....+..++..++|.+||..||++|||+.|+|+|-..-
T Consensus 399 --y~f~p----~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~ 441 (475)
T KOG0615|consen 399 --YAFGP----LQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFK 441 (475)
T ss_pred --ccccC----hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence 11111 12235667789999999999999999999999875543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=380.68 Aligned_cols=263 Identities=24% Similarity=0.422 Sum_probs=220.9
Q ss_pred CCcceeEeeeCceEEEEEEEec----ccEEEEEecCCC-CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 487 FDESYVIGVGGFGKVYKGVIED----KLKVAIKRSNPS-SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 487 f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
..++++||.|.||.|++|+++- ...||||.++.. .+++..+|+.|+.||.++.||||++|.|+.......++|.|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 3577899999999999999763 357999999976 45567899999999999999999999999999999999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
||+||+|+.||..+.+.+++.++..|+++||.||.||-+ +++|||||.++|||++.+..+|++||||+|...+....
T Consensus 711 yMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~ 787 (996)
T KOG0196|consen 711 YMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 787 (996)
T ss_pred hhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccceeecccCCCc
Confidence 999999999999888899999999999999999999995 45999999999999999999999999999976443322
Q ss_pred c-eeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccc
Q 039107 642 H-VSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719 (817)
Q Consensus 642 ~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (817)
. ......-+.+|.|||.+..++++.+|||||||+||||+++ |.+|+......+-+ ..++...
T Consensus 788 ~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI----------------kaIe~gy 851 (996)
T KOG0196|consen 788 AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI----------------KAIEQGY 851 (996)
T ss_pred cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHH----------------HHHHhcc
Confidence 1 1222233579999999999999999999999999999886 88887654332211 1112222
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhccccc
Q 039107 720 KDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVESTEA 768 (817)
Q Consensus 720 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~ 768 (817)
+-+-+.+|+..|.+|++.||++|-.+||+..+|+.+|.+++..+.+-..
T Consensus 852 RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~ 900 (996)
T KOG0196|consen 852 RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKT 900 (996)
T ss_pred CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcc
Confidence 3334668999999999999999999999999999999999977765544
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=345.02 Aligned_cols=255 Identities=25% Similarity=0.365 Sum_probs=205.8
Q ss_pred CCCcceeEeeeCceEEEEEE-EecccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEE-EEecCCe-EEEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGV-IEDKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIG-FCEEGNE-MCLVY 560 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g-~~~~~~~-~~lV~ 560 (817)
+|.+.++||+|.||+|||+. +.++..||.|.+.-. ..+..+++..|+.+|++|+|||||+.++ -+.+..+ +.+||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 46667799999999999998 568889999987744 4455678999999999999999999998 3444444 89999
Q ss_pred EeccCCchhhhhhc---cccccchHhHHHHHHHHHHHHHHHHhCCC-CceEecCCccCcEEEcCCceeEEeeeccCccCC
Q 039107 561 DYMALGTLREHIYN---TKKALSWKQRLEICIGAARGLHYLHTGAK-YTIIHRDVKTTNILLDENWVAKVSDFGLSKTGP 636 (817)
Q Consensus 561 Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 636 (817)
|||+.|+|.+.+.. .++.++++.+++++.|+++||..+|++-. ..|+||||||.||+|+.+|.+||+||||++.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 99999999998863 34479999999999999999999998421 238999999999999999999999999999864
Q ss_pred CCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccC
Q 039107 637 NMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIID 716 (817)
Q Consensus 637 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (817)
.. ........||+.||+||.+....|+.||||||+||++|||+.-++||.+.+- ..|..-+. .+.
T Consensus 180 s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~---~~L~~KI~----qgd------ 244 (375)
T KOG0591|consen 180 SK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL---LSLCKKIE----QGD------ 244 (375)
T ss_pred ch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH---HHHHHHHH----cCC------
Confidence 42 2334567899999999999999999999999999999999999999988721 12221111 111
Q ss_pred ccccCCCC-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 717 PLLKDKIS-PECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 717 ~~l~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
. .+.+ .-.+..+.+|+..|+..||+.||+.-.+++.+..
T Consensus 245 --~-~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 245 --Y-PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred --C-CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1 1122 4567789999999999999999997655555444
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=342.36 Aligned_cols=264 Identities=26% Similarity=0.357 Sum_probs=209.3
Q ss_pred CCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCCCc-cc-HHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 486 SFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPSSE-QG-VNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
.|+...++|+|+||+|||++.++ |+.||||++....+ +. .+-.++|+++|++|+|+|+|.|+.+|.....++||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 35556689999999999999764 68999999876543 22 34567999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
|+..-|.+ |......++.+.+.+++.|+++|+.|+|++. +|||||||+||||+.++.+||||||+|+.... .+.
T Consensus 83 ~dhTvL~e-Le~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pgd 156 (396)
T KOG0593|consen 83 CDHTVLHE-LERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA--PGD 156 (396)
T ss_pred cchHHHHH-HHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC--Ccc
Confidence 99755544 5555567999999999999999999999665 99999999999999999999999999997643 344
Q ss_pred eeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHH---------HhhccCchh
Q 039107 643 VSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWAL---------HCKRKGILD 712 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~---------~~~~~~~~~ 712 (817)
..+....|.+|.|||.+.+ .+|...+||||+||++.||++|.+.|.+..+-++..++.-.. .....+...
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 5566778999999999887 789999999999999999999999999887777654432211 111111111
Q ss_pred hccCcccc-----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 713 DIIDPLLK-----DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 713 ~~~d~~l~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.+.-|... +..-+....-+++++..||+.||++|++.++++.+
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 11111111 11112344578999999999999999999999965
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=348.11 Aligned_cols=250 Identities=27% Similarity=0.360 Sum_probs=204.9
Q ss_pred hcCCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 559 (817)
..+|+..++||+|+||+||.++.++ ++.+|+|.+++. .....+...+|..+|.+++||.||+++-.|++.+.++||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 3468889999999999999998764 577999988764 234567788999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC
Q 039107 560 YDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 639 (817)
+||+.||.|..+|.+++ .+++..+.-.+..|+.||.|||+.+ ||||||||+|||||++|.++|+||||++... .
T Consensus 104 ld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~--~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL--K 177 (357)
T ss_pred EeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc--c
Confidence 99999999999997654 5899999999999999999999776 9999999999999999999999999998632 2
Q ss_pred CCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccc
Q 039107 640 NGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719 (817)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (817)
.+..+...+||+.|||||++.+..|+..+|.||+|+++||||+|.+||...+... +........ +
T Consensus 178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~------~~~~I~~~k---------~ 242 (357)
T KOG0598|consen 178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK------MYDKILKGK---------L 242 (357)
T ss_pred CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH------HHHHHhcCc---------C
Confidence 3334455899999999999999999999999999999999999999998764322 111111111 0
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCC----CHHHHHHH
Q 039107 720 KDKISPECLKKFADTAEKCLSDSGIDRP----SMGDVLWN 755 (817)
Q Consensus 720 ~~~~~~~~~~~l~~li~~cl~~dP~~RP----t~~evl~~ 755 (817)
...+.-...+..+++.++|..+|++|. .+.+|-+|
T Consensus 243 -~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 243 -PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred -CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence 011112445678999999999999995 45555444
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=361.46 Aligned_cols=267 Identities=27% Similarity=0.453 Sum_probs=216.2
Q ss_pred HHHHHhhcCCCcceeEeeeCceEEEEEEEecccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecCCe
Q 039107 478 AEIKHATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNE 555 (817)
Q Consensus 478 ~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 555 (817)
++.....+++.....||+|.||+||+|.+-+. ||||.+... +.+..+.|++|+.++++-+|.||+-++|||.....
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd--VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD--VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccccc--eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 33344444556677999999999999998764 999987754 45567899999999999999999999999987666
Q ss_pred EEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccC
Q 039107 556 MCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTG 635 (817)
Q Consensus 556 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 635 (817)
.+|..+|++.+|+.+|+..+..+...+.+.|++||++|+.|||.+. |||||||..||+|.+++.+||+||||+...
T Consensus 463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeee
Confidence 9999999999999999988888999999999999999999999876 999999999999999999999999998753
Q ss_pred CCCCCCceeeeeecCcCCCChhhhcc---CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchh
Q 039107 636 PNMENGHVSTVVKGSFGYLDPEYFKR---QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILD 712 (817)
Q Consensus 636 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 712 (817)
.............|...|||||+++. .+|+..+||||||+|+|||+||..|+. ....+++- .....|.+.
T Consensus 539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIi------fmVGrG~l~ 611 (678)
T KOG0193|consen 539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQII------FMVGRGYLM 611 (678)
T ss_pred eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheE------EEecccccC
Confidence 33222233334467889999999975 478999999999999999999999998 33333321 112222111
Q ss_pred hccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 039107 713 DIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQL 762 (817)
Q Consensus 713 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 762 (817)
.|.. .....|..++.+|+..||..++++||...+|+..|+.++..
T Consensus 612 --pd~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 612 --PDLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred --ccch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 1111 12346778899999999999999999999999999998874
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=361.10 Aligned_cols=260 Identities=23% Similarity=0.387 Sum_probs=203.6
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe------cccEEEEEecCCCC-cccHHHHHHHHHHHhcc-CccceeeEEEEEecC-C
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE------DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEG-N 554 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~ 554 (817)
.++|...++||+|+||.||+|... .+..||+|++.... ....+.+.+|+.+++++ +||||++++++|... .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 356888899999999999999742 23579999987543 23346789999999999 899999999988754 4
Q ss_pred eEEEEEEeccCCchhhhhhccc----------------------------------------------------------
Q 039107 555 EMCLVYDYMALGTLREHIYNTK---------------------------------------------------------- 576 (817)
Q Consensus 555 ~~~lV~Ey~~~gsL~~~l~~~~---------------------------------------------------------- 576 (817)
..++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 5899999999999999886421
Q ss_pred ---cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceeeeeecCcCC
Q 039107 577 ---KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGY 653 (817)
Q Consensus 577 ---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y 653 (817)
..+++.+++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++...............++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 24778899999999999999999765 999999999999999999999999999864322211122233467889
Q ss_pred CChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCHHHHHHHH
Q 039107 654 LDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFA 732 (817)
Q Consensus 654 ~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 732 (817)
+|||++.+..++.++|||||||+||||++ |+.||......+. + .... ..+.. . ..+..++..+.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~---~~~~-~~~~~-----~----~~~~~~~~~l~ 307 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--F---CQRL-KDGTR-----M----RAPENATPEIY 307 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--H---HHHH-hcCCC-----C----CCCCCCCHHHH
Confidence 99999999999999999999999999997 9999875432211 1 1111 11100 0 11223455689
Q ss_pred HHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 039107 733 DTAEKCLSDSGIDRPSMGDVLWNLEFVLQ 761 (817)
Q Consensus 733 ~li~~cl~~dP~~RPt~~evl~~L~~~~~ 761 (817)
+++.+||+.||.+|||+.+|++.|+.+++
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=349.09 Aligned_cols=261 Identities=26% Similarity=0.374 Sum_probs=208.2
Q ss_pred CCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCC--eEEEEEEe
Q 039107 486 SFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGN--EMCLVYDY 562 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~Ey 562 (817)
++...+.||+|+||+||++...+ +...|||.+........+.+.+|+.+|++++|||||+.+|...... .+++.|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 45556789999999999999764 7889999987654333677899999999999999999999754444 68999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcC-CceeEEeeeccCccCCC-CCC
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDE-NWVAKVSDFGLSKTGPN-MEN 640 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DFGla~~~~~-~~~ 640 (817)
+++|+|.+++.+.+..|++..+.+..+||++||.|||+++ ||||||||+||||+. ++.+||+|||+++.... ...
T Consensus 98 ~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 98 APGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 9999999999876657999999999999999999999776 999999999999999 79999999999986542 111
Q ss_pred CceeeeeecCcCCCChhhhccC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQ-QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (817)
........||+.|||||++..+ ....++|||||||+++||+||++||.... + ..++........ .
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~--~---~~~~~~~ig~~~---------~ 240 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF--E---EAEALLLIGRED---------S 240 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc--c---hHHHHHHHhccC---------C
Confidence 2233457899999999999864 33459999999999999999999997641 1 111111111111 1
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 039107 720 KDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLV 763 (817)
Q Consensus 720 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 763 (817)
...++...+.+..+++.+|+..+|++|||+++++++..-.....
T Consensus 241 ~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 241 LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 11344556677899999999999999999999999877655443
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=323.26 Aligned_cols=266 Identities=25% Similarity=0.345 Sum_probs=213.8
Q ss_pred CCCcceeEeeeCceEEEEEEE-ecccEEEEEecCCCCcc-c-HHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 486 SFDESYVIGVGGFGKVYKGVI-EDKLKVAIKRSNPSSEQ-G-VNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
+|...++||+|.||.||+|+. +.++.||||+++..... + .....+|+..|+.++|+||+.|++++...+.+.||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 466677899999999999984 56789999998866432 2 34578999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
|+ .+|...+......++..++..++.++++||+|||++. |+||||||.|+|++++|.+||+||||++.........
T Consensus 83 m~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 83 MP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred cc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence 98 5999999888889999999999999999999999877 9999999999999999999999999999865433332
Q ss_pred eeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCc---hhhccC--
Q 039107 643 VSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGI---LDDIID-- 716 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~d-- 716 (817)
+...-|..|.|||.+.+ +.|+...|+||.||++.||+-|.+.|.+..+-+|...+--+........ +..+-|
T Consensus 159 --~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~ 236 (318)
T KOG0659|consen 159 --THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV 236 (318)
T ss_pred --ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence 22356899999999875 6899999999999999999999999998887777655432221111110 111111
Q ss_pred -------ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 717 -------PLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 717 -------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
+.+.. .-..+.....+++..++..||.+|+|+.|++++=-+
T Consensus 237 ~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf 284 (318)
T KOG0659|consen 237 KIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKHPYF 284 (318)
T ss_pred HHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcchhh
Confidence 11111 233455667999999999999999999999976544
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=351.04 Aligned_cols=262 Identities=27% Similarity=0.356 Sum_probs=209.3
Q ss_pred CCCcceeEeeeCceEEEEEE-EecccEEEEEecCCCC--cccHHHHHHHHHHHhccCccceeeEEEEEecC--CeEEEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGV-IEDKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEG--NEMCLVY 560 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 560 (817)
.|+..++||+|.||.||||+ ..++..||+|++.... +....-..+||.||++|+||||++|.+...+. ..+|||+
T Consensus 118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF 197 (560)
T KOG0600|consen 118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF 197 (560)
T ss_pred HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence 46666789999999999998 5677899999987664 33345567999999999999999999988765 7899999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
|||++ +|.-++....-.+++.++..+++|++.||+|+|+++ |+|||||.+|||||.+|.+||+|||||+++.....
T Consensus 198 eYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 198 EYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS 273 (560)
T ss_pred ecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence 99996 888888776668999999999999999999999776 99999999999999999999999999997654433
Q ss_pred CceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHH----------HHHHhhccC
Q 039107 641 GHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLAD----------WALHCKRKG 709 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~----------~~~~~~~~~ 709 (817)
. ..+..+-|+.|.|||++.+ ..|+.+.|+||.||||.||+.|++.+.+..+.+|+..+- |... +-
T Consensus 274 ~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~---kL 349 (560)
T KOG0600|consen 274 A-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS---KL 349 (560)
T ss_pred c-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc---cC
Confidence 2 2445567999999999876 589999999999999999999999999998877765532 2210 00
Q ss_pred chhhccCc------cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 710 ILDDIIDP------LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 710 ~~~~~~d~------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
.....+.+ .+.+. -...+...++|+..+|..||.+|.|+.++++.=
T Consensus 350 P~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~se 401 (560)
T KOG0600|consen 350 PHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQSE 401 (560)
T ss_pred CcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcCc
Confidence 00011111 11111 122345578999999999999999999998653
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=350.69 Aligned_cols=248 Identities=27% Similarity=0.422 Sum_probs=210.4
Q ss_pred cCCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
++|...+.||+|.||+||||+.+. .+.||+|.+.+. .++..+.+.+|++++++++|||||.++++|+...++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 457777789999999999999765 467999987764 34556779999999999999999999999999999999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
|+.+ +|..+|.... .|+++++..|+.+++.||.|||+.. |+|||+||.||||+..+.+|+||||+++... .+.
T Consensus 82 ~a~g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~--~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMS--TNT 154 (808)
T ss_pred hhhh-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcc--cCc
Confidence 9986 9999997554 5999999999999999999999765 9999999999999999999999999999753 345
Q ss_pred ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccC
Q 039107 642 HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKD 721 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (817)
...+.+.||+-|||||++.+++|+..+|+||+||+|||+..|++||....- .+.+.....+ +.
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si------~~Lv~~I~~d--------~v--- 217 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI------TQLVKSILKD--------PV--- 217 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH------HHHHHHHhcC--------CC---
Confidence 677788999999999999999999999999999999999999999975421 1122221111 11
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 722 KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 722 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
..+......+..+++..|.+||.+|.|..+++.|-
T Consensus 218 ~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp 252 (808)
T KOG0597|consen 218 KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHP 252 (808)
T ss_pred CCcccccHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence 12346677789999999999999999999999774
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=381.68 Aligned_cols=262 Identities=29% Similarity=0.471 Sum_probs=216.1
Q ss_pred CCCcceeEeeeCceEEEEEEEec--c----cEEEEEecCCC-CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIED--K----LKVAIKRSNPS-SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCL 558 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~~--~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 558 (817)
+....+.||+|.||.||.|.+.+ + ..||||.+... +.+...+|.+|..+|++++|||||+++|+|.+....++
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 34456689999999999999764 2 35999998875 55667899999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhcc------ccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccC
Q 039107 559 VYDYMALGTLREHIYNT------KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLS 632 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla 632 (817)
++|||++|+|..+|.+. ...|+....+.|+.|||+|+.||++++ +|||||.++|+||++...+||+|||||
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchh
Confidence 99999999999999876 457999999999999999999999776 999999999999999999999999999
Q ss_pred ccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCch
Q 039107 633 KTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGIL 711 (817)
Q Consensus 633 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 711 (817)
+.....+.........-...|||||.++.+.++.|+|||||||+||||++ |..|+......+-. ..| .+.+++
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~--~~~----~~ggRL 923 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVL--LDV----LEGGRL 923 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHH--HHH----HhCCcc
Confidence 95444333333322344679999999999999999999999999999999 66666544332211 111 222221
Q ss_pred hhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhccc
Q 039107 712 DDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVEST 766 (817)
Q Consensus 712 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 766 (817)
..+..|+..+.++|..||+.+|++||+...|++.++.+.......
T Consensus 924 ----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~ 968 (1025)
T KOG1095|consen 924 ----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGT 968 (1025)
T ss_pred ----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccC
Confidence 235678889999999999999999999999999998888765443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=357.24 Aligned_cols=252 Identities=27% Similarity=0.428 Sum_probs=211.5
Q ss_pred CCCcceeEeeeCceEEEEEEE-ecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEecc
Q 039107 486 SFDESYVIGVGGFGKVYKGVI-EDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMA 564 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 564 (817)
.|..-.+||+|..|.||.+.. ..+..||||++........+-+.+|+.+|+..+|+|||++++.+..++++|+|||||+
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 466667899999999999984 4567899999987766666778899999999999999999999988899999999999
Q ss_pred CCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCcee
Q 039107 565 LGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVS 644 (817)
Q Consensus 565 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 644 (817)
+|+|.+.+.. ..+++.++..||+++++||+|||.++ |+|||||.+|||++.++.+||+|||++....... ...
T Consensus 354 ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~--~KR 426 (550)
T KOG0578|consen 354 GGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ--SKR 426 (550)
T ss_pred CCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc--Ccc
Confidence 9999998854 35999999999999999999999776 9999999999999999999999999998754332 244
Q ss_pred eeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCC
Q 039107 645 TVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKIS 724 (817)
Q Consensus 645 ~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 724 (817)
..+.||+.|||||++....|..|.||||||++++||+-|.+||....+-..+.+ .. ..+ .|.++ .+
T Consensus 427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyL----Ia--~ng------~P~lk--~~ 492 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL----IA--TNG------TPKLK--NP 492 (550)
T ss_pred ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHH----Hh--hcC------CCCcC--Cc
Confidence 567899999999999999999999999999999999999999976443322111 11 111 12222 24
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 725 PECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 725 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
+..+..|.+++.+||..|+++||++.|+|+|-..
T Consensus 493 ~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl 526 (550)
T KOG0578|consen 493 EKLSPELKDFLDRCLVVDVEQRASAKELLEHPFL 526 (550)
T ss_pred cccCHHHHHHHHHHhhcchhcCCCHHHHhcChhh
Confidence 4567789999999999999999999999987443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=352.33 Aligned_cols=269 Identities=23% Similarity=0.332 Sum_probs=214.6
Q ss_pred cCCCcceeEeeeCceEEEEEEE-ecccEEEEEecCCCCcccHHHH--HHHHHHHhccC-ccceeeEEEEEecCC-eEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVI-EDKLKVAIKRSNPSSEQGVNEF--VTEIEMLSKLR-HKHLVSLIGFCEEGN-EMCLV 559 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~--~~E~~~l~~l~-H~niv~l~g~~~~~~-~~~lV 559 (817)
++|...++||.|.||.||+|+- ..+..||||+++..-.. +++. ++|+..|++|+ |||||+|..++.+.+ .+++|
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 4566777999999999999984 56778999998865322 4443 58999999998 999999999998887 99999
Q ss_pred EEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC
Q 039107 560 YDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 639 (817)
||||+ .+|++++..+++.+++..+..|+.||++||+|+|.+| +.||||||+|||+..+..+||+||||||....
T Consensus 89 fE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~S-- 162 (538)
T KOG0661|consen 89 FEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRS-- 162 (538)
T ss_pred HHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccccc--
Confidence 99997 5999999988889999999999999999999999665 99999999999999888999999999997533
Q ss_pred CCceeeeeecCcCCCChhhh-ccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCc------hh
Q 039107 640 NGHVSTVVKGSFGYLDPEYF-KRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGI------LD 712 (817)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~-~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------~~ 712 (817)
....+..+.|..|+|||++ +.+-|+.+.|+||+|||++||.+-++.|.+..+.+++..+--+.....+.. +.
T Consensus 163 -kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La 241 (538)
T KOG0661|consen 163 -KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA 241 (538)
T ss_pred -CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence 3345667889999999986 568899999999999999999999999998887776543322211111110 11
Q ss_pred hccC---cccc----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 039107 713 DIID---PLLK----DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQ 761 (817)
Q Consensus 713 ~~~d---~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 761 (817)
..+. |... ...-+.++.+..+++.+|+..||.+|||+.+++++--+...
T Consensus 242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 1111 1000 11122367788999999999999999999999988665443
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=360.95 Aligned_cols=256 Identities=29% Similarity=0.473 Sum_probs=211.2
Q ss_pred ceeEeeeCceEEEEEEEecc----cE-EEEEecCC---CCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 490 SYVIGVGGFGKVYKGVIEDK----LK-VAIKRSNP---SSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 490 ~~~lG~G~fg~Vy~~~~~~~----~~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
.++||+|+||.||+|+++.+ .. ||||..+. ......++|.+|+++|++++|||||+++|++....++++|||
T Consensus 162 ~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmE 241 (474)
T KOG0194|consen 162 GKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVME 241 (474)
T ss_pred cceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEE
Confidence 46999999999999997642 23 89999885 346678899999999999999999999999999999999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
+|.||+|.++|.+..+.++..++++++.+.|.||+|||++. +|||||.++|+|++.++.+||+||||++......
T Consensus 242 l~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~-- 316 (474)
T KOG0194|consen 242 LCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYV-- 316 (474)
T ss_pred ecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCCccee--
Confidence 99999999999887778999999999999999999999766 9999999999999999999999999998753111
Q ss_pred ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 642 HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
.......-+..|+|||.+..+.++.++|||||||++||+.+ |..|+.+....+ +..++ +....+
T Consensus 317 ~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~---v~~kI------------~~~~~r 381 (474)
T KOG0194|consen 317 MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE---VKAKI------------VKNGYR 381 (474)
T ss_pred eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH---HHHHH------------HhcCcc
Confidence 11112245789999999999999999999999999999998 777877654321 11111 011112
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhcc
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVES 765 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 765 (817)
...+...+..+..++.+|+..+|++||+|.++.+.|+.+......
T Consensus 382 ~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 382 MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 223335566788899999999999999999999999998877654
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=347.76 Aligned_cols=263 Identities=26% Similarity=0.440 Sum_probs=215.2
Q ss_pred cCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcc-cHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQ-GVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
......++||+|.||.|.++...++.+||||.++..... ..++|..|+++|.+|+||||++|+|+|..++.+|+|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 345567799999999999999999999999999987544 4589999999999999999999999999999999999999
Q ss_pred cCCchhhhhhccccc-cchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 564 ALGTLREHIYNTKKA-LSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 564 ~~gsL~~~l~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
++|+|.++|..+..+ +.-....+||.||+.||+||.+ .++|||||.++|+|+|.++++||+|||++|.+...+..+
T Consensus 618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 999999999876443 4666778899999999999995 459999999999999999999999999999766666656
Q ss_pred eeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHH--hCCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 643 VSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVL--CARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ell--tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
......-+.+|||+|.+..++++.++|||+||+.|||++ |...|+....+++. ++-.....+.+.. ...
T Consensus 695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ven~~~~~~~~~~------~~~ 765 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VENAGEFFRDQGR------QVV 765 (807)
T ss_pred eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HHhhhhhcCCCCc------cee
Confidence 655666789999999999999999999999999999974 56677754433221 1111111111111 111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
...+.-|+.++.+++.+||..+..+||+.+++...|++.
T Consensus 766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 123456788899999999999999999999999988764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=350.19 Aligned_cols=257 Identities=24% Similarity=0.329 Sum_probs=213.3
Q ss_pred HHhhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhcc-CccceeeEEEEEecCCe
Q 039107 481 KHATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNE 555 (817)
Q Consensus 481 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 555 (817)
+...++|..++.||+|+|++|++|+.+ .+..+|||++.+. .++..+-...|-++|.+| .||.|++|+-.|++...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 344567888999999999999999954 5688999987653 233345667899999999 89999999999999999
Q ss_pred EEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccC
Q 039107 556 MCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTG 635 (817)
Q Consensus 556 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 635 (817)
+|+|+||+++|+|.++|.+. +.+++......+.+|+.||+|||+.| ||||||||+|||||+++.+||.|||-|+.+
T Consensus 149 LYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred eEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence 99999999999999999765 46999999999999999999999766 999999999999999999999999999876
Q ss_pred CCCCCC---------cee--eeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHH
Q 039107 636 PNMENG---------HVS--TVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALH 704 (817)
Q Consensus 636 ~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 704 (817)
...... ... ...+||..|.+||++..+..+..+|+|+|||+||+||.|.+||.+.++.-..
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliF-------- 296 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIF-------- 296 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHH--------
Confidence 432211 122 4578999999999999999999999999999999999999999877653211
Q ss_pred hhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 705 CKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 705 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
..+++ +.-.+++..++...+|+.+.|..||.+|+|..+|-+|.-+
T Consensus 297 -------qkI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF 341 (604)
T KOG0592|consen 297 -------QKIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFF 341 (604)
T ss_pred -------HHHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCccc
Confidence 11111 1122344555678999999999999999999999988544
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=349.99 Aligned_cols=251 Identities=29% Similarity=0.512 Sum_probs=208.6
Q ss_pred cccCHHHHHHhhcCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEec
Q 039107 473 RRFSLAEIKHATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE 552 (817)
Q Consensus 473 ~~f~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 552 (817)
..+.+++|.. .+-||.|+.|.||+|++++. .||||+++...+ .+|+.|++|+|+||+.+.|+|..
T Consensus 119 WeiPFe~IsE-------LeWlGSGaQGAVF~Grl~ne-tVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtq 183 (904)
T KOG4721|consen 119 WEIPFEEISE-------LEWLGSGAQGAVFLGRLHNE-TVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQ 183 (904)
T ss_pred ccCCHHHhhh-------hhhhccCcccceeeeeccCc-eehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecC
Confidence 4455555543 34799999999999999764 799999874332 57888999999999999999999
Q ss_pred CCeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccC
Q 039107 553 GNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLS 632 (817)
Q Consensus 553 ~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla 632 (817)
...+|+|||||..|-|.+.|... +.+.......+..+||.|++|||.+. |||||||.-||||..+..+||+|||-+
T Consensus 184 sPcyCIiMEfCa~GqL~~VLka~-~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS 259 (904)
T KOG4721|consen 184 SPCYCIIMEFCAQGQLYEVLKAG-RPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTS 259 (904)
T ss_pred CceeEEeeeccccccHHHHHhcc-CccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccch
Confidence 99999999999999999999654 45778888899999999999999654 999999999999999999999999999
Q ss_pred ccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchh
Q 039107 633 KTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILD 712 (817)
Q Consensus 633 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 712 (817)
+..... .....++||..|||||+++..+.++|+|||||||||||||||..|+..-..... -|
T Consensus 260 ~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI----Iw----------- 321 (904)
T KOG4721|consen 260 KELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI----IW----------- 321 (904)
T ss_pred Hhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee----EE-----------
Confidence 864332 445667899999999999999999999999999999999999999864322211 11
Q ss_pred hccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 039107 713 DIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVL 760 (817)
Q Consensus 713 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 760 (817)
.+-...+.-..+..|++.|.-|++.||+..|.+||++++|+.||+-..
T Consensus 322 GVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 322 GVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred eccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 111122334456788888999999999999999999999999998654
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=340.75 Aligned_cols=260 Identities=24% Similarity=0.370 Sum_probs=206.0
Q ss_pred cccCHHHHHHhhcCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCccc---HHHHHHHHHHHhccCccceeeEEEE
Q 039107 473 RRFSLAEIKHATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQG---VNEFVTEIEMLSKLRHKHLVSLIGF 549 (817)
Q Consensus 473 ~~f~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~ 549 (817)
+.++.+++. ......||+|++|.||+|.+ ++..||||.+....... .+.|.+|+.+|++++||||++++|+
T Consensus 13 ~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~ 86 (283)
T PHA02988 13 KCIESDDID-----KYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGF 86 (283)
T ss_pred eecCHHHcC-----CCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeee
Confidence 344555552 23335899999999999998 46789999987653332 4678899999999999999999999
Q ss_pred Eec----CCeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeE
Q 039107 550 CEE----GNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAK 625 (817)
Q Consensus 550 ~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~k 625 (817)
+.+ ....++||||+++|+|.+++... +.+++...++++.|++.||.|||+. .+++||||||+|||+++++.+|
T Consensus 87 ~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~k 163 (283)
T PHA02988 87 IIDIVDDLPRLSLILEYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLK 163 (283)
T ss_pred EEecccCCCceEEEEEeCCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEE
Confidence 876 45689999999999999999754 4689999999999999999999973 2488999999999999999999
Q ss_pred EeeeccCccCCCCCCCceeeeeecCcCCCChhhhcc--CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHH
Q 039107 626 VSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKR--QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWAL 703 (817)
Q Consensus 626 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 703 (817)
|+|||+++...... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||......+ +...+
T Consensus 164 l~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~---~~~~i- 234 (283)
T PHA02988 164 IICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE---IYDLI- 234 (283)
T ss_pred EcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH---HHHHH-
Confidence 99999987543211 22357899999999976 689999999999999999999999997553221 11111
Q ss_pred HhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 039107 704 HCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQ 761 (817)
Q Consensus 704 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 761 (817)
...+ .....+..++..+.+++.+||+.||++|||+.++++.|+....
T Consensus 235 --~~~~---------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 235 --INKN---------NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred --HhcC---------CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 0010 0111223456678999999999999999999999999987654
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=347.95 Aligned_cols=254 Identities=29% Similarity=0.391 Sum_probs=207.5
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC----Cc-ccHHHHHHHHHHHhccC-ccceeeEEEEEecCCeE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS----SE-QGVNEFVTEIEMLSKLR-HKHLVSLIGFCEEGNEM 556 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~ 556 (817)
...|...+.||+|.||+|+.|... .+..||+|.+... .. ...+.+.+|+.++++++ ||||++++.++......
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 456888899999999999999854 5689999976653 11 23456678999999998 99999999999999999
Q ss_pred EEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCC-ceeEEeeeccCccC
Q 039107 557 CLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDEN-WVAKVSDFGLSKTG 635 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DFGla~~~ 635 (817)
++||||+.+|+|.+++.+ .+++.+....++++|++.|++|||+.+ |+||||||+|||++.+ +++||+|||++...
T Consensus 96 ~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred EEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 999999999999999987 667999999999999999999999776 9999999999999999 99999999999875
Q ss_pred CCCCCCceeeeeecCcCCCChhhhccCC-CC-chHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhh
Q 039107 636 PNMENGHVSTVVKGSFGYLDPEYFKRQQ-LT-EKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDD 713 (817)
Q Consensus 636 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 713 (817)
. .........+||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||....... + ... ..++
T Consensus 172 ~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~---l---~~k-i~~~---- 238 (370)
T KOG0583|consen 172 P--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN---L---YRK-IRKG---- 238 (370)
T ss_pred C--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH---H---HHH-HhcC----
Confidence 3 2334556678999999999999877 76 78999999999999999999998633211 1 000 0111
Q ss_pred ccCccccCCCCHHH-HHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 039107 714 IIDPLLKDKISPEC-LKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVL 760 (817)
Q Consensus 714 ~~d~~l~~~~~~~~-~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 760 (817)
.. .++... ..++..++.+||..+|.+|+++.+|+++-....
T Consensus 239 ----~~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 239 ----EF--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred ----Cc--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 00 112222 567799999999999999999999995544443
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=355.59 Aligned_cols=257 Identities=24% Similarity=0.408 Sum_probs=201.4
Q ss_pred cCCCcceeEeeeCceEEEEEEE------ecccEEEEEecCCCC-cccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVI------EDKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEM 556 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 556 (817)
++|...++||+|+||.||+|+. ..+..||||+++... ....+.+.+|+.+|..+ +||||++++++|......
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 3577788999999999999974 234579999987543 33456788999999999 899999999999999999
Q ss_pred EEEEEeccCCchhhhhhccc------------------------------------------------------------
Q 039107 557 CLVYDYMALGTLREHIYNTK------------------------------------------------------------ 576 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~~------------------------------------------------------------ 576 (817)
++||||+++|+|.+++....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 99999999999999885421
Q ss_pred --------------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 577 --------------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 577 --------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
..++|..+++++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 14788899999999999999999765 9999999999999999999999999997643322211
Q ss_pred eeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccC
Q 039107 643 VSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKD 721 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (817)
......++..|+|||.+.+..++.++|||||||++|||++ |..||....... .+..+.. .+. ..
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~~----~~~---------~~ 336 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMIK----EGY---------RM 336 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHHH----hCc---------cC
Confidence 1222335678999999999999999999999999999998 788876532211 1111111 110 00
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 722 KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 722 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
..+...+.++.+|+.+||+.||++||++.+|+++|+..
T Consensus 337 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 337 LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 11112345689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=340.34 Aligned_cols=261 Identities=25% Similarity=0.417 Sum_probs=201.0
Q ss_pred cCCCcceeEeeeCceEEEEEEEec-----------------ccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIED-----------------KLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSL 546 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l 546 (817)
.+|...++||+|+||.||++..++ +..||+|.+.... .....+|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 467778899999999999997542 2369999987643 3345679999999999999999999
Q ss_pred EEEEecCCeEEEEEEeccCCchhhhhhccc------------------cccchHhHHHHHHHHHHHHHHHHhCCCCceEe
Q 039107 547 IGFCEEGNEMCLVYDYMALGTLREHIYNTK------------------KALSWKQRLEICIGAARGLHYLHTGAKYTIIH 608 (817)
Q Consensus 547 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH 608 (817)
++++...+..++||||+++|+|.+++.... ..++|.++++++.|++.||+|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999885421 24788899999999999999999765 999
Q ss_pred cCCccCcEEEcCCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh--CCCC
Q 039107 609 RDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC--ARPA 686 (817)
Q Consensus 609 ~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt--G~~p 686 (817)
|||||+|||+++++.+||+|||+++...............++..|+|||++..+.++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999976433222122223345788999999998999999999999999999987 4456
Q ss_pred CCCCCccccchHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 687 LNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 687 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
+...... ....++......... ......++.++..+.+++.+||+.+|.+|||+.+|.+.|+
T Consensus 242 ~~~~~~~---~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDE---QVIENAGEFFRDQGR------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHH---HHHHHHHHHhhhccc------cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 6543221 112222111111100 0001112344567899999999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=390.50 Aligned_cols=269 Identities=28% Similarity=0.461 Sum_probs=219.9
Q ss_pred cCHHHHHHhhcCCCcceeEeeeCceEEEEEEE-ecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecC
Q 039107 475 FSLAEIKHATKSFDESYVIGVGGFGKVYKGVI-EDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEG 553 (817)
Q Consensus 475 f~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 553 (817)
++++++. ..|...++||+|+||.||+|+. .++..||||++...... ...|++++++++|||||+++|+|.+.
T Consensus 683 ~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~ 755 (968)
T PLN00113 683 ITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSE 755 (968)
T ss_pred hhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcC
Confidence 4444443 3567788999999999999997 46789999998754322 23568899999999999999999999
Q ss_pred CeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCc
Q 039107 554 NEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSK 633 (817)
Q Consensus 554 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 633 (817)
+..++||||+++|+|.++++ .++|.++.+|+.|+++||+|||+.++++|+||||||+||+++.++..++. ||...
T Consensus 756 ~~~~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~ 830 (968)
T PLN00113 756 KGAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG 830 (968)
T ss_pred CCCEEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccc
Confidence 99999999999999999984 38999999999999999999997766789999999999999999888875 66654
Q ss_pred cCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhh
Q 039107 634 TGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDD 713 (817)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 713 (817)
.... .....+|..|+|||++.+..++.++|||||||++|||++|+.|+..... ....+.+|.+..........
T Consensus 831 ~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~ 903 (968)
T PLN00113 831 LLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDM 903 (968)
T ss_pred cccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhh
Confidence 3211 1123578999999999999999999999999999999999999854332 23456778776665555666
Q ss_pred ccCccccCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 039107 714 IIDPLLKDK--ISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQL 762 (817)
Q Consensus 714 ~~d~~l~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 762 (817)
.+|+.+... ...++..++.+++.+|++.+|++||+|+||+++|+.+.+.
T Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 904 WIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred eeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 677766442 3456677889999999999999999999999999987653
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=329.65 Aligned_cols=264 Identities=25% Similarity=0.321 Sum_probs=208.1
Q ss_pred hcCCCcceeEeeeCceEEEEEEE-ecccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVI-EDKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
.+.|+....||.|..++||+|+. ..+..||||++.... ....+.+.+|+..|+.++||||++.+..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 35678888999999999999984 456899999987543 3346889999999999999999999999999999999999
Q ss_pred eccCCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 562 YMALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 562 y~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
||.+|++.+.+...- ..+++..+..|++++++||.|||++| .||||||+.||||+.+|.+||+|||.+..+.....
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 999999999987543 36999999999999999999999776 99999999999999999999999998865433221
Q ss_pred -Ccee-eeeecCcCCCChhhhcc--CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccC
Q 039107 641 -GHVS-TVVKGSFGYLDPEYFKR--QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIID 716 (817)
Q Consensus 641 -~~~~-~~~~gt~~y~aPE~~~~--~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (817)
.... ....||+.|||||+++. ..|+.|+||||||+..+||.+|..||....+.... .+.......... -
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL-----l~tLqn~pp~~~--t 254 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL-----LLTLQNDPPTLL--T 254 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH-----HHHhcCCCCCcc--c
Confidence 1111 45689999999999643 47999999999999999999999999765432211 111111111000 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 717 PLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 717 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
..+..+........+.+++..||..||.+|||+++++++-.
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~F 295 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAF 295 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHH
Confidence 01111112334557899999999999999999999997633
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=334.34 Aligned_cols=249 Identities=37% Similarity=0.578 Sum_probs=195.0
Q ss_pred cceeEeeeCceEEEEEEEe-----cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 489 ESYVIGVGGFGKVYKGVIE-----DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 489 ~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
..+.||.|.||.||+|.+. .+..|+||.++... ....++|.+|++.+++++||||++++|+|...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3568999999999999987 24689999997543 33478899999999999999999999999988889999999
Q ss_pred ccCCchhhhhhcc-ccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 563 MALGTLREHIYNT-KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 563 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
+++|+|.++|... ...+++.++..|+.|+++||+|||+.+ ++|+||+++|||+++++.+||+|||+++........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred ccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 9999999999876 457999999999999999999999865 999999999999999999999999999875222222
Q ss_pred ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 642 HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
...........|+|||.+....++.++||||||+++|||++ |+.|+......+ +.... .++. .
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~------~~~~~-~~~~---------~ 223 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE------IIEKL-KQGQ---------R 223 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH------HHHHH-HTTE---------E
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccc-cccc---------c
Confidence 22233456789999999999999999999999999999999 677775442211 11111 1111 1
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
...+..++..+.+++.+||+.+|++||++.++++.|
T Consensus 224 ~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 112233556789999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=353.02 Aligned_cols=258 Identities=24% Similarity=0.420 Sum_probs=202.1
Q ss_pred cCCCcceeEeeeCceEEEEEEEe------cccEEEEEecCCCC-cccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE------DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEM 556 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 556 (817)
++|...+.||+|+||.||+|+.. ++..||+|++.... ....+.+.+|+++++.+ +|+||++++++|......
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 46778889999999999998742 23579999987543 33346788999999999 899999999999999999
Q ss_pred EEEEEeccCCchhhhhhccc------------------------------------------------------------
Q 039107 557 CLVYDYMALGTLREHIYNTK------------------------------------------------------------ 576 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~~------------------------------------------------------------ 576 (817)
++||||+++|+|.+++....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 99999999999999885321
Q ss_pred ---------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceeeee
Q 039107 577 ---------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVV 647 (817)
Q Consensus 577 ---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 647 (817)
..+++.++++++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..............
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 24788899999999999999999765 999999999999999999999999999764332211112223
Q ss_pred ecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCHH
Q 039107 648 KGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPE 726 (817)
Q Consensus 648 ~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 726 (817)
.++..|+|||++.+..++.++|||||||++|||++ |+.||........ + ... ...+ .....+..
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~---~~~-~~~~---------~~~~~~~~ 339 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--F---YKM-VKRG---------YQMSRPDF 339 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--H---HHH-HHcc---------cCccCCCC
Confidence 35678999999998999999999999999999997 9999865432211 0 000 0000 00111112
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 039107 727 CLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVL 760 (817)
Q Consensus 727 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 760 (817)
.+..+.+++.+||+.+|.+||++.+|++.|+.+.
T Consensus 340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 340 APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 2456899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=333.03 Aligned_cols=255 Identities=22% Similarity=0.391 Sum_probs=205.0
Q ss_pred cCCCcceeEeeeCceEEEEEEEe----cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE----DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 559 (817)
++|+..++||+|+||.||+|.++ .+..||+|.++... ......|.+|+.++++++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 45778889999999999999864 34689999987653 23346789999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC
Q 039107 560 YDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 639 (817)
|||+++|+|.+++......+++.+++.++.|++.||+|||+++ ++||||||+|||++.++.+|++|||++.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 9999999999999766567999999999999999999999765 9999999999999999999999999876532111
Q ss_pred CCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCcc
Q 039107 640 NGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPL 718 (817)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (817)
........++..|+|||.+.+..++.++|||||||++|||++ |+.||......+ +.... ..+
T Consensus 162 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~~~----~~~--------- 224 (266)
T cd05064 162 -IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIKAV----EDG--------- 224 (266)
T ss_pred -hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHH----HCC---------
Confidence 111112335678999999999999999999999999999875 999987553321 11111 111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 719 LKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 719 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
.....+..++..+.+++.+||+.+|.+||++++|++.|+.+
T Consensus 225 ~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 225 FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 01112334566789999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=324.22 Aligned_cols=467 Identities=18% Similarity=0.245 Sum_probs=297.8
Q ss_pred ccceeEEEEecCCCceEEEEEeeeccCCcccccceEEEEEEcCccccc-ccchhhhccCCCccE-EEEEEEEEecC-CCC
Q 039107 256 EFNLTWIFRVDANFTYYVRLHFCEFKPDINKINQRVFNIYINNQTAQA-DADVIAWTHGQGVPI-YKDYAVYVEDL-PGD 332 (817)
Q Consensus 256 ~~~~~~~~p~~~~~~y~v~lhF~e~~~~~~~~~~R~F~i~i~~~~~~~-~~~~~~~~~~~~~p~-~~~~~v~v~~~-~~~ 332 (817)
+|.+.+..||+++..| |||++ ++.+.-.+.|++....... +..+.+.+....+|. .++|.|...|. ..+
T Consensus 51 ~Yal~F~~~Vpani~~---lsFTW-----~a~~~v~Y~i~v~sdd~~vl~~P~vnIs~~GeVP~tlq~f~velkCsG~r~ 122 (563)
T KOG1024|consen 51 DYALNFAVPVPANISD---LSFTW-----QADHPVPYSINVASDDTEVLPRPIVNISRIGEVPVTLQTFGVELKCSGTRN 122 (563)
T ss_pred hhhheeceeccccccc---eEEEE-----ecCCcceeEEEEEeCcceecccceeeccccCcCCcchheeEEEEEeccccc
Confidence 5677778899999988 99998 5677788888877544433 246677888888999 59999999994 444
Q ss_pred cceEEEeCCCCCCc--chhhHhhccCceeeeec---cccCCCCCCC-CCCCCCCCCCCCCCCCcccCCCCceEEEEeech
Q 039107 333 DQIFVAMSPSLKYQ--PEYLDALLNGLEIFKIE---TAKNLAGPNP-EPSALPAKSEGNSTKGFTNKSKSNIHVIGGAAG 406 (817)
Q Consensus 333 ~~l~v~l~p~~~~~--~~~~~~~lnglei~~~~---s~~nl~gp~~-~p~~~~~~~~~~~~~~~~~~s~~~~~ii~~vv~ 406 (817)
.++.|.+....... ...+.-.+..-+|+--. +.-+.....- .|.-.+.-.. ..+.....+++ ++.
T Consensus 123 ~ev~Vt~~l~~~~ns~kn~t~l~fkrkKiC~~~~~~~~~~~~d~~~~~~~~~~~v~~--------p~s~~~~f~V~-v~v 193 (563)
T KOG1024|consen 123 AEVTVTINLEVILNSTKNNTNLIFKRKKICLREEQDSAHEEYDDDDFDPMLRENVVP--------PASGLVTFIVG-VIV 193 (563)
T ss_pred ceEEEEEEEEEEEcCCCCceeEEeehhhhhhcchhhhcccccccccccccccccccC--------CCcccEEEeee-HHH
Confidence 45444443332111 11111122222222211 0000000000 0000000000 01111222333 222
Q ss_pred hhhHHhHhheeeeEEeeec-ccCCCCC-CCCCCCccc------cCCCcc-cccc-cccCCCCCCCC-c---hhhhhhccc
Q 039107 407 GAAAFGLVAALCFVVYQRK-QRIPGTE-SHTSSWLPI------YGHSQT-TQSK-STISGKSNASS-H---LSAIAQGLC 472 (817)
Q Consensus 407 ~~~~~~~v~~~~~~~~~r~-~~~~~~~-~~~~~~~~~------~~~~~~-~~~~-~~~s~~~~~~s-~---~~~~~~~~~ 472 (817)
+.+++++++++++|.+.+. ||..... -.++++... ....+. .++. ..+.+.+...+ . .+.-+....
T Consensus 194 a~a~v~lva~il~c~~~~s~Kr~~~~~~i~tSs~~~l~~~qps~~st~y~~P~t~tpi~sap~~r~~~ns~~~~~p~e~~ 273 (563)
T KOG1024|consen 194 ALALVSLVALILYCAKGPSKKRSNGVHLIKTSSFQRLPTIQPSAHSTIYVTPSTITPIYSAPLTRSSPNSEYEHEPEEFN 273 (563)
T ss_pred HHHHHHHHHHHHHHHhcccchhhccCcccchhhhhcCCcCCccccCCcccCCCccccccCCCcccCCCCccccCChHHHh
Confidence 3333444444444443332 2221111 111111111 000000 0000 00111111110 0 000111111
Q ss_pred cccCHHHHHHhhcCCCcceeEeeeCceEEEEEEEe------cccEEEEEecCCC-CcccHHHHHHHHHHHhccCccceee
Q 039107 473 RRFSLAEIKHATKSFDESYVIGVGGFGKVYKGVIE------DKLKVAIKRSNPS-SEQGVNEFVTEIEMLSKLRHKHLVS 545 (817)
Q Consensus 473 ~~f~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~ 545 (817)
-.+.||..-..++....++.+|.||.||.|.+. +.+.|.+|.++.. ++-+...|+.|..++..+.|||+..
T Consensus 274 --~r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~ 351 (563)
T KOG1024|consen 274 --RRLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLS 351 (563)
T ss_pred --hhHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccc
Confidence 224555556667888889999999999999653 3466888887654 5556778999999999999999999
Q ss_pred EEEEEec-CCeEEEEEEeccCCchhhhhhcc-------ccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEE
Q 039107 546 LIGFCEE-GNEMCLVYDYMALGTLREHIYNT-------KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNIL 617 (817)
Q Consensus 546 l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIl 617 (817)
+.+++.+ .+..+++|.++.-|+|..+|... .+.++..+...++.|++.|++|||..+ |||.||..+|++
T Consensus 352 V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCv 428 (563)
T KOG1024|consen 352 VLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCV 428 (563)
T ss_pred eeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcce
Confidence 9999854 56679999999999999999732 236888899999999999999999665 999999999999
Q ss_pred EcCCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccc
Q 039107 618 LDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQV 696 (817)
Q Consensus 618 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~ 696 (817)
||+..++||+|-.|+|.....+..........+..||+||.+....|+.++|||||||+||||+| |+.|+..-++.+..
T Consensus 429 Idd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~ 508 (563)
T KOG1024|consen 429 IDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME 508 (563)
T ss_pred ehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH
Confidence 99999999999999998777776666666667889999999999999999999999999999988 77777655443321
Q ss_pred hHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 039107 697 SLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVL 760 (817)
Q Consensus 697 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 760 (817)
...++..++ ..+-+|++++..++.-||...|++||+.++++.-|.+--
T Consensus 509 ------~ylkdGyRl----------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 509 ------HYLKDGYRL----------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred ------HHHhcccee----------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 111111122 124578899999999999999999999999998887653
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=341.24 Aligned_cols=259 Identities=24% Similarity=0.411 Sum_probs=205.6
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cc----cEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DK----LKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCL 558 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 558 (817)
.+|+..+.||+|+||.||+|++. ++ ..||+|.++... ....++|.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 45888899999999999999864 23 248999987543 34457899999999999999999999999764 5789
Q ss_pred EEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCC
Q 039107 559 VYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNM 638 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 638 (817)
|+||+++|+|.+++......+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccCC
Confidence 99999999999999876667899999999999999999999765 999999999999999999999999999865432
Q ss_pred CCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCc
Q 039107 639 ENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717 (817)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (817)
..........++..|+|||.+.+..++.++|||||||++|||++ |+.||......+ +..+. ..+
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---~~~~~----~~~-------- 227 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSIL----EKG-------- 227 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH----hCC--------
Confidence 22212222334678999999999999999999999999999997 999986542211 11111 111
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 039107 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLV 763 (817)
Q Consensus 718 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 763 (817)
.....+..+...+.+++.+||..+|.+||++.+++..|..+....
T Consensus 228 -~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 228 -ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred -CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 001112234456789999999999999999999999998876544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=335.72 Aligned_cols=251 Identities=23% Similarity=0.340 Sum_probs=201.5
Q ss_pred CCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC---cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 487 FDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS---EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 487 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
|+..++||+|+||.||++... ++..||+|.+.... ......+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 667789999999999999864 67899999876432 23345678999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 563 MALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 563 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
+++|+|.+++.... ..+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~--- 155 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG--- 155 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC---
Confidence 99999998876443 36899999999999999999999765 999999999999999999999999999764321
Q ss_pred ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccC
Q 039107 642 HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKD 721 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (817)
.......||..|+|||++.+..++.++|||||||++|||++|+.||........... .... ... ...
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~--~~~~-~~~----------~~~ 222 (285)
T cd05631 156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE--VDRR-VKE----------DQE 222 (285)
T ss_pred CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH--HHHH-hhc----------ccc
Confidence 122344689999999999999999999999999999999999999976543221110 0000 000 011
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHH
Q 039107 722 KISPECLKKFADTAEKCLSDSGIDRPS-----MGDVLWNL 756 (817)
Q Consensus 722 ~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~L 756 (817)
.++......+.+|+.+||+.||.+||+ +++++++-
T Consensus 223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~ 262 (285)
T cd05631 223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHP 262 (285)
T ss_pred cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCH
Confidence 122334556889999999999999997 88888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=314.25 Aligned_cols=236 Identities=25% Similarity=0.354 Sum_probs=200.4
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC---cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS---EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
.+|+..+.||.|+||+|.+++.+ ++..+|+|.+.... .++.+...+|..+|+.+.||.++++.+.|.+...++|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 35777889999999999999976 46789999988653 234566789999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
||+++|.|..+|++.+ ++++..++-++.||+.||+|||+.+ |++|||||+|||||.+|.+||.|||.|+...
T Consensus 124 eyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~---- 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS---- 195 (355)
T ss_pred eccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec----
Confidence 9999999999997654 5999999999999999999999766 9999999999999999999999999998742
Q ss_pred CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
......+||+.|+|||.++...+..++|.|||||++|||++|.+||....+.... ..++...+
T Consensus 196 -~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY---------------~KI~~~~v- 258 (355)
T KOG0616|consen 196 -GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIY---------------EKILEGKV- 258 (355)
T ss_pred -CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHH---------------HHHHhCcc-
Confidence 2366789999999999999999999999999999999999999999877652211 11121111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCC
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDR 746 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~R 746 (817)
.++.-....+.+|+...|+.|-.+|
T Consensus 259 -~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 -KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 2344556678899999999999988
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=334.21 Aligned_cols=254 Identities=28% Similarity=0.464 Sum_probs=205.4
Q ss_pred CCCcceeEeeeCceEEEEEEEecc------cEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIEDK------LKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCL 558 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~~~------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 558 (817)
+|+..+.||+|+||.||+|..... ..|++|.+.... .....+|.+|+.++++++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 567778999999999999986532 479999887543 2335678999999999999999999999999899999
Q ss_pred EEEeccCCchhhhhhccc---------------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCce
Q 039107 559 VYDYMALGTLREHIYNTK---------------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWV 623 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~ 623 (817)
+|||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCc
Confidence 999999999999986431 35888999999999999999999765 999999999999999999
Q ss_pred eEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHH
Q 039107 624 AKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWA 702 (817)
Q Consensus 624 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~ 702 (817)
+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||......+ +..++
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---~~~~i 239 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---VIEMI 239 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH
Confidence 99999999976433222222333456788999999998899999999999999999998 999987644321 11111
Q ss_pred HHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 703 LHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 703 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
. ++ .....+..++.++.+|+.+||+.+|.+||++++|+++|+.
T Consensus 240 ~----~~---------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 240 R----SR---------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred H----cC---------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1 11 1112234566788999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=328.69 Aligned_cols=267 Identities=25% Similarity=0.418 Sum_probs=202.4
Q ss_pred ceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhc--cCccceeeEEEEEecCC----eEEEEEEec
Q 039107 490 SYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSK--LRHKHLVSLIGFCEEGN----EMCLVYDYM 563 (817)
Q Consensus 490 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~----~~~lV~Ey~ 563 (817)
.++||+|.||.||||.+.+ +.||||++... ..+.|.+|-+|.+. |+|+||++++++-+.+. +++||+||.
T Consensus 215 ~eli~~Grfg~V~KaqL~~-~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh 290 (534)
T KOG3653|consen 215 LELIGRGRFGCVWKAQLDN-RLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH 290 (534)
T ss_pred HHHhhcCccceeehhhccC-ceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence 4479999999999999977 58999999854 45678888887765 58999999999877666 899999999
Q ss_pred cCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhC------CCCceEecCCccCcEEEcCCceeEEeeeccCccCCC
Q 039107 564 ALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTG------AKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPN 637 (817)
Q Consensus 564 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 637 (817)
++|+|.++|.. ..++|....+|+..+++||+|||+. .+++|+|||||++||||..|+++.|+|||||..+..
T Consensus 291 ~kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p 368 (534)
T KOG3653|consen 291 PKGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEP 368 (534)
T ss_pred cCCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecC
Confidence 99999999954 5799999999999999999999974 467899999999999999999999999999987654
Q ss_pred CCCCceeeeeecCcCCCChhhhccC-CCC-----chHHHHHHHHHHHHHHhCCCCCCC-CCccccchHHHHHHHhhccCc
Q 039107 638 MENGHVSTVVKGSFGYLDPEYFKRQ-QLT-----EKSDIYSFGVVLFEVLCARPALNP-SLPKEQVSLADWALHCKRKGI 710 (817)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s-----~~sDV~S~Gvvl~elltG~~p~~~-~~~~~~~~l~~~~~~~~~~~~ 710 (817)
..........+||.+|||||++.+. .+. .+.||||+|.|||||++....+.. ..+.-+..+..-+.. ...
T Consensus 369 ~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~---hPt 445 (534)
T KOG3653|consen 369 GKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN---HPT 445 (534)
T ss_pred CCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC---CCC
Confidence 4444444447899999999999753 222 468999999999999997765542 222212211110000 000
Q ss_pred hhhc----cCccccCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhcc
Q 039107 711 LDDI----IDPLLKDKIS-----PECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVES 765 (817)
Q Consensus 711 ~~~~----~d~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 765 (817)
+.++ +..+.+..++ ...+..+++.+..||+.|++.|.|+.=|-+++.++....+.
T Consensus 446 ~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 446 LEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred HHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 1110 1111111111 13456789999999999999999999999888887766543
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=328.94 Aligned_cols=256 Identities=25% Similarity=0.426 Sum_probs=207.0
Q ss_pred cCCCcceeEeeeCceEEEEEEEec----ccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIED----KLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 559 (817)
++|...+.||+|+||.||+|..+. ...||+|.+.... .....+|.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 468888999999999999998742 3579999987543 33456789999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC
Q 039107 560 YDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 639 (817)
|||+++++|.+++......+++.++++++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999999999776667999999999999999999999765 9999999999999999999999999998754222
Q ss_pred CCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCcc
Q 039107 640 NGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPL 718 (817)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (817)
.........++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .+.+... .+.
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~~----~~~-------- 225 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DVIKAVE----DGY-------- 225 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HHHHHHH----cCC--------
Confidence 2222222345678999999998999999999999999999998 98888543221 1111111 110
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 719 LKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 719 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
....+..++..+.+++.+|++.+|++||++.+|+++|+.+
T Consensus 226 -~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 -RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011223456689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=347.47 Aligned_cols=260 Identities=22% Similarity=0.395 Sum_probs=204.7
Q ss_pred hcCCCcceeEeeeCceEEEEEEEec------ccEEEEEecCCCCc-ccHHHHHHHHHHHhccC-ccceeeEEEEEecCCe
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIED------KLKVAIKRSNPSSE-QGVNEFVTEIEMLSKLR-HKHLVSLIGFCEEGNE 555 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~ 555 (817)
..+|.+.++||+|+||.||+|+... +..||||++..... ...+.|.+|+++|+++. ||||++++++|.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 4567788899999999999998532 24699999875433 33467999999999996 9999999999999999
Q ss_pred EEEEEEeccCCchhhhhhccc-----------------------------------------------------------
Q 039107 556 MCLVYDYMALGTLREHIYNTK----------------------------------------------------------- 576 (817)
Q Consensus 556 ~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------- 576 (817)
.+||||||++|+|.++|....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999999886421
Q ss_pred ------------------------------------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcC
Q 039107 577 ------------------------------------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDE 620 (817)
Q Consensus 577 ------------------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~ 620 (817)
..+++.+++.++.|++.||+|||+.+ |+||||||+|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 13778889999999999999999765 999999999999999
Q ss_pred CceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHH
Q 039107 621 NWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLA 699 (817)
Q Consensus 621 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~ 699 (817)
++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||........ +.
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~--~~ 350 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--FY 350 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH--HH
Confidence 99999999999986433222122223346788999999998999999999999999999997 8888865422111 10
Q ss_pred HHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 039107 700 DWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQ 761 (817)
Q Consensus 700 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 761 (817)
.. ...+ .....+..++..+.+++.+||+.+|++||++.+|.++|+.+.+
T Consensus 351 ~~----~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 351 NK----IKSG---------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HH----HhcC---------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 00 0011 0111123455678999999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=333.28 Aligned_cols=265 Identities=22% Similarity=0.328 Sum_probs=200.6
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
.+|...++||+|+||.||+|..+ ++..||+|.+.... ......+.+|++++++++||||+++++++......++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 35788889999999999999865 56789999886543 22345678999999999999999999999998999999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
+++ +|.+++......+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...... .
T Consensus 85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--~ 158 (288)
T cd07871 85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--K 158 (288)
T ss_pred CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC--c
Confidence 984 899888766567899999999999999999999765 9999999999999999999999999987533211 1
Q ss_pred eeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHH---------hhccCchh
Q 039107 643 VSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALH---------CKRKGILD 712 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~---------~~~~~~~~ 712 (817)
......++..|+|||.+.+ ..++.++|||||||++|||++|++||......+.......... ........
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 1223457899999999865 5689999999999999999999999976544332211100000 00000000
Q ss_pred hccCccccCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 713 DIIDPLLKDK----ISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 713 ~~~d~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
....+..... ..+....++.+++.+||+.||.+|||++|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0011110000 011223467899999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=338.39 Aligned_cols=266 Identities=23% Similarity=0.306 Sum_probs=206.0
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
.++|+..+.||+|+||.||+++.. ++..+|+|.+.... ....+.+.+|+++|++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 357888899999999999999976 46789999887542 2345679999999999999999999999999999999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 157 (331)
T cd06649 84 HMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (331)
T ss_pred cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc---
Confidence 99999999998654 35889999999999999999999742 5999999999999999999999999998754321
Q ss_pred ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhcc---C---------
Q 039107 642 HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRK---G--------- 709 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~--------- 709 (817)
......|+..|+|||++.+..++.++|||||||++|||++|+.||......+.. ......... +
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 233 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE---AIFGRPVVDGEEGEPHSISPRP 233 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHhcccccccccCCccccCccc
Confidence 123346899999999999999999999999999999999999999654322110 000000000 0
Q ss_pred ------------------chhhccC----ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 710 ------------------ILDDIID----PLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 710 ------------------~~~~~~d----~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
...+..+ .............++.+|+.+||+.||++|||+++++++....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~ 305 (331)
T cd06649 234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIK 305 (331)
T ss_pred ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHh
Confidence 0000000 0000000112456789999999999999999999999886543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=325.17 Aligned_cols=251 Identities=26% Similarity=0.423 Sum_probs=202.6
Q ss_pred cCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEecc
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMA 564 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 564 (817)
.+|...+.||+|+||.||++..+++..+|+|.+... ....++|.+|++++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 346777899999999999999888888999987643 3335688999999999999999999999999999999999999
Q ss_pred CCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCcee
Q 039107 565 LGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVS 644 (817)
Q Consensus 565 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 644 (817)
+|+|.+++......+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++....... ...
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~~ 158 (256)
T cd05114 83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSS 158 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce-ecc
Confidence 99999998765557899999999999999999999765 99999999999999999999999999876432211 111
Q ss_pred eeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCC
Q 039107 645 TVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKI 723 (817)
Q Consensus 645 ~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 723 (817)
....++..|+|||.+....++.++||||||+++|||++ |+.||......+ ....... ... .. .
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~---~~~~i~~---~~~---~~-------~ 222 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE---VVEMISR---GFR---LY-------R 222 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHC---CCC---CC-------C
Confidence 22235668999999998899999999999999999999 888886543221 1111111 100 00 0
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 724 SPECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 724 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
+......+.+++.+||+.+|++||++.++++.|
T Consensus 223 ~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 223 PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 112235689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=343.61 Aligned_cols=248 Identities=23% Similarity=0.318 Sum_probs=206.4
Q ss_pred CCCcceeEeeeCceEEEEEEE-ecccEEEEEecCCCC---cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVI-EDKLKVAIKRSNPSS---EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
-|+.++.||+|+-|.|-.|++ ..|+.+|||++.... ......+.+|+-+|+.+.|||+++++++++...++|||.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 366778999999999999996 478999999987652 2234567799999999999999999999999999999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
|+++|-|.+++-.. ++|++.+..++++||+.|+.|+|..+ |+||||||+|+|||...++||+|||+|.+.. .+
T Consensus 93 yv~gGELFdylv~k-G~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~---~g 165 (786)
T KOG0588|consen 93 YVPGGELFDYLVRK-GPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV---PG 165 (786)
T ss_pred ecCCchhHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc---CC
Confidence 99999999998654 46999999999999999999999655 9999999999999999999999999998732 33
Q ss_pred ceeeeeecCcCCCChhhhccCCCC-chHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 642 HVSTVVKGSFGYLDPEYFKRQQLT-EKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s-~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
..-...+|++.|.+||++++.+|. .++||||+|||||.||+|+.||+.++-.. + ....+.|..
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~---L----LlKV~~G~f--------- 229 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV---L----LLKVQRGVF--------- 229 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHH---H----HHHHHcCcc---------
Confidence 445567899999999999999885 68999999999999999999998543221 1 111122211
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
+.+...+.+..+|+.+|+..||++|.|++||++|.-
T Consensus 230 -~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 230 -EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred -cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 123345566799999999999999999999999854
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=341.30 Aligned_cols=242 Identities=24% Similarity=0.346 Sum_probs=197.3
Q ss_pred eeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccCC
Q 039107 491 YVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALG 566 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 566 (817)
++||+|+||.||+++.+ ++..||+|++... .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999865 5788999988743 2234466889999999999999999999999999999999999999
Q ss_pred chhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceeee
Q 039107 567 TLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTV 646 (817)
Q Consensus 567 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 646 (817)
+|.+++... +.+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~~ 154 (323)
T cd05571 81 ELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATMKT 154 (323)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcccc
Confidence 999988653 46899999999999999999999765 999999999999999999999999998753221 222334
Q ss_pred eecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCHH
Q 039107 647 VKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPE 726 (817)
Q Consensus 647 ~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 726 (817)
..||+.|+|||++.+..++.++|||||||++|||++|+.||....... +...... + +. .++..
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~~~~~~----~------~~----~~p~~ 217 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFELILM----E------EI----RFPRT 217 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH---HHHHHHc----C------CC----CCCCC
Confidence 579999999999999999999999999999999999999996543211 1111100 0 01 11223
Q ss_pred HHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 039107 727 CLKKFADTAEKCLSDSGIDRP-----SMGDVLWN 755 (817)
Q Consensus 727 ~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 755 (817)
....+.+++.+||+.||++|| ++.+++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 218 LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 455678999999999999999 79999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=330.78 Aligned_cols=259 Identities=26% Similarity=0.441 Sum_probs=208.5
Q ss_pred cCCCcceeEeeeCceEEEEEEEe------cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE------DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCL 558 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 558 (817)
.+|...+.||+|+||.||+|+.. ++..+++|.+........+.+.+|++++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 34677789999999999999843 235689999886665556789999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhccc---------------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCce
Q 039107 559 VYDYMALGTLREHIYNTK---------------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWV 623 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~ 623 (817)
||||+++++|.+++.... ..+++.+++.++.|++.||+|||+++ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999986432 24899999999999999999999776 999999999999999999
Q ss_pred eEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHH
Q 039107 624 AKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWA 702 (817)
Q Consensus 624 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~ 702 (817)
+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ..+..
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~~ 238 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VIECI 238 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH
Confidence 99999999975433222222233446788999999999999999999999999999998 999886543322 11111
Q ss_pred HHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 039107 703 LHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQL 762 (817)
Q Consensus 703 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 762 (817)
..+... .....++..+.+++.+||+.+|.+||++.+|++.|+.+...
T Consensus 239 ----~~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 239 ----TQGRVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred ----hCCCCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 111110 11123456689999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=341.25 Aligned_cols=253 Identities=28% Similarity=0.383 Sum_probs=204.3
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC---cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS---EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
++|...+.||+|+||.||+|+.. ++..||+|++.... ....+.+.+|++++..++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888899999999999999976 46889999987432 234567889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
||+++|+|.+++... ..+++.++..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 999999999998643 36899999999999999999999766 99999999999999999999999999976432
Q ss_pred CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccch-HHHHHHHhhccCchhhccCccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVS-LADWALHCKRKGILDDIIDPLL 719 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~~~~~~~~~~~~~~~~d~~l 719 (817)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... +..|. ..+. .+..
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~------~~~~---~~~~ 222 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK------ETLQ---RPVY 222 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc------cccc---CCCC
Confidence 2234568999999999999999999999999999999999999997654332111 11110 0000 0100
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 720 KDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 720 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
.. .......++.+++.+||..+|.+||++.+++++.
T Consensus 223 ~~-~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 223 DD-PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred Cc-cccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence 00 0123456678999999999999999999999874
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=327.64 Aligned_cols=257 Identities=24% Similarity=0.385 Sum_probs=202.8
Q ss_pred CCCcceeEeeeCceEEEEEEEe-ccc----EEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKL----KVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 559 (817)
+|+..+.||+|+||+||+|... ++. ++++|.+.... .....++..|+.++++++||||+++++++.. ...+++
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i 86 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLV 86 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEE
Confidence 4666779999999999999864 232 57888876443 2334678889999999999999999999864 557889
Q ss_pred EEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC
Q 039107 560 YDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 639 (817)
+||+++|+|.+++......+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++......
T Consensus 87 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T cd05111 87 TQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163 (279)
T ss_pred EEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence 9999999999999876667999999999999999999999765 9999999999999999999999999998653332
Q ss_pred CCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCcc
Q 039107 640 NGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPL 718 (817)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (817)
.........++..|+|||.+.++.++.++||||||+++|||++ |+.||....... +.++.. ++.. ..
T Consensus 164 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~~~----~~~~--~~--- 231 (279)
T cd05111 164 KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---VPDLLE----KGER--LA--- 231 (279)
T ss_pred cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHH----CCCc--CC---
Confidence 2222334557789999999998999999999999999999998 999987543221 111111 1110 00
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 039107 719 LKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQL 762 (817)
Q Consensus 719 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 762 (817)
.+..+...+.+++.+|+..+|++|||+.|+++.|..+...
T Consensus 232 ----~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 232 ----QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred ----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 0112334578899999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=326.64 Aligned_cols=255 Identities=27% Similarity=0.458 Sum_probs=209.8
Q ss_pred hhcCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
...+|...++||.|+||.||+|...++..+++|.+.........++.+|+.++++++|+||+++++++......++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34567778899999999999999888889999998876655567899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 563 MALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 563 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
+++++|.+++.... ..+++.++..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~- 159 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY- 159 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc-
Confidence 99999999997643 46899999999999999999999765 99999999999999999999999999976432211
Q ss_pred ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 642 HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
......++..|+|||.+..+.++.++||||||+++++|++ |+.||......+ ....... ...
T Consensus 160 -~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~-------------~~~ 222 (261)
T cd05148 160 -LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---VYDQITA-------------GYR 222 (261)
T ss_pred -cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHHHHh-------------CCc
Confidence 1123345678999999998899999999999999999998 888886543221 1111110 011
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
...+..++..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 223 MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 11223445678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=334.71 Aligned_cols=247 Identities=22% Similarity=0.277 Sum_probs=201.5
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC---cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS---EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
+|...+.||+|+||.||+|..+ ++..||+|++.... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 5778889999999999999976 56889999976432 2335678899999999999999999999999999999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
|+++|+|.+++... +.+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 82 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--- 154 (291)
T cd05612 82 YVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--- 154 (291)
T ss_pred CCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC---
Confidence 99999999998654 46899999999999999999999766 999999999999999999999999999764321
Q ss_pred ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccC
Q 039107 642 HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKD 721 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (817)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||......+. .+.+. .+. .
T Consensus 155 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~---~~~i~----~~~----------~ 215 (291)
T cd05612 155 --TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI---YEKIL----AGK----------L 215 (291)
T ss_pred --cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHH----hCC----------c
Confidence 2234689999999999998999999999999999999999999976533211 11110 000 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHHH
Q 039107 722 KISPECLKKFADTAEKCLSDSGIDRPS-----MGDVLWNLEF 758 (817)
Q Consensus 722 ~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~L~~ 758 (817)
.++......+.+++.+||+.||.+||+ +.+++++-..
T Consensus 216 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~ 257 (291)
T cd05612 216 EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWF 257 (291)
T ss_pred CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccc
Confidence 112223456789999999999999995 8888877443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=330.01 Aligned_cols=259 Identities=27% Similarity=0.446 Sum_probs=207.5
Q ss_pred cCCCcceeEeeeCceEEEEEEEe------cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE------DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCL 558 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 558 (817)
.+|...+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46778889999999999999852 235689999886666666789999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhccc------------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEE
Q 039107 559 VYDYMALGTLREHIYNTK------------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKV 626 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl 626 (817)
||||+++++|.+++.... ..+++.+++.++.|++.||+|||+++ ++||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999986432 24899999999999999999999765 999999999999999999999
Q ss_pred eeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHh
Q 039107 627 SDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHC 705 (817)
Q Consensus 627 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 705 (817)
+|||+++...............++..|+|||.+.+..++.++|||||||+++||++ |.+||......+ .....
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~~~i--- 235 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIECI--- 235 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH---
Confidence 99999975432221111222335778999999998999999999999999999998 888886543221 11111
Q ss_pred hccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 039107 706 KRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQL 762 (817)
Q Consensus 706 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 762 (817)
..+.. .. .+..++..+.+++.+||+.+|.+|||+.+|++.|+.+...
T Consensus 236 -~~~~~-----~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 236 -TQGRV-----LQ----RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred -HcCCc-----CC----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 11110 00 1112345689999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=340.71 Aligned_cols=243 Identities=26% Similarity=0.382 Sum_probs=205.6
Q ss_pred hhcCCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCC---CcccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeEE
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPS---SEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEMC 557 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 557 (817)
.-.+|...++||+|.||+|+++.+++ +..+|||.+++. ....++..+.|.+|+... +||.|++|+.+++..++++
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 34678999999999999999999875 468999998875 355678888999999888 5999999999999999999
Q ss_pred EEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCC
Q 039107 558 LVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPN 637 (817)
Q Consensus 558 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 637 (817)
+||||+.||++..+. ..+.+++..+.-++..|+.||+|||+++ ||+||||.+|||||.+|.+||+||||++...
T Consensus 446 fvmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m- 519 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGM- 519 (694)
T ss_pred EEEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccC-
Confidence 999999999955443 3457999999999999999999999776 9999999999999999999999999999743
Q ss_pred CCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCc
Q 039107 638 MENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717 (817)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (817)
..+..+...+||+.|||||++..+.|+.++|.|||||+|||||.|..||.++++++..+ .++.
T Consensus 520 -~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fd---------------sI~~- 582 (694)
T KOG0694|consen 520 -GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFD---------------SIVN- 582 (694)
T ss_pred -CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---------------HHhc-
Confidence 23446677899999999999999999999999999999999999999999876644221 1110
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 039107 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPSM 749 (817)
Q Consensus 718 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 749 (817)
....++.-++.+...|++++|..+|++|.-+
T Consensus 583 -d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 583 -DEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -CCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 0112344566778999999999999999876
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=325.10 Aligned_cols=253 Identities=24% Similarity=0.436 Sum_probs=205.3
Q ss_pred cCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEecc
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMA 564 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 564 (817)
++|+..++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++......+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 4677888999999999999998888889999977543 345789999999999999999999999999999999999999
Q ss_pred CCchhhhhhcc-ccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCce
Q 039107 565 LGTLREHIYNT-KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643 (817)
Q Consensus 565 ~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 643 (817)
+++|.+++... ...+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++....... ..
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~ 160 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-TA 160 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce-ec
Confidence 99999998654 346899999999999999999999765 99999999999999999999999999986433211 11
Q ss_pred eeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCC
Q 039107 644 STVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDK 722 (817)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (817)
.....++..|+|||.+..+.++.++|||||||++|||++ |+.||....... ...+... .. . ..
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~~----~~-----~----~~ 224 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSALQR----GY-----R----MP 224 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHHHc----CC-----C----CC
Confidence 122345678999999998899999999999999999998 899986543221 1111111 10 0 01
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 723 ISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 723 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
....++..+.+++.+|++.+|++||+++++++.|+.
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 225 RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 112234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=314.03 Aligned_cols=267 Identities=24% Similarity=0.286 Sum_probs=208.8
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCccc--HHHHHHHHHHHhccCccceeeEEEEEe--cCCeEEEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQG--VNEFVTEIEMLSKLRHKHLVSLIGFCE--EGNEMCLVY 560 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~lV~ 560 (817)
+|+..+.|++|.||.||+|+.+ ++..||+|+++...+.. --.-++||.+|.+++|||||.+-.+.. .-+..+|||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 3566778999999999999965 56789999998764321 123579999999999999999988764 346799999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
|||+. +|..++....+++...++..+..|+++||+|||.+. |+|||||++|+|+...|.+||+||||||.+....
T Consensus 157 e~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~- 231 (419)
T KOG0663|consen 157 EYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL- 231 (419)
T ss_pred HHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCCc-
Confidence 99986 999999888888999999999999999999999877 9999999999999999999999999999764432
Q ss_pred CceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhc-----
Q 039107 641 GHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDI----- 714 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~----- 714 (817)
...+..+-|..|.|||.+.+ ..|+.+.|+||+|||+.||+++++.|.+..+.++.+.+--......+......
T Consensus 232 -k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~ 310 (419)
T KOG0663|consen 232 -KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPA 310 (419)
T ss_pred -ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccch
Confidence 23445567999999999876 57999999999999999999999999988877776544221111111100000
Q ss_pred ---------cCccccCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 715 ---------IDPLLKDKISPE-CLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 715 ---------~d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
.-..++..+... ..+.-.+|+..+|..||.+|.|+.|.|++=-+
T Consensus 311 ~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F 364 (419)
T KOG0663|consen 311 VKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYF 364 (419)
T ss_pred hhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccc
Confidence 001112222211 34567899999999999999999999977444
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=328.92 Aligned_cols=254 Identities=27% Similarity=0.448 Sum_probs=202.2
Q ss_pred CCCcceeEeeeCceEEEEEEE-----ecccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVI-----EDKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 559 (817)
+|+..+.||+|+||.||+|.. ..+..+++|.+.... .+...+|.+|++++++++||||+++++++......++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 85 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML 85 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence 466778999999999999984 244689999987533 34456789999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhcc----------------ccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCce
Q 039107 560 YDYMALGTLREHIYNT----------------KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWV 623 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~ 623 (817)
|||+++++|.+++... ...+++.+++.++.|++.||+|||+++ |+||||||+|||+++++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCCc
Confidence 9999999999988532 125789999999999999999999765 999999999999999999
Q ss_pred eEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHH
Q 039107 624 AKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWA 702 (817)
Q Consensus 624 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~ 702 (817)
+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..||....... +.+..
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~---~~~~~ 239 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE---VIEMV 239 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH
Confidence 99999999976433222222233345778999999998899999999999999999998 888886543211 11111
Q ss_pred HHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 703 LHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 703 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
.... ....+..++..+.+++.+|++.+|++||++.+|+++|..
T Consensus 240 ----~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 240 ----RKRQ---------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ----HcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111 011222345678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=339.03 Aligned_cols=259 Identities=24% Similarity=0.416 Sum_probs=203.1
Q ss_pred cCCCcceeEeeeCceEEEEEEEec------ccEEEEEecCCCC-cccHHHHHHHHHHHhcc-CccceeeEEEEEec-CCe
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIED------KLKVAIKRSNPSS-EQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEE-GNE 555 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~-~~~ 555 (817)
.+|+..++||+|+||.||+|...+ +..||+|++.... ....+.+..|+.++.++ +|+||++++++|.. ...
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 467888899999999999997432 3679999987543 23346688999999999 89999999998864 456
Q ss_pred EEEEEEeccCCchhhhhhccc-----------------------------------------------------------
Q 039107 556 MCLVYDYMALGTLREHIYNTK----------------------------------------------------------- 576 (817)
Q Consensus 556 ~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------- 576 (817)
.+++|||+++++|.+++....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 889999999999999885321
Q ss_pred -cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceeeeeecCcCCCC
Q 039107 577 -KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLD 655 (817)
Q Consensus 577 -~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a 655 (817)
..++|..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...............++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 25899999999999999999999765 99999999999999999999999999986533222222223456778999
Q ss_pred hhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHH
Q 039107 656 PEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADT 734 (817)
Q Consensus 656 PE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l 734 (817)
||++.+..++.++|||||||+|+||++ |+.||......+. +... ...+. ....+.....++.++
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~~~----~~~~~---------~~~~~~~~~~~~~~l 308 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FCRR----LKEGT---------RMRAPEYATPEIYSI 308 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HHHH----HhccC---------CCCCCccCCHHHHHH
Confidence 999999999999999999999999998 9999865432211 1111 11110 011122344568999
Q ss_pred HHHccccCCCCCCCHHHHHHHHHHhHh
Q 039107 735 AEKCLSDSGIDRPSMGDVLWNLEFVLQ 761 (817)
Q Consensus 735 i~~cl~~dP~~RPt~~evl~~L~~~~~ 761 (817)
+.+||+.+|++||++.+|+++|+.+++
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=324.54 Aligned_cols=254 Identities=28% Similarity=0.474 Sum_probs=205.4
Q ss_pred hcCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
..+|...+.||+|++|.||+|...++..||+|.++... ...++|.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 35678889999999999999998777889999987543 34577999999999999999999999999999999999999
Q ss_pred cCCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 564 ALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 564 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
++++|.+++.... ..+++.++..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++........
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~- 159 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE- 159 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc-
Confidence 9999999986544 46899999999999999999999765 999999999999999999999999999865322111
Q ss_pred eeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccC
Q 039107 643 VSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKD 721 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (817)
.......+..|+|||.+.+..++.++||||||++++||++ |+.||....... +.. ...... ..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~---~~~~~~----------~~ 223 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VLQ---QVDQGY----------RM 223 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHH---HHHcCC----------CC
Confidence 1111223457999999998999999999999999999999 998886543211 111 000000 01
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 722 KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 722 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
..+..++..+.+++.+|++.+|.+||++.++++.|++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 1122345678999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=329.68 Aligned_cols=266 Identities=21% Similarity=0.259 Sum_probs=202.3
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
++|...+.||+|+||.||+++.+ ++..+|+|++... .....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888899999999999999976 4678999987653 23345678899999999999999999999999999999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
|++++.|..+. .....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 155 (287)
T cd07848 81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN- 155 (287)
T ss_pred cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccccc-
Confidence 99987776543 33456899999999999999999999765 99999999999999999999999999986432221
Q ss_pred ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHH---------HHHhhccCchh
Q 039107 642 HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADW---------ALHCKRKGILD 712 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~---------~~~~~~~~~~~ 712 (817)
.......|+..|+|||++.+..++.++|||||||++|||++|++||......+....... ...........
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 122335689999999999988999999999999999999999999976543222111110 00000111000
Q ss_pred hccCccccC------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 713 DIIDPLLKD------KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 713 ~~~d~~l~~------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
....+.... ......+..+.+++.+||+.||++|||++++++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000010000 0111245568999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=305.67 Aligned_cols=249 Identities=26% Similarity=0.403 Sum_probs=207.2
Q ss_pred cCCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCCC---cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPSS---EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
++|++++.||+|.||.||.|+.+. +-.||+|.+.+.. .+..+++.+|+++-+.|+||||+++++|+.+....||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 468889999999999999999764 5679999977542 233567899999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC
Q 039107 561 DYMALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 639 (817)
||.+.|.|...|.... ..+++.....+..|+|.||.|+|.+ +||||||||+|+|++..+.+||+|||.+-..+
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--- 175 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP--- 175 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC---
Confidence 9999999999997443 3689999999999999999999965 49999999999999999999999999987633
Q ss_pred CCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccc
Q 039107 640 NGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719 (817)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (817)
......++||..|.+||...+...+...|+|++|++.||+|.|.+||......+.. .++.. .
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etY---------------krI~k--~ 237 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETY---------------KRIRK--V 237 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHH---------------HHHHH--c
Confidence 33456788999999999999999999999999999999999999999765422111 01100 0
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 720 KDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 720 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
+-.++........++|.+|+..+|.+|.+..|++.+--
T Consensus 238 ~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 238 DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred cccCCcccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence 11122344556789999999999999999999998743
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=328.26 Aligned_cols=256 Identities=24% Similarity=0.430 Sum_probs=202.1
Q ss_pred hhcCCCcceeEeeeCceEEEEEEEec------ccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCe
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVIED------KLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNE 555 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 555 (817)
.+++|+..+.||+|+||.||+|..++ +..||+|.+.... .....+|.+|+.++++++|+||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45678889999999999999998542 3579999876432 2345678999999999999999999999999999
Q ss_pred EEEEEEeccCCchhhhhhccc---------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEE
Q 039107 556 MCLVYDYMALGTLREHIYNTK---------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKV 626 (817)
Q Consensus 556 ~~lV~Ey~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl 626 (817)
.++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 999999999999999986432 23678899999999999999999765 999999999999999999999
Q ss_pred eeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHh
Q 039107 627 SDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHC 705 (817)
Q Consensus 627 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 705 (817)
+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||....... ...+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~---~~~~~~-- 235 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ---VLRFVM-- 235 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHH--
Confidence 99999875433222111122345778999999999999999999999999999999 678886543221 111111
Q ss_pred hccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 706 KRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 706 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
.... ...+..++..+.+++.+|++.+|++||++.|++++|+
T Consensus 236 --~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 236 --EGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred --cCCc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 1100 0112234557899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=322.33 Aligned_cols=247 Identities=24% Similarity=0.411 Sum_probs=196.7
Q ss_pred eEeeeCceEEEEEEEe-cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccCCchh
Q 039107 492 VIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLR 569 (817)
Q Consensus 492 ~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 569 (817)
.||+|+||.||+|+.. ++..+|+|...... ......|.+|++++++++||||++++++|......++||||+++++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 6999999999999975 67889999876432 334567999999999999999999999999999999999999999999
Q ss_pred hhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceeeeeec
Q 039107 570 EHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKG 649 (817)
Q Consensus 570 ~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 649 (817)
+++......+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++................
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 82 TFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred HHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence 999765557899999999999999999999765 99999999999999999999999999875432111111111123
Q ss_pred CcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCHHHH
Q 039107 650 SFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECL 728 (817)
Q Consensus 650 t~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 728 (817)
+..|+|||.+.++.++.++||||||+++|||++ |..|+......... ... .. ......+..++
T Consensus 159 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~---~~~----~~---------~~~~~~~~~~~ 222 (252)
T cd05084 159 PVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTR---EAI----EQ---------GVRLPCPELCP 222 (252)
T ss_pred ceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHH---HHH----Hc---------CCCCCCcccCC
Confidence 457999999999999999999999999999998 88887543221110 000 00 01111223345
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 729 KKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 729 ~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
..+.+++.+|++.+|++||++.+|++.|+
T Consensus 223 ~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 223 DAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 67899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=351.90 Aligned_cols=250 Identities=22% Similarity=0.303 Sum_probs=202.5
Q ss_pred CCcceeEeeeCceEEEEEEEe-c-ccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEecc
Q 039107 487 FDESYVIGVGGFGKVYKGVIE-D-KLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMA 564 (817)
Q Consensus 487 f~~~~~lG~G~fg~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 564 (817)
|...++||+|+||.||+|... + +..||+|.+..........+.+|+.+|+.++||||+++++++...+..+|||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 777889999999999999854 3 56788888765555555678899999999999999999999999999999999999
Q ss_pred CCchhhhhhcc---ccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 565 LGTLREHIYNT---KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 565 ~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
+|+|.+++... ...+++.++..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++........
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 99999988642 236889999999999999999999765 999999999999999999999999999865433222
Q ss_pred ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccC
Q 039107 642 HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKD 721 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (817)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ +...... +. .+
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~---~~~~~~~----~~----~~----- 289 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE---IMQQVLY----GK----YD----- 289 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHh----CC----CC-----
Confidence 23345569999999999999999999999999999999999999996543211 1111100 00 00
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 722 KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 722 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
..+..+...+.+++.+||+.+|++||++.+++.+
T Consensus 290 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 1122344568999999999999999999999754
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=331.99 Aligned_cols=248 Identities=26% Similarity=0.402 Sum_probs=207.1
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC-CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS-SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
.|....+||+|.||.||||... .++.||+|.+... .+...+++.+|+.+|.+++++||.+.+|.+..+..++++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 4555678999999999999964 5678999998765 4455788899999999999999999999999999999999999
Q ss_pred cCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCce
Q 039107 564 ALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643 (817)
Q Consensus 564 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 643 (817)
.+|++.+.|.. ...+++..+.-|++++..||.|||+++ .+|||||+.|||+..+|.+||+|||.+........ .
T Consensus 94 ~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~--r 167 (467)
T KOG0201|consen 94 GGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK--R 167 (467)
T ss_pred cCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh--c
Confidence 99999998853 334588888999999999999999876 99999999999999999999999999987544332 2
Q ss_pred eeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCC
Q 039107 644 STVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKI 723 (817)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 723 (817)
.....||+.|||||+++...|+.|+||||||++++||.+|.+|+....+..-+ -++-+......
T Consensus 168 r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl----------------flIpk~~PP~L 231 (467)
T KOG0201|consen 168 RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL----------------FLIPKSAPPRL 231 (467)
T ss_pred cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE----------------EeccCCCCCcc
Confidence 25678999999999999889999999999999999999999999765442211 11111222222
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 724 SPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 724 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
...+...+.+++..||+.+|+.||++.+++++
T Consensus 232 ~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 232 DGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 33566778999999999999999999999976
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=328.15 Aligned_cols=268 Identities=24% Similarity=0.414 Sum_probs=203.4
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-----cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEec--CCeEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-----DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE--GNEMC 557 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~ 557 (817)
++|+..+.||+|+||.||++..+ ++..||+|++........+.|.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46777889999999999999853 467899999887766667789999999999999999999998743 35689
Q ss_pred EEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCC
Q 039107 558 LVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPN 637 (817)
Q Consensus 558 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 637 (817)
+|+||+++++|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 999999999999999766567999999999999999999999765 99999999999999999999999999986543
Q ss_pred CCCCc-eeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhc-cC---chh
Q 039107 638 MENGH-VSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKR-KG---ILD 712 (817)
Q Consensus 638 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~-~~---~~~ 712 (817)
..... ......++..|+|||.+.+..++.++|||||||+++||++|..++...... .......... .. .+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----FMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----hhhhcccccccccchHHHH
Confidence 22111 111122345699999999889999999999999999999987665322110 0000000000 00 000
Q ss_pred hccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 713 DIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 713 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
+.+...........++..+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11111111111233456789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=331.39 Aligned_cols=255 Identities=21% Similarity=0.297 Sum_probs=207.6
Q ss_pred HhhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC---cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEE
Q 039107 482 HATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS---EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMC 557 (817)
Q Consensus 482 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 557 (817)
...++|+....||+|+||.||+++.+ .|..+|+|++++.. ..+++..+.|-.+|....+|.||+|+..|++.+.+|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 35568999999999999999999966 46889999998763 445677889999999999999999999999999999
Q ss_pred EEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCC
Q 039107 558 LVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPN 637 (817)
Q Consensus 558 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 637 (817)
|||||++||++..+|.+. ..|++......+.+++.||.-||+.| +|||||||+|+|||..|.+||+||||+.-...
T Consensus 218 LiMEylPGGD~mTLL~~~-~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRK-DTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEEEecCCccHHHHHHhc-CcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhh
Confidence 999999999999998654 46999999999999999999999655 99999999999999999999999999852211
Q ss_pred ----------------------CCCCc----e-------------------eeeeecCcCCCChhhhccCCCCchHHHHH
Q 039107 638 ----------------------MENGH----V-------------------STVVKGSFGYLDPEYFKRQQLTEKSDIYS 672 (817)
Q Consensus 638 ----------------------~~~~~----~-------------------~~~~~gt~~y~aPE~~~~~~~s~~sDV~S 672 (817)
.+... . .....||+.|||||++.+..|+..+|.||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 00000 0 01356999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCcccc-chHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCC---
Q 039107 673 FGVVLFEVLCARPALNPSLPKEQ-VSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPS--- 748 (817)
Q Consensus 673 ~Gvvl~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt--- 748 (817)
||||+||||.|.+||....+.+. ..+..|....... ....+..+..+||.+|+. ||++|--
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP--------------~~~~~s~eA~DLI~rll~-d~~~RLG~~G 438 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFP--------------EEVDLSDEAKDLITRLLC-DPENRLGSKG 438 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCC--------------CcCcccHHHHHHHHHHhc-CHHHhcCccc
Confidence 99999999999999998776543 2344454332211 122334678999999998 9999965
Q ss_pred HHHHHHH
Q 039107 749 MGDVLWN 755 (817)
Q Consensus 749 ~~evl~~ 755 (817)
+.||-+|
T Consensus 439 ~~EIK~H 445 (550)
T KOG0605|consen 439 AEEIKKH 445 (550)
T ss_pred HHHHhcC
Confidence 6666655
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=327.79 Aligned_cols=254 Identities=27% Similarity=0.455 Sum_probs=204.2
Q ss_pred cCCCcceeEeeeCceEEEEEEEec------ccEEEEEecCCCCcc-cHHHHHHHHHHHhccCccceeeEEEEEecCCeEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIED------KLKVAIKRSNPSSEQ-GVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMC 557 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 557 (817)
.+|...+.||+|+||.||+|...+ +..||+|.++..... ..+.|.+|+++|++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 346677799999999999998643 367999998765443 4578999999999999999999999999999999
Q ss_pred EEEEeccCCchhhhhhccc-------------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCcee
Q 039107 558 LVYDYMALGTLREHIYNTK-------------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVA 624 (817)
Q Consensus 558 lV~Ey~~~gsL~~~l~~~~-------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~ 624 (817)
+||||+++++|.+++.... ..+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999986432 35789999999999999999999765 9999999999999999999
Q ss_pred EEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHH
Q 039107 625 KVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWAL 703 (817)
Q Consensus 625 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 703 (817)
||+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||......+ ..+...
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~~~~ 238 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIECIT 238 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHH
Confidence 9999999875432222112223345788999999999999999999999999999998 999986543322 111111
Q ss_pred HhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 704 HCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 704 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
.+.. ...+...+..+.+++.+||+.+|++||++.||++.|+
T Consensus 239 ----~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 239 ----QGRL---------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ----cCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1111 0111234566899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=323.04 Aligned_cols=253 Identities=25% Similarity=0.407 Sum_probs=204.0
Q ss_pred CCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEecc
Q 039107 486 SFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMA 564 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 564 (817)
+|...+.||+|+||.||+|..++ +..|++|.+... ....+++.+|++++++++|+||+++++++......++||||++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 46777899999999999999764 678999998744 3445789999999999999999999999999999999999999
Q ss_pred CCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCce
Q 039107 565 LGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643 (817)
Q Consensus 565 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 643 (817)
+++|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++........ .
T Consensus 86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-~ 161 (263)
T cd05052 86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-A 161 (263)
T ss_pred CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee-c
Confidence 999999986543 36899999999999999999999765 999999999999999999999999999764332111 1
Q ss_pred eeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCC
Q 039107 644 STVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDK 722 (817)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (817)
.....++..|+|||.+.+..++.++|||||||++|||++ |..|+......+ +..... . .....
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~------~~~~~~-~---------~~~~~ 225 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELLE-K---------GYRME 225 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHHH-C---------CCCCC
Confidence 112234568999999999999999999999999999998 888886543211 111110 0 01112
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 723 ISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 723 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
.+..++..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 226 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 2233456789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=322.63 Aligned_cols=251 Identities=28% Similarity=0.405 Sum_probs=202.3
Q ss_pred CCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccC
Q 039107 486 SFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMAL 565 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 565 (817)
+|...+.||+|+||+||+|...++..+|+|.+.... ...++|.+|+.++++++||||+++++++......++||||+.+
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 466677999999999999998777789999887543 3346799999999999999999999999988999999999999
Q ss_pred CchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceee
Q 039107 566 GTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVST 645 (817)
Q Consensus 566 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 645 (817)
|+|.+++......+++.+++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++....... ....
T Consensus 84 ~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~~ 159 (256)
T cd05113 84 GCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSSV 159 (256)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce-eecC
Confidence 9999999765557899999999999999999999765 99999999999999999999999999875432211 1111
Q ss_pred eeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCC
Q 039107 646 VVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKIS 724 (817)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 724 (817)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ..+.... ... ...+
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~---~~~----------~~~~ 223 (256)
T cd05113 160 GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVEKVSQ---GLR----------LYRP 223 (256)
T ss_pred CCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHHhc---CCC----------CCCC
Confidence 2235678999999998889999999999999999998 998886543221 1111111 000 0011
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 725 PECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 725 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
......+.+++.+||+.+|.+||++.++++.|+
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 123467899999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=327.37 Aligned_cols=257 Identities=24% Similarity=0.429 Sum_probs=203.5
Q ss_pred CCCcceeEeeeCceEEEEEEEec------ccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIED------KLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCL 558 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 558 (817)
+|...+.||+|+||.||+|+... ...+++|.+.... ....+++.+|+.+++.++||||+++++.|...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 35667899999999999998542 2468888877543 2335678999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhccc-----------------------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCc
Q 039107 559 VYDYMALGTLREHIYNTK-----------------------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTN 615 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~N 615 (817)
++||+.+++|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999875321 25889999999999999999999765 9999999999
Q ss_pred EEEcCCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccc
Q 039107 616 ILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKE 694 (817)
Q Consensus 616 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~ 694 (817)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.||....+..
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999975432221111223345678999999988899999999999999999998 998886543221
Q ss_pred cchHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 039107 695 QVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQ 761 (817)
Q Consensus 695 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 761 (817)
+.++.. +. .....+..+...+.+++.+|++.+|.+||++.++++.|+.+..
T Consensus 238 ---~~~~~~----~~---------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 ---LFNLLK----TG---------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred ---HHHHHh----CC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 111111 11 0111122344578899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=330.07 Aligned_cols=264 Identities=23% Similarity=0.303 Sum_probs=195.5
Q ss_pred cCCCcceeEeeeCceEEEEEEEe--cccEEEEEecCCCC--cccHHHHHHHHHHHhcc---CccceeeEEEEEe-----c
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE--DKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKL---RHKHLVSLIGFCE-----E 552 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~-----~ 552 (817)
++|...+.||+|+||.||+|+.. ++..||+|++.... ......+.+|+.+++++ +||||++++++|. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36788889999999999999863 45789999876432 22234566788777766 6999999999985 3
Q ss_pred CCeEEEEEEeccCCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeecc
Q 039107 553 GNEMCLVYDYMALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGL 631 (817)
Q Consensus 553 ~~~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGl 631 (817)
....++||||++ ++|.+++.... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999997 68988886543 35899999999999999999999766 99999999999999999999999999
Q ss_pred CccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchH-HHHHHHhhccCc
Q 039107 632 SKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSL-ADWALHCKRKGI 710 (817)
Q Consensus 632 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l-~~~~~~~~~~~~ 710 (817)
++..... .......||..|+|||.+....++.++|||||||++|||++|++||......+.... .+..........
T Consensus 157 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~ 233 (290)
T cd07862 157 ARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233 (290)
T ss_pred eEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence 9764322 223345689999999999988999999999999999999999999987654332211 110000000000
Q ss_pred ------hhhccCccccC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 711 ------LDDIIDPLLKD---KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 711 ------~~~~~d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
....+.+.... ...+.....+.+++.+||+.||++|||+.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 00001100000 0111234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=325.57 Aligned_cols=262 Identities=26% Similarity=0.352 Sum_probs=205.7
Q ss_pred HHHHhhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCc--------------ccHHHHHHHHHHHhccCccce
Q 039107 479 EIKHATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSE--------------QGVNEFVTEIEMLSKLRHKHL 543 (817)
Q Consensus 479 el~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~H~ni 543 (817)
+-.+.-++|.....||+|.||.|-+|+.. ++..||||++.+... ...+...+||.+|++++||||
T Consensus 91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV 170 (576)
T KOG0585|consen 91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV 170 (576)
T ss_pred ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence 33445578999999999999999999854 678899999875321 113578899999999999999
Q ss_pred eeEEEEEec--CCeEEEEEEeccCCchhhhhhccccc-cchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcC
Q 039107 544 VSLIGFCEE--GNEMCLVYDYMALGTLREHIYNTKKA-LSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDE 620 (817)
Q Consensus 544 v~l~g~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~ 620 (817)
|+|+.+..+ .+.+|||+|||..|.+...= ..+. |+..+.++++++++.||+|||.++ ||||||||+|+||++
T Consensus 171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSS 245 (576)
T ss_pred eEEEEeecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcC
Confidence 999999865 46799999999998886532 3344 999999999999999999999876 999999999999999
Q ss_pred CceeEEeeeccCccCCCCC---CCceeeeeecCcCCCChhhhccCC----CCchHHHHHHHHHHHHHHhCCCCCCCCCcc
Q 039107 621 NWVAKVSDFGLSKTGPNME---NGHVSTVVKGSFGYLDPEYFKRQQ----LTEKSDIYSFGVVLFEVLCARPALNPSLPK 693 (817)
Q Consensus 621 ~~~~kl~DFGla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDV~S~Gvvl~elltG~~p~~~~~~~ 693 (817)
+|++||+|||.+....... ....-....||+.|+|||+..++. .+.+.||||+||.||+|+.|+.||..+...
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~ 325 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL 325 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence 9999999999987542211 111222367999999999987633 356889999999999999999999865432
Q ss_pred ccchHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 039107 694 EQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVL 760 (817)
Q Consensus 694 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 760 (817)
+.. ..++...+.-+..++..+.+.+||.++|.+||++|.+..+|..|..-..
T Consensus 326 ~l~---------------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 326 ELF---------------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred HHH---------------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence 211 1222222332333456678899999999999999999999988866543
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=338.67 Aligned_cols=246 Identities=24% Similarity=0.337 Sum_probs=200.8
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
.+|...+.||+|+||.||+|+.+ ++..||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 45788889999999999999976 4678999987643 2234567889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-- 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-- 171 (329)
T ss_pred cCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC--
Confidence 999999999998654 35888999999999999999999765 999999999999999999999999999864321
Q ss_pred CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||....... .. .. ...+. +
T Consensus 172 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~~---~~-i~~~~--------~- 232 (329)
T PTZ00263 172 ---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR---IY---EK-ILAGR--------L- 232 (329)
T ss_pred ---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH---HH---HH-HhcCC--------c-
Confidence 123568999999999999999999999999999999999999997543211 10 00 01110 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHH
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRPS-----MGDVLWNL 756 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~L 756 (817)
.++......+.+++.+||+.||.+||+ +++++.|-
T Consensus 233 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp 272 (329)
T PTZ00263 233 -KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHP 272 (329)
T ss_pred -CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCC
Confidence 111123345789999999999999997 78888774
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=327.89 Aligned_cols=268 Identities=21% Similarity=0.284 Sum_probs=200.0
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCc-ccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSE-QGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
..+|...+.||+|+||.||+|..+ ++..||+|.+..... .....+.+|+.++++++||||+++++++......++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 357888999999999999999976 567899999875432 223467889999999999999999999999999999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
|++ ++|.+++......+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 157 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-- 157 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC--
Confidence 996 6888887666567899999999999999999999766 9999999999999999999999999987532211
Q ss_pred ceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccc-cchHHHHHHHhhccCch---hh--c
Q 039107 642 HVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKE-QVSLADWALHCKRKGIL---DD--I 714 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~-~~~l~~~~~~~~~~~~~---~~--~ 714 (817)
.......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||....+.. ......+.......... .. .
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 12233457899999999865 468899999999999999999999997643221 11111010000000000 00 0
Q ss_pred cCcc-cc----CCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 715 IDPL-LK----DKIS-----PECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 715 ~d~~-l~----~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
.++. .. .... ......+.+++.+||+.||.+|||+.++++|--
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~ 290 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEY 290 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcc
Confidence 0000 00 0000 011245789999999999999999999997643
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=334.13 Aligned_cols=243 Identities=24% Similarity=0.337 Sum_probs=197.3
Q ss_pred eeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccCC
Q 039107 491 YVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALG 566 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 566 (817)
++||+|+||.||++..+ ++..||+|++... .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999865 5688999998643 2334567889999999999999999999999999999999999999
Q ss_pred chhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceeee
Q 039107 567 TLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTV 646 (817)
Q Consensus 567 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 646 (817)
+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~ 154 (328)
T cd05593 81 ELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMKT 154 (328)
T ss_pred CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc--cccccc
Confidence 999888644 46899999999999999999999765 999999999999999999999999998753221 112234
Q ss_pred eecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCHH
Q 039107 647 VKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPE 726 (817)
Q Consensus 647 ~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 726 (817)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||......... ...... +. .++..
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~------~~~~~~-------~~----~~p~~ 217 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF------ELILME-------DI----KFPRT 217 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHH------HHhccC-------Cc----cCCCC
Confidence 56999999999999999999999999999999999999999754322111 000000 01 11223
Q ss_pred HHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 039107 727 CLKKFADTAEKCLSDSGIDRP-----SMGDVLWNL 756 (817)
Q Consensus 727 ~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 756 (817)
....+.+++.+||+.||.+|| ++.+++++.
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 252 (328)
T cd05593 218 LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHS 252 (328)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCC
Confidence 445678999999999999997 899998763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=326.29 Aligned_cols=255 Identities=27% Similarity=0.421 Sum_probs=201.3
Q ss_pred hcCCCcceeEeeeCceEEEEEEEec------ccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIED------KLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEM 556 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 556 (817)
+++|...+.||+|++|.||+|...+ +..|++|...... ......|..|+.++++++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4568888999999999999999764 4678999876543 33346799999999999999999999999988999
Q ss_pred EEEEEeccCCchhhhhhccc------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCc---eeEEe
Q 039107 557 CLVYDYMALGTLREHIYNTK------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENW---VAKVS 627 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~---~~kl~ 627 (817)
++||||+++++|.+++.... ..++|.++++++.||+.||+|||+.+ ++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 99999999999999986543 25899999999999999999999765 99999999999998654 69999
Q ss_pred eeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhh
Q 039107 628 DFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCK 706 (817)
Q Consensus 628 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 706 (817)
|||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||........ .... .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~---~~~~---~ 235 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV---MEFV---T 235 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHH---H
Confidence 9999986422111111112223568999999999999999999999999999997 8888875432211 1111 1
Q ss_pred ccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 707 RKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 707 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
.. .....+..++..+.+++.+|++.+|++||++.+|+++|+
T Consensus 236 ~~----------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 GG----------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cC----------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 00 011122334567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=322.63 Aligned_cols=249 Identities=25% Similarity=0.367 Sum_probs=207.6
Q ss_pred cCCCcceeEeeeCceEEEEEEE-ecccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVI-EDKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
.+|++.+.||+|.||.|-++.. ..|+.||||.+++. ++++.-.+.+|++||+.|+||||+.++.+|+..+...+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 3566677899999999999984 67899999988765 3455566789999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
||..+|.|++++..++ .|++.+...+++||..|+.|+|.+. ++|||||.+|||||+++++||+||||+..+..
T Consensus 133 EYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~--- 205 (668)
T KOG0611|consen 133 EYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD--- 205 (668)
T ss_pred EecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc---
Confidence 9999999999997654 5999999999999999999999654 99999999999999999999999999976432
Q ss_pred CceeeeeecCcCCCChhhhccCCC-CchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQL-TEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (817)
...-+.++|++-|.+||.+.+.+| .+..|.|||||+||-|+.|..||++.+... + +++ +-....
T Consensus 206 ~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~---l---vrQ---------Is~GaY 270 (668)
T KOG0611|consen 206 KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR---L---VRQ---------ISRGAY 270 (668)
T ss_pred ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH---H---HHH---------hhcccc
Confidence 334456789999999999999988 478999999999999999999998764321 1 111 111112
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 720 KDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 720 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
++ ++.+....-||++||..+|++|-|+.+|..|..-
T Consensus 271 rE---P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWv 306 (668)
T KOG0611|consen 271 RE---PETPSDASGLIRWMLMVNPERRATIEDIASHWWV 306 (668)
T ss_pred cC---CCCCchHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence 22 2233445779999999999999999999987544
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=333.28 Aligned_cols=240 Identities=23% Similarity=0.266 Sum_probs=194.6
Q ss_pred EeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccCCch
Q 039107 493 IGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTL 568 (817)
Q Consensus 493 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 568 (817)
||+|+||.||++... ++..||+|++... .......+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999975 4678999987642 234456788999999999999999999999999999999999999999
Q ss_pred hhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceeeeee
Q 039107 569 REHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVK 648 (817)
Q Consensus 569 ~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 648 (817)
.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ........
T Consensus 81 ~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~ 154 (312)
T cd05585 81 FHHLQRE-GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTNTFC 154 (312)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccC--CCcccccc
Confidence 9998654 45899999999999999999999765 999999999999999999999999999753221 12233457
Q ss_pred cCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCHHHH
Q 039107 649 GSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECL 728 (817)
Q Consensus 649 gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 728 (817)
||+.|+|||.+.+..++.++|||||||++|||++|+.||......+ ........ ...++....
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~------~~~~~~~~-----------~~~~~~~~~ 217 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE------MYRKILQE-----------PLRFPDGFD 217 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH------HHHHHHcC-----------CCCCCCcCC
Confidence 9999999999999999999999999999999999999997543211 11111110 011222344
Q ss_pred HHHHHHHHHccccCCCCCCC---HHHHHHH
Q 039107 729 KKFADTAEKCLSDSGIDRPS---MGDVLWN 755 (817)
Q Consensus 729 ~~l~~li~~cl~~dP~~RPt---~~evl~~ 755 (817)
..+.+++.+||+.||.+||+ +.+++.+
T Consensus 218 ~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 218 RDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 56789999999999999975 6777765
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=336.55 Aligned_cols=243 Identities=23% Similarity=0.332 Sum_probs=196.6
Q ss_pred eeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccCC
Q 039107 491 YVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALG 566 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 566 (817)
++||+|+||.||++... ++..||+|.+... .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36999999999999865 5788999998643 2334566788999999999999999999999999999999999999
Q ss_pred chhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceeee
Q 039107 567 TLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTV 646 (817)
Q Consensus 567 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 646 (817)
+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~~ 154 (323)
T cd05595 81 ELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKT 154 (323)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC--CCcccc
Confidence 999888543 36899999999999999999999765 999999999999999999999999998753221 112234
Q ss_pred eecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCHH
Q 039107 647 VKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPE 726 (817)
Q Consensus 647 ~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 726 (817)
..||+.|+|||.+.++.++.++|||||||++|||++|+.||.......... .. .. . +. .++..
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~---~~---~~-~------~~----~~p~~ 217 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE---LI---LM-E------EI----RFPRT 217 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHH---HH---hc-C------CC----CCCCC
Confidence 568999999999999999999999999999999999999997543221110 00 00 0 00 11223
Q ss_pred HHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 039107 727 CLKKFADTAEKCLSDSGIDRP-----SMGDVLWNL 756 (817)
Q Consensus 727 ~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 756 (817)
....+.+++.+||+.||.+|| ++.+++++-
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~ 252 (323)
T cd05595 218 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 252 (323)
T ss_pred CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCC
Confidence 445678999999999999998 899998763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=344.55 Aligned_cols=260 Identities=24% Similarity=0.294 Sum_probs=213.5
Q ss_pred hcCCCcceeEeeeCceEEEEEEEecc-cEEEEEecCCCCcccHHHHHHHHHHHhccC-ccceeeEEEE-Ee-----c-CC
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIEDK-LKVAIKRSNPSSEQGVNEFVTEIEMLSKLR-HKHLVSLIGF-CE-----E-GN 554 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~-~~-----~-~~ 554 (817)
..+..+.+.|.+|||+.||.+....+ .++|+|++....+...+...+|+++|++|+ |+|||.+++. .. . .-
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 45677888999999999999997766 999999988778888999999999999996 9999999993 21 1 24
Q ss_pred eEEEEEEeccCCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCc
Q 039107 555 EMCLVYDYMALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSK 633 (817)
Q Consensus 555 ~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 633 (817)
+.+|.||||.+|.|-+++..+- ..|++.++++|+.|+++|+++||.. +++|||||||-+||||..++..||||||-+.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 6899999999999999997543 3699999999999999999999987 6899999999999999999999999999986
Q ss_pred cCCCCCCCc-e------eeeeecCcCCCChhhh---ccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHH
Q 039107 634 TGPNMENGH-V------STVVKGSFGYLDPEYF---KRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWAL 703 (817)
Q Consensus 634 ~~~~~~~~~-~------~~~~~gt~~y~aPE~~---~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 703 (817)
......... . .-...-|+.|+|||.+ .+...++|+|||+|||+||-|+....||+.....
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l---------- 264 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL---------- 264 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----------
Confidence 432211110 0 0112358999999986 5678899999999999999999999999765322
Q ss_pred HhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 039107 704 HCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLV 763 (817)
Q Consensus 704 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 763 (817)
.|++....-+-.+.....|..||..||+.||.+||++-+|+.++..+....
T Consensus 265 ---------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 265 ---------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ---------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 223333333333577889999999999999999999999999998887554
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=321.31 Aligned_cols=250 Identities=28% Similarity=0.442 Sum_probs=201.2
Q ss_pred CCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccC
Q 039107 486 SFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMAL 565 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 565 (817)
+|...+.||+|+||.||+|..+++..+|+|.+.... ....+|.+|++++++++|+||+++++++......++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 466777999999999999998777789999876432 2346788999999999999999999999999999999999999
Q ss_pred CchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceee
Q 039107 566 GTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVST 645 (817)
Q Consensus 566 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 645 (817)
++|.+++......+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++....... ....
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~~~ 159 (256)
T cd05059 84 GCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TSSQ 159 (256)
T ss_pred CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccc-cccC
Confidence 9999999765567899999999999999999999766 99999999999999999999999999876432111 1111
Q ss_pred eeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCC
Q 039107 646 VVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKIS 724 (817)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 724 (817)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ... ... .. . ....+
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~---~~~-~~-----~----~~~~~ 223 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VVE---SVS-AG-----Y----RLYRP 223 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HHH---HHH-cC-----C----cCCCC
Confidence 1223457999999998999999999999999999999 788886543221 111 100 00 0 01112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 725 PECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 725 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
..++..+.+++.+||+.+|++|||+.++++.|
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 224 KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 23456789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=329.60 Aligned_cols=260 Identities=25% Similarity=0.459 Sum_probs=206.2
Q ss_pred cCCCcceeEeeeCceEEEEEEEec--------ccEEEEEecCCC-CcccHHHHHHHHHHHhcc-CccceeeEEEEEecCC
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIED--------KLKVAIKRSNPS-SEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGN 554 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 554 (817)
.+|...+.||+|+||.||++...+ ...+|+|.+... ......++..|+++++++ +|+||++++++|....
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 457888899999999999997532 246999998754 234456788999999999 7999999999999999
Q ss_pred eEEEEEEeccCCchhhhhhccc---------------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEc
Q 039107 555 EMCLVYDYMALGTLREHIYNTK---------------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLD 619 (817)
Q Consensus 555 ~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~ 619 (817)
..++||||+++|+|.+++.... ..+++.++++++.|++.||+|||+.+ ++||||||+|||++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEc
Confidence 9999999999999999996532 25899999999999999999999765 99999999999999
Q ss_pred CCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchH
Q 039107 620 ENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSL 698 (817)
Q Consensus 620 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l 698 (817)
+++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||......+
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~---- 250 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---- 250 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH----
Confidence 999999999999876433221111222234568999999998899999999999999999998 888876432211
Q ss_pred HHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 039107 699 ADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLV 763 (817)
Q Consensus 699 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 763 (817)
....... . .....+..+...+.+++.+|++.+|++||++.+|++.|+.+.+..
T Consensus 251 --~~~~~~~-~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 251 --LFKLLKE-G---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred --HHHHHHc-C---------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 1111111 1 011122334567889999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=329.15 Aligned_cols=259 Identities=25% Similarity=0.478 Sum_probs=205.8
Q ss_pred hhcCCCcceeEeeeCceEEEEEEEec------ccEEEEEecCCC-CcccHHHHHHHHHHHhcc-CccceeeEEEEEecCC
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVIED------KLKVAIKRSNPS-SEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGN 554 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 554 (817)
..++|+..+.||+|+||.||++...+ ...+|+|.+... ..+...++.+|+++++++ +|+||+++++++....
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 34567788899999999999998643 257899988754 334456788999999999 8999999999999999
Q ss_pred eEEEEEEeccCCchhhhhhcc---------------ccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEc
Q 039107 555 EMCLVYDYMALGTLREHIYNT---------------KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLD 619 (817)
Q Consensus 555 ~~~lV~Ey~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~ 619 (817)
..+++|||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 999999999999999998632 236899999999999999999999765 99999999999999
Q ss_pred CCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchH
Q 039107 620 ENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSL 698 (817)
Q Consensus 620 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l 698 (817)
+++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+......+.
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--- 243 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL--- 243 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH---
Confidence 999999999999986543222122222335678999999998999999999999999999998 8888764432211
Q ss_pred HHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 039107 699 ADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVL 760 (817)
Q Consensus 699 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 760 (817)
.... ..+ .....+..+...+.+++.+|++.+|++|||+.++++.|+.++
T Consensus 244 ~~~~----~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 FKLL----KEG---------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHH----HcC---------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1110 000 011122334567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=335.66 Aligned_cols=266 Identities=24% Similarity=0.308 Sum_probs=196.9
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecC-----CeEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEG-----NEMC 557 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~ 557 (817)
+|...++||+|+||.||+|+.. ++..||||++... .......+.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4677889999999999999965 5689999987643 223345788999999999999999999987533 3479
Q ss_pred EEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCC
Q 039107 558 LVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPN 637 (817)
Q Consensus 558 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 637 (817)
+||||++ ++|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 lv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 81 VVFELME-SDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEecCC-CCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 9999996 6888887543 35999999999999999999999766 99999999999999999999999999975422
Q ss_pred CCCC-ceeeeeecCcCCCChhhhcc--CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHH---------HHHHh
Q 039107 638 MENG-HVSTVVKGSFGYLDPEYFKR--QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLAD---------WALHC 705 (817)
Q Consensus 638 ~~~~-~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~---------~~~~~ 705 (817)
.... .......||..|+|||++.+ ..++.++|||||||++|||++|++||............. +...
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~- 234 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR- 234 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH-
Confidence 2111 11234568999999999875 678999999999999999999999997654322211110 0000
Q ss_pred hccCchhhccC---ccccCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 706 KRKGILDDIID---PLLKDKI---SPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 706 ~~~~~~~~~~d---~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
.........+. +...... .+.....+.+++.+||+.+|++|||+++++++--
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~ 292 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCch
Confidence 00000000000 0000000 0112345789999999999999999999998733
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=321.74 Aligned_cols=265 Identities=27% Similarity=0.319 Sum_probs=202.3
Q ss_pred hcCCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCC-----eEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGN-----EMC 557 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 557 (817)
+-.|...+++|.|+||.||+|.+.. +..||||++....+. -.+|+++|+++.|||||+|+-++.... ...
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 3457778899999999999999754 588999998865432 236999999999999999999885322 346
Q ss_pred EEEEeccCCchhhhhhc---cccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCC-ceeEEeeeccCc
Q 039107 558 LVYDYMALGTLREHIYN---TKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDEN-WVAKVSDFGLSK 633 (817)
Q Consensus 558 lV~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DFGla~ 633 (817)
||||||+. +|.+.+.. .+..++...+.-+..||++||+|||+.+ |+||||||.|+|+|.+ |.+||||||.|+
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcce
Confidence 89999985 88888863 2457888889999999999999999754 9999999999999976 999999999999
Q ss_pred cCCCCCCCceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCch-
Q 039107 634 TGPNMENGHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGIL- 711 (817)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~- 711 (817)
.....+ .......|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+....++..++--+.....+..+
T Consensus 175 ~L~~~e---pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 175 VLVKGE---PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIK 251 (364)
T ss_pred eeccCC---CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence 754433 2345567899999999876 58999999999999999999999999987766665433211111000000
Q ss_pred ------hhccCcccc-----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 712 ------DDIIDPLLK-----DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 712 ------~~~~d~~l~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
.+...+.+. ..+......+..+++.++|..+|.+|.++.|++.+--+.
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFd 310 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFD 310 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhH
Confidence 011111111 112334456789999999999999999999999775443
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=329.72 Aligned_cols=256 Identities=28% Similarity=0.463 Sum_probs=216.3
Q ss_pred CCCcceeEeeeCceEEEEEEEec---c--cEEEEEecCCC-CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIED---K--LKVAIKRSNPS-SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~~---~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 559 (817)
.....++||+|.||.||+|++.+ | ..||||..+.. .....+.|+.|..+|++++||||++|+|.|.+ ...++|
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv 468 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV 468 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence 34456689999999999999532 2 46999987764 44557889999999999999999999999976 678999
Q ss_pred EEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC
Q 039107 560 YDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 639 (817)
||.++.|.|..+|..++..|+......++.||..||+|||+.. +|||||..+|||+...--+||+||||+|......
T Consensus 469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 9999999999999988889999999999999999999999765 9999999999999999999999999999876655
Q ss_pred CCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCcc
Q 039107 640 NGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPL 718 (817)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (817)
....+ ...-+..|||||.+.-.+++.++|||-|||++||++. |..||.+-...+-+- .++..
T Consensus 546 yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~----------------~iEnG 608 (974)
T KOG4257|consen 546 YYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG----------------HIENG 608 (974)
T ss_pred hhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE----------------EecCC
Confidence 44333 4456789999999999999999999999999999876 889998765443210 01111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 039107 719 LKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQL 762 (817)
Q Consensus 719 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 762 (817)
-+-+.++.|+..+..|+.+||+.+|.+||...++...|.++++.
T Consensus 609 eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe 652 (974)
T KOG4257|consen 609 ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE 652 (974)
T ss_pred CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence 23345778999999999999999999999999999999998873
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=337.00 Aligned_cols=246 Identities=22% Similarity=0.314 Sum_probs=200.1
Q ss_pred cCCCcceeEeeeCceEEEEEEEecc--cEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIEDK--LKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 559 (817)
++|...+.||+|+||.||+|..+.. ..||+|++... .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 4578888999999999999986543 57999987542 233456788999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC
Q 039107 560 YDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 639 (817)
|||+++|+|.+++... +.+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 110 ~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~-- 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-- 183 (340)
T ss_pred EeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC--
Confidence 9999999999998654 35899999999999999999999766 99999999999999999999999999976422
Q ss_pred CCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccc
Q 039107 640 NGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719 (817)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (817)
......||+.|+|||++.+..++.++|||||||++|||++|++||......... .. ...+.
T Consensus 184 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~------~~-i~~~~--------- 244 (340)
T PTZ00426 184 ---RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIY------QK-ILEGI--------- 244 (340)
T ss_pred ---CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHH------HH-HhcCC---------
Confidence 123457999999999999888999999999999999999999999764322110 00 00110
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 039107 720 KDKISPECLKKFADTAEKCLSDSGIDRP-----SMGDVLWNL 756 (817)
Q Consensus 720 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 756 (817)
..++......+.+++.+|++.+|.+|+ ++++++++-
T Consensus 245 -~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp 285 (340)
T PTZ00426 245 -IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHP 285 (340)
T ss_pred -CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCC
Confidence 011222344578999999999999995 899988773
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=327.67 Aligned_cols=257 Identities=22% Similarity=0.414 Sum_probs=203.5
Q ss_pred cCCCcceeEeeeCceEEEEEEEe------cccEEEEEecCCCC-cccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE------DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEM 556 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 556 (817)
++|...+.||+|+||.||++... .+..||+|+++... ....+.+.+|+++++++ +|+||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 46888889999999999999742 23579999887543 33346789999999999 799999999999999999
Q ss_pred EEEEEeccCCchhhhhhcccc-ccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccC
Q 039107 557 CLVYDYMALGTLREHIYNTKK-ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTG 635 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 635 (817)
++||||+.+|+|.+++..... .+++.++..++.|++.||+|||+++ |+|+||||+|||+++++.+||+|||+++..
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 191 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDI 191 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccccc
Confidence 999999999999999875433 4899999999999999999999765 999999999999999999999999999764
Q ss_pred CCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhc
Q 039107 636 PNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDI 714 (817)
Q Consensus 636 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 714 (817)
.............++..|+|||.+....++.++|||||||++|||++ |..||......+. +..... .+
T Consensus 192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~~~~----~~----- 260 (302)
T cd05055 192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYKLIK----EG----- 260 (302)
T ss_pred cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHHHHH----cC-----
Confidence 33221111222345678999999999999999999999999999998 8988865432211 111111 01
Q ss_pred cCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 715 IDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 715 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
.....+......+.+++.+|++.+|++||++.++++.|+..
T Consensus 261 ----~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 ----YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ----CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00011112345689999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=350.61 Aligned_cols=258 Identities=26% Similarity=0.350 Sum_probs=205.5
Q ss_pred HHHHhhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecCC-
Q 039107 479 EIKHATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGN- 554 (817)
Q Consensus 479 el~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~- 554 (817)
++....++|...++||+|+||+||+++.. ++..||||++... .......+.+|+.++..++|+|+++++..+...+
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 34445678999999999999999999854 6789999997643 3344567889999999999999999988764332
Q ss_pred -------eEEEEEEeccCCchhhhhhcc---ccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCcee
Q 039107 555 -------EMCLVYDYMALGTLREHIYNT---KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVA 624 (817)
Q Consensus 555 -------~~~lV~Ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~ 624 (817)
..++||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCE
Confidence 368999999999999998643 236889999999999999999999765 9999999999999999999
Q ss_pred EEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHH
Q 039107 625 KVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALH 704 (817)
Q Consensus 625 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 704 (817)
||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~------~~~~ 256 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE------VMHK 256 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH------HHHH
Confidence 9999999986543322233345679999999999999999999999999999999999999997543211 1111
Q ss_pred hhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 705 CKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 705 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.. .+. . ...+...+..+.+++.+||+.+|.+||++.+++++
T Consensus 257 ~~-~~~----~-----~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 TL-AGR----Y-----DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred Hh-cCC----C-----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11 010 0 11223445678999999999999999999999875
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=321.76 Aligned_cols=253 Identities=26% Similarity=0.420 Sum_probs=196.9
Q ss_pred CcceeEeeeCceEEEEEEEecc---cEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecC------CeE
Q 039107 488 DESYVIGVGGFGKVYKGVIEDK---LKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEG------NEM 556 (817)
Q Consensus 488 ~~~~~lG~G~fg~Vy~~~~~~~---~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~ 556 (817)
...++||+|+||.||+|...+. ..+|+|.++.. .....+.|.+|++++++++|+||++++++|... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4567899999999999997643 26899987654 344467889999999999999999999987432 246
Q ss_pred EEEEEeccCCchhhhhhc-----cccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeecc
Q 039107 557 CLVYDYMALGTLREHIYN-----TKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGL 631 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGl 631 (817)
+++|||+++|+|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 899999999999988742 2235899999999999999999999765 99999999999999999999999999
Q ss_pred CccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCc
Q 039107 632 SKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGI 710 (817)
Q Consensus 632 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 710 (817)
++...............++..|+|||.+....++.++||||||+++|||++ |+.||......+ +. .. ...+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~---~~-~~~~~ 231 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---IY---DY-LRQGN 231 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH---HH-HHcCC
Confidence 986433221111223345778999999999999999999999999999999 788886532211 11 11 11111
Q ss_pred hhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 711 LDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 711 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
. ......++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 232 ~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 R---------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred C---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 011223455689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=320.32 Aligned_cols=256 Identities=26% Similarity=0.442 Sum_probs=204.9
Q ss_pred cCCCcceeEeeeCceEEEEEEEec-c---cEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIED-K---LKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 559 (817)
++|...+.||+|+||.||+|+... + ..+++|.+.... ....+++..|++++++++|+|++++++++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 467778899999999999999753 2 369999987553 33456789999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC
Q 039107 560 YDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 639 (817)
|||+++++|.+++......+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 9999999999999766567999999999999999999999765 9999999999999999999999999987643322
Q ss_pred CCce-eeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCc
Q 039107 640 NGHV-STVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717 (817)
Q Consensus 640 ~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (817)
.... ......+..|+|||++..+.++.++|||||||++|||++ |+.||......+ +...... .
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~------~~~~i~~-~-------- 226 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE------VMKAIND-G-------- 226 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHHhc-C--------
Confidence 1111 111223457999999998899999999999999999997 999986543221 1111111 0
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 718 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
........++..+.+++.+|++.+|++||++.+|++.|+++
T Consensus 227 -~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 -FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01111223456689999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=332.59 Aligned_cols=267 Identities=23% Similarity=0.332 Sum_probs=202.9
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
++|+..++||+|+||.||++..+ ++..+|+|.+.... ....+.+.+|++++++++|+||++++++|...+..++||||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 57888899999999999999976 46788999876542 23346789999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
+++++|.+++... +.+++..+..++.|++.||.|||+. .+|+||||||+|||+++++.+||+|||++......
T Consensus 85 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---- 157 (333)
T cd06650 85 MDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---- 157 (333)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh----
Confidence 9999999998654 3588999999999999999999974 25999999999999999999999999998754221
Q ss_pred eeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHH------HHHHh-----hc----
Q 039107 643 VSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLAD------WALHC-----KR---- 707 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~------~~~~~-----~~---- 707 (817)
......|+..|+|||++.+..++.++|||||||++|||++|+.||............. +.... ..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (333)
T cd06650 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRP 237 (333)
T ss_pred ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccch
Confidence 1223468999999999998899999999999999999999999987543221110000 00000 00
Q ss_pred -------c---CchhhccCcccc---CCCC-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 708 -------K---GILDDIIDPLLK---DKIS-PECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 708 -------~---~~~~~~~d~~l~---~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
. .....+.+.... .... .....++.+++.+||+.||++|||+.|++++--.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~ 302 (333)
T cd06650 238 LSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFI 302 (333)
T ss_pred hhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHH
Confidence 0 000000000000 0000 0123568899999999999999999999876443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=339.31 Aligned_cols=254 Identities=22% Similarity=0.338 Sum_probs=197.3
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
.|...+.||+|+||+||+|+.. ++..||+|++... .....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 4777889999999999999865 4678999998643 23345678899999999999999999999999999999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC-
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN- 640 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~- 640 (817)
|+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 82 YIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 99999999998654 35889999999999999999999765 99999999999999999999999999753211000
Q ss_pred --------------------------------------------CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHH
Q 039107 641 --------------------------------------------GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVV 676 (817)
Q Consensus 641 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvv 676 (817)
........||+.|+|||.+.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 001123469999999999998899999999999999
Q ss_pred HHHHHhCCCCCCCCCccccc-hHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHH--ccccCCCCCCCHHHHH
Q 039107 677 LFEVLCARPALNPSLPKEQV-SLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEK--CLSDSGIDRPSMGDVL 753 (817)
Q Consensus 677 l~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~--cl~~dP~~RPt~~evl 753 (817)
+|||++|+.||......+.. ....|. . .+..........++.+++.+ |+..++..||++.+++
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~------~--------~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKVINWE------N--------TLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHHHccc------c--------ccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence 99999999999765432211 011110 0 00000011233456778877 5566777799999999
Q ss_pred HHHH
Q 039107 754 WNLE 757 (817)
Q Consensus 754 ~~L~ 757 (817)
.|-.
T Consensus 304 ~hp~ 307 (381)
T cd05626 304 AHPF 307 (381)
T ss_pred cCcc
Confidence 8743
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=326.50 Aligned_cols=258 Identities=27% Similarity=0.465 Sum_probs=204.0
Q ss_pred cCCCcceeEeeeCceEEEEEEEec-c--cEEEEEecCCC-CcccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIED-K--LKVAIKRSNPS-SEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~-~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 559 (817)
++|...++||+|+||.||+|..++ + ..+++|.++.. .....+.|.+|+++++++ +||||+++++++......++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 467788899999999999998754 3 34788887743 334456789999999999 799999999999999999999
Q ss_pred EEeccCCchhhhhhccc---------------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCcee
Q 039107 560 YDYMALGTLREHIYNTK---------------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVA 624 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~ 624 (817)
+||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999986432 25889999999999999999999765 9999999999999999999
Q ss_pred EEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHH
Q 039107 625 KVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWAL 703 (817)
Q Consensus 625 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 703 (817)
||+|||++....... .......+..|+|||.+.+..++.++|||||||++|||++ |+.||......+. ..
T Consensus 159 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~------~~ 229 (297)
T cd05089 159 KIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL------YE 229 (297)
T ss_pred EECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH------HH
Confidence 999999986422111 1111223567999999998899999999999999999997 9999865432211 11
Q ss_pred HhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhc
Q 039107 704 HCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVE 764 (817)
Q Consensus 704 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 764 (817)
... .+ .....+..++..+.+++.+|++.+|.+||+++++++.|+.+.+...
T Consensus 230 ~~~-~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 230 KLP-QG---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred HHh-cC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 100 00 1111122345668999999999999999999999999998886553
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=322.96 Aligned_cols=259 Identities=23% Similarity=0.374 Sum_probs=204.3
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-ccc----EEEEEecCCC-CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKL----KVAIKRSNPS-SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCL 558 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 558 (817)
.+|...++||+|+||+||+|... ++. .||+|.+... .....+++.+|+.+++.++|+||++++++|.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 46777889999999999999853 333 4899988654 33345678899999999999999999999975 45789
Q ss_pred EEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCC
Q 039107 559 VYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNM 638 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 638 (817)
++||+++|+|.+++......+++.+++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 99999999999999766667999999999999999999999765 999999999999999999999999999865432
Q ss_pred CCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCc
Q 039107 639 ENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717 (817)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (817)
..........++..|+|||.+.+..++.++|||||||++|||++ |..||...... .+..+... +
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~~----~-------- 227 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EIPDLLEK----G-------- 227 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHHC----C--------
Confidence 22111122234678999999998999999999999999999998 88888643221 12222211 0
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 039107 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLV 763 (817)
Q Consensus 718 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 763 (817)
.....+..++..+.+++.+||+.||++||++.++++.|+.+....
T Consensus 228 -~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 228 -ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred -CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 000112234556889999999999999999999999988776544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=323.68 Aligned_cols=267 Identities=25% Similarity=0.372 Sum_probs=202.4
Q ss_pred CcceeEeeeCceEEEEEEE-----ecccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecC--CeEEEE
Q 039107 488 DESYVIGVGGFGKVYKGVI-----EDKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEG--NEMCLV 559 (817)
Q Consensus 488 ~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 559 (817)
...+.||+|+||+||++.. .++..||+|.+.... ......|.+|++++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 6778999999999988753 345689999987543 23456788999999999999999999988653 457999
Q ss_pred EEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC
Q 039107 560 YDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 639 (817)
|||+++++|.+++.. ..+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 87 ~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 161 (283)
T cd05080 87 MEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 161 (283)
T ss_pred ecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence 999999999999854 35999999999999999999999765 9999999999999999999999999998653322
Q ss_pred CC-ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcc
Q 039107 640 NG-HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPL 718 (817)
Q Consensus 640 ~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (817)
.. .......++..|+|||.+....++.++||||||++++||++|+.|+....... ..+..+.........+.+..+..
T Consensus 162 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 162 EYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELLERG 240 (283)
T ss_pred hhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhhhcC
Confidence 11 11122235667999999998899999999999999999999999875432210 11111111000011111222222
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 039107 719 LKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVL 760 (817)
Q Consensus 719 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 760 (817)
.....+..++..+.+++.+||+.+|++|||+++|++.|+.+.
T Consensus 241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 222223345677899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=321.68 Aligned_cols=254 Identities=26% Similarity=0.453 Sum_probs=200.3
Q ss_pred CCcceeEeeeCceEEEEEEEec----ccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecCCe-----
Q 039107 487 FDESYVIGVGGFGKVYKGVIED----KLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNE----- 555 (817)
Q Consensus 487 f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 555 (817)
|...++||+|+||.||+|.+.. +..||+|+++.. .......+.+|+++++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567789999999999998753 257999998754 23345688999999999999999999998866554
Q ss_pred -EEEEEEeccCCchhhhhhcc-----ccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeee
Q 039107 556 -MCLVYDYMALGTLREHIYNT-----KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDF 629 (817)
Q Consensus 556 -~~lV~Ey~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DF 629 (817)
.++++||+++|+|..++... ...+++..++.++.|++.||.|||+++ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 79999999999999988543 236899999999999999999999765 999999999999999999999999
Q ss_pred ccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhcc
Q 039107 630 GLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRK 708 (817)
Q Consensus 630 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 708 (817)
|+++...............++..|+|||.+....++.++||||||+++|||++ |.+||...... .+.++...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~~~~~---- 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYDYLRH---- 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHc----
Confidence 99986533222222222345678999999988899999999999999999999 88888653321 11111111
Q ss_pred CchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 709 GILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 709 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
+. ....+..+...+.+++.+||+.||.+||++.++++.|+.+
T Consensus 231 ~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GN---------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CC---------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 10 0112234456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=322.94 Aligned_cols=259 Identities=24% Similarity=0.388 Sum_probs=206.9
Q ss_pred hcCCCcceeEeeeCceEEEEEEEec-----ccEEEEEecCCC-CcccHHHHHHHHHHHhccCccceeeEEEEEec-CCeE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIED-----KLKVAIKRSNPS-SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE-GNEM 556 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~ 556 (817)
.++|...++||+|+||.||+|...+ +..|++|++... .....+.+.+|+.++++++|+||+++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4567888899999999999999766 678999987754 33345678899999999999999999998765 5678
Q ss_pred EEEEEeccCCchhhhhhccc-------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeee
Q 039107 557 CLVYDYMALGTLREHIYNTK-------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDF 629 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DF 629 (817)
++++||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 99999999999999986532 35899999999999999999999765 999999999999999999999999
Q ss_pred ccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhcc
Q 039107 630 GLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRK 708 (817)
Q Consensus 630 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 708 (817)
|+++...............++..|+|||++.+..++.++||||||+++||+++ |+.||...... .+..+... .
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~---~ 235 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EMAAYLKD---G 235 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HHHHHHHc---C
Confidence 99986433222112223346778999999998889999999999999999998 99998654322 12222111 1
Q ss_pred CchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 039107 709 GILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQ 761 (817)
Q Consensus 709 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 761 (817)
.. ......++..+.+++.+|+..+|++|||+.++++.|+.+..
T Consensus 236 ~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 236 YR----------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CC----------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 10 01112244568999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=338.18 Aligned_cols=258 Identities=22% Similarity=0.409 Sum_probs=201.8
Q ss_pred cCCCcceeEeeeCceEEEEEEEec------ccEEEEEecCCCC-cccHHHHHHHHHHHhccC-ccceeeEEEEEecCCeE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIED------KLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLR-HKHLVSLIGFCEEGNEM 556 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~ 556 (817)
++|...++||+|+||.||+|++.+ +..||+|+++... ....+.+.+|+++|.++. ||||++++++|......
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 346667799999999999998642 3579999987543 233457889999999997 99999999999999999
Q ss_pred EEEEEeccCCchhhhhhccc------------------------------------------------------------
Q 039107 557 CLVYDYMALGTLREHIYNTK------------------------------------------------------------ 576 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~~------------------------------------------------------------ 576 (817)
++||||+++|+|.++++...
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 99999999999999986431
Q ss_pred -------------------------------------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEc
Q 039107 577 -------------------------------------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLD 619 (817)
Q Consensus 577 -------------------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~ 619 (817)
..+++..++.++.|++.||+|||+.+ |+||||||+|||++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEe
Confidence 13677788999999999999999665 99999999999999
Q ss_pred CCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchH
Q 039107 620 ENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSL 698 (817)
Q Consensus 620 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l 698 (817)
+++.+||+|||+++...............++..|+|||.+....++.++|||||||++|||++ |+.||......+..
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~-- 351 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF-- 351 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH--
Confidence 999999999999975422211111122346788999999998899999999999999999998 88887643221110
Q ss_pred HHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 039107 699 ADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVL 760 (817)
Q Consensus 699 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 760 (817)
......+ .....+..+...+.+++.+||+.+|.+||++++|++.|+.++
T Consensus 352 ----~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 352 ----YNAIKRG---------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ----HHHHHcC---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 0000111 011112234567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=330.25 Aligned_cols=261 Identities=25% Similarity=0.451 Sum_probs=205.4
Q ss_pred cCCCcceeEeeeCceEEEEEEEec--------ccEEEEEecCCC-CcccHHHHHHHHHHHhcc-CccceeeEEEEEecCC
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIED--------KLKVAIKRSNPS-SEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGN 554 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 554 (817)
.+|.+.+.||+|+||.||++...+ ...||+|.+... .....+++.+|+++++++ +||||++++++|....
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 357778899999999999997421 236899987754 233467899999999999 7999999999999999
Q ss_pred eEEEEEEeccCCchhhhhhccc---------------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEc
Q 039107 555 EMCLVYDYMALGTLREHIYNTK---------------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLD 619 (817)
Q Consensus 555 ~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~ 619 (817)
..++++||+++|+|.+++.... ..++|.+++.++.|++.||+|||+.+ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999986431 25889999999999999999999765 99999999999999
Q ss_pred CCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchH
Q 039107 620 ENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSL 698 (817)
Q Consensus 620 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l 698 (817)
+++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---- 244 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---- 244 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH----
Confidence 999999999999976433221111222334567999999999999999999999999999998 788876542211
Q ss_pred HHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhc
Q 039107 699 ADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVE 764 (817)
Q Consensus 699 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 764 (817)
+........ ....+..+...+.+++.+|++.+|++||++.++++.|+.+.....
T Consensus 245 --~~~~~~~~~----------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 245 --LFKLLKEGH----------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred --HHHHHHcCC----------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 111111110 111122345678899999999999999999999999998875443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=325.24 Aligned_cols=253 Identities=24% Similarity=0.340 Sum_probs=200.3
Q ss_pred CCcceeEeeeCceEEEEEEEec------ccEEEEEecCCCCcc-cHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEE
Q 039107 487 FDESYVIGVGGFGKVYKGVIED------KLKVAIKRSNPSSEQ-GVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 487 f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 559 (817)
|...+.||+|+||.||+|...+ +..||+|++...... ..+.|.+|+.++++++||||+++++++......+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 4556689999999999998643 467999998755432 246688999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhcc---------------ccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCcee
Q 039107 560 YDYMALGTLREHIYNT---------------KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVA 624 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~ 624 (817)
+||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCce
Confidence 9999999999998521 125888899999999999999999765 9999999999999999999
Q ss_pred EEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHH
Q 039107 625 KVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWAL 703 (817)
Q Consensus 625 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 703 (817)
||+|||+++...............+++.|+|||.+..+.++.++||||||+++|||++ |..|+......+ +..
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~~ 237 (283)
T cd05091 164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD------VIE 237 (283)
T ss_pred EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH------HHH
Confidence 9999999886433222222223345779999999988899999999999999999998 777876543211 111
Q ss_pred HhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 704 HCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 704 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
...... ....+..++..+.+++.+|++.+|.+||++++|++.|+.
T Consensus 238 ~i~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 MIRNRQ----------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHcCC----------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111111 011233456678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=318.12 Aligned_cols=271 Identities=25% Similarity=0.329 Sum_probs=210.1
Q ss_pred hhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecC--CCCcccHHHHHHHHHHHhccCccceeeEEEEEec-----CC
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSN--PSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE-----GN 554 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~ 554 (817)
....|...+.||+|+||.|.++..+ ++..||||++. -...-..++-.+|+.+|++++|+||+.+++.+.- -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3445555678999999999999865 57899999987 3455566788999999999999999999998754 45
Q ss_pred eEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 555 EMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 555 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
..++|+|+|+ .+|...+... +.|+.....-++.|+++||.|+|+.+ |+||||||.|+|++.+..+||+|||||+.
T Consensus 100 DvYiV~elMe-tDL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 100 DVYLVFELME-TDLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred eeEEehhHHh-hHHHHHHHcC-ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceee
Confidence 7899999995 6888888543 34999999999999999999999776 99999999999999999999999999998
Q ss_pred CCCCCCCceeeeeecCcCCCChhhhc-cCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhh
Q 039107 635 GPNMENGHVSTVVKGSFGYLDPEYFK-RQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDD 713 (817)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 713 (817)
..........+....|..|.|||.+. ...|+.+.||||.||+|.|||+|++-|.+...-++..++.-......+..+..
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~ 254 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK 254 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence 65432333446677899999999864 57899999999999999999999999998877666655432111111111111
Q ss_pred cc--------C--ccc-cC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 714 II--------D--PLL-KD---KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 714 ~~--------d--~~l-~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
+- . +.. +. ..-+......++|+.+||..||.+|+|++|+++|--.
T Consensus 255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl 313 (359)
T KOG0660|consen 255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYL 313 (359)
T ss_pred hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhh
Confidence 11 0 000 00 0112344567999999999999999999999987543
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=335.83 Aligned_cols=248 Identities=22% Similarity=0.317 Sum_probs=192.2
Q ss_pred CCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEecc
Q 039107 487 FDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMA 564 (817)
Q Consensus 487 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 564 (817)
|...++||+|+||.||+|+.. +++.||||.+.... ....+.+.+|++++++++|+||+++++++...+..++||||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 344568999999999999865 56899999986543 2334678999999999999999999999999999999999999
Q ss_pred CCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCcee
Q 039107 565 LGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVS 644 (817)
Q Consensus 565 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 644 (817)
+|+|.+.. .+.+..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ...
T Consensus 156 ~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~ 225 (353)
T PLN00034 156 GGSLEGTH-----IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--DPC 225 (353)
T ss_pred CCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc--ccc
Confidence 99987532 3556778899999999999999765 9999999999999999999999999997643221 112
Q ss_pred eeeecCcCCCChhhhcc-----CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccc
Q 039107 645 TVVKGSFGYLDPEYFKR-----QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719 (817)
Q Consensus 645 ~~~~gt~~y~aPE~~~~-----~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (817)
....||..|+|||.+.. ...+.++|||||||++|||++|+.||......+ |........ . ..
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~------~~~~~~~~~-~------~~ 292 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD------WASLMCAIC-M------SQ 292 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc------HHHHHHHHh-c------cC
Confidence 23468999999998743 234568999999999999999999997432221 111100000 0 00
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 720 KDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 720 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
.......+..++.+++.+||+.||++||++.|++++-.
T Consensus 293 ~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~ 330 (353)
T PLN00034 293 PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPF 330 (353)
T ss_pred CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 11112234567899999999999999999999998643
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=320.78 Aligned_cols=255 Identities=24% Similarity=0.417 Sum_probs=203.9
Q ss_pred CCCcceeEeeeCceEEEEEEEec-c---cEEEEEecCCC-CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIED-K---LKVAIKRSNPS-SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
.|+..+.||+|+||.||+|.... + ..||+|.+... .....++|..|+.++++++||||+++++++..+...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46678899999999999999753 2 36999998754 3444678999999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
||+++++|.+++......+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.......
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 85 EFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred ecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 999999999999766667999999999999999999999765 99999999999999999999999999875433221
Q ss_pred Cceeee-e--ecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccC
Q 039107 641 GHVSTV-V--KGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIID 716 (817)
Q Consensus 641 ~~~~~~-~--~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (817)
...... . ..+..|+|||.+....++.++|||||||++|||++ |..||...... ....++...
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~~~----------- 227 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIEQD----------- 227 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHHcC-----------
Confidence 111111 1 12457999999999999999999999999999886 99998654322 122222110
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 717 PLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 717 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
.....+.+++..+.+++.+||+.+|++||++.+|+..|+.+
T Consensus 228 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 --YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00111234456688999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=326.74 Aligned_cols=261 Identities=24% Similarity=0.448 Sum_probs=207.0
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe--------cccEEEEEecCCC-CcccHHHHHHHHHHHhcc-CccceeeEEEEEecC
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE--------DKLKVAIKRSNPS-SEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEG 553 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 553 (817)
..+|...+.||+|+||.||+++.. ++..||+|..... ......++.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 345777889999999999999742 2346999988754 234457789999999999 899999999999999
Q ss_pred CeEEEEEEeccCCchhhhhhccc---------------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEE
Q 039107 554 NEMCLVYDYMALGTLREHIYNTK---------------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILL 618 (817)
Q Consensus 554 ~~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll 618 (817)
...++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 99999999999999999986531 25788999999999999999999765 9999999999999
Q ss_pred cCCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccch
Q 039107 619 DENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVS 697 (817)
Q Consensus 619 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~ 697 (817)
++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+......
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---- 246 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---- 246 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH----
Confidence 9999999999999986543322222223345678999999998899999999999999999998 77777543221
Q ss_pred HHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 039107 698 LADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLV 763 (817)
Q Consensus 698 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 763 (817)
++......... ...+..++..+.+++.+||+.+|.+||++.++++.|+.+....
T Consensus 247 --~~~~~~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 247 --ELFKLLKEGHR----------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred --HHHHHHHcCCc----------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 11111111110 0112244567899999999999999999999999999988664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=317.06 Aligned_cols=248 Identities=25% Similarity=0.431 Sum_probs=197.2
Q ss_pred eEeeeCceEEEEEEEe---cccEEEEEecCCCCc-ccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccCCc
Q 039107 492 VIGVGGFGKVYKGVIE---DKLKVAIKRSNPSSE-QGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGT 567 (817)
Q Consensus 492 ~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 567 (817)
.||+|+||.||+|.+. ++..||+|.+..... ...+.|.+|+.++++++|+||++++++|. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999864 345699999876533 33467999999999999999999999986 457899999999999
Q ss_pred hhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCce-eee
Q 039107 568 LREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV-STV 646 (817)
Q Consensus 568 L~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~-~~~ 646 (817)
|.+++......+++.++++++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++.......... ...
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 99999766667999999999999999999999765 99999999999999999999999999975432221111 111
Q ss_pred eecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCH
Q 039107 647 VKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISP 725 (817)
Q Consensus 647 ~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 725 (817)
..++..|+|||.+..+.++.++||||||+++|||++ |+.||......+ ....+. .+ .....+.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~----~~---------~~~~~~~ 221 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE---VMSFIE----QG---------KRLDCPA 221 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHHH----CC---------CCCCCCC
Confidence 233578999999998889999999999999999996 999986543221 111111 11 0111233
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 726 ECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 726 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
.+..++.+++.+||..+|++||++.+|.+.|+..
T Consensus 222 ~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 222 ECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 4566788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=322.61 Aligned_cols=254 Identities=28% Similarity=0.470 Sum_probs=202.6
Q ss_pred cCCCcceeEeeeCceEEEEEEEe------cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE------DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCL 558 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 558 (817)
+++...++||+|+||.||++... ++..+++|.+........+.|.+|++++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 35666779999999999999742 345789999887766667889999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhccc--------------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCcee
Q 039107 559 VYDYMALGTLREHIYNTK--------------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVA 624 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~ 624 (817)
+|||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 999999999999986532 24889999999999999999999765 9999999999999999999
Q ss_pred EEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHH
Q 039107 625 KVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWAL 703 (817)
Q Consensus 625 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 703 (817)
||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |++||......+.. ....
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~~~~ 238 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI---ECIT 238 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH---HHHH
Confidence 9999999875432221111122335678999999999999999999999999999998 88888643322111 1110
Q ss_pred HhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 704 HCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 704 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
.+. ....+..++..+.+++.+||+.+|++||++.+|++.|+
T Consensus 239 ----~~~---------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 239 ----QGR---------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ----cCc---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 000 00112234456889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=336.37 Aligned_cols=254 Identities=23% Similarity=0.294 Sum_probs=203.7
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
++|...+.||+|+||+||+|... ++..||+|++... .......+.+|++++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888899999999999999976 5788999998643 2234567889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC-
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME- 639 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~- 639 (817)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 999999999998765 56899999999999999999999765 9999999999999999999999999997643322
Q ss_pred --------------------------CCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCcc
Q 039107 640 --------------------------NGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPK 693 (817)
Q Consensus 640 --------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~ 693 (817)
.........||+.|+|||.+.+..++.++|||||||+||||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 001223456899999999999999999999999999999999999999765422
Q ss_pred ccchHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHH
Q 039107 694 EQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPS-MGDVLWNL 756 (817)
Q Consensus 694 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~~L 756 (817)
... ........ .+........+..+.+++.+|+. +|.+||+ +.+++++.
T Consensus 237 ~~~-----~~i~~~~~--------~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 237 ETY-----NKIINWKE--------SLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred HHH-----HHHhccCC--------cccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 111 00000000 00000011135567899999997 9999999 99999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=325.72 Aligned_cols=242 Identities=25% Similarity=0.340 Sum_probs=192.5
Q ss_pred eeEeeeCceEEEEEEEec-ccEEEEEecCCC---CcccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeEEEEEEeccC
Q 039107 491 YVIGVGGFGKVYKGVIED-KLKVAIKRSNPS---SEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEMCLVYDYMAL 565 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 565 (817)
+.||+|+||+||+|...+ +..||+|.++.. .....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 369999999999999764 578999987653 123345667788888765 899999999999999999999999999
Q ss_pred CchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceee
Q 039107 566 GTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVST 645 (817)
Q Consensus 566 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 645 (817)
|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..... .....
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~ 154 (316)
T cd05619 81 GDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DAKTC 154 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCC--CCcee
Confidence 9999988643 45889999999999999999999765 999999999999999999999999998753211 12233
Q ss_pred eeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCH
Q 039107 646 VVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISP 725 (817)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 725 (817)
...||..|+|||++.+..++.++|||||||++|||++|+.||......+ +...+. .. .+.. +.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~~i~----~~------~~~~----~~ 217 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---LFQSIR----MD------NPCY----PR 217 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---HHHHHH----hC------CCCC----Cc
Confidence 4578999999999999999999999999999999999999997543221 111111 00 1111 12
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHH-HHHHH
Q 039107 726 ECLKKFADTAEKCLSDSGIDRPSMG-DVLWN 755 (817)
Q Consensus 726 ~~~~~l~~li~~cl~~dP~~RPt~~-evl~~ 755 (817)
.....+.+++.+||+.+|.+||++. +++++
T Consensus 218 ~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 218 WLTREAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred cCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 2345578999999999999999997 66543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=317.27 Aligned_cols=252 Identities=27% Similarity=0.439 Sum_probs=201.9
Q ss_pred cCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEecc
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMA 564 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 564 (817)
++|...++||+|+||.||+|..+++..+|+|.+..... ..+.|.+|+.++++++|+|++++++++.. ...+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecC
Confidence 35677789999999999999988888899999875433 34679999999999999999999998854 56899999999
Q ss_pred CCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCce
Q 039107 565 LGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643 (817)
Q Consensus 565 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 643 (817)
+++|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++........ ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~-~~ 159 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-TA 159 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc-cc
Confidence 999999987543 35899999999999999999999765 99999999999999999999999999976432211 11
Q ss_pred eeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCC
Q 039107 644 STVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDK 722 (817)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (817)
.....++..|+|||.+.+..++.++||||||+++|||++ |++||......+ ..++.. .. ....
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~---~~----------~~~~ 223 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLEQVE---RG----------YRMP 223 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHH---cC----------CCCC
Confidence 112235678999999988899999999999999999999 888886543221 111111 00 0111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 723 ISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 723 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
.+...+..+.+++.+|+..+|++|||++++.+.|++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 223345678999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=317.23 Aligned_cols=253 Identities=29% Similarity=0.457 Sum_probs=203.1
Q ss_pred cCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEecc
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMA 564 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 564 (817)
.+|...++||+|+||.||+|...+...||+|++.... ...++|.+|++++++++|+||+++++++.+ ...++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence 4578888999999999999998777789999987533 334678999999999999999999998754 56899999999
Q ss_pred CCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCce
Q 039107 565 LGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643 (817)
Q Consensus 565 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 643 (817)
+|+|.+++.... ..+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++....... ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~~ 159 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TA 159 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc-cc
Confidence 999999997543 36899999999999999999999765 99999999999999999999999999975432221 11
Q ss_pred eeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCC
Q 039107 644 STVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDK 722 (817)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (817)
.....++..|+|||...+..++.++||||||+++|||++ |+.||......+.. .. .... ....
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~------~~-~~~~---------~~~~ 223 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL------DQ-VERG---------YRMP 223 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHH------HH-HhcC---------CCCC
Confidence 122346678999999998899999999999999999999 78887654322111 00 0000 0011
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 723 ISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 723 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
...+++..+.+++.+|++.+|++||++.++++.|+..
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 2234566789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=326.35 Aligned_cols=242 Identities=26% Similarity=0.364 Sum_probs=191.3
Q ss_pred eeEeeeCceEEEEEEEec-ccEEEEEecCCC---CcccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeEEEEEEeccC
Q 039107 491 YVIGVGGFGKVYKGVIED-KLKVAIKRSNPS---SEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEMCLVYDYMAL 565 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 565 (817)
++||+|+||.||+|...+ +..||+|.++.. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999754 578999988643 223345566777777655 899999999999999999999999999
Q ss_pred CchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceee
Q 039107 566 GTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVST 645 (817)
Q Consensus 566 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 645 (817)
|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~ 154 (316)
T cd05592 81 GDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAS 154 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cccc
Confidence 9999988654 35899999999999999999999765 9999999999999999999999999997532222 2233
Q ss_pred eeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCH
Q 039107 646 VVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISP 725 (817)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 725 (817)
...||..|+|||.+.+..++.++|||||||++|||++|+.||......+.. ..... . .+ .++.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~------~~i~~-~------~~----~~~~ 217 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF------DSILN-D------RP----HFPR 217 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHH------HHHHc-C------CC----CCCC
Confidence 456899999999999999999999999999999999999999765432111 11000 0 01 1122
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHH-HHHHH
Q 039107 726 ECLKKFADTAEKCLSDSGIDRPSMG-DVLWN 755 (817)
Q Consensus 726 ~~~~~l~~li~~cl~~dP~~RPt~~-evl~~ 755 (817)
.....+.+++.+||+.+|.+||++. +++++
T Consensus 218 ~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 218 WISKEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 2345678999999999999999975 55443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=325.92 Aligned_cols=261 Identities=22% Similarity=0.390 Sum_probs=199.4
Q ss_pred cCCCcceeEeeeCceEEEEEEEec---------------ccEEEEEecCCC-CcccHHHHHHHHHHHhccCccceeeEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIED---------------KLKVAIKRSNPS-SEQGVNEFVTEIEMLSKLRHKHLVSLIG 548 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g 548 (817)
++|...+.||+|+||.||++...+ ...||+|.+... .......|.+|++++++++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 467888899999999999987543 135899998754 2334567999999999999999999999
Q ss_pred EEecCCeEEEEEEeccCCchhhhhhccc-----------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEE
Q 039107 549 FCEEGNEMCLVYDYMALGTLREHIYNTK-----------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNIL 617 (817)
Q Consensus 549 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIl 617 (817)
++......++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ ++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 9999999999999999999999885432 13788999999999999999999765 999999999999
Q ss_pred EcCCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh--CCCCCCCCCcccc
Q 039107 618 LDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC--ARPALNPSLPKEQ 695 (817)
Q Consensus 618 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt--G~~p~~~~~~~~~ 695 (817)
+++++.+||+|||+++...............++..|+|||.+..+.++.++|||||||+++||++ +..||......+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~- 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ- 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-
Confidence 99999999999999976433221112222345678999999998899999999999999999988 555665432221
Q ss_pred chHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 696 VSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 696 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
............. .......+...+..+.+++.+|++.+|++||++.+|++.|+
T Consensus 241 --~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 --VIENTGEFFRNQG------RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred --HHHHHHHhhhhcc------ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1111111000000 00000111223457899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=314.53 Aligned_cols=246 Identities=26% Similarity=0.462 Sum_probs=198.8
Q ss_pred eEeeeCceEEEEEEEecccEEEEEecCCCCc-ccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccCCchhh
Q 039107 492 VIGVGGFGKVYKGVIEDKLKVAIKRSNPSSE-QGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLRE 570 (817)
Q Consensus 492 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 570 (817)
+||+|+||.||+|..+++..+|+|.+..... .....|.+|++++++++||||++++++|......++||||+++++|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 6899999999999988888999999876543 234568899999999999999999999999999999999999999999
Q ss_pred hhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceeeeeecC
Q 039107 571 HIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGS 650 (817)
Q Consensus 571 ~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 650 (817)
++......+++.+++.++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++........ .......++
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~ 157 (250)
T cd05085 82 FLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQIP 157 (250)
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCCCc
Confidence 98765557899999999999999999999765 99999999999999999999999999875322111 111122346
Q ss_pred cCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCHHHHH
Q 039107 651 FGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLK 729 (817)
Q Consensus 651 ~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 729 (817)
..|+|||++.++.++.++||||||+++|||++ |..||....... .... ...+. ....+..++.
T Consensus 158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~---~~~~----~~~~~---------~~~~~~~~~~ 221 (250)
T cd05085 158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ---AREQ----VEKGY---------RMSCPQKCPD 221 (250)
T ss_pred ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH---HHHH----HHcCC---------CCCCCCCCCH
Confidence 78999999998999999999999999999998 888886543221 1110 11110 1111223456
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 730 KFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 730 ~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
.+.+++.+|++.+|++||++.++++.|.
T Consensus 222 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 222 DVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 7899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=332.10 Aligned_cols=243 Identities=25% Similarity=0.361 Sum_probs=195.3
Q ss_pred eeEeeeCceEEEEEEEe----cccEEEEEecCCC----CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 491 YVIGVGGFGKVYKGVIE----DKLKVAIKRSNPS----SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
++||+|+||.||+++.. .+..||+|.+... .......+.+|+++|++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 47999999999999853 4578999987642 223345678999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
+++++|.+++... +.+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~ 155 (323)
T cd05584 82 LSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE--GT 155 (323)
T ss_pred CCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC--CC
Confidence 9999999988654 45788889999999999999999765 999999999999999999999999998753221 12
Q ss_pred eeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCC
Q 039107 643 VSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDK 722 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (817)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .. +.... ..
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~------~~---------~~~~~--~~ 218 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTI------DK---------ILKGK--LN 218 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHH------HH---------HHcCC--CC
Confidence 233456899999999999888999999999999999999999999764322111 11 00100 01
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 039107 723 ISPECLKKFADTAEKCLSDSGIDRP-----SMGDVLWNL 756 (817)
Q Consensus 723 ~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 756 (817)
++......+.+++.+||+.+|++|| ++.+++++-
T Consensus 219 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~ 257 (323)
T cd05584 219 LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHP 257 (323)
T ss_pred CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCC
Confidence 1223345678999999999999999 888888763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=323.09 Aligned_cols=253 Identities=25% Similarity=0.344 Sum_probs=202.0
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC---cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS---EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
+|+..++||+|+||+||++... ++..||+|++.... ......+.+|+.++++++|+||+++++++...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3677889999999999999864 56889999886432 2223557889999999999999999999999999999999
Q ss_pred eccCCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 562 YMALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 562 y~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
|+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence 999999998886543 36899999999999999999999766 9999999999999999999999999987643211
Q ss_pred CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
......|+..|+|||++.+..++.++|||||||++|||++|+.||......... .+ ....... ..
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~--~~-~~~~~~~----------~~ 221 (285)
T cd05605 157 --TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR--EE-VERRVKE----------DQ 221 (285)
T ss_pred --ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH--HH-HHHHhhh----------cc
Confidence 122346899999999999899999999999999999999999999764332111 00 1100000 01
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRP-----SMGDVLWNLE 757 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L~ 757 (817)
..++...+..+.+++.+||+.||.+|| ++++++++-.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~ 263 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPF 263 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcC
Confidence 112234556689999999999999999 8888887643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=331.18 Aligned_cols=254 Identities=21% Similarity=0.331 Sum_probs=195.0
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC---cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS---EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
++|+..+.||+|+||+||++... .+..||+|++.... ......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 36888899999999999999865 46789999986432 233456888999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
||+++|+|.+++... +.+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 81 EFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred cCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 999999999998654 46999999999999999999999765 99999999999999999999999999875322110
Q ss_pred ---------------------------------CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCC
Q 039107 641 ---------------------------------GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPAL 687 (817)
Q Consensus 641 ---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~ 687 (817)
........||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 00112357999999999999999999999999999999999999999
Q ss_pred CCCCccccchHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccc--cCCCCCCCHHHHHHH
Q 039107 688 NPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLS--DSGIDRPSMGDVLWN 755 (817)
Q Consensus 688 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~--~dP~~RPt~~evl~~ 755 (817)
......+.. ..+.. .+.. +. .... ......+.+++.+++. .++..||+++||+++
T Consensus 237 ~~~~~~~~~---~~i~~--~~~~---~~---~p~~--~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 237 CSETPQETY---KKVMN--WKET---LI---FPPE--VPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCHHHHH---HHHHc--CcCc---cc---CCCc--CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 765432211 00100 0000 00 1110 0123345666666432 344467999999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=337.66 Aligned_cols=257 Identities=23% Similarity=0.249 Sum_probs=201.2
Q ss_pred HhhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEE
Q 039107 482 HATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMC 557 (817)
Q Consensus 482 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 557 (817)
....+|...++||+|+||.||+++.+ ++..||+|++... .....+.+.+|+.+++.++||||+++++++.+....+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34567889999999999999999875 4678999998642 2233456789999999999999999999999999999
Q ss_pred EEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCC
Q 039107 558 LVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPN 637 (817)
Q Consensus 558 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 637 (817)
+||||+++|+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 120 lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999998854 35788888999999999999999765 99999999999999999999999999976432
Q ss_pred CCCCceeeeeecCcCCCChhhhccC----CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhh
Q 039107 638 MENGHVSTVVKGSFGYLDPEYFKRQ----QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDD 713 (817)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 713 (817)
.. ........||+.|+|||.+.+. .++.++|||||||++|||++|+.||......... .........
T Consensus 195 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~-----~~i~~~~~~--- 265 (370)
T cd05596 195 NG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY-----SKIMDHKNS--- 265 (370)
T ss_pred CC-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHH-----HHHHcCCCc---
Confidence 11 1122345699999999998653 4789999999999999999999999765332110 000000000
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHH
Q 039107 714 IIDPLLKDKISPECLKKFADTAEKCLSDSGID--RPSMGDVLWNLE 757 (817)
Q Consensus 714 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~L~ 757 (817)
+.-......+..+.+++.+||..+|.+ ||++.+++++-.
T Consensus 266 -----~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~ 306 (370)
T cd05596 266 -----LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPF 306 (370)
T ss_pred -----CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcc
Confidence 000001123566789999999999988 999999998743
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=317.26 Aligned_cols=257 Identities=23% Similarity=0.351 Sum_probs=204.6
Q ss_pred HHHhhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEE
Q 039107 480 IKHATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCL 558 (817)
Q Consensus 480 l~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 558 (817)
++.++.++....+||+|+||.||+|... ++..|++|.+........+.+.+|+.++++++|+||+++++++...+..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 4456677777789999999999999865 567899999887766667789999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhcccccc--chHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcC-CceeEEeeeccCccC
Q 039107 559 VYDYMALGTLREHIYNTKKAL--SWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDE-NWVAKVSDFGLSKTG 635 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DFGla~~~ 635 (817)
|+||+++++|.+++......+ ++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||++...
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 999999999999997654445 88889999999999999999765 999999999999986 679999999998754
Q ss_pred CCCCCCceeeeeecCcCCCChhhhccCC--CCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhh
Q 039107 636 PNMENGHVSTVVKGSFGYLDPEYFKRQQ--LTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDD 713 (817)
Q Consensus 636 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 713 (817)
.... .......|+..|+|||.+.... ++.++||||||+++|||++|+.|+........ ..|.....
T Consensus 160 ~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~------- 227 (268)
T cd06624 160 AGIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMF------- 227 (268)
T ss_pred ccCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhh-------
Confidence 3211 1122345789999999986643 78899999999999999999999865322111 11110000
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 714 IIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 714 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.....++......+.+++.+||+.+|.+|||+.+++++
T Consensus 228 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 228 ----KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ----ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 01111233455668899999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=321.63 Aligned_cols=259 Identities=23% Similarity=0.400 Sum_probs=202.6
Q ss_pred hhcCCCcceeEeeeCceEEEEEEEec------ccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCe
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVIED------KLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNE 555 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 555 (817)
...+|.+.++||+|+||.||+|..++ +..||+|.+.... ......+.+|+.++++++|+||+++++++.....
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 34678888999999999999997543 3579999876443 2234568899999999999999999999999999
Q ss_pred EEEEEEeccCCchhhhhhccc---------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEE
Q 039107 556 MCLVYDYMALGTLREHIYNTK---------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKV 626 (817)
Q Consensus 556 ~~lV~Ey~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl 626 (817)
.++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 999999999999999996422 23567788999999999999999765 999999999999999999999
Q ss_pred eeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHh
Q 039107 627 SDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHC 705 (817)
Q Consensus 627 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 705 (817)
+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||......+ .....
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~~~~--- 234 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VLKFV--- 234 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH---
Confidence 99999875433222111222335678999999999999999999999999999998 677876533221 11111
Q ss_pred hccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 039107 706 KRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVL 760 (817)
Q Consensus 706 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 760 (817)
...+ . ...+..+...+.+++.+|++.+|++||++.++++.|+..+
T Consensus 235 ~~~~---------~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 235 MDGG---------Y-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HcCC---------C-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 0000 0 0112233467899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=330.29 Aligned_cols=249 Identities=21% Similarity=0.342 Sum_probs=196.8
Q ss_pred eeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeEEEEEEeccC
Q 039107 491 YVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEMCLVYDYMAL 565 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 565 (817)
++||+|+||.||++..+ ++..||+|.++.. .....+.+..|..++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 37999999999999975 5678999998753 233446688999999998 799999999999999999999999999
Q ss_pred CchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceee
Q 039107 566 GTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVST 645 (817)
Q Consensus 566 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 645 (817)
|+|.+++... +.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTTS 154 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CCccc
Confidence 9999887543 46999999999999999999999765 999999999999999999999999998742211 12233
Q ss_pred eeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccc--cchHHHHHHHhhccCchhhccCccccCCC
Q 039107 646 VVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKE--QVSLADWALHCKRKGILDDIIDPLLKDKI 723 (817)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 723 (817)
...||..|+|||++.+..++.++|||||||++|||++|+.||......+ .....++......... . .+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--------~--~~ 224 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--------I--RI 224 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--------C--CC
Confidence 4578999999999999999999999999999999999999996432111 1112222222111111 0 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 039107 724 SPECLKKFADTAEKCLSDSGIDRPS------MGDVLWN 755 (817)
Q Consensus 724 ~~~~~~~l~~li~~cl~~dP~~RPt------~~evl~~ 755 (817)
+......+.+++.+||+.||.+||+ +++++++
T Consensus 225 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 225 PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 2234456789999999999999997 6787765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=300.37 Aligned_cols=263 Identities=23% Similarity=0.338 Sum_probs=210.6
Q ss_pred hhcCCCcceeEeeeCceEEEEEE-EecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEec-----CCeE
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE-----GNEM 556 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~~~ 556 (817)
..++|.+.+.||+|||+-||.++ +.++..+|+|++...+.++.+..++|++..++++|||++++++++.. ..+.
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 34678899999999999999998 55677899999988887888899999999999999999999998743 3458
Q ss_pred EEEEEeccCCchhhhhhcc---ccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCc
Q 039107 557 CLVYDYMALGTLREHIYNT---KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSK 633 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 633 (817)
+|+++|...|+|.+.+... +..+++.+.+.|+.++++||++||+. .++++||||||.|||+.+.+.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 9999999999999998753 23799999999999999999999987 4679999999999999999999999999987
Q ss_pred cCCCCCCCce-------eeeeecCcCCCChhhhcc---CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHH
Q 039107 634 TGPNMENGHV-------STVVKGSFGYLDPEYFKR---QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWAL 703 (817)
Q Consensus 634 ~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~---~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 703 (817)
..+....... -.....|..|.|||.+.- ...++++|||||||+||+|+.|..||+.....
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~---------- 247 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ---------- 247 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc----------
Confidence 6433221110 112346889999999853 46789999999999999999999999754321
Q ss_pred HhhccCchh-hccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 039107 704 HCKRKGILD-DIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVL 760 (817)
Q Consensus 704 ~~~~~~~~~-~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 760 (817)
.+.+. .+..+.+.-+.....++.+.+++.+|++.||.+||++.+++.+++.+.
T Consensus 248 ----GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 248 ----GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ----CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 11111 111112211112236678899999999999999999999999988764
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=331.76 Aligned_cols=260 Identities=23% Similarity=0.396 Sum_probs=200.4
Q ss_pred cCCCcceeEeeeCceEEEEEEE------ecccEEEEEecCCCC-cccHHHHHHHHHHHhcc-CccceeeEEEEEec-CCe
Q 039107 485 KSFDESYVIGVGGFGKVYKGVI------EDKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEE-GNE 555 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~-~~~ 555 (817)
.+|+..++||+|+||.||+|.. ..++.||||+++... ......+.+|+.++.++ +|+||++++++|.. +..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 4678888999999999999973 245789999987543 23346788999999999 68999999998864 456
Q ss_pred EEEEEEeccCCchhhhhhccc-----------------------------------------------------------
Q 039107 556 MCLVYDYMALGTLREHIYNTK----------------------------------------------------------- 576 (817)
Q Consensus 556 ~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------- 576 (817)
.++||||+++|+|.+++....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 799999999999999886421
Q ss_pred -------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceeeeeec
Q 039107 577 -------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKG 649 (817)
Q Consensus 577 -------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 649 (817)
..+++.++..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++...............+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 23688889999999999999999765 99999999999999999999999999976432221111222345
Q ss_pred CcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCHHHH
Q 039107 650 SFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECL 728 (817)
Q Consensus 650 t~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 728 (817)
+..|+|||.+.+..++.++||||||+++|||++ |..|+........ +. ....++.. ...+....
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~----~~~~~~~~---------~~~~~~~~ 308 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FC----RRLKEGTR---------MRAPDYTT 308 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HH----HHHhccCC---------CCCCCCCC
Confidence 678999999998999999999999999999997 8888764322111 10 10111100 01111123
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 039107 729 KKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQL 762 (817)
Q Consensus 729 ~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 762 (817)
..+.+++.+||+.+|++||++.+|+++|+.+.+.
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 4678999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=327.27 Aligned_cols=249 Identities=22% Similarity=0.335 Sum_probs=196.5
Q ss_pred eeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeEEEEEEeccC
Q 039107 491 YVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEMCLVYDYMAL 565 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 565 (817)
++||+|+||+||++... ++..+|+|++... .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 37999999999999975 4578999998753 223456688999999888 699999999999999999999999999
Q ss_pred CchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceee
Q 039107 566 GTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVST 645 (817)
Q Consensus 566 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 645 (817)
|+|..++... +.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~ 154 (327)
T cd05617 81 GDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDTTS 154 (327)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCcee
Confidence 9999887543 46999999999999999999999766 999999999999999999999999998753211 12233
Q ss_pred eeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCH
Q 039107 646 VVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISP 725 (817)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 725 (817)
...||+.|+|||++.+..++.++|||||||+||||++|+.||............++......... ..++.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----------~~~p~ 224 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP----------IRIPR 224 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC----------CCCCC
Confidence 45799999999999999999999999999999999999999965433222222222222111110 01122
Q ss_pred HHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 039107 726 ECLKKFADTAEKCLSDSGIDRPSM------GDVLWN 755 (817)
Q Consensus 726 ~~~~~l~~li~~cl~~dP~~RPt~------~evl~~ 755 (817)
.....+.+++.+||+.||.+|+++ .++++|
T Consensus 225 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 225 FLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 334567899999999999999984 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=329.39 Aligned_cols=254 Identities=25% Similarity=0.430 Sum_probs=211.4
Q ss_pred CCCcceeEeeeCceEEEEEEEecc-cEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEecc
Q 039107 486 SFDESYVIGVGGFGKVYKGVIEDK-LKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMA 564 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 564 (817)
+....++||-|.||.||.|+++.- ..||||.++.+ ....++|+.|..+|+.++|||+|+|+|+|..+..+|+|.|||.
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~ 346 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC 346 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence 344567899999999999998753 57999999855 4567999999999999999999999999999999999999999
Q ss_pred CCchhhhhhcccc-ccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCce
Q 039107 565 LGTLREHIYNTKK-ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643 (817)
Q Consensus 565 ~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 643 (817)
.|+|.++|....+ .++--..+.|+.||+.||.||..+. +|||||..+|+|+.++..+|++||||++++.......
T Consensus 347 yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA- 422 (1157)
T KOG4278|consen 347 YGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA- 422 (1157)
T ss_pred CccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCceec-
Confidence 9999999987655 6777788999999999999999654 9999999999999999999999999999865543322
Q ss_pred eeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCC
Q 039107 644 STVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDK 722 (817)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (817)
+....-.+.|.|||.+....++.|+|||+|||+||||.| |-.|+.+- ++.+. -+++....+.+
T Consensus 423 HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi------dlSqV----------Y~LLEkgyRM~ 486 (1157)
T KOG4278|consen 423 HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI------DLSQV----------YGLLEKGYRMD 486 (1157)
T ss_pred ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc------cHHHH----------HHHHhcccccc
Confidence 122234678999999999999999999999999999988 55555432 22111 12233334445
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 039107 723 ISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVL 760 (817)
Q Consensus 723 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 760 (817)
-++.|+.++.+|++.||+..|.+||+.+|+-+.+|...
T Consensus 487 ~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 487 GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 56789999999999999999999999999999988764
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=334.17 Aligned_cols=244 Identities=23% Similarity=0.328 Sum_probs=196.1
Q ss_pred eeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccCC
Q 039107 491 YVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALG 566 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 566 (817)
++||+|+||.||++... ++..||+|.+... .......+..|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999864 5688999987643 2334567788999999999999999999999999999999999999
Q ss_pred chhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceeee
Q 039107 567 TLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTV 646 (817)
Q Consensus 567 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 646 (817)
+|.+++... +.+++.++..++.||+.||+|||+. .+|+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~~ 155 (325)
T cd05594 81 ELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKT 155 (325)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC--Cccccc
Confidence 999888543 4689999999999999999999962 24999999999999999999999999998753221 112234
Q ss_pred eecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCHH
Q 039107 647 VKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPE 726 (817)
Q Consensus 647 ~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 726 (817)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ... .. ... ++..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~---~i~----~~------~~~----~p~~ 218 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE---LIL----ME------EIR----FPRT 218 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHH---HHh----cC------CCC----CCCC
Confidence 569999999999999999999999999999999999999997543221111 000 00 001 1222
Q ss_pred HHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 039107 727 CLKKFADTAEKCLSDSGIDRP-----SMGDVLWNL 756 (817)
Q Consensus 727 ~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 756 (817)
....+.+++.+||+.||++|+ ++.+++++.
T Consensus 219 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 253 (325)
T cd05594 219 LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHK 253 (325)
T ss_pred CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCC
Confidence 345678999999999999996 899998773
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=315.51 Aligned_cols=257 Identities=21% Similarity=0.347 Sum_probs=204.9
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
.+|...+.||+|+||.||+|+.. ++..||||.+... .......+.+|++++++++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46788889999999999999965 5688999986542 2333457889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhcc---ccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCC
Q 039107 561 DYMALGTLREHIYNT---KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPN 637 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 637 (817)
||+++++|.+++... ...+++.++..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999887532 235888999999999999999999765 99999999999999999999999999876432
Q ss_pred CCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCc
Q 039107 638 MENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717 (817)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (817)
.. .......|+..|+|||.+.+..++.++|+||||+++|||++|+.||...... ..++........
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~~~~~~~~-------- 224 (267)
T cd08228 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLCQKIEQCD-------- 224 (267)
T ss_pred hh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHHHHHhcCC--------
Confidence 21 1112345788999999999888999999999999999999999998643221 111111111100
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 718 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
............+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 225 -~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 225 -YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred -CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 01111223456789999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=317.17 Aligned_cols=256 Identities=24% Similarity=0.424 Sum_probs=204.4
Q ss_pred cCCCcceeEeeeCceEEEEEEEe----cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE----DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 559 (817)
.+|+..+.||+|+||.||+|... ....+|+|.++... ....+.|.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 45777889999999999999864 23479999887543 33356789999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC
Q 039107 560 YDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 639 (817)
|||+++++|.+++......+++.+++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999766667899999999999999999999765 9999999999999999999999999998654322
Q ss_pred CCce-eeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCc
Q 039107 640 NGHV-STVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717 (817)
Q Consensus 640 ~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (817)
.... .....++..|+|||.+.++.++.++||||||++++|+++ |+.||......+ ...+... +.
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~~~----~~------- 226 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAIEE----GY------- 226 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHHhC----CC-------
Confidence 1111 111223568999999998899999999999999999886 999986543321 1111111 00
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 718 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
.......++..+.+++.+|++.+|.+||+|.++++.|+.+
T Consensus 227 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 --RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0011223455678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=325.97 Aligned_cols=268 Identities=21% Similarity=0.329 Sum_probs=201.7
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
.+|...+.||+|+||.||+|+.+ ++..||+|.+.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 45788889999999999999865 45789999877543 22335678999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
+++ +|.+++......+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++...... .
T Consensus 86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~ 159 (309)
T cd07872 86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT--K 159 (309)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc--c
Confidence 985 888888666667899999999999999999999765 9999999999999999999999999987532211 1
Q ss_pred eeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHH---------hhccCchh
Q 039107 643 VSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALH---------CKRKGILD 712 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~---------~~~~~~~~ 712 (817)
......++..|+|||.+.+ ..++.++|||||||++|||++|++||......+.......... ........
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 1223457899999999865 5689999999999999999999999976544332221111000 00000000
Q ss_pred hccCccccC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 713 DIIDPLLKD----KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 713 ~~~d~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
....+.... ...+.....+.+++.+||+.||.+|||+.|++++-..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 289 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF 289 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhh
Confidence 000000000 0011234567899999999999999999999976544
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=326.54 Aligned_cols=249 Identities=22% Similarity=0.349 Sum_probs=195.3
Q ss_pred eeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeEEEEEEeccC
Q 039107 491 YVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEMCLVYDYMAL 565 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 565 (817)
++||+|+||.||++..+ ++..+|+|.++.. .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 37999999999999975 4578999998753 223345677899988877 899999999999999999999999999
Q ss_pred CchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceee
Q 039107 566 GTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVST 645 (817)
Q Consensus 566 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 645 (817)
|+|..++... +.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~~~~ 154 (329)
T cd05618 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTTS 154 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CCccc
Confidence 9998887543 46899999999999999999999765 999999999999999999999999998753221 12223
Q ss_pred eeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccc--cchHHHHHHHhhccCchhhccCccccCCC
Q 039107 646 VVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKE--QVSLADWALHCKRKGILDDIIDPLLKDKI 723 (817)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 723 (817)
...||..|+|||++.+..++.++|||||||++|||++|+.||....... ......+......... ..+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----------~~~ 224 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----------IRI 224 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC----------CCC
Confidence 4578999999999999999999999999999999999999996322111 1111122221111110 112
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 039107 724 SPECLKKFADTAEKCLSDSGIDRPS------MGDVLWN 755 (817)
Q Consensus 724 ~~~~~~~l~~li~~cl~~dP~~RPt------~~evl~~ 755 (817)
+......+.+++.+||+.||.+||+ +.++++|
T Consensus 225 p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 225 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 2334556789999999999999998 5677765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=329.70 Aligned_cols=246 Identities=26% Similarity=0.365 Sum_probs=194.8
Q ss_pred CCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHH---hccCccceeeEEEEEecCCeEEEE
Q 039107 487 FDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEML---SKLRHKHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 487 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lV 559 (817)
|...++||+|+||.||+|... ++..||||+++.. .....+.+.+|++++ ++++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 456789999999999999865 5688999998643 223345666776655 566899999999999999999999
Q ss_pred EEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC
Q 039107 560 YDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 639 (817)
|||+++++|..++.. ..+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~- 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF- 154 (324)
T ss_pred EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCC-
Confidence 999999999988743 46999999999999999999999765 999999999999999999999999998753221
Q ss_pred CCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccc
Q 039107 640 NGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719 (817)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (817)
........|++.|+|||.+.+..++.++|||||||++|||++|+.||......+.. ..... . ...
T Consensus 155 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~------~~i~~-~------~~~- 219 (324)
T cd05589 155 -GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF------DSIVN-D------EVR- 219 (324)
T ss_pred -CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH------HHHHh-C------CCC-
Confidence 12233457899999999999999999999999999999999999999765332111 11000 0 001
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 039107 720 KDKISPECLKKFADTAEKCLSDSGIDRP-----SMGDVLWNL 756 (817)
Q Consensus 720 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 756 (817)
.+...+..+.+++.+||+.||.+|| ++.+++++.
T Consensus 220 ---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~ 258 (324)
T cd05589 220 ---YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQP 258 (324)
T ss_pred ---CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence 1223345678999999999999999 577777653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=329.82 Aligned_cols=253 Identities=23% Similarity=0.292 Sum_probs=198.2
Q ss_pred CCCcceeEeeeCceEEEEEEEe----cccEEEEEecCCC----CcccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE----DKLKVAIKRSNPS----SEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEM 556 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 556 (817)
+|...+.||+|+||.||+++.. .+..||+|.+... .....+.+..|+.+++++ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4677889999999999998753 4678999987642 223345678899999999 599999999999999999
Q ss_pred EEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCC
Q 039107 557 CLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGP 636 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 636 (817)
++||||+++|+|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 9999999999999988654 45899999999999999999999765 9999999999999999999999999997643
Q ss_pred CCCCCceeeeeecCcCCCChhhhccC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhcc
Q 039107 637 NMENGHVSTVVKGSFGYLDPEYFKRQ-QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDII 715 (817)
Q Consensus 637 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (817)
.... .......||..|+|||.+.+. .++.++|||||||++|||++|+.||.......... ........ .
T Consensus 157 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~~~~~~~~-------~ 226 (332)
T cd05614 157 SEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS--EVSRRILK-------C 226 (332)
T ss_pred ccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH--HHHHHHhc-------C
Confidence 2221 122345799999999999865 47889999999999999999999996543221111 11111000 1
Q ss_pred CccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 039107 716 DPLLKDKISPECLKKFADTAEKCLSDSGIDRP-----SMGDVLWNL 756 (817)
Q Consensus 716 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 756 (817)
++. ++......+.+++.+||+.||++|| ++++++++-
T Consensus 227 ~~~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 268 (332)
T cd05614 227 DPP----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP 268 (332)
T ss_pred CCC----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCC
Confidence 111 1223345678999999999999999 777888663
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=328.91 Aligned_cols=247 Identities=24% Similarity=0.327 Sum_probs=196.9
Q ss_pred CCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCC---CcccHHHHHHHHHHHhccCc-cceeeEEEEEecCCeEEEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRH-KHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~ 560 (817)
+|...+.||+|+||.||+|+.++ +..||+|++... .....+.+..|.+++..++| ++|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 46778899999999999998764 578999988643 23445678899999999976 56888999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
||+++|+|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~-- 154 (324)
T cd05587 81 EYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-- 154 (324)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC--
Confidence 999999999988644 35889999999999999999999765 999999999999999999999999998743211
Q ss_pred CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
........||..|+|||++.+..++.++|||||||++|||++|+.||......+. ...+. .. .
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~---~~~i~----~~------~---- 217 (324)
T cd05587 155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL---FQSIM----EH------N---- 217 (324)
T ss_pred CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---HHHHH----cC------C----
Confidence 1223455799999999999999999999999999999999999999976533211 11111 00 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRPSM-----GDVLWN 755 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~~ 755 (817)
..++......+.+++.+||+.+|.+|++. ++++++
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 218 VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11122334567899999999999999986 566654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=331.67 Aligned_cols=253 Identities=21% Similarity=0.264 Sum_probs=201.9
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC---cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS---EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
++|...+.||+|+||+||++... ++..||+|+++... ....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36888899999999999999865 56789999987532 234566889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
||+++|+|.+++......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~- 156 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANK- 156 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCC-
Confidence 999999999999776567999999999999999999999765 9999999999999999999999999997643322
Q ss_pred CceeeeeecCcCCCChhhhc------cCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhc
Q 039107 641 GHVSTVVKGSFGYLDPEYFK------RQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDI 714 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 714 (817)
........||+.|+|||++. ...++.++|||||||++|||++|+.||........ .........
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~i~~~~~---- 226 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT------YNNIMNFQR---- 226 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH------HHHHHcCCC----
Confidence 11233456899999999986 45678999999999999999999999975533211 111110000
Q ss_pred cCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 715 IDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 715 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.+.-.........+.+++..|+. +|.+||++.+++++
T Consensus 227 ---~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 227 ---FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ---ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 00000111234567899999997 99999999999876
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=313.78 Aligned_cols=270 Identities=24% Similarity=0.389 Sum_probs=205.5
Q ss_pred hhcCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhc--cCccceeeEEEEEecC----CeE
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSK--LRHKHLVSLIGFCEEG----NEM 556 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~----~~~ 556 (817)
..++....+.||+|.||.||+|.+++. .||||++....+ ..+.+|.++.+. |+|+||+.+++.-... .++
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wrGe-~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWRGE-DVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hhheeEEEEEecCccccceeeccccCC-ceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 345566778999999999999999765 899999985544 567778888776 4999999999876433 468
Q ss_pred EEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHh-----CCCCceEecCCccCcEEEcCCceeEEeeecc
Q 039107 557 CLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHT-----GAKYTIIHRDVKTTNILLDENWVAKVSDFGL 631 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~~ivH~Dikp~NIll~~~~~~kl~DFGl 631 (817)
+||.+|.++|||.|+|.+ ..++....++++..+|.||++||. ++++.|.|||||+.|||+..++.+.|+|+||
T Consensus 285 wLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred EEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 999999999999999954 679999999999999999999994 5789999999999999999999999999999
Q ss_pred CccCCCCCC--CceeeeeecCcCCCChhhhccCC----C--CchHHHHHHHHHHHHHHhC----------CCCCCCCCcc
Q 039107 632 SKTGPNMEN--GHVSTVVKGSFGYLDPEYFKRQQ----L--TEKSDIYSFGVVLFEVLCA----------RPALNPSLPK 693 (817)
Q Consensus 632 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~----~--s~~sDV~S~Gvvl~elltG----------~~p~~~~~~~ 693 (817)
|-....... ........||.+|||||++...- + -..+||||||.|+||+... ++||....+.
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~ 442 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS 442 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence 965433221 12233457999999999986431 1 2368999999999999752 2455443322
Q ss_pred ccchHHHHHHHhhccCchhhccCccccCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhc
Q 039107 694 EQVSLADWALHCKRKGILDDIIDPLLKDK-ISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVE 764 (817)
Q Consensus 694 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 764 (817)
+.. + ...++-...+-+.|.+... .+.+++..+.++++.||..+|.-|-|+-.|-+.|.++.+..+
T Consensus 443 DPs-~-----eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~e 508 (513)
T KOG2052|consen 443 DPS-F-----EEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSDE 508 (513)
T ss_pred CCC-H-----HHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcChh
Confidence 211 0 0112222222233333332 245788899999999999999999999999999988876443
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=324.47 Aligned_cols=258 Identities=30% Similarity=0.494 Sum_probs=202.7
Q ss_pred cCCCcceeEeeeCceEEEEEEEec-c--cEEEEEecCCC-CcccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIED-K--LKVAIKRSNPS-SEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~-~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 559 (817)
++|...+.||+|+||.||+|..+. + ..+++|.++.. .......+.+|++++.++ +|+||+++++++...+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 467778899999999999998653 3 34688877643 334456788999999999 899999999999999999999
Q ss_pred EEeccCCchhhhhhccc---------------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCcee
Q 039107 560 YDYMALGTLREHIYNTK---------------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVA 624 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~ 624 (817)
|||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999986432 25789999999999999999999765 9999999999999999999
Q ss_pred EEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHH
Q 039107 625 KVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWAL 703 (817)
Q Consensus 625 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 703 (817)
||+|||+++..... .......++..|+|||.+.+..++.++|||||||+++||++ |..||......+ . ..
T Consensus 164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~---~~ 234 (303)
T cd05088 164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---L---YE 234 (303)
T ss_pred EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH---H---HH
Confidence 99999998642111 11112234668999999988889999999999999999998 999986543221 1 11
Q ss_pred HhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhc
Q 039107 704 HCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVE 764 (817)
Q Consensus 704 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 764 (817)
.... + .....+......+.+++.+|++.+|++||++.+++++|+.+++...
T Consensus 235 ~~~~-~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 235 KLPQ-G---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred HHhc-C---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 1100 0 0001112234567899999999999999999999999998775543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=316.61 Aligned_cols=238 Identities=24% Similarity=0.402 Sum_probs=189.7
Q ss_pred eEeeeCceEEEEEEEec-------------ccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEE
Q 039107 492 VIGVGGFGKVYKGVIED-------------KLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCL 558 (817)
Q Consensus 492 ~lG~G~fg~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 558 (817)
.||+|+||.||+|+... ...|++|.+..........|.+|+.+++.++||||+++++++......++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 68999999999998532 23589998876655556688999999999999999999999999899999
Q ss_pred EEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCce-------eEEeeecc
Q 039107 559 VYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWV-------AKVSDFGL 631 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~-------~kl~DFGl 631 (817)
||||+++++|..++......+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +|++|||+
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~ 158 (262)
T cd05077 82 VEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158 (262)
T ss_pred EEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence 99999999999988766667999999999999999999999765 999999999999986654 89999999
Q ss_pred CccCCCCCCCceeeeeecCcCCCChhhhc-cCCCCchHHHHHHHHHHHHHH-hCCCCCCCCCccccchHHHHHHHhhccC
Q 039107 632 SKTGPNMENGHVSTVVKGSFGYLDPEYFK-RQQLTEKSDIYSFGVVLFEVL-CARPALNPSLPKEQVSLADWALHCKRKG 709 (817)
Q Consensus 632 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDV~S~Gvvl~ell-tG~~p~~~~~~~~~~~l~~~~~~~~~~~ 709 (817)
+...... ....++..|+|||.+. +..++.++|||||||++|||+ .|+.|+......+.. .. . ..
T Consensus 159 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~------~~-~-~~ 224 (262)
T cd05077 159 PITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE------RF-Y-EG 224 (262)
T ss_pred CccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH------HH-H-hc
Confidence 8653221 2235788999999886 467899999999999999998 577777543221110 00 0 00
Q ss_pred chhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 710 ILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 710 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
.. .. .......+.+++.+||+.||.+||++.+|+++|
T Consensus 225 ~~------~~----~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 225 QC------ML----VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred Cc------cC----CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00 00 111235678999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=332.91 Aligned_cols=263 Identities=22% Similarity=0.237 Sum_probs=198.1
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
..+|...+.||+|+||.||++... .+..||+|.... ..+.+|+++|++|+||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 357999999999999999999864 567899997542 3567899999999999999999999999999999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
+. ++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 165 ~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~ 238 (391)
T PHA03212 165 YK-TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-AN 238 (391)
T ss_pred CC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-cc
Confidence 96 6888877543 45899999999999999999999765 9999999999999999999999999997532211 12
Q ss_pred eeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccc----hHHHHHHHhhcc----------
Q 039107 643 VSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQV----SLADWALHCKRK---------- 708 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~----~l~~~~~~~~~~---------- 708 (817)
......||+.|+|||++.+..++.++|||||||++|||++|+.|+......... .....+......
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 233457999999999999999999999999999999999999887543211100 000000000000
Q ss_pred Cchhhcc---------CccccCCC--CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 709 GILDDII---------DPLLKDKI--SPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 709 ~~~~~~~---------d~~l~~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
..+.... .+..+... ....+..+.+++.+||+.||.+|||+.|++++-..
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f 379 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAF 379 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhh
Confidence 0000000 00000000 01235578899999999999999999999976543
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=314.26 Aligned_cols=246 Identities=27% Similarity=0.429 Sum_probs=194.8
Q ss_pred eEeeeCceEEEEEEEe---cccEEEEEecCCCC--cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccCC
Q 039107 492 VIGVGGFGKVYKGVIE---DKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALG 566 (817)
Q Consensus 492 ~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 566 (817)
.||+|+||.||+|.++ ++..+|+|+++... ....+++.+|+.++++++|+||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 45789999976443 234567899999999999999999999986 45679999999999
Q ss_pred chhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc-eee
Q 039107 567 TLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH-VST 645 (817)
Q Consensus 567 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~-~~~ 645 (817)
+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||.||++++++.+||+|||+++......... ...
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 81 PLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 999998644 46899999999999999999999765 9999999999999999999999999997643322111 111
Q ss_pred eeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCC
Q 039107 646 VVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKIS 724 (817)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 724 (817)
...++..|+|||.+....++.++||||||+++|||++ |+.||......+ +.... +++. ....+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~i----~~~~---------~~~~~ 220 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---VTQMI----ESGE---------RMECP 220 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HCCC---------CCCCC
Confidence 2234578999999988889999999999999999998 999987543221 11111 1111 11122
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 725 PECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 725 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
..++.++.+++.+|++.+|++||++.+|.+.|+.
T Consensus 221 ~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 221 QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 2345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=313.31 Aligned_cols=252 Identities=27% Similarity=0.433 Sum_probs=201.6
Q ss_pred cCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEecc
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMA 564 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 564 (817)
.+|.....||+|++|.||++..+++..+|+|.+.... ...+.|.+|++++++++|+|++++++++.. ...++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence 3467778999999999999998877789999877543 334678999999999999999999998854 56899999999
Q ss_pred CCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCce
Q 039107 565 LGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643 (817)
Q Consensus 565 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 643 (817)
+++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++....... ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~ 159 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TA 159 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc-cc
Confidence 999999997543 35899999999999999999999765 99999999999999999999999999976432211 11
Q ss_pred eeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCC
Q 039107 644 STVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDK 722 (817)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (817)
.....++..|+|||...+..++.++||||||+++|||++ |+.||......+ ..++.. ... ...
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~---~~~----------~~~ 223 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLEQVE---RGY----------RMP 223 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH---cCC----------CCC
Confidence 122345678999999998999999999999999999999 888886543221 111111 100 011
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 723 ISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 723 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
.+...+..+.+++.+||+.+|++||++++|++.|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 223445678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=322.51 Aligned_cols=261 Identities=25% Similarity=0.434 Sum_probs=203.2
Q ss_pred cCCCcceeEeeeCceEEEEEEEec-----------------ccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIED-----------------KLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSL 546 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l 546 (817)
.+|...+.||+|+||.||++...+ +..||+|.+.... ....+.+.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 467888899999999999988643 2458999987553 3446788999999999999999999
Q ss_pred EEEEecCCeEEEEEEeccCCchhhhhhccc----------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcE
Q 039107 547 IGFCEEGNEMCLVYDYMALGTLREHIYNTK----------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNI 616 (817)
Q Consensus 547 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NI 616 (817)
++++......++|+||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhce
Confidence 999999899999999999999999986543 25899999999999999999999765 99999999999
Q ss_pred EEcCCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh--CCCCCCCCCccc
Q 039107 617 LLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC--ARPALNPSLPKE 694 (817)
Q Consensus 617 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt--G~~p~~~~~~~~ 694 (817)
+++.++.++|+|||+++...............++..|+|||.+..+.++.++|||||||++|||++ +..|+......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence 999999999999999976433222222333456778999999998899999999999999999998 566665432211
Q ss_pred cchHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 695 QVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 695 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
.............. ......+..++.++.+++.+|++.+|.+|||+.+|++.|+
T Consensus 242 ---~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 242 ---VIENAGHFFRDDGR------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ---HHHHHHhccccccc------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11111111111100 0001112234467899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=319.61 Aligned_cols=238 Identities=26% Similarity=0.396 Sum_probs=189.2
Q ss_pred eEeeeCceEEEEEEEec-------------------------ccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeE
Q 039107 492 VIGVGGFGKVYKGVIED-------------------------KLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSL 546 (817)
Q Consensus 492 ~lG~G~fg~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 546 (817)
+||+|+||.||+|.+.. ...|++|.+.........+|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999998531 13588998876555555678899999999999999999
Q ss_pred EEEEecCCeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCc----
Q 039107 547 IGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENW---- 622 (817)
Q Consensus 547 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~---- 622 (817)
+++|.+....++||||+++|+|..++......+++..++.++.|+++||+|||+++ |+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcccC
Confidence 99999999999999999999999998766667899999999999999999999765 99999999999997643
Q ss_pred ---eeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHH-hCCCCCCCCCccccch
Q 039107 623 ---VAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVL-CARPALNPSLPKEQVS 697 (817)
Q Consensus 623 ---~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~ell-tG~~p~~~~~~~~~~~ 697 (817)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+......+..
T Consensus 159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~- 231 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE- 231 (274)
T ss_pred ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH-
Confidence 4899999988643211 12246788999998865 56899999999999999985 688888654332211
Q ss_pred HHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 698 LADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 698 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
.+... . ... +......+.+++.+||+.+|++||++.+|++.|
T Consensus 232 --~~~~~---~--------~~~----~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 232 --RFYEK---K--------HRL----PEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred --HHHHh---c--------cCC----CCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 11000 0 001 111234578999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=315.05 Aligned_cols=252 Identities=25% Similarity=0.424 Sum_probs=202.9
Q ss_pred cCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEecc
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMA 564 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 564 (817)
++|...++||+|+||.||+|..+++..+|+|.+.... ....+|.+|+.++++++|+||+++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME 83 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence 4677888999999999999998888899999987543 34578999999999999999999999874 457899999999
Q ss_pred CCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCce
Q 039107 565 LGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643 (817)
Q Consensus 565 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 643 (817)
+++|.+++.... ..+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++........ ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~ 159 (260)
T cd05067 84 NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-TA 159 (260)
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc-cc
Confidence 999999886543 36899999999999999999999665 99999999999999999999999999976432111 11
Q ss_pred eeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCC
Q 039107 644 STVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDK 722 (817)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (817)
.....++..|+|||.+....++.++||||||++++||++ |+.||......+ +.... .. . ....
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~---~~-~---------~~~~ 223 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---VIQNL---ER-G---------YRMP 223 (260)
T ss_pred ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---HHHHH---Hc-C---------CCCC
Confidence 122345678999999998899999999999999999999 999987543221 11111 00 0 0011
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 723 ISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 723 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
.+...+.++.+++.+|++.+|++||+++++++.|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 122334568999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=314.05 Aligned_cols=248 Identities=30% Similarity=0.524 Sum_probs=203.4
Q ss_pred eeEeeeCceEEEEEEEec----ccEEEEEecCCCCcc-cHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccC
Q 039107 491 YVIGVGGFGKVYKGVIED----KLKVAIKRSNPSSEQ-GVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMAL 565 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 565 (817)
++||+|+||.||+|.... +..+++|.+...... ..+.+.+|++++++++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 369999999999999764 678999998865433 367899999999999999999999999999999999999999
Q ss_pred Cchhhhhhcc--------ccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCC
Q 039107 566 GTLREHIYNT--------KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPN 637 (817)
Q Consensus 566 gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 637 (817)
++|.+++... ...+++.++..++.|++.||+|||+++ ++||||||+||++++++.+||+|||++.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999765 367999999999999999999999765 99999999999999999999999999987544
Q ss_pred CCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccC
Q 039107 638 MENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIID 716 (817)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (817)
...........++..|+|||.+....++.++||||||++++||++ |+.||......+ +.+.. .. +
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~---~~-~------- 223 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---VLEYL---RK-G------- 223 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH---Hc-C-------
Confidence 332222334557889999999998899999999999999999999 588887652211 11111 11 1
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 717 PLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 717 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
.....+..++..+.+++.+|++.+|++||++.+++++|+
T Consensus 224 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 --YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 011122334567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=311.95 Aligned_cols=247 Identities=26% Similarity=0.448 Sum_probs=199.2
Q ss_pred eEeeeCceEEEEEEEecccEEEEEecCCCCcc-cHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccCCchhh
Q 039107 492 VIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQ-GVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLRE 570 (817)
Q Consensus 492 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 570 (817)
+||+|+||.||++...++..|++|+....... ....|.+|++++++++|+||+++++++......++||||+++++|.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~ 81 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT 81 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHH
Confidence 69999999999999877889999987755333 45789999999999999999999999999999999999999999999
Q ss_pred hhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceeeeeecC
Q 039107 571 HIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGS 650 (817)
Q Consensus 571 ~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 650 (817)
++......+++..++.++.+++.||+|||+++ ++||||||+|||++.++.+||+|||+++...............++
T Consensus 82 ~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~ 158 (251)
T cd05041 82 FLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIP 158 (251)
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcce
Confidence 99765557899999999999999999999766 999999999999999999999999998754321111111122335
Q ss_pred cCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCHHHHH
Q 039107 651 FGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLK 729 (817)
Q Consensus 651 ~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 729 (817)
..|+|||.+.++.++.++|+||||++++||++ |..||....... ...... . ......+...+.
T Consensus 159 ~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---~~~~~~----~---------~~~~~~~~~~~~ 222 (251)
T cd05041 159 IKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---TRERIE----S---------GYRMPAPQLCPE 222 (251)
T ss_pred eccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---HHHHHh----c---------CCCCCCCccCCH
Confidence 67999999998899999999999999999999 788876543221 111110 0 001111223456
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 730 KFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 730 ~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
.+.+++.+|+..+|++||++.++++.|+
T Consensus 223 ~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 223 EIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 7899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=323.73 Aligned_cols=260 Identities=24% Similarity=0.476 Sum_probs=204.4
Q ss_pred cCCCcceeEeeeCceEEEEEEEe--------cccEEEEEecCCCC-cccHHHHHHHHHHHhcc-CccceeeEEEEEecCC
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE--------DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGN 554 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 554 (817)
.+|...+.||+|+||.||++... ....+|+|.+.... .....++..|+++++++ +||||++++++|....
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 45777889999999999999742 23468999877542 34456788999999999 6999999999999989
Q ss_pred eEEEEEEeccCCchhhhhhccc---------------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEc
Q 039107 555 EMCLVYDYMALGTLREHIYNTK---------------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLD 619 (817)
Q Consensus 555 ~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~ 619 (817)
..++||||+++|+|.+++.... ..+++.++++++.|++.||.|||+.+ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 9999999999999999986432 35899999999999999999999765 99999999999999
Q ss_pred CCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchH
Q 039107 620 ENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSL 698 (817)
Q Consensus 620 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l 698 (817)
+++.+||+|||+++...............++..|+|||.+.++.++.++||||||+++|||++ |+.||......+ +
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~ 245 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE---L 245 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH---H
Confidence 999999999999986433221111122234567999999998999999999999999999999 888885443211 1
Q ss_pred HHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 039107 699 ADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLV 763 (817)
Q Consensus 699 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 763 (817)
.... ..+. ....+..+...+.+++.+|++.+|++||++.++++.|+.+....
T Consensus 246 ~~~~----~~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 246 FKLL----REGH---------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred HHHH----HcCC---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 1111 1110 01112234557889999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=318.78 Aligned_cols=254 Identities=24% Similarity=0.428 Sum_probs=203.1
Q ss_pred cCCCcceeEeeeCceEEEEEEEec------ccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIED------KLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMC 557 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 557 (817)
++|...+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+.+++.++|+||+++++++......+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 467788899999999999998653 2579999987543 234567889999999999999999999999999999
Q ss_pred EEEEeccCCchhhhhhccc---------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEee
Q 039107 558 LVYDYMALGTLREHIYNTK---------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSD 628 (817)
Q Consensus 558 lV~Ey~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 628 (817)
+||||+++|+|.+++.... ..++|..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEECC
Confidence 9999999999999986432 24788999999999999999999765 99999999999999999999999
Q ss_pred eccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhc
Q 039107 629 FGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKR 707 (817)
Q Consensus 629 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 707 (817)
||+++...............++..|+|||.+..+.++.++|||||||++|||++ |+.||......+ +..+..
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~~~---- 235 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VLKFVI---- 235 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HHHHHh----
Confidence 999876433222222233446789999999998899999999999999999998 888886543222 111111
Q ss_pred cCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 708 KGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 708 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
.+. ....+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus 236 ~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 DGG---------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred cCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 110 01112234567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=324.38 Aligned_cols=242 Identities=24% Similarity=0.323 Sum_probs=192.4
Q ss_pred eeEeeeCceEEEEEEEe-cccEEEEEecCCCC---cccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeEEEEEEeccC
Q 039107 491 YVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS---EQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEMCLVYDYMAL 565 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 565 (817)
++||+|+||.||+|..+ ++..||+|.++... ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 37999999999999976 46789999987531 23345677788888765 899999999999999999999999999
Q ss_pred CchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceee
Q 039107 566 GTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVST 645 (817)
Q Consensus 566 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 645 (817)
|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~ 154 (316)
T cd05620 81 GDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNRAS 154 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCcee
Confidence 9999988653 46899999999999999999999765 999999999999999999999999998742211 12234
Q ss_pred eeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCH
Q 039107 646 VVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISP 725 (817)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 725 (817)
...||..|+|||++.+..++.++|||||||++|||++|+.||....... +.+... .. .+.+ +.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~---~~~~~~----~~------~~~~----~~ 217 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---LFESIR----VD------TPHY----PR 217 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHH----hC------CCCC----CC
Confidence 4679999999999999999999999999999999999999997543221 111110 00 1111 12
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHH-HHHHH
Q 039107 726 ECLKKFADTAEKCLSDSGIDRPSMG-DVLWN 755 (817)
Q Consensus 726 ~~~~~l~~li~~cl~~dP~~RPt~~-evl~~ 755 (817)
....++.+++.+||+.||.+||++. ++++|
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 218 WITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 2345678999999999999999984 66544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=328.80 Aligned_cols=242 Identities=23% Similarity=0.332 Sum_probs=194.0
Q ss_pred eeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeEEEEEEeccC
Q 039107 491 YVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEMCLVYDYMAL 565 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 565 (817)
++||+|+||+||+|+.+ ++..||+|++... .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999975 4678999987643 233456778899998877 699999999999999999999999999
Q ss_pred CchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceee
Q 039107 566 GTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVST 645 (817)
Q Consensus 566 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 645 (817)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~~~~ 154 (320)
T cd05590 81 GDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKTTS 154 (320)
T ss_pred chHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CCccc
Confidence 9999988654 35899999999999999999999765 999999999999999999999999998753221 12233
Q ss_pred eeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCH
Q 039107 646 VVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISP 725 (817)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 725 (817)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||......+. ...+ .. +. . ..+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~---~~~i---~~-~~------~----~~~~ 217 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL---FEAI---LN-DE------V----VYPT 217 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH---HHHH---hc-CC------C----CCCC
Confidence 45689999999999999999999999999999999999999976543211 1111 10 00 0 0112
Q ss_pred HHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 039107 726 ECLKKFADTAEKCLSDSGIDRPSM------GDVLWN 755 (817)
Q Consensus 726 ~~~~~l~~li~~cl~~dP~~RPt~------~evl~~ 755 (817)
.....+.+++.+||+.||.+||++ ++++++
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 218 WLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 234567899999999999999998 666654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=312.90 Aligned_cols=248 Identities=29% Similarity=0.506 Sum_probs=203.3
Q ss_pred cCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEecc
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMA 564 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 564 (817)
++|...+.||+|+||.||+|... +..||+|.+..... ..+++.+|+.++++++|+||+++++++......++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 46777889999999999999876 56899999876544 56789999999999999999999999998999999999999
Q ss_pred CCchhhhhhcccc-ccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCce
Q 039107 565 LGTLREHIYNTKK-ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643 (817)
Q Consensus 565 ~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 643 (817)
+++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~---- 156 (256)
T cd05039 84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ---- 156 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc----
Confidence 9999999865543 6999999999999999999999766 9999999999999999999999999998642211
Q ss_pred eeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCC
Q 039107 644 STVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDK 722 (817)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (817)
.....+..|+|||.+..+.++.++||||||++++||++ |+.||......+ +.... ..+ ....
T Consensus 157 -~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~----~~~---------~~~~ 219 (256)
T cd05039 157 -DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPHV----EKG---------YRME 219 (256)
T ss_pred -ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH----hcC---------CCCC
Confidence 12334678999999998899999999999999999997 998886543211 11111 111 0111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 723 ISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 723 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
.+...+..+.+++.+||..+|++||++.+++++|+.
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 122345678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=323.77 Aligned_cols=242 Identities=24% Similarity=0.332 Sum_probs=195.0
Q ss_pred eeEeeeCceEEEEEEEec-ccEEEEEecCCC---CcccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeEEEEEEeccC
Q 039107 491 YVIGVGGFGKVYKGVIED-KLKVAIKRSNPS---SEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEMCLVYDYMAL 565 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 565 (817)
++||+|+||+||++..+. +..||+|.+... .......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999764 578999988743 233456678899999888 799999999999999999999999999
Q ss_pred CchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceee
Q 039107 566 GTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVST 645 (817)
Q Consensus 566 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 645 (817)
|+|..++... ..+++.++..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++..... .....
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~~ 154 (318)
T cd05570 81 GDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--GVTTS 154 (318)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcC--CCccc
Confidence 9999888644 36999999999999999999999765 999999999999999999999999998753221 12223
Q ss_pred eeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCH
Q 039107 646 VVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISP 725 (817)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 725 (817)
...|+..|+|||++.+..++.++|||||||++|||++|+.||....... +. ....... . .++.
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~---~~---~~i~~~~-------~----~~~~ 217 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE---LF---QSILEDE-------V----RYPR 217 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH---HH---HHHHcCC-------C----CCCC
Confidence 4568999999999999999999999999999999999999997543221 11 1111100 0 1122
Q ss_pred HHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 039107 726 ECLKKFADTAEKCLSDSGIDRPSM-----GDVLWN 755 (817)
Q Consensus 726 ~~~~~l~~li~~cl~~dP~~RPt~-----~evl~~ 755 (817)
.....+.+++.+||+.||.+||++ .+++++
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 218 WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 334567999999999999999999 887765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=336.65 Aligned_cols=254 Identities=21% Similarity=0.301 Sum_probs=199.6
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
++|+..++||+|+||+||+++.. +++.||||++... .......+.+|+.+|+.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36888899999999999999975 5688999998643 2233456789999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 81 EYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 999999999998654 36899999999999999999999766 99999999999999999999999999875321110
Q ss_pred C------------------------------------ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCC
Q 039107 641 G------------------------------------HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCAR 684 (817)
Q Consensus 641 ~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~ 684 (817)
. .......||+.|+|||++....++.++|||||||++|||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 0 0011245899999999999999999999999999999999999
Q ss_pred CCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHHH
Q 039107 685 PALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPS---MGDVLWNL 756 (817)
Q Consensus 685 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~L 756 (817)
.||......+. ...+... ... +...........+.+++.+|+. +|.+|++ +.+++++-
T Consensus 237 ~Pf~~~~~~~~---~~~i~~~--~~~--------~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~ 297 (364)
T cd05599 237 PPFCSDNPQET---YRKIINW--KET--------LQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHP 297 (364)
T ss_pred CCCCCCCHHHH---HHHHHcC--CCc--------cCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCC
Confidence 99976543221 1111100 000 0000011234457889999996 8999997 99998764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=314.66 Aligned_cols=253 Identities=22% Similarity=0.364 Sum_probs=201.8
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC-----cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS-----EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCL 558 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 558 (817)
++|...++||+|++|.||++... ++..+++|.+.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46888899999999999999864 56889999876432 1234578899999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCC
Q 039107 559 VYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNM 638 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 638 (817)
|+||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||+++.....
T Consensus 82 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 99999999999988644 35889999999999999999999765 999999999999999999999999998754322
Q ss_pred CCCc-eeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCc
Q 039107 639 ENGH-VSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717 (817)
Q Consensus 639 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (817)
.... ......++..|+|||.+.+..++.++||||||+++|||++|+.||........ ..+. . ..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~---~---------~~ 222 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA---IFKI---A---------TQ 222 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH---HHHH---h---------cc
Confidence 1111 11234578899999999998999999999999999999999999865322111 0000 0 00
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 718 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
......+......+.+++.+||..+|.+|||+.+++++.
T Consensus 223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 223 PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 011122334456688999999999999999999998763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=329.42 Aligned_cols=242 Identities=22% Similarity=0.327 Sum_probs=195.1
Q ss_pred eEeeeCceEEEEEEEec-ccEEEEEecCCC---CcccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeEEEEEEeccCC
Q 039107 492 VIGVGGFGKVYKGVIED-KLKVAIKRSNPS---SEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEMCLVYDYMALG 566 (817)
Q Consensus 492 ~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~g 566 (817)
+||+|+||.||+|+.++ +..||+|.+... .....+.+..|.+++..+ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 69999999999999764 678999998753 233456678899999876 7999999999999999999999999999
Q ss_pred chhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceeee
Q 039107 567 TLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTV 646 (817)
Q Consensus 567 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 646 (817)
+|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ......
T Consensus 82 ~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~--~~~~~~ 155 (321)
T cd05591 82 DLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--GVTTTT 155 (321)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccC--Cccccc
Confidence 999888644 45899999999999999999999765 999999999999999999999999998753221 122334
Q ss_pred eecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCHH
Q 039107 647 VKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPE 726 (817)
Q Consensus 647 ~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 726 (817)
..||..|+|||++.+..++.++|||||||++|||++|+.||......+. .+.. .... .. .+..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~---~~~i---~~~~-------~~----~p~~ 218 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL---FESI---LHDD-------VL----YPVW 218 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH---HHHH---HcCC-------CC----CCCC
Confidence 5689999999999999999999999999999999999999976543221 1111 1100 00 1112
Q ss_pred HHHHHHHHHHHccccCCCCCC-------CHHHHHHHH
Q 039107 727 CLKKFADTAEKCLSDSGIDRP-------SMGDVLWNL 756 (817)
Q Consensus 727 ~~~~l~~li~~cl~~dP~~RP-------t~~evl~~L 756 (817)
....+.+++.+||+.+|++|| ++.+++++-
T Consensus 219 ~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp 255 (321)
T cd05591 219 LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHP 255 (321)
T ss_pred CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCC
Confidence 345678999999999999999 888888663
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=335.29 Aligned_cols=262 Identities=21% Similarity=0.248 Sum_probs=196.8
Q ss_pred hcCCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
...|.+.+.||+|+||.||++.... +..||||.... ..+.+|+++|++|+|+||+++++++......++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 3468889999999999999999764 57899996432 3457899999999999999999999999999999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
+. ++|.+++......++|.+++.|+.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++.........
T Consensus 242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 95 7888888765567999999999999999999999765 9999999999999999999999999998643322222
Q ss_pred eeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCcc-cc----chHHHHHHHhhcc-Cchh----
Q 039107 643 VSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPK-EQ----VSLADWALHCKRK-GILD---- 712 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~-~~----~~l~~~~~~~~~~-~~~~---- 712 (817)
......||..|+|||++.+..++.++|||||||+||||++|..++...... .. ..+...+...... ....
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~ 397 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG 397 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence 233457999999999999999999999999999999999988665432111 10 1111111110000 0000
Q ss_pred -----hcc-------Ccccc-CCCC--HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 713 -----DII-------DPLLK-DKIS--PECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 713 -----~~~-------d~~l~-~~~~--~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
... .+... ..+. ......+.+|+.+||+.||.+|||+.|+|++
T Consensus 398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000 00000 0000 0122357899999999999999999999986
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=311.37 Aligned_cols=263 Identities=23% Similarity=0.310 Sum_probs=201.5
Q ss_pred CCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcc-c-HHHHHHHHHHHhccCccc-eeeEEEEEecCC------eE
Q 039107 487 FDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQ-G-VNEFVTEIEMLSKLRHKH-LVSLIGFCEEGN------EM 556 (817)
Q Consensus 487 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~------~~ 556 (817)
|...++||+|+||+||+|+.+ +|..||+|++....+. + .....+|+.+|++|+|+| |++|++++...+ .+
T Consensus 13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l 92 (323)
T KOG0594|consen 13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL 92 (323)
T ss_pred HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence 444557999999999999954 6789999998766442 2 345679999999999999 999999998776 78
Q ss_pred EEEEEeccCCchhhhhhccc---cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCc
Q 039107 557 CLVYDYMALGTLREHIYNTK---KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSK 633 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 633 (817)
+||+||++ -+|..++.... +.++...+..+++||++||+|||+++ |+||||||+||||+++|.+||+|||+|+
T Consensus 93 ~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 93 YLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred EEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchHH
Confidence 99999997 48999987655 35777899999999999999999776 9999999999999999999999999999
Q ss_pred cCCCCCCCceeeeeecCcCCCChhhhccC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCch-
Q 039107 634 TGPNMENGHVSTVVKGSFGYLDPEYFKRQ-QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGIL- 711 (817)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~- 711 (817)
.... .....+...+|..|.|||++.+. .|+...|+||+||++.||+++++-|.+..+.++...+--......+...
T Consensus 169 a~~i--p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 169 AFSI--PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP 246 (323)
T ss_pred HhcC--CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence 6432 22224455689999999998876 7999999999999999999999999888775554332111111111000
Q ss_pred --hhccCc--ccc-----CCCCHHH---HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 712 --DDIIDP--LLK-----DKISPEC---LKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 712 --~~~~d~--~l~-----~~~~~~~---~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
..+.+- ... ....... .....+++.+||+.+|.+|.|++.+++|
T Consensus 247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 000010 000 0011111 1367899999999999999999999987
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.90 Aligned_cols=247 Identities=31% Similarity=0.513 Sum_probs=195.3
Q ss_pred eEeeeCceEEEEEEEec-c--cEEEEEecCCC-CcccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeEEEEEEeccCC
Q 039107 492 VIGVGGFGKVYKGVIED-K--LKVAIKRSNPS-SEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEMCLVYDYMALG 566 (817)
Q Consensus 492 ~lG~G~fg~Vy~~~~~~-~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~g 566 (817)
+||+|+||.||+|..++ + ..+++|.++.. .....+.+.+|++++.++ +||||+++++++......++||||+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 68999999999999754 3 35788887743 234456789999999999 7999999999999999999999999999
Q ss_pred chhhhhhccc---------------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeecc
Q 039107 567 TLREHIYNTK---------------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGL 631 (817)
Q Consensus 567 sL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGl 631 (817)
+|.+++.... ..+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCCC
Confidence 9999986432 24789999999999999999999765 99999999999999999999999999
Q ss_pred CccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCc
Q 039107 632 SKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGI 710 (817)
Q Consensus 632 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 710 (817)
++..... ........+..|+|||++....++.++||||||++++||++ |+.||......+ + .......
T Consensus 159 ~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~---~~~~~~~-- 227 (270)
T cd05047 159 SRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---L---YEKLPQG-- 227 (270)
T ss_pred ccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---H---HHHHhCC--
Confidence 8642211 11111234567999999988899999999999999999997 999986532211 1 1111110
Q ss_pred hhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 039107 711 LDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVL 760 (817)
Q Consensus 711 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 760 (817)
........+...+.+++.+|++.+|.+||++.++++.|+.++
T Consensus 228 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 --------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred --------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 001112233456889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=315.39 Aligned_cols=256 Identities=22% Similarity=0.352 Sum_probs=204.7
Q ss_pred CCCcceeEeeeCceEEEEEEE-ecccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVI-EDKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
+|...+.||+|+||.||++.. .++..++||.+... .....+++.+|+.+++.++|+||+++++++.+.+..+++||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 567778999999999999995 46789999987643 22344678999999999999999999999999999999999
Q ss_pred eccCCchhhhhhc---cccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCC
Q 039107 562 YMALGTLREHIYN---TKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNM 638 (817)
Q Consensus 562 y~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 638 (817)
|+++++|.+++.. ....+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 9999999998863 2346899999999999999999999765 999999999999999999999999998764322
Q ss_pred CCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcc
Q 039107 639 ENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPL 718 (817)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (817)
.. ......|+..|+|||.+.+..++.++||||||+++|||++|..||...... ..++.... .....+.
T Consensus 160 ~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~------~~~~~~~ 227 (267)
T cd08229 160 TT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKI------EQCDYPP 227 (267)
T ss_pred Cc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhhh------hcCCCCC
Confidence 21 122345889999999999889999999999999999999999998654321 11111110 0011111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 719 LKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 719 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
. ........+.+++.+|++.+|++||||.+|++.+++.
T Consensus 228 ~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 228 L---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred C---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1 1123556789999999999999999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=313.18 Aligned_cols=254 Identities=29% Similarity=0.479 Sum_probs=205.8
Q ss_pred hcCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
.++|...++||+|+||.||+|..+++..+++|.+.... ...+++.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 45688888999999999999998887889999987543 34578999999999999999999999999889999999999
Q ss_pred cCCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 564 ALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 564 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
++++|.+++.... ..+++.++..++.|++.||+|||+++ ++|+||||+||++++++.+||+|||+++....... .
T Consensus 84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-~ 159 (261)
T cd05034 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY-T 159 (261)
T ss_pred CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh-h
Confidence 9999999997654 46899999999999999999999765 99999999999999999999999999876432111 1
Q ss_pred eeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccC
Q 039107 643 VSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKD 721 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (817)
......++..|+|||.+.+..++.++||||||++++||++ |+.||....... ..+... .. ...
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~~~---~~----------~~~ 223 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLEQVE---RG----------YRM 223 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH---cC----------CCC
Confidence 1112234578999999998899999999999999999998 999986543221 111110 00 011
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 722 KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 722 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
..+...+..+.+++.+|+..+|++||+++++++.|+.
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1122335568999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=313.09 Aligned_cols=251 Identities=28% Similarity=0.464 Sum_probs=194.5
Q ss_pred eeEeeeCceEEEEEEEec----ccEEEEEecCCC-CcccHHHHHHHHHHHhccCccceeeEEEEEe-cCCeEEEEEEecc
Q 039107 491 YVIGVGGFGKVYKGVIED----KLKVAIKRSNPS-SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCE-EGNEMCLVYDYMA 564 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lV~Ey~~ 564 (817)
++||+|+||.||+|...+ ...+|+|++... .....+.+.+|+.+++.++||||+++++++. .....++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 368999999999998642 357999997643 2344578889999999999999999999875 4556899999999
Q ss_pred CCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC--c
Q 039107 565 LGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG--H 642 (817)
Q Consensus 565 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~--~ 642 (817)
+|+|.+++......+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++........ .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999999765556788889999999999999999765 999999999999999999999999999754321110 1
Q ss_pred eeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCC-CCCCCCCccccchHHHHHHHhhccCchhhccCccccC
Q 039107 643 VSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCAR-PALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKD 721 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (817)
......++..|+|||.+....++.++||||||+++|||++|. +|+..... ..+..... .... .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~---~~~~----------~ 221 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDITVYLL---QGRR----------L 221 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHh---cCCC----------C
Confidence 112334577899999998889999999999999999999964 55543221 11111111 1000 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 039107 722 KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVL 760 (817)
Q Consensus 722 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 760 (817)
..+...+..+.+++.+||+.+|++||++.+|++.|+.+.
T Consensus 222 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 222 LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 011223456889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=320.84 Aligned_cols=261 Identities=22% Similarity=0.381 Sum_probs=200.1
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-----------------cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-----------------DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSL 546 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l 546 (817)
++|+..++||+|+||.||++... +...+|+|.+.... ....++|.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46888889999999999998533 23468999987543 3345689999999999999999999
Q ss_pred EEEEecCCeEEEEEEeccCCchhhhhhccc----------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcE
Q 039107 547 IGFCEEGNEMCLVYDYMALGTLREHIYNTK----------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNI 616 (817)
Q Consensus 547 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NI 616 (817)
++++...+..++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ ++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 999999999999999999999999986532 24778899999999999999999765 99999999999
Q ss_pred EEcCCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh--CCCCCCCCCccc
Q 039107 617 LLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC--ARPALNPSLPKE 694 (817)
Q Consensus 617 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt--G~~p~~~~~~~~ 694 (817)
|+++++.++|+|||+++...............++..|++||....+.++.++|||||||++|||++ |..||......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999875432221111222334678999999888899999999999999999998 667775433222
Q ss_pred cchHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 695 QVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 695 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
.. ............ . .....+..++..+.+++.+||+.+|.+||++.+|++.|+
T Consensus 242 ~~---~~~~~~~~~~~~-~-----~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 242 VI---ENTGEFFRDQGR-Q-----VYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HH---HHHHHHHhhccc-c-----ccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11 111000000000 0 000112234567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=313.75 Aligned_cols=247 Identities=23% Similarity=0.406 Sum_probs=199.5
Q ss_pred eEeeeCceEEEEEEEec--c--cEEEEEecCCCCc-ccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccCC
Q 039107 492 VIGVGGFGKVYKGVIED--K--LKVAIKRSNPSSE-QGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALG 566 (817)
Q Consensus 492 ~lG~G~fg~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 566 (817)
+||+|++|.||+|.... + ..||+|.+..... ...+.|.+|+.++++++|+||+++++++.. ...++|+||++++
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~ 80 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLG 80 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCC
Confidence 68999999999998654 2 3699999887655 566789999999999999999999999988 8899999999999
Q ss_pred chhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC-cee
Q 039107 567 TLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG-HVS 644 (817)
Q Consensus 567 sL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~ 644 (817)
+|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++........ ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 81 SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred cHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 9999997655 47899999999999999999999765 999999999999999999999999999865432211 111
Q ss_pred eeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCC
Q 039107 645 TVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKI 723 (817)
Q Consensus 645 ~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 723 (817)
....++..|+|||.+.+..++.++|||||||+++||++ |+.||......+. ...... ... ....
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~~~---~~~---------~~~~ 222 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI---LKKIDK---EGE---------RLER 222 (257)
T ss_pred cCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHh---cCC---------cCCC
Confidence 23456789999999999999999999999999999998 9999865432221 111110 000 0011
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 724 SPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 724 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
+...+..+.+++.+|++.+|++||++.++++.|.
T Consensus 223 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 223 PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 2234567899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=318.97 Aligned_cols=246 Identities=24% Similarity=0.345 Sum_probs=195.3
Q ss_pred EeeeCceEEEEEEEe-cccEEEEEecCCCC---cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccCCch
Q 039107 493 IGVGGFGKVYKGVIE-DKLKVAIKRSNPSS---EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTL 568 (817)
Q Consensus 493 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 568 (817)
||+|+||+||++... ++..+|+|++.... ....+.+..|++++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999865 56789999976432 22345678899999999999999999999999999999999999999
Q ss_pred hhhhhc---cccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceee
Q 039107 569 REHIYN---TKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVST 645 (817)
Q Consensus 569 ~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 645 (817)
.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++....... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCC--cccc
Confidence 988753 2346899999999999999999999765 9999999999999999999999999987543221 1223
Q ss_pred eeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCH
Q 039107 646 VVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISP 725 (817)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 725 (817)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||......... ..... .+.... ..++.
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~~~---------~~~~~~--~~~~~ 222 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQ---------RILNDS--VTYPD 222 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HHHHH---------hhcccC--CCCcc
Confidence 456899999999999999999999999999999999999999754322110 00000 011110 11223
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 039107 726 ECLKKFADTAEKCLSDSGIDRP-----SMGDVLWNL 756 (817)
Q Consensus 726 ~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 756 (817)
..+..+.+++.+||+.||++|| ++++++++-
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~ 258 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHP 258 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcCh
Confidence 3456688999999999999999 778888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=313.10 Aligned_cols=249 Identities=27% Similarity=0.404 Sum_probs=203.4
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
+|...+.||+|++|.||+|..+ ++..|++|.+... .....+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 3667789999999999999975 5688999987643 344567889999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcc-ccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 563 MALGTLREHIYNT-KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 563 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
+++++|.+++... ...+++.++..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~-- 155 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-- 155 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc--
Confidence 9999999999765 347899999999999999999999765 9999999999999999999999999987643321
Q ss_pred ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccC
Q 039107 642 HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKD 721 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (817)
.......|+..|+|||++.+..++.++|+||||++++||++|+.||....... ...... .+. ..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~----~~~---------~~ 219 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---LILKII----RGV---------FP 219 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH----cCC---------CC
Confidence 12233468899999999999999999999999999999999999997554211 111110 010 11
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 722 KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 722 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.........+.+++.+|++.+|++||++.+++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1222345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=320.56 Aligned_cols=261 Identities=25% Similarity=0.436 Sum_probs=202.5
Q ss_pred CCCcceeEeeeCceEEEEEEEe-----cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecC--CeEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-----DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEG--NEMC 557 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 557 (817)
.|...+.||+|+||.||++... ++..||+|.+.... ......+.+|++++++++||||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 4677889999999999999742 45789999987553 33456799999999999999999999998765 5689
Q ss_pred EEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCC
Q 039107 558 LVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPN 637 (817)
Q Consensus 558 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 637 (817)
+||||+++++|.+++......+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccccccc
Confidence 999999999999998765557899999999999999999999766 99999999999999999999999999986433
Q ss_pred CCCC-ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCcc---------ccchHHHHHHHhhc
Q 039107 638 MENG-HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPK---------EQVSLADWALHCKR 707 (817)
Q Consensus 638 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~---------~~~~l~~~~~~~~~ 707 (817)
.... .......++..|+|||.+.+..++.++||||||+++|||++++.|....... .+.....+.....
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 240 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE- 240 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH-
Confidence 2211 1122345677899999998889999999999999999999987654321110 0001111111110
Q ss_pred cCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 708 KGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 708 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
.+ ........++..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 241 ~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 241 EG---------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cC---------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00 01111223456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=336.87 Aligned_cols=253 Identities=22% Similarity=0.315 Sum_probs=197.0
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
++|...++||+|+||.||++... ++..||||++... .....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36788899999999999999864 5688999987643 2234567889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 81 EFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 999999999998654 45889999999999999999999766 99999999999999999999999999863211000
Q ss_pred C---------------------------------------------ceeeeeecCcCCCChhhhccCCCCchHHHHHHHH
Q 039107 641 G---------------------------------------------HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGV 675 (817)
Q Consensus 641 ~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gv 675 (817)
. .......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 0001246999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCccccch-HHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCC---CCHHH
Q 039107 676 VLFEVLCARPALNPSLPKEQVS-LADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDR---PSMGD 751 (817)
Q Consensus 676 vl~elltG~~p~~~~~~~~~~~-l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~e 751 (817)
++|||++|++||......+... +..|. .. + .+.. .......+.+++.+|+. +|.+| +++.+
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~------~~---~---~~p~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~ 301 (377)
T cd05629 237 IMFECLIGWPPFCSENSHETYRKIINWR------ET---L---YFPD--DIHLSVEAEDLIRRLIT-NAENRLGRGGAHE 301 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHccC------Cc---c---CCCC--CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence 9999999999997654322110 00010 00 0 0000 11234567899999997 66664 69999
Q ss_pred HHHHH
Q 039107 752 VLWNL 756 (817)
Q Consensus 752 vl~~L 756 (817)
++++-
T Consensus 302 ~l~hp 306 (377)
T cd05629 302 IKSHP 306 (377)
T ss_pred HhcCC
Confidence 99874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=315.24 Aligned_cols=251 Identities=23% Similarity=0.342 Sum_probs=191.0
Q ss_pred eEeeeCceEEEEEEEecc---cEEEEEecCCCCc-ccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccCCc
Q 039107 492 VIGVGGFGKVYKGVIEDK---LKVAIKRSNPSSE-QGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGT 567 (817)
Q Consensus 492 ~lG~G~fg~Vy~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 567 (817)
.||+|+||.||+|...++ ..+++|.+..... .....|.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 689999999999986543 5689998875432 334578899999999999999999999999999999999999999
Q ss_pred hhhhhhccc----cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCce
Q 039107 568 LREHIYNTK----KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643 (817)
Q Consensus 568 L~~~l~~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 643 (817)
|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 999986532 24677888899999999999999765 99999999999999999999999999875332221112
Q ss_pred eeeeecCcCCCChhhhccC-------CCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhcc
Q 039107 644 STVVKGSFGYLDPEYFKRQ-------QLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDII 715 (817)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~-------~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (817)
.....++..|+|||++... .++.++|+||||+++|||++ |+.||......+.. ... ..+......
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~---~~~----~~~~~~~~~ 231 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL---TYT----VREQQLKLP 231 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH---HHH----hhcccCCCC
Confidence 2234567889999998642 35789999999999999996 99998654322211 110 011111112
Q ss_pred CccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 716 DPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 716 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
++.+.. .....+.+++..|+ .+|++|||+++|++.|+
T Consensus 232 ~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 232 KPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 222221 23345788999998 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=318.95 Aligned_cols=255 Identities=27% Similarity=0.458 Sum_probs=201.9
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe------cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE------DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEM 556 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 556 (817)
.++|+..+.||+|+||.||++... ++..+|+|.+.... ....++|.+|+.++++++||||+++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 456888889999999999999864 34689999987543 33456799999999999999999999999999999
Q ss_pred EEEEEeccCCchhhhhhccc---------------------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCc
Q 039107 557 CLVYDYMALGTLREHIYNTK---------------------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTN 615 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~N 615 (817)
++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999986321 24788899999999999999999765 9999999999
Q ss_pred EEEcCCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccc
Q 039107 616 ILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKE 694 (817)
Q Consensus 616 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~ 694 (817)
|++++++.+||+|||+++................+..|+|||.+.+..++.++|||||||++|||++ |..||......+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999875432221111222234668999999998999999999999999999997 877876443221
Q ss_pred cchHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 695 QVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 695 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
+..... .+... ..+..++.++.+++.+|++.+|++|||+.|+++.|+
T Consensus 241 ------~~~~~~-~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 241 ------VIYYVR-DGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred ------HHHHHh-cCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 111111 11110 112234567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=326.14 Aligned_cols=247 Identities=23% Similarity=0.300 Sum_probs=196.5
Q ss_pred CCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCCC---cccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeEEEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPSS---EQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 560 (817)
+|...+.||+|+||.||+|+.++ +..||+|.+.... ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 46778899999999999998764 5789999876432 23345677788888887 5899999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
||+++|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~-- 154 (323)
T cd05616 81 EYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD-- 154 (323)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC--
Confidence 999999999888644 35899999999999999999999765 999999999999999999999999998753211
Q ss_pred CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
........||+.|+|||++.+..++.++|||||||++|||++|+.||....... +...+. . . .
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~~~~i~---~-~--------~-- 217 (323)
T cd05616 155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQSIM---E-H--------N-- 217 (323)
T ss_pred CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---HHHHHH---h-C--------C--
Confidence 122334568999999999999999999999999999999999999997654321 111111 0 0 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRPSM-----GDVLWN 755 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~~ 755 (817)
..++.....++.+++.+||+.+|.+|++. .+++++
T Consensus 218 ~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 218 VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 01122344567899999999999999984 566544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=315.75 Aligned_cols=258 Identities=25% Similarity=0.414 Sum_probs=205.2
Q ss_pred cCCCcceeEeeeCceEEEEEEEec-c----cEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIED-K----LKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCL 558 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~-~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 558 (817)
.+|...+.||+|+||.||+|..++ + ..+|+|...... .....++.+|+.++++++|+||++++++|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 356677899999999999998653 2 358999877553 3345678999999999999999999999987 78899
Q ss_pred EEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCC
Q 039107 559 VYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNM 638 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 638 (817)
|+||+++|+|.+++......+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 99999999999999876667999999999999999999999765 999999999999999999999999999865432
Q ss_pred CCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCc
Q 039107 639 ENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717 (817)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (817)
..........++..|+|||.+....++.++|+||||++++||++ |+.||......+ +.+... ...
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~---~~~-------- 228 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---IPDLLE---KGE-------- 228 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH---HHHHHh---CCC--------
Confidence 22111112224568999999988899999999999999999998 999987543221 111111 100
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 039107 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQL 762 (817)
Q Consensus 718 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 762 (817)
....+..+...+.+++.+||..+|.+||++.++++.|+.+...
T Consensus 229 --~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 229 --RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred --CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 0011122345678999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=314.63 Aligned_cols=254 Identities=24% Similarity=0.343 Sum_probs=200.8
Q ss_pred cCCCcceeEeeeCceEEEEEEE-ecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 485 KSFDESYVIGVGGFGKVYKGVI-EDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
.+|...+.||+|+||.||+|+. .++..||+|++..........+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4678888999999999999996 456789999987655555567889999999999999999999999999999999999
Q ss_pred cCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCce
Q 039107 564 ALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643 (817)
Q Consensus 564 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 643 (817)
++++|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ..
T Consensus 89 ~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~~ 162 (267)
T cd06646 89 GGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI--AK 162 (267)
T ss_pred CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc--cc
Confidence 999999988643 46899999999999999999999765 9999999999999999999999999997643211 11
Q ss_pred eeeeecCcCCCChhhhc---cCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 644 STVVKGSFGYLDPEYFK---RQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 644 ~~~~~gt~~y~aPE~~~---~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
.....|+..|+|||.+. ...++.++|||||||+++||++|+.|+....+.+.... ..... ...+...
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~-------~~~~~---~~~~~~~ 232 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL-------MSKSN---FQPPKLK 232 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee-------eecCC---CCCCCCc
Confidence 22346888999999874 44578899999999999999999999854322211100 00000 0001111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
. ....+..+.+++.+||..+|++||++++++++|
T Consensus 233 ~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 233 D--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred c--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1 112346789999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=338.57 Aligned_cols=265 Identities=23% Similarity=0.270 Sum_probs=194.4
Q ss_pred hhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecC--------
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEG-------- 553 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-------- 553 (817)
...+|...++||+|+||.||+|... .+..||||++.... ....+|+.+|++++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3457999999999999999999975 56789999876432 2345799999999999999999876321
Q ss_pred CeEEEEEEeccCCchhhhhhc---cccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCC-ceeEEeee
Q 039107 554 NEMCLVYDYMALGTLREHIYN---TKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDEN-WVAKVSDF 629 (817)
Q Consensus 554 ~~~~lV~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DF 629 (817)
..+++||||+++ +|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+||||+.+ +.+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 246789999985 67666542 3347899999999999999999999766 9999999999999966 47999999
Q ss_pred ccCccCCCCCCCceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhc-
Q 039107 630 GLSKTGPNMENGHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKR- 707 (817)
Q Consensus 630 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~- 707 (817)
|+++...... ......||+.|+|||++.+ ..++.++|||||||+||||++|++||.+....+.............
T Consensus 216 Gla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 216 GSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred ccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 9998643221 2233568999999999865 4689999999999999999999999976544332211100000000
Q ss_pred ------cCchhh-----ccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 708 ------KGILDD-----IIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 708 ------~~~~~~-----~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
.....+ +....+...++...+.++.+|+.+||..+|.+|||+.|++++-..
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f 354 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFF 354 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhH
Confidence 000000 000111111222334578999999999999999999999977543
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=333.83 Aligned_cols=266 Identities=26% Similarity=0.350 Sum_probs=199.1
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecCC-----eEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGN-----EMC 557 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 557 (817)
+|+..++||+|+||.||++... ++..||+|++... .....+.+.+|+++++.++|+||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4677889999999999999864 6789999998643 2234567889999999999999999999998766 789
Q ss_pred EEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCC
Q 039107 558 LVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPN 637 (817)
Q Consensus 558 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 637 (817)
+|+||+. ++|.+.+... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 lv~e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEeeccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 9999997 5777776443 46899999999999999999999765 99999999999999999999999999976432
Q ss_pred CCCCceeeeeecCcCCCChhhhccC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHH----------HHh-
Q 039107 638 MENGHVSTVVKGSFGYLDPEYFKRQ-QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWA----------LHC- 705 (817)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~----------~~~- 705 (817)
... .......++..|+|||.+.+. .++.++|||||||+++||++|+.||......++....... ...
T Consensus 156 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 156 DES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred Ccc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 221 122234578999999998764 5799999999999999999999999766543332211100 000
Q ss_pred -hccCchhhccCc-ccc--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 706 -KRKGILDDIIDP-LLK--DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 706 -~~~~~~~~~~d~-~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
...........+ ... .........++.+++.+||+.||.+|||+.+++++--
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 290 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHh
Confidence 000000000000 000 0111223456789999999999999999999998743
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=331.68 Aligned_cols=260 Identities=22% Similarity=0.243 Sum_probs=200.6
Q ss_pred HHHHhhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCC
Q 039107 479 EIKHATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGN 554 (817)
Q Consensus 479 el~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 554 (817)
++....++|...++||+|+||.||+++.. ++..+|+|.+... .....+.+.+|+.+++.++||||+++++++....
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 33444578999999999999999999976 4678999987542 2233456889999999999999999999999999
Q ss_pred eEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 555 EMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 555 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
..++||||+++|+|.+++.. ..+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccccee
Confidence 99999999999999998854 35888999999999999999999765 99999999999999999999999999986
Q ss_pred CCCCCCCceeeeeecCcCCCChhhhccC----CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCc
Q 039107 635 GPNMENGHVSTVVKGSFGYLDPEYFKRQ----QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGI 710 (817)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 710 (817)
..... ........||+.|+|||++.+. .++.++|||||||+||||++|+.||......... ........
T Consensus 192 ~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~------~~i~~~~~ 264 (370)
T cd05621 192 MDETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY------SKIMDHKN 264 (370)
T ss_pred cccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHH------HHHHhCCc
Confidence 43211 1122345699999999998754 3788999999999999999999999765322111 00000000
Q ss_pred hhhccCccccCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHH
Q 039107 711 LDDIIDPLLKDKISPECLKKFADTAEKCLSDSGID--RPSMGDVLWNLE 757 (817)
Q Consensus 711 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~L~ 757 (817)
.+.-.........+.+++.+|+..++.+ |+++.++++|-.
T Consensus 265 -------~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~ 306 (370)
T cd05621 265 -------SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPF 306 (370)
T ss_pred -------ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcc
Confidence 0000111123456788899999755544 899999998744
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=310.67 Aligned_cols=250 Identities=30% Similarity=0.527 Sum_probs=201.1
Q ss_pred CCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccC
Q 039107 486 SFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMAL 565 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 565 (817)
+|...+.||+|+||.||++...++..+++|.+.... ....+|.+|++++++++|||++++++++......++||||+++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 466678999999999999998777789999887443 3346799999999999999999999999999999999999999
Q ss_pred CchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceee
Q 039107 566 GTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVST 645 (817)
Q Consensus 566 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 645 (817)
++|.+++......+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++....... ....
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~ 159 (256)
T cd05112 84 GCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TSST 159 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcc-cccC
Confidence 9999998766667899999999999999999999765 99999999999999999999999999875422111 1111
Q ss_pred eeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCC
Q 039107 646 VVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKIS 724 (817)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 724 (817)
...++.+|+|||.+.++.++.++||||||+++|||++ |+.||....... + ..... ++. ....+
T Consensus 160 ~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~---~~~~~-~~~--~~~~~------- 223 (256)
T cd05112 160 GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---V---VETIN-AGF--RLYKP------- 223 (256)
T ss_pred CCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---H---HHHHh-CCC--CCCCC-------
Confidence 2234678999999998899999999999999999998 899886543211 1 11111 110 00111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 725 PECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 725 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
...+..+.+++.+||+.+|++||++.+++++|
T Consensus 224 ~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 224 RLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 11245689999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=311.94 Aligned_cols=247 Identities=30% Similarity=0.481 Sum_probs=198.4
Q ss_pred cCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEE-ecCCeEEEEEEec
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFC-EEGNEMCLVYDYM 563 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~Ey~ 563 (817)
.+|...+.||+|+||.||++... +..+++|...... ..+.|.+|+.++++++|+|++++++++ ......++|+||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 35777889999999999999765 5679999886433 346789999999999999999999976 4556789999999
Q ss_pred cCCchhhhhhcccc-ccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 564 ALGTLREHIYNTKK-ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 564 ~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
++++|.+++..... .+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 99999999876443 5899999999999999999999765 9999999999999999999999999987533211
Q ss_pred eeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccC
Q 039107 643 VSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKD 721 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (817)
....++..|+|||++....++.++||||||+++|||++ |+.|+...... +...... ++ ...
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~------~~~~~~~-~~---------~~~ 218 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------DVVPRVE-KG---------YKM 218 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHh-cC---------CCC
Confidence 22334668999999998899999999999999999997 88887643221 1111111 11 011
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 722 KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 722 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
.....++..+.+++.+|++.+|++|||+.++++.|+.
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 1223345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=316.98 Aligned_cols=246 Identities=24% Similarity=0.342 Sum_probs=192.7
Q ss_pred EeeeCceEEEEEEEe-cccEEEEEecCCCC---cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccCCch
Q 039107 493 IGVGGFGKVYKGVIE-DKLKVAIKRSNPSS---EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTL 568 (817)
Q Consensus 493 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 568 (817)
||+|+||.||++..+ ++..+|+|++.... ......+..|++++++++||||+++++++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999865 57889999886421 12234566799999999999999999999999999999999999999
Q ss_pred hhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceeeee
Q 039107 569 REHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVV 647 (817)
Q Consensus 569 ~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 647 (817)
.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++...... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC---ceeecc
Confidence 98886543 36899999999999999999999765 999999999999999999999999998764321 222345
Q ss_pred ecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCHHH
Q 039107 648 KGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPEC 727 (817)
Q Consensus 648 ~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 727 (817)
.|+..|+|||++.+..++.++|||||||++|||++|+.||....... ...+....... ..... .....
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~---------~~~~~-~~~~~ 222 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELKRRTLE---------DEVKF-EHQNF 222 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHHHHhhc---------ccccc-ccccC
Confidence 68999999999998899999999999999999999999986543211 11111111110 00000 01123
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 728 LKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 728 ~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
..++.+++.+||+.||++||+++|+++.+
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 45679999999999999999997766433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=318.57 Aligned_cols=267 Identities=26% Similarity=0.425 Sum_probs=205.0
Q ss_pred CCCcceeEeeeCceEEEEEEEe-----cccEEEEEecCCCCcc-cHHHHHHHHHHHhccCccceeeEEEEEec--CCeEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-----DKLKVAIKRSNPSSEQ-GVNEFVTEIEMLSKLRHKHLVSLIGFCEE--GNEMC 557 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~ 557 (817)
.|...+.||+|+||.||++.+. .+..+|+|.+...... ..+.|.+|++++++++|+||+++++++.. ....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4566679999999999999864 2578999998765443 46789999999999999999999999877 56789
Q ss_pred EEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCC
Q 039107 558 LVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPN 637 (817)
Q Consensus 558 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 637 (817)
+||||+++++|.+++......+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 85 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred EEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 999999999999999776657999999999999999999999765 99999999999999999999999999986542
Q ss_pred CCCC-ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhc---cCchhh
Q 039107 638 MENG-HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKR---KGILDD 713 (817)
Q Consensus 638 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~---~~~~~~ 713 (817)
.... .......++..|++||.+....++.++||||||++++||++|+.|+......... +...... ...+.+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR----MIGIAQGQMIVTRLLE 237 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc----ccccccccccHHHHHH
Confidence 2111 1111223456799999998889999999999999999999999887543221100 0000000 000001
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 714 IIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 714 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
.+........+..++.++.+++.+||+.+|++||||.+|+++|+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111111111234456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=310.70 Aligned_cols=250 Identities=27% Similarity=0.420 Sum_probs=205.0
Q ss_pred cCCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
++|...++||+|+||.||+|...+ +..+++|.+..... .+++.+|++++++++|+||+++++++......++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 567788899999999999999765 67899999875433 678999999999999999999999999999999999999
Q ss_pred cCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCce
Q 039107 564 ALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643 (817)
Q Consensus 564 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 643 (817)
++++|.+++......+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++....... ..
T Consensus 81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~--~~ 155 (256)
T cd06612 81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--AK 155 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCc--cc
Confidence 999999999766678999999999999999999999765 9999999999999999999999999988643322 12
Q ss_pred eeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCC
Q 039107 644 STVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKI 723 (817)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 723 (817)
.....++..|+|||.+.+..++.++||||||+++|||++|+.|+.......... . .... ..+. ...
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-----~--~~~~-----~~~~--~~~ 221 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-----M--IPNK-----PPPT--LSD 221 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-----h--hccC-----CCCC--CCc
Confidence 234457899999999999999999999999999999999999987543221110 0 0000 0000 011
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 724 SPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 724 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
+......+.+++.+|++.+|++|||+.+|+++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 222 PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred hhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 22344568999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=311.34 Aligned_cols=249 Identities=26% Similarity=0.404 Sum_probs=197.4
Q ss_pred eeEeeeCceEEEEEEEecc----cEEEEEecCCCCc-ccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccC
Q 039107 491 YVIGVGGFGKVYKGVIEDK----LKVAIKRSNPSSE-QGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMAL 565 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~~~~----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 565 (817)
++||+|+||.||+|+.... ..+|+|.+..... ...+++.+|+.+++++.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 3699999999999985322 5799999876543 24567899999999999999999999886 4568999999999
Q ss_pred CchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc-ee
Q 039107 566 GTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH-VS 644 (817)
Q Consensus 566 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~-~~ 644 (817)
++|.+++.... .+++..++.++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++......... ..
T Consensus 80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 99999997554 6899999999999999999999765 9999999999999999999999999998643222111 11
Q ss_pred eeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCC
Q 039107 645 TVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKI 723 (817)
Q Consensus 645 ~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 723 (817)
....++..|+|||.+.+..++.++||||||+++|||++ |++||...... .+..+.... .. ...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~~~~---~~----------~~~ 219 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAMLESG---ER----------LPR 219 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHHcC---Cc----------CCC
Confidence 12234568999999998999999999999999999998 99998654322 122222111 00 011
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 039107 724 SPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVL 760 (817)
Q Consensus 724 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 760 (817)
+..++..+.+++.+||..+|.+||++.++++.|+.+.
T Consensus 220 ~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 220 PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 2234567899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=320.58 Aligned_cols=258 Identities=25% Similarity=0.415 Sum_probs=202.0
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-ccc----EEEEEecCCCCc-ccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKL----KVAIKRSNPSSE-QGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCL 558 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 558 (817)
.+|+..+.||+|+||.||+|... ++. .+|+|.+..... ....++.+|+.++++++||||++++++|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 45667789999999999999864 332 578998775432 2345788999999999999999999998754 4679
Q ss_pred EEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCC
Q 039107 559 VYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNM 638 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 638 (817)
++||+++|+|.+++......+++..++.++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++.....
T Consensus 86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccCc
Confidence 99999999999998766667899999999999999999999765 999999999999999999999999999864332
Q ss_pred CCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCc
Q 039107 639 ENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717 (817)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (817)
..........++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ..++... ....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~~~~~~---~~~~------ 230 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPDLLEK---GERL------ 230 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHC---CCCC------
Confidence 22112222345678999999998999999999999999999997 888886542211 1122111 1000
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 039107 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQL 762 (817)
Q Consensus 718 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 762 (817)
.....+...+.+++.+|+..+|++||+++++++.|+.+...
T Consensus 231 ----~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 231 ----PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred ----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 01122345678999999999999999999999999987544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=318.60 Aligned_cols=251 Identities=25% Similarity=0.398 Sum_probs=203.6
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
..+|...+.||+|+||.||+|... ++..+++|.+........+.+.+|+.+++.++|+||+++++++......++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 356888889999999999999854 5678999998766555567889999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
+++++|.+++.. ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....... .
T Consensus 99 ~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--~ 171 (296)
T cd06654 99 LAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--S 171 (296)
T ss_pred cCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc--c
Confidence 999999998853 35889999999999999999999766 9999999999999999999999999987533221 1
Q ss_pred eeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCC
Q 039107 643 VSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDK 722 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (817)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||........ +..+. ..+ .+.+ .
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~~~~~----~~~------~~~~--~ 237 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYLIA----TNG------TPEL--Q 237 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--HHHHh----cCC------CCCC--C
Confidence 12234688999999999988899999999999999999999999975433211 11000 000 0000 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 723 ISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 723 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.+......+.+++.+||..+|++||++.+++++
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 122344568899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=309.88 Aligned_cols=257 Identities=23% Similarity=0.354 Sum_probs=207.1
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
++|...+.||+|+||.||+|... ++..|++|.++.. .....+.+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 46888889999999999999976 6788999987632 2333568899999999999999999999999999999999
Q ss_pred EeccCCchhhhhhcc---ccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCC
Q 039107 561 DYMALGTLREHIYNT---KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPN 637 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 637 (817)
||+++++|.+++... ...+++.+++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999988542 336899999999999999999999765 99999999999999999999999999875432
Q ss_pred CCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCc
Q 039107 638 MENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717 (817)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (817)
.. .......++..|+|||.+.+..++.++|||||||++|||++|+.||..... .+.++..... .+
T Consensus 159 ~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~-~~-------- 223 (267)
T cd08224 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIE-KC-------- 223 (267)
T ss_pred CC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHhhhh-cC--------
Confidence 21 112334588899999999988999999999999999999999999864421 1111111110 00
Q ss_pred cccCCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 039107 718 LLKDKISP-ECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVL 760 (817)
Q Consensus 718 ~l~~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 760 (817)
.....+. .....+.+++.+||+.+|++||++.+|++.|+.+.
T Consensus 224 -~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 224 -DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0111112 44567899999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=326.66 Aligned_cols=250 Identities=27% Similarity=0.402 Sum_probs=209.8
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecCCe-EEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNE-MCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lV~ 560 (817)
.+|...+++|+|+||.++..+++ +...+++|++... +........+|+.++++++|||||.+.+.+.+++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 35667789999999999998865 4568999986644 34444567899999999999999999999988888 99999
Q ss_pred EeccCCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC
Q 039107 561 DYMALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 639 (817)
+|++||+|.+.|...+ ..++++.+.+++.|++.|+.|||++. |+|||||+.|||++.+..+||+|||+|+......
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999999998766 47899999999999999999999665 9999999999999999999999999999865433
Q ss_pred CCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccc
Q 039107 640 NGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719 (817)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (817)
.....+.||+.||.||.+.+.+|..|+|+|||||++|||++-+++|...+...- + .. +.. ..
T Consensus 161 --~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L---i---~k---------i~~-~~ 222 (426)
T KOG0589|consen 161 --SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL---I---LK---------INR-GL 222 (426)
T ss_pred --hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH---H---HH---------Hhh-cc
Confidence 244567899999999999999999999999999999999999999987643321 1 11 110 11
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 720 KDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 720 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
-...+...+.++..++..|+..+|..||++.+++.+
T Consensus 223 ~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 123445667789999999999999999999999977
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=313.49 Aligned_cols=257 Identities=25% Similarity=0.394 Sum_probs=204.5
Q ss_pred cCCCcceeEeeeCceEEEEEEEecc----cEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIEDK----LKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 559 (817)
++|...++||+|+||.||+|...+. ..|++|...... ....+.|.+|+.++++++||||+++++++.. ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 4577788999999999999986432 468999877554 3455689999999999999999999999875 557899
Q ss_pred EEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC
Q 039107 560 YDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 639 (817)
|||+++++|.+++......+++.+++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 9999999999999765556899999999999999999999765 9999999999999999999999999987643321
Q ss_pred CCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCcc
Q 039107 640 NGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPL 718 (817)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (817)
. .......++..|+|||.+....++.++||||||++++||++ |+.||......+. ..+... ...
T Consensus 162 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~~~~~~---~~~-------- 226 (270)
T cd05056 162 Y-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---IGRIEN---GER-------- 226 (270)
T ss_pred c-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHc---CCc--------
Confidence 1 11122234568999999988889999999999999999986 9999865533221 111110 000
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 039107 719 LKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQL 762 (817)
Q Consensus 719 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 762 (817)
...+..++..+.+++.+|+..+|++|||+.++++.|+.+...
T Consensus 227 --~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 227 --LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred --CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 011233456789999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=336.10 Aligned_cols=251 Identities=22% Similarity=0.312 Sum_probs=194.8
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC---cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS---EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
.|...++||+|+||+||+|+.. ++..+|+|++.... ......+.+|++++++++|+||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 4778899999999999999865 56789999986432 2335678899999999999999999999999999999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC--
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME-- 639 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~-- 639 (817)
|+++|+|.+++.+. +.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 82 YIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 99999999988654 45888999999999999999999765 9999999999999999999999999975321000
Q ss_pred -------------------------------------------CCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHH
Q 039107 640 -------------------------------------------NGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVV 676 (817)
Q Consensus 640 -------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvv 676 (817)
.........||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 0001123468999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCccccc-hHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHH
Q 039107 677 LFEVLCARPALNPSLPKEQV-SLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPS---MGDV 752 (817)
Q Consensus 677 l~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~ev 752 (817)
||||++|++||......+.. ....| ...+..........++.+++.+|+ .+|.+|++ +.++
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~--------------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei 302 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVINW--------------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEI 302 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcc--------------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence 99999999999765432211 00000 000110111122345677777766 48999987 8888
Q ss_pred HHH
Q 039107 753 LWN 755 (817)
Q Consensus 753 l~~ 755 (817)
++|
T Consensus 303 ~~h 305 (382)
T cd05625 303 KAH 305 (382)
T ss_pred hcC
Confidence 866
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=334.83 Aligned_cols=251 Identities=21% Similarity=0.305 Sum_probs=196.4
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC---cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS---EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
+|...+.||+|+||.||+++.. ++..||+|.+.... ....+.+.+|+++|++++|+||+++++.+.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 5788899999999999999865 46789999986431 2334668899999999999999999999999999999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC--
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME-- 639 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~-- 639 (817)
|+++|+|.+++... +.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 82 YIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 99999999998654 35888899999999999999999765 9999999999999999999999999975321000
Q ss_pred ---------------------------------------CCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHH
Q 039107 640 ---------------------------------------NGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEV 680 (817)
Q Consensus 640 ---------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~el 680 (817)
.........||+.|+|||++.+..++.++|||||||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 00011234699999999999999999999999999999999
Q ss_pred HhCCCCCCCCCccccch-HHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCC---CHHHHHHH
Q 039107 681 LCARPALNPSLPKEQVS-LADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRP---SMGDVLWN 755 (817)
Q Consensus 681 ltG~~p~~~~~~~~~~~-l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP---t~~evl~~ 755 (817)
++|+.||......+... +..|. . .+...........+.+++.+|+ .+|.+|+ ++.+++++
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~~~------~--------~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVINWE------T--------TLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhccC------c--------cccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99999997654322110 00000 0 0000001123445677888876 5999999 89999977
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=330.95 Aligned_cols=264 Identities=25% Similarity=0.270 Sum_probs=200.7
Q ss_pred hcCCCcceeEeeeCceEEEEEEEec---ccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIED---KLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
..+|...+.||+|+||.||++...+ +..|++|.+... +.+.+|+++|++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 3468899999999999999997543 467999987643 23568999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
|++. ++|.+++. ....+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 166 e~~~-~~l~~~l~-~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 166 PKYK-CDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred hhcC-CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 9996 68888883 3457999999999999999999999765 99999999999999999999999999976543333
Q ss_pred CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccc-hHHHHHHHhhccCchh-------
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQV-SLADWALHCKRKGILD------- 712 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~------- 712 (817)
........||..|+|||++....++.++|||||||++|||++|+.||.+....... .+..... ..+.....
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~-~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR-CMQVHPLEFPQNGST 319 (392)
T ss_pred cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHH-HhccCccccCCccch
Confidence 23334567999999999999999999999999999999999999999765432211 1111000 00000000
Q ss_pred ---h-c--cCccccCCC--C-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 713 ---D-I--IDPLLKDKI--S-----PECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 713 ---~-~--~d~~l~~~~--~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
. . .....+... + ......+.+++.+||..||++|||+.+++.+-..
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f 378 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLF 378 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchh
Confidence 0 0 000000000 0 0123467889999999999999999999988544
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=328.98 Aligned_cols=238 Identities=25% Similarity=0.309 Sum_probs=191.4
Q ss_pred eeEeeeCceEEEEEEE----ecccEEEEEecCCCC--cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEecc
Q 039107 491 YVIGVGGFGKVYKGVI----EDKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMA 564 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 564 (817)
+.||+|+||.||++.. ..+..+|+|++.... ......+..|+++|++++||||+++++++......++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4799999999999875 246789999987532 2234567789999999999999999999999999999999999
Q ss_pred CCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCcee
Q 039107 565 LGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVS 644 (817)
Q Consensus 565 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 644 (817)
+|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ...
T Consensus 82 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~ 155 (318)
T cd05582 82 GGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKA 155 (318)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Cce
Confidence 99999988543 35899999999999999999999765 9999999999999999999999999987643221 223
Q ss_pred eeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCC
Q 039107 645 TVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKIS 724 (817)
Q Consensus 645 ~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 724 (817)
....|+..|+|||.+.+..++.++|||||||++|||++|+.||......+. .... .. .. ..++
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~---~~~i---~~-~~----------~~~p 218 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET---MTMI---LK-AK----------LGMP 218 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH---HHHH---Hc-CC----------CCCC
Confidence 345789999999999988899999999999999999999999975432211 1111 00 00 0112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHH
Q 039107 725 PECLKKFADTAEKCLSDSGIDRPSMGD 751 (817)
Q Consensus 725 ~~~~~~l~~li~~cl~~dP~~RPt~~e 751 (817)
......+.+++.+||+.||++||++.+
T Consensus 219 ~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 219 QFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 234456789999999999999999444
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=310.34 Aligned_cols=253 Identities=32% Similarity=0.488 Sum_probs=200.0
Q ss_pred CCcceeEeeeCceEEEEEEEecc-cEEEEEecCCCCcccH--HHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 487 FDESYVIGVGGFGKVYKGVIEDK-LKVAIKRSNPSSEQGV--NEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 487 f~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
|+..+.||+|+||+||+++.... ..+|+|.+........ ....+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 45678999999999999997654 6899999886644332 23456999999999999999999999999999999999
Q ss_pred cCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCce
Q 039107 564 ALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643 (817)
Q Consensus 564 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 643 (817)
++++|.+++. ....+++.+++.++.|+++||.+||+.+ |+|+||||+||++++++.++|+|||++... ......
T Consensus 81 ~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL--SENNEN 154 (260)
T ss_dssp TTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES--TSTTSE
T ss_pred cccccccccc-cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc--cccccc
Confidence 9999999997 3456999999999999999999999876 999999999999999999999999998753 112233
Q ss_pred eeeeecCcCCCChhhhc-cCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCC
Q 039107 644 STVVKGSFGYLDPEYFK-RQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDK 722 (817)
Q Consensus 644 ~~~~~gt~~y~aPE~~~-~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (817)
.....++..|+|||++. +...+.++||||+|+++++|++|+.|+......+.......... ..... ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~----~~~~~----~~~-- 224 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILK----RPLPS----SSQ-- 224 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHH----THHHH----HTT--
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccc----ccccc----ccc--
Confidence 44567899999999998 88999999999999999999999999876522221111111000 00000 000
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 723 ISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 723 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
........+.+++.+||+.+|++||++.+++++
T Consensus 225 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 225 QSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred ccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000112678999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=319.20 Aligned_cols=266 Identities=21% Similarity=0.343 Sum_probs=200.5
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
++|...+.||+|+||.||+|+.+ ++..||+|.+.... ......+.+|+.++++++|+||+++++++......++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 45778889999999999999875 46789999876443 23345678899999999999999999999999999999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
++ ++|.+++......+++..+..++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||++....... .
T Consensus 86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~ 159 (301)
T cd07873 86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT--K 159 (301)
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--C
Confidence 97 5898888766667899999999999999999999765 9999999999999999999999999987532211 1
Q ss_pred eeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHH----------HHHHHhhccCch
Q 039107 643 VSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLA----------DWALHCKRKGIL 711 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~----------~~~~~~~~~~~~ 711 (817)
......++..|+|||.+.+ ..++.++|||||||++|||++|++||......+..... .|... ......
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 238 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI-LSNEEF 238 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhh-hccccc
Confidence 1223356889999999865 45788999999999999999999999765433221110 00000 000000
Q ss_pred hhccCccccC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 712 DDIIDPLLKD----KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 712 ~~~~d~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
.....+.... ...+.....+.+++.+||+.||.+|||+.+++++--
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~ 288 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 0000000000 011123456789999999999999999999997543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=345.63 Aligned_cols=262 Identities=24% Similarity=0.330 Sum_probs=204.6
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC---cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS---EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
++|...++||+|+||.||+|... .++.||+|++.... ....++|.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46888899999999999999865 46889999987532 223467999999999999999999999999999999999
Q ss_pred EeccCCchhhhhhcc----------ccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeec
Q 039107 561 DYMALGTLREHIYNT----------KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFG 630 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFG 630 (817)
||+++|+|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 999999999988632 124667888999999999999999765 9999999999999999999999999
Q ss_pred cCccCCCCCC----------------CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccc
Q 039107 631 LSKTGPNMEN----------------GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKE 694 (817)
Q Consensus 631 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~ 694 (817)
+++....... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9976421110 001122469999999999999999999999999999999999999997532211
Q ss_pred cchHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHhHhhh
Q 039107 695 QVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRP-SMGDVLWNLEFVLQLV 763 (817)
Q Consensus 695 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~~~~ 763 (817)
.. +. ..+.++..... ..+.+..+.+++.+|++.||++|| +++++++.|+..++..
T Consensus 239 i~----~~---------~~i~~P~~~~p-~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~ 294 (932)
T PRK13184 239 IS----YR---------DVILSPIEVAP-YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGS 294 (932)
T ss_pred hh----hh---------hhccChhhccc-cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcC
Confidence 10 00 00011100000 113345678999999999999996 5788888888876643
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=316.58 Aligned_cols=251 Identities=25% Similarity=0.390 Sum_probs=200.3
Q ss_pred CCcceeEeeeCceEEEEEEEec-ccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccC
Q 039107 487 FDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMAL 565 (817)
Q Consensus 487 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 565 (817)
|+..+.||+|+||.||+|.... +..+++|.+........+.+.+|+++++.++||||+++++++......++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 3455689999999999999764 567899988766666677899999999999999999999999999999999999999
Q ss_pred CchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceee
Q 039107 566 GTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVST 645 (817)
Q Consensus 566 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 645 (817)
++|..++.+....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...... .....
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~~~~ 161 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRD 161 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccc--ccccc
Confidence 9999988765567999999999999999999999765 999999999999999999999999998754321 11223
Q ss_pred eeecCcCCCChhhhc-----cCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 646 VVKGSFGYLDPEYFK-----RQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 646 ~~~gt~~y~aPE~~~-----~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
...++..|+|||++. +..++.++|||||||++|||++|++||......+. .... .... .+.+
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~~----~~~~------~~~~- 228 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV--LLKI----AKSE------PPTL- 228 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH--HHHH----hhcC------CCCC-
Confidence 346889999999974 45678899999999999999999999865432211 1100 0000 0000
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
..+......+.+++.+||+.+|.+||++.+++++-
T Consensus 229 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 229 -AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred -CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 11223445689999999999999999999998654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=313.16 Aligned_cols=251 Identities=23% Similarity=0.337 Sum_probs=188.4
Q ss_pred eEeeeCceEEEEEEEecc---cEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccCCc
Q 039107 492 VIGVGGFGKVYKGVIEDK---LKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGT 567 (817)
Q Consensus 492 ~lG~G~fg~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 567 (817)
.||+|+||.||+|...++ ..+++|.+.... ......|.+|+++++.++|+||++++++|......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 589999999999986543 468888876443 3334678899999999999999999999999999999999999999
Q ss_pred hhhhhhcccc----ccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCce
Q 039107 568 LREHIYNTKK----ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643 (817)
Q Consensus 568 L~~~l~~~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 643 (817)
|.+++..... ..++...+.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999865432 3567888999999999999999765 99999999999999999999999999875322211111
Q ss_pred eeeeecCcCCCChhhhcc-------CCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhcc
Q 039107 644 STVVKGSFGYLDPEYFKR-------QQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDII 715 (817)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~-------~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (817)
.....++..|+|||++.. ..++.++|||||||++|||++ |+.||....+.+. +. ...... ...+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~----~~~~~~-~~~~~ 231 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV--LK----QVVREQ-DIKLP 231 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH--HH----HHhhcc-CccCC
Confidence 222345678999998753 356889999999999999999 7777754432211 10 001111 01111
Q ss_pred CccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 716 DPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 716 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
++. .+......+.+++..|+ .||++||++++|++.|.
T Consensus 232 ~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 222 22234455677888898 59999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=323.80 Aligned_cols=237 Identities=26% Similarity=0.333 Sum_probs=186.8
Q ss_pred eeEeeeCceEEEEEEEe-cccEEEEEecCCCC---cccHHHHHHHHH-HHhccCccceeeEEEEEecCCeEEEEEEeccC
Q 039107 491 YVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS---EQGVNEFVTEIE-MLSKLRHKHLVSLIGFCEEGNEMCLVYDYMAL 565 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 565 (817)
++||+|+||.||+|+.. ++..||+|.+.... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 37999999999999975 56789999876432 222344555654 57889999999999999999999999999999
Q ss_pred CchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceee
Q 039107 566 GTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVST 645 (817)
Q Consensus 566 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 645 (817)
++|..++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~ 154 (321)
T cd05603 81 GELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EETTS 154 (321)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCccc
Confidence 9998887543 45888889999999999999999765 999999999999999999999999998753221 12233
Q ss_pred eeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCH
Q 039107 646 VVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISP 725 (817)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 725 (817)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||....... +.+.+ .. . . ..++.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i---~~-~--------~--~~~~~ 217 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ---MYDNI---LH-K--------P--LQLPG 217 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH---HHHHH---hc-C--------C--CCCCC
Confidence 4568999999999998899999999999999999999999997643211 11111 00 0 0 11122
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHH
Q 039107 726 ECLKKFADTAEKCLSDSGIDRPSMG 750 (817)
Q Consensus 726 ~~~~~l~~li~~cl~~dP~~RPt~~ 750 (817)
.....+.+++.+||+.+|.+||+..
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 218 GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 3345688999999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=315.56 Aligned_cols=250 Identities=25% Similarity=0.362 Sum_probs=198.4
Q ss_pred CCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC---cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 487 FDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS---EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 487 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
|...++||+|+||+||+|... +++.+|+|.+.... ......+.+|+++|++++|+|++++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566789999999999999865 56789999876432 22234578899999999999999999999999999999999
Q ss_pred ccCCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 563 MALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 563 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~--- 155 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--- 155 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCC---
Confidence 99999998886543 36999999999999999999999765 999999999999999999999999998753321
Q ss_pred ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccC
Q 039107 642 HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKD 721 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (817)
.......|+..|+|||.+.+..++.++|+||||+++|||++|+.||.......... .+... .... ..
T Consensus 156 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~--~~~~~-~~~~----------~~ 222 (285)
T cd05632 156 ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKRE--EVDRR-VLET----------EE 222 (285)
T ss_pred CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHh-hhcc----------cc
Confidence 11233468999999999998999999999999999999999999997543221111 11100 0000 01
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 039107 722 KISPECLKKFADTAEKCLSDSGIDRPS-----MGDVLWN 755 (817)
Q Consensus 722 ~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 755 (817)
.+.......+.+|+.+|++.+|++||+ +.+++.+
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 112234456789999999999999999 6677665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=323.61 Aligned_cols=241 Identities=24% Similarity=0.322 Sum_probs=192.7
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhccC-ccceeeEEEEEecCCeEEEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLR-HKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 560 (817)
+|...++||+|+||+||++... ++..||+|++... .....+.+..|..++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3667789999999999999865 5678999987643 2334466788999998885 578888999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
||+++|+|.+++... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~-- 154 (323)
T cd05615 81 EYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD-- 154 (323)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC--
Confidence 999999999988543 35999999999999999999999765 999999999999999999999999998753221
Q ss_pred CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
........||+.|+|||++.+..++.++|||||||++|||++|+.||....... +...... . .
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~~i~~----~--------~-- 217 (323)
T cd05615 155 GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE---LFQSIME----H--------N-- 217 (323)
T ss_pred CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHHh----C--------C--
Confidence 122334568999999999999999999999999999999999999997653321 1111110 0 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRPSM 749 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 749 (817)
...+......+.+++.+||+.+|.+|++.
T Consensus 218 ~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 01122334567899999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=313.70 Aligned_cols=247 Identities=26% Similarity=0.482 Sum_probs=195.9
Q ss_pred eEeeeCceEEEEEEEec-------ccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 492 VIGVGGFGKVYKGVIED-------KLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 492 ~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
.||+|+||.||+|+..+ +..+++|.+.... .....+|.+|+.++++++||||++++++|......++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 68999999999998653 2468999876543 234578899999999999999999999999999999999999
Q ss_pred cCCchhhhhhcc------ccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCc-----eeEEeeeccC
Q 039107 564 ALGTLREHIYNT------KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENW-----VAKVSDFGLS 632 (817)
Q Consensus 564 ~~gsL~~~l~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~-----~~kl~DFGla 632 (817)
++++|.+++... ...+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.+. .+||+|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999998642 124789999999999999999999765 99999999999999877 8999999998
Q ss_pred ccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCch
Q 039107 633 KTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGIL 711 (817)
Q Consensus 633 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 711 (817)
+...............++..|+|||.+.++.++.++|||||||++|||++ |+.||......+ ..... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~~~---~~~~-- 230 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQHV---TAGG-- 230 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHHHH---hcCC--
Confidence 75432222112222345678999999999999999999999999999998 999886443211 11111 0000
Q ss_pred hhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 712 DDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 712 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
........+..+.+++.+||..+|.+||++.+|++.|+
T Consensus 231 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 231 --------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred --------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 01112334567899999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=310.10 Aligned_cols=237 Identities=27% Similarity=0.427 Sum_probs=189.5
Q ss_pred eEeeeCceEEEEEEEeccc-----------EEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 492 VIGVGGFGKVYKGVIEDKL-----------KVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 492 ~lG~G~fg~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
+||+|+||.||+|...+.. .+++|.+...... ...|.+|+.++++++||||+++++++.. ...++||
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 6999999999999976533 5788877654433 6789999999999999999999999988 7789999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCc-------eeEEeeeccCc
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENW-------VAKVSDFGLSK 633 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~-------~~kl~DFGla~ 633 (817)
||+++|+|.+++......+++..++.++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||++.
T Consensus 80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence 999999999999766557899999999999999999999765 99999999999999887 79999999987
Q ss_pred cCCCCCCCceeeeeecCcCCCChhhhccC--CCCchHHHHHHHHHHHHHHhC-CCCCCCCCccccchHHHHHHHhhccCc
Q 039107 634 TGPNMENGHVSTVVKGSFGYLDPEYFKRQ--QLTEKSDIYSFGVVLFEVLCA-RPALNPSLPKEQVSLADWALHCKRKGI 710 (817)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDV~S~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~ 710 (817)
.... .....++..|+|||++... .++.++||||||+++|||++| ..|+......+.. .+. .....
T Consensus 157 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~---~~~---~~~~~ 224 (259)
T cd05037 157 TVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE---RFY---QDQHR 224 (259)
T ss_pred cccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH---HHH---hcCCC
Confidence 6432 1223467789999998876 789999999999999999994 6666543221111 111 00000
Q ss_pred hhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 711 LDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 711 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
.. ......+.+++.+||..+|.+||++.+|++.|+
T Consensus 225 --------~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 225 --------LP----MPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred --------CC----CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 011157889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=321.77 Aligned_cols=256 Identities=20% Similarity=0.230 Sum_probs=197.0
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
++|...+.||+|+||+||+++.. ++..||+|.+... .....+.|.+|+.++..++|+||+++++++...+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 36788899999999999999965 4688999998642 2233466889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
||+++|+|.+++.+....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG- 156 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCC-
Confidence 999999999999765567999999999999999999999766 9999999999999999999999999987543221
Q ss_pred CceeeeeecCcCCCChhhhcc-----CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhcc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKR-----QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDII 715 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (817)
........||+.|+|||++.. +.++.++|||||||++|||++|+.||......+. ............
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~------~~~i~~~~~~~~-- 228 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHKEHFQ-- 228 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH------HHHHHcCCCccc--
Confidence 112233469999999999863 4578899999999999999999999975432211 111111100000
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccc--CCCCCCCHHHHHHHH
Q 039107 716 DPLLKDKISPECLKKFADTAEKCLSD--SGIDRPSMGDVLWNL 756 (817)
Q Consensus 716 d~~l~~~~~~~~~~~l~~li~~cl~~--dP~~RPt~~evl~~L 756 (817)
+.. .....+..+.+++.+|+.. ++..||++.+++++-
T Consensus 229 ---~~~-~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp 267 (331)
T cd05597 229 ---FPP-DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHP 267 (331)
T ss_pred ---CCC-ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCC
Confidence 000 0112345567888887754 334488999999883
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=324.75 Aligned_cols=260 Identities=23% Similarity=0.272 Sum_probs=193.9
Q ss_pred hhcCCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
...+|...+.||+|+||.||+|.... +..||+|..... ....|+.++++++|+||+++++++......++|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 34579999999999999999999764 467899975432 23569999999999999999999999999999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
++. ++|.+++......+++.+++.|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.... .
T Consensus 138 ~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---~ 210 (357)
T PHA03209 138 HYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVV---A 210 (357)
T ss_pred ccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccccc---C
Confidence 995 6888888766668999999999999999999999765 99999999999999999999999999975221 1
Q ss_pred ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccc--------hHHHHHHHhhc-cCc--
Q 039107 642 HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQV--------SLADWALHCKR-KGI-- 710 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~--------~l~~~~~~~~~-~~~-- 710 (817)
.......||..|+|||++.+..++.++|||||||++|||+++..++....+.... .+......... ...
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 1223456899999999999999999999999999999999876555332221110 01111100000 000
Q ss_pred -------hhhccCc--cccCCC-------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 711 -------LDDIIDP--LLKDKI-------SPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 711 -------~~~~~d~--~l~~~~-------~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
....++. ..+... .......+.+++.+||+.||.+|||+.||++|
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 0000000 000000 00123345679999999999999999999976
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=325.45 Aligned_cols=237 Identities=27% Similarity=0.348 Sum_probs=187.9
Q ss_pred eeEeeeCceEEEEEEEe-cccEEEEEecCCCC---cccHHHHHHHHH-HHhccCccceeeEEEEEecCCeEEEEEEeccC
Q 039107 491 YVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS---EQGVNEFVTEIE-MLSKLRHKHLVSLIGFCEEGNEMCLVYDYMAL 565 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 565 (817)
++||+|+||+||+|+.. +++.||+|++.... ....+++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 37999999999999975 57889999986431 222345555555 56788999999999999999999999999999
Q ss_pred CchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceee
Q 039107 566 GTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVST 645 (817)
Q Consensus 566 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 645 (817)
|+|.+++... +.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~ 154 (323)
T cd05575 81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKTTS 154 (323)
T ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCccc
Confidence 9999988653 46889999999999999999999765 999999999999999999999999998753221 12233
Q ss_pred eeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCH
Q 039107 646 VVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISP 725 (817)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 725 (817)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....... .. ..+ .+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~------~~~~i~~-~~------~~~----~~ 217 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE------MYDNILN-KP------LRL----KP 217 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH------HHHHHHc-CC------CCC----CC
Confidence 4568999999999999999999999999999999999999997543211 1111110 00 011 12
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHH
Q 039107 726 ECLKKFADTAEKCLSDSGIDRPSMG 750 (817)
Q Consensus 726 ~~~~~l~~li~~cl~~dP~~RPt~~ 750 (817)
.....+.+++.+||+.+|.+||++.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 2345678999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=328.13 Aligned_cols=263 Identities=22% Similarity=0.268 Sum_probs=202.9
Q ss_pred HHHHHHhhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEec
Q 039107 477 LAEIKHATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE 552 (817)
Q Consensus 477 ~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 552 (817)
+.++....++|...+.||+|+||.||++..+ ++..+|+|.+... .....+.+.+|+.+++.++||||+++++++..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4445556688999999999999999999976 4578999987532 22334567899999999999999999999999
Q ss_pred CCeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccC
Q 039107 553 GNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLS 632 (817)
Q Consensus 553 ~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla 632 (817)
....++||||+++|+|.+++.. ..++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 9999999999999999998854 35888889999999999999999766 999999999999999999999999999
Q ss_pred ccCCCCCCCceeeeeecCcCCCChhhhccC----CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhcc
Q 039107 633 KTGPNMENGHVSTVVKGSFGYLDPEYFKRQ----QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRK 708 (817)
Q Consensus 633 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 708 (817)
+...... ........||+.|+|||++... .++.++|||||||++|||++|+.||........ +.......
T Consensus 190 ~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-----~~~i~~~~ 263 (371)
T cd05622 190 MKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-----YSKIMNHK 263 (371)
T ss_pred eEcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH-----HHHHHcCC
Confidence 7643221 1122345699999999998754 378999999999999999999999976533211 00000000
Q ss_pred CchhhccCccccCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHHH
Q 039107 709 GILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGID--RPSMGDVLWNLEF 758 (817)
Q Consensus 709 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~L~~ 758 (817)
.. +.-.........+.+++.+||...+.+ ||++.+++++...
T Consensus 264 ~~--------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~ 307 (371)
T cd05622 264 NS--------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 307 (371)
T ss_pred Cc--------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCccc
Confidence 00 000111234556788999999854443 7899999988643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=315.90 Aligned_cols=239 Identities=26% Similarity=0.436 Sum_probs=190.3
Q ss_pred eEeeeCceEEEEEEEec--------ccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 492 VIGVGGFGKVYKGVIED--------KLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 492 ~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
.||+|+||.||+|..+. ..++++|.+........+.+.+|+.+++.++||||+++++++......++||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 69999999999998642 2348888877655555678899999999999999999999999989999999999
Q ss_pred cCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCce--------eEEeeeccCccC
Q 039107 564 ALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWV--------AKVSDFGLSKTG 635 (817)
Q Consensus 564 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~--------~kl~DFGla~~~ 635 (817)
++|+|.+++......+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. ++++|||++...
T Consensus 82 ~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~ 158 (258)
T cd05078 82 KFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV 158 (258)
T ss_pred CCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence 999999999776667899999999999999999999765 999999999999987765 699999988653
Q ss_pred CCCCCCceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCC-CCCCCCCccccchHHHHHHHhhccCchhh
Q 039107 636 PNMENGHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCAR-PALNPSLPKEQVSLADWALHCKRKGILDD 713 (817)
Q Consensus 636 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 713 (817)
.. .....++..|+|||++.+ ..++.++||||||+++|||++|. +|+......... .....
T Consensus 159 ~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~------~~~~~------ 220 (258)
T cd05078 159 LP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL------QFYED------ 220 (258)
T ss_pred CC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH------HHHHc------
Confidence 21 123457889999999976 45799999999999999999995 444332211110 00000
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 714 IIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 714 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
....+.....++.+++.+||+.+|++|||++++++.|+
T Consensus 221 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 ------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 01112223356899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=326.31 Aligned_cols=249 Identities=23% Similarity=0.415 Sum_probs=205.4
Q ss_pred ceeEeeeCceEEEEEEEec--c--cEEEEEecCCCCcc-cHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEecc
Q 039107 490 SYVIGVGGFGKVYKGVIED--K--LKVAIKRSNPSSEQ-GVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMA 564 (817)
Q Consensus 490 ~~~lG~G~fg~Vy~~~~~~--~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 564 (817)
.++||+|.||.|++|.+.. | ..||||++...... ...+|++|+.+|.+|+|+|+++|+|+..+ ..+.||+|.++
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap 193 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP 193 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence 3479999999999999752 3 57999999877544 67899999999999999999999999987 78899999999
Q ss_pred CCchhhhhhc-cccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCce
Q 039107 565 LGTLREHIYN-TKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643 (817)
Q Consensus 565 ~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 643 (817)
.|+|.+.|++ .+..|-......++.|||.||+||.+++ +|||||..+|+||-....+||+||||.+.+...+....
T Consensus 194 lGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yv 270 (1039)
T KOG0199|consen 194 LGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYV 270 (1039)
T ss_pred cchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcceE
Confidence 9999999987 3347888899999999999999999776 99999999999999999999999999997654433221
Q ss_pred -eeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccC
Q 039107 644 -STVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKD 721 (817)
Q Consensus 644 -~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (817)
.....-...|+|||.++.+.++.++|||+|||.||||++ |..||-+-...... +.+|..-+-
T Consensus 271 m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL----------------~~iD~~erL 334 (1039)
T KOG0199|consen 271 MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQIL----------------KNIDAGERL 334 (1039)
T ss_pred ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHH----------------HhccccccC
Confidence 122234678999999999999999999999999999998 66788765443222 222322222
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 722 KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 722 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
..++.|++.+.+++..||..+|++|||+..|.+.+-.
T Consensus 335 pRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 335 PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred CCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 3356789999999999999999999999999855443
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=315.30 Aligned_cols=252 Identities=26% Similarity=0.379 Sum_probs=202.3
Q ss_pred cCCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
..|+..++||+|+||.||+|.... +..+++|.+........+.+.+|+.++++++|+||+++++++......++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 457777899999999999999764 6789999988766666788999999999999999999999999999999999999
Q ss_pred cCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCce
Q 039107 564 ALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643 (817)
Q Consensus 564 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 643 (817)
++++|..++.+....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++...... ...
T Consensus 92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~~ 166 (292)
T cd06644 92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQR 166 (292)
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc--ccc
Confidence 999999888665667999999999999999999999665 999999999999999999999999998753221 122
Q ss_pred eeeeecCcCCCChhhhc-----cCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcc
Q 039107 644 STVVKGSFGYLDPEYFK-----RQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPL 718 (817)
Q Consensus 644 ~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (817)
.....++..|+|||.+. ...++.++|||||||++|||++|++|+........ ...... . ..+.
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~~~~-~-----~~~~ 234 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIAK-S-----EPPT 234 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH------HHHHhc-C-----CCcc
Confidence 23456889999999984 34568899999999999999999999865432110 111000 0 0011
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 719 LKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 719 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
. ..+......+.+++.+||+.+|++||++.+++++
T Consensus 235 ~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 235 L--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred C--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0 1122344568899999999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=315.33 Aligned_cols=253 Identities=25% Similarity=0.371 Sum_probs=200.2
Q ss_pred CCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC---cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 487 FDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS---EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 487 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
|+..++||+|+||.||++... .++.+|+|.+.... ......+.+|+.++++++|+|++++++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 666789999999999999865 56789999876432 22234577899999999999999999999999999999999
Q ss_pred ccCCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 563 MALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 563 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
+++++|.+++.... ..+++.+++.++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 99999999886443 36899999999999999999999665 9999999999999999999999999987532211
Q ss_pred ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccC
Q 039107 642 HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKD 721 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (817)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||.......... .+.. ..+ ....
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~--~~~~----------~~~-~~~~ 222 (285)
T cd05630 157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE--EVER----------LVK-EVQE 222 (285)
T ss_pred -cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH--HHHh----------hhh-hhhh
Confidence 1223468999999999999999999999999999999999999997643211100 0000 000 0001
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHHH
Q 039107 722 KISPECLKKFADTAEKCLSDSGIDRPS-----MGDVLWNLEF 758 (817)
Q Consensus 722 ~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~L~~ 758 (817)
.........+.+++.+||+.||.+||| +.+++++-..
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~ 264 (285)
T cd05630 223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLF 264 (285)
T ss_pred hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhh
Confidence 112234456789999999999999999 8899986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=316.33 Aligned_cols=263 Identities=24% Similarity=0.317 Sum_probs=193.7
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCc--ccHHHHHHHHHHHhcc---CccceeeEEEEEec-----CC
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSE--QGVNEFVTEIEMLSKL---RHKHLVSLIGFCEE-----GN 554 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~-----~~ 554 (817)
+|...+.||+|+||+||+|..+ ++..||+|.+..... .....+.+|+++++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4677889999999999999876 567899998765322 2234566777777766 69999999998854 34
Q ss_pred eEEEEEEeccCCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCc
Q 039107 555 EMCLVYDYMALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSK 633 (817)
Q Consensus 555 ~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 633 (817)
..++||||+. ++|.+++.... ..+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccc
Confidence 5799999998 48888876543 35899999999999999999999776 9999999999999999999999999997
Q ss_pred cCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccch-HHHHHHHhhccCch-
Q 039107 634 TGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVS-LADWALHCKRKGIL- 711 (817)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~~~~~~~~~~~~- 711 (817)
...... ......||..|+|||++.+..++.++|||||||++|||++|++||......+... +..+..........
T Consensus 157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 157 IYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred cccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 643221 1223467899999999998899999999999999999999999987654332211 11110000000000
Q ss_pred -----hhccCcccc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 712 -----DDIIDPLLK---DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 712 -----~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.....+... ....++....+.+++.+||+.||++|||+.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000000 01112344567899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=322.08 Aligned_cols=256 Identities=20% Similarity=0.230 Sum_probs=198.0
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
++|...+.||+|+||.||+++.. ++..||+|.+... .......+.+|+.++..++|+||+++++++...+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888899999999999999975 4578999987642 2233456888999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
||+++|+|.+++......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG- 156 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCC-
Confidence 999999999999765567899999999999999999999765 9999999999999999999999999997643221
Q ss_pred CceeeeeecCcCCCChhhhcc-----CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhcc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKR-----QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDII 715 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (817)
........||+.|+|||++.+ +.++.++|||||||+||||++|+.||......+. ......... .
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~------~~~i~~~~~--~-- 226 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHEE--R-- 226 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH------HHHHHcCCC--c--
Confidence 112233569999999999875 5678999999999999999999999975432211 111110000 0
Q ss_pred CccccCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHH
Q 039107 716 DPLLKDKISPECLKKFADTAEKCLSDSGID--RPSMGDVLWNL 756 (817)
Q Consensus 716 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~L 756 (817)
..+... ....+..+.+++.+|+...+.+ |+++++++++.
T Consensus 227 -~~~p~~-~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~ 267 (331)
T cd05624 227 -FQFPSH-ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHA 267 (331)
T ss_pred -ccCCCc-cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCC
Confidence 000010 1123456788999998865544 56899988763
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=309.20 Aligned_cols=252 Identities=24% Similarity=0.424 Sum_probs=202.6
Q ss_pred cCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEecc
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMA 564 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 564 (817)
.+|...++||+|+||.||++...++..+++|.+.... ...+.|.+|++++++++|+||+++++++.. ...+++|||++
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 4678888999999999999998777889999887543 345678999999999999999999999887 77899999999
Q ss_pred CCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCce
Q 039107 565 LGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643 (817)
Q Consensus 565 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 643 (817)
+++|.+++.... ..+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........ ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~ 159 (260)
T cd05073 84 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TA 159 (260)
T ss_pred CCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc-cc
Confidence 999999997543 36889999999999999999999765 99999999999999999999999999875432211 11
Q ss_pred eeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCC
Q 039107 644 STVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDK 722 (817)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (817)
.....++..|+|||.+..+.++.++|+|||||+++||++ |+.||....... +..+... +. ...
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~~----~~---------~~~ 223 (260)
T cd05073 160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRALER----GY---------RMP 223 (260)
T ss_pred ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHhC----CC---------CCC
Confidence 122345678999999998899999999999999999998 898886543221 1111111 10 001
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 723 ISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 723 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
.....+..+.+++.+|++.+|++||++.++++.|+.
T Consensus 224 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 112344568899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=318.39 Aligned_cols=264 Identities=25% Similarity=0.345 Sum_probs=203.0
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
+|+..+.||+|+||.||++... ++..+|+|.+.... .....++.+|++++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~ 81 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM 81 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence 6888899999999999999865 45778888876542 233466889999999999999999999999999999999999
Q ss_pred cCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCce
Q 039107 564 ALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643 (817)
Q Consensus 564 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 643 (817)
++++|.+++... +.+++..+..++.|+++||.|||+. .+++||||||+|||+++++.+||+|||++...... .
T Consensus 82 ~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~ 154 (308)
T cd06615 82 DGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----M 154 (308)
T ss_pred CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCccccccc----c
Confidence 999999998654 4689999999999999999999973 35999999999999999999999999998754221 1
Q ss_pred eeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCc-------------
Q 039107 644 STVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGI------------- 710 (817)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------------- 710 (817)
.....|+..|+|||.+.+..++.++||||||++++||++|+.||....... +..+.........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCcccccCCCC
Confidence 223468899999999988889999999999999999999999986443211 1111100000000
Q ss_pred -------hhhccCccc---cCCCC-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 711 -------LDDIIDPLL---KDKIS-PECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 711 -------~~~~~d~~l---~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
..+..+... ....+ ......+.+++.+||..+|++||++.+|+++.-..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~ 291 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK 291 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhh
Confidence 000000000 00000 11345689999999999999999999999886554
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=313.66 Aligned_cols=253 Identities=29% Similarity=0.420 Sum_probs=198.5
Q ss_pred HhhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhcc-CccceeeEEEEEecC------
Q 039107 482 HATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEG------ 553 (817)
Q Consensus 482 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~------ 553 (817)
.++..|...+.||+|+||.||+|... +++.||+|++.... ....++..|+.+++++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35567788889999999999999865 46789999986543 3446788999999999 799999999998642
Q ss_pred CeEEEEEEeccCCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccC
Q 039107 554 NEMCLVYDYMALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLS 632 (817)
Q Consensus 554 ~~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla 632 (817)
...++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 45899999999999999987643 46899999999999999999999765 999999999999999999999999998
Q ss_pred ccCCCCCCCceeeeeecCcCCCChhhhc-----cCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhc
Q 039107 633 KTGPNMENGHVSTVVKGSFGYLDPEYFK-----RQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKR 707 (817)
Q Consensus 633 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 707 (817)
+...... .......|+..|+|||++. ...++.++|||||||++|||++|+.||........ +... ..
T Consensus 159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~-----~~~~-~~ 230 (272)
T cd06637 159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-----LFLI-PR 230 (272)
T ss_pred eeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH-----HHHH-hc
Confidence 7643221 1223456899999999986 34678899999999999999999999864322111 1100 00
Q ss_pred cCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 708 KGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 708 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
. ..+.. ....++..+.+++.+||..+|.+|||+.+++++
T Consensus 231 ~------~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 231 N------PAPRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred C------CCCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 0 00111 112234568899999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=338.96 Aligned_cols=271 Identities=21% Similarity=0.306 Sum_probs=197.9
Q ss_pred HHHHHhhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCc------cceeeEEEEE
Q 039107 478 AEIKHATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRH------KHLVSLIGFC 550 (817)
Q Consensus 478 ~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H------~niv~l~g~~ 550 (817)
+++...+.+|...++||+|+||+||+|... .+..||||+++... ....++..|+.++++++| .+++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 445556788999999999999999999865 46789999986432 223456677877777754 4588999988
Q ss_pred ecC-CeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCc-------
Q 039107 551 EEG-NEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENW------- 622 (817)
Q Consensus 551 ~~~-~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~------- 622 (817)
... ...++|||++ +++|.+++... ..+++..+..|+.||+.||+|||++ .+||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCccccccc
Confidence 654 5789999988 56888887644 4699999999999999999999973 2499999999999998765
Q ss_pred ---------eeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCcc
Q 039107 623 ---------VAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPK 693 (817)
Q Consensus 623 ---------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~ 693 (817)
.+||+|||++.... .......||+.|+|||++.+..++.++|||||||+||||++|++||......
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred ccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 49999999886421 1233467999999999999999999999999999999999999999876543
Q ss_pred ccchHHH---------HHHHhhcc---------CchhhccCccc-----c-CCC-CHHHHHHHHHHHHHccccCCCCCCC
Q 039107 694 EQVSLAD---------WALHCKRK---------GILDDIIDPLL-----K-DKI-SPECLKKFADTAEKCLSDSGIDRPS 748 (817)
Q Consensus 694 ~~~~l~~---------~~~~~~~~---------~~~~~~~d~~l-----~-~~~-~~~~~~~l~~li~~cl~~dP~~RPt 748 (817)
+...+.. |...+... +.+....++.. . ... .......+++|+.+||+.||.+|||
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 3332221 11100000 00000000000 0 000 0011345789999999999999999
Q ss_pred HHHHHHHHHH
Q 039107 749 MGDVLWNLEF 758 (817)
Q Consensus 749 ~~evl~~L~~ 758 (817)
++|+++|--.
T Consensus 432 a~e~L~Hp~~ 441 (467)
T PTZ00284 432 ARQMTTHPYV 441 (467)
T ss_pred HHHHhcCccc
Confidence 9999987543
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=307.90 Aligned_cols=254 Identities=28% Similarity=0.381 Sum_probs=205.8
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
++|...+.||+|+||.||+|... ++..+++|.+........+.+.+|++++++++||||+++++++......+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 56888889999999999999875 45789999987665556788999999999999999999999999999999999999
Q ss_pred cCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCce
Q 039107 564 ALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643 (817)
Q Consensus 564 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 643 (817)
++++|.+++......+++.++..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||++....... ..
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~ 157 (262)
T cd06613 83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--AK 157 (262)
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh--hc
Confidence 999999998766567999999999999999999999765 9999999999999999999999999987543211 12
Q ss_pred eeeeecCcCCCChhhhccC---CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 644 STVVKGSFGYLDPEYFKRQ---QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~---~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
.....++..|+|||.+... .++.++||||||+++|||++|++|+........... ..... ...+.+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~-------~~~~~---~~~~~~- 226 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL-------ISKSN---FPPPKL- 226 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------HHhcc---CCCccc-
Confidence 2334678899999998776 889999999999999999999999875432221100 00000 000011
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
......+..+.+++.+||..+|.+|||+.+|+.+
T Consensus 227 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 227 -KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred -cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1123445678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=313.61 Aligned_cols=251 Identities=22% Similarity=0.310 Sum_probs=197.0
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC-CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS-SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
+|+..++||+|+||.||+|... ++..||+|.+... .....+++.+|++++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 5667789999999999999854 5678999987644 2334567899999999999999999999999999999999999
Q ss_pred cCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCce
Q 039107 564 ALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643 (817)
Q Consensus 564 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 643 (817)
++++|..+. .+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++...... .
T Consensus 82 ~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----~ 149 (279)
T cd06619 82 DGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----I 149 (279)
T ss_pred CCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc----c
Confidence 999986542 4778888999999999999999765 999999999999999999999999998754221 1
Q ss_pred eeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccc-hHHHHHHHhhccCchhhccCccccCC
Q 039107 644 STVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQV-SLADWALHCKRKGILDDIIDPLLKDK 722 (817)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (817)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||......... ....+...... . ..+.+.
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~-----~~~~~~-- 221 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD-E-----DPPVLP-- 221 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhc-c-----CCCCCC--
Confidence 23346899999999999889999999999999999999999998653322111 01111111000 0 001111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 723 ISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 723 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
.......+.+++.+|++.+|++||++++++++..
T Consensus 222 -~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~ 255 (279)
T cd06619 222 -VGQFSEKFVHFITQCMRKQPKERPAPENLMDHPF 255 (279)
T ss_pred -CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence 1123346789999999999999999999997743
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=309.87 Aligned_cols=252 Identities=23% Similarity=0.424 Sum_probs=200.0
Q ss_pred CCCcceeEeeeCceEEEEEEEecccEEEEEecCCCC------cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSS------EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 559 (817)
+|...+.||+|+||.||+|...++..+|+|.+.... ....+.+.+|++++++++|+||++++++|.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 366778999999999999988788899999876432 12235688999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC
Q 039107 560 YDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 639 (817)
+||+++++|.+++.+. ..+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 81 MEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 9999999999998654 35889999999999999999999765 9999999999999999999999999987532111
Q ss_pred ----CCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhcc
Q 039107 640 ----NGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDII 715 (817)
Q Consensus 640 ----~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (817)
.........|+..|+|||.+.+..++.++||||||++++||++|+.||......... ........ .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~-----~~~~~~~~-----~ 226 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM-----FYIGAHRG-----L 226 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH-----HHhhhccC-----C
Confidence 111122346889999999999889999999999999999999999999654221110 00000000 0
Q ss_pred CccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 716 DPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 716 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.+. .+......+.+++.+||+.+|.+||++.+++++
T Consensus 227 ~~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 227 MPR----LPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred CCC----CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 111 222345567999999999999999999999863
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=307.09 Aligned_cols=253 Identities=28% Similarity=0.344 Sum_probs=207.5
Q ss_pred CCCcceeEeeeCceEEEEEEEecc-cEEEEEecCCCC---cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIEDK-LKVAIKRSNPSS---EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
.|+..+.||+|.-|+||++.+++. ..+|+|.+.+.. .+...+...|-+||+.+.||.++.|++.++..+..|||||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 355566899999999999998865 789999988653 3445667789999999999999999999999999999999
Q ss_pred eccCCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCC---
Q 039107 562 YMALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPN--- 637 (817)
Q Consensus 562 y~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~--- 637 (817)
||+||+|..+++++. +.+++..+.-.+..|+.||+|||..| ||.|||||+||||.++|.+.|+||.|+.....
T Consensus 158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 999999999987654 48999999999999999999999665 99999999999999999999999999753210
Q ss_pred ------------------------------CCC---------------------CceeeeeecCcCCCChhhhccCCCCc
Q 039107 638 ------------------------------MEN---------------------GHVSTVVKGSFGYLDPEYFKRQQLTE 666 (817)
Q Consensus 638 ------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ 666 (817)
... ...+...+||-.|+|||++.+...+.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 000 01223457999999999999999999
Q ss_pred hHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCC
Q 039107 667 KSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDR 746 (817)
Q Consensus 667 ~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R 746 (817)
++|.|+|||+|||||.|..||.+....+. +..++...+.-...++.+..+.+||++.|.+||.+|
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~~T---------------l~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kR 379 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNKET---------------LRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKR 379 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCchhh---------------HHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhh
Confidence 99999999999999999999988765432 222332222222233566778999999999999999
Q ss_pred CC----HHHHHHHH
Q 039107 747 PS----MGDVLWNL 756 (817)
Q Consensus 747 Pt----~~evl~~L 756 (817)
.. +.||-+|-
T Consensus 380 lg~~rGA~eIK~Hp 393 (459)
T KOG0610|consen 380 LGSKRGAAEIKRHP 393 (459)
T ss_pred hccccchHHhhcCc
Confidence 88 88887663
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=314.23 Aligned_cols=251 Identities=25% Similarity=0.393 Sum_probs=203.9
Q ss_pred hcCCCcceeEeeeCceEEEEEEE-ecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVI-EDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
.++|...+.||+|+||.||++.. .++..||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 35788889999999999999996 46789999998766555567788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
+++++|.+++.. ..+++.++..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++....... .
T Consensus 98 ~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~--~ 170 (297)
T cd06656 98 LAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--S 170 (297)
T ss_pred cCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc--c
Confidence 999999998853 45889999999999999999999765 9999999999999999999999999987543221 1
Q ss_pred eeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCC
Q 039107 643 VSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDK 722 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (817)
......++..|+|||.+.+..++.++|||||||++|+|++|+.||........... . ...+ .+. ..
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~---~---~~~~------~~~--~~ 236 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---I---ATNG------TPE--LQ 236 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee---e---ccCC------CCC--CC
Confidence 12234688899999999998999999999999999999999999975433221100 0 0000 000 01
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 723 ISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 723 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.+......+.+++.+||+.+|++||++.+++++
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 237 NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 122344567899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=314.87 Aligned_cols=253 Identities=24% Similarity=0.383 Sum_probs=204.8
Q ss_pred cCCCcceeEeeeCceEEEEEEE-ecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 485 KSFDESYVIGVGGFGKVYKGVI-EDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
.+|...+.||.|++|.||+|.. .++..|++|.+........+.+.+|+.+++.++|+||+++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688888999999999999985 467889999987665555678899999999999999999999999999999999999
Q ss_pred cCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCce
Q 039107 564 ALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643 (817)
Q Consensus 564 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 643 (817)
++++|.+++.. ..+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++........ .
T Consensus 99 ~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~ 171 (296)
T cd06655 99 AGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--K 171 (296)
T ss_pred CCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc--c
Confidence 99999998853 35899999999999999999999765 99999999999999999999999999875432211 1
Q ss_pred eeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCC
Q 039107 644 STVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKI 723 (817)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 723 (817)
.....++..|+|||.+.+..++.++|||||||++|||++|+.||.......... .... ... +.+ ..
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~---~~~~----~~~-----~~~--~~ 237 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY---LIAT----NGT-----PEL--QN 237 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHh----cCC-----ccc--CC
Confidence 223468889999999998889999999999999999999999997654322110 0000 000 000 01
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 724 SPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 724 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
+......+.+++.+||..+|.+||++.+++.+=..
T Consensus 238 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~ 272 (296)
T cd06655 238 PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272 (296)
T ss_pred cccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHh
Confidence 22344567899999999999999999999966443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=307.10 Aligned_cols=249 Identities=22% Similarity=0.346 Sum_probs=200.8
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC-CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS-SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
+|...++||+|+||.||++... ++..+++|.+... .....+.+.+|+.++++++|+||+++++.+..+...++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677889999999999999865 5678999987543 3344577889999999999999999999999999999999999
Q ss_pred cCCchhhhhhcc-ccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 564 ALGTLREHIYNT-KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 564 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
++++|.+++... ...+++..++.++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||+++...... .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--~ 155 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--A 155 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc--c
Confidence 999999988653 336889999999999999999999765 9999999999999999999999999987643221 1
Q ss_pred eeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCC
Q 039107 643 VSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDK 722 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (817)
......|+..|+|||++.+..++.++|+||||+++|+|++|+.||........ ..... .+.. ..
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~~~~-~~~~---------~~ 219 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL------ILKVC-QGSY---------KP 219 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH------HHHHh-cCCC---------CC
Confidence 22335688999999999988999999999999999999999999975432111 11100 1110 11
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 723 ISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 723 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.+......+.+++.+||+.+|++||++.+++..
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 122344568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=324.01 Aligned_cols=238 Identities=26% Similarity=0.341 Sum_probs=188.2
Q ss_pred eeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHH-HHhccCccceeeEEEEEecCCeEEEEEEeccC
Q 039107 491 YVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIE-MLSKLRHKHLVSLIGFCEEGNEMCLVYDYMAL 565 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 565 (817)
++||+|+||+||++... ++..+|+|++... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36999999999999864 5788999987643 2233445566655 46778999999999999999999999999999
Q ss_pred CchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceee
Q 039107 566 GTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVST 645 (817)
Q Consensus 566 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 645 (817)
|+|..++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..... .....
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~ 154 (325)
T cd05604 81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDTTT 154 (325)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCCcc
Confidence 9999888643 46899999999999999999999765 999999999999999999999999998753221 12233
Q ss_pred eeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCH
Q 039107 646 VVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISP 725 (817)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 725 (817)
...||..|+|||++.+..++.++|||||||++|||++|+.||......+. ........ ..+ .+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~------~~~~~~~~-------~~~----~~ 217 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM------YDNILHKP-------LVL----RP 217 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH------HHHHHcCC-------ccC----CC
Confidence 45799999999999999999999999999999999999999975432211 11111100 011 12
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHH
Q 039107 726 ECLKKFADTAEKCLSDSGIDRPSMGD 751 (817)
Q Consensus 726 ~~~~~l~~li~~cl~~dP~~RPt~~e 751 (817)
.....+.+++.+|++.+|.+||++++
T Consensus 218 ~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 218 GASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred CCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 23456789999999999999998863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=313.60 Aligned_cols=252 Identities=27% Similarity=0.407 Sum_probs=204.0
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
++|...+.||.|+||.||++... ++..+|+|..........+.|.+|++++++++|+||+++++++......++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 45777788999999999999975 56889999987666666678999999999999999999999999999999999999
Q ss_pred cCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCce
Q 039107 564 ALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643 (817)
Q Consensus 564 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 643 (817)
++++|.+++......+++.++..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++....... ..
T Consensus 85 ~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~~ 159 (280)
T cd06611 85 DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--QK 159 (280)
T ss_pred CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc--cc
Confidence 999999998776667999999999999999999999776 9999999999999999999999999987543221 12
Q ss_pred eeeeecCcCCCChhhhc-----cCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcc
Q 039107 644 STVVKGSFGYLDPEYFK-----RQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPL 718 (817)
Q Consensus 644 ~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (817)
.....++..|+|||.+. ...++.++||||||+++|||++|+.||........ +. ... ... .+.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~~----~~~-~~~-----~~~ 227 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--LL----KIL-KSE-----PPT 227 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--HH----HHh-cCC-----CCC
Confidence 23456899999999975 34577899999999999999999999875432111 11 100 000 011
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 719 LKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 719 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
+ ..+......+.+++.+||+.+|.+||++.+++++
T Consensus 228 ~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 228 L--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred c--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 1 1122344567899999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=319.38 Aligned_cols=251 Identities=23% Similarity=0.301 Sum_probs=209.3
Q ss_pred hcCCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCCCc---ccHHHHHHHHHHHhccC-ccceeeEEEEEecCCeEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPSSE---QGVNEFVTEIEMLSKLR-HKHLVSLIGFCEEGNEMCL 558 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~l 558 (817)
...|...+.||+|.||.||+++.+. |..+|+|.+.+... ...+.+.+|+.+|+++. |||||.+.+.++.....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 3456667899999999999999775 78999999876533 23468899999999998 9999999999999999999
Q ss_pred EEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcC----CceeEEeeeccCcc
Q 039107 559 VYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDE----NWVAKVSDFGLSKT 634 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~----~~~~kl~DFGla~~ 634 (817)
|||++.+|.|.+.+... .+++.....++.|++.+++|||+.+ |+||||||+|+|+.. ++.+|++|||++..
T Consensus 114 vmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred EEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 99999999999998766 3999999999999999999999765 999999999999963 35899999999987
Q ss_pred CCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhc
Q 039107 635 GPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDI 714 (817)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 714 (817)
... .......+||+.|+|||++....|+..+||||+||++|.|++|.+||.......... ....+.
T Consensus 189 ~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~---- 254 (382)
T KOG0032|consen 189 IKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGD---- 254 (382)
T ss_pred ccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCC----
Confidence 544 445667889999999999999999999999999999999999999998765433211 001111
Q ss_pred cCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 715 IDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 715 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.......-+.....+.+++..|+..||.+|+|+.++++|
T Consensus 255 --~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 255 --FDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred --CCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 112222223456778999999999999999999999996
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=311.43 Aligned_cols=263 Identities=22% Similarity=0.309 Sum_probs=196.4
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC--cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
+|...+.||+|++|.||+|+.+ ++..||+|++.... ....+.+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 3667789999999999999975 57889999876432 22346788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccc--cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 563 MALGTLREHIYNTK--KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 563 ~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
++ ++|.+++.... ..+++.++..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 68888876433 46899999999999999999999765 9999999999999999999999999987532211
Q ss_pred CceeeeeecCcCCCChhhhccC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccch-H-H--------HHHHHhh---
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQ-QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVS-L-A--------DWALHCK--- 706 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l-~--------~~~~~~~--- 706 (817)
.......++..|+|||.+.+. .++.++||||||++++||++|++||......+... . . .|.....
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 112233568899999988654 57899999999999999999999997654322110 0 0 0000000
Q ss_pred ccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 707 RKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 707 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
............... .......++.+++.+||+.||++|||+.+|+++
T Consensus 235 ~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 235 YKNTFPKWKKGSLRS-AVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHhhccccCcchhHH-hcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000000000000 011234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=310.18 Aligned_cols=254 Identities=28% Similarity=0.466 Sum_probs=200.9
Q ss_pred cCCCcceeEeeeCceEEEEEEEec------ccEEEEEecCCCCcc-cHHHHHHHHHHHhccCccceeeEEEEEecCCeEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIED------KLKVAIKRSNPSSEQ-GVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMC 557 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 557 (817)
.+|.....||+|+||.||+|+.+. ...+++|.+...... ..+++.+|++++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 467788899999999999998642 356899988754433 4578999999999999999999999999989999
Q ss_pred EEEEeccCCchhhhhhccc--------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeee
Q 039107 558 LVYDYMALGTLREHIYNTK--------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDF 629 (817)
Q Consensus 558 lV~Ey~~~gsL~~~l~~~~--------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DF 629 (817)
+||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999987543 15899999999999999999999765 999999999999999999999999
Q ss_pred ccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhcc
Q 039107 630 GLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRK 708 (817)
Q Consensus 630 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 708 (817)
|+++....... .......++..|+|||.+.+...+.++||||||++++||++ |..||....... ..... . .
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~~~---~-~ 233 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLNRL---Q-A 233 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHHHH---H-c
Confidence 99875322111 11222345678999999988889999999999999999998 777875432211 11111 1 0
Q ss_pred CchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 709 GILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 709 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
+.. .......++..+.+++.+||+.+|.+||++.+++++|.
T Consensus 234 ~~~--------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GKL--------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCc--------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 110 01112234557899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=293.57 Aligned_cols=258 Identities=24% Similarity=0.337 Sum_probs=204.3
Q ss_pred hhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC-----cc---cHHHHHHHHHHHhcc-CccceeeEEEEEec
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS-----EQ---GVNEFVTEIEMLSKL-RHKHLVSLIGFCEE 552 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~---~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 552 (817)
.-+.|...+.||+|..++|-++.++ ++...|+|++.... +. -.+.-..|+.+|+++ .||+|+++.++++.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3455777789999999999988865 55788888865432 11 123456899999998 69999999999999
Q ss_pred CCeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccC
Q 039107 553 GNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLS 632 (817)
Q Consensus 553 ~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla 632 (817)
...+++|+|.|+.|.|.++|... -.++++...+|++|+.+|++|||... ||||||||+|||+|++.++||+|||++
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecccee
Confidence 99999999999999999999643 36999999999999999999999765 999999999999999999999999999
Q ss_pred ccCCCCCCCceeeeeecCcCCCChhhhcc------CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhh
Q 039107 633 KTGPNMENGHVSTVVKGSFGYLDPEYFKR------QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCK 706 (817)
Q Consensus 633 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 706 (817)
..... +..-+..+||++|+|||.+.. ..|+...|+|++||+||-||.|.+||.... ++-....++
T Consensus 171 ~~l~~---GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk---QmlMLR~Im--- 241 (411)
T KOG0599|consen 171 CQLEP---GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK---QMLMLRMIM--- 241 (411)
T ss_pred eccCC---chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH---HHHHHHHHH---
Confidence 87543 344567899999999999864 357889999999999999999999997532 111111111
Q ss_pred ccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 039107 707 RKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVL 760 (817)
Q Consensus 707 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 760 (817)
++.. ....+.-.+......+|+.+||+.||.+|.|++|+++|-.++.
T Consensus 242 -eGky------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 242 -EGKY------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred -hccc------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 1110 0111111245567899999999999999999999998866643
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=316.98 Aligned_cols=196 Identities=26% Similarity=0.377 Sum_probs=158.8
Q ss_pred ceeEeeeCceEEEEEEEe---cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEec--CCeEEEEEEecc
Q 039107 490 SYVIGVGGFGKVYKGVIE---DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE--GNEMCLVYDYMA 564 (817)
Q Consensus 490 ~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~Ey~~ 564 (817)
.++||+|+||+||+|+.+ .+..+|+|.+..... ...+.+|+++|++++||||+++++++.. ....++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 458999999999999865 346899999875422 3457889999999999999999998853 456899999987
Q ss_pred CCchhhhhhcc--------ccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEE----cCCceeEEeeeccC
Q 039107 565 LGTLREHIYNT--------KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILL----DENWVAKVSDFGLS 632 (817)
Q Consensus 565 ~gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll----~~~~~~kl~DFGla 632 (817)
++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4777776422 125889999999999999999999766 9999999999999 45689999999999
Q ss_pred ccCCCCCC-CceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Q 039107 633 KTGPNMEN-GHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSL 691 (817)
Q Consensus 633 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~ 691 (817)
+....... ........||+.|+|||++.+ ..++.++||||+||+++||++|++||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 86432211 112234568999999999876 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=319.62 Aligned_cols=255 Identities=20% Similarity=0.236 Sum_probs=197.1
Q ss_pred cCCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
++|...++||+|+||.||+++.+. +..+|+|.+... .......|.+|+.++..++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 367888999999999999999764 567999987632 2223455888999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
||+++|+|.+++.+....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~- 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG- 156 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCC-
Confidence 999999999999765567999999999999999999999765 9999999999999999999999999987532211
Q ss_pred CceeeeeecCcCCCChhhhc-----cCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhcc
Q 039107 641 GHVSTVVKGSFGYLDPEYFK-----RQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDII 715 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (817)
........||+.|+|||++. .+.++.++|||||||++|||++|+.||......+ .......... ..
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~~--~~- 227 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHKE--RF- 227 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH------HHHHHhCCCc--cc-
Confidence 12223456999999999986 3468899999999999999999999997543221 1111111100 00
Q ss_pred CccccCCCCHHHHHHHHHHHHHccccCCC--CCCCHHHHHHH
Q 039107 716 DPLLKDKISPECLKKFADTAEKCLSDSGI--DRPSMGDVLWN 755 (817)
Q Consensus 716 d~~l~~~~~~~~~~~l~~li~~cl~~dP~--~RPt~~evl~~ 755 (817)
... .....+...+.+++.+|+..++. .|+++.+++++
T Consensus 228 --~~p-~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 --QFP-AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred --cCC-CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 000 01123345678889888855444 47899999988
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=307.21 Aligned_cols=249 Identities=26% Similarity=0.424 Sum_probs=198.5
Q ss_pred CCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcc---------cHHHHHHHHHHHhccCccceeeEEEEEecCCeE
Q 039107 487 FDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQ---------GVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEM 556 (817)
Q Consensus 487 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 556 (817)
|.....||+|++|.||+|... ++..+|+|.+...... ..+.+.+|+.++++++||||+++++++.+....
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 556779999999999999864 5678999987643221 235688999999999999999999999999999
Q ss_pred EEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCC
Q 039107 557 CLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGP 636 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 636 (817)
++|+||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 82 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred EEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 9999999999999998654 45889999999999999999999765 9999999999999999999999999988653
Q ss_pred CCCC----CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchh
Q 039107 637 NMEN----GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILD 712 (817)
Q Consensus 637 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 712 (817)
.... ........|+..|+|||.+.+..++.++||||||+++|||++|+.||......... .. . .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~------~~-~-----~ 225 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI------FK-I-----G 225 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH------HH-H-----h
Confidence 2111 11112345788999999999889999999999999999999999999754221110 00 0 0
Q ss_pred hccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 713 DIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 713 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
....+ ..+......+.+++.+||+.+|.+||++.+|+++
T Consensus 226 ~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 226 ENASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred ccCCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 01111 1223345668899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=324.18 Aligned_cols=265 Identities=21% Similarity=0.255 Sum_probs=197.2
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecC------C
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEG------N 554 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 554 (817)
.++|...+.||+|+||.||++... .+..||+|++... .......+.+|+.+++.++||||+++++++... .
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 467888999999999999999864 5688999998643 233456788999999999999999999988643 3
Q ss_pred eEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 555 EMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 555 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
..++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 100 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 172 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCccc
Confidence 57999999975 5655553 24788899999999999999999765 99999999999999999999999999975
Q ss_pred CCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchH------------HH--
Q 039107 635 GPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSL------------AD-- 700 (817)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l------------~~-- 700 (817)
... ........||..|+|||++.+..++.++|||||||++|||++|+.||......+.... ..
T Consensus 173 ~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 173 ACT---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred ccc---CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 322 1122334689999999999999999999999999999999999999976543221100 00
Q ss_pred --HHHHhh-ccC-----chhhccCcccc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 701 --WALHCK-RKG-----ILDDIIDPLLK---DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 701 --~~~~~~-~~~-----~~~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
...... ... ...+....... ..........+.+++.+||+.||++|||+.|++++-..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~ 318 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 318 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence 000000 000 00000000000 00111224567899999999999999999999987543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=323.43 Aligned_cols=240 Identities=26% Similarity=0.364 Sum_probs=188.0
Q ss_pred eeEeeeCceEEEEEEEe-cccEEEEEecCCCC---cccHHHHHHHHH-HHhccCccceeeEEEEEecCCeEEEEEEeccC
Q 039107 491 YVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS---EQGVNEFVTEIE-MLSKLRHKHLVSLIGFCEEGNEMCLVYDYMAL 565 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 565 (817)
+.||+|+||+||+++.. ++..+|+|++.... ......+..|.. +++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999976 45779999876431 222334444544 56788999999999999999999999999999
Q ss_pred CchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceee
Q 039107 566 GTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVST 645 (817)
Q Consensus 566 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 645 (817)
|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~~~ 154 (325)
T cd05602 81 GELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGTTS 154 (325)
T ss_pred CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCCcc
Confidence 9999988654 35778888899999999999999766 999999999999999999999999998753221 22233
Q ss_pred eeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCH
Q 039107 646 VVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISP 725 (817)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 725 (817)
...||+.|+|||++.+..++.++|||||||++|||++|++||......+ ...... ... ....+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~---~~~-----------~~~~~ 217 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYDNIL---NKP-----------LQLKP 217 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH---HHHHHH---hCC-----------cCCCC
Confidence 4579999999999999999999999999999999999999997543221 111111 100 01122
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHH
Q 039107 726 ECLKKFADTAEKCLSDSGIDRPSMGDVL 753 (817)
Q Consensus 726 ~~~~~l~~li~~cl~~dP~~RPt~~evl 753 (817)
.....+.+++.+||+.+|.+||++.+.+
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 218 NITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 3345678999999999999999977443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=309.76 Aligned_cols=249 Identities=29% Similarity=0.403 Sum_probs=202.0
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
+|...+.||.|++|.||+|... ++..+++|.+.... ......+.+|++++++++|+||+++++++.+....++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 5667788999999999999965 56789999976543 344567889999999999999999999999999999999999
Q ss_pred cCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCce
Q 039107 564 ALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643 (817)
Q Consensus 564 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 643 (817)
++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++...... ..
T Consensus 82 ~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~ 154 (274)
T cd06609 82 GGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SK 154 (274)
T ss_pred CCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc--cc
Confidence 999999998654 7899999999999999999999765 9999999999999999999999999997654321 12
Q ss_pred eeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCC
Q 039107 644 STVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKI 723 (817)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 723 (817)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||........ ... .... ..+.+...
T Consensus 155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~------~~~-~~~~-----~~~~~~~~- 221 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV------LFL-IPKN-----NPPSLEGN- 221 (274)
T ss_pred cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH------HHH-hhhc-----CCCCCccc-
Confidence 2334678899999999988899999999999999999999999975432111 000 0001 11111111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 724 SPECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 724 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
..+..+.+++.+||..+|++||++++++++-
T Consensus 222 --~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~ 252 (274)
T cd06609 222 --KFSKPFKDFVSLCLNKDPKERPSAKELLKHK 252 (274)
T ss_pred --ccCHHHHHHHHHHhhCChhhCcCHHHHhhCh
Confidence 1445688999999999999999999998763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=328.36 Aligned_cols=252 Identities=21% Similarity=0.317 Sum_probs=195.9
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
+|+..+.||+|+||.||++..+ ++..||+|++... .......+.+|+.++.+++|+||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 5788899999999999999875 5688999988642 23345678899999999999999999999999999999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC-
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN- 640 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~- 640 (817)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 82 FLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred CCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 99999999998654 45899999999999999999999765 99999999999999999999999999874321100
Q ss_pred --------------------------------CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCC
Q 039107 641 --------------------------------GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALN 688 (817)
Q Consensus 641 --------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~ 688 (817)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 001123469999999999999999999999999999999999999997
Q ss_pred CCCccccchHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 039107 689 PSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPS---MGDVLWN 755 (817)
Q Consensus 689 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~ 755 (817)
.......... +. ..... . ..... .....++.+++.+|+. +|.+|++ +.++++|
T Consensus 238 ~~~~~~~~~~---i~--~~~~~---~---~~p~~--~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 238 SETPQETYRK---VM--NWKET---L---VFPPE--VPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCHHHHHHH---HH--cCCCc---e---ecCCC--CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 6543221100 00 00000 0 00110 1123456778888764 9999985 6777766
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=321.86 Aligned_cols=265 Identities=22% Similarity=0.256 Sum_probs=197.3
Q ss_pred hhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecC------
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEG------ 553 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 553 (817)
..++|...+.||+|+||.||++... .+..||+|++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 3467888999999999999999864 4678999998753 233346788999999999999999999988543
Q ss_pred CeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCc
Q 039107 554 NEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSK 633 (817)
Q Consensus 554 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 633 (817)
...++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccc
Confidence 357999999975 6666553 24888999999999999999999765 9999999999999999999999999997
Q ss_pred cCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHH---------HH---
Q 039107 634 TGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLA---------DW--- 701 (817)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~---------~~--- 701 (817)
.... ........||..|+|||++.+..++.++|||||||++|||++|+.||......+..... ++
T Consensus 168 ~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (355)
T cd07874 168 TAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_pred cCCC---ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 6322 11223356899999999999999999999999999999999999999765422211100 00
Q ss_pred ----HHHhhc-cCchhhccCccc--------cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 702 ----ALHCKR-KGILDDIIDPLL--------KDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 702 ----~~~~~~-~~~~~~~~d~~l--------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
...... .........+.. ...........+.+++.+||+.||++|||+.|++++-.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~ 313 (355)
T cd07874 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPY 313 (355)
T ss_pred hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcc
Confidence 000000 000000000000 00011123456789999999999999999999998743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=305.79 Aligned_cols=250 Identities=25% Similarity=0.363 Sum_probs=202.9
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
+|+..++||.|+||.||.++.. ++..+++|.+... +....+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4677889999999999998854 5678999986643 344567789999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcc-ccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 563 MALGTLREHIYNT-KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 563 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
+++++|.+++... ...+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999765 346899999999999999999999765 99999999999999999999999999876433221
Q ss_pred ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccC
Q 039107 642 HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKD 721 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (817)
......++..|+|||.+.+..++.++||||||++++||++|+.||......+. ...... +. ..
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~~~~~~-~~--------~~- 219 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL------VVKIVQ-GN--------YT- 219 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHc-CC--------CC-
Confidence 22334689999999999888889999999999999999999999865432211 111110 10 00
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 722 KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 722 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
.........+.+++.+||+.+|.+||++.++++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11133456688999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.00 Aligned_cols=251 Identities=23% Similarity=0.383 Sum_probs=194.9
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC-----cccHHHHHHHHHHHhccCccceeeEEEEEec--CCeE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS-----EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE--GNEM 556 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~ 556 (817)
.+|...++||+|+||.||+|... .+..|++|++.... .+..+.+.+|+.++++++||||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888899999999999999865 46789999875431 2334568899999999999999999998865 3567
Q ss_pred EEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCC
Q 039107 557 CLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGP 636 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 636 (817)
++++||+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 89999999999999986543 5889999999999999999999665 9999999999999999999999999987543
Q ss_pred CCCC-CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhcc
Q 039107 637 NMEN-GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDII 715 (817)
Q Consensus 637 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (817)
.... ........++..|+|||.+.+..++.++|||||||++|||++|+.||........ ........ .
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~------~~~~~~~~-----~ 226 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA------IFKIATQP-----T 226 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH------HHHHhcCC-----C
Confidence 2111 1112234578999999999988999999999999999999999999865422111 11110000 0
Q ss_pred CccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 716 DPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 716 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
. ..++......+.+++ +||..+|++||+++||+++
T Consensus 227 ~----~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 227 N----PQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred C----CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 1 112223344556666 6888999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=322.68 Aligned_cols=244 Identities=27% Similarity=0.412 Sum_probs=205.8
Q ss_pred eEeeeCceEEEEEEEec-ccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccCCchhh
Q 039107 492 VIGVGGFGKVYKGVIED-KLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLRE 570 (817)
Q Consensus 492 ~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 570 (817)
+||+|.||+||.|+..+ ...+|||.+.....+..+-+..|+.+-++|+|+|||+.+|.|.+.+.+-+.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999999655 46799999987777777889999999999999999999999999999999999999999999
Q ss_pred hhhcccccc--chHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcC-CceeEEeeeccCccCCCCCCCceeeee
Q 039107 571 HIYNTKKAL--SWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDE-NWVAKVSDFGLSKTGPNMENGHVSTVV 647 (817)
Q Consensus 571 ~l~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~ 647 (817)
+|...=++| .+.++--..+||++||.|||++. |||||||-.|||++. .|.+||+|||-++..... ...+..+
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TETF 736 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTETF 736 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC--Ccccccc
Confidence 997665566 77888889999999999999776 999999999999974 689999999999875433 2344567
Q ss_pred ecCcCCCChhhhccC--CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCH
Q 039107 648 KGSFGYLDPEYFKRQ--QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISP 725 (817)
Q Consensus 648 ~gt~~y~aPE~~~~~--~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 725 (817)
.||..|||||++..+ .|..++|||||||.+.||.||++||..-..... ++..... -....+++.
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA------AMFkVGm--------yKvHP~iPe 802 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA------AMFKVGM--------YKVHPPIPE 802 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH------hhhhhcc--------eecCCCCcH
Confidence 899999999999765 588999999999999999999999975443221 1111110 122345677
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 039107 726 ECLKKFADTAEKCLSDSGIDRPSMGDVLW 754 (817)
Q Consensus 726 ~~~~~l~~li~~cl~~dP~~RPt~~evl~ 754 (817)
+...+...+|.+|+.++|.+||++.++++
T Consensus 803 elsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 803 ELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 88889999999999999999999999985
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=313.75 Aligned_cols=261 Identities=22% Similarity=0.342 Sum_probs=205.8
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
.+|+..++||+|+||+||++... ++..+|+|.+.... ....+.+.+|+++++.++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 35666779999999999999865 56789999866443 33457889999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
+++++|.+++... +.+++..+..++.+++.||.|||+. ++++||||||+||++++++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~---- 157 (284)
T cd06620 85 MDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---- 157 (284)
T ss_pred CCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhh----
Confidence 9999999987643 4689999999999999999999963 35999999999999999999999999998653221
Q ss_pred eeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCcccc-----chHHHHHHHhhccCchhhccCc
Q 039107 643 VSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQ-----VSLADWALHCKRKGILDDIIDP 717 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~-----~~l~~~~~~~~~~~~~~~~~d~ 717 (817)
......|+..|+|||++.+..++.++|||||||++|||++|+.||......+. ..+.++........ .+
T Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~ 231 (284)
T cd06620 158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------PP 231 (284)
T ss_pred ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------CC
Confidence 11234689999999999888999999999999999999999999975443211 11112222111110 00
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 039107 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQ 761 (817)
Q Consensus 718 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 761 (817)
.+. ...++..+.+++.+|++.||++|||+.|++++...+..
T Consensus 232 ~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 232 RLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred CCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 110 11255678999999999999999999999988665443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=307.71 Aligned_cols=252 Identities=25% Similarity=0.423 Sum_probs=199.1
Q ss_pred CCCcceeEeeeCceEEEEEEEec--ccEEEEEecCCC----------CcccHHHHHHHHHHHhc-cCccceeeEEEEEec
Q 039107 486 SFDESYVIGVGGFGKVYKGVIED--KLKVAIKRSNPS----------SEQGVNEFVTEIEMLSK-LRHKHLVSLIGFCEE 552 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~ 552 (817)
+|...+.||+|+||.||+|..+. +..+|+|.+... ......++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36667789999999999999765 578999986532 22234567789988875 699999999999999
Q ss_pred CCeEEEEEEeccCCchhhhhhc---cccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeee
Q 039107 553 GNEMCLVYDYMALGTLREHIYN---TKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDF 629 (817)
Q Consensus 553 ~~~~~lV~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DF 629 (817)
.+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+. .+++|+||||+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999988753 234689999999999999999999962 25999999999999999999999999
Q ss_pred ccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccC
Q 039107 630 GLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKG 709 (817)
Q Consensus 630 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 709 (817)
|++....... ......|+..|+|||.+.++.++.++||||||+++|||++|++||....... ...... ..
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~------~~~~~~-~~ 228 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS------LATKIV-EA 228 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH------HHHHHh-hc
Confidence 9997643322 2334568899999999998889999999999999999999999986442211 111100 00
Q ss_pred chhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 710 ILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 710 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
. ..+.. .......+.+++.+||+.||++||++.|+..+++
T Consensus 229 ~----~~~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 V----YEPLP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred c----CCcCC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0 00101 1123456889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=309.15 Aligned_cols=255 Identities=23% Similarity=0.382 Sum_probs=199.0
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCc----------ccHHHHHHHHHHHhccCccceeeEEEEEecCC
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSE----------QGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGN 554 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 554 (817)
+|...+.||+|+||.||+|... ++..+|+|.+..... ...+.+..|+.++++++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 3566779999999999999864 578899998753211 11346788999999999999999999999999
Q ss_pred eEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 555 EMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 555 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||+++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccccc
Confidence 999999999999999998655 46899999999999999999999765 99999999999999999999999999976
Q ss_pred CCCCCCCceeeeeecCcCCCChhhhccCC--CCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchh
Q 039107 635 GPNMENGHVSTVVKGSFGYLDPEYFKRQQ--LTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILD 712 (817)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 712 (817)
..............|+..|+|||.+.... ++.++||||||++++||++|..|+....... .+. .... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-----~~~-~~~~-~~~- 229 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA-----AMF-KLGN-KRS- 229 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH-----HHH-Hhhc-ccc-
Confidence 43322222233456889999999987654 7899999999999999999999985332111 010 0000 000
Q ss_pred hccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 713 DIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 713 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.+..........+..+.+++.+|++.+|++||++.+|+++
T Consensus 230 ---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 230 ---APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ---CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1111111222345678999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=311.60 Aligned_cols=248 Identities=26% Similarity=0.381 Sum_probs=199.5
Q ss_pred CCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEecc
Q 039107 487 FDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMA 564 (817)
Q Consensus 487 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 564 (817)
|...+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++||||+++++++......++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 445567999999999999865 46789999876443 3445678999999999999999999999999999999999999
Q ss_pred CCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCcee
Q 039107 565 LGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVS 644 (817)
Q Consensus 565 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 644 (817)
+++|.+++.. ..+++..+..++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||++....... ...
T Consensus 86 ~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~~ 158 (277)
T cd06642 86 GGSALDLLKP--GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKR 158 (277)
T ss_pred CCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc--hhh
Confidence 9999998853 46899999999999999999999765 9999999999999999999999999987643221 112
Q ss_pred eeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCC
Q 039107 645 TVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKIS 724 (817)
Q Consensus 645 ~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 724 (817)
....++..|+|||.+.+..++.++||||||++++||++|+.|+......... .+ .... ......
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---~~----~~~~---------~~~~~~ 222 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL---FL----IPKN---------SPPTLE 222 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH---hh----hhcC---------CCCCCC
Confidence 2345788999999999989999999999999999999999998644322110 00 0000 011122
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 725 PECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 725 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
..+...+.+++.+|++.+|++||++.+++++-.
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06642 223 GQYSKPFKEFVEACLNKDPRFRPTAKELLKHKF 255 (277)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHHhHH
Confidence 234566889999999999999999999998643
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=305.70 Aligned_cols=248 Identities=26% Similarity=0.393 Sum_probs=200.0
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC-----cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS-----EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 559 (817)
+|...+.||+|++|.||+|... ++..|++|.+.... .+..+.+.+|+.++++++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3566779999999999999976 67889999875432 23456789999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC
Q 039107 560 YDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 639 (817)
+||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 81 LELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 9999999999998654 35889999999999999999999766 9999999999999999999999999987643322
Q ss_pred CCceeeeeecCcCCCChhhhccCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcc
Q 039107 640 NGHVSTVVKGSFGYLDPEYFKRQQ-LTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPL 718 (817)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (817)
......|+..|++||.+.... ++.++|+||||+++|+|++|+.||........ .........
T Consensus 157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~------~~~~~~~~~-------- 219 (258)
T cd06632 157 ---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA------VFKIGRSKE-------- 219 (258)
T ss_pred ---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH------HHHHHhccc--------
Confidence 223456889999999987766 89999999999999999999999865432111 111000000
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 719 LKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 719 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
...++......+.+++.+||+.+|.+||++.+++++
T Consensus 220 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 220 -LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred -CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 011222345667899999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=304.27 Aligned_cols=249 Identities=29% Similarity=0.508 Sum_probs=199.9
Q ss_pred CcceeEeeeCceEEEEEEEec-----ccEEEEEecCCCCcc-cHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 488 DESYVIGVGGFGKVYKGVIED-----KLKVAIKRSNPSSEQ-GVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 488 ~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
...+.||.|+||.||++...+ +..||+|.+...... ..+.+..|++++++++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456689999999999999764 377999998765433 56789999999999999999999999999999999999
Q ss_pred eccCCchhhhhhccccc-cchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 562 YMALGTLREHIYNTKKA-LSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
|+++++|.+++...... +++.++..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||+++.......
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999998765444 999999999999999999999765 99999999999999999999999999976543321
Q ss_pred CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (817)
... ....++..|+|||.+....++.++||||||++++||++ |++|+...... .+..... ....
T Consensus 159 ~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~---~~~~~~~---~~~~--------- 222 (258)
T smart00219 159 YKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE---EVLEYLK---KGYR--------- 222 (258)
T ss_pred ccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHh---cCCC---------
Confidence 111 12236789999999988889999999999999999998 77887653221 1111111 1110
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 720 KDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 720 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
.......+..+.+++.+|+..+|++|||+.++++.|
T Consensus 223 -~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 -LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111222456789999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=307.26 Aligned_cols=250 Identities=24% Similarity=0.375 Sum_probs=203.7
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
.|...+.||.|+||.||+|... .+..||+|.+.... ....+.+.+|+.++++++|+||+++++++.+....++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 3556678999999999999875 46789999876442 344678899999999999999999999999999999999999
Q ss_pred cCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCce
Q 039107 564 ALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643 (817)
Q Consensus 564 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 643 (817)
++++|.+++.. ..+++.++..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 85 ~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~ 157 (277)
T cd06640 85 GGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IK 157 (277)
T ss_pred CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc--cc
Confidence 99999998853 46889999999999999999999765 9999999999999999999999999997643221 12
Q ss_pred eeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCC
Q 039107 644 STVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKI 723 (817)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 723 (817)
.....++..|+|||.+.+..++.++|||||||++|||++|..|+.......... . .........
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~------~----------~~~~~~~~~ 221 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF------L----------IPKNNPPTL 221 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh------h----------hhcCCCCCC
Confidence 233457889999999998899999999999999999999999987543221110 0 000111223
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 724 SPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 724 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
...++..+.+++.+||+.+|++||++.+++++-..
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 256 (277)
T cd06640 222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFI 256 (277)
T ss_pred chhhhHHHHHHHHHHcccCcccCcCHHHHHhChHh
Confidence 34566778999999999999999999999987443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=308.84 Aligned_cols=253 Identities=24% Similarity=0.337 Sum_probs=199.5
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
++|...+.||+|+||.||+|... ++..||+|.++.........+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 35666778999999999999865 56789999987665555567889999999999999999999999999999999999
Q ss_pred cCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCce
Q 039107 564 ALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643 (817)
Q Consensus 564 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 643 (817)
++++|.+++... +.+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++...... ...
T Consensus 89 ~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~~~ 162 (267)
T cd06645 89 GGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAK 162 (267)
T ss_pred CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc--ccc
Confidence 999999988644 36899999999999999999999765 999999999999999999999999998754321 112
Q ss_pred eeeeecCcCCCChhhhc---cCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 644 STVVKGSFGYLDPEYFK---RQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 644 ~~~~~gt~~y~aPE~~~---~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
.....|+..|+|||.+. .+.++.++|||||||++|||++|+.|+....+..... .. .... ...+...
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~----~~--~~~~----~~~~~~~ 232 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF----LM--TKSN----FQPPKLK 232 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH----hh--hccC----CCCCccc
Confidence 23446899999999974 4568899999999999999999999986543221110 00 0000 0001111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
. ....+..+.+++.+|++.+|++||++++|+++
T Consensus 233 ~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 233 D--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred c--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 1 01233467899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=310.42 Aligned_cols=265 Identities=21% Similarity=0.314 Sum_probs=196.9
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCc-ccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSE-QGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
++|...++||+|++|.||+|..+ ++..||+|.+..... .....+.+|++++++++|+||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 56788889999999999999975 568899999765432 2234577899999999999999999999999999999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
+++ +|.+++......+++.....++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++...... .
T Consensus 85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~--~ 158 (291)
T cd07844 85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS--K 158 (291)
T ss_pred CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC--c
Confidence 984 899988766567899999999999999999999765 9999999999999999999999999987532211 1
Q ss_pred eeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCcc-ccchHHHHHHHhhccCchhhc------
Q 039107 643 VSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPK-EQVSLADWALHCKRKGILDDI------ 714 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~-~~~~l~~~~~~~~~~~~~~~~------ 714 (817)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ++...................
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 1122346789999999865 45889999999999999999999999654321 111111000000000000000
Q ss_pred -------c-CccccCCCC-HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 715 -------I-DPLLKDKIS-PECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 715 -------~-d~~l~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
. ...+..... ......+.+++.+||+.+|++|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0 000000000 0112567899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=312.88 Aligned_cols=260 Identities=23% Similarity=0.307 Sum_probs=186.3
Q ss_pred ceeEeeeCceEEEEEEEec---ccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEe--cCCeEEEEEEecc
Q 039107 490 SYVIGVGGFGKVYKGVIED---KLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCE--EGNEMCLVYDYMA 564 (817)
Q Consensus 490 ~~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~lV~Ey~~ 564 (817)
..+||+|+||.||+|+.++ +..||+|.+..... ...+.+|++++++++||||+++++++. .....++|+||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 4589999999999999754 36799998875432 246789999999999999999999884 3567899999987
Q ss_pred CCchhhhhhcc--------ccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEE----cCCceeEEeeeccC
Q 039107 565 LGTLREHIYNT--------KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILL----DENWVAKVSDFGLS 632 (817)
Q Consensus 565 ~gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll----~~~~~~kl~DFGla 632 (817)
+ +|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+ ++++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 776666421 125888999999999999999999765 9999999999999 56689999999999
Q ss_pred ccCCCCCC-CceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccc-------hH-----
Q 039107 633 KTGPNMEN-GHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQV-------SL----- 698 (817)
Q Consensus 633 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~-------~l----- 698 (817)
+....... ........||..|+|||.+.+ ..++.++|||||||++|||++|++||......... .+
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 86433221 112234568999999999876 45899999999999999999999999754322110 00
Q ss_pred -------HHHHHHhhcc--CchhhccC-cc-----cc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 699 -------ADWALHCKRK--GILDDIID-PL-----LK---DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 699 -------~~~~~~~~~~--~~~~~~~d-~~-----l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
..|....... ..+..... .. +. ..........+.+++.+||..||.+|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 0111100000 00000000 00 00 00001122457889999999999999999999865
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=310.87 Aligned_cols=262 Identities=24% Similarity=0.355 Sum_probs=202.9
Q ss_pred cCHHHHHHhhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhcc-CccceeeEEEEEe-
Q 039107 475 FSLAEIKHATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCE- 551 (817)
Q Consensus 475 f~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~- 551 (817)
+.++.+..+.++|...+.||+|+||.||++... .+..+|+|.+.... ....++.+|+.+++++ +|+||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 445566677889999999999999999999865 46789999876432 2236788999999999 6999999999873
Q ss_pred ----cCCeEEEEEEeccCCchhhhhhc---cccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCcee
Q 039107 552 ----EGNEMCLVYDYMALGTLREHIYN---TKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVA 624 (817)
Q Consensus 552 ----~~~~~~lV~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~ 624 (817)
.+...++||||+++++|.+++.. ....+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 34568999999999999998753 2346889999999999999999999765 9999999999999999999
Q ss_pred EEeeeccCccCCCCCCCceeeeeecCcCCCChhhhcc-----CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHH
Q 039107 625 KVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKR-----QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLA 699 (817)
Q Consensus 625 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~ 699 (817)
||+|||+++...... .......|+..|+|||.+.. ..++.++|||||||++|||++|+.|+.........
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~--- 238 (286)
T cd06638 164 KLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL--- 238 (286)
T ss_pred EEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH---
Confidence 999999987643221 12233468999999998753 45788999999999999999999998754322111
Q ss_pred HHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 700 DWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 700 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
.. ..... .+.+. .+..+...+.+++.+||+.+|++||++.+|++++
T Consensus 239 --~~--~~~~~-----~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 239 --FK--IPRNP-----PPTLH--QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred --hh--ccccC-----CCccc--CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00 00000 00000 1112334688999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=304.26 Aligned_cols=251 Identities=21% Similarity=0.327 Sum_probs=187.9
Q ss_pred eEeeeCceEEEEEEEecc---cEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccCCc
Q 039107 492 VIGVGGFGKVYKGVIEDK---LKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGT 567 (817)
Q Consensus 492 ~lG~G~fg~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 567 (817)
.||+|+||.||+|...++ ..+++|.+.... ....+.|.+|+.+++.++||||++++++|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999985543 346677765443 3345789999999999999999999999999999999999999999
Q ss_pred hhhhhhccc---cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCcee
Q 039107 568 LREHIYNTK---KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVS 644 (817)
Q Consensus 568 L~~~l~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 644 (817)
|.+++.... ..+++..+..++.||++||+|||+.+ ++||||||+|||++.++.+||+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999997542 24667788899999999999999765 999999999999999999999999998642221111122
Q ss_pred eeeecCcCCCChhhhcc-------CCCCchHHHHHHHHHHHHHHhC-CCCCCCCCccccchHHHHHHHhhccCchhhccC
Q 039107 645 TVVKGSFGYLDPEYFKR-------QQLTEKSDIYSFGVVLFEVLCA-RPALNPSLPKEQVSLADWALHCKRKGILDDIID 716 (817)
Q Consensus 645 ~~~~gt~~y~aPE~~~~-------~~~s~~sDV~S~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (817)
....++..|+|||++.. ..++.++||||||+++|||+++ ..|+....+.+ ....... +....+.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~-~~~~~~~~ 231 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE------VLNHVIK-DQQVKLFK 231 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHh-hcccccCC
Confidence 23457889999998753 2457899999999999999974 56665432211 1111111 11122233
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 717 PLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 717 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
+.+... ....+.+++..|+ .+|++||++++|++.|.
T Consensus 232 ~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 333322 3345788999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=308.83 Aligned_cols=262 Identities=24% Similarity=0.313 Sum_probs=202.0
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC--cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
+|...+.||+|+||.||+|... ++..|++|++.... ....+.+.+|+.++++++|+||+++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4677889999999999999965 57889999977543 33356789999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
+ +++|.+++......+++.+++.++.|+++||+|||+.+ ++|+||||+||++++++.++|+|||++........ .
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R 155 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence 9 99999998766677999999999999999999999765 99999999999999999999999999986543221 1
Q ss_pred eeeeeecCcCCCChhhhccC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccC------------
Q 039107 643 VSTVVKGSFGYLDPEYFKRQ-QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKG------------ 709 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~------------ 709 (817)
......|+..|+|||.+.+. .++.++||||+|++++||++|+++|......... .+........
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQL---AIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHH---HHHHHHcCCCChHHHhhccCcc
Confidence 22234688999999998654 4689999999999999999998887654332211 1111100000
Q ss_pred chhhccCcccc----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 710 ILDDIIDPLLK----DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 710 ~~~~~~d~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
....+..+... ....++....+.+++.+||+.+|.+||++++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 00111234678999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=303.54 Aligned_cols=251 Identities=24% Similarity=0.372 Sum_probs=196.4
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC-----cccHHHHHHHHHHHhccCccceeeEEEEEecC--CeE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS-----EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEG--NEM 556 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 556 (817)
.+|...++||+|+||.||+|... ++..|++|.+.... ....+.+.+|+.++++++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888899999999999999865 46889999865321 22346788999999999999999999988653 467
Q ss_pred EEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCC
Q 039107 557 CLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGP 636 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 636 (817)
+++|||+++++|.+++... ..+++...++++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||+++...
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 8999999999999988644 35888999999999999999999766 9999999999999999999999999987543
Q ss_pred CCCC-CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhcc
Q 039107 637 NMEN-GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDII 715 (817)
Q Consensus 637 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (817)
.... ........|+..|+|||.+.+..++.++|||||||++|||++|+.||......... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~------~~~~~~------- 224 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI------FKIATQ------- 224 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH------HHHhcC-------
Confidence 2111 11122345889999999998888999999999999999999999998643211110 000000
Q ss_pred CccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 716 DPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 716 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
......+......+.+++.+|+. +|.+||++++|+++
T Consensus 225 --~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 225 --PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred --CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 01112234455667889999995 89999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=321.32 Aligned_cols=264 Identities=25% Similarity=0.302 Sum_probs=206.2
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccC-c-----cceeeEEEEEecCCeEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLR-H-----KHLVSLIGFCEEGNEMCL 558 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~g~~~~~~~~~l 558 (817)
+|.+.++||+|.||.|-||... .++.||||+++... .-..+-..|+.+|..|+ | -|+|++++|+...+++||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 7888999999999999999854 57899999998553 33456678999999996 4 499999999999999999
Q ss_pred EEEeccCCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCC--ceeEEeeeccCccC
Q 039107 559 VYDYMALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDEN--WVAKVSDFGLSKTG 635 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~--~~~kl~DFGla~~~ 635 (817)
|+|.++ -+|.++|..++ ..++...+..|+.||+.||..||+.+ |||+||||+||||.+- ..+||+|||.+...
T Consensus 266 VfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccccc
Confidence 999996 59999997654 37999999999999999999999655 9999999999999643 47999999999863
Q ss_pred CCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHH--------HHHHhh-
Q 039107 636 PNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLAD--------WALHCK- 706 (817)
Q Consensus 636 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~--------~~~~~~- 706 (817)
.. ... ...-+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.+..+.+++..+. |+....
T Consensus 342 ~q----~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~ 416 (586)
T KOG0667|consen 342 SQ----RVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK 416 (586)
T ss_pred CC----cce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 22 222 5567889999999999999999999999999999999999999888777654331 111000
Q ss_pred -------c-cCch-----hh-----------------ccCcccc-------CCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 039107 707 -------R-KGIL-----DD-----------------IIDPLLK-------DKISPECLKKFADTAEKCLSDSGIDRPSM 749 (817)
Q Consensus 707 -------~-~~~~-----~~-----------------~~d~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 749 (817)
. ++.. .+ ..+.... .......-..+.+++.+||+.||.+|+|.
T Consensus 417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp 496 (586)
T KOG0667|consen 417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP 496 (586)
T ss_pred ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence 0 0000 00 0000000 00111234568999999999999999999
Q ss_pred HHHHHHHHHh
Q 039107 750 GDVLWNLEFV 759 (817)
Q Consensus 750 ~evl~~L~~~ 759 (817)
.++++|-..-
T Consensus 497 ~qal~Hpfl~ 506 (586)
T KOG0667|consen 497 AQALNHPFLT 506 (586)
T ss_pred HHHhcCcccc
Confidence 9999885443
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=310.22 Aligned_cols=262 Identities=26% Similarity=0.357 Sum_probs=204.7
Q ss_pred ccCHHHHHHhhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhcc-CccceeeEEEEEe
Q 039107 474 RFSLAEIKHATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCE 551 (817)
Q Consensus 474 ~f~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 551 (817)
.+.+.++..+.++|...+.||+|+||.||++... ++..+|+|.+.... .....+.+|+.++.++ +|||++++++++.
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 3556677778899999999999999999999874 56789999986543 2346678899999999 8999999999986
Q ss_pred cC-----CeEEEEEEeccCCchhhhhhc---cccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCce
Q 039107 552 EG-----NEMCLVYDYMALGTLREHIYN---TKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWV 623 (817)
Q Consensus 552 ~~-----~~~~lV~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~ 623 (817)
.. ...++|+||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCC
Confidence 53 358999999999999998853 2346899999999999999999999765 999999999999999999
Q ss_pred eEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccC-----CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchH
Q 039107 624 AKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQ-----QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSL 698 (817)
Q Consensus 624 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l 698 (817)
+||+|||+++....... ......|+..|+|||.+... .++.++|||||||++|||++|+.|+........ +
T Consensus 167 ~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--~ 242 (291)
T cd06639 167 VKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--L 242 (291)
T ss_pred EEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--H
Confidence 99999999876432211 12234578899999998644 368899999999999999999999875432211 1
Q ss_pred HHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 699 ADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 699 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
..+. + .....+. .+......+.+++.+|++.+|++||++.+++++
T Consensus 243 ~~~~----~-~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 243 FKIP----R-NPPPTLL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHHh----c-CCCCCCC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1110 0 1000010 112334568999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=318.71 Aligned_cols=264 Identities=20% Similarity=0.266 Sum_probs=196.7
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecC------C
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEG------N 554 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 554 (817)
.++|...+.||+|+||.||++... .+..||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 467888999999999999999864 4678999998753 233456788999999999999999999987543 3
Q ss_pred eEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 555 EMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 555 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
..++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 103 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 175 (364)
T ss_pred eEEEEEeCCCC-CHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence 57999999975 6666663 24888999999999999999999765 99999999999999999999999999976
Q ss_pred CCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHH---------HHHHH-
Q 039107 635 GPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLA---------DWALH- 704 (817)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~---------~~~~~- 704 (817)
.... .......||..|+|||++.+..++.++|||||||++|||++|+.||......+..... ++...
T Consensus 176 ~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 176 AGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred cCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 4221 1223346899999999999999999999999999999999999999765432211100 00000
Q ss_pred ------h-hccCc-----hhhccCccc---cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 705 ------C-KRKGI-----LDDIIDPLL---KDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 705 ------~-~~~~~-----~~~~~d~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
. ..... ..+...... ...........+.+++.+||+.||.+|||+.+++++-.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~ 320 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcc
Confidence 0 00000 000000000 00011112346789999999999999999999998743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=302.16 Aligned_cols=248 Identities=25% Similarity=0.401 Sum_probs=208.8
Q ss_pred CCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccC
Q 039107 487 FDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMAL 565 (817)
Q Consensus 487 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 565 (817)
|.+..+||+|+||.|||+.++ .|..+|||++...+ +.+++..|+.+|+++..|++|+.+|.+-....+++|||||.-
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 555678999999999999875 57889999988654 468899999999999999999999988888999999999999
Q ss_pred CchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceee
Q 039107 566 GTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVST 645 (817)
Q Consensus 566 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 645 (817)
|+..+.+..++++|++.++..+++..++||+|||. ..-||||||+.||||+.+|.+||+|||.+..+.+ ......
T Consensus 113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMAKRN 187 (502)
T KOG0574|consen 113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMAKRN 187 (502)
T ss_pred CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhh--hHHhhC
Confidence 99999999888999999999999999999999995 4589999999999999999999999999976432 223345
Q ss_pred eeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCH
Q 039107 646 VVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISP 725 (817)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 725 (817)
.+.||+.|||||++..-.|+.++||||||+...||..|++|+..-.+...+-. +. ..|...-..++
T Consensus 188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM------------IP--T~PPPTF~KPE 253 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM------------IP--TKPPPTFKKPE 253 (502)
T ss_pred ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe------------cc--CCCCCCCCChH
Confidence 67899999999999999999999999999999999999999865433211100 00 01111112245
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 726 ECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 726 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
+.+.++-++++.||-++|++|-|+.++++|
T Consensus 254 ~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 254 EWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 678889999999999999999999999877
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=306.58 Aligned_cols=254 Identities=25% Similarity=0.422 Sum_probs=197.1
Q ss_pred CCcceeEeeeCceEEEEEEEe----cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecCC------
Q 039107 487 FDESYVIGVGGFGKVYKGVIE----DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGN------ 554 (817)
Q Consensus 487 f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 554 (817)
|...++||+|+||.||+|... .+..||||++... .....+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 455678999999999999864 2578999987654 2344667899999999999999999999885432
Q ss_pred eEEEEEEeccCCchhhhhhccc-----cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeee
Q 039107 555 EMCLVYDYMALGTLREHIYNTK-----KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDF 629 (817)
Q Consensus 555 ~~~lV~Ey~~~gsL~~~l~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DF 629 (817)
..++++||+.+|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999988875321 25788999999999999999999765 999999999999999999999999
Q ss_pred ccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhcc
Q 039107 630 GLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRK 708 (817)
Q Consensus 630 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 708 (817)
|+++...............++..|++||.+....++.++||||||+++|||++ |++|+...... .+..+... .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~~~~---~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNYLIK---G 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHHHHc---C
Confidence 99986433221112222345678999999998899999999999999999999 88888654321 11111111 0
Q ss_pred CchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 709 GILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 709 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
... .........+.+++.+|++.+|++||++.++++.|+.+
T Consensus 232 ~~~----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NRL----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000 01123446789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=305.58 Aligned_cols=264 Identities=23% Similarity=0.292 Sum_probs=199.0
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC--cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
+|+....||+|+||.||+|+.+ ++..||+|++.... ....+.+.+|+.++++++|+||+++++++......++||||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 5777889999999999999976 47889999876432 22345688999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
++++.|..++... ..+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-- 155 (286)
T cd07847 82 CDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-- 155 (286)
T ss_pred cCccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc--
Confidence 9998888776433 35899999999999999999999765 99999999999999999999999999986533221
Q ss_pred eeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHH-----HHHH---hh-ccCchh
Q 039107 643 VSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLAD-----WALH---CK-RKGILD 712 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~-----~~~~---~~-~~~~~~ 712 (817)
......++..|+|||.+.+ ..++.++||||||+++|||++|++||......+...... +... .. ......
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence 1223457889999999876 567899999999999999999999997654332211100 0000 00 000000
Q ss_pred hccCccccCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 713 DIIDPLLKDKI-----SPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 713 ~~~d~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
....+...... .......+.+++.+||+.+|++||++.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00001100000 01224568899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=319.99 Aligned_cols=244 Identities=30% Similarity=0.424 Sum_probs=203.7
Q ss_pred CCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcc---cHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 487 FDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQ---GVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 487 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
|...+-||.|+||.||.++.. +...||||++....++ .+++++.|+..|.+++|||++.+.|||......||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 556667999999999999854 5578999998876544 467889999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
|- |+-.|+|.-.+++|.+.++..|+.+.+.||+|||+.+ .||||||+.||||.+.|.+||+|||.+....
T Consensus 108 Cl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~------ 177 (948)
T KOG0577|consen 108 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA------ 177 (948)
T ss_pred Hh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC------
Confidence 96 6888888878889999999999999999999999765 9999999999999999999999999987632
Q ss_pred eeeeeecCcCCCChhhhc---cCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccc
Q 039107 643 VSTVVKGSFGYLDPEYFK---RQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (817)
....+.||+.|||||++. .+.|+-|+||||||+...||.-.++|+...+.... + .+. .+.-.|.+
T Consensus 178 PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA--L----YHI------AQNesPtL 245 (948)
T KOG0577|consen 178 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--L----YHI------AQNESPTL 245 (948)
T ss_pred chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH--H----HHH------HhcCCCCC
Confidence 234578999999999974 57999999999999999999999999765433211 1 111 11112222
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 720 KDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 720 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
. ..+.+..|+.++..||++-|.+|||.+++++|
T Consensus 246 q---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 246 Q---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred C---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 2 35678889999999999999999999999876
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=302.77 Aligned_cols=249 Identities=25% Similarity=0.381 Sum_probs=199.4
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEec-CCeEEEEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE-GNEMCLVYD 561 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E 561 (817)
+|+..+.||+|++|.||++..+ ++..+++|++... .....+.+.+|++++++++|+|++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 3677889999999999999965 4578999997643 23445678899999999999999999998764 446789999
Q ss_pred eccCCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 562 YMALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 562 y~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
|+++++|.+++.... ..+++.+++.++.|++.||++||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~- 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC- 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence 999999999987643 36899999999999999999999766 9999999999999999999999999987643221
Q ss_pred CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
.......+++.|+|||.+.+..++.++||||||++++||++|+.||....... +..... .+.+
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~------~~~~~~-~~~~--------- 219 (257)
T cd08223 157 -DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS------LVYRII-EGKL--------- 219 (257)
T ss_pred -CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHH-hcCC---------
Confidence 12234468899999999999999999999999999999999999986543211 111110 1111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
...+......+.+++.+|++.+|++||++.+++++
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11123445678999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=291.89 Aligned_cols=251 Identities=25% Similarity=0.324 Sum_probs=199.9
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
.+|+..+.||+|.|+.||++... .|+.+|+|.+... +..+.+++.+|++|-+.|+|||||+|.....+....+||+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 34555668999999999998754 5778888876532 33467889999999999999999999999999999999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEc---CCceeEEeeeccCccCCCC
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLD---ENWVAKVSDFGLSKTGPNM 638 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~---~~~~~kl~DFGla~~~~~~ 638 (817)
+|+|++|..-|-.+ -..++..+-..++||+++|.|+|.++ |||||+||+|+||. ..--+||+|||++....
T Consensus 91 ~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-- 164 (355)
T KOG0033|consen 91 LVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-- 164 (355)
T ss_pred cccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC--
Confidence 99999998766433 35777788889999999999999876 99999999999995 33568999999998754
Q ss_pred CCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcc
Q 039107 639 ENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPL 718 (817)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (817)
.+.......||++|||||+++..+|+..+|||+.||+||-||.|++||.+.... .+.+-+.. + ..-+++.
T Consensus 165 -~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rlye~I~~----g--~yd~~~~ 234 (355)
T KOG0033|consen 165 -DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYEQIKA----G--AYDYPSP 234 (355)
T ss_pred -CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HHHHHHhc----c--ccCCCCc
Confidence 344455678999999999999999999999999999999999999999864322 12111111 1 1111221
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 719 LKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 719 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.. +...++..+|+++||..||.+|.|+.|.|.|
T Consensus 235 ~w----~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 235 EW----DTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred cc----CcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 12 2334556899999999999999999999865
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=301.00 Aligned_cols=251 Identities=25% Similarity=0.373 Sum_probs=205.8
Q ss_pred CCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCCCc-ccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 486 SFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPSSE-QGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
+|+..+.||+|++|.||+++.+. +..|++|++..... .....+.+|+.++.+++|+||+++++++......++|+||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 57778899999999999999764 78899999876543 44678999999999999999999999999999999999999
Q ss_pred cCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHh-CCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 564 ALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHT-GAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 564 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
++++|.+++... ..+++..++.++.|+++||+|||+ .+ ++||||+|+||+++.++.++|+|||++........
T Consensus 82 ~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~-- 155 (264)
T cd06623 82 DGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD-- 155 (264)
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCC--
Confidence 999999998654 568999999999999999999997 55 99999999999999999999999999876433221
Q ss_pred eeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCC
Q 039107 643 VSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDK 722 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (817)
......++..|+|||.+.+..++.++|+||||+++|||++|+.|+..........+..+.. ... ...
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---~~~----------~~~ 222 (264)
T cd06623 156 QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC---DGP----------PPS 222 (264)
T ss_pred cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh---cCC----------CCC
Confidence 1124467899999999999999999999999999999999999987654212222221111 000 011
Q ss_pred CCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 723 ISPE-CLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 723 ~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.+.. .+..+.+++.+||+.+|++||++.+++++
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 223 LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1222 45678999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=304.28 Aligned_cols=246 Identities=30% Similarity=0.465 Sum_probs=196.5
Q ss_pred cCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEecc
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMA 564 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 564 (817)
++|...+.||+|+||.||++.. .+..+|+|...... ..+.+.+|+.++++++|||++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 3477788999999999999975 45679999986432 346789999999999999999999998654 5799999999
Q ss_pred CCchhhhhhcccc-ccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCce
Q 039107 565 LGTLREHIYNTKK-ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643 (817)
Q Consensus 565 ~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 643 (817)
+++|.+++..... .+++.+++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence 9999999875433 6899999999999999999999765 9999999999999999999999999987532211
Q ss_pred eeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCC
Q 039107 644 STVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDK 722 (817)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (817)
.....+..|+|||.+.++.++.++|+||||++++||++ |+.||......+ +..... .+. ...
T Consensus 155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~-~~~---------~~~ 217 (254)
T cd05083 155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE------VKECVE-KGY---------RME 217 (254)
T ss_pred -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH------HHHHHh-CCC---------CCC
Confidence 12234568999999998899999999999999999998 898886543221 111111 110 011
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 723 ISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 723 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
....++..+.+++.+||+.+|++||+++++++.|+.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 122345667899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=303.52 Aligned_cols=249 Identities=27% Similarity=0.388 Sum_probs=201.7
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
+|+..+.||+|+||.||++... ++..+++|++... .....+++.+|+.++++++|+||+++++++......++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4677889999999999999864 5688999987643 233456889999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcccc-ccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 563 MALGTLREHIYNTKK-ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
+++++|.+++..... .+++.+++.++.|++.||.|||+.+ ++|+||+|+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 155 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV-- 155 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch--
Confidence 999999998865433 6889999999999999999999765 9999999999999999999999999997643321
Q ss_pred ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccC
Q 039107 642 HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKD 721 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (817)
.......|+..|+|||.+.++..+.++|+|||||+++||++|+.|+......+ ....... +. ..
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~~~-~~---------~~ 219 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN------LVLKIIR-GS---------YP 219 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH------HHHHHhc-CC---------CC
Confidence 11223457889999999998899999999999999999999999986543221 1111110 00 01
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 722 KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 722 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
..+......+.+++.+|++.+|++||++.+|+++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1223345668999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=310.78 Aligned_cols=264 Identities=26% Similarity=0.362 Sum_probs=199.0
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCc--ccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSE--QGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
+|+..++||+|+||.||+|..+ ++..+|+|++..... ...+.+.+|+++++.++||||+++++++..+...++|+||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 5777889999999999999976 468899998764322 2346788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
+++++|.++.... ..+++.+++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++....... .
T Consensus 82 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--~ 155 (286)
T cd07846 82 VDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--E 155 (286)
T ss_pred CCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--c
Confidence 9999998876543 35899999999999999999999765 9999999999999999999999999987643322 2
Q ss_pred eeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccch-HHHHHHHhhc-------c-Cchh
Q 039107 643 VSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVS-LADWALHCKR-------K-GILD 712 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~~~~~~~~-------~-~~~~ 712 (817)
......++..|+|||.+.+ ..++.++||||||++++||++|++||......+... +..+...... . ....
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence 2233457889999999875 457889999999999999999999886543222110 1100000000 0 0000
Q ss_pred hccCccccC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 713 DIIDPLLKD-----KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 713 ~~~d~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
....+.... ...+..+..+.+++.+||+.+|++||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 000000000 0112345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=341.26 Aligned_cols=253 Identities=23% Similarity=0.324 Sum_probs=196.9
Q ss_pred hcCCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEec--CCeEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE--GNEMCL 558 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~l 558 (817)
..+|.+.++||+|+||+||++.... +..+|+|.+... .......|..|+.+|++|+|||||++++++.. ...++|
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI 91 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI 91 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence 4578889999999999999999754 567889987643 23345678999999999999999999998743 456899
Q ss_pred EEEeccCCchhhhhhcc---ccccchHhHHHHHHHHHHHHHHHHhCCC----CceEecCCccCcEEEcC-----------
Q 039107 559 VYDYMALGTLREHIYNT---KKALSWKQRLEICIGAARGLHYLHTGAK----YTIIHRDVKTTNILLDE----------- 620 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~ivH~Dikp~NIll~~----------- 620 (817)
||||+++|+|.++|... ...+++..++.|+.||+.||+|||+.+. .+||||||||+||||+.
T Consensus 92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~ 171 (1021)
T PTZ00266 92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171 (1021)
T ss_pred EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence 99999999999998653 2469999999999999999999997431 35999999999999964
Q ss_pred ------CceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhcc--CCCCchHHHHHHHHHHHHHHhCCCCCCCCCc
Q 039107 621 ------NWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKR--QQLTEKSDIYSFGVVLFEVLCARPALNPSLP 692 (817)
Q Consensus 621 ------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~ 692 (817)
.+.+||+|||+++..... .......||+.|+|||++.. ..++.++|||||||+||||++|+.||.....
T Consensus 172 ~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~ 248 (1021)
T PTZ00266 172 ANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248 (1021)
T ss_pred ccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 245899999999764321 22234568999999999854 4588999999999999999999999965432
Q ss_pred cccchHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 693 KEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 693 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.. ......... +.+. ....+..+.+||..||+.+|.+||++.+++.+
T Consensus 249 ~~-----qli~~lk~~--------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 249 FS-----QLISELKRG--------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred HH-----HHHHHHhcC--------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 21 111111111 0110 01234568899999999999999999999964
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=311.47 Aligned_cols=253 Identities=26% Similarity=0.315 Sum_probs=201.1
Q ss_pred cCCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCCCc---ccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPSSE---QGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
++|...+.||+|++|.||++...+ +..+|+|.+..... ...+.+..|++++++++|+||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 367788899999999999999764 78899999875432 24567889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC
Q 039107 561 DYMALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 639 (817)
||+.+++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 9999999999987543 46899999999999999999999765 9999999999999999999999999987542211
Q ss_pred CC---------------------------ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCc
Q 039107 640 NG---------------------------HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLP 692 (817)
Q Consensus 640 ~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~ 692 (817)
.. .......|+..|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 10 011123578899999999988899999999999999999999999975433
Q ss_pred cccchHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCC----HHHHHHH
Q 039107 693 KEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPS----MGDVLWN 755 (817)
Q Consensus 693 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt----~~evl~~ 755 (817)
.... .. +.+..............+.+++.+||+.+|++||+ +.+++.+
T Consensus 238 ~~~~-----~~----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 238 DETF-----SN----------ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HHHH-----HH----------HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 2111 00 01111111111124567899999999999999999 6666664
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=307.80 Aligned_cols=265 Identities=23% Similarity=0.300 Sum_probs=201.4
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
+|+..++||+|+||.||+|..+ ++..|++|++... .....+.+.+|++++++++|+||+++++++...+..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 5778889999999999999976 4678999987653 233457789999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
++++.|..++. ....+++.++..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++........ .
T Consensus 82 ~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~ 156 (288)
T cd07833 82 VERTLLELLEA-SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPA-S 156 (288)
T ss_pred CCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-c
Confidence 99877766553 3346899999999999999999999765 99999999999999999999999999886543322 1
Q ss_pred eeeeeecCcCCCChhhhccC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHH---------hhccCch-
Q 039107 643 VSTVVKGSFGYLDPEYFKRQ-QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALH---------CKRKGIL- 711 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~---------~~~~~~~- 711 (817)
......++..|+|||++.+. .++.++||||||+++|||++|++||......+.......... .......
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence 22335678899999999887 889999999999999999999999875433221111000000 0000000
Q ss_pred ----hhccCcc-ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 712 ----DDIIDPL-LKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 712 ----~~~~d~~-l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.+..++. .....+..++.++.+++++||+.+|++||++++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0000000 0001122336778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=308.52 Aligned_cols=253 Identities=25% Similarity=0.369 Sum_probs=199.8
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC-CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS-SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
+|+..+.||+|+||.||++..+ .+..+|+|.+... .......+.+|++++++++|+||+++++++......++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 4667779999999999999976 5688999987643 3334567899999999999999999999999999999999999
Q ss_pred cCCchhhhhhcc--ccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 564 ALGTLREHIYNT--KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 564 ~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
++++|.+++... ...+++..+..++.|++.||.|||++ ++|+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 156 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--- 156 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC---
Confidence 999999988653 23689999999999999999999963 35999999999999999999999999998754221
Q ss_pred ceeeeeecCcCCCChhhhccCC------CCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhcc
Q 039107 642 HVSTVVKGSFGYLDPEYFKRQQ------LTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDII 715 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~------~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (817)
......++..|+|||.+.+.. ++.++|+|||||++|||++|+.||.......... . +..+.
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~------~------~~~~~ 223 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA------Q------LSAIV 223 (286)
T ss_pred -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHH------H------HHHHh
Confidence 122345788999999985543 4889999999999999999999986532211100 0 00111
Q ss_pred CccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 716 DPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 716 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
+.. ....+..+...+.+++.+||+.+|++||++.+++.+-.
T Consensus 224 ~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~ 264 (286)
T cd06622 224 DGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW 264 (286)
T ss_pred hcC-CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence 100 11223345667899999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=313.08 Aligned_cols=264 Identities=21% Similarity=0.233 Sum_probs=194.1
Q ss_pred ceeEeee--CceEEEEEEEe-cccEEEEEecCCCC--cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEecc
Q 039107 490 SYVIGVG--GFGKVYKGVIE-DKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMA 564 (817)
Q Consensus 490 ~~~lG~G--~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 564 (817)
..+||+| +|++||++..+ ++..||+|++.... ....+.+.+|+++++.++||||++++++|...+..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4579999 78999999865 56889999987542 2334567789999999999999999999999999999999999
Q ss_pred CCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC--
Q 039107 565 LGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG-- 641 (817)
Q Consensus 565 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~-- 641 (817)
+|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.++++||+...........
T Consensus 83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 999999986542 35899999999999999999999765 999999999999999999999999865432211110
Q ss_pred ---ceeeeeecCcCCCChhhhcc--CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhc---------
Q 039107 642 ---HVSTVVKGSFGYLDPEYFKR--QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKR--------- 707 (817)
Q Consensus 642 ---~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--------- 707 (817)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ..........
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHhcCCccccccccchh
Confidence 01122346778999999876 4689999999999999999999999964322110 0000000000
Q ss_pred c-----CchhhccC-----------------ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 708 K-----GILDDIID-----------------PLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 708 ~-----~~~~~~~d-----------------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
. .......+ ..............+.+++.+||+.||++|||+++++++--.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f 310 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 310 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhh
Confidence 0 00000000 000001122345678999999999999999999999986543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=302.07 Aligned_cols=252 Identities=25% Similarity=0.353 Sum_probs=201.1
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEe--cCCeEEEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCE--EGNEMCLVY 560 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~lV~ 560 (817)
+|...+.||.|+||.||++... ++..+++|.+... .....+.+..|++++++++|+||+++++++. .+...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 3667789999999999999864 5678999987643 3344567889999999999999999999775 345679999
Q ss_pred EeccCCchhhhhhcc---ccccchHhHHHHHHHHHHHHHHHHhCC--CCceEecCCccCcEEEcCCceeEEeeeccCccC
Q 039107 561 DYMALGTLREHIYNT---KKALSWKQRLEICIGAARGLHYLHTGA--KYTIIHRDVKTTNILLDENWVAKVSDFGLSKTG 635 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 635 (817)
||+++++|.+++... ...+++..++.++.|++.||+|||..+ +.+++|+||||+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998653 347999999999999999999999433 345999999999999999999999999999865
Q ss_pred CCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhcc
Q 039107 636 PNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDII 715 (817)
Q Consensus 636 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (817)
..... ......++..|+|||.+....++.++||||||+++++|++|+.|+...... .+.+.. ..+.
T Consensus 161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~----~~~~----- 226 (265)
T cd08217 161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLASKI----KEGK----- 226 (265)
T ss_pred cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHHHHH----hcCC-----
Confidence 43221 123346899999999999888999999999999999999999998765321 111111 1111
Q ss_pred CccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 716 DPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 716 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
....+......+.+++.+|++.+|++||++.+|+++
T Consensus 227 ----~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 227 ----FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ----CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 112233455678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=320.80 Aligned_cols=263 Identities=22% Similarity=0.300 Sum_probs=195.4
Q ss_pred hhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC--cccHHHHHHHHHHHhccCccceeeEEEEEecC------
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEG------ 553 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 553 (817)
..++|...+.||+|+||.||+|... ++..||||++.... ....+.+.+|+++|++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4567888899999999999999864 56789999987532 22345678999999999999999999987532
Q ss_pred CeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCc
Q 039107 554 NEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSK 633 (817)
Q Consensus 554 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 633 (817)
...++++|++ +++|.+++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~ 166 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR 166 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccce
Confidence 4578999988 678888774 346999999999999999999999766 9999999999999999999999999998
Q ss_pred cCCCCCCCceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhh------
Q 039107 634 TGPNMENGHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCK------ 706 (817)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~------ 706 (817)
..... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||......+.. ..+.....
T Consensus 167 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~ 239 (343)
T cd07878 167 QADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQL--KRIMEVVGTPSPEV 239 (343)
T ss_pred ecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH--HHHHHHhCCCCHHH
Confidence 64321 223468999999999876 57899999999999999999999999754322211 00000000
Q ss_pred ----ccCchhhccC--ccccCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 707 ----RKGILDDIID--PLLKDK----ISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 707 ----~~~~~~~~~d--~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
.......... +..... ........+.+++.+||+.||.+|||+.+++++--.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~ 301 (343)
T cd07878 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYF 301 (343)
T ss_pred HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcch
Confidence 0000000000 000000 000122346899999999999999999999987433
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=303.05 Aligned_cols=254 Identities=24% Similarity=0.414 Sum_probs=200.9
Q ss_pred CCCcceeEeeeCceEEEEEEE-ecccEEEEEecCCCC------cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVI-EDKLKVAIKRSNPSS------EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCL 558 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 558 (817)
+|+..++||+|++|.||++.. .++..+|+|.+.... ....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 467778999999999999985 456889999876432 1234678999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCc-eeEEeeeccCccCCC
Q 039107 559 VYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENW-VAKVSDFGLSKTGPN 637 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DFGla~~~~~ 637 (817)
|+||+++++|.+++... +.+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++ .+||+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 99999999999998643 46899999999999999999999765 99999999999998775 699999999876543
Q ss_pred CCCC--ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhcc
Q 039107 638 MENG--HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDII 715 (817)
Q Consensus 638 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (817)
.... .......++..|+|||.+.+..++.++||||+|++++||++|+.||........... .... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~---------~ 224 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL---IFKI---------A 224 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH---HHHH---------h
Confidence 2111 112234678999999999888899999999999999999999999864332211111 1100 0
Q ss_pred CccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 716 DPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 716 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
........+......+.+++.+|+..+|++||++.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 225 SATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred ccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 0011122334456678999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=308.36 Aligned_cols=262 Identities=23% Similarity=0.293 Sum_probs=198.5
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcc-----cHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQ-----GVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 559 (817)
+|...++||+|+||.||+|... ++..|++|++...... ....+..|++++++++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3667789999999999999965 5789999998754322 235577899999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC
Q 039107 560 YDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 639 (817)
|||+ +++|.+++......+++..++.++.||++||+|||+.+ |+|+||||+||+++.++.+||+|||+++......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 89999998765446999999999999999999999765 9999999999999999999999999998653322
Q ss_pred CCceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhc--------cCc
Q 039107 640 NGHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKR--------KGI 710 (817)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--------~~~ 710 (817)
. ......++..|+|||.+.+ ..++.++|||||||+++||++|.++|....+.+..... ...... ...
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 157 R--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKI--FEALGTPTEENWPGVTS 232 (298)
T ss_pred c--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHH--HHHcCCCchhhhhhccc
Confidence 1 1122346788999999864 46789999999999999999998877654432211100 000000 000
Q ss_pred hhhccCccccC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 711 LDDIIDPLLKD-----KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 711 ~~~~~d~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
+.......... .........+.+++.+||+.+|++|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000000 0112335678999999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=306.23 Aligned_cols=246 Identities=22% Similarity=0.348 Sum_probs=207.7
Q ss_pred CCcceeEeeeCceEEEEEEE-ecccEEEEEecCCCC--cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 487 FDESYVIGVGGFGKVYKGVI-EDKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 487 f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
|..++.||+|.|..|-++++ -.|.+||||++.+.. ......+.+|++.|+.++|||||+|+.+......+|||+|.=
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG 99 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG 99 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence 55566899999999999984 467899999988653 333467889999999999999999999999999999999999
Q ss_pred cCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcC-CceeEEeeeccCccCCCCCCCc
Q 039107 564 ALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDE-NWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 564 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DFGla~~~~~~~~~~ 642 (817)
++|+|+++|.+....+.+....+.+.||+.|+.|+|+-+ +|||||||+||.+-+ -|.+||.|||++..+. .+.
T Consensus 100 D~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~---PG~ 173 (864)
T KOG4717|consen 100 DGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ---PGK 173 (864)
T ss_pred CCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCC---Ccc
Confidence 999999999988888999999999999999999999655 999999999998754 5899999999987543 334
Q ss_pred eeeeeecCcCCCChhhhccCCCC-chHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccC
Q 039107 643 VSTVVKGSFGYLDPEYFKRQQLT-EKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKD 721 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s-~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (817)
.-+..+|++.|.|||.+.+..|+ ++.|||||||+||-|+||++||+..++.+... .++|-..
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT---------------mImDCKY-- 236 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT---------------MIMDCKY-- 236 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh---------------hhhcccc--
Confidence 45567899999999999998886 68999999999999999999999877665432 2222211
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 722 KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 722 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.++.....++.+||..||..||.+|.+.++|+..
T Consensus 237 tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 237 TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 2344566778999999999999999999998743
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=304.52 Aligned_cols=252 Identities=25% Similarity=0.370 Sum_probs=202.1
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
+|+..+.||+|++|.||++..+ ++..+++|++.... ....+++.+|++++++++||||+++++++......++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 4666778999999999999976 56789999877653 344567899999999999999999999999999999999999
Q ss_pred cCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHh-CCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 564 ALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHT-GAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 564 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
++++|.+++......+++..+..++.|++.||+|||+ . +++|+||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~--- 155 (265)
T cd06605 82 DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--- 155 (265)
T ss_pred CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH---
Confidence 9999999997665678999999999999999999997 4 49999999999999999999999999986532111
Q ss_pred eeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCC
Q 039107 643 VSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDK 722 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (817)
.....++..|+|||.+.+..++.++||||||+++++|++|+.|+........ ...+......... .+ .
T Consensus 156 -~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~------~~----~ 223 (265)
T cd06605 156 -AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIVNEP------PP----R 223 (265)
T ss_pred -hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHHhcCC------CC----C
Confidence 1125688899999999999999999999999999999999999865432111 1111111111100 01 1
Q ss_pred CCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 723 ISPE-CLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 723 ~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.+.. ....+.+++.+||..+|++|||+.+++.+
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 224 LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1111 55668999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=307.72 Aligned_cols=260 Identities=30% Similarity=0.434 Sum_probs=203.4
Q ss_pred cCHHHHHHhhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhcc-CccceeeEEEEEec
Q 039107 475 FSLAEIKHATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEE 552 (817)
Q Consensus 475 f~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 552 (817)
.++.++..+...|+..+.||+|+||.||+|... .+..+|+|...... ....++..|+.+++++ +|+||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 456667777788999999999999999999974 56789999876543 3346788999999999 79999999999843
Q ss_pred ------CCeEEEEEEeccCCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeE
Q 039107 553 ------GNEMCLVYDYMALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAK 625 (817)
Q Consensus 553 ------~~~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~k 625 (817)
....+++|||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.++
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 457899999999999999886543 35888889999999999999999765 99999999999999999999
Q ss_pred EeeeccCccCCCCCCCceeeeeecCcCCCChhhhc-----cCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHH
Q 039107 626 VSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFK-----RQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLAD 700 (817)
Q Consensus 626 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~ 700 (817)
|+|||++....... .......|+..|+|||.+. ...++.++|||||||++|||++|+.||....+......
T Consensus 162 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~-- 237 (282)
T cd06636 162 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL-- 237 (282)
T ss_pred EeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh--
Confidence 99999987542211 1223356889999999975 34678899999999999999999999865432211100
Q ss_pred HHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 701 WALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 701 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
......+.. ....++..+.+++.+||+.+|.+||++.+++++
T Consensus 238 ----------~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 238 ----------IPRNPPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred ----------HhhCCCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 000000111 112345678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=308.11 Aligned_cols=262 Identities=21% Similarity=0.297 Sum_probs=196.1
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC--cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
+|...+.||+|+||.||+|+.. ++..+++|++.... ......+.+|++++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 3677789999999999999975 57789999876432 22235678899999999999999999999999999999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
++ ++|.+++......+++..++.++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--~ 154 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--R 154 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC--C
Confidence 97 5788877665567999999999999999999999765 9999999999999999999999999987542211 1
Q ss_pred eeeeeecCcCCCChhhhccC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccC------chhhcc
Q 039107 643 VSTVVKGSFGYLDPEYFKRQ-QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKG------ILDDII 715 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~------~~~~~~ 715 (817)
......++..|+|||.+.+. .++.++|||||||++|||++|+.|+........ .+ .......... .+.+..
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QL-KRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH-HH-HHHHHHhCCCChHHhHHhhhcc
Confidence 12234578899999998764 468999999999999999999988654332111 00 0000000000 000000
Q ss_pred Cc----ccc-----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 716 DP----LLK-----DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 716 d~----~l~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
+. ... ....+.....+.+++.+||+.||.+|||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00 000 01112345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=300.82 Aligned_cols=248 Identities=27% Similarity=0.349 Sum_probs=199.9
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
+|...+.||+|+||.||++... ++..+++|.+... .....+.+.+|++++++++||||+++++.+......++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4677889999999999999864 5678999987643 234467899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCC-ceeEEeeeccCccCCCCCC
Q 039107 563 MALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDEN-WVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 563 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DFGla~~~~~~~~ 640 (817)
+++++|.+++.... ..+++..+..++.|++.||+|||+++ ++|+||||+||+++++ +.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 99999999997643 35899999999999999999999765 9999999999999854 568999999998643321
Q ss_pred CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
......++..|+|||.+.+..++.++||||||+++++|++|+.||....... ..... .... .
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~---~~~~----------~ 218 (256)
T cd08220 157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---LVLKI---MSGT----------F 218 (256)
T ss_pred --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---HHHHH---HhcC----------C
Confidence 1223468899999999998889999999999999999999999986543221 11111 1100 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
...+......+.+++.+||+.+|++|||+.+++++
T Consensus 219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11122345568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=302.66 Aligned_cols=258 Identities=24% Similarity=0.317 Sum_probs=201.0
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEec--CCeEEEEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE--GNEMCLVYD 561 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~E 561 (817)
+|...+.||.|++|.||++... ++..+|+|.+.... .....++.+|++++++++||||++++++|.. ....++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 5778889999999999999975 46789999877543 2345678999999999999999999998854 346899999
Q ss_pred eccCCchhhhhhc---cccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCC
Q 039107 562 YMALGTLREHIYN---TKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNM 638 (817)
Q Consensus 562 y~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 638 (817)
|+++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999988753 2346889999999999999999999765 999999999999999999999999998753221
Q ss_pred CCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCcc--ccchHHHHHHHhhccCchhhccC
Q 039107 639 ENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPK--EQVSLADWALHCKRKGILDDIID 716 (817)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~--~~~~l~~~~~~~~~~~~~~~~~d 716 (817)
. .....++..|+|||.+.+..++.++||||||+++|||++|+.||...... ....+..|..... ...+.+
T Consensus 159 ~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~ 230 (287)
T cd06621 159 L----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP----NPELKD 230 (287)
T ss_pred c----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC----chhhcc
Confidence 1 12345788999999999999999999999999999999999999765321 1122222222110 000000
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 717 PLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 717 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
.. .........+.+++.+||+.+|.+|||+.|++++-.
T Consensus 231 -~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~ 268 (287)
T cd06621 231 -EP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268 (287)
T ss_pred -CC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence 00 001124567899999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=301.61 Aligned_cols=256 Identities=27% Similarity=0.409 Sum_probs=204.0
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
++|+..+.||.|+||+||+|... ++..+++|++.... ....+.+.+|+++++.++|+||+++++.+...+..++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 36788899999999999999964 56789999986432 23567899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcc--ccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 563 MALGTLREHIYNT--KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 563 ~~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 9999999998654 246899999999999999999999765 99999999999999999999999999876543222
Q ss_pred C--ceeeeeecCcCCCChhhhccC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCc
Q 039107 641 G--HVSTVVKGSFGYLDPEYFKRQ-QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717 (817)
Q Consensus 641 ~--~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (817)
. .......|+..|+|||.+... .++.++|+|||||+++||++|+.||....... .+..... .. .+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~----~~------~~ 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLMLTLQ----ND------PP 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHHHhc----CC------CC
Confidence 2 122345688999999998877 78999999999999999999999986543221 1111110 00 01
Q ss_pred cccCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 718 LLKDKI-SPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 718 ~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.+.... ....+..+.+++.+|++.+|++||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 111110 12445678999999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=306.15 Aligned_cols=267 Identities=22% Similarity=0.288 Sum_probs=197.1
Q ss_pred hhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCc-ccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSE-QGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
++.+|...+.||+|+||.||+|... ++..|++|.+..... .....+.+|++++++++|+||+++++++......++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4567888999999999999999864 567899999865432 22346789999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
||+. ++|.+++......+++.++..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||+++......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 157 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS- 157 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC-
Confidence 9996 6777776555556888899999999999999999765 9999999999999999999999999987532211
Q ss_pred CceeeeeecCcCCCChhhhccC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHh----------hcc-
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQ-QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHC----------KRK- 708 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~----------~~~- 708 (817)
.......++..|+|||.+.+. .++.++|||||||++|||++|+.||.........-...|.... ...
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 158 -QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred -CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence 112233468899999998754 5788999999999999999999999754332111000010000 000
Q ss_pred CchhhccCccccCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 709 GILDDIIDPLLKDKI-----SPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 709 ~~~~~~~d~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
............... .......+.+++.+|+..||.+|||+.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 000000000000000 00113567899999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=310.89 Aligned_cols=248 Identities=23% Similarity=0.366 Sum_probs=199.0
Q ss_pred ceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccCCch
Q 039107 490 SYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTL 568 (817)
Q Consensus 490 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 568 (817)
...||+|+||.||++... ++..||||.+........+.+.+|+.++++++|+||+++++.+...+..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 347999999999999865 5678999998765555567789999999999999999999999999999999999999999
Q ss_pred hhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceeeeee
Q 039107 569 REHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVK 648 (817)
Q Consensus 569 ~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 648 (817)
.+++.. ..+++.++..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++....... .......
T Consensus 107 ~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~ 179 (292)
T cd06658 107 TDIVTH--TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PKRKSLV 179 (292)
T ss_pred HHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--ccCceee
Confidence 998743 35899999999999999999999765 9999999999999999999999999987543222 1223356
Q ss_pred cCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCHHHH
Q 039107 649 GSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECL 728 (817)
Q Consensus 649 gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 728 (817)
|+..|+|||.+.+..++.++||||||+++|||++|+.||........... . .....+.+.. .....
T Consensus 180 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~---~---------~~~~~~~~~~--~~~~~ 245 (292)
T cd06658 180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR---I---------RDNLPPRVKD--SHKVS 245 (292)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---H---------HhcCCCcccc--ccccC
Confidence 89999999999888999999999999999999999999875432211100 0 0011111111 11234
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 729 KKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 729 ~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
..+.+++.+|+..+|.+|||+++++++-..
T Consensus 246 ~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 275 (292)
T cd06658 246 SVLRGFLDLMLVREPSQRATAQELLQHPFL 275 (292)
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhChhh
Confidence 467889999999999999999999986333
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=309.87 Aligned_cols=249 Identities=29% Similarity=0.418 Sum_probs=198.4
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC---cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS---EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
+.|...+.||+|+||.||+|... ++..||+|.+.... ....+++.+|+++++.++||||++++++|...+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45777889999999999999875 57889999876432 233457889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
||+. |+|.+++....+.+++.++..++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence 9997 5777777655567999999999999999999999765 999999999999999999999999998754321
Q ss_pred CceeeeeecCcCCCChhhhc---cCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCc
Q 039107 641 GHVSTVVKGSFGYLDPEYFK---RQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (817)
....++..|+|||.+. .+.++.++||||||+++|||++|++|+........ ........ .+
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~------~~~~~~~~------~~ 232 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQND------SP 232 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH------HHHHhcCC------CC
Confidence 2345788999999874 45688999999999999999999999865432111 00000000 00
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 718 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
.+ ....+...+.+++.+||+.+|++||++.+|+.+...
T Consensus 233 ~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 270 (307)
T cd06607 233 TL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFV 270 (307)
T ss_pred CC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence 11 122355678999999999999999999999986543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=321.81 Aligned_cols=248 Identities=25% Similarity=0.420 Sum_probs=193.1
Q ss_pred ceeEeeeCceEEEEEEEe-cccEEEEEecC---C-CCcccHHHHHHHHHHHhccCccceeeEEEEEecCC--eEEEEEEe
Q 039107 490 SYVIGVGGFGKVYKGVIE-DKLKVAIKRSN---P-SSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGN--EMCLVYDY 562 (817)
Q Consensus 490 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~---~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~Ey 562 (817)
..+||+|+|-+||||... .|..||--.++ . .+....+.|..|+++|+.|+||||++++.++.+.. ...+|.|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 347999999999999864 45666532222 1 23445688999999999999999999999987654 47899999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCC-ceeEEeeeccCccCCCCCCC
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDEN-WVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DFGla~~~~~~~~~ 641 (817)
|..|+|..|+.+.+ .++.+.+..||+||++||.|||++ .++|||||||.+||+|+.+ |.+||+|+|||.....
T Consensus 125 ~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~---- 198 (632)
T KOG0584|consen 125 FTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK---- 198 (632)
T ss_pred ccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc----
Confidence 99999999987654 488899999999999999999998 6899999999999999865 9999999999987432
Q ss_pred ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccC
Q 039107 642 HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKD 721 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (817)
.....+.||+.|||||++. ..|++..||||||++|+||+|+.-|+..=....++ .. ..-.|.....+.
T Consensus 199 s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQI-----YK-KV~SGiKP~sl~----- 266 (632)
T KOG0584|consen 199 SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQI-----YK-KVTSGIKPAALS----- 266 (632)
T ss_pred cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHH-----HH-HHHcCCCHHHhh-----
Confidence 2334478999999999988 78999999999999999999999998542222111 00 011111111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 722 KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 722 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
... -.++.+||.+|+.. ..+|||+.|+|.+--..
T Consensus 267 kV~---dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~ 300 (632)
T KOG0584|consen 267 KVK---DPEVREFIEKCLAT-KSERLSAKELLKDPFFD 300 (632)
T ss_pred ccC---CHHHHHHHHHHhcC-chhccCHHHHhhChhhc
Confidence 111 23478999999999 99999999999764443
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=296.88 Aligned_cols=252 Identities=25% Similarity=0.390 Sum_probs=205.3
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCc--ccHHHHHHHHHHHhccCccceeeEEEEEecC--CeEEEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSE--QGVNEFVTEIEMLSKLRHKHLVSLIGFCEEG--NEMCLVY 560 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 560 (817)
+|...+.||+|++|.||+|... ++..|++|....... ...+.+.+|+.++++++|+||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3667789999999999999976 578899999775542 4567899999999999999999999999888 8899999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
||+++++|.+++.... .+++.++..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 9999999999987554 7999999999999999999999765 99999999999999999999999999886543322
Q ss_pred CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
........++..|+|||.+.....+.++||||||+++++|++|+.||....... ...... ......
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~---------~~~~~~ 222 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM-----AALYKI---------GSSGEP 222 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-----HHHHhc---------cccCCC
Confidence 111334568899999999988889999999999999999999999997654111 001110 111111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
..++......+.+++.+|++.+|++||++.+++++
T Consensus 223 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 223 PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 22233446678999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=309.48 Aligned_cols=249 Identities=22% Similarity=0.337 Sum_probs=199.6
Q ss_pred ceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccCCch
Q 039107 490 SYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTL 568 (817)
Q Consensus 490 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 568 (817)
...||+|+||.||++... ++..||+|.+........+.+.+|+.+++.++||||+++++++..++..++|+||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 447999999999999865 5788999998765555567788999999999999999999999999999999999999999
Q ss_pred hhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceeeeee
Q 039107 569 REHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVK 648 (817)
Q Consensus 569 ~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 648 (817)
.+++.. ..+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++....... .......
T Consensus 106 ~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~ 178 (297)
T cd06659 106 TDIVSQ--TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKSLV 178 (297)
T ss_pred HHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc--cccccee
Confidence 987743 45899999999999999999999765 9999999999999999999999999987533221 1223456
Q ss_pred cCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCHHHH
Q 039107 649 GSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECL 728 (817)
Q Consensus 649 gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 728 (817)
|+..|+|||.+.+..++.++|||||||+++||++|+.||......+.. .... ... .+... ......
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~---~~~~----~~~-----~~~~~--~~~~~~ 244 (297)
T cd06659 179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM---KRLR----DSP-----PPKLK--NAHKIS 244 (297)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHh----ccC-----CCCcc--ccCCCC
Confidence 899999999999889999999999999999999999998754322211 1110 000 00000 011234
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 729 KKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 729 ~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
..+.+++.+|++.+|.+||++.+++++--..
T Consensus 245 ~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~ 275 (297)
T cd06659 245 PVLRDFLERMLTREPQERATAQELLDHPFLL 275 (297)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhhChhhc
Confidence 5578999999999999999999999874433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=318.73 Aligned_cols=249 Identities=27% Similarity=0.438 Sum_probs=204.6
Q ss_pred CCcceeEeeeCceEEEEEEEecc-cEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccC
Q 039107 487 FDESYVIGVGGFGKVYKGVIEDK-LKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMAL 565 (817)
Q Consensus 487 f~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 565 (817)
|.+..-||-|+||.|||++.++. ...|.|.+...+....++|+-||+||..+.||+||+|++.|...+.++++.|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 44556799999999999997754 34577888878888889999999999999999999999988888999999999999
Q ss_pred CchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceee
Q 039107 566 GTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVST 645 (817)
Q Consensus 566 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 645 (817)
|-.+..+..-...|++.++.-+|.|++.||.|||++. |||||||+.|||++-+|.++|+|||.+..... ......
T Consensus 114 GAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qkRD 188 (1187)
T KOG0579|consen 114 GAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQKRD 188 (1187)
T ss_pred chHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh--HHhhhc
Confidence 9999988877889999999999999999999999765 99999999999999999999999999865322 122345
Q ss_pred eeecCcCCCChhhhc-----cCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHH-hhccCchhhccCccc
Q 039107 646 VVKGSFGYLDPEYFK-----RQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALH-CKRKGILDDIIDPLL 719 (817)
Q Consensus 646 ~~~gt~~y~aPE~~~-----~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~-~~~~~~~~~~~d~~l 719 (817)
.+.||+.|||||+.. ..+|+.++||||||+.|.||..+.+|-..-.+.. .... .+.+. |.+
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR------VllKiaKSeP-------PTL 255 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKSEP-------PTL 255 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH------HHHHHhhcCC-------Ccc
Confidence 678999999999874 4689999999999999999999998865433211 1111 01111 111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 720 KDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 720 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.. +......+.+++.+||.+||..||++.++++|
T Consensus 256 lq--PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 256 LQ--PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred cC--cchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 11 33556778999999999999999999999965
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=295.31 Aligned_cols=249 Identities=29% Similarity=0.472 Sum_probs=204.1
Q ss_pred CCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccC
Q 039107 487 FDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMAL 565 (817)
Q Consensus 487 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 565 (817)
|...+.||+|++|.||++... ++..+++|++........+.+.+|++++++++|+|++++++++......++++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 666789999999999999976 5788999998876555668899999999999999999999999999999999999999
Q ss_pred CchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceee
Q 039107 566 GTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVST 645 (817)
Q Consensus 566 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 645 (817)
++|.+++......+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||.+........ ..
T Consensus 82 ~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~ 155 (253)
T cd05122 82 GSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RN 155 (253)
T ss_pred CcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc---cc
Confidence 9999998766567999999999999999999999755 99999999999999999999999999876433221 33
Q ss_pred eeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCH
Q 039107 646 VVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISP 725 (817)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 725 (817)
...++..|++||.+....++.++||||||+++++|++|+.|+......... ..... .... .+.. ..
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~-~~~~-----~~~~--~~ 221 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKAL------FKIAT-NGPP-----GLRN--PE 221 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHH------HHHHh-cCCC-----CcCc--cc
Confidence 456889999999999888999999999999999999999998654321111 01000 0000 0100 11
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 726 ECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 726 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.....+.+++.+|++.+|++|||+.+++++
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 222 KWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 124568999999999999999999999865
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=320.34 Aligned_cols=241 Identities=24% Similarity=0.284 Sum_probs=186.8
Q ss_pred EeeeCceEEEEEEEe-cccEEEEEecCCCC---cccHHHHHHHHHHHhcc---CccceeeEEEEEecCCeEEEEEEeccC
Q 039107 493 IGVGGFGKVYKGVIE-DKLKVAIKRSNPSS---EQGVNEFVTEIEMLSKL---RHKHLVSLIGFCEEGNEMCLVYDYMAL 565 (817)
Q Consensus 493 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lV~Ey~~~ 565 (817)
||+|+||+||+|+.. ++..||+|++.... ......+..|..++.++ +||||+++++++......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999865 46889999976431 22234455677777665 699999999999999999999999999
Q ss_pred CchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceee
Q 039107 566 GTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVST 645 (817)
Q Consensus 566 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 645 (817)
|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~--~~~~~ 154 (330)
T cd05586 81 GELFWHLQKE-GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTD--NKTTN 154 (330)
T ss_pred ChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCC--CCCcc
Confidence 9999888643 46899999999999999999999766 999999999999999999999999998753221 12233
Q ss_pred eeecCcCCCChhhhccC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCC
Q 039107 646 VVKGSFGYLDPEYFKRQ-QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKIS 724 (817)
Q Consensus 646 ~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 724 (817)
...||..|+|||.+.+. .++.++|||||||++|||++|+.||......+. ..... .+. ..+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~------~~~i~-~~~------~~~~~--- 218 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM------YRNIA-FGK------VRFPK--- 218 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH------HHHHH-cCC------CCCCC---
Confidence 45699999999998754 479999999999999999999999975432211 11100 010 01111
Q ss_pred HHHHHHHHHHHHHccccCCCCCC----CHHHHHHH
Q 039107 725 PECLKKFADTAEKCLSDSGIDRP----SMGDVLWN 755 (817)
Q Consensus 725 ~~~~~~l~~li~~cl~~dP~~RP----t~~evl~~ 755 (817)
......+.+++.+||+.+|.+|| ++.+++++
T Consensus 219 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 219 NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 12344578999999999999998 56777664
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=303.81 Aligned_cols=253 Identities=29% Similarity=0.402 Sum_probs=199.1
Q ss_pred hhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhcc-CccceeeEEEEEecCC------
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGN------ 554 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~------ 554 (817)
++++|...+.||+|++|.||+|..+ ++..+++|.+..... ..+++.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4678899999999999999999975 457899998875543 346789999999999 6999999999996544
Q ss_pred eEEEEEEeccCCchhhhhhccc---cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeecc
Q 039107 555 EMCLVYDYMALGTLREHIYNTK---KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGL 631 (817)
Q Consensus 555 ~~~lV~Ey~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGl 631 (817)
..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999999886533 47899999999999999999999765 99999999999999999999999999
Q ss_pred CccCCCCCCCceeeeeecCcCCCChhhhcc-----CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhh
Q 039107 632 SKTGPNMENGHVSTVVKGSFGYLDPEYFKR-----QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCK 706 (817)
Q Consensus 632 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 706 (817)
+....... .......|+..|+|||.+.. ..++.++||||||++|+||++|+.||........ +.. ..
T Consensus 160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~----~~ 231 (275)
T cd06608 160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA--LFK----IP 231 (275)
T ss_pred ceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH--HHH----hh
Confidence 87543221 12233458899999998753 3467899999999999999999999964322111 110 00
Q ss_pred ccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 707 RKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 707 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
... .+.+ .........+.+++.+||..||++|||+.+++++
T Consensus 232 -~~~-----~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 232 -RNP-----PPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred -ccC-----CCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 000 0011 1122355678999999999999999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=305.71 Aligned_cols=253 Identities=25% Similarity=0.402 Sum_probs=203.8
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
.+|...+.||+|+||.||++... ++..|++|.+........+.+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 56778889999999999999854 56789999987555555678899999999999999999999999999999999999
Q ss_pred cCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCce
Q 039107 564 ALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643 (817)
Q Consensus 564 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 643 (817)
++++|.+++.+ ..+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........ .
T Consensus 99 ~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~ 171 (293)
T cd06647 99 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K 171 (293)
T ss_pred CCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc--c
Confidence 99999998854 35889999999999999999999765 99999999999999999999999998875432221 2
Q ss_pred eeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCC
Q 039107 644 STVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKI 723 (817)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 723 (817)
.....++..|+|||.+..+.++.++||||||+++|||++|+.||........... + ...+ .+.. ..
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~--~----~~~~------~~~~--~~ 237 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL--I----ATNG------TPEL--QN 237 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee--h----hcCC------CCCC--CC
Confidence 2234688899999999888899999999999999999999999975433221110 0 0000 0000 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 724 SPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 724 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
.......+.+++.+||+.+|++||++.+++.+--.
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~ 272 (293)
T cd06647 238 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272 (293)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHH
Confidence 12334568899999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=299.33 Aligned_cols=253 Identities=27% Similarity=0.409 Sum_probs=200.5
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCc--ccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSE--QGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
+|...+.||+|+||.||+|... ++..+++|.++.... ...+.+.+|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4677889999999999999865 568899999775543 3567899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
+++++|.+++... ..+++..+..|+.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 81 CSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 9999999998654 35889999999999999999999766 9999999999999999999999999987653322211
Q ss_pred e--eeeeecCcCCCChhhhccCC---CCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCc
Q 039107 643 V--STVVKGSFGYLDPEYFKRQQ---LTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717 (817)
Q Consensus 643 ~--~~~~~gt~~y~aPE~~~~~~---~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (817)
. .....++..|+|||.+.... .+.++||||||++++||++|+.||........ . ...... + ..+
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~--~---~~~~~~-~-----~~~ 225 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ--I---MFHVGA-G-----HKP 225 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH--H---HHHHhc-C-----CCC
Confidence 1 12346788999999998766 88999999999999999999999965432111 0 000000 0 011
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 718 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.+.. .......+.+++.+||+.+|.+||++.+++.+
T Consensus 226 ~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 226 PIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred CCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 1111 11235567899999999999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=308.52 Aligned_cols=251 Identities=27% Similarity=0.388 Sum_probs=199.5
Q ss_pred CCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC---cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 487 FDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS---EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 487 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
|...+.||+|+||.||+++.. ++..+|+|++.... ....+.+.+|++++++++|+|++++++++.+....++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 666778999999999999964 56889999876432 22345788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
+. |+|.+.+......+++.++..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++.....
T Consensus 107 ~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----- 177 (317)
T cd06635 107 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP----- 177 (317)
T ss_pred CC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC-----
Confidence 97 5787877665667999999999999999999999765 99999999999999999999999999875322
Q ss_pred eeeeeecCcCCCChhhhc---cCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccc
Q 039107 643 VSTVVKGSFGYLDPEYFK---RQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (817)
.....|+..|+|||.+. .+.++.++|||||||++|||++|+.||......... ..+. ... .
T Consensus 178 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~--~~~~----~~~---------~ 241 (317)
T cd06635 178 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--YHIA----QNE---------S 241 (317)
T ss_pred -cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH--HHHH----hcc---------C
Confidence 12345788999999973 467899999999999999999999998654221111 0010 000 0
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 039107 720 KDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQL 762 (817)
Q Consensus 720 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 762 (817)
...........+.+++.+|++.+|.+||++.++++++......
T Consensus 242 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 242 PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 0111223455689999999999999999999999987665433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=301.25 Aligned_cols=247 Identities=25% Similarity=0.385 Sum_probs=199.2
Q ss_pred CCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEecc
Q 039107 487 FDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMA 564 (817)
Q Consensus 487 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 564 (817)
|...+.||+|+||.||+|... ++..+|+|...... ....+.+.+|+.++++++||||+++++++......++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 556678999999999999864 56789999876442 3345678899999999999999999999999999999999999
Q ss_pred CCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCcee
Q 039107 565 LGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVS 644 (817)
Q Consensus 565 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 644 (817)
+++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... ...
T Consensus 86 ~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~~ 158 (277)
T cd06641 86 GGSALDLLEP--GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKR 158 (277)
T ss_pred CCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch--hhh
Confidence 9999998853 46899999999999999999999765 9999999999999999999999999987543221 112
Q ss_pred eeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCC
Q 039107 645 TVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKIS 724 (817)
Q Consensus 645 ~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 724 (817)
....++..|+|||.+.+..++.++|+|||||+++||++|..|+....... +.... .... .....
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~~~~-~~~~---------~~~~~ 222 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK------VLFLI-PKNN---------PPTLE 222 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH------HHHHH-hcCC---------CCCCC
Confidence 23457889999999998889999999999999999999999986433211 11110 0000 11122
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 725 PECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 725 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
......+.+++.+|++.+|.+||++.+++++-
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~ 254 (277)
T cd06641 223 GNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 254 (277)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence 23455678999999999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=326.91 Aligned_cols=252 Identities=25% Similarity=0.415 Sum_probs=209.8
Q ss_pred cceeEeeeCceEEEEEEE-ecc----cEEEEEecCCC-CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 489 ESYVIGVGGFGKVYKGVI-EDK----LKVAIKRSNPS-SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 489 ~~~~lG~G~fg~Vy~~~~-~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
..++||+|+||+||||.+ ..+ .+||+|.+... ..+...+++.|+-+|.+|+||||++|+|+|.... +.||.+|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 355899999999999985 233 57899987654 4455688999999999999999999999998755 8899999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
|+.|+|.++++.++..+-.+..+.|+.|||+||.|||.+. +|||||..+||||..-..+|+.|||+++....+....
T Consensus 779 mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred cccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 9999999999988888999999999999999999999654 9999999999999999999999999999876665554
Q ss_pred eeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccC
Q 039107 643 VSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKD 721 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (817)
......-.+.|||-|.+....++.++|||||||.+||++| |..|+.+....+. .+++..-.+-
T Consensus 856 ~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI----------------~dlle~geRL 919 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI----------------PDLLEKGERL 919 (1177)
T ss_pred cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh----------------hHHHhccccC
Confidence 4444555788999999999999999999999999999998 7788765433221 1122211222
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 039107 722 KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVL 760 (817)
Q Consensus 722 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 760 (817)
..++-|...+..++.+||..|++.||+++++...+....
T Consensus 920 sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 920 SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 335678888999999999999999999999998776644
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=307.17 Aligned_cols=255 Identities=24% Similarity=0.340 Sum_probs=198.9
Q ss_pred CCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCCC---cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPSS---EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
+|...+.||+|+||.||++.... +..|++|.+.... ....+.+.+|+++++.++||||+++++.+...+..++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 57788899999999999999764 5789999877543 2334678899999999999999999999999999999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC-
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN- 640 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~- 640 (817)
|+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 82 YVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 99999999998654 46899999999999999999999765 99999999999999999999999999874211000
Q ss_pred ------------CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhcc
Q 039107 641 ------------GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRK 708 (817)
Q Consensus 641 ------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 708 (817)
........++..|+|||.+....++.++|+||||+++|||++|+.||.+....+ +.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~------~~~~~~~~ 231 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------LFGQVISD 231 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhc
Confidence 001112357889999999988899999999999999999999999987543211 11111110
Q ss_pred CchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 709 GILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 709 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
. ...+.. ....+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 232 ~----~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 232 D----IEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred c----cCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 0 001111 11234567999999999999999996655555554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=304.55 Aligned_cols=258 Identities=27% Similarity=0.409 Sum_probs=207.1
Q ss_pred HhhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 482 HATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 482 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
..++.|...+.||+|++|.||+|..+ ++..+++|.+..... ..+.+.+|++++++++|+|++++++++......++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 34566777889999999999999976 567899999876544 5678899999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
||+++++|.+++......+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~- 170 (286)
T cd06614 95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK- 170 (286)
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch-
Confidence 999999999999765547999999999999999999999765 9999999999999999999999999986543221
Q ss_pred CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
.......++..|++||.+.+..++.++||||||+++|||++|+.|+......... ..+ .... ... .
T Consensus 171 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~--~~~----~~~~-~~~-----~- 236 (286)
T cd06614 171 -SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL--FLI----TTKG-IPP-----L- 236 (286)
T ss_pred -hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH--HHH----HhcC-CCC-----C-
Confidence 1122345788999999998888999999999999999999999998654322110 000 0000 000 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
.....+...+.+++.+|++.+|.+||++.+++++.-..
T Consensus 237 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 274 (286)
T cd06614 237 -KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLK 274 (286)
T ss_pred -cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhh
Confidence 01122456789999999999999999999999765443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=301.55 Aligned_cols=248 Identities=23% Similarity=0.376 Sum_probs=198.0
Q ss_pred CCCcceeEeeeCceEEEEEEE-ecccEEEEEecCCC-CcccHHHHHHHHHHHhccC---ccceeeEEEEEecCCeEEEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVI-EDKLKVAIKRSNPS-SEQGVNEFVTEIEMLSKLR---HKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~ 560 (817)
.|+..+.||+|+||.||+|.. .++..+++|.+... .....+++.+|+.++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 356677899999999999996 46788999987654 3344567889999999996 999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06917 82 EYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS- 155 (277)
T ss_pred ecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-
Confidence 99999999998854 36899999999999999999999765 9999999999999999999999999987654322
Q ss_pred CceeeeeecCcCCCChhhhccC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQ-QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (817)
.......|+..|+|||.+.++ .++.++||||||+++|||++|+.||........ .... .....+.+
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~~~~------~~~~~~~~ 222 (277)
T cd06917 156 -SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------MMLI------PKSKPPRL 222 (277)
T ss_pred -cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------hhcc------ccCCCCCC
Confidence 122334688999999998754 568999999999999999999999975432111 1000 00001111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 720 KDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 720 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.. ......+.+++.+||+.+|++||++.+++++
T Consensus 223 ~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 223 ED---NGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred Cc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 11 1144568899999999999999999999875
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=304.53 Aligned_cols=248 Identities=21% Similarity=0.376 Sum_probs=199.8
Q ss_pred CCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccC
Q 039107 487 FDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMAL 565 (817)
Q Consensus 487 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 565 (817)
|...++||+|++|.||++... ++..+++|++........+.+.+|+.++++++|+||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444569999999999999864 5688999988755555556788999999999999999999999999999999999999
Q ss_pred CchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceee
Q 039107 566 GTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVST 645 (817)
Q Consensus 566 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 645 (817)
++|.+++.. ..+++.++..++.|++.||+|||+.+ |+||||+|+||++++++.++|+|||++....... ....
T Consensus 101 ~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~~~ 173 (285)
T cd06648 101 GALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PRRK 173 (285)
T ss_pred CCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC--cccc
Confidence 999998865 46899999999999999999999765 9999999999999999999999999887543221 1223
Q ss_pred eeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCH
Q 039107 646 VVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISP 725 (817)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 725 (817)
...|+..|+|||.+.+..++.++||||||++++||++|+.||....... +...... . ..+.... ..
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~------~~~~~~~-~-----~~~~~~~--~~ 239 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ------AMKRIRD-N-----LPPKLKN--LH 239 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH------HHHHHHh-c-----CCCCCcc--cc
Confidence 3458899999999998889999999999999999999999986543211 1111110 0 0011111 11
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 726 ECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 726 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.....+.+++.+||+.+|++||++.+++++
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 240 KVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred cCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 244578999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=304.38 Aligned_cols=261 Identities=21% Similarity=0.290 Sum_probs=196.2
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC--cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
+|+..+.||+|++|.||+|+.. ++..|+||++.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4777889999999999999865 56889999876442 22345788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 563 MALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 563 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
+. ++|.+++.... ..+++.++..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-- 154 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-- 154 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc--
Confidence 96 68888876543 46899999999999999999999765 9999999999999999999999999987543211
Q ss_pred ceeeeeecCcCCCChhhhccCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhcc------------
Q 039107 642 HVSTVVKGSFGYLDPEYFKRQQ-LTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRK------------ 708 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~-~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~------------ 708 (817)
.......++..|+|||.+.+.. ++.++||||||+++|||++|+.||....+.+. +..........
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhhhhHHH
Confidence 1122334688999999886644 68899999999999999999999976543221 11111000000
Q ss_pred ---CchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 709 ---GILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 709 ---~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
..........+. ...+.....+.+++.+|++.||.+|||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 233 DYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000000000000 0011233557899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=308.95 Aligned_cols=254 Identities=22% Similarity=0.321 Sum_probs=203.8
Q ss_pred hhcCCCcceeEeeeCceEEEEEEEecccEEEEEecCC--CCcccHHHHHHHHHHHhccC-ccceeeEEEEEecCCeEEEE
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNP--SSEQGVNEFVTEIEMLSKLR-HKHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV 559 (817)
....|++.++||+||.+.||++...+.+.+|+|++.. ...+...-|.+|+..|.+|+ |.+||+|++|-..++.+|||
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 3456888889999999999999988888888887553 35566788999999999994 99999999999889999999
Q ss_pred EEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC
Q 039107 560 YDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 639 (817)
|||= ..+|..+|.+....++.-.+..+..||+.|+.++|+++ |||.||||.|+|+-.. .+||+|||+|.......
T Consensus 439 mE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVkG-~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVKG-RLKLIDFGIANAIQPDT 513 (677)
T ss_pred eecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEee-eEEeeeechhcccCccc
Confidence 9964 46999999766554442377889999999999999766 9999999999999764 99999999999876665
Q ss_pred CCceeeeeecCcCCCChhhhccCC-----------CCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhcc
Q 039107 640 NGHVSTVVKGSFGYLDPEYFKRQQ-----------LTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRK 708 (817)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~-----------~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 708 (817)
..-.....+||+.||+||.+.... .+.++||||+||+||+|+.|++||..-. ..|.
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-------n~~a------ 580 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-------NQIA------ 580 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-------HHHH------
Confidence 555666778999999999985432 4578999999999999999999986321 0111
Q ss_pred CchhhccCccccCCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 709 GILDDIIDPLLKDKISP-ECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 709 ~~~~~~~d~~l~~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.+..+.||.-.-+++. ....++.++++.||..||.+||++.++|++
T Consensus 581 -Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 581 -KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 2345556543322221 112238999999999999999999999976
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=304.77 Aligned_cols=265 Identities=22% Similarity=0.300 Sum_probs=198.7
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCc--ccHHHHHHHHHHHhccCccceeeEEEEEecC--CeEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSE--QGVNEFVTEIEMLSKLRHKHLVSLIGFCEEG--NEMCLV 559 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 559 (817)
++|...+.||+|+||.||+|..+ ++..+++|.++.... .....+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 35777789999999999999976 467899998864432 2234577899999999999999999998776 889999
Q ss_pred EEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC
Q 039107 560 YDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 639 (817)
|||++ ++|.+++......+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++......
T Consensus 85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 99998 5899888765557999999999999999999999765 9999999999999999999999999988644321
Q ss_pred CCceeeeeecCcCCCChhhhccC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHH----------HHHHHhh--
Q 039107 640 NGHVSTVVKGSFGYLDPEYFKRQ-QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLA----------DWALHCK-- 706 (817)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~----------~~~~~~~-- 706 (817)
.......++..|+|||.+.+. .++.++|+||||++++||++|++||............ .|.....
T Consensus 161 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 161 --KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred --cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 112234578899999998754 4689999999999999999999999754332211100 0110000
Q ss_pred --ccCchhhccCccccCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 707 --RKGILDDIIDPLLKDKISPE-CLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 707 --~~~~~~~~~d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
............+...++.. ....+.+++.+||+.+|++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000000011111112221 35668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=305.60 Aligned_cols=266 Identities=23% Similarity=0.275 Sum_probs=195.6
Q ss_pred CCCcceeEeeeCceEEEEEEEec---ccEEEEEecCCCC---cccHHHHHHHHHHHhccCccceeeEEEEEecC--CeEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIED---KLKVAIKRSNPSS---EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEG--NEMC 557 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 557 (817)
.|...++||+|+||.||+|.... +..||+|.+.... ....+.+.+|+.++++++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 36777899999999999999754 6789999987632 33346778999999999999999999999887 7899
Q ss_pred EEEEeccCCchhhhhhcc----ccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcC----CceeEEeee
Q 039107 558 LVYDYMALGTLREHIYNT----KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDE----NWVAKVSDF 629 (817)
Q Consensus 558 lV~Ey~~~gsL~~~l~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~----~~~~kl~DF 629 (817)
+||||+++ +|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999985 666655422 126889999999999999999999765 999999999999999 999999999
Q ss_pred ccCccCCCCCC-CceeeeeecCcCCCChhhhccC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCcccc-------chHHH
Q 039107 630 GLSKTGPNMEN-GHVSTVVKGSFGYLDPEYFKRQ-QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQ-------VSLAD 700 (817)
Q Consensus 630 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~-------~~l~~ 700 (817)
|+++....... ........++..|+|||.+.+. .++.++||||||++++||++|++||........ ..+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986433222 1112234678899999988764 578999999999999999999999976543320 01111
Q ss_pred HHHHhhcc-----------CchhhccCccccCCCC---------H--HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 701 WALHCKRK-----------GILDDIIDPLLKDKIS---------P--ECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 701 ~~~~~~~~-----------~~~~~~~d~~l~~~~~---------~--~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
........ .......+.......+ . .....+.+++.+||+.||++|||+.+++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11100000 0000000000000001 0 223468899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=302.82 Aligned_cols=254 Identities=22% Similarity=0.341 Sum_probs=193.6
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC-cccHHHHHHHHHH-HhccCccceeeEEEEEecCCeEEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS-EQGVNEFVTEIEM-LSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
++|...+.||+|+||.||+++.+ ++..||+|+++... .....++..|+.+ ++.++||||+++++++......++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36788889999999999999975 57899999987542 2334556667765 556689999999999999999999999
Q ss_pred eccCCchhhhhhc---cccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCC
Q 039107 562 YMALGTLREHIYN---TKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNM 638 (817)
Q Consensus 562 y~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 638 (817)
|++ |+|.+++.. ....+++..++.++.|++.||+|||++ .+++||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 997 688777653 234689999999999999999999975 25999999999999999999999999998764221
Q ss_pred CCCceeeeeecCcCCCChhhhcc----CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhc
Q 039107 639 ENGHVSTVVKGSFGYLDPEYFKR----QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDI 714 (817)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 714 (817)
.......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||....... ..+. .... +
T Consensus 158 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~----~~~~-~----- 223 (283)
T cd06617 158 ---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-QQLK----QVVE-E----- 223 (283)
T ss_pred ---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-HHHH----HHHh-c-----
Confidence 11223457889999998864 456889999999999999999999986422110 0010 0000 0
Q ss_pred cCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 715 IDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 715 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
..+.+. ....+..+.+++.+||..+|++||++.+++++-..
T Consensus 224 ~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~ 264 (283)
T cd06617 224 PSPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFF 264 (283)
T ss_pred CCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchh
Confidence 001111 11234668999999999999999999999976433
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=300.34 Aligned_cols=263 Identities=21% Similarity=0.298 Sum_probs=198.2
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCc-ccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSE-QGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
+|+..+.||.|++|.||+|+.. ++..||+|.+..... ...+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4777889999999999999975 578899999875533 23466788999999999999999999999999999999999
Q ss_pred cCCchhhhhhccc--cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 564 ALGTLREHIYNTK--KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 564 ~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
++ +|.+++.... ..+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++......
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-- 154 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-- 154 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--
Confidence 85 8888876543 46899999999999999999999765 9999999999999999999999999997542211
Q ss_pred ceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchH-HH---------HHHHhhccCc
Q 039107 642 HVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSL-AD---------WALHCKRKGI 710 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l-~~---------~~~~~~~~~~ 710 (817)
.......++..|++||.+.+ ..++.++||||||+++|||++|+.||......+.... .+ |... .....
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 233 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGI-SQLPE 233 (284)
T ss_pred cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHH-hcCch
Confidence 11223356889999999865 4578999999999999999999999876543322110 00 0000 00000
Q ss_pred hhhccCc---cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 711 LDDIIDP---LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 711 ~~~~~d~---~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
....... .......+.....+.+++.+|++.+|.+||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000000 00001112335668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=302.32 Aligned_cols=264 Identities=24% Similarity=0.303 Sum_probs=198.4
Q ss_pred CCcceeEeeeCceEEEEEEEec-ccEEEEEecCCCC--cccHHHHHHHHHHHhccCccceeeEEEEEecC--CeEEEEEE
Q 039107 487 FDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEG--NEMCLVYD 561 (817)
Q Consensus 487 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E 561 (817)
|...+.||+|++|.||+|...+ +..+|+|++.... ......+.+|++++++++|+|++++++++... ...++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 4567789999999999999764 6789999987653 33446788999999999999999999999887 88999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
|+++ +|.+++......+++.+++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~- 155 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS- 155 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-
Confidence 9984 898888765557999999999999999999999765 99999999999999999999999999976533221
Q ss_pred ceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccC---chh-----
Q 039107 642 HVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKG---ILD----- 712 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~----- 712 (817)
.......++..|+|||.+.+ ..++.++||||||++++||++|+.||...................... ...
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence 11223356788999998764 467899999999999999999999987654322211110000000000 000
Q ss_pred ------hccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 713 ------DIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 713 ------~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
......+...+...+...+.+++.+||+.+|.+||++++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000000111111125678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=303.98 Aligned_cols=244 Identities=23% Similarity=0.342 Sum_probs=199.4
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC---cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS---EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
+|...+.||+|+||.||++... ++..+|+|.+.... ....+.+.+|++++++++||||+++++++..+...++|||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 5777889999999999999965 56889999876432 2335678899999999999999999999999999999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||+|+|||+++++.+||+|||+++.....
T Consensus 82 ~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 82 YVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred cCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 99999999998655 46899999999999999999999765 999999999999999999999999999864332
Q ss_pred ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccC
Q 039107 642 HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKD 721 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (817)
.....+++.|+|||.+.+...+.++||||||++++||++|+.||....... ... .. ..+. .
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~--~~--~~~~----------~ 215 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ---IYE--KI--LEGK----------V 215 (290)
T ss_pred --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---HHH--HH--hcCC----------c
Confidence 233468899999999988889999999999999999999999986543211 000 00 0110 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 039107 722 KISPECLKKFADTAEKCLSDSGIDRP-----SMGDVLWN 755 (817)
Q Consensus 722 ~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 755 (817)
.++......+.+++.+||..+|.+|+ ++++++++
T Consensus 216 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 216 RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 11223345678999999999999999 77787765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=300.47 Aligned_cols=258 Identities=24% Similarity=0.252 Sum_probs=193.5
Q ss_pred CCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC-cccHHHHHHHHHHHhccC-ccceeeEEEEEecC--CeEEEEEE
Q 039107 487 FDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLR-HKHLVSLIGFCEEG--NEMCLVYD 561 (817)
Q Consensus 487 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~E 561 (817)
|...+.||+|+||.||+|... ++..+|+|+++... ........+|+.++.++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 455678999999999999865 56789999877542 222234457899999985 99999999999877 88999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
|++ ++|.+++......+++.+++.++.|++.||+|||+.+ ++||||||+||+++. +.+||+|||+++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~-- 153 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP-- 153 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC--
Confidence 997 5888887665567999999999999999999999765 999999999999999 999999999997643221
Q ss_pred ceeeeeecCcCCCChhhhc-cCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhcc-----------C
Q 039107 642 HVSTVVKGSFGYLDPEYFK-RQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRK-----------G 709 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~-~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-----------~ 709 (817)
......++..|+|||.+. .+.++.++|||||||++|||++|.+||......+. ..+....... .
T Consensus 154 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 154 -PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred -CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHcCCCCHHHHHhhccc
Confidence 112345788999999764 45678999999999999999999999976543221 1111111000 0
Q ss_pred chhhccCccccC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 710 ILDDIIDPLLKD----KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 710 ~~~~~~d~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.......+.... ......+..+.+++.+||+.+|++||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000000000 0112346788999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=305.51 Aligned_cols=265 Identities=26% Similarity=0.302 Sum_probs=197.9
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCc--ccHHHHHHHHHHHhccCccceeeEEEEEecC--CeEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSE--QGVNEFVTEIEMLSKLRHKHLVSLIGFCEEG--NEMCLV 559 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 559 (817)
.+|...++||+|+||.||+|..+ ++..||+|.+..... .....+.+|+.++++++|+||+++++++.+. +..++|
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV 86 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence 56888899999999999999975 578899998764322 2234567899999999999999999998654 568999
Q ss_pred EEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC
Q 039107 560 YDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 639 (817)
|||++ ++|.+++......+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 87 ~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 87 MEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 99997 4888888765567999999999999999999999776 9999999999999999999999999998654322
Q ss_pred CCceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccC---chh---
Q 039107 640 NGHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKG---ILD--- 712 (817)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~--- 712 (817)
. ......++..|+|||.+.+ ..++.++||||||+++|||++|++||......+..... ....... ...
T Consensus 163 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 163 K--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLI---IQLLGTPNESIWPGFS 237 (309)
T ss_pred C--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHhcCCCChhhchhhh
Confidence 1 1122345788999999865 56789999999999999999999999765433221111 0000000 000
Q ss_pred -----hcc--CccccCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 713 -----DII--DPLLKDKI---SPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 713 -----~~~--d~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
... ........ .......+.+++.+||+.||++|||+.+++++-..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f 293 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF 293 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence 000 00000000 01134567899999999999999999999976544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=304.98 Aligned_cols=267 Identities=22% Similarity=0.337 Sum_probs=194.9
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC--cccHHHHHHHHHHHhccCccceeeEEEEEecCC-------
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGN------- 554 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------- 554 (817)
++|...++||+|+||.||+|... ++..||+|++.... ......+.+|++++++++||||++++++|....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 36888899999999999999975 56889999875432 222345678999999999999999999986543
Q ss_pred -eEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCc
Q 039107 555 -EMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSK 633 (817)
Q Consensus 555 -~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 633 (817)
..++||||+.+ +|.+.+......+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 45999999974 788877665557899999999999999999999765 9999999999999999999999999997
Q ss_pred cCCCCCCC--ceeeeeecCcCCCChhhhccC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCc
Q 039107 634 TGPNMENG--HVSTVVKGSFGYLDPEYFKRQ-QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGI 710 (817)
Q Consensus 634 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 710 (817)
........ .......++..|+|||.+.+. .++.++||||||++++||++|++||.......................
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV 247 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 64332211 111234578899999988654 478899999999999999999999876544322222111110000000
Q ss_pred hh-----hccC----cc-----ccCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 711 LD-----DIID----PL-----LKDKI-SPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 711 ~~-----~~~d----~~-----l~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.. +..+ +. ..... .......+.+++.+||..+|.+|||+++++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00 0000 00 00000 00112456799999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=303.22 Aligned_cols=265 Identities=24% Similarity=0.322 Sum_probs=197.5
Q ss_pred hhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC--cccHHHHHHHHHHHhccCccceeeEEEEEecCC-----
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGN----- 554 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----- 554 (817)
..++|+..+.||+|+||.||+|..+ ++..||+|++.... ......+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4567888899999999999999976 46789999986542 233456788999999999999999999987654
Q ss_pred -----eEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeee
Q 039107 555 -----EMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDF 629 (817)
Q Consensus 555 -----~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DF 629 (817)
..++|+||+++ +|.+.+......+++.++..++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCcc
Confidence 78999999986 677777655557999999999999999999999765 999999999999999999999999
Q ss_pred ccCccCCCCCCCceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhcc
Q 039107 630 GLSKTGPNMENGHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRK 708 (817)
Q Consensus 630 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 708 (817)
|++........ .......++..|+|||.+.+ ..++.++|||||||+++||++|++||......+.. ..........
T Consensus 161 g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~--~~~~~~~~~~ 237 (302)
T cd07864 161 GLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQL--ELISRLCGSP 237 (302)
T ss_pred cccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHHHhCCC
Confidence 99986543221 11122345778999998864 45789999999999999999999999754332211 1111100000
Q ss_pred --Cchhhc--------cCc------cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 709 --GILDDI--------IDP------LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 709 --~~~~~~--------~d~------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.....+ .++ .... .....+..+.+++.+||+.+|.+||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred Chhhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000000 000 0000 011234678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=296.86 Aligned_cols=249 Identities=26% Similarity=0.420 Sum_probs=200.0
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
+|...+.||+|+||.||+|..+ ++..+|+|.+... .....+.+.+|+.++++++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4677889999999999999976 4678999987643 223456788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcccc-ccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCc-eeEEeeeccCccCCCCCC
Q 039107 563 MALGTLREHIYNTKK-ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENW-VAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DFGla~~~~~~~~ 640 (817)
+++++|.+++..... .+++..+..++.|++.||+|||+.+ ++|+||||+||++++++ .+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM- 156 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc-
Confidence 999999999865443 5899999999999999999999765 99999999999999875 56999999987643221
Q ss_pred CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
.......|+..|+|||.+.+..++.++||||||++++||++|+.|+...... ++....... . +
T Consensus 157 -~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~-~----~----- 219 (257)
T cd08225 157 -ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVLKICQG-Y----F----- 219 (257)
T ss_pred -ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHhcc-c----C-----
Confidence 1223345889999999998888999999999999999999999998644221 222211111 1 1
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
....+.....+.+++.+|+..+|++|||+.+++++
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 220 APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11122334568999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=310.90 Aligned_cols=263 Identities=26% Similarity=0.369 Sum_probs=195.6
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecC-----CeE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEG-----NEM 556 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 556 (817)
.++|...++||+|+||.||+|... ++..||+|++.... ......+.+|+.++++++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 467889999999999999999864 57889999986532 33446788999999999999999999987543 357
Q ss_pred EEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCC
Q 039107 557 CLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGP 636 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 636 (817)
++|+||+++ +|.+++. .+.+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~lv~e~~~~-~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 84 YIVQELMET-DLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEehhccc-CHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 999999974 7777763 346899999999999999999999765 9999999999999999999999999987643
Q ss_pred CCCC-CceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccC---ch
Q 039107 637 NMEN-GHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKG---IL 711 (817)
Q Consensus 637 ~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~ 711 (817)
.... ........|+..|+|||.+.+ ..++.++|||||||++|||++|++||......... .+........ ..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~---~~~~~~~~~~~~~~~ 234 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQL---NLILGVLGTPSQEDL 234 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCCCCHHHH
Confidence 2211 111223468899999998754 56899999999999999999999999654321111 0010000000 00
Q ss_pred hhccCcc---------ccCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 712 DDIIDPL---------LKDK-----ISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 712 ~~~~d~~---------l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
..+.+.. .... ..+.....+.+++.+||+.+|++|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 0000 001234568899999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=296.19 Aligned_cols=243 Identities=23% Similarity=0.302 Sum_probs=195.5
Q ss_pred EeeeCceEEEEEEEec-ccEEEEEecCCCC---cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccCCch
Q 039107 493 IGVGGFGKVYKGVIED-KLKVAIKRSNPSS---EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTL 568 (817)
Q Consensus 493 lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 568 (817)
||.|++|.||+++... +..+++|.+.... ....+.+.+|+.++++++||||+++++++.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6899999999999764 6789999876432 23456789999999999999999999999999999999999999999
Q ss_pred hhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceeeeee
Q 039107 569 REHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVK 648 (817)
Q Consensus 569 ~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 648 (817)
.+++.+. ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++...... ......
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~ 153 (262)
T cd05572 81 WTILRDR-GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFC 153 (262)
T ss_pred HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccccc
Confidence 9998654 35899999999999999999999765 9999999999999999999999999998653321 223346
Q ss_pred cCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCHHHH
Q 039107 649 GSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECL 728 (817)
Q Consensus 649 gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 728 (817)
++..|++||.+....++.++|+||||+++|||++|..|+....... . +.... +.+.......+....
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~---~~~~~---------~~~~~~~~~~~~~~~ 220 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-M---EIYND---------ILKGNGKLEFPNYID 220 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-H---HHHHH---------HhccCCCCCCCcccC
Confidence 7889999999988889999999999999999999999997654211 1 11111 111011112222335
Q ss_pred HHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 039107 729 KKFADTAEKCLSDSGIDRPS-----MGDVLWN 755 (817)
Q Consensus 729 ~~l~~li~~cl~~dP~~RPt-----~~evl~~ 755 (817)
..+.+++.+||+.+|++||+ ++|++++
T Consensus 221 ~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 221 KAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred HHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 67899999999999999999 6676653
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=299.79 Aligned_cols=260 Identities=23% Similarity=0.312 Sum_probs=200.0
Q ss_pred CCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcc--cHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 487 FDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQ--GVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 487 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
|...+.||+|++|.||++... ++..+++|++...... ....+.+|++++++++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 445678999999999999865 5788999987754322 3567889999999999999999999999999999999999
Q ss_pred cCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCce
Q 039107 564 ALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643 (817)
Q Consensus 564 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 643 (817)
++ +|.+++......+++.++..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||.+....... ..
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~ 154 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RP 154 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cc
Confidence 75 888888765567999999999999999999999765 9999999999999999999999999987653322 11
Q ss_pred eeeeecCcCCCChhhhccC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccC---chhhccC---
Q 039107 644 STVVKGSFGYLDPEYFKRQ-QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKG---ILDDIID--- 716 (817)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~~~d--- 716 (817)
.....++..|+|||.+.+. .++.++|+||||+++++|++|+.||......+...... ...... ......+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIF---RTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---HHcCCCchHhcccchhhhh
Confidence 2224578899999998876 78999999999999999999999986654322211100 000000 0000000
Q ss_pred ------c----cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 717 ------P----LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 717 ------~----~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
+ .......+....++.+++.+||+.+|.+||++.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0 00011123456788999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=300.12 Aligned_cols=261 Identities=24% Similarity=0.303 Sum_probs=195.8
Q ss_pred CCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC--cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 487 FDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 487 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
|+..+.||.|++|.||+|... ++..|++|++.... ......+.+|++++++++|+|++++++++......+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 456778999999999999865 67899999876543 223467889999999999999999999999999999999999
Q ss_pred cCCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 564 ALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 564 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
+ ++|.+++.... ..+++.+++.++.|+++||+|||+.+ ++||||+|+||++++++.++|+|||+++...... .
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~ 154 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV--R 154 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc--c
Confidence 5 68999886544 36899999999999999999999765 9999999999999999999999999997543221 1
Q ss_pred eeeeeecCcCCCChhhhccC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccC--------chhh
Q 039107 643 VSTVVKGSFGYLDPEYFKRQ-QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKG--------ILDD 713 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~--------~~~~ 713 (817)
......++..|+|||.+.+. .++.++||||||+++|||++|++||........ +........... .+.+
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhhhhhchh
Confidence 11223468899999987654 578999999999999999999999876533221 111111000000 0000
Q ss_pred c---cCc---cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 714 I---IDP---LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 714 ~---~d~---~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
. +.. .......+.....+.+++.+|++.+|.+|||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 000 00000112233567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=300.89 Aligned_cols=263 Identities=22% Similarity=0.275 Sum_probs=193.8
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC--cccHHHHHHHHHHHhccC-ccceeeEEEEEecCCe-----
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLR-HKHLVSLIGFCEEGNE----- 555 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~----- 555 (817)
++|+..+.||+|+||.||+|... ++..||+|...... ......+.+|+.++++++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 35788889999999999999965 57889999876542 223467889999999995 6999999999876655
Q ss_pred EEEEEEeccCCchhhhhhccc----cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcC-CceeEEeeec
Q 039107 556 MCLVYDYMALGTLREHIYNTK----KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDE-NWVAKVSDFG 630 (817)
Q Consensus 556 ~~lV~Ey~~~gsL~~~l~~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DFG 630 (817)
.++||||+++ +|.+++.... ..+++.+++.++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 7888876432 35899999999999999999999765 999999999999998 8999999999
Q ss_pred cCccCCCCCCCceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccC
Q 039107 631 LSKTGPNMENGHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKG 709 (817)
Q Consensus 631 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 709 (817)
+++...... .......+++.|+|||.+.+ ..++.++||||||+++|||++|..||....+.... ...........
T Consensus 157 ~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~--~~~~~~~~~~~ 232 (295)
T cd07837 157 LGRAFSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL--LHIFKLLGTPT 232 (295)
T ss_pred cceecCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH--HHHHHHhCCCC
Confidence 987542211 11122346788999998865 45799999999999999999999998764332211 00000000000
Q ss_pred --chhh---ccC----cc----ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 710 --ILDD---IID----PL----LKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 710 --~~~~---~~d----~~----l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.... ..+ +. ......+....++.+++.+||+.+|.+||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000 000 00 0000012345668899999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=298.26 Aligned_cols=248 Identities=28% Similarity=0.326 Sum_probs=201.7
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC---cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS---EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
+|...+.||.|+||.||++... ++..+++|.+.... ....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4777889999999999999976 46889999876432 2346789999999999999999999999999999999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
|+.+++|.+++... ..+++.++..++.|+++||.|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence 99999999998654 46899999999999999999999765 9999999999999999999999999987643321
Q ss_pred ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccC
Q 039107 642 HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKD 721 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (817)
......|+..|+|||.+....++.++|+||||+++|+|++|+.|+....... .++....... ...
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~----------~~~ 219 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET----------ADV 219 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc----------ccc
Confidence 2234568889999999998889999999999999999999999987654321 1111111110 111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCH--HHHHH
Q 039107 722 KISPECLKKFADTAEKCLSDSGIDRPSM--GDVLW 754 (817)
Q Consensus 722 ~~~~~~~~~l~~li~~cl~~dP~~RPt~--~evl~ 754 (817)
..+...+..+.+++.+||+.+|.+||+. +|+++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 220 LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred cCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 2233345678999999999999999999 66553
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=298.48 Aligned_cols=244 Identities=23% Similarity=0.328 Sum_probs=188.0
Q ss_pred eEeeeCceEEEEEEEe-cccEEEEEecCCCC---cccHHHHHHHHHHHhc---cCccceeeEEEEEecCCeEEEEEEecc
Q 039107 492 VIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS---EQGVNEFVTEIEMLSK---LRHKHLVSLIGFCEEGNEMCLVYDYMA 564 (817)
Q Consensus 492 ~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~---l~H~niv~l~g~~~~~~~~~lV~Ey~~ 564 (817)
+||+|+||.||++... ++..+|+|.+.... ......+.+|..+++. .+|+||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999865 46889999876432 1222334455544443 479999999999998899999999999
Q ss_pred CCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCcee
Q 039107 565 LGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVS 644 (817)
Q Consensus 565 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 644 (817)
+++|.+++... +.+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.++|+|||++....... .
T Consensus 81 ~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~ 152 (279)
T cd05633 81 GGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P 152 (279)
T ss_pred CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC----c
Confidence 99999988644 45999999999999999999999766 9999999999999999999999999987532211 1
Q ss_pred eeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCC
Q 039107 645 TVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKI 723 (817)
Q Consensus 645 ~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 723 (817)
....|+..|+|||.+.. ..++.++|||||||+++||++|+.||..........+... .. ......
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~----~~----------~~~~~~ 218 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM----TL----------TVNVEL 218 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH----hh----------cCCcCC
Confidence 23468999999999864 5689999999999999999999999975433221111100 00 011122
Q ss_pred CHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 039107 724 SPECLKKFADTAEKCLSDSGIDRP-----SMGDVLWNLE 757 (817)
Q Consensus 724 ~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L~ 757 (817)
+...+..+.+++.+||+.||.+|| ++++++++.-
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~ 257 (279)
T cd05633 219 PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVF 257 (279)
T ss_pred ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCcc
Confidence 334556789999999999999999 5999988743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=309.80 Aligned_cols=266 Identities=25% Similarity=0.368 Sum_probs=197.3
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhcc-CccceeeEEEEEecC--CeEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEG--NEMC 557 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~--~~~~ 557 (817)
.++|...+.||+|+||.||+|... ++..+|+|++... .......+.+|+.+++++ +|+||++++++|... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 456777889999999999999975 5678999987542 233445678899999999 999999999998643 4689
Q ss_pred EEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCC
Q 039107 558 LVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPN 637 (817)
Q Consensus 558 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 637 (817)
+||||++ ++|.+++... .++|..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 86 lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred EEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 9999997 5898887543 6889999999999999999999765 99999999999999999999999999986543
Q ss_pred CCCC---ceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHh--------
Q 039107 638 MENG---HVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHC-------- 705 (817)
Q Consensus 638 ~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~-------- 705 (817)
.... .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||......+...........
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES 239 (337)
T ss_pred ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 2221 12234568999999998754 56788999999999999999999998654433221110000000
Q ss_pred hccCchhhccC----cccc--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 706 KRKGILDDIID----PLLK--DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 706 ~~~~~~~~~~d----~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
........+++ .... ....+.....+.+++.+||+.+|++|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000111 0000 00111245678999999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=294.21 Aligned_cols=251 Identities=24% Similarity=0.367 Sum_probs=197.8
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC-----CcccHHHHHHHHHHHhccCccceeeEEEEEecC--CeE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS-----SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEG--NEM 556 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 556 (817)
.+|...++||+|+||.||+|... ++..+++|.+... ..+....+.+|++++++++|+||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888899999999999999864 4788999986432 223456788999999999999999999998654 468
Q ss_pred EEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCC
Q 039107 557 CLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGP 636 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 636 (817)
++++||+++++|.+++... ..+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++...
T Consensus 82 ~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 8999999999999988654 35889999999999999999999776 9999999999999999999999999997643
Q ss_pred CCCC-CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhcc
Q 039107 637 NMEN-GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDII 715 (817)
Q Consensus 637 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (817)
.... ........++..|+|||.+.+..++.++|+|||||+++||++|+.||......... .. ..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~---------~~ 222 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI------FK---------IA 222 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH------HH---------HH
Confidence 2111 11122345889999999999888999999999999999999999998654221110 00 00
Q ss_pred CccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 716 DPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 716 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.......++......+.+++.+|+. +|.+||+..+++.|
T Consensus 223 ~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 223 TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 0011122344455678999999998 57999999998865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=291.90 Aligned_cols=249 Identities=29% Similarity=0.440 Sum_probs=203.7
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCc--ccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSE--QGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
+|...+.||+|+||.||++... ++..+++|++..... ...+.+.+|++++++++|+|++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4677889999999999999975 567899999875532 4567788999999999999999999999988999999999
Q ss_pred ccCCchhhhhhccc---cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC
Q 039107 563 MALGTLREHIYNTK---KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 563 ~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 639 (817)
+++++|.+++.... ..+++.++..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999987653 57999999999999999999999765 9999999999999999999999999997643322
Q ss_pred CCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccc
Q 039107 640 NGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719 (817)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (817)
.......|+..|+|||.+....++.++||||+|+++++|++|+.|+......+ ........ .
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~~~-~--------- 219 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE------LALKILKG-Q--------- 219 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH------HHHHHhcC-C---------
Confidence 22334468889999999998899999999999999999999999986543211 11111110 0
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 720 KDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 720 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
....+......+.+++.+||..+|++||++.+++++
T Consensus 220 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 220 YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111122345668999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=298.79 Aligned_cols=264 Identities=22% Similarity=0.302 Sum_probs=194.6
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC--cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
++|...+.||+|++|.||+|..+ +++.||+|++.... ....+.+.+|++++++++|+||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46788889999999999999975 56889999876442 2334678899999999999999999999999999999999
Q ss_pred eccCCchhhhhhcccc-ccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcC-CceeEEeeeccCccCCCCC
Q 039107 562 YMALGTLREHIYNTKK-ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDE-NWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DFGla~~~~~~~ 639 (817)
|++ ++|.+++..... .+++..+..++.||+.||+|||+++ ++||||||+||++++ ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 996 578777754332 4678888999999999999999765 999999999999985 5679999999997543211
Q ss_pred CCceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchH-HHHHHHhhccCc------h
Q 039107 640 NGHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSL-ADWALHCKRKGI------L 711 (817)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l-~~~~~~~~~~~~------~ 711 (817)
.......++..|+|||.+.+ ..++.++||||||+++|||++|++||......+.... ..+... ..... +
T Consensus 158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 234 (294)
T PLN00009 158 --RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGT-PNEETWPGVTSL 234 (294)
T ss_pred --cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC-CChhhccccccc
Confidence 11123356889999999866 4578999999999999999999999975433221110 000000 00000 0
Q ss_pred hhccC--ccccC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 712 DDIID--PLLKD----KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 712 ~~~~d--~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.+... +.... ...+.....+.+++.+|++.+|++||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 00000 0012234567899999999999999999999975
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=307.57 Aligned_cols=265 Identities=21% Similarity=0.263 Sum_probs=198.0
Q ss_pred hhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecC------
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEG------ 553 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 553 (817)
..++|...+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3467888999999999999999865 6788999997643 233446778899999999999999999988543
Q ss_pred CeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCc
Q 039107 554 NEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSK 633 (817)
Q Consensus 554 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 633 (817)
...++||||+. ++|.+.+... +++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccce
Confidence 35799999996 5888777432 888999999999999999999765 9999999999999999999999999998
Q ss_pred cCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchH---------HHHHHH
Q 039107 634 TGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSL---------ADWALH 704 (817)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l---------~~~~~~ 704 (817)
...... ......++..|+|||.+.+..++.++|||||||++++|++|+.||........... .++...
T Consensus 167 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 167 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred eCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 643221 12234578899999999999999999999999999999999999975432211100 000000
Q ss_pred --------hhccC-----chhhccCcccc----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 705 --------CKRKG-----ILDDIIDPLLK----DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 705 --------~~~~~-----~~~~~~d~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
..... ...++...... ..........+.+++.+||+.||++|||+.|++++--
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~ 313 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPY 313 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChh
Confidence 00000 00111111000 0001133556889999999999999999999997643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=299.67 Aligned_cols=254 Identities=24% Similarity=0.363 Sum_probs=193.6
Q ss_pred CCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC-cccHHHHHHHHHHHhccC-ccceeeEEEEEecCCeEEEEEEec
Q 039107 487 FDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLR-HKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 487 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
|...+.||+|+||.||++... ++..+|+|++.... ......+.+|+.++.++. |+||+++++++......+++|||+
T Consensus 6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~ 85 (288)
T cd06616 6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM 85 (288)
T ss_pred hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecc
Confidence 444568999999999999865 46889999987543 234567889999999996 999999999999888999999998
Q ss_pred cCCchhhh---hhcc-ccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC
Q 039107 564 ALGTLREH---IYNT-KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 564 ~~gsL~~~---l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 639 (817)
.. +|.++ +... ...+++..+..++.|++.||+|||+. .+++||||||+||+++.++.+||+|||+++......
T Consensus 86 ~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 86 DI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred cC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 74 54443 3222 34689999999999999999999974 259999999999999999999999999987543221
Q ss_pred CCceeeeeecCcCCCChhhhccC---CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccC
Q 039107 640 NGHVSTVVKGSFGYLDPEYFKRQ---QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIID 716 (817)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (817)
......|+..|+|||.+.+. .++.++|||||||++|||++|+.||..... ..+-....... ..
T Consensus 163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~------~~ 228 (288)
T cd06616 163 ---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVKG------DP 228 (288)
T ss_pred ---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcCC------CC
Confidence 12233578999999998766 689999999999999999999999864321 11111111000 01
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 717 PLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 717 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
+.+........+..+.+++.+||+.+|++|||+.+|+++--
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~ 269 (288)
T cd06616 229 PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPF 269 (288)
T ss_pred CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 11222222335667899999999999999999999997633
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=290.03 Aligned_cols=248 Identities=26% Similarity=0.416 Sum_probs=201.9
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCc--ccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSE--QGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
+|...+.||+|++|.||++... ++..+++|.+..... ...+.+.+|++++++++|+|++++++++......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 3667789999999999999865 567899999876543 4567899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-- 154 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc--
Confidence 9999999998654 56999999999999999999999765 99999999999999999999999999986543222
Q ss_pred eeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCC
Q 039107 643 VSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDK 722 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (817)
......++..|+|||...+..++.++|||+||+++++|++|+.|+....... ..|... . . ....
T Consensus 155 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~----~~~~~~--~-~---------~~~~ 218 (254)
T cd06627 155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA----ALFRIV--Q-D---------DHPP 218 (254)
T ss_pred cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH----HHHHHh--c-c---------CCCC
Confidence 1233467899999999988888999999999999999999999986433211 011110 0 0 0011
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 723 ISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 723 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.+......+.+++.+||..+|++||++.+++.+
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 219 LPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 222335567899999999999999999999853
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=299.33 Aligned_cols=244 Identities=21% Similarity=0.369 Sum_probs=196.8
Q ss_pred eeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccCCchh
Q 039107 491 YVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLR 569 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 569 (817)
.+||+|+||.||++..+ ++..||+|++..........+.+|+.++++++|+|++++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 47999999999999875 57889999987655555677899999999999999999999999999999999999999999
Q ss_pred hhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceeeeeec
Q 039107 570 EHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKG 649 (817)
Q Consensus 570 ~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 649 (817)
+++.. ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++....... .......|
T Consensus 106 ~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~ 178 (292)
T cd06657 106 DIVTH--TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLVG 178 (292)
T ss_pred HHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--cccccccc
Confidence 97743 35899999999999999999999765 9999999999999999999999999987543221 12233568
Q ss_pred CcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCHHHHH
Q 039107 650 SFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLK 729 (817)
Q Consensus 650 t~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 729 (817)
+..|+|||.+.+..++.++|+||||+++|||++|..||......... ..... ...+.+.. ......
T Consensus 179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~---~~~~~---------~~~~~~~~--~~~~~~ 244 (292)
T cd06657 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM---KMIRD---------NLPPKLKN--LHKVSP 244 (292)
T ss_pred CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHh---------hCCcccCC--cccCCH
Confidence 89999999998888999999999999999999999998754322111 11100 00111111 112344
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 730 KFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 730 ~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.+.+++.+||+.+|.+||++.+++++
T Consensus 245 ~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 245 SLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 57889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=295.69 Aligned_cols=243 Identities=26% Similarity=0.342 Sum_probs=194.1
Q ss_pred EeeeCceEEEEEEEec-ccEEEEEecCCCCc---ccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccCCch
Q 039107 493 IGVGGFGKVYKGVIED-KLKVAIKRSNPSSE---QGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTL 568 (817)
Q Consensus 493 lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 568 (817)
||+|+||.||+++... +..+++|.+..... ...+.+.+|++++++++|+||+++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999864 78999999875432 3456788999999999999999999999999999999999999999
Q ss_pred hhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC------Cc
Q 039107 569 REHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN------GH 642 (817)
Q Consensus 569 ~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~------~~ 642 (817)
.+++.+.. .+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++........ ..
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 99986544 6899999999999999999999765 99999999999999999999999999875432211 11
Q ss_pred eeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCC
Q 039107 643 VSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDK 722 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (817)
......++..|++||.......+.++||||||++++||++|+.||......+. ...... +. ..
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~------~~~~~~-~~--------~~-- 219 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI------FQNILN-GK--------IE-- 219 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHhc-CC--------cC--
Confidence 22344578899999999888899999999999999999999999865432211 111110 00 00
Q ss_pred CCHH--HHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 723 ISPE--CLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 723 ~~~~--~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
.+.. ....+.+++.+|++.+|.+|||+.++.+.|
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 220 WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 0111 256689999999999999999995554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=308.28 Aligned_cols=264 Identities=25% Similarity=0.338 Sum_probs=197.4
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecC-----Ce
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEG-----NE 555 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 555 (817)
.++|...+.||+|+||+||+|... ++..||||.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 456888999999999999999864 5688999987653 233345678899999999999999999987643 35
Q ss_pred EEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccC
Q 039107 556 MCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTG 635 (817)
Q Consensus 556 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 635 (817)
.++|+||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++..
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 799999996 6888887543 46999999999999999999999765 999999999999999999999999999864
Q ss_pred CCCCCCceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHH--------Hhh
Q 039107 636 PNMENGHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWAL--------HCK 706 (817)
Q Consensus 636 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~--------~~~ 706 (817)
.... .......++..|+|||.+.. ..++.++|||||||++|||++|++||.............-.. ...
T Consensus 159 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 159 SEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred CCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 3321 12233457889999998865 468899999999999999999999997543221111100000 000
Q ss_pred ccCchhhcc-------CccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 707 RKGILDDII-------DPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 707 ~~~~~~~~~-------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
........+ ++... ...+.++..+.+++.+||+.+|++|||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred CchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 000000000 00000 0112345678999999999999999999999988
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=306.66 Aligned_cols=265 Identities=22% Similarity=0.311 Sum_probs=194.6
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecC------C
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEG------N 554 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 554 (817)
..+|...+.||+|+||.||+|+.. ++..||+|++... .......+.+|+.++++++|+||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 368888999999999999999964 5789999987643 223345688999999999999999999998654 3
Q ss_pred eEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 555 EMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 555 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
..++|+||+.. +|.+++ ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 94 ~~~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred eEEEEeccccc-CHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 46999999974 666654 235889999999999999999999765 99999999999999999999999999876
Q ss_pred CCCCCCCceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHh--------
Q 039107 635 GPNMENGHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHC-------- 705 (817)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~-------- 705 (817)
.... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..................
T Consensus 167 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 167 ADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241 (342)
T ss_pred CCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 4221 123457889999999876 46899999999999999999999999765432211110000000
Q ss_pred hccCchhhccC--cc-ccCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHhH
Q 039107 706 KRKGILDDIID--PL-LKDKI---SPECLKKFADTAEKCLSDSGIDRPSMGDVLWN--LEFVL 760 (817)
Q Consensus 706 ~~~~~~~~~~d--~~-l~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~ 760 (817)
........... +. ..... .+.....+.+++.+||+.||.+||++.+++.+ ++...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 00000000000 00 00000 01233567899999999999999999999976 54443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=292.11 Aligned_cols=247 Identities=28% Similarity=0.443 Sum_probs=201.6
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
+|+..++||+|+||.||+++.+ ++..+++|.+... ......++.+|++++++++|+||+++++++......++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4677889999999999999854 5678999987753 233456788999999999999999999999988999999999
Q ss_pred ccCCchhhhhhcc---ccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC
Q 039107 563 MALGTLREHIYNT---KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 563 ~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 639 (817)
+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999988652 246899999999999999999999765 999999999999999999999999999865432
Q ss_pred CCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccc
Q 039107 640 NGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719 (817)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (817)
......++..|++||.+.+..++.++|+||||++++||++|+.||....... +.... ... .
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~~~----~~~---------~ 217 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD---LRYKV----QRG---------K 217 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH----hcC---------C
Confidence 1223457889999999999999999999999999999999999987543221 11110 001 1
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 720 KDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 720 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
....+......+.+++.+|++.+|++||++.+++++
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 218 YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 112233456678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=295.52 Aligned_cols=244 Identities=25% Similarity=0.378 Sum_probs=192.5
Q ss_pred EeeeCceEEEEEEEe-cccEEEEEecCCCC---cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccCCch
Q 039107 493 IGVGGFGKVYKGVIE-DKLKVAIKRSNPSS---EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTL 568 (817)
Q Consensus 493 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 568 (817)
||+|+||+||++..+ ++..+++|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999855 56789999876432 22345677899999999999999999999999999999999999999
Q ss_pred hhhhhcccc-ccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceeeee
Q 039107 569 REHIYNTKK-ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVV 647 (817)
Q Consensus 569 ~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 647 (817)
.+++..... .+++.+++.++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++..... .......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccc
Confidence 999876543 6899999999999999999999765 99999999999999999999999999875432 1122234
Q ss_pred ecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCHHH
Q 039107 648 KGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPEC 727 (817)
Q Consensus 648 ~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 727 (817)
.++..|+|||.+.++.++.++||||||+++++|++|+.||.......... .. .. .... .....+...
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~-~~----~~~~------~~~~~~~~~ 221 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE--EL-KR----RTLE------MAVEYPDKF 221 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH--HH-Hh----cccc------ccccCCccC
Confidence 57889999999988889999999999999999999999996543311110 00 00 0000 011122233
Q ss_pred HHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 039107 728 LKKFADTAEKCLSDSGIDRP-----SMGDVLWN 755 (817)
Q Consensus 728 ~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 755 (817)
...+.+++.+||+.+|.+|| ++.+++++
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 55678999999999999999 66667654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=320.79 Aligned_cols=270 Identities=20% Similarity=0.216 Sum_probs=188.7
Q ss_pred hhcCCCcceeEeeeCceEEEEEEEecc--cEEEEE------------------ecCCCCcccHHHHHHHHHHHhccCccc
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVIEDK--LKVAIK------------------RSNPSSEQGVNEFVTEIEMLSKLRHKH 542 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~~~~--~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~H~n 542 (817)
...+|...+.||+|+||+||++.++.. ...++| .+. ........+.+|+.+|++++|+|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 356899999999999999999876432 112222 111 11223456889999999999999
Q ss_pred eeeEEEEEecCCeEEEEEEeccCCchhhhhhccc----cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEE
Q 039107 543 LVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTK----KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILL 618 (817)
Q Consensus 543 iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll 618 (817)
|+++++++...+..++|+|++. ++|.+++.... ......++..|+.||+.||+|||+++ ||||||||+||||
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9999999999999999999986 56766664321 12345667789999999999999765 9999999999999
Q ss_pred cCCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCC-CCCccccch
Q 039107 619 DENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALN-PSLPKEQVS 697 (817)
Q Consensus 619 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~-~~~~~~~~~ 697 (817)
+.++.+||+|||+++...... ........||..|+|||++.+..++.++|||||||+||||++|..++. .........
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 999999999999998643321 112234569999999999999999999999999999999999885443 222221111
Q ss_pred HHHHHHHhh--ccC------chhhccCcc-c---cCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 698 LADWALHCK--RKG------ILDDIIDPL-L---KDKIS-----PECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 698 l~~~~~~~~--~~~------~~~~~~d~~-l---~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
+.+...... .+. .+.+.++.. . ...+. ......+.+++.+||+.||.+|||+.|++++-.+
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f 457 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF 457 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence 211111000 000 000000000 0 00000 0122356788999999999999999999987443
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=295.21 Aligned_cols=260 Identities=23% Similarity=0.306 Sum_probs=194.6
Q ss_pred CCcceeEeeeCceEEEEEEEec-ccEEEEEecCCCCc--ccHHHHHHHHHHHhcc---CccceeeEEEEEecCCe-----
Q 039107 487 FDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPSSE--QGVNEFVTEIEMLSKL---RHKHLVSLIGFCEEGNE----- 555 (817)
Q Consensus 487 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~----- 555 (817)
|++.+.||+|+||.||+|+.+. +..+|+|++..... .....+.+|+.+++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 4567899999999999999864 78999999874322 2234566788877666 59999999999987776
Q ss_pred EEEEEEeccCCchhhhhhcccc-ccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 556 MCLVYDYMALGTLREHIYNTKK-ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 556 ~~lV~Ey~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
.+++|||+. ++|.+++..... .+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCccee
Confidence 899999997 488888865433 6899999999999999999999765 99999999999999999999999999876
Q ss_pred CCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCch---
Q 039107 635 GPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGIL--- 711 (817)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~--- 711 (817)
..... ......++..|+|||.+.+..++.++|+||||++++||++|++||......+.. ..+..........
T Consensus 157 ~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 157 YSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQL--DKIFDVIGLPSEEEWP 231 (287)
T ss_pred ccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHH--HHHHHHcCCCChHhcC
Confidence 43321 112234788999999999999999999999999999999999998764432211 1111110000000
Q ss_pred ------hhccCcccc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 712 ------DDIIDPLLK---DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 712 ------~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
......... ....++....+.+++.+||+.||.+||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 000000000 11112345677899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=286.00 Aligned_cols=249 Identities=26% Similarity=0.350 Sum_probs=203.9
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC---cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS---EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
++|...++||+|.||+|-+++.+ .++.+|+|++++.- +.....-+.|-++|+..+||.+..|.-.++..+.+|+||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 46777889999999999999865 56789999988652 334455678999999999999999998899999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
||+.||.|.-+|.+. +.+++....-.-..|+.||.|||+++ ||.||||.+|.|||.+|.+||+||||++.. ...
T Consensus 248 eyanGGeLf~HLsre-r~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~--I~~ 321 (516)
T KOG0690|consen 248 EYANGGELFFHLSRE-RVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE--IKY 321 (516)
T ss_pred EEccCceEeeehhhh-hcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc--ccc
Confidence 999999999998654 45888888888999999999999876 999999999999999999999999999863 334
Q ss_pred CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
+......+||+.|+|||++....|..+.|.|.+|||+|||+|||.||....... +-+.+.. -|-+
T Consensus 322 g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k---LFeLIl~----------ed~k-- 386 (516)
T KOG0690|consen 322 GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK---LFELILM----------EDLK-- 386 (516)
T ss_pred cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH---HHHHHHh----------hhcc--
Confidence 556677899999999999999999999999999999999999999997654322 2111111 0112
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRP-----SMGDVLWNL 756 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 756 (817)
++.....+...|+...|.+||.+|. .+.||.++-
T Consensus 387 --FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~ 425 (516)
T KOG0690|consen 387 --FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHR 425 (516)
T ss_pred --CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhh
Confidence 2334445568899999999999994 367777653
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=307.93 Aligned_cols=271 Identities=21% Similarity=0.281 Sum_probs=200.8
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC--cccHHHHHHHHHHHhccCccceeeEEEEEec----CCeE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE----GNEM 556 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~ 556 (817)
..+|...+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.+|++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367888889999999999999865 57899999987542 2345677889999999999999999998753 3568
Q ss_pred EEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCC
Q 039107 557 CLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGP 636 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 636 (817)
++||||+. ++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 99999996 6898888644 35999999999999999999999765 9999999999999999999999999987543
Q ss_pred CCCCC--ceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHH--------h
Q 039107 637 NMENG--HVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALH--------C 705 (817)
Q Consensus 637 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~--------~ 705 (817)
..... .......|+..|+|||.+.. ..++.++||||||+++|||++|+.||.............-... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~ 238 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence 22211 11223468899999999865 4688999999999999999999999976543222111100000 0
Q ss_pred hccCchhhccCc---ccc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 706 KRKGILDDIIDP---LLK---DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 706 ~~~~~~~~~~d~---~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
.....+....+. ... ....+..+..+.+++.+||+.+|++||++.+++.+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~ 298 (334)
T cd07855 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA 298 (334)
T ss_pred hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhh
Confidence 000000000000 000 001123456789999999999999999999999875543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=297.15 Aligned_cols=256 Identities=18% Similarity=0.194 Sum_probs=183.3
Q ss_pred hcCCCcceeEeeeCceEEEEEEEecc----cEEEEEecCCCCcccH-----------HHHHHHHHHHhccCccceeeEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIEDK----LKVAIKRSNPSSEQGV-----------NEFVTEIEMLSKLRHKHLVSLIG 548 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~~----~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~H~niv~l~g 548 (817)
.++|...++||+|+||+||+|...+. ..+++|.......... .....++..+..+.|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 35788899999999999999997543 4566665433322111 11223444566778999999999
Q ss_pred EEecCC----eEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCcee
Q 039107 549 FCEEGN----EMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVA 624 (817)
Q Consensus 549 ~~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~ 624 (817)
++.... ..++++|++. .++.+.+... ...++..+..|+.|++.||+|||+.+ |+||||||+|||++.++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcE
Confidence 765443 3466777664 3555554332 23678888999999999999999765 9999999999999999999
Q ss_pred EEeeeccCccCCCCCC-----CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccc-h-
Q 039107 625 KVSDFGLSKTGPNMEN-----GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQV-S- 697 (817)
Q Consensus 625 kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~-~- 697 (817)
+|+|||+++....... ........||+.|+|||++.+..++.++|||||||+|+||++|+.||......... .
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 9999999976432111 11122346999999999999999999999999999999999999999765322211 1
Q ss_pred -HHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 698 -LADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 698 -l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
..++.. .+..+.+. ...++..+.+++..|+..+|++||++.++++.|
T Consensus 246 ~~~~~~~---------~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 246 AKCDFIK---------RLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred hHHHHHH---------Hhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 111111 11111111 123356789999999999999999999999876
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=305.80 Aligned_cols=246 Identities=26% Similarity=0.344 Sum_probs=205.9
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC--cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
...|.+...||+|.|++|.+|++. .+..||||.+.+.. ....+.+.+|+++|+.|+|||||+++.+.+....+++||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 456788889999999999999965 56899999988753 233355889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
||+.+|.++++|.+... +.......++.|+.+|++|||+++ |||||||++||||+.+.++||+|||++..+. .
T Consensus 135 eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~---~ 207 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD---Y 207 (596)
T ss_pred EeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec---c
Confidence 99999999999987655 555889999999999999999776 9999999999999999999999999998753 4
Q ss_pred CceeeeeecCcCCCChhhhccCCC-CchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQL-TEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (817)
.......+|++.|.|||++.+..| .++.|+||+|++||-|++|..||++..-.+ +-++.+
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~-------------------Lr~rvl 268 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE-------------------LRPRVL 268 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc-------------------ccchhe
Confidence 455667889999999999998776 578999999999999999999998654221 111112
Q ss_pred cCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 720 KDK--ISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 720 ~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.+. ++.-...++.++++++|-++|.+|++++++.++
T Consensus 269 ~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 269 RGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred eeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 211 222234456889999999999999999999876
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=301.80 Aligned_cols=264 Identities=21% Similarity=0.313 Sum_probs=195.3
Q ss_pred eEeee--CceEEEEEEEe-cccEEEEEecCCCC--cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccCC
Q 039107 492 VIGVG--GFGKVYKGVIE-DKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALG 566 (817)
Q Consensus 492 ~lG~G--~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 566 (817)
.||+| +||+||++... .+..||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 99999999864 67899999977532 233567889999999999999999999999999999999999999
Q ss_pred chhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc---
Q 039107 567 TLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH--- 642 (817)
Q Consensus 567 sL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~--- 642 (817)
+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++||+.+..........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 9999886543 35899999999999999999999765 9999999999999999999999998654321111100
Q ss_pred --eeeeeecCcCCCChhhhccC--CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHH--------------
Q 039107 643 --VSTVVKGSFGYLDPEYFKRQ--QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALH-------------- 704 (817)
Q Consensus 643 --~~~~~~gt~~y~aPE~~~~~--~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~-------------- 704 (817)
......++..|+|||++.+. .++.++|||||||+++||++|+.||......... ......
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML--LQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH--HHHhcCCCCCCccccccchh
Confidence 01112346679999998763 4789999999999999999999999754322110 000000
Q ss_pred ------------------hhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 039107 705 ------------------CKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVL 760 (817)
Q Consensus 705 ------------------~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 760 (817)
.........+.+..+.......+...+.+++.+||..||++|||+.+++++--...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~ 313 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ 313 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence 00000000111111222223456778999999999999999999999997755433
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=299.27 Aligned_cols=244 Identities=28% Similarity=0.427 Sum_probs=193.7
Q ss_pred CCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCc---ccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 487 FDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSE---QGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 487 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
|...+.||+|+||+||+|+.. ++..|++|++..... ...+.+.+|++++++++|+|++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 445567999999999999864 567899998764322 3345788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
+. |+|.+++......+++.+++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----- 173 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP----- 173 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence 96 5787877665667999999999999999999999765 99999999999999999999999999864221
Q ss_pred eeeeeecCcCCCChhhhc---cCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccc
Q 039107 643 VSTVVKGSFGYLDPEYFK---RQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (817)
.....|+..|+|||++. .+.++.++|||||||++|||++|++|+......... ....... . +..
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~------~~~~~~~-~-----~~~ 240 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQND-S-----PTL 240 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHHhcC-C-----CCC
Confidence 12345888999999974 466889999999999999999999998654322111 1111000 0 001
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 720 KDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 720 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
........+.+++.+||+.+|.+||++.+++.+
T Consensus 241 ---~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 241 ---QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 112233457899999999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=298.79 Aligned_cols=254 Identities=20% Similarity=0.330 Sum_probs=194.6
Q ss_pred cCCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCCC-cccHHHHHHHHHHHhccC-ccceeeEEEEEecCCeEEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLR-HKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 561 (817)
++|...+.||+|+||.||+|..++ +..||||.+.... .....++..|+.++.++. |+||++++++|......++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 456778899999999999999875 7889999987543 233456777888777775 9999999999999999999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
|+. ++|.+++......+++..+..++.|++.||+|||+. ++|+||||+|+||++++++.+||+|||++.......
T Consensus 95 ~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~-- 169 (296)
T cd06618 95 LMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK-- 169 (296)
T ss_pred ccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCC--
Confidence 986 477777655455799999999999999999999973 259999999999999999999999999987543211
Q ss_pred ceeeeeecCcCCCChhhhccCC----CCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCc
Q 039107 642 HVSTVVKGSFGYLDPEYFKRQQ----LTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~----~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (817)
......++..|+|||.+.+.. ++.++||||||+++|||++|+.||....... ...... .... . +
T Consensus 170 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~---~~~~-~-----~ 237 (296)
T cd06618 170 -AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF--EVLTKI---LQEE-P-----P 237 (296)
T ss_pred -cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH--HHHHHH---hcCC-C-----C
Confidence 112234788999999987553 7889999999999999999999986432111 111000 0000 0 0
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 718 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
... ....+..++.+++.+||+.+|.+||++.+++++.-
T Consensus 238 ~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 238 SLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred CCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 000 01123456899999999999999999999997754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=290.59 Aligned_cols=248 Identities=19% Similarity=0.212 Sum_probs=190.3
Q ss_pred HHHhhcCCCcceeE--eeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhcc-CccceeeEEEEEecCCe
Q 039107 480 IKHATKSFDESYVI--GVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNE 555 (817)
Q Consensus 480 l~~~~~~f~~~~~l--G~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 555 (817)
+....++|...+.+ |+|+||.||++..+ ++..+|+|......... .|+.....+ +|+||+++++++...+.
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 33344555555555 99999999999865 56778999876432211 122222223 69999999999999999
Q ss_pred EEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCc-eeEEeeeccCcc
Q 039107 556 MCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENW-VAKVSDFGLSKT 634 (817)
Q Consensus 556 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DFGla~~ 634 (817)
.++||||+++++|.+++.... .+++.++..++.|+++||.|||+.+ ++||||||+||+++.++ .++|+|||+++.
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~ 159 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKI 159 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCcccee
Confidence 999999999999999986543 7999999999999999999999765 99999999999999998 999999999875
Q ss_pred CCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhc
Q 039107 635 GPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDI 714 (817)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 714 (817)
.... ....++..|+|||++.+..++.++||||||++++||++|+.||..... +......|......
T Consensus 160 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~------- 225 (267)
T PHA03390 160 IGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED-EELDLESLLKRQQK------- 225 (267)
T ss_pred cCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc-chhhHHHHHHhhcc-------
Confidence 4221 123578999999999998999999999999999999999999974432 22222223222100
Q ss_pred cCccccCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 039107 715 IDPLLKDKISPECLKKFADTAEKCLSDSGIDRPS-MGDVLWN 755 (817)
Q Consensus 715 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~~ 755 (817)
. ..........+.+++.+||+.+|.+||+ +++++++
T Consensus 226 ---~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 226 ---K--LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred ---c--CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 0 0111234566899999999999999996 6998864
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=306.00 Aligned_cols=275 Identities=22% Similarity=0.290 Sum_probs=203.7
Q ss_pred ccccCHHHHHHhhcCCCcceeEeeeCceEEEEEEE-ecccEEEEEecCCCC--cccHHHHHHHHHHHhccCccceeeEEE
Q 039107 472 CRRFSLAEIKHATKSFDESYVIGVGGFGKVYKGVI-EDKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHLVSLIG 548 (817)
Q Consensus 472 ~~~f~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g 548 (817)
.+.....++..++.+|...+.||+|+||.||+|.. .++..||+|++.... ....+.+.+|++++++++|+||+++++
T Consensus 4 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~ 83 (345)
T cd07877 4 YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 83 (345)
T ss_pred chhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceee
Confidence 35566778888999999999999999999999985 467889999987532 223467889999999999999999999
Q ss_pred EEecC------CeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCc
Q 039107 549 FCEEG------NEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENW 622 (817)
Q Consensus 549 ~~~~~------~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~ 622 (817)
++... ...+++++++ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++
T Consensus 84 ~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 84 VFTPARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDC 157 (345)
T ss_pred eeeecccccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCC
Confidence 88533 3467888876 6789887743 35899999999999999999999766 99999999999999999
Q ss_pred eeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHH
Q 039107 623 VAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADW 701 (817)
Q Consensus 623 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~ 701 (817)
.+||+|||+++.... ......++..|+|||.+.+ ..++.++|||||||+++||++|+.||..............
T Consensus 158 ~~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 232 (345)
T cd07877 158 ELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 232 (345)
T ss_pred CEEEecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999999875322 1223467889999999866 5688999999999999999999999865432221110000
Q ss_pred HHHhhccCchhhc-----------cCccccCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 702 ALHCKRKGILDDI-----------IDPLLKDKI---SPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 702 ~~~~~~~~~~~~~-----------~d~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
............+ +.......+ .......+.+++.+|++.+|.+||++.+++.+--
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 302 (345)
T cd07877 233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 302 (345)
T ss_pred HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChh
Confidence 0000000000000 000000000 0012456789999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=300.25 Aligned_cols=250 Identities=29% Similarity=0.399 Sum_probs=197.1
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
.|...+.||+|+||.||+|+.. ++..+++|.+... .....+++.+|+++++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3556678999999999999965 4578999987642 22334678899999999999999999999999999999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
|+. |+|.+.+......+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---- 167 (308)
T cd06634 96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (308)
T ss_pred ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC----
Confidence 997 6888877655567899999999999999999999765 99999999999999999999999999875322
Q ss_pred ceeeeeecCcCCCChhhhc---cCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcc
Q 039107 642 HVSTVVKGSFGYLDPEYFK---RQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPL 718 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (817)
.....++..|+|||.+. .+.++.++|||||||++|||++|+.|+......+. ........ . +.
T Consensus 168 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~-~-----~~ 233 (308)
T cd06634 168 --ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQNE-S-----PA 233 (308)
T ss_pred --cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH------HHHHhhcC-C-----CC
Confidence 12345788999999974 35678899999999999999999999865322111 11111100 0 11
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 039107 719 LKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVL 760 (817)
Q Consensus 719 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 760 (817)
. ........+.+++.+||+.+|.+||++.+++++.....
T Consensus 234 ~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 234 L---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred c---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 1 11234566889999999999999999999998765544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=323.52 Aligned_cols=258 Identities=26% Similarity=0.467 Sum_probs=207.1
Q ss_pred cCCCcceeEeeeCceEEEEEEEec--------ccEEEEEecCCC-CcccHHHHHHHHHHHhcc-CccceeeEEEEEecCC
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIED--------KLKVAIKRSNPS-SEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGN 554 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 554 (817)
+++...+.||+|.||.|++|...+ ...||||.++.. ...+.+.+..|+++|+.+ +|+||+.++|+|....
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 334455599999999999998541 356999998865 335668899999999999 6999999999999999
Q ss_pred eEEEEEEeccCCchhhhhhccc---------------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEc
Q 039107 555 EMCLVYDYMALGTLREHIYNTK---------------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLD 619 (817)
Q Consensus 555 ~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~ 619 (817)
..++|+||+..|+|.++|...+ ..|+....+.++.|||.|++||++.. +|||||.++|||+.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLIT 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEec
Confidence 9999999999999999998766 34899999999999999999999765 99999999999999
Q ss_pred CCceeEEeeeccCccCCCCCCCceeeeee--cCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccc
Q 039107 620 ENWVAKVSDFGLSKTGPNMENGHVSTVVK--GSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQV 696 (817)
Q Consensus 620 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~ 696 (817)
++..+||+|||+++........... ... -...|||||.+....|+.++|||||||+||||++ |..|+.+-... .
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~--~ 529 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT--E 529 (609)
T ss_pred CCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH--H
Confidence 9999999999999965443332211 111 2457999999999999999999999999999998 56666542111 1
Q ss_pred hHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 039107 697 SLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQ 761 (817)
Q Consensus 697 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 761 (817)
.+.++... | .+.+.+..|..++.++++.||+.+|++||+..++++.|+..++
T Consensus 530 ~l~~~l~~----G---------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 530 ELLEFLKE----G---------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred HHHHHHhc----C---------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 22222222 2 1122345677889999999999999999999999999999643
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=304.10 Aligned_cols=265 Identities=25% Similarity=0.329 Sum_probs=201.8
Q ss_pred CCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCCC--cccHHHHHHHHHHHhccCccceeeEEEEEecCC-----eEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGN-----EMC 557 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 557 (817)
+|...+.||+|++|.||+|+... +..+++|++.... ....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 46778899999999999999754 7889999887643 334567899999999999999999999987765 789
Q ss_pred EEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCC
Q 039107 558 LVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPN 637 (817)
Q Consensus 558 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 637 (817)
+||||++ ++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||.|||+++++.++|+|||++.....
T Consensus 81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 9999998 58888886543 7999999999999999999999766 99999999999999999999999999986543
Q ss_pred CCCC-ceeeeeecCcCCCChhhhccC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhcc-------
Q 039107 638 MENG-HVSTVVKGSFGYLDPEYFKRQ-QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRK------- 708 (817)
Q Consensus 638 ~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~------- 708 (817)
.... .......++..|+|||.+.+. .++.++|+||||+++++|++|++||......+.... .......
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~~ 232 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNL---IVEVLGTPSEEDLK 232 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHH---HHHhcCCCChhHhh
Confidence 3210 112334578899999999887 889999999999999999999999976543221111 0000000
Q ss_pred ----CchhhccC---ccc---cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 709 ----GILDDIID---PLL---KDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 709 ----~~~~~~~d---~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
......+. ... .....+.....+.+++.+||+.+|.+||++.+++++-..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~ 292 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYL 292 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccH
Confidence 00000000 000 000112235668999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=299.76 Aligned_cols=267 Identities=26% Similarity=0.304 Sum_probs=195.6
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC--cccHHHHHHHHHHHhccCccceeeEEEEEecC-------
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEG------- 553 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------- 553 (817)
.++|...++||+|+||.||+|..+ ++..+++|++.... ......+.+|++++++++|+||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 467888999999999999999965 56889999875432 22234678899999999999999999987443
Q ss_pred -CeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccC
Q 039107 554 -NEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLS 632 (817)
Q Consensus 554 -~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla 632 (817)
...++|+||+.. +|...+......+++.++..++.|+++||+|||+.+ |+|+||||+||++++++.+||+|||++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccc
Confidence 346999999975 677777655557999999999999999999999765 999999999999999999999999999
Q ss_pred ccCCCCCCC---------ceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHH
Q 039107 633 KTGPNMENG---------HVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWA 702 (817)
Q Consensus 633 ~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~ 702 (817)
+........ ...+...++..|+|||.+.+ ..++.++||||||+++|||++|++||...............
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~ 242 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 754322111 11233467888999998765 45789999999999999999999999765443222111110
Q ss_pred HHhhccC------chhhcc--------CccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 703 LHCKRKG------ILDDII--------DPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 703 ~~~~~~~------~~~~~~--------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
....... .+.... .+.+... .......+.+++.+||+.+|.+|||+.+++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEER-FGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHHH-cccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 0000000 000000 0000000 01123568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=307.50 Aligned_cols=270 Identities=26% Similarity=0.376 Sum_probs=203.0
Q ss_pred CCcceeEeeeCceEEEEEEE-ecccEEEEEecCCC-CcccHHHHHHHHHHHhccCccceeeEEEEEecC------CeEEE
Q 039107 487 FDESYVIGVGGFGKVYKGVI-EDKLKVAIKRSNPS-SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEG------NEMCL 558 (817)
Q Consensus 487 f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~l 558 (817)
+...+.||+|+||.||+|+. +.|..||||.+... .....+...+|+++|++|+|+|||++++.=+.. ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 34455899999999999995 57899999998764 344457788999999999999999999976543 35789
Q ss_pred EEEeccCCchhhhhhcccc--ccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEc--C--CceeEEeeeccC
Q 039107 559 VYDYMALGTLREHIYNTKK--ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLD--E--NWVAKVSDFGLS 632 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~--~--~~~~kl~DFGla 632 (817)
|||||.+|||+..|.+..+ .|++.+.+.++.+++.||.|||+++ ||||||||.||++- + .-.-||+|||+|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999987654 7999999999999999999999665 99999999999993 3 335699999999
Q ss_pred ccCCCCCCCceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCch
Q 039107 633 KTGPNMENGHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGIL 711 (817)
Q Consensus 633 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 711 (817)
+.... +...+.+.||..|++||++.. +.|+..+|.|||||++||+.||..||..........-..|.........+
T Consensus 172 rel~d---~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v 248 (732)
T KOG4250|consen 172 RELDD---NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV 248 (732)
T ss_pred ccCCC---CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence 97543 346778899999999999984 88999999999999999999999999765443221122233222221111
Q ss_pred hhccCcccc------------CCCCHHHHHHHHHHHHHccccCCCCCC--CHHHHHHHHHHhHhh
Q 039107 712 DDIIDPLLK------------DKISPECLKKFADTAEKCLSDSGIDRP--SMGDVLWNLEFVLQL 762 (817)
Q Consensus 712 ~~~~d~~l~------------~~~~~~~~~~l~~li~~cl~~dP~~RP--t~~evl~~L~~~~~~ 762 (817)
.-...+... ..........+-..+..+|.-+|.+|. ...+....+..++..
T Consensus 249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 111111111 112234445566777778888888888 555666555555544
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=298.52 Aligned_cols=261 Identities=21% Similarity=0.236 Sum_probs=192.4
Q ss_pred eEeeeCceEEEEEEEecccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccCCchh
Q 039107 492 VIGVGGFGKVYKGVIEDKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLR 569 (817)
Q Consensus 492 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 569 (817)
.+|.|+++.||++.. ++..||+|++... .....+.+.+|++++++++|+||+++++++...+..+++|||+++|+|.
T Consensus 9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 87 (314)
T cd08216 9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87 (314)
T ss_pred hhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHH
Confidence 445555655666554 5678999997654 3445678999999999999999999999999999999999999999999
Q ss_pred hhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC-----Cce
Q 039107 570 EHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN-----GHV 643 (817)
Q Consensus 570 ~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~-----~~~ 643 (817)
+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||.+........ ...
T Consensus 88 ~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~ 164 (314)
T cd08216 88 DLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF 164 (314)
T ss_pred HHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccccc
Confidence 9987543 36889999999999999999999765 99999999999999999999999998864322111 111
Q ss_pred eeeeecCcCCCChhhhcc--CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhh----c-------cCc
Q 039107 644 STVVKGSFGYLDPEYFKR--QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCK----R-------KGI 710 (817)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~--~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~----~-------~~~ 710 (817)
.....++..|+|||.+.. ..++.++|||||||++|||++|+.||........ +.+-..... . ...
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 242 (314)
T cd08216 165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPLYEDS 242 (314)
T ss_pred cccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhhhcCC
Confidence 233457788999999875 3588999999999999999999999975432211 110000000 0 000
Q ss_pred hhh----ccCcc----ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 711 LDD----IIDPL----LKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 711 ~~~----~~d~~----l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
..+ ..++. ............+.+++.+||..+|++|||+++++++-..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~ 298 (314)
T cd08216 243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFF 298 (314)
T ss_pred cCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchH
Confidence 000 00000 0111123445678999999999999999999999987554
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=277.31 Aligned_cols=248 Identities=21% Similarity=0.347 Sum_probs=197.5
Q ss_pred ceeEeeeCceEEEEEEEec-ccEEEEEecCCC-CcccHHHHHHHHHHHhccC-ccceeeEEEEEecCCeEEEEEEeccCC
Q 039107 490 SYVIGVGGFGKVYKGVIED-KLKVAIKRSNPS-SEQGVNEFVTEIEMLSKLR-HKHLVSLIGFCEEGNEMCLVYDYMALG 566 (817)
Q Consensus 490 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~g 566 (817)
...||.|..|.|++++.+. +..+|||.+... +....++++..+.++.+-+ .|.||+.+|||......++.||.|. .
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~ 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-T 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-H
Confidence 3379999999999999764 678999998765 4555677888888877664 8999999999999999999999986 4
Q ss_pred chhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceeee
Q 039107 567 TLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTV 646 (817)
Q Consensus 567 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 646 (817)
.++.+|.+..+++++..+-++...++.||.||.++ ++|+|||+||+|||+|+.|++||||||++..+.+ ....+.
T Consensus 176 C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd---SkAhtr 250 (391)
T KOG0983|consen 176 CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD---SKAHTR 250 (391)
T ss_pred HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeec---cccccc
Confidence 66777777777899988899999999999999984 5899999999999999999999999999976433 233455
Q ss_pred eecCcCCCChhhhc---cCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCC
Q 039107 647 VKGSFGYLDPEYFK---RQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKI 723 (817)
Q Consensus 647 ~~gt~~y~aPE~~~---~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 723 (817)
..|-+.|||||.+. ...|+.++||||||+.|+||.||+.|+.+-..+- ..+.. +. .. .-|.+.+.
T Consensus 251 sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF-e~ltk-vl--n~-------ePP~L~~~- 318 (391)
T KOG0983|consen 251 SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF-EVLTK-VL--NE-------EPPLLPGH- 318 (391)
T ss_pred ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH-HHHHH-HH--hc-------CCCCCCcc-
Confidence 67999999999985 3478999999999999999999999997643221 11110 00 01 11333332
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 724 SPECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 724 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
..++..+++++..||.+|+.+||...++++|-
T Consensus 319 -~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~ 350 (391)
T KOG0983|consen 319 -MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHP 350 (391)
T ss_pred -cCcCHHHHHHHHHHhhcCcccCcchHHHhcCc
Confidence 22667789999999999999999999999763
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=293.58 Aligned_cols=262 Identities=25% Similarity=0.329 Sum_probs=195.5
Q ss_pred CCcceeEeeeCceEEEEEEEec-ccEEEEEecCCCCc-ccHHHHHHHHHHHhccC-ccceeeEEEEEecCCeEEEEEEec
Q 039107 487 FDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPSSE-QGVNEFVTEIEMLSKLR-HKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 487 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
|...+.||+|++|+||+|...+ +..|++|++..... .......+|+..+++++ |+||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 4567789999999999999764 67899998765422 22234567999999998 999999999999999999999999
Q ss_pred cCCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 564 ALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 564 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
+|+|.+++.... ..+++.+++.++.|++.+|.|||+++ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--- 153 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--- 153 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC---
Confidence 789998887654 46899999999999999999999765 9999999999999999999999999997643221
Q ss_pred eeeeeecCcCCCChhhhc-cCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHH----------HHHHHhhccCch
Q 039107 643 VSTVVKGSFGYLDPEYFK-RQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLA----------DWALHCKRKGIL 711 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~-~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~----------~~~~~~~~~~~~ 711 (817)
......++..|+|||.+. ...++.++|+||||++++||++|++||......+..... .|..........
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 122345788999999875 456789999999999999999999998655432221100 011110000000
Q ss_pred hhccCcccc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 712 DDIIDPLLK---DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 712 ~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
...+..... ....+.....+.+++++|++.+|++|||++|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000000 00001124568999999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=288.85 Aligned_cols=239 Identities=24% Similarity=0.304 Sum_probs=185.2
Q ss_pred eeEeeeCceEEEEEEEe-cccEEEEEecCCCC---cccHHHHHHHHHHH-hccCccceeeEEEEEecCCeEEEEEEeccC
Q 039107 491 YVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS---EQGVNEFVTEIEML-SKLRHKHLVSLIGFCEEGNEMCLVYDYMAL 565 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 565 (817)
+.||+|+||.||+|... ++..||+|.+.... ......+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 36899999999999864 56889999986542 12223445555544 445899999999999999999999999999
Q ss_pred CchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceee
Q 039107 566 GTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVST 645 (817)
Q Consensus 566 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 645 (817)
++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++.... ..
T Consensus 82 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~ 151 (260)
T cd05611 82 GDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NK 151 (260)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------cc
Confidence 9999988643 45899999999999999999999765 99999999999999999999999999875322 22
Q ss_pred eeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCH
Q 039107 646 VVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISP 725 (817)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 725 (817)
...++..|+|||.+.+..++.++||||||++++||++|..||........ +... ..... ........
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~~~~--~~~~~------~~~~~~~~ 218 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV-----FDNI--LSRRI------NWPEEVKE 218 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH-----HHHH--Hhccc------CCCCcccc
Confidence 34578899999999888899999999999999999999999965432211 1000 00000 00111122
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHH
Q 039107 726 ECLKKFADTAEKCLSDSGIDRPSMGDV 752 (817)
Q Consensus 726 ~~~~~l~~li~~cl~~dP~~RPt~~ev 752 (817)
.++..+.+++.+||+.+|++||++.++
T Consensus 219 ~~~~~~~~~i~~~l~~~p~~R~~~~~~ 245 (260)
T cd05611 219 FCSPEAVDLINRLLCMDPAKRLGANGY 245 (260)
T ss_pred cCCHHHHHHHHHHccCCHHHccCCCcH
Confidence 345678999999999999999976543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=291.74 Aligned_cols=254 Identities=25% Similarity=0.341 Sum_probs=205.1
Q ss_pred hhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEE
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCL 558 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 558 (817)
..+.|..-++||+||||.||-++.+ .|..+|.|++.+. .+++..-.++|-.+|++++.+.||.+--.++.++.+||
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 3456889999999999999999866 4677888876543 34455667899999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhcccc-ccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCC
Q 039107 559 VYDYMALGTLREHIYNTKK-ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPN 637 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 637 (817)
|+..|.||+|.-||.+.+. .+++..++-.+.+|+-||++||.+. ||.|||||+|||||+.|+++|+|+|||.....
T Consensus 263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 9999999999999987664 6999999999999999999999776 99999999999999999999999999986543
Q ss_pred CCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCc
Q 039107 638 MENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717 (817)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (817)
. ...+...||.+|||||+++++.|+...|.|||||+||||+.|+.||....+.....- + .+.+ .
T Consensus 340 g---~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eE---v---------drr~-~ 403 (591)
T KOG0986|consen 340 G---KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREE---V---------DRRT-L 403 (591)
T ss_pred C---CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHH---H---------HHHH-h
Confidence 2 233344799999999999999999999999999999999999999975533221100 0 0000 0
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 039107 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPS-----MGDVLWN 755 (817)
Q Consensus 718 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 755 (817)
....+++...+++..+|.+..|.+||.+|.- +++|-+|
T Consensus 404 ~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 404 EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred cchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 1123345566777889999999999999965 4455544
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=293.13 Aligned_cols=250 Identities=25% Similarity=0.343 Sum_probs=201.3
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhccC-ccceeeEEEEEecCCeEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLR-HKHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV 559 (817)
++|...+.||+|+||.||++... ++..|++|.+... .....+.+.+|++++++++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36778889999999999999975 5788999987653 2233467889999999998 99999999999999999999
Q ss_pred EEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC
Q 039107 560 YDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 639 (817)
|||+++++|.+++.... .+++..++.|+.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 99999999999986543 6999999999999999999999765 9999999999999999999999999987543322
Q ss_pred CC------------------ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHH
Q 039107 640 NG------------------HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADW 701 (817)
Q Consensus 640 ~~------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~ 701 (817)
.. .......++..|+|||.+....++.++||||||++++||++|+.||....... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~ 233 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL---TFQK 233 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH---HHHH
Confidence 10 12233457889999999988889999999999999999999999987553211 0000
Q ss_pred HHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCH----HHHHHH
Q 039107 702 ALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSM----GDVLWN 755 (817)
Q Consensus 702 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~----~evl~~ 755 (817)
.. ......+......+.+++.+||+.+|.+||++ ++++++
T Consensus 234 ~~--------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 234 IL--------------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HH--------------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 00 00111222335668999999999999999999 787754
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=296.98 Aligned_cols=266 Identities=23% Similarity=0.302 Sum_probs=197.9
Q ss_pred HHHHhhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEec-CC
Q 039107 479 EIKHATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE-GN 554 (817)
Q Consensus 479 el~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~ 554 (817)
++..++++|...+.||+|+||.||++... ++..||+|++... .....+.+.+|++++++++||||+++++++.. ..
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 34557788999999999999999999855 6788999987542 22345678899999999999999999998865 56
Q ss_pred eEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 555 EMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 555 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
..++|+||+. ++|.+++.. ..+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 84 ~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 84 DIYFVTELLG-TDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred cEEEEeehhc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 7899999985 688887743 35788888899999999999999765 99999999999999999999999999875
Q ss_pred CCCCCCCceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccch-HH--------HHHHH
Q 039107 635 GPNMENGHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVS-LA--------DWALH 704 (817)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~--------~~~~~ 704 (817)
.... .....++..|+|||.+.+ ..++.++||||||++++||++|++||.......... +. +|...
T Consensus 158 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 158 QDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred cCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 3221 122356889999998765 578999999999999999999999996543211110 00 11110
Q ss_pred hhccCchhhccCccccCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 705 CKRKGILDDIIDPLLKDKIS-----PECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 705 ~~~~~~~~~~~d~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
...................+ +.....+.+++.+||+.+|++||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000000001111 1234678999999999999999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=298.63 Aligned_cols=261 Identities=22% Similarity=0.292 Sum_probs=193.4
Q ss_pred ceeEeeeCceEEEEEEEe-cccEEEEEecCCCCccc--------------HHHHHHHHHHHhccCccceeeEEEEEecCC
Q 039107 490 SYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQG--------------VNEFVTEIEMLSKLRHKHLVSLIGFCEEGN 554 (817)
Q Consensus 490 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 554 (817)
.+.||+|+||+||+|... ++..||+|.+....... ...+.+|++++++++|+||+++++++...+
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 457999999999999865 57889999876432211 125778999999999999999999999999
Q ss_pred eEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 555 EMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 555 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
..++||||++ |+|.+++... ..+++.....++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg~~~~ 168 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDRK-IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARR 168 (335)
T ss_pred cEEEEEeccc-cCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCccceee
Confidence 9999999997 6898888543 45899999999999999999999765 99999999999999999999999999875
Q ss_pred CCCCC------------CCceeeeeecCcCCCChhhhccC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHH
Q 039107 635 GPNME------------NGHVSTVVKGSFGYLDPEYFKRQ-QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADW 701 (817)
Q Consensus 635 ~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~ 701 (817)
..... .........++..|+|||.+.+. .++.++|||||||+++||++|++||......+.. ..
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~---~~ 245 (335)
T PTZ00024 169 YGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL---GR 245 (335)
T ss_pred cccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HH
Confidence 43110 01111223467889999998764 4689999999999999999999999765433221 11
Q ss_pred HHHhhccCc---hhhc--------cCccccC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 702 ALHCKRKGI---LDDI--------IDPLLKD---KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 702 ~~~~~~~~~---~~~~--------~d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
+........ ..+. ....... .........+.+++.+||+.+|++||++++++.+-..
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~ 316 (335)
T PTZ00024 246 IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF 316 (335)
T ss_pred HHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCccc
Confidence 111111000 0000 0000000 0011234568899999999999999999999975443
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=289.82 Aligned_cols=243 Identities=22% Similarity=0.293 Sum_probs=186.8
Q ss_pred eEeeeCceEEEEEEEe-cccEEEEEecCCCCc---ccHHHHHHHHHH---HhccCccceeeEEEEEecCCeEEEEEEecc
Q 039107 492 VIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSE---QGVNEFVTEIEM---LSKLRHKHLVSLIGFCEEGNEMCLVYDYMA 564 (817)
Q Consensus 492 ~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~---l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 564 (817)
+||+|+||.||++... .++.||+|.+..... .....+..|..+ ++...||||+++++++...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999865 467899998765321 222234445443 444579999999999999999999999999
Q ss_pred CCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCcee
Q 039107 565 LGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVS 644 (817)
Q Consensus 565 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 644 (817)
+++|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++....... .
T Consensus 81 g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~ 152 (278)
T cd05606 81 GGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P 152 (278)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC----C
Confidence 99999888543 46999999999999999999999765 9999999999999999999999999987543211 1
Q ss_pred eeeecCcCCCChhhhccC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCC
Q 039107 645 TVVKGSFGYLDPEYFKRQ-QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKI 723 (817)
Q Consensus 645 ~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 723 (817)
....|+..|+|||.+.++ .++.++||||||++++||++|+.||........... .... ....+ ..
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~----~~~~------~~~~~----~~ 218 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMT------LTMAV----EL 218 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH----HHHh------hccCC----CC
Confidence 234689999999998754 689999999999999999999999976532221110 0000 00011 12
Q ss_pred CHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 039107 724 SPECLKKFADTAEKCLSDSGIDRP-----SMGDVLWNL 756 (817)
Q Consensus 724 ~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 756 (817)
+...+..+.+++.+|+..+|.+|| ++.+++++-
T Consensus 219 ~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~ 256 (278)
T cd05606 219 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHP 256 (278)
T ss_pred CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCc
Confidence 223356789999999999999999 999998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=291.63 Aligned_cols=262 Identities=24% Similarity=0.321 Sum_probs=198.6
Q ss_pred CCcceeEeeeCceEEEEEEEec-ccEEEEEecCCCC--cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 487 FDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 487 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
|+..+.||+|++|.||+|+... +..+++|.+.... ....+.+..|+.++++++|+|++++++++......++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 3455689999999999999764 7899999987653 333467889999999999999999999999999999999999
Q ss_pred cCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCce
Q 039107 564 ALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643 (817)
Q Consensus 564 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 643 (817)
+ ++|.+++......+++..++.++.|++.||+|||+.+ |+||||+|+||++++++.+||+|||+++....... .
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~ 154 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--T 154 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc--c
Confidence 8 5899999766457999999999999999999999765 99999999999999999999999999976433221 1
Q ss_pred eeeeecCcCCCChhhhccC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchH-H---------HHHHHhhccCchh
Q 039107 644 STVVKGSFGYLDPEYFKRQ-QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSL-A---------DWALHCKRKGILD 712 (817)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l-~---------~~~~~~~~~~~~~ 712 (817)
.....++..|+|||.+.+. .++.++||||||++++||++|++||......+.... . .|..... .....
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 233 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTK-LPDYK 233 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcc-ccccc
Confidence 2223457789999998766 889999999999999999999999876543221110 0 0100000 00000
Q ss_pred hccCccccC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 713 DIIDPLLKD---KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 713 ~~~d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
......... ...+.....+.+++.+||..+|++||++.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 000000000 0011224578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=290.60 Aligned_cols=256 Identities=23% Similarity=0.282 Sum_probs=197.6
Q ss_pred CCCcceeEeeeCceEEEEEEEe----cccEEEEEecCCCC----cccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE----DKLKVAIKRSNPSS----EQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEM 556 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 556 (817)
+|...+.||+|++|.||++... ++..+|||.+.... ....+.+.+|+.++.++ +|+||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3667789999999999999853 45789999876432 22345688999999999 599999999999999999
Q ss_pred EEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCC
Q 039107 557 CLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGP 636 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 636 (817)
++||||+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.++|+|||+++...
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 9999999999999988643 45889999999999999999999765 9999999999999999999999999987643
Q ss_pred CCCCCceeeeeecCcCCCChhhhccCC--CCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhc
Q 039107 637 NMENGHVSTVVKGSFGYLDPEYFKRQQ--LTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDI 714 (817)
Q Consensus 637 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 714 (817)
.... .......|+..|+|||.+.+.. .+.++||||||++++||++|..||....... ...+........
T Consensus 157 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~------ 227 (288)
T cd05583 157 AEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKS------ 227 (288)
T ss_pred cccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHcc------
Confidence 3221 1222346889999999987655 7889999999999999999999986432211 111111111000
Q ss_pred cCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 715 IDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 715 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
.+ ..+......+.+++.+||+.+|++|||+.++.+.|+..
T Consensus 228 -~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 228 -KP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred -CC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 01 11223345678999999999999999988776665543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=331.92 Aligned_cols=254 Identities=25% Similarity=0.333 Sum_probs=203.5
Q ss_pred HhhcCCCcceeEeeeCceEEEEEE-EecccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEE
Q 039107 482 HATKSFDESYVIGVGGFGKVYKGV-IEDKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCL 558 (817)
Q Consensus 482 ~~~~~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 558 (817)
..+-++.....||.|.||.||-|. .+.|.-.|+|.++.. .....+...+|+.++..|+|||+|+.+|+-.+.+..++
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 345567778899999999999998 556778899976543 34455678899999999999999999999988999999
Q ss_pred EEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCC
Q 039107 559 VYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNM 638 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 638 (817)
.||||++|+|.+++.. .+.+++.....+..|++.|++|||+.| ||||||||.||+|+.+|.+|++|||.|......
T Consensus 1312 FMEyC~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHHHhccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 9999999999998853 334777777788999999999999766 999999999999999999999999999865433
Q ss_pred CC--CceeeeeecCcCCCChhhhccC---CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHH-HhhccCchh
Q 039107 639 EN--GHVSTVVKGSFGYLDPEYFKRQ---QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWAL-HCKRKGILD 712 (817)
Q Consensus 639 ~~--~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~-~~~~~~~~~ 712 (817)
.. ........||+.|||||++.+. .-..+.||||+|||++||+||++||...+. +|.. .....+..
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aIMy~V~~gh~- 1459 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAIMYHVAAGHK- 1459 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHHHhHHhccCC-
Confidence 21 1223456899999999999753 345689999999999999999999975432 2322 22222222
Q ss_pred hccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 713 DIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 713 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
..++.....+-.+++..||..||.+|.++.|++++
T Consensus 1460 --------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1460 --------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred --------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 23344566777999999999999999998887765
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=278.87 Aligned_cols=273 Identities=24% Similarity=0.300 Sum_probs=199.1
Q ss_pred cCCCcceeEeeeCceEEEEEEEec-----ccEEEEEecCCCCcc-c-HHHHHHHHHHHhccCccceeeEEEEEec-CCeE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIED-----KLKVAIKRSNPSSEQ-G-VNEFVTEIEMLSKLRHKHLVSLIGFCEE-GNEM 556 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~ 556 (817)
..|+....||+|.||.||||+-++ ...+|+|+++...+. + -....+|+.+++.++||||+.|..++.. ....
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 457778899999999999997432 236899998865322 1 2346789999999999999999998866 7789
Q ss_pred EEEEEeccCCchhhhhhcc----ccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCC----ceeEEee
Q 039107 557 CLVYDYMALGTLREHIYNT----KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDEN----WVAKVSD 628 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~----~~~kl~D 628 (817)
+|++||.+. +|.+.|+-. .+.++...+..|+.||+.|++|||++. |+||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 999999986 787777532 247888999999999999999999998 9999999999999877 9999999
Q ss_pred eccCccCCCCCCCc-eeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCcccc------chHHH
Q 039107 629 FGLSKTGPNMENGH-VSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQ------VSLAD 700 (817)
Q Consensus 629 FGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~------~~l~~ 700 (817)
||++|...+.-..- ....+.-|..|.|||.+.+ ..||.+.|||+.||++.|||+-.+.|.+....-. .+..+
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 99999865543321 3344567999999999876 5799999999999999999999988876532211 11111
Q ss_pred HHHHhhccCc------hhhccCc-----ccc-CCCCH-----------HHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 701 WALHCKRKGI------LDDIIDP-----LLK-DKISP-----------ECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 701 ~~~~~~~~~~------~~~~~d~-----~l~-~~~~~-----------~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
.+.....-.. +..+-+- ..+ ..... .-.....+|+.++|..||.+|.|+++.+++.-
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 1111100000 0000000 000 00000 00112678999999999999999999998876
Q ss_pred HhHh
Q 039107 758 FVLQ 761 (817)
Q Consensus 758 ~~~~ 761 (817)
+...
T Consensus 340 F~~d 343 (438)
T KOG0666|consen 340 FTED 343 (438)
T ss_pred cccC
Confidence 6543
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-32 Score=289.98 Aligned_cols=252 Identities=23% Similarity=0.292 Sum_probs=195.3
Q ss_pred CCCcceeEeeeCceEEEEEEE----ecccEEEEEecCCCC----cccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeE
Q 039107 486 SFDESYVIGVGGFGKVYKGVI----EDKLKVAIKRSNPSS----EQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEM 556 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 556 (817)
+|+..+.||+|+||.||++.. .++..||+|++.... ....+.+.+|+.+++++ +|+||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 366778999999999999986 356789999986532 22346688999999999 599999999999998999
Q ss_pred EEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCC
Q 039107 557 CLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGP 636 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 636 (817)
++|+||+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 9999999999999998654 45889999999999999999999765 9999999999999999999999999987643
Q ss_pred CCCCCceeeeeecCcCCCChhhhccC--CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhc
Q 039107 637 NMENGHVSTVVKGSFGYLDPEYFKRQ--QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDI 714 (817)
Q Consensus 637 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 714 (817)
... ........|+..|+|||.+... .++.++||||||+++|||++|+.|+....... ...++.......
T Consensus 157 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~------ 227 (290)
T cd05613 157 EDE-VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRILKS------ 227 (290)
T ss_pred ccc-ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhhcc------
Confidence 221 1122234688999999998753 46789999999999999999999986432211 111111111110
Q ss_pred cCccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 039107 715 IDPLLKDKISPECLKKFADTAEKCLSDSGIDRP-----SMGDVLWN 755 (817)
Q Consensus 715 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 755 (817)
. ...+......+.+++.+|++.+|++|| ++.+++.+
T Consensus 228 -~----~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 228 -E----PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred -C----CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0 112233455678999999999999997 67777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=301.89 Aligned_cols=265 Identities=22% Similarity=0.333 Sum_probs=194.1
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecC----------
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEG---------- 553 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~---------- 553 (817)
.+|...+.||.|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 57888999999999999999865 5678999998766556667889999999999999999999776543
Q ss_pred ----CeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEc-CCceeEEee
Q 039107 554 ----NEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLD-ENWVAKVSD 628 (817)
Q Consensus 554 ----~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~-~~~~~kl~D 628 (817)
...++||||++ ++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++ +++.+||+|
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEECC
Confidence 35789999997 588887743 35889999999999999999999765 99999999999997 556889999
Q ss_pred eccCccCCCCCCC-ceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhh
Q 039107 629 FGLSKTGPNMENG-HVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCK 706 (817)
Q Consensus 629 FGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 706 (817)
||+++........ .......++..|+|||.+.. ..++.++|||||||++|||++|+.||....+.+............
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9999754322111 11122357889999998754 567889999999999999999999997654322211100000000
Q ss_pred cc---C----chhh-ccCccccC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 707 RK---G----ILDD-IIDPLLKD-----KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 707 ~~---~----~~~~-~~d~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.. . .+.. ........ ...+....++.+++.+||..||.+|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 00 0 0000 00000000 0011234567899999999999999999999865
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=296.21 Aligned_cols=265 Identities=22% Similarity=0.279 Sum_probs=191.5
Q ss_pred CCCcceeEeeeCceEEEEEEEec---ccEEEEEecCCC--CcccHHHHHHHHHHHhcc-CccceeeEEEEEecC----Ce
Q 039107 486 SFDESYVIGVGGFGKVYKGVIED---KLKVAIKRSNPS--SEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEG----NE 555 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~----~~ 555 (817)
+|...+.||+|+||.||++.... +..+|+|++... .....+.+.+|+++++++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 46778899999999999999653 568999987643 222346788999999999 599999999975432 45
Q ss_pred EEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccC
Q 039107 556 MCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTG 635 (817)
Q Consensus 556 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 635 (817)
.++++||+. ++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 788889886 6888887543 46899999999999999999999765 999999999999999999999999999754
Q ss_pred CCCCCC--ceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHH---------HHHH
Q 039107 636 PNMENG--HVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLA---------DWAL 703 (817)
Q Consensus 636 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~---------~~~~ 703 (817)
...... .......|+..|+|||.+.+ ..++.++|+|||||++++|++|++||............ ++..
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 322111 11223468999999998765 46899999999999999999999998764422111100 0000
Q ss_pred HhhccCc--hhhccCcccc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 704 HCKRKGI--LDDIIDPLLK---DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 704 ~~~~~~~--~~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
....... .......... ....+.....+.+++.+|++.+|.+|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000 0000000000 00111224568899999999999999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=286.11 Aligned_cols=248 Identities=27% Similarity=0.392 Sum_probs=192.2
Q ss_pred CCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCC-----CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPS-----SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 559 (817)
+|...+.||+|+||.||++.... +..+++|.++.. ......++..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 36677899999999999998653 233444444321 222334577899999999999999999999988999999
Q ss_pred EEeccCCchhhhhhc---cccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCC
Q 039107 560 YDYMALGTLREHIYN---TKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGP 636 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 636 (817)
|||+++++|.+++.. ....+++.+++.++.|++.||.|||+.+ ++|+||||+||+++++ .+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~~-~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKNN-LLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeecC-CEeecccCceeecC
Confidence 999999999998864 2346999999999999999999999765 9999999999999864 69999999987643
Q ss_pred CCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccC
Q 039107 637 NMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIID 716 (817)
Q Consensus 637 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (817)
... .......|+..|+|||.+.+..++.++|+||||+++|+|++|+.|+...... ........ +
T Consensus 157 ~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~~~~~~~~-~------- 220 (260)
T cd08222 157 GSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL------SVVLRIVE-G------- 220 (260)
T ss_pred CCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHHc-C-------
Confidence 221 1223345788999999998888999999999999999999999998643211 11111100 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 717 PLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 717 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.....+..+...+.+++.+|+..+|++||++.+++++
T Consensus 221 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 221 --PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred --CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 0111233455678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=317.94 Aligned_cols=254 Identities=28% Similarity=0.384 Sum_probs=188.2
Q ss_pred hhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC-CcccHHHHHHHHHHHhccCccceeeEEEEEec--------
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS-SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE-------- 552 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-------- 552 (817)
-..+|++..+||+||||.|||++.+ ||+.+|||++... +.+......+|+.+|++|+|||||+++..+.+
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 3457888889999999999999976 8899999997755 34445678899999999999999998732100
Q ss_pred ---------------------------------------------------------C----------------------
Q 039107 553 ---------------------------------------------------------G---------------------- 553 (817)
Q Consensus 553 ---------------------------------------------------------~---------------------- 553 (817)
.
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence 0
Q ss_pred --------------------------------CeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhC
Q 039107 554 --------------------------------NEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTG 601 (817)
Q Consensus 554 --------------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~ 601 (817)
..+|+=||||+...|.+++.++.-.-.-...++++++|++||+|+|++
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence 125778899998888887754432113567789999999999999977
Q ss_pred CCCceEecCCccCcEEEcCCceeEEeeeccCccCC----------------CCCCCceeeeeecCcCCCChhhhccC---
Q 039107 602 AKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGP----------------NMENGHVSTVVKGSFGYLDPEYFKRQ--- 662 (817)
Q Consensus 602 ~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~--- 662 (817)
+ ||||||||.||+||++..+||+|||++.... ........+...||.-|+|||++.+.
T Consensus 717 g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 717 G---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred c---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 6 9999999999999999999999999998621 01112244667899999999999764
Q ss_pred CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccC
Q 039107 663 QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDS 742 (817)
Q Consensus 663 ~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~d 742 (817)
.|+.|+|+||+||||+||+.. |....+... +....+++.+..- ..+..+....-..+|+++++.|
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~yP---F~TsMERa~------iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hd 858 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLYP---FGTSMERAS------ILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHD 858 (1351)
T ss_pred cccchhhhHHHHHHHHHHhcc---CCchHHHHH------HHHhcccCCCCCC------cccccccchHHHHHHHHHhcCC
Confidence 499999999999999999853 443322110 1111223322211 1112223344578999999999
Q ss_pred CCCCCCHHHHHH
Q 039107 743 GIDRPSMGDVLW 754 (817)
Q Consensus 743 P~~RPt~~evl~ 754 (817)
|.+|||+.|+|.
T Consensus 859 P~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 859 PSKRPTATELLN 870 (1351)
T ss_pred CccCCCHHHHhh
Confidence 999999999984
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-32 Score=297.88 Aligned_cols=261 Identities=22% Similarity=0.354 Sum_probs=194.9
Q ss_pred hhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecCC-----
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGN----- 554 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----- 554 (817)
..++|...+.||+|+||.||++... ++..||||++... .....+.+.+|+++|++++|+||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4667989999999999999999854 6788999987643 2233456889999999999999999999886543
Q ss_pred -eEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCc
Q 039107 555 -EMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSK 633 (817)
Q Consensus 555 -~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 633 (817)
..++||||+ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||++.
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~ 166 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 166 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccccc
Confidence 458999999 6788887743 46899999999999999999999765 9999999999999999999999999997
Q ss_pred cCCCCCCCceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccc-hH--------HHHHH
Q 039107 634 TGPNMENGHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQV-SL--------ADWAL 703 (817)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~-~l--------~~~~~ 703 (817)
..... .....++..|+|||.+.+ ..++.++|+||||+++++|++|+.||......... .. .+|..
T Consensus 167 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07880 167 QTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ 241 (343)
T ss_pred ccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 64221 123357889999999876 46889999999999999999999999754322110 00 00110
Q ss_pred HhhccCchhhccC--cccc----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 704 HCKRKGILDDIID--PLLK----DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 704 ~~~~~~~~~~~~d--~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
...... ...... +... ....+.+...+.+++.+|++.||.+|||+.+++.+
T Consensus 242 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 242 KLQSED-AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred hhcchh-HHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 000000 0000 00112234567899999999999999999999965
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=300.22 Aligned_cols=262 Identities=23% Similarity=0.307 Sum_probs=196.4
Q ss_pred HhhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecCCe---
Q 039107 482 HATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNE--- 555 (817)
Q Consensus 482 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--- 555 (817)
...++|...+.||+|++|.||+|+.. ++..||+|++... .....+.+.+|+.++++++|+||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34667888999999999999999975 4678999987643 22334667889999999999999999998765554
Q ss_pred ---EEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccC
Q 039107 556 ---MCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLS 632 (817)
Q Consensus 556 ---~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla 632 (817)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||++
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999998 5699888854 46899999999999999999999765 999999999999999999999999999
Q ss_pred ccCCCCCCCceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchH-HH--------HH
Q 039107 633 KTGPNMENGHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSL-AD--------WA 702 (817)
Q Consensus 633 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l-~~--------~~ 702 (817)
...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........... .+ +.
T Consensus 166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 240 (343)
T cd07851 166 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240 (343)
T ss_pred cccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence 764321 223457889999999865 3678999999999999999999999975543221110 00 00
Q ss_pred HHhhccCchhhccCccc---cCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 703 LHCKRKGILDDIIDPLL---KDK---ISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 703 ~~~~~~~~~~~~~d~~l---~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.... .......+.... ... ........+.+++.+||+.+|++|||+.+|+++
T Consensus 241 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 241 QKIS-SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred hhcc-chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0000 000000000000 000 001125678999999999999999999999876
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=276.18 Aligned_cols=267 Identities=22% Similarity=0.334 Sum_probs=206.0
Q ss_pred HHHHHHhhcCCCcceeEeeeCceEEEEEE-EecccEEEEEecCCCCcccHHHHHHHHHHHhccC-ccceeeEEEEEecCC
Q 039107 477 LAEIKHATKSFDESYVIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLR-HKHLVSLIGFCEEGN 554 (817)
Q Consensus 477 ~~el~~~~~~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~ 554 (817)
++++.+.+. ++||+|+|+.|--++ +..+..+|||++.+.......+..+|++++.+.+ |+||++|+.||++++
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 466666663 379999999999887 6788899999999887777788999999999995 999999999999999
Q ss_pred eEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCC---ceeEEeeecc
Q 039107 555 EMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDEN---WVAKVSDFGL 631 (817)
Q Consensus 555 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~---~~~kl~DFGl 631 (817)
.+|||||-|.||.|..+|+++ +.+++.++.++.++|+.||.+||.++ |.||||||+|||.... .-+|||||.|
T Consensus 150 ~FYLVfEKm~GGplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKR-KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred eEEEEEecccCchHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecccc
Confidence 999999999999999999765 45999999999999999999999776 9999999999999654 4579999998
Q ss_pred CccCCCC-----CCCceeeeeecCcCCCChhhhc-----cCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHH
Q 039107 632 SKTGPNM-----ENGHVSTVVKGSFGYLDPEYFK-----RQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADW 701 (817)
Q Consensus 632 a~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~ 701 (817)
..-.... .....-....|+..|||||+.. ...|+.+.|.||||||||-||+|.+||.+....+. .|
T Consensus 226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC----GW 301 (463)
T KOG0607|consen 226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC----GW 301 (463)
T ss_pred ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC----Cc
Confidence 7532111 1112223457899999999863 34688999999999999999999999988765432 22
Q ss_pred HHHhh----ccCchhhccCccccCCCCH----HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 702 ALHCK----RKGILDDIIDPLLKDKISP----ECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 702 ~~~~~----~~~~~~~~~d~~l~~~~~~----~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
.+... ++.-...+-+... ++++ ..+.+..+++...+..++.+|-++.+++.+-..
T Consensus 302 drGe~Cr~CQ~~LFesIQEGkY--eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~ 364 (463)
T KOG0607|consen 302 DRGEVCRVCQNKLFESIQEGKY--EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWV 364 (463)
T ss_pred cCCCccHHHHHHHHHHHhccCC--cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccc
Confidence 21110 0000111111111 1222 345667889999999999999999999975433
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=279.69 Aligned_cols=236 Identities=26% Similarity=0.328 Sum_probs=191.0
Q ss_pred EeeeCceEEEEEEEe-cccEEEEEecCCCCc---ccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccCCch
Q 039107 493 IGVGGFGKVYKGVIE-DKLKVAIKRSNPSSE---QGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTL 568 (817)
Q Consensus 493 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 568 (817)
||+|+||.||++... ++..+++|.+..... .....+..|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999976 468899998765432 2456789999999999999999999999999999999999999999
Q ss_pred hhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceeeeee
Q 039107 569 REHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVK 648 (817)
Q Consensus 569 ~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 648 (817)
.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~ 154 (250)
T cd05123 81 FSHLSKEG-RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFC 154 (250)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCc
Confidence 99986543 5899999999999999999999765 9999999999999999999999999987643321 1233456
Q ss_pred cCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCHHHH
Q 039107 649 GSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECL 728 (817)
Q Consensus 649 gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 728 (817)
++..|++||...+...+.++|+||||+++|||++|+.||...... .+.... .. . ...++....
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~~~---~~-~----------~~~~~~~~~ 217 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK---EIYEKI---LK-D----------PLRFPEFLS 217 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHH---hc-C----------CCCCCCCCC
Confidence 788999999998888999999999999999999999998654321 111111 00 0 011222235
Q ss_pred HHHHHHHHHccccCCCCCCCHHH
Q 039107 729 KKFADTAEKCLSDSGIDRPSMGD 751 (817)
Q Consensus 729 ~~l~~li~~cl~~dP~~RPt~~e 751 (817)
..+.+++.+||..+|++||++.+
T Consensus 218 ~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 218 PEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHHHHhcCCHhhCCCccc
Confidence 66789999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=249.07 Aligned_cols=263 Identities=22% Similarity=0.284 Sum_probs=201.9
Q ss_pred CCcceeEeeeCceEEEEEEEec-ccEEEEEecCCCC--cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 487 FDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 487 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
|...++||+|.||+||||+.++ ++.||+|++.... +-.....++|+.+|+.++|+|||+++++....+.+-||+|||
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence 4445689999999999999654 5789999876543 222456789999999999999999999999999999999999
Q ss_pred cCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCce
Q 039107 564 ALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643 (817)
Q Consensus 564 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 643 (817)
. -+|..+....++.++......++.|+++||.++|++. +.||||||.|.||+.+|++||+|||+++...-.. ..
T Consensus 84 d-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv--rc 157 (292)
T KOG0662|consen 84 D-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--RC 157 (292)
T ss_pred h-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce--Ee
Confidence 7 4888888777778999999999999999999999765 9999999999999999999999999998643221 12
Q ss_pred eeeeecCcCCCChhhhccC-CCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCc---hhhccCcc
Q 039107 644 STVVKGSFGYLDPEYFKRQ-QLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGI---LDDIIDPL 718 (817)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~d~~ 718 (817)
.....-|..|.+|.++.+. -|+...|+||.||++.|+.. |++.|.+..-.++...+-|......+.. +..+-|-.
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 2233568999999998764 68999999999999999986 6666766665666555555543333322 22222221
Q ss_pred ccCCCC---------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 719 LKDKIS---------PECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 719 l~~~~~---------~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.-.-++ +.....-.+++++.+.-+|.+|.++++.+++
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 111111 2222345678888888999999999998875
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=311.85 Aligned_cols=145 Identities=28% Similarity=0.386 Sum_probs=129.0
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC---cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS---EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
++|.+.++||+|+||.||+|... .+..||||++.... ......+..|+.+++.++|+||+++++++......+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 46888899999999999999976 56789999986432 233467889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCc
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSK 633 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 633 (817)
||+.+++|.+++... +.+++..++.|+.||+.||+|||+.+ ||||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999998653 35888999999999999999999765 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=297.34 Aligned_cols=257 Identities=29% Similarity=0.407 Sum_probs=206.9
Q ss_pred HHHHhhcCCCcceeEeeeCceEEEEEEE-ecccEEEEEecCCCCcccHHHHHHHHHHHhcc-CccceeeEEEEEec----
Q 039107 479 EIKHATKSFDESYVIGVGGFGKVYKGVI-EDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEE---- 552 (817)
Q Consensus 479 el~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~---- 552 (817)
.+...+.-|.+..+||.|.+|.||+++. ++++.+|+|++....+. .++...|.++|+.+ .|||++.++|++..
T Consensus 13 ~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 13 SLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred hCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 3334456688889999999999999995 46788999998876543 36778899999998 69999999998853
Q ss_pred -CCeEEEEEEeccCCchhhhhhcc-ccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeec
Q 039107 553 -GNEMCLVYDYMALGTLREHIYNT-KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFG 630 (817)
Q Consensus 553 -~~~~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFG 630 (817)
++++|||||||.+|+..|++... ...+.|..+..|++.+++||++||.+. ++|||||-.||||+.++.+||+|||
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFG 168 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFG 168 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeee
Confidence 57899999999999999998654 347999999999999999999999665 9999999999999999999999999
Q ss_pred cCccCCCCCCCceeeeeecCcCCCChhhhccC-----CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHh
Q 039107 631 LSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQ-----QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHC 705 (817)
Q Consensus 631 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 705 (817)
++...... ........||+.|||||++... .|+.++|+||||++..||--|.+|+....+...+ -..
T Consensus 169 vSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL------F~I 240 (953)
T KOG0587|consen 169 VSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL------FLI 240 (953)
T ss_pred eeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh------ccC
Confidence 99865332 2334456799999999998653 4678999999999999999999998655432111 000
Q ss_pred hccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 706 KRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 706 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
. -.|...-.-+....+++.++|..||.+|-.+||++.++++|
T Consensus 241 p--------RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 241 P--------RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred C--------CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 0 11112222245678899999999999999999999999865
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-32 Score=287.58 Aligned_cols=245 Identities=23% Similarity=0.295 Sum_probs=200.2
Q ss_pred ceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccCC
Q 039107 490 SYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALG 566 (817)
Q Consensus 490 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 566 (817)
.++||+|.||+||-|+++ .|+.||||.+.+. ..++..++.+|+.||++++||.||.|...|+..+..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 458999999999999965 6799999987754 2344578899999999999999999999999999999999999876
Q ss_pred chhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCC---ceeEEeeeccCccCCCCCCCce
Q 039107 567 TLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDEN---WVAKVSDFGLSKTGPNMENGHV 643 (817)
Q Consensus 567 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~---~~~kl~DFGla~~~~~~~~~~~ 643 (817)
-|.-.|....+.|++..-.-++.||+.||.|||.++ |+|+||||+||||... -++||||||.+|.... ..-
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE---ksF 722 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE---KSF 722 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecch---hhh
Confidence 677777777779999999999999999999999765 9999999999999643 6899999999997533 334
Q ss_pred eeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCC
Q 039107 644 STVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKI 723 (817)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 723 (817)
...+.||+.|+|||+++.+.|...-|+||.||++|--|+|..||+.+.+-.+ -+ +.. .-+.-+...
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd-----QI----QNA--aFMyPp~PW--- 788 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND-----QI----QNA--AFMYPPNPW--- 788 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH-----Hh----hcc--ccccCCCch---
Confidence 4567899999999999999999999999999999999999999986643211 00 000 111111112
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 724 SPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 724 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.+.....+++|...|+..-.+|-+..+.+.+
T Consensus 789 -~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 789 -SEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred -hhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 2445567899999999999999999888755
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-32 Score=268.43 Aligned_cols=251 Identities=25% Similarity=0.316 Sum_probs=194.2
Q ss_pred hcCCCcc-eeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhcc-CccceeeEEEEEec----CCeE
Q 039107 484 TKSFDES-YVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEE----GNEM 556 (817)
Q Consensus 484 ~~~f~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~~ 556 (817)
+++|.+. ++||-|-.|.|-.+..+ .+.++|+|.+... ....+|+++--.. .|||||.++++++. ...+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 3444433 47999999999999876 5678999998754 3346788876555 69999999998753 4678
Q ss_pred EEEEEeccCCchhhhhhcccc-ccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcC---CceeEEeeeccC
Q 039107 557 CLVYDYMALGTLREHIYNTKK-ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDE---NWVAKVSDFGLS 632 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DFGla 632 (817)
++|||.|+||.|...+..++. .++++++..|++||..|+.|||+. +|.||||||+|+|... |-.+||+|||+|
T Consensus 135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccc
Confidence 899999999999999987654 799999999999999999999965 4999999999999964 567899999999
Q ss_pred ccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchh
Q 039107 633 KTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILD 712 (817)
Q Consensus 633 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 712 (817)
+.... .......+-|+.|.|||++...+|+...|+||+||++|-||||.+||........ ..+.-.
T Consensus 212 K~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai-----------spgMk~ 277 (400)
T KOG0604|consen 212 KETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPGMKR 277 (400)
T ss_pred cccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC-----------ChhHHh
Confidence 86322 2233445679999999999999999999999999999999999999986543111 011111
Q ss_pred hccCcc--ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 713 DIIDPL--LKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 713 ~~~d~~--l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
.+.... +..+.-...++...++|+.+|..+|.+|.|+.+++.+-
T Consensus 278 rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp 323 (400)
T KOG0604|consen 278 RIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHP 323 (400)
T ss_pred HhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCc
Confidence 111111 11111124567789999999999999999999998763
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=274.34 Aligned_cols=219 Identities=20% Similarity=0.158 Sum_probs=174.8
Q ss_pred eCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccCCchhhhhhc
Q 039107 496 GGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYN 574 (817)
Q Consensus 496 G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~ 574 (817)
|.+|.||++... ++..+|+|++.... .+..|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999865 56889999987543 234455556666799999999999999999999999999999998865
Q ss_pred cccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceeeeeecCcCCC
Q 039107 575 TKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYL 654 (817)
Q Consensus 575 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~ 654 (817)
. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++...... .....++..|+
T Consensus 79 ~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~ 149 (237)
T cd05576 79 F-LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYC 149 (237)
T ss_pred h-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcccc
Confidence 4 35899999999999999999999765 999999999999999999999999987653221 12234567899
Q ss_pred ChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHH
Q 039107 655 DPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADT 734 (817)
Q Consensus 655 aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l 734 (817)
|||.+....++.++||||+|++++||++|+.++....... .... ...++......+.++
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------------~~~~----~~~~~~~~~~~~~~l 208 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------------NTHT----TLNIPEWVSEEARSL 208 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------------cccc----ccCCcccCCHHHHHH
Confidence 9999988889999999999999999999998764321100 0000 001122344567899
Q ss_pred HHHccccCCCCCCCH
Q 039107 735 AEKCLSDSGIDRPSM 749 (817)
Q Consensus 735 i~~cl~~dP~~RPt~ 749 (817)
+.+|++.||++||++
T Consensus 209 i~~~l~~dp~~R~~~ 223 (237)
T cd05576 209 LQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHccCCHHHhcCC
Confidence 999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=292.14 Aligned_cols=243 Identities=22% Similarity=0.269 Sum_probs=194.1
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeEEEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 561 (817)
+..|.....+|.|+|+.|-++... +.+..++|++.... .+-.+|+.++... +||||+++.+.+.++.+.++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 455666667999999999999865 45789999987652 2234577777776 79999999999999999999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEE-cCCceeEEeeeccCccCCCCCC
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILL-DENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll-~~~~~~kl~DFGla~~~~~~~~ 640 (817)
.+.++-|.+.+.... ....++..|+.+|+.|+.|||+++ ||||||||+|||+ ++.++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~~--~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKP--EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred hccccHHHHHHHhcc--hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 999998877664432 223777789999999999999876 9999999999999 58899999999999875432
Q ss_pred CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
....+-|..|.|||++....|++++|+||||++||+||+|+.|+...... .+ ++.... .
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~e----i~~~i~------------~ 528 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IE----IHTRIQ------------M 528 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HH----HHHhhc------------C
Confidence 22335688999999999999999999999999999999999999765332 11 111111 1
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
+.+....+....+|+.+||+.||.+||+|.++..+-..
T Consensus 529 ~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 529 PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred CccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 22234556778999999999999999999999876554
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=267.73 Aligned_cols=266 Identities=27% Similarity=0.366 Sum_probs=199.0
Q ss_pred ceeEeeeCceEEEEEEEe-cccEEEEEecCCCCc-cc-HHHHHHHHHHHhccCccceeeEEEEEec--------CCeEEE
Q 039107 490 SYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSE-QG-VNEFVTEIEMLSKLRHKHLVSLIGFCEE--------GNEMCL 558 (817)
Q Consensus 490 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~--------~~~~~l 558 (817)
..+||+|.||.||+|+.+ .+++||+|++...++ .+ ....++|+.+|..|+|+|++.++..|.. ...++|
T Consensus 22 ~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~yl 101 (376)
T KOG0669|consen 22 LAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYL 101 (376)
T ss_pred HHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeee
Confidence 447999999999999965 457789987554322 22 2456799999999999999999998843 245899
Q ss_pred EEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCC
Q 039107 559 VYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNM 638 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 638 (817)
||++|+. +|.-+|......++..++.+++.++..||.|+|... |+|||+|+.|+||+.++.+||+|||+++.+...
T Consensus 102 Vf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~fs~~ 177 (376)
T KOG0669|consen 102 VFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLARAFSTS 177 (376)
T ss_pred eHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccccceecc
Confidence 9999986 888888777678999999999999999999999765 999999999999999999999999999764332
Q ss_pred CC--CceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHH--------HHhhc
Q 039107 639 EN--GHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWA--------LHCKR 707 (817)
Q Consensus 639 ~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~ 707 (817)
.+ ....+...-|+.|.+||.+.+ ..|+++.|||..||++.||+++.+-+.+..+..+..++.-. |....
T Consensus 178 ~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d 257 (376)
T KOG0669|consen 178 KNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVD 257 (376)
T ss_pred cccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcc
Confidence 22 122334456999999999875 57999999999999999999999999887766655443211 11111
Q ss_pred cCchhhcc--CccccCCCC--HHHH------HHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 708 KGILDDII--DPLLKDKIS--PECL------KKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 708 ~~~~~~~~--d~~l~~~~~--~~~~------~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
+-.+-+-+ .|...+... ++.. ...++++..++..||.+|+++.+++.+--+-
T Consensus 258 ~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~ 319 (376)
T KOG0669|consen 258 NLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFW 319 (376)
T ss_pred cchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhh
Confidence 11111111 111111100 1111 2568999999999999999999999876554
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=274.50 Aligned_cols=239 Identities=25% Similarity=0.353 Sum_probs=196.9
Q ss_pred CCCcceeEeeeCceEEEEEEEecc-cEEEEEecCCCC---cccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeEEEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIEDK-LKVAIKRSNPSS---EQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 560 (817)
+|....+||+|+||.|-++..++. ..+|||++++.- ..+.+--..|-++|... +-|.+++++.+++.-+.+++||
T Consensus 350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM 429 (683)
T KOG0696|consen 350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM 429 (683)
T ss_pred ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence 577788999999999999987754 568999988652 23344455677888776 5789999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
||+.+|+|--++++-+ .+.+..+.-.|..||-||-+||+++ ||.||||..|||||.+|.+||+|||+++.. .-.
T Consensus 430 EyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn--i~~ 503 (683)
T KOG0696|consen 430 EYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN--IFD 503 (683)
T ss_pred EEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc--ccC
Confidence 9999999988886544 4788888999999999999999876 999999999999999999999999999863 333
Q ss_pred CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
...+...+||+.|+|||.+..++|..++|.|||||+|||||.|++||++.++.+.. ..+.+..
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF---------------~aI~ehn-- 566 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF---------------QAIMEHN-- 566 (683)
T ss_pred CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH---------------HHHHHcc--
Confidence 45667789999999999999999999999999999999999999999987654321 1111111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCC
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRP 747 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RP 747 (817)
-.++...+.+...+....|.+.|.+|.
T Consensus 567 vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 567 VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 123456667778899999999999995
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=269.15 Aligned_cols=262 Identities=24% Similarity=0.316 Sum_probs=198.3
Q ss_pred cccCHHHHHHhhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCc-ccHHHHHHHHHHHhcc-CccceeeEEEE
Q 039107 473 RRFSLAEIKHATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSE-QGVNEFVTEIEMLSKL-RHKHLVSLIGF 549 (817)
Q Consensus 473 ~~f~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~ 549 (817)
..|+-+.|+. ...||.|.||+|+|-.++ .++..|||++..... .+.++|+.|.+...+- +.||||+++|.
T Consensus 59 ~~F~~~~Lqd-------lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa 131 (361)
T KOG1006|consen 59 HTFTSDNLQD-------LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGA 131 (361)
T ss_pred cccccchHHH-------HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhh
Confidence 4455555544 337999999999999875 578899999886543 5667899999877666 68999999999
Q ss_pred EecCCeEEEEEEeccCCchhhhh---hcc-ccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeE
Q 039107 550 CEEGNEMCLVYDYMALGTLREHI---YNT-KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAK 625 (817)
Q Consensus 550 ~~~~~~~~lV~Ey~~~gsL~~~l---~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~k 625 (817)
+-.++..|+.||.|+ -+|+.+. +.. +..+++.-+-.|....+.||.||.. .+.||||||||+|||||..|.+|
T Consensus 132 ~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vK 208 (361)
T KOG1006|consen 132 LFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVK 208 (361)
T ss_pred hhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEe
Confidence 988889999999997 4665543 222 2368888888999999999999998 45799999999999999999999
Q ss_pred EeeeccCccCCCCCCCceeeeeecCcCCCChhhhcc--CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHH
Q 039107 626 VSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKR--QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWAL 703 (817)
Q Consensus 626 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 703 (817)
|||||++..+.. .-..+.-.|-..|||||.+.. ..|+.+|||||||+.|+|+.||+.|+...... .+-+.
T Consensus 209 LCDFGIcGqLv~---SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv-----feql~ 280 (361)
T KOG1006|consen 209 LCDFGICGQLVD---SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV-----FEQLC 280 (361)
T ss_pred eecccchHhHHH---HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH-----HHHHH
Confidence 999999875422 223445678899999999853 35899999999999999999999998754321 11111
Q ss_pred HhhccCchhhccCcccc-CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 704 HCKRKGILDDIIDPLLK-DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 704 ~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
.... +.. |.+. .....+....+..++..|+-+|-..||...++.++--.
T Consensus 281 ~Vv~-gdp-----p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fy 330 (361)
T KOG1006|consen 281 QVVI-GDP-----PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFY 330 (361)
T ss_pred HHHc-CCC-----CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchh
Confidence 1111 110 1111 11123456778999999999999999999998865433
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=266.73 Aligned_cols=239 Identities=28% Similarity=0.345 Sum_probs=192.6
Q ss_pred CceEEEEEEEec-ccEEEEEecCCCCccc-HHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccCCchhhhhhc
Q 039107 497 GFGKVYKGVIED-KLKVAIKRSNPSSEQG-VNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYN 574 (817)
Q Consensus 497 ~fg~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~ 574 (817)
+||.||+|+..+ +..+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999864 7889999988665544 68899999999999999999999999998999999999999999998865
Q ss_pred cccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceeeeeecCcCCC
Q 039107 575 TKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYL 654 (817)
Q Consensus 575 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~ 654 (817)
... +++..+..++.+++++|.|||+.+ ++|+||+|+||++++++.++|+|||++....... ......++..|+
T Consensus 81 ~~~-~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~ 153 (244)
T smart00220 81 RGR-LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYM 153 (244)
T ss_pred ccC-CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCC
Confidence 433 899999999999999999999765 9999999999999999999999999998644321 223445788999
Q ss_pred ChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHH
Q 039107 655 DPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADT 734 (817)
Q Consensus 655 aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l 734 (817)
+||.+....++.++|||+||+++++|++|..|+....... ...++.. ..... ...........+.++
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--~~~~~~~----~~~~~-------~~~~~~~~~~~~~~~ 220 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--ELFKKIG----KPKPP-------FPPPEWKISPEAKDL 220 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHh----ccCCC-------CccccccCCHHHHHH
Confidence 9999998889999999999999999999999986532111 1111111 00000 000000144678999
Q ss_pred HHHccccCCCCCCCHHHHHHH
Q 039107 735 AEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 735 i~~cl~~dP~~RPt~~evl~~ 755 (817)
+.+|+..+|++||++.+++++
T Consensus 221 i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 221 IRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred HHHHccCCchhccCHHHHhhC
Confidence 999999999999999999863
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=276.27 Aligned_cols=256 Identities=24% Similarity=0.376 Sum_probs=195.3
Q ss_pred CCCcceeEeeeCceEEEEEE-EecccEEEEEecCCC--Cccc-----HHHHHHHHHHHhccCccceeeEEEEEe-cCCeE
Q 039107 486 SFDESYVIGVGGFGKVYKGV-IEDKLKVAIKRSNPS--SEQG-----VNEFVTEIEMLSKLRHKHLVSLIGFCE-EGNEM 556 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~--~~~~-----~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~ 556 (817)
+|-..++||+|||+.|||+. +...+.||||+-... -+.. .+...+|.+|-+.|.||.||++++|+. +.+.+
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF 543 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF 543 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence 35556789999999999998 455678999974432 1111 234568999999999999999999985 56778
Q ss_pred EEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcC---CceeEEeeeccCc
Q 039107 557 CLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDE---NWVAKVSDFGLSK 633 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DFGla~ 633 (817)
|-|+|||+|.+|+-+|... +.++++++..|++||+.||.||.+. +++|||-||||.||||-. -|.+||.||||++
T Consensus 544 CTVLEYceGNDLDFYLKQh-klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLKQH-KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred eeeeeecCCCchhHHHHhh-hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 9999999999998888654 4699999999999999999999987 689999999999999953 4899999999999
Q ss_pred cCCCCCCC-----ceeeeeecCcCCCChhhhccC----CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHH
Q 039107 634 TGPNMENG-----HVSTVVKGSFGYLDPEYFKRQ----QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALH 704 (817)
Q Consensus 634 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 704 (817)
.+...... .......||.+|++||++.-+ ..+.|+||||.||++|..|-|+.||..+..... +.
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd--IL----- 694 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD--IL----- 694 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH--HH-----
Confidence 87654443 234556899999999998543 468899999999999999999999976543221 11
Q ss_pred hhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 039107 705 CKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLW 754 (817)
Q Consensus 705 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 754 (817)
+...+.....-.+ +..+....+...+|++||+..-++|....++..
T Consensus 695 --qeNTIlkAtEVqF--P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 695 --QENTILKATEVQF--PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred --hhhchhcceeccC--CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 1111111111011 112334556789999999999999988777653
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=303.35 Aligned_cols=263 Identities=22% Similarity=0.248 Sum_probs=209.4
Q ss_pred HHHHHHhhcCCCcceeEeeeCceEEEEEEEec-ccEEEEEecCC---CCcccHHHHHHHHHHHhccCccceeeEEEEEec
Q 039107 477 LAEIKHATKSFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNP---SSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE 552 (817)
Q Consensus 477 ~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 552 (817)
..+++....+|.+.++||+|+||.|..++++. +..+|+|++.+ ........|..|-.+|..-+.+-|++|+-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 45666677889999999999999999999875 46789999876 334455779999999999999999999999999
Q ss_pred CCeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccC
Q 039107 553 GNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLS 632 (817)
Q Consensus 553 ~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla 632 (817)
..++|||||||+||+|-.++.+.. ++++..+.-.+..|+.||.-||+-| +|||||||+|||||..|.+||+|||.+
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhH
Confidence 999999999999999999998776 7999999999999999999999654 999999999999999999999999988
Q ss_pred ccCCCCCCCceeeeeecCcCCCChhhhcc-----CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhc
Q 039107 633 KTGPNMENGHVSTVVKGSFGYLDPEYFKR-----QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKR 707 (817)
Q Consensus 633 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 707 (817)
-.+.. +....+...+|||.|++||+++. +.|...+|.||+||++||||.|..||..+. +++-......
T Consensus 223 lkm~~-dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lveTY~KIm~ 295 (1317)
T KOG0612|consen 223 LKMDA-DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LVETYGKIMN 295 (1317)
T ss_pred HhcCC-CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HHHHHHHHhc
Confidence 66543 23344556689999999999853 678999999999999999999999998642 2111111111
Q ss_pred cCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHHHHH
Q 039107 708 KGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPS---MGDVLWNLEF 758 (817)
Q Consensus 708 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~L~~ 758 (817)
... .+.-+-....+....+||++.+. +|+.|.. +.++-.|..+
T Consensus 296 hk~-------~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF 341 (1317)
T KOG0612|consen 296 HKE-------SLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFF 341 (1317)
T ss_pred hhh-------hcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccc
Confidence 000 01101112356667889988774 5788877 9888877554
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=289.46 Aligned_cols=261 Identities=21% Similarity=0.259 Sum_probs=182.0
Q ss_pred hhcCCCcceeEeeeCceEEEEEEE-----------------ecccEEEEEecCCCCcccHHHH--------------HHH
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVI-----------------EDKLKVAIKRSNPSSEQGVNEF--------------VTE 531 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~E 531 (817)
..++|.+.++||+|+||+||+|.+ ..++.||||++........++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 356899999999999999999964 2346799999875443322333 447
Q ss_pred HHHHhccCccce-----eeEEEEEec--------CCeEEEEEEeccCCchhhhhhccc----------------------
Q 039107 532 IEMLSKLRHKHL-----VSLIGFCEE--------GNEMCLVYDYMALGTLREHIYNTK---------------------- 576 (817)
Q Consensus 532 ~~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~---------------------- 576 (817)
+.++.+++|.++ ++++++|.. ....+|||||+++++|.++++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777778876554 677888753 356899999999999999886421
Q ss_pred -cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceeeeeecCcCCCC
Q 039107 577 -KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLD 655 (817)
Q Consensus 577 -~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a 655 (817)
..++|..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 13467788999999999999999765 99999999999999999999999999975432211 11122335789999
Q ss_pred hhhhccCCC----------------------CchHHHHHHHHHHHHHHhCCC-CCCCCCccc------cchHHHHHHHhh
Q 039107 656 PEYFKRQQL----------------------TEKSDIYSFGVVLFEVLCARP-ALNPSLPKE------QVSLADWALHCK 706 (817)
Q Consensus 656 PE~~~~~~~----------------------s~~sDV~S~Gvvl~elltG~~-p~~~~~~~~------~~~l~~~~~~~~ 706 (817)
||.+..... ..+.||||+||+++||++|.. |+....... ...+..|.....
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 998754321 124699999999999999875 553211000 011122222111
Q ss_pred ccCchhhccCccccCCCCHHHHHHHHHHHHHccccCC---CCCCCHHHHHHHHH
Q 039107 707 RKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSG---IDRPSMGDVLWNLE 757 (817)
Q Consensus 707 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP---~~RPt~~evl~~L~ 757 (817)
.. .+ -...........+++.+||..+| .+|+|++|+++|-.
T Consensus 459 ~~------~~----~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~ 502 (507)
T PLN03224 459 QK------YD----FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRF 502 (507)
T ss_pred cC------CC----cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCC
Confidence 00 00 00112334567899999998766 68999999998743
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=294.80 Aligned_cols=261 Identities=20% Similarity=0.224 Sum_probs=169.5
Q ss_pred hhcCCCcceeEeeeCceEEEEEEEec-----ccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEE------Ee
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVIED-----KLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGF------CE 551 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~------~~ 551 (817)
..++|...++||+|+||.||+|++.+ +..||+|++...... +.+..| .+.+..+.++..++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 45689999999999999999999754 578999987643221 111111 1222222222222211 34
Q ss_pred cCCeEEEEEEeccCCchhhhhhccccc-------------------cchHhHHHHHHHHHHHHHHHHhCCCCceEecCCc
Q 039107 552 EGNEMCLVYDYMALGTLREHIYNTKKA-------------------LSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVK 612 (817)
Q Consensus 552 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~-------------------l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik 612 (817)
...+.++||||+++++|.+++...... .....+..++.|++.||+|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 567899999999999999988643211 123345679999999999999765 9999999
Q ss_pred cCcEEEcC-CceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccC----------------------CCCchHH
Q 039107 613 TTNILLDE-NWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQ----------------------QLTEKSD 669 (817)
Q Consensus 613 p~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~~sD 669 (817)
|+|||+++ ++.+||+|||+++...... ........+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 5899999999998543221 2223445789999999975322 2345679
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCcc-------ccchHHHHHHHhhccCchhhccCccccCCC--CHHHHHHHHHHHHHccc
Q 039107 670 IYSFGVVLFEVLCARPALNPSLPK-------EQVSLADWALHCKRKGILDDIIDPLLKDKI--SPECLKKFADTAEKCLS 740 (817)
Q Consensus 670 V~S~Gvvl~elltG~~p~~~~~~~-------~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~--~~~~~~~l~~li~~cl~ 740 (817)
||||||+||||+++..+....... ....+..|....... ..+.+...+ .........+|+.+||+
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHcc
Confidence 999999999999976654321100 001112222111100 000000000 00112235689999999
Q ss_pred cCCCCCCCHHHHHHHHH
Q 039107 741 DSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 741 ~dP~~RPt~~evl~~L~ 757 (817)
.||.+|||+.++++|-.
T Consensus 436 ~dP~kR~ta~e~L~Hpf 452 (566)
T PLN03225 436 FKGRQRISAKAALAHPY 452 (566)
T ss_pred CCcccCCCHHHHhCCcC
Confidence 99999999999998733
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=271.41 Aligned_cols=267 Identities=19% Similarity=0.259 Sum_probs=205.1
Q ss_pred hcCCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCCCcccHHHHHHHHHHHhccC-c-c----ceeeEEEEEecCCeE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPSSEQGVNEFVTEIEMLSKLR-H-K----HLVSLIGFCEEGNEM 556 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-~----niv~l~g~~~~~~~~ 556 (817)
+++|.+..++|+|.||.|-++.... +..||||+++...+. .+..+-|+++|+++. + | -+|.+.+|++-.++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 6788889999999999999987543 578999998855432 355677999999994 2 2 377888899999999
Q ss_pred EEEEEeccCCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEc----------------
Q 039107 557 CLVYDYMALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLD---------------- 619 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~---------------- 619 (817)
|+|+|.+ |-|+.++|..+. .+++..++..|+.|+++++++||+.. ++|-||||+|||+-
T Consensus 167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccce
Confidence 9999988 359999997643 37899999999999999999999665 99999999999993
Q ss_pred ----CCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCcccc
Q 039107 620 ----ENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQ 695 (817)
Q Consensus 620 ----~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~ 695 (817)
.+..+||+|||.|+... . ....+..|..|.|||++.+-..+..+||||+||||.||.+|...|+.....++
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~----e-~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDH----E-HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH 317 (415)
T ss_pred eccCCCcceEEEecCCcceec----c-CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence 13468999999998622 2 22456789999999999999999999999999999999999999988776665
Q ss_pred chHHHHHHHh--------------hccCch-----------hhccCccc----cCCCCHHHHHHHHHHHHHccccCCCCC
Q 039107 696 VSLADWALHC--------------KRKGIL-----------DDIIDPLL----KDKISPECLKKFADTAEKCLSDSGIDR 746 (817)
Q Consensus 696 ~~l~~~~~~~--------------~~~~~~-----------~~~~d~~l----~~~~~~~~~~~l~~li~~cl~~dP~~R 746 (817)
+.+.+.+..- ...+.+ ....++.. .......+..+|.+|+++||..||.+|
T Consensus 318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R 397 (415)
T KOG0671|consen 318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR 397 (415)
T ss_pred HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence 5444332110 000100 11111100 001123456779999999999999999
Q ss_pred CCHHHHHHHHHHhH
Q 039107 747 PSMGDVLWNLEFVL 760 (817)
Q Consensus 747 Pt~~evl~~L~~~~ 760 (817)
+|++|++++--+..
T Consensus 398 iTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 398 ITLREALSHPFFAR 411 (415)
T ss_pred ccHHHHhcCHHhhc
Confidence 99999998765543
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=275.28 Aligned_cols=248 Identities=21% Similarity=0.308 Sum_probs=202.7
Q ss_pred cceeEeeeCceEEEEEEEeccc-EEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEecc
Q 039107 489 ESYVIGVGGFGKVYKGVIEDKL-KVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMA 564 (817)
Q Consensus 489 ~~~~lG~G~fg~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 564 (817)
....||-|+||.|=+...+... .+|+|++++. ...+.+....|-++|...+.|.||+++-.|.+.+..|+.||-|-
T Consensus 424 ~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaCl 503 (732)
T KOG0614|consen 424 RIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACL 503 (732)
T ss_pred hhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhc
Confidence 3447999999999998876543 3777776543 34455677899999999999999999999999999999999999
Q ss_pred CCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCcee
Q 039107 565 LGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVS 644 (817)
Q Consensus 565 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 644 (817)
||.|...|..+ +.++..+..-++..+++|+.|||+++ ||.|||||+|.|||.+|-+||.|||+|+... .+..+
T Consensus 504 GGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~---~g~KT 576 (732)
T KOG0614|consen 504 GGELWTILRDR-GSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIG---SGRKT 576 (732)
T ss_pred Cchhhhhhhhc-CCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhc---cCCce
Confidence 99999998654 45888888999999999999999776 9999999999999999999999999998743 34566
Q ss_pred eeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCC
Q 039107 645 TVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKIS 724 (817)
Q Consensus 645 ~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 724 (817)
...+||+.|.|||.+.+...+.++|.||||++++|||+|.+||.+.++....+++ +...-.-.++
T Consensus 577 wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I---------------LkGid~i~~P 641 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI---------------LKGIDKIEFP 641 (732)
T ss_pred eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH---------------Hhhhhhhhcc
Confidence 7889999999999999999999999999999999999999999987654332221 1111111233
Q ss_pred HHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHHH
Q 039107 725 PECLKKFADTAEKCLSDSGIDRPS-----MGDVLWNLEF 758 (817)
Q Consensus 725 ~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~L~~ 758 (817)
........+++++.+..+|.+|.- +.+|-+|-.+
T Consensus 642 r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf 680 (732)
T KOG0614|consen 642 RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWF 680 (732)
T ss_pred cccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhh
Confidence 444556788999999999999975 6777766544
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=265.58 Aligned_cols=221 Identities=26% Similarity=0.404 Sum_probs=178.7
Q ss_pred HHHHHHhhc---CCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEE
Q 039107 477 LAEIKHATK---SFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGF 549 (817)
Q Consensus 477 ~~el~~~~~---~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~ 549 (817)
+-.|+++.- -|...+.||-|+||.|.++..-| ...+|.|.+.+. .+.+....+.|-.||.....+-||+|+-.
T Consensus 618 YiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS 697 (1034)
T KOG0608|consen 618 YIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS 697 (1034)
T ss_pred HHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE
Confidence 444555543 37888899999999999997544 456899987754 23445667889999999999999999999
Q ss_pred EecCCeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeee
Q 039107 550 CEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDF 629 (817)
Q Consensus 550 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DF 629 (817)
|.+++.+|+||||++||++-.+|.+. +.+.+..+.-.+..+..|+++.| +.++|||||||+|||||.+|.+||.||
T Consensus 698 FQDkdnLYFVMdYIPGGDmMSLLIrm-gIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDF 773 (1034)
T KOG0608|consen 698 FQDKDNLYFVMDYIPGGDMMSLLIRM-GIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDF 773 (1034)
T ss_pred eccCCceEEEEeccCCccHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeec
Confidence 99999999999999999999988654 35788888888899999999999 555999999999999999999999999
Q ss_pred ccCccCCCC-------CCCc---------------------------------eeeeeecCcCCCChhhhccCCCCchHH
Q 039107 630 GLSKTGPNM-------ENGH---------------------------------VSTVVKGSFGYLDPEYFKRQQLTEKSD 669 (817)
Q Consensus 630 Gla~~~~~~-------~~~~---------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~sD 669 (817)
||+.-+... ...+ ......||..|+|||++....++..+|
T Consensus 774 GLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cd 853 (1034)
T KOG0608|consen 774 GLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCD 853 (1034)
T ss_pred cccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccch
Confidence 998532100 0000 012357999999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCccc-cchHHHH
Q 039107 670 IYSFGVVLFEVLCARPALNPSLPKE-QVSLADW 701 (817)
Q Consensus 670 V~S~Gvvl~elltG~~p~~~~~~~~-~~~l~~~ 701 (817)
.||.|||||||+.|++||..+.+.+ +..+..|
T Consensus 854 wws~gvil~em~~g~~pf~~~tp~~tq~kv~nw 886 (1034)
T KOG0608|consen 854 WWSVGVILYEMLVGQPPFLADTPGETQYKVINW 886 (1034)
T ss_pred hhHhhHHHHHHhhCCCCccCCCCCcceeeeeeh
Confidence 9999999999999999998776544 3334444
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-29 Score=250.13 Aligned_cols=248 Identities=22% Similarity=0.373 Sum_probs=196.3
Q ss_pred hcCCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCC---CcccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPS---SEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEMCL 558 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 558 (817)
.++|...++||+|+|.+|..++++. .+.+|+|++++. ......=...|-.+..+. +||.+|-|+.++..+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 3568888999999999999999765 467899987653 223333345677777776 79999999999999999999
Q ss_pred EEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCC
Q 039107 559 VYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNM 638 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 638 (817)
|.||+++|+|--++++.+ +|+++.+.-....|..||.|||+.+ ||.||||..|||||..|.+||.|+|+++.. .
T Consensus 329 vieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~--l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG--L 402 (593)
T ss_pred EEEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC--C
Confidence 999999999987776544 5999999999999999999999877 999999999999999999999999999863 3
Q ss_pred CCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCC-ccccchHHHHHHHhhccCchhhccCc
Q 039107 639 ENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSL-PKEQVSLADWALHCKRKGILDDIIDP 717 (817)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (817)
..+..+...+||+.|.|||.+++..|....|.|++||+++||+.||.||+-.. +....+..++..+. ++.+
T Consensus 403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv--------ilek 474 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV--------ILEK 474 (593)
T ss_pred CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH--------Hhhh
Confidence 34455667899999999999999999999999999999999999999997422 11122222222211 1111
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCC
Q 039107 718 LLKDKISPECLKKFADTAEKCLSDSGIDRP 747 (817)
Q Consensus 718 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 747 (817)
.+ .++...+.+...+++.-|++||.+|.
T Consensus 475 qi--riprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 475 QI--RIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred cc--cccceeehhhHHHHHHhhcCCcHHhc
Confidence 11 13444556677889999999999985
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=284.22 Aligned_cols=246 Identities=28% Similarity=0.385 Sum_probs=187.4
Q ss_pred CCCcceeEeeeCceE-EEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeEEEEEEec
Q 039107 486 SFDESYVIGVGGFGK-VYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
-|...+++|.|+-|+ ||+|..++ +.||||++-.... .-..+|+..|+.- .|||||+.++.-.+....|+..|.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye~-R~VAVKrll~e~~---~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYEG-REVAVKRLLEEFF---DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeCC-ceehHHHHhhHhH---HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 355666899999887 79999865 4999999875432 3456899999988 6999999999888889999999999
Q ss_pred cCCchhhhhhcccc---ccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcC-----CceeEEeeeccCccC
Q 039107 564 ALGTLREHIYNTKK---ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDE-----NWVAKVSDFGLSKTG 635 (817)
Q Consensus 564 ~~gsL~~~l~~~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~-----~~~~kl~DFGla~~~ 635 (817)
. .+|.+++..... ...-...+.++.|++.||++||+- +||||||||.||||+. ...++|+|||+++..
T Consensus 586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 6 699999976411 111144578899999999999964 5999999999999975 368899999999976
Q ss_pred CCCCCC-ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhC-CCCCCCCCccccchHHHHHHHhhccCchhh
Q 039107 636 PNMENG-HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCA-RPALNPSLPKEQVSLADWALHCKRKGILDD 713 (817)
Q Consensus 636 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 713 (817)
...... .......||-+|+|||++....-+.++||||+|||+|+.++| .+||......+ .++. .....+..
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-~NIl------~~~~~L~~ 734 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-ANIL------TGNYTLVH 734 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-hhhh------cCccceee
Confidence 543322 223456799999999999998888899999999999999887 78886543322 1110 11111110
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 714 IIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 714 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
+.. ..++ +..+||.+|++++|..||++.+|+.|
T Consensus 735 -----L~~--~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 735 -----LEP--LPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred -----ecc--CchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 111 1122 67899999999999999999999944
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=239.78 Aligned_cols=211 Identities=38% Similarity=0.589 Sum_probs=183.4
Q ss_pred EeeeCceEEEEEEEec-ccEEEEEecCCCCcc-cHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccCCchhh
Q 039107 493 IGVGGFGKVYKGVIED-KLKVAIKRSNPSSEQ-GVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLRE 570 (817)
Q Consensus 493 lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 570 (817)
||+|.+|.||++...+ +..+++|+....... ..+.+.+|++.+++++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999864 788999998865432 35678999999999999999999999999899999999999999999
Q ss_pred hhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcC-CceeEEeeeccCccCCCCCCCceeeeeec
Q 039107 571 HIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDE-NWVAKVSDFGLSKTGPNMENGHVSTVVKG 649 (817)
Q Consensus 571 ~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~g 649 (817)
++......+++..+..++.+++++|++||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~ 155 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG 155 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence 98655346899999999999999999999765 999999999999999 89999999999976433221 1233457
Q ss_pred CcCCCChhhhccC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCHHHH
Q 039107 650 SFGYLDPEYFKRQ-QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECL 728 (817)
Q Consensus 650 t~~y~aPE~~~~~-~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 728 (817)
...|++||.+... ..+.+.|+|++|+++++|
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 8899999999877 888999999999999998
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 729 KKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 729 ~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
..+.+++.+|++.+|++||++.+++++|
T Consensus 188 ~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 4578899999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-29 Score=235.62 Aligned_cols=198 Identities=22% Similarity=0.350 Sum_probs=164.2
Q ss_pred CCcceeEeeeCceEEEEEEE-ecccEEEEEecCCC-CcccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeEEEEEEec
Q 039107 487 FDESYVIGVGGFGKVYKGVI-EDKLKVAIKRSNPS-SEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 487 f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
......||+|++|.|-+-++ .+|+..|+|++... +.+..++.++|+.+..+. .+|.+|.++|....+...++.||.|
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M 127 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM 127 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence 33345799999999988875 46788999998754 455567888999987776 7999999999888888999999999
Q ss_pred cCCchhhhhh---ccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 564 ALGTLREHIY---NTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 564 ~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
+ .||+.+.. ..++.+++..+-+|+..+++||.|||+ ++.|||||+||+||||+.+|++|+||||++..+.+.
T Consensus 128 ~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS-- 202 (282)
T KOG0984|consen 128 D-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS-- 202 (282)
T ss_pred h-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhh--
Confidence 7 47766543 345578999999999999999999999 457999999999999999999999999999764332
Q ss_pred CceeeeeecCcCCCChhhhcc----CCCCchHHHHHHHHHHHHHHhCCCCCCCC
Q 039107 641 GHVSTVVKGSFGYLDPEYFKR----QQLTEKSDIYSFGVVLFEVLCARPALNPS 690 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~----~~~s~~sDV~S~Gvvl~elltG~~p~~~~ 690 (817)
-..+...|...|||||.+.. ..|+.|+||||||+.+.||.+++.|+...
T Consensus 203 -iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 203 -IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred -hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 22334568889999998753 47899999999999999999999998644
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-29 Score=249.59 Aligned_cols=264 Identities=25% Similarity=0.341 Sum_probs=197.4
Q ss_pred CcceeEeeeCceEEEEEEE-ecccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecC-----CeEEEE
Q 039107 488 DESYVIGVGGFGKVYKGVI-EDKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEG-----NEMCLV 559 (817)
Q Consensus 488 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~lV 559 (817)
+..+.||-|+||.||..+. ++++.|++|++... +-...+.+.+|+.+|.-++|.|++..++...-. .++|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 3456899999999999885 57889999998753 223457788999999999999999998866432 356788
Q ss_pred EEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC
Q 039107 560 YDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 639 (817)
.|.|. .+|...|-. .+.|+-..+.-++.||++||.|||+.+ |.||||||.|.|++.+..+|||||||++.....+
T Consensus 136 TELmQ-SDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 136 TELMQ-SDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHH-hhhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhh
Confidence 88886 477776643 356888999999999999999999776 9999999999999999999999999999754333
Q ss_pred CCceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHH---------HHHhhccC
Q 039107 640 NGHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADW---------ALHCKRKG 709 (817)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~---------~~~~~~~~ 709 (817)
..+ .+...-|..|.|||.+++ ..|+.+.||||.||++.|||..+..|....+-++.+++.- ++... ++
T Consensus 211 ~~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC-EG 288 (449)
T KOG0664|consen 211 RLN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC-EG 288 (449)
T ss_pred hhh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh-hh
Confidence 222 333456889999999986 5799999999999999999999998888777766655321 11111 11
Q ss_pred chhhccCccccCC---------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 710 ILDDIIDPLLKDK---------ISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 710 ~~~~~~d~~l~~~---------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
--..++....+.. .+..--.+...+.+.++..||++|.+..+.+.++..
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 1111111111100 011222345778899999999999999999877654
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-28 Score=237.17 Aligned_cols=254 Identities=19% Similarity=0.299 Sum_probs=190.3
Q ss_pred cCCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCCCcccHHHHHHHHHHHhcc-CccceeeEEEE-EecCCeEEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPSSEQGVNEFVTEIEMLSKL-RHKHLVSLIGF-CEEGNEMCLVYD 561 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~-~~~~~~~~lV~E 561 (817)
..|.+.+.||+|.||.+-++.++. .+.+++|.+.... ...++|.+|...--.| .|.||+.-++. ++..+..++++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 457778899999999999999875 4678899877542 3458899999887777 58999988774 567778899999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEc--CCceeEEeeeccCccCCCCC
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLD--ENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~--~~~~~kl~DFGla~~~~~~~ 639 (817)
|++.|+|.+-+.. ..+-+....+++.|++.||.|+|++. +||||||.+||||- +..++||||||+.+...
T Consensus 103 ~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g--- 174 (378)
T KOG1345|consen 103 FAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG--- 174 (378)
T ss_pred cCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC---
Confidence 9999999987744 35778888899999999999999776 99999999999993 34589999999987532
Q ss_pred CCceeeeeecCcCCCChhhhccC-----CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhc
Q 039107 640 NGHVSTVVKGSFGYLDPEYFKRQ-----QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDI 714 (817)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 714 (817)
.......-+..|.+||..... ...+.+|+|.||++++.+|+|++||+... ......++|.....++..
T Consensus 175 --~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~-~~d~~Y~~~~~w~~rk~~---- 247 (378)
T KOG1345|consen 175 --TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS-IMDKPYWEWEQWLKRKNP---- 247 (378)
T ss_pred --ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh-ccCchHHHHHHHhcccCc----
Confidence 222333456789999986432 34678999999999999999999998433 233345555544433321
Q ss_pred cCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 715 IDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 715 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
.-|..... ..+.+.++.++-+.+++.+|-...++-++...
T Consensus 248 ~~P~~F~~----fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~ 287 (378)
T KOG1345|consen 248 ALPKKFNP----FSEKALRLFKKSLTPRFKDRCKIWTAKKMRKC 287 (378)
T ss_pred cCchhhcc----cCHHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence 11222222 34556788899999999999666665554443
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-28 Score=231.86 Aligned_cols=262 Identities=19% Similarity=0.286 Sum_probs=194.3
Q ss_pred cCCCcceeEeeeCceEEEEEE-EecccEEEEEecCCCCcccHHHHHHHHHHHhccC-ccceeeEEEEEecC--CeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLR-HKHLVSLIGFCEEG--NEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~ 560 (817)
.+|++.+++|+|.++.||.|. ..+.++++||.+++... +.+.+|+.+|..|+ ||||++|++...+. ....||+
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF 114 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF 114 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence 467778899999999999998 45678999999997643 67889999999997 99999999988654 5678999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcC-CceeEEeeeccCccCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDE-NWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DFGla~~~~~~~ 639 (817)
||+.+.+...+. ..|+...+...+.+++.||.|+|+.| |.|||+||.|++||. ...++|+|+|||...-..
T Consensus 115 E~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~- 186 (338)
T KOG0668|consen 115 EYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG- 186 (338)
T ss_pred hhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCC-
Confidence 999998876654 35778888999999999999999776 999999999999985 478999999999875322
Q ss_pred CCceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCC-ccccchHH----------HHHHHhhc
Q 039107 640 NGHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSL-PKEQVSLA----------DWALHCKR 707 (817)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~-~~~~~~l~----------~~~~~~~~ 707 (817)
........+..|.-||.+-. +.|+..-|+|||||+|.+|+..+.||.... ..++...+ .+.....-
T Consensus 187 --~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 187 --KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI 264 (338)
T ss_pred --ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence 22233345778889999754 578899999999999999999998875443 33332211 11111000
Q ss_pred --cCchhhccCccccCC--------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 708 --KGILDDIIDPLLKDK--------ISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 708 --~~~~~~~~d~~l~~~--------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
......++....+.. -..-...+..+++.+.|..|.++|+|++|.+.|--+.
T Consensus 265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~ 326 (338)
T KOG0668|consen 265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFA 326 (338)
T ss_pred CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHH
Confidence 001111111111100 0011235678999999999999999999999875443
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-26 Score=233.58 Aligned_cols=199 Identities=32% Similarity=0.461 Sum_probs=172.3
Q ss_pred CCcceeEeeeCceEEEEEEEec-ccEEEEEecCCCCcc-cHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEecc
Q 039107 487 FDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPSSEQ-GVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMA 564 (817)
Q Consensus 487 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 564 (817)
|...+.||+|++|.||++...+ +..+++|........ ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4556789999999999999875 788999998866544 57889999999999999999999999999899999999999
Q ss_pred CCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCcee
Q 039107 565 LGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVS 644 (817)
Q Consensus 565 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 644 (817)
+++|.+++......+++..+..++.+++.+|.+||+.+ ++|+||+|.||+++.++.++|+|||++......... ..
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LL 156 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cc
Confidence 99999998654433899999999999999999999765 999999999999999999999999998865433211 22
Q ss_pred eeeecCcCCCChhhh-ccCCCCchHHHHHHHHHHHHHHhCCCCCCC
Q 039107 645 TVVKGSFGYLDPEYF-KRQQLTEKSDIYSFGVVLFEVLCARPALNP 689 (817)
Q Consensus 645 ~~~~gt~~y~aPE~~-~~~~~s~~sDV~S~Gvvl~elltG~~p~~~ 689 (817)
....++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 345678899999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-26 Score=241.20 Aligned_cols=130 Identities=28% Similarity=0.482 Sum_probs=108.8
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccC-----c---cceeeEEEEEec---
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLR-----H---KHLVSLIGFCEE--- 552 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~g~~~~--- 552 (817)
.+|...++||-|.|++||++... ..+.||+|+.+.. +.-.+..+.||++|++++ | .+||+|+++|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 57889999999999999999854 4578999998843 334466788999999984 2 479999999854
Q ss_pred -CCeEEEEEEeccCCchhhhhhcc-ccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEE
Q 039107 553 -GNEMCLVYDYMALGTLREHIYNT-KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILL 618 (817)
Q Consensus 553 -~~~~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll 618 (817)
+.+.|||+|++. .+|..+|... .+.++...+.+|++||+.||.|||.++ +|||-||||+|||+
T Consensus 157 NG~HVCMVfEvLG-dnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVLG-DNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhhh-hHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 568999999995 4677776543 457999999999999999999999955 89999999999999
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-26 Score=248.38 Aligned_cols=195 Identities=23% Similarity=0.379 Sum_probs=164.2
Q ss_pred CCCcceeEeeeCceEEEEEEEecc-cEEEEEecCCCCc--------ccHHHHHHHHHHHhccC---ccceeeEEEEEecC
Q 039107 486 SFDESYVIGVGGFGKVYKGVIEDK-LKVAIKRSNPSSE--------QGVNEFVTEIEMLSKLR---HKHLVSLIGFCEEG 553 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~ 553 (817)
+|...+.||+|+||.|+.+.++.. ..|+||.+.+..- ...-..-.|+.||..|+ |+||++++++|++.
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 577788999999999999998765 5688998765321 11122446999999997 99999999999999
Q ss_pred CeEEEEEEecc-CCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccC
Q 039107 554 NEMCLVYDYMA-LGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLS 632 (817)
Q Consensus 554 ~~~~lV~Ey~~-~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla 632 (817)
+.++|++|--. +-+|.++|... ..+++.+...|++||+.|+++||+++ |||||||-+||.++.+|-+||+|||.+
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccch
Confidence 99999999754 45899998644 45999999999999999999999776 999999999999999999999999998
Q ss_pred ccCCCCCCCceeeeeecCcCCCChhhhccCCC-CchHHHHHHHHHHHHHHhCCCCCC
Q 039107 633 KTGPNMENGHVSTVVKGSFGYLDPEYFKRQQL-TEKSDIYSFGVVLFEVLCARPALN 688 (817)
Q Consensus 633 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~S~Gvvl~elltG~~p~~ 688 (817)
.... .......+||..|.|||++.+.+| ...-|||++|++||-++....|+.
T Consensus 718 a~~k----sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 718 AYTK----SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhc----CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 7532 334557789999999999998877 456899999999999988877764
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.6e-27 Score=235.23 Aligned_cols=261 Identities=23% Similarity=0.236 Sum_probs=189.7
Q ss_pred cCCCcceeEeeeCceEEEEEEE-ecccEEEEEecCC--CCcccHHHHHHHHHHHhccCccceeeEEEEEec------CCe
Q 039107 485 KSFDESYVIGVGGFGKVYKGVI-EDKLKVAIKRSNP--SSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE------GNE 555 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~ 555 (817)
.+|...+.+|.|.- .|--+.. -.++.||+|++.. ...+..+...+|..++..++|+||++++.++.- ..+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 34555556777777 4444432 2356899998653 244556778899999999999999999998843 346
Q ss_pred EEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccC
Q 039107 556 MCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTG 635 (817)
Q Consensus 556 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 635 (817)
.++|||+|. .+|.+.++ -.++-.++..|+.|++.|++|||+.+ |+||||||+||++..+..+||.|||+++..
T Consensus 96 ~y~v~e~m~-~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVIL---MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HHHHHHhhh-hHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhccc
Confidence 799999997 58888876 34777888999999999999999776 999999999999999999999999999863
Q ss_pred CCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHH---------------
Q 039107 636 PNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLAD--------------- 700 (817)
Q Consensus 636 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~--------------- 700 (817)
.. .-..+-...|..|.|||++.+..+.+.+||||.||++.||++|+.-|.+...-++...+.
T Consensus 169 ~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 169 DT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred Cc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 22 124455678899999999988889999999999999999999998887654333221110
Q ss_pred -HHHHhhcc------Cchhhcc-CccccC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 701 -WALHCKRK------GILDDII-DPLLKD--KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 701 -~~~~~~~~------~~~~~~~-d~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
-++...+. -...+.+ |..... +.++-......+++.+||-.+|++|-+++++|+|-
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP 311 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence 01110000 0001111 111110 01112334578999999999999999999999874
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7e-27 Score=248.14 Aligned_cols=272 Identities=23% Similarity=0.279 Sum_probs=203.3
Q ss_pred ccCHHHHHHhhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccC------ccceeeE
Q 039107 474 RFSLAEIKHATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLR------HKHLVSL 546 (817)
Q Consensus 474 ~f~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------H~niv~l 546 (817)
++.+.|+. ..+|.+....|+|-|++|-+|... .+..||||++..... -.+.=+.|+++|++|+ .-|+++|
T Consensus 423 rv~igE~L--D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl 499 (752)
T KOG0670|consen 423 RVRIGELL--DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRL 499 (752)
T ss_pred EEehhhhh--cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence 34445544 356877888999999999999854 457999999985532 2344568999999995 2589999
Q ss_pred EEEEecCCeEEEEEEeccCCchhhhhhcccc--ccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCC-ce
Q 039107 547 IGFCEEGNEMCLVYDYMALGTLREHIYNTKK--ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDEN-WV 623 (817)
Q Consensus 547 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~-~~ 623 (817)
+-.|...+++|||+|-+. .+|.++|..-++ .|....+...+.|++.||..|.. ++|+|.||||.|||+++. ..
T Consensus 500 ~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 500 FRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCcce
Confidence 999999999999999885 699999976544 68889999999999999999994 459999999999999976 56
Q ss_pred eEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHH--
Q 039107 624 AKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADW-- 701 (817)
Q Consensus 624 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~-- 701 (817)
+||||||.|....... .+-+.-+..|.|||.+.+.+|+...|+||.||+||||.||+..|.+......+.+.--
T Consensus 576 LKLCDfGSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~K 651 (752)
T KOG0670|consen 576 LKLCDFGSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELK 651 (752)
T ss_pred eeeccCcccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhc
Confidence 8999999987643221 1223346689999999999999999999999999999999999987765544332110
Q ss_pred ---HHHhhccC-chhhccCcc--------------------------------ccC--CC---CHHHHHHHHHHHHHccc
Q 039107 702 ---ALHCKRKG-ILDDIIDPL--------------------------------LKD--KI---SPECLKKFADTAEKCLS 740 (817)
Q Consensus 702 ---~~~~~~~~-~~~~~~d~~--------------------------------l~~--~~---~~~~~~~l~~li~~cl~ 740 (817)
-..+.+++ ...+-+|.. +.. .+ .......|.+|+.+||.
T Consensus 652 Gk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~ 731 (752)
T KOG0670|consen 652 GKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLI 731 (752)
T ss_pred CCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhc
Confidence 00111111 011111110 000 11 23455678999999999
Q ss_pred cCCCCCCCHHHHHHHH
Q 039107 741 DSGIDRPSMGDVLWNL 756 (817)
Q Consensus 741 ~dP~~RPt~~evl~~L 756 (817)
.||++|.|..++|+|-
T Consensus 732 LdP~KRit~nqAL~Hp 747 (752)
T KOG0670|consen 732 LDPEKRITVNQALKHP 747 (752)
T ss_pred cChhhcCCHHHHhcCC
Confidence 9999999999998764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7e-27 Score=255.28 Aligned_cols=253 Identities=25% Similarity=0.366 Sum_probs=201.9
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
..+|.....+|.|.||.|||++.. .+...|+|.++........-...|+-+++..+|+||+.++|-+...+.+++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 346777889999999999999954 5678899998877666667778899999999999999999999999999999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
|.+|+|.+..+. ..+|++.++..+++...+||+|||+.+ =+|||||-.|||+++.+.+|++|||.+...... -.
T Consensus 94 cgggslQdiy~~-TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat--i~ 167 (829)
T KOG0576|consen 94 CGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT--IA 167 (829)
T ss_pred cCCCcccceeee-cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh--hh
Confidence 999999996643 357999999999999999999999876 799999999999999999999999998654322 22
Q ss_pred eeeeeecCcCCCChhhh---ccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCc-c
Q 039107 643 VSTVVKGSFGYLDPEYF---KRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP-L 718 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~---~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~-~ 718 (817)
......||+.|||||+. +.+.|...+|||++|+...|+---++|...-.+....-+ +. ...++| .
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~L----mT-------kS~~qpp~ 236 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFL----MT-------KSGFQPPT 236 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHH----hh-------ccCCCCCc
Confidence 34567899999999986 467899999999999999999887777543322111100 00 111222 2
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 719 LKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 719 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
++. .....+.+-++++.|+-++|.+||+++.++.|
T Consensus 237 lkD--k~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 237 LKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred ccC--CccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 222 12345568899999999999999999988754
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.1e-26 Score=236.63 Aligned_cols=269 Identities=25% Similarity=0.320 Sum_probs=197.8
Q ss_pred HHHhhcCCCcceeEeeeCceEEEEEEEec----ccEEEEEecCCCCcccHHHHHHHHHHHhcc-CccceeeEEEEEecCC
Q 039107 480 IKHATKSFDESYVIGVGGFGKVYKGVIED----KLKVAIKRSNPSSEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGN 554 (817)
Q Consensus 480 l~~~~~~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 554 (817)
+....+.|...++||+|.|++||++.+.. ...||+|.+...+.. ....+|+++|..+ -+.||+++.+++...+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 33445678889999999999999998543 468999998876543 5688999999999 5999999999999999
Q ss_pred eEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcC-CceeEEeeeccCc
Q 039107 555 EMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDE-NWVAKVSDFGLSK 633 (817)
Q Consensus 555 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DFGla~ 633 (817)
..++|+||++.....+++. .++..++...++.++.||.++|.+| ||||||||.|+|.+. .+.-.|+||||+.
T Consensus 109 ~v~ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred eeEEEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHH
Confidence 9999999999988888773 3678889999999999999999776 999999999999985 4677899999986
Q ss_pred cCCCCC------------------------------------------CCceeeeeecCcCCCChhhhc-cCCCCchHHH
Q 039107 634 TGPNME------------------------------------------NGHVSTVVKGSFGYLDPEYFK-RQQLTEKSDI 670 (817)
Q Consensus 634 ~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDV 670 (817)
...... .........||+||.|||++. ....+.+.||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 210000 000112346999999999975 4677899999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCccccchHHHHHH----Hhhc-----cCc--hhh---------c------cC-----c--
Q 039107 671 YSFGVVLFEVLCARPALNPSLPKEQVSLADWAL----HCKR-----KGI--LDD---------I------ID-----P-- 717 (817)
Q Consensus 671 ~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~----~~~~-----~~~--~~~---------~------~d-----~-- 717 (817)
||.||+++.+++++.||....+.- ..+.+.+. ...+ .+. +.+ . ++ +
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~-~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDA-DALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeccceeehhhccccccccCcccc-chHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 999999999999999986543221 11211100 0000 011 000 0 00 0
Q ss_pred --cccC-CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 718 --LLKD-KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 718 --~l~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
.... ......+..+.+++.+|++.||.+|.|+++.|+|--+
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF 384 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFF 384 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCC
Confidence 0000 1111223468999999999999999999999987443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-25 Score=274.43 Aligned_cols=197 Identities=18% Similarity=0.228 Sum_probs=140.5
Q ss_pred ccCc-cceeeEEEEE-------ecCCeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEe
Q 039107 537 KLRH-KHLVSLIGFC-------EEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIH 608 (817)
Q Consensus 537 ~l~H-~niv~l~g~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH 608 (817)
.++| +||++++++| .+...+++++|++ +++|.++|......+++.+++.++.||++||+|||+++ |+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---IvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG---IVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence 4556 6888888887 2334678889987 46999999766567999999999999999999999766 999
Q ss_pred cCCccCcEEEcCC-------------------ceeEEeeeccCccCCCCCC--------------CceeeeeecCcCCCC
Q 039107 609 RDVKTTNILLDEN-------------------WVAKVSDFGLSKTGPNMEN--------------GHVSTVVKGSFGYLD 655 (817)
Q Consensus 609 ~Dikp~NIll~~~-------------------~~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~a 655 (817)
|||||+||||+.. +.+|++|||+++....... ........||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 9999999999654 4556666666653211000 000112357889999
Q ss_pred hhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHH
Q 039107 656 PEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTA 735 (817)
Q Consensus 656 PE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li 735 (817)
||++.+..++.++|||||||+||||++|.+|+..... .+..+.. ..+.+.. .........++
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~---------~~~~~~~-----~~~~~~~~~~~ 245 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRH---------RVLPPQI-----LLNWPKEASFC 245 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHH---------hhcChhh-----hhcCHHHHHHH
Confidence 9999999999999999999999999999887542110 0000100 0111111 11123456788
Q ss_pred HHccccCCCCCCCHHHHHHH
Q 039107 736 EKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 736 ~~cl~~dP~~RPt~~evl~~ 755 (817)
.+||+++|.+||+|.||+++
T Consensus 246 ~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 246 LWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHhCCCChhhCcChHHHhhc
Confidence 99999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-24 Score=213.72 Aligned_cols=169 Identities=24% Similarity=0.244 Sum_probs=128.7
Q ss_pred CchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceee
Q 039107 566 GTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVST 645 (817)
Q Consensus 566 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 645 (817)
|+|.+++...+..++|.+++.|+.|++.||+|||+++ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc------
Confidence 6899999766667999999999999999999999753 999999999999999 99987643211
Q ss_pred eeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCH
Q 039107 646 VVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISP 725 (817)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 725 (817)
..||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+..+...... . ++.. .....
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~~-~------~~~~-~~~~~ 133 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILLNGMPA-D------DPRD-RSNLE 133 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHHHHhcc-C------Cccc-cccHH
Confidence 258899999999999999999999999999999999999986443211 111111111000 0 0000 01112
Q ss_pred HHHH--HHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 039107 726 ECLK--KFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQ 761 (817)
Q Consensus 726 ~~~~--~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 761 (817)
.... .+.+++.+||+.+|.+||++.++++++.....
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 2233 68999999999999999999999999987754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-22 Score=218.29 Aligned_cols=262 Identities=21% Similarity=0.226 Sum_probs=197.4
Q ss_pred CCCcceeEeeeCceEEEEEEEecc--cEEEEEecCCCCcccHHHHHHHHHHHhccCc----cceeeEEEEE-ecCCeEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIEDK--LKVAIKRSNPSSEQGVNEFVTEIEMLSKLRH----KHLVSLIGFC-EEGNEMCL 558 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~g~~-~~~~~~~l 558 (817)
+|...++||+|+||.||++..... ..+|+|............+..|..++..+.+ +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 788999999999999999996553 4788888765433333367889999999873 6899999988 47778899
Q ss_pred EEEeccCCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCC-----ceeEEeeeccC
Q 039107 559 VYDYMALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDEN-----WVAKVSDFGLS 632 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~-----~~~kl~DFGla 632 (817)
||+.+ +.+|.++..... +.++..+.++|+.|++.+|++||+.| ++||||||.|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99977 579999875444 68999999999999999999999776 9999999999999754 57999999999
Q ss_pred ccCC--CCCCC-----ce-eeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHH
Q 039107 633 KTGP--NMENG-----HV-STVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALH 704 (817)
Q Consensus 633 ~~~~--~~~~~-----~~-~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 704 (817)
+... ..... .. .....||..|+++.+..+.+.+.+.|+||++.++.|++.|..||............ ...
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~--~~~ 252 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF--EKD 252 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH--HHH
Confidence 8322 11111 11 23456999999999999999999999999999999999999999654432211100 000
Q ss_pred hhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 039107 705 CKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLV 763 (817)
Q Consensus 705 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 763 (817)
.. ...... .....+..+.++...+-..+..++|....+...|+.+....
T Consensus 253 -~~----~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 253 -PR----KLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred -hh----hhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 00 000000 11123345666777777789999999999999988877654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=204.98 Aligned_cols=264 Identities=19% Similarity=0.218 Sum_probs=207.8
Q ss_pred cCCCcceeEeeeCceEEEEEE-EecccEEEEEecCCCCcccHHHHHHHHHHHhccC-ccceeeEEEEEecCCeEEEEEEe
Q 039107 485 KSFDESYVIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLR-HKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
-.|.+.++||+|.||..+.|+ +-+++.||||.-...++. .++..|.+..+.|. .++|...+-|..++.+-.||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A--PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA--PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCCc--chHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 368889999999999999998 557789999987655443 57788999998884 69999999998999999999998
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcC-----CceeEEeeeccCccCCC
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDE-----NWVAKVSDFGLSKTGPN 637 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~-----~~~~kl~DFGla~~~~~ 637 (817)
+ |-+|.|++.-..+.++.++++.||.|++.-++|+|++. +|.|||||+|+||.. ...+.++|||+|+.+.+
T Consensus 106 L-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred h-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 8 46999988777888999999999999999999999776 999999999999963 24689999999997655
Q ss_pred CCCC-----ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchh
Q 039107 638 MENG-----HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILD 712 (817)
Q Consensus 638 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 712 (817)
.... .......||.+||+-....+.+.+.+.|+-|||-|++..|-|..||.+-....-....+-+...++...+.
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~ 261 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIE 261 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHH
Confidence 4332 34456789999999999999999999999999999999999999998764332211111111212222222
Q ss_pred hccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 039107 713 DIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLV 763 (817)
Q Consensus 713 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 763 (817)
+ +....+.++..-+.-.-..+-.+-|..+-+...+..++...
T Consensus 262 ~---------Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~ 303 (449)
T KOG1165|consen 262 V---------LCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL 303 (449)
T ss_pred H---------HHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence 2 12234555666666666778888999998888888877654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=197.49 Aligned_cols=261 Identities=18% Similarity=0.212 Sum_probs=206.0
Q ss_pred cCCCcceeEeeeCceEEEEEE-EecccEEEEEecCCCCcccHHHHHHHHHHHhccCc-cceeeEEEEEecCCeEEEEEEe
Q 039107 485 KSFDESYVIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRH-KHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~Ey 562 (817)
..|...++||+|+||.+|.|. +.+|.+||||.-..... ..++.-|..+...|+| ..|..+..|..++..-.||||.
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL 92 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL 92 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence 468889999999999999998 56789999999765433 3567789999999975 7788888888999999999998
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCC---ceeEEeeeccCccCCCCC
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDEN---WVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~---~~~kl~DFGla~~~~~~~ 639 (817)
+ +-+|.+++.-..+.++.++++.++-|++.-++|+|.++ +|||||||+|+|..-+ ..+.|+||||++...+..
T Consensus 93 L-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~ 168 (341)
T KOG1163|consen 93 L-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR 168 (341)
T ss_pred c-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence 8 56999988777778999999999999999999999776 9999999999999643 478899999998765443
Q ss_pred CC-----ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhc
Q 039107 640 NG-----HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDI 714 (817)
Q Consensus 640 ~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 714 (817)
.. ...+...||.+|.+-....+.+.+.+.|+-|+|.+|..+.-|..||++-.........+-+.+.+-...+..
T Consensus 169 t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~- 247 (341)
T KOG1163|consen 169 TRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEV- 247 (341)
T ss_pred ccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHH-
Confidence 32 234567899999999988888889999999999999999999999998765544433333333222222211
Q ss_pred cCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 039107 715 IDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVL 760 (817)
Q Consensus 715 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 760 (817)
.....+.++.-.+.-|-..--++-|...-+.+.++-+.
T Consensus 248 --------LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf 285 (341)
T KOG1163|consen 248 --------LCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF 285 (341)
T ss_pred --------HhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence 12334556777888898888899999777766655543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.7e-23 Score=203.88 Aligned_cols=244 Identities=19% Similarity=0.328 Sum_probs=190.9
Q ss_pred eEeeeCceEEEEEEEecccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccCCchh
Q 039107 492 VIGVGGFGKVYKGVIEDKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLR 569 (817)
Q Consensus 492 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 569 (817)
+|.+...|..|+|++++. .+++|++... ....-.+|..|.-.|+-+.||||+.++|.|.....+.++..||+.|+|+
T Consensus 197 kl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsly 275 (448)
T KOG0195|consen 197 KLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLY 275 (448)
T ss_pred hhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHH
Confidence 688889999999999765 4666665532 2222367889999999999999999999999999999999999999999
Q ss_pred hhhhcccc-ccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceeeeee
Q 039107 570 EHIYNTKK-ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVK 648 (817)
Q Consensus 570 ~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 648 (817)
..|+.... ..+..+..+++.++|+|++|||+-. +-|.---|.+..+++|++.+++|+ .+-+++.. + .....
T Consensus 276 nvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltaris-mad~kfsf----q--e~gr~ 347 (448)
T KOG0195|consen 276 NVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARIS-MADTKFSF----Q--EVGRA 347 (448)
T ss_pred HHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhhee-cccceeee----e--ccccc
Confidence 99987655 6788899999999999999999863 445555689999999999998874 22222110 0 11123
Q ss_pred cCcCCCChhhhccCCCC---chHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCH
Q 039107 649 GSFGYLDPEYFKRQQLT---EKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISP 725 (817)
Q Consensus 649 gt~~y~aPE~~~~~~~s---~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 725 (817)
-.+.||+||.++..+.+ .+.|+|||+++||||.|...||..-.+.+.. ..+.-..++..+++
T Consensus 348 y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg---------------mkialeglrv~ipp 412 (448)
T KOG0195|consen 348 YSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG---------------MKIALEGLRVHIPP 412 (448)
T ss_pred cCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh---------------hhhhhccccccCCC
Confidence 46899999999876654 4799999999999999999999755443321 11122234556677
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 726 ECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 726 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
.....+.+++.-|+..||.+||....|+-.||..
T Consensus 413 gis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 413 GISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred CccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 7788899999999999999999999999888864
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.1e-22 Score=217.63 Aligned_cols=167 Identities=20% Similarity=0.136 Sum_probs=127.2
Q ss_pred HhhcCCCcceeEeeeCceEEEEEEEe--cccEEEEEecCCC-----CcccHHHHHHHHHHHhccCccceeeEEEEEecCC
Q 039107 482 HATKSFDESYVIGVGGFGKVYKGVIE--DKLKVAIKRSNPS-----SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGN 554 (817)
Q Consensus 482 ~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 554 (817)
....+|...++||+|+||+||+|..+ ++..+|||++... .....+.|.+|+++|++++|+|+++.+..+ .
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---G 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---C
Confidence 34567888999999999999999865 4667899986533 122345689999999999999998543322 4
Q ss_pred eEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCC-ccCcEEEcCCceeEEeeeccCc
Q 039107 555 EMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDV-KTTNILLDENWVAKVSDFGLSK 633 (817)
Q Consensus 555 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Di-kp~NIll~~~~~~kl~DFGla~ 633 (817)
..+|||||+++++|... . ... ...++.|++++|.|||+.+ |+|||| ||+|||++.++.+||+|||+++
T Consensus 92 ~~~LVmE~~~G~~L~~~-~-~~~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-R-PHG------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred CcEEEEEccCCCCHHHh-C-ccc------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccce
Confidence 57999999999999632 1 111 1467889999999999765 999999 9999999999999999999998
Q ss_pred cCCCCCCCc------eeeeeecCcCCCChhhhccC
Q 039107 634 TGPNMENGH------VSTVVKGSFGYLDPEYFKRQ 662 (817)
Q Consensus 634 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~ 662 (817)
......... .-+...+++.|+|||.+...
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 654322111 11355688899999988643
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.5e-20 Score=198.70 Aligned_cols=259 Identities=29% Similarity=0.411 Sum_probs=196.3
Q ss_pred CCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcc---cHHHHHHHHHHHhccCcc-ceeeEEEEEecCCeEEEEEEe
Q 039107 487 FDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQ---GVNEFVTEIEMLSKLRHK-HLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 487 f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~Ey 562 (817)
|.....||.|+||.||++... ..+++|.+...... ....|.+|+.+++.+.|+ +++++.+++......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 556678999999999999977 67899987765332 367899999999999988 799999999777778999999
Q ss_pred ccCCchhhhhhccc--cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCc-eeEEeeeccCccCCCCC
Q 039107 563 MALGTLREHIYNTK--KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENW-VAKVSDFGLSKTGPNME 639 (817)
Q Consensus 563 ~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DFGla~~~~~~~ 639 (817)
+.+++|.+++.... ..+.......++.|++.++.|+|+.+ ++||||||+||+++... .++++|||+++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997665443 26888999999999999999999776 99999999999999988 79999999997543322
Q ss_pred CCc----eeeeeecCcCCCChhhhcc---CCCCchHHHHHHHHHHHHHHhCCCCCCCCCcc-ccchHHHHHHHhhccCch
Q 039107 640 NGH----VSTVVKGSFGYLDPEYFKR---QQLTEKSDIYSFGVVLFEVLCARPALNPSLPK-EQVSLADWALHCKRKGIL 711 (817)
Q Consensus 640 ~~~----~~~~~~gt~~y~aPE~~~~---~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~-~~~~l~~~~~~~~~~~~~ 711 (817)
... ......|+..|+|||.+.. .......|+|++|++++++++|..|+...... ............... ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~ 235 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-SL 235 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-cc
Confidence 211 3456689999999999987 57899999999999999999999996554321 001111111111100 00
Q ss_pred hhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 712 DDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 712 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
. ..............+.+++..|+..+|..|.++.+....
T Consensus 236 ~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 236 A----SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred c----cccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 000000001223567899999999999999999888765
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.1e-22 Score=229.24 Aligned_cols=253 Identities=20% Similarity=0.234 Sum_probs=185.6
Q ss_pred cceeEeeeCceEEEEEEEe-cccEEEEEecC----CC-Cc-ccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 489 ESYVIGVGGFGKVYKGVIE-DKLKVAIKRSN----PS-SE-QGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 489 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~----~~-~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
...++|.|.+|.|+..... .....+.|... .. .. +....+..|+.+-..++|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4568999999977776643 22223333221 11 11 112225678888888999999888887777666666699
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
||+. +|..++... ..+....+..++.|+..|+.|||+.| |.|||||++|+++..++.+||+|||.+.........
T Consensus 402 ~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred cccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence 9999 999988654 35888899999999999999999766 999999999999999999999999999765443333
Q ss_pred --ceeeeeecCcCCCChhhhccCCCCc-hHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcc
Q 039107 642 --HVSTVVKGSFGYLDPEYFKRQQLTE-KSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPL 718 (817)
Q Consensus 642 --~~~~~~~gt~~y~aPE~~~~~~~s~-~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (817)
.......|+..|+|||.+...+|++ ..||||.|+++..|++|+.||......+.... ......+.-...
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~--------~~~~~~~~~~~~ 548 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK--------TNNYSDQRNIFE 548 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh--------hhcccccccccc
Confidence 5566778999999999999999976 48999999999999999999976544432210 000000000000
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 039107 719 LKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLW 754 (817)
Q Consensus 719 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 754 (817)
-...+....+.....++.++|+.+|.+|-|+++|++
T Consensus 549 ~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 549 GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 111122345566788999999999999999999985
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.5e-19 Score=180.94 Aligned_cols=137 Identities=18% Similarity=0.155 Sum_probs=106.6
Q ss_pred eeEeeeCceEEEEEEEecccEEEEEecCCCCcc--c-------HHHH-----------------HHHHHHHhccCcccee
Q 039107 491 YVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQ--G-------VNEF-----------------VTEIEMLSKLRHKHLV 544 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~-------~~~~-----------------~~E~~~l~~l~H~niv 544 (817)
..||+|+||.||+|...+|..||||+++..... . ...| ..|++.|.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 479999999999999888899999998654211 1 1122 3499999999887764
Q ss_pred eEEEEEecCCeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHH-HhCCCCceEecCCccCcEEEcCCce
Q 039107 545 SLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYL-HTGAKYTIIHRDVKTTNILLDENWV 623 (817)
Q Consensus 545 ~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~Dikp~NIll~~~~~ 623 (817)
....+.. ...+|||||+++++|...+.. ...+++.+...++.|++.+|.|| |+.+ |+||||||+|||+++ +.
T Consensus 83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~~-~~ 155 (190)
T cd05147 83 CPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYHD-GK 155 (190)
T ss_pred CCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEEC-Cc
Confidence 4333222 223899999998877654322 34688999999999999999999 6655 999999999999984 68
Q ss_pred eEEeeeccCcc
Q 039107 624 AKVSDFGLSKT 634 (817)
Q Consensus 624 ~kl~DFGla~~ 634 (817)
++|+|||++..
T Consensus 156 v~LiDFG~a~~ 166 (190)
T cd05147 156 LYIIDVSQSVE 166 (190)
T ss_pred EEEEEcccccc
Confidence 99999999875
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.1e-19 Score=184.13 Aligned_cols=171 Identities=15% Similarity=0.119 Sum_probs=131.8
Q ss_pred hhcCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccH---HH------HHHHHHHHhccCccceeeEEEEEecC
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGV---NE------FVTEIEMLSKLRHKHLVSLIGFCEEG 553 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~---~~------~~~E~~~l~~l~H~niv~l~g~~~~~ 553 (817)
..++|+..++||.|+||.||+... ++..+|+|.+.+...... .. +.+|++.+.+++|++|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 467899999999999999999765 456899999875432222 22 67999999999999999999886532
Q ss_pred --------CeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeE
Q 039107 554 --------NEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAK 625 (817)
Q Consensus 554 --------~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~k 625 (817)
...+|||||++|.+|.++.. ++. ....+++.+|..||+.+ ++||||||.||++++++ ++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EE
Confidence 35799999999999988631 222 34569999999999766 99999999999999988 99
Q ss_pred EeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHH
Q 039107 626 VSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVL 681 (817)
Q Consensus 626 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ell 681 (817)
|+|||.......... . ..+.....+..++|+|+||+.+.-+.
T Consensus 175 liDfg~~~~~~e~~a--~------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 175 IIDLSGKRCTAQRKA--K------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEECCCcccccchhh--H------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999998865321110 0 11334456678999999999987664
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.6e-19 Score=199.57 Aligned_cols=218 Identities=24% Similarity=0.394 Sum_probs=166.0
Q ss_pred HhccCccceeeEEEEEecCCeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccC
Q 039107 535 LSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTT 614 (817)
Q Consensus 535 l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~ 614 (817)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+......++|.-...+.++++.||+|||.. +--.|+.+++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeeeccc
Confidence 4678999999999999999999999999999999999988777899999999999999999999974 23399999999
Q ss_pred cEEEcCCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccC-------CCCchHHHHHHHHHHHHHHhCCCCC
Q 039107 615 NILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQ-------QLTEKSDIYSFGVVLFEVLCARPAL 687 (817)
Q Consensus 615 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~s~~sDV~S~Gvvl~elltG~~p~ 687 (817)
|+++|..+.+||+|||+.................-..-|.|||.++.. ..+.+.||||||++++|+++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999998765321111112222345679999998763 2477899999999999999999999
Q ss_pred CCCCcccc-chHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 039107 688 NPSLPKEQ-VSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQ 761 (817)
Q Consensus 688 ~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 761 (817)
........ ..++..+.. .....+.|.+... .+....+..++..||..+|.+||++++|-..++.+..
T Consensus 159 ~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKK-----GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccccCChHHHHHHHHh-----cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 76433222 223222221 1111122222211 1444478999999999999999999999887776654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.3e-18 Score=172.30 Aligned_cols=189 Identities=16% Similarity=0.094 Sum_probs=142.1
Q ss_pred CcceeEeeeCceEEEEEEEecccEEEEEecCCCCcc----cHHHHHHHHHHHhccC-ccceeeEEEEEecCCeEEEEEEe
Q 039107 488 DESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQ----GVNEFVTEIEMLSKLR-HKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 488 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
.+...|++|+||+||.+.- ++.+++.+.+.....- ....|.+|+++|++|. |+++++++++ ...+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3456899999999997655 5678888877755331 1225789999999995 5889999987 346999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCC-ccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDV-KTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Di-kp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
+.+.+|.+.+.. ....++.|++.+|.++|+++ |+|||| ||+|||+++++.++|+|||++.........
T Consensus 80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred ecCccHHhhhhh--------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 999888754311 12357889999999999776 999999 799999999999999999999854322210
Q ss_pred ----c-------eeeeeecCcCCCChhhhccC-CCC-chHHHHHHHHHHHHHHhCCCCCCCCCc
Q 039107 642 ----H-------VSTVVKGSFGYLDPEYFKRQ-QLT-EKSDIYSFGVVLFEVLCARPALNPSLP 692 (817)
Q Consensus 642 ----~-------~~~~~~gt~~y~aPE~~~~~-~~s-~~sDV~S~Gvvl~elltG~~p~~~~~~ 692 (817)
. .......++.|++|+...-. ..+ .+.+.++-|.-+|.++|++.+...+.+
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 0 01123468889999865432 333 678999999999999999988765543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-18 Score=174.38 Aligned_cols=139 Identities=16% Similarity=0.118 Sum_probs=109.3
Q ss_pred ceeEeeeCceEEEEEEEecccEEEEEecCCCCcc---------------------c-----HHHHHHHHHHHhccCccce
Q 039107 490 SYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQ---------------------G-----VNEFVTEIEMLSKLRHKHL 543 (817)
Q Consensus 490 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~E~~~l~~l~H~ni 543 (817)
...||+|++|.||+|...+|+.||||++...... . ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 3579999999999999878899999997754211 0 1123578999999999987
Q ss_pred eeEEEEEecCCeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHh-CCCCceEecCCccCcEEEcCCc
Q 039107 544 VSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHT-GAKYTIIHRDVKTTNILLDENW 622 (817)
Q Consensus 544 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dikp~NIll~~~~ 622 (817)
.....+... ..+|||||++++++..... ....++..+..+++.|++.+|.+||+ .+ |+||||||+|||++ ++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l-~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~ 154 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL-KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh-hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CC
Confidence 554444332 2489999999886544322 22457788899999999999999998 65 99999999999999 78
Q ss_pred eeEEeeeccCccC
Q 039107 623 VAKVSDFGLSKTG 635 (817)
Q Consensus 623 ~~kl~DFGla~~~ 635 (817)
.++|+|||++...
T Consensus 155 ~~~liDFG~a~~~ 167 (190)
T cd05145 155 KPYIIDVSQAVEL 167 (190)
T ss_pred CEEEEEcccceec
Confidence 9999999999764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.77 E-value=9.7e-18 Score=174.95 Aligned_cols=230 Identities=19% Similarity=0.283 Sum_probs=148.8
Q ss_pred CCcceeEeeeCceEEEEEEEec-ccEEEEEecCCC---CcccHHHHHHHHHHHhccC----------ccceeeEEEEEe-
Q 039107 487 FDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLR----------HKHLVSLIGFCE- 551 (817)
Q Consensus 487 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~----------H~niv~l~g~~~- 551 (817)
+.....||.|+++.||.++... ++++|+|..... .....+++++|.-....+. |-.++-.++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 4456789999999999999765 688999974432 3345677777776665542 223333333221
Q ss_pred --------cC---C-----eEEEEEEeccCCchhhhhhc---cc---cccchHhHHHHHHHHHHHHHHHHhCCCCceEec
Q 039107 552 --------EG---N-----EMCLVYDYMALGTLREHIYN---TK---KALSWKQRLEICIGAARGLHYLHTGAKYTIIHR 609 (817)
Q Consensus 552 --------~~---~-----~~~lV~Ey~~~gsL~~~l~~---~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~ 609 (817)
.. . ..+++|+-+. ++|.+++.. .. ..+....++.+..|+++.+++||+.+ +||+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred cCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence 11 1 2367777774 688877542 11 24566677888899999999999877 9999
Q ss_pred CCccCcEEEcCCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccC--------CCCchHHHHHHHHHHHHHH
Q 039107 610 DVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQ--------QLTEKSDIYSFGVVLFEVL 681 (817)
Q Consensus 610 Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~s~~sDV~S~Gvvl~ell 681 (817)
||||+|++++++|.++|+||+...... ........+..|.+||..... .++.+.|.|++|+++|.|+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g-----~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAG-----TRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETT-----EEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecC-----ceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 999999999999999999998776421 111113456789999987442 5789999999999999999
Q ss_pred hCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCC
Q 039107 682 CARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDR 746 (817)
Q Consensus 682 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R 746 (817)
|++.||....+..... | .-.... +.++.+..||..+|+.+|.+|
T Consensus 245 C~~lPf~~~~~~~~~~---~-----------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPE---W-----------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSG---G-----------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCcccccc---c-----------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999998653322110 0 111122 667788999999999999988
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.7e-19 Score=203.89 Aligned_cols=251 Identities=20% Similarity=0.225 Sum_probs=175.5
Q ss_pred CCCcceeEeeeCceEEEEEEEecccEEEEEecCCC-CcccHHHHHHHHHHH--hccCccceeeEEEEEecCCeEEEEEEe
Q 039107 486 SFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPS-SEQGVNEFVTEIEML--SKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l--~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
++...+.||++.|=+|.+|+.+.|. |+||.+-.. ..-....|.++++-+ ..++|||.+++.-+-......|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 4566778999999999999998885 888875443 344455555554444 445899999988776666777888888
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccC--CCCCC
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTG--PNMEN 640 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~--~~~~~ 640 (817)
+.+ +|+|.|..+ ..|...+.+-|+.|++.||..+|..+ |+|||||.+||||+.-.=+.|+||.--+.. +....
T Consensus 103 vkh-nLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred Hhh-hhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 864 888888543 35778888899999999999999665 999999999999998877899999876532 11111
Q ss_pred Ccee---eeeecCcCCCChhhhccC-----------CCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHh
Q 039107 641 GHVS---TVVKGSFGYLDPEYFKRQ-----------QLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHC 705 (817)
Q Consensus 641 ~~~~---~~~~gt~~y~aPE~~~~~-----------~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 705 (817)
..-. .....-.+|+|||.+... ..+++.||||+||++.||++ |+++|.-. .|..+....
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~aYr~~~ 251 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLAYRSGN 251 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHhHhccC
Confidence 1111 111223479999987431 26789999999999999987 57777421 111111000
Q ss_pred hccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 706 KRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 706 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
.......+ +++. ...+..++..|++.||++|-++++.|+.-++
T Consensus 252 --~~~~e~~L-----e~Ie---d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 252 --ADDPEQLL-----EKIE---DVSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred --ccCHHHHH-----HhCc---CccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 00001111 1111 1246889999999999999999999987433
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.6e-18 Score=198.54 Aligned_cols=254 Identities=21% Similarity=0.214 Sum_probs=186.5
Q ss_pred HHHhhcCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccC---ccceeeEEEEEecCCeE
Q 039107 480 IKHATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLR---HKHLVSLIGFCEEGNEM 556 (817)
Q Consensus 480 l~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~ 556 (817)
+......|.+.+.||+|+||+||+|...++..||+|.-++.+.- +|.-=.+++.+|+ -+.|..+...+.-.+..
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 33445578899999999999999999888999999998876542 2222334455555 23444444444556778
Q ss_pred EEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEc-------CCceeEEeee
Q 039107 557 CLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLD-------ENWVAKVSDF 629 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~-------~~~~~kl~DF 629 (817)
+||+||.+.|+|.+++. ..+.++|.....+..|+++-+..||..+ |||+||||+|+||. +..-++|+||
T Consensus 770 ~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred eeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEec
Confidence 99999999999999987 4457999999999999999999999665 99999999999994 3456899999
Q ss_pred ccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccC
Q 039107 630 GLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKG 709 (817)
Q Consensus 630 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 709 (817)
|.+-.+.-...+......++|-.+--+|...++..+...|.|.++.+++.||.|+..- ...+
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q------------------~~~g 907 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME------------------VKNG 907 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH------------------hcCC
Confidence 9997665555555667778999999999999999999999999999999999997421 0011
Q ss_pred chhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 039107 710 ILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQL 762 (817)
Q Consensus 710 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 762 (817)
. ...++..+++.+..+...+ +...+|.++-..=|...++...|++++..
T Consensus 908 ~-~~~~~~~~~Ry~~~~~W~~---~F~~lLN~~~~~~p~l~~lr~~~~~~~~~ 956 (974)
T KOG1166|consen 908 S-SWMVKTNFPRYWKRDMWNK---FFDLLLNPDCDTLPNLQELRTELEEVLAE 956 (974)
T ss_pred c-ceeccccchhhhhHHHHHH---HHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence 1 1112222333333344433 44445555555557788888777777644
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.4e-17 Score=168.40 Aligned_cols=138 Identities=20% Similarity=0.205 Sum_probs=106.4
Q ss_pred CCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhcc-----CccceeeEEEEEecCC---e-EE
Q 039107 487 FDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKL-----RHKHLVSLIGFCEEGN---E-MC 557 (817)
Q Consensus 487 f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~g~~~~~~---~-~~ 557 (817)
+....+||+|+||.||. +......+||++........+.+.+|+.+++.+ .||||++++|+++... . ..
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34466899999999996 433333478987765444567899999999999 5799999999998763 3 34
Q ss_pred EEEEe--ccCCchhhhhhccccccchHhHHHHHHHHHHHH-HHHHhCCCCceEecCCccCcEEEcC----CceeEEeeec
Q 039107 558 LVYDY--MALGTLREHIYNTKKALSWKQRLEICIGAARGL-HYLHTGAKYTIIHRDVKTTNILLDE----NWVAKVSDFG 630 (817)
Q Consensus 558 lV~Ey--~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivH~Dikp~NIll~~----~~~~kl~DFG 630 (817)
+|+|| +.+++|.+++.+. .+++. ..++.|++.++ +|||+++ |+||||||+|||++. ++.++|+||+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 78999 5579999999542 35554 35677888777 9999776 999999999999974 3489999965
Q ss_pred cCc
Q 039107 631 LSK 633 (817)
Q Consensus 631 la~ 633 (817)
.++
T Consensus 155 G~~ 157 (210)
T PRK10345 155 GES 157 (210)
T ss_pred CCc
Confidence 443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.2e-18 Score=192.32 Aligned_cols=225 Identities=22% Similarity=0.250 Sum_probs=175.3
Q ss_pred eEeeeCceEEEEEE----EecccEEEEEecCCCCccc--HHHHHHHHHHHhccC-ccceeeEEEEEecCCeEEEEEEecc
Q 039107 492 VIGVGGFGKVYKGV----IEDKLKVAIKRSNPSSEQG--VNEFVTEIEMLSKLR-HKHLVSLIGFCEEGNEMCLVYDYMA 564 (817)
Q Consensus 492 ~lG~G~fg~Vy~~~----~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~ 564 (817)
++|+|.||.|+++. .+.+.-+|+|.+++..... ......|..++..++ ||.+|++.-.++.....+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37899999998764 2334567777665442111 124556888888886 9999999999999999999999999
Q ss_pred CCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCcee
Q 039107 565 LGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVS 644 (817)
Q Consensus 565 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 644 (817)
+|.|...+.... .............++-++.+||+.+ |+|||+|++||+++.+|.+|+.|||+++..-....
T Consensus 81 gg~lft~l~~~~-~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~---- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEV-MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI---- 152 (612)
T ss_pred cchhhhccccCC-chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh----
Confidence 999998886544 3666666777788899999999554 99999999999999999999999999986433221
Q ss_pred eeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCC
Q 039107 645 TVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKIS 724 (817)
Q Consensus 645 ~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 724 (817)
.+||..|||||.+. ....+.|.||||++++||++|..||... .. ..++ ......+
T Consensus 153 --~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~----~~---------------~~Il--~~~~~~p 207 (612)
T KOG0603|consen 153 --ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD----TM---------------KRIL--KAELEMP 207 (612)
T ss_pred --cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH----HH---------------HHHh--hhccCCc
Confidence 17999999999998 5678899999999999999999999761 10 1111 1122345
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCH
Q 039107 725 PECLKKFADTAEKCLSDSGIDRPSM 749 (817)
Q Consensus 725 ~~~~~~l~~li~~cl~~dP~~RPt~ 749 (817)
.+......+++..++..+|.+|--.
T Consensus 208 ~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 208 RELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 6777788899999999999999654
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.9e-16 Score=161.78 Aligned_cols=134 Identities=23% Similarity=0.329 Sum_probs=111.7
Q ss_pred eeEeeeCceEEEEEEEecccEEEEEecCCCCcc--------cHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 491 YVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQ--------GVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
+.||+|++|.||+|.. .+..+++|+....... ....+.+|++++..++|+++.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4799999999999987 5567889976543211 124578899999999999988877777777788999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
+++++|.+++.... + .+..++.+++.+|.+||+.+ ++|||++|.|||++ ++.++|+|||+++.
T Consensus 81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999885322 2 78899999999999999765 99999999999999 78999999998865
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2e-16 Score=164.43 Aligned_cols=198 Identities=19% Similarity=0.206 Sum_probs=137.6
Q ss_pred CccceeeEEEEEec---------------------------CCeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHH
Q 039107 539 RHKHLVSLIGFCEE---------------------------GNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGA 591 (817)
Q Consensus 539 ~H~niv~l~g~~~~---------------------------~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i 591 (817)
+|||||++.++|.+ ...+|+||.-.+ .+|.+++.. +..+.....-|+.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~--~~~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT--RHRSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc--CCCchHHHHHHHHHH
Confidence 69999998876532 245789998775 488888843 346777888899999
Q ss_pred HHHHHHHHhCCCCceEecCCccCcEEE--cCC--ceeEEeeeccCccCCCC----CCCceeeeeecCcCCCChhhhccCC
Q 039107 592 ARGLHYLHTGAKYTIIHRDVKTTNILL--DEN--WVAKVSDFGLSKTGPNM----ENGHVSTVVKGSFGYLDPEYFKRQQ 663 (817)
Q Consensus 592 a~gL~yLH~~~~~~ivH~Dikp~NIll--~~~--~~~kl~DFGla~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~ 663 (817)
++|+.|||.++ |.|||+|++|||| |+| -.+.|+|||++-..... .........-|...-||||+....+
T Consensus 351 LEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 99999999665 9999999999999 344 46789999998542221 1111112234677889999976432
Q ss_pred --C----CchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHH
Q 039107 664 --L----TEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEK 737 (817)
Q Consensus 664 --~----s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~ 737 (817)
. -.|.|.|+.|.+.||++....||....+. ..+... .++.. -...+..++..+.+++..
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~r~-----Yqe~q---------LPalp~~vpp~~rqlV~~ 492 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDTRT-----YQESQ---------LPALPSRVPPVARQLVFD 492 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eechhh-----hhhhh---------CCCCcccCChHHHHHHHH
Confidence 1 24899999999999999999999863211 111110 11111 112344566678899999
Q ss_pred ccccCCCCCCCHHHHHHHHH
Q 039107 738 CLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 738 cl~~dP~~RPt~~evl~~L~ 757 (817)
.|+.||.+|++..-....|.
T Consensus 493 lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 493 LLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HhcCCccccCCccHHHhHHH
Confidence 99999999998665544443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.8e-16 Score=158.93 Aligned_cols=144 Identities=19% Similarity=0.135 Sum_probs=112.2
Q ss_pred HHHHHhhcCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCc----------------------ccHHHHHHHHHHH
Q 039107 478 AEIKHATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSE----------------------QGVNEFVTEIEML 535 (817)
Q Consensus 478 ~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l 535 (817)
.++......|...+.||+|+||.||++..++++.||||+...... .....+..|+.++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 455555555777889999999999999988889999998654320 0112366789999
Q ss_pred hccCcc--ceeeEEEEEecCCeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCcc
Q 039107 536 SKLRHK--HLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKT 613 (817)
Q Consensus 536 ~~l~H~--niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp 613 (817)
.++.|+ .++..++. ...++||||+++++|...... .....++.+++.++.+||+.+ |+||||||
T Consensus 88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p 153 (198)
T cd05144 88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHG---IIHGDLSE 153 (198)
T ss_pred HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCc
Confidence 999877 45555543 345899999999998775421 345678899999999999765 99999999
Q ss_pred CcEEEcCCceeEEeeeccCccC
Q 039107 614 TNILLDENWVAKVSDFGLSKTG 635 (817)
Q Consensus 614 ~NIll~~~~~~kl~DFGla~~~ 635 (817)
+||++++++.++|+|||++...
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred ccEEEcCCCcEEEEECCccccC
Confidence 9999999999999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.7e-16 Score=162.87 Aligned_cols=147 Identities=15% Similarity=0.108 Sum_probs=111.8
Q ss_pred HHHhhcCCCcceeEeeeCceEEEEEE--EecccEEEEEecCCCCcc------------------------cHHHHHHHHH
Q 039107 480 IKHATKSFDESYVIGVGGFGKVYKGV--IEDKLKVAIKRSNPSSEQ------------------------GVNEFVTEIE 533 (817)
Q Consensus 480 l~~~~~~f~~~~~lG~G~fg~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~ 533 (817)
+..-..-|...+.||+|+||.||+|. ..+++.||+|++...... ....+..|++
T Consensus 23 ~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 102 (237)
T smart00090 23 LLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR 102 (237)
T ss_pred HHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence 33334457788899999999999998 567899999987653210 0123568999
Q ss_pred HHhccCcc--ceeeEEEEEecCCeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCC
Q 039107 534 MLSKLRHK--HLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDV 611 (817)
Q Consensus 534 ~l~~l~H~--niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Di 611 (817)
+++++.+. .+.+++++ ...++||||+++++|...+... ..+...+...++.|++.+|++||+.+ +|+||||
T Consensus 103 ~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Di 175 (237)
T smart00090 103 NLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDL 175 (237)
T ss_pred HHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCC
Confidence 99999753 34455543 2348999999998887654322 24556667899999999999999543 3999999
Q ss_pred ccCcEEEcCCceeEEeeeccCcc
Q 039107 612 KTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 612 kp~NIll~~~~~~kl~DFGla~~ 634 (817)
||+||+++ ++.++|+|||++..
T Consensus 176 kp~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 176 SEYNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred ChhhEEEE-CCCEEEEEChhhhc
Confidence 99999999 78999999999875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.9e-16 Score=157.96 Aligned_cols=130 Identities=25% Similarity=0.336 Sum_probs=105.0
Q ss_pred eEeeeCceEEEEEEEecccEEEEEecCCCCc--------ccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 492 VIGVGGFGKVYKGVIEDKLKVAIKRSNPSSE--------QGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 492 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
+||+|+||.||+|.. ++..+++|....... ....++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 456899998553221 11356778999999999887665555555666779999999
Q ss_pred cCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 564 ALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 564 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
++++|.+++..... .++.+++.+|.+||+.+ ++|||++|.||+++ ++.++++|||+++.
T Consensus 80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND--------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH--------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999987743211 78999999999999765 99999999999999 78999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.9e-16 Score=182.76 Aligned_cols=135 Identities=21% Similarity=0.258 Sum_probs=109.8
Q ss_pred CCCcceeEeeeCceEEEEEEEecccEEEEEe-cCCC-C------cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIEDKLKVAIKR-SNPS-S------EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMC 557 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~-~~~~-~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 557 (817)
.|...++||+|+||+||+|.+.+.. +++|+ .... . ....+.+.+|++++++++|++++....++......+
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 3456779999999999999876553 33333 2211 1 112356889999999999999998888887777889
Q ss_pred EEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 558 LVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 558 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
+||||+++++|.+++. ....++.+++++|.+||+.+ ++||||||+|||+ +++.++|+|||+++.
T Consensus 413 lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 9999999999998774 45679999999999999765 9999999999999 567999999999976
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.8e-17 Score=177.21 Aligned_cols=173 Identities=27% Similarity=0.394 Sum_probs=129.3
Q ss_pred CeEEEEEEeccCCchhhhhhcccc--ccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeecc
Q 039107 554 NEMCLVYDYMALGTLREHIYNTKK--ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGL 631 (817)
Q Consensus 554 ~~~~lV~Ey~~~gsL~~~l~~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGl 631 (817)
..+++.|++|...+|.++|.+++. ..++...+.++.|++.|+.| ++ .+|+|+||.||+...+.++||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence 357899999999999999964433 68889999999999999999 44 99999999999999999999999999
Q ss_pred CccCCCCC----CCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhh
Q 039107 632 SKTGPNME----NGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCK 706 (817)
Q Consensus 632 a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 706 (817)
........ .....+...||..||+||.+.++.|+.|+||||||++|+||+. -...+.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e------------------ 464 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE------------------ 464 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH------------------
Confidence 87654433 1234556689999999999999999999999999999999997 222111
Q ss_pred ccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 039107 707 RKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGD 751 (817)
Q Consensus 707 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 751 (817)
+...+.++-|..+.+.+..+. ..-..++++++++.|.+||++.+
T Consensus 465 r~~t~~d~r~g~ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 465 RIATLTDIRDGIIPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred HHHhhhhhhcCCCChHHhhcC-cHHHHHHHHhcCCCcccCchHHH
Confidence 011112222222221111111 12257999999999999994443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.2e-14 Score=139.17 Aligned_cols=134 Identities=19% Similarity=0.188 Sum_probs=115.1
Q ss_pred ceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCc--cceeeEEEEEecCCeEEEEEEeccCCc
Q 039107 490 SYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRH--KHLVSLIGFCEEGNEMCLVYDYMALGT 567 (817)
Q Consensus 490 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~Ey~~~gs 567 (817)
.+.||+|.++.||++...+ ..+++|....... ...+.+|+.++..++| .++++++++....+..++++||++++.
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 4679999999999999866 6899999875543 4678899999999976 589999999888888999999999887
Q ss_pred hhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 568 LREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 568 L~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
+..+ +......++.+++++|++||.....+++|+||+|+||++++.+.++++|||+++.
T Consensus 80 ~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 7654 5566778899999999999975445799999999999999989999999998865
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.6e-16 Score=178.99 Aligned_cols=210 Identities=24% Similarity=0.338 Sum_probs=142.0
Q ss_pred hcCCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
..+|...++|..|++|.||..+++. .+.+|+|+-+ .+. +.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~l-----ilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QNL-----ILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccc-cch-----hhhc--cccccCCccee------------------
Confidence 3568888999999999999998875 3567774322 211 1110 22222233332
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC--
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN-- 640 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~-- 640 (817)
|+-...+... +.++.. ++.+++|||+.+ |+|||+||+|.+|+.-|.+|+.|||+++..-....
T Consensus 136 ---gDc~tllk~~-g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 ---GDCATLLKNI-GPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred ---chhhhhcccC-CCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 3444444322 223322 278899999665 99999999999999999999999999875321110
Q ss_pred -----------CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccC
Q 039107 641 -----------GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKG 709 (817)
Q Consensus 641 -----------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 709 (817)
.-....++||+.|.|||++..+.|...+|.|++|+++||.+-|+.||.++.+++..... +.
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~v--is------ 272 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV--IS------ 272 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhh--hh------
Confidence 01123568999999999999999999999999999999999999999988665432110 00
Q ss_pred chhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 039107 710 ILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPS 748 (817)
Q Consensus 710 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt 748 (817)
+ .....+-++....+..+++.+.|+.+|..|--
T Consensus 273 ---d---~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 273 ---D---DIEWPEEDEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred ---h---hccccccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence 0 00011112334456788999999999999943
|
|
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.7e-15 Score=148.77 Aligned_cols=137 Identities=27% Similarity=0.319 Sum_probs=83.2
Q ss_pred eeeeccCccccCCCCCcccccccccCCCCceeccCCCCccCC-CceeeeeccCCCCCCChhhhhhhhhcCCCcccccccc
Q 039107 180 MFRLNVAGQYISPKNDSGGLMRSWQNDEPYLFGAGYGIPMKA-DEVQIDYKSLPDYSAPPDVYMTARYMGVDAHTNMEFN 258 (817)
Q Consensus 180 ~~R~n~Gg~~i~~~~d~~~~~R~W~~d~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~P~~v~~ta~~~~~~~~~~~~~~ 258 (817)
++|+|+||+.. .|. ....|++|..|..+......... ...............++.+|+|+|.... +
T Consensus 2 ~~~IN~Gg~~~---~~~--~g~~w~~D~~~~~g~~~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~~--------~ 68 (174)
T PF11721_consen 2 VLRINAGGPAY---TDS--SGIVWEADQYYTGGSWGYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGPS--------S 68 (174)
T ss_dssp EEEEEETSSSE---EET--TTEEE-SSSSSTTSS-----------SSTTS--TTS-HHHHHTTT-----SS--------S
T ss_pred EEEEECCCCcc---cCC--CCCEEcCCCCCCCCCcccccccccccccccccccccCCCchhhhHhhcCCCC--------c
Confidence 68999999755 555 66999999987433321000000 0000000111122467899999999644 6
Q ss_pred eeEEEEecCCCceEEEEEeeeccCCc----ccccceEEEEEEcCcccccccchhhhccCCCccEEEEE-EEEEecC
Q 039107 259 LTWIFRVDANFTYYVRLHFCEFKPDI----NKINQRVFNIYINNQTAQADADVIAWTHGQGVPIYKDY-AVYVEDL 329 (817)
Q Consensus 259 ~~~~~p~~~~~~y~v~lhF~e~~~~~----~~~~~R~F~i~i~~~~~~~~~~~~~~~~~~~~p~~~~~-~v~v~~~ 329 (817)
++|.+|+.++..|.|+|||||+...- ...++|+|||+|||+++.++|||.+.+|+..+|+++.| .|.|.++
T Consensus 69 f~Y~ip~~~~G~Y~V~L~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v~dg 144 (174)
T PF11721_consen 69 FSYDIPVVPNGTYTVRLHFAELYFGASGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTVTDG 144 (174)
T ss_dssp EEEEEE--S-EEEEEEEEEE-SSS--------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEEETT
T ss_pred eEEEEecCCCcEEEEEEEeccccccccccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEEeCC
Confidence 99999977777899999999997632 23799999999999999999999999998888888777 8888765
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.4e-14 Score=143.29 Aligned_cols=137 Identities=19% Similarity=0.167 Sum_probs=97.3
Q ss_pred ceeEeeeCceEEEEEEEecccEEEEEecCCCCcc--cHHH----------------------HHHHHHHHhccCcc--ce
Q 039107 490 SYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQ--GVNE----------------------FVTEIEMLSKLRHK--HL 543 (817)
Q Consensus 490 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~H~--ni 543 (817)
.+.||+|+||+||+|...+++.||||+....... .... ...|.+.+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 3579999999999999888889999987653211 1111 13566666666443 24
Q ss_pred eeEEEEEecCCeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCce
Q 039107 544 VSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWV 623 (817)
Q Consensus 544 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~ 623 (817)
.+.+++ ...++||||++++.+......... .. .+...++.+++.++.+||.. .+|+|+||||+||+++ ++.
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYRE--AGLVHGDLSEYNILVD-DGK 152 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhc--cCcCcCCCChhhEEEE-CCc
Confidence 445543 245899999998654321111110 11 66788999999999999971 3599999999999999 889
Q ss_pred eEEeeeccCccC
Q 039107 624 AKVSDFGLSKTG 635 (817)
Q Consensus 624 ~kl~DFGla~~~ 635 (817)
++|+|||++...
T Consensus 153 ~~liDfg~a~~~ 164 (187)
T cd05119 153 VYIIDVPQAVEI 164 (187)
T ss_pred EEEEECcccccc
Confidence 999999998753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.53 E-value=5.8e-14 Score=145.73 Aligned_cols=135 Identities=16% Similarity=0.166 Sum_probs=104.0
Q ss_pred ceeEe-eeCceEEEEEEEecccEEEEEecCCCC-------------cccHHHHHHHHHHHhccCccce--eeEEEEEecC
Q 039107 490 SYVIG-VGGFGKVYKGVIEDKLKVAIKRSNPSS-------------EQGVNEFVTEIEMLSKLRHKHL--VSLIGFCEEG 553 (817)
Q Consensus 490 ~~~lG-~G~fg~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~~ 553 (817)
..+|| .|+.|+||+.... +..++||+..... ......+.+|++++.+|+|+++ ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 34788 8999999999876 4578888764311 1223567889999999998875 7777775432
Q ss_pred C----eEEEEEEeccC-CchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEee
Q 039107 554 N----EMCLVYDYMAL-GTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSD 628 (817)
Q Consensus 554 ~----~~~lV~Ey~~~-gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 628 (817)
. ..++|+|++++ .+|.+++.. ..++.. .+.+++.+|.+||+.+ |+||||||.|||++.++.++|+|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEE
Confidence 2 23599999997 689888743 234433 3678999999999776 99999999999999988999999
Q ss_pred eccCcc
Q 039107 629 FGLSKT 634 (817)
Q Consensus 629 FGla~~ 634 (817)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 998865
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.47 E-value=3.3e-15 Score=173.44 Aligned_cols=253 Identities=24% Similarity=0.276 Sum_probs=188.7
Q ss_pred CCCcceeEeeeCceEEEEEEEec--ccEEEEEecCCCC--cccHHHHHHHHHHHhccC-ccceeeEEEEEecCCeEEEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIED--KLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLR-HKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 560 (817)
.|...+.||+|.|+.|-...... ...+|+|.+.... .........|..+-+.+. |+|++.+++.....+..+++.
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 34445569999999998776533 3456777665443 222334445777777786 999999999999999999999
Q ss_pred EeccCCchhhhh-hccccccchHhHHHHHHHHHHHHHHHH-hCCCCceEecCCccCcEEEcCCc-eeEEeeeccCccCCC
Q 039107 561 DYMALGTLREHI-YNTKKALSWKQRLEICIGAARGLHYLH-TGAKYTIIHRDVKTTNILLDENW-VAKVSDFGLSKTGPN 637 (817)
Q Consensus 561 Ey~~~gsL~~~l-~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~Dikp~NIll~~~~-~~kl~DFGla~~~~~ 637 (817)
+|..++++.+.+ +......+....-..+.|+..++.|+| ..+ +.|+||||+|.+++..+ ..+++|||+|.....
T Consensus 101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred CcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999988 444335677778889999999999999 655 99999999999999999 999999999987665
Q ss_pred -CCCCceeeeeec-CcCCCChhhhccC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhc
Q 039107 638 -MENGHVSTVVKG-SFGYLDPEYFKRQ-QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDI 714 (817)
Q Consensus 638 -~~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 714 (817)
...........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+....... .....|.... ..
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~~---~~---- 249 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSNK---GR---- 249 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeecccc---cc----
Confidence 333444455678 9999999998874 45678999999999999999999987654433 1222232221 00
Q ss_pred cCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 039107 715 IDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVL 753 (817)
Q Consensus 715 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 753 (817)
...... ........+++.+++..+|..|.+.+++.
T Consensus 250 ~~~~~~----~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 250 FTQLPW----NSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred cccCcc----ccCChhhhhcccccccCCchhcccccccc
Confidence 000111 12234467888999999999999988775
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.45 E-value=4.4e-14 Score=144.10 Aligned_cols=203 Identities=25% Similarity=0.360 Sum_probs=141.8
Q ss_pred HHHhccCccceeeEEEEEecC-----CeEEEEEEeccCCchhhhhhccc---cccchHhHHHHHHHHHHHHHHHHhCCCC
Q 039107 533 EMLSKLRHKHLVSLIGFCEEG-----NEMCLVYDYMALGTLREHIYNTK---KALSWKQRLEICIGAARGLHYLHTGAKY 604 (817)
Q Consensus 533 ~~l~~l~H~niv~l~g~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 604 (817)
.-|-.+-|.|||+++.|+.+. ....++.|||..|+|.++|.+.+ +.+......+++-||..||.|||+. .+
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence 345556799999999998543 45789999999999999997643 3688888899999999999999987 68
Q ss_pred ceEecCCccCcEEEcCCceeEEeeeccCccCCC--CCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh
Q 039107 605 TIIHRDVKTTNILLDENWVAKVSDFGLSKTGPN--MENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC 682 (817)
Q Consensus 605 ~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt 682 (817)
+|+|+++..+-|++..++-+|+.--.-...-.. ...........+-++|.+||.-.....+.++|||+||+..+||-.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 999999999999999999888742111110000 000112223456789999999877788889999999999999987
Q ss_pred CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 683 ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 683 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
+..-.......... +..+...+- .+... .-..++.+|++..|..||+|++++.|
T Consensus 278 lEiq~tnseS~~~~-----------ee~ia~~i~-~len~-------lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 278 LEIQSTNSESKVEV-----------EENIANVII-GLENG-------LQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred heeccCCCcceeeh-----------hhhhhhhee-eccCc-------cccCcCcccccCCCCCCcchhhhhcC
Confidence 76432211111000 000000000 00000 11457899999999999999999866
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.42 E-value=7.6e-13 Score=149.23 Aligned_cols=143 Identities=19% Similarity=0.215 Sum_probs=101.6
Q ss_pred CCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccH----------------------------------------
Q 039107 486 SFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGV---------------------------------------- 525 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~---------------------------------------- 525 (817)
.|. .+.||.|++|.||+|++++|+.||||+..+......
T Consensus 119 ~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 119 EFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred hCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 344 357999999999999999999999999876532110
Q ss_pred HHHHHHHHHHhccC----ccceeeEEEE-EecCCeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHH-HHHHHH
Q 039107 526 NEFVTEIEMLSKLR----HKHLVSLIGF-CEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAAR-GLHYLH 599 (817)
Q Consensus 526 ~~~~~E~~~l~~l~----H~niv~l~g~-~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~-gL~yLH 599 (817)
-+|.+|++.+.+++ |.+-+.+-.. .......+|||||++|++|.++.......+ .+.+++..++. .+..+|
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVL 274 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHH
Confidence 02455666665552 2222232222 233456799999999999988764322222 34567777766 467889
Q ss_pred hCCCCceEecCCccCcEEEcCCceeEEeeeccCccC
Q 039107 600 TGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTG 635 (817)
Q Consensus 600 ~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 635 (817)
..+ ++|+|+||.||++++++.++|+|||++...
T Consensus 275 ~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 275 RDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred hCC---ceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 655 999999999999999999999999998754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.29 E-value=3.2e-12 Score=142.01 Aligned_cols=248 Identities=21% Similarity=0.213 Sum_probs=180.2
Q ss_pred CCCcceeEee--eCceEEEEEEE---ecccEEEEEecCC--CCcccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeEE
Q 039107 486 SFDESYVIGV--GGFGKVYKGVI---EDKLKVAIKRSNP--SSEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEMC 557 (817)
Q Consensus 486 ~f~~~~~lG~--G~fg~Vy~~~~---~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 557 (817)
.|.....+|. |.+|.||++.. .+...+|+|+-+. ...+....=.+|+...+++ .|+|.++....++..+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3455667899 99999999986 3557789988332 2223333334677777777 4999999888999999999
Q ss_pred EEEEeccCCchhhhhhccccccchHhHHHHHHHHHH----HHHHHHhCCCCceEecCCccCcEEEcCC-ceeEEeeeccC
Q 039107 558 LVYDYMALGTLREHIYNTKKALSWKQRLEICIGAAR----GLHYLHTGAKYTIIHRDVKTTNILLDEN-WVAKVSDFGLS 632 (817)
Q Consensus 558 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DFGla 632 (817)
+-.|++. .+|.++.+.....++....+.+..+..+ ||.++|+.. ++|-|+||.||++..+ ...++.|||+.
T Consensus 195 iqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred eeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCccee
Confidence 9999886 7888888777667888888888888888 999999765 9999999999999999 88999999998
Q ss_pred ccCCCCCCC---ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccC
Q 039107 633 KTGPNMENG---HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKG 709 (817)
Q Consensus 633 ~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 709 (817)
.......-. .......|...|++||..+ +.++.++|+|++|.+.+|..++-......... .|.. .+..
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~W~~--~r~~ 341 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS------SWSQ--LRQG 341 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC------Cccc--cccc
Confidence 765433211 1122336788999999876 56789999999999999998887654332111 1111 0110
Q ss_pred chhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 039107 710 ILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLW 754 (817)
Q Consensus 710 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 754 (817)
. +..++...-..++...+..+++.+|..|++.+.+..
T Consensus 342 -----~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 342 -----Y---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -----c---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0 111122222334555889999999999999887764
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.6e-11 Score=119.13 Aligned_cols=130 Identities=18% Similarity=0.102 Sum_probs=97.0
Q ss_pred eeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCcccee-eEEEEEecCCeEEEEEEeccCCchh
Q 039107 491 YVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLV-SLIGFCEEGNEMCLVYDYMALGTLR 569 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey~~~gsL~ 569 (817)
+.|+.|.++.||++... +..+++|....... ....+..|+.+++.+.+.+++ +++.+.. ...++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccc
Confidence 46889999999999875 55899999765432 223567899999998765544 4555433 3458999999998876
Q ss_pred hhhhccccccchHhHHHHHHHHHHHHHHHHhCC--CCceEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 570 EHIYNTKKALSWKQRLEICIGAARGLHYLHTGA--KYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 570 ~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
+.. .....++.+++++|+.||+.. ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 80 ~~~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED---------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc---------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 530 112345678999999999764 23469999999999999 56899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.9e-11 Score=118.83 Aligned_cols=144 Identities=22% Similarity=0.328 Sum_probs=81.5
Q ss_pred CCCCCCCcCCCCCccccCCCcccCCCCCC---------ceeeccCCCCCCCCccceeeeeecceeEEEeccCCCeEEEEE
Q 039107 1 CGSKDGGIDADGRSWEPDDKYLSKGESKP---------TRATYQDSSLVSKVPYMDARVFKQEMSYELPIRSQSRYWVRF 71 (817)
Q Consensus 1 CG~~~~~~~~~~~~w~~D~~~~~~g~~~~---------~~~~~~~~~~~~~~~~~t~R~f~~~~~Y~~~~~~~~~y~vR~ 71 (817)
||++.- +|..|+.|.+|..|..++..-. ......-+....+..|+|.|.-|..++|.||+.+.|.|.|||
T Consensus 7 ~Gg~~~-~~~~g~~w~~D~~~~~g~~~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~~~f~Y~ip~~~~G~Y~V~L 85 (174)
T PF11721_consen 7 AGGPAY-TDSSGIVWEADQYYTGGSWGYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGPSSFSYDIPVVPNGTYTVRL 85 (174)
T ss_dssp ETSSSE-EETTTEEE-SSSSSTTSS-----------SSTTS--TTS-HHHHHTTT-----SSSEEEEEE--S-EEEEEEE
T ss_pred CCCCcc-cCCCCCEEcCCCCCCCCCcccccccccccccccccccccCCCchhhhHhhcCCCCceEEEEecCCCcEEEEEE
Confidence 788655 7778999999999976555100 000001111223455999999888899999977889999999
Q ss_pred EeccCCCCC----CCcccceeEEEeCCeEEEeccCcchhhhcccce-eEEEEE-EecCCCCCcEEEEEeeCC--------
Q 039107 72 HFYPSTYPE----LNVANSYFSVVANDVTLLSNFSASITAQAVAQA-YLIKEF-SLAPMDSDILKIIFRPSD-------- 137 (817)
Q Consensus 72 ~f~~~~~~~----~~~~~~~f~v~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~l~f~p~~-------- 137 (817)
||....+.. .....|.|+|.++|..++.||+... .+.... ...+.+ -+. .+.+.|.|.|....
T Consensus 86 ~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~~Di~~--~~G~~~~~~~~~~~~v~-v~dg~L~i~f~~~~~~~~~i~~ 162 (174)
T PF11721_consen 86 HFAELYFGASGGASGPGQRVFDVYVNGETVLKNFDIYA--EAGGFNKAAVRRFFNVT-VTDGTLNIQFVWAGKGTLCIPF 162 (174)
T ss_dssp EEE-SSS--------SSSS-EEEEETTEEEEEEE-HHH--HHSSSS---EEEEEEEE-EETTEEETTEEEE--SEEEEEE
T ss_pred EeccccccccccccCCCceEEEEEecceEEEeccCHHH--HcCCCceEEEEEEEEEE-EeCCcEEEEEEecCCCcEEeec
Confidence 997666555 4567899999999999999995443 332222 233333 342 35567777777311
Q ss_pred -CCCCcceeEeee
Q 039107 138 -KHSGTFAFINGI 149 (817)
Q Consensus 138 -~~~~~~~fi~~i 149 (817)
...+. |.||||
T Consensus 163 ~~~~~~-p~IsaI 174 (174)
T PF11721_consen 163 IGSYGN-PLISAI 174 (174)
T ss_dssp ESSSSS-SSEEEE
T ss_pred cccCCC-cEEeeC
Confidence 12345 888887
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.7e-10 Score=131.60 Aligned_cols=141 Identities=16% Similarity=0.120 Sum_probs=93.9
Q ss_pred cCCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCCCccc----------------------------------H----
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPSSEQG----------------------------------V---- 525 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~----------------------------------~---- 525 (817)
..|+. +.||+|++|.||+|++++ |+.||||+..+...+. .
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45666 689999999999999987 8999999987652110 0
Q ss_pred --HHHHHHHHHHhccC----ccceeeEEEEEe-cCCeEEEEEEeccCCchhhhh--hccc---cccchHhHHHHHHHHHH
Q 039107 526 --NEFVTEIEMLSKLR----HKHLVSLIGFCE-EGNEMCLVYDYMALGTLREHI--YNTK---KALSWKQRLEICIGAAR 593 (817)
Q Consensus 526 --~~~~~E~~~l~~l~----H~niv~l~g~~~-~~~~~~lV~Ey~~~gsL~~~l--~~~~---~~l~~~~~~~i~~~ia~ 593 (817)
-+|.+|+..+.+++ +.+.+.+=.++. -....+|||||++|+.|.++- ...+ +.+.......++.|++
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif- 277 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF- 277 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-
Confidence 12344555555442 333333333332 245678999999999997742 2111 1233333334444443
Q ss_pred HHHHHHhCCCCceEecCCccCcEEEcCCc----eeEEeeeccCccCC
Q 039107 594 GLHYLHTGAKYTIIHRDVKTTNILLDENW----VAKVSDFGLSKTGP 636 (817)
Q Consensus 594 gL~yLH~~~~~~ivH~Dikp~NIll~~~~----~~kl~DFGla~~~~ 636 (817)
.. +++|+|+||.||+++.++ +++++|||++....
T Consensus 278 ------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 ------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 23 499999999999999887 99999999987643
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.13 E-value=5.6e-10 Score=114.61 Aligned_cols=142 Identities=19% Similarity=0.282 Sum_probs=111.9
Q ss_pred eeEeeeCceEEEEEEEecccEEEEEecCCCCc-ccHHHHHHHHHHHhccCc--cceeeEEEEEecCC---eEEEEEEecc
Q 039107 491 YVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSE-QGVNEFVTEIEMLSKLRH--KHLVSLIGFCEEGN---EMCLVYDYMA 564 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~---~~~lV~Ey~~ 564 (817)
+.|+.|..+.||++...++..+++|....... .....+..|+++++.+++ .++.+++.++.... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 46899999999999987767899999765432 234678899999999975 44677888876643 5689999999
Q ss_pred CCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhC-------------------------------------------
Q 039107 565 LGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTG------------------------------------------- 601 (817)
Q Consensus 565 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------- 601 (817)
+.+|.+.+.. ..++..++..++.+++++|..||+.
T Consensus 84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 9988876532 3467777888888888888888842
Q ss_pred ----------CCCceEecCCccCcEEEcC--CceeEEeeeccCcc
Q 039107 602 ----------AKYTIIHRDVKTTNILLDE--NWVAKVSDFGLSKT 634 (817)
Q Consensus 602 ----------~~~~ivH~Dikp~NIll~~--~~~~kl~DFGla~~ 634 (817)
....++|+|+++.||++++ ++.+.|+||+.+..
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1256899999999999998 67789999998765
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.4e-09 Score=122.08 Aligned_cols=166 Identities=16% Similarity=0.202 Sum_probs=123.8
Q ss_pred EecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccCCchhhhhhccccccchHhHH
Q 039107 506 IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL 585 (817)
Q Consensus 506 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~ 585 (817)
..++.+|.|...+..+........+-++.|+.|+||||++++...+..+..|||.|-+. -|..++.. +......
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~----l~~~~v~ 107 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE----LGKEEVC 107 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH----hHHHHHH
Confidence 34566788877766655334556778899999999999999999999999999999875 45555533 3355667
Q ss_pred HHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCC
Q 039107 586 EICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLT 665 (817)
Q Consensus 586 ~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s 665 (817)
-.+.||+.||.+||+.+ +++|++|...-|++++.|.-||++|.++........ ......---.|..|+.+....
T Consensus 108 ~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--
Confidence 78899999999999754 799999999999999999999999998865322221 111111122456666543222
Q ss_pred chHHHHHHHHHHHHHHhC
Q 039107 666 EKSDIYSFGVVLFEVLCA 683 (817)
Q Consensus 666 ~~sDV~S~Gvvl~elltG 683 (817)
-..|.|-||++++|++.|
T Consensus 182 ~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhhHHHHHHHHhCc
Confidence 356999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.09 E-value=8.7e-10 Score=109.65 Aligned_cols=134 Identities=13% Similarity=0.115 Sum_probs=96.4
Q ss_pred eeEeeeCceEEEEEEEec-------ccEEEEEecCCCCc---------------------cc-HHHHH----HHHHHHhc
Q 039107 491 YVIGVGGFGKVYKGVIED-------KLKVAIKRSNPSSE---------------------QG-VNEFV----TEIEMLSK 537 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~~---------------------~~-~~~~~----~E~~~l~~ 537 (817)
..||.|.-+.||.|.-.+ +..+|||..+.... .. .+.+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 379999999999998543 46899997553210 00 12233 79999999
Q ss_pred cCc--cceeeEEEEEecCCeEEEEEEeccCCchhh-hhhccccccchHhHHHHHHHHHHHHHHH-HhCCCCceEecCCcc
Q 039107 538 LRH--KHLVSLIGFCEEGNEMCLVYDYMALGTLRE-HIYNTKKALSWKQRLEICIGAARGLHYL-HTGAKYTIIHRDVKT 613 (817)
Q Consensus 538 l~H--~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~-~l~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~Dikp 613 (817)
+.. -++.+++++ ...+|||||+.+..+.. .+.. ..++..+...+..+++.+|..| |.. +|||+||++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~ 153 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSE 153 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCH
Confidence 953 566677765 45689999998754422 1211 1344456677889999999999 755 499999999
Q ss_pred CcEEEcCCceeEEeeeccCcc
Q 039107 614 TNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 614 ~NIll~~~~~~kl~DFGla~~ 634 (817)
.|||+++ +.+.|+|||.+-.
T Consensus 154 ~NIL~~~-~~v~iIDF~qav~ 173 (197)
T cd05146 154 YNMLWHD-GKVWFIDVSQSVE 173 (197)
T ss_pred HHEEEEC-CcEEEEECCCcee
Confidence 9999975 5899999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.5e-09 Score=128.21 Aligned_cols=141 Identities=19% Similarity=0.259 Sum_probs=97.6
Q ss_pred CCccccCCCcccCCC-C--CCceeec--cCCCCCCCCccceeeeeec---ceeEEEeccCCCeEEEEEEeccCCCCCCCc
Q 039107 12 GRSWEPDDKYLSKGE-S--KPTRATY--QDSSLVSKVPYMDARVFKQ---EMSYELPIRSQSRYWVRFHFYPSTYPELNV 83 (817)
Q Consensus 12 ~~~w~~D~~~~~~g~-~--~~~~~~~--~~~~~~~~~~~~t~R~f~~---~~~Y~~~~~~~~~y~vR~~f~~~~~~~~~~ 83 (817)
.|.|.+|..|..+.. . ....+.+ ..|...+...|+|||.+.. ..+|.+++.++++|+|||||+.........
T Consensus 217 dR~W~~d~~~~~~~~~~~st~~~I~~~~~~~~~~P~~VyqTA~~~~~~~~~lty~~~v~~~~~Y~VrLhFaEi~~~~~~~ 296 (623)
T PLN03150 217 DRFWNRMQTFGSGSDQAISTENVIKKASNAPNFYPESLYQSALVSTDTQPDLSYTMDVDPNRNYSVWLHFAEIDNSITAE 296 (623)
T ss_pred ccccCcCcccCCCcccccccccccccccCCCccChHHHhhhhccccCCCCceEEEeecCCCCCEEEEEEEEeccCccCCC
Confidence 699999998864321 1 1111111 1222234456999999986 367999999999999999999987555555
Q ss_pred ccceeEEEeCCeEEEeccCcchhhhcccceeEEEEEEecCCCCCcEEEEEeeCCCCCCcceeEeeeeeecCCcc
Q 039107 84 ANSYFSVVANDVTLLSNFSASITAQAVAQAYLIKEFSLAPMDSDILKIIFRPSDKHSGTFAFINGIELVPSPDL 157 (817)
Q Consensus 84 ~~~~f~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~f~p~~~~~~~~~fi~~iEl~~~~~~ 157 (817)
..+.|+|.++|..+..+|........... .+++.+.+... .+.+.|.|+|.+. +.||||||||+.+...
T Consensus 297 ~~R~F~V~ing~~~~~~~di~~~~g~~~~-~~~~~~~v~~~-~g~l~isl~p~~~---s~pilNaiEI~~~~~~ 365 (623)
T PLN03150 297 GKRVFDVLINGDTAFKDVDIVKMSGERYT-ALVLNKTVAVS-GRTLTIVLQPKKG---THAIINAIEVFEIITA 365 (623)
T ss_pred ceEEEEEEECCEEeecccChhhhcCCccc-ceEEEeEEeec-CCeEEEEEeeCCC---Ccceeeeeeeeecccc
Confidence 67999999999999998864322211222 34444555443 4789999999743 3499999999998864
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=3.1e-09 Score=102.01 Aligned_cols=130 Identities=21% Similarity=0.261 Sum_probs=100.2
Q ss_pred eEeeeCceEEEEEEEecccEEEEEe-cCCCCc-------ccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 492 VIGVGGFGKVYKGVIEDKLKVAIKR-SNPSSE-------QGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 492 ~lG~G~fg~Vy~~~~~~~~~vavK~-~~~~~~-------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
++++|+-+.+|.+.+.+. .+++|. +++.-. -....-.+|+++|.+++--.|...+=+..+.....++|||+
T Consensus 3 ~i~~GAEa~i~~~~~~g~-~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGL-PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeeccCc-ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 578999999999977554 466665 332211 11234678999999997666665555666778889999999
Q ss_pred cCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 564 ALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 564 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
++-.|.+.+... +..++..+-.-+.-||..+ |||+||.++||++.... +.++||||+..
T Consensus 82 ~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA--------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc--------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999888544 3567788888889999766 99999999999999874 89999999875
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=3.8e-09 Score=100.70 Aligned_cols=142 Identities=22% Similarity=0.235 Sum_probs=103.8
Q ss_pred cceeEeeeCceEEEEEEEecccEEEEEe-cCCCC-------cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 489 ESYVIGVGGFGKVYKGVIEDKLKVAIKR-SNPSS-------EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 489 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~-~~~~~-------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
...+|-+|+-+.|+++...+. ...||. ..+.- +-..++.++|+++|.+++--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~Ge-~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGE-AAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccCCc-eeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 455899999999999988664 555554 33221 122456788999999987555555444555566678999
Q ss_pred EeccC-CchhhhhhccccccchHhH-HHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCC---ceeEEeeeccCcc
Q 039107 561 DYMAL-GTLREHIYNTKKALSWKQR-LEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDEN---WVAKVSDFGLSKT 634 (817)
Q Consensus 561 Ey~~~-gsL~~~l~~~~~~l~~~~~-~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~---~~~kl~DFGla~~ 634 (817)
||+++ .++.+++......-..... ..++..|-+.+.-||.++ |||+||..+||+|..+ ..+.|+||||+..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99986 3788887654433333333 788999999999999876 9999999999999654 3458999999865
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.99 E-value=3.4e-10 Score=126.02 Aligned_cols=249 Identities=20% Similarity=0.197 Sum_probs=176.6
Q ss_pred hhcCCCcceeEeeeCceEEEEEEEe--cccEEEEEecCCCCcccHHH--HHHHHHHHhcc-CccceeeEEEEEecCCeEE
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVIE--DKLKVAIKRSNPSSEQGVNE--FVTEIEMLSKL-RHKHLVSLIGFCEEGNEMC 557 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 557 (817)
-..+|.....||.|.|+.|++...+ ++..+++|.+.........+ -..|+.+...+ .|.++++....+..-...+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 3457888899999999999998744 56789999877543322222 23566666666 5888888777666667778
Q ss_pred EEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCC-ceeEEeeeccCccCC
Q 039107 558 LVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDEN-WVAKVSDFGLSKTGP 636 (817)
Q Consensus 558 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DFGla~~~~ 636 (817)
+-.||++++++...+ .....++...++++..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||++..+.
T Consensus 343 ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred CchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccccc
Confidence 999999999887665 23346788889999999999999999655 9999999999999886 788999999986421
Q ss_pred CCCCCceeeeeecCcCCC--ChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhc
Q 039107 637 NMENGHVSTVVKGSFGYL--DPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDI 714 (817)
Q Consensus 637 ~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 714 (817)
.. .....+.-+++ +++......+-.+.|++|||.-+.|.+++........ +|.. .+.+.+
T Consensus 419 ~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~~~~--i~~~~~--- 480 (524)
T KOG0601|consen 419 FS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------QSLT--IRSGDT--- 480 (524)
T ss_pred ee-----cccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------ccee--eecccc---
Confidence 11 11112233444 5666667788899999999999999998875332111 1111 011111
Q ss_pred cCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 039107 715 IDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVL 760 (817)
Q Consensus 715 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 760 (817)
+.+ +.....+..+...+..+++..||...++..+.+...
T Consensus 481 --p~~-----~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 481 --PNL-----PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred --cCC-----CchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 111 122256778889999999999999999887776654
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.4e-08 Score=110.48 Aligned_cols=167 Identities=17% Similarity=0.225 Sum_probs=127.2
Q ss_pred ceEEEEEEE-ecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEe----cCCeEEEEEEeccC-Cchhhh
Q 039107 498 FGKVYKGVI-EDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCE----EGNEMCLVYDYMAL-GTLREH 571 (817)
Q Consensus 498 fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~----~~~~~~lV~Ey~~~-gsL~~~ 571 (817)
-.+.||+.. .||..+++|+++....+.......-+++++++.|.|+|++..++. ....++|||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 356899985 478899999996554444434456688999999999999998875 34568999999986 477776
Q ss_pred hhcc--------------ccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCC
Q 039107 572 IYNT--------------KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPN 637 (817)
Q Consensus 572 l~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 637 (817)
.... +..+++..++.++.|+..||.++|+.| +..+-|.+++||++.+.+++|+..|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 5421 124778899999999999999999877 88899999999999999999988777654322
Q ss_pred CCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCC
Q 039107 638 MENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPA 686 (817)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p 686 (817)
.. . |.+.. -.+-|.=.||.+++.|.||+..
T Consensus 446 d~--------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DP--------------T--EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CC--------------C--cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 11 0 11211 2367999999999999999753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.4e-09 Score=126.91 Aligned_cols=247 Identities=20% Similarity=0.238 Sum_probs=161.2
Q ss_pred cCCCcceeEeeeCceEEEEEEEec-ccEEEEEecC---CCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSN---PSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~---~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
..|.+.+-+-+|.++.++.+.-.. +...++|... .......+....+-.++-..+||-+++...-+.-.....|++
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 345555567888899888765322 1112222211 111112222223333333345566665554445567889999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCC--
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNM-- 638 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~-- 638 (817)
+|+.+++|...|+... .++..-.......+..+++|||+.. ++|+|++|.|+|...++..++.|||+.......
T Consensus 884 ~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred HHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccccccC
Confidence 9999999999987654 3444444555667788999999754 899999999999999999999999843221000
Q ss_pred -------------------C------C--CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Q 039107 639 -------------------E------N--GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSL 691 (817)
Q Consensus 639 -------------------~------~--~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~ 691 (817)
. . ........||+.|.+||...+......+|.|++|++++|.++|.+||....
T Consensus 960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence 0 0 011234578999999999999999999999999999999999999998665
Q ss_pred ccccchHHHHHHHhhccCchhhccCcccc-CCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 039107 692 PKEQVSLADWALHCKRKGILDDIIDPLLK-DKISPECLKKFADTAEKCLSDSGIDRPSMG 750 (817)
Q Consensus 692 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 750 (817)
+.... ..++..... ...+.+......+++...+..+|.+|-.|.
T Consensus 1040 pq~~f---------------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1040 PQQIF---------------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhhh---------------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 43211 111111110 111234455677888889999999997765
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.77 E-value=8.1e-08 Score=100.99 Aligned_cols=139 Identities=14% Similarity=0.069 Sum_probs=99.7
Q ss_pred eEeeeCceEEEEEEEecccEEEEEecCCCCcc-----------cHHHHHHHHHHHhccCccc--eeeEEEEEec-----C
Q 039107 492 VIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQ-----------GVNEFVTEIEMLSKLRHKH--LVSLIGFCEE-----G 553 (817)
Q Consensus 492 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~-----~ 553 (817)
++-.-....|.+..+ +|+.+.||+....... ....+.+|.+.+.+|...+ .++++++.+. .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 455445555777666 4457999976433211 1124789999999885433 3455666643 2
Q ss_pred CeEEEEEEeccCC-chhhhhhcc-ccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcC-------Ccee
Q 039107 554 NEMCLVYDYMALG-TLREHIYNT-KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDE-------NWVA 624 (817)
Q Consensus 554 ~~~~lV~Ey~~~g-sL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~-------~~~~ 624 (817)
..-+||+|++++. +|.+++... ....+...+..++.+++..+.-||..+ |+|+|+++.|||++. +..+
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceE
Confidence 3568999999976 798887432 234555677789999999999999776 999999999999975 5789
Q ss_pred EEeeeccCcc
Q 039107 625 KVSDFGLSKT 634 (817)
Q Consensus 625 kl~DFGla~~ 634 (817)
.|+||+.++.
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 9999998753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.74 E-value=9.2e-08 Score=94.89 Aligned_cols=124 Identities=22% Similarity=0.227 Sum_probs=82.2
Q ss_pred EEEEEEEecccEEEEEecCCCCc---------------------c-----cHHHHHHHHHHHhccCcc--ceeeEEEEEe
Q 039107 500 KVYKGVIEDKLKVAIKRSNPSSE---------------------Q-----GVNEFVTEIEMLSKLRHK--HLVSLIGFCE 551 (817)
Q Consensus 500 ~Vy~~~~~~~~~vavK~~~~~~~---------------------~-----~~~~~~~E~~~l~~l~H~--niv~l~g~~~ 551 (817)
.||.|...++..+|||....... . ......+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999988888999997553210 0 012356899999999755 566777553
Q ss_pred cCCeEEEEEEecc--CCchhhhhhccccccchHhHHHHHHHHHHHHHH-HHhCCCCceEecCCccCcEEEcCCceeEEee
Q 039107 552 EGNEMCLVYDYMA--LGTLREHIYNTKKALSWKQRLEICIGAARGLHY-LHTGAKYTIIHRDVKTTNILLDENWVAKVSD 628 (817)
Q Consensus 552 ~~~~~~lV~Ey~~--~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~y-LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 628 (817)
..+|||||++ +..+..+... .++......++.+++..+.. +|.. +|+|+||.+.|||++++ .+.|+|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~---~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV---DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC---GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE--
T ss_pred ---CCEEEEEecCCCccchhhHHhc---cccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEEe
Confidence 3489999999 5555443321 23355667788888886666 4644 59999999999999998 999999
Q ss_pred eccCcc
Q 039107 629 FGLSKT 634 (817)
Q Consensus 629 FGla~~ 634 (817)
||.+..
T Consensus 150 f~qav~ 155 (188)
T PF01163_consen 150 FGQAVD 155 (188)
T ss_dssp GTTEEE
T ss_pred cCccee
Confidence 998754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.4e-06 Score=92.87 Aligned_cols=260 Identities=15% Similarity=0.170 Sum_probs=158.8
Q ss_pred ceeEeeeCceEEEEEE-EecccEEEEEecCCCCcccHHHHHHHHHHHhcc-CccceeeEEEEE-------ecCCeEEEEE
Q 039107 490 SYVIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKL-RHKHLVSLIGFC-------EEGNEMCLVY 560 (817)
Q Consensus 490 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~-------~~~~~~~lV~ 560 (817)
.+.||+|+.+.+|-.- ..+ .+.|+..........+ .+..|.+. .||-+-.-+.|= ..+....+.|
T Consensus 16 gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 16 GRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CccccCCccceeeecchhhc---hhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 4579999999998542 222 3445544332222222 23444444 466443322221 1223367777
Q ss_pred EeccCCc-hhhhhh---c--cccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 561 DYMALGT-LREHIY---N--TKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 561 Ey~~~gs-L~~~l~---~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
..+.+.- ...++. + ......|.-.++.++.++.+.+-||..| .+-+|+.++|+|+.+++.+.|.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 7776542 222221 1 1125889999999999999999999766 88999999999999999999988654332
Q ss_pred CCCCCCCceeeeeecCcCCCChhhhc-----cCCCCchHHHHHHHHHHHHHHhC-CCCCCCCCcccc--chHHHHHHHhh
Q 039107 635 GPNMENGHVSTVVKGSFGYLDPEYFK-----RQQLTEKSDIYSFGVVLFEVLCA-RPALNPSLPKEQ--VSLADWALHCK 706 (817)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~S~Gvvl~elltG-~~p~~~~~~~~~--~~l~~~~~~~~ 706 (817)
. .++.......|...|.+||.-. +-.-+...|.|.+||++++||.| ++||.+-..... -.+..-+
T Consensus 167 ~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I---- 239 (637)
T COG4248 167 N---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI---- 239 (637)
T ss_pred c---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh----
Confidence 1 3344445557889999999754 33557789999999999999886 899875321110 0000000
Q ss_pred ccCchhhccC---cc--ccCCCCH-HHHHHHHHHHHHccccC--CCCCCCHHHHHHHHHHhHhhhcc
Q 039107 707 RKGILDDIID---PL--LKDKISP-ECLKKFADTAEKCLSDS--GIDRPSMGDVLWNLEFVLQLVES 765 (817)
Q Consensus 707 ~~~~~~~~~d---~~--l~~~~~~-~~~~~l~~li~~cl~~d--P~~RPt~~evl~~L~~~~~~~~~ 765 (817)
..+.....-| +. ....++- -.+..+..+..+|+... +.-||+++..+..|..+.+....
T Consensus 240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~ 306 (637)
T COG4248 240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK 306 (637)
T ss_pred hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence 0000000000 00 0111222 23455677888888553 56899999999999888766543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.50 E-value=6.2e-07 Score=91.40 Aligned_cols=133 Identities=23% Similarity=0.196 Sum_probs=94.2
Q ss_pred CcceeEeeeCceEEEEEEEecccEEEEEecCCCCc----------------------ccHHHHHHHHHHHhccCcc--ce
Q 039107 488 DESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSE----------------------QGVNEFVTEIEMLSKLRHK--HL 543 (817)
Q Consensus 488 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~H~--ni 543 (817)
.+...||.|.-+.||.|....+.++|||.-..... .......+|.++|.+|.-. .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 44568999999999999999899999995332100 0123456899999999654 77
Q ss_pred eeEEEEEecCCeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCce
Q 039107 544 VSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWV 623 (817)
Q Consensus 544 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~ 623 (817)
.+.+++ +...+||||+++--|...- ++....-.|+..|+.-+.-+-..| |||+|+.+-||+++++|.
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCCC
Confidence 777765 4568999999986665432 122333344444444444444333 999999999999999999
Q ss_pred eEEeeeccCc
Q 039107 624 AKVSDFGLSK 633 (817)
Q Consensus 624 ~kl~DFGla~ 633 (817)
+.++||--+.
T Consensus 241 ~~vIDwPQ~v 250 (304)
T COG0478 241 IVVIDWPQAV 250 (304)
T ss_pred EEEEeCcccc
Confidence 9999996543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.48 E-value=8.6e-07 Score=90.08 Aligned_cols=106 Identities=23% Similarity=0.243 Sum_probs=84.5
Q ss_pred HHHHHHHHHHHhccCc--cceeeEEEEEecCC----eEEEEEEeccCC-chhhhhhccccccchHhHHHHHHHHHHHHHH
Q 039107 525 VNEFVTEIEMLSKLRH--KHLVSLIGFCEEGN----EMCLVYDYMALG-TLREHIYNTKKALSWKQRLEICIGAARGLHY 597 (817)
Q Consensus 525 ~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~----~~~lV~Ey~~~g-sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~y 597 (817)
.....+|.+.+.+|.. -...+.+++.+... ..+||+|++++. +|.+++..... ++......++.++++.++-
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAK 133 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHH
Confidence 3567889998888853 34556777765532 458999999974 79888865333 6667788999999999999
Q ss_pred HHhCCCCceEecCCccCcEEEcCCc---eeEEeeeccCcc
Q 039107 598 LHTGAKYTIIHRDVKTTNILLDENW---VAKVSDFGLSKT 634 (817)
Q Consensus 598 LH~~~~~~ivH~Dikp~NIll~~~~---~~kl~DFGla~~ 634 (817)
||..+ |+|+|+++.|||++.+. .+.|+||+.++.
T Consensus 134 lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 134 LHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99776 99999999999999886 899999998765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.46 E-value=2.2e-06 Score=85.53 Aligned_cols=138 Identities=19% Similarity=0.135 Sum_probs=103.2
Q ss_pred eEeeeCceEEEEEEEecccEEEEEecCCC---C---cccHHHHHHHHHHHhccCc--cceeeEEEEEe-c----CCeEEE
Q 039107 492 VIGVGGFGKVYKGVIEDKLKVAIKRSNPS---S---EQGVNEFVTEIEMLSKLRH--KHLVSLIGFCE-E----GNEMCL 558 (817)
Q Consensus 492 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~---~---~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~-~----~~~~~l 558 (817)
--|+||-+-|++-.+.+. .+-+|+-... + ..+...|.+|+..|.+|.. -.+.+++ ++. . .-.-+|
T Consensus 25 N~~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 25 NYRRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred CcCCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 357799999999877665 6888875421 1 3356789999999999953 3355555 332 2 123589
Q ss_pred EEEeccC-Cchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCce--eEEeeeccCcc
Q 039107 559 VYDYMAL-GTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWV--AKVSDFGLSKT 634 (817)
Q Consensus 559 V~Ey~~~-gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~--~kl~DFGla~~ 634 (817)
|+|-+++ -+|.+++.... .+.+..++..++.+++..|.-||+.+ +.|+|+-+.|||++.++. ++++||.-++.
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 9997764 48888875432 25677788899999999999999766 999999999999986656 99999987664
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.42 E-value=9.2e-07 Score=100.63 Aligned_cols=144 Identities=17% Similarity=0.212 Sum_probs=94.8
Q ss_pred CCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCccc------------------------------H----------
Q 039107 486 SFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQG------------------------------V---------- 525 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~------------------------------~---------- 525 (817)
.|+. .-|+.++-|.||+|++++|+.||||+..+.-+.. .
T Consensus 127 eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~E 205 (517)
T COG0661 127 EFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREE 205 (517)
T ss_pred HcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHH
Confidence 3443 4799999999999999999999999988753210 0
Q ss_pred HHHHHHHHHHhccC-----ccceeeEEEEEecCCeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHh
Q 039107 526 NEFVTEIEMLSKLR-----HKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHT 600 (817)
Q Consensus 526 ~~~~~E~~~l~~l~-----H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~ 600 (817)
-++.+|..-+.+++ .+++.-..=|.+-.....|+|||++|-.+.+........++.+.+.....++.- ..+-.
T Consensus 206 lDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~--~q~~~ 283 (517)
T COG0661 206 LDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFL--RQLLR 283 (517)
T ss_pred hCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHH--HHHHh
Confidence 12344555555552 233332222334457789999999998888875333334443333322222221 12221
Q ss_pred CCCCceEecCCccCcEEEcCCceeEEeeeccCccC
Q 039107 601 GAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTG 635 (817)
Q Consensus 601 ~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 635 (817)
. ++.|.|..|.||+++.++++.+.|||+....
T Consensus 284 d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 284 D---GFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred c---CccccCCCccceEEecCCcEEEEcCcceecC
Confidence 2 4999999999999999999999999998754
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.40 E-value=8.1e-08 Score=108.65 Aligned_cols=151 Identities=18% Similarity=0.283 Sum_probs=103.3
Q ss_pred HHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC-------CceeeeeecCcCCCChhhhcc
Q 039107 589 IGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN-------GHVSTVVKGSFGYLDPEYFKR 661 (817)
Q Consensus 589 ~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~ 661 (817)
.+++.||.|||.. .++||++|.|++|.++.++..||+.|+.+........ ........-...|.|||++..
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 4455999999974 5799999999999999999999999998754322110 111222334568999999998
Q ss_pred CCCCchHHHHHHHHHHHHHHhCCCC-CCCCCccccchHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccc
Q 039107 662 QQLTEKSDIYSFGVVLFEVLCARPA-LNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLS 740 (817)
Q Consensus 662 ~~~s~~sDV~S~Gvvl~elltG~~p-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~ 740 (817)
...+.++|+||+|+++|-+..|..+ +..........+ ....+..-...+..+.+.++.+-+.+++.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~-------------~~~~~~~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF-------------SRNLLNAGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhh-------------hhcccccccccccccCcHHHHHHHHHHhc
Confidence 8889999999999999999855443 332211111100 00111111111234556678888999999
Q ss_pred cCCCCCCCHHHHHH
Q 039107 741 DSGIDRPSMGDVLW 754 (817)
Q Consensus 741 ~dP~~RPt~~evl~ 754 (817)
.++.-||++.++..
T Consensus 251 ~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLS 264 (700)
T ss_pred CCcccCcchhhhhc
Confidence 99999998877763
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.32 E-value=7.8e-06 Score=84.22 Aligned_cols=138 Identities=19% Similarity=0.214 Sum_probs=86.3
Q ss_pred eeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccc--eeeEEEEEecCCeEEEEEEeccCCc-
Q 039107 491 YVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKH--LVSLIGFCEEGNEMCLVYDYMALGT- 567 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~Ey~~~gs- 567 (817)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.++++...+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 37899999999984 24467888876543 2355688999999986443 4677888887788899999999863
Q ss_pred hhhhh---------------------hccc-cccchHhHHH-HHH----------HHHH-HHHHHHh-CCCCceEecCCc
Q 039107 568 LREHI---------------------YNTK-KALSWKQRLE-ICI----------GAAR-GLHYLHT-GAKYTIIHRDVK 612 (817)
Q Consensus 568 L~~~l---------------------~~~~-~~l~~~~~~~-i~~----------~ia~-gL~yLH~-~~~~~ivH~Dik 612 (817)
+...+ |... .......... +-. .+.. ...+|.. .....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 22111 1100 0001000000 000 0111 1222221 123457899999
Q ss_pred cCcEEEcCCceeEEeeeccCcc
Q 039107 613 TTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 613 p~NIll~~~~~~kl~DFGla~~ 634 (817)
|.||++++++ +.|+||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999988 99999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan [] | Back alignment and domain information |
|---|
Probab=98.18 E-value=8.7e-06 Score=89.34 Aligned_cols=110 Identities=19% Similarity=0.299 Sum_probs=74.1
Q ss_pred CCCccceeeeeecc-----eeEEEeccCCCeEEEEEEeccCCCCCCCcccceeEEEeCCeEEEeccCcchhhhcccceeE
Q 039107 41 SKVPYMDARVFKQE-----MSYELPIRSQSRYWVRFHFYPSTYPELNVANSYFSVVANDVTLLSNFSASITAQAVAQAYL 115 (817)
Q Consensus 41 ~~~~~~t~R~f~~~-----~~Y~~~~~~~~~y~vR~~f~~~~~~~~~~~~~~f~v~~~~~~~~~~~~~~~~~~~~~~~~~ 115 (817)
+...|+|||.-... ..|.+ +.++..|+||+||+.......+...+.|+|.++|.....++.... .......+
T Consensus 233 P~~V~~TA~~~~~~s~~~nltw~~-~~~~~~y~v~lHFaEi~~~~~~~~~R~F~IyiN~~~~~~~~~~~~--~~~~~~~~ 309 (347)
T PF12819_consen 233 PSAVYQTARTPSNSSDPLNLTWSF-VDPGFSYYVRLHFAEIQSLSPNNNQREFDIYINGQTAYSDVSPPY--LGADTVPY 309 (347)
T ss_pred hHHHHHhhhcccccccceEEEecc-CCCCccEEEEEEEeecccccCCCCeEEEEEEECCeEccCccCccc--ccCcceEe
Confidence 44459999987755 34777 788889999999999877655555789999999988775443211 11111223
Q ss_pred EEEEEecCCCCCcEEEEEeeCCCCCCcceeEeeeeeecC
Q 039107 116 IKEFSLAPMDSDILKIIFRPSDKHSGTFAFINGIELVPS 154 (817)
Q Consensus 116 ~~~~~~~~~~~~~~~l~f~p~~~~~~~~~fi~~iEl~~~ 154 (817)
+.-+.+.......+.|++.|.+..+-. |+|||+||..+
T Consensus 310 ~~d~~~~~~~~~~~~isL~~t~~S~lp-piLNalEIy~v 347 (347)
T PF12819_consen 310 YSDYVVNVPDSGFLNISLGPTPDSTLP-PILNALEIYKV 347 (347)
T ss_pred ecceEEEecCCCEEEEEEEeCCCCCcC-ceeEeeeeEeC
Confidence 443444434445667777777654444 99999999864
|
This entry represents a malectin-like domain found in a number of plant receptor kinases. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.17 E-value=2.1e-05 Score=81.15 Aligned_cols=141 Identities=18% Similarity=0.185 Sum_probs=85.2
Q ss_pred eeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCcc--ceeeEEEEEec---CCeEEEEEEeccC
Q 039107 491 YVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHK--HLVSLIGFCEE---GNEMCLVYDYMAL 565 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~---~~~~~lV~Ey~~~ 565 (817)
+.|+.|..+.||+....+ ..+++|..... .....+..|..+++.+... .+.+++.++.. ....+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 478999999999999887 48999997654 3456778899999888533 35677765532 3346899999998
Q ss_pred Cchhh----------------hh---hcc---ccccch-H--------hHHHH------------HHHHHH-HHHHHHh-
Q 039107 566 GTLRE----------------HI---YNT---KKALSW-K--------QRLEI------------CIGAAR-GLHYLHT- 600 (817)
Q Consensus 566 gsL~~----------------~l---~~~---~~~l~~-~--------~~~~i------------~~~ia~-gL~yLH~- 600 (817)
..+.. .+ +.. ...+.+ . ..... ...+.+ .+..++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 87777 11 111 000000 0 00000 111222 2333332
Q ss_pred ---CCCCceEecCCccCcEEEc-CCceeEEeeeccCcc
Q 039107 601 ---GAKYTIIHRDVKTTNILLD-ENWVAKVSDFGLSKT 634 (817)
Q Consensus 601 ---~~~~~ivH~Dikp~NIll~-~~~~~kl~DFGla~~ 634 (817)
.....++|+|+.+.|||++ +++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2356799999999999999 666668999987653
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.15 E-value=8.2e-06 Score=92.61 Aligned_cols=138 Identities=17% Similarity=0.178 Sum_probs=92.1
Q ss_pred eeEeeeCceEEEEEEEecccEEEEEecCCCCccc-------------------------------------HHHHHHHHH
Q 039107 491 YVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQG-------------------------------------VNEFVTEIE 533 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------------------~~~~~~E~~ 533 (817)
+.||.-+.|.||+|++++|+.||||.-++.-++. .-+|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 4799999999999999999999999877643221 113455555
Q ss_pred HHhcc----Cccc------eeeEEEEEecCCeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCC
Q 039107 534 MLSKL----RHKH------LVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAK 603 (817)
Q Consensus 534 ~l~~l----~H~n------iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 603 (817)
-..++ .|-+ |.+++ ..-.....|+||||+|..+.+.-.-....++-..+..-+.++..-+-+ .
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf-----~ 319 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIF-----K 319 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHH-----h
Confidence 44443 3444 22332 223457899999999998877654333445555443333332222222 2
Q ss_pred CceEecCCccCcEEEcC----CceeEEeeeccCccC
Q 039107 604 YTIIHRDVKTTNILLDE----NWVAKVSDFGLSKTG 635 (817)
Q Consensus 604 ~~ivH~Dikp~NIll~~----~~~~kl~DFGla~~~ 635 (817)
.+++|+|=.|.||+++. ++.+.+.|||+....
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 35999999999999984 678999999998754
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.12 E-value=2.8e-05 Score=81.20 Aligned_cols=138 Identities=16% Similarity=0.123 Sum_probs=86.1
Q ss_pred EeeeCc-eEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccC-ccceeeEEEEEecCCeEEEEEEeccCCchhh
Q 039107 493 IGVGGF-GKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLR-HKHLVSLIGFCEEGNEMCLVYDYMALGTLRE 570 (817)
Q Consensus 493 lG~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 570 (817)
|-.|.. ..||+...++ ..+.+|+..... ..++.+|+++++.+. +--+.+++++....+..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~~-~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGKN-PGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCCC-CcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444554 7789987654 678888876543 345678999998884 4446678888776667899999999877764
Q ss_pred hhh-------------------cccc---ccc--hHhHHHHHH--------------------HHHHHHHHHHh----CC
Q 039107 571 HIY-------------------NTKK---ALS--WKQRLEICI--------------------GAARGLHYLHT----GA 602 (817)
Q Consensus 571 ~l~-------------------~~~~---~l~--~~~~~~i~~--------------------~ia~gL~yLH~----~~ 602 (817)
... .... ... ....+.... .+...+..|-. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 321 0000 000 000000000 01111222211 12
Q ss_pred CCceEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 603 KYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 603 ~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
.+.++|+|+.|.|||++++....|+||+.+..
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 35699999999999999987889999997754
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.09 E-value=7.1e-05 Score=74.61 Aligned_cols=101 Identities=22% Similarity=0.241 Sum_probs=82.0
Q ss_pred HHHHHHhccCc-cceeeEEEEEecCCeEEEEEEeccCCchhhhhhc--cccccchHhHHHHHHHHHHHHHHHHhCCCCce
Q 039107 530 TEIEMLSKLRH-KHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYN--TKKALSWKQRLEICIGAARGLHYLHTGAKYTI 606 (817)
Q Consensus 530 ~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 606 (817)
.|.-+|+.+++ +++++++|+|- .++|.||...+++...-.. .--..+|..|.+||.++++.+.+|++.....+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 58888999976 69999999993 3779999997766432100 11247899999999999999999998654558
Q ss_pred EecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 607 IHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 607 vH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
.-.|++++|+-+++++.+|++|...+..
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcch
Confidence 8999999999999999999999987754
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.05 E-value=3.9e-05 Score=77.06 Aligned_cols=138 Identities=14% Similarity=0.121 Sum_probs=90.1
Q ss_pred hhcCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHH---------HHHHHHHHhccCc---cceeeEEEEE
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNE---------FVTEIEMLSKLRH---KHLVSLIGFC 550 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~H---~niv~l~g~~ 550 (817)
..++|...+++-......|.+-..++ ..+++|..........+. ..+++..+.+++. .....++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~~-~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEIDG-KKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEECC-cEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 34567777777777766676666554 589999877543322222 2344444444432 2333333332
Q ss_pred e-----cCCeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeE
Q 039107 551 E-----EGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAK 625 (817)
Q Consensus 551 ~-----~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~k 625 (817)
+ -....+|+|||++|-.|.++.. ++. .++..++++|.-||..| +.|+|..|.|++++++ .++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i~ 174 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GIR 174 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cEE
Confidence 2 2345679999999988876532 221 24566778899999765 9999999999999976 589
Q ss_pred EeeeccCcc
Q 039107 626 VSDFGLSKT 634 (817)
Q Consensus 626 l~DFGla~~ 634 (817)
++||+..+.
T Consensus 175 iID~~~k~~ 183 (229)
T PF06176_consen 175 IIDTQGKRM 183 (229)
T ss_pred EEECccccc
Confidence 999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.03 E-value=6.1e-05 Score=76.37 Aligned_cols=153 Identities=17% Similarity=0.157 Sum_probs=100.7
Q ss_pred cccCHHHHHHhhcCCCccee---EeeeCceEEEEEEEecccEEEEEecCCCCccc-------------------HHH---
Q 039107 473 RRFSLAEIKHATKSFDESYV---IGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQG-------------------VNE--- 527 (817)
Q Consensus 473 ~~f~~~el~~~~~~f~~~~~---lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-------------------~~~--- 527 (817)
...+++.|.....+-.+..+ |..|.-+.||+|.-.++..+|||+........ ..+
T Consensus 33 D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~ 112 (268)
T COG1718 33 DKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVF 112 (268)
T ss_pred hhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHH
Confidence 34556666666666555554 55677888999998888899999877532111 011
Q ss_pred --HHHHHHHHhccC--ccceeeEEEEEecCCeEEEEEEeccCCchh-hhhhccccccchHhHHHHHHHHHHHHHHHHhCC
Q 039107 528 --FVTEIEMLSKLR--HKHLVSLIGFCEEGNEMCLVYDYMALGTLR-EHIYNTKKALSWKQRLEICIGAARGLHYLHTGA 602 (817)
Q Consensus 528 --~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~-~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 602 (817)
..+|+.-|+++. +-.+.+.+++. .-.|||||+....+- -.|.. -.+...+...+..++++.+.-|-..
T Consensus 113 ~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD--v~~e~~e~~~~~~~~v~~~~~l~~~- 185 (268)
T COG1718 113 AWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD--VPLELEEAEGLYEDVVEYMRRLYKE- 185 (268)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc--CCcCchhHHHHHHHHHHHHHHHHHh-
Confidence 135677777763 44555666554 348999999754111 11111 1233335667777888888877752
Q ss_pred CCceEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 603 KYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 603 ~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
.++||+||+.-|||+. ++.+.++|+|-+..
T Consensus 186 -a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~ 215 (268)
T COG1718 186 -AGLVHGDLSEYNILVH-DGEPYIIDVSQAVT 215 (268)
T ss_pred -cCcccccchhhheEEE-CCeEEEEECccccc
Confidence 3599999999999999 77999999997754
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00013 Score=73.10 Aligned_cols=129 Identities=22% Similarity=0.290 Sum_probs=89.7
Q ss_pred cceeEeeeCceEEEEEEEecccEEEEEecCCCC----------------cccHHHHHHHHHHHhccC------ccceeeE
Q 039107 489 ESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSS----------------EQGVNEFVTEIEMLSKLR------HKHLVSL 546 (817)
Q Consensus 489 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------H~niv~l 546 (817)
....||+|+.-.||.- .+....+||+..... ....+++.+|+.-...+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 4558999999999974 444557888776654 223456677777666555 8899999
Q ss_pred EEEEecCCeEEEEEEeccCC------chhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcC
Q 039107 547 IGFCEEGNEMCLVYDYMALG------TLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDE 620 (817)
Q Consensus 547 ~g~~~~~~~~~lV~Ey~~~g------sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~ 620 (817)
+|+.+......+|+|.+.+. +|.+++.. ..++. ...+.+.+.. .||-..+ |+.+||+|.||++..
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~--~~~~~-~~~~~L~~f~---~~l~~~~---Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE--GGLTE-ELRQALDEFK---RYLLDHH---IVIRDLNPHNIVVQR 153 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc--CCccH-HHHHHHHHHH---HHHHHcC---CeecCCCcccEEEEe
Confidence 99999999999999987542 57777732 23544 4444444444 4555443 999999999999953
Q ss_pred C---c-eeEEee
Q 039107 621 N---W-VAKVSD 628 (817)
Q Consensus 621 ~---~-~~kl~D 628 (817)
. . .+.|+|
T Consensus 154 ~~~~~~~lvlID 165 (199)
T PF10707_consen 154 RDSGEFRLVLID 165 (199)
T ss_pred cCCCceEEEEEe
Confidence 3 2 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00013 Score=89.56 Aligned_cols=146 Identities=14% Similarity=0.261 Sum_probs=93.0
Q ss_pred ceeEeeeCceEEEEEEEecc---cEEEEEecCCCC-cccHHHHHHHHHHHhccC-ccce--eeEEEEEecC---CeEEEE
Q 039107 490 SYVIGVGGFGKVYKGVIEDK---LKVAIKRSNPSS-EQGVNEFVTEIEMLSKLR-HKHL--VSLIGFCEEG---NEMCLV 559 (817)
Q Consensus 490 ~~~lG~G~fg~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~ni--v~l~g~~~~~---~~~~lV 559 (817)
...|+.|.+..+|+....++ ..+++|+..... ......+.+|+++|+.+. |.++ .+++++|.+. ...++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 45788999999999876654 367888765432 223457889999999995 6665 7888888764 457899
Q ss_pred EEeccCCchhhh-----------------------hhccc----------cccch--HhHHHHH---------------H
Q 039107 560 YDYMALGTLREH-----------------------IYNTK----------KALSW--KQRLEIC---------------I 589 (817)
Q Consensus 560 ~Ey~~~gsL~~~-----------------------l~~~~----------~~l~~--~~~~~i~---------------~ 589 (817)
|||+++..+.+. ||... .+..+ .++..+. -
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 999997654321 11100 00000 0111111 1
Q ss_pred HHHHHHHHHHhCC--------CCceEecCCccCcEEEcCC-c-eeEEeeeccCccC
Q 039107 590 GAARGLHYLHTGA--------KYTIIHRDVKTTNILLDEN-W-VAKVSDFGLSKTG 635 (817)
Q Consensus 590 ~ia~gL~yLH~~~--------~~~ivH~Dikp~NIll~~~-~-~~kl~DFGla~~~ 635 (817)
.+.+.+.+|..+. ...+||+|+++.|||++.+ . .+-|.||+++...
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 2334456674431 1359999999999999853 3 3579999998764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.90 E-value=9.3e-07 Score=98.91 Aligned_cols=180 Identities=19% Similarity=0.126 Sum_probs=130.7
Q ss_pred eEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccc-eeeEEEEEecCCeEEEEEEeccCC-chh
Q 039107 492 VIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKH-LVSLIGFCEEGNEMCLVYDYMALG-TLR 569 (817)
Q Consensus 492 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~Ey~~~g-sL~ 569 (817)
-+++|++++++|.+-...+....+.+... ....-++++|.+++||| .+..++-++.+...+++++++..+ +-.
T Consensus 249 ~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~ 323 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA 323 (829)
T ss_pred HHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence 46889999999987433333334444322 44567899999999999 677777777778889999999877 322
Q ss_pred hhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceeeeeec
Q 039107 570 EHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKG 649 (817)
Q Consensus 570 ~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 649 (817)
.......-.+..-+...+++.-+++|++||+.. =+|+| ||+..+ ...|+.||+....+.... ......+
T Consensus 324 ~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~~ 392 (829)
T KOG0576|consen 324 LEMTVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAIG 392 (829)
T ss_pred ccCChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc---ccccCCC
Confidence 222112223555566677888889999999743 48998 877776 588999999887643322 3445678
Q ss_pred CcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCC
Q 039107 650 SFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPAL 687 (817)
Q Consensus 650 t~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~ 687 (817)
++.++|||+.....+..+.|+|+.|+-..++--|-+|-
T Consensus 393 ~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 393 TPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 99999999999999999999999998777776666554
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00022 Score=74.08 Aligned_cols=138 Identities=17% Similarity=0.193 Sum_probs=77.8
Q ss_pred eeEeeeCce-EEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCcc---ceeeEEEEEecC---CeEEEEEEec
Q 039107 491 YVIGVGGFG-KVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHK---HLVSLIGFCEEG---NEMCLVYDYM 563 (817)
Q Consensus 491 ~~lG~G~fg-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~~~---~~~~lV~Ey~ 563 (817)
+.|+.|+.. .||+. +..+++|..... .....+.+|.++|..|... -+.++++.+... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 357777766 48875 235777775532 2345788999999888532 344555544332 2348899999
Q ss_pred cCCchhhhh------------------hcccc---cc-------------chHhHH--HHH-------HHHHHH-HH-HH
Q 039107 564 ALGTLREHI------------------YNTKK---AL-------------SWKQRL--EIC-------IGAARG-LH-YL 598 (817)
Q Consensus 564 ~~gsL~~~l------------------~~~~~---~l-------------~~~~~~--~i~-------~~ia~g-L~-yL 598 (817)
+|.++.+.. |.... .. .|.... .+. .+.+.. ++ ++
T Consensus 77 ~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 156 (235)
T cd05155 77 EGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAAL 156 (235)
T ss_pred cCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHh
Confidence 987774321 11000 00 011110 000 011111 11 11
Q ss_pred Hh--CCCCceEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 599 HT--GAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 599 H~--~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
+. .....++|+|+.+.|||++++...-|+||+.+..
T Consensus 157 ~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 157 RAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred cccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 11 1244599999999999999876677999998754
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.0004 Score=74.71 Aligned_cols=77 Identities=10% Similarity=-0.006 Sum_probs=57.6
Q ss_pred cceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCc---cceeeEEEEEecC---CeEEEEEEe
Q 039107 489 ESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRH---KHLVSLIGFCEEG---NEMCLVYDY 562 (817)
Q Consensus 489 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~~---~~~~lV~Ey 562 (817)
..+.||.|..+.||+....++ ++++|..+... ....|..|.+.|+.|.- -.+.+++++|... +..+||||+
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQG-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeeecCCccceeEEEEEcCCC-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 345799999999999876666 46777744311 23578899999999853 4688899888543 568999999
Q ss_pred ccCCch
Q 039107 563 MALGTL 568 (817)
Q Consensus 563 ~~~gsL 568 (817)
+++.++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998765
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00054 Score=72.16 Aligned_cols=136 Identities=15% Similarity=0.155 Sum_probs=78.9
Q ss_pred EeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccce-eeEEEEEecCCeEEEEEEeccCCchhhh
Q 039107 493 IGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHL-VSLIGFCEEGNEMCLVYDYMALGTLREH 571 (817)
Q Consensus 493 lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~gsL~~~ 571 (817)
+..|-...+|+.. .++.++++|........-.-+..+|.++++.+....+ .++++.+. -++||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 4557778899887 3456788887654432211245789999998864333 44555442 3689999998765431
Q ss_pred -----------------hhccc---cccchHhHH-HHHH---------HHHHHHHHHHhC-----CCCceEecCCccCcE
Q 039107 572 -----------------IYNTK---KALSWKQRL-EICI---------GAARGLHYLHTG-----AKYTIIHRDVKTTNI 616 (817)
Q Consensus 572 -----------------l~~~~---~~l~~~~~~-~i~~---------~ia~gL~yLH~~-----~~~~ivH~Dikp~NI 616 (817)
||... ..++....+ .... .+...+..+-.. ....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 11110 111111111 1110 111112222111 134689999999999
Q ss_pred EEcCCceeEEeeeccCcc
Q 039107 617 LLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 617 ll~~~~~~kl~DFGla~~ 634 (817)
++++++ +.|+||..+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999876 78999998765
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00098 Score=69.08 Aligned_cols=139 Identities=17% Similarity=0.151 Sum_probs=81.8
Q ss_pred eeEeeeCceEEEEEEEec--ccEEEEEecCCCCcccHHHHHHHHHHHhccCccc-eeeEEEEEecCCeEEEEEEeccCCc
Q 039107 491 YVIGVGGFGKVYKGVIED--KLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKH-LVSLIGFCEEGNEMCLVYDYMALGT 567 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~Ey~~~gs 567 (817)
+.|..|-...+|+....+ +..+++|........ ..+-.+|+.+++.+...+ .+++++.+. -.+||||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 457778888999988664 568889977644322 123347888888885433 344554433 247999999876
Q ss_pred hhhh-------h----------hcccccc-----------chHhHHHHH-------------------------HHHHHH
Q 039107 568 LREH-------I----------YNTKKAL-----------SWKQRLEIC-------------------------IGAARG 594 (817)
Q Consensus 568 L~~~-------l----------~~~~~~l-----------~~~~~~~i~-------------------------~~ia~g 594 (817)
+... + |...... -|..+..+. .+.+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 6321 0 1110011 111111111 111111
Q ss_pred HH-HHHhC-CCCceEecCCccCcEEEcC-CceeEEeeeccCcc
Q 039107 595 LH-YLHTG-AKYTIIHRDVKTTNILLDE-NWVAKVSDFGLSKT 634 (817)
Q Consensus 595 L~-yLH~~-~~~~ivH~Dikp~NIll~~-~~~~kl~DFGla~~ 634 (817)
|. .+... ....++|+|+.+.|||+++ +..+.|+||..+..
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 11 12211 2356999999999999998 57899999988764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.00058 Score=65.71 Aligned_cols=127 Identities=17% Similarity=0.183 Sum_probs=85.1
Q ss_pred cceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceee-EEEEEecCCeEEEEEEeccCCc
Q 039107 489 ESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVS-LIGFCEEGNEMCLVYDYMALGT 567 (817)
Q Consensus 489 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~g~~~~~~~~~lV~Ey~~~gs 567 (817)
..+.|++|.+|.||+|.+.++ .+|+|.-...+. ...+..|+++|..+.--++-+ ++.|.. -.+.|||+.|-.
T Consensus 26 v~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~ 98 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWRGG-EVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhcccccEEEEeeccCc-eEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcc
Confidence 345799999999999998776 788887665543 367889999999997666554 444432 244599999878
Q ss_pred hhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCc-cC-cEEEcCCceeEEeeeccCcc
Q 039107 568 LREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVK-TT-NILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 568 L~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik-p~-NIll~~~~~~kl~DFGla~~ 634 (817)
|.+.-... +-+++ ..+++.---|. ..+|-|+.|. |. ||++.+ ..+.|+||.-|+.
T Consensus 99 L~~~~~~~----~rk~l----~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~-~~~~iIDFd~At~ 155 (201)
T COG2112 99 LGKLEIGG----DRKHL----LRVLEKAYKLD---RLGIEHGELSRPWKNVLVND-RDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhcc----cHHHH----HHHHHHHHHHH---HhccchhhhcCCceeEEecC-CcEEEEEccchhh
Confidence 87654221 12222 33444423333 2358888887 44 555554 4999999998864
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.00087 Score=72.15 Aligned_cols=141 Identities=19% Similarity=0.184 Sum_probs=86.0
Q ss_pred ceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccc--eeeEEEE------EecCCeEEEEEE
Q 039107 490 SYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKH--LVSLIGF------CEEGNEMCLVYD 561 (817)
Q Consensus 490 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~------~~~~~~~~lV~E 561 (817)
.+.|..|....+|+....++ .+++|+... ........|++++..|.+.+ +.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~~~-~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSG-RYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCCC-cEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 34577777789999876554 688888764 22355667888888885432 4455442 122345689999
Q ss_pred eccCCchhh----hh----------hccc----------cccchHhHH----------HHHHHHHHHHHHHHh----CCC
Q 039107 562 YMALGTLRE----HI----------YNTK----------KALSWKQRL----------EICIGAARGLHYLHT----GAK 603 (817)
Q Consensus 562 y~~~gsL~~----~l----------~~~~----------~~l~~~~~~----------~i~~~ia~gL~yLH~----~~~ 603 (817)
|++|..+.. .+ |... ....|.... .....+..++.++.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999876542 01 1000 011222111 011123344455543 123
Q ss_pred CceEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 604 YTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 604 ~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
..+||+|+.|.|||++++..+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4699999999999999987788999997754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0026 Score=70.69 Aligned_cols=74 Identities=16% Similarity=0.135 Sum_probs=54.7
Q ss_pred eeEeeeCceEEEEEEEecc-cEEEEEecCCCC-------cccHHHHHHHHHHHhccC---ccceeeEEEEEecCCeEEEE
Q 039107 491 YVIGVGGFGKVYKGVIEDK-LKVAIKRSNPSS-------EQGVNEFVTEIEMLSKLR---HKHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV 559 (817)
+.||.|.+..||++...++ +.++||.-.+.. ....+.+..|.+.|..+. ..++++++.+.. +..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEEE
Confidence 4689999999999998877 589999854221 224567788888888873 245777887743 557899
Q ss_pred EEeccCC
Q 039107 560 YDYMALG 566 (817)
Q Consensus 560 ~Ey~~~g 566 (817)
|||+++.
T Consensus 110 ME~L~~~ 116 (401)
T PRK09550 110 MEDLSDH 116 (401)
T ss_pred EecCCCc
Confidence 9999864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.00055 Score=82.37 Aligned_cols=198 Identities=19% Similarity=0.184 Sum_probs=133.0
Q ss_pred HHHHHHHHHhccCccceeeEEEEEecCCeEE----EEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCC
Q 039107 527 EFVTEIEMLSKLRHKHLVSLIGFCEEGNEMC----LVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGA 602 (817)
Q Consensus 527 ~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~----lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 602 (817)
...-|+..+.++.|+|++.++.|.-+..... +..|++..-++...+... ..++..+.+.+..++..||.|+|+..
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v-~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV-GSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc-cccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 3445777788889999999999876544333 344677777777766433 35788888899999999999999763
Q ss_pred CCceEecCCccC---cEEEcCCceeEEe--eeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCc--hHHHHHHHH
Q 039107 603 KYTIIHRDVKTT---NILLDENWVAKVS--DFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTE--KSDIYSFGV 675 (817)
Q Consensus 603 ~~~ivH~Dikp~---NIll~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--~sDV~S~Gv 675 (817)
..|.-+..+ +.-.+..+...++ ||+.++........ ....-+..+.++|......++. ..|+|++|.
T Consensus 307 ---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 307 ---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred ---cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHHH
Confidence 555444444 4445566667766 88888765443322 1223455677888876655544 479999999
Q ss_pred HHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 676 VLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 676 vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.+..+..|..+...... ...++ +..+...+.+...+|+..++++|+...+++.+
T Consensus 381 l~~~~~~~~~i~~~~~~------------------~~~~l--------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKSAV------------------PVSLL--------DVLSTSELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred HHhhhhhcCcccccccc------------------hhhhh--------ccccchhhhhhhhhhcchhhhhccchhhhhhc
Confidence 99999988654321100 00001 01111146778899999999999999999876
Q ss_pred HH
Q 039107 756 LE 757 (817)
Q Consensus 756 L~ 757 (817)
.-
T Consensus 435 ~f 436 (1351)
T KOG1035|consen 435 PF 436 (1351)
T ss_pred hh
Confidence 54
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0033 Score=62.57 Aligned_cols=125 Identities=25% Similarity=0.281 Sum_probs=87.2
Q ss_pred cCCCcceeEeeeCc-eEEEEEEEecccEEEEEecCC---CCc------------------ccHHHHHHHHHHHhccC---
Q 039107 485 KSFDESYVIGVGGF-GKVYKGVIEDKLKVAIKRSNP---SSE------------------QGVNEFVTEIEMLSKLR--- 539 (817)
Q Consensus 485 ~~f~~~~~lG~G~f-g~Vy~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~E~~~l~~l~--- 539 (817)
.+++..+.||.|.- |.|||+++.+. .+|+|.... ... .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~-~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGR-IYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCe-EEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 66777889999999 99999998765 899998221 110 11235888999888874
Q ss_pred ccce--eeEEEEEecC------------------CeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHH
Q 039107 540 HKHL--VSLIGFCEEG------------------NEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLH 599 (817)
Q Consensus 540 H~ni--v~l~g~~~~~------------------~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH 599 (817)
+.++ |+.+||..-. ....+|.||++... .+.. +-+.+|.+-|..+|
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~----~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQI----RDIPQMLRDLKILH 181 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccch----hHHHHHHHHHHHHH
Confidence 4566 8999987211 12367777776432 1222 33455666778899
Q ss_pred hCCCCceEecCCccCcEEEcCCceeEEeeeccC
Q 039107 600 TGAKYTIIHRDVKTTNILLDENWVAKVSDFGLS 632 (817)
Q Consensus 600 ~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla 632 (817)
..+ |+-+|+|+.|.. .-||+|||.+
T Consensus 182 k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCC---eeeccCcccccc-----CCEEEecccC
Confidence 554 999999999986 4589999854
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0058 Score=66.53 Aligned_cols=140 Identities=12% Similarity=0.166 Sum_probs=77.4
Q ss_pred eeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccc--eeeEEE------EEecCCeEEEEEEe
Q 039107 491 YVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKH--LVSLIG------FCEEGNEMCLVYDY 562 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g------~~~~~~~~~lV~Ey 562 (817)
+.|+.|....+|+....++ .+++|+..... .+....|+.++..|...+ +.+.+. +....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 3466777778999887666 68888875212 233444556666553222 333332 12234567899999
Q ss_pred ccCCchhh-----------h---hhcccc----------ccch-HhHHH------------HHHH-HHHHHHHHHhC---
Q 039107 563 MALGTLRE-----------H---IYNTKK----------ALSW-KQRLE------------ICIG-AARGLHYLHTG--- 601 (817)
Q Consensus 563 ~~~gsL~~-----------~---l~~~~~----------~l~~-~~~~~------------i~~~-ia~gL~yLH~~--- 601 (817)
++|..+.. . +|.... .+.| ..... .+.+ +...++.+...
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 99875421 0 111000 1112 11111 1111 11122333211
Q ss_pred -CCCceEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 602 -AKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 602 -~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
-..++||+|+.+.||+++++...-|+||+.+..
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 234699999999999999776668999998754
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0031 Score=68.09 Aligned_cols=138 Identities=22% Similarity=0.250 Sum_probs=83.7
Q ss_pred eEeeeCceEEEEEEEec-------ccEEEEEecCCCCcccHHHHHHHHHHHhccCccc-eeeEEEEEecCCeEEEEEEec
Q 039107 492 VIGVGGFGKVYKGVIED-------KLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKH-LVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 492 ~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~Ey~ 563 (817)
.|..|-...+|+....+ +..+++|+...... ...+..+|.+++..+...+ ..++++++.. .+|+||+
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i 79 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI 79 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence 45666677899988665 46888998665432 2245578888888885333 3456666542 3589999
Q ss_pred cCCchhhh-h----------------hccccc----------cchHhHHH--------------------------HHHH
Q 039107 564 ALGTLREH-I----------------YNTKKA----------LSWKQRLE--------------------------ICIG 590 (817)
Q Consensus 564 ~~gsL~~~-l----------------~~~~~~----------l~~~~~~~--------------------------i~~~ 590 (817)
+|..+... + |..... .-|..+.. +...
T Consensus 80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (302)
T cd05156 80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED 159 (302)
T ss_pred CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence 98766431 1 110000 00111111 1122
Q ss_pred HHHHHHHHHh------CCCCceEecCCccCcEEEcCC----ceeEEeeeccCcc
Q 039107 591 AARGLHYLHT------GAKYTIIHRDVKTTNILLDEN----WVAKVSDFGLSKT 634 (817)
Q Consensus 591 ia~gL~yLH~------~~~~~ivH~Dikp~NIll~~~----~~~kl~DFGla~~ 634 (817)
+..-+..|.. .....++|+|+.+.|||++++ +.++|+||..+..
T Consensus 160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 2233344432 234679999999999999984 7899999998754
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0053 Score=66.49 Aligned_cols=141 Identities=14% Similarity=0.139 Sum_probs=82.8
Q ss_pred eeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccc--eeeEEEEE------ecCCeEEEEEEe
Q 039107 491 YVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKH--LVSLIGFC------EEGNEMCLVYDY 562 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~------~~~~~~~lV~Ey 562 (817)
+.++.|....+|+....++ .+++|+...... ..+...|++++..|...+ +.+++... ...+..++++||
T Consensus 28 ~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred cccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 3566777788999876555 677887654321 244556777777774322 44544422 224567899999
Q ss_pred ccCCchhhh--------------hhcccc-----------ccchHhHH------------HHHHHHHHHHHHHHh----C
Q 039107 563 MALGTLREH--------------IYNTKK-----------ALSWKQRL------------EICIGAARGLHYLHT----G 601 (817)
Q Consensus 563 ~~~gsL~~~--------------l~~~~~-----------~l~~~~~~------------~i~~~ia~gL~yLH~----~ 601 (817)
++|..+... +|.... .-.|.... .....+.+.+++|.. .
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 998554211 111000 01121111 011123344555542 2
Q ss_pred CCCceEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 602 AKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 602 ~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
...++||+|+.+.||++++++...|+||+.+..
T Consensus 185 ~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred CCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 245799999999999999987778999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0091 Score=64.09 Aligned_cols=126 Identities=17% Similarity=0.298 Sum_probs=75.2
Q ss_pred ccEEEEEecCC--CCcccHHHHHHHHHHHhccCc--cceeeEEEEEecCC--eEEEEEEeccCCchhhhhhcccc-----
Q 039107 509 KLKVAIKRSNP--SSEQGVNEFVTEIEMLSKLRH--KHLVSLIGFCEEGN--EMCLVYDYMALGTLREHIYNTKK----- 577 (817)
Q Consensus 509 ~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~--~~~lV~Ey~~~gsL~~~l~~~~~----- 577 (817)
++++++. ... ..........+|+++|+.+.- --+...+++|.++. ..+.||+|+++..+.+.+.....
T Consensus 48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~ 126 (321)
T COG3173 48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFA 126 (321)
T ss_pred CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHH
Confidence 5667777 331 222334556788888888742 33456677887666 67999999998544332211000
Q ss_pred --------------------------------ccchHhHHHHHH--------HHHHHHHHHHh-----CCCCceEecCCc
Q 039107 578 --------------------------------ALSWKQRLEICI--------GAARGLHYLHT-----GAKYTIIHRDVK 612 (817)
Q Consensus 578 --------------------------------~l~~~~~~~i~~--------~ia~gL~yLH~-----~~~~~ivH~Dik 612 (817)
.-.|...++.++ ....-..+|+. .+...++|+|+.
T Consensus 127 ~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~ 206 (321)
T COG3173 127 LDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYR 206 (321)
T ss_pred HHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcc
Confidence 001111111000 11122334433 234679999999
Q ss_pred cCcEEEcCCceeEEeeeccCccC
Q 039107 613 TTNILLDENWVAKVSDFGLSKTG 635 (817)
Q Consensus 613 p~NIll~~~~~~kl~DFGla~~~ 635 (817)
+.||++++...+-+.||+++...
T Consensus 207 ~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 207 PGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred cCCEEEeCCCeeEEEeccccccC
Confidence 99999999988999999999764
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.0097 Score=65.48 Aligned_cols=138 Identities=17% Similarity=0.201 Sum_probs=82.3
Q ss_pred eEeeeCceEEEEEEEec-----ccEEEEEecCCCCcccHHHHHHHHHHHhccCccce-eeEEEEEecCCeEEEEEEeccC
Q 039107 492 VIGVGGFGKVYKGVIED-----KLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHL-VSLIGFCEEGNEMCLVYDYMAL 565 (817)
Q Consensus 492 ~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~ 565 (817)
.|-.|-.-.+|+....+ +..+++|+........... .+|..+++.+...++ .++++.+..+ .|+||+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 45457777899987532 2578999877654433333 679999998854443 3556665432 58999987
Q ss_pred Cchhhh-----------------hhccc----c-ccchHhHHHHHHH-----------------HHHHHHHH----Hh-C
Q 039107 566 GTLREH-----------------IYNTK----K-ALSWKQRLEICIG-----------------AARGLHYL----HT-G 601 (817)
Q Consensus 566 gsL~~~-----------------l~~~~----~-~l~~~~~~~i~~~-----------------ia~gL~yL----H~-~ 601 (817)
.+|... +|... . ...|.++.++..+ +...+..| .. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 666421 11111 0 1123332222211 11112222 21 2
Q ss_pred CCCceEecCCccCcEEEcC-CceeEEeeeccCcc
Q 039107 602 AKYTIIHRDVKTTNILLDE-NWVAKVSDFGLSKT 634 (817)
Q Consensus 602 ~~~~ivH~Dikp~NIll~~-~~~~kl~DFGla~~ 634 (817)
....++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 2446899999999999986 47899999998754
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.0091 Score=63.62 Aligned_cols=74 Identities=20% Similarity=0.302 Sum_probs=48.5
Q ss_pred cceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccC---ccceeeEEEEEecCCeEEEEEEeccC
Q 039107 489 ESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLR---HKHLVSLIGFCEEGNEMCLVYDYMAL 565 (817)
Q Consensus 489 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~Ey~~~ 565 (817)
..+.|+.|....+|+.. .++..+.||.-. ......|..|.+-|+.|. --.+.+++++....+..+||+||++.
T Consensus 21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred eeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 34578889999999877 556789999866 223356888999888883 45677899988777778999999987
Q ss_pred C
Q 039107 566 G 566 (817)
Q Consensus 566 g 566 (817)
+
T Consensus 97 ~ 97 (288)
T PF03881_consen 97 G 97 (288)
T ss_dssp -
T ss_pred C
Confidence 6
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.002 Score=67.56 Aligned_cols=132 Identities=20% Similarity=0.170 Sum_probs=88.9
Q ss_pred CCcceeEeeeCceEEEEEEEecccEEEEEecCCC--C---------------cccH-----HHHHHHHHHHhccC-cc-c
Q 039107 487 FDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPS--S---------------EQGV-----NEFVTEIEMLSKLR-HK-H 542 (817)
Q Consensus 487 f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~---------------~~~~-----~~~~~E~~~l~~l~-H~-n 542 (817)
+...+.||-|.-+.||.+....|.+.++|.-... + ...+ -...+|...|+.|. |. -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 4567789999999999999998888888842211 0 0011 12356888888884 32 2
Q ss_pred eeeEEEEEecCCeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCc
Q 039107 543 LVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENW 622 (817)
Q Consensus 543 iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~ 622 (817)
+.+.+++ +..|+|||++.+-.|.+.-+ ..+..++..-+.++ +--|- +.++||+|..--||+++++.
T Consensus 174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~----v~d~~~ly~~lm~~---Iv~la---~~GlIHgDFNEFNimv~dd~ 239 (465)
T KOG2268|consen 174 VPKPIDH----NRHCVVMELVDGYPLRQVRH----VEDPPTLYDDLMGL---IVRLA---NHGLIHGDFNEFNIMVKDDD 239 (465)
T ss_pred CCCcccc----cceeeHHHhhcccceeeeee----cCChHHHHHHHHHH---HHHHH---HcCceecccchheeEEecCC
Confidence 4455554 35689999999877766432 22333333333333 33344 34599999999999999999
Q ss_pred eeEEeeeccC
Q 039107 623 VAKVSDFGLS 632 (817)
Q Consensus 623 ~~kl~DFGla 632 (817)
.++++||--+
T Consensus 240 ~i~vIDFPQm 249 (465)
T KOG2268|consen 240 KIVVIDFPQM 249 (465)
T ss_pred CEEEeechHh
Confidence 9999999644
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.016 Score=61.60 Aligned_cols=31 Identities=26% Similarity=0.433 Sum_probs=26.0
Q ss_pred CceEecCCccCcEEEcCCce-eEEeeeccCcc
Q 039107 604 YTIIHRDVKTTNILLDENWV-AKVSDFGLSKT 634 (817)
Q Consensus 604 ~~ivH~Dikp~NIll~~~~~-~kl~DFGla~~ 634 (817)
..++|+|+++.|||+++++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997554 56999998865
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.024 Score=60.76 Aligned_cols=139 Identities=20% Similarity=0.204 Sum_probs=92.8
Q ss_pred cceeEeeeCceEEEEEEEecccEEEEEecCCCCc---------cc----------------HHH-HHHHHHHHhccCccc
Q 039107 489 ESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSE---------QG----------------VNE-FVTEIEMLSKLRHKH 542 (817)
Q Consensus 489 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---------~~----------------~~~-~~~E~~~l~~l~H~n 542 (817)
+...|..|.-+.||-+.-.+|..+|||+.+.+-- .+ .+- ...|++-|++|+...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 3447889999999999999999999998664210 00 011 135777777776544
Q ss_pred eeeEEEEEecCCeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCc
Q 039107 543 LVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENW 622 (817)
Q Consensus 543 iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~ 622 (817)
|.-.--... ....|||+|+....-..-.. ..-.++...+..+-.|++.-|.-|-+.+ ++||.||.--|+|+.+.
T Consensus 228 IP~PePIlL--k~hVLVM~FlGrdgw~aPkL-Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~LyhdG- 301 (520)
T KOG2270|consen 228 IPCPEPILL--KNHVLVMEFLGRDGWAAPKL-KDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHDG- 301 (520)
T ss_pred CCCCCceee--ecceEeeeeccCCCCcCccc-ccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEECC-
Confidence 332211111 23489999997432211110 1124666677778888888888888754 79999999999999875
Q ss_pred eeEEeeeccCc
Q 039107 623 VAKVSDFGLSK 633 (817)
Q Consensus 623 ~~kl~DFGla~ 633 (817)
.+.++|-+-+-
T Consensus 302 ~lyiIDVSQSV 312 (520)
T KOG2270|consen 302 KLYIIDVSQSV 312 (520)
T ss_pred EEEEEEccccc
Confidence 88899987654
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.067 Score=59.41 Aligned_cols=73 Identities=18% Similarity=0.143 Sum_probs=50.5
Q ss_pred ceeEeeeCceEEEEEEEecccEEEEEecCCCCc-------ccHHHHHHHHHHHhccC---ccceeeEEEEEecCCeEEEE
Q 039107 490 SYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSE-------QGVNEFVTEIEMLSKLR---HKHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 490 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV 559 (817)
.+.||-|..-.||+.... +..++||+-.+... ....+-..|.+.|+.+. ...+.+++.+|. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 446899999999998764 44699998552211 12334445677776663 357888999987 446889
Q ss_pred EEeccC
Q 039107 560 YDYMAL 565 (817)
Q Consensus 560 ~Ey~~~ 565 (817)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.05 E-value=0.048 Score=59.66 Aligned_cols=138 Identities=17% Similarity=0.259 Sum_probs=79.7
Q ss_pred eEeeeCceEEEEEEEecc----cEEEEEecCCCCcccHHHHHHHHHHHhccCccce-eeEEEEEecCCeEEEEEEeccCC
Q 039107 492 VIGVGGFGKVYKGVIEDK----LKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHL-VSLIGFCEEGNEMCLVYDYMALG 566 (817)
Q Consensus 492 ~lG~G~fg~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~g 566 (817)
.|..|-.-.+|+....+. ..|++|......... -+-.+|..+++.+..-++ .++++++..+ +|.+|+++.
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g~ 95 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV-IDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINAR 95 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE-echHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcCC
Confidence 444466777888875432 378899877654432 233678999998865444 4566665322 589999776
Q ss_pred chhhh-------h----------hccc----c-ccchHhHHHHHHHH----------------------HHHHHH---HH
Q 039107 567 TLREH-------I----------YNTK----K-ALSWKQRLEICIGA----------------------ARGLHY---LH 599 (817)
Q Consensus 567 sL~~~-------l----------~~~~----~-~l~~~~~~~i~~~i----------------------a~gL~y---LH 599 (817)
.|... + |... . .--|..+.++..++ .+-+.. +.
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 55321 1 1111 0 11122222222111 111211 11
Q ss_pred -h-CCCCceEecCCccCcEEEcC-CceeEEeeeccCcc
Q 039107 600 -T-GAKYTIIHRDVKTTNILLDE-NWVAKVSDFGLSKT 634 (817)
Q Consensus 600 -~-~~~~~ivH~Dikp~NIll~~-~~~~kl~DFGla~~ 634 (817)
. .....++|+|+.+.|||+++ ++.++++||..|..
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1 12235789999999999975 57899999998754
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.93 E-value=0.033 Score=56.69 Aligned_cols=120 Identities=21% Similarity=0.227 Sum_probs=59.7
Q ss_pred cEEEEEecCCCCcccHHHHHHHHHHHhccCccce-eeEEEEEecCCeEEEEEEeccCCchhhh-h---------------
Q 039107 510 LKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHL-VSLIGFCEEGNEMCLVYDYMALGTLREH-I--------------- 572 (817)
Q Consensus 510 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~gsL~~~-l--------------- 572 (817)
.+|+|++...... ..-.-..|..+++.+...++ .++++++.. .+|+||+++..|..- +
T Consensus 3 ~~~~~Ri~g~~t~-~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~~ 77 (211)
T PF01633_consen 3 EKYLVRIPGEGTE-NFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLAK 77 (211)
T ss_dssp SEEEEEEEESCGC-SHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHHH
T ss_pred CEEEEEeCCCCcc-cccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHHH
Confidence 4678888765533 33455789999998864444 556666543 257799976665321 1
Q ss_pred -hccc------cccchHhHHHH----------------------HHHHHHHHHHHH----hC-CCCceEecCCccCcEEE
Q 039107 573 -YNTK------KALSWKQRLEI----------------------CIGAARGLHYLH----TG-AKYTIIHRDVKTTNILL 618 (817)
Q Consensus 573 -~~~~------~~l~~~~~~~i----------------------~~~ia~gL~yLH----~~-~~~~ivH~Dikp~NIll 618 (817)
|... ..--|.....+ ...+..-+..+. .. ....++|+|+.+.|||+
T Consensus 78 lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil~ 157 (211)
T PF01633_consen 78 LHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNILI 157 (211)
T ss_dssp HHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEEE
T ss_pred HhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEEe
Confidence 0000 00111222111 011111222221 11 12457899999999999
Q ss_pred -cCCceeEEeeeccCcc
Q 039107 619 -DENWVAKVSDFGLSKT 634 (817)
Q Consensus 619 -~~~~~~kl~DFGla~~ 634 (817)
+.++.++|+||..+..
T Consensus 158 ~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 158 NNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp TSSSSCEEE--GTT-EE
T ss_pred ccCCCeEEEecHHHHhh
Confidence 8889999999998754
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.57 E-value=0.0023 Score=78.78 Aligned_cols=158 Identities=16% Similarity=0.041 Sum_probs=110.9
Q ss_pred HHHHHHHHhccCccceeeEEEEEe--cCCeEEEEEEeccCCchhhhhhcccc---ccchHhHHHHHHHHHHHHHHHHhC-
Q 039107 528 FVTEIEMLSKLRHKHLVSLIGFCE--EGNEMCLVYDYMALGTLREHIYNTKK---ALSWKQRLEICIGAARGLHYLHTG- 601 (817)
Q Consensus 528 ~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~lV~Ey~~~gsL~~~l~~~~~---~l~~~~~~~i~~~ia~gL~yLH~~- 601 (817)
...|..-++...|+++.....-.. +..+.+.+++|+..|.+.+.|.+.-. .+...-+.....+...+..-+|+.
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 344555556678888776554432 34566889999999999998864322 233333333333334555555543
Q ss_pred -CCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHH
Q 039107 602 -AKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEV 680 (817)
Q Consensus 602 -~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~el 680 (817)
.....+|++||+.|.+|..+..+|+.++|+.+..... ........+++.|+.|+....-.++.++|+|..|+.+|++
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 2345789999999999999999999999999842221 1222334577889999999888999999999999999999
Q ss_pred HhCCCCC
Q 039107 681 LCARPAL 687 (817)
Q Consensus 681 ltG~~p~ 687 (817)
..|..++
T Consensus 1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred hcccHHH
Confidence 8877655
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.39 E-value=0.11 Score=56.10 Aligned_cols=31 Identities=29% Similarity=0.302 Sum_probs=26.1
Q ss_pred CCceEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 603 KYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 603 ~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
..+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 356999999999999998 5788999997643
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.22 E-value=0.14 Score=55.95 Aligned_cols=72 Identities=13% Similarity=0.139 Sum_probs=48.1
Q ss_pred eEeeeCceEEEEEEEecc-cEEEEEecCCC-------CcccHHHHHHHHHHHhccC--cc-ceeeEEEEEecCCeEEEEE
Q 039107 492 VIGVGGFGKVYKGVIEDK-LKVAIKRSNPS-------SEQGVNEFVTEIEMLSKLR--HK-HLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 492 ~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~--H~-niv~l~g~~~~~~~~~lV~ 560 (817)
.||-|...-||++...++ ..|+||.-.+- -.....+..-|.+.|+... -| .+.+++.| +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 378899999999998754 57999974321 1333455667888887663 34 34455544 345567999
Q ss_pred EeccC
Q 039107 561 DYMAL 565 (817)
Q Consensus 561 Ey~~~ 565 (817)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99964
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.12 E-value=0.2 Score=54.20 Aligned_cols=32 Identities=16% Similarity=0.277 Sum_probs=28.5
Q ss_pred CCceEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 603 KYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 603 ~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
..++||+|+.+.|||+++++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 44799999999999999998999999998764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.98 E-value=0.11 Score=51.98 Aligned_cols=138 Identities=12% Similarity=0.143 Sum_probs=86.2
Q ss_pred EEEEEecCCCCcc-cHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccCCchhhhhhccccccchHhHHHHHH
Q 039107 511 KVAIKRSNPSSEQ-GVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICI 589 (817)
Q Consensus 511 ~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~ 589 (817)
...+|++....-. ...-|..+.+++++++ .|++|.. .......++.|+|-.- +.+ ..-.|..
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~----------~i~---~~N~i~a 149 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKI----------KIN---FSNFITA 149 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCc----------ccc---hhHHHHH
Confidence 4556665533222 3456788899998875 5677763 2445667888987421 101 1111222
Q ss_pred HHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHH
Q 039107 590 GAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSD 669 (817)
Q Consensus 590 ~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sD 669 (817)
+ +..|.-.|++ ....+|+|-.|+||+-|..|.+||.|=+..-. .. .-|.-- .....++++.
T Consensus 150 g-i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~------~~--------V~~vN~---~Y~~lT~~aE 210 (308)
T PF07387_consen 150 G-IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE------NQ--------VNMVNI---EYESLTQEAE 210 (308)
T ss_pred h-HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh------he--------eeEEee---eccccChHHH
Confidence 2 4677888966 46799999999999999999999999775421 00 111111 1234577888
Q ss_pred HHHHHHHHHHHHhCC
Q 039107 670 IYSFGVVLFEVLCAR 684 (817)
Q Consensus 670 V~S~Gvvl~elltG~ 684 (817)
+=+|=.-+++++...
T Consensus 211 ~~~fv~s~l~~v~~~ 225 (308)
T PF07387_consen 211 VKVFVKSCLKLVEKQ 225 (308)
T ss_pred HHHHHHHHHHHHHHH
Confidence 888877777777544
|
The function of this family is unknown. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.36 E-value=0.032 Score=62.26 Aligned_cols=48 Identities=15% Similarity=0.319 Sum_probs=37.0
Q ss_pred HHHHHHHHHHhccCccceeeEEEEEecCC-eEEEEEEeccCCchhhhhhc
Q 039107 526 NEFVTEIEMLSKLRHKHLVSLIGFCEEGN-EMCLVYDYMALGTLREHIYN 574 (817)
Q Consensus 526 ~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~Ey~~~gsL~~~l~~ 574 (817)
.+.+-...+++.+.|+|+...+.+..... ...+|+|++. .+|.+.+..
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~ 75 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKT 75 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHh
Confidence 45566778899999999999999876543 4678899885 688887743
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.20 E-value=0.33 Score=52.73 Aligned_cols=138 Identities=20% Similarity=0.255 Sum_probs=81.7
Q ss_pred EeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCc---cc---eeeEEE----EEecCCeEEEEEEe
Q 039107 493 IGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRH---KH---LVSLIG----FCEEGNEMCLVYDY 562 (817)
Q Consensus 493 lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---~n---iv~l~g----~~~~~~~~~lV~Ey 562 (817)
|.+ .--.+|+....++.. ++|..... ....+...|+..|..|.- += +..+=| ........+-+++|
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 444 456789988877755 88887765 234566677888877732 11 222222 11222377889999
Q ss_pred ccCCchhh-h----h----------hc--------cc---cccchHh-------------HHHHHHHHHHHHHHHHhC--
Q 039107 563 MALGTLRE-H----I----------YN--------TK---KALSWKQ-------------RLEICIGAARGLHYLHTG-- 601 (817)
Q Consensus 563 ~~~gsL~~-~----l----------~~--------~~---~~l~~~~-------------~~~i~~~ia~gL~yLH~~-- 601 (817)
++|..+.. . + |. +. ....|.. ......++...+..+.+.
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 99888772 1 1 10 00 1233430 011233344444444432
Q ss_pred --CC-Cc--eEecCCccCcEEEcCCce-eEEeeeccCcc
Q 039107 602 --AK-YT--IIHRDVKTTNILLDENWV-AKVSDFGLSKT 634 (817)
Q Consensus 602 --~~-~~--ivH~Dikp~NIll~~~~~-~kl~DFGla~~ 634 (817)
-. .+ +||+|+.|.||+++++.. +.++||+-+..
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred hhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 11 22 999999999999999875 88999997754
|
|
| >KOG3593 consensus Predicted receptor-like serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=94.18 E-value=0.027 Score=57.55 Aligned_cols=73 Identities=18% Similarity=0.278 Sum_probs=61.3
Q ss_pred CChhhhhhhhhcCCCcccccccceeEEEEecCCCceEEEEEeeeccCCcccccceEEEEEEc-CcccccccchhhhccCC
Q 039107 236 APPDVYMTARYMGVDAHTNMEFNLTWIFRVDANFTYYVRLHFCEFKPDINKINQRVFNIYIN-NQTAQADADVIAWTHGQ 314 (817)
Q Consensus 236 ~P~~v~~ta~~~~~~~~~~~~~~~~~~~p~~~~~~y~v~lhF~e~~~~~~~~~~R~F~i~i~-~~~~~~~~~~~~~~~~~ 314 (817)
....+|+|+|.... .+-|..|......|-+.|.|||..+ ...+.-+|||-+| +..+.+.+|++...|+.
T Consensus 106 ed~ily~ter~nee--------tFgyd~pik~dgdyalvlkfaevyF--~~~q~kvfdvrln~sh~vVk~ldi~~~vg~r 175 (355)
T KOG3593|consen 106 EDIILYQTERYNEE--------TFGYDVPIKEDGDYALVLKFAEVYF--KTCQHKVFDVRLNCSHCVVKALDIFDQVGDR 175 (355)
T ss_pred hhhhhhhhcccchh--------hhcccccccCCCceehhhhHHHHHH--HhhhhhheeeeeccceeEEeccchhhhcCCC
Confidence 45678999998633 4557788988889999999999875 6789999999999 99999999999999866
Q ss_pred CccE
Q 039107 315 GVPI 318 (817)
Q Consensus 315 ~~p~ 318 (817)
+++.
T Consensus 176 g~Ah 179 (355)
T KOG3593|consen 176 GKAH 179 (355)
T ss_pred cccc
Confidence 6554
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 817 | ||||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-82 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 6e-82 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 7e-38 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-37 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-32 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-32 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-32 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-30 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-23 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-22 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-22 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-22 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-22 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-21 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-21 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-20 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-19 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-19 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-19 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-19 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-19 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-19 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-19 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-19 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-19 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-19 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-19 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-19 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-19 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-19 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-19 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-19 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-19 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-19 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-19 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-18 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-18 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-18 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-18 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-18 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-18 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-18 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-18 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-18 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-18 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-18 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-18 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-18 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-17 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-17 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-17 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-17 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-17 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-17 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 8e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-16 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-16 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-15 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-15 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 9e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 9e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 9e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 9e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-13 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-13 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-13 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 9e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 9e-13 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 9e-13 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-13 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 9e-13 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 8e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 8e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 9e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 7e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 7e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 7e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 7e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 8e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 8e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 8e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 8e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 9e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 9e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 9e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 9e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-10 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-10 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-10 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 7e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-10 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-10 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 8e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 9e-10 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-09 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 8e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 9e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-08 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 9e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 9e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 9e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 9e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 6e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 6e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 7e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 9e-07 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-06 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-06 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-06 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-06 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-06 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-06 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-06 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-06 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-06 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-06 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-06 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-06 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-06 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-06 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-06 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-06 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-06 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-06 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-06 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-06 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-06 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-06 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-06 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-06 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-06 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-06 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-06 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-06 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 7e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 8e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 9e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 9e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 9e-06 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-05 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-05 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-05 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-05 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-05 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-05 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-05 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-05 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-05 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-05 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-05 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 6e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 8e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-04 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-04 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-04 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-04 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-04 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-04 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-04 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-04 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-04 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-04 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-04 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-04 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-04 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-04 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-04 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-04 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-04 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-04 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 5e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 7e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 9e-04 |
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 556 bits (1434), Expect = 0.0
Identities = 185/319 (57%), Positives = 229/319 (71%), Gaps = 6/319 (1%)
Query: 450 SKSTISGKSNASSHLSAIAQGLCRRFSLAEIKHATKSFDESYVIGVGGFGKVYKGVIEDK 509
S + N + S + R L +++ AT +FD ++IG G FGKVYKGV+ D
Sbjct: 4 KYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG 63
Query: 510 LKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLR 569
KVA+KR P S QG+ EF TEIE LS RH HLVSLIGFC+E NEM L+Y YM G L+
Sbjct: 64 AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123
Query: 570 EHIYNT---KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKV 626
H+Y + ++SW+QRLEICIGAARGLHYLHT A IIHRDVK+ NILLDEN+V K+
Sbjct: 124 RHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKI 180
Query: 627 SDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPA 686
+DFG+SK G ++ H+STVVKG+ GY+DPEYF + +LTEKSD+YSFGVVLFEVLCAR A
Sbjct: 181 TDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240
Query: 687 LNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDR 746
+ SLP+E V+LA+WA+ G L+ I+DP L DKI PE L+KF DTA KCL+ S DR
Sbjct: 241 IVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDR 300
Query: 747 PSMGDVLWNLEFVLQLVES 765
PSMGDVLW LE+ L+L ES
Sbjct: 301 PSMGDVLWKLEYALRLQES 319
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 382 bits (984), Expect = e-127
Identities = 102/301 (33%), Positives = 164/301 (54%), Gaps = 21/301 (6%)
Query: 473 RRFSLAEIKHATKSFDESY------VIGVGGFGKVYKGVIEDKLKVAIKR----SNPSSE 522
FS E+K+ T +FDE +G GGFG VYKG + + VA+K+ + ++E
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT-TVAVKKLAAMVDITTE 71
Query: 523 QGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKK--ALS 580
+ +F EI++++K +H++LV L+GF +G+++CLVY YM G+L + + LS
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131
Query: 581 WKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640
W R +I GAA G+++LH IHRD+K+ NILLDE + AK+SDFGL++
Sbjct: 132 WHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 641 GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLAD 700
+++ + G+ Y+ PE R ++T KSDIYSFGVVL E++ PA++ + L D
Sbjct: 189 TVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--LLLD 245
Query: 701 WALHC-KRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759
+ ++D ID + D ++ A +CL + RP + V L+ +
Sbjct: 246 IKEEIEDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304
Query: 760 L 760
Sbjct: 305 T 305
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 371 bits (954), Expect = e-122
Identities = 111/304 (36%), Positives = 170/304 (55%), Gaps = 7/304 (2%)
Query: 460 ASSHLSAIAQGLCRRFSLAEIKHATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNP 519
+ + G +RFSL E++ A+ +F ++G GGFGKVYKG + D VA+KR
Sbjct: 5 PAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKE 64
Query: 520 SSEQGVN-EFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIY---NT 575
QG +F TE+EM+S H++L+ L GFC E LVY YMA G++ + +
Sbjct: 65 ERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPES 124
Query: 576 KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTG 635
+ L W +R I +G+ARGL YLH IIHRDVK NILLDE + A V DFGL+K
Sbjct: 125 QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 184
Query: 636 PNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQ 695
++ HV+T V+G+ G++ PEY + +EK+D++ +GV+L E++ + A + +
Sbjct: 185 DY-KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 243
Query: 696 --VSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
V L DW ++ L+ ++D L+ E +++ A C S ++RP M +V+
Sbjct: 244 DDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303
Query: 754 WNLE 757
LE
Sbjct: 304 RMLE 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 269 bits (689), Expect = 1e-83
Identities = 68/310 (21%), Positives = 131/310 (42%), Gaps = 26/310 (8%)
Query: 475 FSLAEIKHATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEM 534
+ + V G FG V+K + ++ VA+K +Q + E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNE-YVAVKIFPIQDKQSW-QNEYEVYS 71
Query: 535 LSKLRHKHLVSLIGFCEEGN----EMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIG 590
L ++H++++ IG + G ++ L+ + G+L + + +SW + I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAET 129
Query: 591 AARGLHYLHT-------GAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643
ARGL YLH G K I HRD+K+ N+LL N A ++DFGL+ ++
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189
Query: 644 STVVKGSFGYLDPEYF-----KRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSL 698
+ G+ Y+ PE ++ + D+Y+ G+VL+E+ A + + + +
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249
Query: 699 ADW-----ALHCKRKGILDDIIDPLLKDKISP-ECLKKFADTAEKCLSDSGIDRPSMGDV 752
+ +L ++ ++ P+L+D + +T E+C R S G V
Sbjct: 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCV 309
Query: 753 LWNLEFVLQL 762
+ + +L
Sbjct: 310 GERITQMQRL 319
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 2e-68
Identities = 79/332 (23%), Positives = 142/332 (42%), Gaps = 32/332 (9%)
Query: 444 HSQTTQSKSTISGKSNASSHLSAIAQGLCRRFSLAEIKHATKSFDESYVIGVGGFGKVYK 503
H S I N + + +I + E IG G FG V++
Sbjct: 5 HHHHPMSDYDIPTTENLYFQGAMDGDDM-------DIPWCDLNIKE--KIGAGSFGTVHR 55
Query: 504 GVIEDKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561
VA+K + VNEF+ E+ ++ +LRH ++V +G + + +V +
Sbjct: 56 AEWHGS-DVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114
Query: 562 YMALGTLRE--HIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLD 619
Y++ G+L H ++ L ++RL + A+G++YLH I+HR++K+ N+L+D
Sbjct: 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVD 173
Query: 620 ENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFE 679
+ + KV DFGLS+ S G+ ++ PE + + EKSD+YSFGV+L+E
Sbjct: 174 KKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWE 231
Query: 680 VLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCL 739
+ + P ++ A K + +I + A E C
Sbjct: 232 LATLQ------QPWGNLNPAQVVAAVGFKC---------KRLEIPRNLNPQVAAIIEGCW 276
Query: 740 SDSGIDRPSMGDVLWNLEFVLQLVESTEASSN 771
++ RPS ++ L +++ S+
Sbjct: 277 TNEPWKRPSFATIMDLLRPLIKSAVPPPNRSD 308
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 5e-65
Identities = 67/334 (20%), Positives = 131/334 (39%), Gaps = 41/334 (12%)
Query: 475 FSLAEIKHATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQG-VNEFVTEIE 533
+ +E + +IG G +G VYKG ++++ VA+K + ++ Q +NE I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDER-PVAVKVFSFANRQNFINE--KNIY 59
Query: 534 MLSKLRHKHLVSLIGFCEEGN-----EMCLVYDYMALGTLREHIYNTKKALSWKQRLEIC 588
+ + H ++ I E E LV +Y G+L +++ W +
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS--LHTSDWVSSCRLA 117
Query: 589 IGAARGLHYLHT------GAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT------GP 636
RGL YLHT K I HRD+ + N+L+ + +SDFGLS
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177
Query: 637 NMENGHVSTVVKGSFGYLDPEYFK-------RQQLTEKSDIYSFGVVLFEVLCARPALNP 689
E + + G+ Y+ PE + + ++ D+Y+ G++ +E+ L P
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237
Query: 690 SLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPE----------CLKKFADTAEKCL 739
+ +A + +D+ + ++K P+ ++ +T E C
Sbjct: 238 GESVPEYQMA-FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCW 296
Query: 740 SDSGIDRPSMGDVLWNLEFVLQLVESTEASSNRS 773
R + + ++ + E ++ S +
Sbjct: 297 DQDAEARLTAQXAEERMAELMMIWERNKSVSPTA 330
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 2e-64
Identities = 83/312 (26%), Positives = 138/312 (44%), Gaps = 31/312 (9%)
Query: 476 SLAEIKHATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEML 535
SL I + K + V+G G FG V K K VAIK+ SE+ F+ E+ L
Sbjct: 1 SLHMIDY--KEIEVEEVVGRGAFGVVCKAKWRAK-DVAIKQIESESER--KAFIVELRQL 55
Query: 536 SKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKA--LSWKQRLEICIGAAR 593
S++ H ++V L G C N +CLV +Y G+L ++ + + + C+ ++
Sbjct: 56 SRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ 113
Query: 594 GLHYLHTGAKYTIIHRDVKTTNILLDENW-VAKVSDFGLSKTGPNMENGHVSTVVKGSFG 652
G+ YLH+ +IHRD+K N+LL V K+ DFG + + T KGS
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAA 168
Query: 653 YLDPEYFKRQQLTEKSDIYSFGVVLFEVLCAR-PALNPSLPKEQVSLADWALHCKRKGIL 711
++ PE F+ +EK D++S+G++L+EV+ R P P ++ A + R
Sbjct: 169 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA--VHNGTR---- 222
Query: 712 DDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVESTEASSN 771
P + K +C S RPSM +++ + +++ +
Sbjct: 223 -----P----PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQ 273
Query: 772 RSRGSSIDGAED 783
S+ ED
Sbjct: 274 YPCQHSLPPGED 285
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 1e-63
Identities = 76/270 (28%), Positives = 128/270 (47%), Gaps = 22/270 (8%)
Query: 493 IGVGGFGKVYKGVIEDKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFC 550
IG G FG VYKG VA+K N + + Q + F E+ +L K RH +++ +G+
Sbjct: 32 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 551 EEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRD 610
+ +V + +L H++ ++ K+ ++I ARG+ YLH +IIHRD
Sbjct: 90 TAPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRD 145
Query: 611 VKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQL---TEK 667
+K+ NI L E+ K+ DFGL+ H + GS ++ PE + Q + +
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 668 SDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPEC 727
SD+Y+FG+VL+E++ + LP ++ D + +G L K+ C
Sbjct: 206 SDVYAFGIVLYELMTGQ------LPYSNINNRDQIIEMVGRGSL-----SPDLSKVRSNC 254
Query: 728 LKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757
K+ +CL +RPS +L +E
Sbjct: 255 PKRMKRLMAECLKKKRDERPSFPRILAEIE 284
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 1e-62
Identities = 59/303 (19%), Positives = 119/303 (39%), Gaps = 39/303 (12%)
Query: 492 VIGVGGFGKVYKGVIEDKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGF 549
+IG G FG+VY G + VAI+ + +E + F E+ + RH+++V +G
Sbjct: 40 LIGKGRFGQVYHGRWHGE--VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 550 CEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHR 609
C + ++ TL + + K L + +I +G+ YLH I+H+
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHK 154
Query: 610 DVKTTNILLDENWVAKVSDFGLSK---TGPNMENGHVSTVVKGSFGYLDPEYFKRQQL-- 664
D+K+ N+ D N ++DFGL + G +L PE ++
Sbjct: 155 DLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDT 213
Query: 665 -------TEKSDIYSFGVVLFEVLCARPALNP--SLPKEQVSLADWALHCKRKGILDDII 715
++ SD+++ G + +E+ P + P E + W + G+ ++
Sbjct: 214 EEDKLPFSKHSDVFALGTIWYELHAREW---PFKTQPAEAII---WQMG---TGMKPNLS 264
Query: 716 DPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVESTEASSNRSRG 775
K+ +D C + +RP+ ++ LE + + + +
Sbjct: 265 Q--------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWKS 316
Query: 776 SSI 778
+ +
Sbjct: 317 AEL 319
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 2e-62
Identities = 75/291 (25%), Positives = 135/291 (46%), Gaps = 36/291 (12%)
Query: 479 EIKHATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQ----GVNEFVTEIEM 534
EI A + +E +IG+GGFGKVY+ +VA+K + ++ + E ++
Sbjct: 3 EIDFAELTLEE--IIGIGGFGKVYRAFWIGD-EVAVKAARHDPDEDISQTIENVRQEAKL 59
Query: 535 LSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARG 594
+ L+H ++++L G C + +CLV ++ G L + + K + + + ARG
Sbjct: 60 FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIARG 117
Query: 595 LHYLHTGAKYTIIHRDVKTTNILLDE--------NWVAKVSDFGLSKTGPNMENGHVSTV 646
++YLH A IIHRD+K++NIL+ + N + K++DFGL++ +
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKMS 173
Query: 647 VKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCK 706
G++ ++ PE + ++ SD++S+GV+L+E+L +P + A
Sbjct: 174 AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE------VPFRGIDGLAVAYGVA 227
Query: 707 RKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757
L I C + FA E C + RPS ++L L
Sbjct: 228 MNK---------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 5e-62
Identities = 72/296 (24%), Positives = 126/296 (42%), Gaps = 42/296 (14%)
Query: 479 EIKHATKSFDESYVIGVGGFGKVYKGV-IEDKLKVAIKR-------SNPSSEQGVNEFVT 530
+ +++ IG GGFG V+KG ++DK VAIK + EF
Sbjct: 15 TLADNEIEYEK--QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR 72
Query: 531 EIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIG 590
E+ ++S L H ++V L G N +V +++ G L + + + W +L + +
Sbjct: 73 EVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLD 130
Query: 591 AARGLHYLHTGAKYTIIHRDVKTTNILLDE-----NWVAKVSDFGLSKTGPNMENGHVST 645
A G+ Y+ I+HRD+++ NI L AKV+DFGLS+ ++ H +
Sbjct: 131 IALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVS 184
Query: 646 VVKGSFGYLDPEYFKRQQL--TEKSDIYSFGVVLFEVLCARPALNP--SLPKEQVSLADW 701
+ G+F ++ PE ++ TEK+D YSF ++L+ +L P ++ +
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG---PFDEYSYGKIKFINM 241
Query: 702 ALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757
+ P I +C + + E C S RP ++ L
Sbjct: 242 IREEGLR--------P----TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 2e-60
Identities = 48/274 (17%), Positives = 112/274 (40%), Gaps = 32/274 (11%)
Query: 492 VIGVGGFGKVYKGVIEDKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGF 549
+ G+++KG + + +K S + +F E L H +++ ++G
Sbjct: 17 KLNENHSGELWKGRWQGN-DIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 550 CEE--GNEMCLVYDYMALGTLREHIY-NTKKALSWKQRLEICIGAARGLHYLHTGAKYTI 606
C+ L+ +M G+L ++ T + Q ++ + ARG+ +LHT + I
Sbjct: 76 CQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LEPLI 134
Query: 607 IHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQL-- 664
+ + ++++DE+ A++S + + S + ++ PE +++
Sbjct: 135 PRHALNSRSVMIDEDMTARISMADVKFS-------FQSPGRMYAPAWVAPEALQKKPEDT 187
Query: 665 -TEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKI 723
+D++SF V+L+E++ +P +S + + +G L+ I
Sbjct: 188 NRRSADMWSFAVLLWELVTRE------VPFADLSNMEIGMKVALEG---------LRPTI 232
Query: 724 SPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757
P + + C+++ RP ++ LE
Sbjct: 233 PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILE 266
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 1e-59
Identities = 68/282 (24%), Positives = 109/282 (38%), Gaps = 36/282 (12%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFC 550
V+G G FG+ K E + +K E+ F+ E++++ L H +++ IG
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 551 EEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRD 610
+ + + +Y+ GTLR I + W QR+ A G+ YLH IIHRD
Sbjct: 77 YKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRD 133
Query: 611 VKTTNILLDENWVAKVSDFGLSK------------TGPNMENGHVSTVVKGSFGYLDPEY 658
+ + N L+ EN V+DFGL++ + V G+ ++ PE
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193
Query: 659 FKRQQLTEKSDIYSFGVVLFEVLC---ARPALNPSLPKEQVSLADWALHCKRKGILDDII 715
+ EK D++SFG+VL E++ A P P + +
Sbjct: 194 INGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPR----TMDFGLNVRGFLDR------- 242
Query: 716 DPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757
P C F +C RPS + LE
Sbjct: 243 ------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 3e-57
Identities = 75/299 (25%), Positives = 131/299 (43%), Gaps = 31/299 (10%)
Query: 492 VIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQG-VNEFVTEIEMLSKLRHKHLVSLIGFC 550
IG G +G+V+ G + KVA+K + E E TEI +RH++++ I
Sbjct: 44 QIGKGRYGEVWMGKWRGE-KVAVKVFFTTEEASWFRE--TEIYQTVLMRHENILGFIAAD 100
Query: 551 EEGN----EMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHT-----G 601
+G ++ L+ DY G+L +++ L K L++ + GL +LHT
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158
Query: 602 AKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH--VSTVVKGSFGYLDPE-- 657
K I HRD+K+ NIL+ +N ++D GL+ + N G+ Y+ PE
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL 218
Query: 658 ----YFKRQQLTEKSDIYSFGVVLFEVL--CARPALNPS--LPKEQVSLADWALHCKRKG 709
Q +D+YSFG++L+EV C + LP + +D + R+
Sbjct: 219 DESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREI 278
Query: 710 ILDDIIDPLLKDKISP-ECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVESTE 767
+ + P ++ S ECL++ +C + + R + V L ++ ES +
Sbjct: 279 VCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA---KMSESQD 334
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 1e-55
Identities = 66/291 (22%), Positives = 120/291 (41%), Gaps = 32/291 (10%)
Query: 492 VIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEM--LSKLRHKHLVSLIGF 549
+G G +G+V++G + + VA+K + E+ + E E+ LRH++++ I
Sbjct: 15 CVGKGRYGEVWRGSWQGE-NVAVKIFSSRDEK---SWFRETELYNTVMLRHENILGFIAS 70
Query: 550 CEEGN----EMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHT----- 600
++ L+ Y +G+L +++ L L I + A GL +LH
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 601 GAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT---GPNMENGHVSTVVKGSFGYLDPE 657
K I HRD+K+ NIL+ +N ++D GL+ N + + V G+ Y+ PE
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYMAPE 187
Query: 658 ------YFKRQQLTEKSDIYSFGVVLFEVLC----ARPALNPSLPKEQVSLADWALHCKR 707
++ DI++FG+VL+EV + P V D + R
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMR 247
Query: 708 KGILDDIIDPLLKDKISP-ECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757
K + D P + ++ L A ++C + R + + L
Sbjct: 248 KVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 5e-54
Identities = 71/290 (24%), Positives = 138/290 (47%), Gaps = 30/290 (10%)
Query: 492 VIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQG-VNEFVTEIEMLSKLRHKHLVSLIGFC 550
IG G FG+V++G + +VA+K + E+ E EI LRH++++ I
Sbjct: 49 SIGKGRFGEVWRGKWRGE-EVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAAD 105
Query: 551 EEGN----EMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLH-----TG 601
+ N ++ LV DY G+L +++ + ++ + +++ + A GL +LH T
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 602 AKYTIIHRDVKTTNILLDENWVAKVSDFGLSK---TGPNMENGHVSTVVKGSFGYLDPE- 657
K I HRD+K+ NIL+ +N ++D GL+ + + + + V G+ Y+ PE
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV-GTKRYMAPEV 222
Query: 658 -----YFKRQQLTEKSDIYSFGVVLFEVL--CARPALNPS--LPKEQVSLADWALHCKRK 708
K + +++DIY+ G+V +E+ C+ ++ LP + +D ++ RK
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 282
Query: 709 GILDDIIDPLLKDKI-SPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757
+ + + P + ++ S E L+ A +C +G R + + L
Sbjct: 283 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 7e-42
Identities = 63/269 (23%), Positives = 113/269 (42%), Gaps = 25/269 (9%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKR---SNPSSEQGVNEFVTEIEMLSKLRHKHLVSLI 547
IG G F +VY+ + D + VA+K+ + + + + EI++L +L H +++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 548 GFCEEGNEMCLVYDYMALGTLREHIYNTKKA---LSWKQRLEICIGAARGLHYLHTGAKY 604
E NE+ +V + G L I + KK + + + + L ++H
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SR 155
Query: 605 TIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQL 664
++HRD+K N+ + V K+ D GL + + + ++V G+ Y+ PE
Sbjct: 156 RVMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLV-GTPYYMSPERIHENGY 213
Query: 665 TEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKIS 724
KSDI+S G +L+E+ + SL K I PL D S
Sbjct: 214 NFKSDIWSLGCLLYEMAALQSPFYGD-KMNLYSLC--------KKIEQCDYPPLPSDHYS 264
Query: 725 PECLKKFADTAEKCLSDSGIDRPSMGDVL 753
E L++ + C++ RP + V
Sbjct: 265 EE-LRQLVN---MCINPDPEKRPDVTYVY 289
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-41
Identities = 59/234 (25%), Positives = 100/234 (42%), Gaps = 21/234 (8%)
Query: 462 SHLSAIAQGLCRRFSLA----------EIKHATKSFDESYVIGVGGFGKVYKGVI-EDKL 510
HL + Q L ++ + + H E IG G FG+V+ G + D
Sbjct: 83 DHLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGE--QIGRGNFGEVFSGRLRADNT 140
Query: 511 KVAIKRSNP-SSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLR 569
VA+K +F+ E +L + H ++V LIG C + + +V + + G
Sbjct: 141 LVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 200
Query: 570 EHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDF 629
+ L K L++ AA G+ YL IHRD+ N L+ E V K+SDF
Sbjct: 201 TFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDF 257
Query: 630 GLSKTGPNMENGHVSTVVKGSFGY--LDPEYFKRQQLTEKSDIYSFGVVLFEVL 681
G+S+ + + ++ PE + + +SD++SFG++L+E
Sbjct: 258 GMSREEA--DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETF 309
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 6e-41
Identities = 69/317 (21%), Positives = 110/317 (34%), Gaps = 35/317 (11%)
Query: 441 IYGHSQTTQSKSTISGKSNASSHLSAIAQGLCRRFSLAEIKHATKSFDESYVIGVGGFGK 500
+Y S +S + AS L + R S + +SF +G G +G+
Sbjct: 18 LYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQ-----QSFQRLSRLGHGSYGE 72
Query: 501 VYKGV-IEDKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEM 556
V+K ED A+KRS + + E+ K+ +H V L EEG +
Sbjct: 73 VFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL 132
Query: 557 CLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNI 616
L + +L++H +L Q L +LH ++H DVK NI
Sbjct: 133 YLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANI 188
Query: 617 LLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVV 676
L K+ DFGL + V +G Y+ PE + +D++S G+
Sbjct: 189 FLGPRGRCKLGDFGLLV---ELGTAGAGEVQEGDPRYMAPELL-QGSYGTAADVFSLGLT 244
Query: 677 LFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAE 736
+ EV C LP W + + + P +S E
Sbjct: 245 ILEVACNME-----LPHG---GEGW------QQLRQGYLPPEFTAGLSSE----LRSVLV 286
Query: 737 KCLSDSGIDRPSMGDVL 753
L R + +L
Sbjct: 287 MMLEPDPKLRATAEALL 303
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 3e-40
Identities = 76/302 (25%), Positives = 124/302 (41%), Gaps = 49/302 (16%)
Query: 487 FDESYVIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVS 545
F E +IG GGFG+V+K D IKR ++E+ E ++ L+KL H ++V
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVH 68
Query: 546 LIGFCEE----------------GNEMCLVYDYMALGTLREHIYNTK-KALSWKQRLEIC 588
G + + + ++ GTL + I + + L LE+
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 589 IGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVK 648
+G+ Y+H +I+RD+K +NI L + K+ DFGL + ++N T K
Sbjct: 129 EQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS---LKNDGKRTRSK 182
Query: 649 GSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRK 708
G+ Y+ PE Q ++ D+Y+ G++L E+L E R
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-----AFETSKF----FTDLRD 233
Query: 709 GILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVESTEA 768
GI+ DI D K + K LS DRP+ ++L L + E E
Sbjct: 234 GIISDIFDKKEKTLLQ------------KLLSKKPEDRPNTSEILRTLTVWKKSPEKNER 281
Query: 769 SS 770
+
Sbjct: 282 HT 283
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-39
Identities = 65/275 (23%), Positives = 107/275 (38%), Gaps = 34/275 (12%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIG 548
IG G +G+ K D + K + +E V+E+ +L +L+H ++V
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 549 --FCEEGNEMCLVYDYMALGTLREHIYNTKKA---LSWKQRLEICIGAARGLHYLHT--G 601
+ +V +Y G L I K L + L + L H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 602 AKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV--STVVKGSFGYLDPEYF 659
+T++HRD+K N+ LD K+ DFGL++ + + T V G+ Y+ PE
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI---LNHDTSFAKTFV-GTPYYMSPEQM 188
Query: 660 KRQQLTEKSDIYSFGVVLFEVLCARPALN-PSLPKEQVSLADWALHCKRKGILDDIIDPL 718
R EKSDI+S G +L+E+ P S L K I +
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---------ELAGK---IREGKFRR- 235
Query: 719 LKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
+ + S E + + L+ RPS+ ++L
Sbjct: 236 IPYRYSDEL----NEIITRMLNLKDYHRPSVEEIL 266
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 4e-39
Identities = 69/207 (33%), Positives = 109/207 (52%), Gaps = 15/207 (7%)
Query: 479 EIKHATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIK--RSNPSSEQGVNEFVTEIEMLS 536
I + +F + IG G FG V+ G +K KVAIK R SE+ +F+ E E++
Sbjct: 4 VIDPSELTFVQ--EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMM 58
Query: 537 KLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLH 596
KL H LV L G C E +CLV ++M G L +++ + + + L +C+ G+
Sbjct: 59 KLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 118
Query: 597 YLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGY--L 654
YL + +IHRD+ N L+ EN V KVSDFG+++ + + ++ F
Sbjct: 119 YL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTR---FVLDDQYTSSTGTKFPVKWA 172
Query: 655 DPEYFKRQQLTEKSDIYSFGVVLFEVL 681
PE F + + KSD++SFGV+++EV
Sbjct: 173 SPEVFSFSRYSSKSDVWSFGVLMWEVF 199
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 5e-39
Identities = 68/267 (25%), Positives = 111/267 (41%), Gaps = 27/267 (10%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIG 548
IG G FGK ED + IK N S S + E E+ +L+ ++H ++V
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 549 FCEEGNEMCLVYDYMALGTLREHIYNTKKA-LSWKQRLEICIGAARGLHYLHTGAKYTII 607
EE + +V DY G L + I K Q L+ + L ++H I+
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKIL 147
Query: 608 HRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEK 667
HRD+K+ NI L ++ ++ DFG+++ N + G+ YL PE + + K
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARACI-GTPYYLSPEICENKPYNNK 205
Query: 668 SDIYSFGVVLFEVLCARPALN-PSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPE 726
SDI++ G VL+E+ + A S+ L K I+ P + S +
Sbjct: 206 SDIWALGCVLYELCTLKHAFEAGSMK---------NLVLK---IISGSFPP-VSLHYSYD 252
Query: 727 CLKKFADTAEKCLSDSGIDRPSMGDVL 753
+ + DRPS+ +L
Sbjct: 253 ----LRSLVSQLFKRNPRDRPSVNSIL 275
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-38
Identities = 53/196 (27%), Positives = 100/196 (51%), Gaps = 10/196 (5%)
Query: 492 VIGVGGFGKVYKGV-----IEDKLKVAIKRSNP-SSEQGVNEFVTEIEMLSKLRHKHLVS 545
V+G G FG VYKG+ + K+ VAIK +S + E + E +++ + + H+
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 546 LIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYT 605
L+G C + + L+ M G L +++ K + + L C+ A+G++YL
Sbjct: 82 LLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EDRR 137
Query: 606 IIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLT 665
++HRD+ N+L+ K++DFGL+K E + + K ++ E + T
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 666 EKSDIYSFGVVLFEVL 681
+SD++S+GV ++E++
Sbjct: 198 HQSDVWSYGVTVWELM 213
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-38
Identities = 65/201 (32%), Positives = 104/201 (51%), Gaps = 17/201 (8%)
Query: 492 VIGVGGFGKVYKGVIED----KLKVAIKRSNP-SSEQGVNEFVTEIEMLSKLRHKHLVSL 546
VIG G FG VY G + D K+ A+K N + V++F+TE ++ H +++SL
Sbjct: 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 547 IGFC-EEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYT 605
+G C +V YM G LR I N + K + + A+G+ YL K+
Sbjct: 92 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL-ASKKF- 149
Query: 606 IIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYL-----DPEYFK 660
+HRD+ N +LDE + KV+DFGL++ +M + +V + L E +
Sbjct: 150 -VHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEYYSVHNKTGAKLPVKWMALESLQ 205
Query: 661 RQQLTEKSDIYSFGVVLFEVL 681
Q+ T KSD++SFGV+L+E++
Sbjct: 206 TQKFTTKSDVWSFGVLLWELM 226
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-38
Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 15/207 (7%)
Query: 479 EIKHATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIK--RSNPSSEQGVNEFVTEIEMLS 536
EI +F + +G G FG V G + VAIK + SE EF+ E +++
Sbjct: 20 EIDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMM 74
Query: 537 KLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLH 596
L H+ LV L G C + + ++ +YMA G L ++ + +Q LE+C +
Sbjct: 75 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 134
Query: 597 YLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGY--L 654
YL +HRD+ N L+++ V KVSDFGLS+ + + ++ V F
Sbjct: 135 YL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR---YVLDDEYTSSVGSKFPVRWS 188
Query: 655 DPEYFKRQQLTEKSDIYSFGVVLFEVL 681
PE + + KSDI++FGV+++E+
Sbjct: 189 PPEVLMYSKFSSKSDIWAFGVLMWEIY 215
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-38
Identities = 61/201 (30%), Positives = 104/201 (51%), Gaps = 17/201 (8%)
Query: 492 VIGVGGFGKVYKGVIEDK----LKVAIKRSNP-SSEQGVNEFVTEIEMLSKLRHKHLVSL 546
VIG G FG VY G D+ ++ AIK + + Q V F+ E ++ L H ++++L
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 547 IGFCEEGNEMCL-VYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYT 605
IG + + YM G L + I + ++ + K + + ARG+ YL A+
Sbjct: 88 IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL---AEQK 144
Query: 606 IIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYL-----DPEYFK 660
+HRD+ N +LDE++ KV+DFGL++ ++ + +V + L E +
Sbjct: 145 FVHRDLAARNCMLDESFTVKVADFGLAR---DILDREYYSVQQHRHARLPVKWTALESLQ 201
Query: 661 RQQLTEKSDIYSFGVVLFEVL 681
+ T KSD++SFGV+L+E+L
Sbjct: 202 TYRFTTKSDVWSFGVLLWELL 222
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-38
Identities = 59/228 (25%), Positives = 95/228 (41%), Gaps = 44/228 (19%)
Query: 479 EIKHATKSFDESYVIGVGGFGKVYKGV--------IEDKLKVAIKRSNPSSEQGVNEFVT 530
+I++ F+E +G G F K++KGV + +V +K + + F
Sbjct: 4 KIRNEDLIFNE--SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE 61
Query: 531 EIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIG 590
M+SKL HKHLV G C G+E LV +++ G+L ++ K ++ +LE+
Sbjct: 62 AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQ 121
Query: 591 AARGLHYLHTGAKYTIIHRDVKTTNILLD--------ENWVAKVSDFGLSKTGPNMENGH 642
A +H+L + T+IH +V NILL K+SD G+S
Sbjct: 122 LAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI--------- 169
Query: 643 VSTVVKGSFGYLDP---------EYFKRQQLTEKSDIYSFGVVLFEVL 681
V + E K L +D +SFG L+E+
Sbjct: 170 ---TVLPKDILQERIPWVPPECIENPKN--LNLATDKWSFGTTLWEIC 212
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 6e-38
Identities = 64/201 (31%), Positives = 103/201 (51%), Gaps = 17/201 (8%)
Query: 492 VIGVGGFGKVYKGVIED----KLKVAIKRSNP-SSEQGVNEFVTEIEMLSKLRHKHLVSL 546
VIG G FG VY G + D K+ A+K N + V++F+TE ++ H +++SL
Sbjct: 96 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 547 IGFC-EEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYT 605
+G C +V YM G LR I N + K + + A+G+ +L A
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASKK 212
Query: 606 IIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYL-----DPEYFK 660
+HRD+ N +LDE + KV+DFGL++ +M + +V + L E +
Sbjct: 213 FVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEFDSVHNKTGAKLPVKWMALESLQ 269
Query: 661 RQQLTEKSDIYSFGVVLFEVL 681
Q+ T KSD++SFGV+L+E++
Sbjct: 270 TQKFTTKSDVWSFGVLLWELM 290
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 8e-38
Identities = 58/194 (29%), Positives = 96/194 (49%), Gaps = 13/194 (6%)
Query: 492 VIGVGGFGKVYKGVIEDKLKVAIK--RSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGF 549
+G G FG V G + + VA+K + SE EF E + + KL H LV G
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMKLSHPKLVKFYGV 71
Query: 550 CEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHR 609
C + + +V +Y++ G L ++ + K L Q LE+C G+ +L + IHR
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHR 128
Query: 610 DVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGY--LDPEYFKRQQLTEK 667
D+ N L+D + KVSDFG+++ + + + V F PE F + + K
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTR---YVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSK 185
Query: 668 SDIYSFGVVLFEVL 681
SD+++FG++++EV
Sbjct: 186 SDVWAFGILMWEVF 199
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 9e-38
Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 24/212 (11%)
Query: 487 FDESYV-----IGVGGFGKVYKGVIE-----DKLKVAIKRSNPSSEQGVNEFVTEIEMLS 536
F+E ++ +G G FG V + VA+K+ S+E+ + +F EIE+L
Sbjct: 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66
Query: 537 KLRHKHLVSLIGFCEEGNE--MCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARG 594
L+H ++V G C + L+ +Y+ G+LR+++ K+ + + L+ +G
Sbjct: 67 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 595 LHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTV-----VKG 649
+ YL T +Y IHRD+ T NIL++ K+ DFGL+K P + +
Sbjct: 127 MEYLGT-KRY--IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF- 182
Query: 650 SFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVL 681
+ PE + + SD++SFGVVL+E+
Sbjct: 183 ---WYAPESLTESKFSVASDVWSFGVVLYELF 211
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 20/203 (9%)
Query: 492 VIGVGGFGKVYKGVIE-----DKLKVAIKRSNP-SSEQGVNEFVTEIEMLSKLRHKHLVS 545
+G G FGKV + +VA+K P S + + EIE+L L H+++V
Sbjct: 28 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 546 LIGFC--EEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAK 603
G C + GN + L+ +++ G+L+E++ K ++ KQ+L+ + +G+ YL + +
Sbjct: 88 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS-RQ 146
Query: 604 YTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTV-----VKGSFGYLDPEY 658
Y +HRD+ N+L++ K+ DFGL+K + + V + PE
Sbjct: 147 Y--VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF----WYAPEC 200
Query: 659 FKRQQLTEKSDIYSFGVVLFEVL 681
+ + SD++SFGV L E+L
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELL 223
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 60/212 (28%), Positives = 105/212 (49%), Gaps = 24/212 (11%)
Query: 487 FDESYV-----IGVGGFGKVYKGVIE-----DKLKVAIKRSNPSSEQGVNEFVTEIEMLS 536
F+E ++ +G G FG V + VA+K+ S+E+ + +F EIE+L
Sbjct: 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 97
Query: 537 KLRHKHLVSLIGFCEEGNE--MCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARG 594
L+H ++V G C + L+ +Y+ G+LR+++ K+ + + L+ +G
Sbjct: 98 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 157
Query: 595 LHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTV-----VKG 649
+ YL T +Y IHRD+ T NIL++ K+ DFGL+K P + + +
Sbjct: 158 MEYLGT-KRY--IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF- 213
Query: 650 SFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVL 681
+ PE + + SD++SFGVVL+E+
Sbjct: 214 ---WYAPESLTESKFSVASDVWSFGVVLYELF 242
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 70/293 (23%), Positives = 109/293 (37%), Gaps = 47/293 (16%)
Query: 487 FDESYVIGVGGFGKVYKGV-IEDKLKVAIKRSN-PSSEQGVNEFVTEIEMLSKLRHKHLV 544
F+ +G GGFG V++ D AIKR P+ E + + E++ L+KL H +V
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 545 SLIGFCEEGNEM------------CLVYDYMALGTLREHI--YNTKKALSWKQRLEICIG 590
E N + L++ + T + L I +
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 591 AARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSK----------TGPNMEN 640
A + +LH ++HRD+K +NI + V KV DFGL M
Sbjct: 127 IAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 641 GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLAD 700
T G+ Y+ PE + K DI+S G++LFE+L S E+V
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP-----FSTQMERVRT-- 236
Query: 701 WALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
L R P L + P + LS S ++RP +++
Sbjct: 237 --LTDVRNLKF-----PPLFTQKYPC-EYVM---VQDMLSPSPMERPEAINII 278
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 65/232 (28%), Positives = 105/232 (45%), Gaps = 38/232 (16%)
Query: 493 IGVGGFGKVYKGVI------EDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSL 546
+G G FGKV+ +DK+ VA+K + +F E E+L+ L+H+H+V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 547 IGFCEEGNEMCLVYDYMALGTLRE---------------HIYNTKKALSWKQRLEICIGA 591
G C +G+ + +V++YM G L + K L Q L I
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 592 ARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSF 651
A G+ YL A +HRD+ T N L+ N + K+ DFG+S+ ++ + G
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR---DVYST--DYYRVGGH 194
Query: 652 GYL-----DPEYFKRQQLTEKSDIYSFGVVLFEV--LCARPALNPSLPKEQV 696
L PE ++ T +SD++SFGV+L+E+ +P L +V
Sbjct: 195 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW--FQLSNTEV 244
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 64/296 (21%), Positives = 116/296 (39%), Gaps = 50/296 (16%)
Query: 487 FDESYVIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVS 545
F+E V+G G FG+V K D AIK+ + E+ ++ ++E+ +L+ L H+++V
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVR 66
Query: 546 LIG-FCEEGNE------------MCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAA 592
+ E N + + +Y GTL + I++ + +
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 593 RGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPN-------------ME 639
L Y+H IIHRD+K NI +DE+ K+ DFGL+K
Sbjct: 127 EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 640 NGHVSTVVKGSFGYLDPEYFKRQQL-TEKSDIYSFGVVLFEVLCA-RPALNPSLPKEQVS 697
+ ++++ + G+ Y+ E EK D+YS G++ FE++ + +++
Sbjct: 184 SDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKL- 241
Query: 698 LADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
R ++ P D KK + RP +L
Sbjct: 242 ---------RSVSIE--FPPDFDDNKMKV-EKKI---IRLLIDHDPNKRPGARTLL 282
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-37
Identities = 63/286 (22%), Positives = 104/286 (36%), Gaps = 35/286 (12%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFC 550
+G GGF V + D A+KR +Q E E +M H +++ L+ +C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 551 EE----GNEMCLVYDYMALGTLREHIYNTKKA---LSWKQRLEICIGAARGLHYLHTGAK 603
+E L+ + GTL I K L+ Q L + +G RGL +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---A 152
Query: 604 YTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVV-------KGSFGYLDP 656
HRD+K TNILL + + D G G + + + Y P
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 657 EYF---KRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDD 713
E F + E++D++S G VL+ ++ P + V ++ + L
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG------PYDMVFQKGDSVALAVQNQLSI 266
Query: 714 IIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759
P + S ++ RP + +L LE +
Sbjct: 267 PQSP----RHSSA----LWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-37
Identities = 53/208 (25%), Positives = 90/208 (43%), Gaps = 21/208 (10%)
Query: 492 VIGVGGFGKVYKGVI-----EDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSL 546
+G G FG V VA+K+ S +F EI++L L +V
Sbjct: 30 QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 547 IGFCEEGNE--MCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKY 604
G + LV +Y+ G LR+ + + L + L +G+ YL + +
Sbjct: 90 RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS-RRC 148
Query: 605 TIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTV-----VKGSFGYLDPEYF 659
+HRD+ NIL++ K++DFGL+K P ++ +V + + PE
Sbjct: 149 --VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF----WYAPESL 202
Query: 660 KRQQLTEKSDIYSFGVVLFEV--LCARP 685
+ +SD++SFGVVL+E+ C +
Sbjct: 203 SDNIFSRQSDVWSFGVVLYELFTYCDKS 230
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 5e-37
Identities = 63/261 (24%), Positives = 113/261 (43%), Gaps = 21/261 (8%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIK--RSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIG 548
IG G F VYKG+ E ++VA + ++ F E EML L+H ++V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 549 ----FCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKY 604
+ + LV + M GTL+ ++ K + K C +GL +LHT
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLHT-RTP 150
Query: 605 TIIHRDVKTTNILLD-ENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQ 663
IIHRD+K NI + K+ D GL+ ++ + V G+ ++ PE ++ ++
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPEFMAPEMYE-EK 205
Query: 664 LTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKI 723
E D+Y+FG+ + E+ + + Q+ + D + P +K+ I
Sbjct: 206 YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR--VTSGVKPASFDKVAIPEVKEII 263
Query: 724 SPECLKKFAD---TAEKCLSD 741
C+++ D + + L+
Sbjct: 264 E-GCIRQNKDERYSIKDLLNH 283
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 9e-37
Identities = 66/232 (28%), Positives = 103/232 (44%), Gaps = 37/232 (15%)
Query: 492 VIGVGGFGKVYKGVI------EDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVS 545
+G G FGKV+ +DK+ VA+K +SE +F E E+L+ L+H+H+V
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 546 LIGFCEEGNEMCLVYDYMALGTLRE--------------HIYNTKKALSWKQRLEICIGA 591
G C EG + +V++YM G L L Q L +
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 592 ARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSF 651
A G+ YL A +HRD+ T N L+ + V K+ DFG+S+ ++ + G
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR---DIYSTDYYR--VGGR 219
Query: 652 GYL-----DPEYFKRQQLTEKSDIYSFGVVLFEV--LCARPALNPSLPKEQV 696
L PE ++ T +SD++SFGVVL+E+ +P L +
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW--YQLSNTEA 269
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-36
Identities = 69/251 (27%), Positives = 115/251 (45%), Gaps = 25/251 (9%)
Query: 463 HLSAIAQGLCRRFSLAEIKHATKSFDESY--------------VIGVGGFGKVYKGVIED 508
+ S A GLC R + ++ + +G G FG+V+ G
Sbjct: 148 YYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG 207
Query: 509 KLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTL 568
+VAIK P + F+ E +++ KLRH+ LV L E + +V +YM+ G+L
Sbjct: 208 TTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSL 265
Query: 569 REHIY-NTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVS 627
+ + T K L Q +++ A G+ Y+ + +HRD++ NIL+ EN V KV+
Sbjct: 266 LDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVA 322
Query: 628 DFGLSKTGPNMENGHVSTVVKGSFGY--LDPEYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
DFGL++ +E+ + F PE + T KSD++SFG++L E+
Sbjct: 323 DFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 379
Query: 686 ALNPSLPKEQV 696
P + +V
Sbjct: 380 VPYPGMVNREV 390
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 53/196 (27%), Positives = 100/196 (51%), Gaps = 10/196 (5%)
Query: 492 VIGVGGFGKVYKGV-----IEDKLKVAIKRSNP-SSEQGVNEFVTEIEMLSKLRHKHLVS 545
V+G G FG VYKG+ + K+ VAIK +S + E + E +++ + + H+
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 546 LIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYT 605
L+G C + + L+ M G L +++ K + + L C+ A+G++YL
Sbjct: 82 LLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EDRR 137
Query: 606 IIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLT 665
++HRD+ N+L+ K++DFGL+K E + + K ++ E + T
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 666 EKSDIYSFGVVLFEVL 681
+SD++S+GV ++E++
Sbjct: 198 HQSDVWSYGVTVWELM 213
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 69/214 (32%), Positives = 103/214 (48%), Gaps = 36/214 (16%)
Query: 492 VIGVGGFGKVYKGVI---EDKLKVAIKRSNP-SSEQGVNEFVTEIEMLSKL-RHKHLVSL 546
VIG G FG+V K I ++ AIKR +S+ +F E+E+L KL H ++++L
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 547 IGFCEEGNEMCLVYDYMALGTLREH---------------IYNTKKALSWKQRLEICIGA 591
+G CE + L +Y G L + +T LS +Q L
Sbjct: 92 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 592 ARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSF 651
ARG+ YL ++ IHRD+ NIL+ EN+VAK++DFGLS+ VK +
Sbjct: 152 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ--------EVYVKKTM 200
Query: 652 GYL-----DPEYFKRQQLTEKSDIYSFGVVLFEV 680
G L E T SD++S+GV+L+E+
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 234
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 16/210 (7%)
Query: 479 EIKHATKSFDESYVIGVGGFGKVYKGV----IEDKLKVAIKRSNP-SSEQGVNEFVTEIE 533
I + ++G G FG+VY+GV +K+ VA+K + +F++E
Sbjct: 8 GIAREDVVLNR--ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV 65
Query: 534 MLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAAR 593
++ L H H+V LIG EE ++ + G L ++ K +L + + +
Sbjct: 66 IMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICK 124
Query: 594 GLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSF-- 651
+ YL + +HRD+ NIL+ K+ DFGLS+ +E+
Sbjct: 125 AMAYLES-INC--VHRDIAVRNILVASPECVKLGDFGLSRY---IEDEDYYKASVTRLPI 178
Query: 652 GYLDPEYFKRQQLTEKSDIYSFGVVLFEVL 681
++ PE ++ T SD++ F V ++E+L
Sbjct: 179 KWMSPESINFRRFTTASDVWMFAVCMWEIL 208
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 59/209 (28%), Positives = 104/209 (49%), Gaps = 11/209 (5%)
Query: 479 EIKHATKSFDESYVIGVGGFGKVYKGVI----EDKLKVAIKRSNP-SSEQGVNEFVTEIE 533
EI+ + ++ +IG G G+V G + + + VAIK +E+ +F++E
Sbjct: 45 EIEASRIHIEK--IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEAS 102
Query: 534 MLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAAR 593
++ + H +++ L G G +V +YM G+L + + Q + + G
Sbjct: 103 IMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGA 162
Query: 594 GLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT-GPNMENGHVSTVVKGSFG 652
G+ YL + +HRD+ N+L+D N V KVSDFGLS+ + + + +T K
Sbjct: 163 GMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIR 219
Query: 653 YLDPEYFKRQQLTEKSDIYSFGVVLFEVL 681
+ PE + + SD++SFGVV++EVL
Sbjct: 220 WTAPEAIAFRTFSSASDVWSFGVVMWEVL 248
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-36
Identities = 48/212 (22%), Positives = 90/212 (42%), Gaps = 30/212 (14%)
Query: 492 VIGVGGFGKVYKGVIEDK----LKVAIK--RSNPSSEQGVNEFVTEIEMLSKLRHKHLVS 545
++G G FG V + ++ + +KVA+K +++ + + EF+ E + + H H+
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 546 LIGFCEEG------NEMCLVYDYMALGTLREHI-----YNTKKALSWKQRLEICIGAARG 594
L+G ++ +M G L + L + + + A G
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 595 LHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYL 654
+ YL + IHRD+ N +L E+ V+DFGLS+ + +G +G L
Sbjct: 150 MEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR---KIYSGDYYR--QGCASKL 201
Query: 655 -----DPEYFKRQQLTEKSDIYSFGVVLFEVL 681
E T SD+++FGV ++E++
Sbjct: 202 PVKWLALESLADNLYTVHSDVWAFGVTMWEIM 233
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-36
Identities = 66/254 (25%), Positives = 117/254 (46%), Gaps = 21/254 (8%)
Query: 439 LPIYGHSQTTQSKSTISGKSNASSHLSAIAQGLCRRFSLAEIKHATKSFDESYVIGVGGF 498
+ Y H + + + +F+ EI + + + VIG G F
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMGSDPNQAVLKFTT-EIHPSCVTRQK--VIGAGEF 57
Query: 499 GKVYKGV-----IEDKLKVAIKRSNP-SSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE 552
G+VYKG+ + ++ VAIK +E+ +F+ E ++ + H +++ L G +
Sbjct: 58 GEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117
Query: 553 GNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVK 612
M ++ +YM G L + + S Q + + G A G+ YL Y +HRD+
Sbjct: 118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL-ANMNY--VHRDLA 174
Query: 613 TTNILLDENWVAKVSDFGLSKTGPNMENGHVSTV-----VKGSFGYLDPEYFKRQQLTEK 667
NIL++ N V KVSDFGLS+ + +T ++ + PE ++ T
Sbjct: 175 ARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR----WTAPEAISYRKFTSA 230
Query: 668 SDIYSFGVVLFEVL 681
SD++SFG+V++EV+
Sbjct: 231 SDVWSFGIVMWEVM 244
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-36
Identities = 63/228 (27%), Positives = 104/228 (45%), Gaps = 33/228 (14%)
Query: 492 VIGVGGFGKVYKGVI------EDKLKVAIKRSNP-SSEQGVNEFVTEIEMLSKLRHKHLV 544
+G G FG VY+GV E + +VAIK N +S + EF+ E ++ + H+V
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 545 SLIGFCEEGNEMCLVYDYMALGTLREHI---------YNTKKALSWKQRLEICIGAARGL 595
L+G +G ++ + M G L+ ++ S + +++ A G+
Sbjct: 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 596 HYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYL- 654
YL +HRD+ N ++ E++ K+ DFG+++ ++ KG G L
Sbjct: 152 AYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR---DIYET--DYYRKGGKGLLP 203
Query: 655 ----DPEYFKRQQLTEKSDIYSFGVVLFEV--LCARPALNPSLPKEQV 696
PE K T SD++SFGVVL+E+ L +P L EQV
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--QGLSNEQV 249
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-36
Identities = 57/234 (24%), Positives = 95/234 (40%), Gaps = 39/234 (16%)
Query: 492 VIGVGGFGKVYKGVI------EDKLKVAIKRSNP-SSEQGVNEFVTEIEMLSKLRHKHLV 544
+G FGKVYKG + E VAIK + EF E + ++L+H ++V
Sbjct: 16 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 545 SLIGFCEEGNEMCLVYDYMALGTLRE---------------HIYNTKKALSWKQRLEICI 589
L+G + + +++ Y + G L E K AL + +
Sbjct: 76 CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 590 GAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKG 649
A G+ YL + + ++H+D+ T N+L+ + K+SD GL + +
Sbjct: 136 QIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR---EVYAA--DYYKLL 187
Query: 650 SFGYL-----DPEYFKRQQLTEKSDIYSFGVVLFEV--LCARPALNPSLPKEQV 696
L PE + + SDI+S+GVVL+EV +P + V
Sbjct: 188 GNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY--CGYSNQDV 239
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-36
Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 19/200 (9%)
Query: 492 VIGVGGFGKVYKGVIEDK---LKVAIK--RSNPSSEQGVNEFVTEIEMLSKLRHKHLVSL 546
+G G FG V KG + K VA+K ++ + +E + E ++ +L + ++V +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 547 IGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTI 606
IG CE LV + LG L +++ + + K +E+ + G+ YL +
Sbjct: 84 IGICE-AESWMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYL---EESNF 138
Query: 607 IHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTV-----VKGSFGYLDPEYFKR 661
+HRD+ N+LL AK+SDFGLSK EN + + VK + PE
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK----WYAPECINY 194
Query: 662 QQLTEKSDIYSFGVVLFEVL 681
+ + KSD++SFGV+++E
Sbjct: 195 YKFSSKSDVWSFGVLMWEAF 214
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-36
Identities = 69/251 (27%), Positives = 115/251 (45%), Gaps = 25/251 (9%)
Query: 463 HLSAIAQGLCRRFSLAEIKHATKSFDESY--------------VIGVGGFGKVYKGVIED 508
+ S A GLC R + ++ + +G G FG+V+ G
Sbjct: 231 YYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG 290
Query: 509 KLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTL 568
+VAIK P + F+ E +++ KLRH+ LV L E + +V +YM+ G+L
Sbjct: 291 TTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSL 348
Query: 569 REHIY-NTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVS 627
+ + T K L Q +++ A G+ Y+ + +HRD++ NIL+ EN V KV+
Sbjct: 349 LDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVA 405
Query: 628 DFGLSKTGPNMENGHVSTVVKGSFGY--LDPEYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
DFGL++ +E+ + F PE + T KSD++SFG++L E+
Sbjct: 406 DFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 462
Query: 686 ALNPSLPKEQV 696
P + +V
Sbjct: 463 VPYPGMVNREV 473
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 6e-36
Identities = 52/215 (24%), Positives = 88/215 (40%), Gaps = 22/215 (10%)
Query: 479 EIKHATKSFDESYVIGVGGFGKVYKGV----IEDKLKVAIK---RSNPSSEQGVNEFVTE 531
I E +G G FG V +G + VA+K S + +++F+ E
Sbjct: 14 LIGEKDLRLLE--KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 71
Query: 532 IEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGA 591
+ + L H++L+ L G M +V + LG+L + + + +
Sbjct: 72 VNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 130
Query: 592 ARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTV----- 646
A G+ YL IHRD+ N+LL + K+ DFGL + P ++ +V
Sbjct: 131 AEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 187
Query: 647 VKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVL 681
+ PE K + + SD + FGV L+E+
Sbjct: 188 FA----WCAPESLKTRTFSHASDTWMFGVTLWEMF 218
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 6e-36
Identities = 56/207 (27%), Positives = 103/207 (49%), Gaps = 13/207 (6%)
Query: 479 EIKHATKSFDESYVIGVGGFGKVYKGVIEDK-LKVAIKRSNPSSEQGVNEFVTEIEMLSK 537
E++ + +G G +G+VY+GV + L VA+K + + V EF+ E ++ +
Sbjct: 216 EMERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKE 272
Query: 538 LRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHI-YNTKKALSWKQRLEICIGAARGLH 596
++H +LV L+G C ++ ++M G L +++ ++ +S L + + +
Sbjct: 273 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 332
Query: 597 YLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGY--L 654
YL K IHR++ N L+ EN + KV+DFGLS+ M + F
Sbjct: 333 YL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWT 386
Query: 655 DPEYFKRQQLTEKSDIYSFGVVLFEVL 681
PE + + KSD+++FGV+L+E+
Sbjct: 387 APESLAYNKFSIKSDVWAFGVLLWEIA 413
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 6e-36
Identities = 74/310 (23%), Positives = 142/310 (45%), Gaps = 61/310 (19%)
Query: 492 VIGVGGFGKVYKGVI--------EDKLKVAIKRSNP-SSEQGVNEFVTEIEMLSKL-RHK 541
+G G FG+V ++ + VA+K ++E+ +++ V+E+EM+ + +HK
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147
Query: 542 HLVSLIGFCEEGNEMCLVYDYMALGTLREH---------------IYNTKKALSWKQRLE 586
++++L+G C + + ++ +Y + G LRE+ ++ +++K +
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 587 ICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTV 646
ARG+ YL A IHRD+ N+L+ EN V K++DFGL++ ++ N
Sbjct: 208 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR---DINNI--DYY 259
Query: 647 VKGSFGYL-----DPEYFKRQQLTEKSDIYSFGVVLFEV--LCARPALNPSLPKEQVSLA 699
K + G L PE + T +SD++SFGV+++E+ L P P +P E++
Sbjct: 260 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY--PGIPVEEL--- 314
Query: 700 DWALHCKRKG-ILDDIIDPLLKDKISPE-CLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757
++G +D P C + C RP+ ++ +L+
Sbjct: 315 ---FKLLKEGHRMD-----------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 360
Query: 758 FVLQLVESTE 767
+L L + E
Sbjct: 361 RILTLTTNEE 370
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 7e-36
Identities = 53/213 (24%), Positives = 102/213 (47%), Gaps = 20/213 (9%)
Query: 479 EIKHATKSFDESYVIGVGGFGKVYKGV---IEDKLKVAIK--RSNPSSEQGVNEFVTEIE 533
+K + +G G FG V +GV + ++ VAIK + + + E + E +
Sbjct: 5 FLKRDNLLIAD-IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQ 62
Query: 534 MLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAAR 593
++ +L + ++V LIG C+ + LV + G L + + ++ + E+ +
Sbjct: 63 IMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 121
Query: 594 GLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTV-----VK 648
G+ YL + +HRD+ N+LL AK+SDFGLSK ++ + + +K
Sbjct: 122 GMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 178
Query: 649 GSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVL 681
+ PE ++ + +SD++S+GV ++E L
Sbjct: 179 ----WYAPECINFRKFSSRSDVWSYGVTMWEAL 207
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 8e-36
Identities = 53/197 (26%), Positives = 98/197 (49%), Gaps = 12/197 (6%)
Query: 492 VIGVGGFGKVYKGVIED-----KLKVAIK--RSNPSSEQGVNEFVTEIEMLSKLRHKHLV 544
V+G G FG V+KGV K+ V IK + + + L H H+V
Sbjct: 20 VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS-FQAVTDHMLAIGSLDHAHIV 78
Query: 545 SLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKY 604
L+G C + + LV Y+ LG+L +H+ + AL + L + A+G++YL ++
Sbjct: 79 RLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL---EEH 134
Query: 605 TIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQL 664
++HR++ N+LL +V+DFG++ P + + + K ++ E +
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 194
Query: 665 TEKSDIYSFGVVLFEVL 681
T +SD++S+GV ++E++
Sbjct: 195 THQSDVWSYGVTVWELM 211
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-35
Identities = 67/239 (28%), Positives = 112/239 (46%), Gaps = 33/239 (13%)
Query: 463 HLSAIAQGLCRRFSLAEIKHATKSFDESY----------------VIGVGGFGKVYKGVI 506
H + A GLC R ++ T + + + IG G FG V G
Sbjct: 155 HYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY 214
Query: 507 EDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFC-EEGNEMCLVYDYMAL 565
KVA+K + F+ E ++++LRH +LV L+G EE + +V +YMA
Sbjct: 215 RGN-KVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 271
Query: 566 GTLREHI-YNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVA 624
G+L +++ + L L+ + + YL +HRD+ N+L+ E+ VA
Sbjct: 272 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVA 328
Query: 625 KVSDFGLSKTGPNMENGHVSTV--VKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVL 681
KVSDFGL+K + + VK + PE + ++ + KSD++SFG++L+E+
Sbjct: 329 KVSDFGLTK---EASSTQDTGKLPVK----WTAPEALREKKFSTKSDVWSFGILLWEIY 380
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 58/197 (29%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 492 VIGVGGFGKVYKGV----IEDKLKVAIKRSNP-SSEQGVNEFVTEIEMLSKLRHKHLVSL 546
IG G FG V++G+ L VAIK +S+ +F+ E + + H H+V L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 547 IGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTI 606
IG E N + ++ + LG LR + K +L + + L YL ++
Sbjct: 82 IGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL-ESKRF-- 137
Query: 607 IHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSF--GYLDPEYFKRQQL 664
+HRD+ N+L+ N K+ DFGLS+ ME+ KG ++ PE ++
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSR---YMEDSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 665 TEKSDIYSFGVVLFEVL 681
T SD++ FGV ++E+L
Sbjct: 195 TSASDVWMFGVCMWEIL 211
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 69/256 (26%), Positives = 109/256 (42%), Gaps = 31/256 (12%)
Query: 463 HLSAIAQGLCRRFSLAEIKHATKSFDESYV-----IGVGGFGKVYKGVIED-----KLKV 512
H G L + F + Y+ +G G FGKV + V
Sbjct: 6 HHHHHHHGALEV--LFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMV 63
Query: 513 AIKRSNP-SSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNE--MCLVYDYMALGTLR 569
A+K + Q + + EI++L L H+H++ G CE+ + LV +Y+ LG+LR
Sbjct: 64 AVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLR 123
Query: 570 EHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDF 629
+ Y + ++ Q L G+ YLH Y IHRD+ N+LLD + + K+ DF
Sbjct: 124 D--YLPRHSIGLAQLLLFAQQICEGMAYLHA-QHY--IHRDLAARNVLLDNDRLVKIGDF 178
Query: 630 GLSKTGPNMENGHVSTV-----VKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEV--LC 682
GL+K P + V + PE K + SD++SFGV L+E+ C
Sbjct: 179 GLAKAVPEGHEYYRVREDGDSPVF----WYAPECLKEYKFYYASDVWSFGVTLYELLTHC 234
Query: 683 ARPALNPSLPKEQVSL 698
P+ E + +
Sbjct: 235 DSSQSPPTKFLELIGI 250
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 80/317 (25%), Positives = 128/317 (40%), Gaps = 52/317 (16%)
Query: 492 VIGVGGFGKVYKGVI------EDKLKVAIKRSNP-SSEQGVNEFVTEIEMLSKLRHKHLV 544
+G G FG+VY+G + L+VA+K SEQ +F+ E ++SK H+++V
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 545 SLIGFCEEGNEMCLVYDYMALGTLRE------HIYNTKKALSWKQRLEICIGAARGLHYL 598
IG + ++ + MA G L+ + +L+ L + A G YL
Sbjct: 97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 599 HTGAKYTIIHRDVKTTNILLD---ENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYL- 654
+ IHRD+ N LL VAK+ DFG+++ ++ S KG L
Sbjct: 157 ---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR---DIYRA--SYYRKGGCAMLP 208
Query: 655 ----DPEYFKRQQLTEKSDIYSFGVVLFEV--LCARPALNPSLPKEQVSLADWALHCKRK 708
PE F T K+D +SFGV+L+E+ L P PS ++V L
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY--PSKSNQEV------LEFVTS 260
Query: 709 G-ILDDIIDPLLKDKISPE-CLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVEST 766
G +D P+ C +C DRP+ +L +E+ Q +
Sbjct: 261 GGRMD-----------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI 309
Query: 767 EASSNRSRGSSIDGAED 783
+ G ++ E
Sbjct: 310 NTALPIEYGPLVEEEEK 326
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-35
Identities = 59/209 (28%), Positives = 105/209 (50%), Gaps = 11/209 (5%)
Query: 479 EIKHATKSFDESYVIGVGGFGKVYKGVI----EDKLKVAIKRSNP-SSEQGVNEFVTEIE 533
E+ S D+ V+G G FG+V G + + ++ VAIK +E+ +F+ E
Sbjct: 41 ELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS 98
Query: 534 MLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAAR 593
++ + H +++ L G + + +V +YM G+L + + Q + + G A
Sbjct: 99 IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 594 GLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT-GPNMENGHVSTVVKGSFG 652
G+ YL + +HRD+ NIL++ N V KVSDFGL + + E + + K
Sbjct: 159 GMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR 215
Query: 653 YLDPEYFKRQQLTEKSDIYSFGVVLFEVL 681
+ PE ++ T SD++S+G+VL+EV+
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVM 244
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-35
Identities = 57/197 (28%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 492 VIGVGGFGKVYKGV----IEDKLKVAIKRSNP-SSEQGVNEFVTEIEMLSKLRHKHLVSL 546
IG G FG V++G+ + VAIK +S+ +F+ E + + H H+V L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 547 IGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTI 606
IG E N + ++ + LG LR + K +L + + L YL + ++
Sbjct: 457 IGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES-KRF-- 512
Query: 607 IHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSF--GYLDPEYFKRQQL 664
+HRD+ N+L+ N K+ DFGLS+ ME+ KG ++ PE ++
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSR---YMEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 665 TEKSDIYSFGVVLFEVL 681
T SD++ FGV ++E+L
Sbjct: 570 TSASDVWMFGVCMWEIL 586
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-35
Identities = 56/235 (23%), Positives = 104/235 (44%), Gaps = 24/235 (10%)
Query: 463 HLSAIAQGLCRRFSLAEIKHATKS--------FDESYV-----IGVGGFGKVYKGVIEDK 509
H GLC++ S+ + + + +G G FG+V+
Sbjct: 153 HYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKH 212
Query: 510 LKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLR 569
KVA+K P S V F+ E ++ L+H LV L + + ++ ++MA G+L
Sbjct: 213 TKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLL 270
Query: 570 EHIY-NTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSD 628
+ + + + ++ A G+ ++ + IHRD++ NIL+ + V K++D
Sbjct: 271 DFLKSDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHRDLRAANILVSASLVCKIAD 327
Query: 629 FGLSKTGPNMENGHVSTVVKGSFGY--LDPEYFKRQQLTEKSDIYSFGVVLFEVL 681
FGL++ +E+ + F PE T KSD++SFG++L E++
Sbjct: 328 FGLAR---VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIV 379
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 60/252 (23%), Positives = 111/252 (44%), Gaps = 39/252 (15%)
Query: 459 NASSHLSAIAQGLCRRFSLA--------EIKHATKSFDESYVIGVGGFGKVYKGVIEDK- 509
+S H + GL R S I + ++G G FG V +G ++ +
Sbjct: 2 GSSHHHHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGK--ILGEGEFGSVMEGNLKQED 59
Query: 510 ---LKVAIK--RSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMC-----LV 559
LKVA+K + + SS++ + EF++E + H +++ L+G C E + ++
Sbjct: 60 GTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVI 119
Query: 560 YDYMALGTLREHI-----YNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTT 614
+M G L ++ K + + L+ + A G+ YL + +HRD+
Sbjct: 120 LPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAAR 176
Query: 615 NILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYL-----DPEYFKRQQLTEKSD 669
N +L ++ V+DFGLSK + +G +G + E + T KSD
Sbjct: 177 NCMLRDDMTVCVADFGLSK---KIYSGDYYR--QGRIAKMPVKWIAIESLADRVYTSKSD 231
Query: 670 IYSFGVVLFEVL 681
+++FGV ++E+
Sbjct: 232 VWAFGVTMWEIA 243
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 51/193 (26%), Positives = 95/193 (49%), Gaps = 11/193 (5%)
Query: 492 VIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCE 551
+G G FG+V+ G KVA+K S + F+ E ++ +L+H+ LV L
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 552 EGNEMCLVYDYMALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRD 610
+ + ++ +YM G+L + + L+ + L++ A G+ ++ + IHRD
Sbjct: 79 Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIHRD 134
Query: 611 VKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGY--LDPEYFKRQQLTEKS 668
++ NIL+ + K++DFGL++ +E+ + F PE T KS
Sbjct: 135 LRAANILVSDTLSCKIADFGLAR---LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 669 DIYSFGVVLFEVL 681
D++SFG++L E++
Sbjct: 192 DVWSFGILLTEIV 204
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 4e-35
Identities = 72/344 (20%), Positives = 128/344 (37%), Gaps = 49/344 (14%)
Query: 432 ESHTSSWLPIYGHSQTTQSKSTISGKSNASSHLSAIAQGLCRRFSLAEIKHATKSFDESY 491
H SS L G + + + S L + I + +
Sbjct: 3 HHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILK 62
Query: 492 VIGVGGFGKVYKGVIEDKLKVAIKRSN--PSSEQGVNEFVTEIEMLSKLRHK--HLVSLI 547
IG GG KV++ + E K AIK N + Q ++ + EI L+KL+ ++ L
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 548 GFCEEGNEMCLVYDYMALGTLREHIYNTKKALS-------WKQRLEICIGAARGLHYLHT 600
+ + +V + L + KK++ WK LE +H +H
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLE-------AVHTIH- 172
Query: 601 GAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFK 660
++ I+H D+K N L+ + + K+ DFG++ V G+ Y+ PE K
Sbjct: 173 --QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229
Query: 661 RQ-----------QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKG 709
+++ KSD++S G +L+ + + P +Q+ LH
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT------PFQQIINQISKLHA---- 279
Query: 710 ILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
I+D + D + D + CL R S+ ++L
Sbjct: 280 IIDPNHEIEFPDIPEKDLQ----DVLKCCLKRDPKQRISIPELL 319
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-35
Identities = 63/284 (22%), Positives = 114/284 (40%), Gaps = 49/284 (17%)
Query: 492 VIGVGGFGKVYKGVIEDKLKVAIKRSN--PSSEQGVNEFVTEIEMLSKLRHK--HLVSLI 547
IG GG KV++ + E K AIK N + Q ++ + EI L+KL+ ++ L
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 548 GFCEEGNEMCLVYDYMALGTLREHIYNTKKALS-------WKQRLEICIGAARGLHYLHT 600
+ + +V + L + KK++ WK LE +H +H
Sbjct: 95 DYEITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKSYWKNMLE-------AVHTIH- 144
Query: 601 GAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPE--- 657
++ I+H D+K N L+ + + K+ DFG++ V G+ Y+ PE
Sbjct: 145 --QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201
Query: 658 --------YFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKG 709
+ +++ KSD++S G +L+ + + P +Q+ LH
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT------PFQQIINQISKLHA---- 251
Query: 710 ILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
I+D + D + D + CL R S+ ++L
Sbjct: 252 IIDPNHEIEFPDIPEKDLQ----DVLKCCLKRDPKQRISIPELL 291
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-35
Identities = 57/224 (25%), Positives = 98/224 (43%), Gaps = 43/224 (19%)
Query: 492 VIGVGGFGKVYKGVI------EDKLKVAIKRSNP-SSEQGVNEFVTEIEMLSKLRHKHLV 544
+G G FGKV K VA+K +S + + ++E +L ++ H H++
Sbjct: 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 545 SLIGFCEEGNEMCLVYDYMALGTLREH-----------------------IYNTKKALSW 581
L G C + + L+ +Y G+LR + ++AL+
Sbjct: 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 582 KQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641
+ ++G+ YL A+ ++HRD+ NIL+ E K+SDFGLS+ ++
Sbjct: 150 GDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR---DVYEE 203
Query: 642 HVSTVVKGSFGYL-----DPEYFKRQQLTEKSDIYSFGVVLFEV 680
VK S G + E T +SD++SFGV+L+E+
Sbjct: 204 DS--YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 5e-35
Identities = 55/196 (28%), Positives = 99/196 (50%), Gaps = 15/196 (7%)
Query: 492 VIGVGGFGKVYKGVIEDK-LKVAIK--RSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIG 548
+G G +G+VY+GV + L VA+K + + + EF+ E ++ +++H +LV L+G
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLLG 76
Query: 549 FCEEGNEMCLVYDYMALGTLREHI-YNTKKALSWKQRLEICIGAARGLHYLHTGAKYTII 607
C ++ ++M G L +++ ++ +S L + + + YL K I
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 133
Query: 608 HRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGY--LDPEYFKRQQLT 665
HRD+ N L+ EN + KV+DFGLS+ M + F PE + +
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 666 EKSDIYSFGVVLFEVL 681
KSD+++FGV+L+E+
Sbjct: 191 IKSDVWAFGVLLWEIA 206
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 7e-35
Identities = 60/197 (30%), Positives = 98/197 (49%), Gaps = 23/197 (11%)
Query: 492 VIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFC- 550
IG G FG V G KVA+K + F+ E ++++LRH +LV L+G
Sbjct: 28 TIGKGEFGDVMLGDYRGN-KVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 551 EEGNEMCLVYDYMALGTLREHI-YNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHR 609
EE + +V +YMA G+L +++ + L L+ + + YL +HR
Sbjct: 85 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHR 141
Query: 610 DVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTV-----VKGSFGYLDPEYFKRQQL 664
D+ N+L+ E+ VAKVSDFGL+K + VK + PE + ++
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVK----WTAPEALREKKF 191
Query: 665 TEKSDIYSFGVVLFEVL 681
+ KSD++SFG++L+E+
Sbjct: 192 STKSDVWSFGILLWEIY 208
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 7e-35
Identities = 44/289 (15%), Positives = 87/289 (30%), Gaps = 37/289 (12%)
Query: 479 EIKHATKSFDESYVIGVGGFGKVYKGV------IEDKLKVAIKRSNPSSEQGVNEFVTEI 532
E + +K +++G G F +VY+ ++K K +K P++ +
Sbjct: 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM 118
Query: 533 EMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHI----YNTKKALSWKQRLEIC 588
E L + N LV + + GTL I +K + +
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178
Query: 589 IGAARGLHYLHTGAKYTIIHRDVKTTNILL-----------DENWVAKVSDFGLSKTGPN 637
+ + +H IIH D+K N +L D + + D G S
Sbjct: 179 MRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 638 MENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVS 697
G + T + G+ E + + D + ++ +L K +
Sbjct: 236 FPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY------MKVKNE 289
Query: 698 LADWALHCKRKG-----ILDDIIDPLLK--DKISPECLKKFADTAEKCL 739
+ + + ++ +L D L +K
Sbjct: 290 GGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-34
Identities = 64/284 (22%), Positives = 114/284 (40%), Gaps = 49/284 (17%)
Query: 492 VIGVGGFGKVYKGVIEDKLKVAIKRSN--PSSEQGVNEFVTEIEMLSKLRHK--HLVSLI 547
IG GG KV++ + E K AIK N + Q ++ + EI L+KL+ ++ L
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 548 GFCEEGNEMCLVYDYMALGTLREHIYNTKKALS-------WKQRLEICIGAARGLHYLHT 600
+ + +V + L + KK++ WK LE +H +H
Sbjct: 76 DYEITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLE-------AVHTIH- 125
Query: 601 GAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFK 660
++ I+H D+K N L+ + + K+ DFG++ V G+ Y+ PE K
Sbjct: 126 --QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182
Query: 661 RQ-----------QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKG 709
+++ KSD++S G +L+ + + P +Q+ LH
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT------PFQQIINQISKLHA---- 232
Query: 710 ILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
I+D + D + D + CL R S+ ++L
Sbjct: 233 IIDPNHEIEFPDIPEKDLQ----DVLKCCLKRDPKQRISIPELL 272
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 74/310 (23%), Positives = 142/310 (45%), Gaps = 61/310 (19%)
Query: 492 VIGVGGFGKVYKGVI--------EDKLKVAIKRSNP-SSEQGVNEFVTEIEMLSKL-RHK 541
+G G FG+V ++ + VA+K ++E+ +++ V+E+EM+ + +HK
Sbjct: 42 PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 542 HLVSLIGFCEEGNEMCLVYDYMALGTLREH---------------IYNTKKALSWKQRLE 586
++++L+G C + + ++ +Y + G LRE+ ++ +++K +
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 587 ICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTV 646
ARG+ YL A IHRD+ N+L+ EN V K++DFGL++ ++ N
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR---DINNIDY--Y 213
Query: 647 VKGSFGYL-----DPEYFKRQQLTEKSDIYSFGVVLFEV--LCARPALNPSLPKEQVSLA 699
K + G L PE + T +SD++SFGV+++E+ L P P +P E++
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY--PGIPVEEL--- 268
Query: 700 DWALHCKRKG-ILDDIIDPLLKDKISPE-CLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757
++G +D P C + C RP+ ++ +L+
Sbjct: 269 ---FKLLKEGHRMD-----------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314
Query: 758 FVLQLVESTE 767
+L L + E
Sbjct: 315 RILTLTTNEE 324
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-34
Identities = 79/317 (24%), Positives = 127/317 (40%), Gaps = 52/317 (16%)
Query: 492 VIGVGGFGKVYKGVI------EDKLKVAIKRSNP-SSEQGVNEFVTEIEMLSKLRHKHLV 544
+G G FG+VY+G + L+VA+K SEQ +F+ E ++SK H+++V
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 545 SLIGFCEEGNEMCLVYDYMALGTLRE------HIYNTKKALSWKQRLEICIGAARGLHYL 598
IG + ++ + MA G L+ + +L+ L + A G YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 599 HTGAKYTIIHRDVKTTNILLD---ENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYL- 654
+ IHRD+ N LL VAK+ DFG+++ ++ KG L
Sbjct: 198 ---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR---DIYRA--GYYRKGGCAMLP 249
Query: 655 ----DPEYFKRQQLTEKSDIYSFGVVLFEV--LCARPALNPSLPKEQVSLADWALHCKRK 708
PE F T K+D +SFGV+L+E+ L P PS ++V L
Sbjct: 250 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY--PSKSNQEV------LEFVTS 301
Query: 709 G-ILDDIIDPLLKDKISPE-CLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVEST 766
G +D P+ C +C DRP+ +L +E+ Q +
Sbjct: 302 GGRMD-----------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI 350
Query: 767 EASSNRSRGSSIDGAED 783
+ G ++ E
Sbjct: 351 NTALPIEYGPLVEEEEK 367
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 56/219 (25%), Positives = 95/219 (43%), Gaps = 38/219 (17%)
Query: 492 VIGVGGFGKVYKGVI------EDKLKVAIKRSNPS-SEQGVNEFVTEIEMLSKL-RHKHL 543
+G G FGKV + + + VA+K PS ++E+++LS L H ++
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 544 VSLIGFCEEGNEMCLVYDYMALGTLRE-----------------HIYNTKKALSWKQRLE 586
V+L+G C G ++ +Y G L + + + AL + L
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 587 ICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTV 646
A+G+ +L A IHRD+ NILL + K+ DFGL++ +++N
Sbjct: 150 FSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR---DIKNDSN--Y 201
Query: 647 VKGSFGYL-----DPEYFKRQQLTEKSDIYSFGVVLFEV 680
V L PE T +SD++S+G+ L+E+
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 240
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-34
Identities = 80/315 (25%), Positives = 130/315 (41%), Gaps = 66/315 (20%)
Query: 492 VIGVGGFGKVYKGVI------EDKLKVAIKRSNP-SSEQGVNEFVTEIEMLSKLRHKHLV 544
IG G FG+V++ E VA+K +S +F E ++++ + ++V
Sbjct: 54 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 545 SLIGFCEEGNEMCLVYDYMALGTLRE-----------------------HIYNTKKALSW 581
L+G C G MCL+++YMA G L E LS
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 582 KQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641
++L I A G+ YL ++ +HRD+ T N L+ EN V K++DFGLS+ N+ +
Sbjct: 174 AEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR---NIYSA 227
Query: 642 HVSTVVKGSFGYL-----DPEYFKRQQLTEKSDIYSFGVVLFEV--LCARPALNPSLPKE 694
+ PE + T +SD++++GVVL+E+ +P + E
Sbjct: 228 --DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY--YGMAHE 283
Query: 695 QVSLADWALHCKRKG-ILDDIIDPLLKDKISPE-CLKKFADTAEKCLSDSGIDRPSMGDV 752
+V ++ R G IL PE C + + C S DRPS +
Sbjct: 284 EV------IYYVRDGNILA-----------CPENCPLELYNLMRLCWSKLPADRPSFCSI 326
Query: 753 LWNLEFVLQLVESTE 767
L+ + + E T
Sbjct: 327 HRILQRMCERAEGTV 341
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-34
Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 34/215 (15%)
Query: 492 VIGVGGFGKVYKGVI------EDKLKVAIKRSNPS-SEQGVNEFVTEIEMLSKL-RHKHL 543
+G G FGKV + + LKVA+K + ++E++++S L +H+++
Sbjct: 53 TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 544 VSLIGFCEEGNEMCLVYDYMALGTLRE-------------HIYNTKKALSWKQRLEICIG 590
V+L+G C G + ++ +Y G L S + L
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172
Query: 591 AARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGS 650
A+G+ +L A IHRDV N+LL VAK+ DFGL++ ++ N S +
Sbjct: 173 VAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR---DIMND--SNYIVKG 224
Query: 651 FGYL-----DPEYFKRQQLTEKSDIYSFGVVLFEV 680
L PE T +SD++S+G++L+E+
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-34
Identities = 52/218 (23%), Positives = 94/218 (43%), Gaps = 37/218 (16%)
Query: 492 VIGVGGFGKVYKGVI------EDKLKVAIKRSNP-SSEQGVNEFVTEIEMLSKL-RHKHL 543
+G G FG+V + VA+K ++ ++E+++L + H ++
Sbjct: 34 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 544 VSLIGFC-EEGNEMCLVYDYMALGTLRE---------------HIYNTKKALSWKQRLEI 587
V+L+G C + G + ++ ++ G L K L+ + +
Sbjct: 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 588 CIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVV 647
A+G+ +L A IHRD+ NILL E V K+ DFGL++ ++ V
Sbjct: 154 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR---DIYKDPD--YV 205
Query: 648 KGSFGYL-----DPEYFKRQQLTEKSDIYSFGVVLFEV 680
+ L PE + T +SD++SFGV+L+E+
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-33
Identities = 75/313 (23%), Positives = 141/313 (45%), Gaps = 61/313 (19%)
Query: 492 VIGVGGFGKVYKGVI--------EDKLKVAIKRSNP-SSEQGVNEFVTEIEMLSKL-RHK 541
+G G FG+V KVA+K ++E+ +++ ++E+EM+ + +HK
Sbjct: 76 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135
Query: 542 HLVSLIGFCEEGNEMCLVYDYMALGTLREH---------------IYNTKKALSWKQRLE 586
++++L+G C + + ++ +Y + G LRE+ +N ++ LS K +
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195
Query: 587 ICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTV 646
ARG+ YL A IHRD+ N+L+ E+ V K++DFGL++ ++ +
Sbjct: 196 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR---DIHHI--DYY 247
Query: 647 VKGSFGYL-----DPEYFKRQQLTEKSDIYSFGVVLFEV--LCARPALNPSLPKEQVSLA 699
K + G L PE + T +SD++SFGV+L+E+ L P P +P E++
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY--PGVPVEEL--- 302
Query: 700 DWALHCKRKG-ILDDIIDPLLKDKISPE-CLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757
++G +D P C + C RP+ ++ +L+
Sbjct: 303 ---FKLLKEGHRMD-----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 348
Query: 758 FVLQLVESTEASS 770
++ L + E
Sbjct: 349 RIVALTSNQEMGY 361
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 63/301 (20%), Positives = 110/301 (36%), Gaps = 36/301 (11%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKR-SNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGF 549
++G G V++G + AIK +N S + V+ + E E+L KL HK++V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 550 CEEGN--EMCLVYDYMALGTLREHIYNTKKA--LSWKQRLEICIGAARGLHYLHTGAKYT 605
EE L+ ++ G+L + A L + L + G+++L +
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132
Query: 606 IIHRDVKTTNILL----DENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKR 661
I+HR++K NI+ D V K++DFG ++ +E+ + G+ YL P+ ++R
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE---LEDDEQFVSLYGTEEYLHPDMYER 189
Query: 662 QQL--------TEKSDIYSFGVVLFEVLCARP----ALNPSLPKE--------QVSLADW 701
L D++S GV + P KE + S A
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAIS 249
Query: 702 ALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQ 761
+ G +D D + +S L +L
Sbjct: 250 GVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309
Query: 762 L 762
Sbjct: 310 R 310
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-33
Identities = 62/302 (20%), Positives = 123/302 (40%), Gaps = 22/302 (7%)
Query: 389 GFTNKSKSNIHVIGGAAGGAAAFGLVAALCFVVYQRKQRIPGTESHTSSWLPIYGHSQTT 448
G K + AA + A + ++RI S + P +
Sbjct: 245 GLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNS--DGYTPEPARITSP 302
Query: 449 QSKSTISGKSNASSHLSAIAQGLCRRFSLAEIKHATKSFDESYVIGVGGFGKVYKGVIE- 507
+ ++ + + L + +K + +G G FG V +GV
Sbjct: 303 DKPRPMPMDTSVFESPFSDPEELKDKK--LFLKRDNLLIADI-ELGCGNFGSVRQGVYRM 359
Query: 508 --DKLKVAIKRSNP-SSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMA 564
++ VAIK + + E + E +++ +L + ++V LIG C+ + LV +
Sbjct: 360 RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAG 418
Query: 565 LGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVA 624
G L + + ++ + E+ + G+ YL + +HR++ N+LL A
Sbjct: 419 GGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYA 475
Query: 625 KVSDFGLSKTGPNMENGHVSTV-----VKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFE 679
K+SDFGLSK ++ + + +K + PE ++ + +SD++S+GV ++E
Sbjct: 476 KISDFGLSKALGADDSYYTARSAGKWPLK----WYAPECINFRKFSSRSDVWSYGVTMWE 531
Query: 680 VL 681
L
Sbjct: 532 AL 533
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-33
Identities = 50/224 (22%), Positives = 94/224 (41%), Gaps = 43/224 (19%)
Query: 492 VIGVGGFGKVYKGVI------EDKLKVAIKRSNPS-SEQGVNEFVTEIEMLSKL-RHKHL 543
V+G G FGKV ++VA+K ++E++M+++L H+++
Sbjct: 52 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 544 VSLIGFCEEGNEMCLVYDYMALGTLRE----------------------HIYNTKKALSW 581
V+L+G C + L+++Y G L L++
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 582 KQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641
+ L A+G+ +L + +HRD+ N+L+ V K+ DFGL++ ++ +
Sbjct: 172 EDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR---DIMSD 225
Query: 642 HVSTVVKGSFGYL-----DPEYFKRQQLTEKSDIYSFGVVLFEV 680
V L PE T KSD++S+G++L+E+
Sbjct: 226 SN--YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-33
Identities = 73/312 (23%), Positives = 119/312 (38%), Gaps = 40/312 (12%)
Query: 486 SFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKL-RHKHLV 544
SF V+G G G + + D VA+KR P + E+++L + H +++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR---EVQLLRESDEHPNVI 81
Query: 545 SLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKY 604
++ + + A TL+E++ A + + + GL +LH
Sbjct: 82 RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SL 137
Query: 605 TIIHRDVKTTNILLDE-----NWVAKVSDFGLSK-TGPNMENGHVSTVVKGSFGYLDPEY 658
I+HRD+K NIL+ A +SDFGL K + + V G+ G++ PE
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
Query: 659 FKR---QQLTEKSDIYSFGVVLFEVLCA-RPALNPSLPKEQVSLADWALHCKRKGILDDI 714
+ T DI+S G V + V+ SL ++ A LD +
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-------ANILLGACSLDCL 250
Query: 715 IDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVL-----WNLEFVLQLVESTEAS 769
+ EK ++ RPS VL W+LE LQ +
Sbjct: 251 HPE---KHEDVI----ARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDV--- 300
Query: 770 SNRSRGSSIDGA 781
S+R S+DG
Sbjct: 301 SDRIEKESLDGP 312
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 9e-33
Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 25/220 (11%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIK----RSNPSSEQGVNEFVTEIEMLSKLRHKHLVSL 546
+G GGFG V + + + +VAIK +P + + EI+++ KL H ++VS
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL---EIQIMKKLNHPNVVSA 77
Query: 547 IGFCEEGNEM------CLVYDYMALGTLREHIYNTKKA--LSWKQRLEICIGAARGLHYL 598
+ ++ L +Y G LR+++ + L + + L YL
Sbjct: 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 599 HTGAKYTIIHRDVKTTNILLD---ENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLD 655
H + IIHRD+K NI+L + + K+ D G +K ++ G + T G+ YL
Sbjct: 138 H---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE---LDQGELCTEFVGTLQYLA 191
Query: 656 PEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQ 695
PE ++++ T D +SFG + FE + P+ Q
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ 231
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-32
Identities = 63/302 (20%), Positives = 111/302 (36%), Gaps = 36/302 (11%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKR-SNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGF 549
++G G V++G + AIK +N S + V+ + E E+L KL HK++V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 550 CEEGN--EMCLVYDYMALGTLREHIYNTKKA--LSWKQRLEICIGAARGLHYLHTGAKYT 605
EE L+ ++ G+L + A L + L + G+++L +
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132
Query: 606 IIHRDVKTTNILL----DENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKR 661
I+HR++K NI+ D V K++DFG ++ +E+ + G+ YL P+ ++R
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE---LEDDEQFVSLYGTEEYLHPDMYER 189
Query: 662 QQL--------TEKSDIYSFGVVLFEVLCARP----ALNPSLPKE--------QVSLADW 701
L D++S GV + P KE + S A
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAIS 249
Query: 702 ALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQ 761
+ G +D D + +S L +L
Sbjct: 250 GVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309
Query: 762 LV 763
+
Sbjct: 310 RM 311
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-32
Identities = 66/199 (33%), Positives = 99/199 (49%), Gaps = 13/199 (6%)
Query: 493 IGVGGFGKVYKGVIEDKL---KVAIK--RSNPSSEQG-VNEFVTEIEMLSKLRHKHLVSL 546
+G GG VY ED + KVAIK P ++ + F E+ S+L H+++VS+
Sbjct: 19 LGGGGMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 547 IGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTI 606
I EE + LV +Y+ TL E+I + LS + G+ + H I
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDGIKHAH---DMRI 132
Query: 607 IHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTE 666
+HRD+K NIL+D N K+ DFG++K + V+ G+ Y PE K + E
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL-GTVQYFSPEQAKGEATDE 191
Query: 667 KSDIYSFGVVLFEVLCARP 685
+DIYS G+VL+E+L P
Sbjct: 192 CTDIYSIGIVLYEMLVGEP 210
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 8e-32
Identities = 46/221 (20%), Positives = 94/221 (42%), Gaps = 35/221 (15%)
Query: 492 VIGVGGFGKVYKGVIEDKLKVAIK----------------RSNPSSEQGVNEFV-TEIEM 534
+ G F K+ +D A+K ++ S + + E+++
Sbjct: 38 TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 535 LSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAAR- 593
++ +++++ ++ G +E+ ++Y+YM ++ + L I I +
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFV-LDKNYTCFIPIQVIKC 155
Query: 594 -------GLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTV 646
Y+H + I HRDVK +NIL+D+N K+SDFG S+ M + +
Sbjct: 156 IIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEY---MVDKKIKGS 210
Query: 647 VKGSFGYLDPEYFKRQQLT--EKSDIYSFGVVLFEVLCARP 685
G++ ++ PE+F + K DI+S G+ L+ +
Sbjct: 211 R-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-31
Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 19/217 (8%)
Query: 480 IKHATKSFDESY----VIGVGGFGKVYKGV-IEDKLKVAIK---RSNPSSEQGVNEFVTE 531
++H+T F + Y V+G G FG+V + A+K + + + E
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 532 IEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGA 591
+++L +L H +++ L F E+ LV + G L + I ++K S I
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI-ISRKRFSEVDAARIIRQV 135
Query: 592 ARGLHYLHTGAKYTIIHRDVKTTNILL---DENWVAKVSDFGLSKTGPNMENGHVSTVVK 648
G+ Y+H K I+HRD+K N+LL ++ ++ DFGLS + E
Sbjct: 136 LSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLST---HFEASKKMKDKI 189
Query: 649 GSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
G+ Y+ PE EK D++S GV+L+ +L P
Sbjct: 190 GTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCP 225
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-31
Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 19/205 (9%)
Query: 493 IGVGGFGKVYKGVIEDKL---KVAIK--RSNPSSEQG-VNEFVTEIEMLSKLRHKHLVSL 546
+G GG +V+ D VA+K R++ + + F E + + L H +V++
Sbjct: 20 LGFGGMSEVHLA--RDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 547 --IGFCEEGNEMCLVYDYMAL---GTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTG 601
G E L Y M TLR+ + +T+ ++ K+ +E+ A + L++ H
Sbjct: 78 YDTG-EAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQALNFSH-- 133
Query: 602 AKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVST-VVKGSFGYLDPEYFK 660
+ IIHRDVK NI++ KV DFG+++ + N T V G+ YL PE +
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 661 RQQLTEKSDIYSFGVVLFEVLCARP 685
+ +SD+YS G VL+EVL P
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-30
Identities = 50/258 (19%), Positives = 108/258 (41%), Gaps = 29/258 (11%)
Query: 441 IYGHSQTTQSKSTISGKSNAS--SHLSAIAQGLCRRFSLAEIKHATKSFDESY----VIG 494
+ G S + GK + + + + +++ ++ S + Y +G
Sbjct: 1 MRGSHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELG 60
Query: 495 VGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEG 553
G FG V++ V K N EI ++++L H L++L E+
Sbjct: 61 SGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK 120
Query: 554 NEMCLVYDYMALGTL------REHIYNTKKALS-WKQRLEICIGAARGLHYLHTGAKYTI 606
EM L+ ++++ G L ++ + + ++ +Q E GL ++H +++I
Sbjct: 121 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE-------GLKHMH---EHSI 170
Query: 607 IHRDVKTTNILL--DENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQL 664
+H D+K NI+ + K+ DFGL+ + + V + + PE R+ +
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATK---LNPDEIVKVTTATAEFAAPEIVDREPV 227
Query: 665 TEKSDIYSFGVVLFEVLC 682
+D+++ GV+ + +L
Sbjct: 228 GFYTDMWAIGVLGYVLLS 245
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 50/220 (22%), Positives = 88/220 (40%), Gaps = 27/220 (12%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLR-HKHLVSLIGF 549
V+ GGF VY+ + + A+KR + E+ + E+ + KL H ++V
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 550 C-------EEGNEMCLVYDYMALGTLREHIYNT--KKALSWKQRLEICIGAARGLHYLHT 600
+ G L+ + G L E + + LS L+I R + ++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 601 GAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVK-----------G 649
K IIHRD+K N+LL K+ DFG + T + + + +
Sbjct: 155 -QKPPIIHRDLKVENLLLSNQGTIKLCDFGSA-TTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 650 SFGYLDPE---YFKRQQLTEKSDIYSFGVVLFEVLCARPA 686
+ Y PE + + EK DI++ G +L+ + +
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 61/216 (28%), Positives = 101/216 (46%), Gaps = 28/216 (12%)
Query: 484 TKSFDESY----VIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKL 538
T + +++ V+G G F +V+ A+K S + EI +L K+
Sbjct: 4 TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI 63
Query: 539 RHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHI-----YNTKKALS-WKQRLEICIGAA 592
+H+++V+L E LV ++ G L + I Y K A +Q L
Sbjct: 64 KHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLS------ 117
Query: 593 RGLHYLHTGAKYTIIHRDVKTTNILL---DENWVAKVSDFGLSKTGPNMENGHVSTVVKG 649
+ YLH + I+HRD+K N+L +EN ++DFGLSK +NG +ST G
Sbjct: 118 -AVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGIMSTAC-G 169
Query: 650 SFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
+ GY+ PE ++ ++ D +S GV+ + +LC P
Sbjct: 170 TPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYP 205
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 51/200 (25%), Positives = 85/200 (42%), Gaps = 13/200 (6%)
Query: 492 VIGVGGFGKVYKGVIEDKLK---VAIK--RSNPSSEQGVNE-FVTEIEMLSKLRHKHLVS 545
++G GG G VY+ ED ++ VA+K SS+ E +L+ H+V
Sbjct: 41 LVGRGGMGDVYEA--EDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 546 LIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYT 605
+ F E ++ + + L + + L+ + + I L H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDAAH---AAG 154
Query: 606 IIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLT 665
HRDVK NIL+ + A + DFG++ + + + V G+ Y+ PE F T
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYMAPERFSESHAT 213
Query: 666 EKSDIYSFGVVLFEVLCARP 685
++DIY+ VL+E L P
Sbjct: 214 YRADIYALTCVLYECLTGSP 233
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 65/297 (21%), Positives = 108/297 (36%), Gaps = 55/297 (18%)
Query: 484 TKSFDESYVIGVGGFGKVYKGV-IEDKLKVAIKRSN--PSSEQGVNEFVTEIEMLSKL-R 539
T F E IG G FG V+K V D AIKRS + + E+ + L +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 540 HKHLVSLIGFCEEGNEMCLVYDYMALGTLREHI---YNTKKALSWKQRLEICIGAARGLH 596
H H+V E + M + +Y G+L + I Y + ++ + RGL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 597 YLHTGAKYTIIHRDVKTTNILLDEN-------------------WVAKVSDFGLSKTGPN 637
Y+H +++H D+K +NI + + K+ D G +
Sbjct: 130 YIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 638 MENGHVSTVVKGSFGYLDPEYFKRQQL-TEKSDIYSFGVVLFEVLCARPALNPSLPKEQV 696
V +G +L E + K+DI++ + + A P LP+
Sbjct: 187 P------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP-----LPRN-- 233
Query: 697 SLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
W H R+G L P + +S E F + + + RPS ++
Sbjct: 234 -GDQW--HEIRQGRL-----PRIPQVLSQE----FTELLKVMIHPDPERRPSAMALV 278
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 122 bits (306), Expect = 4e-30
Identities = 24/287 (8%), Positives = 64/287 (22%), Gaps = 49/287 (17%)
Query: 440 PIYGHSQTTQSKSTISGKSNASSHLSAIAQGLCRRFSLAEIKHATKSFDESY----VIGV 495
+ + ++ + A+ + + + + + + V
Sbjct: 13 DLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRV 72
Query: 496 GGFGKVYKGV-IEDKLKVAIK---RSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFC- 550
G V+ +E A+K +S + ++L +
Sbjct: 73 GDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRR 132
Query: 551 -------------------------EEGNEMCLVYDYMA-----LGTLREHIYNTKKALS 580
L+ + L + + +Y +
Sbjct: 133 LLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEG 192
Query: 581 WKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640
+ R L ++H N+ + + + D +
Sbjct: 193 ILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW-----KV 244
Query: 641 GHVSTVVKGSFGYLDPEYFKRQ--QLTEKSDIYSFGVVLFEVLCARP 685
G Y E+ T + + G+ ++ V C
Sbjct: 245 GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 4e-30
Identities = 52/197 (26%), Positives = 93/197 (47%), Gaps = 10/197 (5%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIK---RSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIG 548
+G GGF K ++ + K A K +S + EI + L H+H+V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 549 FCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIH 608
F E+ + + +V + +L E +KAL+ + G YLH + +IH
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELH-KRRKALTEPEARYYLRQIVLGCQYLH---RNRVIH 138
Query: 609 RDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKS 668
RD+K N+ L+E+ K+ DFGL+ +G V+ G+ Y+ PE ++ + +
Sbjct: 139 RDLKLGNLFLNEDLEVKIGDFGLATK--VEYDGERKKVLCGTPNYIAPEVLSKKGHSFEV 196
Query: 669 DIYSFGVVLFEVLCARP 685
D++S G +++ +L +P
Sbjct: 197 DVWSIGCIMYTLLVGKP 213
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-30
Identities = 73/365 (20%), Positives = 131/365 (35%), Gaps = 71/365 (19%)
Query: 477 LAEIKHATKSFDESY----VIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEI 532
+A I + +S ++G G G V VA+KR EI
Sbjct: 3 IANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM---EI 59
Query: 533 EMLSKL-RHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGA 591
++L++ H +++ + + + L++ + + K +L+
Sbjct: 60 KLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVES-KNVSDENLKLQKEYNP 117
Query: 592 AR-------GLHYLHTGAKYTIIHRDVKTTNILLD-------------ENWVAKVSDFGL 631
G+ +LH IIHRD+K NIL+ EN +SDFGL
Sbjct: 118 ISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174
Query: 632 SK---TGPNMENGHVSTVVKGSFGYLDPEYFK-------RQQLTEKSDIYSFGVVLFEVL 681
K +G + +++ G+ G+ PE + +++LT DI+S G V + +L
Sbjct: 175 CKKLDSGQSSFRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233
Query: 682 CA--RPALNPSLPKEQVSLADWALHCKRKGILD-DIIDPLLKDKISPECLKKFADTAEKC 738
P + + + +GI D + L + E D +
Sbjct: 234 SKGKHPFGDKYSRESNI----------IRGIFSLDEMKCLHDRSLIAEAT----DLISQM 279
Query: 739 LSDSGIDRPSMGDVL-----WN----LEFVLQLVESTEASSNRSRGSSIDGAEDDNARNC 789
+ + RP+ VL W LEF+L++ + E NR S++ D +
Sbjct: 280 IDHDPLKRPTAMKVLRHPLFWPKSKKLEFLLKVSDRLEI-ENRDPPSALLMKFDAGSDFV 338
Query: 790 SIGSD 794
D
Sbjct: 339 IPSGD 343
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 25/207 (12%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFC 550
V+G G +G VY G + +++++AIK + EI + L+HK++V +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 551 EEGNEMCLVYDYMALGTLREHIYNTKKALSW---------KQRLEICIGAARGLHYLHTG 601
E + + + + G+L + + L KQ LE GL YLH
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILE-------GLKYLHDN 141
Query: 602 AKYTIIHRDVKTTNILLD-ENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFK 660
I+HRD+K N+L++ + V K+SDFG SK + + G+ Y+ PE
Sbjct: 142 Q---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIID 196
Query: 661 RQQL--TEKSDIYSFGVVLFEVLCARP 685
+ + +DI+S G + E+ +P
Sbjct: 197 KGPRGYGKAADIWSLGCTIIEMATGKP 223
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-30
Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 20/217 (9%)
Query: 480 IKHATKSFDESY----VIGVGGFGKVYKGV-IEDKLKVAIK---RSNPSSEQGVNEFVTE 531
I E Y +G G +G+V ++ AIK +++ S+ ++ + E
Sbjct: 28 ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS-NSKLLEE 86
Query: 532 IEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGA 591
+ +L L H +++ L F E+ LV + G L + I + + I
Sbjct: 87 VAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI-IHRMKFNEVDAAVIIKQV 145
Query: 592 ARGLHYLHTGAKYTIIHRDVKTTNILL---DENWVAKVSDFGLSKTGPNMENGHVSTVVK 648
G+ YLH K+ I+HRD+K N+LL +++ + K+ DFGLS EN
Sbjct: 146 LSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA---VFENQKKMKERL 199
Query: 649 GSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
G+ Y+ PE ++ + EK D++S GV+LF +L P
Sbjct: 200 GTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYP 235
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 9e-30
Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIK---RSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLI 547
+G G FG VY + K +A+K ++ ++ E+E+ S LRH +++ L
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 548 GFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL---EICIGAARGLHYLHTGAKY 604
G+ + + L+ +Y LGT+ + K + E+ L Y H
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA----NALSYCH---SK 128
Query: 605 TIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQL 664
+IHRD+K N+LL K++DFG S P + + + G+ YL PE + +
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTDLC-GTLDYLPPEMIEGRMH 184
Query: 665 TEKSDIYSFGVVLFEVLCARP 685
EK D++S GV+ +E L +P
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKP 205
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-29
Identities = 61/279 (21%), Positives = 110/279 (39%), Gaps = 31/279 (11%)
Query: 421 VYQRKQRIPGTESHTSSWLPIYGHSQTTQSKSTISGKSNASSHLSAIAQGLCRRFSLAEI 480
+Y + + G + S + KS +S L+ F +
Sbjct: 19 LYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIV 78
Query: 481 KHATKSFDESY------VIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIE 533
+ + Y ++G G FG+V+K LK+A K + E EI
Sbjct: 79 TAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEIS 138
Query: 534 MLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTL------REHIYNTKKALS-WKQRLE 586
++++L H +L+ L E N++ LV +Y+ G L + + KQ E
Sbjct: 139 VMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICE 198
Query: 587 ICIGAARGLHYLHTGAKYTIIHRDVKTTNILL---DENWVAKVSDFGLSKTGPNMENGHV 643
G+ ++H + I+H D+K NIL D + K+ DFGL++ +
Sbjct: 199 -------GIRHMH---QMYILHLDLKPENILCVNRDAKQI-KIIDFGLARR---YKPREK 244
Query: 644 STVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC 682
V G+ +L PE ++ +D++S GV+ + +L
Sbjct: 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLS 283
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 56/197 (28%), Positives = 94/197 (47%), Gaps = 9/197 (4%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIK---RSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIG 548
+G G F VY+ I L+VAIK + V E+++ +L+H ++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 549 FCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIH 608
+ E+ N + LV + G + ++ N K S + G+ YLH + I+H
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILH 135
Query: 609 RDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKS 668
RD+ +N+LL N K++DFGL+ T M + T+ G+ Y+ PE R +S
Sbjct: 136 RDLTLSNLLLTRNMNIKIADFGLA-TQLKMPHEKHYTLC-GTPNYISPEIATRSAHGLES 193
Query: 669 DIYSFGVVLFEVLCARP 685
D++S G + + +L RP
Sbjct: 194 DVWSLGCMFYTLLIGRP 210
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-29
Identities = 28/194 (14%), Positives = 57/194 (29%), Gaps = 36/194 (18%)
Query: 177 MQTMFRLNVAGQYISPKNDSGGLMRSWQNDEPYLFGAGYGIPMKADEVQIDYKSLPDYSA 236
+ ++ +N G+ D G ++ D +A + + L
Sbjct: 4 DKVIWAVNAGGESH---VDVHG--IHYRKDPLEGRVG------RASDYGMKLPILRSNPE 52
Query: 237 PPDVYMTARYMGVDAHTNMEFNLTWIFRVDANFTYYVRLHFCEFKPDINKINQRVFNIYI 296
+Y T RY E + + + Y + L F E + Q+VF++ +
Sbjct: 53 DQVLYQTERYN--------EDSFGYDIPIKEEGEYVLVLKFAE--VYFAQSQQKVFDVRV 102
Query: 297 NNQTAQADADVIAWTHGQGVPIYKDYAVYVED---------LPGDDQIFVAMSPSLKYQP 347
N T D D+ G + + ++ ++ V
Sbjct: 103 NGHTVVKDLDIFDRV-GHSTAHDEIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYD-- 159
Query: 348 EYLDALLNGLEIFK 361
+ + L I K
Sbjct: 160 ---NPKVCALFIMK 170
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174 | Back alignment and structure |
|---|
Score = 79.6 bits (196), Expect = 2e-17
Identities = 21/167 (12%), Positives = 48/167 (28%), Gaps = 18/167 (10%)
Query: 1 CGSKDGGIDADGRSWEPDDKY--LSKGESKPTRATYQDSSLVSKVPYMDARVFKQEMSYE 58
G + +D G + D + + + S+ +V Y R + Y+
Sbjct: 12 AGGESH-VDVHGIHYRKDPLEGRVGRASDYGMKLPILRSNPEDQVLYQTERYNEDSFGYD 70
Query: 59 LPIRSQSRYWVRFHFYPSTYPELNVANSYFSVVANDVTLLSNFSASITAQAVAQAYLIKE 118
+PI+ + Y + F + + F V N T++ + I + +
Sbjct: 71 IPIKEEGEYVLVLKFAEVYFAQSQ--QKVFDVRVNGHTVVKDL--DIFDRVGHSTAHDEI 126
Query: 119 FSLAPMDSDILKIIFRPSD----------KHSGTFAFINGIELVPSP 155
+ L + S K + + ++
Sbjct: 127 IP-ISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDNPKVCALFIMKGT 172
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-29
Identities = 62/227 (27%), Positives = 95/227 (41%), Gaps = 29/227 (12%)
Query: 480 IKHATKSFDESY----VIGVGGFGKVYKGV-IEDKLKVAIK-------------RSNPSS 521
++ ESY +G G +G+V + AIK N +
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 522 EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSW 581
E+ E EI +L L H +++ L E+ LV ++ G L E I N +
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN-RHKFDE 145
Query: 582 KQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILL---DENWVAKVSDFGLSKTGPNM 638
I G+ YLH K+ I+HRD+K NILL + K+ DFGLS
Sbjct: 146 CDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSS---FF 199
Query: 639 ENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
+ G+ Y+ PE K+ + EK D++S GV+++ +LC P
Sbjct: 200 SKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYP 245
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIK---RSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLI 547
+G G FG VY ++K +A+K +S E ++ EIE+ S LRH +++ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 548 GFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL---EICIGAARGLHYLHTGAKY 604
+ + + L+ ++ G L + + + + E+ A LHY H +
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL----ADALHYCH---ER 133
Query: 605 TIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQL 664
+IHRD+K N+L+ K++DFG S P + T+ G+ YL PE + +
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWSVHAP---SLRRRTMC-GTLDYLPPEMIEGKTH 189
Query: 665 TEKSDIYSFGVVLFEVLCARP 685
EK D++ GV+ +E L P
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMP 210
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 52/197 (26%), Positives = 93/197 (47%), Gaps = 10/197 (5%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIK---RSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIG 548
+G GGF K ++ + K A K +S + EI + L H+H+V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 549 FCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIH 608
F E+ + + +V + +L E +KAL+ + G YLH + +IH
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELH-KRRKALTEPEARYYLRQIVLGCQYLH---RNRVIH 164
Query: 609 RDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKS 668
RD+K N+ L+E+ K+ DFGL+ +G V+ G+ Y+ PE ++ + +
Sbjct: 165 RDLKLGNLFLNEDLEVKIGDFGLATK--VEYDGERKKVLCGTPNYIAPEVLSKKGHSFEV 222
Query: 669 DIYSFGVVLFEVLCARP 685
D++S G +++ +L +P
Sbjct: 223 DVWSIGCIMYTLLVGKP 239
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 39/150 (26%), Positives = 74/150 (49%), Gaps = 4/150 (2%)
Query: 484 TKSFDESYVIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKH 542
+ ++ +G G FGKVYK E A K SE+ + +++ EIE+L+ H +
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 543 LVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGA 602
+V L+G ++ ++ ++ G + + + L+ Q +C L++LH+
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 137
Query: 603 KYTIIHRDVKTTNILLDENWVAKVSDFGLS 632
IHRD+K N+L+ +++DFG+S
Sbjct: 138 I---IHRDLKAGNVLMTLEGDIRLADFGVS 164
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 4e-29
Identities = 43/203 (21%), Positives = 78/203 (38%), Gaps = 24/203 (11%)
Query: 492 VIGVGGFGKVYKGV--IEDKLKVAIKRSNPSSEQGVNE-FVTEIEMLSKLRHKHLVSLIG 548
I GG G +Y + + V +K S + + E + L+++ H +V +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 549 FCEEGNEMCLVYDYMAL-----GTLREHIYNTKKALSWKQRLEICIGAARGLHYLHT-GA 602
F E + Y+ + +L+ + L + + + L YLH+ G
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSK---GQKLPVAEAIAYLLEILPALSYLHSIG- 202
Query: 603 KYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQ 662
+++ D+K NI+L E + K+ D G + G+ G+ PE R
Sbjct: 203 ---LVYNDLKPENIMLTEEQL-KLIDLGAVSRI-----NSFGYLY-GTPGFQAPEIV-RT 251
Query: 663 QLTEKSDIYSFGVVLFEVLCARP 685
T +DIY+ G L + P
Sbjct: 252 GPTVATDIYTVGRTLAALTLDLP 274
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 57/197 (28%), Positives = 94/197 (47%), Gaps = 8/197 (4%)
Query: 484 TKSFDESYVIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKH 542
+ FD +G G +G VYK + E VAIK+ E + E + EI ++ + H
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSPH 85
Query: 543 LVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGA 602
+V G + ++ +V +Y G++ + I K L+ + I +GL YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 603 KYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQ 662
K IHRD+K NILL+ AK++DFG++ +TV+ G+ ++ PE +
Sbjct: 146 K---IHRDIKAGNILLNTEGHAKLADFGVAGQ-LTDTMAKRNTVI-GTPFWMAPEVIQEI 200
Query: 663 QLTEKSDIYSFGVVLFE 679
+DI+S G+ E
Sbjct: 201 GYNCVADIWSLGITAIE 217
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 53/201 (26%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 484 TKSFDESYVIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKH 542
K + IG G G VY + + +VAI++ N + + EI ++ + ++ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 543 LVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGA 602
+V+ + G+E+ +V +Y+A G+L + + T+ + Q +C + L +LH+
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 603 KYTIIHRDVKTTNILLDENWVAKVSDFG----LSKTGPNMENGHVSTVVKGSFGYLDPEY 658
IHRD+K+ NILL + K++DFG ++ ST+V G+ ++ PE
Sbjct: 137 V---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-----STMV-GTPYWMAPEV 187
Query: 659 FKRQQLTEKSDIYSFGVVLFE 679
R+ K DI+S G++ E
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIE 208
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-28
Identities = 56/256 (21%), Positives = 105/256 (41%), Gaps = 29/256 (11%)
Query: 445 SQTTQSKSTISGKSNASSHLSAIAQGLCRRFSLAEIKHATKSFDESY----VIGVGGFGK 500
+ + GK SS+ + +++ ++ + Y +G G FG
Sbjct: 113 YDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGV 172
Query: 501 VYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLV 559
V++ A K E EI+ +S LRH LV+L E+ NEM ++
Sbjct: 173 VHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232
Query: 560 YDYMALGTLREHIYNTKKALS-------WKQRLEICIGAARGLHYLHTGAKYTIIHRDVK 612
Y++M+ G L E + + +S +Q + GL ++H + +H D+K
Sbjct: 233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK-------GLCHMH---ENNYVHLDLK 282
Query: 613 TTNILL---DENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSD 669
NI+ N + K+ DFGL+ ++ V G+ + PE + + + +D
Sbjct: 283 PENIMFTTKRSNEL-KLIDFGLTAH---LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTD 338
Query: 670 IYSFGVVLFEVLCARP 685
++S GV+ + +L
Sbjct: 339 MWSVGVLSYILLSGLS 354
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-28
Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 20/221 (9%)
Query: 476 SLAEIKHATKSFDESY----VIGVGGFGKVYKGV-IEDKLKVAIK---RSNPSSEQGVNE 527
S E + +F E Y ++G G FG+V K + + A+K +++ ++ +
Sbjct: 9 SGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-TST 67
Query: 528 FVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEI 587
+ E+E+L KL H +++ L E+ + +V + G L + I +K S I
Sbjct: 68 ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI-IKRKRFSEHDAARI 126
Query: 588 CIGAARGLHYLHTGAKYTIIHRDVKTTNILL---DENWVAKVSDFGLSKTGPNMENGHVS 644
G+ Y+H K+ I+HRD+K NILL +++ K+ DFGLS +
Sbjct: 127 IKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST---CFQQNTKM 180
Query: 645 TVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
G+ Y+ PE + EK D++S GV+L+ +L P
Sbjct: 181 KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTP 220
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 117 bits (293), Expect = 2e-28
Identities = 37/241 (15%), Positives = 76/241 (31%), Gaps = 56/241 (23%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIK----------------------------RSNPSSE 522
V+G + E + N
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 523 QGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMA----LGTLREHIYN---T 575
+ F+ +++ + K ++ + + + + Y L T E + + T
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 576 KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTG 635
K+L RL++ + R L LH Y ++H ++ +I+LD+ ++ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254
Query: 636 PNMENGHVSTVVKGSFGYLDPEYFKRQQL-----------TEKSDIYSFGVVLFEVLCAR 684
+G S G+ PE R+ T D ++ G+V++ + CA
Sbjct: 255 ---RDGARVVSS-VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 685 P 685
Sbjct: 311 L 311
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 31/219 (14%)
Query: 484 TKSFDESY----VIGVGGFGKVYKGV-IEDKLKVAIK---RSNPSSEQGVNEFVTEIEML 535
+ F ++Y +G G F V + V L+ A K S+ + E +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD-FQKLEREARIC 59
Query: 536 SKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHI-----YNTKKALSW-KQRLEICI 589
KL+H ++V L +E + LV+D + G L E I Y+ A +Q LE
Sbjct: 60 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE--- 116
Query: 590 GAARGLHYLHTGAKYTIIHRDVKTTNILL---DENWVAKVSDFGLSKTGPNMENGHVSTV 646
+ Y H I+HR++K N+LL + K++DFGL+ + +
Sbjct: 117 ----SIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE---VNDSEAWHG 166
Query: 647 VKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
G+ GYL PE K+ ++ DI++ GV+L+ +L P
Sbjct: 167 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 205
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 50/201 (24%), Positives = 90/201 (44%), Gaps = 16/201 (7%)
Query: 484 TKSFDESYVIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKH 542
D IG G G V +VA+K + +Q E+ ++ +H +
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 543 LVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGA 602
+V + G E+ ++ +++ G L + + + L+ +Q +C + L YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR--LNEEQIATVCEAVLQALAYLHAQG 161
Query: 603 KYTIIHRDVKTTNILLDENWVAKVSDFG----LSKTGPNMENGHVSTVVKGSFGYLDPEY 658
IHRD+K+ +ILL + K+SDFG +SK P ++V G+ ++ PE
Sbjct: 162 V---IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR-----KSLV-GTPYWMAPEV 212
Query: 659 FKRQQLTEKSDIYSFGVVLFE 679
R + DI+S G+++ E
Sbjct: 213 ISRSLYATEVDIWSLGIMVIE 233
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-28
Identities = 64/300 (21%), Positives = 118/300 (39%), Gaps = 44/300 (14%)
Query: 487 FDESYVIGVGGFGKVYKGV-IEDKLKVAIKR-SNPSSEQGVNEFVTEIEMLSKLRHKHLV 544
F++ +G G G V+K L +A K N+ + E+++L + ++V
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 545 SLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKY 604
G E+ + ++M G+L + + + + ++ I +GL YL K
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK- 152
Query: 605 TIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQL 664
I+HRDVK +NIL++ K+ DFG+S + + ++ V G+ Y+ PE +
Sbjct: 153 -IMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFV-GTRSYMSPERLQGTHY 207
Query: 665 TEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKG--------------- 709
+ +SDI+S G+ L E+ R + P KE + +
Sbjct: 208 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267
Query: 710 ----------------ILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
I+++ L S E F D KCL + +R + ++
Sbjct: 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLE----FQDFVNKCLIKNPAERADLKQLM 323
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 50/210 (23%), Positives = 89/210 (42%), Gaps = 16/210 (7%)
Query: 484 TKSFDESY----VIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKL 538
++ Y IG G +G+V V +++ A K+ + V+ F EIE++ L
Sbjct: 4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL 63
Query: 539 RHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYL 598
H +++ L E+ ++ LV + G L E + K+ I + Y
Sbjct: 64 DHPNIIRLYETFEDNTDIYLVMELCTGGELFERV-VHKRVFRESDAARIMKDVLSAVAYC 122
Query: 599 HTGAKYTIIHRDVKTTNILL---DENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLD 655
H K + HRD+K N L + K+ DFGL+ + G + G+ Y+
Sbjct: 123 H---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR---FKPGKMMRTKVGTPYYVS 176
Query: 656 PEYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
P+ + + D +S GV+++ +LC P
Sbjct: 177 PQVLEG-LYGPECDEWSAGVMMYVLLCGYP 205
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 59/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 481 KHATKSFDESY----VIGVGGFGKVYKGV-IEDKLKVAIK---------RSNPSSEQGVN 526
H+T F E+Y ++G G V + + + A+K S ++
Sbjct: 9 SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68
Query: 527 EFVTEIEMLSKL-RHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL 585
+ E+++L K+ H +++ L E LV+D M G L +++ K LS K+
Sbjct: 69 ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETR 127
Query: 586 EICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVST 645
+I + LH K I+HRD+K NILLD++ K++DFG S ++ G
Sbjct: 128 KIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPGEKLR 181
Query: 646 VVKGSFGYLDPEYFKRQQL------TEKSDIYSFGVVLFEVLCARP 685
V G+ YL PE + ++ D++S GV+++ +L P
Sbjct: 182 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 9e-28
Identities = 61/240 (25%), Positives = 106/240 (44%), Gaps = 29/240 (12%)
Query: 462 SHLSAIAQGLCRRFSLAEIKHATKSFDESY----VIGVGGFGKVYKGV-IEDKLKVAIK- 515
H++++ G + +A+ F ++Y +G G F V + V L+ A K
Sbjct: 2 PHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI 61
Query: 516 -RSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHI-- 572
+ S + + E + KL+H ++V L +E + LV+D + G L E I
Sbjct: 62 INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA 121
Query: 573 ---YNTKKALSW-KQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILL---DENWVAK 625
Y+ A +Q LE + Y H I+HR++K N+LL + K
Sbjct: 122 REFYSEADASHCIQQILE-------SIAYCH---SNGIVHRNLKPENLLLASKAKGAAVK 171
Query: 626 VSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
++DFGL+ + + G+ GYL PE K+ ++ DI++ GV+L+ +L P
Sbjct: 172 LADFGLAIE---VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 228
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 20/215 (9%)
Query: 482 HATKSFDESY----VIGVGGFGKVYKGV-IEDKLKVAIK---RSNPSSEQGVNEFVTEIE 533
+ +F E Y ++G G FG+V K + + A+K +++ ++ + + E+E
Sbjct: 15 YFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-TSTILREVE 73
Query: 534 MLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAAR 593
+L KL H +++ L E+ + +V + G L + I +K S I
Sbjct: 74 LLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI-IKRKRFSEHDAARIIKQVFS 132
Query: 594 GLHYLHTGAKYTIIHRDVKTTNILL---DENWVAKVSDFGLSKTGPNMENGHVSTVVKGS 650
G+ Y+H K+ I+HRD+K NILL +++ K+ DFGLS + G+
Sbjct: 133 GITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRIGT 186
Query: 651 FGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
Y+ PE + EK D++S GV+L+ +L P
Sbjct: 187 AYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTP 220
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 50/222 (22%), Positives = 95/222 (42%), Gaps = 34/222 (15%)
Query: 482 HATKSFDESY----VIGVGGFGKVYKGV-IEDKLKVAIK------RSNPSSEQGVNEFVT 530
+ ++ Y +G G F V K L+ A K E
Sbjct: 5 FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIER 64
Query: 531 EIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHI-----YNTKKALS-WKQR 584
E+ +L ++ H ++++L E ++ L+ + ++ G L + + + ++A S KQ
Sbjct: 65 EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 585 LEICIGAARGLHYLHTGAKYTIIHRDVKTTNILL----DENWVAKVSDFGLSKTGPNMEN 640
L+ G++YLH I H D+K NI+L K+ DFGL+ +E+
Sbjct: 125 LD-------GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE---IED 171
Query: 641 GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC 682
G + G+ ++ PE + L ++D++S GV+ + +L
Sbjct: 172 GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 19/216 (8%)
Query: 482 HATKSFDESY----VIGVGGFGKVYKGV-IEDKLKVAIKR-SNPSSEQGVNEFVTEIEML 535
+ + D+ + +G G FG V+ L+ IK + S+ + + EIE+L
Sbjct: 15 YFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVL 74
Query: 536 SKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHI---YNTKKALSWKQRLEICIGAA 592
L H +++ + E+ + M +V + G L E I KALS E+
Sbjct: 75 KSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMM 134
Query: 593 RGLHYLHTGAKYTIIHRDVKTTNILL---DENWVAKVSDFGLSKTGPNMENGHVSTVVKG 649
L Y H ++H+D+K NIL + K+ DFGL++ ++ ST G
Sbjct: 135 NALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL---FKSDEHSTNAAG 188
Query: 650 SFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
+ Y+ PE FKR +T K DI+S GVV++ +L
Sbjct: 189 TALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCL 223
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 72/295 (24%), Positives = 128/295 (43%), Gaps = 42/295 (14%)
Query: 484 TKSFDESYVIGVGGFGKVYKGV-IEDKLKVAIKRSN-PSSEQGVNEFVTEIEMLSKLRHK 541
+ F + IG G FG+V+KG+ + VAIK + +E + + EI +LS+
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 542 HLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTG 601
++ G + ++ ++ +Y+ G+ + + L Q I +GL YLH+
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSE 138
Query: 602 AKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKR 661
K IHRD+K N+LL E+ K++DFG++ + + +T V G+ ++ PE K+
Sbjct: 139 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR-NTFV-GTPFWMAPEVIKQ 193
Query: 662 QQLTEKSDIYSFGVVLFEVLCARP---ALNPS-----LPKEQVSLADWALHCKRKGILDD 713
K+DI+S G+ E+ P L+P +PK
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN------------------ 235
Query: 714 IIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVESTEA 768
P L+ S + E CL+ RP+ ++L +F+L+ + T
Sbjct: 236 --PPTLEGNYSKP----LKEFVEACLNKEPSFRPTAKELL-KHKFILRNAKKTSY 283
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-27
Identities = 72/267 (26%), Positives = 113/267 (42%), Gaps = 32/267 (11%)
Query: 440 PIYGHSQTTQSKSTISGKSNASSHLSAIAQGLCRRFSLAEIKHATKSFDESY----VIGV 495
P + ++K + + +L + G A K F + Y VIG
Sbjct: 48 PSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDEL---PDWAAAKEFYQKYDPKDVIGR 104
Query: 496 GGFGKVYKGV-IEDKLKVAIK--------RSNPSSEQGVNEFVTEIEMLSKLR-HKHLVS 545
G V + V + A+K S E+ E +L ++ H H+++
Sbjct: 105 GVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164
Query: 546 LIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYT 605
LI E + M LV+D M G L +++ K ALS K+ I + +LH
Sbjct: 165 LIDSYESSSFMFLVFDLMRKGELFDYL-TEKVALSEKETRSIMRSLLEAVSFLH---ANN 220
Query: 606 IIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV-STVVKGSFGYLDPEYFKRQQL 664
I+HRD+K NILLD+N ++SDFG S +E G + G+ GYL PE K
Sbjct: 221 IVHRDLKPENILLDDNMQIRLSDFGFSCH---LEPGEKLRELC-GTPGYLAPEILKCSMD 276
Query: 665 ------TEKSDIYSFGVVLFEVLCARP 685
++ D+++ GV+LF +L P
Sbjct: 277 ETHPGYGKEVDLWACGVILFTLLAGSP 303
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 4e-27
Identities = 59/244 (24%), Positives = 97/244 (39%), Gaps = 32/244 (13%)
Query: 466 AIAQGLCRRF-----SLAEIKHATKSFDESY----VIGVGGFGKVYKGV-IEDKLKVAIK 515
A++ + F ++ + K+ + Y +G G G+V + KVAI+
Sbjct: 107 ALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIR 166
Query: 516 --------RSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGT 567
+ TEIE+L KL H ++ + F + + +V + M G
Sbjct: 167 IISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGE 225
Query: 568 LREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILL---DENWVA 624
L + + K L + YLH + IIHRD+K N+LL +E+ +
Sbjct: 226 LFDKVVG-NKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLI 281
Query: 625 KVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPE---YFKRQQLTEKSDIYSFGVVLFEVL 681
K++DFG SK + + + G+ YL PE D +S GV+LF L
Sbjct: 282 KITDFGHSKI---LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 338
Query: 682 CARP 685
P
Sbjct: 339 SGYP 342
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 65/250 (26%), Positives = 103/250 (41%), Gaps = 28/250 (11%)
Query: 444 HSQTTQSKSTISGKSNASSHLSAIAQGLCRRFSLAEIKHA---TKSFDESYVIGVGGFGK 500
H + + + + G + +AE+ K F + IG G FG
Sbjct: 10 HDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGA 69
Query: 501 VYKGV-IEDKLKVAIKR---SNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEM 556
VY + + VAIK+ S S + + + E+ L KLRH + + G +
Sbjct: 70 VYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA 129
Query: 557 CLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNI 616
LV +Y G+ + + KK L + + GA +GL YLH+ IHRDVK NI
Sbjct: 130 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM---IHRDVKAGNI 185
Query: 617 LLDENWVAKVSDFG----LSKTGPNMENGHVSTVVKGSFGYLDPE---YFKRQQLTEKSD 669
LL E + K+ DFG ++ ++ V G+ ++ PE Q K D
Sbjct: 186 LLSEPGLVKLGDFGSASIMAPA---------NSFV-GTPYWMAPEVILAMDEGQYDGKVD 235
Query: 670 IYSFGVVLFE 679
++S G+ E
Sbjct: 236 VWSLGITCIE 245
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-27
Identities = 50/222 (22%), Positives = 95/222 (42%), Gaps = 34/222 (15%)
Query: 482 HATKSFDESY----VIGVGGFGKVYKGV-IEDKLKVAIK------RSNPSSEQGVNEFVT 530
+ ++ Y +G G F V K L+ A K E
Sbjct: 5 FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIER 64
Query: 531 EIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHI-----YNTKKALS-WKQR 584
E+ +L ++ H ++++L E ++ L+ + ++ G L + + + ++A S KQ
Sbjct: 65 EVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 585 LEICIGAARGLHYLHTGAKYTIIHRDVKTTNILL----DENWVAKVSDFGLSKTGPNMEN 640
L+ G++YLH I H D+K NI+L K+ DFGL+ +E+
Sbjct: 125 LD-------GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE---IED 171
Query: 641 GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC 682
G + G+ ++ PE + L ++D++S GV+ + +L
Sbjct: 172 GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-27
Identities = 49/223 (21%), Positives = 95/223 (42%), Gaps = 34/223 (15%)
Query: 484 TKSFDESY----VIGVGGFGKVYKGV-IEDKLKVAIK------RSNPSSEQGVNEFVTEI 532
++ D+ Y +G G F V K L+ A K + + E+
Sbjct: 6 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 533 EMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHI-----YNTKKALS-WKQRLE 586
+L +++H ++++L E ++ L+ + +A G L + + ++A KQ L
Sbjct: 66 SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 587 ICIGAARGLHYLHTGAKYTIIHRDVKTTNILL----DENWVAKVSDFGLSKTGPNMENGH 642
G++YLH I H D+K NI+L K+ DFGL+ ++ G+
Sbjct: 126 -------GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFGN 172
Query: 643 VSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
+ G+ ++ PE + L ++D++S GV+ + +L
Sbjct: 173 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 215
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-27
Identities = 56/230 (24%), Positives = 94/230 (40%), Gaps = 35/230 (15%)
Query: 479 EIKHATKSFDESY----VIGVGGFGKVYKGV-IEDKLKVAIK-----RSNPSSEQGVNEF 528
++ F++ Y VIG G F V + + E + A+K + S +
Sbjct: 14 DMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDL 73
Query: 529 VTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHI---------YNTKKAL 579
E + L+H H+V L+ + +V+++M L I Y+ A
Sbjct: 74 KREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVAS 133
Query: 580 S-WKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILL---DENWVAKVSDFGLSKTG 635
+Q LE L Y H IIHRDVK +LL + + K+ FG++
Sbjct: 134 HYMRQILE-------ALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183
Query: 636 PNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
E+G V+ G+ ++ PE KR+ + D++ GV+LF +L
Sbjct: 184 G--ESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCL 231
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 9e-27
Identities = 51/214 (23%), Positives = 85/214 (39%), Gaps = 21/214 (9%)
Query: 484 TKSFDESY-------VIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEML 535
F + Y +G G F K V + A+K + E + EI L
Sbjct: 3 DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITAL 59
Query: 536 SKLR-HKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARG 594
H ++V L + LV + + G L E I KK S + I
Sbjct: 60 KLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKK-KKHFSETEASYIMRKLVSA 118
Query: 595 LHYLHTGAKYTIIHRDVKTTNILL---DENWVAKVSDFGLSKTGPNMENGHVSTVVKGSF 651
+ ++H ++HRD+K N+L ++N K+ DFG ++ P +N + T +
Sbjct: 119 VSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP-DNQPLKTPC-FTL 173
Query: 652 GYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
Y PE + E D++S GV+L+ +L +
Sbjct: 174 HYAAPELLNQNGYDESCDLWSLGVILYTMLSGQV 207
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 45/199 (22%), Positives = 80/199 (40%), Gaps = 16/199 (8%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIKRSN-PSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFC 550
+G G FG+V++ + + A+K+ E+ + L +V L G
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV------EELVACAGLSSPRIVPLYGAV 119
Query: 551 EEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRD 610
EG + + + + G+L + L + L A GL YLHT I+H D
Sbjct: 120 REGPWVNIFMELLEGGSLG-QLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGD 175
Query: 611 VKTTNILLDEN-WVAKVSDFGLSK--TGPNMENGHVSTV-VKGSFGYLDPEYFKRQQLTE 666
VK N+LL + A + DFG + + ++ + G+ ++ PE +
Sbjct: 176 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDA 235
Query: 667 KSDIYSFGVVLFEVLCARP 685
K DI+S ++ +L
Sbjct: 236 KVDIWSSCCMMLHMLNGCH 254
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 51/218 (23%), Positives = 94/218 (43%), Gaps = 34/218 (15%)
Query: 486 SFDESY----VIGVGGFGKVYKGV-IEDKLKVAIK------RSNPSSEQGVNEFVTEIEM 534
++ Y +G G F V K + A K S+ E E+ +
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 535 LSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHI-----YNTKKALS-WKQRLEIC 588
L ++RH ++++L E ++ L+ + ++ G L + + +A KQ L+
Sbjct: 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD-- 119
Query: 589 IGAARGLHYLHTGAKYTIIHRDVKTTNILL----DENWVAKVSDFGLSKTGPNMENGHVS 644
G+HYLH I H D+K NI+L N K+ DFG++ +E G+
Sbjct: 120 -----GVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK---IEAGNEF 168
Query: 645 TVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC 682
+ G+ ++ PE + L ++D++S GV+ + +L
Sbjct: 169 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 206
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 42/215 (19%), Positives = 88/215 (40%), Gaps = 28/215 (13%)
Query: 485 KSFDESY----VIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLR 539
K E Y +G G FG V++ V K K EI +L+ R
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAK-FVKVKGTDQVLVKKEISILNIAR 59
Query: 540 HKHLVSLIGFCEEGNEMCLVYDYMALGTL------REHIYNTKKALS-WKQRLEICIGAA 592
H++++ L E E+ +++++++ + N ++ +S Q E
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE------ 113
Query: 593 RGLHYLHTGAKYTIIHRDVKTTNILL--DENWVAKVSDFGLSKTGPNMENGHVSTVVKGS 650
L +LH + I H D++ NI+ + K+ +FG ++ ++ G ++ +
Sbjct: 114 -ALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ---LKPGDNFRLLFTA 166
Query: 651 FGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
Y PE + ++ +D++S G +++ +L
Sbjct: 167 PEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGIN 201
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 62/202 (30%), Positives = 95/202 (47%), Gaps = 18/202 (8%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKRSN-PSSEQGVNEFVTEIEMLSKLRHKHLVSLIGF 549
VIG G V K KVAIKR N + ++E + EI+ +S+ H ++VS
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 550 CEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL--EICIGAA-----RGLHYLHTGA 602
+E+ LV ++ G++ + I + K + E I GL YLH
Sbjct: 82 FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG 141
Query: 603 KYTIIHRDVKTTNILLDENWVAKVSDFG----LSKTGPNMENGHVSTVVKGSFGYLDPEY 658
+ IHRDVK NILL E+ +++DFG L+ G N T V G+ ++ PE
Sbjct: 142 Q---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV-GTPCWMAPEV 197
Query: 659 FKRQQL-TEKSDIYSFGVVLFE 679
++ + K+DI+SFG+ E
Sbjct: 198 MEQVRGYDFKADIWSFGITAIE 219
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 61/226 (26%), Positives = 93/226 (41%), Gaps = 39/226 (17%)
Query: 485 KSFDESY----VIGVGGFGKVYKGV-IEDKLKVAIK-------RSNPSSEQGVNEFV-TE 531
K+ + Y +G G G+V + KVAIK + E V TE
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 532 IEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHI-----YNTKKA-LSWKQRL 585
IE+L KL H ++ + F + + +V + M G L + + L + Q L
Sbjct: 66 IEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124
Query: 586 EICIGAARGLHYLHTGAKYTIIHRDVKTTNILL---DENWVAKVSDFGLSKTGPNMENGH 642
+ YLH + IIHRD+K N+LL +E+ + K++DFG SK +
Sbjct: 125 L-------AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETS 171
Query: 643 VSTVVKGSFGYLDPE---YFKRQQLTEKSDIYSFGVVLFEVLCARP 685
+ + G+ YL PE D +S GV+LF L P
Sbjct: 172 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 60/256 (23%), Positives = 103/256 (40%), Gaps = 29/256 (11%)
Query: 444 HSQTTQSKSTISGKSNASSHLSAIAQGLCRRFSLAEIKHATKSFDESY----VIGVGGFG 499
S + +S +S SA + + + +G G
Sbjct: 8 SSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATS 67
Query: 500 KVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCL 558
VY+ + A+K + + TEI +L +L H +++ L E E+ L
Sbjct: 68 IVYRCKQKGTQKPYALKVLKKTVD--KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL 125
Query: 559 VYDYMALGTLREHI-----YNTKKALS-WKQRLEICIGAARGLHYLHTGAKYTIIHRDVK 612
V + + G L + I Y+ + A KQ LE + YLH + I+HRD+K
Sbjct: 126 VLELVTGGELFDRIVEKGYYSERDAADAVKQILE-------AVAYLH---ENGIVHRDLK 175
Query: 613 TTNILL---DENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSD 669
N+L + K++DFGLSK +E+ + V G+ GY PE + + D
Sbjct: 176 PENLLYATPAPDAPLKIADFGLSKI---VEHQVLMKTVCGTPGYCAPEILRGCAYGPEVD 232
Query: 670 IYSFGVVLFEVLCARP 685
++S G++ + +LC
Sbjct: 233 MWSVGIITYILLCGFE 248
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 59/315 (18%), Positives = 98/315 (31%), Gaps = 51/315 (16%)
Query: 484 TKSFDESYVIGVG--GFGKVYKGV-IEDKLKVAIKRSN--PSSEQGVNEFVTEIEMLSKL 538
++ VIG G V V ++R N S + V E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 539 RHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTK-KALSWKQRLEICIGAARGLHY 597
H ++V NE+ +V +MA G+ ++ I ++ I G + L Y
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 598 LHTGAKYTIIHRDVKTTNILLDENWVAKVSDFG----LSKTGPNMENGHVSTVVK-GSFG 652
+H +HR VK ++IL+ + +S + G H
Sbjct: 144 IHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP 200
Query: 653 YLDPEYFKRQQL--TEKSDIYSFGV-------------------VLFEVLCARPALNPSL 691
+L PE ++ KSDIYS G+ +L E L P L
Sbjct: 201 WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV---PCL 257
Query: 692 PKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECL-------------KKFADTAEKC 738
A+ + + + + L F E+C
Sbjct: 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQC 317
Query: 739 LSDSGIDRPSMGDVL 753
L + RPS +L
Sbjct: 318 LQRNPDARPSASTLL 332
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 55/262 (20%), Positives = 94/262 (35%), Gaps = 60/262 (22%)
Query: 480 IKHATKSFDESY----VIGVGGFGKVYKGV-IEDKLKVAIK-----RSNPSSEQGVNEFV 529
+ + Y IG G +G V + + + AIK + + + V
Sbjct: 17 QGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIK 76
Query: 530 TEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICI 589
TE+ ++ KL H ++ L E+ +CLV + G L + + + K +++
Sbjct: 77 TEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVK 136
Query: 590 G--------------------------------AAR-------GLHYLHTGAKYTIIHRD 610
+ LHYLH I HRD
Sbjct: 137 TQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRD 193
Query: 611 VKTTNILL--DENWVAKVSDFGLSK---TGPNMENGHVSTVVKGSFGYLDPE--YFKRQQ 663
+K N L ++++ K+ DFGLSK N E ++T G+ ++ PE +
Sbjct: 194 IKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNES 252
Query: 664 LTEKSDIYSFGVVLFEVLCARP 685
K D +S GV+L +L
Sbjct: 253 YGPKCDAWSAGVLLHLLLMGAV 274
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-26
Identities = 49/223 (21%), Positives = 93/223 (41%), Gaps = 33/223 (14%)
Query: 480 IKHATKSFDESY-----VIGVGGFGKVYKGV-IEDKLKVAIK--RSNPSSEQGVNEFVTE 531
+ ++F+ Y +G G F V + + + A K + + E + E
Sbjct: 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHE 78
Query: 532 IEMLSKLRH-KHLVSLIGFCEEGNEMCLVYDYMALGTLREHI-------YNTKKALS-WK 582
I +L + +++L E +E+ L+ +Y A G + + + K
Sbjct: 79 IAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIK 138
Query: 583 QRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILL---DENWVAKVSDFGLSKTGPNME 639
Q LE G++YLH + I+H D+K NILL K+ DFG+S+ +
Sbjct: 139 QILE-------GVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK---IG 185
Query: 640 NGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC 682
+ + G+ YL PE +T +D+++ G++ + +L
Sbjct: 186 HACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLT 228
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 58/202 (28%), Positives = 90/202 (44%), Gaps = 25/202 (12%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVT-EIEMLSKLRHKHLVSLIGFC 550
+G G +G+V V + VA+K + E + EI + L H+++V G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 551 EEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAAR--------GLHYLHTGA 602
EGN L +Y + G L + I + A+ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEP-------DIGMPE--PDAQRFFHQLMAGVVYLH--- 122
Query: 603 KYTIIHRDVKTTNILLDENWVAKVSDFGLSKT-GPNMENGHVSTVVKGSFGYLDPEYFKR 661
I HRD+K N+LLDE K+SDFGL+ N ++ + G+ Y+ PE KR
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKR 181
Query: 662 QQLT-EKSDIYSFGVVLFEVLC 682
++ E D++S G+VL +L
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLA 203
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-25
Identities = 44/310 (14%), Positives = 95/310 (30%), Gaps = 61/310 (19%)
Query: 426 QRIPGTESHTSSWLPIYGHSQTTQSKSTISGKSNASSHL---SAIAQGLCRRFSLAEIKH 482
Q GT+ ++ ++T +A+ L S G R +E+
Sbjct: 17 QGFRGTDPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVE-SELGE 75
Query: 483 ATKSFDESYVIGVGGFGKVYKGV-IEDKLKVAIK-------------------------- 515
++ V+G + E +
Sbjct: 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 135
Query: 516 --RSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMA----LGTLR 569
N + F+ +++ + K ++ + + + + Y L T
Sbjct: 136 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 195
Query: 570 EHIYN---TKKALSWKQRLEICIGAARGLHYLHT-GAKYTIIHRDVKTTNILLDENWVAK 625
E + + T K+L RL++ + R L LH G ++H ++ +I+LD+
Sbjct: 196 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVF 251
Query: 626 VSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYF----------KRQQLTEKSDIYSFGV 675
++ F +G + G + PE +T D ++ G+
Sbjct: 252 LTGFEHLV-----RDGASAVSPIGRG-FAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305
Query: 676 VLFEVLCARP 685
++ + CA
Sbjct: 306 AIYWIWCADL 315
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-25
Identities = 52/218 (23%), Positives = 90/218 (41%), Gaps = 28/218 (12%)
Query: 484 TKSFDESY----VIGVGGFGKVYKGV-IEDKLKVAIK--RSNPSSEQGVNEFVTEIEMLS 536
F E Y +G G F V + V + + A + S + + E +
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65
Query: 537 KLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHI-----YNTKKALSW-KQRLEICIG 590
L+H ++V L E L++D + G L E I Y+ A +Q LE
Sbjct: 66 LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILE---- 121
Query: 591 AARGLHYLHTGAKYTIIHRDVKTTNILL---DENWVAKVSDFGLSKTGPNMENGHVSTVV 647
+ + H + ++HR++K N+LL + K++DFGL+ E
Sbjct: 122 ---AVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG-EQQAWFGFA 174
Query: 648 KGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
G+ GYL PE ++ + D+++ GV+L+ +L P
Sbjct: 175 -GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYP 211
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 54/214 (25%), Positives = 89/214 (41%), Gaps = 40/214 (18%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIK-------RSNPSSEQGVNEFVTEIEMLSKLRHKHL 543
++G G +GKV + + E + A+K R P+ E V EI++L +LRHK++
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVK---KEIQLLRRLRHKNV 68
Query: 544 VSL--IGFCEEGNEMCLV-----------YDYMALGTLREHIYNTKKALSWKQRLEICIG 590
+ L + + EE +M +V D + +A + +L I
Sbjct: 69 IQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVC-----QAHGYFCQL-ID-- 120
Query: 591 AARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGS 650
GL YLH I+H+D+K N+LL K+S G+++ +GS
Sbjct: 121 ---GLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGS 174
Query: 651 FGYLDPEYFKRQQLTE--KSDIYSFGVVLFEVLC 682
+ PE K DI+S GV L+ +
Sbjct: 175 PAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITT 208
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 52/217 (23%), Positives = 98/217 (45%), Gaps = 20/217 (9%)
Query: 479 EIKHATKSFDESY----VIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIE 533
++ + F + Y IGVG + + + ++ A+K + S EIE
Sbjct: 12 QLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT----EEIE 67
Query: 534 MLSKL-RHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAA 592
+L + +H ++++L ++G + +V + M G L + I +K S ++ +
Sbjct: 68 ILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR-QKFFSEREASAVLFTIT 126
Query: 593 RGLHYLHTGAKYTIIHRDVKTTNILL----DENWVAKVSDFGLSKTGPNMENGHVSTVVK 648
+ + YLH ++HRD+K +NIL ++ DFG +K ENG + T
Sbjct: 127 KTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA-ENGLLMTPC- 181
Query: 649 GSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
+ ++ PE +RQ DI+S GV+L+ +L
Sbjct: 182 YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYT 218
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 54/224 (24%), Positives = 96/224 (42%), Gaps = 28/224 (12%)
Query: 484 TKSFDESY-----VIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSK 537
+ F++ Y V+G G +V + + + A+K + E+EML +
Sbjct: 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQ 66
Query: 538 LR-HKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLH 596
+ H++++ LI F EE + LV++ M G++ HI+ ++ + + + A L
Sbjct: 67 CQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIH-KRRHFNELEASVVVQDVASALD 125
Query: 597 YLHT-GAKYTIIHRDVKTTNILL---DENWVAKVSDFGLSK------TGPNMENGHVSTV 646
+LH G I HRD+K NIL ++ K+ DF L + + T
Sbjct: 126 FLHNKG----IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP 181
Query: 647 VKGSFGYLDPEYFKRQQLTEKS-----DIYSFGVVLFEVLCARP 685
GS Y+ PE + D++S GV+L+ +L P
Sbjct: 182 C-GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYP 224
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 58/202 (28%), Positives = 90/202 (44%), Gaps = 25/202 (12%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVT-EIEMLSKLRHKHLVSLIGFC 550
+G G +G+V V + VA+K + E + EI + L H+++V G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 551 EEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAAR--------GLHYLHTGA 602
EGN L +Y + G L + I + A+ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEP-------DIGMPE--PDAQRFFHQLMAGVVYLH--- 122
Query: 603 KYTIIHRDVKTTNILLDENWVAKVSDFGLSKT-GPNMENGHVSTVVKGSFGYLDPEYFKR 661
I HRD+K N+LLDE K+SDFGL+ N ++ + G+ Y+ PE KR
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKR 181
Query: 662 QQLT-EKSDIYSFGVVLFEVLC 682
++ E D++S G+VL +L
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLA 203
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 61/220 (27%), Positives = 104/220 (47%), Gaps = 20/220 (9%)
Query: 474 RFSLAEIKHATKSFDESYVIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEI 532
L+ ++ F+ ++G G +G+VYKG ++ AIK + + ++ E EI
Sbjct: 13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEI 71
Query: 533 EMLSKL-RHKHLVSLIG------FCEEGNEMCLVYDYMALGTLREHIYNTK-KALSWKQR 584
ML K H+++ + G +++ LV ++ G++ + I NTK L +
Sbjct: 72 NMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI 131
Query: 585 LEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVS 644
IC RGL +LH IHRD+K N+LL EN K+ DFG+S + G +
Sbjct: 132 AYICREILRGLSHLHQHKV---IHRDIKGQNVLLTENAEVKLVDFGVSAQ-LDRTVGRRN 187
Query: 645 TVVKGSFGYLDPEYFKRQQLTE-----KSDIYSFGVVLFE 679
T + G+ ++ PE + + KSD++S G+ E
Sbjct: 188 TFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 50/250 (20%), Positives = 88/250 (35%), Gaps = 41/250 (16%)
Query: 520 SSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTK--- 576
SS ++ +I + K+ V + + + L++ +
Sbjct: 100 SSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE 159
Query: 577 ---KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSK 633
+ ++I + +LH ++HRD+K +NI + V KV DFGL
Sbjct: 160 DREHGVCLHIFIQIA----EAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVT 212
Query: 634 ----------TGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCA 683
M T G+ Y+ PE + K DI+S G++LFE+L +
Sbjct: 213 AMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
Query: 684 RPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSG 743
E+V + + R PLL + P+ + LS S
Sbjct: 273 FSTQM-----ERVRI----ITDVRNLKF-----PLLFTQKYPQ----EHMMVQDMLSPSP 314
Query: 744 IDRPSMGDVL 753
+RP D++
Sbjct: 315 TERPEATDII 324
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 22/93 (23%), Positives = 35/93 (37%), Gaps = 2/93 (2%)
Query: 487 FDESYVIGVGGFGKVYKGV-IEDKLKVAIKRSN-PSSEQGVNEFVTEIEMLSKLRHKHLV 544
F+ +G GGFG V++ D AIKR P+ E + + E++ L+KL H +V
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 545 SLIGFCEEGNEMCLVYDYMALGTLREHIYNTKK 577
E + + E
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLS 100
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 63/203 (31%), Positives = 94/203 (46%), Gaps = 28/203 (13%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIK---RSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIG 548
+GVG FGKV G KVA+K R S V + EI+ L RH H++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 549 FCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAAR--------GLHYLHT 600
+ +V +Y++ G L ++I R+E AR + Y H
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICK-------HGRVEE--MEARRLFQQILSAVDYCH- 128
Query: 601 GAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFK 660
++ ++HRD+K N+LLD + AK++DFGLS M +G GS Y PE
Sbjct: 129 --RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGSPNYAAPEVIS 183
Query: 661 RQQLT-EKSDIYSFGVVLFEVLC 682
+ + DI+S GV+L+ +LC
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLC 206
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 33/205 (16%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIK-----RSNPSSEQGVNEFVTEIEMLSKLRHKHLVSL 546
IG G F KV I +VAIK + NP+S Q + E+ ++ L H ++V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKL---FREVRIMKILNHPNIVKL 79
Query: 547 IGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAAR--------GLHYL 598
E + L+ +Y + G + +++ R++ AR + Y
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYLVA-------HGRMKE--KEARSKFRQIVSAVQYC 130
Query: 599 HTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEY 658
H + I+HRD+K N+LLD + K++DFG S G G+ Y PE
Sbjct: 131 H---QKRIVHRDLKAENLLLDADMNIKIADFGFSNE---FTVGGKLDAFCGAPPYAAPEL 184
Query: 659 FKRQQLT-EKSDIYSFGVVLFEVLC 682
F+ ++ + D++S GV+L+ ++
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVS 209
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-24
Identities = 69/273 (25%), Positives = 123/273 (45%), Gaps = 38/273 (13%)
Query: 475 FSLAEIKHATKS-FDESYVIGVGGFGKVYKGVIEDKLKV-AIK---RSNPSSEQGVNEFV 529
+ E + TK+ F + V+G GGFG+V + K+ A K + +G +
Sbjct: 173 WKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL 232
Query: 530 TEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL---- 585
E ++L K+ + +VSL E + +CLV M G L+ HIY+ +A + R
Sbjct: 233 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYA 292
Query: 586 -EICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVS 644
EIC G L LH + I++RD+K NILLD++ ++SD GL+ ++ G
Sbjct: 293 AEICCG----LEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAV---HVPEGQTI 342
Query: 645 TVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARP---ALNPSLPKEQVSLADW 701
G+ GY+ PE K ++ T D ++ G +L+E++ + + +E+V
Sbjct: 343 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE---- 398
Query: 702 ALHCKRKGILDDIIDPLLKDKISPEC---LKKF 731
+ + + ++ SP+ +
Sbjct: 399 ------RLVKEV--PEEYSERFSPQARSLCSQL 423
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-24
Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 24/211 (11%)
Query: 487 FDESYVIGVGGFGKVYKGVIEDK-------LKVAIKRSNPSSEQGVNEFVTEIEMLSKLR 539
F+ IG G FGKV +++ +K + + V E++++ L
Sbjct: 17 FEILRAIGKGSFGKVC--IVQKNDTKKMYAMKY-MNKQKCVERNEVRNVFKELQIMQGLE 73
Query: 540 HKHLVSLIG-FCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEIC-IGAARGLHY 597
H LV+L F +E + M +V D + G LR H+ +L IC + A L Y
Sbjct: 74 HPFLVNLWYSFQDEED-MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMA--LDY 130
Query: 598 LHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPE 657
L IIHRD+K NILLDE+ ++DF ++ + T + G+ Y+ PE
Sbjct: 131 LQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAA---MLPRETQITTMAGTKPYMAPE 184
Query: 658 YFKRQQLTEKS---DIYSFGVVLFEVLCARP 685
F ++ S D +S GV +E+L R
Sbjct: 185 MFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-24
Identities = 60/205 (29%), Positives = 92/205 (44%), Gaps = 29/205 (14%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIK---RSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIG 548
+G G FGKV + + KVA+K R EI L LRH H++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 549 FCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAAR--------GLHYLHT 600
++ +V +Y A G L ++I K+R+ R + Y H
Sbjct: 77 VITTPTDIVMVIEY-AGGELFDYIVE-------KKRMTE--DEGRRFFQQIICAIEYCH- 125
Query: 601 GAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFK 660
++ I+HRD+K N+LLD+N K++DFGLS M +G+ GS Y PE
Sbjct: 126 --RHKIVHRDLKPENLLLDDNLNVKIADFGLSNI---MTDGNFLKTSCGSPNYAAPEVIN 180
Query: 661 RQQLT-EKSDIYSFGVVLFEVLCAR 684
+ + D++S G+VL+ +L R
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-23
Identities = 65/280 (23%), Positives = 119/280 (42%), Gaps = 47/280 (16%)
Query: 474 RFSLAEIKHATKS-FDESYVIGVGGFGKVYKGVIEDKLKV-AIK---RSNPSSEQGVNEF 528
++ E + + F + V+G GGFG+V+ ++ K+ A K + +G
Sbjct: 173 QWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA 232
Query: 529 VTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL--- 585
+ E ++L+K+ + +VSL E ++CLV M G +R HIYN +
Sbjct: 233 MVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDE----DNPGFQE 288
Query: 586 --------EICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPN 637
+I G L +LH + II+RD+K N+LLD++ ++SD GL+
Sbjct: 289 PRAIFYTAQIVSG----LEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAV--EL 339
Query: 638 MENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARP---ALNPSLPKE 694
+ G+ G++ PE ++ D ++ GV L+E++ AR A + +
Sbjct: 340 KAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK 399
Query: 695 QVSLADWALHCKRKGILDDIIDPLLKDKISPEC---LKKF 731
++ + +L+ DK SP +
Sbjct: 400 ELK----------QRVLEQ--AVTYPDKFSPASKDFCEAL 427
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 55/272 (20%), Positives = 114/272 (41%), Gaps = 30/272 (11%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKRSNP-SSEQGVNEFVTEIEM-LSKLRHKHLVSLIG 548
+G G +G V K + +A+KR + Q + ++++ + + V+ G
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 549 FCEEGNEMCLVYDYMA--LGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTI 606
++ + + M L + + + + + +I + + L +LH+ +
Sbjct: 74 ALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--V 131
Query: 607 IHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQL-- 664
IHRDVK +N+L++ K+ DFG+S + + + G Y+ PE +
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAKDIDAGCKPYMAPERINPELNQK 188
Query: 665 --TEKSDIYSFGVVLFEVLCARPALNPSL-PKEQVSLADWALHCKRKGILDDIIDPLLKD 721
+ KSDI+S G+ + E+ R + P +Q+ ++++ L D
Sbjct: 189 GYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQ-----------VVEEPSPQLPAD 237
Query: 722 KISPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
K S E F D +CL + +RP+ +++
Sbjct: 238 KFSAE----FVDFTSQCLKKNSKERPTYPELM 265
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 49/220 (22%), Positives = 93/220 (42%), Gaps = 27/220 (12%)
Query: 481 KHATKSFDESY-----VIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEM 534
+ + + Y V+G+G GKV + K A+K S + E++
Sbjct: 20 EPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKAR-----QEVDH 74
Query: 535 LSKL-RHKHLVSLIGFCEEGNEMC----LVYDYMALGTLREHIYN-TKKALSWKQRLEIC 588
+ H+V ++ E + ++ + M G L I +A + ++ EI
Sbjct: 75 HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIM 134
Query: 589 IGAARGLHYLHTGAKYTIIHRDVKTTNILL---DENWVAKVSDFGLSKTGPNMENGHVST 645
+ +LH + I HRDVK N+L +++ V K++DFG +K + T
Sbjct: 135 RDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE---TTQNALQT 188
Query: 646 VVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
+ Y+ PE ++ + D++S GV+++ +LC P
Sbjct: 189 PC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFP 227
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 63/203 (31%), Positives = 97/203 (47%), Gaps = 28/203 (13%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIK---RSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIG 548
+GVG FGKV G KVA+K R S V + EI+ L RH H++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 549 FCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAAR--------GLHYLHT 600
+++ +V +Y++ G L ++I RL+ +R G+ Y H
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICK-------NGRLDE--KESRRLFQQILSGVDYCH- 133
Query: 601 GAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFK 660
++ ++HRD+K N+LLD + AK++DFGLS M +G GS Y PE
Sbjct: 134 --RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGSPNYAAPEVIS 188
Query: 661 RQQLT-EKSDIYSFGVVLFEVLC 682
+ + DI+S GV+L+ +LC
Sbjct: 189 GRLYAGPEVDIWSSGVILYALLC 211
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 53/251 (21%), Positives = 104/251 (41%), Gaps = 44/251 (17%)
Query: 458 SNASSHLSAIAQGLCRRFSLAEIKHATKSFDESY----VIGVGGFGKVYKGV-IEDKLKV 512
S S +A + + + Y ++G GGFG VY G+ + D L V
Sbjct: 12 SGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPV 71
Query: 513 AIK---RSNPSSEQGVNEFVT---EIEMLSKLRHK--HLVSLIGFCEEGNEMCLV----- 559
AIK + S + E+ +L K+ ++ L+ + E + L+
Sbjct: 72 AIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPE 131
Query: 560 -----YDYMAL-GTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKT 613
+D++ G L+E + A S+ ++ + + H ++HRD+K
Sbjct: 132 PVQDLFDFITERGALQE-----ELARSFFWQV------LEAVRHCH---NCGVLHRDIKD 177
Query: 614 TNILLDEN-WVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLT-EKSDIY 671
NIL+D N K+ DFG +++ + G+ Y PE+ + + + ++
Sbjct: 178 ENILIDLNRGELKLIDFGSGAL---LKDTVYTDFD-GTRVYSPPEWIRYHRYHGRSAAVW 233
Query: 672 SFGVVLFEVLC 682
S G++L++++C
Sbjct: 234 SLGILLYDMVC 244
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 53/215 (24%), Positives = 97/215 (45%), Gaps = 42/215 (19%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIK---RSNPSSEQGVNEFVT---EIEMLSKLR----H 540
++G GGFG V+ G + D+L+VAIK R+ +++ VT E+ +L K+ H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 541 KHLVSLIGFCEEGNEMCLV----------YDYMAL-GTLREHIYNTKKALSWKQRLEICI 589
++ L+ + E LV +DY+ G L E + + ++
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGE-----GPSRCFFGQV---- 148
Query: 590 GAARGLHYLHTGAKYTIIHRDVKTTNILLD-ENWVAKVSDFGLSKTGPNMENGHVSTVVK 648
+ + H ++HRD+K NIL+D AK+ DFG + + +
Sbjct: 149 --VAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL---LHDEPYTDFD- 199
Query: 649 GSFGYLDPEYFKRQQLT-EKSDIYSFGVVLFEVLC 682
G+ Y PE+ R Q + ++S G++L++++C
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVC 234
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 46/211 (21%), Positives = 85/211 (40%), Gaps = 38/211 (18%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIK---RSNPSSEQGVNEFVT-----EIEMLSKLRHKHL 543
+G G FG V+ V E +V +K + + + + EI +LS++ H ++
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 544 VSLIGFCEEGNEMCLV----------YDYMAL-GTLREHIYNTKKALSWKQRLEICIGAA 592
+ ++ E LV + ++ L E A ++L
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDE-----PLASYIFRQL------V 140
Query: 593 RGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFG 652
+ YL IIHRD+K NI++ E++ K+ DFG + +E G + G+
Sbjct: 141 SAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY---LERGKLFYTFCGTIE 194
Query: 653 YLDPEYFKRQQLT-EKSDIYSFGVVLFEVLC 682
Y PE + +++S GV L+ ++
Sbjct: 195 YCAPEVLMGNPYRGPELEMWSLGVTLYTLVF 225
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 56/275 (20%), Positives = 102/275 (37%), Gaps = 32/275 (11%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKRSNP-SSEQGVNEFVTEIE-MLSKLRHKHLVSLIG 548
IG G +G V K V +A+KR E+ + + +++ ++ ++V G
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 549 FCEEGNEMCLVYDYMALG---TLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYT 605
+ + + M+ + + + +I + + L++L K
Sbjct: 89 ALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK-- 146
Query: 606 IIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQL- 664
IIHRD+K +NILLD + K+ DFG+S + + T G Y+ PE
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPERIDPSASR 203
Query: 665 ---TEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIID---PL 718
+SD++S G+ L+E+ R L ++ P
Sbjct: 204 QGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ--------------LTQVVKGDPPQ 249
Query: 719 LKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
L + E F + CL+ RP ++L
Sbjct: 250 LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELL 284
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 54/275 (19%), Positives = 109/275 (39%), Gaps = 37/275 (13%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKR-SNPSSEQGVNEFVTEIEMLSKL-RHKHLVSLIG 548
+G G G+V+K + +A+K+ +++ + +++++ K ++V G
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 549 FCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIH 608
++ + + M + + + + ++ + + L+YL K+ +IH
Sbjct: 92 TFITNTDVFIAMELMGTCAE-KLKKRMQGPIPERILGKMTVAIVKALYYLKE--KHGVIH 148
Query: 609 RDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTE-- 666
RDVK +NILLDE K+ DFG+S + + G Y+ PE T+
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPD 205
Query: 667 ---KSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIID---PLLK 720
++D++S G+ L E+ + +V L ++ PLL
Sbjct: 206 YDIRADVWSLGISLVELATGQFPYKNCKTDFEV--------------LTKVLQEEPPLLP 251
Query: 721 DKI--SPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
+ S + F + CL+ RP +L
Sbjct: 252 GHMGFSGD----FQSFVKDCLTKDHRKRPKYNKLL 282
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 4e-22
Identities = 57/206 (27%), Positives = 82/206 (39%), Gaps = 32/206 (15%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVT-EIEMLSKLRHKHLVSLIGFC 550
IG G FG K VA+K ++E V EI LRH ++V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIE--RGAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 551 EEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAAR--------GLHYLHTGA 602
+ ++ +Y + G L E I N R AR G+ Y H
Sbjct: 86 LTPTHLAIIMEYASGGELYERICN-------AGRFSE--DEARFFFQQLLSGVSYCH--- 133
Query: 603 KYTIIHRDVKTTNILLDENWVA--KVSDFGLSKTGPNMENGHV-STVVKGSFGYLDPEYF 659
I HRD+K N LLD + K+ DFG SK+ + V G+ Y+ PE
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQPKSTV-GTPAYIAPEVL 189
Query: 660 KRQQLT-EKSDIYSFGVVLFEVLCAR 684
RQ+ + +D++S GV L+ +L
Sbjct: 190 LRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 9e-22
Identities = 56/233 (24%), Positives = 90/233 (38%), Gaps = 57/233 (24%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIK---------------RSNPSSEQGVNEFVT------ 530
IG G +G V D A+K R P +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 531 -----EIEMLSKLRHKHLVSLIGFCEEGNEMCL-----------VYDYMALGTLREHIYN 574
EI +L KL H ++V L+ ++ NE L V + L L E
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSE---- 136
Query: 575 TKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634
+A + Q L I G+ YLH IIHRD+K +N+L+ E+ K++DFG+S
Sbjct: 137 -DQARFYFQDL-IK-----GIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 635 GPNMENGHVSTVVKGSFGYLDPEYFKRQQLT---EKSDIYSFGVVLFEVLCAR 684
+ +S V G+ ++ PE + + D+++ GV L+ + +
Sbjct: 187 -FKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 1e-21
Identities = 62/254 (24%), Positives = 103/254 (40%), Gaps = 23/254 (9%)
Query: 444 HSQTTQSKSTISGKSNASSHLSAIAQGLCRRFSLAEIKHATKS-FDESYVIGVGGFGKVY 502
+ + G S C+ ++ H T + F +IG GGFG+VY
Sbjct: 147 QPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVY 206
Query: 503 KGVIEDKLKV-AIK---RSNPSSEQGVNEFVTEIEMLSKL---RHKHLVSLIGFCEEGNE 555
D K+ A+K + +QG + E MLS + +V + ++
Sbjct: 207 GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 266
Query: 556 MCLVYDYMALGTLREHIYNTKKALSWKQRL---EICIGAARGLHYLHTGAKYTIIHRDVK 612
+ + D M G L H+ R EI +G L ++H +++RD+K
Sbjct: 267 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG----LEHMH---NRFVVYRDLK 319
Query: 613 TTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKS-DIY 671
NILLDE+ ++SD GL+ V G+ GY+ PE ++ + S D +
Sbjct: 320 PANILLDEHGHVRISDLGLACDFS---KKKPHASV-GTHGYMAPEVLQKGVAYDSSADWF 375
Query: 672 SFGVVLFEVLCARP 685
S G +LF++L
Sbjct: 376 SLGCMLFKLLRGHS 389
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 6e-21
Identities = 49/215 (22%), Positives = 91/215 (42%), Gaps = 20/215 (9%)
Query: 481 KHATKSFDESYVIGVGGFGKVYKGVIEDK-------LKVAIKRSNPSSEQGVNEFVTEIE 533
K + F ++G G F V + + +K+ +++ + E V E +
Sbjct: 26 KKRPEDFKFGKILGEGSFSTVV--LARELATSREYAIKI-LEKRHIIKENKVPYVTRERD 82
Query: 534 MLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL---EICIG 590
++S+L H V L ++ ++ Y G L ++I R EI
Sbjct: 83 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 142
Query: 591 AARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGS 650
L YLH IIHRD+K NILL+E+ +++DFG +K + G+
Sbjct: 143 ----LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195
Query: 651 FGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
Y+ PE + + SD+++ G ++++++ P
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 230
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 29/263 (11%), Positives = 75/263 (28%), Gaps = 53/263 (20%)
Query: 492 VIGVGGFGKVYKGVIEDKL--KVAIK---RSNPSSEQGVNEFVTEIEMLSKLRHKHLVSL 546
G + ++ + + L +VA+ + + E ++ LS++ + +
Sbjct: 38 FHGGVPPLQFWQAL-DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 547 IGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLH-TGAKYT 605
+ +V +++ G+L+E + S + A H G
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAAADAAHRAG---- 149
Query: 606 IIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLT 665
+ + + + + + +
Sbjct: 150 VALSIDHPSRVRVSIDGDVVL----------------------AYPATMPDA-------N 180
Query: 666 EKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISP 725
+ DI G L+ +L R L + + ++ A + I+P I
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-------ERDTAGQPIEP---ADIDR 230
Query: 726 ECLKKFADTAEKCLSDSGIDRPS 748
+ + + A + + G R +
Sbjct: 231 DIPFQISAVAARSVQGDGGIRSA 253
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 3e-20
Identities = 52/262 (19%), Positives = 104/262 (39%), Gaps = 27/262 (10%)
Query: 440 PIYGHSQTTQSKSTISGKSNASSHLSAIAQGLCRRFSLAE-IKHATKSFDESY-----VI 493
P+ + + + + +F + ++ + + Y V+
Sbjct: 11 PVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVL 70
Query: 494 GVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCE 551
G+G GKV + + K A+K + E+E+ + + H+V ++ E
Sbjct: 71 GLGINGKVLQIFNKRTQEKFALKMLQDCPKAR-----REVELHWRASQCPHIVRIVDVYE 125
Query: 552 EGNEMC----LVYDYMALGTLREHIYN-TKKALSWKQRLEICIGAARGLHYLHTGAKYTI 606
+V + + G L I + +A + ++ EI + YLH I
Sbjct: 126 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINI 182
Query: 607 IHRDVKTTNILL---DENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQ 663
HRDVK N+L N + K++DFG +K + ++T + Y+ PE ++
Sbjct: 183 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--SHNSLTTPC-YTPYYVAPEVLGPEK 239
Query: 664 LTEKSDIYSFGVVLFEVLCARP 685
+ D++S GV+++ +LC P
Sbjct: 240 YDKSCDMWSLGVIMYILLCGYP 261
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 1e-19
Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 487 FDESYVIGVGGFGKVYKGVIEDK-------LKVAIKRSNPSSEQGVNEFVTEIEMLSKLR 539
F+ ++G G FGKV ++++K +K+ +K+ ++ V +TE +L R
Sbjct: 150 FEYLKLLGKGTFGKVI--LVKEKATGRYYAMKI-LKKEVIVAKDEVAHTLTENRVLQNSR 206
Query: 540 HKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL---EICIGAARGLH 596
H L +L + + +C V +Y G L H+ + + R EI L
Sbjct: 207 HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA----LD 262
Query: 597 YLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDP 656
YLH ++ +++RD+K N++LD++ K++DFGL K +++G G+ YL P
Sbjct: 263 YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAP 318
Query: 657 EYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
E + D + GVV++E++C R
Sbjct: 319 EVLEDNDYGRAVDWWGLGVVMYEMMCGRL 347
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 6e-19
Identities = 41/149 (27%), Positives = 72/149 (48%), Gaps = 15/149 (10%)
Query: 493 IGVGGFGKVYKGVIEDKL---KVAIKRSNPSSEQ-GVNEFVT---EIEMLSKLRHKHLVS 545
IG G +G V+K ++ VAIK+ S + + EI ML +L+H +LV+
Sbjct: 11 IGEGSYGVVFKCR--NRDTGQIVAIKKFLESEDDPVIK--KIALREIRMLKQLKHPNLVN 66
Query: 546 LIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYT 605
L+ + LV++Y T+ + ++ + I + +++ H K+
Sbjct: 67 LLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---KHN 122
Query: 606 IIHRDVKTTNILLDENWVAKVSDFGLSKT 634
IHRDVK NIL+ ++ V K+ DFG ++
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARL 151
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 6e-19
Identities = 47/217 (21%), Positives = 85/217 (39%), Gaps = 29/217 (13%)
Query: 487 FDESYVIGVGGFGKVYKGVIEDK-------LKVAIKRSNPSSEQGVNEFVTEIEMLSKLR 539
F+ VIG G F +V V++ K +K+ + + + V+ F E ++L
Sbjct: 63 FEILKVIGRGAFSEVA--VVKMKQTGQVYAMKI-MNKWDMLKRGEVSCFREERDVLVNGD 119
Query: 540 HKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQ-RL---EICIGAARGL 595
+ + L ++ N + LV +Y G L + + + + R EI + +
Sbjct: 120 RRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMA----I 175
Query: 596 HYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLD 655
+H + +HRD+K NILLD +++DFG V G+ YL
Sbjct: 176 DSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLS 231
Query: 656 PEYFKRQQLTEKSDIY-------SFGVVLFEVLCARP 685
PE + + Y + GV +E+ +
Sbjct: 232 PEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 9e-19
Identities = 42/147 (28%), Positives = 76/147 (51%), Gaps = 11/147 (7%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQ-GVNEFVT---EIEMLSKLRHKHLVSLI 547
+G G +G V K + VAIK+ S + V EI++L +LRH++LV+L+
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVK--KIAMREIKLLKQLRHENLVNLL 90
Query: 548 GFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTII 607
C++ LV++++ T+ + + L ++ + G+ + H + II
Sbjct: 91 EVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCH---SHNII 146
Query: 608 HRDVKTTNILLDENWVAKVSDFGLSKT 634
HRD+K NIL+ ++ V K+ DFG ++T
Sbjct: 147 HRDIKPENILVSQSGVVKLCDFGFART 173
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 1e-18
Identities = 52/215 (24%), Positives = 89/215 (41%), Gaps = 27/215 (12%)
Query: 487 FDESYVIGVGGFGKVYKGVIEDK-------LKVAIKRSNPSSEQGVNEFVTEIEMLSKLR 539
F+ VIG G FG+V V++ K +K+ + + F E ++L
Sbjct: 76 FEILKVIGRGAFGEVA--VVKLKNADKVFAMKI-LNKWEMLKRAETACFREERDVLVNGD 132
Query: 540 HKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQ-RL---EICIGAARGL 595
K + +L ++ N + LV DY G L + + L + R E+ I +
Sbjct: 133 SKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIA----I 188
Query: 596 HYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLD 655
+H + +HRD+K NIL+D N +++DFG S V G+ Y+
Sbjct: 189 DSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYIS 244
Query: 656 PEYFKRQQLTEKS-----DIYSFGVVLFEVLCARP 685
PE + + + D +S GV ++E+L
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 42/148 (28%), Positives = 73/148 (49%), Gaps = 13/148 (8%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVT---EIEMLSKLRHKHLVSLIG 548
+G G + VYKG+ + VA+K SE+G T EI ++ +L+H+++V L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTP--STAIREISLMKELKHENIVRLYD 70
Query: 549 FCEEGNEMCLVYDYMA--LGTLREH--IYNTKKALSWKQRLEICIGAARGLHYLHTGAKY 604
N++ LV+++M L + + NT + L +GL + H
Sbjct: 71 VIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK-- 128
Query: 605 TIIHRDVKTTNILLDENWVAKVSDFGLS 632
I+HRD+K N+L+++ K+ DFGL+
Sbjct: 129 -ILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 22/206 (10%)
Query: 492 VIGVGGFGKVY---KGVIEDK-----LKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHL 543
V+G GG+GKV+ K + +KV K + + E +L +++H +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 544 VSLIGFC-EEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL---EICIGAARGLHYLH 599
V LI + + G ++ L+ +Y++ G L + + EI + L +LH
Sbjct: 84 VDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMA----LGHLH 138
Query: 600 TGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYF 659
+ II+RD+K NI+L+ K++DFGL K ++ +G V+ G+ Y+ PE
Sbjct: 139 ---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTIEYMAPEIL 193
Query: 660 KRQQLTEKSDIYSFGVVLFEVLCARP 685
R D +S G +++++L P
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTGAP 219
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 9e-18
Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 492 VIGVGGFGKVY---KGVIEDKLKV-AIK--RSNPSSEQGVNEFVTEIEMLSKLRHKHLVS 545
V+G G FGKV+ K D ++ A+K + + E ++L ++ H +V
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 546 LIGFC-EEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL---EICIGAARGLHYLHTG 601
L + + ++ L+ D++ G L + + E+ + L +LH
Sbjct: 91 LH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALA----LDHLH-- 143
Query: 602 AKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKR 661
II+RD+K NILLDE K++DFGLSK ++++ + G+ Y+ PE R
Sbjct: 144 -SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNR 200
Query: 662 QQLTEKSDIYSFGVVLFEVLCARP 685
+ T+ +D +SFGV++FE+L
Sbjct: 201 RGHTQSADWWSFGVLMFEMLTGTL 224
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 9e-18
Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 492 VIGVGGFGKVYKGVIEDK-------LKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLV 544
++G G FGKV ++ +K +K+ +++ ++ V VTE +L RH L
Sbjct: 12 LLGKGTFGKVI--LVREKATGRYYAMKI-LRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 545 SLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL---EICIGAARGLHYLHTG 601
+L + + +C V +Y G L H+ + + R EI L YLH
Sbjct: 69 ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA----LEYLH-- 122
Query: 602 AKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKR 661
+++RD+K N++LD++ K++DFGL K + +G G+ YL PE +
Sbjct: 123 -SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLED 179
Query: 662 QQLTEKSDIYSFGVVLFEVLCARP 685
D + GVV++E++C R
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-17
Identities = 49/150 (32%), Positives = 78/150 (52%), Gaps = 14/150 (9%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIKR----SNPSSEQGVNEFVT---EIEMLSKLRHKHLV 544
+G G F VYK VAIK+ ++ G+N T EI++L +L H +++
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGIN--RTALREIKLLQELSHPNII 75
Query: 545 SLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKY 604
L+ + + LV+D+M L I + L+ + +GL YLH ++
Sbjct: 76 GLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QH 131
Query: 605 TIIHRDVKTTNILLDENWVAKVSDFGLSKT 634
I+HRD+K N+LLDEN V K++DFGL+K+
Sbjct: 132 WILHRDLKPNNLLLDENGVLKLADFGLAKS 161
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 44/145 (30%), Positives = 74/145 (51%), Gaps = 10/145 (6%)
Query: 493 IGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQ-GVNEFVT---EIEMLSKLRHKHLVSLIG 548
+G G +G VYK VA+KR +E G+ T EI +L +L H ++VSLI
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIP--STAIREISLLKELHHPNIVSLID 86
Query: 549 FCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIH 608
+ LV+++M L++ + K L Q RG+ + H ++ I+H
Sbjct: 87 VIHSERCLTLVFEFMEKD-LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILH 142
Query: 609 RDVKTTNILLDENWVAKVSDFGLSK 633
RD+K N+L++ + K++DFGL++
Sbjct: 143 RDLKPQNLLINSDGALKLADFGLAR 167
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 52/220 (23%), Positives = 85/220 (38%), Gaps = 36/220 (16%)
Query: 485 KSFDESYVIGVGGFGKVYKGVIEDK-------LKVAIKRSNPSSEQGVNEFVTEIEMLSK 537
+ ++ VIG G FG+V ++ K +K+ K F E ++++
Sbjct: 69 EDYEVVKVIGRGAFGEVQ--LVRHKSTRKVYAMKLLSKFEMIKRSD-SAFFWEERDIMAF 125
Query: 538 LRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAAR---- 593
+V L ++ + +V +YM G L ++ ++ AR
Sbjct: 126 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL----------VNLMSNYDVPEKWARFYTA 175
Query: 594 ----GLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKG 649
L +H IHRDVK N+LLD++ K++DFG T V G
Sbjct: 176 EVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-G 231
Query: 650 SFGYLDPEYFKRQQLTEK----SDIYSFGVVLFEVLCARP 685
+ Y+ PE K Q D +S GV L+E+L
Sbjct: 232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 37/145 (25%), Positives = 67/145 (46%), Gaps = 10/145 (6%)
Query: 493 IGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQ-GVNEFVT---EIEMLSKLRHKHLVSLIG 548
IG G +G VYK A+K+ E G+ T EI +L +L+H ++V L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIP--STTIREISILKELKHSNIVKLYD 67
Query: 549 FCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIH 608
+ LV++++ L++ + + L + G+ Y H ++H
Sbjct: 68 VIHTKKRLVLVFEHLDQD-LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLH 123
Query: 609 RDVKTTNILLDENWVAKVSDFGLSK 633
RD+K N+L++ K++DFGL++
Sbjct: 124 RDLKPQNLLINREGELKIADFGLAR 148
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 2e-17
Identities = 39/146 (26%), Positives = 72/146 (49%), Gaps = 11/146 (7%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQ-GVNEFVT---EIEMLSKLRHKHLVSLI 547
IG G +G V+K E VA+KR + GV + EI +L +L+HK++V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVP--SSALREICLLKELKHKNIVRLH 67
Query: 548 GFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTII 607
++ LV+++ L+++ + L + +GL + H ++
Sbjct: 68 DVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVL 123
Query: 608 HRDVKTTNILLDENWVAKVSDFGLSK 633
HRD+K N+L++ N K+++FGL++
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLAR 149
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-17
Identities = 55/244 (22%), Positives = 97/244 (39%), Gaps = 48/244 (19%)
Query: 473 RRFSLAEIKHATKSFDESY----VIGVGGFGKVYKGVIEDKLKVAIKR--SNPSSEQGVN 526
++ ++ + Y I G +G V GV + + VAIKR + S + VN
Sbjct: 6 GEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVN 65
Query: 527 EFVT---------EIEMLSKLRHKHLVSLI-----GFCEEGNEMCLVYDYMALGT-LREH 571
EI +L+ H +++ L +++ LV + M T L +
Sbjct: 66 ILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM--RTDLAQV 123
Query: 572 IYNTKKALSWK-------QRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVA 624
I++ + +S + L GLH LH ++HRD+ NILL +N
Sbjct: 124 IHDQRIVISPQHIQYFMYHIL-------LGLHVLHEAG---VVHRDLHPGNILLADNNDI 173
Query: 625 KVSDFGLSKTGPNMEN--GHVSTVVKGSFGYLDPEY-FKRQQLTEKSDIYSFGVVLFEVL 681
+ DF L++ N +V+ Y PE + + T+ D++S G V+ E+
Sbjct: 174 TICDFNLAREDTADANKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228
Query: 682 CARP 685
+
Sbjct: 229 NRKA 232
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 39/153 (25%), Positives = 75/153 (49%), Gaps = 10/153 (6%)
Query: 485 KSFDESYVIGVGGFGKVYKG-VIEDKLKVAIKRSNPSSEQGVNEFVT---EIEMLSKLRH 540
+++ + +G G + VYKG VA+K E+G T E+ +L L+H
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAP--CTAIREVSLLKDLKH 59
Query: 541 KHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHT 600
++V+L + LV++Y+ L++++ + ++ RGL Y H
Sbjct: 60 ANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH- 117
Query: 601 GAKYTIIHRDVKTTNILLDENWVAKVSDFGLSK 633
+ ++HRD+K N+L++E K++DFGL++
Sbjct: 118 --RQKVLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 54/228 (23%), Positives = 91/228 (39%), Gaps = 39/228 (17%)
Query: 481 KHATKSFDESYVIGVGGFGKVYKGV-IEDKLKVAIKR--SNPSSEQGVNEFVTEIEMLSK 537
+ F + G G FG V G + VAIK+ +P N + ++ L+
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR---NRELQIMQDLAV 75
Query: 538 LRHKHLVSLIGF-----CEEGNEMCL--VYDYMALGTLREHIYNTKKALSWKQRLE---- 586
L H ++V L + + ++ L V +Y+ TL N + +
Sbjct: 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRR---QVAPPPILI 131
Query: 587 ------ICIGAARGLHYLHTGAKYTIIHRDVKTTNILLD-ENWVAKVSDFGLSKT-GPNM 638
+ R + LH + + HRD+K N+L++ + K+ DFG +K P+
Sbjct: 132 KVFLFQLI----RSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE 186
Query: 639 ENGHVSTVVKGSFGYLDPEY-FKRQQLTEKSDIYSFGVVLFEVLCARP 685
N V+ + S Y PE F Q T DI+S G + E++ P
Sbjct: 187 PN--VAYIC--SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEP 230
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 4e-17
Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 44/222 (19%)
Query: 488 DESY----VIGVGGFGKVYKGVIEDKLKVAIKR-SNPSSEQGVNEFVTEIEMLSKLRHKH 542
+ +Y VIG G FG V++ + + +VAIK+ + E++++ ++H +
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN-----RELQIMRIVKHPN 93
Query: 543 LVSLIGF----CEEGNEMC--LVYDYMALGTLREHIYNTKKALSWKQRLE---------- 586
+V L F ++ +E+ LV +Y+ T+ + K KQ +
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKL---KQTMPMLLIKLYMYQ 149
Query: 587 ICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDEN-WVAKVSDFGLSKT-GPNMENGHVS 644
+ R L Y+H+ I HRD+K N+LLD V K+ DFG +K N VS
Sbjct: 150 LL----RSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN--VS 200
Query: 645 TVVKGSFGYLDPE-YFKRQQLTEKSDIYSFGVVLFEVLCARP 685
+ S Y PE F T DI+S G V+ E++ +P
Sbjct: 201 YIC--SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQP 240
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 9e-17
Identities = 77/281 (27%), Positives = 115/281 (40%), Gaps = 54/281 (19%)
Query: 429 PGTESHTSSWLPIYGHSQTTQSKSTISGKSNASSHLSAIAQGLCRRFSLAEIKHATKSFD 488
P T S S P+ S K + + + + A R S+
Sbjct: 5 PRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDR-------PQEVSYT 57
Query: 489 ESYVIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVT----EIEMLSKLRHKHL 543
++ VIG G FG VY+ + VAIK+ V + E++++ KL H ++
Sbjct: 58 DTKVIGNGSFGVVYQAKLCDSGELVAIKK--------VLQDKRFKNRELQIMRKLDHCNI 109
Query: 544 VSLIGF----CEEGNEMCL--VYDYMALGTLREHIYNTKKALSWKQRLE----------I 587
V L F E+ +E+ L V DY+ T+ + +A KQ L +
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRA---KQTLPVIYVKLYMYQL 165
Query: 588 CIGAARGLHYLHTGAKYTIIHRDVKTTNILLDEN-WVAKVSDFGLSKT-GPNMENGHVST 645
R L Y+H+ I HRD+K N+LLD + V K+ DFG +K N VS
Sbjct: 166 F----RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSY 216
Query: 646 VVKGSFGYLDPEY-FKRQQLTEKSDIYSFGVVLFEVLCARP 685
+ S Y PE F T D++S G VL E+L +P
Sbjct: 217 IC--SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 255
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 80.6 bits (200), Expect = 1e-16
Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQ-GVNEFVT---EIEMLSKLRHKHLVSLI 547
IG G +G VYK VA+K+ +E GV T EI +L +L H ++V L+
Sbjct: 11 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP--STAIREISLLKELNHPNIVKLL 68
Query: 548 GFCEEGNEMCLVYDYMA--LGTLREHIYNTKKALSW-----KQRLEICIGAARGLHYLHT 600
N++ LV++++ L + T L Q L +GL + H
Sbjct: 69 DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL-------QGLAFCH- 120
Query: 601 GAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634
+ ++HRD+K N+L++ K++DFGL++
Sbjct: 121 --SHRVLHRDLKPQNLLINTEGAIKLADFGLARA 152
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 83.1 bits (205), Expect = 1e-16
Identities = 62/271 (22%), Positives = 106/271 (39%), Gaps = 30/271 (11%)
Query: 426 QRIPGTESHTSSWLPIYGHSQTTQSKSTISGKSNASSHLSAIAQGLCRRFSLAEIKHATK 485
+P S + L + + A++ G R L
Sbjct: 289 VPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKL-------T 341
Query: 486 SFDESYVIGVGGFGKVYKGVIEDK-------LKVAIKRSNPSSEQGVNEFVTEIEMLSK- 537
F+ V+G G FGKV + E K +K+ +K+ + V + E +L+
Sbjct: 342 DFNFLMVLGKGSFGKVM--LSERKGTDELYAVKI-LKKDVVIQDDDVECTMVEKRVLALP 398
Query: 538 LRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL---EICIGAARG 594
+ L L + + + V +Y+ G L HI + EI IG
Sbjct: 399 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG---- 454
Query: 595 LHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYL 654
L +L II+RD+K N++LD K++DFG+ K + +G + G+ Y+
Sbjct: 455 LFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN--IWDGVTTKTFCGTPDYI 509
Query: 655 DPEYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
PE Q + D ++FGV+L+E+L +
Sbjct: 510 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 540
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 5e-16
Identities = 63/257 (24%), Positives = 113/257 (43%), Gaps = 36/257 (14%)
Query: 492 VIGVGGFGKVYKGVIEDK-------LKVAIKRSNPSSEQGVNEFVTEIEMLSK-LRHKHL 543
VIG G + KV ++ K +KV +K+ + ++ ++ TE + + H L
Sbjct: 16 VIGRGSYAKVL--LVRLKKTDRIYAMKV-VKKELVNDDEDIDWVQTEKHVFEQASNHPFL 72
Query: 544 VSLIGFC-EEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL---EICIGAARGLHYLH 599
V L C + + + V +Y+ G L H+ +K R EI + L+YLH
Sbjct: 73 VGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNYLH 127
Query: 600 TGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYF 659
+ II+RD+K N+LLD K++D+G+ K G + G ++ G+ Y+ PE
Sbjct: 128 ---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG--LRPGDTTSTFCGTPNYIAPEIL 182
Query: 660 KRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDII--DP 717
+ + D ++ GV++FE++ R P + V +D + I+
Sbjct: 183 RGEDYGFSVDWWALGVLMFEMMAGRS------PFDIVGSSDNPDQNTEDYLFQVILEKQI 236
Query: 718 LLKDKISPEC---LKKF 731
+ +S + LK F
Sbjct: 237 RIPRSLSVKAASVLKSF 253
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 5e-16
Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 23/205 (11%)
Query: 492 VIGVGGFGKVYKGVIEDK-------LKVAIKRSNPSSEQGVNEFVTEIEMLSK-LRHKHL 543
V+G G FGKV + K +KV +K+ + V +TE +LS H L
Sbjct: 30 VLGKGSFGKVM--LARVKETGDLYAVKV-LKKDVILQDDDVECTMTEKRILSLARNHPFL 86
Query: 544 VSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL---EICIGAARGLHYLHT 600
L + + + V +++ G L HI +++ + R EI L +LH
Sbjct: 87 TQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISA----LMFLH- 141
Query: 601 GAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFK 660
II+RD+K N+LLD K++DFG+ K + NG + G+ Y+ PE +
Sbjct: 142 --DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAPEILQ 197
Query: 661 RQQLTEKSDIYSFGVVLFEVLCARP 685
D ++ GV+L+E+LC
Sbjct: 198 EMLYGPAVDWWAMGVLLYEMLCGHA 222
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 9e-16
Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 25/206 (12%)
Query: 492 VIGVGGFGKVYKGVIEDK-------LKVAIKRSNPSSEQGVNEFVTEIEMLSK-LRHKHL 543
V+G G FGKV + E K +K+ +K+ + V + E +L+ + L
Sbjct: 27 VLGKGSFGKVM--LSERKGTDELYAVKI-LKKDVVIQDDDVECTMVEKRVLALPGKPPFL 83
Query: 544 VSLIGFC-EEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL---EICIGAARGLHYLH 599
L C + + + V +Y+ G L HI + EI IG L +L
Sbjct: 84 TQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG----LFFLQ 138
Query: 600 TGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYF 659
II+RD+K N++LD K++DFG+ K + +G + G+ Y+ PE
Sbjct: 139 ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN--IWDGVTTKTFCGTPDYIAPEII 193
Query: 660 KRQQLTEKSDIYSFGVVLFEVLCARP 685
Q + D ++FGV+L+E+L +
Sbjct: 194 AYQPYGKSVDWWAFGVLLYEMLAGQA 219
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 47/209 (22%), Positives = 92/209 (44%), Gaps = 25/209 (11%)
Query: 487 FDESYVIGVGGFGKVYKGVIEDK-------LKVAIKRSNPSSEQGVNEFVTEIEMLSKLR 539
FD +G G FG+V +++ K +K+ K+ +Q + + E +L +
Sbjct: 43 FDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 99
Query: 540 HKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL---EICIGAARGLH 596
LV L ++ + + +V +Y+A G + H+ + R +I +
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FE 155
Query: 597 YLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDP 656
YLH +I+RD+K N+L+D+ +V+DFG +K + + G+ L P
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAP 207
Query: 657 EYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
E + + D ++ GV+++E+ P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYP 236
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 492 VIGVGGFGKVY--KGVIEDKL---KVAIKRSNPSSEQGVNEFVTEIEMLSK-LRHKHLVS 545
VIG G FGKV + E+ KV +++ ++ ++E +L K ++H LV
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKV-LQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 546 LIGFC-EEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL---EICIGAARGLHYLHTG 601
L F + +++ V DY+ G L H+ + L + R EI L YLH
Sbjct: 104 LH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASA----LGYLH-- 156
Query: 602 AKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKR 661
I++RD+K NILLD ++DFGL K N+E+ ++ G+ YL PE +
Sbjct: 157 -SLNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAPEVLHK 213
Query: 662 QQLTEKSDIYSFGVVLFEVLCARP 685
Q D + G VL+E+L P
Sbjct: 214 QPYDRTVDWWCLGAVLYEMLYGLP 237
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 25/206 (12%)
Query: 492 VIGVGGFGKV----YKGVIEDKL---KVAIKRSNPSSEQGVNEFVTEIEMLSK-LRHKHL 543
++G G FGKV +K ++ K +K+ + V + E +LS H L
Sbjct: 24 MLGKGSFGKVFLAEFKK--TNQFFAIKA-LKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 80
Query: 544 VSLIG-FCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL---EICIGAARGLHYLH 599
+ F + N + V +Y+ G L HI + K + EI +G L +LH
Sbjct: 81 THMFCTFQTKEN-LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILG----LQFLH 135
Query: 600 TGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYF 659
I++RD+K NILLD++ K++DFG+ K NM + G+ Y+ PE
Sbjct: 136 ---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGTPDYIAPEIL 190
Query: 660 KRQQLTEKSDIYSFGVVLFEVLCARP 685
Q+ D +SFGV+L+E+L +
Sbjct: 191 LGQKYNHSVDWWSFGVLLYEMLIGQS 216
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 62/257 (24%), Positives = 113/257 (43%), Gaps = 36/257 (14%)
Query: 492 VIGVGGFGKVYKGVIEDK-------LKVAIKRSNPSSEQGVNEFVTEIEMLSK-LRHKHL 543
VIG G + KV ++ K ++V +K+ + ++ ++ TE + + H L
Sbjct: 59 VIGRGSYAKVL--LVRLKKTDRIYAMRV-VKKELVNDDEDIDWVQTEKHVFEQASNHPFL 115
Query: 544 VSLIGFC-EEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL---EICIGAARGLHYLH 599
V L C + + + V +Y+ G L H+ +K R EI + L+YLH
Sbjct: 116 VGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNYLH 170
Query: 600 TGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYF 659
+ II+RD+K N+LLD K++D+G+ K G + G ++ G+ Y+ PE
Sbjct: 171 ---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG--LRPGDTTSTFCGTPNYIAPEIL 225
Query: 660 KRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDII--DP 717
+ + D ++ GV++FE++ R P + V +D + I+
Sbjct: 226 RGEDYGFSVDWWALGVLMFEMMAGRS------PFDIVGSSDNPDQNTEDYLFQVILEKQI 279
Query: 718 LLKDKISPEC---LKKF 731
+ +S + LK F
Sbjct: 280 RIPRSLSVKAASVLKSF 296
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 47/228 (20%), Positives = 88/228 (38%), Gaps = 50/228 (21%)
Query: 482 HATKSFDESYVIGVGGFGKVYKGV-IEDKLKVAIKR-----SNPSSEQGVNEFVTEIEML 535
K++ +G G +G V + KVAIK+ + + E+ +L
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRA---YRELLLL 77
Query: 536 SKLRHKHLVSLI------GFCEEGNEMCLVYDYMALGT-----LREHIYNTKKALSWKQR 584
++H++++ L+ + LV +M T + K Q
Sbjct: 78 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM--QTDLQKIMGLKFSEEKIQYLVYQM 135
Query: 585 LEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVS 644
L +GL Y+H+ ++HRD+K N+ ++E+ K+ DFGL++ G+V
Sbjct: 136 L-------KGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV 185
Query: 645 T-------VVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
T V+ Y + DI+S G ++ E+L +
Sbjct: 186 TRWYRAPEVILSWMHY-----------NQTVDIWSVGCIMAEMLTGKT 222
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 41/199 (20%), Positives = 82/199 (41%), Gaps = 26/199 (13%)
Query: 445 SQTTQSKSTISGKSNASSHLSAIAQGLCRRFSLAEIKHATKSFDESYVIGVGGFGKVYKG 504
T+ ++ +S A + +G G +G+VYK
Sbjct: 3 HHHHHHMGTLEAQTQGPGSMSVSAAPSATSID---------RYRRITKLGEGTYGEVYKA 53
Query: 505 V-IEDKLKVAIKRSNPSSEQ-GVNEFVT---EIEMLSKLRHKHLVSLIGFCEEGNEMCLV 559
+ VAIKR E+ GV T E+ +L +L+H++++ L + + L+
Sbjct: 54 IDTVTNETVAIKRIRLEHEEEGVP--GTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111
Query: 560 YDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLD 619
++Y L++++ + +S + G+++ H +HRD+K N+LL
Sbjct: 112 FEYAEN-DLKKYM-DKNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLS 166
Query: 620 ENWVA-----KVSDFGLSK 633
+ + K+ DFGL++
Sbjct: 167 VSDASETPVLKIGDFGLAR 185
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 3e-15
Identities = 55/209 (26%), Positives = 99/209 (47%), Gaps = 25/209 (11%)
Query: 487 FDESYVIGVGGFGKVYKGVIEDK-------LKVAIKRSNPSSEQGVNEFVTEIEMLSKLR 539
F +G G FG+V+ +I + +KV K +Q V E MLS +
Sbjct: 8 FQILRTLGTGSFGRVH--LIRSRHNGRYYAMKVLKKEIVVRLKQ-VEHTNDERLMLSIVT 64
Query: 540 HKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRL---EICIGAARGLH 596
H ++ + G ++ ++ ++ DY+ G L + +++ + + E+C+ L
Sbjct: 65 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLA----LE 120
Query: 597 YLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDP 656
YLH II+RD+K NILLD+N K++DFG +K V+ + G+ Y+ P
Sbjct: 121 YLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAP 172
Query: 657 EYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
E + + D +SFG++++E+L
Sbjct: 173 EVVSTKPYNKSIDWWSFGILIYEMLAGYT 201
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 4e-15
Identities = 63/258 (24%), Positives = 109/258 (42%), Gaps = 24/258 (9%)
Query: 443 GHSQTTQSKSTISGKSNASSHLSAIAQGLCRRFSLAEIKHATKSFDESYVIGVGGFGKVY 502
G S + ++ G L+ + + K ++F+ V+G G +GKV+
Sbjct: 12 GGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVF 71
Query: 503 ---KGVIEDK-----LKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKH-LVSLIGFC-EE 552
K D +KV K + + TE ++L +R LV+L + +
Sbjct: 72 LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH-YAFQT 130
Query: 553 GNEMCLVYDYMALGTLREHIYNTKKALSWKQRL---EICIGAARGLHYLHTGAKYTIIHR 609
++ L+ DY+ G L H+ ++ + ++ EI + L +LH K II+R
Sbjct: 131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA----LEHLH---KLGIIYR 183
Query: 610 DVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPE--YFKRQQLTEK 667
D+K NILLD N ++DFGLSK E G+ Y+ P+ +
Sbjct: 184 DIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEYMAPDIVRGGDSGHDKA 242
Query: 668 SDIYSFGVVLFEVLCARP 685
D +S GV+++E+L
Sbjct: 243 VDWWSLGVLMYELLTGAS 260
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 8e-15
Identities = 46/159 (28%), Positives = 79/159 (49%), Gaps = 33/159 (20%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQ-GVNEFVT---EIEMLSKLRHKHLVSLI 547
IG G FG+V+K + KVA+K+ +E+ G +T EI++L L+H+++V+LI
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP--ITALREIKILQLLKHENVVNLI 82
Query: 548 G--------FCEEGNEMCLVYDYMA--LGTLREHIYNT-----KKALSWKQRLEICIGAA 592
+ + LV+D+ L L ++ K + + L
Sbjct: 83 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM-QMLLN------ 135
Query: 593 RGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGL 631
GL+Y+H + I+HRD+K N+L+ + V K++DFGL
Sbjct: 136 -GLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGL 170
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 8e-15
Identities = 41/193 (21%), Positives = 86/193 (44%), Gaps = 33/193 (17%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKR-----SNPSSEQGVNEFVTEIEMLSKLRHKHLVS 545
+IG G +G VY + VAIK+ + + + + EI +L++L+ +++
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRI---LREITILNRLKSDYIIR 89
Query: 546 LI-----GFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWK-------QRLEICIGAAR 593
L + +E+ +V + + + ++ T L+ + L
Sbjct: 90 LYDLIIPDDLLKFDELYIVLEIA--DSDLKKLFKTPIFLTEEHIKTILYNLL-------L 140
Query: 594 GLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGY 653
G +++H IIHRD+K N LL+++ KV DFGL++T + ++ ++ ++ +
Sbjct: 141 GENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 654 LDPEYFKRQQLTE 666
++QLT
Sbjct: 198 GPHNKNLKKQLTS 210
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 52/231 (22%), Positives = 95/231 (41%), Gaps = 55/231 (23%)
Query: 482 HATKSFDESYVIGVGGFGKVYKGV-IEDKLKVAIKR-----SNPSSEQGVNEFVTEIEML 535
+ + +G G +G V V KVAIK+ + + E+ +L
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA---YRELRLL 78
Query: 536 SKLRHKHLVSLI------GFCEEGNEMCLVYDYMALGT-LREHIYNTKKALSWK------ 582
+RH++++ L+ ++ + LV +M GT L + + + + L
Sbjct: 79 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKH--EKLGEDRIQFLV 134
Query: 583 -QRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641
Q L +GL Y+H IIHRD+K N+ ++E+ K+ DFGL++ + G
Sbjct: 135 YQML-------KGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG 184
Query: 642 HVST-------VVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
+V T V+ Y T+ DI+S G ++ E++ +
Sbjct: 185 YVVTRWYRAPEVILNWMRY-----------TQTVDIWSVGCIMAEMITGKT 224
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 13/113 (11%)
Query: 573 YNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLS 632
K L+ + + A+G+ +L A IHRD+ NILL E V K+ DFGL+
Sbjct: 184 DLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLA 240
Query: 633 KTGPNMENGHVSTVVKGSFGYLD-----PEYFKRQQLTEKSDIYSFGVVLFEV 680
+ ++ V+ L PE + T +SD++SFGV+L+E+
Sbjct: 241 R---DIYKD--PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 288
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 44/257 (17%), Positives = 94/257 (36%), Gaps = 81/257 (31%)
Query: 488 DESY----VIGVGGFGKVYKGVI-EDKLKVAIKRSNPSSEQGVNEFVT----EIEMLSKL 538
+ Y +G G FG V + E + A+K+ V + E++++ L
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKK--------VLQDPRYKNRELDIMKVL 57
Query: 539 RHKHLVSLIGF--------------------------------------CEEGNEMCLVY 560
H +++ L+ + + + ++
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 561 DYMALGTLREHIYNTKKALSWKQRLE----------ICIGAARGLHYLHTGAKYTIIHRD 610
+Y+ TL + + + ++ + + + R + ++H+ I HRD
Sbjct: 118 EYVPD-TLHKVLKSFIRS---GRSIPMNLISIYIYQLF----RAVGFIHSLG---ICHRD 166
Query: 611 VKTTNILLD-ENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPE-YFKRQQLTEKS 668
+K N+L++ ++ K+ DFG +K E V+ + S Y PE + T
Sbjct: 167 IKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP-SVAYIC--SRFYRAPELMLGATEYTPSI 223
Query: 669 DIYSFGVVLFEVLCARP 685
D++S G V E++ +P
Sbjct: 224 DLWSIGCVFGELILGKP 240
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 2e-14
Identities = 47/252 (18%), Positives = 91/252 (36%), Gaps = 44/252 (17%)
Query: 443 GHSQTTQSKSTISGKSNASSHLSAIAQGLCRRFSLAEIKHATKSFDESY----VIGVGGF 498
+Q S + + + + + H+ + Y +IG G +
Sbjct: 7 AAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSY 66
Query: 499 GKVYKGV-IEDKLKVAIKR-SNPSSEQGVNEFVT-----EIEMLSKLRHKHLVSLI---- 547
G V + +K VAIK+ + EI +L++L H H+V ++
Sbjct: 67 GHVCEAYDKLEKRVVAIKKILRVFE----DLIDCKRILREIAILNRLNHDHVVKVLDIVI 122
Query: 548 -GFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWK-------QRLEICIGAARGLHYLH 599
E+ +E+ +V + + + ++ T L+ L G+ Y+H
Sbjct: 123 PKDVEKFDELYVVLEIA--DSDFKKLFRTPVYLTELHIKTLLYNLL-------VGVKYVH 173
Query: 600 TGAKYTIIHRDVKTTNILLDENWVAKVSDFGLS-----KTGPNMENGHVSTVVKGSFGYL 654
+ I+HRD+K N L++++ KV DFGL+ N + +
Sbjct: 174 SA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230
Query: 655 DPEYFKRQQLTE 666
++QLT
Sbjct: 231 PHTKNLKRQLTG 242
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 41/161 (25%), Positives = 71/161 (44%), Gaps = 25/161 (15%)
Query: 489 ESYVIGVGGFGKVYKGVIEDKL---KVAIKRSNPSSEQGVN-EFVTEIEMLSKLRHKHLV 544
E +G G +G VYK +D A+K+ G++ EI +L +L+H +++
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE---GTGISMSACREIALLRELKHPNVI 81
Query: 545 SLIGFCEEGNEMC--LVYDYMALGTLREHIYNTKKALSWKQRLEICIGAA--------RG 594
SL + L++DY L I + + + K+ +++ G G
Sbjct: 82 SLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 140
Query: 595 LHYLHTGAKYTIIHRDVKTTNILL----DENWVAKVSDFGL 631
+HYLH ++HRD+K NIL+ E K++D G
Sbjct: 141 IHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGF 178
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 56/295 (18%), Positives = 103/295 (34%), Gaps = 50/295 (16%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIK--RSNPS-SEQGVNEFVTEIEMLSKLR-------- 539
+G G F V+ + + VA+K R + +E EI++L ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE----DEIKLLQRVNDADNTKED 81
Query: 540 ---HKHLVSLIGF----CEEGNEMCLVYDYMALGTLREHI-YNTKKALSWKQRLEICIGA 591
H++ L+ G + +V++ + L I + + +I
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQISKQL 140
Query: 592 ARGLHYLHTGAKYTIIHRDVKTTNILLDENWVA------KVSDFGLSKTGPNMENGHVST 645
GL Y+H IIH D+K N+L++ K++D G + + H +
Sbjct: 141 LLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWYDEHYTN 194
Query: 646 VVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHC 705
++ Y PE +DI+S ++FE++ P D H
Sbjct: 195 SIQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD---HI 250
Query: 706 KRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVL 760
+ II+ L ++ L+ + G+ R W LE VL
Sbjct: 251 AQ------IIE--LLGELPSYLLRN-GKYTRTFFNSRGLLRNISKLKFWPLEDVL 296
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 49/209 (23%), Positives = 87/209 (41%), Gaps = 31/209 (14%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKR-----SNPSSEQGVNEFVTEIEMLSKLRHKHLVS 545
IG G G V + VAIK+ N + + E+ ++ + HK+++
Sbjct: 32 PIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA---YRELVLMKCVNHKNIIG 88
Query: 546 LI------GFCEEGNEMCLVYDYMALGT-LREHIYNTKKALSWKQRLEICIGAARGLHYL 598
L+ EE ++ +V + M L + I + L ++ + G+ +L
Sbjct: 89 LLNVFTPQKSLEEFQDVYIVMELM--DANLCQVI---QMELDHERMSYLLYQMLCGIKHL 143
Query: 599 HTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN--GHVSTVVKGSFGYLDP 656
H+ IIHRD+K +NI++ + K+ DFGL++T +V T Y P
Sbjct: 144 HSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAP 195
Query: 657 EYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
E E DI+S G ++ E++
Sbjct: 196 EVILGMGYKENVDIWSVGCIMGEMIKGGV 224
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 4e-14
Identities = 51/209 (24%), Positives = 88/209 (42%), Gaps = 31/209 (14%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKR-----SNPSSEQGVNEFVTEIEMLSKLRHKHLVS 545
IG G G V VAIK+ N + + E+ ++ + HK+++S
Sbjct: 69 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA---YRELVLMKCVNHKNIIS 125
Query: 546 LI------GFCEEGNEMCLVYDYMALGT-LREHIYNTKKALSWKQRLEICIGAARGLHYL 598
L+ EE ++ LV + M L + I + L ++ + G+ +L
Sbjct: 126 LLNVFTPQKTLEEFQDVYLVMELM--DANLCQVI---QMELDHERMSYLLYQMLCGIKHL 180
Query: 599 HTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN--GHVSTVVKGSFGYLDP 656
H+ IIHRD+K +NI++ + K+ DFGL++T +V T Y P
Sbjct: 181 HSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAP 232
Query: 657 EYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
E E DI+S G ++ E++ +
Sbjct: 233 EVILGMGYKENVDIWSVGCIMGEMVRHKI 261
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 7e-14
Identities = 51/213 (23%), Positives = 95/213 (44%), Gaps = 39/213 (18%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKR-----SNPSSEQGVNEFVTEIEMLSKLRHKHLVS 545
+G G +G V + L+VA+K+ + + E+ +L ++H++++
Sbjct: 36 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMKHENVIG 92
Query: 546 LI------GFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLH 599
L+ EE N++ LV M G +I +K L+ + RGL Y+H
Sbjct: 93 LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIH 149
Query: 600 TGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVST-------VVKGSFG 652
+ IIHRD+K +N+ ++E+ K+ DFGL++ + G+V+T ++
Sbjct: 150 SAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMH 206
Query: 653 YLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
Y + DI+S G ++ E+L R
Sbjct: 207 Y-----------NQTVDIWSVGCIMAELLTGRT 228
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 8e-14
Identities = 48/221 (21%), Positives = 88/221 (39%), Gaps = 47/221 (21%)
Query: 480 IKHATKSFDESY-----VIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIE 533
++ + + Y V+G+G GKV + + K A+K Q + E+E
Sbjct: 8 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVE 62
Query: 534 MLSKL-RHKHLVSLIGFCEEG----NEMCLVYDYMALGTLREHIYN-TKKALSWKQRLEI 587
+ + + H+V ++ E + +V + + G L I + +A + ++ EI
Sbjct: 63 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 122
Query: 588 CIGAARGLHYLHTGAKYTIIHRDVKTTNILL---DENWVAKVSDFGLSKTGPNMENGHVS 644
+ YLH I HRDVK N+L N + K++DFG +K E
Sbjct: 123 MKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----E----- 169
Query: 645 TVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
+ + D++S GV+++ +LC P
Sbjct: 170 -TTGEKYD-------------KSCDMWSLGVIMYILLCGYP 196
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 9e-14
Identities = 52/231 (22%), Positives = 88/231 (38%), Gaps = 64/231 (27%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVT---------EIEMLSKLRHK 541
++G G +G V VAIK+ P F EI++L +H+
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIKILKHFKHE 69
Query: 542 HLVSLI-----GFCEEGNEMCLVYDYMA--LGTL-------REHI----YNTKKALSWKQ 583
+++++ E NE+ ++ + M L + +HI Y Q
Sbjct: 70 NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIY---------Q 120
Query: 584 RLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643
L R + LH +IHRD+K +N+L++ N KV DFGL++ +
Sbjct: 121 TL-------RAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170
Query: 644 STVVKGSFG--------YLDPEY-FKRQQLTEKSDIYSFGVVLFEVLCARP 685
+ S Y PE + + D++S G +L E+ RP
Sbjct: 171 EPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 1e-13
Identities = 45/164 (27%), Positives = 72/164 (43%), Gaps = 33/164 (20%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIKRSN-PSSEQGVNEF-VT---EIEMLSKLR---HKHL 543
IGVG +G VYK VA+K P+ G ++ E+ +L +L H ++
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 544 VSLI-----GFCEEGNEMCLVYDYMA--LGTLREHIYNTK------KALSWKQRLEICIG 590
V L+ + ++ LV++++ L T + K L Q L
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR-QFL----- 130
Query: 591 AARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634
RGL +LH I+HRD+K NIL+ K++DFGL++
Sbjct: 131 --RGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARI 169
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 57/235 (24%), Positives = 100/235 (42%), Gaps = 59/235 (25%)
Query: 482 HATKSFDESYVIGVGGFGKVYKGV-IEDKLKVAIKRSNP-SSEQGVNEFVTEIEMLSKLR 539
+ IG G +G V +K++VAIK+ +P + + EI++L + R
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 83
Query: 540 HKHLVSLI-----GFCEEGNEMCLVYDYMALGT-LREHIYNTKKALSWKQRLE------- 586
H++++ + E+ ++ +V D M T L + + Q L
Sbjct: 84 HENIIGINDIIRAPTIEQMKDVYIVQDLM--ETDLYKLLK--------TQHLSNDHICYF 133
Query: 587 ---ICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN--- 640
I RGL Y+H+ ++HRD+K +N+LL+ K+ DFGL++ +
Sbjct: 134 LYQIL----RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186
Query: 641 ---GHVST-------VVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
+V+T ++ S GY T+ DI+S G +L E+L RP
Sbjct: 187 FLTEYVATRWYRAPEIMLNSKGY-----------TKSIDIWSVGCILAEMLSNRP 230
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 3e-13
Identities = 56/201 (27%), Positives = 87/201 (43%), Gaps = 26/201 (12%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIK--RSNPS-SEQGVNEFVTEIEMLSKLRHK------ 541
VIG G FG+V K + VA+K R+ Q EI +L LR +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAA----EEIRILEHLRKQDKDNTM 159
Query: 542 HLVSLIGFCEEGNEMCLVYDYMALGTLREHI-YNTKKALSWKQRLEICIGAARGLHYLHT 600
+++ ++ N +C+ ++ +++ L E I N + S + + L LH
Sbjct: 160 NVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH- 217
Query: 601 GAKYTIIHRDVKTTNILLDENWVA--KVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEY 658
K IIH D+K NILL + + KV DFG S E+ V T ++ F Y PE
Sbjct: 218 --KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC----YEHQRVYTYIQSRF-YRAPEV 270
Query: 659 FKRQQLTEKSDIYSFGVVLFE 679
+ D++S G +L E
Sbjct: 271 ILGARYGMPIDMWSLGCILAE 291
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 49/207 (23%), Positives = 84/207 (40%), Gaps = 24/207 (11%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIK--RSNPS-SEQGVNEFVTEIEMLSKLRH------K 541
+IG G FG+V K ++ VAIK ++ + Q E+ +L +
Sbjct: 61 LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ----IEVRLLELMNKHDTEMKY 116
Query: 542 HLVSLIGFCEEGNEMCLVYDYMALGTLREHI-YNTKKALSWKQRLEICIGAARGLHYLHT 600
++V L N +CLV++ ++ L + + + +S + L +L T
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 175
Query: 601 GAKYTIIHRDVKTTNILL--DENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEY 658
+ +IIH D+K NILL + K+ DFG S + ++ F Y PE
Sbjct: 176 -PELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSC---QLGQRIYQYIQSRF-YRSPEV 229
Query: 659 FKRQQLTEKSDIYSFGVVLFEVLCARP 685
D++S G +L E+ P
Sbjct: 230 LLGMPYDLAIDMWSLGCILVEMHTGEP 256
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 4e-13
Identities = 43/165 (26%), Positives = 78/165 (47%), Gaps = 37/165 (22%)
Query: 493 IGVGGFGKVYKGVIEDKLK---VAIKRSNPSSEQ-GVNEFVT---EIEMLSKLR---HKH 542
IG G +GKV+K + K VA+KR + + G+ ++ E+ +L L H +
Sbjct: 19 IGEGAYGKVFKA-RDLKNGGRFVALKRVRVQTGEEGMP--LSTIREVAVLRHLETFEHPN 75
Query: 543 LVSLI-----GFCEEGNEMCLVYDYMA--LGTLREHIYNTK------KALSWKQRLEICI 589
+V L + ++ LV++++ L T + + K + + Q L
Sbjct: 76 VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF-QLL---- 130
Query: 590 GAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634
RGL +LH + ++HRD+K NIL+ + K++DFGL++
Sbjct: 131 ---RGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI 169
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 54/249 (21%), Positives = 99/249 (39%), Gaps = 78/249 (31%)
Query: 482 HATKSFDESYVIGVGGFGKVYKGV-IEDKLKVAIKR---SNPSSEQGVNEFVTEIEMLSK 537
+ + +G GG G V+ V + +VAIK+ ++P S + + EI+++ +
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA---LREIKIIRR 64
Query: 538 LRHKHLVSLI--------------GFCEEGNEMCLVYDYM--------ALGTL-REH--- 571
L H ++V + G E N + +V +YM G L EH
Sbjct: 65 LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL 124
Query: 572 -IYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLD-ENWVAKVSDF 629
+Y Q L RGL Y+H+ ++HRD+K N+ ++ E+ V K+ DF
Sbjct: 125 FMY---------QLL-------RGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDF 165
Query: 630 GLSKTGPNMEN------GHVST-------VVKGSFGYLDPEYFKRQQLTEKSDIYSFGVV 676
GL++ + + T ++ Y T+ D+++ G +
Sbjct: 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNY-----------TKAIDMWAAGCI 214
Query: 677 LFEVLCARP 685
E+L +
Sbjct: 215 FAEMLTGKT 223
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 4e-12
Identities = 45/213 (21%), Positives = 92/213 (43%), Gaps = 43/213 (20%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLR-HKHLVSLIGFC 550
+G G + +V++ + I + KV +K P ++ + EI++L LR ++++L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLADIV 100
Query: 551 EEGNEMCLVY--DYMALGTLREHIYNTKKALSWKQRL----------EICIGAARGLHYL 598
++ +++ ++ Q L EI + L Y
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLY----------QTLTDYDIRFYMYEIL----KALDYC 146
Query: 599 HTGAKYTIIHRDVKTTNILLD-ENWVAKVSDFGLSKTG-PNME-NGHVSTVVKGSFGYLD 655
H+ I+HRDVK N+++D E+ ++ D+GL++ P E N V++ +
Sbjct: 147 HSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FKG 198
Query: 656 PEYFKRQQLTEKS-DIYSFGVVLFEVLCARPAL 687
PE Q+ + S D++S G +L ++ +
Sbjct: 199 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 55/242 (22%), Positives = 100/242 (41%), Gaps = 76/242 (31%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKR-SNPSSEQGVNEFVT---------EIEMLSKLR- 539
+G G +G V+K + VA+K+ + F EI +L++L
Sbjct: 16 KLGKGAYGIVWKSIDRRTGEVVAVKKIFDA--------FQNSTDAQRTFREIMILTELSG 67
Query: 540 HKHLVSL--IGFCEEGNEMCLVYDYMA--LGTL-------REHI----YNTKKALSWKQR 584
H+++V+L + + ++ LV+DYM L + H Y Q
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVY---------QL 118
Query: 585 LEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVS 644
+ + + YLH+G ++HRD+K +NILL+ KV+DFGLS++ N+ +
Sbjct: 119 I-------KVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNN 168
Query: 645 TVVKGSFGYLDPEYFKRQQLTE---------------------KSDIYSFGVVLFEVLCA 683
+ + + + + LT+ D++S G +L E+LC
Sbjct: 169 IPLSINENTENFDD-DQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227
Query: 684 RP 685
+P
Sbjct: 228 KP 229
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 49/225 (21%), Positives = 83/225 (36%), Gaps = 56/225 (24%)
Query: 492 VIGVGGFGKVYKGV--IEDKLKVAIK--RSNPS-SEQGVNEFVTEIEMLSKLRHK----- 541
+G G FGKV + + K +VA+K R+ E EI +L K++ K
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAAR----LEINVLKKIKEKDKENK 81
Query: 542 -HLVSLIGFCEEGNEMCLVYDYMALGTLREHI-YNTKKALSWKQRLEICIGAARGLHYLH 599
V + + MC+ ++ + E + N + + L +LH
Sbjct: 82 FLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH 140
Query: 600 TGAKYTIIHRDVKTTNILLDENWVA-------------------KVSDFGLSKTGPNMEN 640
+ + H D+K NIL + +V+DFG S T ++
Sbjct: 141 ---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-SAT---FDH 193
Query: 641 GHVSTVVKGSFGYLDPE------YFKRQQLTEKSDIYSFGVVLFE 679
H +T+V Y PE + + D++S G +LFE
Sbjct: 194 EHHTTIVATRH-YRPPEVILELGW------AQPCDVWSIGCILFE 231
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 37/147 (25%), Positives = 60/147 (40%), Gaps = 13/147 (8%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRH-KHLVSLIGFC 550
IG G FG +Y G I +VAIK ++ E ++ ++ + ++
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVGIPTIRWCG 74
Query: 551 EEGNEMCLVYDYMALG-TLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHR 609
EG+ +V + LG +L + + S K L + + Y+H IHR
Sbjct: 75 AEGDYNVMVMEL--LGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHR 129
Query: 610 DVKTTNILLDENWVAK---VSDFGLSK 633
DVK N L+ + DFGL+K
Sbjct: 130 DVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.7 bits (154), Expect = 5e-11
Identities = 34/199 (17%), Positives = 61/199 (30%), Gaps = 52/199 (26%)
Query: 483 ATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIK--------RSNPSSEQGVNEFVTEIEM 534
T+ IG G FG+V++ + + VAIK N S ++ E + EI +
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIADHT-PVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 535 LSKL---------RHKHLVSLIGFC------------------------------EEGNE 555
+L R + + L + ++
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 556 MCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTN 615
+ +V ++ G E + K S I L HRD+ N
Sbjct: 137 LFIVLEFEFGGIDLEQM--RTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGN 192
Query: 616 ILLDENWVAKVSDFGLSKT 634
+LL + + K+ K+
Sbjct: 193 VLLKKTSLKKLHYTLNGKS 211
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 8e-11
Identities = 35/149 (23%), Positives = 60/149 (40%), Gaps = 15/149 (10%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRH-KHLVSLIGFC 550
IG G FG +++G + + +VAIK S+ E L + ++ F
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD--EYRTYKLLAGCTGIPNVYYFG 75
Query: 551 EEGNEMCLVYDYMALG-TLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHR 609
+EG LV D LG +L + + + S K + +H + ++++R
Sbjct: 76 QEGLHNVLVIDL--LGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYR 130
Query: 610 DVKTTNILLDENWVAK-----VSDFGLSK 633
D+K N L+ V DFG+ K
Sbjct: 131 DIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 52/229 (22%), Positives = 90/229 (39%), Gaps = 60/229 (26%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIK--RSNPS-SEQGVNEFVTEIEMLSKLRH-----KH 542
+G G FG+V I++K A+K R+ + E ++L K+++ +
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAK----IEADILKKIQNDDINNNN 97
Query: 543 LVSLIGFCEEGNEMCLVYDYMALGTLREHI-YNTKKALSWKQRLEICIGAARGLHYLHTG 601
+V G + MCL+++ + +L E I N + CI + L+YL
Sbjct: 98 IVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR-- 154
Query: 602 AKYTIIHRDVKTTNILLDENWVA-------------------------KVSDFGLSKTGP 636
K ++ H D+K NILLD+ + K+ DFG T
Sbjct: 155 -KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG-CAT-- 210
Query: 637 NMENGHVSTVVKGSFGYLDPE------YFKRQQLTEKSDIYSFGVVLFE 679
++ + +++ Y PE + SD++SFG VL E
Sbjct: 211 -FKSDYHGSIINTRQ-YRAPEVILNLGW------DVSSDMWSFGCVLAE 251
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 62.7 bits (152), Expect = 3e-10
Identities = 41/147 (27%), Positives = 68/147 (46%), Gaps = 13/147 (8%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLR-HKHLVSLIGFC 550
IG G FG++Y G I+ +VAIK N ++ + E ++ L+ + ++ F
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTGIPNVRWFG 72
Query: 551 EEGNEMCLVYDYMALG-TLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHR 609
EG+ LV D LG +L + + LS K L + + ++H + +HR
Sbjct: 73 VEGDYNVLVMDL--LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHR 127
Query: 610 DVKTTNILLDENWVAK---VSDFGLSK 633
D+K N L+ A + DFGL+K
Sbjct: 128 DIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 37/150 (24%), Positives = 58/150 (38%), Gaps = 17/150 (11%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRH-KHLVSLIGFC 550
IG G FG++ G + VAIK S E +L + + F
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDGIPQVYYFG 74
Query: 551 EEGNEMCLVYDYMALGTLREHIYNT-KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHR 609
G +V + LG E +++ + S K L I I + Y+H +I+R
Sbjct: 75 PCGKYNAMVLEL--LGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYR 129
Query: 610 DVKTTNILL------DENWVAKVSDFGLSK 633
DVK N L+ + + + DF L+K
Sbjct: 130 DVKPENFLIGRPGNKTQQVI-HIIDFALAK 158
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 27/165 (16%), Positives = 55/165 (33%), Gaps = 29/165 (17%)
Query: 493 IGVGGFGKVYKGV---------IEDKLKVAIK----RSNPSSEQGVNEFVTEIEMLSKLR 539
G +Y+ K K ++K +EQ + + ++K +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 540 HKHLVSLIGF-------CEEGNEMCLVYDYMALGTLREHIYNT--KKALSWKQRLEICIG 590
+ L+ + LV LG + + K LS + L++
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPS--LGRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 591 AARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKV--SDFGLSK 633
L +LH + +H +V NI +D ++V + +G +
Sbjct: 168 LLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 4e-10
Identities = 48/225 (21%), Positives = 86/225 (38%), Gaps = 56/225 (24%)
Query: 492 VIGVGGFGKVYKGV--IEDKLKVAIK--RSNPS-SEQGVNEFVTEIEMLSKLRHK----- 541
+G G FGKV + + VA+K ++ E +EI++L L
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAAR----SEIQVLEHLNTTDPNST 76
Query: 542 -HLVSLIGFCEEGNEMCLVYDYMALGTLREHI-YNTKKALSWKQRLEICIGAARGLHYLH 599
V ++ + E +C+V++ + L + + I N ++ + +++LH
Sbjct: 77 FRCVQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH 135
Query: 600 TGAKYTIIHRDVKTTNILLDENWVA-------------------KVSDFGLSKTGPNMEN 640
+ H D+K NIL ++ KV DFG S T ++
Sbjct: 136 ---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG-SAT---YDD 188
Query: 641 GHVSTVVKGSFGYLDPE------YFKRQQLTEKSDIYSFGVVLFE 679
H ST+V Y PE + ++ D++S G +L E
Sbjct: 189 EHHSTLVSTRH-YRAPEVILALGW------SQPCDVWSIGCILIE 226
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 56/283 (19%), Positives = 90/283 (31%), Gaps = 80/283 (28%)
Query: 487 FDESYVI----GVGGFGKVYKGV-IEDKLKVAIK--RSNPSSEQGVNEFVTEIEMLSKLR 539
F+ Y + G G F V+ I+ K VA+K +S + + EI +L +R
Sbjct: 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD---EIRLLKSVR 91
Query: 540 --------HKHLVSLIG-FCEEGNE---MCLVYDYMALGTLREHI-YNTKKALSWKQRLE 586
+ +V L+ F G +C+V++ + L + I + + L +
Sbjct: 92 NSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKK 150
Query: 587 ICIGAARGLHYLHTGAKYTIIHRDVKTTNILL---------------------------- 618
I +GL YLHT + IIH D+K NILL
Sbjct: 151 IIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 619 ---------------------DENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPE 657
E K++D G + + T Y E
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLE 263
Query: 658 YFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLAD 700
+DI+S + FE+ P +E D
Sbjct: 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDED 306
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 35/162 (21%), Positives = 59/162 (36%), Gaps = 26/162 (16%)
Query: 493 IGVGGFGKVYKGV-IEDKLKVAIK------RSNPS--SEQGVNEFVTEIEMLSKLRHKHL 543
IG GGFG +Y K A + N SE + V + + + K +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 544 VSLIGF----------CEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAAR 593
+ +G + + +V + LG + I L++ I
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMER--LGIDLQKISGQNGTFKKSTVLQLGIRMLD 162
Query: 594 GLHYLHTGAKYTIIHRDVKTTNILLDENWVAKV--SDFGLSK 633
L Y+H + +H D+K N+LL +V +D+GLS
Sbjct: 163 VLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 7e-08
Identities = 33/165 (20%), Positives = 60/165 (36%), Gaps = 29/165 (17%)
Query: 493 IGVGGFGKVYKGV------IEDKLKVAIKRSNPSSEQGVNEF-----VTEIEMLSKLRHK 541
IG GGFG +Y + +K + E + E + K
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 542 HLVSLIGFC----------EEGNEMCLVYDYMALGTLREHIYNT-KKALSWKQRLEICIG 590
+ +G + ++ D G+ + IY K S K L++ +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDR--FGSDLQKIYEANAKRFSRKTVLQLSLR 160
Query: 591 AARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKV--SDFGLSK 633
L Y+H ++ +H D+K +N+LL+ +V D+GL+
Sbjct: 161 ILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 53.7 bits (128), Expect = 3e-07
Identities = 91/629 (14%), Positives = 188/629 (29%), Gaps = 203/629 (32%)
Query: 252 HTNMEFNLTWIFRVDANFTY----------YVRLHFCEFKPDINK--INQRVFNIYINNQ 299
H +M+F + + Y +V C+ D+ K +++ + I ++
Sbjct: 4 HHHMDFETG-----EHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSK 58
Query: 300 TAQADADVIAWT-HGQGVPIYKDYAVYVEDLPGDDQIFVA-------MSPSLKYQP--EY 349
A + + WT + + + + VE++ + F+ PS+ + E
Sbjct: 59 DAVSGTLRLFWTLLSKQEEMVQKF---VEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQ 115
Query: 350 LDALLNGLEIFKIETAKNLAGPNPEP-SALPAKSEGNSTKGFTN-KSKSNIHVIGGAAGG 407
D L N ++F N+ +P L + + N+ +I G G
Sbjct: 116 RDRLYNDNQVF---AKYNV--SRLQPYLKL--------RQALLELRPAKNV-LIDGVLG- 160
Query: 408 AAAFG---LVAALCFVVYQRKQRIPGTESHTSSWLPIYGHSQTTQSKSTISGKSNASSHL 464
G + +C Y+ + ++ + WL + N+ +
Sbjct: 161 ---SGKTWVALDVCLS-YKVQCKMDF-KIF---WLNL--------------KNCNSPETV 198
Query: 465 SAIAQGLCRRFSLAEIKHATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIK-RSNPSS-- 521
+ Q L + + T D S I K+ I+ +L+ +K + +
Sbjct: 199 LEMLQKLLYQID----PNWTSRSDHSSNI------KLRIHSIQAELRRLLKSKPYENCLL 248
Query: 522 -------EQGVNEF-------VTE-----IEMLSKLRHKHLVS---LIGFCE-EGNEMCL 558
+ N F +T + LS H+ + E + L
Sbjct: 249 VLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLL 308
Query: 559 VYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILL 618
Y L E+ R L + RD T
Sbjct: 309 KYLDCRPQDLPR---------------EVLTTNPRRLSII--AESI----RDGLATW--- 344
Query: 619 DENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQ-----------QLTEK 667
+NW ++ ++T+++ S L+P +++ +
Sbjct: 345 -DNW-------------KHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTI 390
Query: 668 ------SDIYSFGVVLFEVLCARPAL---NP-----SLPKEQVSLA-----DWALHCKRK 708
D+ V++ + +L P S+P + L ++ALH +
Sbjct: 391 LLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALH---R 447
Query: 709 GILD--DIIDPLLKDKISPEC------------LKKFADTAEKCLSDSGIDRPSMGDVLW 754
I+D +I D + P LK + E+ V
Sbjct: 448 SIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKN-IEHPER--------MTLFRMVFL 498
Query: 755 NLEFVLQLVESTEASSNRSRGSSIDGAED 783
+ F+ Q + + N + GS ++ +
Sbjct: 499 DFRFLEQKIRHDSTAWN-ASGSILNTLQQ 526
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 817 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 99.78 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.77 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.6 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.26 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.13 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.94 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.88 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.51 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.48 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.36 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.36 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.34 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.26 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.91 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.88 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.87 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.74 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.43 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.37 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.27 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.2 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.12 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.09 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.06 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.93 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.88 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.7 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.49 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.07 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.3 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.24 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 87.78 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 87.66 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 84.0 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 82.77 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-53 Score=458.28 Aligned_cols=260 Identities=28% Similarity=0.453 Sum_probs=210.6
Q ss_pred cCCCcceeEeeeCceEEEEEEEe------cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE------DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCL 558 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 558 (817)
.+|...++||+|+||+||+|+++ ++..||||+++..+....++|.+|+++|++++|||||+++|+|.+.+.++|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45677889999999999999864 367899999988777778899999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhccc--------------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCcee
Q 039107 559 VYDYMALGTLREHIYNTK--------------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVA 624 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~ 624 (817)
|||||++|+|.++|+... ..++|.+++.|+.||++||+|||+++ ||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 999999999999997532 35999999999999999999999765 9999999999999999999
Q ss_pred EEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHH
Q 039107 625 KVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWAL 703 (817)
Q Consensus 625 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 703 (817)
||+|||+++...............||+.|||||++.+..++.++|||||||+||||+| |+.||......+ +...+.
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~~i~ 274 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE---AIDCIT 274 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH---HHHHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH---HHHHHH
Confidence 9999999987544433344455679999999999999999999999999999999999 899997654322 111111
Q ss_pred HhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 039107 704 HCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLV 763 (817)
Q Consensus 704 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 763 (817)
. +. +...+..++.++.+|+.+||+.||++||||+||+++|+.+.+.+
T Consensus 275 ~----g~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p 321 (329)
T 4aoj_A 275 Q----GR---------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321 (329)
T ss_dssp H----TC---------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred c----CC---------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence 1 10 11223445667899999999999999999999999999987653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-53 Score=454.44 Aligned_cols=259 Identities=26% Similarity=0.436 Sum_probs=215.2
Q ss_pred cCCCcceeEeeeCceEEEEEEEe------cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE------DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCL 558 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 558 (817)
++|...+.||+|+||+||+|++. ++..||||+++..+....++|.+|+++|++++|||||+++|+|.+.+..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46777889999999999999864 357899999988777777899999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhccc------------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEE
Q 039107 559 VYDYMALGTLREHIYNTK------------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKV 626 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl 626 (817)
|||||++|+|.++|+... ..++|.+++.|+.||++||+|||+++ ||||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999997532 36999999999999999999999876 999999999999999999999
Q ss_pred eeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHh
Q 039107 627 SDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHC 705 (817)
Q Consensus 627 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 705 (817)
+|||+|+...............||+.|||||++.++.++.++|||||||+||||+| |+.||......+ +...+..
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~~i~~- 245 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIECITQ- 245 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHHHHHH-
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHc-
Confidence 99999986433322223334579999999999999999999999999999999998 899997654322 2211111
Q ss_pred hccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 039107 706 KRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQL 762 (817)
Q Consensus 706 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 762 (817)
+. ....+..++.++.+|+.+||+.||++|||+++|++.|+.+.+.
T Consensus 246 ---~~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 246 ---GR---------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp ---TC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CC---------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 11 1122345567789999999999999999999999999987654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=446.13 Aligned_cols=261 Identities=26% Similarity=0.486 Sum_probs=207.8
Q ss_pred cCCCcceeEeeeCceEEEEEEEecccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
+++...++||+|+||+||+|++++ .||||.++.. +.+..++|.+|+++|++++|||||+++|+|.+ +.++|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 467778899999999999998765 5899988643 34456789999999999999999999999865 568999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
|++|+|.++|+.....++|.+++.|+.|||+||+|||+++ ||||||||+||||++++.+||+|||+|+.........
T Consensus 113 ~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 113 CEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp CSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 9999999999877778999999999999999999999875 9999999999999999999999999998754433334
Q ss_pred eeeeeecCcCCCChhhhcc---CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccc
Q 039107 643 VSTVVKGSFGYLDPEYFKR---QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~---~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (817)
......||+.|||||++.+ +.|+.++|||||||+||||+||+.||......... ......+ ...|.+
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~------~~~~~~~----~~~p~~ 259 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI------IFMVGRG----YASPDL 259 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH------HHHHHTT----CCCCCS
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH------HHHHhcC----CCCCCc
Confidence 4456689999999999964 46899999999999999999999999765432211 1111111 111111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 039107 720 KDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQL 762 (817)
Q Consensus 720 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 762 (817)
...+..++..+.+|+.+||+.||++||||.||+++|+.+...
T Consensus 260 -~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 260 -SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp -TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred -ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 122345667789999999999999999999999999877543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=449.30 Aligned_cols=253 Identities=23% Similarity=0.347 Sum_probs=209.6
Q ss_pred CCcceeEeeeCceEEEEEEEe------cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEE
Q 039107 487 FDESYVIGVGGFGKVYKGVIE------DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 487 f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 559 (817)
++..+.||+|+||+||+|++. +++.||||+++... ....++|.+|+.+|++++|||||+++|+|.+.+..+||
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV 107 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI 107 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence 445678999999999999863 35789999987653 34467899999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhcc---------------ccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCcee
Q 039107 560 YDYMALGTLREHIYNT---------------KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVA 624 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~ 624 (817)
||||++|+|.++|... ...++|.++++|+.|||+||+|||+++ ||||||||+||||++++.+
T Consensus 108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCE
T ss_pred EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCCE
Confidence 9999999999999643 236999999999999999999999876 9999999999999999999
Q ss_pred EEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHH
Q 039107 625 KVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWAL 703 (817)
Q Consensus 625 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 703 (817)
||+|||+++...............||+.|||||++.++.++.++|||||||+||||+| |+.||.+....+ +...+.
T Consensus 185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~~~~i~ 261 (308)
T 4gt4_A 185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VVEMIR 261 (308)
T ss_dssp EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---HHHHHH
T ss_pred EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH
Confidence 9999999986543333333445679999999999999999999999999999999998 899997654322 222221
Q ss_pred HhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 704 HCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 704 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
.+. ..+.+..++..+.+|+.+||+.||++||||.||+++|+.
T Consensus 262 ----~~~---------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 262 ----NRQ---------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp ----TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ----cCC---------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 111 112344566778999999999999999999999999975
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=442.19 Aligned_cols=265 Identities=22% Similarity=0.375 Sum_probs=216.6
Q ss_pred HHhhcCCCcceeEeeeCceEEEEEEEec------ccEEEEEecCCCCc-ccHHHHHHHHHHHhccCc-cceeeEEEEEec
Q 039107 481 KHATKSFDESYVIGVGGFGKVYKGVIED------KLKVAIKRSNPSSE-QGVNEFVTEIEMLSKLRH-KHLVSLIGFCEE 552 (817)
Q Consensus 481 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~ 552 (817)
....++|...+.||+|+||+||+|.+.+ ++.||||++..... ...++|.+|+++|++++| ||||+++|+|.+
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 3345678899999999999999999754 25799999876543 345779999999999965 899999999965
Q ss_pred -CCeEEEEEEeccCCchhhhhhccc---------------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcE
Q 039107 553 -GNEMCLVYDYMALGTLREHIYNTK---------------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNI 616 (817)
Q Consensus 553 -~~~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NI 616 (817)
.+.++||||||++|+|.++|+... ..++|.+++.|+.|||+||+|||+++ ||||||||+||
T Consensus 140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NI 216 (353)
T 4ase_A 140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNI 216 (353)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccce
Confidence 467899999999999999997532 24899999999999999999999876 99999999999
Q ss_pred EEcCCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCcccc
Q 039107 617 LLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQ 695 (817)
Q Consensus 617 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~ 695 (817)
||++++.+||+|||+|+...............||+.|||||++.++.|+.++|||||||+||||+| |+.||.+....+.
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~ 296 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 296 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999997654444444456789999999999999999999999999999999998 8999976543221
Q ss_pred chHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 039107 696 VSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLV 763 (817)
Q Consensus 696 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 763 (817)
+...+ .++ .+...+..++.++.+++.+||+.||++|||+.+|+++|+.+++..
T Consensus 297 --~~~~i----~~g---------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 297 --FCRRL----KEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp --HHHHH----HHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred --HHHHH----HcC---------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 11111 111 111223345567899999999999999999999999999988653
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=428.20 Aligned_cols=257 Identities=23% Similarity=0.252 Sum_probs=208.9
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
..|...++||+|+||+||+|+.+ +++.||||+++.... +.+|+.+|++++|||||++++++.+.+.++||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 45777889999999999999975 578999999875432 247999999999999999999999999999999999
Q ss_pred cCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCc-eeEEeeeccCccCCCCCCC-
Q 039107 564 ALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENW-VAKVSDFGLSKTGPNMENG- 641 (817)
Q Consensus 564 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DFGla~~~~~~~~~- 641 (817)
++|+|.++|... +.+++.+++.++.||+.||+|||+++ ||||||||+||||+.++ .+||+|||+|+........
T Consensus 133 ~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 133 EGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp TTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 999999999654 46999999999999999999999765 99999999999999987 6999999999865432211
Q ss_pred --ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccc
Q 039107 642 --HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719 (817)
Q Consensus 642 --~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (817)
......+||+.|||||++.+..|+.++|||||||+||||++|++||......+... .+.. ....
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~---~i~~--~~~~--------- 274 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL---KIAS--EPPP--------- 274 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHH---HHHH--SCCG---------
T ss_pred ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH---HHHc--CCCC---------
Confidence 12234579999999999999999999999999999999999999997654432211 1111 0000
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhc
Q 039107 720 KDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVE 764 (817)
Q Consensus 720 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 764 (817)
...+++.++..+.+++.+||+.||.+|||+.|++++|..+++...
T Consensus 275 ~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 275 IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 112234456678999999999999999999999999998886544
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-50 Score=433.33 Aligned_cols=251 Identities=21% Similarity=0.353 Sum_probs=209.8
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
..|+..+.||+|+||+||+|+.+ +++.||||++........+.+.+|+++|++++|||||++++++.+.+.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46888899999999999999975 57899999987655555677899999999999999999999999999999999999
Q ss_pred cCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCce
Q 039107 564 ALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643 (817)
Q Consensus 564 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 643 (817)
++|+|.+++.. ..+++.++..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+..... ...
T Consensus 154 ~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--~~~ 226 (346)
T 4fih_A 154 EGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPR 226 (346)
T ss_dssp TTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSS--SCC
T ss_pred CCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCC--CCc
Confidence 99999998854 46999999999999999999999876 999999999999999999999999999865332 223
Q ss_pred eeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCC
Q 039107 644 STVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKI 723 (817)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 723 (817)
....+||+.|||||++.+..|+.++|||||||+||||++|++||......+.. ..+.. . ..+.+. .
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~---~~i~~----~-----~~~~~~--~ 292 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM---KMIRD----N-----LPPRLK--N 292 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHHHH----S-----SCCCCS--C
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH---HHHHc----C-----CCCCCC--c
Confidence 44568999999999999999999999999999999999999999765432211 11111 0 111111 1
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 724 SPECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 724 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
....+.++.+|+.+||+.||++|||+.|+++|-
T Consensus 293 ~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp 325 (346)
T 4fih_A 293 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHP 325 (346)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence 223456689999999999999999999998763
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-50 Score=429.26 Aligned_cols=269 Identities=23% Similarity=0.332 Sum_probs=201.9
Q ss_pred cCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCC----eEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGN----EMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV~ 560 (817)
+++...++||+|+||+||+|+++ ++.||||++..... ....+..|+..+.+++|||||+++|+|.+.+ .++|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 45667889999999999999984 67899999874322 1122345666667889999999999997653 579999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhC-----CCCceEecCCccCcEEEcCCceeEEeeeccCccC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTG-----AKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTG 635 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 635 (817)
|||++|+|.++|+. ..++|..+++|+.|+++||+|||++ ++++||||||||+||||++++.+||+|||+++..
T Consensus 81 Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp ECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred cCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 99999999999964 4699999999999999999999976 2347999999999999999999999999999865
Q ss_pred CCCCCC--ceeeeeecCcCCCChhhhccC------CCCchHHHHHHHHHHHHHHhCCCCCCCCCcccc---------chH
Q 039107 636 PNMENG--HVSTVVKGSFGYLDPEYFKRQ------QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQ---------VSL 698 (817)
Q Consensus 636 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~---------~~l 698 (817)
...... .......||+.|||||++.+. .++.++|||||||+||||+||++|+........ ...
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~ 238 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence 332221 122345799999999998754 467899999999999999999987754322111 001
Q ss_pred HHHHHHhhccCchhhccCccccCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 039107 699 ADWALHCKRKGILDDIIDPLLKDK-ISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQL 762 (817)
Q Consensus 699 ~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 762 (817)
.++... ...+.++|.+... ...+++..+.+|+.+||+.||++||||.||++.|+.+.+.
T Consensus 239 ~~~~~~-----~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 239 EEMRKV-----VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHH-----HTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHH-----HhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 111111 1111122222221 1235778899999999999999999999999999988754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=436.29 Aligned_cols=251 Identities=26% Similarity=0.374 Sum_probs=203.1
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
++|...+.||+|+||+||+|+.. +++.||||++... .....+.|.+|+++|++|+|||||++++++.+.+.++||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 57899999999999999999965 5789999998654 33446789999999999999999999999999999999999
Q ss_pred eccCCchhhhhhcccc-ccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 562 YMALGTLREHIYNTKK-ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
||++|+|.++|...+. .+++.+++.|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.... .
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--T 178 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCH--H
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecC--C
Confidence 9999999999975543 5789999999999999999999876 99999999999999999999999999986422 1
Q ss_pred CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
........||+.|||||++.+..|+.++|||||||+||||++|++||......+. . ..... +. . +
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~---~---~~i~~-~~----~-~--- 243 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL---V---LKIIS-GS----F-P--- 243 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---H---HHHHH-TC----C-C---
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---H---HHHHc-CC----C-C---
Confidence 1223456799999999999999999999999999999999999999976543221 1 11111 10 0 1
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
..+..++.++.+|+.+||+.||++|||++|++++-
T Consensus 244 -~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp 278 (350)
T 4b9d_A 244 -PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKG 278 (350)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred -CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 12233456689999999999999999999999863
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=421.52 Aligned_cols=247 Identities=26% Similarity=0.413 Sum_probs=197.2
Q ss_pred CcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEec----CCeEEEEE
Q 039107 488 DESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE----GNEMCLVY 560 (817)
Q Consensus 488 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 560 (817)
+..++||+|+||+||+|... .+..||+|++... .....+.|.+|+++|++|+|||||+++++|.. ...++|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45668999999999999975 4688999997643 33445779999999999999999999999864 35589999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEc-CCceeEEeeeccCccCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLD-ENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~-~~~~~kl~DFGla~~~~~~~ 639 (817)
|||++|+|.+++.+. ..+++..+..|+.||+.||+|||+++ ++||||||||+||||+ +++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~--- 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--- 183 (290)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC---
T ss_pred eCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC---
Confidence 999999999999653 46999999999999999999999763 4699999999999998 47999999999998632
Q ss_pred CCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccc
Q 039107 640 NGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719 (817)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (817)
........||+.|||||++. +.|+.++|||||||+||||+||++||........ +. .. ...+. ..+..
T Consensus 184 -~~~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--~~---~~-i~~~~----~~~~~ 251 (290)
T 3fpq_A 184 -ASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IY---RR-VTSGV----KPASF 251 (290)
T ss_dssp -TTSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HH---HH-HTTTC----CCGGG
T ss_pred -CCccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH--HH---HH-HHcCC----CCCCC
Confidence 22345568999999999986 4699999999999999999999999975433221 11 11 11110 00111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 720 KDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 720 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
. ...+.++.+|+.+||+.||++|||++|+++|
T Consensus 252 ~----~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 252 D----KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp G----GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred C----ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 1223457899999999999999999999875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=425.07 Aligned_cols=250 Identities=21% Similarity=0.289 Sum_probs=209.3
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
.+|+..++||+|+||+||+|+.+ +++.||||++... .....+.+.+|+++|++|+|||||++++++++.+.++|||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46999999999999999999965 5789999998643 2334578999999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
|||++|+|.++|.+. +.+++.++..++.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.......
T Consensus 112 Ey~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 999999999999654 46999999999999999999999876 99999999999999999999999999987654443
Q ss_pred CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
.......+||+.|||||++.+..|+.++||||+||+||||++|++||......+ +..-+.. + +..
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~i~~----~------~~~-- 252 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL---IFAKIIK----L------EYD-- 252 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHH----T------CCC--
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHc----C------CCC--
Confidence 444556789999999999999999999999999999999999999997654322 1111111 1 011
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
++...+.++.+|+.+||+.||++|||++|++.+
T Consensus 253 --~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 253 --FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp --CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred --CCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 122334567899999999999999999997644
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-49 Score=435.19 Aligned_cols=251 Identities=21% Similarity=0.353 Sum_probs=210.2
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
+.|+..+.||+|+||+||+|+.+ +++.||||++........+.+.+|+.+|++++|||||++++++.+.+.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56889999999999999999975 57899999987666666678999999999999999999999999999999999999
Q ss_pred cCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCce
Q 039107 564 ALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643 (817)
Q Consensus 564 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 643 (817)
++|+|.+++.. ..+++.++..|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+..... ...
T Consensus 231 ~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~--~~~ 303 (423)
T 4fie_A 231 EGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPR 303 (423)
T ss_dssp TTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSS--CCC
T ss_pred CCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCC--Ccc
Confidence 99999998853 46999999999999999999999876 999999999999999999999999999865332 223
Q ss_pred eeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCC
Q 039107 644 STVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKI 723 (817)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 723 (817)
....+||+.|||||++.+..|+.++|||||||+||||++|++||......+.. ..+.. . ..+.+. .
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~---~~i~~----~-----~~~~~~--~ 369 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM---KMIRD----N-----LPPRLK--N 369 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHHHH----S-----CCCCCS--C
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH---HHHHc----C-----CCCCCc--c
Confidence 44568999999999999999999999999999999999999999765432211 11111 0 111111 1
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 724 SPECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 724 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
...++..+.+|+.+||..||++|||+.|+++|-
T Consensus 370 ~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp 402 (423)
T 4fie_A 370 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHP 402 (423)
T ss_dssp TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence 123445678999999999999999999998763
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=408.14 Aligned_cols=249 Identities=26% Similarity=0.368 Sum_probs=192.4
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
.+|+..+.||+|+||+||+|+.. +++.||||++... .....+.+.+|+++|++++|||||++++++.+.+..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 47999999999999999999964 5789999998643 2334567999999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
||+ +|+|.+++.+. +.+++.++..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--- 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD--- 164 (275)
T ss_dssp ECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred eCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC---
Confidence 999 58999988654 46999999999999999999999876 99999999999999999999999999986432
Q ss_pred CceeeeeecCcCCCChhhhccCCC-CchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQL-TEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (817)
........||+.|||||++.+..+ +.++||||+||+||||++|+.||....... + ..... .+. ..
T Consensus 165 ~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~---~---~~~i~-~~~------~~- 230 (275)
T 3hyh_A 165 GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV---L---FKNIS-NGV------YT- 230 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---HHHHH-HTC------CC-
T ss_pred CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH---H---HHHHH-cCC------CC-
Confidence 223345689999999999998876 579999999999999999999997643221 1 11111 110 11
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 720 KDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 720 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
++...+.++.+|+.+||+.||++|||++|+++|-..
T Consensus 231 ---~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~ 266 (275)
T 3hyh_A 231 ---LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWF 266 (275)
T ss_dssp ---CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHH
T ss_pred ---CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccc
Confidence 122334567899999999999999999999987543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=416.88 Aligned_cols=248 Identities=24% Similarity=0.304 Sum_probs=197.3
Q ss_pred cCCCcceeEeeeCceEEEEEEEe----cccEEEEEecCCCC--cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE----DKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCL 558 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 558 (817)
.+|+..+.||+|+||+||+|+.. .++.||||++.... ......+.+|+++|++++|||||++++++.+.+.++|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46889999999999999999863 35789999986542 2334578899999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCC
Q 039107 559 VYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNM 638 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 638 (817)
|||||++|+|.++|.+. +.+++.++..++.||+.||+|||+++ ||||||||+|||+++++.+||+|||+|+.....
T Consensus 104 vmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 99999999999999654 46999999999999999999999876 999999999999999999999999999864322
Q ss_pred CCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcc
Q 039107 639 ENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPL 718 (817)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (817)
........||+.|||||++.+..++.++|||||||+||||++|++||.+....+.. ..+. ++. .
T Consensus 180 --~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~---~~i~----~~~------~- 243 (304)
T 3ubd_A 180 --EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM---TMIL----KAK------L- 243 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHH----HCC------C-
T ss_pred --CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHH---HHHH----cCC------C-
Confidence 22334567999999999999999999999999999999999999999865432211 1111 110 1
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 039107 719 LKDKISPECLKKFADTAEKCLSDSGIDRPS-----MGDVLWN 755 (817)
Q Consensus 719 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 755 (817)
.++...+.++.+|+.+||+.||++||| ++|+++|
T Consensus 244 ---~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 244 ---GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred ---CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 112234556789999999999999998 4677654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=406.11 Aligned_cols=290 Identities=63% Similarity=1.071 Sum_probs=256.6
Q ss_pred cccCHHHHHHhhcCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEec
Q 039107 473 RRFSLAEIKHATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE 552 (817)
Q Consensus 473 ~~f~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 552 (817)
..+.+.++..++++|...+.||+|+||.||+|+.+++..||||++........+.+.+|++++++++||||+++++++..
T Consensus 27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred eeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 45666777788999999999999999999999988889999999887777777889999999999999999999999999
Q ss_pred CCeEEEEEEeccCCchhhhhhccc---cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeee
Q 039107 553 GNEMCLVYDYMALGTLREHIYNTK---KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDF 629 (817)
Q Consensus 553 ~~~~~lV~Ey~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DF 629 (817)
.+..++||||+++|+|.+++.... ..++|.+++.++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Df 183 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDF 183 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeec
Confidence 999999999999999999996543 25899999999999999999999876 999999999999999999999999
Q ss_pred ccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccC
Q 039107 630 GLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKG 709 (817)
Q Consensus 630 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 709 (817)
|+++...............||+.|+|||.+.+..++.++||||||+++|||++|+.||....+.+...+..|.......+
T Consensus 184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 263 (321)
T 2qkw_B 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263 (321)
T ss_dssp TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT
T ss_pred ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc
Confidence 99986543333333445678999999999999999999999999999999999999998877777777888887777777
Q ss_pred chhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhcc
Q 039107 710 ILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVES 765 (817)
Q Consensus 710 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 765 (817)
.+.+.+++.+......+++..+.+++.+||+.||++|||+.+|+++|+.+++..++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~~ 319 (321)
T 2qkw_B 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQES 319 (321)
T ss_dssp CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSCC
T ss_pred cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcccC
Confidence 77788888887778889999999999999999999999999999999999877654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=404.15 Aligned_cols=250 Identities=26% Similarity=0.385 Sum_probs=186.8
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCC--------
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGN-------- 554 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-------- 554 (817)
.+|+..+.||+|+||+||+|+.+ +++.||||++.... ....+.+.+|+++|++|+|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 35888899999999999999975 57899999986543 334567999999999999999999999986543
Q ss_pred ----eEEEEEEeccCCchhhhhhcccc--ccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEee
Q 039107 555 ----EMCLVYDYMALGTLREHIYNTKK--ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSD 628 (817)
Q Consensus 555 ----~~~lV~Ey~~~gsL~~~l~~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 628 (817)
.+++|||||++|+|.+++..... ..++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36999999999999999975433 3556678899999999999999876 99999999999999999999999
Q ss_pred eccCccCCCCCCC----------ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchH
Q 039107 629 FGLSKTGPNMENG----------HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSL 698 (817)
Q Consensus 629 FGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l 698 (817)
||+|+........ ...+...||+.|||||++.+..|+.++|||||||+||||++ ||.... +....
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~~ 236 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--ERVRT 236 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHHH
Confidence 9999865432211 12234579999999999999999999999999999999996 554211 11110
Q ss_pred HHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 699 ADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 699 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
... ...... | .........+.+|+.+||+.||.+|||+.|++++
T Consensus 237 ---~~~-~~~~~~-----p----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 237 ---LTD-VRNLKF-----P----PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp ---HHH-HHTTCC-----C----HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---HHH-HhcCCC-----C----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 000 011100 0 0112333456789999999999999999999874
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=403.73 Aligned_cols=267 Identities=21% Similarity=0.290 Sum_probs=203.3
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC--cccHHHHHHHHHHHhccCccceeeEEEEEec------CCe
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE------GNE 555 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~ 555 (817)
++|...+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+++|++|+|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57899999999999999999975 57899999987543 3345678899999999999999999998753 367
Q ss_pred EEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccC
Q 039107 556 MCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTG 635 (817)
Q Consensus 556 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 635 (817)
+|||||||+ |+|.+++... +.+++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++..
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EEEEEeCCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeec
Confidence 899999996 6899988654 46999999999999999999999876 999999999999999999999999999865
Q ss_pred CCCC--CCceeeeeecCcCCCChhhhccC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhc-----
Q 039107 636 PNME--NGHVSTVVKGSFGYLDPEYFKRQ-QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKR----- 707 (817)
Q Consensus 636 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~----- 707 (817)
.... .........||+.|||||++.+. .++.++||||+||++|||++|++||.+....++...+.-......
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~ 288 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ 288 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 3321 12233456899999999998765 569999999999999999999999987655443322211000000
Q ss_pred ---cCchhhcc---CccccC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 708 ---KGILDDII---DPLLKD---KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 708 ---~~~~~~~~---d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
.......+ .+.... ...+....++.+|+.+||..||.+|||+.|+++|-
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 346 (398)
T 4b99_A 289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHP 346 (398)
T ss_dssp -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSG
T ss_pred hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCH
Confidence 00000000 000000 00012245678999999999999999999998764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=388.97 Aligned_cols=287 Identities=38% Similarity=0.651 Sum_probs=247.5
Q ss_pred ccccCHHHHHHhhcCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCc-ccHHHHHHHHHHHhccCccceeeEEEEE
Q 039107 472 CRRFSLAEIKHATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSE-QGVNEFVTEIEMLSKLRHKHLVSLIGFC 550 (817)
Q Consensus 472 ~~~f~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~ 550 (817)
...|++.++..+.++|...++||+|+||.||+|..+++..||||++..... .....+.+|++++++++||||++++++|
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 467899999999999999999999999999999988888999999876532 2334789999999999999999999999
Q ss_pred ecCCeEEEEEEeccCCchhhhhhcccc---ccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEe
Q 039107 551 EEGNEMCLVYDYMALGTLREHIYNTKK---ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVS 627 (817)
Q Consensus 551 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 627 (817)
......++||||+++|+|.+++..... .+++..+..|+.|++.||+|||+.+..+|+||||||+|||+++++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 999999999999999999999976432 59999999999999999999998733359999999999999999999999
Q ss_pred eeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCC--CccccchHHHHHHHh
Q 039107 628 DFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPS--LPKEQVSLADWALHC 705 (817)
Q Consensus 628 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~--~~~~~~~l~~~~~~~ 705 (817)
|||+++...... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||... .......+.+|....
T Consensus 177 Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 177 DFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred cCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 999998653322 23344456999999999999999999999999999999999999999632 122334566787777
Q ss_pred hccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 706 KRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 706 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
.....+..+.+..+......+++..+.+++.+||+.||.+|||+.+|+++|+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 777778888888888888889999999999999999999999999999999864
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=392.66 Aligned_cols=201 Identities=21% Similarity=0.353 Sum_probs=170.8
Q ss_pred HhhcCCCcceeEeeeCceEEEEEEEe----cccEEEEEecCCCCcccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeE
Q 039107 482 HATKSFDESYVIGVGGFGKVYKGVIE----DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEM 556 (817)
Q Consensus 482 ~~~~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 556 (817)
...+.|+..++||+|+||+||+|+.+ .++.||+|++.... ...++.+|+++|+.+ +||||+++++++.+.+..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 35678999999999999999999864 35789999987553 346788999999998 699999999999999999
Q ss_pred EEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCC-ceeEEeeeccCccC
Q 039107 557 CLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDEN-WVAKVSDFGLSKTG 635 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DFGla~~~ 635 (817)
++|||||++|+|.+++. .+++.++..++.||+.||+|||+++ ||||||||+|||++.+ +.+||+|||+|+..
T Consensus 96 ~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp EEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 99999999999999883 4899999999999999999999876 9999999999999876 79999999999754
Q ss_pred CCCCC--------------------------CceeeeeecCcCCCChhhhccC-CCCchHHHHHHHHHHHHHHhCCCCCC
Q 039107 636 PNMEN--------------------------GHVSTVVKGSFGYLDPEYFKRQ-QLTEKSDIYSFGVVLFEVLCARPALN 688 (817)
Q Consensus 636 ~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvvl~elltG~~p~~ 688 (817)
..... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 32110 1112345799999999999775 58999999999999999999999996
Q ss_pred CCC
Q 039107 689 PSL 691 (817)
Q Consensus 689 ~~~ 691 (817)
...
T Consensus 249 ~~~ 251 (361)
T 4f9c_A 249 KAS 251 (361)
T ss_dssp CCS
T ss_pred CCC
Confidence 543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=415.46 Aligned_cols=252 Identities=23% Similarity=0.288 Sum_probs=211.2
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
++|...+.||+|+||+||+|+.+ ++..||+|++........+.+.+|+++|+.|+|||||++++++.+...++||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 57889999999999999999975 57899999987766666778999999999999999999999999999999999999
Q ss_pred cCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCC--ceeEEeeeccCccCCCCCCC
Q 039107 564 ALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDEN--WVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 564 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~--~~~kl~DFGla~~~~~~~~~ 641 (817)
++|+|.++|......+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+++.... .
T Consensus 237 ~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~---~ 310 (573)
T 3uto_A 237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP---K 310 (573)
T ss_dssp CCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCT---T
T ss_pred CCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccC---C
Confidence 999999999776668999999999999999999999876 9999999999999854 8999999999987432 3
Q ss_pred ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccC
Q 039107 642 HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKD 721 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (817)
.......||+.|||||++.+..|+.++|||||||+||||++|++||.+....+.. ..+.. .... +.....
T Consensus 311 ~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~---~~i~~--~~~~----~~~~~~- 380 (573)
T 3uto_A 311 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL---RNVKS--CDWN----MDDSAF- 380 (573)
T ss_dssp SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---HHHHT--TCCC----CCSGGG-
T ss_pred CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH---HHHHh--CCCC----CCcccc-
Confidence 3445668999999999999999999999999999999999999999865443221 11110 0000 111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 722 KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 722 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
...+..+.+|+.+||+.||.+|||+.|+++|
T Consensus 381 ---~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 381 ---SGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp ---TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1234567899999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=404.35 Aligned_cols=250 Identities=22% Similarity=0.292 Sum_probs=200.0
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC---cccHHHH---HHHHHHHhccCccceeeEEEEEecCCeEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS---EQGVNEF---VTEIEMLSKLRHKHLVSLIGFCEEGNEMC 557 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 557 (817)
++|...++||+|+||+||+|+.+ ++..||||++.... ......+ ..++.+++.++|||||++++++.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 56999999999999999999976 57899999986421 1222233 34467777889999999999999999999
Q ss_pred EEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCC
Q 039107 558 LVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPN 637 (817)
Q Consensus 558 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 637 (817)
||||||+||+|.++|.+. +.+++..+..++.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+....
T Consensus 269 lVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp EEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 999999999999999754 46999999999999999999999766 99999999999999999999999999986432
Q ss_pred CCCCceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccC
Q 039107 638 MENGHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIID 716 (817)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (817)
. .....+||+.|||||++.. ..|+.++|+|||||+||||++|++||......+...+...... . .
T Consensus 345 ~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~----~------~ 410 (689)
T 3v5w_A 345 K----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT----M------A 410 (689)
T ss_dssp C----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH----C------C
T ss_pred C----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC----C------C
Confidence 2 2334679999999999975 5799999999999999999999999976433222111111110 0 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHH
Q 039107 717 PLLKDKISPECLKKFADTAEKCLSDSGIDRPS-----MGDVLWNL 756 (817)
Q Consensus 717 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~L 756 (817)
. .++...+.++.+|+.+||+.||.+|++ ++||++|-
T Consensus 411 ~----~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hp 451 (689)
T 3v5w_A 411 V----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP 451 (689)
T ss_dssp C----CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSG
T ss_pred C----CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCc
Confidence 1 122334556799999999999999998 68888764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=364.58 Aligned_cols=281 Identities=36% Similarity=0.648 Sum_probs=230.9
Q ss_pred ccccCHHHHHHhhcCCCcc------eeEeeeCceEEEEEEEecccEEEEEecCCC----CcccHHHHHHHHHHHhccCcc
Q 039107 472 CRRFSLAEIKHATKSFDES------YVIGVGGFGKVYKGVIEDKLKVAIKRSNPS----SEQGVNEFVTEIEMLSKLRHK 541 (817)
Q Consensus 472 ~~~f~~~el~~~~~~f~~~------~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H~ 541 (817)
...|++.++..++++|... +.||+|+||.||+|.. ++..||+|++... .....+.+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4679999999999999887 8999999999999987 4678999987643 233457899999999999999
Q ss_pred ceeeEEEEEecCCeEEEEEEeccCCchhhhhhccc--cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEc
Q 039107 542 HLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTK--KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLD 619 (817)
Q Consensus 542 niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~ 619 (817)
||+++++++...+..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEc
Confidence 99999999999999999999999999999986543 36999999999999999999999876 99999999999999
Q ss_pred CCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHH
Q 039107 620 ENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLA 699 (817)
Q Consensus 620 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~ 699 (817)
+++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|||++|++||........ +.
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~ 244 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--LL 244 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--TT
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--HH
Confidence 999999999999986543333333344578999999998864 589999999999999999999999976543322 12
Q ss_pred HHHHHhh-ccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 039107 700 DWALHCK-RKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVL 760 (817)
Q Consensus 700 ~~~~~~~-~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 760 (817)
.+..... ....+.+.+++.+. .........+.+++.+||+.+|.+|||+.+|+++|+.+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 245 DIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 2222211 22234444444443 345677889999999999999999999999999999875
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=371.25 Aligned_cols=263 Identities=26% Similarity=0.391 Sum_probs=215.9
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
.+|...++||+|+||+||+|... ++..||+|++........+.|.+|++++++++||||+++++++.+.+..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 46788899999999999999975 57889999987766677788999999999999999999999999999999999999
Q ss_pred cCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc-
Q 039107 564 ALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH- 642 (817)
Q Consensus 564 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~- 642 (817)
++|+|.+++......+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.........
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 90 KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp TTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence 999999999876678999999999999999999999876 9999999999999999999999999998643322111
Q ss_pred -----------eeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCch
Q 039107 643 -----------VSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGIL 711 (817)
Q Consensus 643 -----------~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 711 (817)
......||+.|+|||++.+..++.++||||||+++|||++|..|+............ ..
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~----------~~ 236 (310)
T 3s95_A 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL----------NV 236 (310)
T ss_dssp -------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB----------CH
T ss_pred ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh----------hh
Confidence 111457999999999999999999999999999999999999988654332211000 00
Q ss_pred hhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhc
Q 039107 712 DDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVE 764 (817)
Q Consensus 712 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 764 (817)
....+. ..+..++..+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 237 ~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 237 RGFLDR----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp HHHHHH----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred hccccc----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 111111 1122344567899999999999999999999999999876543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=381.20 Aligned_cols=262 Identities=25% Similarity=0.468 Sum_probs=214.6
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe--------cccEEEEEecCCCC-cccHHHHHHHHHHHhcc-CccceeeEEEEEecC
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE--------DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEG 553 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 553 (817)
..+|...+.||+|+||.||+|... ++..||||+++... ....+.+.+|+++|+++ +||||++++++|...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 356888899999999999999863 34579999987653 34457899999999999 899999999999999
Q ss_pred CeEEEEEEeccCCchhhhhhccc---------------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEE
Q 039107 554 NEMCLVYDYMALGTLREHIYNTK---------------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILL 618 (817)
Q Consensus 554 ~~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll 618 (817)
+..++||||+++|+|.+++.... ..+++.+++.++.||+.||+|||+++ |+||||||+||||
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 99999999999999999997543 24899999999999999999999876 9999999999999
Q ss_pred cCCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccch
Q 039107 619 DENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVS 697 (817)
Q Consensus 619 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~ 697 (817)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--- 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence 9999999999999986543332222334457889999999999999999999999999999999 999987643322
Q ss_pred HHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhc
Q 039107 698 LADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVE 764 (817)
Q Consensus 698 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 764 (817)
+..... .+ .....+..+...+.+++.+||+.+|.+||++.|++++|+.++....
T Consensus 314 ~~~~~~----~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 314 LFKLLK----EG---------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp HHHHHH----TT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHh----cC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 111111 11 0111233455678999999999999999999999999999987654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=373.43 Aligned_cols=264 Identities=25% Similarity=0.413 Sum_probs=213.6
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe----cccEEEEEecCCC-CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE----DKLKVAIKRSNPS-SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCL 558 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 558 (817)
..+|...++||+|+||.||+|... .+..||||++... .....+.|.+|+.++++++||||+++++++.+....++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 356888899999999999999974 3456999998765 34445789999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCC
Q 039107 559 VYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNM 638 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 638 (817)
||||+++|+|.+++......+++.+++.|+.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 99999999999999776668999999999999999999999876 999999999999999999999999999865432
Q ss_pred CC-CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccC
Q 039107 639 EN-GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIID 716 (817)
Q Consensus 639 ~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (817)
.. ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+.. ..+. . +
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~---~~~~---~-~------- 270 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVI---SSVE---E-G------- 270 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH---HHHH---T-T-------
T ss_pred ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHH---HHHH---c-C-------
Confidence 22 122233456788999999999999999999999999999999 99999765432211 1111 0 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhccc
Q 039107 717 PLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVEST 766 (817)
Q Consensus 717 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 766 (817)
.....+..++..+.+++.+||+.||.+|||+.+|++.|+.++...++.
T Consensus 271 --~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~ 318 (325)
T 3kul_A 271 --YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESL 318 (325)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC--
T ss_pred --CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccc
Confidence 111123345567899999999999999999999999999998765543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=378.52 Aligned_cols=261 Identities=23% Similarity=0.400 Sum_probs=203.8
Q ss_pred cCCCcceeEeeeCceEEEEEEEe----cccEEEEEecCCC-CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE----DKLKVAIKRSNPS-SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 559 (817)
.+|...++||+|+||.||+|+.. ++..||||+++.. .....++|.+|+.++++++||||+++++++.+....++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 47888999999999999999875 4678999998765 334457899999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC
Q 039107 560 YDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 639 (817)
|||+++|+|.+++......+++.+++.|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 9999999999999876667999999999999999999999876 9999999999999999999999999998653322
Q ss_pred CC-ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCc
Q 039107 640 NG-HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717 (817)
Q Consensus 640 ~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (817)
.. .......++..|+|||++.+..++.++||||||+++|||++ |+.||......+ +...+. .
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~---~~~~i~----~--------- 265 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---VIKAVD----E--------- 265 (373)
T ss_dssp ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH---HHHHHH----T---------
T ss_pred ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----c---------
Confidence 11 11222345788999999999999999999999999999998 999987543221 111111 1
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhc
Q 039107 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVE 764 (817)
Q Consensus 718 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 764 (817)
......+..++..+.+++.+||+.+|.+||++.+|++.|+.+.....
T Consensus 266 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 312 (373)
T 2qol_A 266 GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG 312 (373)
T ss_dssp TEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGG
T ss_pred CCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcc
Confidence 11111223455678999999999999999999999999999986544
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=373.36 Aligned_cols=275 Identities=24% Similarity=0.343 Sum_probs=210.3
Q ss_pred hcCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCC----eEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGN----EMCLV 559 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV 559 (817)
.++|...++||+|+||+||+|+.. +..||||++.... .....+..|+.++++++||||+++++++.... ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 457888999999999999999876 5789999987543 33445667999999999999999999997643 47999
Q ss_pred EEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhC-------CCCceEecCCccCcEEEcCCceeEEeeeccC
Q 039107 560 YDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTG-------AKYTIIHRDVKTTNILLDENWVAKVSDFGLS 632 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------~~~~ivH~Dikp~NIll~~~~~~kl~DFGla 632 (817)
|||+++|+|.+++.. ..+++..++.++.|++.||+|||+. ...+|+||||||+|||++.++.+||+|||++
T Consensus 101 ~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a 178 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178 (322)
T ss_dssp EECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcc
Confidence 999999999999954 4599999999999999999999965 0115999999999999999999999999999
Q ss_pred ccCCCCCCCceeeeeecCcCCCChhhhcc-----CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhc
Q 039107 633 KTGPNMENGHVSTVVKGSFGYLDPEYFKR-----QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKR 707 (817)
Q Consensus 633 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 707 (817)
+...............||+.|+|||++.+ ..++.++|||||||++|||++|+.||....................
T Consensus 179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 258 (322)
T 3soc_A 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258 (322)
T ss_dssp EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence 76543333223334579999999999986 3556789999999999999999999987654333222211100000
Q ss_pred cCch-----hhccCccccCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 039107 708 KGIL-----DDIIDPLLKDK-ISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQL 762 (817)
Q Consensus 708 ~~~~-----~~~~d~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 762 (817)
...+ .....+.+... ....++..+.+++.+||+.||++|||+.+|++.|+.+.+.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 259 LEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0000 00011111111 1235667799999999999999999999999999998765
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=381.79 Aligned_cols=260 Identities=24% Similarity=0.396 Sum_probs=211.9
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
.++|...+.||+|+||.||+|... ++..||||.+.... ....++|.+|+++|++++||||++++++|...+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 346788889999999999999986 67899999987543 2334578899999999999999999999999999999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
|+++|+|.+++......+++.+++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++........
T Consensus 193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 99999999999876667999999999999999999999876 999999999999999999999999999863221111
Q ss_pred ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 642 HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
.......++..|+|||.+..+.++.++|||||||++|||++ |+.||......+ ..+.+. .+ ..
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~---~~~~~~----~~---------~~ 333 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ---TREFVE----KG---------GR 333 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH---HHHHHH----TT---------CC
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----cC---------CC
Confidence 11112235778999999999999999999999999999998 999987543321 111111 11 01
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQL 762 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 762 (817)
...+..++..+.+++.+||+.||++|||+.+|++.|+.+...
T Consensus 334 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 334 LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 112333456789999999999999999999999999988653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=366.50 Aligned_cols=262 Identities=27% Similarity=0.447 Sum_probs=205.2
Q ss_pred HhhcCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCC--cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEE
Q 039107 482 HATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 482 ~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 559 (817)
....+|...+.||+|+||+||+|+. .+..||||++.... ....++|.+|++++++++||||+++++++......++|
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 3456788899999999999999987 46689999987543 33456799999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhcccc--ccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCC
Q 039107 560 YDYMALGTLREHIYNTKK--ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPN 637 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 637 (817)
|||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 999999999999976532 5999999999999999999999652 3499999999999999999999999999975322
Q ss_pred CCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCc
Q 039107 638 MENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717 (817)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (817)
. ........||+.|+|||++.+..++.++||||||+++|||++|+.||......+.. ..... ..
T Consensus 192 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~---~~~~~---~~-------- 255 (309)
T 3p86_A 192 T--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV---AAVGF---KC-------- 255 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHH---HHHHH---SC--------
T ss_pred c--ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHh---cC--------
Confidence 1 12234457999999999999999999999999999999999999999765432211 11100 00
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 039107 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQL 762 (817)
Q Consensus 718 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 762 (817)
.....+..+...+.+++.+||+.+|.+|||+.++++.|+.++..
T Consensus 256 -~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 256 -KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred -CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 01112234455689999999999999999999999999988754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=368.64 Aligned_cols=272 Identities=24% Similarity=0.385 Sum_probs=210.3
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-----cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEec--CCeE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-----DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE--GNEM 556 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~ 556 (817)
.++|+..+.||+|+||+||+|++. ++..||||++........+.|.+|++++++++||||+++++++.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 356888899999999999999852 567899999987776667889999999999999999999999854 3568
Q ss_pred EEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCC
Q 039107 557 CLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGP 636 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 636 (817)
++||||+++|+|.+++......+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 9999999999999999877667999999999999999999999876 9999999999999999999999999998653
Q ss_pred CCCCC-ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhcc----Cch
Q 039107 637 NMENG-HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRK----GIL 711 (817)
Q Consensus 637 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~----~~~ 711 (817)
..... .......++..|+|||.+.+..++.++||||||+++|||++|..|+...... ...+....... ..+
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH----HHHHHCTTCCTHHHHHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH----HHhhhcCccccchhHHHH
Confidence 32211 1222335677899999999999999999999999999999999987543111 00000000000 000
Q ss_pred hhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 039107 712 DDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQL 762 (817)
Q Consensus 712 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 762 (817)
.+.+........+..++..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 242 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 011111111222345567789999999999999999999999999998754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=376.68 Aligned_cols=270 Identities=21% Similarity=0.361 Sum_probs=216.5
Q ss_pred cCHHHHHHhhcCCCcceeEeeeCceEEEEEEEe------cccEEEEEecCCCC-cccHHHHHHHHHHHhcc-CccceeeE
Q 039107 475 FSLAEIKHATKSFDESYVIGVGGFGKVYKGVIE------DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKL-RHKHLVSL 546 (817)
Q Consensus 475 f~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l 546 (817)
+...+.....++|...+.||+|+||.||+|.+. ++..||||++.... ....+.+.+|+++++++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 344455556788999999999999999999843 34689999987643 33456799999999999 79999999
Q ss_pred EEEEecCC-eEEEEEEeccCCchhhhhhcccc------------------------------------------------
Q 039107 547 IGFCEEGN-EMCLVYDYMALGTLREHIYNTKK------------------------------------------------ 577 (817)
Q Consensus 547 ~g~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~------------------------------------------------ 577 (817)
+++|.+.+ ..++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99997754 48999999999999999975432
Q ss_pred -----------------ccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 578 -----------------ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 578 -----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
.+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 2899999999999999999999876 99999999999999999999999999986544333
Q ss_pred CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (817)
........||+.|+|||++.+..++.++||||||+++|||++ |+.||......+.. ..... .+ .
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~~~~~----~~---------~ 313 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRRLK----EG---------T 313 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH--HHHHH----HT---------C
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH--HHHHH----cC---------C
Confidence 334455678999999999999999999999999999999998 99999765432211 11111 11 0
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 039107 720 KDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQL 762 (817)
Q Consensus 720 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 762 (817)
....+..+...+.+++.+||+.||.+|||+.+|+++|+.+++.
T Consensus 314 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 314 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 1111223445689999999999999999999999999998864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=368.68 Aligned_cols=259 Identities=23% Similarity=0.386 Sum_probs=206.4
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cc----cEEEEEecCCC-CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DK----LKVAIKRSNPS-SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCL 558 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 558 (817)
.+|...++||+|+||+||+|+.. ++ .+||+|.+... .....++|.+|+.++++++||||++++++|.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 46888899999999999999864 33 34789987644 3445678999999999999999999999998754 789
Q ss_pred EEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCC
Q 039107 559 VYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNM 638 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 638 (817)
|+||+.+|+|.+++......+++..++.|+.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 99999999999999877778999999999999999999999876 999999999999999999999999999865443
Q ss_pred CCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCc
Q 039107 639 ENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717 (817)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (817)
..........+|..|+|||.+.+..++.++|||||||++|||++ |+.||........ ......
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~~~~~------------- 234 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---SSILEK------------- 234 (327)
T ss_dssp CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHHHT-------------
T ss_pred cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH---HHHHHc-------------
Confidence 33333344567889999999999999999999999999999999 9999976543321 111111
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 039107 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLV 763 (817)
Q Consensus 718 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 763 (817)
......+..+...+.+++.+||+.+|.+||++.+++++|+.+....
T Consensus 235 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 280 (327)
T 3poz_A 235 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred CCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence 1111122334567899999999999999999999999999987654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=368.79 Aligned_cols=260 Identities=24% Similarity=0.373 Sum_probs=208.9
Q ss_pred cCCCcceeEeeeCceEEEEEEEec-cc----EEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIED-KL----KVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCL 558 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 558 (817)
.+|...++||+|+||+||+|.... +. +||+|.+.... ....+.+.+|+.++++++||||++++++|. ....++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 468888999999999999999643 33 48888875442 344467789999999999999999999996 466899
Q ss_pred EEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCC
Q 039107 559 VYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNM 638 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 638 (817)
||||+++|+|.+++......+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 99999999999999877678999999999999999999999876 999999999999999999999999999876544
Q ss_pred CCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCc
Q 039107 639 ENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717 (817)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (817)
..........||..|+|||.+.++.++.++||||||+++|||++ |+.||......+. .+.... +
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~~~----~-------- 233 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV---PDLLEK----G-------- 233 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH---HHHHHT----T--------
T ss_pred cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH---HHHHHc----C--------
Confidence 44444455678899999999999999999999999999999999 9999976543221 111111 1
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhc
Q 039107 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVE 764 (817)
Q Consensus 718 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 764 (817)
.....+..+...+.+++.+||+.||.+||++.+++++|+.+.....
T Consensus 234 -~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~~ 279 (325)
T 3kex_A 234 -ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPP 279 (325)
T ss_dssp -CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSHH
T ss_pred -CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 0011112234457889999999999999999999999999876543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=362.86 Aligned_cols=253 Identities=24% Similarity=0.381 Sum_probs=209.0
Q ss_pred hcCCCcceeEeeeCceEEEEEEE-ecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVI-EDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
.++|...+.||+|+||+||+|.. .++..||+|++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 45789999999999999999985 46789999998766555667899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
+++|+|.+++.. ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 99 ~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 171 (297)
T 3fxz_A 99 LAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--S 171 (297)
T ss_dssp CTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--C
T ss_pred CCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc--c
Confidence 999999999854 35899999999999999999999876 9999999999999999999999999987643322 2
Q ss_pred eeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCC
Q 039107 643 VSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDK 722 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (817)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......... ....... + ...
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~------~~~~~~~------~--~~~ 237 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIATNGT------P--ELQ 237 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHHCS------C--CCS
T ss_pred ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhCCC------C--CCC
Confidence 2344579999999999999999999999999999999999999997654322111 0000000 0 011
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 723 ISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 723 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
.+...+..+.+++.+||+.||.+|||+.|++++-.
T Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~ 272 (297)
T 3fxz_A 238 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQF 272 (297)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred CccccCHHHHHHHHHHccCChhHCcCHHHHhhChh
Confidence 12334566889999999999999999999997643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=364.08 Aligned_cols=265 Identities=22% Similarity=0.313 Sum_probs=217.3
Q ss_pred cccCHHHHHHhhcC----------CCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCcc
Q 039107 473 RRFSLAEIKHATKS----------FDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHK 541 (817)
Q Consensus 473 ~~f~~~el~~~~~~----------f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ 541 (817)
..++.++++.+++. |...+.||+|+||.||+|+.. +++.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 46788888888764 667779999999999999976 6789999998877666778899999999999999
Q ss_pred ceeeEEEEEecCCeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCC
Q 039107 542 HLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDEN 621 (817)
Q Consensus 542 niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~ 621 (817)
||+++++++...+..++||||+++++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLD 177 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTT
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCC
Confidence 999999999999999999999999999998853 46999999999999999999999876 9999999999999999
Q ss_pred ceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHH
Q 039107 622 WVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADW 701 (817)
Q Consensus 622 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~ 701 (817)
+.+||+|||+++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ....
T Consensus 178 ~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~---~~~~ 252 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---AMKR 252 (321)
T ss_dssp CCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHH
T ss_pred CcEEEeeeeeeeecccCc--cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH
Confidence 999999999997643321 12334579999999999999999999999999999999999999997653321 1111
Q ss_pred HHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 702 ALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 702 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
... ...+.+. .....+..+.+++.+||+.||++|||+.+++++...
T Consensus 253 ~~~---------~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~ 298 (321)
T 2c30_A 253 LRD---------SPPPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFL 298 (321)
T ss_dssp HHH---------SSCCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred Hhc---------CCCCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 111 0011111 112234567899999999999999999999986443
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=357.43 Aligned_cols=257 Identities=29% Similarity=0.463 Sum_probs=212.3
Q ss_pred cCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEecc
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMA 564 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 564 (817)
++|...+.||+|+||.||+|...++..||+|++.... ...+++.+|++++++++||||+++++++.+....++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 4688889999999999999998888889999988653 335789999999999999999999999999999999999999
Q ss_pred CCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCcee
Q 039107 565 LGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVS 644 (817)
Q Consensus 565 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 644 (817)
+++|.+++......+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ....
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 164 (269)
T 4hcu_A 89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSS 164 (269)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHST
T ss_pred CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc-cccc
Confidence 99999999776677999999999999999999999876 9999999999999999999999999997542211 1112
Q ss_pred eeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCC
Q 039107 645 TVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKI 723 (817)
Q Consensus 645 ~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 723 (817)
....+|+.|+|||.+.+..++.++||||||++++||++ |+.||......+.. ..... + . ....
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~------~~~~~-~-----~----~~~~ 228 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV------EDIST-G-----F----RLYK 228 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH------HHHHT-T-----C----CCCC
T ss_pred cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHH------HHHhc-C-----c----cCCC
Confidence 23346778999999999999999999999999999999 89998764332211 11110 0 0 1111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 039107 724 SPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQL 762 (817)
Q Consensus 724 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 762 (817)
+...+..+.+++.+||+.+|.+||++.+++++|+.+.+.
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 229 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 222345689999999999999999999999999998753
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=374.40 Aligned_cols=265 Identities=25% Similarity=0.451 Sum_probs=216.4
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe--------cccEEEEEecCCCC-cccHHHHHHHHHHHhcc-CccceeeEEEEEecC
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE--------DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEG 553 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 553 (817)
.++|...++||+|+||+||+|+.. .+..||||++.... ....+++.+|+++++++ +||||++++++|...
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 357888899999999999999863 23579999987653 34457899999999999 899999999999999
Q ss_pred CeEEEEEEeccCCchhhhhhccc---------------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEE
Q 039107 554 NEMCLVYDYMALGTLREHIYNTK---------------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILL 618 (817)
Q Consensus 554 ~~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll 618 (817)
+..++||||+++|+|.+++.... ..+++.+++.|+.||+.||+|||+.+ |+||||||+||||
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence 99999999999999999997543 35999999999999999999999876 9999999999999
Q ss_pred cCCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccch
Q 039107 619 DENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVS 697 (817)
Q Consensus 619 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~ 697 (817)
++++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~--- 301 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--- 301 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence 9999999999999986544333333344567889999999999999999999999999999999 999987543221
Q ss_pred HHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhcccc
Q 039107 698 LADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVESTE 767 (817)
Q Consensus 698 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~ 767 (817)
+...+. .+. ....+..+...+.+++.+||+.||++|||+.+|+++|+.++......+
T Consensus 302 ~~~~~~----~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 302 LFKLLK----EGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp HHHHHH----TTC---------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred HHHHHH----cCC---------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 111111 110 111122345568999999999999999999999999999987765443
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=354.24 Aligned_cols=258 Identities=25% Similarity=0.393 Sum_probs=212.2
Q ss_pred hcCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
.++|...+.||+|+||.||+|..+++..||+|++.... ...+++.+|++++++++||||+++++++......++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 45688899999999999999998888889999987553 33577999999999999999999999999999999999999
Q ss_pred cCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCce
Q 039107 564 ALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643 (817)
Q Consensus 564 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 643 (817)
++++|.+++......+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~ 161 (268)
T 3sxs_A 86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-YVS 161 (268)
T ss_dssp TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC-EEE
T ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh-hhc
Confidence 999999999876667999999999999999999999876 9999999999999999999999999998643321 112
Q ss_pred eeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCC
Q 039107 644 STVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDK 722 (817)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (817)
.....+|+.|+|||.+.+..++.++||||||++++||++ |+.||......+.. ....... ...
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~------~~~~~~~----------~~~ 225 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV------LKVSQGH----------RLY 225 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH------HHHHTTC----------CCC
T ss_pred ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH------HHHHcCC----------CCC
Confidence 223346778999999999899999999999999999999 99998755432211 1111100 001
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 039107 723 ISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQL 762 (817)
Q Consensus 723 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 762 (817)
.+...+..+.+++.+||+.+|.+|||+.+++++|+.+.+.
T Consensus 226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 226 RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 1122345688999999999999999999999999887654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=360.51 Aligned_cols=262 Identities=23% Similarity=0.405 Sum_probs=214.3
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe------cccEEEEEecCCCCc-ccHHHHHHHHHHHhcc-CccceeeEEEEEecCCe
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE------DKLKVAIKRSNPSSE-QGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNE 555 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 555 (817)
.++|...+.||+|+||.||+|+.. ++..||+|++..... ...+.+.+|+.+++++ +||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 457888899999999999999852 357899999876543 3457799999999999 99999999999999999
Q ss_pred EEEEEEeccCCchhhhhhcccc-----------------ccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEE
Q 039107 556 MCLVYDYMALGTLREHIYNTKK-----------------ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILL 618 (817)
Q Consensus 556 ~~lV~Ey~~~gsL~~~l~~~~~-----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll 618 (817)
.++||||+++|+|.+++..... .+++.+++.++.|++.||+|||+++ |+||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 9999999999999999975432 4899999999999999999999876 9999999999999
Q ss_pred cCCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccch
Q 039107 619 DENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVS 697 (817)
Q Consensus 619 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~ 697 (817)
+.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-- 256 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-- 256 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH--
Confidence 9999999999999987544433333344567889999999999999999999999999999999 9999876543221
Q ss_pred HHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 039107 698 LADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLV 763 (817)
Q Consensus 698 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 763 (817)
+...... . .....+...+..+.+++.+||+.||.+|||+.+++++|+.++...
T Consensus 257 ~~~~~~~----~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 257 FYKMIKE----G---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp HHHHHHH----T---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHHhcc----C---------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 1111110 0 111112234566899999999999999999999999999988653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=366.60 Aligned_cols=264 Identities=22% Similarity=0.385 Sum_probs=211.1
Q ss_pred hhcCCCcceeEeeeCceEEEEEEEe------cccEEEEEecCCC-CcccHHHHHHHHHHHhcc-CccceeeEEEEEecCC
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVIE------DKLKVAIKRSNPS-SEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGN 554 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 554 (817)
..++|...+.||+|+||.||+|... .+..||+|.+... .....+.+.+|+.+++++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 3567888999999999999999962 3467999998754 233457899999999999 8999999999999999
Q ss_pred eEEEEEEeccCCchhhhhhcccc----------------------ccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCc
Q 039107 555 EMCLVYDYMALGTLREHIYNTKK----------------------ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVK 612 (817)
Q Consensus 555 ~~~lV~Ey~~~gsL~~~l~~~~~----------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik 612 (817)
..++||||+++|+|.+++..... .+++..++.++.||+.||+|||+++ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 99999999999999999975432 3799999999999999999999876 9999999
Q ss_pred cCcEEEcCCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCC
Q 039107 613 TTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSL 691 (817)
Q Consensus 613 p~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~ 691 (817)
|+|||++.++.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999986544333333445567889999999999999999999999999999998 999997654
Q ss_pred ccccchHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhc
Q 039107 692 PKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVE 764 (817)
Q Consensus 692 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 764 (817)
.... +..... .+ .....+..++..+.+++.+||+.||.+|||+.+|+++|+.++...+
T Consensus 280 ~~~~--~~~~~~----~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 280 VDAN--FYKLIQ----NG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp CSHH--HHHHHH----TT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred cHHH--HHHHHh----cC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 3221 111111 11 1111222345668999999999999999999999999999876543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=375.70 Aligned_cols=263 Identities=26% Similarity=0.407 Sum_probs=211.7
Q ss_pred cCCCcceeEeeeCceEEEEEEEe------cccEEEEEecCCC-CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE------DKLKVAIKRSNPS-SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMC 557 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 557 (817)
++|...++||+|+||+||+|+.. .+..||||++... ......++.+|+.++++++||||+++++++......+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 56888899999999999999853 3468999998754 3445567899999999999999999999999999999
Q ss_pred EEEEeccCCchhhhhhccc------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCc---eeEEee
Q 039107 558 LVYDYMALGTLREHIYNTK------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENW---VAKVSD 628 (817)
Q Consensus 558 lV~Ey~~~gsL~~~l~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~---~~kl~D 628 (817)
+||||+++|+|.+++.... ..+++.+++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEECC
Confidence 9999999999999997543 35899999999999999999999876 99999999999999544 599999
Q ss_pred eccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhc
Q 039107 629 FGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKR 707 (817)
Q Consensus 629 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 707 (817)
||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||......+ +...+..
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~---~~~~i~~--- 301 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VLEFVTS--- 301 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHHHHT---
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHc---
Confidence 999974322222222334467899999999999999999999999999999998 999987654322 1111111
Q ss_pred cCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhccc
Q 039107 708 KGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVEST 766 (817)
Q Consensus 708 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 766 (817)
.. ....+..++..+.+|+.+||+.+|.+||++.+|+++|+.+.+.....
T Consensus 302 ~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~~ 350 (367)
T 3l9p_A 302 GG----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI 350 (367)
T ss_dssp TC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHH
T ss_pred CC----------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhhc
Confidence 10 11112334556899999999999999999999999999998765433
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=360.36 Aligned_cols=261 Identities=23% Similarity=0.404 Sum_probs=213.5
Q ss_pred hhcCCCcceeEeeeCceEEEEEEEe------cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCe
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVIE------DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNE 555 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 555 (817)
..++|...+.||+|+||.||+|... ++..||+|++.... ....+.+.+|++++++++||||+++++++...+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 3567888999999999999999862 34789999987543 3445788999999999999999999999999999
Q ss_pred EEEEEEeccCCchhhhhhccc-----------------------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCc
Q 039107 556 MCLVYDYMALGTLREHIYNTK-----------------------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVK 612 (817)
Q Consensus 556 ~~lV~Ey~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik 612 (817)
.++||||+++++|.+++.... ..+++.+++.++.||+.||+|||+++ |+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 999999999999999997532 24899999999999999999999876 9999999
Q ss_pred cCcEEEcCCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCC
Q 039107 613 TTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSL 691 (817)
Q Consensus 613 p~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~ 691 (817)
|+|||+++++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999986543322222334457889999999999999999999999999999999 999997654
Q ss_pred ccccchHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 039107 692 PKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQL 762 (817)
Q Consensus 692 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 762 (817)
.... ...... + .....+..++..+.+++.+||+.||.+||++.+++++|+.++..
T Consensus 258 ~~~~---~~~~~~----~---------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 258 PERL---FNLLKT----G---------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp GGGH---HHHHHT----T---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHH---HHHhhc----C---------CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 3221 111111 1 01112233456789999999999999999999999999998754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=360.33 Aligned_cols=264 Identities=18% Similarity=0.186 Sum_probs=212.8
Q ss_pred hcCCCcceeEeeeCceEEEEEEE-ecccEEEEEecCCCCcccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeEEEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVI-EDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 561 (817)
..+|...+.||+|+||.||+|+. .++..||||.+..... .+.+.+|+++++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 35788899999999999999996 4678899999765432 24688999999999 99999999999999999999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCce-----eEEeeeccCccCC
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWV-----AKVSDFGLSKTGP 636 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~-----~kl~DFGla~~~~ 636 (817)
|+ +++|.+++......+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99 89999999876668999999999999999999999876 999999999999999887 9999999998643
Q ss_pred CCCCCc-----eeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCch
Q 039107 637 NMENGH-----VSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGIL 711 (817)
Q Consensus 637 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 711 (817)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.......+.........
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 241 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI 241 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH
Confidence 322211 124567999999999999999999999999999999999999999875433322222111111111100
Q ss_pred hhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 039107 712 DDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLV 763 (817)
Q Consensus 712 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 763 (817)
. .+ ...++ .+.+++.+||+.+|.+||++.+|++.|+.+....
T Consensus 242 ~-----~~----~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 242 E-----VL----CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp H-----HH----TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred H-----HH----hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 0 00 11123 7899999999999999999999999999887664
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=362.24 Aligned_cols=261 Identities=23% Similarity=0.379 Sum_probs=205.7
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-ccc----EEEEEecCCC-CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKL----KVAIKRSNPS-SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMC 557 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 557 (817)
..+|...++||+|+||.||+|... ++. +|++|.+... .....+.+.+|+.++++++||||++++++|.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 356888999999999999999964 332 4688887644 3455688999999999999999999999998754 88
Q ss_pred EEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCC
Q 039107 558 LVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPN 637 (817)
Q Consensus 558 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 637 (817)
+|+||+.+|+|.+++......+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 999999999999999877778999999999999999999999876 99999999999999999999999999986543
Q ss_pred CCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccC
Q 039107 638 MENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIID 716 (817)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (817)
...........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......+.. .....
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~---~~~~~------------ 234 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEK------------ 234 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HHHHT------------
T ss_pred ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH---HHHHc------------
Confidence 333333344557889999999999999999999999999999999 99999765433211 11111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhc
Q 039107 717 PLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVE 764 (817)
Q Consensus 717 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 764 (817)
......+..++..+.+++.+||+.||.+||++.++++.|+.+.....
T Consensus 235 -~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 281 (327)
T 3lzb_A 235 -GERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQ 281 (327)
T ss_dssp -TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHH
T ss_pred -CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcC
Confidence 01111223345568999999999999999999999999999886543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=356.47 Aligned_cols=258 Identities=27% Similarity=0.417 Sum_probs=210.0
Q ss_pred hcCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
.++|...+.||+|+||.||+|..+++..||+|++.... ...+++.+|++++++++||||+++++++.+....++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 45688889999999999999999888899999988653 33578999999999999999999999999999999999999
Q ss_pred cCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCce
Q 039107 564 ALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643 (817)
Q Consensus 564 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 643 (817)
++++|.+++......+++.+++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++...... ...
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~ 177 (283)
T 3gen_A 102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTS 177 (283)
T ss_dssp TTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-HHS
T ss_pred CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc-ccc
Confidence 999999999876677999999999999999999999876 9999999999999999999999999997643211 111
Q ss_pred eeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCC
Q 039107 644 STVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDK 722 (817)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (817)
.....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.. ..... + . ...
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~------~~~~~-~-----~----~~~ 241 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA------EHIAQ-G-----L----RLY 241 (283)
T ss_dssp TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH------HHHHT-T-----C----CCC
T ss_pred ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHH------HHHhc-c-----c----CCC
Confidence 122346778999999999999999999999999999998 99999765432211 11010 0 0 011
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 039107 723 ISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQL 762 (817)
Q Consensus 723 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 762 (817)
.+......+.+++.+||+.+|.+|||+.+++++|+.+...
T Consensus 242 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 242 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 1122345688999999999999999999999999998754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=367.98 Aligned_cols=266 Identities=26% Similarity=0.445 Sum_probs=213.7
Q ss_pred HHHhhcCCCcceeEeeeCceEEEEEEEec------ccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEec
Q 039107 480 IKHATKSFDESYVIGVGGFGKVYKGVIED------KLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE 552 (817)
Q Consensus 480 l~~~~~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 552 (817)
+....++|...+.||+|+||.||+|+..+ +..||||.+.... ....+.|.+|+.++++++||||+++++++..
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 33456789999999999999999999753 3789999988653 3345779999999999999999999999999
Q ss_pred CCeEEEEEEeccCCchhhhhhccc-----------------------cccchHhHHHHHHHHHHHHHHHHhCCCCceEec
Q 039107 553 GNEMCLVYDYMALGTLREHIYNTK-----------------------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHR 609 (817)
Q Consensus 553 ~~~~~lV~Ey~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~ 609 (817)
.+..++||||+++|+|.+++.... ..+++.+++.++.||+.||+|||+++ |+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 999999999999999999997532 46899999999999999999999876 9999
Q ss_pred CCccCcEEEcCCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCC
Q 039107 610 DVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALN 688 (817)
Q Consensus 610 Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~ 688 (817)
||||+|||+++++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999975432222222334568899999999999999999999999999999999 999987
Q ss_pred CCCccccchHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhc
Q 039107 689 PSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVE 764 (817)
Q Consensus 689 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 764 (817)
.....+ +...+ ..+.. ...+..++..+.+++.+||+.||.+||++.+|+++|+.+.+..+
T Consensus 279 ~~~~~~---~~~~~----~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 279 GMAHEE---VIYYV----RDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp TSCHHH---HHHHH----HTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred CCChHH---HHHHH----hCCCc---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 543221 11111 11111 11223345678999999999999999999999999999876543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=364.69 Aligned_cols=248 Identities=22% Similarity=0.332 Sum_probs=204.9
Q ss_pred hcCCCcceeEeeeCceEEEEEEE-ecccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVI-EDKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
..+|...+.||+|+||.||+|.. .++..||||++... .....+.+.+|+++|++++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 35788899999999999999997 46789999997643 3344567889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
||+++|+|.+++... +.+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 94 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-- 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-- 167 (328)
T ss_dssp CCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS--
T ss_pred ECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC--
Confidence 999999999998654 45999999999999999999999876 999999999999999999999999999764322
Q ss_pred CceeeeeecCcCCCChhhhccCCCC-chHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQLT-EKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (817)
.......||+.|+|||.+.+..+. .++|||||||++|||++|+.||......+. ...+ .. +.
T Consensus 168 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i---~~-~~--------- 230 (328)
T 3fe3_A 168 -GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL---RERV---LR-GK--------- 230 (328)
T ss_dssp -CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH---HH-CC---------
T ss_pred -CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH---HHHH---Hh-CC---------
Confidence 223445799999999999888775 899999999999999999999976543221 1111 10 10
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 720 KDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 720 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
...+...+..+.+++.+||..||.+|||++|++++
T Consensus 231 -~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 231 -YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp -CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred -CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 01122234567899999999999999999999876
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=363.22 Aligned_cols=266 Identities=23% Similarity=0.399 Sum_probs=198.8
Q ss_pred HHhhcCCCcceeEeeeCceEEEEEEEecc----cEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecCC
Q 039107 481 KHATKSFDESYVIGVGGFGKVYKGVIEDK----LKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGN 554 (817)
Q Consensus 481 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~----~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 554 (817)
....++|...+.||+|+||.||+|..... ..||||.+... .....+.+.+|++++++++||||+++++++....
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 34456899999999999999999986543 27999998764 3445678999999999999999999999998766
Q ss_pred eE------EEEEEeccCCchhhhhhcccc-----ccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCce
Q 039107 555 EM------CLVYDYMALGTLREHIYNTKK-----ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWV 623 (817)
Q Consensus 555 ~~------~lV~Ey~~~gsL~~~l~~~~~-----~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~ 623 (817)
.. ++||||+++|+|.+++..... .+++.+++.++.|++.||+|||+++ |+||||||+|||+++++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCC
Confidence 55 999999999999999864321 5899999999999999999999876 999999999999999999
Q ss_pred eEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHH
Q 039107 624 AKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWA 702 (817)
Q Consensus 624 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~ 702 (817)
+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+.. ...
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~---~~~ 252 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY---NYL 252 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HHH
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH---HHH
Confidence 99999999986543332233344567889999999999999999999999999999999 89998765433211 111
Q ss_pred HHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhcc
Q 039107 703 LHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVES 765 (817)
Q Consensus 703 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 765 (817)
.... ....+..++..+.+++.+||+.||.+|||+.++++.|+.++.....
T Consensus 253 ---~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~ 302 (323)
T 3qup_A 253 ---IGGN----------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSV 302 (323)
T ss_dssp ---HTTC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred ---hcCC----------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhh
Confidence 1100 0111233456789999999999999999999999999999876543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=358.66 Aligned_cols=263 Identities=22% Similarity=0.294 Sum_probs=204.1
Q ss_pred hcCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCC--cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
.++|...++||+|+||+||+|+..++..||+|++.... ....+.+.+|++++++++||||+++++++......++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 35788899999999999999999888999999987542 2234678899999999999999999999999999999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
|++ ++|.+++......+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 100 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~ 173 (311)
T 3niz_A 100 FME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP--V 173 (311)
T ss_dssp CCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC--C
T ss_pred CCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC--c
Confidence 998 5888888776667999999999999999999999876 999999999999999999999999999864322 1
Q ss_pred ceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCc---hh-----
Q 039107 642 HVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGI---LD----- 712 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~----- 712 (817)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+..... ........ ..
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i---~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKI---FSILGTPNPREWPQVQEL 250 (311)
T ss_dssp C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHH---HHHHCCCCTTTSGGGTTS
T ss_pred ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HHHHCCCChHHhhhhhcc
Confidence 22334568999999999876 56899999999999999999999999866544332111 11000000 00
Q ss_pred --------hccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 713 --------DIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 713 --------~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
...+........+....++.+++.+||+.||.+|||++|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0000000000111234567899999999999999999999875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=351.94 Aligned_cols=266 Identities=17% Similarity=0.174 Sum_probs=214.3
Q ss_pred hcCCCcceeEeeeCceEEEEEEE-ecccEEEEEecCCCCcccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeEEEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVI-EDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 561 (817)
.++|...+.||+|+||.||+|.. .++..||||++..... .+.+.+|+.+++++ +|+|++++++++......++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 35688899999999999999996 4678999998764432 35678999999999 79999999999999999999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCce-----eEEeeeccCccCC
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWV-----AKVSDFGLSKTGP 636 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~-----~kl~DFGla~~~~ 636 (817)
|+ +++|.+++......+++.+++.++.|++.||+|||+++ |+||||||+|||++.++. +||+|||+++...
T Consensus 87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99 89999999876667999999999999999999999765 999999999999987766 9999999998654
Q ss_pred CCCCC-----ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCch
Q 039107 637 NMENG-----HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGIL 711 (817)
Q Consensus 637 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 711 (817)
..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........................
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 242 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH
Confidence 33221 1234557999999999999999999999999999999999999999875433322222211111111111
Q ss_pred hhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhc
Q 039107 712 DDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVE 764 (817)
Q Consensus 712 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 764 (817)
.. + ...++..+.+++.+||+.||++||++++|++.|+.+.....
T Consensus 243 ~~-----~----~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 243 RE-----L----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp HH-----H----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HH-----H----HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 11 1 11234568999999999999999999999999999886543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=351.03 Aligned_cols=252 Identities=28% Similarity=0.498 Sum_probs=197.0
Q ss_pred cCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCC----cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSS----EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
.+|...++||+|+||.||+|... +..||||++.... ....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 56888899999999999999975 6789999987542 233577899999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcC--------CceeEEeeeccC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDE--------NWVAKVSDFGLS 632 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~--------~~~~kl~DFGla 632 (817)
||+++++|.+++. .+.+++..++.++.|++.||+|||+++..+|+||||||+|||++. ++.+||+|||++
T Consensus 86 e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~ 163 (271)
T 3dtc_A 86 EFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163 (271)
T ss_dssp ECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-
T ss_pred EcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcc
Confidence 9999999999884 346999999999999999999999876455999999999999986 678999999999
Q ss_pred ccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchh
Q 039107 633 KTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILD 712 (817)
Q Consensus 633 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 712 (817)
+..... ......||+.|+|||.+.+..++.++||||||++++||++|+.||......... .....
T Consensus 164 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~~~~~----- 228 (271)
T 3dtc_A 164 REWHRT----TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA------YGVAM----- 228 (271)
T ss_dssp ----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH------HHHHT-----
T ss_pred cccccc----cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------Hhhhc-----
Confidence 754322 122456899999999999999999999999999999999999999764322111 00000
Q ss_pred hccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 713 DIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 713 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
.......+..++..+.+++.+||+.||.+|||+.+++++|+.
T Consensus 229 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 229 ----NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp ----SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred ----CCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 111112233445678999999999999999999999999975
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=362.95 Aligned_cols=256 Identities=24% Similarity=0.327 Sum_probs=204.0
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
++|...++||+|+||+||+|+.. ++..||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 57888999999999999999976 67889999976443 22346688999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
+++|+|.+++... ..+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 87 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 87 CSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp CTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred CCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 9999999998643 35999999999999999999999776 9999999999999999999999999997643222222
Q ss_pred eeeeeecCcCCCChhhhccCCC-CchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccC
Q 039107 643 VSTVVKGSFGYLDPEYFKRQQL-TEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKD 721 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (817)
......||+.|+|||++.+..+ +.++|||||||++|||++|+.||....... .....|.... .. ..
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~~---~~----~~----- 229 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKK---TY----LN----- 229 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS-HHHHHHHTTC---TT----ST-----
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHHhccc---cc----CC-----
Confidence 3345679999999999987765 789999999999999999999997654322 1122221110 00 00
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 722 KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 722 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
........+.+++.+||+.||.+|||+.|++++-..
T Consensus 230 -~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~ 265 (323)
T 3tki_A 230 -PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 265 (323)
T ss_dssp -TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred -ccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhh
Confidence 012234567899999999999999999999876443
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=352.77 Aligned_cols=271 Identities=21% Similarity=0.289 Sum_probs=213.3
Q ss_pred cCCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCC--eEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGN--EMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~ 560 (817)
++|...++||+|+||+||+|.... +..||||++.... ....+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 568889999999999999999764 7899999987543 334577889999999999999999999987655 789999
Q ss_pred EeccCCchhhhhhcccc--ccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEE----cCCceeEEeeeccCcc
Q 039107 561 DYMALGTLREHIYNTKK--ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILL----DENWVAKVSDFGLSKT 634 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll----~~~~~~kl~DFGla~~ 634 (817)
||+++++|.+++..... .+++.+++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999976543 3999999999999999999999876 9999999999999 8888999999999986
Q ss_pred CCCCCCCceeeeeecCcCCCChhhhc--------cCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccc-hHHHHHHHh
Q 039107 635 GPNMENGHVSTVVKGSFGYLDPEYFK--------RQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQV-SLADWALHC 705 (817)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~ 705 (817)
..... ......||..|+|||++. +..++.++|||||||++|||++|+.||......... ....-....
T Consensus 166 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 166 LEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp CCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred cCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 43322 223456999999999986 578899999999999999999999999754332211 111111111
Q ss_pred hccCchhhcc-----------CccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 039107 706 KRKGILDDII-----------DPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQ 761 (817)
Q Consensus 706 ~~~~~~~~~~-----------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 761 (817)
........+. +..............+.+++.+||+.||++|||++|++++..+...
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 1111110000 0011123456788889999999999999999999999999987653
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=381.05 Aligned_cols=257 Identities=23% Similarity=0.407 Sum_probs=211.3
Q ss_pred hcCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
.++|...+.||+|+||.||+|..+++..||||+++... ...+.|.+|+++|++++||||+++++++. .+..++||||+
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 45678889999999999999999888899999998654 45688999999999999999999999987 56789999999
Q ss_pred cCCchhhhhhcccc-ccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 564 ALGTLREHIYNTKK-ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 564 ~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
++|+|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...... ..
T Consensus 265 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-~~ 340 (454)
T 1qcf_A 265 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YT 340 (454)
T ss_dssp TTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-HH
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-ee
Confidence 99999999976543 6899999999999999999999876 9999999999999999999999999998643211 11
Q ss_pred eeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccC
Q 039107 643 VSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKD 721 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (817)
......++..|+|||++..+.++.++|||||||+||||++ |+.||......+ +...+.. + ...
T Consensus 341 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~---~~~~i~~----~---------~~~ 404 (454)
T 1qcf_A 341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRALER----G---------YRM 404 (454)
T ss_dssp TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHHHHH----T---------CCC
T ss_pred ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHc----C---------CCC
Confidence 1123346788999999999999999999999999999999 999997643322 1111111 1 111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 039107 722 KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQL 762 (817)
Q Consensus 722 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 762 (817)
..+..++..+.+++.+||+.||++|||+++|++.|+.+...
T Consensus 405 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 405 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 12334566789999999999999999999999999887643
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=351.49 Aligned_cols=259 Identities=24% Similarity=0.388 Sum_probs=201.1
Q ss_pred hcCCCcceeEeeeCceEEEEEEEec----ccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIED----KLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCL 558 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 558 (817)
.++|...+.||+|+||.||+|.... +..||+|...... ....+.|.+|+.++++++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 3578889999999999999998743 3569999987543 344567999999999999999999999985 467899
Q ss_pred EEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCC
Q 039107 559 VYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNM 638 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 638 (817)
||||+++++|.+++......+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCcc
Confidence 99999999999999766667999999999999999999999876 999999999999999999999999999864332
Q ss_pred CCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCc
Q 039107 639 ENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717 (817)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (817)
. ........+|+.|+|||.+....++.++||||||+++|||++ |+.||......+. ...+.. ..
T Consensus 170 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~~~i~~---~~-------- 234 (281)
T 1mp8_A 170 T-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRIEN---GE-------- 234 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHHHT---TC--------
T ss_pred c-ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---HHHHHc---CC--------
Confidence 2 112233456789999999999999999999999999999996 9999976543321 111111 00
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 039107 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLV 763 (817)
Q Consensus 718 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 763 (817)
....+..++..+.+++.+||+.||.+|||+.+++++|+.+++..
T Consensus 235 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 235 --RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 01122344567899999999999999999999999999987653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=353.44 Aligned_cols=262 Identities=27% Similarity=0.390 Sum_probs=206.2
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 559 (817)
.++|...+.||+|+||.||+|... ++..||+|.+... .....+.|.+|+.++++++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 356888999999999999999865 5688999987543 233456789999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC
Q 039107 560 YDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 639 (817)
|||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 90 ~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 9999999999998654 46999999999999999999999876 9999999999999999999999999998643221
Q ss_pred CCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccc
Q 039107 640 NGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719 (817)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (817)
........||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ........ . +..
T Consensus 166 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~-~-----~~~ 232 (294)
T 4eqm_A 166 -LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI------AIKHIQDS-V-----PNV 232 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH------HHHHHSSC-C-----CCH
T ss_pred -ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhhcc-C-----CCc
Confidence 1223345699999999999999999999999999999999999999976543211 11111110 0 011
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHhHhh
Q 039107 720 KDKISPECLKKFADTAEKCLSDSGIDRP-SMGDVLWNLEFVLQL 762 (817)
Q Consensus 720 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~~~ 762 (817)
........+..+.+++.+||+.||.+|| +++++.+.|+.++..
T Consensus 233 ~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 233 TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 1111223456689999999999999998 899999888876644
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=357.10 Aligned_cols=271 Identities=21% Similarity=0.360 Sum_probs=216.5
Q ss_pred cCHHHHHHhhcCCCcceeEeeeCceEEEEEEEe------cccEEEEEecCCCCc-ccHHHHHHHHHHHhcc-CccceeeE
Q 039107 475 FSLAEIKHATKSFDESYVIGVGGFGKVYKGVIE------DKLKVAIKRSNPSSE-QGVNEFVTEIEMLSKL-RHKHLVSL 546 (817)
Q Consensus 475 f~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l 546 (817)
+...+.....++|...+.||+|+||.||+|... ++..||||++..... ...+.+.+|+.+++++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 334444455678999999999999999999853 357899999876533 3456789999999999 79999999
Q ss_pred EEEEecCC-eEEEEEEeccCCchhhhhhcccc---------------ccchHhHHHHHHHHHHHHHHHHhCCCCceEecC
Q 039107 547 IGFCEEGN-EMCLVYDYMALGTLREHIYNTKK---------------ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRD 610 (817)
Q Consensus 547 ~g~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~---------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~D 610 (817)
++++...+ ..++||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ |+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 99987654 58999999999999999976533 2899999999999999999999876 99999
Q ss_pred CccCcEEEcCCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCC
Q 039107 611 VKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNP 689 (817)
Q Consensus 611 ikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~ 689 (817)
|||+|||++.++.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999986544333333445568899999999999999999999999999999998 9999876
Q ss_pred CCccccchHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 039107 690 SLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLV 763 (817)
Q Consensus 690 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 763 (817)
...... +..... .+. ....+......+.+++.+||+.||.+|||+.+|+++|+.+++..
T Consensus 254 ~~~~~~--~~~~~~----~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 254 VKIDEE--FCRRLK----EGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp CCCSHH--HHHHHH----HTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cchhHH--HHHHhc----cCc---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 543221 111111 110 01112223456899999999999999999999999999988654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=362.68 Aligned_cols=245 Identities=24% Similarity=0.299 Sum_probs=195.0
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC--cccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 560 (817)
++|...++||+|+||+||+|+.. ++..||||++.... ......+..|+..+.++ +||||++++++|.+.+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57899999999999999999976 67899999876532 23344556677666666 8999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
||+ +++|.+++......++|..++.|+.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~--- 209 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT--- 209 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc---
Confidence 999 67999988776668999999999999999999999876 99999999999999999999999999876432
Q ss_pred CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
........||+.|+|||++.+ .++.++|||||||++|||++|..++..... |... ..+. ..+...
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~--------~~~~--~~~~----~~~~~~ 274 (311)
T 3p1a_A 210 AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG--------WQQL--RQGY----LPPEFT 274 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH--------HHHH--TTTC----CCHHHH
T ss_pred CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH--------HHHH--hccC----CCcccc
Confidence 222344569999999999875 799999999999999999999776643211 1110 1111 111111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
. .....+.+++.+||+.||++|||+.+++++
T Consensus 275 ~----~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 275 A----GLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp T----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred c----CCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 1 234568999999999999999999999874
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=359.33 Aligned_cols=256 Identities=17% Similarity=0.242 Sum_probs=209.9
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
.++|...+.||+|+||.||+|... ++..+|+|.+.... .....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 467888999999999999999976 46789999987543 3456788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcC--CceeEEeeeccCccCCCCCC
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDE--NWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~--~~~~kl~DFGla~~~~~~~~ 640 (817)
+++|+|.+++......+++.+++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++....
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~--- 156 (321)
T 1tki_A 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--- 156 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT---
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC---
Confidence 9999999999766667999999999999999999999876 999999999999987 78999999999986432
Q ss_pred CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..+. .... ..+....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i~---~~~~---~~~~~~~ 227 (321)
T 1tki_A 157 GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII---ENIM---NAEY---TFDEEAF 227 (321)
T ss_dssp TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---HHHH---HTCC---CCCHHHH
T ss_pred CCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHH---HHHH---cCCC---CCChhhh
Confidence 23345567999999999999888999999999999999999999999765432211 1111 1000 0000011
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
. ..+..+.+++.+||+.||.+|||+.|++++-...
T Consensus 228 ~----~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~ 262 (321)
T 1tki_A 228 K----EISIEAMDFVDRLLVKERKSRMTASEALQHPWLK 262 (321)
T ss_dssp T----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred c----cCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhc
Confidence 1 2345678999999999999999999999876543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=360.55 Aligned_cols=250 Identities=24% Similarity=0.344 Sum_probs=206.5
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
++|...++||+|+||+||+++.+ ++..||+|++... .....+.+.+|+++|++++||||+++++++...+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 56888999999999999999976 5788999998643 2334567899999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
||+++|+|.+++... +.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-- 158 (337)
T 1o6l_A 85 EYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-- 158 (337)
T ss_dssp ECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT--
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC--
Confidence 999999999988643 46899999999999999999999876 999999999999999999999999999863221
Q ss_pred CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
........||+.|+|||++.+..++.++|||||||++|||++|+.||....... +...+. . . ..
T Consensus 159 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~i~---~-~------~~--- 222 (337)
T 1o6l_A 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFELIL---M-E------EI--- 222 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH---H-C------CC---
T ss_pred CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH---HHHHHH---c-C------CC---
Confidence 223345679999999999999999999999999999999999999997643221 111111 0 0 00
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRP-----SMGDVLWNLE 757 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L~ 757 (817)
.++...+..+.+++.+||+.||.+|| ++++|++|-.
T Consensus 223 -~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~ 263 (337)
T 1o6l_A 223 -RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263 (337)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred -CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCC
Confidence 11223445678999999999999999 8999998743
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=363.85 Aligned_cols=278 Identities=22% Similarity=0.337 Sum_probs=212.8
Q ss_pred cCCCcceeEeeeCceEEEEEEE-----ecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEe--cCCeEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVI-----EDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCE--EGNEMC 557 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~ 557 (817)
++|...+.||+|+||.||+|++ ..+..||||++........+.+.+|++++++++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5688899999999999999984 356789999998776666778999999999999999999999886 456789
Q ss_pred EEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCC
Q 039107 558 LVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPN 637 (817)
Q Consensus 558 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 637 (817)
+||||+++++|.+++......+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 999999999999999876667999999999999999999999876 99999999999999999999999999986533
Q ss_pred CCCC-ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccC
Q 039107 638 MENG-HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIID 716 (817)
Q Consensus 638 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (817)
.... .......||..|+|||.+.+..++.++||||||+++|||++|+.||....... .....+.........+.+.+.
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 258 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF-LRMMGCERDVPALSRLLELLE 258 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHCC----CCHHHHHHHHHH
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh-hhhcccccccccHHHHHHHhh
Confidence 2211 12233457888999999999999999999999999999999999886432110 000000000000000111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhccc
Q 039107 717 PLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVEST 766 (817)
Q Consensus 717 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 766 (817)
.......+..++..+.+++.+||+.||.+|||+.+++++|+.+.......
T Consensus 259 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 308 (327)
T 3lxl_A 259 EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGC 308 (327)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-------
T ss_pred cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCc
Confidence 11222233455677899999999999999999999999999987655433
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=372.97 Aligned_cols=252 Identities=29% Similarity=0.461 Sum_probs=207.8
Q ss_pred hcCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCC-eEEEEEEe
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGN-EMCLVYDY 562 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~Ey 562 (817)
.++|...+.||+|+||.||+|..+ +..||||+++... ..+.|.+|+++|++++||||+++++++.+.. ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 456788899999999999999886 5689999988654 4578999999999999999999999987654 79999999
Q ss_pred ccCCchhhhhhcccc-ccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 563 MALGTLREHIYNTKK-ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
+++|+|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 342 (450)
T ss_dssp CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc---
Confidence 999999999976544 4799999999999999999999876 999999999999999999999999999853221
Q ss_pred ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 642 HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
.....++..|+|||.+.+..++.++|||||||+||||++ |+.||......+.. ..+ ..+ .+
T Consensus 343 --~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~---~~i----~~~---------~~ 404 (450)
T 1k9a_A 343 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---PRV----EKG---------YK 404 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH---HHH----HTT---------CC
T ss_pred --ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHH----HcC---------CC
Confidence 122357889999999999999999999999999999998 99998765432211 111 111 11
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQL 762 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 762 (817)
...+..++..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 405 ~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 405 MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 122344567789999999999999999999999999988754
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=356.83 Aligned_cols=263 Identities=26% Similarity=0.447 Sum_probs=207.5
Q ss_pred cCCCcceeEeeeCceEEEEEEEec-----ccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIED-----KLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCL 558 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 558 (817)
.+|...++||+|+||.||+|.... +..||||.+.... ......+.+|+.++++++||||+++++++...+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 456778899999999999998653 2469999987543 3345678999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCC
Q 039107 559 VYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNM 638 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 638 (817)
||||+++|+|.+++......+++.+++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 99999999999999776667999999999999999999999876 999999999999999999999999999864332
Q ss_pred CCC-ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccC
Q 039107 639 ENG-HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIID 716 (817)
Q Consensus 639 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (817)
... .......+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+ +...+ . .+
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---~~~~~---~-~~------- 266 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---VMKAI---N-DG------- 266 (333)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHH---H-TT-------
T ss_pred cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH---HHHHH---H-CC-------
Confidence 211 11223346788999999999999999999999999999999 999996543221 11111 1 11
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhccc
Q 039107 717 PLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVEST 766 (817)
Q Consensus 717 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 766 (817)
.....+..++..+.+++.+||+.+|.+||++.+++++|+.++......
T Consensus 267 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~ 314 (333)
T 1mqb_A 267 --FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 314 (333)
T ss_dssp --CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGG
T ss_pred --CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhh
Confidence 011112234567899999999999999999999999999988765543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=364.68 Aligned_cols=253 Identities=21% Similarity=0.270 Sum_probs=208.8
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
..+|...+.||+|+||.||+|... ++..||+|.+..........+.+|+++|++++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 357889999999999999999975 5688999998766555567899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcC--CceeEEeeeccCccCCCCCC
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDE--NWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~--~~~~kl~DFGla~~~~~~~~ 640 (817)
+++|+|.+++......+++.+++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++....
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~--- 203 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP--- 203 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT---
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCC---
Confidence 9999999999776667999999999999999999999876 999999999999974 47899999999986432
Q ss_pred CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..+.. .. ....
T Consensus 204 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~---~~i~~---~~-------~~~~ 270 (387)
T 1kob_A 204 DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL---QNVKR---CD-------WEFD 270 (387)
T ss_dssp TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---HHHHH---CC-------CCCC
T ss_pred CcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHH---HHHHh---CC-------CCCC
Confidence 22334557999999999999999999999999999999999999999765432211 11111 00 0011
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.......+..+.+++.+||+.||.+|||+.+++++
T Consensus 271 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 271 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 11112344568999999999999999999999976
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=376.09 Aligned_cols=257 Identities=29% Similarity=0.454 Sum_probs=206.9
Q ss_pred hcCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
.++|...++||+|+||.||+|..+++..||||+++... ...++|.+|+++|++++||||+++++++.+ +..++||||+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 35677888999999999999999888889999998654 345789999999999999999999999976 6789999999
Q ss_pred cCCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 564 ALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 564 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
++|+|.+++.... ..+++.+++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~ 336 (452)
T 1fmk_A 261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YT 336 (452)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCc-ee
Confidence 9999999997543 36999999999999999999999876 9999999999999999999999999998643321 11
Q ss_pred eeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccC
Q 039107 643 VSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKD 721 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (817)
......++..|+|||.+..+.++.++||||||++||||++ |+.||......+. ...+ . .+ .+.
T Consensus 337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~~~i---~-~~---------~~~ 400 (452)
T 1fmk_A 337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---LDQV---E-RG---------YRM 400 (452)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHHH---H-TT---------CCC
T ss_pred cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH---HHHH---H-cC---------CCC
Confidence 2233457889999999999999999999999999999999 8999876543221 1111 1 11 111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 039107 722 KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQL 762 (817)
Q Consensus 722 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 762 (817)
..+..++..+.+++.+||+.||++|||+++|++.|+.+...
T Consensus 401 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 401 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 22334566789999999999999999999999999987643
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=359.21 Aligned_cols=263 Identities=25% Similarity=0.469 Sum_probs=213.0
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe--------cccEEEEEecCCCC-cccHHHHHHHHHHHhcc-CccceeeEEEEEecC
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE--------DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEG 553 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 553 (817)
.++|...+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+++++++ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 457888999999999999999863 45789999987653 34457799999999999 899999999999999
Q ss_pred CeEEEEEEeccCCchhhhhhccc---------------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEE
Q 039107 554 NEMCLVYDYMALGTLREHIYNTK---------------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILL 618 (817)
Q Consensus 554 ~~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll 618 (817)
+..++||||+++|+|.+++.... ..+++.+++.++.||+.||+|||+.+ |+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 99999999999999999997543 24899999999999999999999876 9999999999999
Q ss_pred cCCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccch
Q 039107 619 DENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVS 697 (817)
Q Consensus 619 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~ 697 (817)
+.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--- 267 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 267 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH---
Confidence 9999999999999986543322222334457889999999999999999999999999999999 999987543221
Q ss_pred HHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhcc
Q 039107 698 LADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVES 765 (817)
Q Consensus 698 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 765 (817)
+...... +. ....+..+...+.+++.+||+.+|.+||++.+++++|+.++.....
T Consensus 268 ~~~~~~~----~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 268 LFKLLKE----GH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp HHHHHHH----TC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHHHHhc----CC---------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 1111111 10 0112233456689999999999999999999999999999876543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=354.94 Aligned_cols=252 Identities=25% Similarity=0.394 Sum_probs=205.3
Q ss_pred cCCCcceeEeeeCceEEEEEEEec-c-------cEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIED-K-------LKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEM 556 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 556 (817)
++|...+.||+|+||+||+|.... + ..||+|.+........+.+.+|+.++++++||||+++++++...+..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 568888999999999999998653 2 46999998876666678899999999999999999999999999999
Q ss_pred EEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCce--------eEEee
Q 039107 557 CLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWV--------AKVSD 628 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~--------~kl~D 628 (817)
++||||+++|+|.+++......+++..++.++.|++.||+|||+++ |+||||||+|||++.++. +||+|
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred EEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeeecc
Confidence 9999999999999999877667999999999999999999999876 999999999999998876 99999
Q ss_pred eccCccCCCCCCCceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhc
Q 039107 629 FGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKR 707 (817)
Q Consensus 629 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 707 (817)
||++..... .....||..|+|||.+.+ ..++.++||||||+++|||++|..|+......... . .....
T Consensus 165 fg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~--~---~~~~~ 233 (289)
T 4fvq_A 165 PGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK--L---QFYED 233 (289)
T ss_dssp CCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--H---HHHHT
T ss_pred CcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH--H---HHhhc
Confidence 999875321 223458999999999987 77999999999999999999966554433222110 0 00000
Q ss_pred cCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 039107 708 KGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQL 762 (817)
Q Consensus 708 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 762 (817)
.. .+ +......+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus 234 ~~--------~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 234 RH--------QL----PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp TC--------CC----CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred cC--------CC----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 00 11 111234578999999999999999999999999987753
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=351.21 Aligned_cols=262 Identities=20% Similarity=0.261 Sum_probs=201.8
Q ss_pred cCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCc--ccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSE--QGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
++|...+.||+|+||+||+|....+..||+|++..... ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 46888899999999999999987788999999865432 2346788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
+++ +|.+++......+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP--VR 155 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcc--cc
Confidence 985 999988776667999999999999999999999876 999999999999999999999999999754221 11
Q ss_pred eeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCc------hhh--
Q 039107 643 VSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGI------LDD-- 713 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------~~~-- 713 (817)
......||+.|+|||++.+ ..++.++|||||||++|||++|++||......+.... ......... ..+
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 232 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR---IFRILGTPNSKNWPNVTELP 232 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCCCTTTSTTGGGST
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHHCCCChhhchhhhccc
Confidence 2234468999999999876 4589999999999999999999999976543322111 111000000 000
Q ss_pred ccCccc-------cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 714 IIDPLL-------KDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 714 ~~d~~l-------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
..++.. ...........+.+++.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 001100 011112344567899999999999999999999875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=353.24 Aligned_cols=257 Identities=28% Similarity=0.500 Sum_probs=201.3
Q ss_pred cCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEecc
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMA 564 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 564 (817)
++|...++||+|+||+||+|+.. +..||+|++... ...+.|.+|++++++++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 46788899999999999999875 568999998743 345789999999999999999999998873 4799999999
Q ss_pred CCchhhhhhcccc--ccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCce-eEEeeeccCccCCCCCCC
Q 039107 565 LGTLREHIYNTKK--ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWV-AKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 565 ~gsL~~~l~~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~-~kl~DFGla~~~~~~~~~ 641 (817)
+|+|.+++..... .+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||++.....
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~---- 158 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT---- 158 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc----
Confidence 9999999976543 4788999999999999999999843356999999999999988876 79999999975322
Q ss_pred ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccC
Q 039107 642 HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKD 721 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (817)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ . ..|... .+. .+..
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~-~~~~~~---~~~-----~~~~-- 225 (307)
T 2eva_A 159 -HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF-R-IMWAVH---NGT-----RPPL-- 225 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH-H-HHHHHH---TTC-----CCCC--
T ss_pred -ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH-H-HHHHHh---cCC-----CCCc--
Confidence 12234689999999999999999999999999999999999999975432211 1 111111 110 0111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhcc
Q 039107 722 KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVES 765 (817)
Q Consensus 722 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 765 (817)
...++..+.+++.+||+.||.+|||+.+++++|+.+.+....
T Consensus 226 --~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 226 --IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp --BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred --ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 123345678999999999999999999999999998866543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=361.34 Aligned_cols=252 Identities=21% Similarity=0.264 Sum_probs=204.7
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCc------ccHHHHHHHHHHHhccCccceeeEEEEEecCCeE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSE------QGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEM 556 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 556 (817)
...|...+.||+|+||.||+|+.+ ++..||+|.+..... ...+.+.+|+.+|++++||||+++++++......
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 456888999999999999999976 578899998765422 1357899999999999999999999999999999
Q ss_pred EEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCc----eeEEeeeccC
Q 039107 557 CLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENW----VAKVSDFGLS 632 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~----~~kl~DFGla 632 (817)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++ .+||+|||++
T Consensus 91 ~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 9999999999999998653 46999999999999999999999876 99999999999998876 7999999999
Q ss_pred ccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchh
Q 039107 633 KTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILD 712 (817)
Q Consensus 633 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 712 (817)
+..... .......||+.|+|||++.+..++.++|||||||++|||++|++||......+.. ..+. ...
T Consensus 167 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~---~~i~----~~~-- 234 (361)
T 2yab_A 167 HEIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---ANIT----AVS-- 234 (361)
T ss_dssp EECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---HHHH----TTC--
T ss_pred eEcCCC---CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHH----hcC--
Confidence 864332 2233456999999999999999999999999999999999999999765432211 1110 000
Q ss_pred hccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 713 DIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 713 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
..+++.... ..+..+.+++.+||..||.+|||+.|+++|
T Consensus 235 ~~~~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 235 YDFDEEFFS----QTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp CCCCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCCchhcc----CCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 001111111 224567899999999999999999999975
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=350.32 Aligned_cols=261 Identities=29% Similarity=0.532 Sum_probs=198.3
Q ss_pred hcCCCcceeEeeeCceEEEEEEEecccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
..+|...++||+|+||+||+|+..+ .||+|++... .....+.|.+|++++++++||||+++++++. ....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEEEE
Confidence 4568889999999999999998654 5999987654 3344578999999999999999999999764 466899999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
|+++++|.+++......+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 176 (289)
T 3og7_A 100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS 176 (289)
T ss_dssp CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccccc
Confidence 99999999999777778999999999999999999999876 999999999999999999999999999764433333
Q ss_pred ceeeeeecCcCCCChhhhc---cCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcc
Q 039107 642 HVSTVVKGSFGYLDPEYFK---RQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPL 718 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (817)
.......||+.|+|||.+. ...++.++||||||+++|||++|+.||......+. +...... +.. .+.
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~----~~~----~~~ 246 (289)
T 3og7_A 177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEMVGR----GSL----SPD 246 (289)
T ss_dssp -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHHHHHH----TSC----CCC
T ss_pred ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHHHhcc----ccc----Ccc
Confidence 3334567999999999986 66789999999999999999999999976543321 1111111 111 111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 039107 719 LKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQ 761 (817)
Q Consensus 719 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 761 (817)
+ ......++..+.+++.+||+.+|.+|||+.++++.|+.+.+
T Consensus 247 ~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 247 L-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp T-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred h-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 1 11223455678999999999999999999999999998753
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=381.69 Aligned_cols=257 Identities=24% Similarity=0.414 Sum_probs=212.2
Q ss_pred hcCCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
..+|...++||+|+||.||+|.++. +..||||.++... ...++|.+|+.+|++++||||++++++|......++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 3467788899999999999999875 6789999988653 3468899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 563 MALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 563 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
|++|+|.+++.... ..+++..++.|+.||+.||+|||+++ |+||||||+||||++++.+||+|||+++...... .
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~ 373 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-Y 373 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-E
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc-e
Confidence 99999999997643 46999999999999999999999876 9999999999999999999999999998643221 1
Q ss_pred ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 642 HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
.......++..|+|||++..+.++.++|||||||+||||++ |+.||......+ +.+.+.. ...
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~~~~~~-------------~~~ 437 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELLEK-------------DYR 437 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHHHT-------------TCC
T ss_pred eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHc-------------CCC
Confidence 11223346788999999999999999999999999999999 899987654322 1111111 111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQ 761 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 761 (817)
...+..++..+.+|+.+||+.||.+|||+.+|++.|+.+.+
T Consensus 438 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 12233456678999999999999999999999999987753
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=351.13 Aligned_cols=264 Identities=23% Similarity=0.365 Sum_probs=200.9
Q ss_pred hcCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhc--cCccceeeEEEEEec----CCeEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSK--LRHKHLVSLIGFCEE----GNEMC 557 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~----~~~~~ 557 (817)
.++|...+.||+|+||+||+|+. ++..||||++... ....+..|.+++.. ++||||+++++++.. ....+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 45788899999999999999987 5678999998643 34566677777766 799999999998644 35589
Q ss_pred EEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhC-----CCCceEecCCccCcEEEcCCceeEEeeeccC
Q 039107 558 LVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTG-----AKYTIIHRDVKTTNILLDENWVAKVSDFGLS 632 (817)
Q Consensus 558 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivH~Dikp~NIll~~~~~~kl~DFGla 632 (817)
+||||+++|+|.+++.. ..+++..++.++.|++.||+|||+. ++.+|+||||||+|||++.++.+||+|||++
T Consensus 83 lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 160 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA 160 (301)
T ss_dssp EEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence 99999999999999943 4699999999999999999999921 1235999999999999999999999999999
Q ss_pred ccCCCCCCCc--eeeeeecCcCCCChhhhccC------CCCchHHHHHHHHHHHHHHhC----------CCCCCCCCccc
Q 039107 633 KTGPNMENGH--VSTVVKGSFGYLDPEYFKRQ------QLTEKSDIYSFGVVLFEVLCA----------RPALNPSLPKE 694 (817)
Q Consensus 633 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~~sDV~S~Gvvl~elltG----------~~p~~~~~~~~ 694 (817)
+......... ......||+.|+|||++.+. .++.++|||||||++|||++| +.||.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~ 240 (301)
T 3q4u_A 161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240 (301)
T ss_dssp EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence 7543322111 12234799999999999876 455799999999999999999 77876543322
Q ss_pred cchHHHHHHHhhccCchhhccCcccc-CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 695 QVSLADWALHCKRKGILDDIIDPLLK-DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 695 ~~~l~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
.. ............ ..+.+. ......++..+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus 241 ~~-~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 241 PS-FEDMRKVVCVDQ-----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CC-HHHHHHHHTTSC-----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cc-hhhhhHHHhccC-----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 11 111111111111 011111 112345778899999999999999999999999999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=347.14 Aligned_cols=256 Identities=29% Similarity=0.458 Sum_probs=211.3
Q ss_pred cCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEecc
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMA 564 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 564 (817)
++|...+.||+|+||.||+|...++..||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 46888899999999999999988888999999886543 34789999999999999999999999999999999999999
Q ss_pred CCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCcee
Q 039107 565 LGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVS 644 (817)
Q Consensus 565 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 644 (817)
+++|.+++......+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++...... ....
T Consensus 87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~ 162 (267)
T 3t9t_A 87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSS 162 (267)
T ss_dssp TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHST
T ss_pred CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc-cccc
Confidence 99999999776667999999999999999999999876 9999999999999999999999999997642211 1111
Q ss_pred eeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCC
Q 039107 645 TVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKI 723 (817)
Q Consensus 645 ~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 723 (817)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ..... . .+ . ....
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~i---~-~~-----~----~~~~ 226 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDI---S-TG-----F----RLYK 226 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHH---H-TT-----C----CCCC
T ss_pred ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH---HHHHH---h-cC-----C----cCCC
Confidence 22346788999999999999999999999999999999 899987543221 11111 1 11 0 0111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 039107 724 SPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQ 761 (817)
Q Consensus 724 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 761 (817)
+...+..+.+++.+||+.+|.+||++.+++++|+.+.+
T Consensus 227 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 227 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 22234568899999999999999999999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=359.99 Aligned_cols=268 Identities=23% Similarity=0.392 Sum_probs=214.5
Q ss_pred CHHHHHHhhcCCCcceeEeeeCceEEEEEEEe------cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEE
Q 039107 476 SLAEIKHATKSFDESYVIGVGGFGKVYKGVIE------DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIG 548 (817)
Q Consensus 476 ~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g 548 (817)
..++.....++|...+.||+|+||.||+|+.. .+..||+|.+.... ......|.+|+.++++++||||+++++
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 33444556678999999999999999999865 35789999987543 334567899999999999999999999
Q ss_pred EEecCCeEEEEEEeccCCchhhhhhccc---------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEc
Q 039107 549 FCEEGNEMCLVYDYMALGTLREHIYNTK---------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLD 619 (817)
Q Consensus 549 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~ 619 (817)
++...+..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~ 172 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVA 172 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEEC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEc
Confidence 9999999999999999999999987533 34689999999999999999999876 99999999999999
Q ss_pred CCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchH
Q 039107 620 ENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSL 698 (817)
Q Consensus 620 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l 698 (817)
.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+ +
T Consensus 173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~ 249 (322)
T 1p4o_A 173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---V 249 (322)
T ss_dssp TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH---H
T ss_pred CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH---H
Confidence 999999999999975432222122233457889999999999999999999999999999999 888886543221 1
Q ss_pred HHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 039107 699 ADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQL 762 (817)
Q Consensus 699 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 762 (817)
.... .. +.. ...+..++..+.+++.+||+.||.+|||+.+++++|+..+..
T Consensus 250 ~~~~---~~-~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 250 LRFV---ME-GGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp HHHH---HT-TCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred HHHH---Hc-CCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 1111 11 100 011223456689999999999999999999999999887653
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=359.45 Aligned_cols=263 Identities=24% Similarity=0.386 Sum_probs=212.9
Q ss_pred hhcCCCcceeEeeeCceEEEEEEEec------ccEEEEEecCCCC-cccHHHHHHHHHHHhcc-CccceeeEEEEEecCC
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVIED------KLKVAIKRSNPSS-EQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGN 554 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 554 (817)
..++|...+.||+|+||.||+|.... ...||+|.+.... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 35678889999999999999998643 2479999987653 33456799999999999 8999999999999999
Q ss_pred eEEEEEEeccCCchhhhhhccc-------------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCC
Q 039107 555 EMCLVYDYMALGTLREHIYNTK-------------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDEN 621 (817)
Q Consensus 555 ~~~lV~Ey~~~gsL~~~l~~~~-------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~ 621 (817)
..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCC
Confidence 9999999999999999987542 25789999999999999999999876 9999999999999999
Q ss_pred ceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHH
Q 039107 622 WVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLAD 700 (817)
Q Consensus 622 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~ 700 (817)
+.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........ +..
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~~~ 278 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK--FYK 278 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH--HHH
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH--HHH
Confidence 9999999999986543333233334567889999999999999999999999999999998 8899876543221 111
Q ss_pred HHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 039107 701 WALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLV 763 (817)
Q Consensus 701 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 763 (817)
.... + .....+..++..+.+++.+||+.||.+|||+.+|+++|+.+.+..
T Consensus 279 ~~~~----~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 279 LVKD----G---------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp HHHH----T---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHhc----C---------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 1111 0 011112223456889999999999999999999999999987654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=364.10 Aligned_cols=253 Identities=23% Similarity=0.273 Sum_probs=201.8
Q ss_pred CCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccC
Q 039107 487 FDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMAL 565 (817)
Q Consensus 487 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 565 (817)
+...++||+|+||.||+|... ++..||+|++........+.+.+|+++|++++||||+++++++...+..++||||+++
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 334568999999999999864 5789999998876656678899999999999999999999999999999999999999
Q ss_pred CchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEE--cCCceeEEeeeccCccCCCCCCCce
Q 039107 566 GTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILL--DENWVAKVSDFGLSKTGPNMENGHV 643 (817)
Q Consensus 566 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll--~~~~~~kl~DFGla~~~~~~~~~~~ 643 (817)
++|.+++......+++..++.++.||+.||+|||+.+ |+||||||+|||+ ++++.+||+|||+++...... .
T Consensus 171 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~ 244 (373)
T 2x4f_A 171 GELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---K 244 (373)
T ss_dssp CEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---B
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---c
Confidence 9999999776667999999999999999999999876 9999999999999 677899999999998643322 2
Q ss_pred eeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCC
Q 039107 644 STVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKI 723 (817)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 723 (817)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..... .... +.....
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~i~~---~~~~----~~~~~~--- 312 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETL--NNILA---CRWD----LEDEEF--- 312 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--HHHHH---TCCC----SCSGGG---
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHh---ccCC----CChhhh---
Confidence 23446999999999999999999999999999999999999999765433211 11110 0000 000111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 724 SPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 724 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
......+.+++.+||+.||.+|||+.|++++-..
T Consensus 313 -~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~ 346 (373)
T 2x4f_A 313 -QDISEEAKEFISKLLIKEKSWRISASEALKHPWL 346 (373)
T ss_dssp -TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred -ccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCc
Confidence 1234567999999999999999999999986443
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=363.95 Aligned_cols=271 Identities=15% Similarity=0.166 Sum_probs=209.2
Q ss_pred hcCCCcceeEeeeCceEEEEEEEec------ccEEEEEecCCCCccc-----------HHHHHHHHHHHhccCccceeeE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIED------KLKVAIKRSNPSSEQG-----------VNEFVTEIEMLSKLRHKHLVSL 546 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~H~niv~l 546 (817)
.++|...++||+|+||.||+|.+.. +..||||++....... ...+..|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4578999999999999999998765 3679999977553211 1234456667778889999999
Q ss_pred EEEEecC----CeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEc--C
Q 039107 547 IGFCEEG----NEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLD--E 620 (817)
Q Consensus 547 ~g~~~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~--~ 620 (817)
++++... ...+|||||+ +++|.+++......+++.+++.|+.||+.||+|||+++ |+||||||+||||+ .
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESSC
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecCC
Confidence 9998664 4589999999 99999999876678999999999999999999999876 99999999999999 8
Q ss_pred CceeEEeeeccCccCCCCCCC-----ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCcccc
Q 039107 621 NWVAKVSDFGLSKTGPNMENG-----HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQ 695 (817)
Q Consensus 621 ~~~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~ 695 (817)
++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||+||||++|+.||........
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 899999999999764322111 112344599999999999999999999999999999999999999975432221
Q ss_pred chHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhc
Q 039107 696 VSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVE 764 (817)
Q Consensus 696 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 764 (817)
...+..... ...+.+++++.+.. ..++..+.+++..||+.+|.+||++.+|++.|+.++....
T Consensus 270 --~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~ 332 (364)
T 3op5_A 270 --YVRDSKIRY-RENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG 332 (364)
T ss_dssp --HHHHHHHHH-HHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred --HHHHHHHHh-hhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 111111111 11233333333321 1234568999999999999999999999999999987654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=357.33 Aligned_cols=274 Identities=26% Similarity=0.390 Sum_probs=211.1
Q ss_pred CCcceeEeeeCceEEEEEEEe-----cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEec--CCeEEE
Q 039107 487 FDESYVIGVGGFGKVYKGVIE-----DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE--GNEMCL 558 (817)
Q Consensus 487 f~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~l 558 (817)
|...+.||+|+||+||++.++ ++..||||++.... ....+.+.+|++++++++||||+++++++.. ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 478889999999999998753 56789999988653 3445779999999999999999999999977 467899
Q ss_pred EEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCC
Q 039107 559 VYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNM 638 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 638 (817)
||||+++|+|.+++... .+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 113 v~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp EECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred EEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 99999999999998543 4999999999999999999999876 999999999999999999999999999865432
Q ss_pred CCC-ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCc
Q 039107 639 ENG-HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717 (817)
Q Consensus 639 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (817)
... .......+|..|+|||.+.+..++.++||||||+++|||++|+.||....... ..+..+.........+.+.++.
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 266 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMTVLRLTELLER 266 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHHHHHHHHHHHHT
T ss_pred ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccchhHHHHHHHHhc
Confidence 211 12334467888999999999999999999999999999999999986432110 0000000000000011111112
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhccc
Q 039107 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVEST 766 (817)
Q Consensus 718 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 766 (817)
......+..++..+.+++.+||+.||.+|||+.++++.|+.+.+.....
T Consensus 267 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 267 GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 2222233455677899999999999999999999999999988776544
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=356.27 Aligned_cols=252 Identities=20% Similarity=0.260 Sum_probs=204.1
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCc------ccHHHHHHHHHHHhccCccceeeEEEEEecCCeEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSE------QGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMC 557 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 557 (817)
++|...+.||+|+||.||+|... ++..||+|.+..... ...+.+.+|+.+|++++||||+++++++......+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45888899999999999999976 568899998764321 23578999999999999999999999999999999
Q ss_pred EEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCc----eeEEeeeccCc
Q 039107 558 LVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENW----VAKVSDFGLSK 633 (817)
Q Consensus 558 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~----~~kl~DFGla~ 633 (817)
+||||+++++|.+++... ..+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++
T Consensus 91 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 999999999999998653 46999999999999999999999776 99999999999999887 89999999998
Q ss_pred cCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhh
Q 039107 634 TGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDD 713 (817)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 713 (817)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .... ....
T Consensus 167 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---~~~~--~~~~--- 235 (326)
T 2y0a_A 167 KIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA---NVSA--VNYE--- 235 (326)
T ss_dssp ECCTT---SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH---HHHH--TCCC---
T ss_pred ECCCC---CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH---HHHh--cCCC---
Confidence 64322 12234569999999999999999999999999999999999999997654322111 0000 0000
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 714 IIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 714 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
...... ...+..+.+++.+||+.||.+|||+.+++++-
T Consensus 236 -~~~~~~----~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 273 (326)
T 2y0a_A 236 -FEDEYF----SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 273 (326)
T ss_dssp -CCHHHH----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred -cCcccc----ccCCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence 000011 12345678999999999999999999999863
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=347.50 Aligned_cols=262 Identities=24% Similarity=0.413 Sum_probs=211.9
Q ss_pred cCCCcce-eEeeeCceEEEEEEEe---cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEE
Q 039107 485 KSFDESY-VIGVGGFGKVYKGVIE---DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 485 ~~f~~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 559 (817)
++|.... .||+|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 3455555 8999999999999854 56789999988653 34567899999999999999999999999 45678999
Q ss_pred EEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC
Q 039107 560 YDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 639 (817)
|||+++++|.+++......+++.+++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 164 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164 (287)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence 9999999999999766667999999999999999999999876 9999999999999999999999999998653322
Q ss_pred CC-ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCc
Q 039107 640 NG-HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717 (817)
Q Consensus 640 ~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (817)
.. .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+ +...+.. +
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~i~~----~-------- 229 (287)
T 1u59_A 165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFIEQ----G-------- 229 (287)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHHHHHT----T--------
T ss_pred ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHhc----C--------
Confidence 11 11223356889999999998899999999999999999998 999997654322 1111111 1
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhccc
Q 039107 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVEST 766 (817)
Q Consensus 718 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 766 (817)
.....+..++..+.+++.+||+.+|.+||++.+++++|+.+.......
T Consensus 230 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 230 -KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp -CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred -CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 011123345567899999999999999999999999999998765544
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=375.66 Aligned_cols=268 Identities=21% Similarity=0.251 Sum_probs=213.1
Q ss_pred cCHHHHHHhhcCCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEE
Q 039107 475 FSLAEIKHATKSFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFC 550 (817)
Q Consensus 475 f~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 550 (817)
+.+.+++...++|...++||+|+||+||+|+.+. +..||+|++... .....+.+.+|+.++..++||||++++++|
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 4456677778899999999999999999999865 578999998642 112234488999999999999999999999
Q ss_pred ecCCeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeec
Q 039107 551 EEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFG 630 (817)
Q Consensus 551 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFG 630 (817)
.+.+..+||||||++|+|.+++......+++..+..++.||+.||+|||+.+ ||||||||+||||+.++.+||+|||
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence 9999999999999999999999876667999999999999999999999776 9999999999999999999999999
Q ss_pred cCccCCCCCCCceeeeeecCcCCCChhhhc-----cCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHh
Q 039107 631 LSKTGPNMENGHVSTVVKGSFGYLDPEYFK-----RQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHC 705 (817)
Q Consensus 631 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 705 (817)
+++...... ........||+.|+|||++. .+.++.++|||||||++|||++|++||......+... -+...
T Consensus 221 la~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~---~i~~~ 296 (437)
T 4aw2_A 221 SCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG---KIMNH 296 (437)
T ss_dssp TCEECCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---HHHTH
T ss_pred hhhhcccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHH---hhhhc
Confidence 997643321 22233467999999999987 5678999999999999999999999998654332211 11100
Q ss_pred hccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHHH
Q 039107 706 KRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGID--RPSMGDVLWNLEF 758 (817)
Q Consensus 706 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~L~~ 758 (817)
.. ...-+... ...+..+.+|+.+||..+|++ ||+++|+++|--.
T Consensus 297 ~~-----~~~~p~~~----~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff 342 (437)
T 4aw2_A 297 KE-----RFQFPTQV----TDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFF 342 (437)
T ss_dssp HH-----HCCCCSSC----CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGG
T ss_pred cc-----cccCCccc----ccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCcc
Confidence 00 00001111 123456789999999888888 9999999987443
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=348.79 Aligned_cols=261 Identities=25% Similarity=0.407 Sum_probs=207.9
Q ss_pred CCCcceeEeeeCceEEEEEEEecc----cEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeE-EEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIEDK----LKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEM-CLV 559 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~-~lV 559 (817)
.|...++||+|+||+||+|...+. ..+|+|.+.... ....+.|.+|+.++++++||||+++++++...+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 456678999999999999986432 369999987543 34467899999999999999999999999766655 999
Q ss_pred EEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC
Q 039107 560 YDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 639 (817)
|||+.+|+|.+++......+++.+++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 9999999999999876678999999999999999999999876 9999999999999999999999999997543221
Q ss_pred --CCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCc
Q 039107 640 --NGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717 (817)
Q Consensus 640 --~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (817)
.........+|..|+|||.+.+..++.++||||||+++|||++|..|+....... .+........
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~----------- 245 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF--DLTHFLAQGR----------- 245 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG--GHHHHHHTTC-----------
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH--HHHHHhhcCC-----------
Confidence 1122234467889999999999999999999999999999999665544332221 1111111100
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhc
Q 039107 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVE 764 (817)
Q Consensus 718 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 764 (817)
....+..++..+.+++.+||+.||.+|||+.++++.|+.++....
T Consensus 246 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 246 --RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred --CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 011122344568999999999999999999999999999987654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=350.89 Aligned_cols=250 Identities=22% Similarity=0.316 Sum_probs=196.0
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCc--------------------------ccHHHHHHHHHHHhc
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSE--------------------------QGVNEFVTEIEMLSK 537 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~~ 537 (817)
++|...+.||+|+||.||+|+.. ++..||||++..... ...+.+.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 56888999999999999999865 568899998764321 123578999999999
Q ss_pred cCccceeeEEEEEec--CCeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCc
Q 039107 538 LRHKHLVSLIGFCEE--GNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTN 615 (817)
Q Consensus 538 l~H~niv~l~g~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~N 615 (817)
++||||+++++++.. ....++||||+++++|.+++. ...+++.+++.++.|++.||+|||+++ |+||||||+|
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~N 167 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSN 167 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHH
Confidence 999999999999976 568899999999999998763 346999999999999999999999876 9999999999
Q ss_pred EEEcCCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCC---CCchHHHHHHHHHHHHHHhCCCCCCCCCc
Q 039107 616 ILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQ---LTEKSDIYSFGVVLFEVLCARPALNPSLP 692 (817)
Q Consensus 616 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~sDV~S~Gvvl~elltG~~p~~~~~~ 692 (817)
||++.++.+||+|||+++..... ........||+.|+|||.+.+.. ++.++|||||||++|||++|+.||.....
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGS--DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSS--SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEECCCCCEEEecCCCccccccc--cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 99999999999999999864322 22233457999999999997665 37899999999999999999999975432
Q ss_pred cccchHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 693 KEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 693 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
. .+...... ... . .......+..+.+++.+||+.||.+|||+.|++++-
T Consensus 246 ~------~~~~~~~~-~~~----~----~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp 294 (298)
T 2zv2_A 246 M------CLHSKIKS-QAL----E----FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHP 294 (298)
T ss_dssp H------HHHHHHHH-CCC----C----CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCH
T ss_pred H------HHHHHHhc-ccC----C----CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCc
Confidence 1 11111111 100 0 001112345679999999999999999999998763
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=345.92 Aligned_cols=259 Identities=23% Similarity=0.391 Sum_probs=208.3
Q ss_pred hcCCCcceeEeeeCceEEEEEEEec----ccEEEEEecCCC-CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIED----KLKVAIKRSNPS-SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCL 558 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 558 (817)
.++|...+.||+|+||.||+|+..+ +..||+|.+... .....+.|.+|+.++++++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4578888999999999999998653 246999998765 33446789999999999999999999999875 45689
Q ss_pred EEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCC
Q 039107 559 VYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNM 638 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 638 (817)
||||+++++|.+++......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 99999999999999776667999999999999999999999776 999999999999999999999999999864332
Q ss_pred CCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCc
Q 039107 639 ENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717 (817)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (817)
. ........++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.. ..... ..
T Consensus 167 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~---~~~~~---~~-------- 231 (281)
T 3cc6_A 167 D-YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI---GVLEK---GD-------- 231 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH---HHHHH---TC--------
T ss_pred c-ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH---HHHhc---CC--------
Confidence 2 112233457889999999999999999999999999999998 99999754433211 11111 00
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 039107 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLV 763 (817)
Q Consensus 718 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 763 (817)
....+..++..+.+++.+||+.||.+||++.+++++|+.+.+..
T Consensus 232 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 232 --RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 01112234456899999999999999999999999999988764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=350.75 Aligned_cols=261 Identities=24% Similarity=0.402 Sum_probs=215.7
Q ss_pred hhcCCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
...+|...+.||+|+||.||+|.... +..||+|.+.... ...+.+.+|++++++++||||+++++++......++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 45678889999999999999999865 6789999987543 446789999999999999999999999999999999999
Q ss_pred eccCCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 562 YMALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 562 y~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
|+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 165 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT- 165 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS-
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc-
Confidence 999999999997643 46999999999999999999999876 9999999999999999999999999998654322
Q ss_pred CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (817)
........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........ .+.... ..
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~---~~~~~~-------------~~ 229 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YELLEK-------------DY 229 (288)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHHHHT-------------TC
T ss_pred cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHhc-------------cC
Confidence 223334567889999999999999999999999999999999 8999876543221 111111 11
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhc
Q 039107 720 KDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVE 764 (817)
Q Consensus 720 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 764 (817)
....+..++..+.+++.+||+.||.+|||+.++++.|+.+.+...
T Consensus 230 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~ 274 (288)
T 3kfa_A 230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274 (288)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 111223345678999999999999999999999999999876543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=354.96 Aligned_cols=263 Identities=24% Similarity=0.417 Sum_probs=207.2
Q ss_pred cCCCcceeEeeeCceEEEEEEE-----ecccEEEEEecCCC-CcccHHHHHHHHHHHhccCccceeeEEEEEecC--CeE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVI-----EDKLKVAIKRSNPS-SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEG--NEM 556 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 556 (817)
+.|+..+.||+|+||.||+|++ .++..||+|++... .....+.+.+|++++++++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4577888999999999999984 35688999998754 334567899999999999999999999999776 668
Q ss_pred EEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCC
Q 039107 557 CLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGP 636 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 636 (817)
++||||+++++|.+++......+++.+++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccccc
Confidence 9999999999999999776667999999999999999999999876 9999999999999999999999999998654
Q ss_pred CCCCC-ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCcc---------ccchHHHHHHHhh
Q 039107 637 NMENG-HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPK---------EQVSLADWALHCK 706 (817)
Q Consensus 637 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~---------~~~~l~~~~~~~~ 706 (817)
..... .......||..|+|||.+.+..++.++||||||+++|||++|+.|+...... ...........
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 255 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT-- 255 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH--
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH--
Confidence 32211 1223446788899999999999999999999999999999999875422100 00000001110
Q ss_pred ccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 039107 707 RKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVL 760 (817)
Q Consensus 707 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 760 (817)
+........+..++..+.+++.+||+.||.+|||+.++++.|+.++
T Consensus 256 --------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 256 --------LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp --------HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------HhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 1111111223345567899999999999999999999999999876
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=380.98 Aligned_cols=253 Identities=24% Similarity=0.427 Sum_probs=205.1
Q ss_pred eEeeeCceEEEEEEEe---cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccCCc
Q 039107 492 VIGVGGFGKVYKGVIE---DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGT 567 (817)
Q Consensus 492 ~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 567 (817)
.||+|+||.||+|.++ ++..||||+++... ....++|.+|+++|++++||||++++++|.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999875 45679999988653 3456889999999999999999999999976 56999999999999
Q ss_pred hhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC-ceeee
Q 039107 568 LREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG-HVSTV 646 (817)
Q Consensus 568 L~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~ 646 (817)
|.+++......+++.+++.|+.||+.||+|||+++ |+||||||+||||++++.+||+|||+++........ .....
T Consensus 422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 498 (613)
T 2ozo_A 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 498 (613)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence 99999876668999999999999999999999876 999999999999999999999999999865332211 11223
Q ss_pred eecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCH
Q 039107 647 VKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISP 725 (817)
Q Consensus 647 ~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 725 (817)
..+++.|+|||++.++.++.++|||||||+||||++ |+.||......+ +...+. .+ .....+.
T Consensus 499 ~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~~~i~----~~---------~~~~~p~ 562 (613)
T 2ozo_A 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFIE----QG---------KRMECPP 562 (613)
T ss_dssp ---CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---HHHHHH----TT---------CCCCCCT
T ss_pred CCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHHHH----cC---------CCCCCCC
Confidence 346789999999999999999999999999999998 999997654332 111111 11 1112234
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhc
Q 039107 726 ECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVE 764 (817)
Q Consensus 726 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 764 (817)
.++..+.+|+.+||+.+|++||++.+|++.|+.+.....
T Consensus 563 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~ 601 (613)
T 2ozo_A 563 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 601 (613)
T ss_dssp TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 456778999999999999999999999999999876543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=347.56 Aligned_cols=254 Identities=28% Similarity=0.501 Sum_probs=204.0
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCccc-------HHHHHHHHHHHhccCccceeeEEEEEecCCe
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQG-------VNEFVTEIEMLSKLRHKHLVSLIGFCEEGNE 555 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 555 (817)
.++|...+.||+|+||+||+|+.. ++..||+|++....... .+.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 356888899999999999999974 67889999986543221 267899999999999999999999997655
Q ss_pred EEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCce-----eEEeeec
Q 039107 556 MCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWV-----AKVSDFG 630 (817)
Q Consensus 556 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~-----~kl~DFG 630 (817)
++||||+++|+|.+++......+++..++.++.|++.||+|||+.+ .+|+||||||+|||++.++. +||+|||
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 7999999999999999877778999999999999999999999652 33999999999999987776 9999999
Q ss_pred cCccCCCCCCCceeeeeecCcCCCChhhh--ccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhcc
Q 039107 631 LSKTGPNMENGHVSTVVKGSFGYLDPEYF--KRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRK 708 (817)
Q Consensus 631 la~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 708 (817)
+++.... ......||+.|+|||.+ ....++.++||||||+++|||++|+.||........ ...... ...
T Consensus 175 ~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~---~~~ 245 (287)
T 4f0f_A 175 LSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI-KFINMI---REE 245 (287)
T ss_dssp TCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH-HHHHHH---HHS
T ss_pred ccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH-HHHHHH---hcc
Confidence 9975322 23445799999999998 445678999999999999999999999976543221 111111 111
Q ss_pred CchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 709 GILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 709 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
......+..++..+.+++.+||+.||.+|||+.++++.|+.
T Consensus 246 ---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 246 ---------GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp ---------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ---------CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 11112233445678999999999999999999999999975
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=359.35 Aligned_cols=257 Identities=23% Similarity=0.341 Sum_probs=201.3
Q ss_pred hcCCCcceeEeeeCceEEEEEEEecccEEEEEecCCC--CcccHHHHHHHHHHHhccCc--cceeeEEEEEecCCeEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRH--KHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV 559 (817)
.++|...+.||+|+||.||++...++..||||++... ..+..+.+.+|+.+|++++| +||+++++++......++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4568889999999999999999888889999987644 33445789999999999976 9999999999999999999
Q ss_pred EEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC
Q 039107 560 YDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 639 (817)
|| +.+++|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++......
T Consensus 88 ~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp EC-CCSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred Ee-CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 99 5678999999754 46899999999999999999999876 99999999999997 5689999999998754333
Q ss_pred CCceeeeeecCcCCCChhhhcc-----------CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhcc
Q 039107 640 NGHVSTVVKGSFGYLDPEYFKR-----------QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRK 708 (817)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 708 (817)
.........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... . .
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~-~------- 229 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI----S-K------- 229 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH----H-H-------
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH----H-H-------
Confidence 3333345679999999999865 678999999999999999999999997543211 0 0
Q ss_pred CchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 039107 709 GILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVL 760 (817)
Q Consensus 709 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 760 (817)
+..++++.....++......+.+++.+||+.||.+|||+.+++++.....
T Consensus 230 --~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 279 (343)
T 3dbq_A 230 --LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279 (343)
T ss_dssp --HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred --HHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence 11112222222222333456789999999999999999999999876643
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=345.16 Aligned_cols=259 Identities=24% Similarity=0.425 Sum_probs=210.4
Q ss_pred hcCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
.++|...+.||+|+||.||+|..+++..||+|.+.... ...+.+.+|++++++++||||+++++++.. +..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence 35688889999999999999998888899999987543 345789999999999999999999999874 5689999999
Q ss_pred cCCchhhhhhcccc-ccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 564 ALGTLREHIYNTKK-ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 564 ~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
++++|.+++..... .+++.+++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 165 (279)
T 1qpc_A 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YT 165 (279)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EE
T ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcc-cc
Confidence 99999999976433 6999999999999999999999876 9999999999999999999999999998643221 11
Q ss_pred eeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccC
Q 039107 643 VSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKD 721 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (817)
......++..|+|||.+.+..++.++||||||++++||++ |+.||......+ +.. .... + ...
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~---~~~~-~---------~~~ 229 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---VIQ---NLER-G---------YRM 229 (279)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHH---HHHT-T---------CCC
T ss_pred cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH---HHH---HHhc-c---------cCC
Confidence 1223346788999999998999999999999999999999 899987543321 111 1111 1 001
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhc
Q 039107 722 KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVE 764 (817)
Q Consensus 722 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 764 (817)
..+..++..+.+++.+||+.+|++|||+.++++.|+.+.....
T Consensus 230 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 1122345678999999999999999999999999999876543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=361.92 Aligned_cols=250 Identities=22% Similarity=0.323 Sum_probs=201.1
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEMCL 558 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 558 (817)
.++|...++||+|+||+||+|+.+ ++..||||++... .....+.+.+|.++++.+ +||||+++++++...+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 357889999999999999999976 4688999998643 233456788999999998 79999999999999999999
Q ss_pred EEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCC
Q 039107 559 VYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNM 638 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 638 (817)
||||+++|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 102 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~- 176 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC- 176 (353)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeeccc-
Confidence 99999999999998654 45999999999999999999999876 99999999999999999999999999985322
Q ss_pred CCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcc
Q 039107 639 ENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPL 718 (817)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (817)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .-+ .. + .
T Consensus 177 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~---~~i---~~-~--------~ 240 (353)
T 3txo_A 177 -NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF---EAI---LN-D--------E 240 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHH---HH-C--------C
T ss_pred -CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHH---HHH---Hc-C--------C
Confidence 222344567999999999999999999999999999999999999999765432211 111 11 0 0
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHHHH
Q 039107 719 LKDKISPECLKKFADTAEKCLSDSGIDRPSM------GDVLWNL 756 (817)
Q Consensus 719 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~~L 756 (817)
..++......+.+++.+||+.||.+||++ .++++|-
T Consensus 241 --~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp 282 (353)
T 3txo_A 241 --VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHP 282 (353)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSG
T ss_pred --CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCC
Confidence 01122234567899999999999999998 7787653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=361.49 Aligned_cols=260 Identities=28% Similarity=0.462 Sum_probs=199.8
Q ss_pred CCCcceeEeeeCceEEEEEEEec----ccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEec-CCeEEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIED----KLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE-GNEMCLV 559 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV 559 (817)
.|...++||+|+||+||+|...+ +..||+|.+.... ....++|.+|+.++++++||||++++++|.. .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 46677899999999999998643 2468999987543 3456789999999999999999999998754 5678999
Q ss_pred EEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC
Q 039107 560 YDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 639 (817)
|||+++|+|.+++......+++.+++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccccc
Confidence 9999999999999877677999999999999999999999876 9999999999999999999999999998643222
Q ss_pred CC--ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccC
Q 039107 640 NG--HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIID 716 (817)
Q Consensus 640 ~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (817)
.. .......+|+.|+|||.+.+..++.++|||||||++|||++ |.+||......+ +...... +.
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~~~~----~~------ 313 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLLQ----GR------ 313 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHHHHT----TC------
T ss_pred cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHHHHc----CC------
Confidence 11 12234467889999999999999999999999999999999 667775543322 1111111 10
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhc
Q 039107 717 PLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVE 764 (817)
Q Consensus 717 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 764 (817)
....+..++..+.+++.+||+.+|.+||++.+++++|+.+.....
T Consensus 314 ---~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 314 ---RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 001122345668999999999999999999999999999886544
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=353.42 Aligned_cols=267 Identities=25% Similarity=0.444 Sum_probs=202.3
Q ss_pred HHHHhhcCCCcceeEeeeCceEEEEEEEec----ccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEec
Q 039107 479 EIKHATKSFDESYVIGVGGFGKVYKGVIED----KLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE 552 (817)
Q Consensus 479 el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 552 (817)
++....++|...++||+|+||.||+|.... +..||+|++... .....+.+.+|+.++++++||||+++++++..
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 334456778899999999999999998653 357999998754 33445779999999999999999999999976
Q ss_pred CC-----eEEEEEEeccCCchhhhhhc-----cccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCc
Q 039107 553 GN-----EMCLVYDYMALGTLREHIYN-----TKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENW 622 (817)
Q Consensus 553 ~~-----~~~lV~Ey~~~gsL~~~l~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~ 622 (817)
.. ..++||||+++++|.+++.. ....+++.+++.++.|++.||.|||+++ |+||||||+|||+++++
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDM 184 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTS
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCC
Confidence 54 35999999999999999843 2346999999999999999999999765 99999999999999999
Q ss_pred eeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHH
Q 039107 623 VAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADW 701 (817)
Q Consensus 623 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~ 701 (817)
.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||........ ...
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~~ 261 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM---YDY 261 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHH
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH---HHH
Confidence 999999999986543322233344567889999999999999999999999999999999 8888876543221 111
Q ss_pred HHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhc
Q 039107 702 ALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVE 764 (817)
Q Consensus 702 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 764 (817)
... +. ....+..++..+.+++.+||+.||.+|||+.+++++|+.+++..+
T Consensus 262 ~~~----~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 262 LLH----GH---------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp HHT----TC---------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HHc----CC---------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 111 00 011122345668999999999999999999999999999886543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=360.86 Aligned_cols=257 Identities=22% Similarity=0.342 Sum_probs=202.7
Q ss_pred hcCCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCC---CcccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPS---SEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEMCL 558 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 558 (817)
.++|...++||+|+||+||+|+.+. +..||+|+++.. .....+.+.+|..+|.++ +||||+++++++...+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 3568889999999999999999764 578999987643 233345688999999887 89999999999999999999
Q ss_pred EEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCC
Q 039107 559 VYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNM 638 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 638 (817)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 131 V~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~- 205 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR- 205 (396)
T ss_dssp EEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeeccc-
Confidence 99999999999998654 46999999999999999999999876 99999999999999999999999999985322
Q ss_pred CCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCcccc--chHHHHHHHhhccCchhhccC
Q 039107 639 ENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQ--VSLADWALHCKRKGILDDIID 716 (817)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~d 716 (817)
.........||+.|+|||++.+..++.++|||||||++|||++|++||......+. ....++.........
T Consensus 206 -~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~------ 278 (396)
T 4dc2_A 206 -PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------ 278 (396)
T ss_dssp -TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC------
T ss_pred -CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc------
Confidence 22234456799999999999999999999999999999999999999975432211 111111111111110
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHHHH
Q 039107 717 PLLKDKISPECLKKFADTAEKCLSDSGIDRPSM------GDVLWNL 756 (817)
Q Consensus 717 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~~L 756 (817)
..++......+.+|+.+||+.||.+||++ .||++|-
T Consensus 279 ----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hp 320 (396)
T 4dc2_A 279 ----IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 320 (396)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHST
T ss_pred ----cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCc
Confidence 11223345567899999999999999995 6776653
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=343.12 Aligned_cols=253 Identities=18% Similarity=0.312 Sum_probs=204.8
Q ss_pred cCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCC--cccHHHHHHHHHHHhccCccceeeEEEEEecC--CeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEG--NEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 560 (817)
++|...+.||+|+||.||+|+.+ +..||+|++.... ....+.|.+|+.++++++||||+++++++... ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 46888899999999999999985 6789999987543 34456799999999999999999999999876 7889999
Q ss_pred EeccCCchhhhhhcccc-ccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC
Q 039107 561 DYMALGTLREHIYNTKK-ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 639 (817)
||+++|+|.+++..... .+++.+++.++.|++.||+|||+.+ .+|+||||||+|||+++++.++|+|||++.....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-- 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-- 165 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC--
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc--
Confidence 99999999999976544 5999999999999999999999652 3499999999999999999999999998764221
Q ss_pred CCceeeeeecCcCCCChhhhccCCCC---chHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccC
Q 039107 640 NGHVSTVVKGSFGYLDPEYFKRQQLT---EKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIID 716 (817)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s---~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (817)
....||+.|+|||.+.+..++ .++||||||+++|||++|+.||......+. .......+
T Consensus 166 -----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~------- 227 (271)
T 3kmu_A 166 -----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI------GMKVALEG------- 227 (271)
T ss_dssp -----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH------HHHHHHSC-------
T ss_pred -----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH------HHHHHhcC-------
Confidence 123579999999999865544 489999999999999999999975433221 11111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 039107 717 PLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQ 761 (817)
Q Consensus 717 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 761 (817)
.....+..++..+.+++.+||+.||.+|||++++++.|+.+.+
T Consensus 228 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 228 --LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1112223445668999999999999999999999999998753
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=347.47 Aligned_cols=261 Identities=28% Similarity=0.451 Sum_probs=205.5
Q ss_pred hcCCCcceeEeeeCceEEEEEEEecc----cEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEe-cCCeEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIEDK----LKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCE-EGNEMC 557 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~ 557 (817)
..+|...++||+|+||+||+|...+. ..+|+|.+.... ....+.+.+|+.++++++||||++++++|. .....+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 34678889999999999999986432 358999987543 344577999999999999999999999864 556789
Q ss_pred EEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCC
Q 039107 558 LVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPN 637 (817)
Q Consensus 558 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 637 (817)
+||||+++|+|.+++......+++.+++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccccc
Confidence 999999999999999876677999999999999999999999876 99999999999999999999999999986433
Q ss_pred CCC--CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhC-CCCCCCCCccccchHHHHHHHhhccCchhhc
Q 039107 638 MEN--GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCA-RPALNPSLPKEQVSLADWALHCKRKGILDDI 714 (817)
Q Consensus 638 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 714 (817)
... ........+|+.|+|||.+.+..++.++||||||+++|||++| .+|+......+ ....... ..
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~~~~~---~~----- 249 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLLQ---GR----- 249 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHHHHHT---TC-----
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHHHHhc---CC-----
Confidence 221 1223344678899999999999999999999999999999995 55554433221 1111111 00
Q ss_pred cCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 039107 715 IDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLV 763 (817)
Q Consensus 715 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 763 (817)
....+..++..+.+++.+||+.+|.+|||+.++++.|+.+....
T Consensus 250 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 250 -----RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred -----CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 00112223456899999999999999999999999999988654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=346.06 Aligned_cols=263 Identities=21% Similarity=0.287 Sum_probs=201.4
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC--cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
++|...++||+|+||+||+|... ++..||+|++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46888999999999999999975 56889999976442 3335778899999999999999999999999999999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
|+++ +|.+.+......+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP--V 155 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC--C
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc--c
Confidence 9985 666666555567999999999999999999999876 999999999999999999999999999864322 1
Q ss_pred ceeeeeecCcCCCChhhhccCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCc------hhhc
Q 039107 642 HVSTVVKGSFGYLDPEYFKRQQ-LTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGI------LDDI 714 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~-~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------~~~~ 714 (817)
.......||+.|+|||.+.+.. ++.++|||||||++|||++|+.|+......... +. .+........ ....
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~-~~-~i~~~~~~~~~~~~~~~~~~ 233 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-LK-RIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH-HH-HHHHHHCCCCTTTCTTGGGS
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHH-HH-HHHHHhCCCChhhhhhhccc
Confidence 2233456899999999997765 799999999999999999988886543322211 11 1111100000 0000
Q ss_pred cC---------ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 715 ID---------PLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 715 ~d---------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.+ ........+.....+.+++.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00 000011122345667899999999999999999999875
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=358.28 Aligned_cols=273 Identities=24% Similarity=0.388 Sum_probs=212.0
Q ss_pred hcCCCcceeEeeeCceEEEEEEE-----ecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCC--eE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVI-----EDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGN--EM 556 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~ 556 (817)
.++|...+.||+|+||.||+++. .++..||||++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 34678889999999999999984 356889999998776666788999999999999999999999986543 68
Q ss_pred EEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCC
Q 039107 557 CLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGP 636 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 636 (817)
++||||+++++|.+++......+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 9999999999999999876667999999999999999999999876 9999999999999999999999999998654
Q ss_pred CCCCC-ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhc----cCch
Q 039107 637 NMENG-HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKR----KGIL 711 (817)
Q Consensus 637 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~----~~~~ 711 (817)
..... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+...... .......... ...+
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH----HHHHHCTTCCTHHHHHHH
T ss_pred ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH----HHHhhccccchhhhHHHH
Confidence 32211 1122345677899999999989999999999999999999999887532100 0000000000 0000
Q ss_pred hhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 039107 712 DDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLV 763 (817)
Q Consensus 712 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 763 (817)
.+.+........+..++..+.+++.+||+.||.+|||+.+|++.|+.+....
T Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 273 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 0111111111223345567899999999999999999999999999987643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=341.22 Aligned_cols=266 Identities=19% Similarity=0.232 Sum_probs=210.3
Q ss_pred hcCCCcceeEeeeCceEEEEEEE-ecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEE-ecCCeEEEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVI-EDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFC-EEGNEMCLVYD 561 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~E 561 (817)
.++|...+.||+|+||.||+|+. .+++.||||++..... .+++.+|+.++++++|++++..+.++ ......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46788999999999999999996 5678999998765433 25688999999999988766666655 66778899999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEE---cCCceeEEeeeccCccCCCC
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILL---DENWVAKVSDFGLSKTGPNM 638 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll---~~~~~~kl~DFGla~~~~~~ 638 (817)
|+ +++|.+++......+++.+++.++.|++.||+|||+++ |+||||||+|||+ ++++.+||+|||+++.....
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99 89999999766667999999999999999999999876 9999999999999 48889999999999865433
Q ss_pred CCC-----ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhh
Q 039107 639 ENG-----HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDD 713 (817)
Q Consensus 639 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 713 (817)
... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........................
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-- 239 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-- 239 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH--
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch--
Confidence 221 1124557999999999999999999999999999999999999999865433322222111111110000
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhc
Q 039107 714 IIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVE 764 (817)
Q Consensus 714 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 764 (817)
+.+. ..++..+.+++.+||+.||.+|||+.+|++.|+.+.....
T Consensus 240 ---~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 240 ---EVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp ---HHHT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ---HHHH----hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 0011 1234568999999999999999999999999999886653
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=343.18 Aligned_cols=267 Identities=19% Similarity=0.235 Sum_probs=207.5
Q ss_pred hhcCCCcceeEeeeCceEEEEEEE-ecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEE-ecCCeEEEEE
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVI-EDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFC-EEGNEMCLVY 560 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~ 560 (817)
..++|...+.||+|+||.||+|+. .++..||||.+..... .+.+.+|+.++++++|++++..+.++ ......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 356799999999999999999996 4678899998654432 24578899999999988777666655 6778889999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEE---cCCceeEEeeeccCccCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILL---DENWVAKVSDFGLSKTGPN 637 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll---~~~~~~kl~DFGla~~~~~ 637 (817)
||+ +++|.+++......+++.+++.++.|++.||+|||+.+ |+||||||+|||+ ++++.+||+|||+++....
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 999 89999999766667999999999999999999999876 9999999999999 7889999999999986543
Q ss_pred CCCC-----ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchh
Q 039107 638 MENG-----HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILD 712 (817)
Q Consensus 638 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 712 (817)
.... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.........................
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh
Confidence 3221 12235579999999999999999999999999999999999999998654433322221111111111000
Q ss_pred hccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhc
Q 039107 713 DIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVE 764 (817)
Q Consensus 713 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 764 (817)
... ..++..+.+++.+||+.+|++|||+.+|++.|+.+.+...
T Consensus 241 -----~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 241 -----VLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp -----HHT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred -----hhh----ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 011 1224568999999999999999999999999999986654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=357.63 Aligned_cols=252 Identities=24% Similarity=0.316 Sum_probs=204.3
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
..+|...+.||+|+||.||+|..+ ++..||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457889999999999999999975 5689999998654 2334567899999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCC---ceeEEeeeccCccCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDEN---WVAKVSDFGLSKTGPN 637 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~---~~~kl~DFGla~~~~~ 637 (817)
||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+++....
T Consensus 108 e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 108 DLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp CCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 999999999988654 46899999999999999999999876 9999999999999865 4599999999986542
Q ss_pred CCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCc
Q 039107 638 MENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717 (817)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (817)
. .......||+.|+|||++.+..++.++|||||||++|||++|++||....... +...+.. +.. +
T Consensus 184 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---~~~~i~~----~~~----~- 248 (362)
T 2bdw_A 184 S---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LYAQIKA----GAY----D- 248 (362)
T ss_dssp C---CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHH----TCC----C-
T ss_pred C---cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHh----CCC----C-
Confidence 2 12234579999999999999999999999999999999999999997643221 1111111 100 0
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 718 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.........+..+.+++.+||+.||.+||++.+++++
T Consensus 249 -~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 249 -YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000011234567899999999999999999999876
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=357.75 Aligned_cols=249 Identities=29% Similarity=0.413 Sum_probs=203.3
Q ss_pred cCCCcceeEeeeCceEEEEEEE-ecccEEEEEecCCCCc---ccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVI-EDKLKVAIKRSNPSSE---QGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
+.|...+.||+|+||+||+|+. .++..||||++..... ...+.+.+|++++++++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588889999999999999996 4678899999865432 23467899999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
||+. |+|.+++......+++.++..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~--- 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--- 206 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC---
Confidence 9997 6888888766668999999999999999999999876 99999999999999999999999999976432
Q ss_pred CceeeeeecCcCCCChhhhc---cCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCc
Q 039107 641 GHVSTVVKGSFGYLDPEYFK---RQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (817)
.....||+.|+|||++. .+.++.++|||||||++|||++|++||........ ........ .+
T Consensus 207 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~------~~~~~~~~------~~ 271 (348)
T 1u5q_A 207 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQNE------SP 271 (348)
T ss_dssp ---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHSC------CC
T ss_pred ---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHhcC------CC
Confidence 12346899999999984 56789999999999999999999999875432211 11111111 01
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 718 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
... ....+..+.+++.+||+.||.+|||+.+++++...
T Consensus 272 ~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~ 309 (348)
T 1u5q_A 272 ALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 309 (348)
T ss_dssp CCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred CCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhh
Confidence 111 12234567899999999999999999999987554
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=361.70 Aligned_cols=255 Identities=23% Similarity=0.331 Sum_probs=200.1
Q ss_pred cCCCcceeEeeeCceEEEEEEEecccEEEEEecCCC--CcccHHHHHHHHHHHhccC--ccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLR--HKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~ 560 (817)
.+|...+.||+|+||.||++...++..||||++... .....+.+.+|+.+|++++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 458889999999999999999888889999987643 3345678999999999996 599999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
| +.+++|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++.......
T Consensus 136 E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp E-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred e-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 9 6678999998754 36889999999999999999999765 99999999999996 57999999999986543322
Q ss_pred CceeeeeecCcCCCChhhhcc-----------CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccC
Q 039107 641 GHVSTVVKGSFGYLDPEYFKR-----------QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKG 709 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 709 (817)
........||+.|+|||++.+ ..++.++|||||||+||||++|+.||....... ...
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-----~~~------- 277 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKL------- 277 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-----HHH-------
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-----HHH-------
Confidence 223345579999999999875 468999999999999999999999997543211 001
Q ss_pred chhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 710 ILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 710 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
..++++......+......+.+|+.+||+.||.+|||+.+++++....
T Consensus 278 --~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 325 (390)
T 2zmd_A 278 --HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325 (390)
T ss_dssp --HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred --HHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcc
Confidence 111222211122222245678999999999999999999999886554
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=350.86 Aligned_cols=260 Identities=23% Similarity=0.342 Sum_probs=190.8
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
..+|...+.||+|+||.||+|..+ ++..||+|++.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 356888889999999999999865 57889999986543 2334678899999999999999999999999999999999
Q ss_pred eccCCchhhhhhccc-----cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCC
Q 039107 562 YMALGTLREHIYNTK-----KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGP 636 (817)
Q Consensus 562 y~~~gsL~~~l~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 636 (817)
|++ |+|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 69999886432 35899999999999999999999876 9999999999999999999999999998643
Q ss_pred CCCCCceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccC------
Q 039107 637 NMENGHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKG------ 709 (817)
Q Consensus 637 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~------ 709 (817)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+..... .......
T Consensus 160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i---~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLI---FDIMGTPNESLWP 234 (317)
T ss_dssp SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCSCCTTTCG
T ss_pred CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HHHhCCCChhHhh
Confidence 221 12234468999999999876 46899999999999999999999999876543322111 1100000
Q ss_pred ------------------chhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 710 ------------------ILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 710 ------------------~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
.+.+.+.+... ......+.+++.+||+.||++|||+.|++++-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp 295 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTK----EPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP 295 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGCS----SCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred hhhhhhhcccccccccchhHHHhhccccc----ccCCHHHHHHHHHHCCCCcccCCCHHHHhCCh
Confidence 00001111111 12345689999999999999999999998753
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=353.60 Aligned_cols=250 Identities=26% Similarity=0.366 Sum_probs=195.8
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCC--------
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGN-------- 554 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-------- 554 (817)
.+|...+.||+|+||.||+|+.+ ++..||||++.... ....+.+.+|+++|++++||||++++++|.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 46888999999999999999986 67899999986443 345678999999999999999999999986543
Q ss_pred -------------------------------------------------eEEEEEEeccCCchhhhhhcccc--ccchHh
Q 039107 555 -------------------------------------------------EMCLVYDYMALGTLREHIYNTKK--ALSWKQ 583 (817)
Q Consensus 555 -------------------------------------------------~~~lV~Ey~~~gsL~~~l~~~~~--~l~~~~ 583 (817)
..++||||+++++|.+++..... ..++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 27999999999999999976433 456677
Q ss_pred HHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC----------ceeeeeecCcCC
Q 039107 584 RLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG----------HVSTVVKGSFGY 653 (817)
Q Consensus 584 ~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~gt~~y 653 (817)
++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........ .......||+.|
T Consensus 166 ~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 8999999999999999876 999999999999999999999999999865432211 122335699999
Q ss_pred CChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHH
Q 039107 654 LDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFAD 733 (817)
Q Consensus 654 ~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 733 (817)
+|||.+.+..++.++|||||||++|||++|..|+.. .... ... ...... ..........+.+
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~---~~~-~~~~~~---------~~~~~~~~~~~~~ 304 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRI---ITD-VRNLKF---------PLLFTQKYPQEHM 304 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHH---HHH-HHTTCC---------CHHHHHHCHHHHH
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHH---HHH-hhccCC---------CcccccCChhHHH
Confidence 999999999999999999999999999998765311 0100 000 011100 0011234466789
Q ss_pred HHHHccccCCCCCCCHHHHHHH
Q 039107 734 TAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 734 li~~cl~~dP~~RPt~~evl~~ 755 (817)
++.+||+.||.+|||+.+++++
T Consensus 305 li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 305 MVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHccCCCCcCCCHHHHhhc
Confidence 9999999999999999999875
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=352.19 Aligned_cols=250 Identities=24% Similarity=0.357 Sum_probs=195.5
Q ss_pred cCCCcceeEeeeCceEEEEEEE----ecccEEEEEecCCCC----cccHHHHHHHHHHHhccCccceeeEEEEEecCCeE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVI----EDKLKVAIKRSNPSS----EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEM 556 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 556 (817)
++|...++||+|+||.||+++. .++..||+|++.... ......+.+|+.+|++++||||+++++++...+..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 5688899999999999999987 367899999987542 23345688999999999999999999999999999
Q ss_pred EEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCC
Q 039107 557 CLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGP 636 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 636 (817)
++||||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 97 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 97 YLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp EEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred EEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 9999999999999998653 45889999999999999999999876 9999999999999999999999999997532
Q ss_pred CCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccC
Q 039107 637 NMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIID 716 (817)
Q Consensus 637 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (817)
.. ........||+.|+|||++.+..++.++||||||+++|||++|+.||......... ..+.. .
T Consensus 173 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~----~------- 236 (327)
T 3a62_A 173 HD--GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI---DKILK----C------- 236 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHH----T-------
T ss_pred cC--CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHH---HHHHh----C-------
Confidence 21 12233456899999999999999999999999999999999999999765332211 11110 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 039107 717 PLLKDKISPECLKKFADTAEKCLSDSGIDRP-----SMGDVLWNLE 757 (817)
Q Consensus 717 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L~ 757 (817)
. ..++......+.+++.+||+.||.+|| ++.++++|-.
T Consensus 237 -~--~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~ 279 (327)
T 3a62_A 237 -K--LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279 (327)
T ss_dssp -C--CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGG
T ss_pred -C--CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCc
Confidence 0 011223445678999999999999999 7888887644
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=364.52 Aligned_cols=263 Identities=22% Similarity=0.267 Sum_probs=209.0
Q ss_pred HHHHHHhhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEec
Q 039107 477 LAEIKHATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE 552 (817)
Q Consensus 477 ~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 552 (817)
+.+++...++|...++||+|+||+||+|+.+ ++..||+|++... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 4455566788999999999999999999976 4678999997642 12223458899999999999999999999999
Q ss_pred CCeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccC
Q 039107 553 GNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLS 632 (817)
Q Consensus 553 ~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla 632 (817)
....++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a 215 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC 215 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEecccee
Confidence 9999999999999999998854 35899999999999999999999876 999999999999999999999999999
Q ss_pred ccCCCCCCCceeeeeecCcCCCChhhhccCC----CCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhcc
Q 039107 633 KTGPNMENGHVSTVVKGSFGYLDPEYFKRQQ----LTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRK 708 (817)
Q Consensus 633 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 708 (817)
+...... ........||+.|+|||++.+.. ++.++|||||||+||||++|++||......+.. .-+.....
T Consensus 216 ~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~---~~i~~~~~- 290 (410)
T 3v8s_A 216 MKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY---SKIMNHKN- 290 (410)
T ss_dssp EECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---HHHHTHHH-
T ss_pred EeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHH---HHHHhccc-
Confidence 8643221 11233567999999999998765 789999999999999999999999765432211 11110000
Q ss_pred CchhhccCccccCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHHH
Q 039107 709 GILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGID--RPSMGDVLWNLEF 758 (817)
Q Consensus 709 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~L~~ 758 (817)
. +.-......+..+.+|+.+||..+|.+ ||+++||++|-.+
T Consensus 291 ----~-----~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f 333 (410)
T 3v8s_A 291 ----S-----LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 333 (410)
T ss_dssp ----H-----CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGG
T ss_pred ----c-----ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccc
Confidence 0 000001123456789999999999988 9999999988554
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=364.71 Aligned_cols=253 Identities=21% Similarity=0.255 Sum_probs=203.5
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC--cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
.++|...+.||+|+||.||+|... ++..+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 457888999999999999999864 57889999876543 334567899999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEc---CCceeEEeeeccCccCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLD---ENWVAKVSDFGLSKTGPN 637 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~---~~~~~kl~DFGla~~~~~ 637 (817)
||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++ +++.+||+|||+++....
T Consensus 90 E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 90 DLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp CCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 999999999988654 45999999999999999999999876 99999999999998 568899999999976433
Q ss_pred CCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCc
Q 039107 638 MENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717 (817)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (817)
. ........||+.|+|||++.+..++.++|||||||++|||++|++||......+. ...+. .+.. +
T Consensus 166 ~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~---~~~i~----~~~~----~- 231 (444)
T 3soa_A 166 E--QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL---YQQIK----AGAY----D- 231 (444)
T ss_dssp T--CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHH----HTCC----C-
T ss_pred C--CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH---HHHHH----hCCC----C-
Confidence 2 2223346799999999999999999999999999999999999999976533221 11111 1100 0
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 718 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.........+..+.+++.+||+.||.+|||+.|++++
T Consensus 232 -~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 232 -FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp -CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0011112334568899999999999999999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=368.37 Aligned_cols=267 Identities=22% Similarity=0.256 Sum_probs=211.6
Q ss_pred cCHHHHHHhhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEE
Q 039107 475 FSLAEIKHATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFC 550 (817)
Q Consensus 475 f~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 550 (817)
+.+.++....++|...++||+|+||+||+++.+ +++.||+|++... .....+.+.+|..++.+++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 456666777889999999999999999999975 5789999998642 122335588999999999999999999999
Q ss_pred ecCCeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeec
Q 039107 551 EEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFG 630 (817)
Q Consensus 551 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFG 630 (817)
.+.+..++||||+++|+|.+++.+....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeech
Confidence 9999999999999999999999766567999999999999999999999776 9999999999999999999999999
Q ss_pred cCccCCCCCCCceeeeeecCcCCCChhhhc-------cCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHH
Q 039107 631 LSKTGPNMENGHVSTVVKGSFGYLDPEYFK-------RQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWAL 703 (817)
Q Consensus 631 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 703 (817)
+++...... ........||+.|+|||++. ...++.++|||||||++|||++|++||......+... -+.
T Consensus 208 la~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~---~i~ 283 (412)
T 2vd5_A 208 SCLKLRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYG---KIV 283 (412)
T ss_dssp TCEECCTTS-CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---HHH
T ss_pred hheeccCCC-ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHH---HHH
Confidence 998643321 11223457999999999987 3578999999999999999999999997654322111 011
Q ss_pred HhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCC---CCHHHHHHHHHH
Q 039107 704 HCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDR---PSMGDVLWNLEF 758 (817)
Q Consensus 704 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~evl~~L~~ 758 (817)
.... ...-+.. ....+..+.+++.+||. +|.+| |+++|+++|--+
T Consensus 284 ~~~~-----~~~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff 331 (412)
T 2vd5_A 284 HYKE-----HLSLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFF 331 (412)
T ss_dssp THHH-----HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGG
T ss_pred hccc-----CcCCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCc
Confidence 0000 0000111 12234567999999999 99998 689999877443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=360.34 Aligned_cols=268 Identities=20% Similarity=0.250 Sum_probs=203.3
Q ss_pred hcCCCcceeEeee--CceEEEEEEEe-cccEEEEEecCCCC--cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEE
Q 039107 484 TKSFDESYVIGVG--GFGKVYKGVIE-DKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCL 558 (817)
Q Consensus 484 ~~~f~~~~~lG~G--~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 558 (817)
..+|...++||+| +||+||+|+.. ++..||||++.... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3568889999999 99999999976 57899999986442 3345678899999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCC
Q 039107 559 VYDYMALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPN 637 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 637 (817)
|||||++|+|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 999999999999987642 46999999999999999999999876 99999999999999999999999998864321
Q ss_pred CCC-----CceeeeeecCcCCCChhhhcc--CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhh----
Q 039107 638 MEN-----GHVSTVVKGSFGYLDPEYFKR--QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCK---- 706 (817)
Q Consensus 638 ~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~---- 706 (817)
... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||............ +.....
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~ 259 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK-LNGTVPCLLD 259 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-hcCCCCcccc
Confidence 110 111223468999999999987 67999999999999999999999999765433221000 000000
Q ss_pred -----------------ccCchhhccC---c------cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 707 -----------------RKGILDDIID---P------LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 707 -----------------~~~~~~~~~d---~------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
....+.+.+. + .............+.+|+.+||+.||.+|||+.|++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0000000000 0 00001222345668999999999999999999999976
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=357.45 Aligned_cols=257 Identities=22% Similarity=0.242 Sum_probs=196.2
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
.++|...+.||+|+||+||+++.. ++..||||++..... ..+.+.+|+.++++++||||+++++++......++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 457888999999999999999976 678899999875432 236788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCce--eEEeeeccCccCCCCCC
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWV--AKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~--~kl~DFGla~~~~~~~~ 640 (817)
+++|+|.+++... +.+++..++.++.|++.||+|||+++ |+||||||+|||++.++. +||+|||+++....
T Consensus 98 ~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~--- 170 (361)
T 3uc3_A 98 ASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--- 170 (361)
T ss_dssp CCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc---
Confidence 9999999998654 35999999999999999999999776 999999999999987765 99999999974322
Q ss_pred CceeeeeecCcCCCChhhhccCCCCch-HHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQLTEK-SDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~-sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (817)
........||+.|+|||++.+..++.+ +|||||||++|||++|+.||......... ........ ....
T Consensus 171 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~~~~~~~~---------~~~~ 239 (361)
T 3uc3_A 171 HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY--RKTIQRIL---------SVKY 239 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH--HHHHHHHH---------TTCC
T ss_pred cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH--HHHHHHHh---------cCCC
Confidence 122334569999999999988887666 89999999999999999999765433221 11111111 1001
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 720 KDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 720 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
........+..+.+|+.+||+.||.+|||+.++++|-...
T Consensus 240 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 279 (361)
T 3uc3_A 240 SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFL 279 (361)
T ss_dssp CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHH
T ss_pred CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchh
Confidence 1001112345678999999999999999999999886554
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=358.00 Aligned_cols=251 Identities=24% Similarity=0.326 Sum_probs=204.6
Q ss_pred HhhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC---cccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeE
Q 039107 482 HATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS---EQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEM 556 (817)
Q Consensus 482 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 556 (817)
....+|...++||+|+||.||+|+.+ +++.||+|+++... ....+.+..|..++..+ +||||+++++++...+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34568999999999999999999976 46889999986431 23456788999999887 899999999999999999
Q ss_pred EEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCC
Q 039107 557 CLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGP 636 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 636 (817)
++||||+++|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 9999999999999998654 46999999999999999999999876 9999999999999999999999999998532
Q ss_pred CCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccC
Q 039107 637 NMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIID 716 (817)
Q Consensus 637 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (817)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...+.. . .
T Consensus 170 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~i~~----~------~ 234 (345)
T 1xjd_A 170 LG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL---FHSIRM----D------N 234 (345)
T ss_dssp CT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHH----C------C
T ss_pred cC--CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHH---HHHHHh----C------C
Confidence 21 2233456799999999999999999999999999999999999999976543221 111110 0 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHHH
Q 039107 717 PLLKDKISPECLKKFADTAEKCLSDSGIDRPSMG-DVLWN 755 (817)
Q Consensus 717 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~~ 755 (817)
+. ++......+.+++.+||+.||.+||++. +|++|
T Consensus 235 ~~----~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 235 PF----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp CC----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred CC----CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 11 1222345678999999999999999998 77654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=350.40 Aligned_cols=246 Identities=23% Similarity=0.323 Sum_probs=203.9
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
++|...++||+|+||+||+++.+ +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 56888999999999999999975 5789999998643 1234567889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~--- 158 (318)
T 1fot_A 86 DYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD--- 158 (318)
T ss_dssp CCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS---
T ss_pred eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC---
Confidence 999999999998654 45899999999999999999999765 99999999999999999999999999986432
Q ss_pred CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........ . ...... .
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~---~~i~~~---------~-- 219 (318)
T 1fot_A 159 --VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT---Y---EKILNA---------E-- 219 (318)
T ss_dssp --CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---H---HHHHHC---------C--
T ss_pred --ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---H---HHHHhC---------C--
Confidence 22345799999999999999999999999999999999999999976432211 1 110100 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRP-----SMGDVLWNL 756 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 756 (817)
..++......+.+++.+||..||.+|| +++++++|-
T Consensus 220 ~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp 260 (318)
T 1fot_A 220 LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP 260 (318)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSG
T ss_pred CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCc
Confidence 011223345678999999999999999 889998763
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=354.04 Aligned_cols=252 Identities=22% Similarity=0.315 Sum_probs=204.8
Q ss_pred cCCCcceeEeeeCceEEEEEEE-ecccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVI-EDKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
.+|...+.||+|+||.||+|.. .++..||+|++... .......+.+|+.+++.++||||+++++++......++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4688899999999999999997 46789999987642 1222457889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
||+ +|+|.+++... +.+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 89 E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~-- 161 (336)
T 3h4j_B 89 EYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-- 161 (336)
T ss_dssp CCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS--
T ss_pred ECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC--
Confidence 999 68998888654 46999999999999999999999876 999999999999999999999999999864332
Q ss_pred CceeeeeecCcCCCChhhhccCCC-CchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQL-TEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (817)
.......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||......... ..+...
T Consensus 162 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~---------------~~i~~~-- 223 (336)
T 3h4j_B 162 -NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF---------------KKVNSC-- 223 (336)
T ss_dssp -BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB---------------CCCCSS--
T ss_pred -cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH---------------HHHHcC--
Confidence 22234569999999999988776 78999999999999999999999754322211 000000
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 039107 720 KDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQ 761 (817)
Q Consensus 720 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 761 (817)
....+...+..+.+++.+||+.||.+|||++|++++-.....
T Consensus 224 ~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 224 VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 011222344567899999999999999999999988766543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=347.02 Aligned_cols=271 Identities=25% Similarity=0.371 Sum_probs=203.8
Q ss_pred HHhhcCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhcc--CccceeeEEEEEecC----C
Q 039107 481 KHATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKL--RHKHLVSLIGFCEEG----N 554 (817)
Q Consensus 481 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~g~~~~~----~ 554 (817)
....++|...++||+|+||.||+|+.. +..||||++... ....+..|.+++..+ +||||+++++++... .
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 334568999999999999999999876 678999998633 234556666666655 899999999999876 7
Q ss_pred eEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCC-----CCceEecCCccCcEEEcCCceeEEeee
Q 039107 555 EMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGA-----KYTIIHRDVKTTNILLDENWVAKVSDF 629 (817)
Q Consensus 555 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~Dikp~NIll~~~~~~kl~DF 629 (817)
..++||||+++|+|.+++.. ..+++.+++.++.|++.||+|||+++ +++|+||||||+|||++.++.+||+||
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred ceEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence 89999999999999999954 36999999999999999999999761 125999999999999999999999999
Q ss_pred ccCccCCCCCCCc--eeeeeecCcCCCChhhhccCCCCch------HHHHHHHHHHHHHHhC----------CCCCCCCC
Q 039107 630 GLSKTGPNMENGH--VSTVVKGSFGYLDPEYFKRQQLTEK------SDIYSFGVVLFEVLCA----------RPALNPSL 691 (817)
Q Consensus 630 Gla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~------sDV~S~Gvvl~elltG----------~~p~~~~~ 691 (817)
|+++......... ......||+.|+|||++.+...+.+ +|||||||++|||++| +.||....
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~ 266 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence 9997543222111 1123469999999999987766554 9999999999999999 55554332
Q ss_pred ccccchHHHHHHHhhccCchhhccCccccCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 039107 692 PKEQVSLADWALHCKRKGILDDIIDPLLKDK-ISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLV 763 (817)
Q Consensus 692 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 763 (817)
..... ...+... ..... ..+..... ...+++..+.+++.+||+.||.+|||+.+|+++|+.+.+..
T Consensus 267 ~~~~~-~~~~~~~-~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 267 PSDPS-YEDMREI-VCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp CSSCC-HHHHHHH-HTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred CCCCc-hhhhHHH-Hhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 22111 1111111 10000 11111111 12377888999999999999999999999999999988654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=379.74 Aligned_cols=257 Identities=29% Similarity=0.453 Sum_probs=210.1
Q ss_pred hcCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
.++|...++||+|+||.||+|.++++..||||+++... ...++|.+|+++|++++|+||+++++++.+ +..++|||||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 35677888999999999999999888889999988654 345789999999999999999999999976 6789999999
Q ss_pred cCCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 564 ALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 564 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
++|+|.++|.... ..+++.+++.|+.||+.||+|||+++ |+||||||+||||++++.+||+|||+++...... ..
T Consensus 344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~ 419 (535)
T 2h8h_A 344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YT 419 (535)
T ss_dssp TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-HH
T ss_pred cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-ee
Confidence 9999999997543 46999999999999999999999876 9999999999999999999999999998643211 01
Q ss_pred eeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccC
Q 039107 643 VSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKD 721 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (817)
......++..|+|||++..+.++.++|||||||+||||++ |+.||......+. .+.+ ..+ .+.
T Consensus 420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~---~~~i----~~~---------~~~ 483 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---LDQV----ERG---------YRM 483 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH---HHHH----HTT---------CCC
T ss_pred cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH----HcC---------CCC
Confidence 1122346788999999999999999999999999999999 8999876533221 1111 111 111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 039107 722 KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQL 762 (817)
Q Consensus 722 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 762 (817)
..+..++..+.+|+.+||+.||++|||+++|++.|+.+...
T Consensus 484 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 484 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 12334566789999999999999999999999999877643
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=351.72 Aligned_cols=247 Identities=20% Similarity=0.278 Sum_probs=205.3
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
.+|...+.||+|+||.||+++.. ++..||+|++... .....+.+.+|+++|++++||||+++++++.+....++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57888999999999999999976 5789999998643 2234577889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
||+++|+|.+++... +.+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~--- 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--- 193 (350)
T ss_dssp ECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS---
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC---
Confidence 999999999999654 35999999999999999999999776 99999999999999999999999999986432
Q ss_pred CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
......||+.|+|||++.+..++.++|||||||++|||++|++||......+. . .... .+. .
T Consensus 194 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~---~~i~-~~~------~--- 255 (350)
T 1rdq_E 194 --RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI---Y---EKIV-SGK------V--- 255 (350)
T ss_dssp --CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H---HHHH-HCC------C---
T ss_pred --CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH---H---HHHH-cCC------C---
Confidence 12345799999999999999999999999999999999999999976533211 1 1111 010 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHH
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRPS-----MGDVLWNLE 757 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~L~ 757 (817)
.++...+..+.+++.+||+.||.+||+ +++|++|-.
T Consensus 256 -~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~ 296 (350)
T 1rdq_E 256 -RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296 (350)
T ss_dssp -CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred -CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcC
Confidence 112234556899999999999999998 888887643
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=353.76 Aligned_cols=264 Identities=26% Similarity=0.411 Sum_probs=207.6
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe------cccEEEEEecCCC-CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE------DKLKVAIKRSNPS-SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEM 556 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 556 (817)
.++|...+.||+|+||.||+|+.. ++..||||.+... ......++.+|+.++++++||||+++++++......
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 357888999999999999999842 4568999998754 344556799999999999999999999999999999
Q ss_pred EEEEEeccCCchhhhhhccc------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcC---CceeEEe
Q 039107 557 CLVYDYMALGTLREHIYNTK------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDE---NWVAKVS 627 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~---~~~~kl~ 627 (817)
++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 99999999999999997543 35899999999999999999999876 999999999999984 4569999
Q ss_pred eeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhh
Q 039107 628 DFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCK 706 (817)
Q Consensus 628 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 706 (817)
|||+++...............||+.|+|||.+.+..++.++||||||+++|||++ |+.||......+ +..++..
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~~~~-- 260 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VLEFVTS-- 260 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHHHHT--
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH---HHHHHhc--
Confidence 9999875332222222334467899999999999999999999999999999998 889987543221 1111111
Q ss_pred ccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhccc
Q 039107 707 RKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVEST 766 (817)
Q Consensus 707 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 766 (817)
.. ....+..++..+.+++.+||+.||.+||++.+|+++|+.+.......
T Consensus 261 -~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~ 309 (327)
T 2yfx_A 261 -GG----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI 309 (327)
T ss_dssp -TC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHH
T ss_pred -CC----------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHHh
Confidence 10 01112234456899999999999999999999999999988765433
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=358.98 Aligned_cols=272 Identities=22% Similarity=0.276 Sum_probs=210.7
Q ss_pred cccCHHHHHHhhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccC-----ccceeeE
Q 039107 473 RRFSLAEIKHATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLR-----HKHLVSL 546 (817)
Q Consensus 473 ~~f~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~niv~l 546 (817)
..+++.+.....++|...++||+|+||+||+|+.. ++..||||++... ....+.+..|++++++++ ||||+++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 45666666667789999999999999999999974 5688999998743 344567788999999986 9999999
Q ss_pred EEEEecCCeEEEEEEeccCCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcC-----
Q 039107 547 IGFCEEGNEMCLVYDYMALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDE----- 620 (817)
Q Consensus 547 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~----- 620 (817)
++++...+..++||||+ +++|.+++.... ..+++.+++.++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCE
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccc
Confidence 99999999999999999 899999997654 36999999999999999999999876 999999999999975
Q ss_pred --------------------CceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHH
Q 039107 621 --------------------NWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEV 680 (817)
Q Consensus 621 --------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~el 680 (817)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence 789999999999863321 2345689999999999999999999999999999999
Q ss_pred HhCCCCCCCCCccccchHHHHHH---------HhhccCchhhccC-cccc----CCC-------------C---HHHHHH
Q 039107 681 LCARPALNPSLPKEQVSLADWAL---------HCKRKGILDDIID-PLLK----DKI-------------S---PECLKK 730 (817)
Q Consensus 681 ltG~~p~~~~~~~~~~~l~~~~~---------~~~~~~~~~~~~d-~~l~----~~~-------------~---~~~~~~ 730 (817)
++|+.||......+......... ...... ....++ ..+. ... + ......
T Consensus 253 l~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~-~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (360)
T 3llt_A 253 YTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTN-GSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL 331 (360)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSG-GGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHH
T ss_pred HHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhcc-CccccCcccceecCcccccchhhhhhhhhcccccccchHHH
Confidence 99999998755433222111100 000000 000000 0000 000 0 001156
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHH
Q 039107 731 FADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 731 l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
+.+|+.+||+.||++|||++|++++
T Consensus 332 l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 332 FCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHhcCChhhCCCHHHHhcC
Confidence 7899999999999999999999865
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=354.53 Aligned_cols=250 Identities=22% Similarity=0.298 Sum_probs=204.6
Q ss_pred hcCCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCC---CcccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPS---SEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEMCL 558 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 558 (817)
..+|...++||+|+||+||+|+.+. +..||+|++... .....+.+..|..+|..+ +||||+++++++...+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 4578899999999999999999764 678999998643 223456788999999998 79999999999999999999
Q ss_pred EEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCC
Q 039107 559 VYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNM 638 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 638 (817)
||||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 99 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~- 173 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW- 173 (353)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccccc-
Confidence 99999999999998654 35999999999999999999999876 99999999999999999999999999985322
Q ss_pred CCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcc
Q 039107 639 ENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPL 718 (817)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (817)
.........||+.|+|||++.+..++.++|||||||++|||++|++||......+ +...+. . . .
T Consensus 174 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~~~i~---~-~--------~ 237 (353)
T 2i0e_A 174 -DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQSIM---E-H--------N 237 (353)
T ss_dssp -TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH---H-C--------C
T ss_pred -CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH---HHHHHH---h-C--------C
Confidence 1223345679999999999999999999999999999999999999997653321 111111 1 0 0
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHH
Q 039107 719 LKDKISPECLKKFADTAEKCLSDSGIDRPS-----MGDVLWNL 756 (817)
Q Consensus 719 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~L 756 (817)
..++...+..+.+++.+||+.||.+||+ +++|++|-
T Consensus 238 --~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~ 278 (353)
T 2i0e_A 238 --VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA 278 (353)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSG
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCc
Confidence 0122234556799999999999999995 57777663
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=354.52 Aligned_cols=252 Identities=22% Similarity=0.281 Sum_probs=189.9
Q ss_pred hhcCCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
..++|...+.||+|+||.||+|+... +..||||++.... ..+.+.+|++++++++||||+++++++......++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 45678899999999999999999764 6789999987543 34678899999999999999999999999999999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcC---CceeEEeeeccCccCCCC
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDE---NWVAKVSDFGLSKTGPNM 638 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DFGla~~~~~~ 638 (817)
|+++|+|.+++... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++....
T Consensus 129 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~- 203 (349)
T 2w4o_A 129 LVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH- 203 (349)
T ss_dssp CCCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred eCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCc-
Confidence 99999999998654 45899999999999999999999876 999999999999975 88999999999986432
Q ss_pred CCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcc
Q 039107 639 ENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPL 718 (817)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (817)
........||+.|+|||++.+..++.++|||||||++|||++|+.||........ +. .... .... .
T Consensus 204 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~---~~i~-~~~~------~ 269 (349)
T 2w4o_A 204 --QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MF---RRIL-NCEY------Y 269 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HH---HHHH-TTCC------C
T ss_pred --ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HH---HHHH-hCCC------c
Confidence 2223345789999999999999999999999999999999999999975443221 10 0000 0000 0
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 719 LKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 719 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.........+..+.+++.+||+.||++|||+.+++++
T Consensus 270 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 270 FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111112345568899999999999999999999875
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=357.72 Aligned_cols=250 Identities=26% Similarity=0.322 Sum_probs=203.7
Q ss_pred cCCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
++|...++||+|+||.||++.... +..||+|.+... .....+.+.+|+++|++++||||+++++++......++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 468889999999999999999764 678999987643 2334577899999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
||+.+|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 95 e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--- 167 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR--- 167 (384)
T ss_dssp CCCTTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT---
T ss_pred ecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC---
Confidence 999999999998653 46999999999999999999999876 99999999999999999999999999986432
Q ss_pred CceeeeeecCcCCCChhhhcc---CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKR---QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (817)
........||+.|+|||++.. ..++.++|||||||++|||++|+.||..........+...... .
T Consensus 168 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~----~-------- 235 (384)
T 4fr4_A 168 ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET----T-------- 235 (384)
T ss_dssp TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH----C--------
T ss_pred CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh----c--------
Confidence 223345679999999999864 4589999999999999999999999976543322222111111 0
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 039107 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPS-MGDVLWN 755 (817)
Q Consensus 718 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~~ 755 (817)
...++...+..+.+++.+||+.||.+||+ +++|+++
T Consensus 236 --~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 236 --VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp --CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred --ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 01122334566899999999999999999 7777654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=346.05 Aligned_cols=265 Identities=23% Similarity=0.288 Sum_probs=199.9
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCc--ccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSE--QGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
++|...+.||+|+||+||+|... ++..||+|++..... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 56888999999999999999976 478899998765432 235678899999999999999999999999999999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
|+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 83 ~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~ 156 (311)
T 4agu_A 83 YCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP--S 156 (311)
T ss_dssp CCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred eCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc--c
Confidence 99999999887543 45999999999999999999999876 999999999999999999999999999764322 1
Q ss_pred ceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHH---------HhhccCch
Q 039107 642 HVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWAL---------HCKRKGIL 711 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~---------~~~~~~~~ 711 (817)
.......||..|+|||.+.+ ..++.++||||||+++|||++|++||......+......... ........
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence 22234568999999999876 678999999999999999999999998765443322111100 00000000
Q ss_pred hhccCccccCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 712 DDIIDPLLKDKI-----SPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 712 ~~~~d~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.....+...... .+..+..+.+++.+||+.||.+|||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000000000 01234568899999999999999999999976
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=352.04 Aligned_cols=256 Identities=23% Similarity=0.343 Sum_probs=203.1
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 559 (817)
++|...++||+|+||.||+++.+ +++.||+|++... .....+.+.+|..+++++ +||||+++++++......++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 46888899999999999999976 4678999998643 233456688999999988 899999999999999999999
Q ss_pred EEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC
Q 039107 560 YDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 639 (817)
|||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~- 163 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP- 163 (345)
T ss_dssp ECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT-
T ss_pred EeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCC-
Confidence 9999999999998654 46999999999999999999999876 999999999999999999999999999853221
Q ss_pred CCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccc--hHHHHHHHhhccCchhhccCc
Q 039107 640 NGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQV--SLADWALHCKRKGILDDIIDP 717 (817)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~--~l~~~~~~~~~~~~~~~~~d~ 717 (817)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..............
T Consensus 164 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~------- 235 (345)
T 3a8x_A 164 -GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------- 235 (345)
T ss_dssp -TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC-------
T ss_pred -CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC-------
Confidence 22334567999999999999999999999999999999999999999653221110 00111111111110
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHHHH
Q 039107 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPSM------GDVLWNL 756 (817)
Q Consensus 718 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~~L 756 (817)
..++...+..+.+++.+||+.||.+||++ .++++|-
T Consensus 236 ---~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp 277 (345)
T 3a8x_A 236 ---IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 277 (345)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSG
T ss_pred ---CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCC
Confidence 11223345567899999999999999995 6776653
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=352.88 Aligned_cols=253 Identities=21% Similarity=0.283 Sum_probs=202.2
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC-----CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS-----SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCL 558 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 558 (817)
+.|...+.||+|+||+||+|..+ +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 46888999999999999999875 5789999987532 22246789999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhccc---cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCce---eEEeeeccC
Q 039107 559 VYDYMALGTLREHIYNTK---KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWV---AKVSDFGLS 632 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~---~kl~DFGla 632 (817)
||||+++++|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 999999999998886442 25899999999999999999999876 999999999999986554 999999999
Q ss_pred ccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchh
Q 039107 633 KTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILD 712 (817)
Q Consensus 633 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 712 (817)
+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+...+.. +..
T Consensus 181 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~i~~----~~~- 249 (351)
T 3c0i_A 181 IQLGES--GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLFEGIIK----GKY- 249 (351)
T ss_dssp EECCTT--SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHHHHHHH----TCC-
T ss_pred eEecCC--CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHHHHHHc----CCC-
Confidence 864332 2223345799999999999999999999999999999999999999976421 11111110 000
Q ss_pred hccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 713 DIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 713 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
...+.... ..+..+.+++.+||+.||++|||+.+++++-
T Consensus 250 -~~~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp 288 (351)
T 3c0i_A 250 -KMNPRQWS----HISESAKDLVRRMLMLDPAERITVYEALNHP 288 (351)
T ss_dssp -CCCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred -CCCccccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhcCh
Confidence 00111111 2245678999999999999999999999764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=344.98 Aligned_cols=264 Identities=22% Similarity=0.336 Sum_probs=200.5
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
.+|...+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 46888999999999999999964 6789999998753 2334567899999999999999999999999999999999
Q ss_pred EeccCCchhhhhhcc---ccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCC
Q 039107 561 DYMALGTLREHIYNT---KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPN 637 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 637 (817)
||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 999999999998642 346899999999999999999999876 99999999999999999999999999876432
Q ss_pred CCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCc
Q 039107 638 MENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717 (817)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (817)
. ........|+..|+|||.+.+..++.++||||||+++|||++|+.||...... ...+...... ... +
T Consensus 189 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~-~~~-----~ 256 (310)
T 2wqm_A 189 K--TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIEQ-CDY-----P 256 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHHHHHHT-TCS-----C
T ss_pred C--CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHHHHhhc-ccC-----C
Confidence 2 12223456899999999999999999999999999999999999998754321 1111111111 100 0
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhccc
Q 039107 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVEST 766 (817)
Q Consensus 718 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 766 (817)
.. .....+..+.+++.+||+.||.+|||+.+|+++|+.+.......
T Consensus 257 ~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 257 PL---PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp CC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred CC---cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence 01 11233456889999999999999999999999999998765543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=340.46 Aligned_cols=252 Identities=28% Similarity=0.450 Sum_probs=200.4
Q ss_pred hcCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecC-CeEEEEEEe
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEG-NEMCLVYDY 562 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~Ey 562 (817)
.++|...+.||+|+||.||+|..+ +..||+|++.... ..+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 356888999999999999999875 6789999987543 457899999999999999999999987544 578999999
Q ss_pred ccCCchhhhhhcccc-ccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 563 MALGTLREHIYNTKK-ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
+++++|.+++..... .+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--- 170 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 170 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc---
Confidence 999999999975543 4899999999999999999999876 999999999999999999999999998753221
Q ss_pred ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 642 HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. .... ..+ ..
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~~~----~~~---------~~ 232 (278)
T 1byg_A 171 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRV----EKG---------YK 232 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HHHH----TTT---------CC
T ss_pred --ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH----hcC---------CC
Confidence 223357889999999999999999999999999999998 9999875433221 1111 011 11
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQL 762 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 762 (817)
...+..++..+.+++.+||+.||.+||++.++++.|+.+...
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 233 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 112234456789999999999999999999999999988754
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=356.74 Aligned_cols=273 Identities=21% Similarity=0.291 Sum_probs=213.8
Q ss_pred cCCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCC--eEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGN--EMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~ 560 (817)
++|...++||+|+||+||+|.... +..||||++.... ....+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 568889999999999999999764 7899999987543 334577889999999999999999999997655 789999
Q ss_pred EeccCCchhhhhhcccc--ccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEE----cCCceeEEeeeccCcc
Q 039107 561 DYMALGTLREHIYNTKK--ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILL----DENWVAKVSDFGLSKT 634 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll----~~~~~~kl~DFGla~~ 634 (817)
||+++|+|.+++..... .+++..++.++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 99999999999976543 3999999999999999999999876 9999999999999 7888999999999986
Q ss_pred CCCCCCCceeeeeecCcCCCChhhhcc--------CCCCchHHHHHHHHHHHHHHhCCCCCCCCCcccc-chHHHHHHHh
Q 039107 635 GPNMENGHVSTVVKGSFGYLDPEYFKR--------QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQ-VSLADWALHC 705 (817)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~-~~l~~~~~~~ 705 (817)
... ........||..|+|||++.. ..++.++|||||||++|||++|+.||........ .....-....
T Consensus 166 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 166 LED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp CCC---GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred ccC---CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 432 222334569999999999875 5678899999999999999999999975432221 1111111111
Q ss_pred hccCchhhcc-----------CccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 039107 706 KRKGILDDII-----------DPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLV 763 (817)
Q Consensus 706 ~~~~~~~~~~-----------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 763 (817)
.....+..+. +..............+.+++.+||+.||++||++.++++.++.++...
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 1111000000 001112345678888999999999999999999999999999988654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=353.23 Aligned_cols=262 Identities=24% Similarity=0.279 Sum_probs=202.8
Q ss_pred HHHhhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC-----CcccHHHHHHHHHHHhccCccceeeEEEEEecC
Q 039107 480 IKHATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS-----SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEG 553 (817)
Q Consensus 480 l~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 553 (817)
+....++|...+.||+|+||.||+|... ++..||+|++... .....+.+.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 4455678999999999999999999875 5678999987532 334567899999999999999999999999999
Q ss_pred CeEEEEEEeccCCchhhhhhcc---------------------------------------ccccchHhHHHHHHHHHHH
Q 039107 554 NEMCLVYDYMALGTLREHIYNT---------------------------------------KKALSWKQRLEICIGAARG 594 (817)
Q Consensus 554 ~~~~lV~Ey~~~gsL~~~l~~~---------------------------------------~~~l~~~~~~~i~~~ia~g 594 (817)
+..++||||+++|+|.+++... ...+++..++.|+.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999988421 1135778889999999999
Q ss_pred HHHHHhCCCCceEecCCccCcEEEcCCc--eeEEeeeccCccCCCCCCC--ceeeeeecCcCCCChhhhcc--CCCCchH
Q 039107 595 LHYLHTGAKYTIIHRDVKTTNILLDENW--VAKVSDFGLSKTGPNMENG--HVSTVVKGSFGYLDPEYFKR--QQLTEKS 668 (817)
Q Consensus 595 L~yLH~~~~~~ivH~Dikp~NIll~~~~--~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~s~~s 668 (817)
|+|||+.+ |+||||||+|||++.++ .+||+|||+++........ .......||+.|+|||.+.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999876 99999999999998776 8999999999754322211 12345579999999999975 6889999
Q ss_pred HHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 039107 669 DIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPS 748 (817)
Q Consensus 669 DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt 748 (817)
||||||+++|||++|+.||......+.. ........ .............+.+++.+||+.||.+||+
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~------~~~~~~~~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTI------SQVLNKKL-------CFENPNYNVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHCCC-------CTTSGGGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHH------HHHHhccc-------ccCCcccccCCHHHHHHHHHHcCCChhHCCC
Confidence 9999999999999999999765433211 11111110 0000011123456889999999999999999
Q ss_pred HHHHHHHHH
Q 039107 749 MGDVLWNLE 757 (817)
Q Consensus 749 ~~evl~~L~ 757 (817)
+.+++++-.
T Consensus 325 ~~~~l~hp~ 333 (345)
T 3hko_A 325 AMRALQHPW 333 (345)
T ss_dssp HHHHHHSHH
T ss_pred HHHHhcChh
Confidence 999998643
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=347.84 Aligned_cols=258 Identities=31% Similarity=0.496 Sum_probs=205.8
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-ccc--EEEEEecCCC-CcccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKL--KVAIKRSNPS-SEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 559 (817)
++|...+.||+|+||.||+|+.. ++. .+|+|.+... .....+.+.+|+++++++ +||||+++++++...+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 56888899999999999999965 444 3599987643 334456799999999999 899999999999999999999
Q ss_pred EEeccCCchhhhhhccc---------------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCcee
Q 039107 560 YDYMALGTLREHIYNTK---------------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVA 624 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~ 624 (817)
|||+++++|.+++.... ..+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999997543 36899999999999999999999776 9999999999999999999
Q ss_pred EEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHH
Q 039107 625 KVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWAL 703 (817)
Q Consensus 625 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 703 (817)
||+|||+++.... ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ + ..
T Consensus 182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---~---~~ 252 (327)
T 1fvr_A 182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---L---YE 252 (327)
T ss_dssp EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---H---HH
T ss_pred EEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH---H---HH
Confidence 9999999874321 112233457889999999998899999999999999999998 999997653321 1 11
Q ss_pred HhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhc
Q 039107 704 HCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVE 764 (817)
Q Consensus 704 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 764 (817)
... .+ .....+..++..+.+++.+||+.+|.+|||+.+++++|+.++....
T Consensus 253 ~~~-~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 253 KLP-QG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp HGG-GT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred Hhh-cC---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 111 11 0111222345668999999999999999999999999999886543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=344.56 Aligned_cols=262 Identities=26% Similarity=0.389 Sum_probs=207.8
Q ss_pred hcCCCcce-eEeeeCceEEEEEEEe---cccEEEEEecCCCC--cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEE
Q 039107 484 TKSFDESY-VIGVGGFGKVYKGVIE---DKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMC 557 (817)
Q Consensus 484 ~~~f~~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 557 (817)
..+|...+ .||+|+||.||+|... .+..||||++.... ....+++.+|++++++++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45677777 9999999999999653 35789999987543 23357899999999999999999999999 567789
Q ss_pred EEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCC
Q 039107 558 LVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPN 637 (817)
Q Consensus 558 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 637 (817)
+||||+++++|.+++... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 94 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp EEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 999999999999999654 45999999999999999999999876 99999999999999999999999999986533
Q ss_pred CCCC-ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhcc
Q 039107 638 MENG-HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDII 715 (817)
Q Consensus 638 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (817)
.... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ +..... .+.
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~----~~~----- 237 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAMLE----KGE----- 237 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHH----TTC-----
T ss_pred CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHH----cCC-----
Confidence 2221 11223346789999999998899999999999999999999 999997654322 111111 110
Q ss_pred CccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhccc
Q 039107 716 DPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVEST 766 (817)
Q Consensus 716 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 766 (817)
....+..++..+.+++.+||+.||.+||++.++++.|+.+.......
T Consensus 238 ----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 284 (291)
T 1xbb_A 238 ----RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 284 (291)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhc
Confidence 11122344567899999999999999999999999999988765433
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=364.00 Aligned_cols=265 Identities=20% Similarity=0.239 Sum_probs=211.3
Q ss_pred hcCCCcceeEeeeCceEEEEEEE-ecccEEEEEecCCCCcccHHHHHHHHHHHhccCc-cceeeEEEEEecCCeEEEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVI-EDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRH-KHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 561 (817)
.++|...++||+|+||.||+|+. .++..||||++...... .++..|+++++.|+| +++..+..++...+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 45788899999999999999996 45789999987654332 457899999999976 666677777788889999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEE---cCCceeEEeeeccCccCCCC
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILL---DENWVAKVSDFGLSKTGPNM 638 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll---~~~~~~kl~DFGla~~~~~~ 638 (817)
|+ +++|.+++......+++.+++.|+.||+.||+|||+++ ||||||||+|||| +.++.+||+|||+++.....
T Consensus 84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 99 89999999766678999999999999999999999876 9999999999999 68899999999999865433
Q ss_pred CCC-----ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhh
Q 039107 639 ENG-----HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDD 713 (817)
Q Consensus 639 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 713 (817)
... .......||..|+|||++.+..++.++|||||||+||||++|+.||..............+........+..
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA 239 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH
Confidence 221 122356799999999999999999999999999999999999999987554333322222222111111111
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 039107 714 IIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLV 763 (817)
Q Consensus 714 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 763 (817)
+.. .++.++.+++.+||+.+|++||++.+|++.|+.+....
T Consensus 240 -----l~~----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 240 -----LCR----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp -----HHT----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -----Hhc----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 111 23456899999999999999999999999999987644
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=345.22 Aligned_cols=260 Identities=23% Similarity=0.387 Sum_probs=199.9
Q ss_pred hcCCCcceeEeeeCceEEEEEEEec--c--cEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIED--K--LKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEM 556 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 556 (817)
.++|...+.||+|+||+||+|++.. + ..||+|++... .....+.+.+|++++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 3568889999999999999998642 2 36899998754 2345678999999999999999999999998754 8
Q ss_pred EEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCC
Q 039107 557 CLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGP 636 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 636 (817)
++|+||+++++|.+++......+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccccc
Confidence 9999999999999999876667999999999999999999999876 9999999999999999999999999998654
Q ss_pred CCCCC-ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhc
Q 039107 637 NMENG-HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDI 714 (817)
Q Consensus 637 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 714 (817)
..... .......+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+ + ........
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~---~~~~~~~~----- 241 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---I---LHKIDKEG----- 241 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---H---HHHHHTSC-----
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH---H---HHHHHccC-----
Confidence 32221 12233457889999999998899999999999999999999 999997654321 1 11111111
Q ss_pred cCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 039107 715 IDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQL 762 (817)
Q Consensus 715 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 762 (817)
.....+..++..+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus 242 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 242 ----ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ----CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 01111223456789999999999999999999999999987643
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=350.18 Aligned_cols=255 Identities=25% Similarity=0.370 Sum_probs=194.3
Q ss_pred hcCCCcceeEeeeCceEEEEEEE-ecccEEEEEecCCCC---cccHHHHHHHHHHHhccCccceeeEEEEEecCCe----
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVI-EDKLKVAIKRSNPSS---EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNE---- 555 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~---- 555 (817)
.++|...++||+|+||.||+|+. .+++.||||++.... ....+.|.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 35788899999999999999996 467889999987643 2334678999999999999999999999865443
Q ss_pred EEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccC
Q 039107 556 MCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTG 635 (817)
Q Consensus 556 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 635 (817)
.++||||+++++|.+++... ..+++.+++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred cEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 49999999999999998654 46999999999999999999999876 999999999999999999999999999864
Q ss_pred CCCCCC-ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhc
Q 039107 636 PNMENG-HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDI 714 (817)
Q Consensus 636 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 714 (817)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ..........
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~~~--- 237 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDPI--- 237 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCCCC---
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhcCCCC---
Confidence 332211 223345689999999999999999999999999999999999999976543221 1111111100
Q ss_pred cCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 715 IDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 715 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.+.. .....+..+.+++.+||+.||.+||+..+++++
T Consensus 238 -~~~~---~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~ 274 (311)
T 3ork_A 238 -PPSA---RHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274 (311)
T ss_dssp -CHHH---HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred -Cccc---ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence 0000 011234568899999999999999987766644
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=344.70 Aligned_cols=251 Identities=28% Similarity=0.422 Sum_probs=203.5
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEec----------
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE---------- 552 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~---------- 552 (817)
..+|...+.||+|+||.||+|... ++..||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 456888999999999999999976 67899999987543 356789999999999999999998854
Q ss_pred ------CCeEEEEEEeccCCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeE
Q 039107 553 ------GNEMCLVYDYMALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAK 625 (817)
Q Consensus 553 ------~~~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~k 625 (817)
....++||||+++++|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEE
Confidence 445799999999999999997543 47999999999999999999999876 99999999999999999999
Q ss_pred EeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHh
Q 039107 626 VSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHC 705 (817)
Q Consensus 626 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 705 (817)
|+|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|..|+... ..+....
T Consensus 163 l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------~~~~~~~ 231 (284)
T 2a19_B 163 IGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------SKFFTDL 231 (284)
T ss_dssp ECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------HHHHHHH
T ss_pred ECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------HHHHHHh
Confidence 99999998653322 223446899999999999999999999999999999999998876321 0111110
Q ss_pred hccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhcc
Q 039107 706 KRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVES 765 (817)
Q Consensus 706 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 765 (817)
. +..+. ...+..+.+++.+||+.||.+|||+.+++++|+.+....+.
T Consensus 232 -~--------~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 232 -R--------DGIIS----DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp -H--------TTCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred -h--------ccccc----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 1 11111 12334578999999999999999999999999988765543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=368.47 Aligned_cols=251 Identities=23% Similarity=0.324 Sum_probs=196.2
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 559 (817)
.++|...++||+|+||.||+|... ++..||||++... .......+.+|++++++++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 357889999999999999999965 5688999998642 333456788999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHh-CCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCC
Q 039107 560 YDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHT-GAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNM 638 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 638 (817)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 227 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp ECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 9999999999988654 469999999999999999999997 55 999999999999999999999999999853221
Q ss_pred CCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcc
Q 039107 639 ENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPL 718 (817)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (817)
........||+.|+|||++.+..++.++|||||||+||||++|+.||........ ...+.. .. .
T Consensus 303 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~i~~---~~-------~- 366 (446)
T 4ejn_A 303 --GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FELILM---EE-------I- 366 (446)
T ss_dssp ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHH---CC-------C-
T ss_pred --CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH---HHHHHh---CC-------C-
Confidence 2233456799999999999999999999999999999999999999976543221 111110 00 0
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 039107 719 LKDKISPECLKKFADTAEKCLSDSGIDRP-----SMGDVLWNLE 757 (817)
Q Consensus 719 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L~ 757 (817)
.++......+.+++.+||+.||.+|| +++|+++|--
T Consensus 367 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~ 407 (446)
T 4ejn_A 367 ---RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407 (446)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred ---CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCcc
Confidence 11223345678999999999999999 9999997643
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=352.29 Aligned_cols=254 Identities=19% Similarity=0.219 Sum_probs=206.9
Q ss_pred hhcCCCcceeEeeeCceEEEEEE------EecccEEEEEecCCCCcccHHHHHHHHHHHhccC---ccceeeEEEEEecC
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGV------IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLR---HKHLVSLIGFCEEG 553 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~ 553 (817)
..++|...++||+|+||+||+|. ...+..||||++.... ..++..|++++++++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 45678899999999999999994 4456789999987543 456778888888886 99999999999999
Q ss_pred CeEEEEEEeccCCchhhhhhc----cccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcC---------
Q 039107 554 NEMCLVYDYMALGTLREHIYN----TKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDE--------- 620 (817)
Q Consensus 554 ~~~~lV~Ey~~~gsL~~~l~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~--------- 620 (817)
+..++||||+++|+|.+++.. ....+++.+++.|+.||+.||+|||+++ ||||||||+||||+.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence 999999999999999999975 2346999999999999999999999765 999999999999998
Q ss_pred --CceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchH
Q 039107 621 --NWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSL 698 (817)
Q Consensus 621 --~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l 698 (817)
++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--- 293 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC--- 293 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE---
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce---
Confidence 899999999999754433344455566799999999999999999999999999999999999999854322110
Q ss_pred HHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCC-CCHHHHHHHHHHhHhhh
Q 039107 699 ADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDR-PSMGDVLWNLEFVLQLV 763 (817)
Q Consensus 699 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R-Pt~~evl~~L~~~~~~~ 763 (817)
.+...+.... ....+.+++..|++.+|.+| |+++++.+.|+..++..
T Consensus 294 ---------------~~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 294 ---------------KPEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp ---------------EECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ---------------eechhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 0111111111 13456789999999999998 67899999898887653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=353.10 Aligned_cols=267 Identities=22% Similarity=0.351 Sum_probs=198.6
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCccc-HHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQG-VNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
++|...+.||+|+||+||+|... ++..||+|++....... ...+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888899999999999999976 57889999987543221 22456799999999999999999999999999999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
++ |+|.+++......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP--TK 155 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC--cc
Confidence 98 5999988777677999999999999999999999876 999999999999999999999999999754321 22
Q ss_pred eeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccC-----
Q 039107 643 VSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIID----- 716 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d----- 716 (817)
......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+......................
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence 2334568999999999876 5789999999999999999999999987654432221111000000000000000
Q ss_pred ----ccccC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 717 ----PLLKD----KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 717 ----~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
+.... ...+.....+.+|+.+||+.||.+|||++|++++--
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 284 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChh
Confidence 00000 001123456789999999999999999999997644
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=338.52 Aligned_cols=254 Identities=21% Similarity=0.317 Sum_probs=205.2
Q ss_pred hcCCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
.++|...++||+|+||.||+|.... +..+|+|++........+.+.+|++++++++||||+++++++......++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 4568889999999999999999764 568999998766556678899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEE---cCCceeEEeeeccCccCCCCC
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILL---DENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll---~~~~~~kl~DFGla~~~~~~~ 639 (817)
+++++|.+++... ..+++.+++.++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||++......
T Consensus 88 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~- 162 (277)
T 3f3z_A 88 CTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG- 162 (277)
T ss_dssp CCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT-
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc-
Confidence 9999999988654 45899999999999999999999876 9999999999999 78899999999999764322
Q ss_pred CCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccc
Q 039107 640 NGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719 (817)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (817)
.......||+.|+|||.+.+ .++.++||||||++++||++|+.||......+.. .... .+... .....
T Consensus 163 --~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~~~~-~~~~~--~~~~~ 230 (277)
T 3f3z_A 163 --KMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM------LKIR-EGTFT--FPEKD 230 (277)
T ss_dssp --SCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHH-HCCCC--CCHHH
T ss_pred --cchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHH------HHHH-hCCCC--CCchh
Confidence 22334568999999999875 4899999999999999999999999765432211 1101 11000 00000
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 720 KDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 720 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
. ...+..+.+++.+||+.||.+|||+.+++++--.
T Consensus 231 ~----~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~ 265 (277)
T 3f3z_A 231 W----LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWF 265 (277)
T ss_dssp H----TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred h----hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHH
Confidence 0 0234568899999999999999999999976444
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=350.02 Aligned_cols=251 Identities=21% Similarity=0.262 Sum_probs=179.0
Q ss_pred ceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccC-ccceeeEEEEEecCCeEEEEEEeccCCc
Q 039107 490 SYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLR-HKHLVSLIGFCEEGNEMCLVYDYMALGT 567 (817)
Q Consensus 490 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gs 567 (817)
.++||+|+||.||+|..+ ++..||||++.. .....+.+|+.+++++. ||||+++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 368999999999999975 568899999863 23467889999999997 9999999999999999999999999999
Q ss_pred hhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCc---eeEEeeeccCccCCCCCCCcee
Q 039107 568 LREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENW---VAKVSDFGLSKTGPNMENGHVS 644 (817)
Q Consensus 568 L~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~---~~kl~DFGla~~~~~~~~~~~~ 644 (817)
|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||+++..... ....
T Consensus 93 L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--~~~~ 166 (325)
T 3kn6_A 93 LFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPL 166 (325)
T ss_dssp HHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC--CCcc
Confidence 99999654 46999999999999999999999876 99999999999997665 8999999999864322 2223
Q ss_pred eeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCC
Q 039107 645 TVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKIS 724 (817)
Q Consensus 645 ~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 724 (817)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.....................+.. .......
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~------~~~~~~~ 240 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF------SFEGEAW 240 (325)
T ss_dssp -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC------CCCSHHH
T ss_pred cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC------CCCcccc
Confidence 3456899999999999999999999999999999999999999765432211111111111111110 0000001
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 725 PECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 725 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
...+..+.+++.+||+.||.+|||+++++++
T Consensus 241 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 241 KNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred cCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 1235668999999999999999999998754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=347.26 Aligned_cols=262 Identities=24% Similarity=0.318 Sum_probs=199.6
Q ss_pred hcCCCcceeEeeeCceEEEEEEE-ecccEEEEEecCCCC-----cccHHHHHHHHHHHhccC---ccceeeEEEEEecCC
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVI-EDKLKVAIKRSNPSS-----EQGVNEFVTEIEMLSKLR---HKHLVSLIGFCEEGN 554 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~ 554 (817)
..+|...++||+|+||+||+|+. .++..||+|++.... ......+.+|++++++++ ||||++++++|....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 56899999999999999999996 457889999876321 122356778888887775 999999999997654
Q ss_pred -----eEEEEEEeccCCchhhhhhcccc-ccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEee
Q 039107 555 -----EMCLVYDYMALGTLREHIYNTKK-ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSD 628 (817)
Q Consensus 555 -----~~~lV~Ey~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 628 (817)
..++||||++ ++|.+++..... .+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~D 163 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLAD 163 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEECS
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEee
Confidence 5799999997 599999876543 4999999999999999999999876 99999999999999999999999
Q ss_pred eccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhcc
Q 039107 629 FGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRK 708 (817)
Q Consensus 629 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 708 (817)
||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|++||......+.... +......
T Consensus 164 fg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~---i~~~~~~ 237 (308)
T 3g33_A 164 FGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK---IFDLIGL 237 (308)
T ss_dssp CSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHH---HHHHHCC
T ss_pred CccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCC
Confidence 9999864322 223445789999999999999999999999999999999999999977654332211 1111000
Q ss_pred C---chh-------hccCcccc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 709 G---ILD-------DIIDPLLK---DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 709 ~---~~~-------~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
. ... ..+.+... ....++....+.+++.+||+.||.+|||+.|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 0 000 00000000 00011234568899999999999999999999875
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=340.94 Aligned_cols=249 Identities=24% Similarity=0.394 Sum_probs=184.5
Q ss_pred cCCCcceeEeeeCceEEEEEEE-ecccEEEEEecCCCC---cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVI-EDKLKVAIKRSNPSS---EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
++|...+.||+|+||.||+|+. .++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 5688899999999999999997 467899999986431 223467899999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
||+++++|.+++......+++.+++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~- 166 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH- 166 (278)
T ss_dssp ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCC-
Confidence 999999999999876667999999999999999999999876 9999999999999999999999999997643221
Q ss_pred CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... .+.....
T Consensus 167 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---------------~~~~~~~- 229 (278)
T 3cok_A 167 -EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN---------------KVVLADY- 229 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSSCC-
T ss_pred -CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH---------------HHhhccc-
Confidence 12234568999999999998899999999999999999999999997643322110 0000000
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
..+...+..+.+++.+||+.||++|||+.+++++
T Consensus 230 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 230 -EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp -CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 1122334567899999999999999999999865
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=339.07 Aligned_cols=251 Identities=25% Similarity=0.412 Sum_probs=202.5
Q ss_pred hcCCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCCC---cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPSS---EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 559 (817)
.++|...+.||+|+||.||+|.... +..||+|++.... ......+.+|+.++++++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 4578889999999999999998764 5689999875431 22346788999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC
Q 039107 560 YDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 639 (817)
|||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~-- 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS-- 161 (279)
T ss_dssp ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc--
Confidence 9999999999998654 45899999999999999999999765 99999999999999999999999999865322
Q ss_pred CCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccc
Q 039107 640 NGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719 (817)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (817)
.......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+.. ..... .
T Consensus 162 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~-~---------- 222 (279)
T 3fdn_A 162 --SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY------KRISR-V---------- 222 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHH-T----------
T ss_pred --ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHH------HHHHh-C----------
Confidence 1223457899999999999999999999999999999999999999754322111 00000 0
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 720 KDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 720 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
....+......+.+++.+||+.||.+|||+.|++++-...
T Consensus 223 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~ 262 (279)
T 3fdn_A 223 EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 262 (279)
T ss_dssp CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCcccc
Confidence 0111223345678999999999999999999999886543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=346.39 Aligned_cols=252 Identities=21% Similarity=0.272 Sum_probs=204.3
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCc------ccHHHHHHHHHHHhccCccceeeEEEEEecCCeE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSE------QGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEM 556 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 556 (817)
.++|...+.||+|+||.||+|... ++..||+|.+..... ...+.+.+|+.++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 346888999999999999999976 578899998764322 1357899999999999999999999999999999
Q ss_pred EEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCc----eeEEeeeccC
Q 039107 557 CLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENW----VAKVSDFGLS 632 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~----~~kl~DFGla 632 (817)
++||||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred EEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 9999999999999998653 46999999999999999999999876 99999999999999887 7999999999
Q ss_pred ccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchh
Q 039107 633 KTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILD 712 (817)
Q Consensus 633 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 712 (817)
+..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.. ..... ..
T Consensus 167 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~i~~-~~-- 234 (321)
T 2a2a_A 167 HEIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL------ANITS-VS-- 234 (321)
T ss_dssp EECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH------HHHHT-TC--
T ss_pred eecCcc---ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHH------HHHHh-cc--
Confidence 864332 1223456899999999999999999999999999999999999999765332211 11000 00
Q ss_pred hccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 713 DIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 713 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
...++.... ..+..+.+++.+||+.||.+|||+.+++++
T Consensus 235 ~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 235 YDFDEEFFS----HTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp CCCCHHHHT----TCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred cccChhhhc----ccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 001111111 223567899999999999999999999976
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=353.88 Aligned_cols=266 Identities=17% Similarity=0.148 Sum_probs=198.7
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe----cccEEEEEecCCCCcc-----------cHHHHHHHHHHHhccCccceeeEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE----DKLKVAIKRSNPSSEQ-----------GVNEFVTEIEMLSKLRHKHLVSLIG 548 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~l~g 548 (817)
.++|...+.||+|+||.||+|... .+..+|+|+....... ....+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357888999999999999999976 4578999997755322 1234678889999999999999999
Q ss_pred EEec----CCeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCc--
Q 039107 549 FCEE----GNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENW-- 622 (817)
Q Consensus 549 ~~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~-- 622 (817)
++.. ....++||||+ +++|.+++.... .+++.+++.|+.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTT
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCC
Confidence 9977 77899999999 899999987554 7999999999999999999999876 99999999999999887
Q ss_pred eeEEeeeccCccCCCCCC-----CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccch
Q 039107 623 VAKVSDFGLSKTGPNMEN-----GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVS 697 (817)
Q Consensus 623 ~~kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~ 697 (817)
.+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~- 269 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA- 269 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH-
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH-
Confidence 999999999976432111 11123457999999999999999999999999999999999999999643222111
Q ss_pred HHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 039107 698 LADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVL 760 (817)
Q Consensus 698 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 760 (817)
.. ......... +...+..... ...++..+.+++.+||+.||++||++.+|++.|+...
T Consensus 270 ~~-~~~~~~~~~-~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 270 VQ-TAKTNLLDE-LPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HH-HHHHHHHHT-TTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HH-HHHHhhccc-ccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 11 111100000 0000000000 0123456899999999999999999999999988654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=338.39 Aligned_cols=254 Identities=25% Similarity=0.338 Sum_probs=204.3
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
.++|...+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 356888899999999999999976 57899999976432 3345788999999999999999999999999999999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
|+++++|.+++... ..+++.+++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.........
T Consensus 86 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 86 YCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp CCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred ecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 99999999998643 46999999999999999999999876 999999999999999999999999999754322222
Q ss_pred ceeeeeecCcCCCChhhhccCCC-CchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 642 HVSTVVKGSFGYLDPEYFKRQQL-TEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
.......||..|+|||.+.+..+ +.++||||||+++|||++|+.||....... ..+..|... ... .
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~---~~~----~----- 228 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEK---KTY----L----- 228 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS-HHHHHHHTT---CTT----S-----
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHhhhc---ccc----c-----
Confidence 22334568999999999987665 789999999999999999999997654322 112222211 000 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.........+.+++.+||+.||.+|||+.+++++
T Consensus 229 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 229 -NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp -TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 0011234567899999999999999999999865
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=377.25 Aligned_cols=251 Identities=27% Similarity=0.403 Sum_probs=200.6
Q ss_pred eeEeeeCceEEEEEEEe---cccEEEEEecCCCC--cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccC
Q 039107 491 YVIGVGGFGKVYKGVIE---DKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMAL 565 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 565 (817)
+.||+|+||.||+|.+. .+..||||+++... ....++|.+|+++|++++||||++++++|.. +..++|||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999764 35789999987543 3346789999999999999999999999965 568999999999
Q ss_pred CchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC-Ccee
Q 039107 566 GTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN-GHVS 644 (817)
Q Consensus 566 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~-~~~~ 644 (817)
|+|.+++... ..+++.+++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++....... ....
T Consensus 454 g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 454 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 9999999643 46999999999999999999999876 99999999999999999999999999986533221 1223
Q ss_pred eeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCC
Q 039107 645 TVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKI 723 (817)
Q Consensus 645 ~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 723 (817)
....+|+.|+|||++.+..++.++|||||||+||||++ |+.||......+. ...+ ..+ .....
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~---~~~i----~~~---------~~~~~ 593 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV---TAML----EKG---------ERMGC 593 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHHH----HTT---------CCCCC
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH----HcC---------CCCCC
Confidence 34457889999999999999999999999999999998 9999976543221 1111 111 11122
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 039107 724 SPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQL 762 (817)
Q Consensus 724 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 762 (817)
+..++..+.+|+.+||+.||++||++.+|++.|+.....
T Consensus 594 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 594 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 334566789999999999999999999999999987643
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=347.86 Aligned_cols=271 Identities=23% Similarity=0.390 Sum_probs=198.9
Q ss_pred cCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHH--HhccCccceeeEEEEEe-----cCCeEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEM--LSKLRHKHLVSLIGFCE-----EGNEMC 557 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~H~niv~l~g~~~-----~~~~~~ 557 (817)
++|...++||+|+||.||+|+. ++..||||++.... ...+..|.++ +..++||||+++++++. .....+
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 5788899999999999999976 56789999986432 3445555555 44589999999998653 234678
Q ss_pred EEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCC------CCceEecCCccCcEEEcCCceeEEeeecc
Q 039107 558 LVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGA------KYTIIHRDVKTTNILLDENWVAKVSDFGL 631 (817)
Q Consensus 558 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~ivH~Dikp~NIll~~~~~~kl~DFGl 631 (817)
+||||+++|+|.+++... .+++..++.++.||+.||+|||+.. ..+|+||||||+|||++.++.+||+|||+
T Consensus 89 lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~ 166 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL 166 (336)
T ss_dssp EEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTT
T ss_pred EEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccc
Confidence 999999999999999543 4689999999999999999999761 11599999999999999999999999999
Q ss_pred CccCCCCCC------CceeeeeecCcCCCChhhhcc-------CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchH
Q 039107 632 SKTGPNMEN------GHVSTVVKGSFGYLDPEYFKR-------QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSL 698 (817)
Q Consensus 632 a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l 698 (817)
++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.|+...........
T Consensus 167 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~ 246 (336)
T 3g2f_A 167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM 246 (336)
T ss_dssp CEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCC
T ss_pred eeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHH
Confidence 976432211 112224469999999999976 4567899999999999999999877654332221110
Q ss_pred ------------HHHHHHhhccCchhhccCccccCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhc
Q 039107 699 ------------ADWALHCKRKGILDDIIDPLLKDK--ISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVE 764 (817)
Q Consensus 699 ------------~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 764 (817)
.++........ ..+.+... ....++..+.+++.+||+.||++|||+.|+++.|+.++..-+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~ 321 (336)
T 3g2f_A 247 AFQTEVGNHPTFEDMQVLVSREK-----QRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE 321 (336)
T ss_dssp TTHHHHCSSCCHHHHHHHHTTSC-----CCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred hhhcccCCCchHHHHHhhhcccc-----cCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence 00000000000 01111111 123467789999999999999999999999999999986544
Q ss_pred cc
Q 039107 765 ST 766 (817)
Q Consensus 765 ~~ 766 (817)
..
T Consensus 322 ~~ 323 (336)
T 3g2f_A 322 RN 323 (336)
T ss_dssp C-
T ss_pred hc
Confidence 33
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=348.20 Aligned_cols=257 Identities=23% Similarity=0.302 Sum_probs=197.4
Q ss_pred cCCCc-ceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeEEEEEE
Q 039107 485 KSFDE-SYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 485 ~~f~~-~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 561 (817)
..|.. .++||+|+||+||+|... ++..||||++........+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 34655 368999999999999854 6789999998766666678899999999985 79999999999999999999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCce---eEEeeeccCccCCCC
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWV---AKVSDFGLSKTGPNM 638 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~---~kl~DFGla~~~~~~ 638 (817)
|+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++. +||+|||+++.....
T Consensus 92 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 92 KMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp CCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred cCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 99999999998654 46899999999999999999999876 999999999999998766 999999998754321
Q ss_pred CC-----CceeeeeecCcCCCChhhhcc-----CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchH--------HH
Q 039107 639 EN-----GHVSTVVKGSFGYLDPEYFKR-----QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSL--------AD 700 (817)
Q Consensus 639 ~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l--------~~ 700 (817)
.. ........||+.|+|||++.. ..++.++|||||||++|||++|+.||......+.... ..
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 247 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence 11 111223459999999999875 5688999999999999999999999976543321100 00
Q ss_pred HHHHhhccCchhhccCccccCCCCH----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 701 WALHCKRKGILDDIIDPLLKDKISP----ECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 701 ~~~~~~~~~~~~~~~d~~l~~~~~~----~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
........+. . ..+. ..+..+.+++.+||+.||.+|||+.|++++
T Consensus 248 ~~~~~i~~~~--------~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 248 MLFESIQEGK--------Y--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHCC--------C--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHhccC--------c--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0000000010 0 0111 134568999999999999999999999975
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=348.73 Aligned_cols=269 Identities=25% Similarity=0.288 Sum_probs=201.0
Q ss_pred HHhhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcc-----cHHHHHHHHHHHhccCccceeeEEEEEecCC
Q 039107 481 KHATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQ-----GVNEFVTEIEMLSKLRHKHLVSLIGFCEEGN 554 (817)
Q Consensus 481 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 554 (817)
....++|...+.||+|+||.||+|... ++..||||++...... ..+.+.+|++++++++||||+++++++....
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 334567999999999999999999975 4789999998753221 1346889999999999999999999999999
Q ss_pred eEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 555 EMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 555 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
..++||||+++ +|.+++......+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 99999999985 898888776667999999999999999999999876 99999999999999999999999999986
Q ss_pred CCCCCCCceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchh-
Q 039107 635 GPNMENGHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILD- 712 (817)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~- 712 (817)
..... .......||+.|+|||.+.+ ..++.++|||||||++|||++|.+||......+... ..... .......
T Consensus 162 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~--~i~~~-~~~~~~~~ 236 (346)
T 1ua2_A 162 FGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT--RIFET-LGTPTEEQ 236 (346)
T ss_dssp TTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHH-HCCCCTTT
T ss_pred ccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHH--HHHHH-cCCCChhh
Confidence 43221 22334568999999999875 458999999999999999999999987664332211 11111 0000000
Q ss_pred --------hccCccccCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 713 --------DIIDPLLKDKIS-----PECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 713 --------~~~d~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
+.+........+ ......+.+++.+||+.||.+|||+.|++++-..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f 295 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 295 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhh
Confidence 000000000001 2234678999999999999999999999987543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=337.74 Aligned_cols=255 Identities=23% Similarity=0.296 Sum_probs=205.1
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
.++|...+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.++++++||||+++++++......++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467889999999999999999975 4688999997643 3334577889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCce---eEEeeeccCccCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWV---AKVSDFGLSKTGPN 637 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~---~kl~DFGla~~~~~ 637 (817)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||++.....
T Consensus 85 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 999999999888654 45999999999999999999999876 999999999999986654 99999999976432
Q ss_pred CCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCc
Q 039107 638 MENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717 (817)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (817)
. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ..... +.. .
T Consensus 161 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~---~~~~~----~~~----~- 225 (284)
T 3kk8_A 161 S---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY---AQIKA----GAY----D- 225 (284)
T ss_dssp S---CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHH----TCC----C-
T ss_pred C---ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHH---HHHHh----ccc----c-
Confidence 2 2223456899999999999999999999999999999999999999764332211 11110 000 0
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 718 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
.........+..+.+++.+||+.||.+|||+.+++++-..
T Consensus 226 -~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 265 (284)
T 3kk8_A 226 -YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265 (284)
T ss_dssp -CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHH
T ss_pred -CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccc
Confidence 0011112334567899999999999999999999987543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=349.54 Aligned_cols=266 Identities=16% Similarity=0.198 Sum_probs=207.3
Q ss_pred hcCCCcceeEeeeCceEEEEEEEec---------ccEEEEEecCCCCcccHHHHHHHHHHHhccCccceee---------
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIED---------KLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVS--------- 545 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~--------- 545 (817)
.++|...+.||+|+||.||+|+... +..||+|.+... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3578899999999999999999764 678999998744 46789999999999999988
Q ss_pred ------EEEEEec-CCeEEEEEEeccCCchhhhhhcc-ccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEE
Q 039107 546 ------LIGFCEE-GNEMCLVYDYMALGTLREHIYNT-KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNIL 617 (817)
Q Consensus 546 ------l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIl 617 (817)
+++++.. ....++||||+ +++|.+++... ...+++.+++.|+.||+.||+|||+++ |+||||||+|||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl 191 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIF 191 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEE
Confidence 6777765 77889999999 99999999765 357999999999999999999999876 999999999999
Q ss_pred EcCCc--eeEEeeeccCccCCCCCC-----CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCC
Q 039107 618 LDENW--VAKVSDFGLSKTGPNMEN-----GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPS 690 (817)
Q Consensus 618 l~~~~--~~kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~ 690 (817)
++.++ .+||+|||+++....... ........||+.|+|||.+.+..++.++|||||||+||||++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 999999999976432211 11123347899999999999999999999999999999999999999765
Q ss_pred CccccchHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhc
Q 039107 691 LPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVE 764 (817)
Q Consensus 691 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 764 (817)
.... ..+.......... ...+.+.... ....+..+.+++.+||+.||.+||++.+|++.|+.+++...
T Consensus 272 ~~~~-~~~~~~~~~~~~~--~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 272 LPNT-EDIMKQKQKFVDK--PGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp TTCH-HHHHHHHHHHHHS--CCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CcCH-HHHHHHHHhccCC--hhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 3221 1111111111111 0111111100 01224568999999999999999999999999999886654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=347.77 Aligned_cols=261 Identities=25% Similarity=0.318 Sum_probs=203.9
Q ss_pred hcCCCcceeEeeeCceEEEEEEE-ecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEe----cCCeEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVI-EDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCE----EGNEMCL 558 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~----~~~~~~l 558 (817)
.++|...+.||+|+||.||++.. .++..||||++........+.+.+|++++++++||||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46788999999999999999997 467899999987666666788999999999999999999999986 3457899
Q ss_pred EEEeccCCchhhhhhcc---ccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccC
Q 039107 559 VYDYMALGTLREHIYNT---KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTG 635 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 635 (817)
||||+++|+|.+++... ...+++.+++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999998753 457999999999999999999999876 999999999999999999999999998753
Q ss_pred CCCCCCc-------eeeeeecCcCCCChhhhccCC---CCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHh
Q 039107 636 PNMENGH-------VSTVVKGSFGYLDPEYFKRQQ---LTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHC 705 (817)
Q Consensus 636 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 705 (817)
....... ......||+.|+|||.+.... ++.++||||||+++|||++|+.||........ .+....
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~--- 260 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVALAV--- 260 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHHHH---
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhHHh---
Confidence 2111000 011235799999999987543 68999999999999999999999853211100 000000
Q ss_pred hccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 039107 706 KRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQ 761 (817)
Q Consensus 706 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 761 (817)
.. ..........+..+.+++.+||+.||.+|||+.+++++|+.+..
T Consensus 261 -~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 261 -QN---------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp -HC---------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred -hc---------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 00 01111122344568999999999999999999999999997754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=340.80 Aligned_cols=250 Identities=28% Similarity=0.354 Sum_probs=196.8
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
++|...+.||+|+||.||++... ++..+|+|++.... ....+.+.+|++++++++||||+++++++......++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 45788899999999999999975 56889999876542 33467899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcc---ccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEE---cCCceeEEeeeccCccCC
Q 039107 563 MALGTLREHIYNT---KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILL---DENWVAKVSDFGLSKTGP 636 (817)
Q Consensus 563 ~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll---~~~~~~kl~DFGla~~~~ 636 (817)
+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999988643 246999999999999999999999876 9999999999999 456889999999997643
Q ss_pred CCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccC
Q 039107 637 NMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIID 716 (817)
Q Consensus 637 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (817)
. ........||+.|+|||.+. +.++.++||||||+++|||++|+.||......+.. .... ...
T Consensus 179 ~---~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~---~~~~---~~~------- 241 (285)
T 3is5_A 179 S---DEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQ---QKAT---YKE------- 241 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHH---HCC-------
T ss_pred C---cccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHH---hhhc---cCC-------
Confidence 2 22234557899999999986 57899999999999999999999999765322211 1110 000
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 717 PLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 717 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
+..... .......+.+++.+||+.||.+|||+.|++++
T Consensus 242 ~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 242 PNYAVE-CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp CCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred cccccc-cCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 00123457899999999999999999999865
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=354.31 Aligned_cols=273 Identities=23% Similarity=0.285 Sum_probs=204.9
Q ss_pred ccCHHHHHHhhcCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcc-----------cHHHHHHHHHHHhccCccc
Q 039107 474 RFSLAEIKHATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQ-----------GVNEFVTEIEMLSKLRHKH 542 (817)
Q Consensus 474 ~f~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~n 542 (817)
+..+.++.....+|...++||+|+||.||+|...++..||||++...... ..+.+.+|++++++++|||
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 90 (362)
T 3pg1_A 11 RDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPN 90 (362)
T ss_dssp HHHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTT
T ss_pred HHHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcC
Confidence 34567888999999999999999999999999888899999987643211 1377899999999999999
Q ss_pred eeeEEEEEec-----CCeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEE
Q 039107 543 LVSLIGFCEE-----GNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNIL 617 (817)
Q Consensus 543 iv~l~g~~~~-----~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIl 617 (817)
|+++++++.. ....++||||++ |+|.+++......+++..+..++.||+.||+|||+++ |+||||||+|||
T Consensus 91 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 91 ILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp BCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred ccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 9999999843 346899999998 6888888776668999999999999999999999876 999999999999
Q ss_pred EcCCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccc
Q 039107 618 LDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQV 696 (817)
Q Consensus 618 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~ 696 (817)
++.++.+||+|||+++.... ........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+..
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 243 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL 243 (362)
T ss_dssp ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred EcCCCCEEEEecCccccccc---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999999999975322 222344578999999999876 67899999999999999999999999875433221
Q ss_pred hHHHHHHHhhccCch-----------hhccCcccc-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 697 SLADWALHCKRKGIL-----------DDIIDPLLK-------DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 697 ~l~~~~~~~~~~~~~-----------~~~~d~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
... ......... .+.+..... ....+.....+.+++.+||+.||.+|||+.+++++-
T Consensus 244 ~~i---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 318 (362)
T 3pg1_A 244 NKI---VEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHP 318 (362)
T ss_dssp HHH---HHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred HHH---HHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCc
Confidence 110 000000000 000000000 001122345688999999999999999999998763
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=344.31 Aligned_cols=271 Identities=23% Similarity=0.377 Sum_probs=208.5
Q ss_pred HHhhcCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhc--cCccceeeEEEEEecCC----
Q 039107 481 KHATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSK--LRHKHLVSLIGFCEEGN---- 554 (817)
Q Consensus 481 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~---- 554 (817)
....++|...+.||+|+||.||+|+.. ++.||||++... ....+.+|++++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 344567999999999999999999874 678999998643 34678889999887 78999999999998765
Q ss_pred eEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhC-----CCCceEecCCccCcEEEcCCceeEEeee
Q 039107 555 EMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTG-----AKYTIIHRDVKTTNILLDENWVAKVSDF 629 (817)
Q Consensus 555 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivH~Dikp~NIll~~~~~~kl~DF 629 (817)
..++||||+++|+|.+++.. ..+++.+++.++.|++.||+|||.. ++.+|+||||||+|||++.++.+||+||
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred eeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence 78999999999999999954 4699999999999999999999931 0235999999999999999999999999
Q ss_pred ccCccCCCCCCCc--eeeeeecCcCCCChhhhccC------CCCchHHHHHHHHHHHHHHhC----------CCCCCCCC
Q 039107 630 GLSKTGPNMENGH--VSTVVKGSFGYLDPEYFKRQ------QLTEKSDIYSFGVVLFEVLCA----------RPALNPSL 691 (817)
Q Consensus 630 Gla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~~sDV~S~Gvvl~elltG----------~~p~~~~~ 691 (817)
|+++......... ......||+.|+|||++.+. .++.++||||||+++|||++| +.||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 9997643322111 12344689999999998765 234789999999999999999 66775443
Q ss_pred ccccchHHHHHHHhhccCchhhccCccccCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 039107 692 PKEQVSLADWALHCKRKGILDDIIDPLLKDK-ISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLV 763 (817)
Q Consensus 692 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 763 (817)
.... ....+....... ...+.+... ...++...+.+++.+||+.||++|||+.+|+++|+.+.+..
T Consensus 272 ~~~~-~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 272 PSDP-SVEEMRKVVCEQ-----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp CSSC-CHHHHHHHHTTS-----CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred cCcc-cHHHHHHHHHHH-----HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 2211 111222111111 111111111 12367788999999999999999999999999999987653
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=359.16 Aligned_cols=264 Identities=26% Similarity=0.391 Sum_probs=192.8
Q ss_pred hhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccC-ccceeeEEEEEecC--CeE
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLR-HKHLVSLIGFCEEG--NEM 556 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~ 556 (817)
..++|...+.||+|+||.||+|... ++..||||++... .....+.+.+|+.+|+++. ||||+++++++... ...
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4567999999999999999999865 5789999998643 3344567889999999997 99999999999654 378
Q ss_pred EEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCC
Q 039107 557 CLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGP 636 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 636 (817)
++|||||+ ++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 87 ~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFV 160 (388)
T ss_dssp EEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred EEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence 99999998 689888854 46899999999999999999999876 9999999999999999999999999997643
Q ss_pred CCC-------------------CCceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccc
Q 039107 637 NME-------------------NGHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQV 696 (817)
Q Consensus 637 ~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~ 696 (817)
... .........||+.|+|||++.+ ..++.++|||||||+++||++|++||.+....++.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~ 240 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL 240 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 211 1112334579999999999876 67899999999999999999999999876543332
Q ss_pred hHHHHHHHhhccCchh-----------hcc----------CccccC------------CCCHHHHHHHHHHHHHccccCC
Q 039107 697 SLADWALHCKRKGILD-----------DII----------DPLLKD------------KISPECLKKFADTAEKCLSDSG 743 (817)
Q Consensus 697 ~l~~~~~~~~~~~~~~-----------~~~----------d~~l~~------------~~~~~~~~~l~~li~~cl~~dP 743 (817)
.... ......... ..+ ...... .....+...+.+|+.+||+.||
T Consensus 241 ~~i~---~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP 317 (388)
T 3oz6_A 241 ERII---GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP 317 (388)
T ss_dssp HHHH---HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred HHHH---HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence 2111 000000000 000 000000 0001234568899999999999
Q ss_pred CCCCCHHHHHHH
Q 039107 744 IDRPSMGDVLWN 755 (817)
Q Consensus 744 ~~RPt~~evl~~ 755 (817)
.+|||++|+++|
T Consensus 318 ~~R~t~~e~l~H 329 (388)
T 3oz6_A 318 NKRISANDALKH 329 (388)
T ss_dssp GGSCCHHHHTTS
T ss_pred ccCCCHHHHhCC
Confidence 999999999977
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=367.84 Aligned_cols=254 Identities=24% Similarity=0.363 Sum_probs=208.1
Q ss_pred hhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEE
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCL 558 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 558 (817)
..++|...++||+|+||.||+|+.+ ++..||+|++... .......+.+|+++|++++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3467999999999999999999975 5789999998643 22345678899999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhcccc-ccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCC
Q 039107 559 VYDYMALGTLREHIYNTKK-ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPN 637 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 637 (817)
||||+++|+|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 9999999999999876543 5999999999999999999999876 99999999999999999999999999986432
Q ss_pred CCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccc-hHHHHHHHhhccCchhhccC
Q 039107 638 MENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQV-SLADWALHCKRKGILDDIID 716 (817)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d 716 (817)
. .......||+.|+|||++.+..++.++|||||||++|||++|++||......... .+...+.. .
T Consensus 339 ~---~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~----~------- 404 (576)
T 2acx_A 339 G---QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE----V------- 404 (576)
T ss_dssp T---CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH----C-------
T ss_pred C---ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc----c-------
Confidence 2 2234457999999999999989999999999999999999999999765432211 11111110 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 039107 717 PLLKDKISPECLKKFADTAEKCLSDSGIDRP-----SMGDVLWNL 756 (817)
Q Consensus 717 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 756 (817)
...++...+..+.+|+.+||+.||.+|| +++||++|-
T Consensus 405 ---~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hp 446 (576)
T 2acx_A 405 ---PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHP 446 (576)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSG
T ss_pred ---cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhCh
Confidence 1112233455679999999999999999 789998763
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=355.05 Aligned_cols=253 Identities=21% Similarity=0.311 Sum_probs=193.4
Q ss_pred CCCcc-eeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhcc-CccceeeEEEEEec----CCeEEE
Q 039107 486 SFDES-YVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEE----GNEMCL 558 (817)
Q Consensus 486 ~f~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~~~l 558 (817)
+|... ++||+|+||+||++... ++..||||++... ..+.+|++++.++ +||||+++++++.. ....++
T Consensus 62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l 136 (400)
T 1nxk_A 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136 (400)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence 45554 68999999999999975 5688999998632 4577899887554 89999999998865 567899
Q ss_pred EEEeccCCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcC---CceeEEeeeccCcc
Q 039107 559 VYDYMALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDE---NWVAKVSDFGLSKT 634 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DFGla~~ 634 (817)
||||+++|+|.+++.... ..+++.++..|+.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.
T Consensus 137 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~ 213 (400)
T 1nxk_A 137 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213 (400)
T ss_dssp EEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccc
Confidence 999999999999997654 36999999999999999999999876 999999999999997 78999999999986
Q ss_pred CCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccc-hHHHHHHHhhccCchhh
Q 039107 635 GPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQV-SLADWALHCKRKGILDD 713 (817)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~ 713 (817)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......... .....+.. +..
T Consensus 214 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~----~~~-- 284 (400)
T 1nxk_A 214 TTS---HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM----GQY-- 284 (400)
T ss_dssp CC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH----TCC--
T ss_pred cCC---CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc----Ccc--
Confidence 432 12234557899999999999999999999999999999999999999765432211 01111110 000
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 714 IIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 714 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
.........++..+.+|+.+||+.||.+|||+.+++++....
T Consensus 285 ----~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 326 (400)
T 1nxk_A 285 ----EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 326 (400)
T ss_dssp ----CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred ----cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence 000011123455689999999999999999999999986654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=362.19 Aligned_cols=250 Identities=26% Similarity=0.363 Sum_probs=204.7
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC---cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS---EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
.+|...+.||+|+||.||+|+.. ++..||||++.... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 46888899999999999999976 67899999986432 223567899999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 96 E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~-- 169 (476)
T 2y94_A 96 EYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-- 169 (476)
T ss_dssp ECCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT--
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc--
Confidence 999999999998654 46999999999999999999999765 999999999999999999999999999864332
Q ss_pred CceeeeeecCcCCCChhhhccCCC-CchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQL-TEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (817)
.......||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ . .... .+ ..
T Consensus 170 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~---~---~~i~-~~--------~~ 233 (476)
T 2y94_A 170 -EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL---F---KKIC-DG--------IF 233 (476)
T ss_dssp -CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH---H---HHHH-TT--------CC
T ss_pred -ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH---H---HHHh-cC--------Cc
Confidence 22334579999999999988765 7899999999999999999999976433211 1 1111 11 00
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 720 KDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 720 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
..+......+.+++.+||+.||.+|||+.+++++-..
T Consensus 234 --~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~ 270 (476)
T 2y94_A 234 --YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWF 270 (476)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHH
T ss_pred --CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHh
Confidence 0112234567899999999999999999999986443
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=358.57 Aligned_cols=241 Identities=15% Similarity=0.177 Sum_probs=190.5
Q ss_pred hcCCCcceeEeeeCceEEEEEEE-ecccEEEEEecCC---CCcccHHHHHHHH---HHHhccCccceeeEE-------EE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVI-EDKLKVAIKRSNP---SSEQGVNEFVTEI---EMLSKLRHKHLVSLI-------GF 549 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~---~~l~~l~H~niv~l~-------g~ 549 (817)
.++|...+.||+|+||+||+|+. .++..||||++.. ......+.|.+|+ ++|++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788889999999999999996 4678999999763 2334567899999 455556899999998 66
Q ss_pred EecCC-----------------eEEEEEEeccCCchhhhhhccc------cccchHhHHHHHHHHHHHHHHHHhCCCCce
Q 039107 550 CEEGN-----------------EMCLVYDYMALGTLREHIYNTK------KALSWKQRLEICIGAARGLHYLHTGAKYTI 606 (817)
Q Consensus 550 ~~~~~-----------------~~~lV~Ey~~~gsL~~~l~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 606 (817)
+...+ ..++||||+ +|+|.+++.... ..+++..++.|+.||+.||+|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 65543 278999999 589999997532 24557899999999999999999876 9
Q ss_pred EecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccC-----------CCCchHHHHHHHH
Q 039107 607 IHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQ-----------QLTEKSDIYSFGV 675 (817)
Q Consensus 607 vH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~sDV~S~Gv 675 (817)
+||||||+||||+.++.+||+|||+++... .......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 999999999999999999999999998522 23345567 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 676 VLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 676 vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
+||||++|+.||......... ..+... ...++..+.+++.+||+.||.+|||+.+++++
T Consensus 302 il~elltg~~Pf~~~~~~~~~---------------~~~~~~------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGS---------------EWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHHSSCCC------CCS---------------GGGGSS------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHHCCCCCcccccccch---------------hhhhhh------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 999999999999754432211 111110 01234567899999999999999999999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=349.92 Aligned_cols=260 Identities=22% Similarity=0.286 Sum_probs=190.7
Q ss_pred hhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccC-ccceeeEEEEEe--------c
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLR-HKHLVSLIGFCE--------E 552 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~--------~ 552 (817)
...+|...++||+|+||.||+|... ++..||||++........+.+.+|+.+++++. ||||+++++++. .
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 3457889999999999999999965 56899999987666666678999999999996 999999999983 3
Q ss_pred CCeEEEEEEeccCCchhhhhhc--cccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeec
Q 039107 553 GNEMCLVYDYMALGTLREHIYN--TKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFG 630 (817)
Q Consensus 553 ~~~~~lV~Ey~~~gsL~~~l~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFG 630 (817)
....++||||+. |+|.+++.. ....+++.+++.++.||+.||+|||+.+ ++|+||||||+|||++.++.+||+|||
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence 445899999996 799998865 2346999999999999999999999652 349999999999999999999999999
Q ss_pred cCccCCCCCCCc----------eeeeeecCcCCCChhhh---ccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccch
Q 039107 631 LSKTGPNMENGH----------VSTVVKGSFGYLDPEYF---KRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVS 697 (817)
Q Consensus 631 la~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~ 697 (817)
+++......... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||.........
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~- 262 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV- 262 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh-
Confidence 998654322110 11234589999999998 5677899999999999999999999999653221100
Q ss_pred HHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 039107 698 LADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLV 763 (817)
Q Consensus 698 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 763 (817)
...............+.+++.+||+.||.+|||+.+++++|+.+....
T Consensus 263 ------------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 263 ------------------NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp ---------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred ------------------cCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 000000111122234788999999999999999999999999988654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=337.52 Aligned_cols=252 Identities=19% Similarity=0.267 Sum_probs=200.9
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC------cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS------EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMC 557 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 557 (817)
++|...+.||+|+||.||++... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++......+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46888899999999999999976 57899999876432 123678999999999999999999999999999999
Q ss_pred EEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCc----eeEEeeeccCc
Q 039107 558 LVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENW----VAKVSDFGLSK 633 (817)
Q Consensus 558 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~----~~kl~DFGla~ 633 (817)
+||||+++++|.+++... ..+++.+++.++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||++.
T Consensus 85 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 999999999999998643 46999999999999999999999876 99999999999998877 89999999997
Q ss_pred cCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhh
Q 039107 634 TGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDD 713 (817)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 713 (817)
..... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+.. .... ... .
T Consensus 161 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~-~~~--~ 228 (283)
T 3bhy_A 161 KIEAG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL------TNIS-AVN--Y 228 (283)
T ss_dssp ECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHH-TTC--C
T ss_pred eccCC---CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHH------HHhH-hcc--c
Confidence 64322 1223456899999999999999999999999999999999999999765332111 0000 000 0
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 714 IIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 714 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
...+.... ..+..+.+++.+||+.||.+||++.+++++-
T Consensus 229 ~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 267 (283)
T 3bhy_A 229 DFDEEYFS----NTSELAKDFIRRLLVKDPKRRMTIAQSLEHS 267 (283)
T ss_dssp CCCHHHHT----TCCHHHHHHHHTTSCSSGGGSCCHHHHHHCH
T ss_pred CCcchhcc----cCCHHHHHHHHHHccCCHhHCcCHHHHHhCH
Confidence 00111111 2245678999999999999999999999863
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=348.16 Aligned_cols=255 Identities=22% Similarity=0.323 Sum_probs=202.2
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeEEEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 561 (817)
.++|...+.||+|+||.||++..+ ++..||+|++..... .+.+|++++.++ +||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 456888999999999999999976 568899999875533 235688888888 79999999999999999999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCC----ceeEEeeeccCccCCC
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDEN----WVAKVSDFGLSKTGPN 637 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~----~~~kl~DFGla~~~~~ 637 (817)
|+++|+|.+++... +.+++.++..++.||+.||+|||+++ |+||||||+|||+.++ +.+||+|||+++....
T Consensus 97 ~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 97 LMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp CCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred CCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 99999999998654 46999999999999999999999876 9999999999998543 3599999999986433
Q ss_pred CCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCc
Q 039107 638 MENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717 (817)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (817)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..........+...+. .+..
T Consensus 173 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~----~~~~------ 240 (342)
T 2qr7_A 173 EN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG----SGKF------ 240 (342)
T ss_dssp TT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH----HCCC------
T ss_pred CC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc----cCCc------
Confidence 22 22334578999999999998889999999999999999999999997643222221211111 1110
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 718 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
.+........+..+.+++.+||+.||.+||++.+++++-..
T Consensus 241 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~ 281 (342)
T 2qr7_A 241 SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281 (342)
T ss_dssp CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCee
Confidence 01111122345568899999999999999999999987655
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=347.42 Aligned_cols=268 Identities=23% Similarity=0.317 Sum_probs=202.0
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC--cccHHHHHHHHHHHhccCccceeeEEEEEec--------C
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE--------G 553 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------~ 553 (817)
.+|...+.||+|+||.||+|+.. ++..||+|++.... ......+.+|++++++++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 56888999999999999999974 67899999876543 2234678899999999999999999999876 4
Q ss_pred CeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCc
Q 039107 554 NEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSK 633 (817)
Q Consensus 554 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 633 (817)
+..++||||+++ +|.+.+......+++.+++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred ceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 468999999985 777777766667999999999999999999999876 9999999999999999999999999997
Q ss_pred cCCCCCC--CceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCc
Q 039107 634 TGPNMEN--GHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGI 710 (817)
Q Consensus 634 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 710 (817)
....... ........||+.|+|||++.+ ..++.++|||||||++|||++|++||.......................
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 6432211 122334568999999999876 4689999999999999999999999987654332222111100000000
Q ss_pred hhhc--------cCccccCCCC-HH------HHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 711 LDDI--------IDPLLKDKIS-PE------CLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 711 ~~~~--------~d~~l~~~~~-~~------~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
.... +......... .+ ....+.+|+.+||+.||.+|||++|++++-
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 313 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 313 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCC
Confidence 0000 0000000000 01 124578999999999999999999999764
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=346.34 Aligned_cols=263 Identities=21% Similarity=0.270 Sum_probs=192.9
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCc--ccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSE--QGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
.++|...++||+|+||+||+|... ++..||||++..... ...+.+.+|++++++++||||+++++++...+..++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 457889999999999999999865 568899999875432 23456789999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEE-----cCCceeEEeeeccCccC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILL-----DENWVAKVSDFGLSKTG 635 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll-----~~~~~~kl~DFGla~~~ 635 (817)
||++ |+|.+++.... .+++..++.|+.||+.||+|||+++ |+||||||+|||+ ++++.+||+|||+++..
T Consensus 113 e~~~-~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 113 EYAE-NDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp ECCS-EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred ecCC-CCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 9998 59999886543 5999999999999999999999876 9999999999999 45567999999999754
Q ss_pred CCCCCCceeeeeecCcCCCChhhhccC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhh--ccCch-
Q 039107 636 PNMENGHVSTVVKGSFGYLDPEYFKRQ-QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCK--RKGIL- 711 (817)
Q Consensus 636 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~--~~~~~- 711 (817)
... ........||+.|+|||++.+. .++.++|||||||++|||++|++||......+.... ...... .....
T Consensus 188 ~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~--~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 188 GIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFK--IFEVLGLPDDTTWP 263 (329)
T ss_dssp C-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--HHHHHCCCCTTTST
T ss_pred CCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHH--HHHHhCCCchhhhh
Confidence 321 1223345689999999999874 589999999999999999999999976544322111 111000 00000
Q ss_pred ------------hhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 712 ------------DDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 712 ------------~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.......+...........+.+|+.+||+.||.+|||+.|++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 00000000000011134567899999999999999999999865
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=359.32 Aligned_cols=263 Identities=22% Similarity=0.239 Sum_probs=196.9
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecC------C
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEG------N 554 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 554 (817)
.++|...++||+|+||+||+|... ++..||||++... .....+.+.+|+.+|+.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467899999999999999999865 5688999998754 334457788999999999999999999999654 4
Q ss_pred eEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 555 EMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 555 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
..++||||+++ +|.+.+. ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 141 ~~~lv~E~~~~-~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp EEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred eEEEEEeCCCC-CHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 57999999986 4555553 24899999999999999999999876 99999999999999999999999999986
Q ss_pred CCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHH---------HHH--
Q 039107 635 GPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLAD---------WAL-- 703 (817)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~---------~~~-- 703 (817)
... ........||+.|+|||++.+..++.++|||||||+|+||++|++||.+....++...+. +..
T Consensus 214 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 214 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp ------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred cCC---CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 432 223345679999999999999999999999999999999999999998765433221110 000
Q ss_pred -----Hhhcc------CchhhccCccccCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 704 -----HCKRK------GILDDIIDPLLKDKI---SPECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 704 -----~~~~~------~~~~~~~d~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
..... ......+...+.... .......+.+|+.+||..||.+|||++|+++|-
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 357 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 357 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh
Confidence 00000 000000000000000 112256789999999999999999999999874
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=336.55 Aligned_cols=244 Identities=25% Similarity=0.373 Sum_probs=198.0
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 559 (817)
..+|...+.||+|+||+||+|... ++..||+|++... ......++.+|+..+.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 456888999999999999999976 6789999997753 334457788999999999 999999999999999999999
Q ss_pred EEeccCCchhhhhhccc---cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcC----------------
Q 039107 560 YDYMALGTLREHIYNTK---KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDE---------------- 620 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~---------------- 620 (817)
|||+++++|.+++.... ..+++.+++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999997543 45899999999999999999999876 999999999999984
Q ss_pred ---CceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccc
Q 039107 621 ---NWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQ-QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQV 696 (817)
Q Consensus 621 ---~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~ 696 (817)
...+||+|||++...... ....||..|+|||.+.+. .++.++||||||++++||++|++++.....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---- 236 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---- 236 (289)
T ss_dssp ---CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----
T ss_pred cCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH----
Confidence 447999999999864332 123589999999999765 667899999999999999999987643211
Q ss_pred hHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 697 SLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 697 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
+.. ...+.. +. .+..++..+.+++.+||+.||.+|||+.+++++
T Consensus 237 ----~~~--~~~~~~-----~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 237 ----WHE--IRQGRL-----PR----IPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp ----HHH--HHTTCC-----CC----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ----HHH--HHcCCC-----CC----CCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 110 011111 11 122334567999999999999999999999875
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=349.21 Aligned_cols=244 Identities=19% Similarity=0.282 Sum_probs=201.1
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCc--------ccHHHHHHHHHHHhccCccceeeEEEEEecCC
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSE--------QGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGN 554 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 554 (817)
.++|...+.||+|+||.||+|... ++..||||++..... ...+.+.+|+.++++++||||+++++++...+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 467889999999999999999864 568899998765421 13346778999999999999999999999999
Q ss_pred eEEEEEEeccCC-chhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCc
Q 039107 555 EMCLVYDYMALG-TLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSK 633 (817)
Q Consensus 555 ~~~lV~Ey~~~g-sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 633 (817)
..++||||+..| +|.+++... ..+++..+..|+.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccce
Confidence 999999999777 999988654 35999999999999999999999876 9999999999999999999999999998
Q ss_pred cCCCCCCCceeeeeecCcCCCChhhhccCCC-CchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchh
Q 039107 634 TGPNMENGHVSTVVKGSFGYLDPEYFKRQQL-TEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILD 712 (817)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 712 (817)
..... .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||......
T Consensus 179 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------------- 236 (335)
T 3dls_A 179 YLERG---KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------------- 236 (335)
T ss_dssp ECCTT---CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-------------------
T ss_pred ECCCC---CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-------------------
Confidence 64332 22344679999999999988776 88999999999999999999999642110
Q ss_pred hccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 713 DIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 713 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
...... .+...+..+.+++.+||+.||.+|||+.+++++-.
T Consensus 237 --~~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~ 277 (335)
T 3dls_A 237 --VEAAIH--PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPW 277 (335)
T ss_dssp --TTTCCC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTT
T ss_pred --HhhccC--CCcccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 000000 01123456789999999999999999999998743
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=338.04 Aligned_cols=251 Identities=23% Similarity=0.369 Sum_probs=198.5
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEecc
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMA 564 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 564 (817)
+|....+||+|+||.||+|... ++..||+|.+........+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 3455669999999999999964 567899999877666666889999999999999999999999999999999999999
Q ss_pred CCchhhhhhcccc--ccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcC-CceeEEeeeccCccCCCCCCC
Q 039107 565 LGTLREHIYNTKK--ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDE-NWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 565 ~gsL~~~l~~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DFGla~~~~~~~~~ 641 (817)
+++|.+++..... .+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++......
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-- 177 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-- 177 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC--
Confidence 9999999976533 4678889999999999999999876 999999999999987 8999999999997643221
Q ss_pred ceeeeeecCcCCCChhhhccCC--CCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccc
Q 039107 642 HVSTVVKGSFGYLDPEYFKRQQ--LTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~--~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (817)
.......|+..|+|||.+.+.. ++.++||||||+++|||++|+.||......... . +.... ....+
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~--~~~~~-------~~~~~-- 245 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA-M--FKVGM-------FKVHP-- 245 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH-H--HHHHH-------HCCCC--
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH-H--Hhhcc-------ccccc--
Confidence 1223456899999999997654 899999999999999999999998643222110 0 00000 00111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 720 KDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 720 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
..+...+..+.+++.+||+.||++||++.+++++
T Consensus 246 --~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 246 --EIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp --CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred --cccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1223345567899999999999999999999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=345.25 Aligned_cols=257 Identities=19% Similarity=0.256 Sum_probs=202.8
Q ss_pred HHHhhcCCCcc-eeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhcc-CccceeeEEEEEecCC
Q 039107 480 IKHATKSFDES-YVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGN 554 (817)
Q Consensus 480 l~~~~~~f~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 554 (817)
.....+.|... +.||+|+||.||+|... ++..||+|++... .......+.+|+.+++++ +||||+++++++....
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 34445556665 78999999999999976 5789999987653 233467899999999999 5699999999999999
Q ss_pred eEEEEEEeccCCchhhhhhcc-ccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcC---CceeEEeeec
Q 039107 555 EMCLVYDYMALGTLREHIYNT-KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDE---NWVAKVSDFG 630 (817)
Q Consensus 555 ~~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DFG 630 (817)
..++||||+++|+|.+++... ...+++.+++.++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 999999999999999998654 347999999999999999999999876 999999999999998 7899999999
Q ss_pred cCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCc
Q 039107 631 LSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGI 710 (817)
Q Consensus 631 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 710 (817)
+++..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.... ....
T Consensus 180 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---i~~~----- 248 (327)
T 3lm5_A 180 MSRKIGHA---CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN---ISQV----- 248 (327)
T ss_dssp GCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHT-----
T ss_pred cccccCCc---cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH---HHhc-----
Confidence 99864322 222345799999999999999999999999999999999999999976543221100 0000
Q ss_pred hhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 711 LDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 711 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
...........+...+.+++.+||+.||.+|||+++++++
T Consensus 249 -----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 249 -----NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp -----CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred -----ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0011111122345568899999999999999999999875
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=340.27 Aligned_cols=254 Identities=24% Similarity=0.346 Sum_probs=203.6
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
.++|...++||+|+||.||+++.. ++..||+|.+........+.+.+|+.++++++||||+++++++......++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 456888999999999999999975 5789999998765544556789999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEE---cCCceeEEeeeccCccCCCCC
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILL---DENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll---~~~~~~kl~DFGla~~~~~~~ 639 (817)
+++++|.+++... +.+++..+..++.|++.||+|||+.+ |+||||||+|||+ ++++.+||+|||+++....
T Consensus 88 ~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~-- 161 (304)
T 2jam_A 88 VSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-- 161 (304)
T ss_dssp CCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC--
T ss_pred CCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC--
Confidence 9999999988654 46899999999999999999999876 9999999999999 7889999999999975322
Q ss_pred CCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccc
Q 039107 640 NGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719 (817)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (817)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... +..... .+.. ..
T Consensus 162 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~----~~~~------~~ 226 (304)
T 2jam_A 162 --GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK---LFEKIK----EGYY------EF 226 (304)
T ss_dssp --BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHH----HCCC------CC
T ss_pred --CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHH----cCCC------CC
Confidence 12233468999999999999999999999999999999999999997653321 111111 1100 00
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 720 KDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 720 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
........+..+.+++.+||+.||.+|||+.+++++-..
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 265 (304)
T 2jam_A 227 ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWI 265 (304)
T ss_dssp CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccc
Confidence 111122344568999999999999999999999986543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=352.52 Aligned_cols=256 Identities=10% Similarity=0.017 Sum_probs=186.3
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCc---ccHHHHHHHHHHHhcc--CccceeeEE-------EEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSE---QGVNEFVTEIEMLSKL--RHKHLVSLI-------GFC 550 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~H~niv~l~-------g~~ 550 (817)
..+|...+.||+|+||.||+|... ++..||||++..... ...+.+.+|+.+++.| +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345888899999999999999965 678999999876542 3345677885544444 699988755 444
Q ss_pred ecC-----------------CeEEEEEEeccCCchhhhhhccccccchHhH------HHHHHHHHHHHHHHHhCCCCceE
Q 039107 551 EEG-----------------NEMCLVYDYMALGTLREHIYNTKKALSWKQR------LEICIGAARGLHYLHTGAKYTII 607 (817)
Q Consensus 551 ~~~-----------------~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~iv 607 (817)
... ...++||||++ |+|.+++......+.+..+ +.|+.||+.||+|||+++ |+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---iv 216 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LV 216 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---Cc
Confidence 322 34799999999 8999999876556777777 888999999999999876 99
Q ss_pred ecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhcc--CCCCchHHHHHHHHHHHHHHhCCC
Q 039107 608 HRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKR--QQLTEKSDIYSFGVVLFEVLCARP 685 (817)
Q Consensus 608 H~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~S~Gvvl~elltG~~ 685 (817)
||||||+||||+.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||+||||++|+.
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999986421 2224457799999999987 789999999999999999999999
Q ss_pred CCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 686 ALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 686 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
||........... ....................++..+.+++.+||+.||++|||+.+++++-
T Consensus 292 Pf~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 354 (371)
T 3q60_A 292 PFGLVTPGIKGSW--------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETP 354 (371)
T ss_dssp STTBCCTTCTTCC--------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSH
T ss_pred CCCCcCcccccch--------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCH
Confidence 9976543221100 00000000111111111123456789999999999999999999998753
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=341.59 Aligned_cols=262 Identities=21% Similarity=0.284 Sum_probs=199.9
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC---cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS---EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 559 (817)
.++|...++||+|+||.||+|... ++..||+|++.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 367899999999999999999975 56889999987542 22346789999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC
Q 039107 560 YDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 639 (817)
|||+++++|.+++... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 113 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred EEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 9999999999998654 46999999999999999999999876 9999999999999999999999999997643321
Q ss_pred CCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccc
Q 039107 640 NGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719 (817)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (817)
........|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .+. ........ .
T Consensus 189 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~---~~~~~~~~-----~--- 253 (309)
T 2h34_A 189 -LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---VMG---AHINQAIP-----R--- 253 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---HHH---HHHHSCCC-----C---
T ss_pred -cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---HHH---HHhccCCC-----C---
Confidence 11223456899999999999999999999999999999999999999754321 110 11111000 0
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHhHhhhc
Q 039107 720 KDKISPECLKKFADTAEKCLSDSGIDRP-SMGDVLWNLEFVLQLVE 764 (817)
Q Consensus 720 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~~~~~ 764 (817)
.......++..+.+++.+||+.||.+|| +++++++.|+.++....
T Consensus 254 ~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 254 PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 0111223445678999999999999999 89999999998875543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=351.65 Aligned_cols=270 Identities=22% Similarity=0.326 Sum_probs=206.3
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC-CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS-SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
.++|...+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 356889999999999999999976 5688999998755 33345778999999999999999999999999999999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
|+++++|.+++... ..+++..+..++.|++.||+|||+. .+|+||||||+|||++.++.+||+|||+++....
T Consensus 112 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---- 184 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---- 184 (360)
T ss_dssp CCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH----
T ss_pred CCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCccccc----
Confidence 99999999998654 3589999999999999999999974 1399999999999999999999999999864321
Q ss_pred ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHH---------------------
Q 039107 642 HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLAD--------------------- 700 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~--------------------- 700 (817)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......+......
T Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 185 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence 12234578999999999999999999999999999999999999997654322111000
Q ss_pred --HHHHhhccCchhhccCc----cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 039107 701 --WALHCKRKGILDDIIDP----LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVL 760 (817)
Q Consensus 701 --~~~~~~~~~~~~~~~d~----~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 760 (817)
+...........+.++. ..........+..+.+++.+||+.||.+|||++++++|-....
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 330 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330 (360)
T ss_dssp ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhc
Confidence 00000000000000000 0000011123456899999999999999999999998765543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=352.73 Aligned_cols=244 Identities=26% Similarity=0.354 Sum_probs=190.1
Q ss_pred cCCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCCC---cccHHHHHHHHHH-HhccCccceeeEEEEEecCCeEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPSS---EQGVNEFVTEIEM-LSKLRHKHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV 559 (817)
.+|...++||+|+||+||+|+.+. +..||+|++.... ......+.+|..+ ++.++||||+++++++...+..++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 568889999999999999999764 6789999976432 2234556777776 5678999999999999999999999
Q ss_pred EEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC
Q 039107 560 YDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 639 (817)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 118 ~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~- 192 (373)
T 2r5t_A 118 LDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH- 192 (373)
T ss_dssp EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC-
T ss_pred EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccC-
Confidence 9999999999998654 45889999999999999999999876 999999999999999999999999999853221
Q ss_pred CCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccc
Q 039107 640 NGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719 (817)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (817)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......+. . ...... .+
T Consensus 193 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~---~---~~i~~~---------~~ 256 (373)
T 2r5t_A 193 -NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM---Y---DNILNK---------PL 256 (373)
T ss_dssp -CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH---H---HHHHHS---------CC
T ss_pred -CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH---H---HHHHhc---------cc
Confidence 2233456799999999999999999999999999999999999999976432211 1 111110 00
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 039107 720 KDKISPECLKKFADTAEKCLSDSGIDRPSMGD 751 (817)
Q Consensus 720 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 751 (817)
.++......+.+++.+||+.||.+||++.+
T Consensus 257 --~~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 257 --QLKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp --CCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred --CCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 112233456789999999999999999853
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=347.33 Aligned_cols=268 Identities=24% Similarity=0.373 Sum_probs=202.0
Q ss_pred cCCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCCCc--ccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPSSE--QGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
++|...++||+|+||.||+|+... +..||+|++..... ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 468889999999999999999764 78899998754432 234568899999999999999999999999999999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
|+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 105 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~ 178 (331)
T 4aaa_A 105 FVDHTILDDLELFP-NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--G 178 (331)
T ss_dssp CCSEEHHHHHHHST-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred cCCcchHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC--c
Confidence 99999998876543 45999999999999999999999876 999999999999999999999999999764322 1
Q ss_pred ceeeeeecCcCCCChhhhccC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHH---------HHHHhhccCch
Q 039107 642 HVSTVVKGSFGYLDPEYFKRQ-QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLAD---------WALHCKRKGIL 711 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~---------~~~~~~~~~~~ 711 (817)
.......||..|+|||.+.+. .++.++|||||||++|||++|++||......+...... +..........
T Consensus 179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 223345689999999999875 78999999999999999999999997765433221100 00000000011
Q ss_pred hhccCccccCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 712 DDIIDPLLKDKI-----SPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 712 ~~~~d~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
.....+...... .+.++..+.+++.+||+.||.+|||+.|++++--.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f 310 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence 111111111111 11345678999999999999999999999987443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=342.05 Aligned_cols=262 Identities=26% Similarity=0.372 Sum_probs=186.2
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
.++|...+.||+|+||.||+|... ++..||||++.... ....+++.+|+.++++++||||+++++++...+..++|||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 467889999999999999999854 56899999987543 3345678899999999999999999999999999999999
Q ss_pred eccCCchhhhhhc-------cccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 562 YMALGTLREHIYN-------TKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 562 y~~~gsL~~~l~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
|+++++|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 9999999999864 2345899999999999999999999876 99999999999999999999999999875
Q ss_pred CCCCCC---CceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCc
Q 039107 635 GPNMEN---GHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGI 710 (817)
Q Consensus 635 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 710 (817)
...... ........||+.|+|||.+.. ..++.++||||||+++|||++|+.||......... ...........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~ 247 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL---MLTLQNDPPSL 247 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH---HHHHTSSCCCT
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH---HHHhccCCCcc
Confidence 432211 112234578999999999876 57899999999999999999999999765433211 00100000000
Q ss_pred hhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 711 LDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 711 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.....++... ......+.+++.+||+.||.+||++.+++++
T Consensus 248 ~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 248 ETGVQDKEML----KKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp TC-----CCC----CCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccccccchhh----hhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0011111111 2234567899999999999999999999875
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=337.28 Aligned_cols=253 Identities=25% Similarity=0.377 Sum_probs=207.5
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
..|...+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++......++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 45888899999999999999864 57889999976543 34567899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
+++++|.+++.. ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....... .
T Consensus 102 ~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 174 (303)
T 3a7i_A 102 LGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--I 174 (303)
T ss_dssp CTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--C
T ss_pred CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc--c
Confidence 999999999853 46999999999999999999999876 9999999999999999999999999997643321 1
Q ss_pred eeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCC
Q 039107 643 VSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDK 722 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (817)
......||..|+|||.+.+..++.++||||||+++|||++|+.||....... ....... . ..+.+.
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~----~-----~~~~~~-- 240 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK---VLFLIPK----N-----NPPTLE-- 240 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHH----S-----CCCCCC--
T ss_pred ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH---HHHHhhc----C-----CCCCCc--
Confidence 2234568999999999999999999999999999999999999987543221 1111110 0 011122
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 039107 723 ISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVL 760 (817)
Q Consensus 723 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 760 (817)
..++..+.+++.+||+.||.+|||+.+++++.....
T Consensus 241 --~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 241 --GNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp --SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred --cccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence 223456789999999999999999999998766543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=335.32 Aligned_cols=253 Identities=26% Similarity=0.374 Sum_probs=206.3
Q ss_pred hcCCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 559 (817)
.++|...+.||+|+||.||++...+ +..+|+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 3568888999999999999999764 578999987543 233456789999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC
Q 039107 560 YDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 639 (817)
|||+++++|.+++... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 94 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 94 LELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 9999999999987543 46999999999999999999999876 9999999999999999999999999997643221
Q ss_pred CCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccc
Q 039107 640 NGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719 (817)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (817)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+. ...... .. .
T Consensus 170 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~-~~------~-- 232 (294)
T 2rku_A 170 --ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------YLRIKK-NE------Y-- 232 (294)
T ss_dssp --CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHT-TC------C--
T ss_pred --cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHhh-cc------C--
Confidence 223345689999999999998999999999999999999999999976432211 111110 00 0
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 720 KDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 720 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
..+......+.+++.+||+.||++|||+.+++++....
T Consensus 233 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~ 270 (294)
T 2rku_A 233 --SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFT 270 (294)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHH
T ss_pred --CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChhee
Confidence 11223345678999999999999999999999876553
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=342.02 Aligned_cols=253 Identities=24% Similarity=0.364 Sum_probs=200.5
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
.++|...+.||+|+||.||+|... ++..||+|.+........+.+.+|++++++++||||+++++++...+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 457888999999999999999976 4688999998877666778999999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
+++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~ 172 (302)
T 2j7t_A 98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--LQ 172 (302)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--HH
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc--cc
Confidence 9999999998776667999999999999999999999876 999999999999999999999999987531110 11
Q ss_pred eeeeeecCcCCCChhhhc-----cCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCc
Q 039107 643 VSTVVKGSFGYLDPEYFK-----RQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (817)
......||..|+|||.+. ...++.++||||||+++|||++|+.||........ ......... +
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~------~ 240 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKSDP------P 240 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHSCC------C
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH------HHHHhccCC------c
Confidence 122346899999999983 66789999999999999999999999976433211 111111100 0
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 718 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
. ...+..++..+.+++.+||+.||.+|||+.+++++
T Consensus 241 ~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 241 T--LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp C--CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred c--cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0 01122344568999999999999999999999864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=345.35 Aligned_cols=263 Identities=28% Similarity=0.415 Sum_probs=201.7
Q ss_pred cccCHHHHHHhhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhcc-CccceeeEEEEE
Q 039107 473 RRFSLAEIKHATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKL-RHKHLVSLIGFC 550 (817)
Q Consensus 473 ~~f~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~ 550 (817)
..+++.++....++|...+.||+|+||.||+|... ++..||||++.... ...+.+.+|+.+++++ +||||+++++++
T Consensus 12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 34455566667888999999999999999999974 67899999986543 3347889999999999 799999999999
Q ss_pred ec------CCeEEEEEEeccCCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCce
Q 039107 551 EE------GNEMCLVYDYMALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWV 623 (817)
Q Consensus 551 ~~------~~~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~ 623 (817)
.. ....++||||+++++|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~ 167 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAE 167 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCC
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCC
Confidence 76 467899999999999999997643 47899999999999999999999876 999999999999999999
Q ss_pred eEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhc-----cCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchH
Q 039107 624 AKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFK-----RQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSL 698 (817)
Q Consensus 624 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l 698 (817)
+||+|||++....... .......||+.|+|||.+. ...++.++|||||||++|||++|+.||.........
T Consensus 168 ~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-- 243 (326)
T 2x7f_A 168 VKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL-- 243 (326)
T ss_dssp EEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--
T ss_pred EEEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH--
Confidence 9999999987643211 1223456899999999987 567899999999999999999999999654332111
Q ss_pred HHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 699 ADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 699 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
... .... .+.. .....+..+.+++.+||+.||.+||++.+++++-
T Consensus 244 -~~~---~~~~------~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp 288 (326)
T 2x7f_A 244 -FLI---PRNP------APRL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHP 288 (326)
T ss_dssp -HHH---HHSC------CCCC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSH
T ss_pred -HHh---hcCc------cccC---CccccCHHHHHHHHHHhccChhhCCCHHHHhhCh
Confidence 000 0000 0111 1122345688999999999999999999999864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=356.57 Aligned_cols=253 Identities=26% Similarity=0.344 Sum_probs=191.4
Q ss_pred hhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC--------cccHHHHHHHHHHHhccCccceeeEEEEEecC
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS--------EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEG 553 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 553 (817)
..++|...+.||+|+||+||+|... ++..||||++.... ......+.+|+++|++++||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 4568999999999999999999875 46889999875421 1223458899999999999999999999864
Q ss_pred CeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCC---ceeEEeeec
Q 039107 554 NEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDEN---WVAKVSDFG 630 (817)
Q Consensus 554 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~---~~~kl~DFG 630 (817)
+..++||||+++|+|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.+ +.+||+|||
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred CceEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeecc
Confidence 5689999999999999988654 46999999999999999999999876 9999999999999754 459999999
Q ss_pred cCccCCCCCCCceeeeeecCcCCCChhhhc---cCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhc
Q 039107 631 LSKTGPNMENGHVSTVVKGSFGYLDPEYFK---RQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKR 707 (817)
Q Consensus 631 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 707 (817)
+++.... ........||+.|+|||++. ...++.++|||||||++|||++|++||........ +......
T Consensus 288 ~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~i~~--- 359 (419)
T 3i6u_A 288 HSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQITS--- 359 (419)
T ss_dssp TTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHHHHHT---
T ss_pred cceecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHHHHhc---
Confidence 9986432 22334567999999999985 36788999999999999999999999975433221 1111111
Q ss_pred cCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 708 KGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 708 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
+... ..+.... ..+..+.+++.+||+.||.+|||+.+++++
T Consensus 360 -~~~~--~~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 360 -GKYN--FIPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp -TCCC--CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -CCCC--CCchhhc----ccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 1000 0001111 234568999999999999999999999976
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=334.15 Aligned_cols=250 Identities=25% Similarity=0.378 Sum_probs=204.7
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
++|...+.||+|+||.||+|... ++..||+|.+... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999976 4678999987543 1223467899999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-- 167 (284)
T 2vgo_A 94 EFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-- 167 (284)
T ss_dssp CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS--
T ss_pred EeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc--
Confidence 999999999998654 35899999999999999999999765 999999999999999999999999998754321
Q ss_pred CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||......+.. ..... . +.
T Consensus 168 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~~-~------~~--- 229 (284)
T 2vgo_A 168 --RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH------RRIVN-V------DL--- 229 (284)
T ss_dssp --CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHT-T------CC---
T ss_pred --ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH------HHHhc-c------cc---
Confidence 223456899999999999999999999999999999999999999754322111 11000 0 11
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
.++...+..+.+++.+||+.||.+||++.+++++-...
T Consensus 230 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~ 267 (284)
T 2vgo_A 230 -KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK 267 (284)
T ss_dssp -CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHH
T ss_pred -CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHH
Confidence 11223345678999999999999999999999875443
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=361.11 Aligned_cols=268 Identities=22% Similarity=0.280 Sum_probs=186.3
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEe-----cCCe
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCE-----EGNE 555 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-----~~~~ 555 (817)
..+|...++||+|+||+||+|... ++..||||++... .....+.+.+|+++|++++||||+++++++. ....
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 357889999999999999999865 5688999998653 2334577899999999999999999999984 3357
Q ss_pred EEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccC
Q 039107 556 MCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTG 635 (817)
Q Consensus 556 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 635 (817)
.++||||++ ++|.+++... ..+++..+..++.||+.||+|||+.+ ||||||||+||||+.++.+||+|||+++..
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEEEeccc-cchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhc
Confidence 899999985 7898888643 46999999999999999999999876 999999999999999999999999999865
Q ss_pred CCCCCC-------------------------ceeeeeecCcCCCChhhh-ccCCCCchHHHHHHHHHHHHHHh-------
Q 039107 636 PNMENG-------------------------HVSTVVKGSFGYLDPEYF-KRQQLTEKSDIYSFGVVLFEVLC------- 682 (817)
Q Consensus 636 ~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~sDV~S~Gvvl~ellt------- 682 (817)
...... ...+...||+.|+|||++ ....++.++|||||||+||||++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~ 286 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence 322111 123445789999999986 56679999999999999999999
Q ss_pred ----CCCCCCCCCcccc-----------------chHHHHHHHhhccCch-----------hhc---cC----ccccCCC
Q 039107 683 ----ARPALNPSLPKEQ-----------------VSLADWALHCKRKGIL-----------DDI---ID----PLLKDKI 723 (817)
Q Consensus 683 ----G~~p~~~~~~~~~-----------------~~l~~~~~~~~~~~~~-----------~~~---~d----~~l~~~~ 723 (817)
|+++|.+...... ......+......... ... +. ..+.. .
T Consensus 287 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 365 (458)
T 3rp9_A 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE-R 365 (458)
T ss_dssp SGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG-G
T ss_pred ccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH-H
Confidence 5666654321000 0000000000000000 000 00 00000 0
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 724 SPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 724 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
.+.....+.+|+.+||..||.+|||++|+++|--
T Consensus 366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~ 399 (458)
T 3rp9_A 366 FPASSADAIHLLKRMLVFNPNKRITINECLAHPF 399 (458)
T ss_dssp STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred CCCCCHHHHHHHHHHhccCccccCCHHHHhcCHh
Confidence 1223566889999999999999999999998744
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=334.77 Aligned_cols=249 Identities=25% Similarity=0.410 Sum_probs=197.1
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEec----CCeEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE----GNEMCL 558 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~l 558 (817)
.|...+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 3667779999999999999875 4578999987643 33446778999999999999999999998864 456899
Q ss_pred EEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEc-CCceeEEeeeccCccCCC
Q 039107 559 VYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLD-ENWVAKVSDFGLSKTGPN 637 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~-~~~~~kl~DFGla~~~~~ 637 (817)
||||+++++|.+++... ..+++..++.++.|++.||+|||+.+ .+|+||||||+|||++ +++.+||+|||++.....
T Consensus 107 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 99999999999999653 46899999999999999999999653 3499999999999998 789999999999975322
Q ss_pred CCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCc
Q 039107 638 MENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717 (817)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (817)
.......||+.|+|||.+. +.++.++||||||+++|||++|+.||......... ..... .+.. ..
T Consensus 185 ----~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-----~~~~~-~~~~----~~ 249 (290)
T 1t4h_A 185 ----SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-----YRRVT-SGVK----PA 249 (290)
T ss_dssp ----TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH-----HHHHT-TTCC----CG
T ss_pred ----cccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH-----HHHHh-ccCC----cc
Confidence 2234457999999999886 56899999999999999999999999754332211 11111 1100 01
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 718 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
... ......+.+++.+||+.||.+|||+.+++++
T Consensus 250 ~~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 250 SFD----KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GGG----GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccC----CCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 111 1223458999999999999999999999875
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=348.80 Aligned_cols=261 Identities=22% Similarity=0.315 Sum_probs=196.2
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecC------C
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEG------N 554 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 554 (817)
.++|...+.||+|+||.||+|... ++..||||++... .....+.+.+|+++|++++||||+++++++... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467888999999999999999974 5789999998643 233456788999999999999999999999765 3
Q ss_pred eEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 555 EMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 555 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
..++||||+ +++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 469999999 7899998854 46899999999999999999999876 99999999999999999999999999986
Q ss_pred CCCCCCCceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHH---------HHHH
Q 039107 635 GPNMENGHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLAD---------WALH 704 (817)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~---------~~~~ 704 (817)
... ......||+.|+|||++.+ ..++.++|||||||+++||++|++||.+....++..... +...
T Consensus 178 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 252 (367)
T 1cm8_A 178 ADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 252 (367)
T ss_dssp CCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred ccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 432 1234568999999999887 689999999999999999999999998765433221110 0000
Q ss_pred hhcc---Cchhh---ccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 705 CKRK---GILDD---IIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 705 ~~~~---~~~~~---~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
.... ..+.. .....+ ..........+.+|+.+||..||.+|||+.++++|-
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp 309 (367)
T 1cm8_A 253 LQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 309 (367)
T ss_dssp CSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred hhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcCh
Confidence 0000 00000 000000 011223355689999999999999999999999863
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=342.26 Aligned_cols=253 Identities=26% Similarity=0.374 Sum_probs=206.4
Q ss_pred hcCCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 559 (817)
..+|...+.||+|+||.||++...+ +..+|+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 3568889999999999999999764 578999987643 233457789999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC
Q 039107 560 YDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 639 (817)
|||+++++|.+++... ..+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 120 ~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 120 LELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp ECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 9999999999987543 46999999999999999999999876 9999999999999999999999999998643221
Q ss_pred CCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccc
Q 039107 640 NGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719 (817)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (817)
.......||..|+|||++.+..++.++||||||+++|||++|+.||......+. ........ ..
T Consensus 196 --~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~~~-------~~- 259 (335)
T 2owb_A 196 --ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------YLRIKKNE-------YS- 259 (335)
T ss_dssp --CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHHTC-------CC-
T ss_pred --ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH------HHHHhcCC-------CC-
Confidence 223345689999999999999999999999999999999999999976432211 11111100 01
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 720 KDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 720 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
.+......+.+++.+||+.||++||++.+++++-...
T Consensus 260 ---~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~ 296 (335)
T 2owb_A 260 ---IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFT 296 (335)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHH
T ss_pred ---CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccc
Confidence 1122345678999999999999999999999875543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=349.63 Aligned_cols=256 Identities=23% Similarity=0.290 Sum_probs=203.5
Q ss_pred cCCCcceeEeeeCceEEEEEEE----ecccEEEEEecCCCC----cccHHHHHHHHHHHhcc-CccceeeEEEEEecCCe
Q 039107 485 KSFDESYVIGVGGFGKVYKGVI----EDKLKVAIKRSNPSS----EQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNE 555 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 555 (817)
.+|...++||+|+||.||+++. .++..||||+++... ....+.+.+|+++|+++ +||||+++++++.....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5688899999999999999997 357899999987532 22345677899999999 69999999999999999
Q ss_pred EEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccC
Q 039107 556 MCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTG 635 (817)
Q Consensus 556 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 635 (817)
.++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred EEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 99999999999999999654 36999999999999999999999876 999999999999999999999999999754
Q ss_pred CCCCCCceeeeeecCcCCCChhhhcc--CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhh
Q 039107 636 PNMENGHVSTVVKGSFGYLDPEYFKR--QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDD 713 (817)
Q Consensus 636 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 713 (817)
.... ........||+.|+|||++.+ ..++.++|||||||+||||++|+.||......... ..........
T Consensus 210 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~----- 281 (355)
T 1vzo_A 210 VADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKS----- 281 (355)
T ss_dssp CGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHHC-----
T ss_pred ccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHHHHHHhcc-----
Confidence 3211 122334579999999999985 35789999999999999999999999755432211 1111111100
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHHH
Q 039107 714 IIDPLLKDKISPECLKKFADTAEKCLSDSGIDRP-----SMGDVLWNLEF 758 (817)
Q Consensus 714 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L~~ 758 (817)
....+......+.+|+.+||+.||.+|| ++.+++++...
T Consensus 282 ------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f 325 (355)
T 1vzo_A 282 ------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325 (355)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred ------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence 1112233455678999999999999999 99999987654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=337.85 Aligned_cols=255 Identities=25% Similarity=0.386 Sum_probs=202.8
Q ss_pred hhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
...+|...+.||+|+||.||+|... ++..||+|.+.... ..+.+.+|+.++++++||||+++++++......++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 3567889999999999999999976 47899999987543 34778999999999999999999999999999999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
|+++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...... .
T Consensus 105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--~ 179 (314)
T 3com_A 105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT--M 179 (314)
T ss_dssp CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT--B
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh--c
Confidence 99999999999765667999999999999999999999776 999999999999999999999999999764322 1
Q ss_pred ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccC
Q 039107 642 HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKD 721 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (817)
.......|+..|+|||.+.+..++.++||||||+++|||++|+.||......... ....... .+..
T Consensus 180 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~~~------~~~~-- 245 (314)
T 3com_A 180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI------FMIPTNP------PPTF-- 245 (314)
T ss_dssp SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHSC------CCCC--
T ss_pred cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhcCC------Cccc--
Confidence 1223456899999999999999999999999999999999999999754322111 0000000 0000
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 722 KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 722 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
..+...+..+.+++.+||+.||.+|||+.+++++-..
T Consensus 246 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~ 282 (314)
T 3com_A 246 RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFV 282 (314)
T ss_dssp SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHH
T ss_pred CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHH
Confidence 0112234568999999999999999999999986443
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=338.37 Aligned_cols=257 Identities=25% Similarity=0.375 Sum_probs=202.5
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEe--cCCeEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCE--EGNEMCL 558 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~l 558 (817)
.++|...+.||+|+||.||++... ++..||+|.+... .....+.+.+|+.++++++||||+++++++. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 357888899999999999999975 5688999998654 2344577999999999999999999999874 4678999
Q ss_pred EEEeccCCchhhhhhccc---cccchHhHHHHHHHHHHHHHHHHhCC--CCceEecCCccCcEEEcCCceeEEeeeccCc
Q 039107 559 VYDYMALGTLREHIYNTK---KALSWKQRLEICIGAARGLHYLHTGA--KYTIIHRDVKTTNILLDENWVAKVSDFGLSK 633 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 633 (817)
||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ..+|+||||||+|||+++++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999997543 24999999999999999999999754 1349999999999999999999999999997
Q ss_pred cCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhh
Q 039107 634 TGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDD 713 (817)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 713 (817)
..... ........|+..|+|||.+.+..++.++||||||+++|||++|+.||......+ +..... .+..
T Consensus 165 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~i~----~~~~-- 233 (279)
T 2w5a_A 165 ILNHD--TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAGKIR----EGKF-- 233 (279)
T ss_dssp HC-----CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH----HTCC--
T ss_pred eeccc--cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH---HHHHHh----hccc--
Confidence 64321 112233468999999999999999999999999999999999999997653221 111111 1111
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 714 IIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 714 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
...+..++..+.+++.+||+.||.+||++.+|++++..
T Consensus 234 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 234 -------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 11222345668999999999999999999999986643
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=342.15 Aligned_cols=267 Identities=22% Similarity=0.319 Sum_probs=203.4
Q ss_pred cccCHHHHHHhhcCCCcceeEeeeCceEEEEEEEecccEEEEEecCCC--CcccHHHHHHHHHHHhccC--ccceeeEEE
Q 039107 473 RRFSLAEIKHATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLR--HKHLVSLIG 548 (817)
Q Consensus 473 ~~f~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--H~niv~l~g 548 (817)
+.+.++.+....++|...+.||+|+||.||++...++..||||++... .....+.+.+|++++++++ |+||+++++
T Consensus 16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp ----CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred CCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence 344455555566789999999999999999999888889999997643 3345678899999999997 599999999
Q ss_pred EEecCCeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEee
Q 039107 549 FCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSD 628 (817)
Q Consensus 549 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 628 (817)
++......++||| +.+++|.+++... ..+++.+++.++.|+++||+|||+.+ |+||||||+|||+++ +.+||+|
T Consensus 96 ~~~~~~~~~lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~D 169 (313)
T 3cek_A 96 YEITDQYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLID 169 (313)
T ss_dssp EEECSSEEEEEEC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECC
T ss_pred EeecCCEEEEEEe-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEee
Confidence 9999999999999 6678999998754 46899999999999999999999876 999999999999975 7999999
Q ss_pred eccCccCCCCCCCceeeeeecCcCCCChhhhcc-----------CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccch
Q 039107 629 FGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKR-----------QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVS 697 (817)
Q Consensus 629 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~ 697 (817)
||+++...............||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........
T Consensus 170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-- 247 (313)
T 3cek_A 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-- 247 (313)
T ss_dssp CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--
T ss_pred ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH--
Confidence 999986543322222334568999999999875 4788999999999999999999999965432110
Q ss_pred HHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 698 LADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 698 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
.. ....++......+......+.+++.+||+.||.+||++.+++++....
T Consensus 248 ---~~---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~ 297 (313)
T 3cek_A 248 ---KL---------HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297 (313)
T ss_dssp ---HH---------HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred ---HH---------HHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCcccc
Confidence 01 111111111122222345688999999999999999999999876543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=360.81 Aligned_cols=254 Identities=24% Similarity=0.350 Sum_probs=205.4
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 559 (817)
..+|...++||+|+||.||+|+.+ +++.||+|++... .....+.+.+|+++|++++||||+++++++......++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 357888899999999999999975 5789999998643 123456788999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccc---cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCC
Q 039107 560 YDYMALGTLREHIYNTK---KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGP 636 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 636 (817)
|||+++|+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999987543 36999999999999999999999876 9999999999999999999999999998643
Q ss_pred CCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccC
Q 039107 637 NMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIID 716 (817)
Q Consensus 637 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (817)
... .......||+.|+|||++.+..++.++|||||||++|||++|++||......... .+........
T Consensus 341 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~--~~~~~~i~~~-------- 408 (543)
T 3c4z_A 341 AGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQRVLEQ-------- 408 (543)
T ss_dssp TTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH--HHHHHHHHHC--------
T ss_pred CCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH--HHHHHHHhhc--------
Confidence 322 2233457999999999999999999999999999999999999999765332111 1111111100
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 039107 717 PLLKDKISPECLKKFADTAEKCLSDSGIDRPSM-----GDVLWN 755 (817)
Q Consensus 717 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~~ 755 (817)
. ..++...+..+.+++.+||+.||.+||++ .+|++|
T Consensus 409 -~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 409 -A--VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp -C--CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred -c--cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 0 11223345667899999999999999975 666654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=335.04 Aligned_cols=256 Identities=20% Similarity=0.281 Sum_probs=188.8
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCc-cc-HHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSE-QG-VNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
.++|...+.||+|+||+||+|... ++..||+|++..... .. .+.+.++...++.++||||+++++++...+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 457888999999999999999974 678899999875422 22 233445555688889999999999999999999999
Q ss_pred EeccCCchhhhhhc---cccccchHhHHHHHHHHHHHHHHHHhC-CCCceEecCCccCcEEEcCCceeEEeeeccCccCC
Q 039107 561 DYMALGTLREHIYN---TKKALSWKQRLEICIGAARGLHYLHTG-AKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGP 636 (817)
Q Consensus 561 Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 636 (817)
||++ |+|.+++.. ....+++..++.++.|++.||+|||++ + |+||||||+|||++.++.+||+|||+++...
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9998 588877754 345799999999999999999999986 5 9999999999999999999999999997643
Q ss_pred CCCCCceeeeeecCcCCCChhhh----ccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchh
Q 039107 637 NMENGHVSTVVKGSFGYLDPEYF----KRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILD 712 (817)
Q Consensus 637 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 712 (817)
.. .......||+.|+|||.+ .+..++.++||||||+++|||++|+.||....... ..+... ....
T Consensus 162 ~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~----~~~~--- 230 (290)
T 3fme_A 162 DD---VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF-QQLKQV----VEEP--- 230 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH-HHHHHH----HHSC---
T ss_pred cc---ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH-HHHHHH----hccC---
Confidence 22 222334689999999996 56678999999999999999999999997532211 111111 1111
Q ss_pred hccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 039107 713 DIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVL 760 (817)
Q Consensus 713 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 760 (817)
.........+..+.+++.+||+.||.+|||+.+++++--...
T Consensus 231 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 231 ------SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp ------CCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred ------CCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 001111233456899999999999999999999998655443
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=332.29 Aligned_cols=250 Identities=26% Similarity=0.360 Sum_probs=196.3
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
.+|...+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 56888999999999999999976 6789999997643 2233567899999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
||+++++|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 91 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~-- 164 (276)
T 2h6d_A 91 EYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-- 164 (276)
T ss_dssp ECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred eccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCC--
Confidence 999999999998654 35899999999999999999999876 999999999999999999999999999864322
Q ss_pred CceeeeeecCcCCCChhhhccCCC-CchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQL-TEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (817)
.......|++.|+|||.+.+..+ +.++||||||++++||++|+.||....... +.... ..+.
T Consensus 165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~----~~~~--------- 227 (276)
T 2h6d_A 165 -EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT---LFKKI----RGGV--------- 227 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH----HHCC---------
T ss_pred -cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---HHHHh----hcCc---------
Confidence 22234568999999999987765 689999999999999999999997543211 11111 0110
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 720 KDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 720 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
...+......+.+++.+||+.||.+|||+.+++++--.
T Consensus 228 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~ 265 (276)
T 2h6d_A 228 -FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWF 265 (276)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHH
T ss_pred -ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhh
Confidence 01122234567899999999999999999999987443
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=349.36 Aligned_cols=261 Identities=18% Similarity=0.242 Sum_probs=196.1
Q ss_pred HHhhcCCCcceeEeeeCceEEEEEEE-ecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEec-------
Q 039107 481 KHATKSFDESYVIGVGGFGKVYKGVI-EDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE------- 552 (817)
Q Consensus 481 ~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------- 552 (817)
....++|...++||+|+||+||+|.. .++..||||++..... ...+|+++|+.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567899999999999999999986 4678999999865432 23479999999999999999999843
Q ss_pred -------------------------------CCeEEEEEEeccCCchhhhhhc---cccccchHhHHHHHHHHHHHHHHH
Q 039107 553 -------------------------------GNEMCLVYDYMALGTLREHIYN---TKKALSWKQRLEICIGAARGLHYL 598 (817)
Q Consensus 553 -------------------------------~~~~~lV~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yL 598 (817)
....++||||++ |+|.+.+.. ....+++..+..++.||++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 334889999998 588777753 335799999999999999999999
Q ss_pred HhCCCCceEecCCccCcEEEc-CCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccC-CCCchHHHHHHHHH
Q 039107 599 HTGAKYTIIHRDVKTTNILLD-ENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQ-QLTEKSDIYSFGVV 676 (817)
Q Consensus 599 H~~~~~~ivH~Dikp~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvv 676 (817)
|+.+ |+||||||+|||++ +++.+||+|||+++...... ......||..|+|||.+.+. .++.++|||||||+
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9765 99999999999998 68999999999998643222 23345689999999998764 58999999999999
Q ss_pred HHHHHhCCCCCCCCCccccchHHHHHHHhhccCch----------hh-----ccCccccCCCCHHHHHHHHHHHHHcccc
Q 039107 677 LFEVLCARPALNPSLPKEQVSLADWALHCKRKGIL----------DD-----IIDPLLKDKISPECLKKFADTAEKCLSD 741 (817)
Q Consensus 677 l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~----------~~-----~~d~~l~~~~~~~~~~~l~~li~~cl~~ 741 (817)
+|||++|++||......+.... .+.. ...... .+ .........++...+..+.+|+.+||+.
T Consensus 232 l~ell~g~~pf~~~~~~~~~~~--i~~~-~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQLVR--IIQI-MGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHH--HHHH-HCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHhCCCCCCCCChHHHHHH--HHHH-hCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 9999999999987654332211 1110 000000 00 0000011112223455689999999999
Q ss_pred CCCCCCCHHHHHHH
Q 039107 742 SGIDRPSMGDVLWN 755 (817)
Q Consensus 742 dP~~RPt~~evl~~ 755 (817)
||.+|||+.|+++|
T Consensus 309 dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 309 EPDLRINPYEAMAH 322 (383)
T ss_dssp SGGGSCCHHHHHTS
T ss_pred ChhhCCCHHHHhcC
Confidence 99999999999976
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=347.74 Aligned_cols=263 Identities=24% Similarity=0.264 Sum_probs=201.5
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccC--------ccceeeEEEEEe---
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLR--------HKHLVSLIGFCE--- 551 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~g~~~--- 551 (817)
.++|...++||+|+||+||+|+.. +++.||||++... ....+.+.+|++++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 367899999999999999999864 5688999998744 344577889999999985 788999999987
Q ss_pred -cCCeEEEEEEeccCCchhhhhhcc-ccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCc-------
Q 039107 552 -EGNEMCLVYDYMALGTLREHIYNT-KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENW------- 622 (817)
Q Consensus 552 -~~~~~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~------- 622 (817)
.....++||||+. ++|.+.+... ...+++.+++.++.||+.||+|||+++ +|+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 115 VNGTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TTEEEEEEEECCCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCCceEEEEEeccC-ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhh
Confidence 5668899999995 5555555433 357999999999999999999999861 399999999999999775
Q ss_pred ------------------------------------------eeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhc
Q 039107 623 ------------------------------------------VAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFK 660 (817)
Q Consensus 623 ------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 660 (817)
.+||+|||+++..... .....||+.|+|||++.
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHH
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhhc
Confidence 7999999999864321 23346899999999999
Q ss_pred cCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchH---HHHHHHhhcc-------------------CchhhccCcc
Q 039107 661 RQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSL---ADWALHCKRK-------------------GILDDIIDPL 718 (817)
Q Consensus 661 ~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l---~~~~~~~~~~-------------------~~~~~~~d~~ 718 (817)
+..++.++|||||||+||||++|+.||......+.... .......... +.+..+.+..
T Consensus 267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence 99999999999999999999999999976543322111 0001000000 0000000000
Q ss_pred ---------ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 719 ---------LKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 719 ---------l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.....+......+.+|+.+||+.||.+|||++|++++
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0112356777889999999999999999999999975
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=333.82 Aligned_cols=254 Identities=24% Similarity=0.329 Sum_probs=200.5
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC----cccHHHHHHHHHHHhccCccceeeEEEEE--ecCCeE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS----EQGVNEFVTEIEMLSKLRHKHLVSLIGFC--EEGNEM 556 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~--~~~~~~ 556 (817)
.++|...+.||+|+||.||++... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++ .+....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 357889999999999999999964 56889999987532 23457899999999999999999999998 455688
Q ss_pred EEEEEeccCCchhhhhhcc-ccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccC
Q 039107 557 CLVYDYMALGTLREHIYNT-KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTG 635 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 635 (817)
++||||++++ |.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999976 66666543 347999999999999999999999876 999999999999999999999999999865
Q ss_pred CCCCCCceeeeeecCcCCCChhhhccCCC--CchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhh
Q 039107 636 PNMENGHVSTVVKGSFGYLDPEYFKRQQL--TEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDD 713 (817)
Q Consensus 636 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 713 (817)
.............||..|+|||++.+... +.++||||||+++|||++|+.||......+. .... ..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~i-~~~~--- 229 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL------FENI-GKGS--- 229 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHH-HHCC---
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH------HHHH-hcCC---
Confidence 43333334445679999999999876443 7899999999999999999999976432211 1111 1110
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 714 IIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 714 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
. ..+..+...+.+++.+||+.||.+|||+.+++++-..
T Consensus 230 ---~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 267 (305)
T 2wtk_C 230 ---Y----AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF 267 (305)
T ss_dssp ---C----CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHH
T ss_pred ---C----CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence 0 1122344567899999999999999999999987554
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=343.21 Aligned_cols=256 Identities=27% Similarity=0.354 Sum_probs=203.8
Q ss_pred HHHhhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCc--------ccHHHHHHHHHHHhcc-CccceeeEEEE
Q 039107 480 IKHATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSE--------QGVNEFVTEIEMLSKL-RHKHLVSLIGF 549 (817)
Q Consensus 480 l~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~H~niv~l~g~ 549 (817)
......+|...+.||+|+||.||+|+.. ++..||||++..... ...+.+.+|+.+++++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3445567999999999999999999986 678999998765432 1145678999999999 79999999999
Q ss_pred EecCCeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeee
Q 039107 550 CEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDF 629 (817)
Q Consensus 550 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DF 629 (817)
+......++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+||
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~Df 244 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDF 244 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEec
Confidence 99999999999999999999998643 46999999999999999999999876 999999999999999999999999
Q ss_pred ccCccCCCCCCCceeeeeecCcCCCChhhhcc------CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHH
Q 039107 630 GLSKTGPNMENGHVSTVVKGSFGYLDPEYFKR------QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWAL 703 (817)
Q Consensus 630 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 703 (817)
|++...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ....+.
T Consensus 245 G~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~~~~i~ 318 (365)
T 2y7j_A 245 GFSCHLEPG---EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL---MLRMIM 318 (365)
T ss_dssp TTCEECCTT---CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH
T ss_pred CcccccCCC---cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHH
Confidence 999764332 22334679999999999864 357889999999999999999999997543221 111111
Q ss_pred HhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 704 HCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 704 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
. +... ...+ ... ..+..+.+++.+||+.||.+|||+.+++++
T Consensus 319 ~----~~~~-~~~~-~~~----~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 319 E----GQYQ-FSSP-EWD----DRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp H----TCCC-CCHH-HHS----SSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred h----CCCC-CCCc-ccc----cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1 0000 0000 001 123457899999999999999999999875
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=354.96 Aligned_cols=199 Identities=25% Similarity=0.365 Sum_probs=165.1
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecC-----Ce
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEG-----NE 555 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 555 (817)
.++|...++||+|+||.||+|... ++..||||++... .....+.+.+|+++|++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 457889999999999999999975 4678999998754 333457889999999999999999999999765 57
Q ss_pred EEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccC
Q 039107 556 MCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTG 635 (817)
Q Consensus 556 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 635 (817)
.++||||++ ++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 899999997 5999988643 46999999999999999999999876 999999999999999999999999999865
Q ss_pred CCCCCC--------------------ceeeeeecCcCCCChhhh-ccCCCCchHHHHHHHHHHHHHHhCCCCC
Q 039107 636 PNMENG--------------------HVSTVVKGSFGYLDPEYF-KRQQLTEKSDIYSFGVVLFEVLCARPAL 687 (817)
Q Consensus 636 ~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~sDV~S~Gvvl~elltG~~p~ 687 (817)
...... ...+...||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 332211 123556799999999986 5667999999999999999999854443
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=337.06 Aligned_cols=262 Identities=20% Similarity=0.296 Sum_probs=204.4
Q ss_pred hcCCCcceeEeeeCceEEEEEEE-e-cccEEEEEecCCCCcccHHHHHHHHHHHhccCccc------eeeEEEEEecCCe
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVI-E-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKH------LVSLIGFCEEGNE 555 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~~ 555 (817)
.++|...+.||+|+||.||+|.. . ++..||||++... ....+.+.+|++++++++|++ ++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 35788899999999999999986 3 5688999998754 344577889999999997765 9999999999999
Q ss_pred EEEEEEeccCCchhhhhhcccc-ccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcC--------------
Q 039107 556 MCLVYDYMALGTLREHIYNTKK-ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDE-------------- 620 (817)
Q Consensus 556 ~~lV~Ey~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~-------------- 620 (817)
.++||||+ +++|.+++..... .+++.++..++.|++.||+|||+++ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999 7899999876543 6899999999999999999999876 999999999999987
Q ss_pred -----CceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCcccc
Q 039107 621 -----NWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQ 695 (817)
Q Consensus 621 -----~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~ 695 (817)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred cccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 668999999999863321 2335689999999999999999999999999999999999999986554332
Q ss_pred chHHHHHHH--------hhccCc------------------hhhccCccc-cCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 039107 696 VSLADWALH--------CKRKGI------------------LDDIIDPLL-KDKISPECLKKFADTAEKCLSDSGIDRPS 748 (817)
Q Consensus 696 ~~l~~~~~~--------~~~~~~------------------~~~~~d~~l-~~~~~~~~~~~l~~li~~cl~~dP~~RPt 748 (817)
......... ...... ......+.. .......+...+.+++.+||+.||.+|||
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 221111000 000000 000000000 01123456778999999999999999999
Q ss_pred HHHHHHH
Q 039107 749 MGDVLWN 755 (817)
Q Consensus 749 ~~evl~~ 755 (817)
+.|++++
T Consensus 323 ~~ell~h 329 (339)
T 1z57_A 323 LREALKH 329 (339)
T ss_dssp HHHHTTS
T ss_pred HHHHhcC
Confidence 9999875
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=353.21 Aligned_cols=201 Identities=26% Similarity=0.317 Sum_probs=172.6
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhcc------CccceeeEEEEEecCCeE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKL------RHKHLVSLIGFCEEGNEM 556 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~g~~~~~~~~ 556 (817)
..+|...++||+|+||+||+|... ++..||||++... ....+++.+|+++++.+ +|+||+++++++......
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 456888999999999999999865 4688999998754 33346778888888887 567999999999999999
Q ss_pred EEEEEeccCCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCce--eEEeeeccCc
Q 039107 557 CLVYDYMALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWV--AKVSDFGLSK 633 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~--~kl~DFGla~ 633 (817)
++||||+. ++|.+++.... ..+++..++.|+.||+.||+|||+.+ |+||||||+||||+.++. +||+|||+++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999997 68998887554 35999999999999999999999876 999999999999999887 9999999997
Q ss_pred cCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccc
Q 039107 634 TGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKE 694 (817)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~ 694 (817)
.... ......||+.|+|||++.+..++.++|||||||+||||++|++||......+
T Consensus 251 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~ 306 (429)
T 3kvw_A 251 YEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD 306 (429)
T ss_dssp ETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 5322 1223568999999999999999999999999999999999999998765443
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=336.43 Aligned_cols=258 Identities=18% Similarity=0.273 Sum_probs=199.0
Q ss_pred cCCCcceeEeeeCceEEEEEEE-ecccEEEEEecCCCCcccHHHHHHHHHHHhccC-ccceeeEEEEEec--CCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVI-EDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLR-HKHLVSLIGFCEE--GNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~lV~ 560 (817)
++|...++||+|+||+||+|.. .++..||||++.... .+.+.+|+.++++++ ||||+++++++.. ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 5688899999999999999986 467899999987443 467899999999997 9999999999987 66789999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCc-eeEEeeeccCccCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENW-VAKVSDFGLSKTGPNME 639 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DFGla~~~~~~~ 639 (817)
||+++++|.+++. .+++.++..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+++......
T Consensus 113 e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp ECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred eccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 9999999998873 4889999999999999999999876 99999999999999776 89999999998643322
Q ss_pred CCceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCcccc-ch----------HHHHHHHhhc
Q 039107 640 NGHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQ-VS----------LADWALHCKR 707 (817)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~-~~----------l~~~~~~~~~ 707 (817)
......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||........ .. +.++......
T Consensus 186 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 186 ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp ---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred ---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 2234468999999999877 6789999999999999999999999965432211 10 0011110000
Q ss_pred c--Cchhhcc--------CccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 708 K--GILDDII--------DPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 708 ~--~~~~~~~--------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
. ....+.. ...............+.+++.+||+.||.+|||++|++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 0000000 0001111112245678999999999999999999999975
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=359.09 Aligned_cols=253 Identities=25% Similarity=0.347 Sum_probs=198.8
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC--cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
.++|...++||+|+||+||+|+.+ ++..||+|++.... ......+.+|+.++++++||||++++++|......++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 346888999999999999999976 56789999976542 334577899999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcC---CceeEEeeeccCccCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDE---NWVAKVSDFGLSKTGPN 637 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DFGla~~~~~ 637 (817)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++....
T Consensus 116 e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 116 ECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 999999999988654 45999999999999999999999876 999999999999976 45699999999986433
Q ss_pred CCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCc
Q 039107 638 MENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717 (817)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (817)
. .......||+.|+|||++. +.++.++|||||||++|||++|++||......+.. ..+. .+.. ..+.
T Consensus 192 ~---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i~----~~~~--~~~~ 258 (494)
T 3lij_A 192 Q---KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEIL---RKVE----KGKY--TFDS 258 (494)
T ss_dssp T---BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHH----HTCC--CCCS
T ss_pred C---ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHH----hCCC--CCCc
Confidence 2 2233456999999999986 57999999999999999999999999765432211 1111 1100 0000
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 718 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
... ...+..+.+++.+||+.||.+|||+.+++++-.
T Consensus 259 ~~~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~ 294 (494)
T 3lij_A 259 PEW----KNVSEGAKDLIKQMLQFDSQRRISAQQALEHPW 294 (494)
T ss_dssp GGG----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred hhc----ccCCHHHHHHHHHHCCCChhhCccHHHHhcCcc
Confidence 011 123456789999999999999999999997733
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=359.97 Aligned_cols=254 Identities=24% Similarity=0.325 Sum_probs=205.3
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 559 (817)
.++|...++||+|+||.||+|... ++..||||++... .....+.+.+|+.++++++||||+++++++......++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 346888999999999999999976 6789999997543 234567899999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEE---cCCceeEEeeeccCccCC
Q 039107 560 YDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILL---DENWVAKVSDFGLSKTGP 636 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll---~~~~~~kl~DFGla~~~~ 636 (817)
|||+.+|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 105 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp ECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 9999999999988654 46999999999999999999999876 9999999999999 567899999999997643
Q ss_pred CCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccC
Q 039107 637 NMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIID 716 (817)
Q Consensus 637 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (817)
.. .......||+.|+|||++.+ .++.++|||||||++|||++|++||......+.. ..+. .+...
T Consensus 181 ~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i~----~~~~~---- 245 (484)
T 3nyv_A 181 AS---KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDIL---KKVE----KGKYT---- 245 (484)
T ss_dssp CC---CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHH----HCCCC----
T ss_pred cc---cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHH---HHHH----cCCCC----
Confidence 32 12234569999999999875 7999999999999999999999999865433211 1111 11100
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 717 PLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 717 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
.........+..+.+++.+||+.+|.+|||+.++++|-..
T Consensus 246 --~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~ 285 (484)
T 3nyv_A 246 --FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWI 285 (484)
T ss_dssp --CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHH
T ss_pred --CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhh
Confidence 0000012334567899999999999999999999987544
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=368.47 Aligned_cols=260 Identities=23% Similarity=0.393 Sum_probs=208.4
Q ss_pred hhcCCCcceeEeeeCceEEEEEEEec----ccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEE
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVIED----KLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMC 557 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 557 (817)
...+|...+.||+|+||.||+|.... +..||+|++.... ....+.|.+|+.++++++||||+++++++.+ +..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceE
Confidence 34678889999999999999998743 3579999987543 3345789999999999999999999999854 5689
Q ss_pred EEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCC
Q 039107 558 LVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPN 637 (817)
Q Consensus 558 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 637 (817)
+||||+++|+|.+++......+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 999999999999999766667999999999999999999999876 99999999999999999999999999986533
Q ss_pred CCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccC
Q 039107 638 MENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIID 716 (817)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (817)
.. ........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......+ ....+.. ..
T Consensus 544 ~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~~~~i~~---~~------- 609 (656)
T 2j0j_A 544 ST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIEN---GE------- 609 (656)
T ss_dssp -----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHH---TC-------
T ss_pred Cc-ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHc---CC-------
Confidence 22 122233457889999999999999999999999999999997 999987654322 1111111 00
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 039107 717 PLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLV 763 (817)
Q Consensus 717 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 763 (817)
....+..++..+.+++.+||+.||.+|||+.+|++.|+.+++..
T Consensus 610 ---~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 610 ---RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 01123344567899999999999999999999999999987543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=357.90 Aligned_cols=253 Identities=25% Similarity=0.336 Sum_probs=202.1
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
.++|...++||+|+||+||+|... ++..||||++... .......+.+|+++|++++||||+++++++......++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 356888999999999999999975 5788999997532 2334578999999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEc---CCceeEEeeeccCccCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLD---ENWVAKVSDFGLSKTGPN 637 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~---~~~~~kl~DFGla~~~~~ 637 (817)
||+++|+|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+++....
T Consensus 101 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 999999999988654 46999999999999999999999876 99999999999995 456899999999986432
Q ss_pred CCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCc
Q 039107 638 MENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717 (817)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (817)
. .......||+.|+|||++.+ .++.++|||||||++|||++|++||......+.. ..+.. +... .+
T Consensus 177 ~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i~~----~~~~--~~- 242 (486)
T 3mwu_A 177 N---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---KRVET----GKYA--FD- 242 (486)
T ss_dssp C-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHH----TCCC--SC-
T ss_pred C---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHh----CCCC--CC-
Confidence 2 22334569999999999875 6999999999999999999999999765432211 11111 1000 00
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 718 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
.......+..+.+++.+||+.||.+|||+.+++++-.
T Consensus 243 ---~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~ 279 (486)
T 3mwu_A 243 ---LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279 (486)
T ss_dssp ---SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHH
T ss_pred ---CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHh
Confidence 0001223456789999999999999999999998743
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=348.57 Aligned_cols=260 Identities=23% Similarity=0.269 Sum_probs=193.9
Q ss_pred cCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCC------eEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGN------EMCL 558 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~l 558 (817)
.+|...++||+|+||+||+|+...+..+|+|++...... ..+|+++|+.++||||+++++++.... ..++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 468889999999999999999877767999987644322 236999999999999999999985433 3789
Q ss_pred EEEeccCCchhhhhh--ccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEc-CCceeEEeeeccCccC
Q 039107 559 VYDYMALGTLREHIY--NTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLD-ENWVAKVSDFGLSKTG 635 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~-~~~~~kl~DFGla~~~ 635 (817)
||||++++.+..... .....+++..+..++.||++||+|||+.+ |+||||||+||||+ .++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 999998755443332 22447999999999999999999999876 99999999999999 7999999999999864
Q ss_pred CCCCCCceeeeeecCcCCCChhhhccC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHh---------
Q 039107 636 PNMENGHVSTVVKGSFGYLDPEYFKRQ-QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHC--------- 705 (817)
Q Consensus 636 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~--------- 705 (817)
.... ......||+.|+|||++.+. .++.++|||||||++|||++|++||.+....++.. ......
T Consensus 193 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~--~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 193 IAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLV--EIIKVLGTPSREQIK 267 (394)
T ss_dssp CTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHHHCCCCHHHHH
T ss_pred cCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHhCCCCHHHHH
Confidence 3222 22345689999999998764 58999999999999999999999998765433221 111100
Q ss_pred -hc----cCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 706 -KR----KGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 706 -~~----~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
.. ...............+....+..+.+|+.+||+.||.+|||+.|+++|-
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 323 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHP 323 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcCh
Confidence 00 0000000000000111222445789999999999999999999999763
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=331.59 Aligned_cols=252 Identities=22% Similarity=0.293 Sum_probs=202.2
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC---------cccHHHHHHHHHHHhccC-ccceeeEEEEEec
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS---------EQGVNEFVTEIEMLSKLR-HKHLVSLIGFCEE 552 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~ 552 (817)
.++|...+.||+|+||.||+|..+ ++..||||.+.... ....+.+.+|+++++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 467888999999999999999975 56889999986542 122456889999999995 9999999999999
Q ss_pred CCeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccC
Q 039107 553 GNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLS 632 (817)
Q Consensus 553 ~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla 632 (817)
....++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccch
Confidence 99999999999999999998653 46999999999999999999999776 999999999999999999999999999
Q ss_pred ccCCCCCCCceeeeeecCcCCCChhhhc------cCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhh
Q 039107 633 KTGPNMENGHVSTVVKGSFGYLDPEYFK------RQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCK 706 (817)
Q Consensus 633 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 706 (817)
...... .......|++.|+|||.+. ...++.++||||||++++||++|+.||....... .......
T Consensus 172 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~-- 243 (298)
T 1phk_A 172 CQLDPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---MLRMIMS-- 243 (298)
T ss_dssp EECCTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHH--
T ss_pred hhcCCC---cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH---HHHHHhc--
Confidence 764322 2233456899999999985 4568899999999999999999999997543221 1111111
Q ss_pred ccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 707 RKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 707 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
+.. ..........+..+.+++.+||+.||.+|||+.+++++
T Consensus 244 --~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 244 --GNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp --TCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred --CCc------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 000 00011112345668999999999999999999999864
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=345.77 Aligned_cols=267 Identities=23% Similarity=0.322 Sum_probs=202.9
Q ss_pred HhhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecC-----C
Q 039107 482 HATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEG-----N 554 (817)
Q Consensus 482 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~ 554 (817)
....+|...++||+|+||.||+|... ++..||||++.... ....+.+.+|++++++++||||+++++++... .
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 34567999999999999999999865 56789999987543 33347789999999999999999999998654 4
Q ss_pred eEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 555 EMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 555 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
..++||||++ |+|.+++.. ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 6899999998 589988853 46999999999999999999999876 99999999999999999999999999986
Q ss_pred CCCCCC-CceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCch-
Q 039107 635 GPNMEN-GHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGIL- 711 (817)
Q Consensus 635 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~- 711 (817)
...... ........||+.|+|||++.+ ..++.++|||||||++|||++|++||......+..... .........
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i---~~~~~~~~~~ 254 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI---LGILGSPSQE 254 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHH---HHHHCSCCHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHH---HHHhCCCCHH
Confidence 432211 111234579999999998754 45899999999999999999999999876544332211 000000000
Q ss_pred --------------hhccCccc--cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 712 --------------DDIIDPLL--KDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 712 --------------~~~~d~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
.....+.. ...........+.+|+.+||+.||.+|||+.|++++--
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 316 (364)
T 3qyz_A 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316 (364)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 00000000 00001123456889999999999999999999997643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=337.45 Aligned_cols=252 Identities=27% Similarity=0.336 Sum_probs=195.8
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC--------cccHHHHHHHHHHHhccCccceeeEEEEEecCC
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS--------EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGN 554 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 554 (817)
.++|...+.||+|+||.||+|... ++..||||.+.... ......+.+|++++++++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 457888999999999999999975 46789999986532 122345889999999999999999999997654
Q ss_pred eEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCce---eEEeeecc
Q 039107 555 EMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWV---AKVSDFGL 631 (817)
Q Consensus 555 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~---~kl~DFGl 631 (817)
.++||||+++++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred -eEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 89999999999999988643 46999999999999999999999876 999999999999987654 99999999
Q ss_pred CccCCCCCCCceeeeeecCcCCCChhhhc---cCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhcc
Q 039107 632 SKTGPNMENGHVSTVVKGSFGYLDPEYFK---RQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRK 708 (817)
Q Consensus 632 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 708 (817)
++.... ........||+.|+|||++. ...++.++|||||||++|||++|+.||........ +......
T Consensus 164 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~---- 234 (322)
T 2ycf_A 164 SKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQITS---- 234 (322)
T ss_dssp CEECCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHHHH----
T ss_pred ceeccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHHHh----
Confidence 986422 22223456899999999974 46789999999999999999999999975543221 1111111
Q ss_pred CchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 709 GILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 709 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
+... ..+.... ..+..+.+++.+||+.||.+||++.+++++
T Consensus 235 ~~~~--~~~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 235 GKYN--FIPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp TCCC--CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred Cccc--cCchhhh----hcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 1000 0011111 234567899999999999999999999964
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=342.76 Aligned_cols=262 Identities=20% Similarity=0.295 Sum_probs=203.3
Q ss_pred hcCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcc-----------------cHHHHHHHHHHHhccCccceeeE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQ-----------------GVNEFVTEIEMLSKLRHKHLVSL 546 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~E~~~l~~l~H~niv~l 546 (817)
.++|...+.||+|+||.||+|.. ++..||+|++...... ..+.|.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 35788999999999999999998 8889999987643111 11789999999999999999999
Q ss_pred EEEEecCCeEEEEEEeccCCchhhh------hhcc-ccccchHhHHHHHHHHHHHHHHHHh-CCCCceEecCCccCcEEE
Q 039107 547 IGFCEEGNEMCLVYDYMALGTLREH------IYNT-KKALSWKQRLEICIGAARGLHYLHT-GAKYTIIHRDVKTTNILL 618 (817)
Q Consensus 547 ~g~~~~~~~~~lV~Ey~~~gsL~~~------l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dikp~NIll 618 (817)
++++.+.+..++||||+++++|.++ +... ...+++..++.++.|++.||+|||+ .+ |+||||||+|||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEE
Confidence 9999999999999999999999998 5442 3579999999999999999999997 55 9999999999999
Q ss_pred cCCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccC-CCCc-hHHHHHHHHHHHHHHhCCCCCCCCCccccc
Q 039107 619 DENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQ-QLTE-KSDIYSFGVVLFEVLCARPALNPSLPKEQV 696 (817)
Q Consensus 619 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-~sDV~S~Gvvl~elltG~~p~~~~~~~~~~ 696 (817)
+.++.+||+|||++...... ......|+..|+|||.+.+. .++. ++||||||+++|||++|+.||.......
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-- 259 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV-- 259 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH--
T ss_pred cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH--
Confidence 99999999999999864322 33445789999999999877 6666 9999999999999999999997654321
Q ss_pred hHHHHHHHhhccCc--hhhccCcccc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 697 SLADWALHCKRKGI--LDDIIDPLLK---DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 697 ~l~~~~~~~~~~~~--~~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.+...+........ ......+... .......+..+.+++.+||+.||.+|||+.+++++
T Consensus 260 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11111111000000 0000000000 00012345678999999999999999999999975
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=340.57 Aligned_cols=266 Identities=20% Similarity=0.255 Sum_probs=195.4
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecCC------
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGN------ 554 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 554 (817)
.++|...+.||+|+||.||+|... ++..||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 357889999999999999999865 5678999998653 2334567889999999999999999999997654
Q ss_pred eEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 555 EMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 555 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
..++||||++ ++|.+++. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred ceEEEEEcCC-CCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 7899999998 47877774 35889999999999999999999876 99999999999999999999999999986
Q ss_pred CCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHH---------HHH---
Q 039107 635 GPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLA---------DWA--- 702 (817)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~---------~~~--- 702 (817)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+..... ++.
T Consensus 177 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 177 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred ccc---ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 432 12233457899999999999999999999999999999999999999765432211100 000
Q ss_pred ----HHhh-ccC-----chhhccCccccCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 703 ----LHCK-RKG-----ILDDIIDPLLKDK---ISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 703 ----~~~~-~~~-----~~~~~~d~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
.... ... .....+....... ........+.+|+.+||+.||.+|||++|++++--..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 323 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 323 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchh
Confidence 0000 000 0000010000000 0123356789999999999999999999999886553
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=337.93 Aligned_cols=263 Identities=23% Similarity=0.318 Sum_probs=200.8
Q ss_pred hhcCCCcceeEeeeCceEEEEEEE--ecccEEEEEecCCCC--cccHHHHHHHHHHHhcc---CccceeeEEEEEe----
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVI--EDKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKL---RHKHLVSLIGFCE---- 551 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~---- 551 (817)
+.++|...+.||+|+||.||+|.. .++..||+|++.... ......+.+|+.+++++ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999997 356789999876432 22234567788877776 8999999999987
Q ss_pred -cCCeEEEEEEeccCCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeee
Q 039107 552 -EGNEMCLVYDYMALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDF 629 (817)
Q Consensus 552 -~~~~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DF 629 (817)
.....++||||++ |+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecC
Confidence 5567899999998 69999987543 35999999999999999999999876 999999999999999999999999
Q ss_pred ccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccC
Q 039107 630 GLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKG 709 (817)
Q Consensus 630 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 709 (817)
|+++.... ........||..|+|||.+.+..++.++||||||+++|||++|+.||......+... .+.......
T Consensus 165 g~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~i~~~~~~~ 238 (326)
T 1blx_A 165 GLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG---KILDVIGLP 238 (326)
T ss_dssp CSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCC
T ss_pred cccccccC---CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---HHHHHcCCC
Confidence 99976432 122334568999999999999999999999999999999999999998654432211 111100000
Q ss_pred chh----------hccC---ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 710 ILD----------DIID---PLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 710 ~~~----------~~~d---~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
... ..+. ..............+.+++.+||+.||.+|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 0000 000011122345567899999999999999999999864
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=332.34 Aligned_cols=253 Identities=25% Similarity=0.379 Sum_probs=194.1
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEec----------
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE---------- 552 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~---------- 552 (817)
..+|...+.||+|+||.||+|+.. ++..||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 456888999999999999999975 6789999998642 3445778999999999999999999998854
Q ss_pred ---CCeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeee
Q 039107 553 ---GNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDF 629 (817)
Q Consensus 553 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DF 629 (817)
....++||||+++++|.+++......+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEeeC
Confidence 35689999999999999999876667889999999999999999999876 999999999999999999999999
Q ss_pred ccCccCCCCCC------------CceeeeeecCcCCCChhhhccC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccc
Q 039107 630 GLSKTGPNMEN------------GHVSTVVKGSFGYLDPEYFKRQ-QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQV 696 (817)
Q Consensus 630 Gla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~ 696 (817)
|+++....... ........||..|+|||.+.+. .++.++||||||+++|||++ |+.... +..
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~--~~~ 235 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM--ERV 235 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHH
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--hHH
Confidence 99986432110 1122345689999999999764 78999999999999999998 332211 111
Q ss_pred hHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 697 SLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 697 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
+....... . ............+..+.+++.+||+.||.+|||+.+++++
T Consensus 236 ---~~~~~~~~-~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 236 ---NILKKLRS-V------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp ---HHHHHHHS-T------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---HHHHhccc-c------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 11111110 0 1112222334455668999999999999999999999975
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=357.07 Aligned_cols=254 Identities=25% Similarity=0.315 Sum_probs=201.4
Q ss_pred hhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCc-------------ccHHHHHHHHHHHhccCccceeeEEE
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSE-------------QGVNEFVTEIEMLSKLRHKHLVSLIG 548 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~l~g 548 (817)
..++|...++||+|+||+||+|... ++..||+|++..... ...+.+.+|+.+|++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3567999999999999999999976 467899998764321 33567899999999999999999999
Q ss_pred EEecCCeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCc---eeE
Q 039107 549 FCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENW---VAK 625 (817)
Q Consensus 549 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~---~~k 625 (817)
++.+....++||||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+|
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEE
Confidence 999999999999999999999988654 46999999999999999999999876 99999999999998775 699
Q ss_pred EeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHh
Q 039107 626 VSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHC 705 (817)
Q Consensus 626 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 705 (817)
|+|||+++..... .......||+.|+|||++. +.++.++|||||||++|||++|++||......+.. ..+.
T Consensus 190 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i~-- 260 (504)
T 3q5i_A 190 IVDFGLSSFFSKD---YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDII---KKVE-- 260 (504)
T ss_dssp ECCCTTCEECCTT---SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHH--
T ss_pred EEECCCCEEcCCC---CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHH--
Confidence 9999999864332 2233456999999999987 56899999999999999999999999865433211 1111
Q ss_pred hccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 706 KRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 706 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
.+... .+..... ..+..+.+++.+||+.||.+|||+.+++++-.
T Consensus 261 --~~~~~--~~~~~~~----~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 304 (504)
T 3q5i_A 261 --KGKYY--FDFNDWK----NISDEAKELIKLMLTYDYNKRCTAEEALNSRW 304 (504)
T ss_dssp --HCCCC--CCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred --cCCCC--CCccccC----CCCHHHHHHHHHHcCCChhHCCCHHHHhcCHh
Confidence 11000 0000001 23456799999999999999999999997644
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=350.08 Aligned_cols=261 Identities=26% Similarity=0.273 Sum_probs=194.2
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecC------CeEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEG------NEMC 557 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~ 557 (817)
.+|...++||+|+||.||+|+.. ++..||||++..... .+.+|+++|++++||||+++++++... ..++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 35888899999999999999985 578999999864422 234799999999999999999988432 2367
Q ss_pred EEEEeccCCchhhhhhc---cccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCC-ceeEEeeeccCc
Q 039107 558 LVYDYMALGTLREHIYN---TKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDEN-WVAKVSDFGLSK 633 (817)
Q Consensus 558 lV~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DFGla~ 633 (817)
+||||+++ +|.+.+.. ....+++..++.++.||++||+|||+.+ |+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999985 56555532 3457999999999999999999999765 9999999999999955 678999999998
Q ss_pred cCCCCCCCceeeeeecCcCCCChhhhccC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhc-----
Q 039107 634 TGPNMENGHVSTVVKGSFGYLDPEYFKRQ-QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKR----- 707 (817)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~----- 707 (817)
...... ......||+.|+|||++.+. .++.++|||||||+||||++|++||.+....++. .........
T Consensus 206 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l--~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 206 QLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL--VEIIKVLGTPTREQ 280 (420)
T ss_dssp ECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCSCCHHH
T ss_pred hcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhCCCCHHH
Confidence 643322 22345689999999998764 7999999999999999999999999876543322 111111000
Q ss_pred ----cCchhhccCccccC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 708 ----KGILDDIIDPLLKD-----KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 708 ----~~~~~~~~d~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
.....+...+.+.. .+.......+.+|+.+||+.||.+|||+.|+++|-..
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f 340 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 340 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhh
Confidence 00000000011100 0122334678999999999999999999999987543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=338.41 Aligned_cols=266 Identities=23% Similarity=0.343 Sum_probs=196.8
Q ss_pred hcCCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEe-----------
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCE----------- 551 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~----------- 551 (817)
..+|...+.||+|+||.||+|.... +..||+|++........+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 3578889999999999999999764 7899999988776666788999999999999999999999873
Q ss_pred ---cCCeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEc-CCceeEEe
Q 039107 552 ---EGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLD-ENWVAKVS 627 (817)
Q Consensus 552 ---~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~-~~~~~kl~ 627 (817)
+....++||||++ |+|.+++.. ..+++..++.++.|++.||+|||+++ |+||||||+|||++ +++.+||+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEc
Confidence 4467899999998 699998853 46899999999999999999999876 99999999999997 56799999
Q ss_pred eeccCccCCCCCC-CceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHh
Q 039107 628 DFGLSKTGPNMEN-GHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHC 705 (817)
Q Consensus 628 DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 705 (817)
|||+++....... ........+|..|+|||.+.. ..++.++||||||+++|||++|+.||......+..... ...
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~---~~~ 240 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI---LES 240 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHH
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHh
Confidence 9999986432111 112233457899999998865 68899999999999999999999999866433221110 000
Q ss_pred hcc----------CchhhccCcccc-C-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 706 KRK----------GILDDIIDPLLK-D-----KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 706 ~~~----------~~~~~~~d~~l~-~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
... ..+...+..... . ......+..+.+++.+||+.||.+|||+.+++++--.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 309 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHH
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccc
Confidence 000 000000000000 0 0011235668999999999999999999999987544
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=346.05 Aligned_cols=266 Identities=23% Similarity=0.288 Sum_probs=183.1
Q ss_pred CCc-ceeEeeeCceEEEEEEEe---cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEe--cCCeEEEEE
Q 039107 487 FDE-SYVIGVGGFGKVYKGVIE---DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCE--EGNEMCLVY 560 (817)
Q Consensus 487 f~~-~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~lV~ 560 (817)
|.. .++||+|+||+||+|+.+ ++..||||++..... ...+.+|+.+|++++||||+++++++. .....++||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 443 458999999999999976 457899999875432 357889999999999999999999994 467899999
Q ss_pred EeccCCchhhhhhccc--------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEE----cCCceeEEee
Q 039107 561 DYMALGTLREHIYNTK--------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILL----DENWVAKVSD 628 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~--------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll----~~~~~~kl~D 628 (817)
||++ ++|.+++.... ..+++..++.|+.||+.||+|||+.+ |+||||||+|||| +.++.+||+|
T Consensus 100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9997 57877775322 14899999999999999999999876 9999999999999 7789999999
Q ss_pred eccCccCCCCCC-CceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCcccc------chHHH
Q 039107 629 FGLSKTGPNMEN-GHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQ------VSLAD 700 (817)
Q Consensus 629 FGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~------~~l~~ 700 (817)
||+++....... ........||+.|+|||++.+ ..++.++|||||||+||||++|++||........ .....
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 999986533211 122344678999999999987 4589999999999999999999999976543210 00000
Q ss_pred HHHHhhccC---chhhc------------cCccccCCC---------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 701 WALHCKRKG---ILDDI------------IDPLLKDKI---------SPECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 701 ~~~~~~~~~---~~~~~------------~d~~l~~~~---------~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
.+....... ....+ +........ .......+.+|+.+||+.||.+|||++|+++|-
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp 335 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 335 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 000000000 00000 000000000 001134578999999999999999999999875
Q ss_pred HH
Q 039107 757 EF 758 (817)
Q Consensus 757 ~~ 758 (817)
-.
T Consensus 336 ~f 337 (405)
T 3rgf_A 336 YF 337 (405)
T ss_dssp GG
T ss_pred hh
Confidence 54
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=370.33 Aligned_cols=249 Identities=22% Similarity=0.295 Sum_probs=205.3
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEMCL 558 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 558 (817)
..+|...++||+|+||+||+|+.+ ++..||||+++.. .....+.+..|..+|..+ +||+|+++++++.+.+.++|
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 457899999999999999999976 4678999998643 233456788999999988 79999999999999999999
Q ss_pred EEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCC
Q 039107 559 VYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNM 638 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 638 (817)
||||+++|+|.+++... ..+++.+++.++.||+.||+|||+.+ ||||||||+||||+.++.+||+|||+++.....
T Consensus 420 V~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred EEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 99999999999999754 45999999999999999999999876 999999999999999999999999999853222
Q ss_pred CCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcc
Q 039107 639 ENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPL 718 (817)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (817)
........||+.|+|||++.+..++.++|||||||+||||++|++||......+.. ... +...
T Consensus 496 --~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~------~~i---------~~~~ 558 (674)
T 3pfq_A 496 --GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF------QSI---------MEHN 558 (674)
T ss_dssp --TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHH---------HSSC
T ss_pred --CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHH------HHH---------HhCC
Confidence 22344567999999999999999999999999999999999999999765432211 111 1111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 039107 719 LKDKISPECLKKFADTAEKCLSDSGIDRPSM-----GDVLWN 755 (817)
Q Consensus 719 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~~ 755 (817)
..++.....++.+|+.+||+.||.+||++ +||++|
T Consensus 559 --~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 559 --VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred --CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 11223345668999999999999999997 777655
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=343.16 Aligned_cols=260 Identities=22% Similarity=0.376 Sum_probs=201.6
Q ss_pred hhcCCCcceeEeeeCceEEEEEEEecccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
..++|...++||+|+||.||+|..++ .+|+|.+... .....+.|.+|+.++++++||||+++++++......++||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 45678889999999999999998765 4999987654 2333466888999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC-
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME- 639 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~- 639 (817)
||+++++|.+++......+++.+++.++.|++.||+|||+++ |+||||||+|||++ ++.+||+|||+++......
T Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA 184 (319)
T ss_dssp BCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred ecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence 999999999999876667999999999999999999999876 99999999999998 6799999999987542211
Q ss_pred --CCceeeeeecCcCCCChhhhcc---------CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhcc
Q 039107 640 --NGHVSTVVKGSFGYLDPEYFKR---------QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRK 708 (817)
Q Consensus 640 --~~~~~~~~~gt~~y~aPE~~~~---------~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 708 (817)
.........|++.|+|||.+.. ..++.++||||||+++|||++|+.||........ .... ..
T Consensus 185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~-~~ 257 (319)
T 2y4i_B 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI------IWQM-GT 257 (319)
T ss_dssp ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH------HHHH-HT
T ss_pred cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHh-cc
Confidence 1122234468999999999874 4578999999999999999999999975433211 1111 11
Q ss_pred CchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 039107 709 GILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLV 763 (817)
Q Consensus 709 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 763 (817)
+. .+... ...++..+.+++.+||+.||.+|||+.+++++|+.+....
T Consensus 258 ~~-----~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 258 GM-----KPNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp TC-----CCCCC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred CC-----CCCCC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 10 11111 1123345789999999999999999999999999887654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=347.07 Aligned_cols=260 Identities=23% Similarity=0.322 Sum_probs=185.4
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecC------C
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEG------N 554 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 554 (817)
..+|...+.||+|+||.||+|... ++..||||++... .....+.+.+|+++|++++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 467889999999999999999864 5788999998653 233456788999999999999999999998654 5
Q ss_pred eEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 555 EMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 555 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
..++|+|++ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH 181 (367)
T ss_dssp CCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC------
T ss_pred eEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccccc
Confidence 679999999 6899998854 46999999999999999999999876 99999999999999999999999999986
Q ss_pred CCCCCCCceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCc---
Q 039107 635 GPNMENGHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGI--- 710 (817)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--- 710 (817)
... ......||..|+|||++.+ ..++.++|||||||+++||++|++||.+....++.... ........
T Consensus 182 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i---~~~~g~p~~~~ 253 (367)
T 2fst_X 182 TAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI---LRLVGTPGAEL 253 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCSCCHHH
T ss_pred ccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHhCCCCHHH
Confidence 322 1234578999999999876 68899999999999999999999999876543322211 11000000
Q ss_pred h--------hhccCccc-cCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 711 L--------DDIIDPLL-KDKI-----SPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 711 ~--------~~~~d~~l-~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
+ ...+.... .... .......+.+|+.+||..||.+|||+.+++++--
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~ 314 (367)
T 2fst_X 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314 (367)
T ss_dssp HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChh
Confidence 0 00000000 0000 0122456789999999999999999999997643
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=337.84 Aligned_cols=264 Identities=22% Similarity=0.312 Sum_probs=199.6
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecC-----CeE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEG-----NEM 556 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 556 (817)
..+|...+.||+|+||.||+|... ++..||||++.... ......+.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467888999999999999999976 57889999987543 33456788999999999999999999998654 678
Q ss_pred EEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCC
Q 039107 557 CLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGP 636 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 636 (817)
++||||++ ++|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 90 ~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp EEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 99999997 689988854 46999999999999999999999876 9999999999999999999999999998643
Q ss_pred CCCCCc--------eeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhc
Q 039107 637 NMENGH--------VSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKR 707 (817)
Q Consensus 637 ~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 707 (817)
...... ......||+.|+|||++.. ..++.++|||||||++|||++|++||......+..... .....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~ 240 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI---FGIIG 240 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH---HHHhC
Confidence 221110 1223468999999998764 78899999999999999999999999865433221110 00000
Q ss_pred cCc----h--------hhccCc--ccc----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 708 KGI----L--------DDIIDP--LLK----DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 708 ~~~----~--------~~~~d~--~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
... . .+.+.. ... ....+..+..+.+++.+||+.||.+|||+.+++++-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 307 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHP 307 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 000 0 000000 000 000113345678999999999999999999998753
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=338.29 Aligned_cols=203 Identities=26% Similarity=0.323 Sum_probs=172.6
Q ss_pred hhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccC-cc-----ceeeEEEEEecCCe
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLR-HK-----HLVSLIGFCEEGNE 555 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~g~~~~~~~ 555 (817)
..++|...++||+|+||+||+|... ++..||||++... .....++..|+++++.++ |+ +|+++++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 4568999999999999999999875 5678999998743 334567788999988885 44 49999999999999
Q ss_pred EEEEEEeccCCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEc--CCceeEEeeeccC
Q 039107 556 MCLVYDYMALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLD--ENWVAKVSDFGLS 632 (817)
Q Consensus 556 ~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~--~~~~~kl~DFGla 632 (817)
.++||||++ ++|.+++.... ..+++..+..++.|++.||.|||++ +.+|+||||||+||||+ .++.+||+|||++
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred eEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 999999997 59999987654 4699999999999999999999963 34699999999999994 5788999999999
Q ss_pred ccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCcc
Q 039107 633 KTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPK 693 (817)
Q Consensus 633 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~ 693 (817)
+..... .....||+.|+|||++.+..++.++|||||||++|||++|++||......
T Consensus 209 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~ 264 (382)
T 2vx3_A 209 CQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV 264 (382)
T ss_dssp EETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred eecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 864321 23456899999999999999999999999999999999999999876543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=340.17 Aligned_cols=272 Identities=21% Similarity=0.203 Sum_probs=190.7
Q ss_pred HHHHHhhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCe-
Q 039107 478 AEIKHATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNE- 555 (817)
Q Consensus 478 ~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~- 555 (817)
.+.....++|...++||+|+||.||+|+.. ++..||||++.... .....+.+|++.++.++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 344566678999999999999999999975 57899999876443 233567788899999999999999999865333
Q ss_pred ------EEEEEEeccCCchhhhhh---ccccccchHhHHHHHHHHHHHHHHHH--hCCCCceEecCCccCcEEEcC-Cce
Q 039107 556 ------MCLVYDYMALGTLREHIY---NTKKALSWKQRLEICIGAARGLHYLH--TGAKYTIIHRDVKTTNILLDE-NWV 623 (817)
Q Consensus 556 ------~~lV~Ey~~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~ivH~Dikp~NIll~~-~~~ 623 (817)
.++||||+++ +|.+.+. .....+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCc
Confidence 7899999986 4444333 23346889999999999999999999 655 999999999999997 899
Q ss_pred eEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHH--
Q 039107 624 AKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQ-QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLAD-- 700 (817)
Q Consensus 624 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~-- 700 (817)
+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.............
T Consensus 171 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~ 247 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV 247 (360)
T ss_dssp EEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHH
Confidence 9999999998643322 22345689999999998654 48999999999999999999999998765433221110
Q ss_pred -------HHHHhhccCchhhccC------ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 701 -------WALHCKRKGILDDIID------PLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 701 -------~~~~~~~~~~~~~~~d------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
+..............+ ..............+.+|+.+||+.||.+|||+.|+++|--
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 317 (360)
T 3e3p_A 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPY 317 (360)
T ss_dssp HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGG
T ss_pred cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcc
Confidence 0000000000000000 00001112234677999999999999999999999997643
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=341.20 Aligned_cols=259 Identities=21% Similarity=0.294 Sum_probs=197.3
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC--cccHHHHHHHHHHHhccCccceeeEEEEEecCCeE----
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEM---- 556 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~---- 556 (817)
.++|...+.||+|+||.||+|... ++..||||++.... ....+.+.+|+.++++++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 467888999999999999999865 57899999987542 33357788999999999999999999999876654
Q ss_pred --EEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 557 --CLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 557 --~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
++||||+. ++|.+++. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 121 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred eEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 99999998 68888773 34999999999999999999999876 99999999999999999999999999975
Q ss_pred CCCCCCCceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCc---
Q 039107 635 GPNMENGHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGI--- 710 (817)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--- 710 (817)
... ......||+.|+|||++.+ ..++.++|||||||+++||++|+.||......+..... . .......
T Consensus 194 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i--~-~~~~~~~~~~ 265 (371)
T 4exu_A 194 ADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI--L-KVTGVPGTEF 265 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--H-HHHCCCCHHH
T ss_pred ccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--H-HHhCCCcHHH
Confidence 322 1234568999999999887 78999999999999999999999999765433221110 0 0000000
Q ss_pred --------hhhcc---CccccC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 711 --------LDDII---DPLLKD---KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 711 --------~~~~~---d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
..... ...... ...+.....+.+|+.+||+.||.+|||+.+++++--
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 326 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 326 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcc
Confidence 00000 000000 001123467899999999999999999999997643
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=335.54 Aligned_cols=261 Identities=21% Similarity=0.310 Sum_probs=197.6
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC--cccHHHHHHHHHHHhccCccceeeEEEEEecCCe-----
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNE----- 555 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 555 (817)
.++|...+.||+|+||.||+|... ++..||||++.... ....+.+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 357888899999999999999975 57899999986542 3335678899999999999999999999977654
Q ss_pred -EEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 556 -MCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 556 -~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
.++||||++ ++|.+++. ..+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.
T Consensus 103 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred eEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccC
Confidence 499999998 68888774 24899999999999999999999876 99999999999999999999999999976
Q ss_pred CCCCCCCceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHH---------HHHHH
Q 039107 635 GPNMENGHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLA---------DWALH 704 (817)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~---------~~~~~ 704 (817)
... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+..... +|...
T Consensus 176 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 176 ADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp -------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred CCC-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 322 1234568999999999877 68899999999999999999999999765433221110 00000
Q ss_pred hhcc---Cchhhc---cCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 705 CKRK---GILDDI---IDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 705 ~~~~---~~~~~~---~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
.... ..+..+ ..+.+ ..........+.+++.+||+.||.+|||+.+++++--
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 308 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 308 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred HhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 0000 000000 00000 1112234567899999999999999999999987643
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=331.77 Aligned_cols=257 Identities=23% Similarity=0.326 Sum_probs=180.4
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC-cccHHHHHHHHH-HHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS-EQGVNEFVTEIE-MLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
++|...+.||+|+||.||+|... ++..||||++.... .....++..|+. +++.++||||+++++++...+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 56888889999999999999975 57889999987543 233455666666 6777899999999999999999999999
Q ss_pred eccCCchhhhhhc----cccccchHhHHHHHHHHHHHHHHHHhC-CCCceEecCCccCcEEEcCCceeEEeeeccCccCC
Q 039107 562 YMALGTLREHIYN----TKKALSWKQRLEICIGAARGLHYLHTG-AKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGP 636 (817)
Q Consensus 562 y~~~gsL~~~l~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 636 (817)
|+++ +|.+++.. ....+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 9985 78777653 234789999999999999999999986 5 9999999999999999999999999997643
Q ss_pred CCCCCceeeeeecCcCCCChhhh----ccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchh
Q 039107 637 NMENGHVSTVVKGSFGYLDPEYF----KRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILD 712 (817)
Q Consensus 637 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 712 (817)
.. .......||..|+|||.+ .+..++.++||||||+++|||++|+.||........ ...... .+
T Consensus 178 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~-~~--- 245 (327)
T 3aln_A 178 DS---IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QLTQVV-KG--- 245 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCC-CS---
T ss_pred cc---cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HHHHHh-cC---
Confidence 22 122334689999999998 466789999999999999999999999975422110 000000 00
Q ss_pred hccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 713 DIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 713 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
..+.+.......+...+.+++.+||+.||.+||++.+++++-...
T Consensus 246 --~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~ 290 (327)
T 3aln_A 246 --DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFIL 290 (327)
T ss_dssp --CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred --CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHH
Confidence 001111111123455689999999999999999999999865443
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=332.24 Aligned_cols=263 Identities=20% Similarity=0.273 Sum_probs=201.0
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cc-cEEEEEecCCCCcccHHHHHHHHHHHhccCccc------eeeEEEEEecCCe
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DK-LKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKH------LVSLIGFCEEGNE 555 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~~ 555 (817)
.++|...+.||+|+||+||+|... .+ ..||+|++... ....+.+.+|+.++++++|++ ++.+++++.....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 357888999999999999999864 33 68999998754 334567889999999998776 9999999999999
Q ss_pred EEEEEEeccCCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEE----------------
Q 039107 556 MCLVYDYMALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILL---------------- 618 (817)
Q Consensus 556 ~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll---------------- 618 (817)
.++||||+ +++|.+++.... ..+++.+++.++.||+.||+|||+++ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccccc
Confidence 99999999 456666665443 47999999999999999999999765 9999999999999
Q ss_pred ---cCCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCcccc
Q 039107 619 ---DENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQ 695 (817)
Q Consensus 619 ---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~ 695 (817)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 56789999999999863221 2345689999999999999999999999999999999999999986554332
Q ss_pred chHHHHHHH--------hhccCc------------------hhhccCcc-ccCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 039107 696 VSLADWALH--------CKRKGI------------------LDDIIDPL-LKDKISPECLKKFADTAEKCLSDSGIDRPS 748 (817)
Q Consensus 696 ~~l~~~~~~--------~~~~~~------------------~~~~~d~~-l~~~~~~~~~~~l~~li~~cl~~dP~~RPt 748 (817)
......... ...... ..+...+. ............+.+|+.+||+.||.+|||
T Consensus 248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 327 (355)
T 2eu9_A 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT 327 (355)
T ss_dssp HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence 211111000 000000 00000000 000112345668999999999999999999
Q ss_pred HHHHHHHH
Q 039107 749 MGDVLWNL 756 (817)
Q Consensus 749 ~~evl~~L 756 (817)
+.+++++-
T Consensus 328 ~~e~l~hp 335 (355)
T 2eu9_A 328 LAEALLHP 335 (355)
T ss_dssp HHHHTTSG
T ss_pred HHHHhcCh
Confidence 99998763
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=334.25 Aligned_cols=263 Identities=20% Similarity=0.244 Sum_probs=199.2
Q ss_pred cCCCcceeEeeeCceEEEEEEE-ecccEEEEEecCCCCcccHHHHHHHHHHHhccC-----------ccceeeEEEEEec
Q 039107 485 KSFDESYVIGVGGFGKVYKGVI-EDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLR-----------HKHLVSLIGFCEE 552 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~~ 552 (817)
.+|...+.||+|+||+||+|+. .++..||||++... ....+.+.+|+.++++++ |+||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 5688899999999999999996 46788999998743 334567889999999886 8999999999875
Q ss_pred CC----eEEEEEEeccCCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhC-CCCceEecCCccCcEEEc------C
Q 039107 553 GN----EMCLVYDYMALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTG-AKYTIIHRDVKTTNILLD------E 620 (817)
Q Consensus 553 ~~----~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dikp~NIll~------~ 620 (817)
.. ..++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++ + |+||||||+|||++ .
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCcC
Confidence 44 789999999 889999987643 3699999999999999999999986 5 99999999999994 4
Q ss_pred CceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccc----
Q 039107 621 NWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQV---- 696 (817)
Q Consensus 621 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~---- 696 (817)
.+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 174 ~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 248 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248 (373)
T ss_dssp EEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred cceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence 558999999999764321 22346899999999999999999999999999999999999999765422111
Q ss_pred hHHHHHHHhh------------------ccCchhhccCc---------cccCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 039107 697 SLADWALHCK------------------RKGILDDIIDP---------LLKDKISPECLKKFADTAEKCLSDSGIDRPSM 749 (817)
Q Consensus 697 ~l~~~~~~~~------------------~~~~~~~~~d~---------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 749 (817)
.+........ ..+....+... .....++......+.+|+.+||+.||.+|||+
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 328 (373)
T 1q8y_A 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 328 (373)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence 1111100000 00000000000 00113456778899999999999999999999
Q ss_pred HHHHHHHH
Q 039107 750 GDVLWNLE 757 (817)
Q Consensus 750 ~evl~~L~ 757 (817)
.|++++-.
T Consensus 329 ~ell~hp~ 336 (373)
T 1q8y_A 329 GGLVNHPW 336 (373)
T ss_dssp HHHHTCGG
T ss_pred HHHhhChh
Confidence 99987643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=325.97 Aligned_cols=253 Identities=25% Similarity=0.336 Sum_probs=201.6
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
.++|...++||+|+||.||+|+.. ++..||+|++... .....+.+.+|++++++++||||+++++++......++|+
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 457889999999999999999976 5788999997543 2345678999999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCC---ceeEEeeeccCccCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDEN---WVAKVSDFGLSKTGPN 637 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~---~~~kl~DFGla~~~~~ 637 (817)
||+++++|.+++... ..+++.+++.++.|++.||+|||+.+ |+||||||+||+++.+ +.+||+|||++.....
T Consensus 101 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 101 ELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred EccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 999999999988654 36999999999999999999999876 9999999999999754 4799999999976432
Q ss_pred CCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCc
Q 039107 638 MENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717 (817)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (817)
.. ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||......+ +...+. .+... .+.
T Consensus 177 ~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~----~~~~~--~~~ 243 (287)
T 2wei_A 177 NT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD---ILKRVE----TGKYA--FDL 243 (287)
T ss_dssp CS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH----HCCCC--CCS
T ss_pred CC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH---HHHHHH----cCCCC--CCc
Confidence 21 1223458899999999875 58999999999999999999999997653321 111111 11100 000
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 718 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
... ...+..+.+++.+||+.||.+|||+.+++++-.
T Consensus 244 ~~~----~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~ 279 (287)
T 2wei_A 244 PQW----RTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279 (287)
T ss_dssp GGG----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred hhh----hhcCHHHHHHHHHHcccChhhCcCHHHHhcCHH
Confidence 000 123456789999999999999999999998643
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=341.32 Aligned_cols=251 Identities=21% Similarity=0.253 Sum_probs=188.2
Q ss_pred CCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeEEEEEEecc
Q 039107 486 SFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEMCLVYDYMA 564 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~ 564 (817)
.|...++||+|+||+||.+...+++.||||++... ..+.+.+|+.+|+++ +||||+++++++......++||||++
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 34456789999999998776667889999998643 245678999999987 89999999999999999999999996
Q ss_pred CCchhhhhhcccc------ccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCC-------------ceeE
Q 039107 565 LGTLREHIYNTKK------ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDEN-------------WVAK 625 (817)
Q Consensus 565 ~gsL~~~l~~~~~------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~-------------~~~k 625 (817)
|+|.+++..... ..++..++.++.||+.||+|||+++ |+||||||+|||++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 699999975432 1244567889999999999999876 9999999999999754 4899
Q ss_pred EeeeccCccCCCCCCC--ceeeeeecCcCCCChhhhcc-------CCCCchHHHHHHHHHHHHHHh-CCCCCCCCCcccc
Q 039107 626 VSDFGLSKTGPNMENG--HVSTVVKGSFGYLDPEYFKR-------QQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQ 695 (817)
Q Consensus 626 l~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~ 695 (817)
|+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.......
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~- 247 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE- 247 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence 9999999865432211 11234579999999999975 678999999999999999999 899986543221
Q ss_pred chHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 696 VSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 696 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
. ..... .... +..........+..+.+++.+||+.||.+|||+.+|+++
T Consensus 248 ~---~i~~~---~~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 248 S---NIIRG---IFSL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp H---HHHHT---CCCC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred H---HHhcC---CCCc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 1 11110 0000 111112245677889999999999999999999999964
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=330.82 Aligned_cols=255 Identities=21% Similarity=0.289 Sum_probs=174.3
Q ss_pred hcCCCcc-eeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHH-HHHhccCccceeeEEEEEec----CCeE
Q 039107 484 TKSFDES-YVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEI-EMLSKLRHKHLVSLIGFCEE----GNEM 556 (817)
Q Consensus 484 ~~~f~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~-~~l~~l~H~niv~l~g~~~~----~~~~ 556 (817)
.++|... ++||+|+||+||+|... +++.||||++.... ...+|+ ..++.++||||+++++++.. ....
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 4567774 47999999999999976 57899999986431 222333 34566799999999999865 4558
Q ss_pred EEEEEeccCCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcC---CceeEEeeeccC
Q 039107 557 CLVYDYMALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDE---NWVAKVSDFGLS 632 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DFGla 632 (817)
++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||++
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 99999999999999997654 36999999999999999999999876 999999999999976 456999999999
Q ss_pred ccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchh
Q 039107 633 KTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILD 712 (817)
Q Consensus 633 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 712 (817)
+.... .......||+.|+|||++....++.++||||||+++|||++|+.||........... ........
T Consensus 179 ~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~--- 248 (336)
T 3fhr_A 179 KETTQ----NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG---MKRRIRLG--- 248 (336)
T ss_dssp EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred eeccc----cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh---HHHhhhcc---
Confidence 76432 122345689999999999888899999999999999999999999975543221100 00000000
Q ss_pred hccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 713 DIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 713 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
...........++..+.+++.+||+.||.+|||+.+++++-...
T Consensus 249 ---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 292 (336)
T 3fhr_A 249 ---QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWIN 292 (336)
T ss_dssp -----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred ---ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence 00011111123455689999999999999999999999876543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=329.48 Aligned_cols=245 Identities=22% Similarity=0.361 Sum_probs=191.0
Q ss_pred HHhhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcc------cHHHHHHHHHHHhcc----CccceeeEEEE
Q 039107 481 KHATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQ------GVNEFVTEIEMLSKL----RHKHLVSLIGF 549 (817)
Q Consensus 481 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~H~niv~l~g~ 549 (817)
....++|...+.||+|+||.||+|... ++..||||++...... ....+.+|+.++.++ +|+||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 344578999999999999999999864 5688999998754321 223456799999998 89999999999
Q ss_pred EecCCeEEEEEEe-ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEc-CCceeEEe
Q 039107 550 CEEGNEMCLVYDY-MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLD-ENWVAKVS 627 (817)
Q Consensus 550 ~~~~~~~~lV~Ey-~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~-~~~~~kl~ 627 (817)
+...+..++|+|+ +.+++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++ +++.+||+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~ 182 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLI 182 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEE
Confidence 9999999999999 7899999998653 35999999999999999999999876 99999999999999 88999999
Q ss_pred eeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCC-chHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhh
Q 039107 628 DFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLT-EKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCK 706 (817)
Q Consensus 628 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 706 (817)
|||+++..... ......|+..|+|||++.+..+. .++||||||+++|||++|+.||..... ..
T Consensus 183 dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~---- 246 (312)
T 2iwi_A 183 DFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE--------IL---- 246 (312)
T ss_dssp CCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------HH----
T ss_pred EcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH--------Hh----
Confidence 99999864322 22345689999999999877664 589999999999999999999864210 00
Q ss_pred ccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 707 RKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 707 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
. . . ..++......+.+++.+||+.||++|||+.+++++-
T Consensus 247 ~-~------~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~ 285 (312)
T 2iwi_A 247 E-A------E----LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDP 285 (312)
T ss_dssp H-T------C----CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHST
T ss_pred h-h------c----cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 0 0 0 011223345678999999999999999999999753
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=339.73 Aligned_cols=251 Identities=25% Similarity=0.276 Sum_probs=190.7
Q ss_pred hcCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeEEEEEEe
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
..+|...++||+|+||+||.....+++.||||++..... ..+.+|+++|+++ +||||+++++++.+....++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 456888899999999997655556778999999875433 2356899999999 799999999999999999999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcC-----CceeEEeeeccCccCCC
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDE-----NWVAKVSDFGLSKTGPN 637 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~-----~~~~kl~DFGla~~~~~ 637 (817)
++ |+|.+++......+.+..++.++.||+.||+|||+.+ |+||||||+||||+. ...+||+|||+++....
T Consensus 100 ~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 100 CA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp CS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred CC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 97 6999999776666777788899999999999999876 999999999999953 34688999999986533
Q ss_pred CCC-CceeeeeecCcCCCChhhhc---cCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchh
Q 039107 638 MEN-GHVSTVVKGSFGYLDPEYFK---RQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILD 712 (817)
Q Consensus 638 ~~~-~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 712 (817)
... ........||+.|+|||++. ...++.++|||||||++|||++ |+.||........ .........
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-------~~~~~~~~~- 247 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-------NILLGACSL- 247 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-------HHHTTCCCC-
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-------HHHhccCCc-
Confidence 211 12234467999999999997 4677889999999999999999 8888854322110 000111000
Q ss_pred hccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 713 DIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 713 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
. .. .........+.+|+.+||+.||.+|||+.+|++|
T Consensus 248 ~----~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 248 D----CL--HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp T----TS--CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred c----cc--CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 0 00 0122445668899999999999999999999954
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=327.12 Aligned_cols=255 Identities=20% Similarity=0.277 Sum_probs=181.2
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCc-cc-HHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSE-QG-VNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
.++|...+.||+|+||.||+|... ++..||||++..... .. .+.+.++..+++.++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 356888899999999999999975 578999999875432 22 233445556788889999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
||+ ++.+..++......+++..+..++.|++.||+|||++ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD-- 178 (318)
T ss_dssp CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhh--CCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC--
Confidence 999 4556555544455799999999999999999999974 13999999999999999999999999999754321
Q ss_pred CceeeeeecCcCCCChhhhc-----cCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhcc
Q 039107 641 GHVSTVVKGSFGYLDPEYFK-----RQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDII 715 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (817)
.......||+.|+|||.+. ...++.++||||||+++|||++|+.||....... .. ........
T Consensus 179 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~---~~~~~~~~------ 246 (318)
T 2dyl_A 179 -KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF--EV---LTKVLQEE------ 246 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH--HH---HHHHHHSC------
T ss_pred -ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH--HH---HHHHhccC------
Confidence 2223456899999999984 5678999999999999999999999997533211 11 11111110
Q ss_pred CccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 716 DPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 716 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
.+.+.. ...++..+.+++.+||+.||.+||++.+++++--
T Consensus 247 ~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (318)
T 2dyl_A 247 PPLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSF 286 (318)
T ss_dssp CCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred CCCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHH
Confidence 011111 1123456789999999999999999999997643
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=332.75 Aligned_cols=247 Identities=22% Similarity=0.378 Sum_probs=198.3
Q ss_pred HHHHhhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcc------cHHHHHHHHHHHhccC--ccceeeEEEE
Q 039107 479 EIKHATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQ------GVNEFVTEIEMLSKLR--HKHLVSLIGF 549 (817)
Q Consensus 479 el~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--H~niv~l~g~ 549 (817)
+......+|...++||+|+||.||+|+.. ++..||||++...... ..+.+.+|+.++++++ |+||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 33445678999999999999999999864 5688999997643211 2245678999999996 5999999999
Q ss_pred EecCCeEEEEEEeccC-CchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEc-CCceeEEe
Q 039107 550 CEEGNEMCLVYDYMAL-GTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLD-ENWVAKVS 627 (817)
Q Consensus 550 ~~~~~~~~lV~Ey~~~-gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~-~~~~~kl~ 627 (817)
+...+..++|+|++.+ ++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++ +++.+||+
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence 9999999999999986 8999998653 46899999999999999999999876 99999999999999 78999999
Q ss_pred eeccCccCCCCCCCceeeeeecCcCCCChhhhccCCC-CchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhh
Q 039107 628 DFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQL-TEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCK 706 (817)
Q Consensus 628 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 706 (817)
|||+++..... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||..... ..
T Consensus 193 Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--------~~---- 256 (320)
T 3a99_A 193 DFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------II---- 256 (320)
T ss_dssp CCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------HH----
T ss_pred eCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh--------hh----
Confidence 99999864322 2234568999999999987766 6889999999999999999999864210 00
Q ss_pred ccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 707 RKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 707 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
. .. ..... ..+..+.+++.+||+.||.+|||+.+|+++-
T Consensus 257 ~-~~------~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp 295 (320)
T 3a99_A 257 R-GQ------VFFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQNHP 295 (320)
T ss_dssp H-CC------CCCSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred c-cc------ccccc----cCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 0 00 00111 2345678999999999999999999998753
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=350.54 Aligned_cols=242 Identities=20% Similarity=0.293 Sum_probs=194.5
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe--cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCe-----
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE--DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNE----- 555 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 555 (817)
.++|...++||+|+||+||+|... +++.||||++.... ....+.|.+|++++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 367899999999999999999975 47889999986543 3445678999999999999999999999987655
Q ss_pred EEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccC
Q 039107 556 MCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTG 635 (817)
Q Consensus 556 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 635 (817)
.+|||||+++++|.+++.. .+++.+++.|+.||+.||.|||+++ ||||||||+|||++++ .+||+|||+++..
T Consensus 159 ~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred eEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhc
Confidence 7999999999999987743 6999999999999999999999876 9999999999999986 9999999999864
Q ss_pred CCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhcc
Q 039107 636 PNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDII 715 (817)
Q Consensus 636 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (817)
... ....||+.|+|||++.++. +.++|||||||+|+||++|.+|+....... +.
T Consensus 232 ~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-------------------~~ 285 (681)
T 2pzi_A 232 NSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG-------------------LP 285 (681)
T ss_dssp TCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-------------------CC
T ss_pred ccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-------------------cc
Confidence 332 3456999999999987654 899999999999999999988875421100 00
Q ss_pred CccccCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHHHHhHhh
Q 039107 716 DPLLKDKISPECLKKFADTAEKCLSDSGIDRPS-MGDVLWNLEFVLQL 762 (817)
Q Consensus 716 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~~L~~~~~~ 762 (817)
...........+.+++.+||+.||.+||+ ++++...|..++..
T Consensus 286 ----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 329 (681)
T 2pzi_A 286 ----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE 329 (681)
T ss_dssp ----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred ----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence 00001123456889999999999999996 66677777766543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=311.76 Aligned_cols=234 Identities=12% Similarity=0.108 Sum_probs=184.2
Q ss_pred cCCCcceeEeeeCceEEEEEEEec-ccEEEEEecCCCCc---ccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPSSE---QGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
.+|...+.||+|+||.||+|.... ++.||||.+..... ...+.|.+|+.++++++||||+++++++...+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 568888999999999999999764 78999999876532 33478999999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
||+++++|.+++.. + ....++.+|+.|++.||+|||+++ |+||||||+|||+++++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA---------- 174 (286)
T ss_dssp ECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred EecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc----------
Confidence 99999999999843 2 345568899999999999999876 9999999999999999999997443
Q ss_pred CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
|++ .++.++|||||||++|||++|+.||......+..... .+........ .
T Consensus 175 ------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~-------~~~~~~~~~~---~ 225 (286)
T 3uqc_A 175 ------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-------ERDTAGQPIE---P 225 (286)
T ss_dssp ------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC-------CBCTTSCBCC---H
T ss_pred ------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH-------HHHhccCCCC---h
Confidence 333 3689999999999999999999999876543211000 0000000000 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhc
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVE 764 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 764 (817)
......++..+.+++.+||+.||.+| |+.++++.|+.+.....
T Consensus 226 ~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 226 ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 01112344568999999999999999 99999999999876543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=346.68 Aligned_cols=268 Identities=24% Similarity=0.333 Sum_probs=204.5
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC-CcccHHHHHHHHHHHhccCccceeeEEEEEec------CCeE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS-SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE------GNEM 556 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~~ 556 (817)
.+|...++||+|+||.||+|... ++..||||++... .....+.+.+|++++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 56888999999999999999864 5788999998754 34446779999999999999999999998765 6778
Q ss_pred EEEEEeccCCchhhhhhcccc--ccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCce---eEEeeecc
Q 039107 557 CLVYDYMALGTLREHIYNTKK--ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWV---AKVSDFGL 631 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~---~kl~DFGl 631 (817)
++||||+++|+|.+++..... .+++..++.|+.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence 999999999999999976443 6999999999999999999999876 999999999999996654 99999999
Q ss_pred CccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCch
Q 039107 632 SKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGIL 711 (817)
Q Consensus 632 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 711 (817)
++..... .......||..|+|||.+.+..++.++||||||+++|||++|+.||...... ..|..........
T Consensus 171 a~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 171 AKELDQG---ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKSNE 242 (676)
T ss_dssp CCBTTSC---CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC-----
T ss_pred ccccccc---cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcccch
Confidence 9864332 2234457999999999999999999999999999999999999999754221 1121111110000
Q ss_pred ----hhccC------c--cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHH-----HHHHHHhHhhh
Q 039107 712 ----DDIID------P--LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDV-----LWNLEFVLQLV 763 (817)
Q Consensus 712 ----~~~~d------~--~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev-----l~~L~~~~~~~ 763 (817)
.+... . ..........+..+.+++.+||..||.+|||+.++ .+.++.++...
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 00000 0 01122345577889999999999999999999984 46666665543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-35 Score=326.89 Aligned_cols=242 Identities=16% Similarity=0.160 Sum_probs=182.0
Q ss_pred hhcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCc---ccHHHHHHHHHHHhccCc-cce---------ee---
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSE---QGVNEFVTEIEMLSKLRH-KHL---------VS--- 545 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H-~ni---------v~--- 545 (817)
...+|...++||+|+||+||+|... +++.||||++..... ...+.|.+|+.+++.++| +|. +.
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 3456778889999999999999954 678999999874332 336789999999999977 211 11
Q ss_pred ---------EEEEEec-----CCeEEEEEEeccCCchhhhhh------ccccccchHhHHHHHHHHHHHHHHHHhCCCCc
Q 039107 546 ---------LIGFCEE-----GNEMCLVYDYMALGTLREHIY------NTKKALSWKQRLEICIGAARGLHYLHTGAKYT 605 (817)
Q Consensus 546 ---------l~g~~~~-----~~~~~lV~Ey~~~gsL~~~l~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 605 (817)
++.++.. ....+++|+++ +++|.+++. .....+++..++.|+.||++||+|||+++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 1111111 22356777765 589999884 22447999999999999999999999876
Q ss_pred eEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhh----------ccCCCCchHHHHHHHH
Q 039107 606 IIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYF----------KRQQLTEKSDIYSFGV 675 (817)
Q Consensus 606 ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~~sDV~S~Gv 675 (817)
|+||||||+||||+.++.+||+|||+++.... ......| +.|+|||++ ....++.++|||||||
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv 305 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence 99999999999999999999999999876322 2344567 999999999 5556889999999999
Q ss_pred HHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 676 VLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 676 vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
++|||++|+.||......... ..++.. .. ..+..+.+++.+||+.||.+||++.+++++
T Consensus 306 il~elltg~~Pf~~~~~~~~~---------------~~~~~~--~~----~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 306 AIYWIWCADLPNTDDAALGGS---------------EWIFRS--CK----NIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHHHHSSCCCCTTGGGSCS---------------GGGGSS--CC----CCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHCCCCCCCcchhhhH---------------HHHHhh--cc----cCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 999999999999765332211 111110 01 223568999999999999999999998765
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=307.11 Aligned_cols=230 Identities=22% Similarity=0.346 Sum_probs=179.1
Q ss_pred cCCCcc-eeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHH-hccCccceeeEEEEEec----CCeEE
Q 039107 485 KSFDES-YVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEML-SKLRHKHLVSLIGFCEE----GNEMC 557 (817)
Q Consensus 485 ~~f~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~----~~~~~ 557 (817)
.+|... ++||+|+||.||++... ++..||+|++... ..+.+|++++ +.++||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 345555 68999999999999974 5689999998632 4677899988 55589999999999876 67789
Q ss_pred EEEEeccCCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcC---CceeEEeeeccCc
Q 039107 558 LVYDYMALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDE---NWVAKVSDFGLSK 633 (817)
Q Consensus 558 lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DFGla~ 633 (817)
+||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 9999999999999997654 36999999999999999999999876 999999999999998 7899999999986
Q ss_pred cCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhh
Q 039107 634 TGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDD 713 (817)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 713 (817)
... +..++.++|||||||++|||++|+.||.......... .....
T Consensus 169 ~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-----------~~~~~ 213 (299)
T 3m2w_A 169 ETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-----------GMKTR 213 (299)
T ss_dssp ECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C-----------CSCCS
T ss_pred ccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH-----------HHHHH
Confidence 421 1346789999999999999999999997543321100 00000
Q ss_pred ccCccccCCCC----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 714 IIDPLLKDKIS----PECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 714 ~~d~~l~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
+..... ..+ ..++..+.+++.+||+.||.+|||+.|++++-...
T Consensus 214 ~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~ 261 (299)
T 3m2w_A 214 IRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 261 (299)
T ss_dssp SCTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred Hhhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhc
Confidence 000000 011 12356689999999999999999999999876543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=317.34 Aligned_cols=242 Identities=19% Similarity=0.212 Sum_probs=183.3
Q ss_pred cCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCC--------cccHHHHHHHHHHHhccC---------ccceeeEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSS--------EQGVNEFVTEIEMLSKLR---------HKHLVSLI 547 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------H~niv~l~ 547 (817)
++|...++||+|+||+||+|+. ++..||||++.... ....+.+.+|+.+|++++ ||||+++.
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 4577888999999999999987 56899999976542 233478899999999886 77777777
Q ss_pred EEE-----------------ec-------------CCeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHH
Q 039107 548 GFC-----------------EE-------------GNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHY 597 (817)
Q Consensus 548 g~~-----------------~~-------------~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~y 597 (817)
+.+ .. ....++||||+++|+|.+.+.+ +.+++.+++.|+.||+.||+|
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~~ 176 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLAV 176 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHHH
Confidence 653 22 6789999999999977776633 568999999999999999999
Q ss_pred HH-hCCCCceEecCCccCcEEEcCCc--------------------eeEEeeeccCccCCCCCCCceeeeeecCcCCCCh
Q 039107 598 LH-TGAKYTIIHRDVKTTNILLDENW--------------------VAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDP 656 (817)
Q Consensus 598 LH-~~~~~~ivH~Dikp~NIll~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 656 (817)
|| +.+ |+||||||+||||+.++ .+||+|||+++.... ....||+.|+||
T Consensus 177 lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aP 246 (336)
T 2vuw_A 177 AEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDE 246 (336)
T ss_dssp HHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCS
T ss_pred HHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccCh
Confidence 99 776 99999999999999886 999999999986432 134799999999
Q ss_pred hhhccCCCCchHHHHHHHHH-HHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhh-ccCccccCCCCHHHHHHHHHH
Q 039107 657 EYFKRQQLTEKSDIYSFGVV-LFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDD-IIDPLLKDKISPECLKKFADT 734 (817)
Q Consensus 657 E~~~~~~~s~~sDV~S~Gvv-l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~d~~l~~~~~~~~~~~l~~l 734 (817)
|++.+.. +.++|||||+++ .+++++|..||... .|....... .... ..............+..+.+|
T Consensus 247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---------~~~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~dl 315 (336)
T 2vuw_A 247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV---------LWLHYLTDK-MLKQMTFKTKCNTPAMKQIKRKIQEF 315 (336)
T ss_dssp GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH---------HHHHHHHHH-HHHTCCCSSCCCSHHHHHHHHHHHHH
T ss_pred hhhcCCC-ccceehhhhhCCCCcccccccCCCcch---------hhhhHHHHh-hhhhhccCcccchhhhhhcCHHHHHH
Confidence 9998666 999999998777 77788898887321 121111000 0000 001111111234577889999
Q ss_pred HHHccccCCCCCCCHHHHH-HH
Q 039107 735 AEKCLSDSGIDRPSMGDVL-WN 755 (817)
Q Consensus 735 i~~cl~~dP~~RPt~~evl-~~ 755 (817)
+.+||+.| |++|++ +|
T Consensus 316 i~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 316 HRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHGGGSS-----SHHHHHHHC
T ss_pred HHHHhccC-----CHHHHHhcC
Confidence 99999976 999988 54
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-28 Score=284.03 Aligned_cols=183 Identities=18% Similarity=0.089 Sum_probs=127.3
Q ss_pred EeeeCceEEEEEE-EecccEEEEEecCCCC----------cccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeEEEEE
Q 039107 493 IGVGGFGKVYKGV-IEDKLKVAIKRSNPSS----------EQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 493 lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 560 (817)
.+.|+.|.+..++ .--|..+++|.+.... +...++|.+|+++|+++ .|+||+++++++++....||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4566666665544 3346779999875431 22346799999999999 7999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
||++|++|.++|... ..++.. +|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+++.....
T Consensus 322 Eyv~G~~L~d~i~~~-~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~-- 392 (569)
T 4azs_A 322 EKLPGRLLSDMLAAG-EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD-- 392 (569)
T ss_dssp ECCCSEEHHHHHHTT-CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC----
T ss_pred ecCCCCcHHHHHHhC-CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCC--
Confidence 999999999999654 345543 58999999999999877 999999999999999999999999999864332
Q ss_pred CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCC
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARP 685 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~ 685 (817)
........||++|||||++.+ .+..++|+|++|+++++|.++..
T Consensus 393 ~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 393 CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 223345679999999999875 46778999999999888766543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.1e-25 Score=258.14 Aligned_cols=184 Identities=18% Similarity=0.207 Sum_probs=143.0
Q ss_pred cceeEeeeCceEEEEEEEecccEEEEEecCCCCc--c------cHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 489 ESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSE--Q------GVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 489 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
..++||+|+||+||+|.. .+..+++|+...... . ..+.|.+|+++|++++||||+++..++...+..+|||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 355899999999999954 456788887543321 1 1345899999999999999996666666777889999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
||+++++|.+++.. ++.++.|+++||+|||+++ |+||||||+|||+++ .+||+|||+++.......
T Consensus 419 E~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 419 SYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp ECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred ECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 99999999999865 5689999999999999876 999999999999999 999999999987533211
Q ss_pred Cc-----eeeeeecCcCCCChhhhcc--CCCCchHHHHHHHHHHHHHHhCCCCC
Q 039107 641 GH-----VSTVVKGSFGYLDPEYFKR--QQLTEKSDIYSFGVVLFEVLCARPAL 687 (817)
Q Consensus 641 ~~-----~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~S~Gvvl~elltG~~p~ 687 (817)
.. ......||+.|||||++.. ..|+...|+|+..+-.++.+.++.++
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 11 1235679999999999986 56788899999999999888777654
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.1e-24 Score=208.54 Aligned_cols=158 Identities=16% Similarity=0.150 Sum_probs=122.1
Q ss_pred eeeeeeccCccccCCCCCcccccccccCCCCceeccCCCCccCCCceeeeeccCCCCCCChhhhhhhhhcCCCccccccc
Q 039107 178 QTMFRLNVAGQYISPKNDSGGLMRSWQNDEPYLFGAGYGIPMKADEVQIDYKSLPDYSAPPDVYMTARYMGVDAHTNMEF 257 (817)
Q Consensus 178 ~~~~R~n~Gg~~i~~~~d~~~~~R~W~~d~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~P~~v~~ta~~~~~~~~~~~~~ 257 (817)
++++|+||||+.++ |. .+|.|++|..|........ ......+ . ..+.+|+.||+|||.++.
T Consensus 5 ~~~~~INcGg~~~~---d~--~gr~w~~D~~~~~~g~~~~--~~~~~~~--~--~~~~~~~~lY~TaR~~~~-------- 65 (174)
T 2jwp_A 5 KVIWAVNAGGESHV---DV--HGIHYRKDPLEGRVGRASD--YGMKLPI--L--RSNPEDQVLYQTERYNED-------- 65 (174)
T ss_dssp HEEEEEEETSSSEE---ET--TTEEECSSCSSTTCCCCCC--CCTTSCC--S--SSCHHHHHTTTCCCCCCS--------
T ss_pred cEEEEEECCCCCcc---CC--CCCEEcCCcCcccCCcccc--cccceEe--c--ccCCCCchhhhhhccCCC--------
Confidence 57899999998764 55 7799999987642111110 0111111 1 123578999999999765
Q ss_pred ceeEEEEecCCCceEEEEEeeeccCCcccccceEEEEEEcCcccccccchhhhccCCCccEEEEEEEEEecCC-------
Q 039107 258 NLTWIFRVDANFTYYVRLHFCEFKPDINKINQRVFNIYINNQTAQADADVIAWTHGQGVPIYKDYAVYVEDLP------- 330 (817)
Q Consensus 258 ~~~~~~p~~~~~~y~v~lhF~e~~~~~~~~~~R~F~i~i~~~~~~~~~~~~~~~~~~~~p~~~~~~v~v~~~~------- 330 (817)
+++|.||++++..|+|||||||+.. .+.++|+|||||||+++.++|||.+++++ ++|++++|.+.|.++.
T Consensus 66 ~~tY~f~v~~~G~Y~VrLhF~ei~~--~~~~~rvFdV~ing~~~l~~fdi~~~ag~-~~~~~~~~~~~v~~~~l~i~~~~ 142 (174)
T 2jwp_A 66 SFGYDIPIKEEGEYVLVLKFAEVYF--AQSQQKVFDVRVNGHTVVKDLDIFDRVGH-STAHDEIIPISIKKGKLSVQGEV 142 (174)
T ss_dssp CEEEEEECCSCEEEEEEEEEECCSC--CCSSSSCEEEEETTEEEEEEECHHHHHSS-SSCEEEEEEEEEETTEEEETTEE
T ss_pred CeEEEEEeCCCeEEEEEEEEecccc--CCCCCeEeEEEECCEEeecCcCHHHhhCC-CeeEEEEEEEEEecCceeeeeee
Confidence 7999999999889999999999975 56899999999999999999999999987 7899999999876542
Q ss_pred --CCcceEEEeCCCCCCcchhhHhhccCceeeee
Q 039107 331 --GDDQIFVAMSPSLKYQPEYLDALLNGLEIFKI 362 (817)
Q Consensus 331 --~~~~l~v~l~p~~~~~~~~~~~~lnglei~~~ 362 (817)
.++.|.|.+.|.. ...|.+||+||++-
T Consensus 143 ~~~~g~L~I~f~p~~-----~~~a~inaIEI~~~ 171 (174)
T 2jwp_A 143 STFTGKLSVEFVKGY-----YDNPKVCALFIMKG 171 (174)
T ss_dssp EECCSEEEEEEECSS-----SCSSSEEEEEEESS
T ss_pred cccCCeEEEEEeccC-----CCCcEEEEEEEEeC
Confidence 4567888887642 45688999999963
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.7e-22 Score=213.01 Aligned_cols=153 Identities=14% Similarity=0.079 Sum_probs=122.3
Q ss_pred HHHHHHhhcCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCc------------------ccHHHHHHHHHHHhcc
Q 039107 477 LAEIKHATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSE------------------QGVNEFVTEIEMLSKL 538 (817)
Q Consensus 477 ~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l 538 (817)
+..+......|...+.||+|+||.||+|...++..||+|.+..... .....+.+|+++|+++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 4445555666777899999999999999997788999999864321 1345689999999999
Q ss_pred CccceeeEEEEEecCCeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEE
Q 039107 539 RHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILL 618 (817)
Q Consensus 539 ~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll 618 (817)
+ | +++.+++.. +..++||||+++++|.+ +.. .....++.|++.||.|||+.+ |+||||||+|||+
T Consensus 162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl 226 (282)
T 1zar_A 162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLV 226 (282)
T ss_dssp T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEE
Confidence 9 4 556555543 55699999999999988 421 234579999999999999776 9999999999999
Q ss_pred cCCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhc
Q 039107 619 DENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFK 660 (817)
Q Consensus 619 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 660 (817)
+ ++.+||+|||+++. +..++|||++.
T Consensus 227 ~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp E-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred E-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 9 99999999999863 34578999875
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=4.9e-19 Score=173.09 Aligned_cols=147 Identities=14% Similarity=0.186 Sum_probs=105.3
Q ss_pred CCCCCCCcCCCCCccccCCCcccCCCCCC--ceeeccCCCCCCCCccceeeeeecceeEEEeccCCCeEEEEEEeccCCC
Q 039107 1 CGSKDGGIDADGRSWEPDDKYLSKGESKP--TRATYQDSSLVSKVPYMDARVFKQEMSYELPIRSQSRYWVRFHFYPSTY 78 (817)
Q Consensus 1 CG~~~~~~~~~~~~w~~D~~~~~~g~~~~--~~~~~~~~~~~~~~~~~t~R~f~~~~~Y~~~~~~~~~y~vR~~f~~~~~ 78 (817)
||++.. +|..||+|.+|..|...|.... ....+......+...|+|+|+||..++|.||+.++|+|+|||||++..+
T Consensus 12 cGg~~~-~d~~gr~w~~D~~~~~~g~~~~~~~~~~~~~~~~~~~~lY~TaR~~~~~~tY~f~v~~~G~Y~VrLhF~ei~~ 90 (174)
T 2jwp_A 12 AGGESH-VDVHGIHYRKDPLEGRVGRASDYGMKLPILRSNPEDQVLYQTERYNEDSFGYDIPIKEEGEYVLVLKFAEVYF 90 (174)
T ss_dssp ETSSSE-EETTTEEECSSCSSTTCCCCCCCCTTSCCSSSCHHHHHTTTCCCCCCSCEEEEEECCSCEEEEEEEEEECCSC
T ss_pred CCCCCc-cCCCCCEEcCCcCcccCCcccccccceEecccCCCCchhhhhhccCCCCeEEEEEeCCCeEEEEEEEEecccc
Confidence 998643 5668999999998863343221 1111111122234569999999999999999988899999999999988
Q ss_pred CCCCcccceeEEEeCCeEEEeccCcchhhhcccceeEEEEEEecC------------CCCCcEEEEEeeCCCCCCcceeE
Q 039107 79 PELNVANSYFSVVANDVTLLSNFSASITAQAVAQAYLIKEFSLAP------------MDSDILKIIFRPSDKHSGTFAFI 146 (817)
Q Consensus 79 ~~~~~~~~~f~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~l~f~p~~~~~~~~~fi 146 (817)
.+ ...+.|+|.++|..++.||+....+ .....+.+.|.+.. ...+.|+|.|.|.. ...|||
T Consensus 91 ~~--~~~rvFdV~ing~~~l~~fdi~~~a--g~~~~~~~~~~~~v~~~~l~i~~~~~~~~g~L~I~f~p~~---~~~a~i 163 (174)
T 2jwp_A 91 AQ--SQQKVFDVRVNGHTVVKDLDIFDRV--GHSTAHDEIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGY---YDNPKV 163 (174)
T ss_dssp CC--SSSSCEEEEETTEEEEEEECHHHHH--SSSSCEEEEEEEEEETTEEEETTEEEECCSEEEEEEECSS---SCSSSE
T ss_pred CC--CCCeEeEEEECCEEeecCcCHHHhh--CCCeeEEEEEEEEEecCceeeeeeecccCCeEEEEEeccC---CCCcEE
Confidence 75 5678999999999999999654322 22233445454431 24678999999852 345999
Q ss_pred eeeeeecCC
Q 039107 147 NGIELVPSP 155 (817)
Q Consensus 147 ~~iEl~~~~ 155 (817)
|||||++.+
T Consensus 164 naIEI~~~~ 172 (174)
T 2jwp_A 164 CALFIMKGT 172 (174)
T ss_dssp EEEEEESSC
T ss_pred EEEEEEeCc
Confidence 999999864
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=1e-18 Score=183.07 Aligned_cols=136 Identities=17% Similarity=0.103 Sum_probs=106.1
Q ss_pred CCCcceeEeeeCceEEEEEEE-ecccE--EEEEecCCCCcc------------------------cHHHHHHHHHHHhcc
Q 039107 486 SFDESYVIGVGGFGKVYKGVI-EDKLK--VAIKRSNPSSEQ------------------------GVNEFVTEIEMLSKL 538 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l 538 (817)
-|...+.||+|+||.||+|.. .++.. ||||.++..... ....+.+|+.+|.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 356778999999999999997 67888 999986543111 113678999999999
Q ss_pred Cccce--eeEEEEEecCCeEEEEEEeccC-C----chhhhhhccccccchHhHHHHHHHHHHHHHHHH-hCCCCceEecC
Q 039107 539 RHKHL--VSLIGFCEEGNEMCLVYDYMAL-G----TLREHIYNTKKALSWKQRLEICIGAARGLHYLH-TGAKYTIIHRD 610 (817)
Q Consensus 539 ~H~ni--v~l~g~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~D 610 (817)
+|+++ +.++++ ...+|||||+.+ | +|.++.. ..++..+..++.|++.||.||| +.+ |+|||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrD 196 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR----ELKELDVEGIFNDVVENVKRLYQEAE---LVHAD 196 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG----GGGGSCHHHHHHHHHHHHHHHHHTSC---EECSS
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh----ccChHHHHHHHHHHHHHHHHHHHHCC---EEeCC
Confidence 88764 444443 356899999953 4 4544432 2446678899999999999999 766 99999
Q ss_pred CccCcEEEcCCceeEEeeeccCcc
Q 039107 611 VKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 611 ikp~NIll~~~~~~kl~DFGla~~ 634 (817)
|||+|||+++ .++|+|||++..
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEE
T ss_pred CCHHHEEEcC--cEEEEECccccc
Confidence 9999999998 999999999975
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.60 E-value=1e-15 Score=166.83 Aligned_cols=141 Identities=14% Similarity=0.131 Sum_probs=100.8
Q ss_pred HHHHhhcCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCc--------------ccHHHH--------HHHHHHHh
Q 039107 479 EIKHATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSE--------------QGVNEF--------VTEIEMLS 536 (817)
Q Consensus 479 el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~~--------~~E~~~l~ 536 (817)
.+..-..-|.+...||+|+||.||+|...+|+.||||+++.... ...... .+|...|.
T Consensus 89 ~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~ 168 (397)
T 4gyi_A 89 THAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK 168 (397)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence 33333334888999999999999999988899999998654210 001111 24566666
Q ss_pred ccCcccee--eEEEEEecCCeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccC
Q 039107 537 KLRHKHLV--SLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTT 614 (817)
Q Consensus 537 ~l~H~niv--~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~ 614 (817)
++.+.++. ..+++ ...+|||||++++.|.++.. ......++.|++.+|.|||+.+ ||||||||.
T Consensus 169 rL~~~gv~vp~p~~~----~~~~LVME~i~G~~L~~l~~-------~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~ 234 (397)
T 4gyi_A 169 ALYEEGFPVPEPIAQ----SRHTIVMSLVDALPMRQVSS-------VPDPASLYADLIALILRLAKHG---LIHGDFNEF 234 (397)
T ss_dssp HHHHTTCSCCCEEEE----ETTEEEEECCSCEEGGGCCC-------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTT
T ss_pred HHHhcCCCCCeeeec----cCceEEEEecCCccHhhhcc-------cHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHH
Confidence 66544432 22322 12379999999988876542 2234578899999999999766 999999999
Q ss_pred cEEEcCCc----------eeEEeeeccCc
Q 039107 615 NILLDENW----------VAKVSDFGLSK 633 (817)
Q Consensus 615 NIll~~~~----------~~kl~DFGla~ 633 (817)
||||++++ .+.|+||+-+-
T Consensus 235 NILl~~dgd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 235 NILIREEKDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp SEEEEEEECSSCTTSEEEEEEECCCTTCE
T ss_pred HEEEeCCCCcccccccccceEEEEeCCcc
Confidence 99998876 48899998654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=2.2e-11 Score=127.22 Aligned_cols=145 Identities=17% Similarity=0.094 Sum_probs=113.1
Q ss_pred hhcCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccC-ccceeeEEEEEecCCeEEEEEE
Q 039107 483 ATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLR-HKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 483 ~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 561 (817)
.-..|.....++.|+.+.||+.... +..+++|............+.+|+++++.+. |..+.++++++...+..++|||
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 3346777778888889999998754 4689999986422122346889999999984 6778899999988889999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhC----------------------------------------
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTG---------------------------------------- 601 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------------------------------------- 601 (817)
|++|.+|.+.+. +......++.+++++|..||+.
T Consensus 91 ~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T 3tm0_A 91 EADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp CCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSS
T ss_pred ecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccC
Confidence 999999877531 2233457889999999999981
Q ss_pred ----------------CCCceEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 602 ----------------AKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 602 ----------------~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
....++|+|+++.|||++++..+.|+||+.+..
T Consensus 165 ~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 114599999999999998876678999987643
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.13 E-value=8.8e-11 Score=122.05 Aligned_cols=137 Identities=18% Similarity=0.134 Sum_probs=100.9
Q ss_pred CCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccc--eeeEEEEEecCCeEEEEEEec
Q 039107 486 SFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKH--LVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~Ey~ 563 (817)
.+....+.+.|..+.||+....++..+++|..... ....+.+|+++++.+.+.+ +.+++++....+..++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 34333333455569999998777778999997654 2245788999999996544 556889888878899999999
Q ss_pred cCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 039107 564 ALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGA----------------------------------------- 602 (817)
Q Consensus 564 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------------- 602 (817)
+|.+|. ... . ....++.++++.|..||+..
T Consensus 98 ~G~~l~--~~~----~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
T 1nd4_A 98 PGQDLL--SSH----L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 168 (264)
T ss_dssp SSEETT--TSC----C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred CCcccC--cCc----C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence 998884 211 1 12356777888888888632
Q ss_pred --------------CCceEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 603 --------------KYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 603 --------------~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
...++|+|++|.|||++++..+.|+||+.+..
T Consensus 169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 169 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998887778999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.94 E-value=2.7e-09 Score=116.74 Aligned_cols=142 Identities=16% Similarity=0.206 Sum_probs=107.5
Q ss_pred cceeEeeeCceEEEEEEEecccEEEEEecC--CCC-cccHHHHHHHHHHHhccC--ccceeeEEEEEecC---CeEEEEE
Q 039107 489 ESYVIGVGGFGKVYKGVIEDKLKVAIKRSN--PSS-EQGVNEFVTEIEMLSKLR--HKHLVSLIGFCEEG---NEMCLVY 560 (817)
Q Consensus 489 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~---~~~~lV~ 560 (817)
..+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|+++++.|. +..+.++++++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 45578999999999988765 478888876 332 122356788999999996 45688999998776 4479999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGA-------------------------------------- 602 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------- 602 (817)
||+++..|.+.. -..++..++..++.++++.|+.||+..
T Consensus 121 e~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 121 EFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp ECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred EecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 999998885422 123677888899999999999999720
Q ss_pred -----------------CCceEecCCccCcEEEcCCce--eEEeeeccCcc
Q 039107 603 -----------------KYTIIHRDVKTTNILLDENWV--AKVSDFGLSKT 634 (817)
Q Consensus 603 -----------------~~~ivH~Dikp~NIll~~~~~--~kl~DFGla~~ 634 (817)
...++|+|+++.|||+++++. +.|+||+.+..
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997653 68999998865
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.88 E-value=2.2e-09 Score=114.60 Aligned_cols=187 Identities=16% Similarity=0.170 Sum_probs=123.3
Q ss_pred ceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhcc-Cccc--eeeEEEEEecCC---eEEEEEEec
Q 039107 490 SYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKL-RHKH--LVSLIGFCEEGN---EMCLVYDYM 563 (817)
Q Consensus 490 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~n--iv~l~g~~~~~~---~~~lV~Ey~ 563 (817)
.+.++.|....||+.. ..+++|+.... .....+.+|.++|+.+ .+.. +.+++..+.... ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3468999999999863 46888886532 3456788999999888 3332 455666554433 348899999
Q ss_pred cCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhC------------------------------------------
Q 039107 564 ALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTG------------------------------------------ 601 (817)
Q Consensus 564 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------ 601 (817)
+|..|.+... ..++..++..++.++++.|+.||+.
T Consensus 99 ~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 99 KGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred CCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 9988875332 2467777888888888888888851
Q ss_pred -------------CCCceEecCCccCcEEEcC--CceeEEeeeccCccCCCCCCCc-eee-----------eeecCcCCC
Q 039107 602 -------------AKYTIIHRDVKTTNILLDE--NWVAKVSDFGLSKTGPNMENGH-VST-----------VVKGSFGYL 654 (817)
Q Consensus 602 -------------~~~~ivH~Dikp~NIll~~--~~~~kl~DFGla~~~~~~~~~~-~~~-----------~~~gt~~y~ 654 (817)
....++|+|+++.||++++ ...+.|+||+.+........-. ... ......+..
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~ 255 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHK 255 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCC
Confidence 1246899999999999998 5678899999886532110000 000 000000112
Q ss_pred C-hhhhccCCCCchHHHHHHHHHHHHHHhCCCCC
Q 039107 655 D-PEYFKRQQLTEKSDIYSFGVVLFEVLCARPAL 687 (817)
Q Consensus 655 a-PE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~ 687 (817)
. |+..... ....+.|+++.+++++.+|+.++
T Consensus 256 ~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 256 DIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence 2 2222211 22368999999999999997654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=2.4e-06 Score=89.08 Aligned_cols=135 Identities=19% Similarity=0.162 Sum_probs=97.2
Q ss_pred eEeeeCce-EEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccC-ccceeeEEEEEecCCeEEEEEEeccCCch
Q 039107 492 VIGVGGFG-KVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLR-HKHLVSLIGFCEEGNEMCLVYDYMALGTL 568 (817)
Q Consensus 492 ~lG~G~fg-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 568 (817)
.+..|..+ .||+.... ++..+++|+.... ...++.+|...|+.|. +--+.++++++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45556555 68987754 4567899986533 3457888999998884 43477889999998999999999999887
Q ss_pred hhhhhccccccchHhHHHHHHHHHHHHHHHHhC-----------------------------------------------
Q 039107 569 REHIYNTKKALSWKQRLEICIGAARGLHYLHTG----------------------------------------------- 601 (817)
Q Consensus 569 ~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------------------- 601 (817)
.+.... .......++.+++..|.-||+.
T Consensus 108 ~~~~~~-----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 108 FQVLEE-----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp HHHHHH-----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred cccccC-----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 765421 1223345566666666666641
Q ss_pred --------CCCceEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 602 --------AKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 602 --------~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
....++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 123489999999999999887778999997754
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=3.9e-06 Score=89.37 Aligned_cols=136 Identities=17% Similarity=0.126 Sum_probs=93.0
Q ss_pred ceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCcc---ceeeEEEEEe-cCCeEEEEEEeccC
Q 039107 490 SYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHK---HLVSLIGFCE-EGNEMCLVYDYMAL 565 (817)
Q Consensus 490 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~-~~~~~~lV~Ey~~~ 565 (817)
...++.|....||+. +..+++|+.. .......+.+|.++|+.|.+. .+.+++.++. ..+..++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 446888888899987 4578888853 223456788999999999642 3667777774 44567899999999
Q ss_pred CchhhhhhccccccchHhHHHHHHHHHHHHHHHHhC--------------------------------------------
Q 039107 566 GTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTG-------------------------------------------- 601 (817)
Q Consensus 566 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------------------------------------------- 601 (817)
..|.+... ..++..++..++.++++.|+.||+.
T Consensus 98 ~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 98 QILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp EECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred eECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 88865311 1123334444444444444444431
Q ss_pred -------------CCCceEecCCccCcEEEcC---Cce-eEEeeeccCcc
Q 039107 602 -------------AKYTIIHRDVKTTNILLDE---NWV-AKVSDFGLSKT 634 (817)
Q Consensus 602 -------------~~~~ivH~Dikp~NIll~~---~~~-~kl~DFGla~~ 634 (817)
....++|+|+++.|||+++ ++. +.|+||+.+..
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2346799999999999997 344 58999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=1.7e-06 Score=94.13 Aligned_cols=81 Identities=7% Similarity=-0.005 Sum_probs=57.6
Q ss_pred ceeE-eeeCceEEEEEEEe-------cccEEEEEecCCCC---cccHHHHHHHHHHHhccC-c--cceeeEEEEEecC--
Q 039107 490 SYVI-GVGGFGKVYKGVIE-------DKLKVAIKRSNPSS---EQGVNEFVTEIEMLSKLR-H--KHLVSLIGFCEEG-- 553 (817)
Q Consensus 490 ~~~l-G~G~fg~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H--~niv~l~g~~~~~-- 553 (817)
.+.| +.|....+|+.... ++..+++|+..... ......+.+|+.+|+.|. + -.+.++++++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3467 78888999998765 25678899865432 111245778999999884 3 3577888888665
Q ss_pred -CeEEEEEEeccCCchhh
Q 039107 554 -NEMCLVYDYMALGTLRE 570 (817)
Q Consensus 554 -~~~~lV~Ey~~~gsL~~ 570 (817)
...++||||+++..|.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 35689999999877654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.91 E-value=2.8e-05 Score=83.75 Aligned_cols=139 Identities=19% Similarity=0.194 Sum_probs=81.0
Q ss_pred eeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCcc--ceeeEEE------EEecCCeEEEEEEe
Q 039107 491 YVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHK--HLVSLIG------FCEEGNEMCLVYDY 562 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g------~~~~~~~~~lV~Ey 562 (817)
..|+.|....||+....++ .+++|+.... ..++..|+.+++.|... .+.+++. +....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 3566677899999887665 5889988752 23444566666665321 2333433 12245678999999
Q ss_pred ccCCchh--------------hhhhcccc-------------ccchHhH-------------------------------
Q 039107 563 MALGTLR--------------EHIYNTKK-------------ALSWKQR------------------------------- 584 (817)
Q Consensus 563 ~~~gsL~--------------~~l~~~~~-------------~l~~~~~------------------------------- 584 (817)
++|..+. ..+|.... ...|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986553 01111100 0122110
Q ss_pred HHHHHHHHHHHHHHHh----------CCCCceEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 585 LEICIGAARGLHYLHT----------GAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 585 ~~i~~~ia~gL~yLH~----------~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
..+...+.+++++|+. .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 0111223446667763 1245699999999999998888999999997643
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.88 E-value=4.7e-05 Score=84.06 Aligned_cols=75 Identities=13% Similarity=0.076 Sum_probs=50.3
Q ss_pred ceeEeeeCceEEEEEEEe-cccEEEEEecCCCCc-------ccHHHHHHHHHHHhccCc--c-ceeeEEEEEecCCeEEE
Q 039107 490 SYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSE-------QGVNEFVTEIEMLSKLRH--K-HLVSLIGFCEEGNEMCL 558 (817)
Q Consensus 490 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H--~-niv~l~g~~~~~~~~~l 558 (817)
.+.||.|..+.||++... ++..++||...+... .....+..|.++|+.+.. + .+.+++.+. .+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence 457899999999999754 457899997653221 223567789999988742 3 344666543 345689
Q ss_pred EEEeccCC
Q 039107 559 VYDYMALG 566 (817)
Q Consensus 559 V~Ey~~~g 566 (817)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.87 E-value=0.00014 Score=76.49 Aligned_cols=79 Identities=13% Similarity=0.059 Sum_probs=58.9
Q ss_pred CCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccC-c--cceeeEEEEEecCCeEEEEEEe
Q 039107 486 SFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLR-H--KHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H--~niv~l~g~~~~~~~~~lV~Ey 562 (817)
.......+|.|..+.||+.++.+|+.+++|+...........|..|++.|+.|. . --+.+++++. .-++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 345566799999999999999999999999876554444456889999999884 2 2345566553 23789999
Q ss_pred ccCCch
Q 039107 563 MALGTL 568 (817)
Q Consensus 563 ~~~gsL 568 (817)
++.+..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987644
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00019 Score=76.35 Aligned_cols=138 Identities=14% Similarity=0.123 Sum_probs=92.4
Q ss_pred CcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccC---ccceeeEEEEEecCCeEEEEEEecc
Q 039107 488 DESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLR---HKHLVSLIGFCEEGNEMCLVYDYMA 564 (817)
Q Consensus 488 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~Ey~~ 564 (817)
...+.|+.|....+|+.... +..+++|+.... ....|..|.+.|+.|. ...+.++++++...+..++||||++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 34557899999999998764 557888986532 3567889999999884 3568889999888888999999999
Q ss_pred CCchhh-----------hhhcccc---------------------ccchHhHH---HHH----------------HHHHH
Q 039107 565 LGTLRE-----------HIYNTKK---------------------ALSWKQRL---EIC----------------IGAAR 593 (817)
Q Consensus 565 ~gsL~~-----------~l~~~~~---------------------~l~~~~~~---~i~----------------~~ia~ 593 (817)
+..+.. .||.... .-+|.... ++. ..++.
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 876531 1221110 01343221 111 11121
Q ss_pred H-HHHHHh-CCCCceEecCCccCcEEEcCCceeEEeeec
Q 039107 594 G-LHYLHT-GAKYTIIHRDVKTTNILLDENWVAKVSDFG 630 (817)
Q Consensus 594 g-L~yLH~-~~~~~ivH~Dikp~NIll~~~~~~kl~DFG 630 (817)
. ...|.. ...+.+||+|+.+.|++++.++ +.|+|+.
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 2 223421 2357899999999999999887 8888874
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00062 Score=72.50 Aligned_cols=156 Identities=13% Similarity=0.108 Sum_probs=88.9
Q ss_pred cCHHHHHHhhcCCCc-----ceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccc--eeeEE
Q 039107 475 FSLAEIKHATKSFDE-----SYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKH--LVSLI 547 (817)
Q Consensus 475 f~~~el~~~~~~f~~-----~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~ 547 (817)
++.+++.....+|.. .+.|+.|....+|+....++ .+++|...... ..+.+..|+.++..|...+ +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 455566655555654 23466788889999887666 68899877521 1235567888887774322 23333
Q ss_pred EE------EecCCeEEEEEEeccCCchhhh--------------hhccc-----------cccchHhHHH----------
Q 039107 548 GF------CEEGNEMCLVYDYMALGTLREH--------------IYNTK-----------KALSWKQRLE---------- 586 (817)
Q Consensus 548 g~------~~~~~~~~lV~Ey~~~gsL~~~--------------l~~~~-----------~~l~~~~~~~---------- 586 (817)
.. ....+..+++++|++|..+... +|... ....|.....
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 1223567899999997654210 11100 0012322111
Q ss_pred --HHHHHHHHHHHHHhC----CCCceEecCCccCcEEEcCCceeEEeeeccCc
Q 039107 587 --ICIGAARGLHYLHTG----AKYTIIHRDVKTTNILLDENWVAKVSDFGLSK 633 (817)
Q Consensus 587 --i~~~ia~gL~yLH~~----~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 633 (817)
+...+.+.++.|+.. ....++|+|+.+.|||++++..+.|+||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011234455555531 23569999999999999988666899998764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00083 Score=74.65 Aligned_cols=78 Identities=15% Similarity=0.173 Sum_probs=46.1
Q ss_pred CCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCceeeee-ecCcCCCChhhhccC---CCCchHHHHHHHHHHH
Q 039107 603 KYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVV-KGSFGYLDPEYFKRQ---QLTEKSDIYSFGVVLF 678 (817)
Q Consensus 603 ~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~---~~s~~sDV~S~Gvvl~ 678 (817)
...++|+|+++.|||+++++ ++|+||+.+........ ..... .-...|++|+..... ......++......+|
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D--la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD--IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH--HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH--HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 45799999999999999876 99999998875321000 00000 001235555544311 1122455667777777
Q ss_pred HHHhC
Q 039107 679 EVLCA 683 (817)
Q Consensus 679 elltG 683 (817)
+.+++
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77654
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.27 E-value=0.00077 Score=75.10 Aligned_cols=74 Identities=18% Similarity=0.189 Sum_probs=51.4
Q ss_pred ceeEeeeCceEEEEEEEec--------ccEEEEEecCCCCcccHHHHHHHHHHHhccCccce-eeEEEEEecCCeEEEEE
Q 039107 490 SYVIGVGGFGKVYKGVIED--------KLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHL-VSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 490 ~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~ 560 (817)
.+.|+.|....+|+....+ +..+++|+..... ....+..|..+++.|...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 3467888889999998753 4678899874321 12456689999998854333 677776643 3899
Q ss_pred EeccCCchh
Q 039107 561 DYMALGTLR 569 (817)
Q Consensus 561 Ey~~~gsL~ 569 (817)
||+++-+|.
T Consensus 152 e~l~G~~l~ 160 (429)
T 1nw1_A 152 EYIPSRPLS 160 (429)
T ss_dssp CCCCEEECC
T ss_pred EEeCCcccC
Confidence 999865543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0016 Score=71.12 Aligned_cols=139 Identities=19% Similarity=0.199 Sum_probs=84.3
Q ss_pred eeEeeeCceEEEEEEEec--------ccEEEEEecCCCCcccHHHHHHHHHHHhccC-ccceeeEEEEEecCCeEEEEEE
Q 039107 491 YVIGVGGFGKVYKGVIED--------KLKVAIKRSNPSSEQGVNEFVTEIEMLSKLR-HKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 561 (817)
+.|..|-...+|+....+ +..+++|+.... ........+|.++++.|. +.-..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 357678888899988642 367899986432 234566779999999884 3334667777654 39999
Q ss_pred eccCCchhhh-----------------hhcc----cccc--chHhHHHHHHHHHH-------------------HHHHH-
Q 039107 562 YMALGTLREH-----------------IYNT----KKAL--SWKQRLEICIGAAR-------------------GLHYL- 598 (817)
Q Consensus 562 y~~~gsL~~~-----------------l~~~----~~~l--~~~~~~~i~~~ia~-------------------gL~yL- 598 (817)
|++|..|..- ||.. .+.. -|.++.++..++.. .+..|
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998666421 1111 0111 24445545443321 22333
Q ss_pred ---Hh-CCCCceEecCCccCcEEEcCC----ceeEEeeeccCcc
Q 039107 599 ---HT-GAKYTIIHRDVKTTNILLDEN----WVAKVSDFGLSKT 634 (817)
Q Consensus 599 ---H~-~~~~~ivH~Dikp~NIll~~~----~~~kl~DFGla~~ 634 (817)
.. .....++|+|+.+.|||++++ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 22 124568999999999999876 7899999988753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0016 Score=68.72 Aligned_cols=72 Identities=10% Similarity=0.046 Sum_probs=46.3
Q ss_pred ceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccce-eeEEEEEecCCeEEEEEEec-cCCc
Q 039107 490 SYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHL-VSLIGFCEEGNEMCLVYDYM-ALGT 567 (817)
Q Consensus 490 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~-~~gs 567 (817)
.+.|+.|....+|+. ..+++|+........ ....+|+.+++.+...++ .++++++. +.-++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCCCcc
Confidence 567889999999998 468888876542221 223568888887753333 46666543 3347899999 6555
Q ss_pred hh
Q 039107 568 LR 569 (817)
Q Consensus 568 L~ 569 (817)
|.
T Consensus 95 l~ 96 (301)
T 3dxq_A 95 MS 96 (301)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.09 E-value=0.0034 Score=67.09 Aligned_cols=138 Identities=13% Similarity=0.079 Sum_probs=72.7
Q ss_pred eEeeeCceE-EEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCc--cceeeEEEEEecCCeEEEEEEeccCCch
Q 039107 492 VIGVGGFGK-VYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRH--KHLVSLIGFCEEGNEMCLVYDYMALGTL 568 (817)
Q Consensus 492 ~lG~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~Ey~~~gsL 568 (817)
.|+.|.... +|+....++..+++|....... .++..|+.+++.+.. -.+.+++.++.+.. +++||++++..+
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l 99 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALF 99 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcch
Confidence 465555444 6676554356777877654321 234456777777642 23566777754433 789999977665
Q ss_pred hhhhhccc---------------------c-ccc-h--HhHH-------H-------------HHHHHHHHHHHHH---h
Q 039107 569 REHIYNTK---------------------K-ALS-W--KQRL-------E-------------ICIGAARGLHYLH---T 600 (817)
Q Consensus 569 ~~~l~~~~---------------------~-~l~-~--~~~~-------~-------------i~~~ia~gL~yLH---~ 600 (817)
.+.+.... . .++ | .... . ....+...+..|. .
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~ 179 (333)
T 3csv_A 100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQL 179 (333)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHC
T ss_pred HHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcc
Confidence 43332100 0 011 1 0000 0 0001112222221 1
Q ss_pred CCCCceEecCCccCcEEEcCC----ceeEEeeeccCcc
Q 039107 601 GAKYTIIHRDVKTTNILLDEN----WVAKVSDFGLSKT 634 (817)
Q Consensus 601 ~~~~~ivH~Dikp~NIll~~~----~~~kl~DFGla~~ 634 (817)
.....++|||+.+.|||++.+ ..+.|+||+.+..
T Consensus 180 ~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 180 EGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred cCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 224579999999999999874 6889999998865
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0028 Score=70.93 Aligned_cols=75 Identities=16% Similarity=0.082 Sum_probs=48.8
Q ss_pred ceeEeeeCceEEEEEEEec-ccEEEEEecCCCCcccHHHHHHHHHHHhccCccce-eeEEEEEecCCeEEEEEEeccCCc
Q 039107 490 SYVIGVGGFGKVYKGVIED-KLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHL-VSLIGFCEEGNEMCLVYDYMALGT 567 (817)
Q Consensus 490 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~gs 567 (817)
.+.|+.|-...+|+....+ +..+++|+........ -+-.+|..+++.|...++ .++++++.. .+||||+++..
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence 3468888889999998765 4678888865432221 112578999998864444 567777732 35999999765
Q ss_pred hh
Q 039107 568 LR 569 (817)
Q Consensus 568 L~ 569 (817)
|.
T Consensus 188 l~ 189 (458)
T 2qg7_A 188 LS 189 (458)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0051 Score=65.49 Aligned_cols=140 Identities=12% Similarity=0.158 Sum_probs=82.1
Q ss_pred eeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccc--eeeEEEE-----EecCCeEEEEEEec
Q 039107 491 YVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKH--LVSLIGF-----CEEGNEMCLVYDYM 563 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~-----~~~~~~~~lV~Ey~ 563 (817)
..|+ |....||+....++..+++|...... .....+..|..++..|.... +++++.. ....+..+++||++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3566 88889999877667779999986432 23456777888888874322 3444443 12244568899999
Q ss_pred cCCchhh----h----------hhcc--------ccccchHhH----HHH---------------HHHHHHHHHHHHh--
Q 039107 564 ALGTLRE----H----------IYNT--------KKALSWKQR----LEI---------------CIGAARGLHYLHT-- 600 (817)
Q Consensus 564 ~~gsL~~----~----------l~~~--------~~~l~~~~~----~~i---------------~~~ia~gL~yLH~-- 600 (817)
+|..+.. . +|.. ...+++... ..+ ...+...++.|..
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 9765431 0 1110 001111110 001 1111122233321
Q ss_pred --CCCCceEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 601 --GAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 601 --~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
.....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1245689999999999999 4 889999987764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0038 Score=67.90 Aligned_cols=73 Identities=10% Similarity=0.139 Sum_probs=45.5
Q ss_pred eeEeeeCceEEEEEEEecc---------cEEEEEecCCCCcccHHHHHHHHHHHhccCccc-eeeEEEEEecCCeEEEEE
Q 039107 491 YVIGVGGFGKVYKGVIEDK---------LKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKH-LVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~~~~---------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~ 560 (817)
..|+.|..-.+|+....++ ..+++|+....... ..+...|.++++.|...+ ..++++... -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEecC----CcEEE
Confidence 3577788889999887652 57888887643222 123467888888885334 446666542 26899
Q ss_pred EeccCCch
Q 039107 561 DYMALGTL 568 (817)
Q Consensus 561 Ey~~~gsL 568 (817)
||+++..|
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99997654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.70 E-value=0.0071 Score=59.62 Aligned_cols=103 Identities=15% Similarity=0.123 Sum_probs=69.2
Q ss_pred CCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCcee
Q 039107 565 LGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVS 644 (817)
Q Consensus 565 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 644 (817)
.-+|.+.|...+.++++++++.++.|.+.+|.-+-.+.. + ..+=+.|..|+|..+|.+.+.+ ..+.
T Consensus 32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc-----------
Confidence 348999998888899999999999999999887622111 1 1333457999999999988753 1110
Q ss_pred eeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCC
Q 039107 645 TVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARP 685 (817)
Q Consensus 645 ~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~ 685 (817)
.....+.+||... ...+.+.=|||+|+++|.-+--..
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence 0122456787753 355789999999999999885443
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.07 E-value=0.016 Score=62.15 Aligned_cols=66 Identities=14% Similarity=0.101 Sum_probs=42.8
Q ss_pred eCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCc---cceeeEEEE------EecCCeEEEEEEeccCC
Q 039107 496 GGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRH---KHLVSLIGF------CEEGNEMCLVYDYMALG 566 (817)
Q Consensus 496 G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~g~------~~~~~~~~lV~Ey~~~g 566 (817)
|....||+....++ .+++|+...... ..|+.++..|.. +.+++++.. ....+..+++|+|++|.
T Consensus 34 g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~ 106 (339)
T 3i1a_A 34 DTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAP 106 (339)
T ss_dssp CSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCC
T ss_pred ccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCC
Confidence 33678999987777 899998665432 346666666532 224455432 23346779999999987
Q ss_pred ch
Q 039107 567 TL 568 (817)
Q Consensus 567 sL 568 (817)
.+
T Consensus 107 ~~ 108 (339)
T 3i1a_A 107 NG 108 (339)
T ss_dssp BT
T ss_pred cC
Confidence 66
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.30 E-value=0.12 Score=56.88 Aligned_cols=73 Identities=10% Similarity=0.079 Sum_probs=48.5
Q ss_pred eeEeeeCceEEEEEEEec--------ccEEEEEecCCCCcccHHHHHHHHHHHhccCccc-eeeEEEEEecCCeEEEEEE
Q 039107 491 YVIGVGGFGKVYKGVIED--------KLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKH-LVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~E 561 (817)
+.|..|-...+|+....+ +..+++|+....... .-+-.+|.++++.|...+ ..++++.+. -++|||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 457778888899988763 467889886544322 223357888888885323 455665442 278999
Q ss_pred eccCCch
Q 039107 562 YMALGTL 568 (817)
Q Consensus 562 y~~~gsL 568 (817)
|+++..|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998765
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.24 E-value=0.24 Score=54.26 Aligned_cols=30 Identities=33% Similarity=0.403 Sum_probs=25.1
Q ss_pred ceEecCCccCcEEE------cCCceeEEeeeccCcc
Q 039107 605 TIIHRDVKTTNILL------DENWVAKVSDFGLSKT 634 (817)
Q Consensus 605 ~ivH~Dikp~NIll------~~~~~~kl~DFGla~~ 634 (817)
.++|+|+.+.|||+ +++..++++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4567799999998754
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.78 E-value=0.016 Score=41.05 Aligned_cols=30 Identities=23% Similarity=0.238 Sum_probs=17.8
Q ss_pred eEEEEeechhhhHHhHhheeeeEEeeeccc
Q 039107 398 IHVIGGAAGGAAAFGLVAALCFVVYQRKQR 427 (817)
Q Consensus 398 ~~ii~~vv~~~~~~~~v~~~~~~~~~r~~~ 427 (817)
..|+++++++++++++++++.++++|||++
T Consensus 10 ~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~ 39 (44)
T 2l2t_A 10 PLIAAGVIGGLFILVIVGLTFAVYVRRKSI 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred ceEEEeehHHHHHHHHHHHHHHHHhhhhhh
Confidence 346667777776666666555555555443
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.66 E-value=0.026 Score=40.12 Aligned_cols=28 Identities=18% Similarity=0.188 Sum_probs=15.9
Q ss_pred EEEEeechhhhHHhHhheeeeEEeeecc
Q 039107 399 HVIGGAAGGAAAFGLVAALCFVVYQRKQ 426 (817)
Q Consensus 399 ~ii~~vv~~~~~~~~v~~~~~~~~~r~~ 426 (817)
.|++++++++++++++++++++++|||+
T Consensus 12 ~IA~gVVgGv~~~~ii~~~~~~~~RRr~ 39 (44)
T 2ks1_B 12 SIATGMVGALLLLLVVALGIGLFMRRRH 39 (44)
T ss_dssp SSTHHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred eEEeehhHHHHHHHHHHHHHHHHhhhhH
Confidence 4566667666666555555444444444
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=84.00 E-value=5 Score=39.26 Aligned_cols=116 Identities=9% Similarity=0.130 Sum_probs=79.3
Q ss_pred CccceeeEEEEEecCCeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEE
Q 039107 539 RHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILL 618 (817)
Q Consensus 539 ~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll 618 (817)
.||+++.. ..-...+.+.+.|+.-+.+ ..+- .-+.++...+++++.+|+....+++. =+|--|.|+||++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~--~~f~--~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~f 112 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNH--TPFD--NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELFF 112 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTS--EEGG--GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCccc--CCHH--HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEEE
Confidence 68888876 4556666666666654422 2221 12357788899999999988866664 4788899999999
Q ss_pred cCCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCC
Q 039107 619 DENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALN 688 (817)
Q Consensus 619 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~ 688 (817)
+.++.+++.-.|+-.. ++|. ..+...=+-.+=+++..+++++..|.
T Consensus 113 ~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 113 TRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp CTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred cCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999987775432 1221 22333344467788999999987663
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=82.77 E-value=0.036 Score=38.18 Aligned_cols=30 Identities=10% Similarity=0.040 Sum_probs=17.3
Q ss_pred CCceEEEEeechhhhHHhHhheeeeEEeee
Q 039107 395 KSNIHVIGGAAGGAAAFGLVAALCFVVYQR 424 (817)
Q Consensus 395 ~~~~~ii~~vv~~~~~~~~v~~~~~~~~~r 424 (817)
.+...|++++++.++.++++++++++++||
T Consensus 8 ls~GaIAGiVvG~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 8 LTGGEIVAVIFGLLLGAALLLGILVFRSRR 37 (38)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCceeeeehHHHHHHHHHHHHHHHHeec
Confidence 344556677776666666565555554444
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 817 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-75 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-65 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-64 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-64 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-64 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-63 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-62 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-61 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-61 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 9e-61 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-60 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 8e-60 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-59 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-59 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-59 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-59 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-58 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-58 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-58 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-56 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-56 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-56 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-56 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-55 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-54 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-53 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-52 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-51 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-50 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-50 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-48 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 9e-48 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-47 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-45 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-44 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-44 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-43 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-42 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-40 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-37 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-19 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (619), Expect = 9e-75
Identities = 69/273 (25%), Positives = 124/273 (45%), Gaps = 18/273 (6%)
Query: 492 VIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCE 551
IG G FG VYKG + V + + Q + F E+ +L K RH +++ +G+
Sbjct: 15 RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74
Query: 552 EGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDV 611
+ +V + +L H++ + + ++I A+G+ YLH + IIHRD+
Sbjct: 75 APQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDL 130
Query: 612 KTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQ---LTEKS 668
K+ NI L E+ K+ DFGL+ H + GS ++ PE + Q + +S
Sbjct: 131 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 190
Query: 669 DIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECL 728
D+Y+FG+VL+E++ + P ++ D + +G L + K+ C
Sbjct: 191 DVYAFGIVLYELMTGQL------PYSNINNRDQIIFMVGRGYLSPDL-----SKVRSNCP 239
Query: 729 KKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQ 761
K +CL +RP +L ++E + +
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 217 bits (554), Expect = 4e-65
Identities = 68/311 (21%), Positives = 131/311 (42%), Gaps = 35/311 (11%)
Query: 475 FSLAEIKHATKSFDESY---------VIGVGGFGKVYKGVI----EDKLKVAIKRSNPS- 520
F+ + A + F + VIG G FG+V G + + ++ VAIK
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 521 SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALS 580
+E+ +F++E ++ + H +++ L G + + ++ ++M G+L + +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 581 WKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640
Q + + G A G+ YL +HRD+ NIL++ N V KVSDFGLS+ + +
Sbjct: 127 VIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 641 GHVSTVV---KGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVS 697
T K + PE + ++ T SD++S+G+V++EV+ + + V
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVI 243
Query: 698 LADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757
+ I+ + +C C RP G ++ L+
Sbjct: 244 ---------------NAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288
Query: 758 FVLQLVESTEA 768
+++ S +A
Sbjct: 289 KMIRNPNSLKA 299
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 2e-64
Identities = 66/288 (22%), Positives = 128/288 (44%), Gaps = 26/288 (9%)
Query: 492 VIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCE 551
IG G FG+V++G + +VA+K + E+ EI LRH++++ I
Sbjct: 10 SIGKGRFGEVWRGKWRGE-EVAVKIFSSREERSW-FREAEIYQTVMLRHENILGFIAADN 67
Query: 552 EGN----EMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYT-- 605
+ N ++ LV DY G+L +++ + ++ + +++ + A GL +LH T
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 125
Query: 606 ---IIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN--GHVSTVVKGSFGYLDPEYF- 659
I HRD+K+ NIL+ +N ++D GL+ + + G+ Y+ PE
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185
Query: 660 -----KRQQLTEKSDIYSFGVVLFEVLCARPALNPSL----PKEQVSLADWALHCKRKGI 710
K + +++DIY+ G+V +E+ P + +D ++ RK +
Sbjct: 186 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV 245
Query: 711 LDDIIDPLLKDKI-SPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757
+ + P + ++ S E L+ A +C +G R + + L
Sbjct: 246 CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 5e-64
Identities = 76/274 (27%), Positives = 122/274 (44%), Gaps = 23/274 (8%)
Query: 492 VIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCE 551
IG G FG V+ G +K KVAIK + +F+ E E++ KL H LV L G C
Sbjct: 12 EIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 552 EGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDV 611
E +CLV+++M G L +++ + + + L +C+ G+ YL + +IHRD+
Sbjct: 71 EQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDL 127
Query: 612 KTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIY 671
N L+ EN V KVSDFG+++ + + ST K + PE F + + KSD++
Sbjct: 128 AARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVW 186
Query: 672 SFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKF 731
SFGV+++EV + +V + I +
Sbjct: 187 SFGVLMWEVFSEGKIPYENRSNSEVV---------------EDISTGFRLYKPRLASTHV 231
Query: 732 ADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVES 765
C + DRP+ +L L ++ ES
Sbjct: 232 YQIMNHCWKERPEDRPAFSRLLRQLA---EIAES 262
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (542), Expect = 5e-64
Identities = 68/273 (24%), Positives = 113/273 (41%), Gaps = 20/273 (7%)
Query: 485 KSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLV 544
K +G G FG V G + VAIK S +EF+ E +++ L H+ LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 545 SLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKY 604
L G C + + ++ +YMA G L ++ + +Q LE+C + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SK 119
Query: 605 TIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQL 664
+HRD+ N L+++ V KVSDFGLS+ + E S K + PE +
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKF 178
Query: 665 TEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKIS 724
+ KSDI++FGV+++E+ + + + I L+
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA---------------EHIAQGLRLYRP 223
Query: 725 PECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757
+K C + +RP+ +L N+
Sbjct: 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 7e-63
Identities = 71/293 (24%), Positives = 129/293 (44%), Gaps = 25/293 (8%)
Query: 486 SFDESYVIGVGGFGKVYKGVIED-----KLKVAIKRSNPS-SEQGVNEFVTEIEMLSKLR 539
VIG G FG+VYKG+++ ++ VAIK +E+ +F+ E ++ +
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 540 HKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLH 599
H +++ L G + M ++ +YM G L + + S Q + + G A G+ YL
Sbjct: 68 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA 127
Query: 600 TGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT-GPNMENGHVSTVVKGSFGYLDPEY 658
+HRD+ NIL++ N V KVSDFGLS+ + E + ++ K + PE
Sbjct: 128 ---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 659 FKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPL 718
++ T SD++SFG+V++EV+ L +V I+
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM---------------KAINDG 229
Query: 719 LKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVESTEASSN 771
+ +C +C RP D++ L+ +++ +S + ++
Sbjct: 230 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLAD 282
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 3e-62
Identities = 64/277 (23%), Positives = 115/277 (41%), Gaps = 25/277 (9%)
Query: 492 VIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCE 551
+G G FG+V+ G KVA+K S + F+ E ++ +L+H+ LV L
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 552 EGNEMCLVYDYMALGTLREHIYNTKKA-LSWKQRLEICIGAARGLHYLHTGAKYTIIHRD 610
+ + ++ +YM G+L + + L+ + L++ A G+ ++ + IHRD
Sbjct: 79 QEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 134
Query: 611 VKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDI 670
++ NIL+ + K++DFGL++ + E K + PE T KSD+
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 671 YSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKK 730
+SFG++L E++ P + +V L+ + D E
Sbjct: 194 WSFGILLTEIVTHGRIPYPGMTNPEVIQN-----------LERGYRMVRPDNCPEEL--- 239
Query: 731 FADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVESTE 767
C + DRP+ + LE +TE
Sbjct: 240 -YQLMRLCWKERPEDRPTFDYLRSVLE---DFFTATE 272
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 3e-61
Identities = 64/270 (23%), Positives = 114/270 (42%), Gaps = 24/270 (8%)
Query: 493 IGVGGFGKVYKGVI---EDKLKVAIKRSNPSSEQG-VNEFVTEIEMLSKLRHKHLVSLIG 548
+G G FG V +GV + ++ VAIK +E+ E + E +++ +L + ++V LIG
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 549 FCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIH 608
C+ + LV + G L + + ++ + E+ + G+ YL + +H
Sbjct: 77 VCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVH 132
Query: 609 RDVKTTNILLDENWVAKVSDFGLSK-TGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEK 667
RD+ N+LL AK+SDFGLSK G + + K + PE ++ + +
Sbjct: 133 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 192
Query: 668 SDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPEC 727
SD++S+GV ++E L + +V I+ + + PEC
Sbjct: 193 SDVWSYGVTMWEALSYGQKPYKKMKGPEVM---------------AFIEQGKRMECPPEC 237
Query: 728 LKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757
+ C DRP V +
Sbjct: 238 PPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 6e-61
Identities = 65/300 (21%), Positives = 122/300 (40%), Gaps = 44/300 (14%)
Query: 487 FDESYVIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGV-NEFVTEIEMLSKLRHKHLV 544
F++ +G G G V+K L +A K + + + N+ + E+++L + ++V
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 545 SLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKY 604
G E+ + ++M G+L + + + + + ++ I +GL YL K+
Sbjct: 68 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLRE--KH 124
Query: 605 TIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQL 664
I+HRDVK +NIL++ K+ DFG+S + ++ G+ Y+ PE +
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHY 180
Query: 665 TEKSDIYSFGVVLFEVLCARPALNPSLPKEQV---------------------------- 696
+ +SDI+S G+ L E+ R + P KE
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240
Query: 697 ---SLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
S A+ I+++ L S E F D KCL + +R + ++
Sbjct: 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLE----FQDFVNKCLIKNPAERADLKQLM 296
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 205 bits (522), Expect = 8e-61
Identities = 67/285 (23%), Positives = 129/285 (45%), Gaps = 24/285 (8%)
Query: 479 EIKHATKSFDESYVIGVGGFGKVYKGVIED-KLKVAIKRSNPSSEQGVNEFVTEIEMLSK 537
E++ + +G G +G+VY+GV + L VA+K + + V EF+ E ++ +
Sbjct: 13 EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKE 69
Query: 538 LRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIY-NTKKALSWKQRLEICIGAARGLH 596
++H +LV L+G C ++ ++M G L +++ ++ +S L + + +
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 129
Query: 597 YLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDP 656
YL K IHRD+ N L+ EN + KV+DFGLS+ + K + P
Sbjct: 130 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAP 185
Query: 657 EYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIID 716
E + + KSD+++FGV+L+E+ + P + Q + ++++
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------------VYELLE 230
Query: 717 PLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQ 761
+ + C +K + C + DRPS ++ E + Q
Sbjct: 231 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 9e-61
Identities = 78/283 (27%), Positives = 133/283 (46%), Gaps = 28/283 (9%)
Query: 487 FDESYVIGVGGFGKVYKGVIED----KLKVAIKRSNPSSEQG-VNEFVTEIEMLSKLRHK 541
F+E VIG G FG VY G + D K+ A+K N ++ G V++F+TE ++ H
Sbjct: 31 FNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 88
Query: 542 HLVSLIGFCEEG-NEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHT 600
+++SL+G C +V YM G LR I N + K + + A+G+ +L
Sbjct: 89 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA- 147
Query: 601 GAKYTIIHRDVKTTNILLDENWVAKVSDFGLSK--TGPNMENGHVSTVVKGSFGYLDPEY 658
+HRD+ N +LDE + KV+DFGL++ ++ H T K ++ E
Sbjct: 148 --SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205
Query: 659 FKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPL 718
+ Q+ T KSD++SFGV+L+E++ + P V+ D ++ + L
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRG-----APPYPDVNTFDITVYLLQG-------RRL 253
Query: 719 LKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQ 761
L+ + P+ L + KC RPS +++ + +
Sbjct: 254 LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAIFS 293
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 6e-60
Identities = 70/268 (26%), Positives = 120/268 (44%), Gaps = 28/268 (10%)
Query: 492 VIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFC- 550
IG G FG V G KVA+K ++ F+ E ++++LRH +LV L+G
Sbjct: 14 TIGKGEFGDVMLGDYRGN-KVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIV 70
Query: 551 EEGNEMCLVYDYMALGTLREHIYNTKK-ALSWKQRLEICIGAARGLHYLHTGAKYTIIHR 609
EE + +V +YMA G+L +++ + + L L+ + + YL +HR
Sbjct: 71 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHR 127
Query: 610 DVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSD 669
D+ N+L+ E+ VAKVSDFGL+K + + K + PE + ++ + KSD
Sbjct: 128 DLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSD 182
Query: 670 IYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLK 729
++SFG++L+E+ +P ++ L D ++ +D C
Sbjct: 183 VWSFGILLWEIYSFGR-----VPYPRIPLKDVVPRVEKGYKMD----------APDGCPP 227
Query: 730 KFADTAEKCLSDSGIDRPSMGDVLWNLE 757
+ + C RPS + LE
Sbjct: 228 AVYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 7e-60
Identities = 68/285 (23%), Positives = 120/285 (42%), Gaps = 31/285 (10%)
Query: 481 KHATKSFD--ESY----VIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIE 533
+H T+ + + + +G G FGKVYK E + A K + SE+ + +++ EI+
Sbjct: 2 EHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEID 61
Query: 534 MLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAAR 593
+L+ H ++V L+ N + ++ ++ A G + + ++ L+ Q +C
Sbjct: 62 ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLD 121
Query: 594 GLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGY 653
L+YLH IIHRD+K NIL + K++DFG+S G+ +
Sbjct: 122 ALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQRRDSFIGTPYW 176
Query: 654 LDPEYF-----KRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRK 708
+ PE K + K+D++S G+ L E+ P + P L K
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-------LLKIAK 229
Query: 709 GILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
+ P + S F D +KCL + R + +L
Sbjct: 230 SEPPTLAQP---SRWSSN----FKDFLKKCLEKNVDARWTTSQLL 267
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 8e-60
Identities = 76/280 (27%), Positives = 125/280 (44%), Gaps = 24/280 (8%)
Query: 479 EIKHATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKL 538
EI +S +G G FG+V+ G +VAIK P + F+ E +++ KL
Sbjct: 13 EIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKL 69
Query: 539 RHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYN-TKKALSWKQRLEICIGAARGLHY 597
RH+ LV L E + +V +YM+ G+L + + T K L Q +++ A G+ Y
Sbjct: 70 RHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 128
Query: 598 LHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPE 657
+ + +HRD++ NIL+ EN V KV+DFGL++ + E K + PE
Sbjct: 129 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPE 184
Query: 658 YFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717
+ T KSD++SFG++L E+ P + +V D ++
Sbjct: 185 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL---------------DQVER 229
Query: 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757
+ PEC + D +C +RP+ + LE
Sbjct: 230 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 1e-59
Identities = 63/281 (22%), Positives = 121/281 (43%), Gaps = 25/281 (8%)
Query: 487 FDESYVIGVGGFGKVYKGVI-----EDKLKVAIKRSNPS-SEQGVNEFVTEIEMLSKLRH 540
F + V+G G FG VYKG+ + K+ VAIK + S + E + E +++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 541 KHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHT 600
H+ L+G C + L+ M G L +++ K + + L C+ A+G++YL
Sbjct: 71 PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 128
Query: 601 GAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFK 660
++HRD+ N+L+ K++DFGL+K E + + K ++ E
Sbjct: 129 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186
Query: 661 RQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720
+ T +SD++S+GV ++E++ +P ++S I++ +
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---------------SILEKGER 231
Query: 721 DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQ 761
P C KC RP +++ + +
Sbjct: 232 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 202 bits (515), Expect = 1e-59
Identities = 71/312 (22%), Positives = 127/312 (40%), Gaps = 48/312 (15%)
Query: 476 SLAEIKHATKSFDESYVIGVGGFGKVYKGV------IEDKLKVAIKRSNP-SSEQGVNEF 528
L +++ + + IG G FG+V++ E VA+K +S +F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 529 VTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNT------------- 575
E ++++ + ++V L+G C G MCL+++YMA G L E + +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 576 ----------KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAK 625
LS ++L I A G+ YL + +HRD+ T N L+ EN V K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVK 180
Query: 626 VSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARP 685
++DFGLS+ + + ++ PE + T +SD++++GVVL+E+
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 686 ALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGID 745
+ E+ ++ + D + C + + C S D
Sbjct: 241 QPYYGMAHEE--------------VIYYVRDGNILA-CPENCPLELYNLMRLCWSKLPAD 285
Query: 746 RPSMGDVLWNLE 757
RPS + L+
Sbjct: 286 RPSFCSIHRILQ 297
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 4e-59
Identities = 65/275 (23%), Positives = 113/275 (41%), Gaps = 26/275 (9%)
Query: 489 ESYVIGVGGFGKVYKGVIEDK---LKVAIKRSNPSSEQG--VNEFVTEIEMLSKLRHKHL 543
E +G G FG V KG + K VA+K + +E + E ++ +L + ++
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 544 VSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAK 603
V +IG CE + LV + LG L +++ + + K +E+ + G+ YL +
Sbjct: 71 VRMIGICEAES-WMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLE---E 125
Query: 604 YTIIHRDVKTTNILLDENWVAKVSDFGLSK-TGPNMENGHVSTVVKGSFGYLDPEYFKRQ 662
+HRD+ N+LL AK+SDFGLSK + T K + PE
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 663 QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDK 722
+ + KSD++SFGV+++E + +V +++ +
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV---------------TAMLEKGERMG 230
Query: 723 ISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757
C ++ D C + +RP V L
Sbjct: 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 8e-59
Identities = 69/313 (22%), Positives = 122/313 (38%), Gaps = 46/313 (14%)
Query: 479 EIKHATKSFDESYVIGVGGFGKVYKGVI------EDKLKVAIKRSNPSSEQG-VNEFVTE 531
E SF + +G G FGKV + + + VA+K PS+ ++E
Sbjct: 19 EFPRNRLSFGK--TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSE 76
Query: 532 IEMLSKL-RHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKK------------- 577
+++LS L H ++V+L+G C G ++ +Y G L + +
Sbjct: 77 LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136
Query: 578 ----ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSK 633
AL + L A+G+ +L IHRD+ NILL + K+ DFGL++
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLAR 193
Query: 634 TGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPK 693
N N V + ++ PE T +SD++S+G+ L+E+ + P +P
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253
Query: 694 EQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
+ +I + + D + C + RP+ ++
Sbjct: 254 DS--------------KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299
Query: 754 WNLEFVLQLVEST 766
+E + EST
Sbjct: 300 QLIEKQIS--EST 310
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 1e-58
Identities = 67/275 (24%), Positives = 113/275 (41%), Gaps = 31/275 (11%)
Query: 487 FDESYVIGVGGFGKVYKGV-IEDKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHL 543
FD IG G F VYKG+ E ++VA ++ F E EML L+H ++
Sbjct: 13 FDI--EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 544 VSLIGFCEE----GNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLH 599
V E + LV + M GTL+ ++ K + K C +GL +LH
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLH 129
Query: 600 TGAKYTIIHRDVKTTNILL-DENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEY 658
T IIHRD+K NI + K+ D GL+ ++ + V G+ ++ PE
Sbjct: 130 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPEFMAPEM 184
Query: 659 FKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPL 718
+ ++ E D+Y+FG+ + E+ + + Q+ + + +
Sbjct: 185 Y-EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI----------YRRVTSGVKPAS 233
Query: 719 LKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
PE + E C+ + +R S+ D+L
Sbjct: 234 FDKVAIPEV----KEIIEGCIRQNKDERYSIKDLL 264
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 2e-58
Identities = 78/306 (25%), Positives = 137/306 (44%), Gaps = 41/306 (13%)
Query: 492 VIGVGGFGKVYKGVIED---KLKVAIKRSNP-SSEQGVNEFVTEIEMLSKL-RHKHLVSL 546
VIG G FG+V K I+ ++ AIKR +S+ +F E+E+L KL H ++++L
Sbjct: 17 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 76
Query: 547 IGFCEEGNEMCLVYDYMALGTLREHIYN---------------TKKALSWKQRLEICIGA 591
+G CE + L +Y G L + + T LS +Q L
Sbjct: 77 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 136
Query: 592 ARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSF 651
ARG+ YL + IHRD+ NIL+ EN+VAK++DFGLS+ E T+ +
Sbjct: 137 ARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPV 190
Query: 652 GYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGIL 711
++ E T SD++S+GV+L+E++ P ++ A+
Sbjct: 191 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG-----GTPYCGMTCAELY--------- 236
Query: 712 DDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVESTEASSN 771
+ + + + C + D +C + +RPS +L +L +L+ ++ ++
Sbjct: 237 -EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTL 295
Query: 772 RSRGSS 777
+ +
Sbjct: 296 YEKFTY 301
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 197 bits (503), Expect = 7e-58
Identities = 71/277 (25%), Positives = 107/277 (38%), Gaps = 32/277 (11%)
Query: 484 TKSFDESYVIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQG---VNEFVTEIEMLSKLR 539
K F + IG G FG VY + + VAIK+ + S +Q + + E+ L KLR
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 540 HKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLH 599
H + + G + LV +Y + KK L + + GA +GL YLH
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLH 132
Query: 600 TGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYF 659
+ +IHRDVK NILL E + K+ DFG + G+ ++ PE
Sbjct: 133 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVI 183
Query: 660 ---KRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIID 716
Q K D++S G+ E+ +P L + I +
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-----------YHIAQNESP 232
Query: 717 PLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
L S F + + CL DRP+ +L
Sbjct: 233 ALQSGHWSEY----FRNFVDSCLQKIPQDRPTSEVLL 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 8e-58
Identities = 68/285 (23%), Positives = 121/285 (42%), Gaps = 36/285 (12%)
Query: 473 RRFSLAEIKHATKSFDESYVIGVGGFGKVYKGV-IEDKLKVAIK---RSNPSSEQGVNEF 528
R+++L + F+ +G G FG VY + K +A+K ++ ++
Sbjct: 1 RQWALED-------FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 53
Query: 529 VTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEIC 588
E+E+ S LRH +++ L G+ + + L+ +Y LGT+ + K ++
Sbjct: 54 RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYI 112
Query: 589 IGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVK 648
A L Y H +IHRD+K N+LL K++DFG S P+ +
Sbjct: 113 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LC 165
Query: 649 GSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRK 708
G+ YL PE + + EK D++S GV+ +E L +P + +E + + +
Sbjct: 166 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-----YKRISRVE 220
Query: 709 GILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
D + +D IS + L + RP + +VL
Sbjct: 221 FTFPDFVTEGARDLIS------------RLLKHNPSQRPMLREVL 253
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 4e-57
Identities = 59/296 (19%), Positives = 120/296 (40%), Gaps = 47/296 (15%)
Query: 492 VIGVGGFGKVYKGV------IEDKLKVAIKRSNPSSEQG-VNEFVTEIEMLSKL-RHKHL 543
V+G G FGKV ++VA+K ++ ++E++M+++L H+++
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 544 VSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKK----------------------ALSW 581
V+L+G C + L+++Y G L ++ + ++ L++
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 582 KQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641
+ L A+G+ +L + +HRD+ N+L+ V K+ DFGL++ + N
Sbjct: 164 EDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 642 HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADW 701
V + ++ PE T KSD++S+G++L+E+ P +P +
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA------ 274
Query: 702 ALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757
+I K ++ + C + RPS ++ L
Sbjct: 275 --------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 2e-56
Identities = 66/277 (23%), Positives = 109/277 (39%), Gaps = 28/277 (10%)
Query: 487 FDESYVIGVGGFGKVYKGV-IEDKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHL 543
++ Y IG G +G+ K D + K + S E V+E+ +L +L+H ++
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 544 VSLIGFC--EEGNEMCLVYDYMALGTLREHIYNTKK---ALSWKQRLEICIGAARGLHYL 598
V + +V +Y G L I K L + L + L
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 599 H--TGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDP 656
H + +T++HRD+K N+ LD K+ DFGL++ + + G+ Y+ P
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN--HDTSFAKAFVGTPYYMSP 183
Query: 657 EYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIID 716
E R EKSDI+S G +L+E+ P P Q LA K
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMP---PFTAFSQKELAGKIREGKF--------- 231
Query: 717 PLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
+ + S E + + L+ RPS+ ++L
Sbjct: 232 RRIPYRYSDEL----NEIITRMLNLKDYHRPSVEEIL 264
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 2e-56
Identities = 65/275 (23%), Positives = 111/275 (40%), Gaps = 25/275 (9%)
Query: 492 VIGVGGFGKVYKGVI----EDKLKVAIKRSNPSSEQGVNE-FVTEIEMLSKLRHKHLVSL 546
IG G FG V++G+ L VAIK + V E F+ E + + H H+V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 547 IGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTI 606
IG E + ++ + LG LR + K +L + + L YL
Sbjct: 74 IGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRF 129
Query: 607 IHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTE 666
+HRD+ N+L+ N K+ DFGLS+ + + ++ K ++ PE ++ T
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTS 188
Query: 667 KSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPE 726
SD++ FGV ++E+L + P + + + +R + P
Sbjct: 189 ASDVWMFGVCMWEILMHG--VKPFQGVKNNDVIGRIENGER-------------LPMPPN 233
Query: 727 CLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQ 761
C KC + RP ++ L +L+
Sbjct: 234 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 4e-56
Identities = 64/279 (22%), Positives = 120/279 (43%), Gaps = 22/279 (7%)
Query: 476 SLAEIKHATKSFDESYVIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEM 534
S+ + K + IG G G VY + + +VAI++ N + + EI +
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 535 LSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARG 594
+ + ++ ++V+ + G+E+ +V +Y+A G+L + + T Q +C +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQA 128
Query: 595 LHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYL 654
L +LH +IHRD+K+ NILL + K++DFG + + G+ ++
Sbjct: 129 LEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWM 183
Query: 655 DPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDI 714
PE R+ K DI+S G++ E++ P P L+ ++
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-------LYLIATNGTPEL 236
Query: 715 IDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
+P +K+S F D +CL R S ++L
Sbjct: 237 QNP---EKLSAI----FRDFLNRCLDMDVEKRGSAKELL 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 4e-56
Identities = 64/279 (22%), Positives = 112/279 (40%), Gaps = 29/279 (10%)
Query: 492 VIGVGGFGKVYKGVIE----DKLKVAIKRSNP---SSEQGVNEFVTEIEMLSKLRHKHLV 544
+G G FG V +G + + VA+K P S + +++F+ E+ + L H++L+
Sbjct: 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 545 SLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKY 604
L G M +V + LG+L + + + + A G+ YL
Sbjct: 75 RLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SK 130
Query: 605 TIIHRDVKTTNILLDENWVAKVSDFGLSK-TGPNMENGHVSTVVKGSFGYLDPEYFKRQQ 663
IHRD+ N+LL + K+ DFGL + N ++ + K F + PE K +
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190
Query: 664 LTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKI 723
+ SD + FGV L+E+ L Q IL I +
Sbjct: 191 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--------------ILHKIDKEGERLPR 236
Query: 724 SPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQL 762
+C + + +C + DRP+ + +F+L+
Sbjct: 237 PEDCPQDIYNVMVQCWAHKPEDRPTFVAL---RDFLLEA 272
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 5e-55
Identities = 66/274 (24%), Positives = 104/274 (37%), Gaps = 25/274 (9%)
Query: 487 FDESY----VIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNE-FVTEIEMLSKLRH 540
F E + +G G +G+V V + VA+K + E EI + L H
Sbjct: 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 62
Query: 541 KHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHT 600
+++V G EGN L +Y + G L + I + G+ YLH
Sbjct: 63 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH- 120
Query: 601 GAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFK 660
I HRD+K N+LLDE K+SDFGL+ + + G+ Y+ PE K
Sbjct: 121 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 661 RQQL-TEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719
R++ E D++S G+VL +L + Q + +
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ----------EYSDWKEKKTYLNP 228
Query: 720 KDKISPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
KI L K L ++ R ++ D+
Sbjct: 229 WKKIDSAPL----ALLHKILVENPSARITIPDIK 258
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 189 bits (482), Expect = 2e-54
Identities = 60/265 (22%), Positives = 107/265 (40%), Gaps = 22/265 (8%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFC 550
+G G FG V++ A K E EI+ +S LRH LV+L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 551 EEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRD 610
E+ NEM ++Y++M+ G L E + + +S + +E +GL ++H + +H D
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLD 149
Query: 611 VKTTNILL--DENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKS 668
+K NI+ + K+ DFGL+ +++ V G+ + PE + + + +
Sbjct: 150 LKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYT 206
Query: 669 DIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECL 728
D++S GV+ + +L E L + + +D IS +
Sbjct: 207 DMWSVGVLSYILLSGLSPFGGENDDET-------LRNVKSCDWN--MDDSAFSGISEDGK 257
Query: 729 KKFADTAEKCLSDSGIDRPSMGDVL 753
D K L R ++ L
Sbjct: 258 ----DFIRKLLLADPNTRMTIHQAL 278
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 2e-53
Identities = 67/296 (22%), Positives = 136/296 (45%), Gaps = 43/296 (14%)
Query: 492 VIGVGGFGKVYKGV--------IEDKLKVAIKRSNP-SSEQGVNEFVTEIEMLSKL-RHK 541
+G G FG+V KVA+K ++E+ +++ ++E+EM+ + +HK
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 542 HLVSLIGFCEEGNEMCLVYDYMALGTLREHI---------------YNTKKALSWKQRLE 586
++++L+G C + + ++ +Y + G LRE++ +N ++ LS K +
Sbjct: 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139
Query: 587 ICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTV 646
ARG+ YL IHRD+ N+L+ E+ V K++DFGL++ +++ +T
Sbjct: 140 CAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 647 VKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCK 706
+ ++ PE + T +SD++SFGV+L+E+ + P +P E+
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----------- 245
Query: 707 RKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQL 762
L ++ + C + C RP+ ++ +L+ ++ L
Sbjct: 246 ----LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 1e-52
Identities = 52/274 (18%), Positives = 97/274 (35%), Gaps = 26/274 (9%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIK---RSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLI 547
++G G F V + + AIK + + E V E +++S+L H V L
Sbjct: 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 548 GFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTII 607
++ ++ Y G L ++I L YLH II
Sbjct: 75 FTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEYLH---GKGII 130
Query: 608 HRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEK 667
HRD+K NILL+E+ +++DFG +K + G+ Y+ PE + +
Sbjct: 131 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKS 190
Query: 668 SDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPEC 727
SD+++ G ++++++ P + K + + P +D +
Sbjct: 191 SDLWALGCIIYQLVAGLPPFRAGNEYLI-----FQKIIKLEYDFPEKFFPKARDLVE--- 242
Query: 728 LKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQ 761
K L R ++ +
Sbjct: 243 ---------KLLVLDATKRLGCEEME-GYGPLKA 266
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 6e-52
Identities = 67/299 (22%), Positives = 127/299 (42%), Gaps = 36/299 (12%)
Query: 479 EIKHATKSFDESYVIGVGGFGKVYKGV------IEDKLKVAIKRSNPS-SEQGVNEFVTE 531
E+ + S +G G FG VY+GV E + +VAIK N + S + EF+ E
Sbjct: 16 EVAR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73
Query: 532 IEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKA---------LSWK 582
++ + H+V L+G +G ++ + M G L+ ++ + + A S
Sbjct: 74 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 583 QRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642
+ +++ A G+ YL+ +HRD+ N ++ E++ K+ DFG+++ +
Sbjct: 134 KMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190
Query: 643 VSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWA 702
++ PE K T SD++SFGVVL+E+ L EQ
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ------- 243
Query: 703 LHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQ 761
+L +++ L D C + C + RPS +++ +++ ++
Sbjct: 244 -------VLRFVMEGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 180 bits (457), Expect = 5e-51
Identities = 56/265 (21%), Positives = 107/265 (40%), Gaps = 22/265 (8%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFC 550
+G G FG V++ V K N EI ++++L H L++L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 551 EEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRD 610
E+ EM L+ ++++ G L + I +S + + A GL ++H +++I+H D
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLD 152
Query: 611 VKTTNILLD--ENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKS 668
+K NI+ + + K+ DFGL+ + + V + + PE R+ + +
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATK---LNPDEIVKVTTATAEFAAPEIVDREPVGFYT 209
Query: 669 DIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECL 728
D+++ GV+ + +L E L ++ + D +SPE
Sbjct: 210 DMWAIGVLGYVLLSGLSPFAGEDDLET-------LQNVKRCDWE--FDEDAFSSVSPEAK 260
Query: 729 KKFADTAEKCLSDSGIDRPSMGDVL 753
D + L R ++ D L
Sbjct: 261 ----DFIKNLLQKEPRKRLTVHDAL 281
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 7e-50
Identities = 62/294 (21%), Positives = 116/294 (39%), Gaps = 41/294 (13%)
Query: 492 VIGVGGFGKVYKGV------IEDKLKVAIKRSNPSSEQG-VNEFVTEIEMLSK-LRHKHL 543
+G G FG+V + VA+K + ++E+++L H ++
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 544 VSLIGFC-EEGNEMCLVYDYMALGTLREHIYN---------------TKKALSWKQRLEI 587
V+L+G C + G + ++ ++ G L ++ + K L+ + +
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 588 CIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVV 647
A+G+ +L IHRD+ NILL E V K+ DFGL++ +
Sbjct: 140 SFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196
Query: 648 KGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKR 707
+ ++ PE + T +SD++SFGV+L+E+ P V + +
Sbjct: 197 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-----SPYPGVKIDEEFCR--- 248
Query: 708 KGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQ 761
L + D +PE T C RP+ +++ +L +LQ
Sbjct: 249 --RLKEGTRMRAPDYTTPEM----YQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 8e-50
Identities = 49/276 (17%), Positives = 108/276 (39%), Gaps = 27/276 (9%)
Query: 485 KSFDESY----VIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLR 539
K E Y +G G FG V++ V K K EI +L+ R
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIAR 59
Query: 540 HKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLH 599
H++++ L E E+ +++++++ + E I + L+ ++ + L +LH
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 600 TGAKYTIIHRDVKTTNILLD--ENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPE 657
+ I H D++ NI+ + K+ +FG ++ ++ G ++ + Y PE
Sbjct: 120 ---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR---QLKPGDNFRLLFTAPEYYAPE 173
Query: 658 YFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717
+ ++ +D++S G +++ +L ++ + + D+
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE-----NIMNAEYTFDEEAFK 228
Query: 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
+IS E + D ++ L R + + L
Sbjct: 229 ----EISIEAM----DFVDRLLVKERKSRMTASEAL 256
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (431), Expect = 7e-48
Identities = 67/267 (25%), Positives = 110/267 (41%), Gaps = 25/267 (9%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNE-FVTEIEMLSKLRHKHLVSLIGF 549
V+G G F +V + VAIK + +G EI +L K++H ++V+L
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75
Query: 550 CEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHR 609
E G + L+ ++ G L + I K + + + + YLH I+HR
Sbjct: 76 YESGGHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLH---DLGIVHR 131
Query: 610 DVKTTNILL---DENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTE 666
D+K N+L DE+ +SDFGLSK + G V + G+ GY+ PE ++ ++
Sbjct: 132 DLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQKPYSK 188
Query: 667 KSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPE 726
D +S GV+ + +LC P P + L + L + + D D IS
Sbjct: 189 AVDCWSIGVIAYILLCGYP---PFYDENDAKLFEQILKAEYE------FDSPYWDDISDS 239
Query: 727 CLKKFADTAEKCLSDSGIDRPSMGDVL 753
D + R + L
Sbjct: 240 AK----DFIRHLMEKDPEKRFTCEQAL 262
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 168 bits (427), Expect = 9e-48
Identities = 64/277 (23%), Positives = 118/277 (42%), Gaps = 29/277 (10%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLI 547
++G GG +V+ + VA+K F E + + L H +V++
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 548 GFCEE----GNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAK 603
E G +V +Y+ TLR+ ++ ++ K+ +E+ A + L++ H +
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSH---Q 129
Query: 604 YTIIHRDVKTTNILLDENWVAKVSDFGLSKT-GPNMENGHVSTVVKGSFGYLDPEYFKRQ 662
IIHRDVK NI++ KV DFG+++ + + + V G+ YL PE +
Sbjct: 130 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 189
Query: 663 QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK-D 721
+ +SD+YS G VL+EVL P P + + +D I P + +
Sbjct: 190 SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA----------YQHVREDPIPPSARHE 239
Query: 722 KISPECLKKFADTAEKCLSDSGIDRP-SMGDVLWNLE 757
+S + K L+ + +R + ++ +L
Sbjct: 240 GLSAD----LDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 167 bits (425), Expect = 2e-47
Identities = 64/288 (22%), Positives = 116/288 (40%), Gaps = 41/288 (14%)
Query: 487 FDESY----VIGVGGFGKVYKGV-IEDKLKVAIKRSNPSS---------EQGVNEFVTEI 532
F E+Y ++G G V + + + A+K + + ++ + E+
Sbjct: 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60
Query: 533 EMLSKLR-HKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGA 591
++L K+ H +++ L E LV+D M G L +++ K LS K+ +I
Sbjct: 61 DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRAL 119
Query: 592 ARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSF 651
+ LH K I+HRD+K NILLD++ K++DFG S ++ G V G+
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPGEKLREVCGTP 173
Query: 652 GYLDPEYF------KRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHC 705
YL PE ++ D++S GV+++ +L P P ++Q+ + +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP---PFWHRKQMLMLRMIMSG 230
Query: 706 KRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
+ D S D + L R + + L
Sbjct: 231 NYQ------FGSPEWDDYSDTV----KDLVSRFLVVQPQKRYTAEEAL 268
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 1e-45
Identities = 66/310 (21%), Positives = 113/310 (36%), Gaps = 45/310 (14%)
Query: 470 GLCRRFSLAEIKHATKSFDESY----VIGVGGFGKVYKG--VIEDKLKVAIK--RSNPSS 521
GLCR D+ Y IG G +GKV+K + VA+K R
Sbjct: 1 GLCR-------------ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE 47
Query: 522 EQGVNEFVTEIEMLSKL---RHKHLVSLIGFC-----EEGNEMCLVYDYMALGTLREHIY 573
E + E+ +L L H ++V L C + ++ LV++++
Sbjct: 48 EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK 107
Query: 574 NTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSK 633
+ + + ++ RGL +LH + ++HRD+K NIL+ + K++DFGL++
Sbjct: 108 VPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164
Query: 634 TGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPK 693
T V + Y PE + D++S G + E+ +P S
Sbjct: 165 IYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV 221
Query: 694 EQVSL----------ADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSG 743
+Q+ DW +K + + D KCL+ +
Sbjct: 222 DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNP 281
Query: 744 IDRPSMGDVL 753
R S L
Sbjct: 282 AKRISAYSAL 291
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 1e-44
Identities = 65/280 (23%), Positives = 109/280 (38%), Gaps = 24/280 (8%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNE-----FVTEIEMLSKLRHKHLVS 545
+G G F VYK VAIK+ + + EI++L +L H +++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 546 LIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYT 605
L+ + + LV+D+M L I + L+ + +GL YLH ++
Sbjct: 65 LLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHW 120
Query: 606 IIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQL- 664
I+HRD+K N+LLDEN V K++DFGL+K+ T + Y PE ++
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKS--FGSPNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 665 TEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSL----------ADWALHCKRKGILDDI 714
D+++ G +L E+L P L +Q++ W C +
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 715 IDPLLK-DKISPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
P + I D + + R + L
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 159 bits (403), Expect = 5e-44
Identities = 56/276 (20%), Positives = 106/276 (38%), Gaps = 32/276 (11%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLI 547
+G G FG+V+ + A+K + V E MLS + H ++ +
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 548 GFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTII 607
G ++ ++ ++ DY+ G + + L YLH II
Sbjct: 71 GTFQDAQQIFMIMDYI-EGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDII 126
Query: 608 HRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEK 667
+RD+K NILLD+N K++DFG +K P++ + G+ Y+ PE + +
Sbjct: 127 YRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTKPYNKS 181
Query: 668 SDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPEC 727
D +SFG++++E+L S + + + + +KD +S
Sbjct: 182 IDWWSFGILIYEMLAGYTPFYDSNTMKT-----YEKILNAELRFPPFFNEDVKDLLS-RL 235
Query: 728 LKK--------FADTAEKCLSDSGIDRPSMGDVLWN 755
+ + + E + P +V+W
Sbjct: 236 ITRDLSQRLGNLQNGTEDVKNH-----PWFKEVVWE 266
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 6e-44
Identities = 53/282 (18%), Positives = 102/282 (36%), Gaps = 19/282 (6%)
Query: 487 FDESYVIGVGGFGKVYKGV-IEDKLKVAIK--RSNPSSEQGVNEFVTEIEMLSKLRHKHL 543
F + IG G +G VYK VA+K R + +E + + EI +L +L H ++
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 544 VSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAK 603
V L+ N++ LV++++ + + + +GL + H
Sbjct: 64 VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---S 120
Query: 604 YTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQ 663
+ ++HRD+K N+L++ K++DFGL++ + + V + +
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARA-FGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 664 LTEKSDIYSFGVVLFEVLCARPALNPSLPKEQV----------SLADWALHCKRKGILDD 713
+ DI+S G + E++ R +Q+ W
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 714 IIDPLLKD--KISPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
+D K+ P + + L R S L
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 1e-43
Identities = 63/272 (23%), Positives = 102/272 (37%), Gaps = 28/272 (10%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIK---RSNPSSEQGVNEFVTEIEMLSK-LRHKHLVSL 546
++G G FGKV+ + AIK + + V + E +LS H L +
Sbjct: 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68
Query: 547 IGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTI 606
+ + V +Y+ G L HI + K + GL +LH I
Sbjct: 69 FCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH---SKGI 124
Query: 607 IHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTE 666
++RD+K NILLD++ K++DFG+ K NM + G+ Y+ PE Q+
Sbjct: 125 VYRDLKLDNILLDKDGHIKIADFGMCKE--NMLGDAKTNTFCGTPDYIAPEILLGQKYNH 182
Query: 667 KSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPE 726
D +SFGV+L+E+L + + +E H R +P + E
Sbjct: 183 SVDWWSFGVLLYEMLIGQSPFHGQDEEEL-------FHSIRMD------NPFYPRWLEKE 229
Query: 727 CLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758
D K R + +
Sbjct: 230 A----KDLLVKLFVREPEKRLGVRGDIRQHPL 257
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 2e-43
Identities = 65/282 (23%), Positives = 118/282 (41%), Gaps = 23/282 (8%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQG-VNEFVTEIEMLSKLRHKHLVSLIGF 549
IG G +G V +K++VAIK+ +P Q + EI++L + RH++++ +
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74
Query: 550 CEEGNEMCLVYDYMALGTLREHIYN--TKKALSWKQRLEICIGAARGLHYLHTGAKYTII 607
+ Y+ + +Y + LS RGL Y+H ++
Sbjct: 75 IRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVL 131
Query: 608 HRDVKTTNILLDENWVAKVSDFGLSKT-GPNMENGHVSTVVKGSFGYLDPEYFKRQQL-T 665
HRD+K +N+LL+ K+ DFGL++ P+ ++ T + Y PE + T
Sbjct: 132 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 191
Query: 666 EKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDII---------- 715
+ DI+S G +L E+L RP +Q++ L + L+ II
Sbjct: 192 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 251
Query: 716 ----DPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
+ + +++ P K D +K L+ + R + L
Sbjct: 252 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 155 bits (393), Expect = 5e-43
Identities = 51/276 (18%), Positives = 100/276 (36%), Gaps = 19/276 (6%)
Query: 492 VIGVGGFGKVYKGVIEDKLKVAIK--RSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGF 549
IG G +G VYK A+K R E + + EI +L +L+H ++V L
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 550 CEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHR 609
+ LV++++ L++ + + L + G+ Y H ++HR
Sbjct: 69 IHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHR 124
Query: 610 DVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSD 669
D+K N+L++ K++DFGL++ + + + + ++ + D
Sbjct: 125 DLKPQNLLINREGELKIADFGLARA-FGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTID 183
Query: 670 IYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIID------------P 717
I+S G + E++ P +Q+ L ++ + P
Sbjct: 184 IWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP 243
Query: 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
L + + D K L R + L
Sbjct: 244 LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (391), Expect = 1e-42
Identities = 50/275 (18%), Positives = 87/275 (31%), Gaps = 23/275 (8%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFC 550
IG G FG +Y G I +VAIK ++ + E ++ ++ + I +C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 551 EEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRD 610
+ ++ + +L + + S K L + + Y+H IHRD
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRD 128
Query: 611 VKTTNIL---LDENWVAKVSDFGLSK-----TGPNMENGHVSTVVKGSFGYLDPEYFKRQ 662
VK N L + + + DFGL+K + + G+ Y
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI 188
Query: 663 QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDK 722
+ + + D+ S G VL + + K +L
Sbjct: 189 EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-----TPIEVLCKG 243
Query: 723 ISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757
E FA C S D+P +
Sbjct: 244 YPSE----FATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 154 bits (391), Expect = 6e-42
Identities = 59/272 (21%), Positives = 99/272 (36%), Gaps = 30/272 (11%)
Query: 487 FDESYVIGVGGFGKVYKGV-IEDKLKVAIK---RSNPSSEQGVNEFVTE---IEMLSKLR 539
F +IG GGFG+VY + A+K + +QG + E + ++S
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 540 HKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLH 599
+V + +++ + D M G L H+ S GL ++H
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMH 124
Query: 600 TGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYF 659
+++RD+K NILLDE+ ++SD GL+ + G+ GY+ PE
Sbjct: 125 ---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVL 177
Query: 660 KRQQ-LTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPL 718
++ +D +S G +LF++L K++ + L
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA----------VE 227
Query: 719 LKDKISPECLKKFADTAEKCLSDSGIDRPSMG 750
L D SPE E L R
Sbjct: 228 LPDSFSPEL----RSLLEGLLQRDVNRRLGCL 255
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-41
Identities = 58/284 (20%), Positives = 112/284 (39%), Gaps = 35/284 (12%)
Query: 485 KSFDESY----VIGVGGFGKVYKGV-IEDKLKVAIKRSNPSS------EQGVNEFVTEIE 533
++ D+ Y +G G F V K L+ A K + E+
Sbjct: 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 534 MLSKLRHKHLVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAAR 593
+L +++H ++++L E ++ L+ + +A G L + + K++L+ ++ E
Sbjct: 66 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILN 124
Query: 594 GLHYLHTGAKYTIIHRDVKTTNILLDENWVA----KVSDFGLSKTGPNMENGHVSTVVKG 649
G++YLH I H D+K NI+L + V K+ DFGL+ ++ G+ + G
Sbjct: 125 GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFG 178
Query: 650 SFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKG 709
+ ++ PE + L ++D++S GV+ + +L +E A
Sbjct: 179 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-----LANVSAVNY 233
Query: 710 ILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
+D S D + L R ++ D L
Sbjct: 234 EFEDEYFS----NTSALA----KDFIRRLLVKDPKKRMTIQDSL 269
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 2e-41
Identities = 57/273 (20%), Positives = 103/273 (37%), Gaps = 41/273 (15%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNE------FVTEIEMLSKLRHKH-- 542
++G GGFG VY G+ + D L VAIK E E+ +L K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 543 LVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGA 602
++ L+ + E + L+ + + AL + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 127
Query: 603 KYTIIHRDVKTTNILLDEN-WVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKR 661
++HRD+K NIL+D N K+ DFG + V T G+ Y PE+ +
Sbjct: 128 NCGVLHRDIKDENILIDLNRGELKLIDFGSGA----LLKDTVYTDFDGTRVYSPPEWIRY 183
Query: 662 QQL-TEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720
+ + ++S G++L++++C P E++ +
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDI---PFEHDEEIIRG----------------QVFFR 224
Query: 721 DKISPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
++S EC CL+ DRP+ ++
Sbjct: 225 QRVSSEC----QHLIRWCLALRPSDRPTFEEIQ 253
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 7e-41
Identities = 56/272 (20%), Positives = 107/272 (39%), Gaps = 30/272 (11%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKL-RHKHLVSLIGF 549
V+G+G GKV + + K A+K + E+E+ + + H+V ++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 73
Query: 550 CE----EGNEMCLVYDYMALGTLREHIY-NTKKALSWKQRLEICIGAARGLHYLHTGAKY 604
E + +V + + G L I +A + ++ EI + YLH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SI 130
Query: 605 TIIHRDVKTTNILLD---ENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKR 661
I HRDVK N+L N + K++DFG +K + + T + Y+ PE
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE---TTSHNSLTTPCYTPYYVAPEVLGP 187
Query: 662 QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKD 721
++ + D++S GV+++ +LC P P ++++ R G +
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYP---PFYSNHGLAISPGMKTRIRMGQYE--FPNPEWS 242
Query: 722 KISPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
++S E L R ++ + +
Sbjct: 243 EVSEEVK----MLIRNLLKTEPTQRMTITEFM 270
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 149 bits (376), Expect = 1e-40
Identities = 43/282 (15%), Positives = 88/282 (31%), Gaps = 27/282 (9%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRH-KHLVSLIGF 549
IG G FG +++G + + +VAIK + E L + ++ F
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 550 CEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHR 609
+EG LV D + + + + S K + +H + ++++R
Sbjct: 70 GQEGLHNVLVIDLLGPSL-EDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYR 125
Query: 610 DVKTTNILLDE-----NWVAKVSDFGLSK-----TGPNMENGHVSTVVKGSFGYLDPEYF 659
D+K N L+ + V DFG+ K + G+ Y+
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185
Query: 660 KRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719
++ + + D+ + G V L + K+ L +
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE------ 239
Query: 720 KDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQ 761
+ ++F + + P + VL+
Sbjct: 240 ---LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 5e-40
Identities = 64/290 (22%), Positives = 103/290 (35%), Gaps = 31/290 (10%)
Query: 486 SFDESYVIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLV 544
S+ ++ VIG G FG VY+ + VAIK+ E++++ KL H ++V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIV 76
Query: 545 SLIGFCEEGNE------MCLVYDYMALGTLR--EHIYNTKKALSWKQRLEICIGAARGLH 596
L F E + LV DY+ R H K+ L R L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 597 YLHTGAKYTIIHRDVKTTNILLD-ENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLD 655
Y+H + I HRD+K N+LLD + V K+ DFG +K E + + +
Sbjct: 137 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSRYYRAP 191
Query: 656 PEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDII 715
F T D++S G VL E+L +P +Q+ L + + ++
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 716 DPLLKDKISPECLKKFADTAEKCLSDSGID------------RPSMGDVL 753
+ K + I R + +
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 3e-39
Identities = 62/291 (21%), Positives = 117/291 (40%), Gaps = 33/291 (11%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHLVSLIG 548
IG G FG+V+K + KVA+K+ + E + EI++L L+H+++V+LI
Sbjct: 17 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 76
Query: 549 FCEEG--------NEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHT 600
C + LV+D+ K + + + GL+Y+H
Sbjct: 77 ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQMLLNGLYYIH- 134
Query: 601 GAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVS--TVVKGSFGYLDPEY 658
+ I+HRD+K N+L+ + V K++DFGL++ +N + T + Y PE
Sbjct: 135 --RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 192
Query: 659 FKRQQL-TEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717
++ D++ G ++ E+ P + + + Q++L + ++ +
Sbjct: 193 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 252
Query: 718 LLKDKISPECLKK---------------FADTAEKCLSDSGIDRPSMGDVL 753
L +K+ +K D +K L R D L
Sbjct: 253 ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 1e-38
Identities = 56/278 (20%), Positives = 104/278 (37%), Gaps = 21/278 (7%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIK--RSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIG 548
IG G +G V+K E VA+K R + E + + EI +L +L+HK++V L
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 549 FCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIH 608
++ LV+++ + L + +GL + H ++H
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCH---SRNVLH 124
Query: 609 RDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKS 668
RD+K N+L++ N K+++FGL++ + S V + F + +
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARA-FGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 669 DIYSFGVVLFEVLCARPALNPSLPKEQV-----------SLADWALHCKRKGILDDIIDP 717
D++S G + E+ A L P + + W K + P
Sbjct: 184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP 243
Query: 718 LLKD--KISPECLKKFADTAEKCLSDSGIDRPSMGDVL 753
+ P+ D + L + + R S + L
Sbjct: 244 ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 1e-38
Identities = 61/248 (24%), Positives = 104/248 (41%), Gaps = 16/248 (6%)
Query: 487 FDESYVIGVGGFGKVYKGV-IEDKLKVAIK---RSNPSSEQGVNEFVTEIEMLSKLRHKH 542
FD ++G G FGKV A+K + ++ V VTE +L RH
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 543 LVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGA 602
L +L + + +C V +Y G L H+ ++ + ++ L YLH
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLH--- 122
Query: 603 KYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQ 662
+++RD+K N++LD++ K++DFGL K G + +G G+ YL PE +
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 663 QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDK 722
D + GVV++E++C R + + L + + P K
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-----FELILMEEIRFPRTLSPEAKSL 235
Query: 723 ISPECLKK 730
++ LKK
Sbjct: 236 LA-GLLKK 242
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 2e-38
Identities = 61/306 (19%), Positives = 108/306 (35%), Gaps = 37/306 (12%)
Query: 475 FSLAEIKHATKSFDESY----VIGVGGFGKVYKGV-IEDKLKVAIK--RSNPSSEQGVNE 527
F E+ Y +G G +G V V KVAIK SE
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 528 FVTEIEMLSKLRHKHLVSLIGFCEEGN------EMCLVYDYMALGTLREHIYNTKKALSW 581
E+ +L +RH++++ L+ + LV +M GT + +K L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK-LGE 120
Query: 582 KQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641
+ + +GL Y+H IIHRD+K N+ ++E+ K+ DFGL++ +
Sbjct: 121 DRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR----QADS 173
Query: 642 HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADW 701
++ V + + T+ DI+S G ++ E++ + S +Q+
Sbjct: 174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 233
Query: 702 ALHCKRKGILDDIIDPLLKD--------------KISPECLKKFADTAEKCLSDSGIDRP 747
+ + K+ I + EK L R
Sbjct: 234 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 293
Query: 748 SMGDVL 753
+ G+ L
Sbjct: 294 TAGEAL 299
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 140 bits (353), Expect = 5e-37
Identities = 49/243 (20%), Positives = 92/243 (37%), Gaps = 19/243 (7%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIK---RSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLI 547
+G G FG+V E A+K + + + + E +L + LV L
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 548 GFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTII 607
++ + + +V +Y+A G + H+ + S YLH +I
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 608 HRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEK 667
+RD+K N+L+D+ +V+DFG +K + + G+ L PE + +
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNKA 218
Query: 668 SDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPEC 727
D ++ GV+++E+ P P + + K LKD +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI-----YEKIVSGKVRFPSHFSSDLKDLLR-NL 272
Query: 728 LKK 730
L+
Sbjct: 273 LQV 275
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 129 bits (325), Expect = 2e-33
Identities = 50/289 (17%), Positives = 108/289 (37%), Gaps = 40/289 (13%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLR-HKHLVSLIGF 549
+G G + +V++ + I + KV +K P ++ + EI++L LR ++++L
Sbjct: 42 KLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLADI 98
Query: 550 CEEGNE--MCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTII 607
++ LV++++ ++ + L+ + L Y H I+
Sbjct: 99 VKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH---SMGIM 151
Query: 608 HRDVKTTNILLD-ENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQL-T 665
HRDVK N+++D E+ ++ D+GL++ G V S + PE Q+
Sbjct: 152 HRDVKPHNVMIDHEHRKLRLIDWGLAEF---YHPGQEYNVRVASRYFKGPELLVDYQMYD 208
Query: 666 EKSDIYSFGVVLFEVLCARPALNPS---------LPKEQVSLADWALHCKRKGILDDIID 716
D++S G +L ++ + + K + + K LD +
Sbjct: 209 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 268
Query: 717 PLLKDKISPECLKKFADTAEKCLSDSGID------------RPSMGDVL 753
+L + + +S +D R + + +
Sbjct: 269 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 317
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 1e-32
Identities = 62/318 (19%), Positives = 114/318 (35%), Gaps = 48/318 (15%)
Query: 474 RFSLAEIKHATKSFDESY----VIGVGGFGKVYKGV-IEDKLKVAIKRSNPS--SEQGVN 526
+F E+ +T + + Y IG G G V VAIK+ + ++
Sbjct: 2 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61
Query: 527 EFVTEIEMLSKLRHKHLVSLIGFC------EEGNEMCLVYDYMALGTLREHIYNTKKALS 580
E+ ++ + HK+++SL+ EE ++ LV + M + + L
Sbjct: 62 RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI----QMELD 117
Query: 581 WKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640
++ + G+ +LH IIHRD+K +NI++ + K+ DFGL++T
Sbjct: 118 HERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGT 171
Query: 641 GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLAD 700
+ T + Y PE E DI+S G ++ E++ + +Q +
Sbjct: 172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 231
Query: 701 WALHCKRKGILDDIIDPLLK-------------DKISPECLKKFADTAEKCLSDSGID-- 745
L + + + K+ P+ L K + D
Sbjct: 232 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 291
Query: 746 ----------RPSMGDVL 753
R S+ D L
Sbjct: 292 SKMLVIDPAKRISVDDAL 309
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 5e-32
Identities = 61/270 (22%), Positives = 105/270 (38%), Gaps = 29/270 (10%)
Query: 492 VIGVGGFGKVYKGV----IEDKLKVAIKRSNPSS----EQGVNEFVTEIEMLSKLRHK-H 542
V+G G +GKV+ + A+K ++ + TE ++L +R
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90
Query: 543 LVSLIGFCEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGA 602
LV+L + ++ L+ DY+ G L H+ ++ + + L +LH
Sbjct: 91 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLALEHLH--- 146
Query: 603 KYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQ 662
K II+RD+K NILLD N ++DFGLSK E + G+ Y+ P+ +
Sbjct: 147 KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGG 205
Query: 663 Q--LTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720
+ D +S GV+++E+L K + IL +P
Sbjct: 206 DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-------QAEISRRILKS--EPPYP 256
Query: 721 DKISPECLKKFADTAEKCLSDSGIDRPSMG 750
++S D ++ L R G
Sbjct: 257 QEMSALA----KDLIQRLLMKDPKKRLGCG 282
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 2e-31
Identities = 57/304 (18%), Positives = 109/304 (35%), Gaps = 33/304 (10%)
Query: 475 FSLAEIKHATKSFDESY----VIGVGGFGKVYKGV-IEDKLKVAIKRSNPS--SEQGVNE 527
F E+ E Y +G G +G V + L+VA+K+ + S
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 528 FVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMAL----GTLREHIYNTKKALSWKQ 583
E+ +L ++H++++ L+ + D + G +I +K L+
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDH 122
Query: 584 RLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643
+ RGL Y+H IIHRD+K +N+ ++E+ K+ DFGL+ + +
Sbjct: 123 VQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEM 175
Query: 644 STVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWAL 703
+ V + + DI+S G ++ E+L R + +Q+ L +
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235
Query: 704 HCKRKGILDDIIDPLLKDKIS--PECLKKFADTAEKCLSDSGID------------RPSM 749
+L I ++ I + K + +D R +
Sbjct: 236 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 295
Query: 750 GDVL 753
L
Sbjct: 296 AQAL 299
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 109 bits (272), Expect = 2e-26
Identities = 37/227 (16%), Positives = 72/227 (31%), Gaps = 20/227 (8%)
Query: 492 VIGVGGFGKVYKGV-IEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFC 550
+G G F V+ + + VA+K + EI++L ++
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 551 EE---------------GNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGL 595
G + +V++ + L + + +I GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 596 HYLHTGAKYTIIHRDVKTTNILLD-ENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYL 654
Y+H + IIH D+K N+L++ + + ++ G T + Y
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 655 DPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADW 701
PE +DI+S ++FE++ P D
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 82.9 bits (204), Expect = 9e-19
Identities = 28/201 (13%), Positives = 53/201 (26%), Gaps = 43/201 (21%)
Query: 492 VIGVGGFGKVYKGVIEDKLKVAIKRSNPSS----------EQGVNEFVTEIEMLSKLRHK 541
++G G V+ E + +K + G F ++ +
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 542 HLVSLIGFCE----EGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHY 597
L L G ++ + + L + E+ +
Sbjct: 67 ALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVR--------VENPDEVLDMILEEVAK 118
Query: 598 LHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDP- 656
+ I+H D+ N+L+ E + + DF S L+
Sbjct: 119 FY---HRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEG----------WREILERD 164
Query: 657 -----EYFKRQQLTEKSDIYS 672
YF R + DI S
Sbjct: 165 VRNIITYFSRTY-RTEKDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 817 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.54 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.01 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.32 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.63 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.62 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.37 | |
| d2o14a1 | 146 | Hypothetical protein YxiM {Bacillus subtilis [TaxI | 93.43 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=426.73 Aligned_cols=263 Identities=27% Similarity=0.503 Sum_probs=208.9
Q ss_pred hcCCCcceeEeeeCceEEEEEEEecccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
..+|...++||+|+||+||+|++++ .||||+++.. ..+..+.|.+|+++|++++|||||++++++.+ ...++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 3567888899999999999998754 5999998654 44567889999999999999999999999865 56899999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
||++|+|.+++......+++.+++.|+.||++||+|||+++ ||||||||+||||+.++.+||+|||+++........
T Consensus 84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 99999999999877678999999999999999999999876 999999999999999999999999999875544434
Q ss_pred ceeeeeecCcCCCChhhhcc---CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcc
Q 039107 642 HVSTVVKGSFGYLDPEYFKR---QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPL 718 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~---~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (817)
.......||+.|||||++.+ ..++.++|||||||+||||+||+.||......... ...+.. +. ..+.
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~--~~~~~~----~~----~~p~ 230 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI--IFMVGR----GY----LSPD 230 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH--HHHHHH----TS----CCCC
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH--HHHHhc----CC----CCCc
Confidence 44456689999999999864 35899999999999999999999999765433221 111111 11 1111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 039107 719 LKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLV 763 (817)
Q Consensus 719 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 763 (817)
+ ......++..+.+|+.+||+.||++|||+++|+++|+.+.+..
T Consensus 231 ~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 231 L-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp G-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred c-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 1 1123345567899999999999999999999999999887643
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=423.21 Aligned_cols=257 Identities=28% Similarity=0.455 Sum_probs=203.9
Q ss_pred cCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEecc
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMA 564 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 564 (817)
.+|+..+.||+|+||+||+|.+.++..||||++.... ...++|.+|++++++++|||||+++|+|...+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 4677888999999999999999888889999988643 445789999999999999999999999999999999999999
Q ss_pred CCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCcee
Q 039107 565 LGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVS 644 (817)
Q Consensus 565 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 644 (817)
+|+|.+++......++|..++.|+.||+.||+|||+++ |+||||||+||||++++.+||+|||+++...... ....
T Consensus 84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~-~~~~ 159 (263)
T d1sm2a_ 84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSS 159 (263)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC-ceee
Confidence 99999999877778999999999999999999999776 9999999999999999999999999998654322 2223
Q ss_pred eeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCCC
Q 039107 645 TVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKIS 724 (817)
Q Consensus 645 ~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 724 (817)
....||+.|+|||++.+..++.++|||||||+||||+|+..|+....... .+...+.. + .+...+
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~--~~~~~i~~----~---------~~~~~p 224 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDIST----G---------FRLYKP 224 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH--HHHHHHHH----T---------CCCCCC
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH--HHHHHHHh----c---------CCCCCc
Confidence 34578999999999999999999999999999999999654443322211 11111111 1 011122
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 039107 725 PECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQ 761 (817)
Q Consensus 725 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 761 (817)
..++.++.+|+.+||+.||++||||++|+++|+.+++
T Consensus 225 ~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 3345678999999999999999999999999998865
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.5e-50 Score=430.20 Aligned_cols=259 Identities=23% Similarity=0.407 Sum_probs=203.3
Q ss_pred CCCcceeEeeeCceEEEEEEEec-c---cEEEEEecCCC-CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIED-K---LKVAIKRSNPS-SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
+|+..++||+|+||+||+|+++. + ..||||++... .....++|.+|+++|++++|||||+++|+|...+..++||
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~ 106 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT 106 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 45567899999999999999753 2 35899987754 4445678999999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
|||++|+|.+++......++|.+++.|+.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 107 Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 183 (299)
T d1jpaa_ 107 EFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183 (299)
T ss_dssp ECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred EecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCCCC
Confidence 999999999998877778999999999999999999999766 99999999999999999999999999986543222
Q ss_pred Cc---eeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccC
Q 039107 641 GH---VSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIID 716 (817)
Q Consensus 641 ~~---~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (817)
.. ......||+.|||||.+.++.++.++|||||||+||||+| |++||......+ +...+.. +
T Consensus 184 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~---~~~~i~~----~------- 249 (299)
T d1jpaa_ 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD---VINAIEQ----D------- 249 (299)
T ss_dssp ------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHT----T-------
T ss_pred cceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH---HHHHHHc----C-------
Confidence 11 1223457999999999999999999999999999999998 899987654322 1111111 1
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 039107 717 PLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLV 763 (817)
Q Consensus 717 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 763 (817)
.+...+.+++..+.+|+.+||+.||++||||++|++.|+.+++.+
T Consensus 250 --~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p 294 (299)
T d1jpaa_ 250 --YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294 (299)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred --CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence 111223345667899999999999999999999999999988654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-49 Score=416.83 Aligned_cols=257 Identities=23% Similarity=0.417 Sum_probs=209.0
Q ss_pred hcCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
.++|+..+.||+|+||+||+|.++++..||||+++... ...++|.+|+++|++++|||||+++|+|.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 35678888999999999999999888899999997543 345789999999999999999999998865 5679999999
Q ss_pred cCCchhhhhhcccc-ccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 564 ALGTLREHIYNTKK-ALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 564 ~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
++|+|.+++..... .++|.++++|+.||++||+|||+++ |+||||||+||||++++.+||+|||+++...... ..
T Consensus 90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-~~ 165 (272)
T d1qpca_ 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YT 165 (272)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EE
T ss_pred CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc-cc
Confidence 99999998865543 6999999999999999999999766 9999999999999999999999999998754322 22
Q ss_pred eeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCC
Q 039107 643 VSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDK 722 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (817)
......||+.|+|||++.++.++.++|||||||+||||+||..|+....... .+...+. .+ .+..
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~--~~~~~i~----~~---------~~~~ 230 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNLE----RG---------YRMV 230 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHH----TT---------CCCC
T ss_pred cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH--HHHHHHH----hc---------CCCC
Confidence 2334578999999999999999999999999999999999765554332221 1111111 11 1111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 039107 723 ISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQ 761 (817)
Q Consensus 723 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 761 (817)
.+..++..+.+|+.+||+.||++||||++|++.|+....
T Consensus 231 ~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 223445678999999999999999999999999987653
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-49 Score=416.77 Aligned_cols=263 Identities=26% Similarity=0.425 Sum_probs=207.9
Q ss_pred cCCCcceeEeeeCceEEEEEEEecc-----cEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIEDK-----LKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCL 558 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 558 (817)
..|...++||+|+||+||+|.++.. ..||||++.... .....+|.+|+++|++++|||||+++|+|.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 3577888999999999999997643 469999987543 3345679999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCC
Q 039107 559 VYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNM 638 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 638 (817)
|||||.+++|.+++......++|.+++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 99999999999988777778999999999999999999999766 999999999999999999999999999875432
Q ss_pred CC-CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCc
Q 039107 639 EN-GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717 (817)
Q Consensus 639 ~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (817)
.. ........||+.|+|||++.++.++.++|||||||+||||++|..|+.......+ +...+. .
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~--~~~~i~----~--------- 228 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VMKAIN----D--------- 228 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHH----T---------
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH--HHHHHh----c---------
Confidence 22 2233345689999999999999999999999999999999997666544332211 111111 1
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhcc
Q 039107 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLVES 765 (817)
Q Consensus 718 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 765 (817)
..+...+..++..+.+|+.+||+.||++||||.+|++.|+.+++.+++
T Consensus 229 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~~ 276 (283)
T d1mqba_ 229 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 276 (283)
T ss_dssp TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred cCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCccc
Confidence 111223344567789999999999999999999999999998876543
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=414.65 Aligned_cols=253 Identities=26% Similarity=0.339 Sum_probs=203.6
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
++|+..++||+|+||+||+|+.+ +++.||||++.... ....+.+.+|+++|++++|||||++++++.+.+..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 46888999999999999999975 57899999976543 23346789999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
+++|+|.+++... ..+++.+++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.........
T Consensus 85 ~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 85 CSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp CTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cCCCcHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 9999999998643 46999999999999999999999876 9999999999999999999999999998754333333
Q ss_pred eeeeeecCcCCCChhhhccCCC-CchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccC
Q 039107 643 VSTVVKGSFGYLDPEYFKRQQL-TEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKD 721 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (817)
......||+.|||||++.+..+ +.++|||||||+||||++|++||......... ...+ ..... ..
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~~~----~~~~~---------~~ 226 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDW----KEKKT---------YL 226 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HHHH----HTTCT---------TS
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HHHH----hcCCC---------CC
Confidence 3455689999999999988876 57899999999999999999999765432211 1111 11110 00
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 722 KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 722 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
......+.++.+|+.+||+.||++|||++|++++
T Consensus 227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 227 NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0112234567899999999999999999999764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.5e-49 Score=418.77 Aligned_cols=258 Identities=25% Similarity=0.428 Sum_probs=213.2
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
.++|...+.||+|+||+||+|+++ +++.||||+++... ...++|.+|+++|++++|||||+++++|.+.+..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 356788889999999999999986 46789999987553 4467899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcc-ccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 563 MALGTLREHIYNT-KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 563 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
|++|+|.+++... ...+++..++.|+.||++||+|||+++ |+||||||+||||++++.+||+|||+++..... ..
T Consensus 95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~-~~ 170 (287)
T d1opja_ 95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TY 170 (287)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS-SS
T ss_pred ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCC-Cc
Confidence 9999999998754 347999999999999999999999876 999999999999999999999999999875432 22
Q ss_pred ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccC
Q 039107 642 HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKD 721 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (817)
.......|++.|+|||++.++.++.++|||||||++|||++|..|+........ +.+.+. .....
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~--~~~~i~-------------~~~~~ 235 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELLE-------------KDYRM 235 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHH-------------TTCCC
T ss_pred eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH--HHHHHh-------------cCCCC
Confidence 333445689999999999999999999999999999999998777654433221 111111 11112
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 039107 722 KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQ 761 (817)
Q Consensus 722 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 761 (817)
..+..++..+.+|+.+||+.||++||||++|++.|+.+.+
T Consensus 236 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 2333455678999999999999999999999999987654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=408.19 Aligned_cols=253 Identities=28% Similarity=0.424 Sum_probs=213.8
Q ss_pred cCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEecc
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMA 564 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 564 (817)
++|+..++||+|+||+||+|+++++..||||+++... ...++|.+|+.++++++||||++++|+|.+.+..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 5788889999999999999999888899999987653 345789999999999999999999999999999999999999
Q ss_pred CCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCcee
Q 039107 565 LGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVS 644 (817)
Q Consensus 565 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 644 (817)
+|+|.+++......+++..+++|+.|+++||+|||+++ |+||||||+|||+++++.+||+|||+++....... ...
T Consensus 83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~ 158 (258)
T d1k2pa_ 83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSS 158 (258)
T ss_dssp TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-CCC
T ss_pred CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc-eee
Confidence 99999998877778999999999999999999999766 99999999999999999999999999986543322 233
Q ss_pred eeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCC
Q 039107 645 TVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKI 723 (817)
Q Consensus 645 ~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 723 (817)
....||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+.. ... .++ .+...
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~------~~i-~~~---------~~~~~ 222 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA------EHI-AQG---------LRLYR 222 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH------HHH-HTT---------CCCCC
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHH------HHH-HhC---------CCCCC
Confidence 34578999999999999999999999999999999998 79898765432211 111 111 01112
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 724 SPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 724 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
+..++.++.+++.+||+.||++|||+++|+++|.+
T Consensus 223 p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred cccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 23445678999999999999999999999999864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=411.75 Aligned_cols=259 Identities=24% Similarity=0.425 Sum_probs=210.9
Q ss_pred cCCCccee-EeeeCceEEEEEEEe---cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEE
Q 039107 485 KSFDESYV-IGVGGFGKVYKGVIE---DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 485 ~~f~~~~~-lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 559 (817)
++|....+ ||+|+||+||+|.++ ++..||||+++... ....++|.+|+++|++++|||||+++|+|.. +..+||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 34555664 999999999999864 34579999987653 3446789999999999999999999999975 568999
Q ss_pred EEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC
Q 039107 560 YDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 639 (817)
||||++|+|.+++...+..+++.+++.|+.||++||+|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 9999999999998777678999999999999999999999876 9999999999999999999999999998654322
Q ss_pred CC-ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCc
Q 039107 640 NG-HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717 (817)
Q Consensus 640 ~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (817)
.. .......||+.|+|||++.++.++.++|||||||++|||+| |+.||......+ +...+ .++.
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~---~~~~i----~~~~------- 229 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFI----EQGK------- 229 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHHHH----HTTC-------
T ss_pred cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH---HHHHH----HcCC-------
Confidence 21 22234568999999999999999999999999999999998 899997654322 11111 1111
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 039107 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLV 763 (817)
Q Consensus 718 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 763 (817)
+...++.++.++.+|+.+||+.||++|||+.+|++.|+......
T Consensus 230 --~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 230 --RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp --CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 11223445667899999999999999999999999998876443
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=420.43 Aligned_cols=256 Identities=22% Similarity=0.399 Sum_probs=208.6
Q ss_pred cCCCcceeEeeeCceEEEEEEEecc------cEEEEEecCCC-CcccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIEDK------LKVAIKRSNPS-SEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEM 556 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~~------~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 556 (817)
++|...++||+|+||+||+|+..+. ..||+|.+... .......|.+|+.+|+++ +|||||+++++|.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 5688889999999999999997532 36999998654 334456799999999998 899999999999999999
Q ss_pred EEEEEeccCCchhhhhhccc----------------------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccC
Q 039107 557 CLVYDYMALGTLREHIYNTK----------------------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTT 614 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~~----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~ 614 (817)
++|||||++|+|.++|.... ..+++..++.++.||++||+|||+++ ||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchh
Confidence 99999999999999997543 24899999999999999999999876 999999999
Q ss_pred cEEEcCCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCcc
Q 039107 615 NILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPK 693 (817)
Q Consensus 615 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~ 693 (817)
|||++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||+||||++ |++||.+....
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987554444444445678999999999999999999999999999999997 89999765432
Q ss_pred ccchHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 039107 694 EQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEF 758 (817)
Q Consensus 694 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 758 (817)
.. +...+ ..+ .+...+..++..+.+|+.+||+.||++|||++||+++|..
T Consensus 274 ~~--~~~~~----~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 274 AN--FYKLI----QNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp HH--HHHHH----HTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HH--HHHHH----hcC---------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 21 11111 111 1112233455678999999999999999999999999964
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=406.83 Aligned_cols=247 Identities=26% Similarity=0.428 Sum_probs=206.1
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
.+|...+.||+|+||+||+|+.+ +++.||+|++... .....+.+.+|+++|++++|||||++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 35888999999999999999975 5688999987642 2234567899999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
|||++|+|.+++... ..+++.+++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++....
T Consensus 86 Ey~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~--- 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 158 (263)
T ss_dssp ECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC---
T ss_pred eecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCC---
Confidence 999999999998654 46999999999999999999999876 99999999999999999999999999986432
Q ss_pred CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
.......||+.|||||++.+..++.++|||||||+||||++|+.||......+.. .... +. +.
T Consensus 159 -~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~------~~i~-~~------~~--- 221 (263)
T d2j4za1 159 -SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY------KRIS-RV------EF--- 221 (263)
T ss_dssp -CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHH-TT------CC---
T ss_pred -CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHH------HHHH-cC------CC---
Confidence 2234567999999999999999999999999999999999999999765432211 1100 11 01
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
.++...+.++.+++.+||+.||++|||++|+++|-
T Consensus 222 -~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp 256 (263)
T d2j4za1 222 -TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 256 (263)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCH
T ss_pred -CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCc
Confidence 12223455678999999999999999999999763
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=412.22 Aligned_cols=250 Identities=24% Similarity=0.382 Sum_probs=208.5
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
++|...+.||+|+||+||+|... +++.||||++........+.+.+|+++|++++|||||++++++.+.+..++|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 46899999999999999999964 57899999987665556678999999999999999999999999999999999999
Q ss_pred cCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCce
Q 039107 564 ALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643 (817)
Q Consensus 564 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 643 (817)
++|+|.+++.. +.+++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++..... ...
T Consensus 100 ~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~--~~~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSK 172 (293)
T ss_dssp TTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST--TCC
T ss_pred CCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccc--ccc
Confidence 99999998753 46999999999999999999999876 999999999999999999999999999865332 223
Q ss_pred eeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCC
Q 039107 644 STVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKI 723 (817)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 723 (817)
.....||+.|+|||++.++.++.++|||||||++|||++|+.||......+... .....+. +. ...
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~------~~~~~~~------~~--~~~ 238 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIATNGT------PE--LQN 238 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHHCS------CC--CSS
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHH------HHHhCCC------CC--CCC
Confidence 345579999999999999999999999999999999999999997654322111 1111110 00 111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 724 SPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 724 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
+..++..+.+|+.+||+.||.+|||+.|+++|
T Consensus 239 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 23345668999999999999999999999876
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=411.92 Aligned_cols=251 Identities=25% Similarity=0.375 Sum_probs=207.9
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEecc
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMA 564 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 564 (817)
.|+..+.||+|+||+||+|+.. ++..||||++........+.|.+|+++|++++|||||++++++.+.+..++|||||+
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~ 92 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 92 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCC
Confidence 5788889999999999999975 578899999887766777889999999999999999999999999999999999999
Q ss_pred CCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCcee
Q 039107 565 LGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVS 644 (817)
Q Consensus 565 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 644 (817)
+|+|.+++.+..+.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 93 ~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~~~ 167 (288)
T d2jfla1 93 GGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRR 167 (288)
T ss_dssp TEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HHHH
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC--cccc
Confidence 99999998776667999999999999999999999876 999999999999999999999999999753211 1122
Q ss_pred eeeecCcCCCChhhhc-----cCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccc
Q 039107 645 TVVKGSFGYLDPEYFK-----RQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719 (817)
Q Consensus 645 ~~~~gt~~y~aPE~~~-----~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (817)
....||+.|+|||++. ...++.++|||||||+||||++|+.||......+.. ..+. ... . +.+
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~---~~i~---~~~-~-----~~~ 235 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL---LKIA---KSE-P-----PTL 235 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH---HHHH---HSC-C-----CCC
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHH---HHHH---cCC-C-----CCC
Confidence 3457999999999984 456899999999999999999999999765433211 1011 000 0 001
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 720 KDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 720 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
..+..++.++.+|+.+||+.||.+|||++|+++|
T Consensus 236 --~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 236 --AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp --SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred --CccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1123345678999999999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-48 Score=406.72 Aligned_cols=249 Identities=27% Similarity=0.413 Sum_probs=200.3
Q ss_pred eeEeeeCceEEEEEEEec---ccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEeccC
Q 039107 491 YVIGVGGFGKVYKGVIED---KLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMAL 565 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 565 (817)
++||+|+||+||+|.+++ ++.||||+++.. .....++|.+|+++|++++|||||+++|+|.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998754 357999998653 23345789999999999999999999999965 567899999999
Q ss_pred CchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC-cee
Q 039107 566 GTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG-HVS 644 (817)
Q Consensus 566 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~ 644 (817)
|+|.+++... ..+++.+++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++........ ...
T Consensus 92 g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 92 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 9999998654 46999999999999999999999776 999999999999999999999999999865433222 223
Q ss_pred eeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCC
Q 039107 645 TVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKI 723 (817)
Q Consensus 645 ~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 723 (817)
....||+.|+|||.+.++.++.++|||||||++|||++ |++||......+ +...+. ++ .+...
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~---~~~~i~----~~---------~~~~~ 231 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAMLE----KG---------ERMGC 231 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHH----TT---------CCCCC
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH---HHHHHH----cC---------CCCCC
Confidence 34578999999999999999999999999999999998 899997654322 111111 11 11122
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 039107 724 SPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVL 760 (817)
Q Consensus 724 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 760 (817)
+..++.++.+|+.+||+.||++|||+++|++.|+...
T Consensus 232 p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 3345667899999999999999999999999888754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=409.03 Aligned_cols=253 Identities=26% Similarity=0.402 Sum_probs=194.7
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC--cccHHHHHHHHHHHhccCccceeeEEEEEec--CCeEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE--GNEMCLV 559 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV 559 (817)
++|+..+.||+|+||+||+|+.+ +++.||||.+.... +...+.|.+|+++|++++|||||++++++.+ ...+++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 46888999999999999999975 57889999987553 3445678999999999999999999999864 4568999
Q ss_pred EEeccCCchhhhhhcc---ccccchHhHHHHHHHHHHHHHHHHhCC--CCceEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 560 YDYMALGTLREHIYNT---KKALSWKQRLEICIGAARGLHYLHTGA--KYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
||||++|+|.+++... ...+++.+++.++.||+.||+|||+++ ..+||||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998643 346999999999999999999999854 24699999999999999999999999999987
Q ss_pred CCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhc
Q 039107 635 GPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDI 714 (817)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 714 (817)
.... ........||+.|||||++.+..++.++|||||||++|||++|++||......+ +...+ ..+..
T Consensus 164 ~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~---~~~~i----~~~~~--- 231 (269)
T d2java1 164 LNHD--TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAGKI----REGKF--- 231 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHH----HHTCC---
T ss_pred cccC--CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH---HHHHH----HcCCC---
Confidence 5332 223345679999999999999999999999999999999999999997643321 11111 11111
Q ss_pred cCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 715 IDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 715 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
...+..++.++.+|+.+||+.||.+|||++|+++|
T Consensus 232 ------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 232 ------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 11223345568999999999999999999999864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-48 Score=406.83 Aligned_cols=256 Identities=29% Similarity=0.452 Sum_probs=204.9
Q ss_pred cCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEecc
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYMA 564 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 564 (817)
++|+..+.||+|+||+||+|+++++..||||+++... ...+.|.+|+.+|++++|||||+++|+|.+ +..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 4688899999999999999999888889999987543 445789999999999999999999999965 56899999999
Q ss_pred CCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCce
Q 039107 565 LGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643 (817)
Q Consensus 565 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 643 (817)
+|+|..++.... +.++|.+++.|+.||+.||+|||+++ |+||||||+||||++++.+||+|||+++...... ...
T Consensus 95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~-~~~ 170 (285)
T d1fmka3 95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTA 170 (285)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC-cee
Confidence 999999887554 46999999999999999999999876 9999999999999999999999999998653322 223
Q ss_pred eeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccCCC
Q 039107 644 STVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKI 723 (817)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 723 (817)
.....||+.|+|||++..+.++.++|||||||+||||++|..|+....... .+..++.. + .....
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~--~~~~~i~~----~---------~~~~~ 235 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQVER----G---------YRMPC 235 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHT----T---------CCCCC
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH--HHHHHHHh----c---------CCCCC
Confidence 344578999999999999999999999999999999999766654433221 11222111 1 11123
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 039107 724 SPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQ 761 (817)
Q Consensus 724 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 761 (817)
+..++.++.+++.+||+.||++||+|++|+++|+....
T Consensus 236 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 34456678999999999999999999999998887553
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=413.30 Aligned_cols=259 Identities=24% Similarity=0.406 Sum_probs=208.0
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cc----cEEEEEecCCC-CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DK----LKVAIKRSNPS-SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCL 558 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 558 (817)
.+|+..++||+|+||+||+|.+. ++ .+||+|+++.. ..+..++|.+|+++|++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 35888999999999999999864 33 36999988654 445578899999999999999999999999864 5678
Q ss_pred EEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCC
Q 039107 559 VYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNM 638 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 638 (817)
++||+.+|+|.+++......+++..+++++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++.....
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 89999999999998877778999999999999999999999876 999999999999999999999999999876544
Q ss_pred CCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCc
Q 039107 639 ENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDP 717 (817)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (817)
..........||+.|+|||.+.++.++.++|||||||+||||+| |++||......+ +...+.. +
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~~i~~----~-------- 229 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEK----G-------- 229 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHHHHHH----T--------
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHHHHHc----C--------
Confidence 44444455678999999999999999999999999999999998 788886554322 1111111 1
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 039107 718 LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLV 763 (817)
Q Consensus 718 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 763 (817)
.+...+..++..+.+|+.+||+.||.+|||+.||+++|+.+....
T Consensus 230 -~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~ 274 (317)
T d1xkka_ 230 -ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274 (317)
T ss_dssp -CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSH
T ss_pred -CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhCh
Confidence 111223445667899999999999999999999999999876543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=400.94 Aligned_cols=247 Identities=26% Similarity=0.413 Sum_probs=196.4
Q ss_pred CcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEec----CCeEEEEE
Q 039107 488 DESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE----GNEMCLVY 560 (817)
Q Consensus 488 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 560 (817)
+..++||+|+||+||+|+.. ++..||+|++... .....+.|.+|+++|++++|||||++++++.. ...+++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 44568999999999999975 4678999987643 33445679999999999999999999999864 45689999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEc-CCceeEEeeeccCccCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLD-ENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~-~~~~~kl~DFGla~~~~~~~ 639 (817)
||+++|+|.+++.+. ..+++.+++.++.||++||+|||+++ ++|+||||||+||||+ +++.+||+|||+++...
T Consensus 92 E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~--- 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--- 166 (270)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC---
T ss_pred eCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc---
Confidence 999999999998654 46999999999999999999999763 4599999999999996 57899999999998632
Q ss_pred CCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccc
Q 039107 640 NGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719 (817)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (817)
........||+.|||||++.+ .++.++|||||||+||||++|+.||........ +. ... ..+. ..+.+
T Consensus 167 -~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~~---~~i-~~~~----~~~~~ 234 (270)
T d1t4ha_ 167 -ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IY---RRV-TSGV----KPASF 234 (270)
T ss_dssp -TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HH---HHH-TTTC----CCGGG
T ss_pred -CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--HH---HHH-HcCC----CCccc
Confidence 223345689999999999865 699999999999999999999999975433221 11 111 1110 01111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 720 KDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 720 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
. .....++.+|+.+||+.||++|||++|+++|
T Consensus 235 ~----~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 235 D----KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp G----GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred C----ccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 1 1233457899999999999999999999875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-47 Score=409.62 Aligned_cols=263 Identities=26% Similarity=0.436 Sum_probs=213.0
Q ss_pred HHHHhhcCCCcceeEeeeCceEEEEEEEec------ccEEEEEecCCCCc-ccHHHHHHHHHHHhccCccceeeEEEEEe
Q 039107 479 EIKHATKSFDESYVIGVGGFGKVYKGVIED------KLKVAIKRSNPSSE-QGVNEFVTEIEMLSKLRHKHLVSLIGFCE 551 (817)
Q Consensus 479 el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 551 (817)
+++...++|+..+.||+|+||+||+|+.++ +..||||+++.... +..++|.+|+++|++++||||++++++|.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 344456789999999999999999999753 46899999876543 34567999999999999999999999999
Q ss_pred cCCeEEEEEEeccCCchhhhhhccc-----------------------cccchHhHHHHHHHHHHHHHHHHhCCCCceEe
Q 039107 552 EGNEMCLVYDYMALGTLREHIYNTK-----------------------KALSWKQRLEICIGAARGLHYLHTGAKYTIIH 608 (817)
Q Consensus 552 ~~~~~~lV~Ey~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH 608 (817)
.....++||||+++|+|.+++.... ..+++.+++.|+.|++.||+|||+++ |||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEe
Confidence 9999999999999999999986421 24899999999999999999999766 999
Q ss_pred cCCccCcEEEcCCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCC-CCC
Q 039107 609 RDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCAR-PAL 687 (817)
Q Consensus 609 ~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~-~p~ 687 (817)
|||||+||||+.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||+||||++|. +||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 9999999999999999999999998644333333444567899999999999999999999999999999999996 566
Q ss_pred CCCCccccchHHHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 039107 688 NPSLPKEQVSLADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVL 760 (817)
Q Consensus 688 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 760 (817)
......+ +...+. ++.. ...+..++.++.+|+.+||+.+|++||||.||+++|+.+.
T Consensus 244 ~~~~~~e---~~~~v~----~~~~---------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 244 YGMAHEE---VIYYVR----DGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTSCHHH---HHHHHH----TTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCHHH---HHHHHH----cCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 5443322 111111 1111 1123345567899999999999999999999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.4e-47 Score=411.88 Aligned_cols=252 Identities=23% Similarity=0.303 Sum_probs=210.5
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
++|...+.||+|+||+||+|+.+ ++..||||++........+.+.+|+.+|++++|||||++++++.+.+..++|||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 47888999999999999999975 57899999998776666778999999999999999999999999999999999999
Q ss_pred cCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEc--CCceeEEeeeccCccCCCCCCC
Q 039107 564 ALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLD--ENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 564 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~--~~~~~kl~DFGla~~~~~~~~~ 641 (817)
++|+|.+++......+++.++..|+.||+.||+|||+++ ||||||||+||||+ .++.+||+|||+++.... .
T Consensus 106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~---~ 179 (350)
T d1koaa2 106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP---K 179 (350)
T ss_dssp CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCT---T
T ss_pred CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccc---c
Confidence 999999999776667999999999999999999999876 99999999999996 467899999999986432 2
Q ss_pred ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccC
Q 039107 642 HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKD 721 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (817)
.......||+.|||||++.+..++.++|||||||++|||++|+.||.+....+.. ....... .....
T Consensus 180 ~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~------~~i~~~~-------~~~~~ 246 (350)
T d1koaa2 180 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL------RNVKSCD-------WNMDD 246 (350)
T ss_dssp SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHTC-------CCSCC
T ss_pred cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHH------HHHHhCC-------CCCCc
Confidence 3345678999999999999999999999999999999999999999765432211 1111100 00011
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 722 KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 722 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
......+..+.+|+.+||+.||++|||++|+++|
T Consensus 247 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 247 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1112334567899999999999999999999886
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=406.23 Aligned_cols=252 Identities=21% Similarity=0.281 Sum_probs=204.6
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
.+|+..++||+|+||+||+|+.. +++.||||++... .....+.+.+|+++|++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 46889999999999999999975 5789999997642 2334577999999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
|||++|+|.+++... +.+++..+..++.|++.||+|||+++ ||||||||+|||+++++.+||+|||+++.......
T Consensus 88 Ey~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 999999999988644 46999999999999999999999876 99999999999999999999999999987544433
Q ss_pred CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
........||+.|+|||++.+..++.++|||||||+||||++|+.||......+.. .-+ . .. ..
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~---~~i---~-~~------~~--- 227 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF---QKI---I-KL------EY--- 227 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHH---H-TT------CC---
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHH---HHH---H-cC------CC---
Confidence 44445567999999999999999999999999999999999999999865432211 100 0 11 01
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLE 757 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 757 (817)
.++...+.++.+|+.+||+.||.+|||++|++++..
T Consensus 228 -~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~ 263 (288)
T d1uu3a_ 228 -DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263 (288)
T ss_dssp -CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred -CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHH
Confidence 122234456789999999999999999999876533
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=413.84 Aligned_cols=265 Identities=23% Similarity=0.353 Sum_probs=205.2
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
.++|+..++||+|+||+||+|+.. ++..||+|+++... ....+.+.+|+.+|++++|||||+++++|.+.+..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 467899999999999999999975 57889999986543 3345679999999999999999999999999999999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
||++|+|.+++.+. +.+++..+..++.|++.||+|||++ ++|+||||||+||||++++.+||+|||+|+....
T Consensus 85 y~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~---- 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---- 157 (322)
T ss_dssp CCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH----
T ss_pred cCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCC----
Confidence 99999999999754 4599999999999999999999974 2399999999999999999999999999985322
Q ss_pred ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHH-----------------
Q 039107 642 HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALH----------------- 704 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~----------------- 704 (817)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||......+..........
T Consensus 158 ~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
T d1s9ja_ 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237 (322)
T ss_dssp HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence 123346799999999999999999999999999999999999999976543221100000000
Q ss_pred ------hhccCchhhccCccc---cCCCC-HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 705 ------CKRKGILDDIIDPLL---KDKIS-PECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 705 ------~~~~~~~~~~~d~~l---~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
........+..+... ....+ ...+.++.+++.+||+.||.+|||++|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp --------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 000000000000000 00000 1124568899999999999999999999987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-47 Score=394.79 Aligned_cols=250 Identities=28% Similarity=0.446 Sum_probs=199.4
Q ss_pred cCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEec-CCeEEEEEEec
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE-GNEMCLVYDYM 563 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~Ey~ 563 (817)
++|+..++||+|+||.||+|+++ +..||||+++.. ...++|.+|++++++++||||++++|+|.+ .+.+++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 35677889999999999999985 568999999754 345789999999999999999999999854 46689999999
Q ss_pred cCCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 564 ALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 564 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
++|+|.++|.... ..++|..+++|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~----- 155 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----- 155 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCC-----
Confidence 9999999997654 36999999999999999999999765 99999999999999999999999999986422
Q ss_pred eeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCccccC
Q 039107 643 VSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKD 721 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (817)
......+|..|+|||++.++.++.++|||||||++|||+| |++|+...... .+..++.. + .+.
T Consensus 156 ~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~i~~----~---------~~~ 219 (262)
T d1byga_ 156 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVEK----G---------YKM 219 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHHTT----T---------CCC
T ss_pred CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHHHHc----C---------CCC
Confidence 2234468999999999999999999999999999999998 67777654322 22222211 1 112
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 039107 722 KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQ 761 (817)
Q Consensus 722 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 761 (817)
.++..++.++.+|+.+||+.||.+|||+.+|+++|+.+..
T Consensus 220 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 220 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 2333455678999999999999999999999999998754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-47 Score=397.97 Aligned_cols=258 Identities=24% Similarity=0.407 Sum_probs=202.5
Q ss_pred cCCCcceeEeeeCceEEEEEEEec----ccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIED----KLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 559 (817)
.+|+..+.||+|+||+||+|++.. +..||||.++... ....+.|.+|+++|++++|||||+++++|.+ +..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEE
Confidence 468888999999999999998643 3568999987543 3345679999999999999999999999964 678999
Q ss_pred EEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC
Q 039107 560 YDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 639 (817)
|||+++|+|.+++......+++.+++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 9999999999988777778999999999999999999999876 9999999999999999999999999998654322
Q ss_pred CCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhccCcc
Q 039107 640 NGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPL 718 (817)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (817)
........||+.|+|||.+.++.++.++|||||||+||||++ |++||......+ +...+.. +.
T Consensus 163 -~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~~i~~----~~-------- 226 (273)
T d1mp8a_ 163 -YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIEN----GE-------- 226 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHHT----TC--------
T ss_pred -ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHHHHHc----CC--------
Confidence 223345678999999999999999999999999999999998 888887654332 1111111 10
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 039107 719 LKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLV 763 (817)
Q Consensus 719 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 763 (817)
....+..++..+.+|+.+||+.||++|||+.||+++|+.+++..
T Consensus 227 -~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 227 -RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 11223445667899999999999999999999999999887654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.9e-46 Score=408.54 Aligned_cols=252 Identities=21% Similarity=0.282 Sum_probs=210.9
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
..|+..+.||+|+||+||+|+.. +++.||||++........+.+.+|+++|++++|||||++++++.+.+.+++|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 46888999999999999999974 67899999987665555678899999999999999999999999999999999999
Q ss_pred cCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEc--CCceeEEeeeccCccCCCCCCC
Q 039107 564 ALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLD--ENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 564 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~--~~~~~kl~DFGla~~~~~~~~~ 641 (817)
++|+|.+++......+++.+++.|+.||+.||+|||+++ ||||||||+||||+ .++.+||+|||+++.... .
T Consensus 109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~---~ 182 (352)
T d1koba_ 109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP---D 182 (352)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT---T
T ss_pred CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCC---C
Confidence 999999988766667999999999999999999999776 99999999999998 678999999999987533 3
Q ss_pred ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccC
Q 039107 642 HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKD 721 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (817)
.......||+.|+|||++.+..++.++|||||||+||||++|+.||.+....+.. ..+.. . +.....
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~---~~i~~----~------~~~~~~ 249 (352)
T d1koba_ 183 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL---QNVKR----C------DWEFDE 249 (352)
T ss_dssp SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---HHHHH----C------CCCCCS
T ss_pred CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHh----C------CCCCCc
Confidence 3455677999999999999999999999999999999999999999765433211 11111 0 011111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 722 KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 722 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
......+.++.+|+.+||+.||.+|||+.|+++|
T Consensus 250 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 250 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1222345567899999999999999999999876
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.9e-47 Score=404.73 Aligned_cols=245 Identities=29% Similarity=0.394 Sum_probs=200.6
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCc---ccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSE---QGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
.|+..+.||+|+||+||+|+.. ++..||||++..... ...+.|.+|+++|++++|||||++++++.+.+..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4888899999999999999965 578899999875432 334678999999999999999999999999999999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
||++|+|..++.. .+.+++.+++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++....
T Consensus 96 ~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (309)
T ss_dssp CCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred ecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC----
Confidence 9999999766543 457999999999999999999999876 99999999999999999999999999986432
Q ss_pred ceeeeeecCcCCCChhhhcc---CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcc
Q 039107 642 HVSTVVKGSFGYLDPEYFKR---QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPL 718 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~---~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (817)
.....||+.|||||++.+ +.++.++|||||||++|||++|+.||......+.. ....... .+.
T Consensus 168 --~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~------~~i~~~~------~~~ 233 (309)
T d1u5ra_ 168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQNE------SPA 233 (309)
T ss_dssp --BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHSC------CCC
T ss_pred --CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHH------HHHHhCC------CCC
Confidence 234579999999999864 46899999999999999999999999765332211 1111110 011
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 719 LKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 719 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
+ .+..++..+.+|+.+||+.||.+|||++|+++|
T Consensus 234 ~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 234 L---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp C---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred C---CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 1 112334568999999999999999999999875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=401.03 Aligned_cols=261 Identities=22% Similarity=0.382 Sum_probs=201.3
Q ss_pred hcCCCcceeEeeeCceEEEEEEEec------ccEEEEEecCCCC-cccHHHHHHHHHHHhcc-CccceeeEEEEEec-CC
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIED------KLKVAIKRSNPSS-EQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEE-GN 554 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~-~~ 554 (817)
.++|...++||+|+||.||+|.... ++.||||+++... ....+.+.+|..++.++ +|+||+.+++++.+ ..
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 3578889999999999999999653 3579999987543 34456788899888887 68999999999865 45
Q ss_pred eEEEEEEeccCCchhhhhhccc---------------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEc
Q 039107 555 EMCLVYDYMALGTLREHIYNTK---------------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLD 619 (817)
Q Consensus 555 ~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~ 619 (817)
..++|||||++|+|.+++.... ..+++.+++.++.||++||+|||+++ ||||||||+||||+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeEC
Confidence 6899999999999999996532 24899999999999999999999876 99999999999999
Q ss_pred CCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCC-CCCCCCCccccchH
Q 039107 620 ENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCAR-PALNPSLPKEQVSL 698 (817)
Q Consensus 620 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~-~p~~~~~~~~~~~l 698 (817)
+++.+||+|||+++...............||+.|+|||.+.++.++.++|||||||++|||++|. +||......+. +
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~--~ 246 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--F 246 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH--H
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH--H
Confidence 99999999999998754444333444567999999999999999999999999999999999975 56654332211 1
Q ss_pred HHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 039107 699 ADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQL 762 (817)
Q Consensus 699 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 762 (817)
. ....++. ....+..++.++.+++.+||+.||++|||++||+++|+.+++.
T Consensus 247 ~----~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 247 C----RRLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp H----HHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H----HHHhcCC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1 1111111 1112233456689999999999999999999999999998754
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-47 Score=397.08 Aligned_cols=256 Identities=23% Similarity=0.392 Sum_probs=200.4
Q ss_pred cCCCcceeEeeeCceEEEEEEEec----ccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIED----KLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMC 557 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 557 (817)
++|+..+.||+|+||+||+|++.. ...||||++... ..+..++|.+|+.+|++++||||++++|+|.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 568888899999999999998653 247899998754 33446789999999999999999999999976 4678
Q ss_pred EEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCC
Q 039107 558 LVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPN 637 (817)
Q Consensus 558 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 637 (817)
+||||+++|+|.+++....+.+++..++.++.|++.||+|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhccc
Confidence 999999999999998877778999999999999999999999876 99999999999999999999999999987544
Q ss_pred CCCC-ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchHHHHHHHhhccCchhhcc
Q 039107 638 MENG-HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSLADWALHCKRKGILDDII 715 (817)
Q Consensus 638 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (817)
.... .......|+..|+|||.+.+..++.++|||||||++|||+| |++||......+ ...++. +.+
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~---~~~~i~---~~~------ 231 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILHKID---KEG------ 231 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHH---TSC------
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH---HHHHHH---hCC------
Confidence 3322 22334568889999999999999999999999999999998 899987554332 111211 111
Q ss_pred CccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 039107 716 DPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFV 759 (817)
Q Consensus 716 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 759 (817)
.+.+.+..++..+.+|+.+||+.||++|||+.+|++.|+++
T Consensus 232 ---~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 232 ---ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11122334456789999999999999999999999988875
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-46 Score=402.98 Aligned_cols=252 Identities=24% Similarity=0.358 Sum_probs=191.1
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
.+.|+..++||+|+||+||+|+.+ +++.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 356888999999999999999975 56889999986543 2334568899999999999999999999999999999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEc---CCceeEEeeeccCccCCCC
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLD---ENWVAKVSDFGLSKTGPNM 638 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~---~~~~~kl~DFGla~~~~~~ 638 (817)
||++|+|.+++... +.+++.++..++.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+++....
T Consensus 88 ~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~- 162 (307)
T d1a06a_ 88 LVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP- 162 (307)
T ss_dssp CCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred ccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccC-
Confidence 99999999999653 46999999999999999999999776 99999999999994 578999999999986432
Q ss_pred CCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcc
Q 039107 639 ENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPL 718 (817)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (817)
........||+.|||||++.++.++.++|||||||+||||++|++||......+ +...+.. .. ..
T Consensus 163 --~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~~i~~--~~--------~~ 227 (307)
T d1a06a_ 163 --GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK---LFEQILK--AE--------YE 227 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHT--TC--------CC
T ss_pred --CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH---HHHHHhc--cC--------CC
Confidence 223345679999999999999999999999999999999999999997654322 1111111 00 01
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 719 LKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 719 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.........+..+.+|+.+||+.||++|||++|+++|
T Consensus 228 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 228 FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1111223345668999999999999999999999876
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-46 Score=397.33 Aligned_cols=255 Identities=28% Similarity=0.469 Sum_probs=206.2
Q ss_pred ceeEeeeCceEEEEEEEecc----cEEEEEecCCC-CcccHHHHHHHHHHHhccCccceeeEEEEEec-CCeEEEEEEec
Q 039107 490 SYVIGVGGFGKVYKGVIEDK----LKVAIKRSNPS-SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE-GNEMCLVYDYM 563 (817)
Q Consensus 490 ~~~lG~G~fg~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~Ey~ 563 (817)
.++||+|+||+||+|++.+. ..||||+++.. .....++|.+|+++|++++||||++++|+|.+ +...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999997542 35899998753 44556789999999999999999999999865 56889999999
Q ss_pred cCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC--C
Q 039107 564 ALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN--G 641 (817)
Q Consensus 564 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~--~ 641 (817)
++|+|.+++......+++..+++++.|++.||.|||+.+ |+||||||+||||++++.+||+|||+++....... .
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 999999999877778899999999999999999999765 99999999999999999999999999987543222 1
Q ss_pred ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccccC
Q 039107 642 HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLKD 721 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (817)
.......||..|+|||.+.++.++.++||||||++||||++|+.||....... .+..++....+ .
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~i~~g~~-------------~ 253 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLLQGRR-------------L 253 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHTTCC-------------C
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCCC-------------C
Confidence 22234578999999999999999999999999999999999888776543221 22222221110 1
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 039107 722 KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQL 762 (817)
Q Consensus 722 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 762 (817)
..+..++..+.+|+.+||+.||++||+|.||+++|+.+++.
T Consensus 254 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 254 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 11233456789999999999999999999999999998754
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-46 Score=397.91 Aligned_cols=257 Identities=30% Similarity=0.483 Sum_probs=205.0
Q ss_pred cCCCcceeEeeeCceEEEEEEEecc---cEEEEEecCCC-CcccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIEDK---LKVAIKRSNPS-SEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 559 (817)
++|+..++||+|+||+||+|++++. ..||||++... .....++|.+|+++|+++ +|||||+++|+|.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 5677888999999999999997643 35788887543 444567899999999999 799999999999999999999
Q ss_pred EEeccCCchhhhhhcc---------------ccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCcee
Q 039107 560 YDYMALGTLREHIYNT---------------KKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVA 624 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~ 624 (817)
|||+++|+|.++|+.. ...++|.+++.++.||++||.|||+++ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999643 246999999999999999999999776 9999999999999999999
Q ss_pred EEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCC-CCCCCCccccchHHHHHH
Q 039107 625 KVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARP-ALNPSLPKEQVSLADWAL 703 (817)
Q Consensus 625 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~-p~~~~~~~~~~~l~~~~~ 703 (817)
||+|||+++..... .......||..|+|||.+..+.++.++|||||||++|||++|.. ||...... .+.+.+.
T Consensus 167 kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~---~~~~~i~ 240 (309)
T d1fvra_ 167 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEKLP 240 (309)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHGG
T ss_pred EEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH---HHHHHHH
Confidence 99999999764321 12234568999999999999999999999999999999999765 55443221 1222111
Q ss_pred HhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 039107 704 HCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLV 763 (817)
Q Consensus 704 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 763 (817)
. + .+...+..++.++.+|+.+||+.||++||||++|+++|+.+++..
T Consensus 241 ~----~---------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 241 Q----G---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp G----T---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred h----c---------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 1 1 111223345567899999999999999999999999999987543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-46 Score=398.10 Aligned_cols=260 Identities=23% Similarity=0.386 Sum_probs=212.7
Q ss_pred cCCCcceeEeeeCceEEEEEEEe------cccEEEEEecCCCC-cccHHHHHHHHHHHhcc-CccceeeEEEEEecCCeE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE------DKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGNEM 556 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 556 (817)
++|+..++||+|+||.||+|++. .++.||||+++... .....+|.+|+.+++++ +|||||+++++|.+....
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 46777889999999999999863 34689999987654 33456799999999999 699999999999999999
Q ss_pred EEEEEeccCCchhhhhhccc-----------------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEc
Q 039107 557 CLVYDYMALGTLREHIYNTK-----------------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLD 619 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~~-----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~ 619 (817)
++|||||++|+|.+++.... ..+++..++.++.||++||+|||+++ ||||||||+|||++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccccc
Confidence 99999999999999986532 25899999999999999999999876 99999999999999
Q ss_pred CCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhC-CCCCCCCCccccchH
Q 039107 620 ENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCA-RPALNPSLPKEQVSL 698 (817)
Q Consensus 620 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG-~~p~~~~~~~~~~~l 698 (817)
.++.+||+|||+++...............||+.|+|||.+.++.++.++|||||||++|||+++ .+|+......+. +
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~--~ 257 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--F 257 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--H
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH--H
Confidence 9999999999999976554444555567899999999999999999999999999999999995 555544332221 1
Q ss_pred HHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 039107 699 ADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQL 762 (817)
Q Consensus 699 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 762 (817)
...+.. ..+...+..++..+.+|+.+||+.||.+|||+.+|+++|+..+..
T Consensus 258 ~~~i~~-------------~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 258 YKMIKE-------------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHH-------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhc-------------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 111111 111122233456789999999999999999999999999987643
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-46 Score=395.30 Aligned_cols=251 Identities=21% Similarity=0.275 Sum_probs=204.5
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC------CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS------SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMC 557 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~------~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 557 (817)
++|...+.||+|+||+||+|+.+ +++.||||++... .....+.|.+|+++|++++|||||++++++.+.+..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 56889999999999999999975 5789999987532 1223578999999999999999999999999999999
Q ss_pred EEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCc----eeEEeeeccCc
Q 039107 558 LVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENW----VAKVSDFGLSK 633 (817)
Q Consensus 558 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~----~~kl~DFGla~ 633 (817)
||||||++|+|.+++... +.+++..++.++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+++
T Consensus 90 iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhh
Confidence 999999999999998654 46999999999999999999999776 99999999999998776 59999999998
Q ss_pred cCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhh
Q 039107 634 TGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDD 713 (817)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 713 (817)
.... ........||+.|+|||++.+..++.++|||||||+||||++|+.||.+....+.. ..+.. ....
T Consensus 166 ~~~~---~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~---~~i~~--~~~~--- 234 (293)
T d1jksa_ 166 KIDF---GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---ANVSA--VNYE--- 234 (293)
T ss_dssp ECTT---SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHT--TCCC---
T ss_pred hcCC---CccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHH---HHHHh--cCCC---
Confidence 6432 22334457899999999999999999999999999999999999999865433211 11100 0000
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 714 IIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 714 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
..+... ...+..+.+|+.+||+.||++|||++|+++|
T Consensus 235 -~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 235 -FEDEYF----SNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp -CCHHHH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -CCchhc----CCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000111 1234567899999999999999999999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-46 Score=396.60 Aligned_cols=259 Identities=25% Similarity=0.457 Sum_probs=208.5
Q ss_pred cCCCcceeEeeeCceEEEEEEEec--------ccEEEEEecCCCC-cccHHHHHHHHHHHhcc-CccceeeEEEEEecCC
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIED--------KLKVAIKRSNPSS-EQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEEGN 554 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 554 (817)
++|...+.||+|+||.||+|+... +..||||+++... .....++.+|...+.++ +|||||+++++|.+..
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 467788899999999999998643 2479999987654 34457889999999998 8999999999999999
Q ss_pred eEEEEEEeccCCchhhhhhccc---------------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEc
Q 039107 555 EMCLVYDYMALGTLREHIYNTK---------------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLD 619 (817)
Q Consensus 555 ~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~ 619 (817)
..++||||+++|+|.++|.... ..+++.+++.++.||+.||+|||+.+ ||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeec
Confidence 9999999999999999996443 35899999999999999999999876 99999999999999
Q ss_pred CCceeEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCccccchH
Q 039107 620 ENWVAKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLC-ARPALNPSLPKEQVSL 698 (817)
Q Consensus 620 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l 698 (817)
.++.+||+|||+++...............||+.|+|||.+.++.++.++|||||||++|||++ |++||....... +
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~---~ 246 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---L 246 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---H
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH---H
Confidence 999999999999987655444444555678999999999999999999999999999999998 677776443221 1
Q ss_pred HHHHHHhhccCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 039107 699 ADWALHCKRKGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQL 762 (817)
Q Consensus 699 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 762 (817)
...+. .+ .....+..++..+.+|+.+||+.||.+|||+.||++.|+.+++.
T Consensus 247 ~~~i~----~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 247 FKLLK----EG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp HHHHH----TT---------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHH----cC---------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 11111 11 11112223455689999999999999999999999999998764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=396.32 Aligned_cols=259 Identities=23% Similarity=0.381 Sum_probs=210.6
Q ss_pred cCCCcceeEeeeCceEEEEEEEe------cccEEEEEecCCC-CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE------DKLKVAIKRSNPS-SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMC 557 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 557 (817)
++|...+.||+|+||+||+|.+. ++..||||+++.. ..+....|.+|++++++++||||++++|+|...+..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 56778889999999999999874 2468999998754 3344567999999999999999999999999999999
Q ss_pred EEEEeccCCchhhhhhccc---------cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEee
Q 039107 558 LVYDYMALGTLREHIYNTK---------KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSD 628 (817)
Q Consensus 558 lV~Ey~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 628 (817)
+||||+++|+|.+++.... ..+++..+.+++.|+++||.|||+++ |+||||||+||||++++++||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEee
Confidence 9999999999999986542 24688999999999999999999765 99999999999999999999999
Q ss_pred eccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCC-CCCCCCCccccchHHHHHHHhhc
Q 039107 629 FGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCAR-PALNPSLPKEQVSLADWALHCKR 707 (817)
Q Consensus 629 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~-~p~~~~~~~~~~~l~~~~~~~~~ 707 (817)
||+++...............||+.|+|||.+.++.++.++||||||+++|||++|+ +|+......+ +......
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~------~~~~i~~ 250 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ------VLRFVME 250 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH------HHHHHHT
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHh
Confidence 99998654433333344456899999999999999999999999999999999985 5564432221 1111111
Q ss_pred cCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 039107 708 KGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQL 762 (817)
Q Consensus 708 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 762 (817)
+. ....+..++..+.+++.+||+.+|++||||.+|+++|+..++.
T Consensus 251 -~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 251 -GG---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp -TC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred -CC---------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 11 1112334556789999999999999999999999999877543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=393.70 Aligned_cols=269 Identities=23% Similarity=0.323 Sum_probs=201.4
Q ss_pred cCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHH--HHHHHhccCccceeeEEEEEecCC----eEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVT--EIEMLSKLRHKHLVSLIGFCEEGN----EMCL 558 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~H~niv~l~g~~~~~~----~~~l 558 (817)
++|...+.||+|+||.||+|++ ++..||||++.... .+++.. |+..+.+++||||++++++|.+.+ .+++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 3566678999999999999997 46799999986432 234444 445556789999999999997543 5899
Q ss_pred EEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhC-----CCCceEecCCccCcEEEcCCceeEEeeeccCc
Q 039107 559 VYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTG-----AKYTIIHRDVKTTNILLDENWVAKVSDFGLSK 633 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 633 (817)
|||||++|+|.++|++ ..++|.++++++.|++.||+|||+. .+++||||||||+||||++++.+||+|||+++
T Consensus 79 v~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 9999999999999964 3699999999999999999999974 13579999999999999999999999999998
Q ss_pred cCCCCCCC--ceeeeeecCcCCCChhhhccCC------CCchHHHHHHHHHHHHHHhCCCCCCCCCccccch--------
Q 039107 634 TGPNMENG--HVSTVVKGSFGYLDPEYFKRQQ------LTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVS-------- 697 (817)
Q Consensus 634 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~-------- 697 (817)
........ .......||+.|+|||++.... ++.++|||||||+||||++|++|+..........
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 65433221 1234567999999999987542 5779999999999999999998875433221100
Q ss_pred HHHHHHHhhccCchhhccCccccCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 039107 698 LADWALHCKRKGILDDIIDPLLKDKI-SPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLV 763 (817)
Q Consensus 698 l~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 763 (817)
......... ..+..+|.+.... ..+....+.+|+.+||+.||.+|||+.||+++|+.+.+..
T Consensus 237 ~~~~~~~~~----~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 237 SVEEMRKVV----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CHHHHHHHH----TTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHH----hccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 001111111 1111222222111 2356778999999999999999999999999999887543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-45 Score=395.74 Aligned_cols=248 Identities=24% Similarity=0.355 Sum_probs=206.6
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
++|+..++||+|+||+||+|+.+ +++.||||++... .....+.+.+|+.+|++++||||+++++++.+.+.+++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 46889999999999999999974 6789999998643 2334677899999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
|||++|+|.+++... ..+++..++.++.||+.||+|||+++ ||||||||+|||+++++.+||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~-- 158 (337)
T d1o6la_ 85 EYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-- 158 (337)
T ss_dssp ECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT--
T ss_pred eccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC--
Confidence 999999999988654 45899999999999999999999876 999999999999999999999999999864332
Q ss_pred CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
........||+.|+|||++.+..++.++|||||||+||||++|++||......+ +..... .+ ..
T Consensus 159 ~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~~~~i~----~~------~~--- 222 (337)
T d1o6la_ 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFELIL----ME------EI--- 222 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH----HC------CC---
T ss_pred CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH---HHHHHh----cC------CC---
Confidence 223345679999999999999999999999999999999999999998754322 111111 11 01
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRPS-----MGDVLWN 755 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 755 (817)
.++...+.++.+|+.+||+.||.+||+ +.|+++|
T Consensus 223 -~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 223 -RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 122334456789999999999999995 8888876
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.8e-45 Score=391.83 Aligned_cols=245 Identities=23% Similarity=0.335 Sum_probs=204.0
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
++|+..+.||+|+||+||+|+.+ +++.||||++... .....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46888999999999999999975 5789999998642 2334678999999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
|||++|+|..++... ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++.....
T Consensus 84 E~~~gg~l~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp CCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred eecCCcccccccccc-ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence 999999999887644 45888899999999999999999765 999999999999999999999999999875332
Q ss_pred CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
.....||+.|||||++.+..++.++|||||||+||||++|+.||......+.. ..... + .
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~------~~i~~-~------~---- 217 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY------EKILN-A------E---- 217 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHH-C------C----
T ss_pred ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHH------HHHHc-C------C----
Confidence 23467999999999999999999999999999999999999999765432211 11010 1 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRP-----SMGDVLWN 755 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 755 (817)
..++...+..+.+++.+||..||.+|| |++++++|
T Consensus 218 ~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 218 LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 112223445678999999999999996 89999876
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.7e-45 Score=383.18 Aligned_cols=260 Identities=24% Similarity=0.333 Sum_probs=200.4
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC---cccHHHHHHHHHHHhccCccceeeEEEEEecCC----e
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS---EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGN----E 555 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~ 555 (817)
.++|...+.||+|+||+||+|+.. +++.||||+++... ....+.|.+|+++|++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 356888999999999999999964 67899999987543 233567999999999999999999999986543 3
Q ss_pred EEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccC
Q 039107 556 MCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTG 635 (817)
Q Consensus 556 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 635 (817)
.++||||+++++|.+++... +.+++.+++.++.||+.||+|||+++ ||||||||+||||+.++..+|+|||+++..
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhh
Confidence 79999999999999988644 46999999999999999999999776 999999999999999999999999998754
Q ss_pred CCCC-CCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhc
Q 039107 636 PNME-NGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDI 714 (817)
Q Consensus 636 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 714 (817)
.... .........||+.|+|||++.+..++.++|||||||++|||++|++||......+. ..........
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~~~~~~~~--- 232 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDPI--- 232 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCCCC---
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH------HHHHHhcCCC---
Confidence 3222 12234456799999999999999999999999999999999999999976543221 1111111110
Q ss_pred cCccccCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHhH
Q 039107 715 IDPLLKDKISPECLKKFADTAEKCLSDSGIDRP-SMGDVLWNLEFVL 760 (817)
Q Consensus 715 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~ 760 (817)
.........+..+.+++.+||+.||.+|| |++++++.|..+.
T Consensus 233 ----~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 233 ----PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ----CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ----CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 01111123445678999999999999999 7999988887653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.3e-44 Score=381.07 Aligned_cols=251 Identities=22% Similarity=0.303 Sum_probs=203.7
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCc---------ccHHHHHHHHHHHhccC-ccceeeEEEEEecC
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSE---------QGVNEFVTEIEMLSKLR-HKHLVSLIGFCEEG 553 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~ 553 (817)
++|+..+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|+.+|++++ ||||+++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 57888999999999999999964 678999999765421 12346889999999997 99999999999999
Q ss_pred CeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCc
Q 039107 554 NEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSK 633 (817)
Q Consensus 554 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 633 (817)
+..+||||||++|+|.++|... ..+++.+++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchhee
Confidence 9999999999999999999654 46999999999999999999999776 9999999999999999999999999998
Q ss_pred cCCCCCCCceeeeeecCcCCCChhhhcc------CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhc
Q 039107 634 TGPNMENGHVSTVVKGSFGYLDPEYFKR------QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKR 707 (817)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 707 (817)
.... ........||..|+|||.+.+ ..++.++||||+||+||||++|+.||......+.. .-+.
T Consensus 159 ~~~~---~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~---~~i~---- 228 (277)
T d1phka_ 159 QLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML---RMIM---- 228 (277)
T ss_dssp ECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHH----
T ss_pred EccC---CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH---HHHH----
Confidence 6433 223345679999999999863 35688999999999999999999999865432211 1011
Q ss_pred cCchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 708 KGILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 708 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.+.. ..........+.++.+++.+||+.||.+|||++||++|
T Consensus 229 ~~~~------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 229 SGNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HTCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred hCCC------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1100 01111122345678999999999999999999999865
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=387.99 Aligned_cols=253 Identities=17% Similarity=0.248 Sum_probs=207.4
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
.++|...+.||+|+||+||+|... +++.||||.++.... ....+.+|+++|++++|||||++++++.+.+.++|||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 456888999999999999999975 567899999876543 345688999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCC--ceeEEeeeccCccCCCCCC
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDEN--WVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~--~~~kl~DFGla~~~~~~~~ 640 (817)
|++|+|.+++......+++.++..|+.||+.||+|||+.+ |+||||||+|||++.+ ..+||+|||+++....
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~--- 156 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--- 156 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT---
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc---
Confidence 9999999999776667999999999999999999999776 9999999999999854 5899999999986432
Q ss_pred CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
........||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.. .-+.. .... ++....
T Consensus 157 ~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~---~~i~~--~~~~----~~~~~~ 227 (321)
T d1tkia_ 157 GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII---ENIMN--AEYT----FDEEAF 227 (321)
T ss_dssp TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---HHHHH--TCCC----CCHHHH
T ss_pred CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHH---HHHHh--CCCC----CChhhc
Confidence 33445567999999999999999999999999999999999999999765432211 10100 0000 000111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
. ..+.++.+|+.+||..||.+|||+.|+++|-
T Consensus 228 ~----~~s~~~~~li~~~L~~dp~~R~s~~eil~hp 259 (321)
T d1tkia_ 228 K----EISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp T----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred c----CCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 1 2345578999999999999999999999874
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.5e-44 Score=389.56 Aligned_cols=245 Identities=20% Similarity=0.296 Sum_probs=204.5
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 560 (817)
++|+..+.||+|+||+||+|+.+ +++.||||++... .....+.+.+|+++|++++|||||++++++......++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 46899999999999999999975 6789999997642 2234567899999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMEN 640 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 640 (817)
||+.+|+|.+++... +.+++.++..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++....
T Consensus 121 e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~--- 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--- 193 (350)
T ss_dssp ECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS---
T ss_pred ccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc---
Confidence 999999999998654 36999999999999999999999776 99999999999999999999999999987432
Q ss_pred CceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCcccc
Q 039107 641 GHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLLK 720 (817)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (817)
......||+.|||||++.+..++.++|||||||+||||++|++||.+..... +...+. .+. ..
T Consensus 194 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~i~----~~~------~~-- 256 (350)
T d1rdqe_ 194 --RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ---IYEKIV----SGK------VR-- 256 (350)
T ss_dssp --CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH----HCC------CC--
T ss_pred --ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH---HHHHHh----cCC------CC--
Confidence 2234679999999999999999999999999999999999999997653321 111111 110 01
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 039107 721 DKISPECLKKFADTAEKCLSDSGIDRP-----SMGDVLWN 755 (817)
Q Consensus 721 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 755 (817)
.+...+..+.+++.+||+.||.+|+ |++++++|
T Consensus 257 --~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 257 --FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp --CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 1223445678999999999999994 89999875
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.7e-44 Score=392.32 Aligned_cols=249 Identities=21% Similarity=0.304 Sum_probs=198.8
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC---cccHHHHH---HHHHHHhccCccceeeEEEEEecCCeEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS---EQGVNEFV---TEIEMLSKLRHKHLVSLIGFCEEGNEMC 557 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~H~niv~l~g~~~~~~~~~ 557 (817)
++|...++||+|+||.||+|+.. ++..||||++.... ......+. .|+.+++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 46889999999999999999975 57899999975321 12223344 4477778889999999999999999999
Q ss_pred EEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCC
Q 039107 558 LVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPN 637 (817)
Q Consensus 558 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 637 (817)
+|||||++|+|.++|... ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+....
T Consensus 84 ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 999999999999998654 46889999999999999999999776 99999999999999999999999999986433
Q ss_pred CCCCceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccC
Q 039107 638 MENGHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIID 716 (817)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (817)
. ......||+.|+|||++.. ..++.++|||||||+||||++|+.||......+...+. .. . ..
T Consensus 160 ~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~---~~-~--------~~ 223 (364)
T d1omwa3 160 K----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RM-T--------LT 223 (364)
T ss_dssp S----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH---HH-S--------SS
T ss_pred C----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH---Hh-c--------cc
Confidence 2 2334579999999999975 56899999999999999999999999765443322111 00 0 00
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 039107 717 PLLKDKISPECLKKFADTAEKCLSDSGIDRPS-----MGDVLWN 755 (817)
Q Consensus 717 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 755 (817)
.....+...+.++.+|+.+||+.||.+||| ++|+++|
T Consensus 224 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 224 --MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp --CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred --CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 001112234456799999999999999999 6888876
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-44 Score=381.31 Aligned_cols=257 Identities=23% Similarity=0.251 Sum_probs=195.2
Q ss_pred ceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcc-----cHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEec
Q 039107 490 SYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQ-----GVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDYM 563 (817)
Q Consensus 490 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 563 (817)
.++||+|+||+||+|+.+ +++.||||+++..... ..+.+.+|+.+|++++|||||++++++...+..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 468999999999999965 5789999998654321 1356889999999999999999999999999999999999
Q ss_pred cCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCce
Q 039107 564 ALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGHV 643 (817)
Q Consensus 564 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 643 (817)
.++++..++. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 83 ~~~~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~--~~ 156 (299)
T d1ua2a_ 83 ETDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--RA 156 (299)
T ss_dssp SEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--CC
T ss_pred cchHHhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc--cc
Confidence 9887766553 4456999999999999999999999876 9999999999999999999999999998643322 22
Q ss_pred eeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhc--------
Q 039107 644 STVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDI-------- 714 (817)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~-------- 714 (817)
.....||+.|+|||++.. ..++.++|||||||++|||++|++||....+.+..... ............
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i---~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI---FETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHHHCCCCTTTSSSTTSSTT
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHH---HHhcCCCChhhccchhccch
Confidence 234579999999999865 46799999999999999999999999876544332111 111000000000
Q ss_pred -cCccccCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 715 -IDPLLKDKI-----SPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 715 -~d~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
..-...... .......+.+|+.+||+.||++|||++|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 000000000 11234568999999999999999999999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-44 Score=386.85 Aligned_cols=251 Identities=22% Similarity=0.308 Sum_probs=197.5
Q ss_pred cCCCcc-eeEeeeCceEEEEEEE-ecccEEEEEecCCCCcccHHHHHHHHHHHhcc-CccceeeEEEEEec----CCeEE
Q 039107 485 KSFDES-YVIGVGGFGKVYKGVI-EDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKL-RHKHLVSLIGFCEE----GNEMC 557 (817)
Q Consensus 485 ~~f~~~-~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~~~ 557 (817)
++|.+. ++||+|+||+||+|+. .+++.||||+++.. ..+.+|++++.++ +|||||++++++++ ...++
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 467765 4699999999999996 45789999998632 4677899987665 89999999999864 46689
Q ss_pred EEEEeccCCchhhhhhccc-cccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcC---CceeEEeeeccCc
Q 039107 558 LVYDYMALGTLREHIYNTK-KALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDE---NWVAKVSDFGLSK 633 (817)
Q Consensus 558 lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DFGla~ 633 (817)
+|||||++|+|.++|.... ..+++.++..|+.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+++
T Consensus 86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccceee
Confidence 9999999999999997653 47999999999999999999999776 999999999999985 5679999999998
Q ss_pred cCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhh
Q 039107 634 TGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDD 713 (817)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 713 (817)
..... .......||+.|+|||++.+..++.++|||||||+||||++|++||.+........ ........+.
T Consensus 163 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---~~~~~i~~~~--- 233 (335)
T d2ozaa1 163 ETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTRIRMGQ--- 233 (335)
T ss_dssp ECCCC---CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCS---
T ss_pred eccCC---CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH---HHHHHHhcCC---
Confidence 64332 22345679999999999999999999999999999999999999997654322111 0000000000
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 714 IIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 714 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
...........+.++.+|+.+||+.||++|||+.|+++|
T Consensus 234 ---~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 234 ---YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ---SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 001111112445678999999999999999999999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-44 Score=387.03 Aligned_cols=248 Identities=25% Similarity=0.348 Sum_probs=202.9
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC---CcccHHHHHHHHHHHh-ccCccceeeEEEEEecCCeEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS---SEQGVNEFVTEIEMLS-KLRHKHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lV 559 (817)
++|...+.||+|+||+||+|+.+ +++.||||+++.. .....+.+..|..++. .++|||||++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 46888999999999999999975 5788999998643 2334566777877765 58999999999999999999999
Q ss_pred EEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCC
Q 039107 560 YDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 560 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 639 (817)
||||++|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 82 mEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~- 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG- 156 (320)
T ss_dssp EECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-
T ss_pred EeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcccc-
Confidence 9999999999998654 45899999999999999999999876 999999999999999999999999999864322
Q ss_pred CCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhccCccc
Q 039107 640 NGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDIIDPLL 719 (817)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (817)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+... -+ ..+ .+.
T Consensus 157 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~---~i----~~~------~~~- 221 (320)
T d1xjda_ 157 -DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH---SI----RMD------NPF- 221 (320)
T ss_dssp -TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HH----HHC------CCC-
T ss_pred -cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHH---HH----HcC------CCC-
Confidence 223345679999999999999999999999999999999999999998654332111 01 111 111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHHH
Q 039107 720 KDKISPECLKKFADTAEKCLSDSGIDRPSMG-DVLWN 755 (817)
Q Consensus 720 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~~ 755 (817)
++..++.++.+|+.+||+.||.+||++. ++++|
T Consensus 222 ---~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 222 ---YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp ---CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred ---CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 1223445679999999999999999995 77654
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=379.19 Aligned_cols=266 Identities=21% Similarity=0.273 Sum_probs=200.2
Q ss_pred cCCCcceeEeeeCceEEEEEEE-ecccEEEEEecCCCC--cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVI-EDKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
.+|+..+.||+|+||+||+|+. .+++.||||+++... +...+++.+|+++|++++|||||++++++.+....++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 4688899999999999999997 467899999986543 2345789999999999999999999999999999999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
|+.++.+..........+++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++..... .
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~--~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--V 156 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC--S
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC--c
Confidence 99865554444444557999999999999999999999876 999999999999999999999999999764322 2
Q ss_pred ceeeeeecCcCCCChhhhccCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhc---cC-
Q 039107 642 HVSTVVKGSFGYLDPEYFKRQQ-LTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDI---ID- 716 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~-~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~---~d- 716 (817)
.......||+.|+|||.+.... ++.++|||||||++|||++|+.||.+....+......-......+...... .+
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence 2333457999999999877655 588999999999999999999999865433221110000000000000000 00
Q ss_pred -ccc----cCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 717 -PLL----KDK---ISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 717 -~~l----~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
... ... ........+.+|+.+||+.||++|||+.|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000 000 011233567899999999999999999999976
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.7e-43 Score=373.98 Aligned_cols=265 Identities=20% Similarity=0.240 Sum_probs=201.6
Q ss_pred cCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCC--cccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEEe
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 562 (817)
++|...++||+|+||+||+|+.++++.||||++.... +...+.+.+|+.+|++++||||+++++++...+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 4788899999999999999999888999999986543 33357899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCCc
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENGH 642 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 642 (817)
+.++.+..+. ...+.+++.++..++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||++...... ..
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~--~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP--VR 155 (286)
T ss_dssp CSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred ehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC--cc
Confidence 9877666654 44467999999999999999999999765 999999999999999999999999999764322 12
Q ss_pred eeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCch---hh-----
Q 039107 643 VSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGIL---DD----- 713 (817)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~---~~----- 713 (817)
......|++.|+|||.+.. ..++.++|||||||+++||++|+.||......+................. ..
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence 2334468999999999875 45699999999999999999999999765443322111110000000000 00
Q ss_pred ----ccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 714 ----IIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 714 ----~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
...+.............+.+++.+||+.||++|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000111122334568899999999999999999999865
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=379.26 Aligned_cols=266 Identities=22% Similarity=0.281 Sum_probs=200.3
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-c-ccEEEEEecCCC--CcccHHHHHHHHHHHhcc---CccceeeEEEEEec----
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-D-KLKVAIKRSNPS--SEQGVNEFVTEIEMLSKL---RHKHLVSLIGFCEE---- 552 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~---- 552 (817)
.++|+..+.||+|+||+||+|+.. + ++.||||++... .......+.+|+.+|+.| +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999974 3 567999987542 222234566788777766 79999999999853
Q ss_pred -CCeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeecc
Q 039107 553 -GNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGL 631 (817)
Q Consensus 553 -~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGl 631 (817)
....+++|||++++++..........+++..+..++.|++.||+|||+++ ||||||||+|||+++++.+||+|||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhh
Confidence 35689999999988877666555667999999999999999999999776 99999999999999999999999999
Q ss_pred CccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhc----
Q 039107 632 SKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKR---- 707 (817)
Q Consensus 632 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~---- 707 (817)
++.... ........||+.|+|||++.+..++.++||||+||++|||++|++||......+.............
T Consensus 163 ~~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 163 ARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhhcc---cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 876322 2334456799999999999999999999999999999999999999987654332221111000000
Q ss_pred --cCch-hhccC---ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 708 --KGIL-DDIID---PLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 708 --~~~~-~~~~d---~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.... ..... ..............+.+|+.+||+.||++|||++|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 00000 000111122334567899999999999999999999876
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-44 Score=374.71 Aligned_cols=240 Identities=23% Similarity=0.404 Sum_probs=194.3
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCc------ccHHHHHHHHHHHhccC--ccceeeEEEEEecCCe
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSE------QGVNEFVTEIEMLSKLR--HKHLVSLIGFCEEGNE 555 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~ 555 (817)
++|...++||+|+||+||+|+.. +++.||||++..... ....++.+|+.+|++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57889999999999999999965 678999998764211 11234678999999996 8999999999999999
Q ss_pred EEEEEEeccC-CchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcC-CceeEEeeeccCc
Q 039107 556 MCLVYDYMAL-GTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDE-NWVAKVSDFGLSK 633 (817)
Q Consensus 556 ~~lV~Ey~~~-gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DFGla~ 633 (817)
.++||||+.+ +++.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+++
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccce
Confidence 9999999976 577777654 346999999999999999999999876 999999999999985 4799999999998
Q ss_pred cCCCCCCCceeeeeecCcCCCChhhhccCCC-CchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchh
Q 039107 634 TGPNMENGHVSTVVKGSFGYLDPEYFKRQQL-TEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILD 712 (817)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 712 (817)
.... .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... +. + +
T Consensus 160 ~~~~----~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---------i~---~-~--- 219 (273)
T d1xwsa_ 160 LLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------II---R-G--- 219 (273)
T ss_dssp ECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------HH---H-C---
T ss_pred eccc----ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH---------Hh---h-c---
Confidence 6432 22345679999999999987765 5779999999999999999999964210 00 0 0
Q ss_pred hccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 713 DIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 713 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
....... .+.++.+++.+||+.||++|||++|+++|
T Consensus 220 ---~~~~~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 220 ---QVFFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ---CCCCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---ccCCCCC----CCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0111222 34567899999999999999999999876
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.9e-41 Score=360.60 Aligned_cols=265 Identities=17% Similarity=0.174 Sum_probs=211.4
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCc-cceeeEEEEEecCCeEEEEEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRH-KHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 561 (817)
.++|.+.++||+|+||+||+|+.. +++.||||.+..... ...+.+|++.++.|+| +|++.+++++......++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 357889999999999999999965 578899998754432 2457789999999965 899999999999999999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcC-----CceeEEeeeccCccCC
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDE-----NWVAKVSDFGLSKTGP 636 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~-----~~~~kl~DFGla~~~~ 636 (817)
|+ +++|.+++......+++.++..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+++...
T Consensus 82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99 58999998777778999999999999999999999765 999999999999974 5789999999998654
Q ss_pred CCCCC-----ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCch
Q 039107 637 NMENG-----HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGIL 711 (817)
Q Consensus 637 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 711 (817)
..... .......||+.|||||++.+..++.++|||||||++|||++|+.||.+............+.........
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence 32211 2234567999999999999999999999999999999999999999865544332222222221111111
Q ss_pred hhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 039107 712 DDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQLV 763 (817)
Q Consensus 712 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 763 (817)
.+ +. ..++.++.+++..|+..+|++||+++.+.+.|+++++..
T Consensus 238 ~~-----l~----~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 238 RE-----LC----AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp HH-----HT----TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HH-----hc----CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 11 11 123456889999999999999999999999998887544
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-41 Score=360.43 Aligned_cols=263 Identities=19% Similarity=0.212 Sum_probs=200.5
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCcccee-eEEEEEecCCeEEEEEEe
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLV-SLIGFCEEGNEMCLVYDY 562 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey 562 (817)
++|+..+.||+|+||+||+|+.. +++.||||.+..... .+++..|++++++++|+|++ .+.++..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 46889999999999999999964 578999998765433 24678999999999876655 555566788889999999
Q ss_pred ccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcC---CceeEEeeeccCccCCCCC
Q 039107 563 MALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDE---NWVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 563 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DFGla~~~~~~~ 639 (817)
++ ++|.+.+....+.+++..++.++.|++.||+|||+++ ||||||||+|||++. +..+||+|||+++......
T Consensus 85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 85 LG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp CC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred cC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 95 5666666666668999999999999999999999876 999999999999863 5679999999998654322
Q ss_pred CC-----ceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhhc
Q 039107 640 NG-----HVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDDI 714 (817)
Q Consensus 640 ~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 714 (817)
.. .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........................
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~--- 237 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI--- 237 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH---
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh---
Confidence 21 2234567999999999999999999999999999999999999999765443322211111110000000
Q ss_pred cCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 039107 715 IDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNLEFVLQL 762 (817)
Q Consensus 715 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 762 (817)
+.+ ...++.++.+++.+|++.+|++||+++++.+.|+.+...
T Consensus 238 --~~~----~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 238 --EVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp --HHH----TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred --hHh----ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 011 123345689999999999999999999999988887643
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-41 Score=364.20 Aligned_cols=268 Identities=22% Similarity=0.290 Sum_probs=196.9
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEec--------C
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE--------G 553 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------~ 553 (817)
.+|+..+.||+|+||+||+|+.. +++.||||++... .+...+++.+|+++|++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 57888999999999999999974 6789999987543 33345778999999999999999999998854 3
Q ss_pred CeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCc
Q 039107 554 NEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSK 633 (817)
Q Consensus 554 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 633 (817)
...++||||++++.+.... .....++...+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 90 ~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp -CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ceEEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceee
Confidence 4689999999987766544 34456888999999999999999999776 9999999999999999999999999997
Q ss_pred cCCCCCC--CceeeeeecCcCCCChhhhccC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCc
Q 039107 634 TGPNMEN--GHVSTVVKGSFGYLDPEYFKRQ-QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGI 710 (817)
Q Consensus 634 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 710 (817)
....... ........||+.|+|||++.+. .++.++|||||||++|||++|++||.+..+..................
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 5433221 1222335699999999998765 689999999999999999999999976544332222111110000000
Q ss_pred hhhccCccc---------cCCCCH------HHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 711 LDDIIDPLL---------KDKISP------ECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 711 ~~~~~d~~l---------~~~~~~------~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
......... ...... .....+.+|+.+||+.||++|||++|+++|-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hp 306 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcCh
Confidence 000000000 000000 1134567899999999999999999999764
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=370.42 Aligned_cols=260 Identities=25% Similarity=0.245 Sum_probs=193.4
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccCccceeeEEEEEec------CCeEEE
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE------GNEMCL 558 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~~~l 558 (817)
+|...++||+|+||+||+|+.. +++.||||++..... .+.+|+++|++++||||+++++++.. ...++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5778889999999999999975 578999999875432 23479999999999999999999853 234789
Q ss_pred EEEeccCCchhhhhh--ccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCc-eeEEeeeccCccC
Q 039107 559 VYDYMALGTLREHIY--NTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENW-VAKVSDFGLSKTG 635 (817)
Q Consensus 559 V~Ey~~~gsL~~~l~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DFGla~~~ 635 (817)
|||||+++.+..+.. .....+++.++..++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 999998765444432 23347999999999999999999999765 99999999999999775 8999999999864
Q ss_pred CCCCCCceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHH---------HHHHh
Q 039107 636 PNMENGHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLAD---------WALHC 705 (817)
Q Consensus 636 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~---------~~~~~ 705 (817)
.... ......||..|+|||.+.+ ..++.++||||+||++|||++|++||......+...... +....
T Consensus 174 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 174 VRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 3322 2334579999999998765 578999999999999999999999997665433221111 00000
Q ss_pred hcc---CchhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 706 KRK---GILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 706 ~~~---~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
... ......................+.+|+.+||..||++|||+.|+++|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 00000000000111122344568899999999999999999999976
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-41 Score=368.02 Aligned_cols=260 Identities=23% Similarity=0.304 Sum_probs=193.5
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecCC------
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGN------ 554 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 554 (817)
.++|+..++||+|+||+||+|... +++.||||+++.. ++...+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 457888999999999999999965 5789999998754 3334567899999999999999999999997654
Q ss_pred eEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 555 EMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 555 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
.+++||||+ +.+|..++. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 97 ~~~lv~e~~-~~~l~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecc-cccHHHHHH--hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceec
Confidence 579999999 457777653 346999999999999999999999876 99999999999999999999999999986
Q ss_pred CCCCCCCceeeeeecCcCCCChhhhcc-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHh--------
Q 039107 635 GPNMENGHVSTVVKGSFGYLDPEYFKR-QQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHC-------- 705 (817)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~-------- 705 (817)
... ..+...||+.|+|||.+.+ ..++.++||||+||++|||++|++||..................
T Consensus 171 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 171 ADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp CCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred cCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence 432 2234579999999999876 45789999999999999999999999876443322111110000
Q ss_pred hccC-------chhhccCccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 706 KRKG-------ILDDIIDPLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 706 ~~~~-------~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.... .+.+.....+ ..........+.+|+.+||..||.+|||++|+++|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 246 LQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp CSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 0000000000 01112234567899999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-41 Score=367.13 Aligned_cols=267 Identities=22% Similarity=0.308 Sum_probs=196.1
Q ss_pred hcCCCcceeEeeeCceEEEEEEE-ecccEEEEEecCCCC-cccHHHHHHHHHHHhccCccceeeEEEEEecCC----eEE
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVI-EDKLKVAIKRSNPSS-EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGN----EMC 557 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~ 557 (817)
+.+|...++||+|+||+||+|+. .+++.||||++.... ....+.+.+|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45688899999999999999986 467899999987543 334567899999999999999999999986543 235
Q ss_pred EEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCC
Q 039107 558 LVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPN 637 (817)
Q Consensus 558 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 637 (817)
++++|+.+|+|.+++.. +.+++..++.++.|++.||+|||+++ ||||||||+||||+.++.+||+|||+++....
T Consensus 87 ~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 55566778999999853 36999999999999999999999876 99999999999999999999999999976432
Q ss_pred CCC-CceeeeeecCcCCCChhhhc-cCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCc-----
Q 039107 638 MEN-GHVSTVVKGSFGYLDPEYFK-RQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGI----- 710 (817)
Q Consensus 638 ~~~-~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~----- 710 (817)
... ........||+.|+|||.+. ...++.++||||+||+++||++|+.||......+................
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence 211 11234456999999999985 45678999999999999999999999976654332221111100000000
Q ss_pred ---hhh-c-cCccccC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 711 ---LDD-I-IDPLLKD----KISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 711 ---~~~-~-~d~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
... . ..+.... ...+....++.+|+.+||+.||.+|||+.|+++|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 0 0000000 0011223467899999999999999999999976
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-40 Score=351.82 Aligned_cols=265 Identities=20% Similarity=0.265 Sum_probs=202.5
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEecCCeEEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 561 (817)
++|+..+.||+|+||+||+|+.. +++.||||+++.. .....+.+.+|+.+|++++||||+++++++......++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 47889999999999999999964 6688999997543 33446789999999999999999999999999999999999
Q ss_pred eccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccCCCCCCC
Q 039107 562 YMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMENG 641 (817)
Q Consensus 562 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 641 (817)
++.+++|..++.. .+.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~-- 155 (292)
T d1unla_ 82 FCDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-- 155 (292)
T ss_dssp CCSEEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC--
T ss_pred ecccccccccccc-ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC--
Confidence 9999998887654 456899999999999999999999876 9999999999999999999999999998653322
Q ss_pred ceeeeeecCcCCCChhhhccCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCccc-cchHHHHHHHhhccCc---hhhccC
Q 039107 642 HVSTVVKGSFGYLDPEYFKRQQ-LTEKSDIYSFGVVLFEVLCARPALNPSLPKE-QVSLADWALHCKRKGI---LDDIID 716 (817)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~-~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~-~~~l~~~~~~~~~~~~---~~~~~d 716 (817)
.......++..|+|||.+.... ++.++|||||||+++||++|+.||....... ................ .....+
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
T d1unla_ 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence 2223345788999999987654 6999999999999999999999875433222 1111110000000000 000000
Q ss_pred ---------ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 717 ---------PLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 717 ---------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
..............+.+|+.+||+.||.+|||++||++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000111222344568899999999999999999999875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.9e-40 Score=356.50 Aligned_cols=258 Identities=17% Similarity=0.246 Sum_probs=197.1
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccC-ccceeeEEEEEec--CCeEEEEE
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLR-HKHLVSLIGFCEE--GNEMCLVY 560 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~lV~ 560 (817)
++|+..++||+|+||+||+|+.. +++.||||+++... .+++.+|+++|++++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 47999999999999999999974 57889999987543 467889999999995 9999999999874 45689999
Q ss_pred EeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCC-ceeEEeeeccCccCCCCC
Q 039107 561 DYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDEN-WVAKVSDFGLSKTGPNME 639 (817)
Q Consensus 561 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DFGla~~~~~~~ 639 (817)
|||++++|..+. +.+++..+..++.||+.||+|||+++ |+||||||+|||++.+ ..+||+|||+++.....
T Consensus 112 e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~- 183 (328)
T d3bqca1 112 EHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG- 183 (328)
T ss_dssp ECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTT-
T ss_pred eecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCC-
Confidence 999999998764 35899999999999999999999876 9999999999999865 57999999999864332
Q ss_pred CCceeeeeecCcCCCChhhhccC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccch-H----------HHHHHHhhc
Q 039107 640 NGHVSTVVKGSFGYLDPEYFKRQ-QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVS-L----------ADWALHCKR 707 (817)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l----------~~~~~~~~~ 707 (817)
.......+|+.|+|||.+.+. .++.++||||+||+++||++|+.||.......... . ..|......
T Consensus 184 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 184 --QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp --CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred --CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 223445689999999998765 57999999999999999999999997654332110 0 011111000
Q ss_pred cC--chhhccC--------ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 708 KG--ILDDIID--------PLLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 708 ~~--~~~~~~d--------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.. ....... .............++.+|+.+||..||.+|||++|+++|
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0000000 001111112334567899999999999999999999875
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-40 Score=357.79 Aligned_cols=253 Identities=23% Similarity=0.275 Sum_probs=200.8
Q ss_pred cCCCcceeEeeeCceEEEEEEEe----cccEEEEEecCCCC----cccHHHHHHHHHHHhccCc-cceeeEEEEEecCCe
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE----DKLKVAIKRSNPSS----EQGVNEFVTEIEMLSKLRH-KHLVSLIGFCEEGNE 555 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~ 555 (817)
.+|+..+.||+|+||+||+|+.. +++.||||.++... ....+.+.+|+++|++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 45888999999999999999852 36789999986432 2334678899999999976 899999999999999
Q ss_pred EEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccC
Q 039107 556 MCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTG 635 (817)
Q Consensus 556 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 635 (817)
.++||||+.+|+|.+++.... .++...+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhh
Confidence 999999999999999986544 4778889999999999999999776 999999999999999999999999999764
Q ss_pred CCCCCCceeeeeecCcCCCChhhhccC--CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhhccCchhh
Q 039107 636 PNMENGHVSTVVKGSFGYLDPEYFKRQ--QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCKRKGILDD 713 (817)
Q Consensus 636 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 713 (817)
.... ........|++.|+|||.+... .++.++|||||||+||||++|+.||......+..... ..... ..
T Consensus 180 ~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i--~~~~~-~~---- 251 (322)
T d1vzoa_ 180 VADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRIL-KS---- 251 (322)
T ss_dssp CGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH--HHHHH-HC----
T ss_pred cccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHhcc-cC----
Confidence 3222 2223445799999999999754 4688999999999999999999999776544322111 00000 00
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 039107 714 IIDPLLKDKISPECLKKFADTAEKCLSDSGIDRP-----SMGDVLWN 755 (817)
Q Consensus 714 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 755 (817)
...++...+.++.+++.+||+.||++|| |++|+++|
T Consensus 252 ------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 252 ------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 1112334566789999999999999999 47888865
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-40 Score=358.23 Aligned_cols=262 Identities=21% Similarity=0.242 Sum_probs=192.1
Q ss_pred cCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCC--CcccHHHHHHHHHHHhccCccceeeEEEEEec------CCe
Q 039107 485 KSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPS--SEQGVNEFVTEIEMLSKLRHKHLVSLIGFCEE------GNE 555 (817)
Q Consensus 485 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~ 555 (817)
++|++.++||+|+||+||+|+.. +++.||||++... +....+.+.+|+.+|++++||||+++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999999999999975 5789999998644 33445678899999999999999999999853 467
Q ss_pred EEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccC
Q 039107 556 MCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTG 635 (817)
Q Consensus 556 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 635 (817)
+|+|||||.++.+.. +. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+++..
T Consensus 97 ~~iv~Ey~~~~l~~~-~~---~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 97 VYLVMELMDANLCQV-IQ---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEECCSEEHHHH-HT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eEEEEeccchHHHHh-hh---cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhcc
Confidence 899999998655543 32 35899999999999999999999876 999999999999999999999999998864
Q ss_pred CCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHH---------H-H----
Q 039107 636 PNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLA---------D-W---- 701 (817)
Q Consensus 636 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~---------~-~---- 701 (817)
.. ........||+.|+|||++.+..++.++||||+||+++||++|++||.+.......... + |
T Consensus 170 ~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 170 GT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred cc---ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 32 23344567899999999999999999999999999999999999999765433221110 0 0
Q ss_pred --HH-HhhccC-----chhhccCccccCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 039107 702 --AL-HCKRKG-----ILDDIIDPLLKDK---ISPECLKKFADTAEKCLSDSGIDRPSMGDVLWNL 756 (817)
Q Consensus 702 --~~-~~~~~~-----~~~~~~d~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 756 (817)
.. ...... ............. ........+.+|+.+||+.||++|||++||++|-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hp 312 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCc
Confidence 00 000000 0011111111111 1224567789999999999999999999999873
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-40 Score=358.83 Aligned_cols=262 Identities=21% Similarity=0.275 Sum_probs=194.7
Q ss_pred hcCCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCC--cccHHHHHHHHHHHhccCccceeeEEEEEecC-----Ce
Q 039107 484 TKSFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSS--EQGVNEFVTEIEMLSKLRHKHLVSLIGFCEEG-----NE 555 (817)
Q Consensus 484 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 555 (817)
.++|+..++||+|+||+||+|+.. +++.||||++.... ....+.+.+|+++|++++|||+|++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 457899999999999999999964 67899999987543 33456788999999999999999999998532 34
Q ss_pred EEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeeeccCccC
Q 039107 556 MCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTG 635 (817)
Q Consensus 556 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 635 (817)
.+++++|+.+|+|.+++.. +.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++...
T Consensus 97 ~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred eEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhccc
Confidence 5677788889999998853 46999999999999999999999876 999999999999999999999999998753
Q ss_pred CCCCCCceeeeeecCcCCCChhhhccC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCccccchHHHHHHHhh--------
Q 039107 636 PNMENGHVSTVVKGSFGYLDPEYFKRQ-QLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCK-------- 706 (817)
Q Consensus 636 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~-------- 706 (817)
. .......||..|+|||.+.+. .++.++|||||||++|||++|++||.+.................
T Consensus 172 ~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (348)
T d2gfsa1 172 D-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246 (348)
T ss_dssp T-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred C-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence 2 223345689999999987665 56899999999999999999999998664333221110000000
Q ss_pred ccCchhhccCcccc-CCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 039107 707 RKGILDDIIDPLLK-DKI-----SPECLKKFADTAEKCLSDSGIDRPSMGDVLWN 755 (817)
Q Consensus 707 ~~~~~~~~~d~~l~-~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 755 (817)
.............. ... .......+.+|+.+||+.||.+|||++|+++|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 00000000000000 000 01234567899999999999999999999976
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4e-35 Score=321.43 Aligned_cols=262 Identities=19% Similarity=0.209 Sum_probs=188.9
Q ss_pred CCCcceeEeeeCceEEEEEEEe-cccEEEEEecCCCCcccHHHHHHHHHHHhccC-----------ccceeeEEEEEec-
Q 039107 486 SFDESYVIGVGGFGKVYKGVIE-DKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLR-----------HKHLVSLIGFCEE- 552 (817)
Q Consensus 486 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~~- 552 (817)
+|+..++||+|+||+||+|+.. +++.||||+++... ...+.+.+|+.++++++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 4888999999999999999974 67899999987543 23467788999988875 5789999998754
Q ss_pred -CCeEEEEEEeccCCchhhhh--hccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCc------e
Q 039107 553 -GNEMCLVYDYMALGTLREHI--YNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENW------V 623 (817)
Q Consensus 553 -~~~~~lV~Ey~~~gsL~~~l--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~------~ 623 (817)
....+++++++..+...... ......+++..+..++.||+.||+|||+. .+|+||||||+||||+.++ .
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCcccccce
Confidence 35567777776655433322 22334788899999999999999999972 3599999999999998654 4
Q ss_pred eEEeeeccCccCCCCCCCceeeeeecCcCCCChhhhccCCCCchHHHHHHHHHHHHHHhCCCCCCCCCccccch----HH
Q 039107 624 AKVSDFGLSKTGPNMENGHVSTVVKGSFGYLDPEYFKRQQLTEKSDIYSFGVVLFEVLCARPALNPSLPKEQVS----LA 699 (817)
Q Consensus 624 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~----l~ 699 (817)
+|++|||.+..... ......||+.|+|||.+....++.++||||+||+++||++|+.||.......... +.
T Consensus 171 ~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 171 IKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 99999999875332 1234569999999999999999999999999999999999999997653321111 11
Q ss_pred HHHHHh-------h-ccCchhhccC---------c----------cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 039107 700 DWALHC-------K-RKGILDDIID---------P----------LLKDKISPECLKKFADTAEKCLSDSGIDRPSMGDV 752 (817)
Q Consensus 700 ~~~~~~-------~-~~~~~~~~~d---------~----------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev 752 (817)
...... . .........+ . .............+.+|+.+||+.||.+|||++|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 111000 0 0000000000 0 01123346677889999999999999999999999
Q ss_pred HHH
Q 039107 753 LWN 755 (817)
Q Consensus 753 l~~ 755 (817)
++|
T Consensus 326 L~H 328 (362)
T d1q8ya_ 326 VNH 328 (362)
T ss_dssp HTC
T ss_pred hcC
Confidence 875
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=4.3e-22 Score=196.50 Aligned_cols=164 Identities=15% Similarity=0.113 Sum_probs=120.7
Q ss_pred CcceeEeeeCceEEEEEEEecccEEEEEecCCCCc------------------ccHHHHHHHHHHHhccCccceeeEEEE
Q 039107 488 DESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSE------------------QGVNEFVTEIEMLSKLRHKHLVSLIGF 549 (817)
Q Consensus 488 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~niv~l~g~ 549 (817)
...++||+|+||+||+|+..++..||||.++.... .....+..|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 35679999999999999988889999998653210 011334568889999999999998876
Q ss_pred EecCCeEEEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHhCCCCceEecCCccCcEEEcCCceeEEeee
Q 039107 550 CEEGNEMCLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDF 629 (817)
Q Consensus 550 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DF 629 (817)
.. .+++|||+++..+.+ ++......++.|++++|+|||+.+ |+||||||+|||++++ .++|+||
T Consensus 83 ~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp ET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECCC
T ss_pred cC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEEC
Confidence 42 379999999765533 455667789999999999999776 9999999999999976 5899999
Q ss_pred ccCccCCCCCCCceeeeeecCcCCCC------hhhhccCCCCchHHHHHHHHHHH
Q 039107 630 GLSKTGPNMENGHVSTVVKGSFGYLD------PEYFKRQQLTEKSDIYSFGVVLF 678 (817)
Q Consensus 630 Gla~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~s~~sDV~S~Gvvl~ 678 (817)
|+|........ ..|.. .|. ..+.|+.++|+||..--++
T Consensus 147 G~a~~~~~~~~----------~~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 147 PQSVEVGEEGW----------REILERDVRNIITY-FSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp TTCEETTSTTH----------HHHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred CCcccCCCCCc----------HHHHHHHHHHHHHH-HcCCCCCcccHHHHHHHHh
Confidence 99875322111 01111 111 2356788899999765443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.54 E-value=1.8e-07 Score=94.69 Aligned_cols=150 Identities=17% Similarity=0.124 Sum_probs=100.9
Q ss_pred HHHHHhhcCCCcceeEeeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccC-ccceeeEEEEEecCCeE
Q 039107 478 AEIKHATKSFDESYVIGVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLR-HKHLVSLIGFCEEGNEM 556 (817)
Q Consensus 478 ~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~ 556 (817)
.|++..-..|...+..+.++.+.||+... ++..+++|+...........+.+|...+..+. +--+.+++.++...+..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 35555556666554433344568998764 34568888877554444456778998888774 44467888888888889
Q ss_pred EEEEEeccCCchhhhhhccccccchHhHHHHHHHHHHHHHHHHh------------------------------------
Q 039107 557 CLVYDYMALGTLREHIYNTKKALSWKQRLEICIGAARGLHYLHT------------------------------------ 600 (817)
Q Consensus 557 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~------------------------------------ 600 (817)
++||+++++..+.+.... ......++.++++.|+.||+
T Consensus 86 ~lv~~~l~G~~~~~~~~~------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEECCSSEEHHHHTTT------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred EEEEEecccccccccccc------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 999999998877654321 11223344445555555553
Q ss_pred --------------------CCCCceEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 601 --------------------GAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 601 --------------------~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
.....++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1123489999999999999887778999997753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.01 E-value=1.9e-05 Score=78.83 Aligned_cols=139 Identities=16% Similarity=0.174 Sum_probs=86.8
Q ss_pred EeeeCc-eEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCc--cceeeEEEEEecCCeEEEEEEeccCCchh
Q 039107 493 IGVGGF-GKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRH--KHLVSLIGFCEEGNEMCLVYDYMALGTLR 569 (817)
Q Consensus 493 lG~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 569 (817)
+..|.. +.||+...+++..+++|....... ..+..|...|+.+.. -.+.++++++.+.+..++||+++++.++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 444443 678999888888899998765533 346678888877743 33677888888888899999999987765
Q ss_pred hhhh-----------------cc---ccccchH--hHHH-----H---------------HHHHHHHHHHHHhC----CC
Q 039107 570 EHIY-----------------NT---KKALSWK--QRLE-----I---------------CIGAARGLHYLHTG----AK 603 (817)
Q Consensus 570 ~~l~-----------------~~---~~~l~~~--~~~~-----i---------------~~~ia~gL~yLH~~----~~ 603 (817)
+... .. ...+.+. .... + .......+..|... ..
T Consensus 95 ~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 174 (255)
T d1nd4a_ 95 SSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGED 174 (255)
T ss_dssp TSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCC
T ss_pred cccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCC
Confidence 4210 00 0000000 0000 0 00011223333322 23
Q ss_pred CceEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 604 YTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 604 ~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
..++|+|+.|.|||++++..+-|+||+.+..
T Consensus 175 ~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 175 LVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp EEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 4589999999999999887778999997643
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.32 E-value=0.0004 Score=73.81 Aligned_cols=75 Identities=15% Similarity=0.089 Sum_probs=49.1
Q ss_pred eeEeeeCceEEEEEEEec-ccEEEEEecCCC-------CcccHHHHHHHHHHHhccC-c--cceeeEEEEEecCCeEEEE
Q 039107 491 YVIGVGGFGKVYKGVIED-KLKVAIKRSNPS-------SEQGVNEFVTEIEMLSKLR-H--KHLVSLIGFCEEGNEMCLV 559 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-H--~niv~l~g~~~~~~~~~lV 559 (817)
+.||.|..-.||+....+ +..++||...+. -.....+...|.+.|+.+. + ..+.+++.+. .+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEEE
Confidence 368999999999998654 568999964431 1122345567888887762 2 4566677654 3456899
Q ss_pred EEeccCCc
Q 039107 560 YDYMALGT 567 (817)
Q Consensus 560 ~Ey~~~gs 567 (817)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99998654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.63 E-value=0.0029 Score=64.95 Aligned_cols=134 Identities=11% Similarity=0.151 Sum_probs=79.3
Q ss_pred ceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCcccee--eEEE-----EEecCCeEEEEEEeccCCchhh
Q 039107 498 FGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLV--SLIG-----FCEEGNEMCLVYDYMALGTLRE 570 (817)
Q Consensus 498 fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv--~l~g-----~~~~~~~~~lV~Ey~~~gsL~~ 570 (817)
-=.||+...++|..+++|...+.. ...+++..|...+..|...++. ..+. ........+.++++++|..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 347999999999999999987542 2346778899888887533221 1111 2234566788999998654421
Q ss_pred h----h----------hc--------cccccch-------------------HhHHHHHHHHHHHHHHHH----hCCCCc
Q 039107 571 H----I----------YN--------TKKALSW-------------------KQRLEICIGAARGLHYLH----TGAKYT 605 (817)
Q Consensus 571 ~----l----------~~--------~~~~l~~-------------------~~~~~i~~~ia~gL~yLH----~~~~~~ 605 (817)
. + +. .+..+++ ..+..+...+.+.++.+. +....+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 0 0 10 0001111 111122222223333332 222457
Q ss_pred eEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 606 IIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 606 ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
+||+|+.+.|||++++ ..++||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999854 35899998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.62 E-value=0.0044 Score=65.43 Aligned_cols=73 Identities=15% Similarity=0.127 Sum_probs=50.1
Q ss_pred eeEeeeCceEEEEEEEecc--------cEEEEEecCCCCcccHHHHHHHHHHHhccC-ccceeeEEEEEecCCeEEEEEE
Q 039107 491 YVIGVGGFGKVYKGVIEDK--------LKVAIKRSNPSSEQGVNEFVTEIEMLSKLR-HKHLVSLIGFCEEGNEMCLVYD 561 (817)
Q Consensus 491 ~~lG~G~fg~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 561 (817)
+.|+.|-.=.+|+....++ ..|++++.. .. .......+|..+++.+. +.-..++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 4677788888999987543 346666654 22 23345668999999885 4334578888753 68999
Q ss_pred eccCCchh
Q 039107 562 YMALGTLR 569 (817)
Q Consensus 562 y~~~gsL~ 569 (817)
|+++..|.
T Consensus 122 fi~g~~l~ 129 (395)
T d1nw1a_ 122 YIPSRPLS 129 (395)
T ss_dssp CCCEEECC
T ss_pred EeccccCC
Confidence 99876554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.37 E-value=0.012 Score=59.78 Aligned_cols=157 Identities=13% Similarity=0.056 Sum_probs=86.3
Q ss_pred cCHHHHHHhhcCCCcceeE-----eeeCceEEEEEEEecccEEEEEecCCCCcccHHHHHHHHHHHhccCcccee--eEE
Q 039107 475 FSLAEIKHATKSFDESYVI-----GVGGFGKVYKGVIEDKLKVAIKRSNPSSEQGVNEFVTEIEMLSKLRHKHLV--SLI 547 (817)
Q Consensus 475 f~~~el~~~~~~f~~~~~l-----G~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv--~l~ 547 (817)
.+.+|+.....+|...++. ..|---+.|+.+.+++ ++++|+...... .+++..|+++|..|.+.++. ..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccc
Confidence 4567788888888765443 3455567899887766 589998764322 23455577777777432221 111
Q ss_pred E------EEecCCeEEEEEEeccCCchhhhh--------------hcc------c---c-----------------ccch
Q 039107 548 G------FCEEGNEMCLVYDYMALGTLREHI--------------YNT------K---K-----------------ALSW 581 (817)
Q Consensus 548 g------~~~~~~~~~lV~Ey~~~gsL~~~l--------------~~~------~---~-----------------~l~~ 581 (817)
. +.........++.++.+......- +.. . . ....
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 1 112234566677777654332110 000 0 0 0011
Q ss_pred HhHHHHHHHHHHHHHHHHh-CCCCceEecCCccCcEEEcCCceeEEeeeccCcc
Q 039107 582 KQRLEICIGAARGLHYLHT-GAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKT 634 (817)
Q Consensus 582 ~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 634 (817)
......+..+...+.-.+. ....++||+|+.+.||+++++...-|+||+.+..
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 1122233333333333332 2345799999999999999998778999998753
|
| >d2o14a1 b.18.1.32 (A:14-159) Hypothetical protein YxiM {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Galactose-binding domain-like superfamily: Galactose-binding domain-like family: YxiM N-terminal domain-like domain: Hypothetical protein YxiM species: Bacillus subtilis [TaxId: 1423]
Probab=93.43 E-value=0.12 Score=45.53 Aligned_cols=80 Identities=15% Similarity=0.248 Sum_probs=55.7
Q ss_pred eeEEEeccCCCeEEEEEEeccCCCCCCCcccceeEEEeCCeEEEeccCcchhhhcccceeEEEEEEecCCCCCcEEEEEe
Q 039107 55 MSYELPIRSQSRYWVRFHFYPSTYPELNVANSYFSVVANDVTLLSNFSASITAQAVAQAYLIKEFSLAPMDSDILKIIFR 134 (817)
Q Consensus 55 ~~Y~~~~~~~~~y~vR~~f~~~~~~~~~~~~~~f~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~f~ 134 (817)
..|.+++ +.|.|.|+++|..- ....|-+.+...+.++-.. +.-+.|.|+ ...+.|.|.|+
T Consensus 65 ~~f~v~v-PnG~Y~Vtv~~Gd~---------~~~~~~~eg~~~~~~~~g~---------~~~~~~~V~-VtDG~L~l~ft 124 (146)
T d2o14a1 65 NTFNVDL-PNGLYEVKVTLGNT---------ARASVAAEGVFQVINMTGD---------GAEDTFQIP-VTDGQLNLLVT 124 (146)
T ss_dssp CCEEEEC-CSEEEEEEEEESSC---------SEEEEEETTEEEEEEEEST---------TCEEEEEEE-ECSSEEEEEEE
T ss_pred ceEEEEC-CCCeEEEEEEEecC---------CCccEEEeeEEeccccCCc---------cEEEEEEEE-EECCeEEEEEe
Confidence 4588888 68899999999861 1235677777777765221 223334443 56789999987
Q ss_pred eCCCCCCcceeEeeeeeecCCc
Q 039107 135 PSDKHSGTFAFINGIELVPSPD 156 (817)
Q Consensus 135 p~~~~~~~~~fi~~iEl~~~~~ 156 (817)
.. ..|+.|-||+|||.+.+|
T Consensus 125 ~~--~~G~~~~in~l~I~~~~d 144 (146)
T d2o14a1 125 EG--KAGTAFTLSALKIKKLSD 144 (146)
T ss_dssp ES--STTSCCEEEEEEEEEEES
T ss_pred cC--CCCCccEEEEEEEEeccc
Confidence 54 335679999999998765
|